$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (3aR,4Z,10aS)-1-[(1,1-dimethylethoxy)carbonyl]-2,3,3a,6,7,8,10,10a-oct...
C18H28N2O5
1000049-15-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.8736 3.8500 0.0 0
M  V30 2 O 1.5400 3.0800 0.0 0
M  V30 3 O 4.2073 3.0800 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 0.0000 1.5400 0.0 0
M  V30 6 C 1.5400 0.0000 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 O 5.1053 3.9727 0.0 0
M  V30 9 C 7.6735 4.3336 0.0 0
M  V30 10 C 9.2126 4.2798 0.0 0
M  V30 11 O 9.9356 2.9201 0.0 0
M  V30 12 O 10.0286 5.5859 0.0 0
M  V30 13 C 11.4745 2.8664 0.0 0
M  V30 14 C 4.1195 6.2951 0.0 0 CFG=2
M  V30 15 N 2.8736 5.3900 0.0 0
M  V30 16 C 3.6436 7.7598 0.0 0 CFG=1
M  V30 17 C 5.4254 5.4790 0.0 0
M  V30 18 C 1.6278 6.2951 0.0 0
M  V30 19 C 2.1036 7.7598 0.0 0
M  V30 20 C 4.2205 9.1876 0.0 0
M  V30 21 N 6.9505 5.6934 0.0 0
M  V30 22 C 5.5802 9.9105 0.0 0
M  V30 23 C 7.9809 6.8378 0.0 0
M  V30 24 C 7.0866 9.5903 0.0 0
M  V30 25 C 8.0346 8.3768 0.0 0
M  V30 26 H 4.1732 4.7560 0.0 0
M  V30 27 H 2.7825 9.0364 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 17
M  V30 9 1 9 10
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 14 26 CFG=3
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 1 16 27 CFG=1
M  V30 22 1 17 21
M  V30 23 1 18 19
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 14 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3aR,4Z,10aS)-3,3a,6,7,8,9,10,10a-octahydro-9-[2-(methylami...
C18H29N3O4
1000049-36-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.8736 3.8500 0.0 0
M  V30 2 O 1.5400 3.0800 0.0 0
M  V30 3 O 4.2073 3.0800 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 0.0000 1.5400 0.0 0
M  V30 6 C 1.5400 0.0000 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 O 5.1053 3.9727 0.0 0
M  V30 9 C 7.6735 4.3336 0.0 0
M  V30 10 C 9.2126 4.2798 0.0 0
M  V30 11 N 9.9356 2.9201 0.0 0
M  V30 12 O 10.0286 5.5859 0.0 0
M  V30 13 C 11.4745 2.8664 0.0 0
M  V30 14 C 4.1195 6.2951 0.0 0 CFG=2
M  V30 15 N 2.8736 5.3900 0.0 0
M  V30 16 C 3.6436 7.7598 0.0 0 CFG=1
M  V30 17 C 5.4254 5.4790 0.0 0
M  V30 18 C 1.6278 6.2951 0.0 0
M  V30 19 C 2.1036 7.7598 0.0 0
M  V30 20 C 4.2205 9.1876 0.0 0
M  V30 21 N 6.9505 5.6934 0.0 0
M  V30 22 C 5.5802 9.9105 0.0 0
M  V30 23 C 7.9809 6.8378 0.0 0
M  V30 24 C 7.0866 9.5903 0.0 0
M  V30 25 C 8.0346 8.3768 0.0 0
M  V30 26 H 4.1732 4.7560 0.0 0
M  V30 27 H 2.7825 9.0364 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 17
M  V30 9 1 9 10
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 14 26 CFG=3
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 1 16 27 CFG=1
M  V30 22 1 17 21
M  V30 23 1 18 19
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 14 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1000049-15-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1000049-36-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8488844
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: tert-Butyl
(3aR,8aS)-7-(2-Methoxy-2-oxoethyl)-8-oxo-3,3a,6,7,8,-
8a-hexahydropyrrolo[2,3-c]azepine-1(2H)-carboxylate (11a). Diene 10a (5.0
mg, 0.0142 mmol, see Supporting Information) was dissolved in CH2Cl2 (7
mL), and a solution of the Grubbs’ catalyst of the second generation (I,
0.6 mg)22 in CH2Cl2 (0.5 mL) was added. The mixture was stirred for 2 h
under reflux conditions, and then silica gel (50 mg) was added.
Evaporation and subsequent flash chromatography (petrol ether-EtOAc, 1:1)
of the residue afforded 11a (3.5 mg, 76%) as a colorless oil. tert-Butyl
(3aR,10aS)-9-[2-(Methylamino)-2-oxoethyl)]-10-
oxo-3,3a,6,7,8,9,10,10a-octahydropyrrolo[2,3-c]azonine-1(2H)- carboxylate
(3c). Aminolysis of 11c (3.0 mg, 0.0085 mmol) was analogously performed
with methyl amine in EtOH (1 mL, 8.03 M) as described for 11a. Reaction
time: 1 h. Flash chromatography (CH2Cl2-MeOH 95:5) gave 3c (3.0 mg, 100%)
as a colorless oil. [α]D 20 -73.7° (c = 0.45, CHCl3); IR (film) 3361,
1678, 1657 cm-1; 1H NMR (600 MHz, protons located at the same side of the
ring plane as H-3a are designated as β-protons) δ 1.35-1.43 (m, 1H,
H-7α), 1.38 (s, 1.3H, t-Bu), 1.46 (s, 7.7H, t-Bu), 1.85 (dddd, J = 12.0,
12.0, 12.0, 7.8 Hz, 1H, H-3α), 1.88-1.96 (m, 1H, H-6β), 1.91-2.00 (m, 1H,
H-7β), 1.88-2.05 (m, 1H, H-6α), 2.19 (ddd, J = 12.0, 7.1, 5.6 Hz, 1H,
H-3β), 2.78 (d, J = 4.6 Hz, 3 H, HNCH 3), 3.07 (dddd, J = 12.0, 8.3, 7.1,
6.6 Hz, 1H, H-3α), 3.12 (ddd, J = 14.5, 2.8. 2.8 Hz, 1H, H-8β), 3.44
(ddd, J = 12.0, 10.6, 5.6 Hz, 1H, H-2), 3.48 (d, J = 16.3 Hz, 1H, NCH2),
3.69 (dd, J = 14.5, 14.5 Hz, 1H, H-8α), 3.72 (dd, J = 10.6, 7.8 Hz, 1H,
H-2′), 4.26 (d, J = 8.3 Hz, 1H, H-10a), 4.66 (d, J = 16.3 Hz, 1H, NCH2),
5.60 (dddd, J = 10.9, 10.9, 5.7, 1.2 Hz, 1H, H-5), 5.69 (dd, J = 10.9,
6.6 Hz, 1H, H-4), 6.96 (brs, 0.15H, HNCH3), 7.22 (brs, 0.85H, HNCH3); 13C
NMR δ 23.6 (C-6), 26.4 (HNCH3), 28.0 (C-7), 28.4 (C(CH3)3), 33.6 (C-3),
40.7 (C-3a), 45.0 (C-8), 47.0 (C-2), 49.0 (NCH2), 62.4 (C-10a), 80.3
(C(CH3)3), 131.7 (C-5, conf.), 133.4 (C-4), 154.9 (COOtBu), 169.0
(COONHCH3), 174.0 (C-10, conf.); EIMS 351 [M+]. Anal. Calcd for
C18H29N3O4 (351.45): C, 61.52; H, 8.32; N, 11.96. Found: C, 61.32; H,
8.29; N, 11.88.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Molecular Building Kit of Fused-Proline-Derived Peptide Mimetics Allowing
Specific Adjustment of the Dihedral Ψ Angle
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Einsiedel, Juergen; Lanig, Harald; Waibel, Reiner; Gmeiner, Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2007), 72(24), 9102-9113

$RFMT $RIREG SCHEME2 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (3aS,6Z,10aS)-1-[(1,1-dimethylethoxy)carbonyl]-2,3,3a,4,5,8,10,10a-oct...
C18H28N2O5
1000049-25-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.8736 3.8500 0.0 0
M  V30 2 O 1.5400 3.0800 0.0 0
M  V30 3 O 4.2073 3.0800 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 0.0000 1.5400 0.0 0
M  V30 6 C 1.5400 0.0000 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 O 5.1053 3.9727 0.0 0
M  V30 9 C 7.6735 4.3336 0.0 0
M  V30 10 C 9.2126 4.2798 0.0 0
M  V30 11 O 9.9356 2.9201 0.0 0
M  V30 12 O 10.0286 5.5859 0.0 0
M  V30 13 C 11.4745 2.8664 0.0 0
M  V30 14 C 4.1195 6.2951 0.0 0 CFG=2
M  V30 15 N 2.8736 5.3900 0.0 0
M  V30 16 C 3.6436 7.7598 0.0 0 CFG=1
M  V30 17 C 5.4254 5.4790 0.0 0
M  V30 18 C 1.6278 6.2951 0.0 0
M  V30 19 C 2.1036 7.7598 0.0 0
M  V30 20 C 4.2205 9.1876 0.0 0
M  V30 21 N 6.9505 5.6934 0.0 0
M  V30 22 C 5.5802 9.9105 0.0 0
M  V30 23 C 7.9809 6.8378 0.0 0
M  V30 24 C 7.0866 9.5903 0.0 0
M  V30 25 C 8.0346 8.3768 0.0 0
M  V30 26 H 4.1732 4.7560 0.0 0
M  V30 27 H 2.7825 9.0364 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 17
M  V30 9 1 9 10
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 14 26 CFG=3
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 1 16 27 CFG=1
M  V30 22 1 17 21
M  V30 23 1 18 19
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 14 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3aS,6Z,10aS)-3,3a,4,5,8,9,10,10a-octahydro-9-[2-(methylami...
C18H29N3O4
1000049-47-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.8736 3.8500 0.0 0
M  V30 2 O 1.5400 3.0800 0.0 0
M  V30 3 O 4.2073 3.0800 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 3.0800 1.5400 0.0 0
M  V30 6 C 1.5400 0.0000 0.0 0
M  V30 7 C 0.0000 1.5400 0.0 0
M  V30 8 O 5.1053 3.9727 0.0 0
M  V30 9 C 7.6735 4.3336 0.0 0
M  V30 10 C 9.2126 4.2798 0.0 0
M  V30 11 N 9.9356 2.9201 0.0 0
M  V30 12 O 10.0286 5.5859 0.0 0
M  V30 13 C 11.4745 2.8664 0.0 0
M  V30 14 C 4.1195 6.2951 0.0 0 CFG=2
M  V30 15 N 2.8736 5.3900 0.0 0
M  V30 16 C 3.6436 7.7598 0.0 0 CFG=1
M  V30 17 C 5.4254 5.4790 0.0 0
M  V30 18 C 1.6278 6.2951 0.0 0
M  V30 19 C 2.1036 7.7598 0.0 0
M  V30 20 C 4.2205 9.1876 0.0 0
M  V30 21 N 6.9505 5.6934 0.0 0
M  V30 22 C 5.5802 9.9105 0.0 0
M  V30 23 C 7.9809 6.8378 0.0 0
M  V30 24 C 7.0866 9.5903 0.0 0
M  V30 25 C 8.0346 8.3768 0.0 0
M  V30 26 H 4.1732 4.7560 0.0 0
M  V30 27 H 2.7825 9.0364 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 17
M  V30 9 1 9 10
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 14 26 CFG=3
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 1 16 27 CFG=1
M  V30 22 1 17 21
M  V30 23 1 18 19
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 14 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1000049-25-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1000049-47-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14884754
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: tert-Butyl
(3aR,8aS)-7-(2-Methoxy-2-oxoethyl)-8-oxo-3,3a,6,7,8,-
8a-hexahydropyrrolo[2,3-c]azepine-1(2H)-carboxylate (11a). Diene 10a (5.0
mg, 0.0142 mmol, see Supporting Information) was dissolved in CH2Cl2 (7
mL), and a solution of the Grubbs’ catalyst of the second generation (I,
0.6 mg)22 in CH2Cl2 (0.5 mL) was added. The mixture was stirred for 2 h
under reflux conditions, and then silica gel (50 mg) was added.
Evaporation and subsequent flash chromatography (petrol ether-EtOAc, 1:1)
of the residue afforded 11a (3.5 mg, 76%) as a colorless oil. tert-Butyl
(3aS,10aS)-9-[2-(Methylamino)-2-oxoethyl)]-10-oxo-
3,3a,4,5,8,9,10,10a-octahydropyrrolo[2,3-c]azonine-1(2H)-carboxylate
(3f). Aminolysis of 11f (2.4 mg, 0.0068 mmol) was analogously performed
with methyl amine in EtOH (2 mL, 8.03 M) as described for 11a. Reaction
time: 0.5 h. Column chromatography (CH2Cl2-MeOH 97:3) gave 3f (2.4 mg,
100%) as a colorless oil. [α]D 20 -46.6° (c = 0.14, CHCl3); IR (film)
3338, 1668 (br) cm-1; 1H NMR (600 MHz, protons located at the same side
of the ring plane as H-3a are designated as β-protons) δ 1.41 (s, 1.3H,
t-Bu, conf.), 1.46 (s, 7.7H, t-Bu, conf.), 1.53 (dddd, J = 13.1, 13.1,
4.0, 4.0 Hz, 1H, H-4α), 1.58 (dddd, J = 13.1, 7.5, 5.3, 4.5 Hz, 1H,
H-3α), 1.72 (dddd, J = 13.1, 13.1, 4.5, 4.5 Hz, 1H, H-4β), 2.13-2.20 (m,
1H, H-5β), 2.22 (dddd, J = 13.1, 8.5, 7.5, 7.5 Hz, 1H, H-3β), 2.38
(ddddd, J = 7.5, 4.5, 4.5, 4.0, 3.8 Hz, 1H, H-3a), 2.54-2.62 (m, 1H,
H-5α), 2.78 (d, J = 4.7 Hz, 3H, HNCH 3), 3.43 (ddd, J = 10.5, 7.5, 7.5
Hz, 1H, H-2α), 3.46 (dd, J = 16.7, 4.5 Hz, 1H, H-8β), 3.51 (d, J = 16.2
Hz, 0.85H, NCH2, conf.), 3.65 (ddd, J = 10.5, 8.5, 5.3 Hz, 0.85H, H-2β,
conf.), 3.71 (d, J = 14.4 Hz, 0.15H, NCH2, conf.), 3.73 (ddd, J = 10.5,
8.5, 4.0 Hz, 0.15H, H-2β, conf.), 4.19 (d, J = 14.4 Hz, 0.15H, NCH2,
conf.), 4.56 (dd, J = 16.1, 10.8 Hz, 1H, H-8α), 4.63 (d, J = 3.8 Hz, 1H,
H-10a, conf.), 4.69 (d, J = 16.2 Hz, 0.85H, NCH2, conf.), 4.76 (dd, J =
16.7, 8.4 Hz, 0.85H, H-8α), 5.64-5.73 (m, 1.85H, H-6/ H-7), 5.82 (ddd, J
= 10.6, 10.6, 5.8 Hz, 0.15H, H-7, conf.), 6.64 (brs, 0.15H, HNCH3,
conf.), 6.98 (brs, 0.85H, HNCH3, conf.); 13C NMR δ 23.8, 24.0 (C-5,
conf.), 26.3 (HNCH3), 28.4, 28.6 (C(CH3)3, conf.), 29.6 (C-3, conf.),
29.9 (C-4, conf.), 31.4 (C-3, conf.), 31.6 (C-4, conf.), 40.2, 41.3
(C-3a, conf.), 45.8 (C-8, conf.), 45.9 (C-2, conf.), 46.3 (C-2, conf.),
46.8 (C-8, conf.), 52.5, 53.2 (NCH2, conf.), 59.6 (C-10a), 79.8, 80.4
(C(CH3)3, conf.), 124.9, 125.6 (C-6, conf.), 131.7, 132.2 (C-7, conf.),
153.9, 155.4 (COOtBu, conf.), 169.5, 170.2 (COONHCH3), 174.1, 174.4
(C-10); EIMS 351 [M+]. Anal. Calcd for C18H29N3O4 (351.45): C, 61.52; H,
8.32; N, 11.96. Found: C, 61.32; H, 8.29; N, 11.88.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Molecular Building Kit of Fused-Proline-Derived Peptide Mimetics Allowing
Specific Adjustment of the Dihedral Ψ Angle
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Einsiedel, Juergen; Lanig, Harald; Waibel, Reiner; Gmeiner, Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2007), 72(24), 9102-9113

$RFMT $RIREG SCHEME3 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(7-Bromo-5-iodo-2-benzothiazolyl)-N′-ethylurea
C10H9BrIN3OS
1000289-36-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 2.6674 0.0000 0.0 0
M  V30 2 N 7.9110 3.0800 0.0 0
M  V30 3 C 8.6810 4.4137 0.0 0
M  V30 4 N 10.2210 4.4137 0.0 0
M  V30 5 O 7.9110 5.7473 0.0 0
M  V30 6 C 10.9910 5.7473 0.0 0
M  V30 7 C 12.5310 5.7473 0.0 0
M  V30 8 I 0.0000 4.6200 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 N 5.4658 4.3259 0.0 0
M  V30 12 C 2.6674 4.6200 0.0 0
M  V30 13 S 5.4658 1.8341 0.0 0
M  V30 14 C 2.6674 1.5400 0.0 0
M  V30 15 C 6.3710 3.0800 0.0 0
M  V30 16 C 1.3338 3.8500 0.0 0
M  V30 17 C 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 1 2 15
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 16
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 1 14 17
M  V30 18 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(7-Bromo-5-iodo-2-benzothiazolyl)-3-ethyltetrahydro-5-methyl-1,3,5-triazin-...
C13H14BrIN4OS
1459771-42-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 9.8635 0.0000 0.0 0
M  V30 2 I 12.5310 4.6200 0.0 0
M  V30 3 O 4.6200 5.7473 0.0 0
M  V30 4 C 1.5400 5.7473 0.0 0
M  V30 5 C 0.0000 5.7473 0.0 0
M  V30 6 C 1.5400 0.4126 0.0 0
M  V30 7 C 8.5299 2.3100 0.0 0
M  V30 8 C 8.5299 3.8500 0.0 0
M  V30 9 S 7.0652 1.8341 0.0 0
M  V30 10 C 9.8635 1.5400 0.0 0
M  V30 11 N 7.0652 4.3259 0.0 0
M  V30 12 C 9.8635 4.6200 0.0 0
M  V30 13 C 6.1600 3.0800 0.0 0
M  V30 14 C 11.1972 2.3100 0.0 0
M  V30 15 C 11.1972 3.8500 0.0 0
M  V30 16 N 4.6200 3.0800 0.0 0
M  V30 17 C 3.8500 4.4136 0.0 0
M  V30 18 C 3.8500 1.7462 0.0 0
M  V30 19 N 2.3100 4.4136 0.0 0
M  V30 20 N 2.3100 1.7462 0.0 0
M  V30 21 C 1.5400 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 15
M  V30 3 2 3 17
M  V30 4 1 4 5
M  V30 5 1 4 19
M  V30 6 1 6 20
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 2 14 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1000289-36-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1459771-42-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-6961322
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 1-(7-bromo-5-iodobenzo[d]thiazol-2-yl)-3-ethyl-5-methyl-1,3,5-triazinan-2-one
(Intermediate 8) To a solution of Intermediate 3 (50 g, 117.37 mmol) in
MeOH (1 L) was added formaldehyde (37% aq solution, 95 mL), methylamine
(2M solution in THF, 587 mL, 1.17 mol) and N-methylmorpholine (130 mL,
1.17 mmol). The resulting solution was stirred at 75°C for 5-6 h. The
MeOH was evaporated in vacuo. Then ice-cold H2O, was added and the
mixture stirred for 30 min and then filtered. The residue was washed with
cold H2O followed by n-hexane and EtOAc. The residue was dried under high
vacuum. Intermediate 8 (56 g, quantitative). 1H-NMR (DMSO-d6, 400 MHz): δ
1.11 (t, J=7.20 Hz, 3H), 2.50 (s, 3H), 3.35 (m, 2H), 4.37 (s, 2H), 5.07
(s, 2H), 7.48 (s, 1H), 8.01 (s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzothiazole derivatives as antibacterial agents and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lunniss, Christopher James; Palmer, James T.; Pitt, Gary Robert William;
Axford, Lorraine Claire; Davies, David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013138860 A1 2013-09-26

$RFMT $RIREG SCHEME4 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4′-Methoxyacetophenone
C9H10O2
100-06-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 O 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[1-(4-Methoxyphenyl)ethylidene]methanamine
C10H13NO
118761-91-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 N 1.3337 2.3101 0.0 0
M  V30 3 C 2.6675 0.0000 0.0 0
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 O 8.0023 4.6201 0.0 0
M  V30 6 C 9.3360 3.8501 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 4.0012 3.8501 0.0 0
M  V30 9 C 5.3348 1.5400 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 6.6685 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-06-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 118761-91-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-13282198
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: I. Synthesis of ureas To a stirred solution of
CH3NH2 (8M in EtOH, 4 eq.), the ketone (1 eq.) and M.S. 4Å (250 mg /
mmol) were sequentially added at r.t.. The reaction was stirred for 48h
at r.t. in the case of acetophenone derivatives or at 50°C in the case of
propiophenone derivatives, filtered on celite and washed with CH2Cl2.*
The organic phases were combined and concentrated under reduce pressure
to give the imine (quantitative) as a pale yellow oil.
$DTYPE RXN:VAR(1):NOTES
$DATUM mol. sieves used, alternatively reaction carried out using microwave
reactor at 125 degree Celsius for 30-60 minutes
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tandem β-alkylation-α-arylation of amines by carbolithiation and
rearrangement of N-carbamoyl enamines (vinyl ureas)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Clayden, Jonathan; Donnard, Morgan; Lefranc, Julien; Minassi, Alberto;
Tetlow, Daniel J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2010), 132(19), 6624-6625

$RFMT $RIREG SCHEME4 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4′-Methoxyacetophenone
C9H10O2
100-06-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 O 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[1-(4-Methoxyphenyl)ethylidene]methanamine
C10H13NO
118761-91-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 N 1.3337 2.3101 0.0 0
M  V30 3 C 2.6675 0.0000 0.0 0
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 O 8.0023 4.6201 0.0 0
M  V30 6 C 9.3360 3.8501 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 4.0012 3.8501 0.0 0
M  V30 9 C 5.3348 1.5400 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 6.6685 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-06-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 118761-91-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-13658833
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: I. Synthesis of ureas To a stirred solution of
CH3NH2 (8M in EtOH, 4 eq.), the ketone (1 eq.) and M.S. 4Å (250 mg /
mmol) were sequentially added at r.t.. The reaction was stirred for 48h
at r.t. in the case of acetophenone derivatives or at 50°C in the case of
propiophenone derivatives, filtered on celite and washed with CH2Cl2.*
The organic phases were combined and concentrated under reduce pressure
to give the imine (quantitative) as a pale yellow oil.
$DTYPE RXN:VAR(1):NOTES
$DATUM mol. sieves used, alternatively reaction carried out using microwave
reactor at 125 degree Celsius for 30-60 minutes
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tandem β-alkylation-α-arylation of amines by carbolithiation and
rearrangement of N-carbamoyl enamines (vinyl ureas)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Clayden, Jonathan; Donnard, Morgan; Lefranc, Julien; Minassi, Alberto;
Tetlow, Daniel J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2010), 132(19), 6624-6625

$RFMT $RIREG SCHEME5 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Dimethylamino)benzaldehyde
C9H11NO
100-10-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 6.6687 4.6201 0.0 0
M  V30 5 O 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N-Dimethyl-4-[(methylimino)methyl]benzenamine
C10H14N2
877-79-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0
M  V30 2 C 1.3337 0.0000 0.0 0
M  V30 3 C 0.0000 2.3101 0.0 0
M  V30 4 C 6.6685 4.6201 0.0 0
M  V30 5 N 8.0023 3.8501 0.0 0
M  V30 6 C 9.3360 4.6201 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 2.6675 3.8501 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 2 4 5 CFG=2
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-10-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 877-79-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-2653189
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quantitative Solid-State Reactions of Amines with Carbonyl Compounds and
Isothiocyanates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kaupp, Gerd; Schmeyers, Jens; Boy, Juergen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2000), 56(36), 6899-6911

$RFMT $RIREG SCHEME6 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6-(2-chlorophenyl)-7-(4-chlorophenyl)-2-(chlorosulfonyl)pyrazolo[1,5-a]...
C21H14Cl3N3O4S
1001426-34-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.4106 3.5094 0.0 0
M  V30 2 O 11.5549 4.5398 0.0 0
M  V30 3 O 10.7307 2.0029 0.0 0
M  V30 4 C 13.0196 4.0639 0.0 0
M  V30 5 C 14.1640 5.0943 0.0 0
M  V30 6 S 7.7000 1.5400 0.0 0 VAL=6
M  V30 7 Cl 7.7000 0.0000 0.0 0
M  V30 8 O 9.2400 1.5400 0.0 0
M  V30 9 O 6.1600 1.5400 0.0 0
M  V30 10 Cl 8.4700 10.7846 0.0 0
M  V30 11 Cl 0.0000 6.7835 0.0 0
M  V30 12 C 6.1600 6.7835 0.0 0
M  V30 13 N 6.9300 5.4499 0.0 0
M  V30 14 C 6.9300 8.1172 0.0 0
M  V30 15 C 8.4700 5.4499 0.0 0
M  V30 16 N 6.4541 3.9852 0.0 0
M  V30 17 C 8.4700 8.1172 0.0 0
M  V30 18 C 8.9459 3.9852 0.0 0
M  V30 19 N 9.2400 6.7835 0.0 0
M  V30 20 C 7.7000 3.0800 0.0 0
M  V30 21 C 4.6200 6.7835 0.0 0
M  V30 22 C 3.8500 8.1172 0.0 0
M  V30 23 C 3.8500 5.4499 0.0 0
M  V30 24 C 2.3100 8.1172 0.0 0
M  V30 25 C 2.3100 5.4499 0.0 0
M  V30 26 C 1.5400 6.7835 0.0 0
M  V30 27 C 6.1600 9.4508 0.0 0
M  V30 28 C 6.9300 10.7846 0.0 0
M  V30 29 C 4.6200 9.4508 0.0 0
M  V30 30 C 6.1600 12.1183 0.0 0
M  V30 31 C 3.8500 10.7846 0.0 0
M  V30 32 C 4.6200 12.1183 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 6 9
M  V30 9 1 6 20
M  V30 10 1 10 28
M  V30 11 1 11 26
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 12 21
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 1 14 27
M  V30 19 2 15 18
M  V30 20 1 15 19
M  V30 21 2 16 20
M  V30 22 2 17 19
M  V30 23 1 18 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6-(2-chlorophenyl)-7-(4-chlorophenyl)-2-[(methylamino)sulfonyl]pyrazolo...
C22H18Cl2N4O4S
1001424-81-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.4106 4.2794 0.0 0
M  V30 2 O 11.5549 5.3098 0.0 0
M  V30 3 O 10.7307 2.7729 0.0 0
M  V30 4 C 13.0196 4.8339 0.0 0
M  V30 5 C 14.1640 5.8643 0.0 0
M  V30 6 S 7.7000 2.3100 0.0 0 VAL=6
M  V30 7 N 7.7000 0.7700 0.0 0
M  V30 8 O 9.2400 2.3100 0.0 0
M  V30 9 O 6.1600 2.3100 0.0 0
M  V30 10 C 6.3664 0.0000 0.0 0
M  V30 11 Cl 8.4700 11.5546 0.0 0
M  V30 12 Cl 0.0000 7.5535 0.0 0
M  V30 13 N 6.9300 6.2199 0.0 0
M  V30 14 C 6.1600 7.5535 0.0 0
M  V30 15 C 8.4700 6.2199 0.0 0
M  V30 16 N 6.4541 4.7552 0.0 0
M  V30 17 C 6.9300 8.8872 0.0 0
M  V30 18 C 8.9459 4.7552 0.0 0
M  V30 19 N 9.2400 7.5535 0.0 0
M  V30 20 C 7.7000 3.8500 0.0 0
M  V30 21 C 8.4700 8.8872 0.0 0
M  V30 22 C 4.6200 7.5535 0.0 0
M  V30 23 C 3.8500 6.2199 0.0 0
M  V30 24 C 3.8500 8.8872 0.0 0
M  V30 25 C 2.3100 6.2199 0.0 0
M  V30 26 C 2.3100 8.8872 0.0 0
M  V30 27 C 1.5400 7.5535 0.0 0
M  V30 28 C 6.1600 10.2208 0.0 0
M  V30 29 C 6.9300 11.5546 0.0 0
M  V30 30 C 4.6200 10.2208 0.0 0
M  V30 31 C 6.1600 12.8883 0.0 0
M  V30 32 C 3.8500 11.5546 0.0 0
M  V30 33 C 4.6200 12.8883 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 6 9
M  V30 9 1 6 20
M  V30 10 1 7 10
M  V30 11 1 11 29
M  V30 12 1 12 27
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 2 14 17
M  V30 17 1 14 22
M  V30 18 2 15 18
M  V30 19 1 15 19
M  V30 20 2 16 20
M  V30 21 1 17 21
M  V30 22 1 17 28
M  V30 23 1 18 20
M  V30 24 2 19 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1001426-34-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1001424-81-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-13928197
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a solution of the compound obtained in Reference Example B3 (70mg) in
tetrahydrofuran (2mL)was added a solution of 2M methyl amine in
tetrahydrofuran (0.14mL), and the mixture was stirred at room temperature
for 10 minutes. The reaction mixture was concentrated in vacuo, and to
the residue was added an aqueous saturated sodium hydrogen carbonate
solution. The mixture was extracted with chloroform, and the organic
layer was concentrated in vacuo. The resultant crude product was purified
by column chromatography on NH-silica gel (Chromatorex NH silicagel,
solvent; hexane/ethyl acetate = 80/20 to 30/70) to give
6-(2-chlorophenyl)-7-(4-chlorophenyl)-3-ethoxycarbonyl-2-(N-methylsulfamoyl)pyrazolo[1,5-a]pyrimidine
(75 mg,yield: 100%)as a colorless powder. MS (APCI) m/z; 505/507 [M+H]+
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A pyrazolo[1,5-a]pyrimidine compound as CB1 antagonists and their
preparation, pharmaceutical compositions and use in the treatment of
diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tanimoto, Koichi; Oi, Mariko; Tsuboi, Yasunori; Moritani, Yasunori
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008004698 A2 2008-01-10

$RFMT $RIREG SCHEME7 STEP1
$RXN



  4  1
$MOL
Benzocaine
C9H11NO2
94-09-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 O 6.6684 2.3100 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 C 8.0022 1.5400 0.0 0
M  V30 5 C 9.3359 2.3100 0.0 0
M  V30 6 N 0.0000 4.6201 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 1.5400 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 1.3337 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Ethoxybenzaldehyde
C9H10O2
10031-82-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 C 1.3337 0.0000 0.0 0
M  V30 5 O 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 5.3348 0.7700 0.0 0
M  V30 8 C 4.0012 3.0801 0.0 0
M  V30 9 C 4.0012 0.0000 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propen-1-yl 2,3-dihydro-1H-pyrrole-1-carboxylate
C8H11NO2
110910-76-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 5.1048 2.3101 0.0 0
M  V30 3 O 3.7711 0.0000 0.0 0
M  V30 4 C 6.4386 1.5400 0.0 0
M  V30 5 C 7.7722 2.3101 0.0 0
M  V30 6 C 9.1059 1.5400 0.0 0
M  V30 7 N 2.4374 2.3101 0.0 0
M  V30 8 C 1.0304 1.6836 0.0 0
M  V30 9 C 2.2763 3.8416 0.0 0
M  V30 10 C 0.0000 2.8281 0.0 0
M  V30 11 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-2-Propen-1-yl (3aR,9bR)-4-(4-ethoxyphenyl)-2,3,3a,4,5,9b-hexahydro-8-[(me...
C25H29N3O4
862432-36-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0736 7.6404 0.0 0
M  V30 2 O 4.0432 8.7849 0.0 0
M  V30 3 O 4.5977 6.1758 0.0 0
M  V30 4 C 2.5369 8.4647 0.0 0
M  V30 5 C 1.5063 9.6091 0.0 0
M  V30 6 C 0.0000 9.2890 0.0 0
M  V30 7 C 5.0571 2.3100 0.0 0
M  V30 8 N 5.0571 0.7700 0.0 0
M  V30 9 O 3.7233 3.0800 0.0 0
M  V30 10 C 3.7233 0.0000 0.0 0
M  V30 11 O 15.7267 10.0101 0.0 0
M  V30 12 C 17.0604 9.2401 0.0 0
M  V30 13 C 18.3940 10.0101 0.0 0
M  V30 14 C 7.7244 6.9301 0.0 0 CFG=1
M  V30 15 C 9.0581 7.7001 0.0 0 CFG=2
M  V30 16 C 7.7244 5.3901 0.0 0
M  V30 17 N 6.5801 7.9605 0.0 0
M  V30 18 C 10.3919 6.9301 0.0 0 CFG=3
M  V30 19 C 8.7379 9.2064 0.0 0
M  V30 20 C 9.0581 4.6201 0.0 0
M  V30 21 C 6.3908 4.6201 0.0 0
M  V30 22 C 7.2064 9.3675 0.0 0
M  V30 23 N 10.3919 5.3901 0.0 0
M  V30 24 C 9.0581 3.0800 0.0 0
M  V30 25 C 6.3908 3.0800 0.0 0
M  V30 26 C 7.7244 2.3100 0.0 0
M  V30 27 C 11.7256 7.7001 0.0 0
M  V30 28 C 11.7256 9.2401 0.0 0
M  V30 29 C 13.0592 6.9301 0.0 0
M  V30 30 C 13.0592 10.0101 0.0 0
M  V30 31 C 14.3930 7.7001 0.0 0
M  V30 32 C 14.3930 9.2401 0.0 0
M  V30 33 H 6.3176 6.3038 0.0 0
M  V30 34 H 10.3041 8.6053 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 25
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 1 11 32
M  V30 13 1 12 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 14 33 CFG=1
M  V30 18 1 15 18
M  V30 19 1 15 19
M  V30 20 1 15 34 CFG=1
M  V30 21 1 16 20
M  V30 22 2 16 21
M  V30 23 1 17 22
M  V30 24 1 18 23
M  V30 25 1 18 27
M  V30 26 1 19 22
M  V30 27 1 20 23
M  V30 28 2 20 24
M  V30 29 1 21 25
M  V30 30 1 24 26
M  V30 31 2 25 26
M  V30 32 2 27 28
M  V30 33 1 27 29
M  V30 34 1 28 30
M  V30 35 2 29 31
M  V30 36 2 30 32
M  V30 37 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 94-09-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 10031-82-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 110910-76-4
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 862432-36-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13422678
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 6
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(5):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General/Typical Procedure:
Ethyl4-aminobenzoate (1 equiv.), aldehyde (1.1 equiv.), in dry toluene
was added a drop of TFA. The solution was refluxed for overnight, while
water was removed by Dean Stark trap. After removal of the solvent, the
resulted Schiffbase was used for next step directly. To the residue was
added allyI 2,3-dihydro-1H-pyrrole-1-carboxylate or other reactant as
shown in above scheme (1.1 equivalent) in acetonitrile. The reaction
mixture was stirred at room temperature for 16 hours. The solvent was
removed to give a residue, which was purified by silica gel column
chromatography giving the desired compound at approximately 1:1 ratio. A
mixture of carboxylic acid (1 equiv.), HATU (1.1 equiv.), DIPEA (1.1
equiv.) in DMF was stirred for 5 minutes. Then, a primary or secondary
amine was added to the solution. The reaction mixture was stirred at room
temperature for 4 hours. The solvent was removed in vacuo. The residue
was purified by flash column chromatography.The titled compounds of
Example 2 are made using the titled compounds made in Example 1 as the
starting materials. Tert-Butyl
8-[(4-methylpiperazin-l-yl)carbonyll-4-phenyl-2,3,3a,4,5,9b-hexahydro-
1H-pyrrolo[3,2-c]quinoline-l-carboxylate. The titled compound (235.1mg,
97% yield) was obtained by following the general procedure 5. Allyl
4-(4-ethoxyphenyl)-8-[(methylamino)carbonyl]-2,3,3a,4,5,9b-hexahydro-1H-pyrrolo[3,2-c]quinoline-1-carboxylate.
The titled compound (1.48 g; yield, 100%) was obtained by following the
general procedure 5. (ESI) (M+H)+ = 436.5.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrroloquinolinecarboxamides and
piperidoquinolinecarboxamides as B2 Bradykinin receptor modulators for
pain management and other uses
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hu, Yun-Jin; Tomaszewski, Miroslaw; Walpole, Christopher
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005075476 A1 2005-08-18

$RFMT $RIREG SCHEME8 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanone, 1-(4-bromo-3-fluorophenyl)-2-(4-morpholinyl)-
C12H13BrFNO2
1003879-03-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 2.6674 0.0 0
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 4.6200 1.3338 0.0 0
M  V30 4 F 10.0100 0.0000 0.0 0
M  V30 5 Br 11.5500 2.6674 0.0 0
M  V30 6 C 6.9300 2.6674 0.0 0
M  V30 7 C 7.7000 1.3338 0.0 0
M  V30 8 C 7.7000 4.0011 0.0 0
M  V30 9 C 9.2400 1.3338 0.0 0
M  V30 10 C 9.2400 4.0011 0.0 0
M  V30 11 C 10.0100 2.6674 0.0 0
M  V30 12 N 3.0800 4.0011 0.0 0
M  V30 13 C 2.3100 2.6674 0.0 0
M  V30 14 C 2.3100 5.3349 0.0 0
M  V30 15 C 0.7700 2.6674 0.0 0
M  V30 16 C 0.7700 5.3349 0.0 0
M  V30 17 O 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 12
M  V30 5 1 4 9
M  V30 6 1 5 11
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-(4-Bromo-3-fluorophenyl)-N-methyl-4-morpholineethanamine
C13H18BrFN2O
1003879-04-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 2.6674 0.0 0
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 N 4.6200 1.3338 0.0 0
M  V30 4 C 5.3900 0.0000 0.0 0
M  V30 5 F 10.0100 5.3349 0.0 0
M  V30 6 Br 11.5500 2.6674 0.0 0
M  V30 7 C 6.9300 2.6674 0.0 0
M  V30 8 C 7.7000 4.0011 0.0 0
M  V30 9 C 7.7000 1.3338 0.0 0
M  V30 10 C 9.2400 4.0011 0.0 0
M  V30 11 C 9.2400 1.3338 0.0 0
M  V30 12 C 10.0100 2.6674 0.0 0
M  V30 13 N 3.0800 4.0011 0.0 0
M  V30 14 C 2.3100 2.6674 0.0 0
M  V30 15 C 2.3100 5.3349 0.0 0
M  V30 16 C 0.7700 2.6674 0.0 0
M  V30 17 C 0.7700 5.3349 0.0 0
M  V30 18 O 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 2 13
M  V30 5 1 3 4
M  V30 6 1 5 10
M  V30 7 1 6 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1003879-03-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1003879-04-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-11425767
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM e) 1-(4-bromo-3-fluorophenyl)-N-methyl-2-(4-morpholinyl)ethanamine To an
ambient temperature solution containing 1.52 g of
1-(4-bromo-3-fluorophenyl)-2-(4-morpholinyl)ethanone (5.04 mmols) in 25
mL of THF was added 10.1 mL of MeNH2 (20.2 mmols, 2M solution in THF).
After stirring for 15 min. 0.66 mL of acetic acid and 1.27 g of NaCNBH3
(20.2 mmols) were added to the reaction mixture. The reaction mixture was
then warmed to 40° C. and stirred for 24 h. The reaction mixture was
quenched with 10% aqueous Na2CO3 (10 mL). The reaction was diluted with
100 mL of EtOAc, and the layers were separated. The organic layer was
washed with 10% aqueous Na2CO3 (1×10 mL) and saturated aqueous brine
solution (1×10 mL). The organics were then dried over MgSO4, filtered
through a frit, and concentrated. The crude title product was isolated as
a brown solid (1.6 g, ˜100%) and used without further purification. MS
(ES) m/e 317 [M+H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-[1-biphenylyl-(morpholinyl- and
pyrrolidinyl)ethyl]glycinamide derivatives as antagonists of urotensin II
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Neeb, Michael J.; Sehon, Clark A.; Viet, Andrew Q.; Goodman, Krista B.;
Wang, Gren Z.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008011551 A1 2008-01-24

$RFMT $RIREG SCHEME9 STEP1
$RXN



  4  1
$MOL
Bromoacetic acid
C2H3BrO2
79-08-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 O 0.0000 2.3101 0.0 0
M  V30 5 Br 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzylamine
C7H9N
100-46-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxyethylamine
C3H9NO
109-85-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.7700 0.0 0
M  V30 2 C 1.3338 0.0000 0.0 0
M  V30 3 O 4.0010 0.0000 0.0 0
M  V30 4 N 0.0000 0.7700 0.0 0
M  V30 5 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C17H25N3O5
2172815-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9302 5.3348 0.0 0
M  V30 2 C 6.1601 4.0012 0.0 0
M  V30 3 C 6.1601 6.6685 0.0 0
M  V30 4 C 8.4702 5.3348 0.0 0
M  V30 5 C 4.6201 6.6685 0.0 0
M  V30 6 C 9.2402 6.6685 0.0 0
M  V30 7 O 9.2402 4.0012 0.0 0
M  V30 8 N 3.8501 8.0023 0.0 0
M  V30 9 O 3.8501 5.3348 0.0 0
M  V30 10 N 10.7802 6.6685 0.0 0
M  V30 11 C 2.3101 8.0023 0.0 0
M  V30 12 C 4.6201 9.3360 0.0 0
M  V30 13 C 11.5503 8.0023 0.0 0
M  V30 14 C 1.5400 9.3360 0.0 0
M  V30 15 C 13.0903 8.0023 0.0 0
M  V30 16 O 0.0000 9.3360 0.0 0
M  V30 17 O 2.3101 10.6697 0.0 0
M  V30 18 O 13.8603 9.3360 0.0 0
M  V30 19 C 15.4003 9.3360 0.0 0
M  V30 20 C 6.9302 2.6673 0.0 0
M  V30 21 C 6.1601 1.3337 0.0 0
M  V30 22 C 8.4702 2.6673 0.0 0
M  V30 23 C 6.9302 0.0000 0.0 0
M  V30 24 C 9.2402 1.3337 0.0 0
M  V30 25 C 8.4702 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 20
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 1 18 19
M  V30 20 2 20 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 2 22 24
M  V30 24 2 23 25
M  V30 25 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 79-08-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 100-46-9
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 109-85-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2172815-23-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-18428776
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 920-66-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported reaction, attachment to 2-chlorotrityl resin in stage
1,solid phase peptoide synthesis,cleavage step repeated twice,further
bromoacetic acid-amine coupling carried out by DIC in DMF
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cyclic peptoids as topological templates: Synthesis via central to
conformational chirality induction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM D'Amato, Assunta; Pierri, Giovanni; Costabile, Chiara; Della Sala,
Giorgio; Tedesco, Consiglia; Izzo, Irene; De Riccardis, Francesco
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2018), 20(3), 640-643

$RFMT $RIREG SCHEME10 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-3-nitrobenzonitrile
C7H3FN2O2
1009-35-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 F 1.3337 4.6201 0.0 0
M  V30 5 C 6.6686 1.5400 0.0 0
M  V30 6 N 8.0022 0.7700 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0011 4.6201 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 9
M  V30 5 3 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzonitrile, 4-(methylamino)-3-nitro-
C8H7N3O2
64910-45-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0 VAL=5
M  V30 2 O 0.7700 1.3338 0.0 0
M  V30 3 O 3.0800 0.0000 0.0 0
M  V30 4 N 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 C 6.9300 4.0011 0.0 0
M  V30 7 N 8.4700 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 3 6 7
M  V30 7 1 6 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1009-35-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 64910-45-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8640365
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient solution phase synthesis of 2-(N-acylamino)benzimidazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Seth, Punit P.; Robinson, Dale E.; Jefferson, Elizabeth A.; Swayze, Eric
E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2002), 43(41), 7303-7306

$RFMT $RIREG SCHEME11 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2S,5S)-5-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-1,2,3,4,5,6-hexahy...
C28H26N2O5
1011302-73-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.6392 4.6000 0.0 0
M  V30 2 O 6.8610 5.5375 0.0 0
M  V30 3 C 8.2837 4.9482 0.0 0
M  V30 4 N 9.5055 5.8856 0.0 0
M  V30 5 O 8.4848 3.4213 0.0 0
M  V30 6 O 11.4279 7.8080 0.0 0
M  V30 7 C 16.0690 5.8856 0.0 0
M  V30 8 O 17.2907 4.9482 0.0 0
M  V30 9 O 16.2699 7.4125 0.0 0
M  V30 10 C 18.7135 5.5374 0.0 0
M  V30 11 C 2.9034 4.3847 0.0 0
M  V30 12 C 4.2164 5.1893 0.0 0
M  V30 13 C 1.7323 5.3848 0.0 0
M  V30 14 C 2.6226 2.8704 0.0 0
M  V30 15 C 3.8569 6.6867 0.0 0
M  V30 16 C 2.3217 6.8076 0.0 0
M  V30 17 C 0.2806 4.8707 0.0 0
M  V30 18 C 1.1710 2.3564 0.0 0
M  V30 19 C 4.7292 7.9559 0.0 0
M  V30 20 C 1.6587 8.1976 0.0 0
M  V30 21 C 0.0000 3.3566 0.0 0
M  V30 22 C 4.0662 9.3460 0.0 0
M  V30 23 C 2.5310 9.4667 0.0 0
M  V30 24 C 10.9283 5.2962 0.0 0 CFG=2
M  V30 25 C 10.9283 3.7562 0.0 0
M  V30 26 C 12.0172 6.3853 0.0 0
M  V30 27 C 12.0172 2.6673 0.0 0
M  V30 28 N 13.5572 6.3853 0.0 0
M  V30 29 C 13.5572 2.6673 0.0 0
M  V30 30 C 11.2472 1.3336 0.0 0
M  V30 31 C 14.6462 5.2962 0.0 0 CFG=2
M  V30 32 C 14.6462 3.7562 0.0 0
M  V30 33 C 14.3272 1.3336 0.0 0
M  V30 34 C 12.0172 0.0000 0.0 0
M  V30 35 C 13.5572 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 24 4 CFG=3
M  V30 7 2 6 26
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 31 7 CFG=3
M  V30 11 1 8 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 16
M  V30 20 2 15 19
M  V30 21 2 16 20
M  V30 22 1 17 21
M  V30 23 2 18 21
M  V30 24 1 19 22
M  V30 25 1 20 23
M  V30 26 2 22 23
M  V30 27 1 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 27 30
M  V30 33 1 28 31
M  V30 34 1 29 32
M  V30 35 2 29 33
M  V30 36 1 30 34
M  V30 37 1 31 32
M  V30 38 1 33 35
M  V30 39 2 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 24 31)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2S,5S)-5-Amino-1,2,3,4,5,6-hexahydro-N-methyl-4-oxo-3-benzazocine-2-carboxamide
C13H17N3O2
1011302-67-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.1231 5.6843 0.0 0
M  V30 2 N 8.5460 5.0949 0.0 0
M  V30 3 O 6.9221 7.2111 0.0 0
M  V30 4 C 9.7678 6.0323 0.0 0
M  V30 5 N 3.8413 0.0000 0.0 0
M  V30 6 O 6.4675 0.7036 0.0 0
M  V30 7 C 3.0801 5.1181 0.0 0
M  V30 8 C 2.3101 3.7845 0.0 0
M  V30 9 C 4.5677 5.5167 0.0 0
M  V30 10 C 2.3101 6.4518 0.0 0
M  V30 11 C 2.7088 2.2968 0.0 0
M  V30 12 C 0.7700 3.7845 0.0 0
M  V30 13 C 5.9014 4.7467 0.0 0 CFG=1
M  V30 14 C 0.7700 6.4518 0.0 0
M  V30 15 C 4.0424 1.5268 0.0 0 CFG=2
M  V30 16 C 0.0000 5.1181 0.0 0
M  V30 17 N 6.3000 3.2592 0.0 0
M  V30 18 C 5.5300 1.9255 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 13 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 15 5 CFG=1
M  V30 6 2 6 18
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 14 16
M  V30 18 1 15 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 13 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1011302-73-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1011302-67-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-2324064
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Intermediate 12 (213 mg, 0.453 mmol) was dissolved in 20 mL of 33%
methylamine in EtOH and stirred for 65 min. The solution was evaporated,
and the solid was suspended in 20 mL of dry methylene chloride. Scheme 1.
Yield quantitative.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of bis-phenylalanine, a novel eight-membered cyclic dipeptide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Falcone, Brian V.; Creighton, Christopher J.; Parker, Michael H.; Reitz,
Allen B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2008), 38(3), 411-418

$RFMT $RIREG SCHEME12 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2R,5S)-5-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-1,2,3,4,5,6-hexahy...
C28H26N2O5
1011302-74-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.6392 4.6000 0.0 0
M  V30 2 O 6.8610 5.5375 0.0 0
M  V30 3 C 8.2837 4.9482 0.0 0
M  V30 4 N 9.5055 5.8856 0.0 0
M  V30 5 O 8.4848 3.4213 0.0 0
M  V30 6 O 11.4279 7.8080 0.0 0
M  V30 7 C 16.0690 5.8856 0.0 0
M  V30 8 O 17.2907 4.9482 0.0 0
M  V30 9 O 16.2699 7.4125 0.0 0
M  V30 10 C 18.7135 5.5374 0.0 0
M  V30 11 C 2.9034 4.3847 0.0 0
M  V30 12 C 4.2164 5.1893 0.0 0
M  V30 13 C 1.7323 5.3848 0.0 0
M  V30 14 C 2.6226 2.8704 0.0 0
M  V30 15 C 3.8569 6.6867 0.0 0
M  V30 16 C 2.3217 6.8076 0.0 0
M  V30 17 C 0.2806 4.8707 0.0 0
M  V30 18 C 1.1710 2.3564 0.0 0
M  V30 19 C 4.7292 7.9559 0.0 0
M  V30 20 C 1.6587 8.1976 0.0 0
M  V30 21 C 0.0000 3.3566 0.0 0
M  V30 22 C 4.0662 9.3460 0.0 0
M  V30 23 C 2.5310 9.4667 0.0 0
M  V30 24 C 10.9283 5.2962 0.0 0 CFG=2
M  V30 25 C 10.9283 3.7562 0.0 0
M  V30 26 C 12.0172 6.3853 0.0 0
M  V30 27 C 12.0172 2.6673 0.0 0
M  V30 28 N 13.5572 6.3853 0.0 0
M  V30 29 C 13.5572 2.6673 0.0 0
M  V30 30 C 11.2472 1.3336 0.0 0
M  V30 31 C 14.6462 5.2962 0.0 0 CFG=1
M  V30 32 C 14.6462 3.7562 0.0 0
M  V30 33 C 14.3272 1.3336 0.0 0
M  V30 34 C 12.0172 0.0000 0.0 0
M  V30 35 C 13.5572 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 24 4 CFG=3
M  V30 7 2 6 26
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 31 7 CFG=1
M  V30 11 1 8 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 16
M  V30 20 2 15 19
M  V30 21 2 16 20
M  V30 22 1 17 21
M  V30 23 2 18 21
M  V30 24 1 19 22
M  V30 25 1 20 23
M  V30 26 2 22 23
M  V30 27 1 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 27 30
M  V30 33 1 28 31
M  V30 34 1 29 32
M  V30 35 2 29 33
M  V30 36 1 30 34
M  V30 37 1 31 32
M  V30 38 1 33 35
M  V30 39 2 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 24 31)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2R,5S)-5-Amino-1,2,3,4,5,6-hexahydro-N-methyl-4-oxo-3-benzazocine-2-carboxamide
C13H17N3O2
1011302-68-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.1231 5.6843 0.0 0
M  V30 2 N 8.5460 5.0949 0.0 0
M  V30 3 O 6.9221 7.2111 0.0 0
M  V30 4 C 9.7678 6.0323 0.0 0
M  V30 5 N 3.8413 0.0000 0.0 0
M  V30 6 O 6.4675 0.7036 0.0 0
M  V30 7 C 3.0801 5.1181 0.0 0
M  V30 8 C 2.3101 3.7845 0.0 0
M  V30 9 C 4.5677 5.5167 0.0 0
M  V30 10 C 2.3101 6.4518 0.0 0
M  V30 11 C 2.7088 2.2968 0.0 0
M  V30 12 C 0.7700 3.7845 0.0 0
M  V30 13 C 5.9014 4.7467 0.0 0 CFG=2
M  V30 14 C 0.7700 6.4518 0.0 0
M  V30 15 C 4.0424 1.5268 0.0 0 CFG=2
M  V30 16 C 0.0000 5.1181 0.0 0
M  V30 17 N 6.3000 3.2592 0.0 0
M  V30 18 C 5.5300 1.9255 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 13 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 15 5 CFG=1
M  V30 6 2 6 18
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 14 16
M  V30 18 1 15 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 13 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1011302-74-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1011302-68-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-4461430
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Intermediate 12 (213 mg, 0.453 mmol) was
dissolved in 20 mL of 33% methylamine in EtOH and stirred for 65 min. The
solution was evaporated, and the solid was suspended in 20 mL of dry
methylene chloride. Scheme 1. Yield quantitative.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of bis-phenylalanine, a novel eight-membered cyclic dipeptide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Falcone, Brian V.; Creighton, Christopher J.; Parker, Michael H.; Reitz,
Allen B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2008), 38(3), 411-418

$RFMT $RIREG SCHEME13 STEP1
$RXN



  3  1
$MOL
4-[(3aR,4R,7S,7aR)-3a,4,7,7a-Tetrahydro-1,1-dioxido-4,7-methano-1,2-benzisoth...
C16H13F3N2O2S
1011525-58-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 3.4972 6.6537 0.0 0
M  V30 2 O 5.4573 6.0169 0.0 0
M  V30 3 C 9.6487 1.3336 0.0 0
M  V30 4 F 10.9824 2.1036 0.0 0
M  V30 5 F 10.4187 0.0000 0.0 0
M  V30 6 F 8.3151 0.5636 0.0 0
M  V30 7 C 11.1887 4.0009 0.0 0
M  V30 8 N 12.7287 4.0009 0.0 0
M  V30 9 C 2.6590 4.7709 0.0 0 CFG=2
M  V30 10 C 2.6590 3.2309 0.0 0 CFG=1
M  V30 11 C 1.3346 5.5409 0.0 0 CFG=2
M  V30 12 S 4.1235 5.2469 0.0 0 VAL=6
M  V30 13 C 1.3346 2.4609 0.0 0 CFG=1
M  V30 14 C 4.1235 2.7551 0.0 0
M  V30 15 C 0.8624 4.0009 0.0 0
M  V30 16 C 0.0000 4.7709 0.0 0
M  V30 17 N 5.0287 4.0009 0.0 0
M  V30 18 C 0.0000 3.2309 0.0 0
M  V30 19 C 6.5687 4.0009 0.0 0
M  V30 20 C 7.3387 2.6673 0.0 0
M  V30 21 C 7.3387 5.3347 0.0 0
M  V30 22 C 8.8787 2.6673 0.0 0
M  V30 23 C 8.8787 5.3347 0.0 0
M  V30 24 C 9.6487 4.0009 0.0 0
M  V30 25 H 2.8222 6.3023 0.0 0
M  V30 26 H 2.8222 1.6997 0.0 0
M  V30 27 H 1.3370 7.0809 0.0 0
M  V30 28 H 1.3370 0.9209 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 2 2 12
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 22
M  V30 7 3 7 8
M  V30 8 1 7 24
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 25 CFG=3
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 1 10 26 CFG=3
M  V30 16 1 11 15 CFG=3
M  V30 17 1 11 16
M  V30 18 1 11 27
M  V30 19 1 12 17
M  V30 20 1 13 15 CFG=3
M  V30 21 1 13 18
M  V30 22 1 13 28
M  V30 23 1 14 17
M  V30 24 2 16 18
M  V30 25 1 17 19
M  V30 26 2 19 20
M  V30 27 1 19 21
M  V30 28 1 20 22
M  V30 29 2 21 23
M  V30 30 2 22 24
M  V30 31 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 9 10 11 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Benzyl chloroformate
C8H7ClO2
501-53-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 O 5.3347 2.3100 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 Cl 6.6685 0.0000 0.0 0
M  V30 5 O 8.0021 2.3100 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 2.6674 3.8500 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,7-Methano-1,2-benzisothiazole-7a(2H)-carboxamide, 2-[4-cyano-3-(trifluorome...
C18H17F4N3O3S
2043944-84-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.4007 2.4384 0.0 0
M  V30 2 N 3.1562 1.5314 0.0 0
M  V30 3 O 5.8086 1.8141 0.0 0
M  V30 4 C 3.3195 0.0000 0.0 0
M  V30 5 O 4.8308 4.3839 0.0 0
M  V30 6 O 6.7908 5.0209 0.0 0
M  V30 7 F 0.0000 5.4966 0.0 0
M  V30 8 C 10.9824 9.7042 0.0 0
M  V30 9 F 12.3160 8.9342 0.0 0
M  V30 10 F 11.7524 11.0378 0.0 0
M  V30 11 F 9.6487 10.4742 0.0 0
M  V30 12 C 12.5224 7.0367 0.0 0
M  V30 13 N 14.0624 7.0367 0.0 0
M  V30 14 C 3.9926 6.2667 0.0 0 CFG=1
M  V30 15 C 3.9926 7.8067 0.0 0 CFG=1
M  V30 16 C 2.6682 5.4967 0.0 0 CFG=2
M  V30 17 S 5.4571 5.7909 0.0 0 VAL=6
M  V30 18 C 2.6682 8.5767 0.0 0 CFG=1
M  V30 19 C 5.4571 8.2826 0.0 0
M  V30 20 C 2.1960 7.0367 0.0 0
M  V30 21 C 1.3336 6.2667 0.0 0 CFG=1
M  V30 22 N 6.3624 7.0367 0.0 0
M  V30 23 C 1.3336 7.8067 0.0 0
M  V30 24 C 7.9024 7.0367 0.0 0
M  V30 25 C 8.6724 8.3704 0.0 0
M  V30 26 C 8.6724 5.7031 0.0 0
M  V30 27 C 10.2124 8.3704 0.0 0
M  V30 28 C 10.2124 5.7031 0.0 0
M  V30 29 C 10.9824 7.0367 0.0 0
M  V30 30 H 4.1558 9.3381 0.0 0
M  V30 31 H 2.6707 3.9567 0.0 0
M  V30 32 H 2.6707 10.1167 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 14 1 CFG=1
M  V30 4 1 2 4
M  V30 5 2 5 17
M  V30 6 2 6 17
M  V30 7 1 21 7 CFG=1
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 27
M  V30 12 3 12 13
M  V30 13 1 12 29
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 1 15 19
M  V30 19 1 15 30 CFG=1
M  V30 20 1 16 20 CFG=1
M  V30 21 1 16 21
M  V30 22 1 16 31
M  V30 23 1 17 22
M  V30 24 1 18 20 CFG=1
M  V30 25 1 18 23
M  V30 26 1 18 32
M  V30 27 1 19 22
M  V30 28 1 21 23
M  V30 29 1 22 24
M  V30 30 2 24 25
M  V30 31 1 24 26
M  V30 32 1 25 27
M  V30 33 2 26 28
M  V30 34 2 27 29
M  V30 35 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 14 15 16 18 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1011525-58-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 501-53-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2043944-84-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-233-CAS-16466989
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 7
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 14044-65-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7722-84-1
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 38078-09-0
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 4039-32-1
$DTYPE RXN:VAR(1):RGT(6):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):RGT(7):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent (stage 6)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM [2.2.1]-Bicyclic sultams as potent androgen receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shan, Weifang; Balog, Aaron; Nation, Andrew; Zhu, Xiao; Chen, Jing;
Cvijic, Mary Ellen; Geng, Jieping; Rizzo, Cheryl A.; Spires, Thomas Jr.;
Attar, Ricardo M.; Obermeier, Mary; Traeger, Sarah; Dai, Jun; Zhang,
Yingru; Galella, Michael; Trainor, George; Vite, Gregory D.; Gavai,
Ashvinikumar V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2016), 26(23), 5707-5711

$RFMT $RIREG SCHEME14 STEP1
$RXN



  2  1
$MOL
4,7-Methano-1,2-benzisothiazole-7a(2H)-carboxylic acid, 2-[4-cyano-3-(trifluo...
C17H15F3N2O4S
1011526-48-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 11.1231 6.0679 0.0 0
M  V30 2 O 10.9599 4.5367 0.0 0
M  V30 3 O 12.5310 6.6922 0.0 0
M  V30 4 O 9.2232 6.6684 0.0 0
M  V30 5 O 7.6917 5.2893 0.0 0
M  V30 6 C 1.5400 4.0009 0.0 0
M  V30 7 F 1.5400 2.4609 0.0 0
M  V30 8 F 0.0000 4.0009 0.0 0
M  V30 9 F 1.5400 5.5409 0.0 0
M  V30 10 C 3.0800 1.3336 0.0 0
M  V30 11 N 2.3100 0.0000 0.0 0
M  V30 12 C 8.0118 8.3357 0.0 0 CFG=1
M  V30 13 C 6.6782 9.1057 0.0 0 CFG=1
M  V30 14 C 9.3409 9.0976 0.0 0 CFG=2
M  V30 15 S 7.6917 6.8293 0.0 0 VAL=6
M  V30 16 C 6.6734 10.6376 0.0 0 CFG=1
M  V30 17 C 5.5337 8.0751 0.0 0
M  V30 18 C 8.2433 10.2766 0.0 0
M  V30 19 C 9.3413 10.6383 0.0 0
M  V30 20 N 6.1600 6.6684 0.0 0
M  V30 21 C 8.0077 11.4083 0.0 0
M  V30 22 C 5.3900 5.3347 0.0 0
M  V30 23 C 3.8500 5.3347 0.0 0
M  V30 24 C 6.1600 4.0009 0.0 0
M  V30 25 C 3.0800 4.0009 0.0 0
M  V30 26 C 5.3900 2.6673 0.0 0
M  V30 27 C 3.8500 2.6673 0.0 0
M  V30 28 H 5.2703 9.7299 0.0 0
M  V30 29 H 10.6733 8.3254 0.0 0
M  V30 30 H 5.3386 11.4054 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 12 1 CFG=3
M  V30 4 2 4 15
M  V30 5 2 5 15
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 25
M  V30 10 3 10 11
M  V30 11 1 10 27
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 1 13 28 CFG=3
M  V30 18 1 14 18 CFG=3
M  V30 19 1 14 19
M  V30 20 1 14 29
M  V30 21 1 15 20
M  V30 22 1 16 18 CFG=3
M  V30 23 1 16 21
M  V30 24 1 16 30
M  V30 25 1 17 20
M  V30 26 1 19 21
M  V30 27 1 20 22
M  V30 28 2 22 23
M  V30 29 1 22 24
M  V30 30 1 23 25
M  V30 31 2 24 26
M  V30 32 2 25 27
M  V30 33 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 12 13 14 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,7-Methano-1,2-benzisothiazole-7a(2H)-carboxamide, 2-[4-cyano-3-(trifluorome...
C18H18F3N3O3S
1011526-54-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 11.1230 6.0679 0.0 0
M  V30 2 N 12.5308 6.6922 0.0 0
M  V30 3 O 10.9597 4.5367 0.0 0
M  V30 4 C 13.7753 5.7852 0.0 0
M  V30 5 O 9.2231 6.6684 0.0 0
M  V30 6 O 7.6915 5.2893 0.0 0
M  V30 7 C 1.5400 4.0009 0.0 0
M  V30 8 F 1.5400 5.5409 0.0 0
M  V30 9 F 0.0000 4.0009 0.0 0
M  V30 10 F 1.5400 2.4609 0.0 0
M  V30 11 C 3.0800 1.3336 0.0 0
M  V30 12 N 2.3100 0.0000 0.0 0
M  V30 13 C 8.0117 8.3357 0.0 0 CFG=1
M  V30 14 C 6.6781 9.1057 0.0 0 CFG=1
M  V30 15 C 9.3407 9.0976 0.0 0 CFG=2
M  V30 16 S 7.6915 6.8293 0.0 0 VAL=6
M  V30 17 C 6.6734 10.6376 0.0 0 CFG=1
M  V30 18 C 5.5335 8.0751 0.0 0
M  V30 19 C 8.2432 10.2766 0.0 0
M  V30 20 C 9.3412 10.6383 0.0 0
M  V30 21 N 6.1600 6.6684 0.0 0
M  V30 22 C 8.0075 11.4083 0.0 0
M  V30 23 C 5.3900 5.3347 0.0 0
M  V30 24 C 3.8500 5.3347 0.0 0
M  V30 25 C 6.1600 4.0009 0.0 0
M  V30 26 C 3.0800 4.0009 0.0 0
M  V30 27 C 5.3900 2.6673 0.0 0
M  V30 28 C 3.8500 2.6673 0.0 0
M  V30 29 H 5.2702 9.7299 0.0 0
M  V30 30 H 10.6731 8.3254 0.0 0
M  V30 31 H 5.3384 11.4054 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 13 1 CFG=3
M  V30 4 1 2 4
M  V30 5 2 5 16
M  V30 6 2 6 16
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 26
M  V30 11 3 11 12
M  V30 12 1 11 28
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 1 14 29 CFG=3
M  V30 19 1 15 19 CFG=3
M  V30 20 1 15 20
M  V30 21 1 15 30
M  V30 22 1 16 21
M  V30 23 1 17 19 CFG=3
M  V30 24 1 17 22
M  V30 25 1 17 31
M  V30 26 1 18 21
M  V30 27 1 20 22
M  V30 28 1 21 23
M  V30 29 2 23 24
M  V30 30 1 23 25
M  V30 31 1 24 26
M  V30 32 2 25 27
M  V30 33 2 26 28
M  V30 34 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 13 14 15 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1011526-48-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1011526-54-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16466988
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent (stage 1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM [2.2.1]-Bicyclic sultams as potent androgen receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shan, Weifang; Balog, Aaron; Nation, Andrew; Zhu, Xiao; Chen, Jing;
Cvijic, Mary Ellen; Geng, Jieping; Rizzo, Cheryl A.; Spires, Thomas Jr.;
Attar, Ricardo M.; Obermeier, Mary; Traeger, Sarah; Dai, Jun; Zhang,
Yingru; Galella, Michael; Trainor, George; Vite, Gregory D.; Gavai,
Ashvinikumar V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2016), 26(23), 5707-5711

$RFMT $RIREG SCHEME15 STEP1
$RXN



  2  1
$MOL
Pyrido[2,3-d]pyrimidin-7(8H)-one, 6-(5-amino-4-fluoro-2-methylphenyl)-8-methy...
C16H15FN4OS
1012878-62-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 0.0000 0.0 0
M  V30 2 C 4.6200 5.3349 0.0 0
M  V30 3 C 9.2400 0.0000 0.0 0
M  V30 4 N 1.5400 0.0000 0.0 0
M  V30 5 F 0.0000 2.6674 0.0 0
M  V30 6 S 13.0900 4.0011 0.0 0
M  V30 7 C 13.8600 5.3349 0.0 0
M  V30 8 C 6.1600 2.6674 0.0 0
M  V30 9 C 6.9300 4.0011 0.0 0
M  V30 10 C 6.9300 1.3338 0.0 0
M  V30 11 C 8.4700 4.0011 0.0 0
M  V30 12 N 8.4700 1.3338 0.0 0
M  V30 13 C 9.2400 2.6674 0.0 0
M  V30 14 C 9.2400 5.3349 0.0 0
M  V30 15 N 10.7800 2.6674 0.0 0
M  V30 16 N 10.7800 5.3349 0.0 0
M  V30 17 C 11.5500 4.0011 0.0 0
M  V30 18 C 4.6200 2.6674 0.0 0
M  V30 19 C 3.8500 4.0011 0.0 0
M  V30 20 C 3.8500 1.3338 0.0 0
M  V30 21 C 2.3100 4.0011 0.0 0
M  V30 22 C 2.3100 1.3338 0.0 0
M  V30 23 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 19
M  V30 3 1 3 12
M  V30 4 1 4 22
M  V30 5 1 5 23
M  V30 6 1 6 7
M  V30 7 1 6 17
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 18
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 13
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrido[2,3-d]pyrimidin-7(8H)-one, 6-(5-amino-4-fluoro-2-methylphenyl)-8-methy...
C16H16FN5O
1012879-02-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 0.0000 0.0 0
M  V30 2 C 4.6200 5.3349 0.0 0
M  V30 3 C 9.2400 0.0000 0.0 0
M  V30 4 N 1.5400 0.0000 0.0 0
M  V30 5 F 0.0000 2.6674 0.0 0
M  V30 6 N 13.0900 4.0011 0.0 0
M  V30 7 C 13.8600 5.3349 0.0 0
M  V30 8 C 6.1600 2.6674 0.0 0
M  V30 9 C 6.9300 4.0011 0.0 0
M  V30 10 C 6.9300 1.3338 0.0 0
M  V30 11 C 8.4700 4.0011 0.0 0
M  V30 12 N 8.4700 1.3338 0.0 0
M  V30 13 C 9.2400 2.6674 0.0 0
M  V30 14 C 9.2400 5.3349 0.0 0
M  V30 15 N 10.7800 2.6674 0.0 0
M  V30 16 N 10.7800 5.3349 0.0 0
M  V30 17 C 11.5500 4.0011 0.0 0
M  V30 18 C 4.6200 2.6674 0.0 0
M  V30 19 C 3.8500 4.0011 0.0 0
M  V30 20 C 3.8500 1.3338 0.0 0
M  V30 21 C 2.3100 4.0011 0.0 0
M  V30 22 C 2.3100 1.3338 0.0 0
M  V30 23 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 19
M  V30 3 1 3 12
M  V30 4 1 4 22
M  V30 5 1 5 23
M  V30 6 1 6 7
M  V30 7 1 6 17
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 18
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 13
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1012878-62-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1012879-02-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8518450
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 937-14-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7631-90-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General/Typical Procedure: Example A1: To a
solution of Example A3 (6.0 g, 19 mmol) in CH2Cl2 (50 mL) was added
m-chloroperoxybenzoic acid (mCPBA, 6.5 g, 38 mmol) in one portion. After
stirring for 2h at RT, sat. aq NaHCO3and aq NaHSO3 solution were added
and stirring was continued for a few minutes. The combined organic layer
was washed with brine, dried and concentrated in vacuo. The residue was
dissolved in DMSO (5 mL) and ammonia in dioxane (2 M, 200 mL, 400 mmol)
was added. The resultant reaction mixture was stirred overnight at RT.
The solvent was removed under reduced pressure and the residue was
purified by reverse phase prep-HPLC.
6-(5-amino-4-fluoro-2-methylphenyl)-8-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one
(1.56 g, 105% yield) as an orange foam MS (ESI) m/z: 314.3 (M+H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic ureas as kinase inhibitors useful for the
treatment of proliferative and inflammatory diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Flynn, Daniel L.; Kaufman, Michael D.; Patt, William C.; Petillo, Peter
A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008034008 A2 2008-03-20

$RFMT $RIREG SCHEME16 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxybenzenesulfonyl chloride
C7H7ClO3S
10130-74-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3337 3.0801 0.0 0 VAL=6
M  V30 2 Cl 0.0000 3.8501 0.0 0
M  V30 3 O 0.5637 1.7464 0.0 0
M  V30 4 O 2.1037 4.4137 0.0 0
M  V30 5 O 6.6687 3.0801 0.0 0
M  V30 6 C 8.0023 2.3101 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 4.0012 3.0801 0.0 0
M  V30 9 C 2.6675 0.7700 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0012 0.0000 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-N-methylbenzenesulfonamide
C8H11NO3S
1538358-34-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.6675 3.0801 0.0 0 VAL=6
M  V30 2 N 1.3337 3.8501 0.0 0
M  V30 3 O 1.8975 1.7464 0.0 0
M  V30 4 O 3.4375 4.4137 0.0 0
M  V30 5 C 0.0000 3.0801 0.0 0
M  V30 6 O 8.0023 3.0801 0.0 0
M  V30 7 C 9.3360 2.3101 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 5.3348 3.0801 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 5.3348 0.0000 0.0 0
M  V30 13 C 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 1 6 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 10130-74-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1538358-34-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-20947929
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of
hydroxysulfonyloxaazaspirodecanylaminopropoxybenzenesulfonamide
derivatives for use as beta-3 adrenergic receptor modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tran, Thuy-Anh; Ullman, Brett; Kramer, Bryan Aubrey; Do, Quyen-Quyen
Thuy; Shin, Young-Jun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019113359 A1 2019-06-13

$RFMT $RIREG SCHEME17 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Oxopyrrolidine-1-carboxylic acid tert-butyl ester
C9H15NO3
101385-93-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 2.6218 0.0 0
M  V30 2 O 2.6673 1.8517 0.0 0
M  V30 3 O 4.0010 4.1618 0.0 0
M  V30 4 C 1.3337 2.6218 0.0 0
M  V30 5 C 0.5637 1.2881 0.0 0
M  V30 6 C 0.0000 3.3918 0.0 0
M  V30 7 C 2.1037 3.9554 0.0 0
M  V30 8 O 9.3037 1.4946 0.0 0
M  V30 9 N 5.3348 1.8517 0.0 0
M  V30 10 C 5.4958 0.3202 0.0 0
M  V30 11 C 6.7417 2.4782 0.0 0
M  V30 12 C 7.0021 0.0000 0.0 0
M  V30 13 C 7.7721 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 13
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Pyrrolidinecarboxylic acid, 3-(methylimino)-, 1,1-dimethylethyl ester, (3Z)-
C10H18N2O2
3044763-12-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.6218 0.0 0
M  V30 2 O 2.6673 1.8517 0.0 0
M  V30 3 O 4.0012 4.1618 0.0 0
M  V30 4 C 1.3337 2.6218 0.0 0
M  V30 5 C 2.1037 3.9554 0.0 0
M  V30 6 C 0.0000 3.3918 0.0 0
M  V30 7 C 0.5637 1.2881 0.0 0
M  V30 8 N 9.3038 1.4946 0.0 0
M  V30 9 C 9.9301 2.9016 0.0 0
M  V30 10 N 5.3348 1.8517 0.0 0
M  V30 11 C 6.7417 2.4782 0.0 0
M  V30 12 C 5.4958 0.3202 0.0 0
M  V30 13 C 7.7722 1.3337 0.0 0
M  V30 14 C 7.0022 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 13
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 101385-93-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3044763-12-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41806320
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted tetrahydropyrrolo-pyridinone compounds and
their use in treating medical conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gardinier, Kevin Matthew; Audia, James Edmund; Monn, James; Myers, Jason;
Ahmad, Nadia M.; Gancia, Emanuela; Wagstaff, Niall; Skidmore, Elizabeth
Anne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024130064 A1 2024-06-20

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(3-Amino-4-fluorophenoxy)-2-pyridinecarboxylic acid
C12H9FN2O3
1020172-94-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 4.6201 0.0 0
M  V30 2 C 10.6697 1.5400 0.0 0
M  V30 3 O 12.0033 2.3101 0.0 0
M  V30 4 O 10.6697 0.0000 0.0 0
M  V30 5 N 0.0000 4.6201 0.0 0
M  V30 6 F 0.0000 1.5400 0.0 0
M  V30 7 C 6.6685 3.8501 0.0 0
M  V30 8 C 6.6685 2.3101 0.0 0
M  V30 9 C 8.0022 4.6201 0.0 0
M  V30 10 C 8.0022 1.5400 0.0 0
M  V30 11 N 9.3360 3.8501 0.0 0
M  V30 12 C 9.3360 2.3101 0.0 0
M  V30 13 C 4.0012 3.8501 0.0 0
M  V30 14 C 2.6673 4.6201 0.0 0
M  V30 15 C 4.0012 2.3101 0.0 0
M  V30 16 C 1.3337 3.8501 0.0 0
M  V30 17 C 2.6673 1.5400 0.0 0
M  V30 18 C 1.3337 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 12
M  V30 6 1 5 16
M  V30 7 1 6 18
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(3-Amino-4-fluorophenoxy)-N-methyl-2-pyridinecarboxamide
C13H12FN3O2
2627292-01-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 4.6201 0.0 0
M  V30 2 N 0.0000 4.6201 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 C 10.6697 1.5400 0.0 0
M  V30 5 N 12.0033 2.3101 0.0 0
M  V30 6 O 10.6697 0.0000 0.0 0
M  V30 7 C 13.3370 1.5400 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 4.6201 0.0 0
M  V30 10 C 4.0010 2.3101 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 1.5400 0.0 0
M  V30 13 C 1.3337 2.3101 0.0 0
M  V30 14 C 6.6685 3.8501 0.0 0
M  V30 15 C 8.0022 4.6201 0.0 0
M  V30 16 C 6.6685 2.3101 0.0 0
M  V30 17 C 9.3360 3.8501 0.0 0
M  V30 18 N 8.0022 1.5400 0.0 0
M  V30 19 C 9.3360 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 1 2 11
M  V30 4 1 3 13
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 19
M  V30 8 1 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1020172-94-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2627292-01-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26964470
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example A21: In DMF (5 mL) was placed
5-(3-amino-4-fluorophenoxy)picolinic acid from Example A12 (500 mg, 2.01
mmol), 2.0 M methylamine solution/THF (10 mL, 20.1 mmol) and HOBt (324
mg, 2.12 mmol). To this was added
N1-((ethylimino)methylene)-N3,N3-dimethylpropane-1,3-diamine
hydrochloride (772 mg, 4.03 mmol) and the solution stirred overnight at
RT. The solution was treated with an additional equiv of
N1-((ethylimino)methylene)-N3,N3-dimethylpropane-1,3-diamine
hydrochloride (775 mg) and warmed to 40 °C, then cooled to RT and stirred
overnight. The solution was diluted with ethyl acetate (30 mL) and washed
with water (30 mL), brine (30 mL), dried (Na2SO4) and concentrated in
vacuo to yield 5-(3-amino-4-fluorophenoxy)-N-methylpicolinamide (530 mg,
101% yield) as a thick oil, which was used without further purification.
MS (ESI) m/z: 262,0 (M+H+).
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of EDCI
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of urea derivatives as kinase inhibitors useful for the
treatment of myleoproliferative diseases and other proliferative diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Petillo, Peter A.; Kaufman, Michael D.; Flynn, Daniel L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008046003 A2 2008-04-17

$RFMT $RIREG SCHEME19 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 2-[(4-fluorophenyl)methyl]-5,6,8,9-tetrahydro-4-[[(trifluor...
C21H23F4N3O5S
1023954-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.5378 3.6437 0.0 0
M  V30 2 S 7.3078 2.3101 0.0 0 VAL=6
M  V30 3 C 5.9741 1.5400 0.0 0
M  V30 4 O 8.0778 0.9764 0.0 0
M  V30 5 O 8.6414 3.0801 0.0 0
M  V30 6 F 4.6404 2.3101 0.0 0
M  V30 7 F 4.6404 0.7700 0.0 0
M  V30 8 F 5.9741 0.0000 0.0 0
M  V30 9 C 11.1579 6.3112 0.0 0
M  V30 10 C 2.6673 9.4349 0.0 0
M  V30 11 O 2.6673 10.9749 0.0 0
M  V30 12 O 1.3337 8.6648 0.0 0
M  V30 13 C 1.3337 11.7449 0.0 0
M  V30 14 C 2.1037 13.0786 0.0 0
M  V30 15 C 0.0000 12.5149 0.0 0
M  V30 16 C 0.5637 10.4112 0.0 0
M  V30 17 F 14.2379 11.6460 0.0 0
M  V30 18 C 7.3078 4.9774 0.0 0
M  V30 19 C 6.5378 6.3112 0.0 0
M  V30 20 N 8.8478 4.9774 0.0 0
M  V30 21 C 7.3078 7.6449 0.0 0
M  V30 22 C 5.0150 6.0816 0.0 0
M  V30 23 C 9.6178 6.3112 0.0 0
M  V30 24 N 8.8478 7.6449 0.0 0
M  V30 25 C 6.7452 9.0785 0.0 0
M  V30 26 C 3.8860 7.1291 0.0 0
M  V30 27 C 5.2735 9.5323 0.0 0
M  V30 28 N 4.0012 8.6648 0.0 0
M  V30 29 C 11.9279 7.6449 0.0 0
M  V30 30 C 11.1579 8.9786 0.0 0
M  V30 31 C 13.4679 7.6449 0.0 0
M  V30 32 C 11.9279 10.3122 0.0 0
M  V30 33 C 14.2379 8.9786 0.0 0
M  V30 34 C 13.4679 10.3122 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 3 8
M  V30 9 1 9 23
M  V30 10 1 9 29
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 28
M  V30 14 1 11 13
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 17 34
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 19 22
M  V30 23 2 20 23
M  V30 24 2 21 24
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 1 23 24
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 2-[(4-fluorophenyl)methyl]-5,6,8,9-tetrahydro-4-(methylamin...
C21H27FN4O2
1065112-87-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.0973 0.7700 0.0 0
M  V30 2 C 11.4310 0.0000 0.0 0
M  V30 3 C 12.7646 5.3900 0.0 0
M  V30 4 C 3.8500 3.8500 0.0 0
M  V30 5 O 3.0800 5.1836 0.0 0
M  V30 6 O 3.0800 2.5164 0.0 0
M  V30 7 C 1.5400 5.1836 0.0 0
M  V30 8 C 1.5400 6.7236 0.0 0
M  V30 9 C 0.0000 5.1836 0.0 0
M  V30 10 C 1.5400 3.6436 0.0 0
M  V30 11 F 18.0993 2.3100 0.0 0
M  V30 12 C 8.7635 3.0800 0.0 0
M  V30 13 C 8.7635 4.6200 0.0 0
M  V30 14 C 10.0973 2.3100 0.0 0
M  V30 15 C 7.5596 2.1198 0.0 0
M  V30 16 N 10.0973 5.3900 0.0 0
M  V30 17 C 7.5596 5.5802 0.0 0
M  V30 18 N 11.4310 3.0800 0.0 0
M  V30 19 C 6.0582 2.4625 0.0 0
M  V30 20 C 11.4310 4.6200 0.0 0
M  V30 21 C 6.0582 5.2375 0.0 0
M  V30 22 N 5.3900 3.8500 0.0 0
M  V30 23 C 14.0982 4.6200 0.0 0
M  V30 24 C 14.0982 3.0800 0.0 0
M  V30 25 C 15.4320 5.3900 0.0 0
M  V30 26 C 15.4320 2.3100 0.0 0
M  V30 27 C 16.7657 4.6200 0.0 0
M  V30 28 C 16.7657 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 3 20
M  V30 4 1 3 23
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 22
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 11 28
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 15
M  V30 16 2 13 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 2 18 20
M  V30 23 1 19 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1023954-05-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1065112-87-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2880848
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 127-19-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Tert-butyl
2-(4-fluorobenzyl)-4-(methylamino)-5,6,8,9-tetrahydro-7H-pyrimido[4,5,d]azepine-7-carboxylate
To a solution of the triflate from Step C (90.0mg, 0.18mmoi) in DMA (2mL)
was added methylamine solution in THF (0.45mL, 2.0M, 0.59mmol) and the
reaction was stirred for 48h. The reaction mixture was concentrated in
vacuo and the material was used without further purification. A
quantitative yield was assumed. LRMS ES+ and AP+ m/z 387 [MH]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimido[4,5-d]azepine derivatives as 5-HT2C agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Andrews, Mark David; Blagg, Julian; Brennan, Paul Edward; Fish, Paul
Vincent; Roberts, Lee Richard; Storer, Robert Ian; Whitlock, Gavin
Alistair
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008117169 A1 2008-10-02

$RFMT $RIREG SCHEME20 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 5-[[2-[3-[[3-(1,1-dimethylethoxy)-1,3-dioxopropyl]amino]phe...
C33H34N6O5
1024582-66-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 48 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3510 4.0010 0.0 0
M  V30 2 N 13.8212 8.0022 0.0 0
M  V30 3 C 14.5912 9.3358 0.0 0
M  V30 4 C 16.1312 9.3358 0.0 0
M  V30 5 O 13.8212 10.6697 0.0 0
M  V30 6 C 16.9013 10.6697 0.0 0
M  V30 7 O 18.4413 10.6697 0.0 0
M  V30 8 O 16.1312 12.0033 0.0 0
M  V30 9 C 19.2113 12.0033 0.0 0
M  V30 10 C 17.8776 12.7733 0.0 0
M  V30 11 C 19.9813 13.3370 0.0 0
M  V30 12 C 20.5450 11.2333 0.0 0
M  V30 13 C 2.3307 10.6530 0.0 0
M  V30 14 O 1.1861 11.6835 0.0 0
M  V30 15 O 3.7953 11.1289 0.0 0
M  V30 16 C 1.5063 13.1899 0.0 0
M  V30 17 C 0.0000 13.5101 0.0 0
M  V30 18 C 1.8265 14.6962 0.0 0
M  V30 19 C 3.0128 12.8698 0.0 0
M  V30 20 C 6.8910 4.0010 0.0 0
M  V30 21 C 7.6611 2.6673 0.0 0
M  V30 22 N 7.6611 5.3348 0.0 0
M  V30 23 C 9.2011 2.6673 0.0 0
M  V30 24 C 6.8910 1.3337 0.0 0
M  V30 25 C 9.2011 5.3348 0.0 0
M  V30 26 N 9.9711 4.0010 0.0 0
M  V30 27 C 9.9711 1.3337 0.0 0
M  V30 28 C 7.6611 0.0000 0.0 0
M  V30 29 C 9.2011 0.0000 0.0 0
M  V30 30 C 4.5810 5.3348 0.0 0
M  V30 31 C 3.0410 5.3348 0.0 0
M  V30 32 C 5.3510 6.6685 0.0 0
M  V30 33 C 2.2709 6.6685 0.0 0
M  V30 34 C 4.5810 8.0022 0.0 0
M  V30 35 C 3.0410 8.0022 0.0 0
M  V30 36 C 0.7645 6.9887 0.0 0
M  V30 37 N 2.0105 9.1467 0.0 0
M  V30 38 N 0.6035 8.5202 0.0 0
M  V30 39 C 9.9711 6.6685 0.0 0
M  V30 40 C 11.5111 6.6685 0.0 0
M  V30 41 C 9.2011 8.0022 0.0 0
M  V30 42 C 12.2812 8.0022 0.0 0
M  V30 43 C 9.9711 9.3358 0.0 0
M  V30 44 C 11.5111 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 20
M  V30 2 1 1 30
M  V30 3 1 2 3
M  V30 4 1 2 42
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 13 37
M  V30 17 1 14 16
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 1 20 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 21 24
M  V30 25 1 22 25
M  V30 26 1 23 26
M  V30 27 1 23 27
M  V30 28 2 24 28
M  V30 29 2 25 26
M  V30 30 1 25 39
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 1 30 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 33 36
M  V30 39 2 34 35
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 1 37 38
M  V30 43 2 39 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 2 41 43
M  V30 47 2 42 44
M  V30 48 1 43 44
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-[4-(1H-Indazol-5-ylamino)-2-quinazolinyl]phenyl]-2-(methylamino)acetamide
C24H21N7O
911417-30-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.7473 4.0011 0.0 0
M  V30 2 N 13.2174 8.0022 0.0 0
M  V30 3 C 13.9874 9.3359 0.0 0
M  V30 4 C 15.5274 9.3359 0.0 0
M  V30 5 O 13.2174 10.6695 0.0 0
M  V30 6 N 16.2974 10.6695 0.0 0
M  V30 7 C 17.8374 10.6695 0.0 0
M  V30 8 C 7.0573 2.6673 0.0 0
M  V30 9 C 6.2873 4.0011 0.0 0
M  V30 10 C 8.5973 2.6673 0.0 0
M  V30 11 C 6.2873 1.3337 0.0 0
M  V30 12 N 7.0573 5.3348 0.0 0
M  V30 13 N 9.3673 4.0011 0.0 0
M  V30 14 C 9.3673 1.3337 0.0 0
M  V30 15 C 7.0573 0.0000 0.0 0
M  V30 16 C 8.5973 5.3348 0.0 0
M  V30 17 C 8.5973 0.0000 0.0 0
M  V30 18 C 3.9772 5.3348 0.0 0
M  V30 19 C 2.4372 5.3348 0.0 0
M  V30 20 C 4.7473 6.6684 0.0 0
M  V30 21 C 1.6672 6.6684 0.0 0
M  V30 22 C 3.9772 8.0022 0.0 0
M  V30 23 C 2.4372 8.0022 0.0 0
M  V30 24 C 0.1609 6.9886 0.0 0
M  V30 25 N 1.4068 9.1466 0.0 0
M  V30 26 N 0.0000 8.5203 0.0 0
M  V30 27 C 9.3673 6.6684 0.0 0
M  V30 28 C 10.9073 6.6684 0.0 0
M  V30 29 C 8.5973 8.0022 0.0 0
M  V30 30 C 11.6773 8.0022 0.0 0
M  V30 31 C 9.3673 9.3359 0.0 0
M  V30 32 C 10.9073 9.3359 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 2 30
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 2 13 16
M  V30 18 2 14 17
M  V30 19 1 15 17
M  V30 20 1 16 27
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 21 24
M  V30 27 2 22 23
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 1 25 26
M  V30 31 2 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1024582-66-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 911417-30-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-12341105
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 14:
N-(3-(4-(1H-indazol-5-ylamino)quinazolin-2-yl)phenyl)-2-(methylamino)acetamide.
To tert-butyl
5-(2-(3-(2-(tert-butoxycarbonyl)acetamido)phenyl)quinazolin-4-ylamino)-1H-indazole-1-carboxylate
(123 mg, 0.20 mmol) was added a solution of 1:1 TFA:CH2Cl2 (4 mL) and
stirred at RT for 2 h. The reaction mixture was concentrated in vacuo and
the residue was triturated with ethyl ether to afford 2-methoxyacetyl
chloride
N-(3-(4-(1H-indazol-5-ylamino)quinazolin-2-yl)phenyl)-2-(dimethylamino)acetamide.
(95 mg, 0.22 mmol, 100%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of indazolylaminoquinazolines as Rho kinase inhibitors with
improved pharmacokinetic and pharmacodynamic properties and their use
with statins in combination therapy of diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bartolozzi, Alessandra; Campbell, Stewart; Cole, Bridget; Ellis, James;
Foudoulakis, Hope; Kirk, Brian; Ram, Siya; Sweetnam, Paul; Hauer-Jensen,
Martin; Boerma, Marjan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008054599 A2 2008-05-08

$RFMT $RIREG SCHEME21 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2S)-2-[(3-Bromophenoxy)methyl]oxirane
C9H9BrO2
1024843-97-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 2.3101 0.0 0
M  V30 2 O 5.3348 3.0801 0.0 0
M  V30 3 Br 0.0000 3.0801 0.0 0
M  V30 4 C 8.0023 3.0801 0.0 0 CFG=1
M  V30 5 C 9.5424 3.0801 0.0 0
M  V30 6 O 8.7723 4.4137 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 2.6675 3.0801 0.0 0
M  V30 9 C 4.0012 0.7700 0.0 0
M  V30 10 C 1.3337 2.3101 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 4 1 CFG=1
M  V30 3 1 2 7
M  V30 4 1 3 10
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2S)-1-(3-Bromophenoxy)-3-(methylamino)-2-propanol
C10H14BrNO2
1628832-51-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 3.0801 0.0 0 CFG=1
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 O 8.0022 4.6201 0.0 0
M  V30 6 N 10.6697 3.0801 0.0 0
M  V30 7 C 12.0033 2.3101 0.0 0
M  V30 8 Br 0.0000 3.0801 0.0 0
M  V30 9 C 4.0012 2.3101 0.0 0
M  V30 10 C 2.6673 3.0801 0.0 0
M  V30 11 C 4.0012 0.7700 0.0 0
M  V30 12 C 1.3337 2.3101 0.0 0
M  V30 13 C 2.6673 0.0000 0.0 0
M  V30 14 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5 CFG=1
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1024843-97-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1628832-51-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-19775214
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM CARM1 inhibitors for treating Cancer and Metabolic disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chesworth, Richard; Moradei, Oscar Miguel; Shapiro, Gideon; Jin, Lei;
Babine, Robert E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016044641 A2 2016-03-24

$RFMT $RIREG SCHEME21 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2S)-2-[(3-Bromophenoxy)methyl]oxirane
C9H9BrO2
1024843-97-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 2.3101 0.0 0
M  V30 2 O 5.3348 3.0801 0.0 0
M  V30 3 Br 0.0000 3.0801 0.0 0
M  V30 4 C 8.0023 3.0801 0.0 0 CFG=1
M  V30 5 C 9.5424 3.0801 0.0 0
M  V30 6 O 8.7723 4.4137 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 2.6675 3.0801 0.0 0
M  V30 9 C 4.0012 0.7700 0.0 0
M  V30 10 C 1.3337 2.3101 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 4 1 CFG=1
M  V30 3 1 2 7
M  V30 4 1 3 10
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2S)-1-(3-Bromophenoxy)-3-(methylamino)-2-propanol
C10H14BrNO2
1628832-51-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 3.0801 0.0 0 CFG=1
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 O 8.0022 4.6201 0.0 0
M  V30 6 N 10.6697 3.0801 0.0 0
M  V30 7 C 12.0033 2.3101 0.0 0
M  V30 8 Br 0.0000 3.0801 0.0 0
M  V30 9 C 4.0012 2.3101 0.0 0
M  V30 10 C 2.6673 3.0801 0.0 0
M  V30 11 C 4.0012 0.7700 0.0 0
M  V30 12 C 1.3337 2.3101 0.0 0
M  V30 13 C 2.6673 0.0000 0.0 0
M  V30 14 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5 CFG=1
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1024843-97-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1628832-51-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-8074506
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1-Amino-3-(aryloxy)propanol derivatives as CARM1 inhibitors and uses
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chesworth, Richard; Moradei, Oscar Miguel; Shapiro, Gideon; Jin, Lei;
Babine, Robert E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014144169 A1 2014-09-18

$RFMT $RIREG SCHEME22 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzoic acid
C19H15N5O2
1030274-25-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.3399 2.6675 0.0 0
M  V30 2 C 9.8799 0.0000 0.0 0
M  V30 3 C 12.9600 5.3348 0.0 0
M  V30 4 O 12.1900 6.6685 0.0 0
M  V30 5 O 14.5000 5.3348 0.0 0
M  V30 6 C 6.0298 4.0012 0.0 0
M  V30 7 C 5.2598 5.3348 0.0 0
M  V30 8 C 7.5699 4.0012 0.0 0
M  V30 9 C 4.9994 2.8566 0.0 0
M  V30 10 N 3.7535 5.0147 0.0 0
M  V30 11 N 6.0298 6.6685 0.0 0
M  V30 12 N 8.3399 5.3348 0.0 0
M  V30 13 N 3.5926 3.4831 0.0 0
M  V30 14 C 7.5699 6.6685 0.0 0
M  V30 15 C 2.6091 6.0451 0.0 0
M  V30 16 C 1.1444 5.5692 0.0 0
M  V30 17 C 2.9293 7.5516 0.0 0
M  V30 18 C 0.0000 6.5997 0.0 0
M  V30 19 C 1.7847 8.5820 0.0 0
M  V30 20 C 0.3202 8.1061 0.0 0
M  V30 21 C 9.8799 2.6675 0.0 0
M  V30 22 C 10.6499 4.0012 0.0 0
M  V30 23 C 10.6499 1.3337 0.0 0
M  V30 24 C 12.1900 4.0012 0.0 0
M  V30 25 C 12.1900 1.3337 0.0 0
M  V30 26 C 12.9600 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 21
M  V30 3 1 2 23
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 24
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 1 10 13
M  V30 15 1 10 15
M  V30 16 1 11 14
M  V30 17 2 12 14
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,4-Dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide
C20H18N6O
630106-60-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.3399 2.6675 0.0 0
M  V30 2 C 9.8799 0.0000 0.0 0
M  V30 3 C 12.9600 5.3348 0.0 0
M  V30 4 N 14.5000 5.3348 0.0 0
M  V30 5 O 12.1900 6.6685 0.0 0
M  V30 6 C 15.2701 6.6685 0.0 0
M  V30 7 C 6.0298 4.0012 0.0 0
M  V30 8 C 5.2598 5.3348 0.0 0
M  V30 9 C 7.5699 4.0012 0.0 0
M  V30 10 C 4.9994 2.8566 0.0 0
M  V30 11 N 3.7535 5.0147 0.0 0
M  V30 12 N 6.0298 6.6685 0.0 0
M  V30 13 N 8.3399 5.3348 0.0 0
M  V30 14 N 3.5926 3.4831 0.0 0
M  V30 15 C 7.5699 6.6685 0.0 0
M  V30 16 C 2.6091 6.0451 0.0 0
M  V30 17 C 2.9293 7.5516 0.0 0
M  V30 18 C 1.1444 5.5692 0.0 0
M  V30 19 C 1.7847 8.5820 0.0 0
M  V30 20 C 0.0000 6.5997 0.0 0
M  V30 21 C 0.3202 8.1061 0.0 0
M  V30 22 C 9.8799 2.6675 0.0 0
M  V30 23 C 10.6499 4.0012 0.0 0
M  V30 24 C 10.6499 1.3337 0.0 0
M  V30 25 C 12.1900 4.0012 0.0 0
M  V30 26 C 12.1900 1.3337 0.0 0
M  V30 27 C 12.9600 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 22
M  V30 3 1 2 24
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 25
M  V30 7 1 4 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 1 11 14
M  V30 16 1 11 16
M  V30 17 1 12 15
M  V30 18 2 13 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1030274-25-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 630106-60-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15104229
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1892-57-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrazolo-pyrimidines: A novel heterocyclic scaffold for potent and
selective p38α inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Das, Jagabandhu; Moquin, Robert V.; Pitt, Sidney; Zhang, Rosemary; Shen,
Ding Ren; McIntyre, Kim W.; Gillooly, Kathleen; Doweyko, Arthur M.; Sack,
John S.; Zhang, Hongjian; Kiefer, Susan E.; Kish, Kevin; McKinnon,
Murray; Barrish, Joel C.; Dodd, John H.; Schieven, Gary L.; Leftheris,
Katerina
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2008), 18(8), 2652-2657

$RFMT $RIREG SCHEME23 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(5-Pyrimidinyloxy)benzaldehyde
C11H8N2O2
1030379-80-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 0.0000 0.0 0
M  V30 2 C 9.3360 3.0801 0.0 0
M  V30 3 O 10.6697 2.3101 0.0 0
M  V30 4 C 5.3348 0.7700 0.0 0
M  V30 5 C 6.6685 0.0000 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 8.0023 0.7700 0.0 0
M  V30 8 C 6.6685 3.0801 0.0 0
M  V30 9 C 8.0023 2.3101 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 1.3337 0.0000 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 N 0.0000 0.7700 0.0 0
M  V30 14 N 1.3337 3.0801 0.0 0
M  V30 15 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 10
M  V30 3 2 2 3
M  V30 4 1 2 9
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-(5-pyrimidinyloxy)benzenemethanamine
C12H13N3O
1030379-81-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 0.0000 0.0 0
M  V30 2 C 9.3360 3.0801 0.0 0
M  V30 3 N 10.6697 2.3101 0.0 0
M  V30 4 C 12.0033 3.0801 0.0 0
M  V30 5 C 5.3348 0.7700 0.0 0
M  V30 6 C 6.6685 0.0000 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 8.0022 0.7700 0.0 0
M  V30 9 C 6.6685 3.0801 0.0 0
M  V30 10 C 8.0022 2.3101 0.0 0
M  V30 11 C 2.6673 0.7700 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 1.3337 0.0000 0.0 0
M  V30 14 N 1.3337 3.0801 0.0 0
M  V30 15 N 0.0000 0.7700 0.0 0
M  V30 16 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 2 10
M  V30 5 1 3 4
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1030379-80-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1030379-81-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-12965963
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM d) N-Methyl-N-{[4-(pyrimidin-5-yloxy)phenyl]methyl}amine
4-(Pyrimidin-5-yloxy)benzaldehyde (0.344 g, 1.7 mmol) was stirred with
33% methylamine in EtOH (30 mL) at reflux for 3 hours and then
concentrated. The residue was dissolved in MeOH and treated with sodium
borohydride (0.195 g, 5.2 mmol) over 1 hour and stirred for a further 1
hour. Water was added and the product was extracted three times with
EtOAc. The organic phases were combined, washed with brine, dried and
concentrated to give 0.267 g (100%) of product that was used without
further purification. APCI-MS m/z: 216 (M+1). 1H NMR (CDCll3): δ 2.38 (s,
3H), 3.68 (s, 2H), 6.94 (d, 2H), 7.28 (d, 2H), 8.38 (d, 2H), 8.87 (s, 1H)
ppm.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of hydantoin derivatives for use as MMP inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chapman, David; Gabos, Balint; Munck af Rosenschold, Magnus
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008065393 A1 2008-06-05

$RFMT $RIREG SCHEME24 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Dimethyl 1-methyl-4-oxo-2,6-di-2-quinolinyl-3,5-piperidinedicarboxylate
C28H25N3O5
103098-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 8.0021 0.0 0
M  V30 2 O 1.5400 9.3359 0.0 0
M  V30 3 O 1.5400 6.6684 0.0 0
M  V30 4 C 0.0000 9.3359 0.0 0
M  V30 5 C 6.9301 5.3348 0.0 0
M  V30 6 O 3.8500 10.6695 0.0 0
M  V30 7 C 6.9301 10.6695 0.0 0
M  V30 8 O 6.1601 12.0032 0.0 0
M  V30 9 O 8.4701 10.6695 0.0 0
M  V30 10 C 6.9301 13.3369 0.0 0
M  V30 11 C 4.6201 6.6684 0.0 0
M  V30 12 C 3.8500 8.0021 0.0 0
M  V30 13 N 6.1601 6.6684 0.0 0
M  V30 14 C 4.6201 9.3359 0.0 0
M  V30 15 C 6.9301 8.0021 0.0 0
M  V30 16 C 6.1601 9.3359 0.0 0
M  V30 17 C 3.8500 5.3348 0.0 0
M  V30 18 N 4.6201 4.0010 0.0 0
M  V30 19 C 2.3100 5.3348 0.0 0
M  V30 20 C 3.8500 2.6673 0.0 0
M  V30 21 C 1.5400 4.0010 0.0 0
M  V30 22 C 2.3100 2.6673 0.0 0
M  V30 23 C 4.6201 1.3337 0.0 0
M  V30 24 C 1.5400 1.3337 0.0 0
M  V30 25 C 3.8500 0.0000 0.0 0
M  V30 26 C 2.3100 0.0000 0.0 0
M  V30 27 C 8.4701 8.0021 0.0 0
M  V30 28 N 9.2401 6.6684 0.0 0
M  V30 29 C 9.2401 9.3359 0.0 0
M  V30 30 C 10.7801 6.6684 0.0 0
M  V30 31 C 10.7801 9.3359 0.0 0
M  V30 32 C 11.5501 8.0021 0.0 0
M  V30 33 C 11.5501 5.3348 0.0 0
M  V30 34 C 13.0901 8.0021 0.0 0
M  V30 35 C 13.0901 5.3348 0.0 0
M  V30 36 C 13.8602 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 13
M  V30 6 2 6 14
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 16
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 17
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 1 15 27
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 20 23
M  V30 25 1 21 22
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 30 33
M  V30 36 1 31 32
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-1,5-Dimethyl (1S,2S,4S,5R)-3,7-dimethyl-9-oxo-2,4-di-2-quinolinyl-3,7-dia...
C31H30N4O5
250339-63-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6011 11.4616 0.0 0
M  V30 2 O 7.2006 12.9486 0.0 0
M  V30 3 O 9.0892 11.0649 0.0 0
M  V30 4 C 8.2881 14.0389 0.0 0
M  V30 5 O 5.6352 8.4038 0.0 0
M  V30 6 C 7.6025 6.4364 0.0 0
M  V30 7 C 2.5773 6.4378 0.0 0
M  V30 8 O 1.0903 6.8384 0.0 0
M  V30 9 O 2.9740 4.9497 0.0 0
M  V30 10 C 0.0000 5.7508 0.0 0
M  V30 11 C 2.5787 11.4602 0.0 0
M  V30 12 C 6.5136 10.3713 0.0 0 CFG=1
M  V30 13 C 7.1089 8.9483 0.0 0 CFG=2
M  V30 14 C 4.5462 9.4927 0.0 0
M  V30 15 C 5.0980 10.9593 0.0 0
M  V30 16 N 6.5136 7.5254 0.0 0
M  V30 17 C 3.6677 7.5254 0.0 0 CFG=1
M  V30 18 N 3.6677 10.3713 0.0 0
M  V30 19 C 5.0906 6.9300 0.0 0 CFG=1
M  V30 20 C 3.0797 8.9409 0.0 0
M  V30 21 C 8.6489 8.9483 0.0 0
M  V30 22 N 9.4189 7.6147 0.0 0
M  V30 23 C 9.4189 10.2820 0.0 0
M  V30 24 C 10.9589 7.6147 0.0 0
M  V30 25 C 10.9589 10.2820 0.0 0
M  V30 26 C 11.7289 8.9483 0.0 0
M  V30 27 C 11.7289 6.2809 0.0 0
M  V30 28 C 13.2689 8.9483 0.0 0
M  V30 29 C 13.2689 6.2809 0.0 0
M  V30 30 C 14.0389 7.6147 0.0 0
M  V30 31 C 5.0906 5.3900 0.0 0
M  V30 32 N 6.4243 4.6200 0.0 0
M  V30 33 C 3.7570 4.6200 0.0 0
M  V30 34 C 6.4243 3.0800 0.0 0
M  V30 35 C 3.7570 3.0800 0.0 0
M  V30 36 C 5.0906 2.3100 0.0 0
M  V30 37 C 7.7581 2.3100 0.0 0
M  V30 38 C 5.0906 0.7700 0.0 0
M  V30 39 C 7.7581 0.7700 0.0 0
M  V30 40 C 6.4243 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 2 5 14
M  V30 6 1 6 16
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 17
M  V30 10 1 8 10
M  V30 11 1 11 18
M  V30 12 1 12 13
M  V30 13 1 12 14 CFG=3
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 13 21 CFG=3
M  V30 17 1 17 14 CFG=3
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 1 18 20
M  V30 23 1 19 31 CFG=1
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 24 27
M  V30 30 1 25 26
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 34 37
M  V30 41 1 35 36
M  V30 42 1 36 38
M  V30 43 2 37 39
M  V30 44 2 38 40
M  V30 45 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 12 13 17 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 103098-18-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 250339-63-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-6378119
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for Synthesis of
2,4-Diaryl-Substituted
1,5-Dialkyl-3,7-dimethyl-3,7-diaza-9-oxobicyclo-[3.3.1]nonane-1,5-dicarboxylates
11-19 (modified after procedures in ref 19). Exactly 0.0025 mol of the
piperidin-4-one was dissolved in 20 mL of methanol by refluxing. To this
solution, was added 0.6 mL of a 35% aqueous solution of HCHO, followed by
0.4 mL of a 40% aqueous solution of methylamine. The mixture was refluxed
for 7-8 min, and afterward it was allowed to stand for 3 h at ambient
temperature. Three different workup procedures were possible. First, the
obtained precipitate was filtered and washed with a mixture of
ethanol/diethyl ether. When no precipitate appeared within 24 h, the
solvent was removed in vacuo at 40-50 °C, and the remaining oil was
dissolved in a small amount of ethanol and diethyl ether. Crystals
usually appeared within 2 days. When no crystals were obtained during
this time, the solvent was removed again, and the remaining oil was
treated with diethyl ether. The raw product can be recrystallized from
ethanol. The perchlorates and oxalates of HZ2 were formed according to
known procedures.20 Entry: 11a Entry: 17a x EtOH 1.34g; Yield: 100%
molecular formula: C31H30N4O5, 538.7 mp: 145°C (dec.) elemental analyses
calc: 67.78%C, 6.21%H, 9.59%N found: 66.82%C, 6.12%H, 9.32%N
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Opioid Receptor Affinity of a Series of
2,4-Diaryl-Substituted 3,7-Diazabicyclononanones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Siener, Tom; Cambareri, Antonella; Kuhl, Ulrich; Englberger, Werner;
Haurand, Michael; Koegel, Babette; Holzgrabe, Ulrike
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2000), 43(20), 3746-3751

$RFMT $RIREG SCHEME25 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetic acid, 2-[4-(hydroxymethyl)phenoxy]-, ethyl ester
C11H14O4
103258-64-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 1.5400 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 1.5400 0.0 0
M  V30 4 O 10.6697 2.3101 0.0 0
M  V30 5 O 9.3360 0.0000 0.0 0
M  V30 6 C 12.0033 1.5400 0.0 0
M  V30 7 C 13.3370 2.3101 0.0 0
M  V30 8 C 1.3337 4.6201 0.0 0
M  V30 9 O 0.0000 3.8501 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 12 C 4.0010 1.5400 0.0 0
M  V30 13 C 4.0010 4.6201 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[4-(Hydroxymethyl)phenoxy]-N-methylacetamide
C10H13NO3
666846-74-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 1.5400 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 1.5400 0.0 0
M  V30 4 N 10.6697 2.3101 0.0 0
M  V30 5 O 9.3360 0.0000 0.0 0
M  V30 6 C 12.0033 1.5400 0.0 0
M  V30 7 C 1.3337 4.6201 0.0 0
M  V30 8 O 0.0000 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 4.0012 1.5400 0.0 0
M  V30 12 C 4.0012 4.6201 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 103258-64-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 666846-74-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7346650
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 104219-64-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polymer-assisted solution phase synthesis of the antihyperglycemic agent
Rosiglitazone (Avandia)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Xin; Abell, Chris; Warrington, Brian H.; Ladlow, Mark
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2003), 1(24), 4392-4395

$RFMT $RIREG SCHEME26 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,1,3-Benzothiadiazole, 1-[[4-(bromomethyl)phenyl]methyl]-3-(2-fluorophenyl)-...
C20H16BrFN2O2S
1033227-21-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.3953 6.4210 0.0 0
M  V30 2 O 4.3794 5.9926 0.0 0
M  V30 3 F 2.7844 1.4510 0.0 0
M  V30 4 C 8.3659 5.2309 0.0 0
M  V30 5 C 13.7008 2.1508 0.0 0
M  V30 6 Br 15.0344 2.9208 0.0 0
M  V30 7 N 4.5948 3.9428 0.0 0
M  V30 8 C 5.3649 2.6091 0.0 0
M  V30 9 S 5.6253 5.0873 0.0 0 VAL=6
M  V30 10 C 6.8712 2.9293 0.0 0
M  V30 11 C 4.8890 1.1444 0.0 0
M  V30 12 N 7.0321 4.4609 0.0 0
M  V30 13 C 7.9016 1.7849 0.0 0
M  V30 14 C 5.9194 0.0000 0.0 0
M  V30 15 C 7.4257 0.3202 0.0 0
M  V30 16 C 3.0631 4.1039 0.0 0
M  V30 17 C 2.1580 2.8578 0.0 0
M  V30 18 C 2.4368 5.5107 0.0 0
M  V30 19 C 0.6263 3.0189 0.0 0
M  V30 20 C 0.9052 5.6716 0.0 0
M  V30 21 C 0.0000 4.4257 0.0 0
M  V30 22 C 9.6996 4.4609 0.0 0
M  V30 23 C 11.0333 5.2309 0.0 0
M  V30 24 C 9.6996 2.9208 0.0 0
M  V30 25 C 12.3669 4.4609 0.0 0
M  V30 26 C 11.0333 2.1508 0.0 0
M  V30 27 C 12.3669 2.9208 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 9
M  V30 3 1 3 17
M  V30 4 1 4 12
M  V30 5 1 4 22
M  V30 6 1 5 6
M  V30 7 1 5 27
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 16
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 1 9 12
M  V30 14 1 10 12
M  V30 15 2 10 13
M  V30 16 1 11 14
M  V30 17 1 13 15
M  V30 18 2 14 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[[3-(2-Fluorophenyl)-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]methyl]-N-m...
C21H20FN3O2S
1033219-44-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.3953 6.4210 0.0 0
M  V30 2 O 4.3794 5.9926 0.0 0
M  V30 3 F 2.7844 1.4510 0.0 0
M  V30 4 C 8.3659 5.2309 0.0 0
M  V30 5 C 13.7008 2.1508 0.0 0
M  V30 6 N 15.0344 2.9208 0.0 0
M  V30 7 C 16.3681 2.1508 0.0 0
M  V30 8 N 4.5948 3.9428 0.0 0
M  V30 9 C 5.3649 2.6091 0.0 0
M  V30 10 S 5.6253 5.0873 0.0 0 VAL=6
M  V30 11 C 6.8712 2.9293 0.0 0
M  V30 12 C 4.8888 1.1444 0.0 0
M  V30 13 N 7.0321 4.4609 0.0 0
M  V30 14 C 7.9016 1.7849 0.0 0
M  V30 15 C 5.9194 0.0000 0.0 0
M  V30 16 C 7.4257 0.3202 0.0 0
M  V30 17 C 3.0631 4.1039 0.0 0
M  V30 18 C 2.1579 2.8578 0.0 0
M  V30 19 C 2.4368 5.5107 0.0 0
M  V30 20 C 0.6263 3.0189 0.0 0
M  V30 21 C 0.9052 5.6716 0.0 0
M  V30 22 C 0.0000 4.4257 0.0 0
M  V30 23 C 9.6996 4.4609 0.0 0
M  V30 24 C 11.0333 5.2309 0.0 0
M  V30 25 C 9.6996 2.9208 0.0 0
M  V30 26 C 12.3669 4.4609 0.0 0
M  V30 27 C 11.0333 2.1508 0.0 0
M  V30 28 C 12.3669 2.9208 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 10
M  V30 3 1 3 18
M  V30 4 1 4 13
M  V30 5 1 4 23
M  V30 6 1 5 6
M  V30 7 1 5 28
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 17
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 11 13
M  V30 16 2 11 14
M  V30 17 1 12 15
M  V30 18 1 14 16
M  V30 19 2 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1033227-21-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1033219-44-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-9432342
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Step 3:
1-(3-Bromo-propyl)-3-(4-chloro-phenyl)-1,3-dihydro
benzo[1,2,5]thiadiazole 2,2-dioxide (0.12 g, 0.29 mmol) was dissolved in
8N methylamine in methanol (20 mL) and stirred for 16 hours in a sealed
flask. The mixture was concentrated in vacuo to give the crude product.
The crude product was purified via chromatography (silica, 5% methanol
saturated with ammonia in chloroform) to give 70 mg of
3-[3-(4-chlorophenyl)-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-N-methylpropan-1-amine
Example 315: 1
-(4-{[3-(2-fluorophenyl)-2,2-dioxido-2,1,3-benzothiacliazol-1(3H)-yl]methyl}phenyl)-N-methylmethanamine
In an analogous manner to general procedure A, step 3,
1-[4-(bromomethyl)benzyl]-3-(2-fluorophenyl)-1,3-dihydro-2,1,3-benzothiadiazole
2,2-dioxide (0.11 g, 0.24 mmol) was treated with methylamine (10 mL) to
provide 0.09 g, (100%) of
1-(4-{[3-(2-fluorophenyl)-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]methyl}phenyl)-N-methylmethanamine.
MS (ES) m/z 397.0. HPLC purity 100.0% at 210-370 nm, 7.7 min.; Xterra
RP18, 3.5u, 150 x 4.6 mm column, 1.2 mL/min, 85/15-5/95 (Ammon. Form.
Buff. Ph=3.5/ACN+MeOH) for 10min, hold 4min.
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed flask
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aryl sulfamide derivatives as monoamine reuptake inhibitors and their
preparation and methods of their use
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM McComas, Casey Cameron; Cohn, Stephen Todd; Crawley, Matthew L.; Fensome,
Andrew; Goldberg, Joel Adam; Jenkins, Douglas John; Kim, Callain
Younghee; Mahaney, Paige Erin; Mann, Charles William; Marella, Michael
Anthony; O'Neill, David John; Sabatucci, Joseph P.; Terefenko, Eugene
Anthony; Trybulski, Eugene John; Vu, An Thien; Woodworth, Richard Page,
Jr.; Zhang, Puwen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008073459 A1 2008-06-19

$RFMT $RIREG SCHEME27 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-2-chloro-5-fluoroquinazoline
C8H3BrClFN2
1036756-07-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 1.5400 4.0010 0.0 0
M  V30 2 Br 0.0000 1.3337 0.0 0
M  V30 3 Cl 8.4702 2.6673 0.0 0
M  V30 4 C 3.8501 2.6673 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 4.6201 4.0010 0.0 0
M  V30 8 N 6.1601 1.3337 0.0 0
M  V30 9 C 3.8501 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 11 N 6.1601 4.0010 0.0 0
M  V30 12 C 6.9302 2.6673 0.0 0
M  V30 13 C 2.3101 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 10
M  V30 3 1 3 12
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 13
M  V30 14 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-5-fluoro-N-methyl-2-quinazolinamine
C9H7BrFN3
1644663-99-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 2.6675 0.0000 0.0 0
M  V30 2 Br 0.0000 1.5400 0.0 0
M  V30 3 N 8.0023 4.6201 0.0 0
M  V30 4 C 9.3360 3.8501 0.0 0
M  V30 5 C 4.0012 2.3101 0.0 0
M  V30 6 C 4.0012 3.8501 0.0 0
M  V30 7 C 2.6675 1.5400 0.0 0
M  V30 8 C 5.3348 1.5400 0.0 0
M  V30 9 N 5.3348 4.6201 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 N 6.6685 2.3101 0.0 0
M  V30 13 C 6.6685 3.8501 0.0 0
M  V30 14 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 14
M  V30 15 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1036756-07-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1644663-99-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-6994792
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General Procedure for the Synthesis of Intermediates 18a,b. A suspension
of 17a (Aurum PharmaTech) or 17b (56 mmol) in EtOH (125 mL) and
methylamine (33% solution in EtOH, 37.5 mL, 300 mmol) was heated at 80°C
for 1 h in a sealed tube. The mixture was allowed to cool to rt and
diluted with water (300 mL). The solid was collected by filtration and
purified by silica gel chromatography, eluting with a gradient of 0-2.5%
MeOH/DCM. 18a,b. 6-Bromo-5-fluoro-N-methylquinazolin-2-amine (18a). White
solid; yield 100% (2.06 g, 8.04 mmol). 1H NMR (400 MHz, CDCl3): δ 9.22
(br s, 1H), 7.73 (dd, J = 9.0, 7.6 Hz, 1H), 7.32 (d, J = 9.2 Hz, 1H),
5.47 (br s, 1H), 3.14 (s, 3H). HPLC-MS (ESI) m/z calculated for C9H7BrFN3
+ H+ [M + H+]: 256.0/258.0. Found: 255.9/257.9.
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of 1H-Pyrazol-3(2H)-ones as Potent and Selective Inhibitors of
Protein Kinase R-like Endoplasmic Reticulum Kinase (PERK)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Smith, Adrian L.; Andrews, Kristin L.; Beckmann, Holger; Bellon, Steven
F.; Beltran, Pedro J.; Booker, Shon; Chen, Hao; Chung, Young-Ah;
D'Angelo, Noel D.; Dao, Jennifer; Dellamaggiore, Kenneth R.; Jaeckel,
Peter; Kendall, Richard; Labitzke, Katja; Long, Alexander M.;
Materna-Reichelt, Silvia; Mitchell, Petia; Norman, Mark H.; Powers,
David; Rose, Mark; Shaffer, Paul L.; Wu, Michelle M.; Lipford, J. Russell
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2015), 58(3), 1426-1441

$RFMT $RIREG SCHEME28 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxy-6-(3-methoxyphenyl)-1-naphthalenecarboxylic acid
C19H16O4
1041115-11-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 0.7700 0.0 0
M  V30 2 O 2.6673 0.0000 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 O 1.3337 2.3101 0.0 0
M  V30 5 C 0.0000 3.0801 0.0 0
M  V30 6 O 13.3370 4.6201 0.0 0
M  V30 7 C 14.6707 5.3901 0.0 0
M  V30 8 C 5.3348 3.0801 0.0 0
M  V30 9 C 5.3348 4.6201 0.0 0
M  V30 10 C 4.0010 2.3101 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 6.6685 5.3901 0.0 0
M  V30 13 C 4.0010 5.3901 0.0 0
M  V30 14 C 2.6673 3.0801 0.0 0
M  V30 15 C 8.0022 3.0801 0.0 0
M  V30 16 C 8.0022 4.6201 0.0 0
M  V30 17 C 2.6673 4.6201 0.0 0
M  V30 18 C 9.3358 5.3901 0.0 0
M  V30 19 C 10.6697 4.6201 0.0 0
M  V30 20 C 9.3358 6.9302 0.0 0
M  V30 21 C 12.0033 5.3901 0.0 0
M  V30 22 C 10.6697 7.7002 0.0 0
M  V30 23 C 12.0033 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 6 7
M  V30 7 1 6 21
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 1 14 17
M  V30 18 1 15 16
M  V30 19 1 16 18
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxy-6-(3-methoxyphenyl)-N-methyl-1-naphthalenecarboxamide
C20H19NO3
1041115-15-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 2.3101 0.0 0
M  V30 2 N 2.6673 1.5400 0.0 0
M  V30 3 O 5.3348 1.5400 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 O 1.3337 3.8501 0.0 0
M  V30 6 C 0.0000 4.6201 0.0 0
M  V30 7 O 13.3370 6.1601 0.0 0
M  V30 8 C 14.6707 6.9302 0.0 0
M  V30 9 C 5.3348 4.6201 0.0 0
M  V30 10 C 4.0010 3.8501 0.0 0
M  V30 11 C 5.3348 6.1601 0.0 0
M  V30 12 C 6.6685 3.8501 0.0 0
M  V30 13 C 2.6673 4.6201 0.0 0
M  V30 14 C 6.6685 6.9302 0.0 0
M  V30 15 C 4.0010 6.9302 0.0 0
M  V30 16 C 8.0022 4.6201 0.0 0
M  V30 17 C 2.6673 6.1601 0.0 0
M  V30 18 C 8.0022 6.1601 0.0 0
M  V30 19 C 9.3358 6.9302 0.0 0
M  V30 20 C 10.6697 6.1601 0.0 0
M  V30 21 C 9.3358 8.4702 0.0 0
M  V30 22 C 12.0033 6.9302 0.0 0
M  V30 23 C 10.6697 9.2402 0.0 0
M  V30 24 C 12.0033 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 7 8
M  V30 8 1 7 22
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 2 14 18
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 18 19
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1041115-11-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1041115-15-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-4220305
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
3-Methoxy-5-(6-methoxy-2-naphthyl)-N-methylbenzamide (7a). The title
compound was General procedures for amide bond formation: Method B: A
mixture of carboxylic acid (1 eq) and amino derivative (1 eq) dissolved
in dichloromethane was added dropwise to a solution of EDCI (1 eq) and
HOBt (1 eq) in dichloromethane at 0 °C. The reaction mixture was stirred
at room temperature overnight. After evaporation of the solvent, the
residue was dissolved in ethyl acetate, washed with saturated sodium
carbonate solution and brine, dried over MgSO4, filtered and
concentrated. The product was purified by chromatography.
2-Methoxy-6-(3-methoxyphenyl)-N-methyl-1-naphthamide (19a). The title
compound was prepared by reaction of
2-methoxy-6-(3-methoxyphenyl)-1-naphthoic acid 19b (300 mg, 0.97 mmol, 1
eq) with a solution of methylamine (33% in ethanol, 0.12 ml, 0.97 mmol, 1
eq) according to method B. The crude product was purified by column
chromatography (hexane/ethyl acetate 2:1) and 19a was obtained in
quantitative yield (311 mg). C20H19NO3; MW 321; 1H-NMR (CDCl3): δ 8.00
(d, J = 1.9 Hz, 1H), 7.96 (d, J = 1.8 Hz, 1H), 7.92 (d, J = 8.8 Hz, 1H),
7.75 (dd, J = 1.8 Hz, J = 8.8 Hz, 1H), 7.39 (t, J = 7.7 Hz, 1H), 7.29 (d,
J = 8.8 Hz, 1H), 7.28-7.27 (m, 1H), 7.22-7.21 (m, 1H), 6.94 (ddd, J = 0.6
Hz, J = 2.7 Hz, J = 5.5 Hz, 1H), 3.97 (s, 3H), 3.89 (s, 3H), 3.14 (s,
3H); IR: 2992, 2939, 1637, 1595, 1528 cm-1.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituted 6-Phenyl-2-naphthols. Potent and Selective Nonsteroidal
Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1): Design,
Synthesis, Biological Evaluation, and Pharmacokinetics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Marchais-Oberwinkler, Sandrine; Kruchten, Patricia; Frotscher, Martin;
Ziegler, Erika; Neugebauer, Alexander; Bhoga, Umadevi; Bey, Emmanuel;
Mueller-Vieira, Ursula; Messinger, Josef; Thole, Hubert; Hartmann, Rolf
W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2008), 51(15), 4685-4698

$RFMT $RIREG SCHEME29 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
O-(2-Ethoxy-2-oxoethyl)-N-[(phenylmethoxy)carbonyl]-L-serine methyl ester
C16H21NO7
1042070-13-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.2400 4.0011 0.0 0 CFG=2
M  V30 2 N 7.7000 4.0011 0.0 0
M  V30 3 C 10.0100 5.3347 0.0 0
M  V30 4 C 10.0100 2.6674 0.0 0
M  V30 5 C 6.9300 5.3347 0.0 0
M  V30 6 O 11.5500 5.3347 0.0 0
M  V30 7 O 9.2400 1.3336 0.0 0
M  V30 8 O 11.5500 2.6674 0.0 0
M  V30 9 O 5.3900 5.3347 0.0 0
M  V30 10 O 7.7000 6.6684 0.0 0
M  V30 11 C 12.3200 6.6684 0.0 0
M  V30 12 C 10.0100 0.0000 0.0 0
M  V30 13 C 4.6200 6.6684 0.0 0
M  V30 14 C 13.8600 6.6684 0.0 0
M  V30 15 O 14.6300 8.0021 0.0 0
M  V30 16 O 14.6300 5.3347 0.0 0
M  V30 17 C 16.1700 8.0021 0.0 0
M  V30 18 C 16.9400 9.3358 0.0 0
M  V30 19 C 3.0800 6.6684 0.0 0
M  V30 20 C 2.3100 8.0021 0.0 0
M  V30 21 C 2.3100 5.3347 0.0 0
M  V30 22 C 0.7700 8.0021 0.0 0
M  V30 23 C 0.7700 5.3347 0.0 0
M  V30 24 C 0.0000 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 9 13
M  V30 13 1 11 14
M  V30 14 1 13 19
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 17 18
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 23
M  V30 23 2 22 24
M  V30 24 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Phenylmethyl N-[(6S)-hexahydro-4-methyl-3,5-dioxo-1,4-oxazepin-6-yl]carbamate
C14H16N2O5
1042070-01-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.1761 3.3532 0.0 0
M  V30 2 C 7.5098 2.5832 0.0 0
M  V30 3 O 8.8436 3.3532 0.0 0
M  V30 4 O 7.5098 1.0432 0.0 0
M  V30 5 C 10.1772 2.5832 0.0 0
M  V30 6 O 3.7995 4.9735 0.0 0
M  V30 7 C 1.0509 4.1257 0.0 0
M  V30 8 O 0.0000 1.4481 0.0 0
M  V30 9 C 4.8424 2.5832 0.0 0 CFG=1
M  V30 10 C 3.5701 3.4507 0.0 0
M  V30 11 C 4.9575 1.0475 0.0 0
M  V30 12 N 2.0984 2.9969 0.0 0
M  V30 13 O 3.8286 0.0000 0.0 0
M  V30 14 C 1.5357 1.5633 0.0 0
M  V30 15 C 2.3057 0.2296 0.0 0
M  V30 16 C 11.5109 3.3532 0.0 0
M  V30 17 C 11.5109 4.8933 0.0 0
M  V30 18 C 12.8445 2.5832 0.0 0
M  V30 19 C 12.8445 5.6633 0.0 0
M  V30 20 C 14.1783 3.3532 0.0 0
M  V30 21 C 14.1783 4.8933 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 9 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 16
M  V30 7 2 6 10
M  V30 8 1 7 12
M  V30 9 2 8 14
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1042070-13-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1042070-01-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9566487
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of 6-amino-1,4-oxazepane-3,5-dione derivatives as
novel broad spectrum anticonvulsants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sharma, Gitalee; Park, Jin Yup; Park, Min Soo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2008), 18(11), 3188-3191

$RFMT $RIREG SCHEME30 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(Bromomethyl)-α,α-diphenyl-3-isoxazolemethanol
C17H14BrNO2
1046497-49-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.6200 0.0 0
M  V30 2 O 4.6200 6.1600 0.0 0
M  V30 3 C 9.7758 6.2952 0.0 0
M  V30 4 Br 11.1826 5.6689 0.0 0
M  V30 5 C 6.1600 4.6200 0.0 0
M  V30 6 C 7.0652 5.8659 0.0 0
M  V30 7 N 7.0652 3.3742 0.0 0
M  V30 8 C 8.5298 5.3900 0.0 0
M  V30 9 O 8.5298 3.8500 0.0 0
M  V30 10 C 3.0800 4.6200 0.0 0
M  V30 11 C 2.3100 5.9537 0.0 0
M  V30 12 C 2.3100 3.2864 0.0 0
M  V30 13 C 0.7700 5.9537 0.0 0
M  V30 14 C 0.7700 3.2864 0.0 0
M  V30 15 C 0.0000 4.6200 0.0 0
M  V30 16 C 4.6200 3.0800 0.0 0
M  V30 17 C 3.2864 2.3100 0.0 0
M  V30 18 C 5.9537 2.3100 0.0 0
M  V30 19 C 3.2864 0.7700 0.0 0
M  V30 20 C 5.9537 0.7700 0.0 0
M  V30 21 C 4.6200 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 1 10
M  V30 4 1 1 16
M  V30 5 1 3 4
M  V30 6 1 3 8
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(Methylamino)methyl]-α,α-diphenyl-3-isoxazolemethanol
C18H18N2O2
1046497-51-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.6200 0.0 0
M  V30 2 O 4.6200 6.1600 0.0 0
M  V30 3 C 9.7757 6.2952 0.0 0
M  V30 4 N 11.1826 5.6688 0.0 0
M  V30 5 C 12.4285 6.5740 0.0 0
M  V30 6 C 6.1600 4.6200 0.0 0
M  V30 7 C 7.0652 5.8659 0.0 0
M  V30 8 N 7.0652 3.3742 0.0 0
M  V30 9 C 8.5298 5.3900 0.0 0
M  V30 10 O 8.5298 3.8500 0.0 0
M  V30 11 C 4.6200 3.0800 0.0 0
M  V30 12 C 5.9537 2.3100 0.0 0
M  V30 13 C 3.2864 2.3100 0.0 0
M  V30 14 C 5.9537 0.7700 0.0 0
M  V30 15 C 3.2864 0.7700 0.0 0
M  V30 16 C 4.6200 0.0000 0.0 0
M  V30 17 C 3.0800 4.6200 0.0 0
M  V30 18 C 2.3100 5.9537 0.0 0
M  V30 19 C 2.3100 3.2864 0.0 0
M  V30 20 C 0.7700 5.9537 0.0 0
M  V30 21 C 0.7700 3.2864 0.0 0
M  V30 22 C 0.0000 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 1 11
M  V30 4 1 1 17
M  V30 5 1 3 4
M  V30 6 1 3 9
M  V30 7 1 4 5
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1046497-49-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1046497-51-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-13592868
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (5-Methylaminomethyl-isoxazol-3-yl)-diphenyl-methanol A solution of
(5-bromomethyl-isoxazol-3-yl)-diphenyl-methanol (45 mol%, 700 mg, 0.94
mmol) in THF (10 mL) was added by syringe pump over 2 h to a stirred
solution of methylamine in ethanol (10 mL), and the reaction mixture was
then stirred at RT overnight. The reaction mixture was concentrated in
vacuo and taken up in MeCN/DCM (white solids formed) and passed through
an SCX-2 cartridge which was rinsed with MeCN, then eluted with 2 M NH3
in MeOH to afford the desired product. Yield: 277 mg (quant.). LC-MS
(Method 3): Rt 2.28 min, m/z 295 [MH]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nitrogen containing heterocyclic compounds useful as bifunctional
modulators of M3 receptors and β2 receptors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sutton, Jonathan Mark; Roussel, Fabien; Van Den Heuvel, Marco; Ray,
Nicholas Charles; Alcaraz, Lilian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010015792 A1 2010-02-11

$RFMT $RIREG SCHEME31 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl acetoacetate
C5H8O3
105-45-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6674 2.3100 0.0 0
M  V30 3 O 5.3347 2.3100 0.0 0
M  V30 4 O 4.0011 0.0000 0.0 0
M  V30 5 C 1.3338 1.5400 0.0 0
M  V30 6 C 6.6685 1.5400 0.0 0
M  V30 7 C 0.0000 2.3100 0.0 0
M  V30 8 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methylaminobut-2-enoic acid methyl ester
C6H11NO2
13412-12-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 2.6675 1.5400 0.0 0
M  V30 4 N 6.6686 2.3100 0.0 0
M  V30 5 C 5.3348 0.0000 0.0 0
M  V30 6 O 1.3337 2.3100 0.0 0
M  V30 7 O 2.6675 0.0000 0.0 0
M  V30 8 C 8.0022 1.5400 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 105-45-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 13412-12-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-9550609
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for continuous flow synthesis of β-amino crotonate
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kulkarni, Amol Arvind; Joshi, Ramesh Anna; Joshi, Rohini Ramesh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM India, IN2011DE01205 A 2013-09-27

$RFMT $RIREG SCHEME31 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl acetoacetate
C5H8O3
105-45-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6674 2.3100 0.0 0
M  V30 3 O 5.3347 2.3100 0.0 0
M  V30 4 O 4.0011 0.0000 0.0 0
M  V30 5 C 1.3338 1.5400 0.0 0
M  V30 6 C 6.6685 1.5400 0.0 0
M  V30 7 C 0.0000 2.3100 0.0 0
M  V30 8 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methylaminobut-2-enoic acid methyl ester
C6H11NO2
13412-12-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 2.6675 1.5400 0.0 0
M  V30 4 N 6.6686 2.3100 0.0 0
M  V30 5 C 5.3348 0.0000 0.0 0
M  V30 6 O 1.3337 2.3100 0.0 0
M  V30 7 O 2.6675 0.0000 0.0 0
M  V30 8 C 8.0022 1.5400 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 105-45-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 13412-12-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-15021239
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 10: Process for the preparation of Methyl 3-methyl amino
crotonate Continuous flow experiment was carried out in a 5S316 tubular
reactor of 1.58 mm o.d. by mixing methyl acetoacetate with methyl amine
in isoproponol in the ratio 1:3 using a simple T-mixer and reactor with 1
m length at 40 °C. Complete conversion of the substrates is observed in
30 s. Yield 100 %.
$DTYPE RXN:VAR(1):NOTES
$DATUM tubular reactor, T-mixer, flow system, zero discharge, base and solvent
recycled
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for continuous flow synthesis of β-amino crotonate
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kulkarni, Amol Arvind; Joshi, Ramesh Anna; Joshi, Rohini Ramesh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012147103 A2 2012-11-01

$RFMT $RIREG SCHEME31 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl acetoacetate
C5H8O3
105-45-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6674 2.3100 0.0 0
M  V30 3 O 5.3347 2.3100 0.0 0
M  V30 4 O 4.0011 0.0000 0.0 0
M  V30 5 C 1.3338 1.5400 0.0 0
M  V30 6 C 6.6685 1.5400 0.0 0
M  V30 7 C 0.0000 2.3100 0.0 0
M  V30 8 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methylaminobut-2-enoic acid methyl ester
C6H11NO2
13412-12-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 2.6675 1.5400 0.0 0
M  V30 4 N 6.6686 2.3100 0.0 0
M  V30 5 C 5.3348 0.0000 0.0 0
M  V30 6 O 1.3337 2.3100 0.0 0
M  V30 7 O 2.6675 0.0000 0.0 0
M  V30 8 C 8.0022 1.5400 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 105-45-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 13412-12-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-8619536
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Continuous flow synthesis of β-amino α, β-unsaturated esters in aqueous
medium
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Joshi, Ramesh A.; Joshi, Rohini R.; Tibhe, Jagdish; Nivangune, Nayana T.;
Kulkarni, Amol A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Processing and Synthesis (2012), 1(2), 205-210

$RFMT $RIREG SCHEME32 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-(hydroxymethyl)-5-methylbenzoate
C10H12O3
105578-30-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 O 8.0023 3.8501 0.0 0
M  V30 3 O 6.6685 6.1601 0.0 0
M  V30 4 C 9.3360 4.6201 0.0 0
M  V30 5 C 1.3337 4.6201 0.0 0
M  V30 6 O 0.0000 3.8501 0.0 0
M  V30 7 C 4.0012 0.0000 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Hydroxymethyl)-N,5-dimethylbenzamide
C10H13NO2
1000896-26-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 N 8.0023 3.8501 0.0 0
M  V30 3 O 6.6685 6.1601 0.0 0
M  V30 4 C 9.3360 4.6201 0.0 0
M  V30 5 C 1.3337 4.6201 0.0 0
M  V30 6 O 0.0000 3.8501 0.0 0
M  V30 7 C 4.0012 0.0000 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 105578-30-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1000896-26-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5857706
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-24-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 6381-59-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 3-(hydroxymethyl)-N,5-dimethyl-benzamide was prepared from:-A solution of
trimethylaluminium (2M in toluene, 25 ml, 12.5 mmol) was added dropwise
at-50°C to a stirred solution of methyl
3-(hydroxymethyl)-5-methyl-benzoate (3.5g, 20 mmol) and methylamine (2.0M
solution in THF, 50 ml, 100 mmol) in dry THF (100ml). The reaction
mixture was stirred for 15 mins at-50°C, then at 20°C for 18 h. The
reaction was cooled to-50°C and quenched with saturated potassium sodium
tartrate solution and stirred for 1 h. The reaction mixture was extracted
with ethyl acetate (2 × 50 ml) and washed with saturated brine solution
(25 ml). The extracts were dried (MgSO4), filtered and evaporated. The
crude product was purified by silica column chromatography, eluting with
a gradient of 0-5% methanol in dichloromethane. The pure fractions were
combined and evaporated to dryness to give
3-(hydroxymethyl)-N,5-dimethyl-benzamide as an oil (3.7g, ∼ 100%). 1H NMR
(399.9 MHz, DMSO-d6) δ 2.35 (3H, s), 2.78 (3H, d), 4.52 (2H, d), 5.22
(1H, t), 7.27-7.28 (1H, m), 7.52 (1H, s), 7.60 (1H, s), 8.34 (1H, d). MS
m/z: 180 (MH+)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrimidine derivatives useful in the treatment of cancer and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Buttar, David; Foote, Kevin Michael; Nowak, Thorsten; Rudge, David Alan;
Theoclitou, Maria-Elena; Thomas, Andrew Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008001070 A1 2008-01-03

$RFMT $RIREG SCHEME33 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 5,6,8,9-tetrahydro-2-(1-methyl-1-phenylethyl)-4-[[(trifluor...
C23H28F3N3O5S
1065113-01-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.5378 3.6437 0.0 0
M  V30 2 S 7.3078 2.3101 0.0 0 VAL=6
M  V30 3 C 5.9741 1.5400 0.0 0
M  V30 4 O 8.0778 0.9764 0.0 0
M  V30 5 O 8.6414 3.0801 0.0 0
M  V30 6 F 4.6404 2.3101 0.0 0
M  V30 7 F 4.6404 0.7700 0.0 0
M  V30 8 F 5.9741 0.0000 0.0 0
M  V30 9 C 11.1579 6.3112 0.0 0
M  V30 10 C 10.3878 4.9774 0.0 0
M  V30 11 C 11.9279 4.9774 0.0 0
M  V30 12 C 2.6673 9.4349 0.0 0
M  V30 13 O 2.6673 10.9749 0.0 0
M  V30 14 O 1.3337 8.6648 0.0 0
M  V30 15 C 1.3337 11.7449 0.0 0
M  V30 16 C 2.1037 13.0786 0.0 0
M  V30 17 C 0.0000 12.5149 0.0 0
M  V30 18 C 0.5637 10.4112 0.0 0
M  V30 19 C 6.5378 6.3112 0.0 0
M  V30 20 C 7.3078 4.9774 0.0 0
M  V30 21 C 7.3078 7.6449 0.0 0
M  V30 22 C 5.0150 6.0816 0.0 0
M  V30 23 N 8.8478 4.9774 0.0 0
M  V30 24 N 8.8478 7.6449 0.0 0
M  V30 25 C 6.7452 9.0785 0.0 0
M  V30 26 C 3.8860 7.1291 0.0 0
M  V30 27 C 9.6178 6.3112 0.0 0
M  V30 28 C 5.2735 9.5323 0.0 0
M  V30 29 N 4.0012 8.6648 0.0 0
M  V30 30 C 11.9279 7.6449 0.0 0
M  V30 31 C 13.4679 7.6449 0.0 0
M  V30 32 C 11.1579 8.9786 0.0 0
M  V30 33 C 14.2379 8.9786 0.0 0
M  V30 34 C 11.9279 10.3122 0.0 0
M  V30 35 C 13.4679 10.3122 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 3 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 27
M  V30 12 1 9 30
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 29
M  V30 16 1 13 15
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 19 22
M  V30 23 1 20 23
M  V30 24 2 21 24
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 2 23 27
M  V30 28 1 24 27
M  V30 29 1 25 28
M  V30 30 1 26 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 5,6,8,9-tetrahydro-4-(methylamino)-2-(1-methyl-1-phenylethy...
C23H32N4O2
1065113-06-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6684 0.7700 0.0 0
M  V30 2 C 5.3347 0.0000 0.0 0
M  V30 3 C 4.0011 5.3900 0.0 0
M  V30 4 C 2.6674 6.1600 0.0 0
M  V30 5 C 4.0011 6.9300 0.0 0
M  V30 6 C 12.9157 3.8500 0.0 0
M  V30 7 O 13.6857 5.1836 0.0 0
M  V30 8 O 13.6857 2.5164 0.0 0
M  V30 9 C 15.2257 5.1836 0.0 0
M  V30 10 C 15.2257 3.6436 0.0 0
M  V30 11 C 16.7657 5.1836 0.0 0
M  V30 12 C 15.2257 6.7236 0.0 0
M  V30 13 C 8.0021 3.0800 0.0 0
M  V30 14 C 8.0021 4.6200 0.0 0
M  V30 15 C 6.6684 2.3100 0.0 0
M  V30 16 C 9.2061 2.1198 0.0 0
M  V30 17 N 6.6684 5.3900 0.0 0
M  V30 18 C 9.2061 5.5802 0.0 0
M  V30 19 N 5.3347 3.0800 0.0 0
M  V30 20 C 10.7075 2.4625 0.0 0
M  V30 21 C 5.3347 4.6200 0.0 0
M  V30 22 C 10.7075 5.2375 0.0 0
M  V30 23 N 11.3757 3.8500 0.0 0
M  V30 24 C 2.6674 4.6200 0.0 0
M  V30 25 C 2.6674 3.0800 0.0 0
M  V30 26 C 1.3336 5.3900 0.0 0
M  V30 27 C 1.3336 2.3100 0.0 0
M  V30 28 C 0.0000 4.6200 0.0 0
M  V30 29 C 0.0000 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 21
M  V30 6 1 3 24
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 23
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 13 16
M  V30 17 2 14 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 2 19 21
M  V30 24 1 20 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1065113-01-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1065113-06-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-11215524
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM tert-Butyl
4-(methylamino)-2-(1-methy1-phenylethyl)-5,6,8,9-tetrahydro-7H-p[4,5-d]azepine-7-carboxylate.
A solution of methylamine (0.2M, 0.24 mL, 0.49 mmol) was added to a
solution of
tert-buty2-(1-methy1-phenylethyl)-4-{[(trifluoromethyl)sulfonyl]oxy}-5,6,8,9-tetrahydro-7H
p[4,5-d]azepine-7-carboxylate (50 mg, 0.10 mmol) in acetonitrile (2.0 mL)
at room temperature with stirring. The mixture was stirred at room
temperature for 20 h. The solvent was evaporated under reduced pressure
to provide the crude compound . The material was used in the subsequent
reaction without further purification Brown gum, yield:40mg,100%. 1H NMR
(400 MHz, CDCl3 ) δ: 1.42 (s, 9H), 1.79 (s, 6H), 2.58-2.65 (m, 2H),
2.95-3.16 (m, 5H), 3.55-3.75 (m, 4H), 7.16-7.21 (m, 5H); HPLC (6 min),
Rt=2.33 min, ELSD >95% purity; LRMS (ESI APCI) m/z 397 [M+H]+ .
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Multiparameter Optimization in CNS Drug Discovery: Design of
Pyrimido[4,5-d]azepines as Potent 5-Hydroxytryptamine 2C (5-HT2C)
Receptor Agonists with Exquisite Functional Selectivity over 5-HT2A and
5-HT2B Receptors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Storer, R. Ian; Brennan, Paul E.; Brown, Alan D.; Bungay, Peter J.;
Conlon, Kelly M.; Corbett, Matthew S.; DePianta, Robert P.; Fish, Paul
V.; Heifetz, Alexander; Ho, Danny K. H.; Jessiman, Alan S.; McMurray,
Gordon; de Oliveira, Cesar Augusto F.; Roberts, Lee R.; Root, James A.;
Shanmugasundaram, Veerabahu; Shapiro, Michael J.; Skerten, Melanie;
Westbrook, Dominique; Wheeler, Simon; Whitlock, Gavin A.; Wright, John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2014), 57(12), 5258-5269

$RFMT $RIREG SCHEME34 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3,6,7-Tetramethoxy-9-oxo-9H-xanthene-4-sulfonyl chloride
C17H15ClO8S
1070775-24-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.3101 6.6685 0.0 0 VAL=6
M  V30 2 Cl 1.5400 8.0023 0.0 0
M  V30 3 O 0.9764 5.8985 0.0 0
M  V30 4 O 3.6437 7.4385 0.0 0
M  V30 5 O 5.3901 1.3337 0.0 0
M  V30 6 C 4.6201 0.0000 0.0 0
M  V30 7 O 7.7002 2.6673 0.0 0
M  V30 8 O 0.7700 4.0012 0.0 0
M  V30 9 C 0.0000 2.6675 0.0 0
M  V30 10 O 10.0102 9.3360 0.0 0
M  V30 11 C 9.2402 10.6697 0.0 0
M  V30 12 O 11.5503 6.6685 0.0 0
M  V30 13 C 12.3203 5.3348 0.0 0
M  V30 14 C 4.6201 5.3348 0.0 0
M  V30 15 C 5.3901 4.0012 0.0 0
M  V30 16 C 3.0801 5.3348 0.0 0
M  V30 17 O 5.3901 6.6685 0.0 0
M  V30 18 C 4.6201 2.6673 0.0 0
M  V30 19 C 6.9302 4.0012 0.0 0
M  V30 20 C 2.3101 4.0012 0.0 0
M  V30 21 C 6.9302 6.6685 0.0 0
M  V30 22 C 3.0801 2.6673 0.0 0
M  V30 23 C 7.7002 5.3348 0.0 0
M  V30 24 C 7.7002 8.0023 0.0 0
M  V30 25 C 9.2402 5.3348 0.0 0
M  V30 26 C 9.2402 8.0023 0.0 0
M  V30 27 C 10.0102 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 16
M  V30 5 1 5 6
M  V30 6 1 5 18
M  V30 7 2 7 19
M  V30 8 1 8 9
M  V30 9 1 8 20
M  V30 10 1 10 11
M  V30 11 1 10 26
M  V30 12 1 12 13
M  V30 13 1 12 27
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 17
M  V30 17 2 15 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 25 2 21 24
M  V30 26 2 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3,6,7-Tetramethoxy-N-methyl-9-oxo-9H-xanthene-4-sulfonamide
C18H19NO8S
1228884-54-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 1.3336 0.0 0
M  V30 2 C 4.6200 0.0000 0.0 0
M  V30 3 O 7.7000 2.6673 0.0 0
M  V30 4 S 2.3100 6.6684 0.0 0 VAL=6
M  V30 5 N 1.5400 8.0021 0.0 0
M  V30 6 O 0.9764 5.8984 0.0 0
M  V30 7 O 3.6436 7.4384 0.0 0
M  V30 8 C 0.0000 8.0021 0.0 0
M  V30 9 O 0.7700 4.0011 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 11 O 11.5500 6.6684 0.0 0
M  V30 12 C 12.3200 5.3347 0.0 0
M  V30 13 O 10.0100 9.3358 0.0 0
M  V30 14 C 9.2400 10.6694 0.0 0
M  V30 15 C 5.3900 4.0011 0.0 0
M  V30 16 C 4.6200 5.3347 0.0 0
M  V30 17 C 4.6200 2.6673 0.0 0
M  V30 18 C 6.9300 4.0011 0.0 0
M  V30 19 C 3.0800 5.3347 0.0 0
M  V30 20 O 5.3900 6.6684 0.0 0
M  V30 21 C 3.0800 2.6673 0.0 0
M  V30 22 C 7.7000 5.3347 0.0 0
M  V30 23 C 2.3100 4.0011 0.0 0
M  V30 24 C 6.9300 6.6684 0.0 0
M  V30 25 C 9.2400 5.3347 0.0 0
M  V30 26 C 7.7000 8.0021 0.0 0
M  V30 27 C 10.0100 6.6684 0.0 0
M  V30 28 C 9.2400 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 2 3 18
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 4 7
M  V30 7 1 4 19
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 9 23
M  V30 11 1 11 12
M  V30 12 1 11 27
M  V30 13 1 13 14
M  V30 14 1 13 28
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 15 18
M  V30 18 2 16 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 2 22 25
M  V30 27 2 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1070775-24-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1228884-54-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-7590855
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM First identification of xanthone sulfonamides as potent
acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hu, Honggang; Liao, Hongli; Zhang, Jun; Wu, Weifeng; Yan, Jufang; Yan,
Yonghong; Zhao, Qingjie; Zou, Yan; Chai, Xiaoyun; Yu, Shichong; Wu, Qiuye
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2010), 20(10), 3094-3097

$RFMT $RIREG SCHEME35 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 10,11-dihydro-5H-pyrido[2,3-c][2]benzazepine-10-carboxylate
C15H14N2O2
1071504-70-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.8143 5.0568 0.0 0
M  V30 2 O 1.4715 6.5581 0.0 0
M  V30 3 O 0.6853 4.0093 0.0 0
M  V30 4 C 0.0000 7.0120 0.0 0
M  V30 5 C 3.5154 3.0800 0.0 0
M  V30 6 C 3.2858 4.6028 0.0 0
M  V30 7 C 4.8490 2.3100 0.0 0
M  V30 8 C 2.1817 2.3100 0.0 0
M  V30 9 N 4.3333 5.7318 0.0 0
M  V30 10 C 6.2826 2.8726 0.0 0
M  V30 11 C 4.8490 0.7700 0.0 0
M  V30 12 C 2.1817 0.7700 0.0 0
M  V30 13 C 5.8690 5.6166 0.0 0
M  V30 14 C 6.7365 4.3442 0.0 0
M  V30 15 C 3.5154 0.0000 0.0 0
M  V30 16 N 6.5372 7.0041 0.0 0
M  V30 17 C 8.2722 4.4593 0.0 0
M  V30 18 C 8.0729 7.1192 0.0 0
M  V30 19 C 8.9404 5.8468 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 15
M  V30 16 1 13 14
M  V30 17 2 13 16
M  V30 18 2 14 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
10,11-Dihydro-N-methyl-5H-pyrido[2,3-c][2]benzazepine-10-carboxamide
C15H15N3O
1071504-65-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.8143 5.0568 0.0 0
M  V30 2 N 1.4715 6.5581 0.0 0
M  V30 3 O 0.6853 4.0093 0.0 0
M  V30 4 C 0.0000 7.0120 0.0 0
M  V30 5 C 3.5154 3.0800 0.0 0
M  V30 6 C 3.2858 4.6028 0.0 0
M  V30 7 C 4.8490 2.3100 0.0 0
M  V30 8 C 2.1817 2.3100 0.0 0
M  V30 9 N 4.3333 5.7318 0.0 0
M  V30 10 C 6.2826 2.8726 0.0 0
M  V30 11 C 4.8490 0.7700 0.0 0
M  V30 12 C 2.1817 0.7700 0.0 0
M  V30 13 C 5.8690 5.6166 0.0 0
M  V30 14 C 6.7365 4.3442 0.0 0
M  V30 15 C 3.5154 0.0000 0.0 0
M  V30 16 N 6.5372 7.0041 0.0 0
M  V30 17 C 8.2722 4.4593 0.0 0
M  V30 18 C 8.0729 7.1192 0.0 0
M  V30 19 C 8.9404 5.8468 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 15
M  V30 16 1 13 14
M  V30 17 2 13 16
M  V30 18 2 14 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1071504-70-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1071504-65-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-6967930
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Methylamine (250 ml 40% in water) was added to the crude methyl ester
compound(22.5 g, 88.6mmol)atroom temperature. The mixture was heated to
65°C. on a water bath for 5 minutes. The obtained solution was stirred
overnight while cooling to room temperature. The reaction mixture was
heated to reflux for one hour and then evaporated under vacuum to
dryness. Toluene (50 ml) was added and the mixture was evaporated to
dryness. Acetone (50 ml) was added and the mixture was again evaporated
to dryness to give the crude racemic carboxamide nearly quantitatively.
racemic carboxamide, quantitative yield Mass analysis: M+1=254 major
peak. 1H-NMR (CDCl3) δ (ppm) 2.88 3H, quasi d, N-CH3; 3.49 1H, d, J=15.0
Hz, CHH; 4.15 1H, d, J=15 Hz, CHH; 4.92 1H, br 5, CH; 5.95 1H, br s, NH;
6.58 1H, dd, J=5.1 and 7.5 Hz, ArH; 6.96 1H, br 5, NH; 7.16-7.32 5H, m,
ArH; 7.90 1H, dd, J=1.2 and 5.1 Hz, ArH.
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Method for the preparation of an enantiomerically pure benzazepine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kemperman, Gerardus Johannes; Seerden, Johannes Paulus Gerardus
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20080255349 A1 2008-10-16

$RFMT $RIREG SCHEME36 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(-)-Ethyl 10,11-dihydro-5H-pyrido[2,3-c][2]benzazepine-10-carboxylate
C16H16N2O2
1071504-74-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5768 4.3307 0.0 0
M  V30 2 O 7.3468 5.6645 0.0 0
M  V30 3 O 7.3468 2.9970 0.0 0
M  V30 4 C 8.8868 5.6645 0.0 0
M  V30 5 C 9.6568 6.9981 0.0 0
M  V30 6 C 4.3685 2.9433 0.0 0
M  V30 7 C 5.0367 4.3307 0.0 0 CFG=3
M  V30 8 C 2.8672 2.6005 0.0 0
M  V30 9 C 5.4161 1.8143 0.0 0
M  V30 10 N 4.3685 5.7182 0.0 0
M  V30 11 C 1.6631 3.5607 0.0 0
M  V30 12 C 2.4132 1.1290 0.0 0
M  V30 13 C 4.9621 0.3427 0.0 0
M  V30 14 C 2.8672 6.0609 0.0 0
M  V30 15 C 1.6631 5.1007 0.0 0
M  V30 16 C 3.4607 0.0000 0.0 0
M  V30 17 N 2.6376 7.5836 0.0 0
M  V30 18 C 0.2296 5.6634 0.0 0
M  V30 19 C 1.2041 8.1463 0.0 0
M  V30 20 C 0.0000 7.1861 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 13 16
M  V30 17 1 14 15
M  V30 18 2 14 17
M  V30 19 2 15 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(+)-Ethyl 10,11-dihydro-5H-pyrido[2,3-c][2]benzazepine-10-carboxylate
C16H16N2O2
1071504-75-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5768 4.3307 0.0 0
M  V30 2 O 7.3468 5.6645 0.0 0
M  V30 3 O 7.3468 2.9970 0.0 0
M  V30 4 C 8.8868 5.6645 0.0 0
M  V30 5 C 9.6568 6.9981 0.0 0
M  V30 6 C 4.3685 2.9433 0.0 0
M  V30 7 C 5.0367 4.3307 0.0 0 CFG=3
M  V30 8 C 2.8672 2.6005 0.0 0
M  V30 9 C 5.4161 1.8143 0.0 0
M  V30 10 N 4.3685 5.7182 0.0 0
M  V30 11 C 1.6631 3.5607 0.0 0
M  V30 12 C 2.4132 1.1290 0.0 0
M  V30 13 C 4.9621 0.3427 0.0 0
M  V30 14 C 2.8672 6.0609 0.0 0
M  V30 15 C 1.6631 5.1007 0.0 0
M  V30 16 C 3.4607 0.0000 0.0 0
M  V30 17 N 2.6376 7.5836 0.0 0
M  V30 18 C 0.2296 5.6634 0.0 0
M  V30 19 C 1.2041 8.1463 0.0 0
M  V30 20 C 0.0000 7.1861 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 13 16
M  V30 17 1 14 15
M  V30 18 2 14 17
M  V30 19 2 15 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
10,11-Dihydro-N-methyl-5H-pyrido[2,3-c][2]benzazepine-10-carboxamide
C15H15N3O
1071504-65-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.8143 5.0568 0.0 0
M  V30 2 N 1.4715 6.5581 0.0 0
M  V30 3 O 0.6853 4.0093 0.0 0
M  V30 4 C 0.0000 7.0120 0.0 0
M  V30 5 C 3.5154 3.0800 0.0 0
M  V30 6 C 3.2858 4.6028 0.0 0
M  V30 7 C 4.8490 2.3100 0.0 0
M  V30 8 C 2.1817 2.3100 0.0 0
M  V30 9 N 4.3333 5.7318 0.0 0
M  V30 10 C 6.2826 2.8726 0.0 0
M  V30 11 C 4.8490 0.7700 0.0 0
M  V30 12 C 2.1817 0.7700 0.0 0
M  V30 13 C 5.8690 5.6166 0.0 0
M  V30 14 C 6.7365 4.3442 0.0 0
M  V30 15 C 3.5154 0.0000 0.0 0
M  V30 16 N 6.5372 7.0041 0.0 0
M  V30 17 C 8.2722 4.4593 0.0 0
M  V30 18 C 8.0729 7.1192 0.0 0
M  V30 19 C 8.9404 5.8468 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 15
M  V30 16 1 13 14
M  V30 17 2 13 16
M  V30 18 2 14 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1071504-74-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1071504-75-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1071504-65-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-6125793
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Method A. From methyl ester compound obtained in example 4: Methylamine
(250 ml 40% in water) was added to the crude methyl ester compound (22.5
g, 88.6 mmol) at room temperature. The mixture was heated to 65 °C on a
water bath for 5 minutes. The obtained solution was stirred overnight
while cooling to room temperature. The reaction mixture was heated to
reflux for one hour and then evaporated under vacuum to dryness. Toluene
(50 ml) was added and the mixture was evaporated to dryness. Acetone (50
ml) was added and the mixture was again evaporated to dryness to give the
crude racemic carboxamide nearly quantitattively. The crude product was
used without further purification. Yield quantitattive. Mass analysis:
M+1 = 254 major peak 1H-NMR (CDCl3) δ (ppm) 2.88 3H, quasi d, N-CH3; 3.49
1H, d, J= 15.0 Hz, CHH; 4.15 1H, d, J= 15 Hz, CHH;4.92 1H, br s, CH; 5.95
1H, br s, NH; 6.58 1H, dd, J= 5.1 and 7.5 Hz, ArH; 6.96 1H, br s, NH;
7.16-7.32 5H, m, ArH; 7.90 1H,dd, J= 1.2 and 5.1 Hz, ArH.
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for the preparation of enantiomerically pure pyridobenzazepines
via a cyclocondensation reaction.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kemperman, Gerardus Johannes
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008125577 A1 2008-10-23

$RFMT $RIREG SCHEME37 STEP1
$RXN



  2  1
$MOL
Methyl 4-[[(17β)-4-chloro-3-cyano-17-hydroxyestra-1,3,5(10)-trien-17-yl]methy...
C28H30ClNO3
1071831-46-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.7429 4.7636 0.0 0
M  V30 2 C 11.8142 7.1905 0.0 0
M  V30 3 O 11.3857 5.1747 0.0 0
M  V30 4 Cl 1.3338 3.8501 0.0 0
M  V30 5 C 1.3338 0.7700 0.0 0
M  V30 6 N 0.0000 0.0000 0.0 0
M  V30 7 C 17.1490 4.1105 0.0 0
M  V30 8 O 18.4827 4.8805 0.0 0
M  V30 9 O 17.1490 2.5705 0.0 0
M  V30 10 C 19.8165 4.1105 0.0 0
M  V30 11 C 8.0023 6.1601 0.0 0 CFG=1
M  V30 12 C 9.3360 5.3901 0.0 0 CFG=1
M  V30 13 C 6.6686 5.3901 0.0 0 CFG=2
M  V30 14 C 8.3225 7.6664 0.0 0
M  V30 15 C 10.4805 6.4205 0.0 0 CFG=2
M  V30 16 C 9.3360 3.8501 0.0 0
M  V30 17 C 6.6686 3.8501 0.0 0 CFG=1
M  V30 18 C 5.3350 6.1601 0.0 0
M  V30 19 C 9.8540 7.8274 0.0 0
M  V30 20 C 8.0023 3.0801 0.0 0
M  V30 21 C 5.3350 3.0801 0.0 0
M  V30 22 C 4.0011 5.3901 0.0 0
M  V30 23 C 4.0011 3.8501 0.0 0
M  V30 24 C 5.3350 1.5400 0.0 0
M  V30 25 C 2.6675 3.0801 0.0 0
M  V30 26 C 4.0011 0.7700 0.0 0
M  V30 27 C 2.6675 1.5400 0.0 0
M  V30 28 C 13.1478 6.4205 0.0 0
M  V30 29 C 14.4815 7.1905 0.0 0
M  V30 30 C 13.1478 4.8805 0.0 0
M  V30 31 C 15.8153 6.4205 0.0 0
M  V30 32 C 14.4815 4.1105 0.0 0
M  V30 33 C 15.8153 4.8805 0.0 0
M  V30 34 H 7.2557 7.5070 0.0 0
M  V30 35 H 6.2701 6.8776 0.0 0
M  V30 36 H 6.6686 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 12 1 CFG=3
M  V30 2 1 15 2 CFG=1
M  V30 3 1 2 28
M  V30 4 1 15 3 CFG=3
M  V30 5 1 4 25
M  V30 6 3 5 6
M  V30 7 1 5 27
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 33
M  V30 11 1 8 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 34 CFG=1
M  V30 16 1 12 15
M  V30 17 1 12 16
M  V30 18 1 13 17
M  V30 19 1 13 18
M  V30 20 1 13 35 CFG=3
M  V30 21 1 14 19
M  V30 22 1 15 19
M  V30 23 1 16 20
M  V30 24 1 17 20
M  V30 25 1 17 21
M  V30 26 1 17 36 CFG=1
M  V30 27 1 18 22
M  V30 28 1 21 23
M  V30 29 2 21 24
M  V30 30 1 22 23
M  V30 31 2 23 25
M  V30 32 1 24 26
M  V30 33 1 25 27
M  V30 34 2 26 27
M  V30 35 2 28 29
M  V30 36 1 28 30
M  V30 37 1 29 31
M  V30 38 2 30 32
M  V30 39 2 31 33
M  V30 40 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 11 12 13 15 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[[(17β)-4-Chloro-3-cyano-17-hydroxyestra-1,3,5(10)-trien-17-yl]methyl]-N-me...
C28H31ClN2O2
1071831-93-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.7429 4.7636 0.0 0
M  V30 2 C 11.8142 7.1905 0.0 0
M  V30 3 O 11.3857 5.1747 0.0 0
M  V30 4 Cl 1.3338 3.8501 0.0 0
M  V30 5 C 1.3338 0.7700 0.0 0
M  V30 6 N 0.0000 0.0000 0.0 0
M  V30 7 C 17.1490 4.1105 0.0 0
M  V30 8 N 18.4827 4.8805 0.0 0
M  V30 9 O 17.1490 2.5705 0.0 0
M  V30 10 C 19.8165 4.1105 0.0 0
M  V30 11 C 8.0023 6.1601 0.0 0 CFG=1
M  V30 12 C 9.3360 5.3901 0.0 0 CFG=1
M  V30 13 C 6.6686 5.3901 0.0 0 CFG=2
M  V30 14 C 8.3225 7.6664 0.0 0
M  V30 15 C 10.4805 6.4205 0.0 0 CFG=2
M  V30 16 C 9.3360 3.8501 0.0 0
M  V30 17 C 6.6686 3.8501 0.0 0 CFG=1
M  V30 18 C 5.3350 6.1601 0.0 0
M  V30 19 C 9.8540 7.8274 0.0 0
M  V30 20 C 8.0023 3.0801 0.0 0
M  V30 21 C 5.3350 3.0801 0.0 0
M  V30 22 C 4.0011 5.3901 0.0 0
M  V30 23 C 4.0011 3.8501 0.0 0
M  V30 24 C 5.3350 1.5400 0.0 0
M  V30 25 C 2.6675 3.0801 0.0 0
M  V30 26 C 4.0011 0.7700 0.0 0
M  V30 27 C 2.6675 1.5400 0.0 0
M  V30 28 C 13.1478 6.4205 0.0 0
M  V30 29 C 13.1478 4.8805 0.0 0
M  V30 30 C 14.4815 7.1905 0.0 0
M  V30 31 C 14.4815 4.1105 0.0 0
M  V30 32 C 15.8153 6.4205 0.0 0
M  V30 33 C 15.8153 4.8805 0.0 0
M  V30 34 H 7.2557 7.5070 0.0 0
M  V30 35 H 6.2701 6.8776 0.0 0
M  V30 36 H 6.6686 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 12 1 CFG=3
M  V30 2 1 15 2 CFG=1
M  V30 3 1 2 28
M  V30 4 1 15 3 CFG=3
M  V30 5 1 4 25
M  V30 6 3 5 6
M  V30 7 1 5 27
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 33
M  V30 11 1 8 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 34 CFG=1
M  V30 16 1 12 15
M  V30 17 1 12 16
M  V30 18 1 13 17
M  V30 19 1 13 18
M  V30 20 1 13 35 CFG=3
M  V30 21 1 14 19
M  V30 22 1 15 19
M  V30 23 1 16 20
M  V30 24 1 17 20
M  V30 25 1 17 21
M  V30 26 1 17 36 CFG=1
M  V30 27 1 18 22
M  V30 28 1 21 23
M  V30 29 2 21 24
M  V30 30 1 22 23
M  V30 31 2 23 25
M  V30 32 1 24 26
M  V30 33 1 25 27
M  V30 34 2 26 27
M  V30 35 2 28 29
M  V30 36 1 28 30
M  V30 37 1 29 31
M  V30 38 2 30 32
M  V30 39 2 31 33
M  V30 40 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 11 12 13 15 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1071831-46-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1071831-93-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12783205
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 143-33-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of EM-5728 [0249] In a Schlenk tube, a mixture of compound 77
(100 mg, 0.22 mmol) and sodium cyanide (421 mg, 8.59 mmol) in dry
methanol (5 mL) was purged with argon while stirring for 15 min. The
mixture was cooled to -78&#x00B0; C. Methylamine (2 mL) was condensed and
the tube was sealed. The mixture was stirred for 60 h at 65&#x00B0; C.
After completion of the reaction, the mixture was cooled to -78&#x00B0;
C. before the tube was opened. The temperature was brought back to
22&#x00B0; C. and the excess of methylamine was evaporated. The mixture
was diluted with water and extracted with ethyl acetate (3×). The
combined organic layer was washed with water and brine, dried over MgSO4,
filtered, and concentrated under reduced pressure. The crude compound was
purified by flash chromatography (silica gel, 0-10% methanol in
chloroform) to give 100 mg (quantitative) of EM-5728. 1H NMR (400 MHz,
CDCl3) &#x03B4; : 0.97 (s, 3H, Me), 2.71 (m, 2H, C-CH2-Ph, H-6), 3.03 (m,
5H, C-CH2-Ph H-6, NH-Me), 7.37 (m, 3H, Ar), 7.49 (d, J = 8.1 Hz, 1H, Ar),
7.72 (d, J = 8.1 Hz, 2H, Ar).
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed tube in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 17α-substituted steroids as systemic antiandrogens and
selective androgen receptor modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Labrie, Fernand; Gauthier, Sylvain; Cloutier, Julie; Mailhot, Josee;
Potvin, Steeves; Dion, Sylvain; Sanceau, Jean-Yves
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008124922 A1 2008-10-23

$RFMT $RIREG SCHEME38 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethyl 10-oxo-4aH,10H-pyrano[4,3-b][1]benzopyran-3,4-dicarboxylate
C16H12O7
1071928-08-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 2.3101 0.0 0
M  V30 2 O 5.3348 1.5400 0.0 0
M  V30 3 O 8.0022 1.5400 0.0 0
M  V30 4 C 5.3348 0.0000 0.0 0
M  V30 5 O 4.0012 8.4702 0.0 0
M  V30 6 C 9.3360 3.8501 0.0 0
M  V30 7 O 10.6697 4.6201 0.0 0
M  V30 8 O 9.3360 2.3101 0.0 0
M  V30 9 C 12.0033 3.8501 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 5.3348 6.1601 0.0 0
M  V30 12 C 6.6685 3.8501 0.0 0
M  V30 13 O 4.0012 3.8501 0.0 0
M  V30 14 C 4.0012 6.9302 0.0 0
M  V30 15 C 6.6685 6.9302 0.0 0
M  V30 16 C 8.0022 4.6201 0.0 0
M  V30 17 C 2.6673 4.6201 0.0 0
M  V30 18 C 2.6673 6.1601 0.0 0
M  V30 19 O 8.0022 6.1601 0.0 0
M  V30 20 C 1.3337 3.8501 0.0 0
M  V30 21 C 1.3337 6.9302 0.0 0
M  V30 22 C 0.0000 4.6201 0.0 0
M  V30 23 C 0.0000 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 2 5 14
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 16
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 19
M  V30 20 1 17 18
M  V30 21 2 17 20
M  V30 22 2 18 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dimethyl 1,2-dihydro-2-hydroxy-5-(2-hydroxybenzoyl)-1-methyl-2,3-pyridine...
C17H17NO7
1448991-50-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.5065 4.3527 0.0 0
M  V30 2 O 1.5166 5.5323 0.0 0
M  V30 3 O 1.9798 2.9055 0.0 0
M  V30 4 C 0.0000 5.2648 0.0 0
M  V30 5 O 3.4964 6.0671 0.0 0
M  V30 6 C 2.6895 2.3100 0.0 0
M  V30 7 O 2.6895 0.7700 0.0 0
M  V30 8 O 1.3558 3.0800 0.0 0
M  V30 9 C 1.3558 0.0000 0.0 0
M  V30 10 C 5.3569 6.9300 0.0 0
M  V30 11 C 8.0242 2.3100 0.0 0
M  V30 12 O 8.0242 0.7700 0.0 0
M  V30 13 O 10.6916 0.7700 0.0 0
M  V30 14 C 4.0231 4.6200 0.0 0
M  V30 15 C 4.0231 3.0800 0.0 0
M  V30 16 N 5.3569 5.3900 0.0 0
M  V30 17 C 5.3569 2.3100 0.0 0
M  V30 18 C 6.6905 4.6200 0.0 0
M  V30 19 C 6.6905 3.0800 0.0 0
M  V30 20 C 9.3578 3.0800 0.0 0
M  V30 21 C 10.6916 2.3100 0.0 0
M  V30 22 C 9.3578 4.6200 0.0 0
M  V30 23 C 12.0252 3.0800 0.0 0
M  V30 24 C 10.6916 5.3900 0.0 0
M  V30 25 C 12.0252 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 15
M  V30 9 1 7 9
M  V30 10 1 10 16
M  V30 11 2 11 12
M  V30 12 1 11 19
M  V30 13 1 11 20
M  V30 14 1 13 21
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1071928-08-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1448991-50-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-4303623
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cascade Syntheses Routes to the Centrocountins
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Eschenbrenner-Lux, Vincent; Dueckert, Heiko; Khedkar, Vivek; Bruss,
Hanna; Waldmann, Herbert; Kumar, Kamal
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2013), 19(7), 2294-2304

$RFMT $RIREG SCHEME39 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 10-oxo-4aH,10H-pyrano[4,3-b][1]benzopyran-4-carboxylate
C14H10O5
1071928-11-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 4.0011 0.0 0
M  V30 2 O 9.2400 4.0011 0.0 0
M  V30 3 O 6.9300 5.3349 0.0 0
M  V30 4 C 10.0100 5.3349 0.0 0
M  V30 5 O 2.3100 0.0000 0.0 0
M  V30 6 C 5.3900 2.6674 0.0 0
M  V30 7 C 4.6200 1.3338 0.0 0
M  V30 8 C 6.9300 2.6674 0.0 0
M  V30 9 O 4.6200 4.0011 0.0 0
M  V30 10 C 3.0800 1.3338 0.0 0
M  V30 11 C 5.3900 0.0000 0.0 0
M  V30 12 C 7.7000 1.3338 0.0 0
M  V30 13 C 3.0800 4.0011 0.0 0
M  V30 14 C 2.3100 2.6674 0.0 0
M  V30 15 O 6.9300 0.0000 0.0 0
M  V30 16 C 2.3100 5.3349 0.0 0
M  V30 17 C 0.7700 2.6674 0.0 0
M  V30 18 C 0.7700 5.3349 0.0 0
M  V30 19 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 2 5 10
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 15
M  V30 16 1 13 14
M  V30 17 2 13 16
M  V30 18 2 14 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1,10a-dihydro-1-methyl-5-oxo-5H-[1]benzopyrano[2,3-b]pyridine-3-carbox...
C15H13NO4
1448991-53-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 6.1601 0.0 0
M  V30 2 C 6.6685 0.0000 0.0 0
M  V30 3 C 9.3360 4.6201 0.0 0
M  V30 4 O 10.6697 3.8501 0.0 0
M  V30 5 O 9.3360 6.1601 0.0 0
M  V30 6 C 12.0033 4.6201 0.0 0
M  V30 7 C 5.3348 3.8501 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 6.6685 4.6201 0.0 0
M  V30 11 O 4.0012 1.5400 0.0 0
M  V30 12 N 6.6685 1.5400 0.0 0
M  V30 13 C 2.6673 3.8501 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 2.6673 2.3101 0.0 0
M  V30 16 C 8.0022 2.3101 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 1.3337 1.5400 0.0 0
M  V30 19 C 0.0000 3.8501 0.0 0
M  V30 20 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 12
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 14
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 2 13 17
M  V30 18 2 14 16
M  V30 19 2 15 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1071928-11-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1448991-53-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-177-CAS-7070936
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cascade Syntheses Routes to the Centrocountins
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Eschenbrenner-Lux, Vincent; Dueckert, Heiko; Khedkar, Vivek; Bruss,
Hanna; Waldmann, Herbert; Kumar, Kamal
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2013), 19(7), 2294-2304

$RFMT $RIREG SCHEME40 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(5E,10R)-5-(3-Bromopropylidene)-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-10-ol
C18H17BrO
1076130-58-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.4633 4.9154 0.0 0
M  V30 2 C 7.5108 3.7866 0.0 0
M  V30 3 C 9.0122 4.1293 0.0 0
M  V30 4 Br 10.0597 3.0004 0.0 0
M  V30 5 O 0.0000 4.9154 0.0 0
M  V30 6 C 4.9620 4.5728 0.0 0
M  V30 7 C 4.0017 5.7769 0.0 0
M  V30 8 C 4.6191 3.0714 0.0 0
M  V30 9 C 2.4617 5.7769 0.0 0
M  V30 10 C 4.7718 7.1106 0.0 0
M  V30 11 C 3.2317 2.4032 0.0 0
M  V30 12 C 5.8917 2.2039 0.0 0
M  V30 13 C 1.5015 4.5728 0.0 0 CFG=2
M  V30 14 C 1.6917 7.1106 0.0 0
M  V30 15 C 4.0017 8.4443 0.0 0
M  V30 16 C 1.8442 3.0714 0.0 0
M  V30 17 C 3.1165 0.8675 0.0 0
M  V30 18 C 5.7765 0.6682 0.0 0
M  V30 19 C 2.4617 8.4443 0.0 0
M  V30 20 C 4.3891 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 6
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 13 5 CFG=1
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 2 9 14
M  V30 14 1 10 15
M  V30 15 1 11 16
M  V30 16 2 11 17
M  V30 17 1 12 18
M  V30 18 1 13 16
M  V30 19 1 14 19
M  V30 20 2 15 19
M  V30 21 1 17 20
M  V30 22 2 18 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(5E)-(-)-10,11-Dihydro-5-[3-(methylamino)propylidene]-5H-dibenzo[a,d]cyclohep...
C19H21NO
112839-35-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1760 5.3085 0.0 0
M  V30 2 C 7.5098 4.5385 0.0 0
M  V30 3 C 8.8435 5.3085 0.0 0
M  V30 4 N 10.1771 4.5385 0.0 0
M  V30 5 C 11.5108 5.3085 0.0 0
M  V30 6 O 0.0000 3.4035 0.0 0
M  V30 7 C 4.8423 4.5385 0.0 0
M  V30 8 C 3.5699 5.4060 0.0 0
M  V30 9 C 4.9574 3.0028 0.0 0
M  V30 10 C 2.0983 4.9521 0.0 0
M  V30 11 C 3.9126 6.9075 0.0 0
M  V30 12 C 3.8285 1.9552 0.0 0
M  V30 13 C 6.4290 2.5489 0.0 0
M  V30 14 C 1.5357 3.5185 0.0 0 CFG=3
M  V30 15 C 0.9694 5.9996 0.0 0
M  V30 16 C 2.7836 7.9549 0.0 0
M  V30 17 C 2.3057 2.1848 0.0 0
M  V30 18 C 4.1712 0.4538 0.0 0
M  V30 19 C 6.7717 1.0474 0.0 0
M  V30 20 C 1.3121 7.5010 0.0 0
M  V30 21 C 5.6428 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 2 10 15
M  V30 15 1 11 16
M  V30 16 1 12 17
M  V30 17 2 12 18
M  V30 18 1 13 19
M  V30 19 1 14 17
M  V30 20 1 15 20
M  V30 21 2 16 20
M  V30 22 1 18 21
M  V30 23 2 19 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1076130-58-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 112839-35-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-2194602
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of M-E-10-OH-NT. compound (-)-8. (-)-E-10-OH-NT was synthesized
by heating a solution of (-)-7 (2.45 g, 6.7 mmol, 1.00 eq) and methyl
amine (40% by weight in water, 25.0 mL, 290 mmol, 43 eq) in acetonitrile
(35 mL) at 60°C for 5 hours in a pressure vessel. The reaction was
concentrated and purified by a silica gel plug using a 5-9%
methanol/chloroform gradient (plus 1% ammonium hydroxide). Because there
was some Z isomer present, i.e., (-)-Z-10-OH-NT, the impure free base was
dissolved in dichloromethane, filtered to remove any insoluble particles,
concentrated and dried to give 1.9 g of a light yellow foam in
quantitative yield. The free base (1.37 g, 4.9 mmol, 1.00 eq) was
dissolved in acetonitrile (40 mL) and maleic acid (0.654 g, 5.64 mmol,
1.15 eq) is added. The mixture was stirred for 60 minutes and a solid
precipitated out. The mixture was concentrated, dried and recrystallized
from isopropanol (70 mL) to give 820 mg of pale orange needles of
(-)-E-10-OH-NT as the maleate salt. Chiral LC Analysis: 98.6% 30 chiral
purity. Column: Chromtech CHIRAL-AGP 150 x 4.0 mm, 5|o.. Flow: 1.0mL/min.
Mobile Phase: 80% 20 mM sodium phosphate pH 6.0,20% IPA 1H NMR (400MHz,
DMSO-d6) δ 8.29 (brs, 2H), 7.50-7.12 (m, 8H), 6.02 (s, 2H), 5.90 (brm,
1/3H), 5.71 (brs, 2/3H), 5.31 (brs, 1/3H), 5.08 (brs, 1/3H), 4.60 (brs,
1/3H), 3.36 (m, 1H), 3.06-2.86 (brm, 3H), 2.52 (d, 3H), 2.36 (brm, 2H).
Mass Spectral Analysis m/z = 280.1 (M+H)+. Detector: UV at 240 nm. Peak
Retention Time: Peak 1 [(+)-E-10-OH-NT] = 6.1 min. Peak 2
[(-)-E-10-OH-NT] = 8.6 min. Elemental analysis: C19H21NO.C4H4O4. Theory:
%C 69.86; %H 6.37; %N 3.54. Found: %C 69.53; %H 6.44; %N 3.57. [α] D 23.4
= -24.12 (c. 10.7 mg/mL, MeOH). m.p. = 177.5-179.0°C.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions of (-)-E-10-hydroxynortriptyline, and methods for synthesis
and therapeutic use thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Le Bourdonnec, Bertrand; Dolle, Roland
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008134325 A1 2008-11-06

$RFMT $RIREG SCHEME41 STEP1
$RXN



  3  1
$MOL
Acetic anhydride
C4H6O3
108-24-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 C 5.3349 2.3100 0.0 0
M  V30 5 O 4.0011 0.0000 0.0 0
M  V30 6 C 1.3338 0.0000 0.0 0
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Methyl (4aR,6S,8aR)-decahydro-8a-methyl-8-oxo-6-phenyl-1,7-naphthyridine-...
C17H22N2O3
595581-95-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8615 2.6268 0.0 0
M  V30 2 O 4.8716 1.4471 0.0 0
M  V30 3 O 7.3781 2.3594 0.0 0
M  V30 4 C 5.3983 0.0000 0.0 0
M  V30 5 O 4.0011 7.9239 0.0 0
M  V30 6 C 2.6674 7.1539 0.0 0
M  V30 7 C 5.3347 4.0739 0.0 0 CFG=2
M  V30 8 C 4.0011 3.3039 0.0 0
M  V30 9 N 5.3347 5.6139 0.0 0
M  V30 10 C 2.6674 4.0739 0.0 0 CFG=1
M  V30 11 C 4.0011 6.3839 0.0 0
M  V30 12 C 2.6674 5.6139 0.0 0 CFG=2
M  V30 13 C 1.3338 3.3039 0.0 0
M  V30 14 N 1.3338 6.3839 0.0 0
M  V30 15 C 0.0000 4.0739 0.0 0
M  V30 16 C 0.0000 5.6139 0.0 0
M  V30 17 C 6.8513 4.3414 0.0 0
M  V30 18 C 7.3781 5.7886 0.0 0
M  V30 19 C 7.8412 3.1616 0.0 0
M  V30 20 C 8.8947 6.0559 0.0 0
M  V30 21 C 9.3578 3.4291 0.0 0
M  V30 22 C 9.8846 4.8763 0.0 0
M  V30 23 H 2.6674 2.5339 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 7 1 CFG=1
M  V30 4 1 2 4
M  V30 5 2 5 11
M  V30 6 1 12 6 CFG=3
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 17 CFG=3
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 10 23 CFG=3
M  V30 15 1 11 12
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 7 10 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(4aR,6S,8aR)-1-Acetyldecahydro-N,8a-dimethyl-8-oxo-6-phenyl-1,7-naphthyri...
C19H25N3O3
595581-96-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6268 2.5065 0.0 0
M  V30 2 N 2.8943 0.9899 0.0 0
M  V30 3 O 1.1798 3.0332 0.0 0
M  V30 4 C 1.7146 0.0000 0.0 0
M  V30 5 O 6.8866 6.1638 0.0 0
M  V30 6 C 7.6566 4.8301 0.0 0
M  V30 7 C 9.1966 4.8301 0.0 0
M  V30 8 C 8.4266 6.1638 0.0 0
M  V30 9 O 10.7366 4.8301 0.0 0
M  V30 10 C 3.8066 3.4964 0.0 0 CFG=2
M  V30 11 C 4.5766 2.1628 0.0 0
M  V30 12 N 4.5766 4.8301 0.0 0
M  V30 13 C 6.1166 2.1628 0.0 0 CFG=1
M  V30 14 C 6.1166 4.8301 0.0 0
M  V30 15 C 6.8866 3.4964 0.0 0 CFG=2
M  V30 16 C 6.8866 0.8290 0.0 0
M  V30 17 N 8.4266 3.4964 0.0 0
M  V30 18 C 8.4266 0.8291 0.0 0
M  V30 19 C 9.1966 2.1628 0.0 0
M  V30 20 C 2.6268 4.4863 0.0 0
M  V30 21 C 2.8943 6.0029 0.0 0
M  V30 22 C 1.1798 3.9596 0.0 0
M  V30 23 C 1.7145 6.9928 0.0 0
M  V30 24 C 0.0000 4.9496 0.0 0
M  V30 25 C 0.2675 6.4662 0.0 0
M  V30 26 H 5.3466 0.8290 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 10 1 CFG=3
M  V30 4 1 2 4
M  V30 5 2 5 14
M  V30 6 1 15 6 CFG=1
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 17
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 20 CFG=1
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 13 26 CFG=1
M  V30 18 1 14 15
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 10 13 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 595581-95-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 595581-96-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-4060889
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of a functionalizable external β-turn mimic based on a
cis-fused 1,7-naphthyridine scaffold
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rombouts, Frederik J. R.; De Borggraeve, Wim M.; Delaere, David; Froeyen,
Matheus; Toppet, Suzanne M.; Compernolle, Frans; Hoornaert, Georges J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2003), (10), 1868-1878

$RFMT $RIREG SCHEME42 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Maleic anhydride
C4H2O3
108-31-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 2.6218 0.0 0
M  V30 2 O 5.3026 1.4946 0.0 0
M  V30 3 O 2.7406 2.4782 0.0 0
M  V30 4 C 1.3337 1.8517 0.0 0
M  V30 5 C 3.7711 1.3337 0.0 0
M  V30 6 C 1.4946 0.3202 0.0 0
M  V30 7 C 3.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 4
M  V30 2 2 2 5
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Butenoic acid, 4-(methylamino)-4-oxo-, (E)-
C5H7NO3
124378-37-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 N 6.6686 1.5400 0.0 0
M  V30 4 O 5.3348 3.8500 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 8.0022 2.3100 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108-31-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 124378-37-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-117-CAS-16478005
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polyfluorinated arylpyrazolopyrimidine compounds acting as Bruton's
tyrosine kinase inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM He, Wei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20160200730 A1 2016-07-14

$RFMT $RIREG SCHEME43 STEP1
$RXN



  2  1
$MOL
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-1-(triphenylmethyl)-L-histidine
C40H33N3O4
109425-51-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  47 53 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 5.0257 0.0 0
M  V30 2 C 9.3038 3.8986 0.0 0
M  V30 3 C 10.2090 2.6527 0.0 0 CFG=1
M  V30 4 N 11.7406 2.8138 0.0 0
M  V30 5 C 9.5826 1.2459 0.0 0
M  V30 6 C 12.3669 4.2206 0.0 0
M  V30 7 O 10.4878 0.0000 0.0 0
M  V30 8 O 8.0510 1.0850 0.0 0
M  V30 9 O 13.8986 4.3815 0.0 0
M  V30 10 O 11.4619 5.4665 0.0 0
M  V30 11 C 14.5250 5.7885 0.0 0
M  V30 12 N 5.3348 4.2557 0.0 0
M  V30 13 C 6.7417 4.8822 0.0 0
M  V30 14 C 5.4958 2.7242 0.0 0
M  V30 15 C 7.7722 3.7377 0.0 0
M  V30 16 N 7.0022 2.4040 0.0 0
M  V30 17 C 3.2311 3.6921 0.0 0
M  V30 18 C 1.6911 3.6921 0.0 0
M  V30 19 C 4.0012 2.3584 0.0 0
M  V30 20 C 0.9211 2.3584 0.0 0
M  V30 21 C 3.2311 1.0247 0.0 0
M  V30 22 C 1.6911 1.0247 0.0 0
M  V30 23 C 2.6673 5.7958 0.0 0
M  V30 24 C 2.6673 7.3358 0.0 0
M  V30 25 C 1.3337 5.0257 0.0 0
M  V30 26 C 1.3337 8.1058 0.0 0
M  V30 27 C 0.0000 5.7958 0.0 0
M  V30 28 C 0.0000 7.3358 0.0 0
M  V30 29 C 4.7712 6.3596 0.0 0
M  V30 30 C 6.3112 6.3596 0.0 0
M  V30 31 C 4.0012 7.6932 0.0 0
M  V30 32 C 7.0812 7.6932 0.0 0
M  V30 33 C 4.7712 9.0269 0.0 0
M  V30 34 C 6.3112 9.0269 0.0 0
M  V30 35 C 16.0565 5.9495 0.0 0
M  V30 36 C 17.0870 4.8051 0.0 0
M  V30 37 C 16.8266 7.2831 0.0 0
M  V30 38 C 18.4940 5.4314 0.0 0
M  V30 39 C 16.9260 3.2733 0.0 0
M  V30 40 C 18.3330 6.9630 0.0 0
M  V30 41 C 16.3507 8.7479 0.0 0
M  V30 42 C 19.7398 4.5262 0.0 0
M  V30 43 C 18.1719 2.3683 0.0 0
M  V30 44 C 19.3635 8.1075 0.0 0
M  V30 45 C 17.3811 9.8923 0.0 0
M  V30 46 C 19.5789 2.9946 0.0 0
M  V30 47 C 18.8876 9.5721 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 17
M  V30 3 1 1 23
M  V30 4 1 1 29
M  V30 5 1 2 3
M  V30 6 1 2 15
M  V30 7 1 3 4 CFG=3
M  V30 8 1 3 5
M  V30 9 1 4 6
M  V30 10 1 5 7
M  V30 11 2 5 8
M  V30 12 1 6 9
M  V30 13 2 6 10
M  V30 14 1 9 11
M  V30 15 1 11 35
M  V30 16 1 12 13
M  V30 17 1 12 14
M  V30 18 2 13 15
M  V30 19 2 14 16
M  V30 20 1 15 16
M  V30 21 2 17 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 2 19 21
M  V30 25 2 20 22
M  V30 26 1 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 1 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 36 39
M  V30 43 1 37 40
M  V30 44 2 37 41
M  V30 45 1 38 40
M  V30 46 2 38 42
M  V30 47 1 39 43
M  V30 48 2 40 44
M  V30 49 1 41 45
M  V30 50 1 42 46
M  V30 51 2 43 46
M  V30 52 1 44 47
M  V30 53 2 45 47
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9H-Fluoren-9-ylmethyl N-[(1S)-2-(methylamino)-2-oxo-1-[[1-(triphenylmethyl)-1...
C41H36N4O3
1262323-28-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  48 54 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 8.2492 0.0 0
M  V30 2 C 7.6284 4.2205 0.0 0
M  V30 3 C 9.1601 4.0596 0.0 0 CFG=1
M  V30 4 N 10.0653 5.3055 0.0 0
M  V30 5 C 9.7864 2.6527 0.0 0
M  V30 6 C 11.5969 5.1446 0.0 0
M  V30 7 N 8.8812 1.4068 0.0 0
M  V30 8 O 11.3180 2.4917 0.0 0
M  V30 9 O 12.5021 6.3904 0.0 0
M  V30 10 O 12.2232 3.7376 0.0 0
M  V30 11 C 9.5077 0.0000 0.0 0
M  V30 12 C 14.0336 6.2293 0.0 0
M  V30 13 N 5.3347 7.4792 0.0 0
M  V30 14 C 5.4958 5.9475 0.0 0
M  V30 15 C 6.7417 8.1055 0.0 0
M  V30 16 C 7.0021 5.6273 0.0 0
M  V30 17 N 7.7721 6.9611 0.0 0
M  V30 18 C 3.2311 6.9154 0.0 0
M  V30 19 C 1.6911 6.9154 0.0 0
M  V30 20 C 4.0011 5.5818 0.0 0
M  V30 21 C 0.9211 5.5818 0.0 0
M  V30 22 C 3.2311 4.2481 0.0 0
M  V30 23 C 1.6911 4.2481 0.0 0
M  V30 24 C 2.6674 9.0192 0.0 0
M  V30 25 C 2.6674 10.5592 0.0 0
M  V30 26 C 1.3338 8.2492 0.0 0
M  V30 27 C 1.3338 11.3292 0.0 0
M  V30 28 C 0.0000 9.0192 0.0 0
M  V30 29 C 0.0000 10.5592 0.0 0
M  V30 30 C 4.7711 9.5829 0.0 0
M  V30 31 C 6.3111 9.5829 0.0 0
M  V30 32 C 4.0011 10.9165 0.0 0
M  V30 33 C 7.0811 10.9165 0.0 0
M  V30 34 C 4.7711 12.2501 0.0 0
M  V30 35 C 6.3111 12.2501 0.0 0
M  V30 36 C 14.9388 7.4754 0.0 0
M  V30 37 C 16.4789 7.4754 0.0 0
M  V30 38 C 14.4630 8.9399 0.0 0
M  V30 39 C 16.9547 8.9399 0.0 0
M  V30 40 C 17.5093 6.3308 0.0 0
M  V30 41 C 15.7089 9.8451 0.0 0
M  V30 42 C 13.0560 9.5662 0.0 0
M  V30 43 C 18.4610 9.2601 0.0 0
M  V30 44 C 19.0157 6.6510 0.0 0
M  V30 45 C 15.5478 11.3767 0.0 0
M  V30 46 C 12.8951 11.0979 0.0 0
M  V30 47 C 19.4916 8.1157 0.0 0
M  V30 48 C 14.1410 12.0031 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 18
M  V30 3 1 1 24
M  V30 4 1 1 30
M  V30 5 1 2 3
M  V30 6 1 2 16
M  V30 7 1 3 4 CFG=3
M  V30 8 1 3 5
M  V30 9 1 4 6
M  V30 10 1 5 7
M  V30 11 2 5 8
M  V30 12 1 6 9
M  V30 13 2 6 10
M  V30 14 1 7 11
M  V30 15 1 9 12
M  V30 16 1 12 36
M  V30 17 1 13 14
M  V30 18 1 13 15
M  V30 19 2 14 16
M  V30 20 2 15 17
M  V30 21 1 16 17
M  V30 22 2 18 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 2 20 22
M  V30 26 2 21 23
M  V30 27 1 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 40 1 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 37 40
M  V30 44 1 38 41
M  V30 45 2 38 42
M  V30 46 1 39 41
M  V30 47 2 39 43
M  V30 48 1 40 44
M  V30 49 2 41 45
M  V30 50 1 42 46
M  V30 51 1 43 47
M  V30 52 2 44 47
M  V30 53 1 45 48
M  V30 54 2 46 48
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 109425-51-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1262323-28-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9028853
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for Preparation of 7a-n. To
a stirred solution of Fmoc-His-(Trt)-OH (2) (2.5 g; 4 mmol) in dry DMF
(40 mL), DIPEA (1.03 mL; 6 mmol), HBTU (2.29 g; 6 mmol), and HOBt (0.08
g; 0.6 mmol) were added. After 10 min, the appropriate amine 3a-n (6
mmol) was added; the reaction mixture was allowed to stir at rt until TLC
showed complete consumption of starting material (1-18 h). The solvent
was removed under reduced pressure (oil pump) and the residue taken up
with CH2Cl2 (40 mL) and washed with water (3 × 30 mL) and brine (30 mL),
then dried and evaporated under reduced pressure. The residual was
purified by flash chromatography eluting with CH2Cl2 /MeOH 9.9/0.1 to
9.5/0.5. intermediate 4b (56-100%), oil.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, Physicochemical Characterization, and Biological Activities of
New Carnosine Derivatives Stable in Human Serum As Potential
Neuroprotective Agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bertinaria, Massimo; Rolando, Barbara; Giorgis, Marta; Montanaro,
Gabriele; Guglielmo, Stefano; Buonsanti, M. Federica; Carabelli,
Valentina; Gavello, Daniela; Daniele, Pier Giuseppe; Fruttero, Roberta;
Gasco, Alberto
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2011), 54(2), 611-621

$RFMT $RIREG SCHEME44 STEP1
$RXN



  3  1
$MOL
1,1′-Carbonyldiimidazole
C7H6N4O
530-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 N 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 C 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 N 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 N 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Pyrrolidinecarboxylic acid, 3-hydroxy-, 1,1-dimethylethyl ester, (3R)-
C9H17NO3
109431-87-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 2.6218 0.0 0
M  V30 2 O 2.6673 1.8517 0.0 0
M  V30 3 O 4.0010 4.1618 0.0 0
M  V30 4 C 1.3337 2.6218 0.0 0
M  V30 5 C 0.5637 1.2881 0.0 0
M  V30 6 C 0.0000 3.3918 0.0 0
M  V30 7 C 2.1037 3.9554 0.0 0
M  V30 8 O 9.3037 1.4946 0.0 0
M  V30 9 N 5.3348 1.8517 0.0 0
M  V30 10 C 5.4958 0.3202 0.0 0
M  V30 11 C 6.7417 2.4782 0.0 0
M  V30 12 C 7.0021 0.0000 0.0 0
M  V30 13 C 7.7721 1.3337 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 13 8 CFG=3
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3R)-3-[[(methylamino)carbonyl]oxy]-1-pyrrolidinecarboxylate
C11H20N2O4
2344749-46-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 O 9.0058 4.5489 0.0 0
M  V30 9 C 10.4126 3.9224 0.0 0
M  V30 10 N 11.6584 4.8276 0.0 0
M  V30 11 O 10.5736 2.3909 0.0 0
M  V30 12 C 13.0654 4.2013 0.0 0
M  V30 13 N 5.3900 2.8736 0.0 0
M  V30 14 C 6.2952 4.1195 0.0 0
M  V30 15 C 6.2952 1.6278 0.0 0
M  V30 16 C 7.7599 3.6436 0.0 0 CFG=2
M  V30 17 C 7.7599 2.1036 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 16 8 CFG=3
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 109431-87-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2344749-46-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29353541
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed tube in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolopyrimidines having activity against the
respiratory syncytial virus (RSV)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lancois, David Francis Alain; Guillemont, Jerome Emile Georges;
Raboisson, Pierre Jean-Marie Bernard; Roymans, Dirk Andre Emmy; Rigaux,
Peter; Michaut, Antoine Benjamin; Mercey, Guillaume Jean Maurice
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019106004 A1 2019-06-06

$RFMT $RIREG SCHEME45 STEP1
$RXN



  2  1
$MOL
(1S)-6-Bromo-2,3-dihydro-1H-inden-1-ol
C9H9BrO
1096537-29-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 0.4294 0.0000 0.0 0
M  V30 2 Br 6.3710 1.1704 0.0 0
M  V30 3 C 2.3699 1.9404 0.0 0
M  V30 4 C 2.3699 3.4804 0.0 0
M  V30 5 C 0.9052 1.4645 0.0 0 CFG=1
M  V30 6 C 3.7036 1.1704 0.0 0
M  V30 7 C 3.7036 4.2504 0.0 0
M  V30 8 C 0.9052 3.9564 0.0 0
M  V30 9 C 0.0000 2.7104 0.0 0
M  V30 10 C 5.0372 1.9404 0.0 0
M  V30 11 C 5.0372 3.4804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 5 1 CFG=1
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 9
M  V30 12 2 10 11
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1R)-6-Bromo-2,3-dihydro-N-methyl-1H-inden-1-amine
C10H12BrN
1509899-79-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 1.5063 0.3202 0.0 0
M  V30 2 C 0.0000 0.0000 0.0 0
M  V30 3 Br 7.4478 1.4907 0.0 0
M  V30 4 C 3.4468 2.2607 0.0 0
M  V30 5 C 3.4468 3.8007 0.0 0
M  V30 6 C 1.9821 1.7849 0.0 0 CFG=2
M  V30 7 C 4.7805 1.4907 0.0 0
M  V30 8 C 1.9821 4.2766 0.0 0
M  V30 9 C 4.7805 4.5707 0.0 0
M  V30 10 C 1.0769 3.0307 0.0 0
M  V30 11 C 6.1141 2.2607 0.0 0
M  V30 12 C 6.1141 3.8007 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 6 1 CFG=3
M  V30 3 1 3 11
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1096537-29-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1509899-79-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-2192881
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 124-63-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrocyclic inhibitors of flaviviridae viruses
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aciro, Caroline; Steadman, Victoria Alexandra; Pettit, Simon Neil;
Poullennec, Karine G.; Lazarides, Linos; Dean, David Kenneth; Dunbar,
Neil Andrew; Highton, Adrian John; Keats, Andrew John; Siegel, Dustin
Scott; Karki, Kapil Kumar; Schrier, Adam James; Jansa, Petr; MacKman,
Richard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013185090 A1 2013-12-12

$RFMT $RIREG SCHEME45 STEP1
$RXN



  2  1
$MOL
(1S)-6-Bromo-2,3-dihydro-1H-inden-1-ol
C9H9BrO
1096537-29-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 0.4294 0.0000 0.0 0
M  V30 2 Br 6.3710 1.1704 0.0 0
M  V30 3 C 2.3699 1.9404 0.0 0
M  V30 4 C 2.3699 3.4804 0.0 0
M  V30 5 C 0.9052 1.4645 0.0 0 CFG=1
M  V30 6 C 3.7036 1.1704 0.0 0
M  V30 7 C 3.7036 4.2504 0.0 0
M  V30 8 C 0.9052 3.9564 0.0 0
M  V30 9 C 0.0000 2.7104 0.0 0
M  V30 10 C 5.0372 1.9404 0.0 0
M  V30 11 C 5.0372 3.4804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 5 1 CFG=1
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 9
M  V30 12 2 10 11
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1R)-6-Bromo-2,3-dihydro-N-methyl-1H-inden-1-amine
C10H12BrN
1509899-79-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 1.5063 0.3202 0.0 0
M  V30 2 C 0.0000 0.0000 0.0 0
M  V30 3 Br 7.4478 1.4907 0.0 0
M  V30 4 C 3.4468 2.2607 0.0 0
M  V30 5 C 3.4468 3.8007 0.0 0
M  V30 6 C 1.9821 1.7849 0.0 0 CFG=2
M  V30 7 C 4.7805 1.4907 0.0 0
M  V30 8 C 1.9821 4.2766 0.0 0
M  V30 9 C 4.7805 4.5707 0.0 0
M  V30 10 C 1.0769 3.0307 0.0 0
M  V30 11 C 6.1141 2.2607 0.0 0
M  V30 12 C 6.1141 3.8007 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 6 1 CFG=3
M  V30 3 1 3 11
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1096537-29-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1509899-79-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-12776553
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 124-63-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of macrocyclic peptides as inhibitors of flaviviridae viruses
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aciro, Caroline; Steadman, Victoria Alexandra; Pettit, Simon Neil;
Poullennec, Karine G.; Lazarides, Linos; Dean, David Kenneth; Dunbar,
Neil Andrew; Highton, Adrian John; Keats, Andrew John; Siegel, Dustin
Scott; Karki, Kapil Kumar; Schrier, Adam James; Jansa, Petr; MacKman,
Richard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013185103 A1 2013-12-12

$RFMT $RIREG SCHEME46 STEP1
$RXN



  4  1
$MOL
Bromoacetic acid
C2H3BrO2
79-08-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 O 0.0000 2.3101 0.0 0
M  V30 5 Br 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxyethylamine
C3H9NO
109-85-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.7700 0.0 0
M  V30 2 C 1.3338 0.0000 0.0 0
M  V30 3 O 4.0010 0.0000 0.0 0
M  V30 4 N 0.0000 0.7700 0.0 0
M  V30 5 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-(phenylmethyl)-L-alanine
C25H23NO4
672917-68-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 4.0011 0.0 0
M  V30 2 O 5.3900 4.0011 0.0 0
M  V30 3 C 4.6200 5.3347 0.0 0
M  V30 4 N 3.0800 5.3347 0.0 0
M  V30 5 O 5.3900 6.6685 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 2.3100 6.6685 0.0 0 CFG=1
M  V30 8 C 0.7700 6.6685 0.0 0
M  V30 9 C 3.0800 8.0021 0.0 0
M  V30 10 O 0.0000 8.0021 0.0 0
M  V30 11 O 0.0000 5.3347 0.0 0
M  V30 12 C 7.7000 5.3347 0.0 0
M  V30 13 C 9.2315 5.4958 0.0 0
M  V30 14 C 7.0735 6.7417 0.0 0
M  V30 15 C 9.5517 7.0021 0.0 0
M  V30 16 C 10.3759 4.4652 0.0 0
M  V30 17 C 8.2181 7.7721 0.0 0
M  V30 18 C 5.6090 7.2175 0.0 0
M  V30 19 C 11.0164 7.4779 0.0 0
M  V30 20 C 11.8406 4.9411 0.0 0
M  V30 21 C 7.8979 9.2785 0.0 0
M  V30 22 C 5.2888 8.7238 0.0 0
M  V30 23 C 12.1608 6.4475 0.0 0
M  V30 24 C 6.4332 9.7544 0.0 0
M  V30 25 C 3.0800 2.6674 0.0 0
M  V30 26 C 2.3100 1.3338 0.0 0
M  V30 27 C 4.6200 2.6674 0.0 0
M  V30 28 C 3.0800 0.0000 0.0 0
M  V30 29 C 5.3900 1.3338 0.0 0
M  V30 30 C 4.6200 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 6 25
M  V30 9 1 7 8
M  V30 10 1 7 9 CFG=3
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 15 17
M  V30 20 2 15 19
M  V30 21 1 16 20
M  V30 22 2 17 21
M  V30 23 1 18 22
M  V30 24 1 19 23
M  V30 25 2 20 23
M  V30 26 1 21 24
M  V30 27 2 22 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C18H27N3O5
2172815-26-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.9302 6.6685 0.0 0
M  V30 2 C 5.3901 6.6685 0.0 0 CFG=1
M  V30 3 C 7.7002 5.3348 0.0 0
M  V30 4 C 7.7002 8.0022 0.0 0
M  V30 5 C 4.6201 5.3348 0.0 0
M  V30 6 C 4.6201 8.0022 0.0 0
M  V30 7 C 6.9302 9.3360 0.0 0
M  V30 8 O 9.2402 8.0022 0.0 0
M  V30 9 N 3.0801 5.3348 0.0 0
M  V30 10 O 5.3901 4.0012 0.0 0
M  V30 11 N 7.7002 10.6697 0.0 0
M  V30 12 C 2.3101 4.0012 0.0 0
M  V30 13 C 2.3101 6.6685 0.0 0
M  V30 14 C 6.9302 12.0033 0.0 0
M  V30 15 C 3.0801 2.6673 0.0 0
M  V30 16 C 0.7700 6.6685 0.0 0
M  V30 17 O 2.3101 1.3337 0.0 0
M  V30 18 O 0.0000 8.0022 0.0 0
M  V30 19 O 0.0000 5.3348 0.0 0
M  V30 20 C 3.0801 0.0000 0.0 0
M  V30 21 C 9.2402 5.3348 0.0 0
M  V30 22 C 10.0102 4.0012 0.0 0
M  V30 23 C 10.0102 6.6685 0.0 0
M  V30 24 C 11.5503 4.0012 0.0 0
M  V30 25 C 11.5503 6.6685 0.0 0
M  V30 26 C 12.3203 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 21
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 5 9
M  V30 10 2 5 10
M  V30 11 1 7 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 2 21 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 2 23 25
M  V30 25 2 24 26
M  V30 26 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 79-08-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 109-85-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 672917-68-9
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2172815-26-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-18429979
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 6
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 110-89-4
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 920-66-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported reaction, attachment to 2-chlorotrityl resin in stage
1,solid phase peptoide synthesis,cleavage step repeated twice,further
bromoacetic acid-amine coupling carried out by DIC in DMF
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cyclic peptoids as topological templates: Synthesis via central to
conformational chirality induction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM D'Amato, Assunta; Pierri, Giovanni; Costabile, Chiara; Della Sala,
Giorgio; Tedesco, Consiglia; Izzo, Irene; De Riccardis, Francesco
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2018), 20(3), 640-643

$RFMT $RIREG SCHEME47 STEP1
$RXN



  4  1
$MOL
Benzocaine
C9H11NO2
94-09-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 O 6.6684 2.3100 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 C 8.0022 1.5400 0.0 0
M  V30 5 C 9.3359 2.3100 0.0 0
M  V30 6 N 0.0000 4.6201 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 1.5400 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 1.3337 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Furfural
C5H4O2
98-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 O 5.1049 1.8517 0.0 0
M  V30 3 C 2.4374 1.8517 0.0 0
M  V30 4 C 2.2765 0.3202 0.0 0
M  V30 5 O 1.0306 2.4782 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propen-1-yl 2,3-dihydro-1H-pyrrole-1-carboxylate
C8H11NO2
110910-76-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 5.1048 2.3101 0.0 0
M  V30 3 O 3.7711 0.0000 0.0 0
M  V30 4 C 6.4386 1.5400 0.0 0
M  V30 5 C 7.7722 2.3101 0.0 0
M  V30 6 C 9.1059 1.5400 0.0 0
M  V30 7 N 2.4374 2.3101 0.0 0
M  V30 8 C 1.0304 1.6836 0.0 0
M  V30 9 C 2.2763 3.8416 0.0 0
M  V30 10 C 0.0000 2.8281 0.0 0
M  V30 11 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-2-Propen-1-yl (3aR,9bR)-4-(2-furanyl)-2,3,3a,4,5,9b-hexahydro-8-[(methyla...
C21H23N3O4
862432-52-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.0893 7.6404 0.0 0
M  V30 2 O 10.1199 8.7850 0.0 0
M  V30 3 O 9.5653 6.1758 0.0 0
M  V30 4 C 11.6262 8.4648 0.0 0
M  V30 5 C 12.6568 9.6092 0.0 0
M  V30 6 C 14.1631 9.2890 0.0 0
M  V30 7 C 9.1059 2.3101 0.0 0
M  V30 8 N 9.1059 0.7700 0.0 0
M  V30 9 O 10.4396 3.0801 0.0 0
M  V30 10 C 10.4396 0.0000 0.0 0
M  V30 11 C 6.4386 6.9302 0.0 0 CFG=1
M  V30 12 C 5.1047 7.7002 0.0 0 CFG=2
M  V30 13 C 6.4386 5.3901 0.0 0
M  V30 14 N 7.5830 7.9606 0.0 0
M  V30 15 C 3.7711 6.9302 0.0 0 CFG=3
M  V30 16 C 5.4249 9.2066 0.0 0
M  V30 17 C 5.1047 4.6201 0.0 0
M  V30 18 C 7.7722 4.6201 0.0 0
M  V30 19 C 6.9566 9.3676 0.0 0
M  V30 20 N 3.7711 5.3901 0.0 0
M  V30 21 C 5.1047 3.0801 0.0 0
M  V30 22 C 7.7722 3.0801 0.0 0
M  V30 23 C 6.4386 2.3101 0.0 0
M  V30 24 C 2.4374 7.7002 0.0 0
M  V30 25 C 1.0304 7.0738 0.0 0
M  V30 26 O 2.2763 9.2317 0.0 0
M  V30 27 C 0.0000 8.2182 0.0 0
M  V30 28 C 0.7700 9.5519 0.0 0
M  V30 29 H 7.8454 6.3038 0.0 0
M  V30 30 H 3.8589 8.6054 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 22
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 29 CFG=3
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 12 30 CFG=3
M  V30 18 1 13 17
M  V30 19 2 13 18
M  V30 20 1 14 19
M  V30 21 1 15 20
M  V30 22 1 15 24
M  V30 23 1 16 19
M  V30 24 1 17 20
M  V30 25 2 17 21
M  V30 26 1 18 22
M  V30 27 1 21 23
M  V30 28 2 22 23
M  V30 29 2 24 25
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 2 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 11 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 94-09-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-01-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 110910-76-4
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 862432-52-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8215002
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 6
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(5):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General/Typical Procedure:
Ethyl4-aminobenzoate (1 equiv.), aldehyde (1.1 equiv.), in dry toluene
was added a drop of TFA. The solution was refluxed for overnight, while
water was removed by Dean Stark trap. After removal of the solvent, the
resulted Schiffbase was used for next step directly. To the residue was
added allyI 2,3-dihydro-1H-pyrrole-1-carboxylate or other reactant as
shown in above scheme (1.1 equivalent) in acetonitrile. The reaction
mixture was stirred at room temperature for 16 hours. The solvent was
removed to give a residue, which was purified by silica gel column
chromatography giving the desired compound at approximately 1:1 ratio. A
mixture of carboxylic acid (1 equiv.), HATU (1.1 equiv.), DIPEA (1.1
equiv.) in DMF was stirred for 5 minutes. Then, a primary or secondary
amine was added to the solution. The reaction mixture was stirred at room
temperature for 4 hours. The solvent was removed in vacuo. The residue
was purified by flash column chromatography.The titled compounds of
Example 2 are made using the titled compounds made in Example 1 as the
starting materials. Tert-Butyl
8-[(4-methylpiperazin-l-yl)carbonyll-4-phenyl-2,3,3a,4,5,9b-hexahydro-
1H-pyrrolo[3,2-c]quinoline-l-carboxylate. The titled compound (235.1mg,
97% yield) was obtained by following the general procedure 5. Allyl
4-{2-furyl)-8-[(methylamino)carbonyl]-2,3,3
a,4,5,9b-hexahydro-1H-pyrrolo[3,2-c]quinoline-1-carboxylate. The titled
compound (1.30g; yield, 100%) was obtained by following the general
procedure 5. (ESI) (M+H)+ = 382.4.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrroloquinolinecarboxamides and
piperidoquinolinecarboxamides as B2 Bradykinin receptor modulators for
pain management and other uses
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hu, Yun-Jin; Tomaszewski, Miroslaw; Walpole, Christopher
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005075476 A1 2005-08-18

$RFMT $RIREG SCHEME48 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-methoxy-1-methyl-1H-indole-2-carboxylate
C12H13NO3
111258-25-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.4149 2.2645 0.0 0
M  V30 2 C 8.9549 2.2645 0.0 0
M  V30 3 C 1.6840 5.6420 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 O 1.3338 0.7700 0.0 0
M  V30 6 O 0.0000 3.0800 0.0 0
M  V30 7 C 0.0000 0.0000 0.0 0
M  V30 8 C 5.1049 3.5981 0.0 0
M  V30 9 C 4.3349 4.9318 0.0 0
M  V30 10 C 6.6449 3.5981 0.0 0
M  V30 11 C 4.0743 2.4536 0.0 0
M  V30 12 N 2.8284 4.6116 0.0 0
M  V30 13 C 5.1049 6.2654 0.0 0
M  V30 14 C 7.4149 4.9318 0.0 0
M  V30 15 C 2.6675 3.0800 0.0 0
M  V30 16 C 6.6449 6.2654 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 15
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 2 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N,1-dimethyl-1H-indole-2-carboxamide
C12H14N2O2
335031-52-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.4149 2.2645 0.0 0
M  V30 2 C 8.9549 2.2645 0.0 0
M  V30 3 C 1.6840 5.6420 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 N 1.3338 0.7700 0.0 0
M  V30 6 O 0.0000 3.0800 0.0 0
M  V30 7 C 0.0000 0.0000 0.0 0
M  V30 8 C 5.1049 3.5981 0.0 0
M  V30 9 C 4.3349 4.9318 0.0 0
M  V30 10 C 6.6449 3.5981 0.0 0
M  V30 11 C 4.0743 2.4536 0.0 0
M  V30 12 N 2.8284 4.6116 0.0 0
M  V30 13 C 5.1049 6.2654 0.0 0
M  V30 14 C 7.4149 4.9318 0.0 0
M  V30 15 C 2.6675 3.0800 0.0 0
M  V30 16 C 6.6449 6.2654 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 15
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 2 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 111258-25-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 335031-52-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11252541
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM b) N,1-Dimethyl-4-methoxy-1H-indol-2-carboxamide. A solution of methyl
4-methoxy-1-methyl-1H-indol-2-carboxylate (1.03 g, 4.7 mmole) in 2.0 M
methylamine in methanol (40 mL) was sealed in a pressure bottle and
heated at 55-60 °C for 60 hr. Concentration in vacuo yielded the title
compound. Yield: (1.05 g, quantitative) as a white solid. MS (ES) m/e
219.2 (M + H)+.
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed pressure bottle used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-heteroarylmethyl acrylamides as Fab I inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Miller, William H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas,
Irene N.; Dewolf, Walter E., Jr.; Jakas, Dalia R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001027103 A1 2001-04-19

$RFMT $RIREG SCHEME49 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-(6-oxospiro[3.3]hept-2-yl)carbamate
C12H19NO3
1118786-86-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.4137 4.0011 0.0 0
M  V30 2 C 3.6437 2.6675 0.0 0
M  V30 3 O 2.1037 2.6675 0.0 0
M  V30 4 O 4.4137 1.3337 0.0 0
M  V30 5 C 1.3337 1.3337 0.0 0
M  V30 6 C 2.6673 0.5636 0.0 0
M  V30 7 C 0.5636 0.0000 0.0 0
M  V30 8 C 0.0000 2.1037 0.0 0
M  V30 9 O 11.8495 4.0011 0.0 0
M  V30 10 C 8.1316 4.0011 0.0 0
M  V30 11 C 7.0426 5.0901 0.0 0
M  V30 12 C 7.0426 2.9122 0.0 0
M  V30 13 C 9.2205 5.0901 0.0 0
M  V30 14 C 9.2205 2.9122 0.0 0
M  V30 15 C 5.9537 4.0011 0.0 0
M  V30 16 C 10.3095 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 2 9 16
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C13H24N2O2
2417398-63-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.7179 0.0 0
M  V30 2 C 4.0010 2.9479 0.0 0
M  V30 3 O 2.6673 3.7179 0.0 0
M  V30 4 O 4.0010 1.4079 0.0 0
M  V30 5 C 1.3337 2.9479 0.0 0
M  V30 6 C 2.1037 1.6143 0.0 0
M  V30 7 C 0.0000 2.1779 0.0 0
M  V30 8 C 0.5637 4.2816 0.0 0
M  V30 9 N 11.7745 0.0000 0.0 0
M  V30 10 C 13.1082 0.7700 0.0 0
M  V30 11 C 8.5546 1.8590 0.0 0
M  V30 12 C 7.0671 1.4604 0.0 0
M  V30 13 C 8.1560 3.3465 0.0 0
M  V30 14 C 10.0423 2.2575 0.0 0
M  V30 15 C 8.9533 0.3715 0.0 0
M  V30 16 C 6.6685 2.9479 0.0 0
M  V30 17 C 10.4408 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 9 17
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1118786-86-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2417398-63-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-22070232
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted pyrrolopyrimidinamines and
pyrazolopyrimidinamines as JAK 1 inhibitors for treating pruritus and
atopic dermatitis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Speake, Jason D.; Pandi, Bharathi; Perales, Joe B.; Fan, Weiming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20200138811 A1 2020-05-07

$RFMT $RIREG SCHEME50 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Glutarimide
C5H7NO2
1121-89-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.0800 0.0 0
M  V30 2 O 5.3349 3.0800 0.0 0
M  V30 3 N 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 1.3338 0.7700 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 4
M  V30 2 2 2 5
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N1-Methylpentanediamide
C6H12N2O2
307950-16-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 N 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 1.5400 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 N 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1121-89-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 307950-16-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-905175
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quantitative Solid-State Reactions of Amines with Carbonyl Compounds and
Isothiocyanates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kaupp, Gerd; Schmeyers, Jens; Boy, Juergen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2000), 56(36), 6899-6911

$RFMT $RIREG SCHEME51 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methyl-2-pyridinecarboxaldehyde
C7H7NO
1122-72-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 O 6.6687 2.3101 0.0 0
M  V30 3 C 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 N 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(6-Methyl-2-pyridinyl)methylene]methanamine
C8H10N2
2798825-91-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0800 0.0 0
M  V30 2 N 6.6686 2.3100 0.0 0
M  V30 3 C 8.0022 3.0800 0.0 0
M  V30 4 C 0.0000 3.0800 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 N 2.6675 3.0800 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 1.3337 2.3100 0.0 0
M  V30 9 C 2.6675 0.0000 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1122-72-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2798825-91-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33619782
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, molecular sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Diaminopyrazolo[1,5-a]pyrimidine-6-carbonitrile compounds as adenosine 2a
receptor and adenosine 2b receptor antagonist and preparation thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Peer Mohamed, Shahul Hameed; Bharatham, Nagakumar; Kajipalya Ranganatha
Rao, Ranga Rao; Nandishaiah, Radha; Katagihalli Math, Nainesh; Kaushik
Kotakonda, Harish; Reddy, Sambasiva
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022149167 A1 2022-07-14

$RFMT $RIREG SCHEME51 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methyl-2-pyridinecarboxaldehyde
C7H7NO
1122-72-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 O 6.6687 2.3101 0.0 0
M  V30 3 C 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 N 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(6-Methyl-2-pyridinyl)methylene]methanamine
C8H10N2
2798825-91-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0800 0.0 0
M  V30 2 N 6.6686 2.3100 0.0 0
M  V30 3 C 8.0022 3.0800 0.0 0
M  V30 4 C 0.0000 3.0800 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 N 2.6675 3.0800 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 1.3337 2.3100 0.0 0
M  V30 9 C 2.6675 0.0000 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1122-72-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2798825-91-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32427350
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, molecular sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Diaminopyrazolo[1,5-a]pyrimidine-6-carbonitrile compounds as adenosine 2A
receptor and adenosine 2B receptor antagonist
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Peer Mohamed, Shahul Hameed; Bharatham, Nagakumar; Kajipalya Ranganatha
Rao, Ranga Rao; Nandishaiah, Radha; Katagihallimath, Nainesh; Kaushik
Kotakonda, Harish; Reddy, Sambasiva
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM India, IN202141001078 A 2022-06-03

$RFMT $RIREG SCHEME52 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzaldehyde
C7H5BrO
1122-91-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Bromophenyl)methylene]methanamine
C8H8BrN
35003-56-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 1.3337 0.0 0
M  V30 2 N 6.9301 2.6673 0.0 0
M  V30 3 C 8.4701 2.6673 0.0 0
M  V30 4 Br 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1122-91-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35003-56-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-15864890
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7487-88-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Four-Electron Electrocyclic Ring-Opening/Intermolecular [4+2]
Cycloadditions of α-Hydroxycyclobutenones: Stereoselective Synthesis of
Multiple Substituted δ-Lactams
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Song, Peidong; Li, Qing; Wang, Congcong; Wu, Wenfa; Mao, Xu; Wang,
Jiajia; Hu, Xiangdong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2016), 358(8), 1208-1212

$RFMT $RIREG SCHEME52 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzaldehyde
C7H5BrO
1122-91-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Bromophenyl)methylene]methanamine
C8H8BrN
35003-56-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 1.3337 0.0 0
M  V30 2 N 6.9301 2.6673 0.0 0
M  V30 3 C 8.4701 2.6673 0.0 0
M  V30 4 Br 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1122-91-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35003-56-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-12911001
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7487-88-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituent-Controlled Annuloselectivity and Stereoselectivity in the
Sulfa-Staudinger Cycloadditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhanhui; Chen, Ning; Xu, Jiaxi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2015), 80(7), 3611-3620

$RFMT $RIREG SCHEME53 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzaldehyde
C7H5BrO
1122-91-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanamine, N-[(4-bromophenyl)methylene]-, (E)-
C8H8BrN
86402-04-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 1.3337 0.0 0
M  V30 2 N 6.9301 2.6673 0.0 0
M  V30 3 C 8.4701 2.6673 0.0 0
M  V30 4 Br 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 2.3100 0.0000 0.0 0
M  V30 9 C 2.3100 2.6673 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1122-91-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 86402-04-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-14515050
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Synthesis of the
Alkyl Imines The imines were prepared by a modified protocol of Hachiya
and coworkers. In an oven-dried flask equipped with a magnetic stirring
bar and molecular sieve (4 Å, 1 g) a solution of the aldehyde (3 mmol) in
5 mL DCM was added. Then an amine solution e.g. methylamine solution (2 M
in MeOH, 6 mmol, 2.0 equiv.) was added slowly and the stirring continued
for additional 18 hours. The mixture was filtered and the clear filtrate
was washed with saturated NaHCO3 solution and dried over magnesium
sulfate. By concentration under reduced pressure and drying in vacuo the
product were obtained without further purification. Alkyl Imine: 3g,
yield:100%.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, molecular sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asymmetric Synthesis of Tetrahydropyridines via an Organocatalytic
One-Pot Multicomponent Michael/Aza-Henry/Cyclization Triple Domino
Reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bluemel, Marcus; Chauhan, Pankaj; Hahn, Robert; Raabe, Gerhard; Enders,
Dieter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2014), 16(22), 6012-6015

$RFMT $RIREG SCHEME54 STEP1
$RXN



  2  1
$MOL
Undecylenic acid
C11H20O2
112-38-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 5.3348 2.3101 0.0 0
M  V30 4 C 9.3358 1.5400 0.0 0
M  V30 5 C 4.0010 1.5400 0.0 0
M  V30 6 C 10.6697 2.3101 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 C 12.0033 1.5400 0.0 0
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 C 13.3370 2.3101 0.0 0
M  V30 11 O 0.0000 2.3101 0.0 0
M  V30 12 O 1.3337 0.0000 0.0 0
M  V30 13 C 14.6707 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 2 10 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-10-undecenamide
C12H23NO
50278-84-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 2.3101 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 8.0023 1.5400 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 9.3360 2.3101 0.0 0
M  V30 6 C 2.6675 1.5400 0.0 0
M  V30 7 C 10.6698 1.5400 0.0 0
M  V30 8 N 1.3338 2.3101 0.0 0
M  V30 9 O 2.6675 0.0000 0.0 0
M  V30 10 C 12.0035 2.3101 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 C 13.3372 1.5400 0.0 0
M  V30 13 C 14.6708 2.3101 0.0 0
M  V30 14 C 16.0046 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 112-38-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 50278-84-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9814020
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 102-69-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 543-27-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A modular approach for the construction and modification of glyco-SAMs
utilizing 1,3-dipolar cycloaddition
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kleinert, Mike; Winkler, Tobias; Terfort, Andreas; Lindhorst, Thisbe K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2008), 6(12), 2118-2132

$RFMT $RIREG SCHEME55 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-cyclohexyl-1-(2,2-dimethoxyethyl)-2-(2-formyl-4-methoxyphenyl)-1H-in...
C28H33NO6
1132679-29-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.3594 3.7535 0.0 0
M  V30 2 C 8.3898 2.6091 0.0 0
M  V30 3 O 7.9139 1.1444 0.0 0
M  V30 4 O 9.8962 2.9292 0.0 0
M  V30 5 C 8.9443 0.0000 0.0 0
M  V30 6 C 10.9266 1.7849 0.0 0
M  V30 7 C 5.3900 3.7967 0.0 0
M  V30 8 O 4.6200 2.4629 0.0 0
M  V30 9 C 13.3009 4.9240 0.0 0
M  V30 10 O 14.6347 5.6940 0.0 0
M  V30 11 O 13.3009 3.3840 0.0 0
M  V30 12 C 15.9683 4.9240 0.0 0
M  V30 13 O 0.7700 6.4640 0.0 0
M  V30 14 C 0.0000 7.7977 0.0 0
M  V30 15 C 6.9300 6.4640 0.0 0
M  V30 16 C 7.8352 7.7099 0.0 0
M  V30 17 N 7.8352 5.2181 0.0 0
M  V30 18 C 9.2999 7.2340 0.0 0
M  V30 19 C 9.2999 5.6940 0.0 0
M  V30 20 C 10.6336 8.0040 0.0 0
M  V30 21 C 10.6336 4.9240 0.0 0
M  V30 22 C 11.9672 7.2340 0.0 0
M  V30 23 C 11.9672 5.6940 0.0 0
M  V30 24 C 5.3900 6.4640 0.0 0
M  V30 25 C 4.6200 5.1304 0.0 0
M  V30 26 C 4.6200 7.7977 0.0 0
M  V30 27 C 3.0800 5.1304 0.0 0
M  V30 28 C 3.0800 7.7977 0.0 0
M  V30 29 C 2.3100 6.4640 0.0 0
M  V30 30 C 7.3594 9.1746 0.0 0
M  V30 31 C 8.3898 10.3190 0.0 0
M  V30 32 C 5.8529 9.4947 0.0 0
M  V30 33 C 7.9139 11.7836 0.0 0
M  V30 34 C 5.3771 10.9594 0.0 0
M  V30 35 C 6.4075 12.1038 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 1 7 25
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 23
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 1 13 29
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 15 24
M  V30 18 1 16 18
M  V30 19 1 16 30
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 1 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-cyclohexyl-1-(2,2-dimethoxyethyl)-2-[4-methoxy-2-[(methylamino)methy...
C29H38N2O5
1132679-31-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.3594 8.3503 0.0 0
M  V30 2 C 8.3898 9.4947 0.0 0
M  V30 3 O 7.9139 10.9594 0.0 0
M  V30 4 O 9.8962 9.1746 0.0 0
M  V30 5 C 8.9443 12.1038 0.0 0
M  V30 6 C 10.9266 10.3189 0.0 0
M  V30 7 C 5.3900 8.3071 0.0 0
M  V30 8 N 4.6200 9.6409 0.0 0
M  V30 9 C 3.0800 9.6409 0.0 0
M  V30 10 C 13.3008 7.1798 0.0 0
M  V30 11 O 14.6346 6.4098 0.0 0
M  V30 12 O 13.3008 8.7198 0.0 0
M  V30 13 C 15.9683 7.1798 0.0 0
M  V30 14 O 0.7700 5.6398 0.0 0
M  V30 15 C 0.0000 4.3061 0.0 0
M  V30 16 C 6.9300 5.6398 0.0 0
M  V30 17 C 7.8352 4.3939 0.0 0
M  V30 18 N 7.8352 6.8856 0.0 0
M  V30 19 C 9.2999 4.8698 0.0 0
M  V30 20 C 9.2999 6.4098 0.0 0
M  V30 21 C 10.6335 4.0998 0.0 0
M  V30 22 C 10.6335 7.1798 0.0 0
M  V30 23 C 11.9672 4.8698 0.0 0
M  V30 24 C 11.9672 6.4098 0.0 0
M  V30 25 C 5.3900 5.6398 0.0 0
M  V30 26 C 4.6200 6.9734 0.0 0
M  V30 27 C 4.6200 4.3061 0.0 0
M  V30 28 C 3.0800 6.9734 0.0 0
M  V30 29 C 3.0800 4.3061 0.0 0
M  V30 30 C 2.3100 5.6398 0.0 0
M  V30 31 C 7.3594 2.9292 0.0 0
M  V30 32 C 8.3898 1.7849 0.0 0
M  V30 33 C 5.8529 2.6091 0.0 0
M  V30 34 C 7.9139 0.3202 0.0 0
M  V30 35 C 5.3771 1.1444 0.0 0
M  V30 36 C 6.4075 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 26
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 24
M  V30 13 1 11 13
M  V30 14 1 14 15
M  V30 15 1 14 30
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 16 25
M  V30 19 1 17 19
M  V30 20 1 17 31
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 1 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1132679-29-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1132679-31-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-8707623
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM 85-100% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tetracyclic indole inhibitors of hepatitis C virus NS5B-polymerase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Stansfield, Ian; Ercolani, Caterina; Mackay, Angela; Conte, Immacolata;
Pompei, Marco; Koch, Uwe; Gennari, Nadia; Giuliano, Claudio; Rowley,
Michael; Narjes, Frank
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(3), 627-632

$RFMT $RIREG SCHEME56 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2-Fluoro-3-pyridinyl)-5-(2-pyridinylthio)-2-thiophenecarboxaldehyde
C15H9FN2OS2
1138034-75-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.8690 6.2078 0.0 0
M  V30 2 F 0.5546 4.0727 0.0 0
M  V30 3 C 4.7418 0.9052 0.0 0
M  V30 4 O 3.4960 0.0000 0.0 0
M  V30 5 C 3.5673 4.7132 0.0 0
M  V30 6 C 5.0990 4.8741 0.0 0
M  V30 7 C 3.2471 3.2068 0.0 0
M  V30 8 S 5.7253 3.4672 0.0 0
M  V30 9 C 4.5809 2.4368 0.0 0
M  V30 10 C 2.5369 5.8576 0.0 0
M  V30 11 C 1.0306 5.5374 0.0 0
M  V30 12 C 3.0127 7.3223 0.0 0
M  V30 13 N 0.0000 6.6818 0.0 0
M  V30 14 C 1.9823 8.4667 0.0 0
M  V30 15 C 0.4760 8.1465 0.0 0
M  V30 16 C 7.4090 6.2078 0.0 0
M  V30 17 C 8.1790 7.5414 0.0 0
M  V30 18 N 8.1790 4.8741 0.0 0
M  V30 19 C 9.7190 7.5414 0.0 0
M  V30 20 C 9.7190 4.8741 0.0 0
M  V30 21 C 10.4890 6.2078 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 16
M  V30 3 1 2 11
M  V30 4 2 3 4
M  V30 5 1 3 9
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 5 10
M  V30 9 1 6 8
M  V30 10 2 7 9
M  V30 11 1 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2-Fluoro-3-pyridinyl)-N-methyl-5-(2-pyridinylthio)-2-thiophenemethanamine
C16H14FN3S2
1138034-73-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.0800 5.6399 0.0 0
M  V30 2 F 7.5861 2.1049 0.0 0
M  V30 3 C 8.2357 7.3149 0.0 0
M  V30 4 N 9.6427 6.6886 0.0 0
M  V30 5 C 10.8886 7.5938 0.0 0
M  V30 6 C 5.5253 4.3938 0.0 0
M  V30 7 C 4.6201 5.6399 0.0 0
M  V30 8 C 6.9898 4.8699 0.0 0
M  V30 9 S 5.5253 6.8857 0.0 0
M  V30 10 C 6.9898 6.4099 0.0 0
M  V30 11 C 5.0494 2.9293 0.0 0
M  V30 12 C 6.0798 1.7847 0.0 0
M  V30 13 C 3.5430 2.6091 0.0 0
M  V30 14 N 5.6040 0.3202 0.0 0
M  V30 15 C 3.0671 1.1444 0.0 0
M  V30 16 C 4.0975 0.0000 0.0 0
M  V30 17 C 2.3100 6.9735 0.0 0
M  V30 18 C 3.0800 8.3072 0.0 0
M  V30 19 N 0.7700 6.9735 0.0 0
M  V30 20 C 2.3100 9.6408 0.0 0
M  V30 21 C 0.0000 8.3072 0.0 0
M  V30 22 C 0.7700 9.6408 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 17
M  V30 3 1 2 12
M  V30 4 1 3 4
M  V30 5 1 3 10
M  V30 6 1 4 5
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 6 11
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1138034-75-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1138034-73-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-2142177
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Reference Example 97
1-{4-(2-fluoropyridin-3-yl)-5-[(pyridin-2-yl)thio]thiophen-2-yl}-N-methylmethanamine
To a solution of
4-(2-fluoropyridin-3-yl)-5-[(pyridin-2-yl)thio]thiophene-2-carbaldehyde
(270 mg) in tetrahydrofuran (2 mL) were added 40% methylamine-methanol
solution (0.9 mL) and methanol (2 mL), and the mixture was stirred at
room temperature for 2 days, and concentrated under reduced pressure. The
residue was dissolved in methanol (3 mL), and sodium borohydride (222 mg)
was added at 0&#x00B0; C. The mixture was stirred at room temperature for
1 days, and concentrated under reduced pressure. Saturated aqueous sodium
hydrogen carbonate solution was added to the residue, and the mixture was
extracted with ethyl acetate. The extract was washed successively with
saturated aqueous sodium hydrogen carbonate solution, water and saturated
brine, dried over anhydrous magnesium sulfate, and concentrated under
reduced pressure to give the title compound as a pale-yellow oil (286 mg,
yield quantitative). 1H-NMR (CDCl3) &#x03B4; : 2.54 (3H, s), 4.00 (2H, d,
J=1.2 Hz), 6.86-6.88 (1H, m), 6.96-7.01 (1H, m), 7.13-7.18 (2H, m),
7.44-7.50 (1H, m), 7.85-7.91 (1H, m), 8.12-8.15 (1H, m), 8.35-8.37 (1H,
m), 1H: not detected.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thiophene and pyrazole derivatives and related analogous
as acid secretion inhibitors and antiulcer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nishida, Haruyuki; Arikawa, Yasuyoshi; Hirase, Keizo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009041705 A2 2009-04-02

$RFMT $RIREG SCHEME57 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-carboxylic acid, 5-[(6-chloro-3-pyridinyl)thio]-1-(2,5-difluoro...
C17H12ClF2N3O2S
1138037-35-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.3171 4.9301 0.0 0
M  V30 2 F 1.6472 4.1219 0.0 0
M  V30 3 C 3.6896 8.9586 0.0 0
M  V30 4 O 2.1580 9.1197 0.0 0
M  V30 5 O 4.5948 10.2047 0.0 0
M  V30 6 C 1.5317 10.5265 0.0 0
M  V30 7 C 0.0000 10.6875 0.0 0
M  V30 8 F 6.2251 0.0000 0.0 0
M  V30 9 Cl 12.6519 8.0101 0.0 0
M  V30 10 N 4.5765 5.0736 0.0 0
M  V30 11 C 5.9833 5.7001 0.0 0
M  V30 12 N 3.5461 6.2182 0.0 0
M  V30 13 C 5.8224 7.2316 0.0 0
M  V30 14 C 4.3161 7.5518 0.0 0
M  V30 15 C 4.2563 3.5673 0.0 0
M  V30 16 C 2.7916 3.0914 0.0 0
M  V30 17 C 5.4007 2.5367 0.0 0
M  V30 18 C 2.4714 1.5850 0.0 0
M  V30 19 C 5.0805 1.0304 0.0 0
M  V30 20 C 3.6160 0.5546 0.0 0
M  V30 21 C 8.6508 5.7001 0.0 0
M  V30 22 C 9.9844 4.9301 0.0 0
M  V30 23 C 8.6508 7.2401 0.0 0
M  V30 24 C 11.3181 5.7001 0.0 0
M  V30 25 N 9.9844 8.0101 0.0 0
M  V30 26 C 11.3181 7.2401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 21
M  V30 3 1 2 16
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 14
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 8 19
M  V30 10 1 9 26
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 15
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-carboxamide, 5-[(6-chloro-3-pyridinyl)thio]-1-(2,5-difluorophen...
C16H11ClF2N4OS
1138037-59-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.8690 7.7393 0.0 0
M  V30 2 F 0.5546 5.6044 0.0 0
M  V30 3 C 4.7418 2.4368 0.0 0
M  V30 4 N 3.4960 1.5315 0.0 0
M  V30 5 O 6.1486 1.8104 0.0 0
M  V30 6 C 3.6569 0.0000 0.0 0
M  V30 7 F 2.4582 11.4629 0.0 0
M  V30 8 Cl 12.0290 7.7393 0.0 0
M  V30 9 N 3.5673 6.2447 0.0 0
M  V30 10 C 5.0990 6.4057 0.0 0
M  V30 11 N 3.2471 4.7383 0.0 0
M  V30 12 C 5.7253 4.9989 0.0 0
M  V30 13 C 4.5809 3.9683 0.0 0
M  V30 14 C 2.5369 7.3891 0.0 0
M  V30 15 C 1.0306 7.0689 0.0 0
M  V30 16 C 3.0127 8.8538 0.0 0
M  V30 17 C 0.0000 8.2135 0.0 0
M  V30 18 C 1.9823 9.9982 0.0 0
M  V30 19 C 0.4760 9.6780 0.0 0
M  V30 20 C 7.4090 7.7393 0.0 0
M  V30 21 C 8.1790 9.0731 0.0 0
M  V30 22 C 8.1790 6.4057 0.0 0
M  V30 23 C 9.7190 9.0731 0.0 0
M  V30 24 N 9.7190 6.4057 0.0 0
M  V30 25 C 10.4890 7.7393 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 20
M  V30 3 1 2 15
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 13
M  V30 7 1 4 6
M  V30 8 1 7 18
M  V30 9 1 8 25
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 14
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1138037-35-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1138037-59-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9785617
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Reference Example 281
5-[(6-chloropyridin-3-yl)thio]-1-(2,5-difluorophenyl)-N-methyl-1H-pyrazole-3-carboxamide
To a solution of ethyl
5-[(6-chloropyridin-3-yl)thio]-1-(2,5-difluorophenyl)-1H-pyrazole-3-carboxylate
(471 mg) in methanol (3 mL) was added 40% methylamine-methanol solution
(5 mL) at room temperature. The mixture was stirred for 1 hr, and
concentrated under reduced pressure, and the residue was purified by
silica gel column chromatography (eluent: hexane-ethyl
acetate=2:1&#x2192;1:1) to give the title compound as colorless crystals
(457 mg, yield quantitative). 1H-NMR (CDCl3) &#x03B4; : 2.98 (3H, d,
J=4.8 Hz), 6.83 (1H, br), 7.04-7.10 (1H, m), 7.17-7.27 (4H, m), 7.36-7.40
(1H, m), 8.07-8.08 (1H, m).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thiophene and pyrazole derivatives and related analogous
as acid secretion inhibitors and antiulcer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nishida, Haruyuki; Arikawa, Yasuyoshi; Hirase, Keizo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009041705 A2 2009-04-02

$RFMT $RIREG SCHEME58 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-carboxylic acid, 5-[(6-chloro-3-pyridinyl)thio]-1-(5-fluoro-2-m...
C18H15ClFN3O2S
1138037-41-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.3171 4.9301 0.0 0
M  V30 2 C 1.6472 4.1219 0.0 0
M  V30 3 C 3.6896 8.9586 0.0 0
M  V30 4 O 2.1580 9.1197 0.0 0
M  V30 5 O 4.5948 10.2047 0.0 0
M  V30 6 C 1.5317 10.5265 0.0 0
M  V30 7 C 0.0000 10.6875 0.0 0
M  V30 8 F 6.2251 0.0000 0.0 0
M  V30 9 Cl 12.6519 8.0101 0.0 0
M  V30 10 N 4.5765 5.0736 0.0 0
M  V30 11 C 5.9833 5.7001 0.0 0
M  V30 12 N 3.5461 6.2182 0.0 0
M  V30 13 C 5.8224 7.2316 0.0 0
M  V30 14 C 4.3161 7.5518 0.0 0
M  V30 15 C 4.2563 3.5673 0.0 0
M  V30 16 C 2.7916 3.0914 0.0 0
M  V30 17 C 5.4007 2.5367 0.0 0
M  V30 18 C 2.4714 1.5850 0.0 0
M  V30 19 C 5.0805 1.0304 0.0 0
M  V30 20 C 3.6160 0.5546 0.0 0
M  V30 21 C 8.6508 5.7001 0.0 0
M  V30 22 C 9.9844 4.9301 0.0 0
M  V30 23 C 8.6508 7.2401 0.0 0
M  V30 24 C 11.3181 5.7001 0.0 0
M  V30 25 N 9.9844 8.0101 0.0 0
M  V30 26 C 11.3181 7.2401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 21
M  V30 3 1 2 16
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 14
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 8 19
M  V30 10 1 9 26
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 15
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-carboxamide, 5-[(6-chloro-3-pyridinyl)thio]-1-(5-fluoro-2-methy...
C17H14ClFN4OS
1138037-64-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.8690 7.7393 0.0 0
M  V30 2 C 0.5546 5.6044 0.0 0
M  V30 3 C 4.7418 2.4368 0.0 0
M  V30 4 N 3.4960 1.5315 0.0 0
M  V30 5 O 6.1486 1.8104 0.0 0
M  V30 6 C 3.6569 0.0000 0.0 0
M  V30 7 F 2.4582 11.4629 0.0 0
M  V30 8 Cl 12.0290 7.7393 0.0 0
M  V30 9 N 3.5673 6.2447 0.0 0
M  V30 10 C 5.0990 6.4057 0.0 0
M  V30 11 N 3.2471 4.7383 0.0 0
M  V30 12 C 5.7253 4.9989 0.0 0
M  V30 13 C 4.5809 3.9683 0.0 0
M  V30 14 C 2.5369 7.3891 0.0 0
M  V30 15 C 1.0306 7.0689 0.0 0
M  V30 16 C 3.0127 8.8538 0.0 0
M  V30 17 C 0.0000 8.2135 0.0 0
M  V30 18 C 1.9823 9.9982 0.0 0
M  V30 19 C 0.4760 9.6780 0.0 0
M  V30 20 C 7.4090 7.7393 0.0 0
M  V30 21 C 8.1790 9.0731 0.0 0
M  V30 22 C 8.1790 6.4057 0.0 0
M  V30 23 C 9.7190 9.0731 0.0 0
M  V30 24 N 9.7190 6.4057 0.0 0
M  V30 25 C 10.4890 7.7393 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 20
M  V30 3 1 2 15
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 13
M  V30 7 1 4 6
M  V30 8 1 7 18
M  V30 9 1 8 25
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 14
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1138037-41-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1138037-64-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12192403
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Reference Example 286
5-[(6-chloropyridin-3-yl)thio]-1-(5-fluoro-2-methylphenyl)-N-methyl-1H-pyrazole-3-carboxamide
To a solution of ethyl
5-[(6-chloropyridin-3-yl)thio]-1-(5-fluoro-2-methylphenyl)-1H-pyrazole-3-carboxylate
(2.57 g) in methanol (3 mL) was added 40% methylamine-methanol solution
(15 mL) at room temperature. The mixture was stirred for 1.5 hr, and
concentrated under reduced pressure, and the residue was azeotroped with
toluene to give the title compound as a pale-yellow oil (2.47 g, yield
quantitative). 1H-NMR (CDCl3) &#x03B4; : 1.85 (3H, d, J=2.3 Hz), 2.98
(3H, d, J=5.1 Hz), 6.77-6.90 (2H, m), 7.14-7.25 (4H, m), 7.38 (1H, dd,
J=8.3, 2.6 Hz), 8.03 (1H, d, J=1.9 Hz).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thiophene and pyrazole derivatives and related analogous
as acid secretion inhibitors and antiulcer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nishida, Haruyuki; Arikawa, Yasuyoshi; Hirase, Keizo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009041705 A2 2009-04-02

$RFMT $RIREG SCHEME59 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-carboxylic acid, 1-(2-chloro-5-fluorophenyl)-5-[(6-chloro-3-pyr...
C17H12Cl2FN3O2S
1138037-44-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.3171 4.9301 0.0 0
M  V30 2 Cl 1.6472 4.1219 0.0 0
M  V30 3 C 3.6896 8.9586 0.0 0
M  V30 4 O 2.1580 9.1197 0.0 0
M  V30 5 O 4.5948 10.2047 0.0 0
M  V30 6 C 1.5317 10.5265 0.0 0
M  V30 7 C 0.0000 10.6875 0.0 0
M  V30 8 F 6.2251 0.0000 0.0 0
M  V30 9 Cl 12.6519 8.0101 0.0 0
M  V30 10 N 4.5765 5.0736 0.0 0
M  V30 11 C 5.9833 5.7001 0.0 0
M  V30 12 N 3.5461 6.2182 0.0 0
M  V30 13 C 5.8224 7.2316 0.0 0
M  V30 14 C 4.3161 7.5518 0.0 0
M  V30 15 C 4.2563 3.5673 0.0 0
M  V30 16 C 2.7916 3.0914 0.0 0
M  V30 17 C 5.4007 2.5367 0.0 0
M  V30 18 C 2.4714 1.5850 0.0 0
M  V30 19 C 5.0805 1.0304 0.0 0
M  V30 20 C 3.6160 0.5546 0.0 0
M  V30 21 C 8.6508 5.7001 0.0 0
M  V30 22 C 9.9844 4.9301 0.0 0
M  V30 23 C 8.6508 7.2401 0.0 0
M  V30 24 C 11.3181 5.7001 0.0 0
M  V30 25 N 9.9844 8.0101 0.0 0
M  V30 26 C 11.3181 7.2401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 21
M  V30 3 1 2 16
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 14
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 8 19
M  V30 10 1 9 26
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 15
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-carboxamide, 1-(2-chloro-5-fluorophenyl)-5-[(6-chloro-3-pyridin...
C16H11Cl2FN4OS
1138037-66-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.8690 7.7393 0.0 0
M  V30 2 Cl 0.5546 5.6044 0.0 0
M  V30 3 C 4.7418 2.4368 0.0 0
M  V30 4 N 3.4960 1.5315 0.0 0
M  V30 5 O 6.1486 1.8104 0.0 0
M  V30 6 C 3.6569 0.0000 0.0 0
M  V30 7 F 2.4582 11.4629 0.0 0
M  V30 8 Cl 12.0290 7.7393 0.0 0
M  V30 9 N 3.5673 6.2447 0.0 0
M  V30 10 C 5.0990 6.4057 0.0 0
M  V30 11 N 3.2471 4.7383 0.0 0
M  V30 12 C 5.7253 4.9989 0.0 0
M  V30 13 C 4.5809 3.9683 0.0 0
M  V30 14 C 2.5369 7.3891 0.0 0
M  V30 15 C 1.0306 7.0689 0.0 0
M  V30 16 C 3.0127 8.8538 0.0 0
M  V30 17 C 0.0000 8.2135 0.0 0
M  V30 18 C 1.9823 9.9982 0.0 0
M  V30 19 C 0.4760 9.6780 0.0 0
M  V30 20 C 7.4090 7.7393 0.0 0
M  V30 21 C 8.1790 9.0731 0.0 0
M  V30 22 C 8.1790 6.4057 0.0 0
M  V30 23 C 9.7190 9.0731 0.0 0
M  V30 24 N 9.7190 6.4057 0.0 0
M  V30 25 C 10.4890 7.7393 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 20
M  V30 3 1 2 15
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 13
M  V30 7 1 4 6
M  V30 8 1 7 18
M  V30 9 1 8 25
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 14
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1138037-44-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1138037-66-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-937481
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Reference Example 288
1-(2-chloro-5-fluorophenyl)-5-[(6-chloropyridin-3-yl)thio]-N-methyl-1H-pyrazole-3-carboxamide
To a solution of ethyl
1-(2-chloro-5-fluorophenyl)-5-[(6-chloropyridin-3-yl)thio]-1H-pyrazole-3-carboxylate
(327 mg) in methanol (3 mL) was added 40% methylamine-methanol solution
(3 mL) at room temperature. The mixture was stirred for 2 hr, and
concentrated under reduced pressure, and the residue was purified by
silica gel column chromatography (eluent: hexane-ethyl
acetate=3:1&#x2192;1:1) to give the title compound as a pale-yellow solid
(343 g, yield quantitative). 1H-NMR (CDCl3) &#x03B4; : 2.97 (3H, d, J=5.4
Hz), 6.82 (1H, br), 7.01-7.05 (1H, m), 7.17-7.25 (3H, m), 7.39-7.50 (2H,
m), 8.05-8.06 (1H, m).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thiophene and pyrazole derivatives and related analogous
as acid secretion inhibitors and antiulcer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nishida, Haruyuki; Arikawa, Yasuyoshi; Hirase, Keizo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009041705 A2 2009-04-02

$RFMT $RIREG SCHEME60 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Chlorophenyl)-5-[(6-methyl-2-pyridinyl)thio]-1H-pyrazole-3-carboxaldehyde
C16H12ClN3OS
1138037-74-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.5626 5.6399 0.0 0
M  V30 2 Cl 2.0565 2.1049 0.0 0
M  V30 3 C 1.4068 7.3149 0.0 0
M  V30 4 O 0.0000 6.6886 0.0 0
M  V30 5 C 11.1827 8.3072 0.0 0
M  V30 6 N 4.1174 4.3938 0.0 0
M  V30 7 C 5.0226 5.6399 0.0 0
M  V30 8 N 2.6528 4.8699 0.0 0
M  V30 9 C 4.1174 6.8857 0.0 0
M  V30 10 C 2.6528 6.4099 0.0 0
M  V30 11 C 4.5933 2.9293 0.0 0
M  V30 12 C 3.5628 1.7847 0.0 0
M  V30 13 C 6.0997 2.6091 0.0 0
M  V30 14 C 4.0387 0.3202 0.0 0
M  V30 15 C 6.5756 1.1444 0.0 0
M  V30 16 C 5.5452 0.0000 0.0 0
M  V30 17 C 7.3327 6.9735 0.0 0
M  V30 18 N 8.8727 6.9735 0.0 0
M  V30 19 C 6.5626 8.3072 0.0 0
M  V30 20 C 9.6427 8.3072 0.0 0
M  V30 21 C 7.3327 9.6408 0.0 0
M  V30 22 C 8.8727 9.6408 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 17
M  V30 3 1 2 12
M  V30 4 2 3 4
M  V30 5 1 3 10
M  V30 6 1 5 20
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 11
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Chlorophenyl)-N-methyl-5-[(6-methyl-2-pyridinyl)thio]-1H-pyrazole-3-meth...
C17H17ClN4S
1138037-79-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 5.6398 0.0 0
M  V30 2 Cl 9.1261 2.1049 0.0 0
M  V30 3 C 9.7757 7.3149 0.0 0
M  V30 4 N 11.1826 6.6886 0.0 0
M  V30 5 C 12.4285 7.5938 0.0 0
M  V30 6 C 0.0000 8.3071 0.0 0
M  V30 7 N 7.0652 4.3938 0.0 0
M  V30 8 C 6.1600 5.6398 0.0 0
M  V30 9 N 8.5298 4.8698 0.0 0
M  V30 10 C 7.0652 6.8857 0.0 0
M  V30 11 C 8.5298 6.4098 0.0 0
M  V30 12 C 6.5894 2.9292 0.0 0
M  V30 13 C 7.6198 1.7847 0.0 0
M  V30 14 C 5.0830 2.6091 0.0 0
M  V30 15 C 7.1439 0.3202 0.0 0
M  V30 16 C 4.6071 1.1444 0.0 0
M  V30 17 C 5.6375 0.0000 0.0 0
M  V30 18 C 3.8500 6.9735 0.0 0
M  V30 19 N 2.3100 6.9735 0.0 0
M  V30 20 C 4.6200 8.3071 0.0 0
M  V30 21 C 1.5400 8.3071 0.0 0
M  V30 22 C 3.8500 9.6408 0.0 0
M  V30 23 C 2.3100 9.6408 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 18
M  V30 3 1 2 13
M  V30 4 1 3 4
M  V30 5 1 3 11
M  V30 6 1 4 5
M  V30 7 1 6 21
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 12
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1138037-74-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1138037-79-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-7836048
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Reference Example 300
1-{1-(2-chlorophenyl)-5-[(6-methylpyridin-2-yl)thio]-1H-pyrazol-3-yl}-N-methylmethanamine
To a solution of
1-(2-chlorophenyl)-5-[(6-methylpyridin-2-yl)thio]-1H-pyrazole-3-carbaldehyde
(415 mg) in tetrahydrofuran (4 mL) were added 40% methylamine-methanol
solution (1.5 mL) and methanol (4 mL) at 0&#x00B0; C., and the mixture
was stirred at room temperature for 4 hr. Sodium borohydride (905 mg) was
added at 0&#x00B0; C. to the reaction mixture, and the mixture was
stirred at room temperature for 1 hr, and concentrated under reduced
pressure. Water was added to the residue, and the mixture was extracted
with ethyl acetate. The extract was washed successively with saturated
aqueous sodium hydrogen carbonate solution, water and saturated brine,
dried over anhydrous sodium sulfate, and concentrated under reduced
pressure to give the title compound as a yellow oil (450 mg, yield
quantitative). 1H-NMR (CDCl3) &#x03B4; : 2.42 (3H, s), 2.53 (3H, s), 3.89
(2H, s), 6.66 (1H, d, J=7.8 Hz), 6.72 (1H, s), 6.83 (1H, d, J=7.8 Hz),
7.20-7.26 (1H, m), 7.30-7.36 (3H, m), 7.42-7.46 (1H, m), 1H: not
detected.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thiophene and pyrazole derivatives and related analogous
as acid secretion inhibitors and antiulcer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nishida, Haruyuki; Arikawa, Yasuyoshi; Hirase, Keizo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009041705 A2 2009-04-02

$RFMT $RIREG SCHEME61 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Chlorophenyl)-5-[(6-methoxy-2-pyridinyl)thio]-1H-pyrazole-3-carboxaldehyde
C16H12ClN3O2S
1138037-76-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.6699 4.3754 0.0 0
M  V30 2 Cl 0.0000 3.5673 0.0 0
M  V30 3 C 2.0424 8.4041 0.0 0
M  V30 4 O 0.5108 8.5651 0.0 0
M  V30 5 O 11.0048 4.3754 0.0 0
M  V30 6 C 12.3384 5.1454 0.0 0
M  V30 7 N 2.9293 4.5191 0.0 0
M  V30 8 C 4.3363 5.1454 0.0 0
M  V30 9 N 1.8989 5.6635 0.0 0
M  V30 10 C 4.1752 6.6771 0.0 0
M  V30 11 C 2.6689 6.9973 0.0 0
M  V30 12 C 2.6091 3.0128 0.0 0
M  V30 13 C 1.1444 2.5367 0.0 0
M  V30 14 C 3.7535 1.9822 0.0 0
M  V30 15 C 0.8242 1.0304 0.0 0
M  V30 16 C 3.4334 0.4759 0.0 0
M  V30 17 C 1.9688 0.0000 0.0 0
M  V30 18 C 7.0036 5.1454 0.0 0
M  V30 19 N 8.3373 4.3754 0.0 0
M  V30 20 C 7.0036 6.6854 0.0 0
M  V30 21 C 9.6711 5.1454 0.0 0
M  V30 22 C 8.3373 7.4555 0.0 0
M  V30 23 C 9.6711 6.6854 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 18
M  V30 3 1 2 13
M  V30 4 2 3 4
M  V30 5 1 3 11
M  V30 6 1 5 6
M  V30 7 1 5 21
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 12
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Chlorophenyl)-5-[(6-methoxy-2-pyridinyl)thio]-N-methyl-1H-pyrazole-3-met...
C17H17ClN4OS
1138037-81-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3901 5.6399 0.0 0
M  V30 2 Cl 9.8962 2.1049 0.0 0
M  V30 3 C 10.5458 7.3149 0.0 0
M  V30 4 N 11.9527 6.6886 0.0 0
M  V30 5 C 13.1986 7.5938 0.0 0
M  V30 6 O 0.7700 8.3072 0.0 0
M  V30 7 C 0.0000 9.6408 0.0 0
M  V30 8 N 7.8353 4.3938 0.0 0
M  V30 9 C 6.9301 5.6399 0.0 0
M  V30 10 N 9.2999 4.8699 0.0 0
M  V30 11 C 7.8353 6.8857 0.0 0
M  V30 12 C 9.2999 6.4099 0.0 0
M  V30 13 C 7.3595 2.9293 0.0 0
M  V30 14 C 8.3899 1.7847 0.0 0
M  V30 15 C 5.8530 2.6091 0.0 0
M  V30 16 C 7.9140 0.3202 0.0 0
M  V30 17 C 5.3771 1.1444 0.0 0
M  V30 18 C 6.4076 0.0000 0.0 0
M  V30 19 C 4.6201 6.9735 0.0 0
M  V30 20 N 3.0800 6.9735 0.0 0
M  V30 21 C 5.3901 8.3072 0.0 0
M  V30 22 C 2.3100 8.3072 0.0 0
M  V30 23 C 4.6201 9.6408 0.0 0
M  V30 24 C 3.0800 9.6408 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 19
M  V30 3 1 2 14
M  V30 4 1 3 4
M  V30 5 1 3 12
M  V30 6 1 4 5
M  V30 7 1 6 7
M  V30 8 1 6 22
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 13
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1138037-76-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1138037-81-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-14214720
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Reference Example 302
1-{1-(2-chlorophenyl)-5-[(6-methoxypyridin-2-yl)thio]-1H-pyrazol-3-yl}-N-methylmethanamine
To a solution of
1-(2-chlorophenyl)-5-[(6-methoxypyridin-2-yl)thio]-1H-pyrazole-3-carbaldehyde
(404 mg) in tetrahydrofuran (4 mL) were added 40% methylamine-methanol
solution (1.5 mL) and methanol (4 mL) at 0&#x00B0; C., and the mixture
was stirred at room temperature for 14 hr, and concentrated under reduced
pressure. The residue was dissolved in methanol (4 mL), and sodium
borohydride (76 mg) was added at 0&#x00B0; C. The mixture was stirred at
room temperature for 1 hr, and concentrated under reduced pressure.
Saturated aqueous sodium hydrogen carbonate solution was added to the
residue, and the mixture was extracted with ethyl acetate. The extract
was washed successively with saturated aqueous sodium hydrogen carbonate
solution, water and saturated brine, dried over anhydrous sodium sulfate,
and concentrated under reduced pressure to give the title compound as a
yellow oil (436 mg, yield quantitative). 1H-NMR (CDCl3) &#x03B4; : 2.52
(3H, s), 3.78 (3H, s), 3.89 (2H, s), 6.41-6.47 (2H, m), 6.72 (1H, s),
7.21-7.37 (4H, m), 7.45-7.48 (1H, m), 1H: not detected.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thiophene and pyrazole derivatives and related analogous
as acid secretion inhibitors and antiulcer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nishida, Haruyuki; Arikawa, Yasuyoshi; Hirase, Keizo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009041705 A2 2009-04-02

$RFMT $RIREG SCHEME62 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl 6-Oxa-3-azabicyclo[3.1.0]hexane-3-carboxylate
C9H15NO3
114214-49-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8737 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 C 7.7598 2.1037 0.0 0
M  V30 9 C 7.7598 3.6437 0.0 0
M  V30 10 O 9.0934 2.8737 0.0 0
M  V30 11 C 6.2952 1.6278 0.0 0
M  V30 12 C 6.2952 4.1195 0.0 0
M  V30 13 N 5.3900 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 10
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3-hydroxy-4-(methylamino)-1-pyrrolidinecarboxylate
C10H20N2O3
143588-01-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.0287 0.0 0
M  V30 2 O 2.6673 3.2587 0.0 0
M  V30 3 O 4.0012 5.5688 0.0 0
M  V30 4 C 1.3337 4.0287 0.0 0
M  V30 5 C 2.1037 5.3624 0.0 0
M  V30 6 C 0.0000 4.7987 0.0 0
M  V30 7 C 0.5637 2.6951 0.0 0
M  V30 8 N 9.3038 2.9016 0.0 0
M  V30 9 C 9.9301 4.3086 0.0 0
M  V30 10 O 7.6286 0.0000 0.0 0
M  V30 11 N 5.3348 3.2587 0.0 0
M  V30 12 C 6.7417 3.8850 0.0 0
M  V30 13 C 5.4958 1.7271 0.0 0
M  V30 14 C 7.7722 2.7406 0.0 0
M  V30 15 C 7.0022 1.4070 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 14
M  V30 10 1 10 15
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 114214-49-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 143588-01-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-1371486
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 3-Hydroxy-4-(methylamino)pyrrolidine-1-carboxylic acid tert-butyl ester
To a solution of Intermediate 6 (1.0 g, 5.4 mmol) in MeOH (50 mL) was
added 33% methylamine in methanol (20 mL, 200 mmol) and the mixture
stirred with heating overnight at 80°C. After this time the mixture was
evaporated in vacuo to give the title compound as a colourless oil (1.1
g, quant.). 3-Hydroxy-4-(methylamino)pyrrolidine-1-carboxylic acid
tert-butyl ester, yield (1.1 g, quant.). δH (DMSO-d6) 4.96 (1H, m), 3.90
(1H, m), 3.33 (2H, m), 3.08 (2H, m), 2.81 (1H, m), 2.25 (3H, s), 1.39
(9H, s).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Thienopyridine derivatives as MEK inhibitors and their preparation,
pharmaceutical compositions and use in the treatment of diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Johnson, James Andrew; Brookings, Daniel Christopher; Langham, Barry
John; Neuss, Judi Charlotte; Thorne, Joanna Rachel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009153554 A1 2009-12-23

$RFMT $RIREG SCHEME63 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Isoxazolemethanol, α-methyl-5-(3-methylphenyl)-, 3-methanesulfonate, (αR)-
C13H15NO4S
1147757-30-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.9685 3.4370 0.0 0 CFG=1
M  V30 2 O 3.0633 4.6831 0.0 0
M  V30 3 C 3.3420 2.0302 0.0 0
M  V30 4 S 1.5317 4.5220 0.0 0 VAL=6
M  V30 5 C 1.3706 6.0535 0.0 0
M  V30 6 O 0.0000 4.3610 0.0 0
M  V30 7 O 1.6926 2.9904 0.0 0
M  V30 8 C 13.2722 3.0800 0.0 0
M  V30 9 C 7.9374 3.0800 0.0 0
M  V30 10 C 6.5305 2.4536 0.0 0
M  V30 11 O 7.7763 4.6116 0.0 0
M  V30 12 C 5.5000 3.5981 0.0 0
M  V30 13 N 6.2700 4.9318 0.0 0
M  V30 14 C 9.2711 2.3100 0.0 0
M  V30 15 C 10.6047 3.0800 0.0 0
M  V30 16 C 9.2711 0.7700 0.0 0
M  V30 17 C 11.9384 2.3100 0.0 0
M  V30 18 C 10.6047 0.0000 0.0 0
M  V30 19 C 11.9384 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 4 7
M  V30 8 1 8 17
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 14
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αS)-N,α-Dimethyl-5-(3-methylphenyl)-3-isoxazolemethanamine
C13H16N2O
1147756-71-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3037 3.4372 0.0 0 CFG=2
M  V30 2 N 10.2090 4.6831 0.0 0
M  V30 3 C 9.9301 2.0302 0.0 0
M  V30 4 C 11.7405 4.5220 0.0 0
M  V30 5 C 0.0000 3.0800 0.0 0
M  V30 6 C 5.3348 3.0800 0.0 0
M  V30 7 C 6.7416 2.4536 0.0 0
M  V30 8 O 5.4957 4.6116 0.0 0
M  V30 9 C 7.7722 3.5981 0.0 0
M  V30 10 N 7.0022 4.9318 0.0 0
M  V30 11 C 4.0011 2.3100 0.0 0
M  V30 12 C 2.6673 3.0800 0.0 0
M  V30 13 C 4.0011 0.7700 0.0 0
M  V30 14 C 1.3337 2.3100 0.0 0
M  V30 15 C 2.6673 0.0000 0.0 0
M  V30 16 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 14
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1147757-30-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1147756-71-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-15541339
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 1.1:
N-{[5-(3-Chlorophenyl)isoxazol-3-yl]methyl}cyclopropanamine
[5-(3-Chlorophenyl)isoxazol-3-yl]methyl methanesulfonate (WO 2004/014881)
(1.45 g, 5.04 mmol) was dissolved in THF (30 mL) and cyclopropylamine
(2.0 mL, 25 mmol) was added. The reaction mixture was stirred at rt
overnight. The next day, more cyclopropylamine (2.0 mL, 25 mmol) was
added and the reaction mixture was heated at 40 °C with reflux condenser
for 3 h. The solvent was evaporated and the residue was dissolved in DCM
(80 mL), washed with saturated NaHCO3 solution (50 mL) and dried (MgSO4).
The crude title compound (yield 90%) was used in the next step without
further purification.
(1S)-N-Methyl-1-[5-(3-methylphenyl)-isoxazol-3-yl]ethanamine, yield Quant
3.3g. 1H NMR (400 MHz, DMSO-d6): δ 7.64 (m, 2H), 7.41 (m, 1H), 7.30 (m,
1H), 6.94 (s, 1H), 3.75 (q, 1H), 2.37 (s, 3H), 2.19 (s, 3H), 1.33 (d, 3H)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of amino 1,2,4-triazole derivatives as modulators of mGluR5
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Isaac, Methvin; Waallberg, Andreas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009054794 A1 2009-04-30

$RFMT $RIREG SCHEME64 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzyloxycarbonyl-L-proline
C13H15NO4
1148-11-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.8384 3.7710 0.0 0
M  V30 2 O 6.3784 3.7710 0.0 0
M  V30 3 O 4.0684 5.1048 0.0 0
M  V30 4 C 7.1484 5.1048 0.0 0
M  V30 5 C 1.5063 3.4208 0.0 0
M  V30 6 O 1.9823 4.8855 0.0 0
M  V30 7 O 0.0000 3.1006 0.0 0
M  V30 8 N 4.0684 2.4374 0.0 0
M  V30 9 C 2.5368 2.2764 0.0 0 CFG=2
M  V30 10 C 4.6947 1.0306 0.0 0
M  V30 11 C 2.2167 0.7700 0.0 0
M  V30 12 C 3.5503 0.0000 0.0 0
M  V30 13 C 8.6884 5.1048 0.0 0
M  V30 14 C 9.4584 6.4384 0.0 0
M  V30 15 C 9.4584 3.7710 0.0 0
M  V30 16 C 10.9984 6.4384 0.0 0
M  V30 17 C 10.9984 3.7710 0.0 0
M  V30 18 C 11.7684 5.1048 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 9 5 CFG=1
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Phenylmethyl (2S)-2-[(methylamino)carbonyl]-1-pyrrolidinecarboxylate
C14H18N2O3
65057-32-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 3.7710 0.0 0
M  V30 2 O 5.3900 3.7710 0.0 0
M  V30 3 O 7.6999 5.1048 0.0 0
M  V30 4 C 4.6200 5.1048 0.0 0
M  V30 5 C 10.2620 3.4208 0.0 0
M  V30 6 N 11.7683 3.1006 0.0 0
M  V30 7 O 9.7862 4.8855 0.0 0
M  V30 8 C 12.7989 4.2450 0.0 0
M  V30 9 N 7.6999 2.4373 0.0 0
M  V30 10 C 9.2316 2.2764 0.0 0 CFG=2
M  V30 11 C 7.0736 1.0306 0.0 0
M  V30 12 C 9.5518 0.7700 0.0 0
M  V30 13 C 8.2180 0.0000 0.0 0
M  V30 14 C 3.0800 5.1048 0.0 0
M  V30 15 C 2.3100 6.4384 0.0 0
M  V30 16 C 2.3100 3.7710 0.0 0
M  V30 17 C 0.7700 6.4384 0.0 0
M  V30 18 C 0.7700 3.7710 0.0 0
M  V30 19 C 0.0000 5.1048 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 10 5 CFG=3
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1148-11-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 65057-32-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-862744
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, characterisation and in vitro cytotoxicity studies of a series
of chiral platinum(II) complexes based on the 2-aminomethylpyrrolidine
ligand: X-ray crystal structure of [PtCl2(R-dimepyrr)] (R-dimepyrr =
N-dimethyl-2(R)-aminomethylpyrrolidine)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Diakos, Connie I.; Zhang, Mei; Beale, Philip J.; Fenton, Ronald R.;
Hambley, Trevor W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2009), 44(7), 2807-2814

$RFMT $RIREG SCHEME65 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-D-proline methyl ester
C7H13NO2
114883-82-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 O 5.1049 1.8517 0.0 0
M  V30 3 O 3.7711 4.1618 0.0 0
M  V30 4 C 6.4386 2.6217 0.0 0
M  V30 5 C 0.7103 3.9845 0.0 0
M  V30 6 C 2.4374 1.8517 0.0 0 CFG=1
M  V30 7 N 1.0306 2.4782 0.0 0
M  V30 8 C 2.2765 0.3202 0.0 0
M  V30 9 C 0.0000 1.3337 0.0 0
M  V30 10 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 6 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 5 7
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2R)-N,1-Dimethyl-2-pyrrolidinecarboxamide
C7H14N2O
2411469-73-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 N 5.1049 1.8517 0.0 0
M  V30 3 O 3.7711 4.1618 0.0 0
M  V30 4 C 6.4386 2.6217 0.0 0
M  V30 5 C 0.7103 3.9845 0.0 0
M  V30 6 C 2.4374 1.8517 0.0 0 CFG=1
M  V30 7 N 1.0306 2.4782 0.0 0
M  V30 8 C 2.2765 0.3202 0.0 0
M  V30 9 C 0.0000 1.3337 0.0 0
M  V30 10 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 6 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 5 7
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 114883-82-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2411469-73-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-23459259
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel sulfonamide urea compounds as NLRP3 inhibitors and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cooper, Matthew; Miller, David; Macleod, Angus; Shannon, Jonathan;
Carrillo Arregui, Jokin; Van Wiltenburg, Jimmy; Van Herpt, Jochem
Theodoor
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020035464 A1 2020-02-20

$RFMT $RIREG SCHEME66 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-2-(2-furanyl)-6-iodoquinazoline
C12H6ClIN2O
1158963-50-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 6.9898 0.0000 0.0 0
M  V30 2 I 10.8398 4.0011 0.0 0
M  V30 3 C 6.2198 4.0011 0.0 0
M  V30 4 C 6.9898 2.6674 0.0 0
M  V30 5 N 4.6798 4.0011 0.0 0
M  V30 6 C 6.9898 5.3349 0.0 0
M  V30 7 C 6.2198 1.3338 0.0 0
M  V30 8 C 8.5298 2.6674 0.0 0
M  V30 9 C 3.9098 2.6674 0.0 0
M  V30 10 C 8.5298 5.3349 0.0 0
M  V30 11 N 4.6798 1.3338 0.0 0
M  V30 12 C 9.2998 4.0011 0.0 0
M  V30 13 C 2.3698 2.6674 0.0 0
M  V30 14 C 1.4645 1.4216 0.0 0
M  V30 15 O 1.4645 3.9133 0.0 0
M  V30 16 C 0.0000 1.8974 0.0 0
M  V30 17 C 0.0000 3.4374 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 12
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 11
M  V30 13 1 9 13
M  V30 14 1 10 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-3-buten-2-ol
C5H10O
115-18-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.3337 0.0 0
M  V30 2 C 2.6673 2.1037 0.0 0
M  V30 3 C 2.1037 0.0000 0.0 0
M  V30 4 C 0.0000 0.5637 0.0 0
M  V30 5 O 0.5637 2.6673 0.0 0
M  V30 6 C 4.0010 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3E)-4-[2-(2-Furanyl)-4-(methylamino)-6-quinazolinyl]-2-methyl-3-buten-2-ol
C18H19N3O2
1235475-68-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9898 1.3338 0.0 0
M  V30 2 C 6.2198 0.0000 0.0 0
M  V30 3 C 10.8398 5.3347 0.0 0
M  V30 4 C 11.6098 6.6685 0.0 0
M  V30 5 C 13.1498 6.6685 0.0 0
M  V30 6 C 13.1498 5.1285 0.0 0
M  V30 7 C 14.6898 6.6685 0.0 0
M  V30 8 O 13.1498 8.2085 0.0 0
M  V30 9 C 6.9898 4.0011 0.0 0
M  V30 10 C 6.2198 5.3347 0.0 0
M  V30 11 C 6.2198 2.6674 0.0 0
M  V30 12 C 8.5298 4.0011 0.0 0
M  V30 13 N 4.6798 5.3347 0.0 0
M  V30 14 C 6.9898 6.6685 0.0 0
M  V30 15 N 4.6798 2.6674 0.0 0
M  V30 16 C 9.2998 5.3347 0.0 0
M  V30 17 C 3.9098 4.0011 0.0 0
M  V30 18 C 8.5298 6.6685 0.0 0
M  V30 19 C 2.3698 4.0011 0.0 0
M  V30 20 C 1.4645 5.2469 0.0 0
M  V30 21 O 1.4645 2.7552 0.0 0
M  V30 22 C 0.0000 4.7711 0.0 0
M  V30 23 C 0.0000 3.2311 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 2 3 4
M  V30 4 1 3 16
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1158963-50-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 115-18-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1235475-68-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-7342042
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 6163-58-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 3375-31-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
2-(Furan-2-yl)-6-iodo-N-isopropylquinazolin-4-amine (10) A solution of
4-chloro-2-(furan-2-yl)-6-iodoquinazoline (7) (1.70 g, 4.70 mmol) and
i-propylamine (1.02 ml, 11.9 mmol) in i-propanol (70 ml) was stirred
overnight at 35 0C. The yellow suspension turned to a clear solution.
After removal of the solvent under reduced pressure the crude product was
purified by column chromatography (n-hexane/ethyl acetate 3:1 v/v, Rf:
0.35). 10 (1.77 g, 4.67 mmol, 98%) as a orange-coloured solid.
3-(2-(Furan-2-yl)-4-(isopropylamino)quinazolin-6-yl)prop-2-yn-1-ol (C) A
mixture of DMF (2.0 ml) and triethylamine (0.8 ml, 10.8 mmol) was
degassed with ultrasound for 45 min. After addition of
6-(3-aminophenyl)-2-(furan-2-yl)-N-isopropylquinazolin-4-annine (10) (120
mg, 0.32 mmol) and prop-2-yn-1-ol (92 μl, 1.58 mmol) the degassing was
continued for 10 min. Afterwards bis(triphenylphosphine)
palladium(II)dichloride (6.7 mg, 9.50 μmol),
1,1'-bis(diphenylphosphino)ferrocene (10.5 mg, 19.0 μmol), and
copper(l)-iodide (0.6 mg, 3.17 μmol) were added. The catalysts were dried
before use. The solution was heated to 50 °C and stirred for 16 h at this
temperature (TLC-control). After cooling down to rt the solution was
poured in ethyl acetate (10 ml). The organic phase was washed with
diluted NH4Cl (5 ml) solution and brine (5 ml). After drying over Na2SO4
the solvent was removed at reduced pressure. The crude product was
purified by column chromatography (n-hexane/ethyl acetate 1 :2 v/v, Rf:
0.35). Compound (C) (59 mg, 0.19 mmol, 61 %) as a yellow solid.
2-(Furan-2-yl)-N-methyl-6-(2-phenylethynyl)quinazolin-4-amine (D)
(E)-4-(2-(Furan-2-yl)-4-methylannino)quinazolin-6-yl)-2-methylbut-3-en-2-ol
(N) Appearence: yellow solid; yield: quantitative. Rf: 0.25
(n-hexane/ethylacetate, 1 :3, v/v); mp: 250 °C (decomposition); UV
(CH3OH) λ (Ig ε) = 222 nm (4.341 ), 287 nm (4.434), 337 nm (4.333); IR
(KBr) v = 3356 cm-1, 2974 cm-1, 1594 cm-1, 1568 cm-1, 1537 cm-1, 1384
cm-1; 1H-NMR (400 MHz, CDCl3/CD3OD, 57:43, v/v) δ = 1.39 (s, 6 H,
C(CH3)2OH); 3.18 (s, 3 H, NHCH3); 6.43 (d, 3 J = 16.0 Hz, 1 H,
(CH3)2(OH)C-CH=CH); 6.54 (dd, 3 J = 3.6 Hz, 3 J = 2.0 Hz, 1 H, furan
H-4); 6.63 (d, 3 J = 16.4 Hz, 1 H, (CH3)2(OH)C-CH=CH); 7.30 (dd, 3 J =
3.2 Hz, 4 J = 0.8 Hz, 1 H, furan H-3); 7.61 (dd, 3 J = 1.8 Hz, 4 J = 1.0
Hz, 1 H, furan H-5); 7.73 (m, 2 H, quinazolin H-7 und quinazolin H-8);
7.88 (d, 4 J = 1.2 Hz, 1 H, quinazolin H-5); 13C-NMR (100 MHz,
CDCl3/CD3OD, 1.3:1 , v/v) δ = 28.1 (NHCH3), 29.7 (C(CH3)2OH), 70.9
(C(CH3)2OH), 112.4 (furan C-3), 113.6 (furan C-4), 114.7 (quinazolin
C-4a), 120.1 (quinazolin C-5), 125.8 (CH3)2(OH)C-CH=CH), 127.3
(CH3)2(OH)C-CH=CH), 131.2 (quinazolin C-8), 135.3 (quinazolin C-6), 139.1
(quinazolin C-7), 144.9 (furan C-5), 148.8 (quinazolin C-8a), 153.2
(furan C-2), 153.9 (quinazolin C-4), 161.0 (quinazolin C-2); HR-ESI MS
(positive, CHCl3/CH3OH); [M+H]+ (C18H20N3O2), calculated: 310.15555
found: 310.15500; [2M+Na]+ (C36H38N6O4Na), calculated: 641.28522 found:
641 .28467.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, Pyrex-pressure tube used (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quinazolines as aurora kinase inhibitors and their preparation and use
for the treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Giannis, Athanassios; Cottin, Thomas; Sardon Urtiaga, Teresa; Vernos
Ruscassier, Isabelle J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010081881 A1 2010-07-22

$RFMT $RIREG SCHEME67 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1S,3R,5S,7R,8S,9S,10R)-2-acetyl-7-(azidomethyl)-8,9,10-trihydroxy-3-(...
C14H22N4O8
1152330-53-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.5788 6.4122 0.0 0
M  V30 2 O 5.2586 7.9185 0.0 0
M  V30 3 O 7.0435 5.9364 0.0 0
M  V30 4 C 6.4030 8.9491 0.0 0
M  V30 5 O 3.2616 1.5400 0.0 0
M  V30 6 C 2.3016 7.1088 0.0 0
M  V30 7 C 3.2068 8.3547 0.0 0
M  V30 8 O 0.7700 7.2697 0.0 0
M  V30 9 C 0.6263 4.2072 0.0 0
M  V30 10 O 0.0000 2.8004 0.0 0
M  V30 11 C 8.5965 4.6201 0.0 0
M  V30 12 N 9.9301 3.8501 0.0 0
M  V30 13 N 11.2638 4.6201 0.0 0 CHG=1 VAL=4
M  V30 14 N 12.5975 5.3901 0.0 0 CHG=-1
M  V30 15 O 5.9290 0.0000 0.0 0
M  V30 16 O 8.5965 1.5400 0.0 0
M  V30 17 C 4.5953 3.8501 0.0 0 CFG=1
M  V30 18 C 4.4344 5.3818 0.0 0 CFG=1
M  V30 19 C 3.1883 3.2238 0.0 0
M  V30 20 O 5.9290 4.6201 0.0 0
M  V30 21 C 4.5953 2.3101 0.0 0 CFG=2
M  V30 22 N 2.9279 5.7020 0.0 0
M  V30 23 C 2.1579 4.3682 0.0 0 CFG=2
M  V30 24 C 7.2626 3.8501 0.0 0 CFG=2
M  V30 25 C 5.9290 1.5400 0.0 0 CFG=1
M  V30 26 C 7.2626 2.3101 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 18 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 21 5 CFG=1
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 22
M  V30 9 1 9 10
M  V30 10 1 23 9 CFG=3
M  V30 11 1 11 12
M  V30 12 1 24 11 CFG=3
M  V30 13 2 12 13
M  V30 14 2 13 14
M  V30 15 1 25 15 CFG=3
M  V30 16 1 26 16 CFG=1
M  V30 17 1 17 18
M  V30 18 1 17 19 CFG=1
M  V30 19 1 17 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 1 22 23
M  V30 26 1 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 17 18 21 23 24 25 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1S,3R,5S,7R,8S,9S,10R)-2-Acetyl-7-(azidomethyl)-8,9,10-trihydroxy-3-(hydroxy...
C14H23N5O7
1202357-56-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.5788 6.4122 0.0 0
M  V30 2 N 5.2586 7.9185 0.0 0
M  V30 3 O 7.0435 5.9364 0.0 0
M  V30 4 C 6.4030 8.9491 0.0 0
M  V30 5 O 3.2616 1.5400 0.0 0
M  V30 6 C 2.3016 7.1088 0.0 0
M  V30 7 C 3.2068 8.3547 0.0 0
M  V30 8 O 0.7700 7.2697 0.0 0
M  V30 9 C 0.6263 4.2072 0.0 0
M  V30 10 O 0.0000 2.8004 0.0 0
M  V30 11 C 8.5965 4.6201 0.0 0
M  V30 12 N 9.9301 3.8501 0.0 0
M  V30 13 N 11.2638 4.6201 0.0 0 CHG=1 VAL=4
M  V30 14 N 12.5975 5.3901 0.0 0 CHG=-1
M  V30 15 O 5.9290 0.0000 0.0 0
M  V30 16 O 8.5965 1.5400 0.0 0
M  V30 17 C 4.5953 3.8501 0.0 0 CFG=1
M  V30 18 C 4.4344 5.3818 0.0 0 CFG=1
M  V30 19 C 3.1883 3.2238 0.0 0
M  V30 20 O 5.9290 4.6201 0.0 0
M  V30 21 C 4.5953 2.3101 0.0 0 CFG=2
M  V30 22 N 2.9279 5.7020 0.0 0
M  V30 23 C 2.1579 4.3682 0.0 0 CFG=2
M  V30 24 C 7.2626 3.8501 0.0 0 CFG=2
M  V30 25 C 5.9290 1.5400 0.0 0 CFG=1
M  V30 26 C 7.2626 2.3101 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 18 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 21 5 CFG=1
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 22
M  V30 9 1 9 10
M  V30 10 1 23 9 CFG=3
M  V30 11 1 11 12
M  V30 12 1 24 11 CFG=3
M  V30 13 2 12 13
M  V30 14 2 13 14
M  V30 15 1 25 15 CFG=3
M  V30 16 1 26 16 CFG=1
M  V30 17 1 17 18
M  V30 18 1 17 19 CFG=1
M  V30 19 1 17 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 1 22 23
M  V30 26 1 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 17 18 21 23 24 25 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1152330-53-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1202357-56-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10022422
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a solution of methylamine in ethanol (37% wt, 1 mL) was added compound
3-20 (15 mg, 0.04 mmol) and stirred for 18 hours at room temperature. The
mixture was concentrated and purified by flash column chromatography
(dichloromethane/methanol:2/1). Quantitatively afford C-terminal methyl
amide intermediate.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of peptide-based β-turn mimetics, especially
glucose-templated proline mimetics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Kaidong; Schweizer, Frank
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010113035 A2 2010-10-07

$RFMT $RIREG SCHEME67 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1S,3R,5S,7R,8S,9S,10R)-2-acetyl-7-(azidomethyl)-8,9,10-trihydroxy-3-(...
C14H22N4O8
1152330-53-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.5788 6.4122 0.0 0
M  V30 2 O 5.2586 7.9185 0.0 0
M  V30 3 O 7.0435 5.9364 0.0 0
M  V30 4 C 6.4030 8.9491 0.0 0
M  V30 5 O 3.2616 1.5400 0.0 0
M  V30 6 C 2.3016 7.1088 0.0 0
M  V30 7 C 3.2068 8.3547 0.0 0
M  V30 8 O 0.7700 7.2697 0.0 0
M  V30 9 C 0.6263 4.2072 0.0 0
M  V30 10 O 0.0000 2.8004 0.0 0
M  V30 11 C 8.5965 4.6201 0.0 0
M  V30 12 N 9.9301 3.8501 0.0 0
M  V30 13 N 11.2638 4.6201 0.0 0 CHG=1 VAL=4
M  V30 14 N 12.5975 5.3901 0.0 0 CHG=-1
M  V30 15 O 5.9290 0.0000 0.0 0
M  V30 16 O 8.5965 1.5400 0.0 0
M  V30 17 C 4.5953 3.8501 0.0 0 CFG=1
M  V30 18 C 4.4344 5.3818 0.0 0 CFG=1
M  V30 19 C 3.1883 3.2238 0.0 0
M  V30 20 O 5.9290 4.6201 0.0 0
M  V30 21 C 4.5953 2.3101 0.0 0 CFG=2
M  V30 22 N 2.9279 5.7020 0.0 0
M  V30 23 C 2.1579 4.3682 0.0 0 CFG=2
M  V30 24 C 7.2626 3.8501 0.0 0 CFG=2
M  V30 25 C 5.9290 1.5400 0.0 0 CFG=1
M  V30 26 C 7.2626 2.3101 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 18 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 21 5 CFG=1
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 22
M  V30 9 1 9 10
M  V30 10 1 23 9 CFG=3
M  V30 11 1 11 12
M  V30 12 1 24 11 CFG=3
M  V30 13 2 12 13
M  V30 14 2 13 14
M  V30 15 1 25 15 CFG=3
M  V30 16 1 26 16 CFG=1
M  V30 17 1 17 18
M  V30 18 1 17 19 CFG=1
M  V30 19 1 17 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 1 22 23
M  V30 26 1 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 17 18 21 23 24 25 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1S,3R,5S,7R,8S,9S,10R)-2-Acetyl-7-(azidomethyl)-8,9,10-trihydroxy-3-(hydroxy...
C14H23N5O7
1202357-56-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.5788 6.4122 0.0 0
M  V30 2 N 5.2586 7.9185 0.0 0
M  V30 3 O 7.0435 5.9364 0.0 0
M  V30 4 C 6.4030 8.9491 0.0 0
M  V30 5 O 3.2616 1.5400 0.0 0
M  V30 6 C 2.3016 7.1088 0.0 0
M  V30 7 C 3.2068 8.3547 0.0 0
M  V30 8 O 0.7700 7.2697 0.0 0
M  V30 9 C 0.6263 4.2072 0.0 0
M  V30 10 O 0.0000 2.8004 0.0 0
M  V30 11 C 8.5965 4.6201 0.0 0
M  V30 12 N 9.9301 3.8501 0.0 0
M  V30 13 N 11.2638 4.6201 0.0 0 CHG=1 VAL=4
M  V30 14 N 12.5975 5.3901 0.0 0 CHG=-1
M  V30 15 O 5.9290 0.0000 0.0 0
M  V30 16 O 8.5965 1.5400 0.0 0
M  V30 17 C 4.5953 3.8501 0.0 0 CFG=1
M  V30 18 C 4.4344 5.3818 0.0 0 CFG=1
M  V30 19 C 3.1883 3.2238 0.0 0
M  V30 20 O 5.9290 4.6201 0.0 0
M  V30 21 C 4.5953 2.3101 0.0 0 CFG=2
M  V30 22 N 2.9279 5.7020 0.0 0
M  V30 23 C 2.1579 4.3682 0.0 0 CFG=2
M  V30 24 C 7.2626 3.8501 0.0 0 CFG=2
M  V30 25 C 5.9290 1.5400 0.0 0 CFG=1
M  V30 26 C 7.2626 2.3101 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 18 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 21 5 CFG=1
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 22
M  V30 9 1 9 10
M  V30 10 1 23 9 CFG=3
M  V30 11 1 11 12
M  V30 12 1 24 11 CFG=3
M  V30 13 2 12 13
M  V30 14 2 13 14
M  V30 15 1 25 15 CFG=3
M  V30 16 1 26 16 CFG=1
M  V30 17 1 17 18
M  V30 18 1 17 19 CFG=1
M  V30 19 1 17 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 1 22 23
M  V30 26 1 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 17 18 21 23 24 25 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1152330-53-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1202357-56-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13137161
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of glucose-templated proline-lysine chimera:
polyfunctional amino acid chimera with high prolyl cis amide rotamer
population
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Kaidong; Schweizer, Frank
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Carbohydrate Research (2009), 344(5), 576-585

$RFMT $RIREG SCHEME68 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1S,3S,5S,7R,8S,9S,10R)-2-acetyl-7-(azidomethyl)-8,9,10-trihydroxy-3-(...
C14H22N4O8
1152330-54-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.5788 6.4122 0.0 0
M  V30 2 O 5.2586 7.9185 0.0 0
M  V30 3 O 7.0435 5.9364 0.0 0
M  V30 4 C 6.4030 8.9491 0.0 0
M  V30 5 O 3.2616 1.5400 0.0 0
M  V30 6 C 2.3016 7.1088 0.0 0
M  V30 7 C 3.2068 8.3547 0.0 0
M  V30 8 O 0.7700 7.2697 0.0 0
M  V30 9 C 0.6263 4.2072 0.0 0
M  V30 10 O 0.0000 2.8004 0.0 0
M  V30 11 C 8.5965 4.6201 0.0 0
M  V30 12 N 9.9301 3.8501 0.0 0
M  V30 13 N 11.2638 4.6201 0.0 0 CHG=1 VAL=4
M  V30 14 N 12.5975 5.3901 0.0 0 CHG=-1
M  V30 15 O 5.9290 0.0000 0.0 0
M  V30 16 O 8.5965 1.5400 0.0 0
M  V30 17 C 4.5953 3.8501 0.0 0 CFG=1
M  V30 18 C 4.4344 5.3818 0.0 0 CFG=1
M  V30 19 C 3.1883 3.2238 0.0 0
M  V30 20 O 5.9290 4.6201 0.0 0
M  V30 21 C 4.5953 2.3101 0.0 0 CFG=2
M  V30 22 N 2.9279 5.7020 0.0 0
M  V30 23 C 2.1579 4.3682 0.0 0 CFG=1
M  V30 24 C 7.2626 3.8501 0.0 0 CFG=2
M  V30 25 C 5.9290 1.5400 0.0 0 CFG=1
M  V30 26 C 7.2626 2.3101 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 18 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 21 5 CFG=1
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 22
M  V30 9 1 9 10
M  V30 10 1 23 9 CFG=1
M  V30 11 1 11 12
M  V30 12 1 24 11 CFG=3
M  V30 13 2 12 13
M  V30 14 2 13 14
M  V30 15 1 25 15 CFG=3
M  V30 16 1 26 16 CFG=1
M  V30 17 1 17 18
M  V30 18 1 17 19 CFG=1
M  V30 19 1 17 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 1 22 23
M  V30 26 1 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 17 18 21 23 24 25 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1S,3S,5S,7R,8S,9S,10R)-2-Acetyl-7-(azidomethyl)-8,9,10-trihydroxy-3-(hydroxy...
C14H23N5O7
1202357-57-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.5788 6.4122 0.0 0
M  V30 2 N 5.2586 7.9185 0.0 0
M  V30 3 O 7.0435 5.9364 0.0 0
M  V30 4 C 6.4030 8.9491 0.0 0
M  V30 5 O 3.2616 1.5400 0.0 0
M  V30 6 C 2.3016 7.1088 0.0 0
M  V30 7 C 3.2068 8.3547 0.0 0
M  V30 8 O 0.7700 7.2697 0.0 0
M  V30 9 C 0.6263 4.2072 0.0 0
M  V30 10 O 0.0000 2.8004 0.0 0
M  V30 11 C 8.5965 4.6201 0.0 0
M  V30 12 N 9.9301 3.8501 0.0 0
M  V30 13 N 11.2638 4.6201 0.0 0 CHG=1 VAL=4
M  V30 14 N 12.5975 5.3901 0.0 0 CHG=-1
M  V30 15 O 5.9290 0.0000 0.0 0
M  V30 16 O 8.5965 1.5400 0.0 0
M  V30 17 C 4.5953 3.8501 0.0 0 CFG=1
M  V30 18 C 4.4344 5.3818 0.0 0 CFG=1
M  V30 19 C 3.1883 3.2238 0.0 0
M  V30 20 O 5.9290 4.6201 0.0 0
M  V30 21 C 4.5953 2.3101 0.0 0 CFG=2
M  V30 22 N 2.9279 5.7020 0.0 0
M  V30 23 C 2.1579 4.3682 0.0 0 CFG=1
M  V30 24 C 7.2626 3.8501 0.0 0 CFG=2
M  V30 25 C 5.9290 1.5400 0.0 0 CFG=1
M  V30 26 C 7.2626 2.3101 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 18 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 21 5 CFG=1
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 22
M  V30 9 1 9 10
M  V30 10 1 23 9 CFG=1
M  V30 11 1 11 12
M  V30 12 1 24 11 CFG=3
M  V30 13 2 12 13
M  V30 14 2 13 14
M  V30 15 1 25 15 CFG=3
M  V30 16 1 26 16 CFG=1
M  V30 17 1 17 18
M  V30 18 1 17 19 CFG=1
M  V30 19 1 17 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 1 22 23
M  V30 26 1 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 17 18 21 23 24 25 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1152330-54-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1202357-57-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15266914
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of glucose-templated proline-lysine chimera:
polyfunctional amino acid chimera with high prolyl cis amide rotamer
population
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Kaidong; Schweizer, Frank
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Carbohydrate Research (2009), 344(5), 576-585

$RFMT $RIREG SCHEME69 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(3β)-3-Hydroxy-28-oxolup-20(29)-en-28-yl]-4-piperidinebutanoic acid
C39H63NO4
1155394-73-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  48 53 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 12.4551 6.2609 0.0 0
M  V30 2 O 11.8287 7.6677 0.0 0
M  V30 3 C 11.4902 1.0304 0.0 0
M  V30 4 C 12.6346 0.0000 0.0 0
M  V30 5 C 10.0256 0.5546 0.0 0
M  V30 6 C 8.3357 6.5490 0.0 0
M  V30 7 C 7.3286 6.5025 0.0 0
M  V30 8 C 18.5813 5.6168 0.0 0
M  V30 9 C 19.4865 6.8629 0.0 0
M  V30 10 C 21.0181 6.7018 0.0 0
M  V30 11 C 21.9233 7.9478 0.0 0
M  V30 12 O 23.4548 7.7867 0.0 0
M  V30 13 O 21.2970 9.3546 0.0 0
M  V30 14 C 4.7541 2.1471 0.0 0
M  V30 15 C 0.8629 5.5417 0.0 0
M  V30 16 C 2.5773 6.5316 0.0 0
M  V30 17 O 0.0000 3.6812 0.0 0
M  V30 18 C 11.5500 5.0149 0.0 0 CFG=1
M  V30 19 C 10.7800 3.6812 0.0 0 CFG=2
M  V30 20 C 10.7800 6.3486 0.0 0
M  V30 21 C 13.0563 4.6947 0.0 0
M  V30 22 C 9.2400 3.6812 0.0 0 CFG=1
M  V30 23 C 11.8104 2.5368 0.0 0 CFG=2
M  V30 24 C 9.2400 6.3486 0.0 0
M  V30 25 C 13.2172 3.1632 0.0 0
M  V30 26 C 8.4700 5.0149 0.0 0 CFG=1
M  V30 27 C 8.4700 2.3476 0.0 0
M  V30 28 C 6.9300 5.0149 0.0 0 CFG=1
M  V30 29 C 6.9300 2.3476 0.0 0
M  V30 30 C 6.1600 3.6812 0.0 0 CFG=1
M  V30 31 C 6.1600 6.3486 0.0 0
M  V30 32 C 4.6200 3.6812 0.0 0 CFG=2
M  V30 33 C 4.6200 6.3486 0.0 0
M  V30 34 C 3.8500 5.0149 0.0 0 CFG=2
M  V30 35 C 3.8500 2.3476 0.0 0
M  V30 36 C 2.3100 5.0149 0.0 0
M  V30 37 C 2.3100 2.3476 0.0 0
M  V30 38 C 1.5400 3.6812 0.0 0 CFG=1
M  V30 39 N 13.9867 6.0998 0.0 0
M  V30 40 C 14.8918 7.3458 0.0 0
M  V30 41 C 14.6131 4.6930 0.0 0
M  V30 42 C 16.4235 7.1847 0.0 0
M  V30 43 C 16.1446 4.5321 0.0 0
M  V30 44 C 17.0498 5.7779 0.0 0
M  V30 45 H 10.5390 2.1602 0.0 0
M  V30 46 H 9.6386 2.1937 0.0 0
M  V30 47 H 6.0257 2.1471 0.0 0
M  V30 48 H 3.0800 6.3486 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 18 1 CFG=3
M  V30 3 1 1 39
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 23 3 CFG=1
M  V30 7 1 26 6 CFG=1
M  V30 8 1 28 7 CFG=3
M  V30 9 1 8 9
M  V30 10 1 8 44
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 32 14 CFG=3
M  V30 16 1 15 36
M  V30 17 1 16 36
M  V30 18 1 38 17 CFG=3
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 21
M  V30 22 1 19 22
M  V30 23 1 19 23
M  V30 24 1 19 45 CFG=1
M  V30 25 1 20 24
M  V30 26 1 21 25
M  V30 27 1 22 26
M  V30 28 1 22 27
M  V30 29 1 22 46 CFG=3
M  V30 30 1 23 25
M  V30 31 1 24 26
M  V30 32 1 26 28
M  V30 33 1 27 29
M  V30 34 1 28 30
M  V30 35 1 28 31
M  V30 36 1 29 30
M  V30 37 1 30 32
M  V30 38 1 30 47 CFG=1
M  V30 39 1 31 33
M  V30 40 1 32 34
M  V30 41 1 32 35
M  V30 42 1 33 34
M  V30 43 1 34 36
M  V30 44 1 34 48 CFG=1
M  V30 45 1 35 37
M  V30 46 1 36 38
M  V30 47 1 37 38
M  V30 48 1 39 40
M  V30 49 1 39 41
M  V30 50 1 40 42
M  V30 51 1 41 43
M  V30 52 1 42 44
M  V30 53 1 43 44
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 18 19 22 23 26 28 30 32 34 38)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-[(3β)-3-Hydroxy-28-oxolup-20(29)-en-28-yl]-N-methyl-4-piperidinebutanamide
C40H66N2O3
1155394-77-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 54 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 12.4551 6.2609 0.0 0
M  V30 2 O 11.8287 7.6677 0.0 0
M  V30 3 C 11.4902 1.0304 0.0 0
M  V30 4 C 12.6346 0.0000 0.0 0
M  V30 5 C 10.0256 0.5546 0.0 0
M  V30 6 C 8.3357 6.5490 0.0 0
M  V30 7 C 7.0641 6.5490 0.0 0
M  V30 8 C 18.5813 5.6170 0.0 0
M  V30 9 C 19.4865 6.8629 0.0 0
M  V30 10 C 21.0181 6.7018 0.0 0
M  V30 11 C 21.9233 7.9478 0.0 0
M  V30 12 N 23.4550 7.7867 0.0 0
M  V30 13 O 21.2970 9.3546 0.0 0
M  V30 14 C 24.3600 9.0326 0.0 0
M  V30 15 C 4.7541 2.1471 0.0 0
M  V30 16 C 0.8629 5.5417 0.0 0
M  V30 17 C 2.5773 6.5316 0.0 0
M  V30 18 O 0.0000 3.6812 0.0 0
M  V30 19 C 11.5500 5.0149 0.0 0 CFG=1
M  V30 20 C 10.7800 3.6812 0.0 0 CFG=2
M  V30 21 C 10.7800 6.3486 0.0 0
M  V30 22 C 13.0563 4.6947 0.0 0
M  V30 23 C 9.2400 3.6812 0.0 0 CFG=1
M  V30 24 C 11.8104 2.5368 0.0 0 CFG=2
M  V30 25 C 9.2400 6.3486 0.0 0
M  V30 26 C 13.2172 3.1632 0.0 0
M  V30 27 C 8.4700 5.0149 0.0 0 CFG=1
M  V30 28 C 8.4700 2.3476 0.0 0
M  V30 29 C 6.9300 5.0149 0.0 0 CFG=1
M  V30 30 C 6.9300 2.3476 0.0 0
M  V30 31 C 6.1600 3.6812 0.0 0 CFG=1
M  V30 32 C 6.1600 6.3486 0.0 0
M  V30 33 C 4.6200 3.6812 0.0 0 CFG=2
M  V30 34 C 4.6200 6.3486 0.0 0
M  V30 35 C 3.8500 5.0149 0.0 0 CFG=2
M  V30 36 C 3.8500 2.3476 0.0 0
M  V30 37 C 2.3100 5.0149 0.0 0
M  V30 38 C 2.3100 2.3476 0.0 0
M  V30 39 C 1.5400 3.6812 0.0 0 CFG=1
M  V30 40 N 13.9867 6.0998 0.0 0
M  V30 41 C 14.6131 4.6930 0.0 0
M  V30 42 C 14.8920 7.3458 0.0 0
M  V30 43 C 16.1446 4.5321 0.0 0
M  V30 44 C 16.4235 7.1847 0.0 0
M  V30 45 C 17.0498 5.7779 0.0 0
M  V30 46 H 10.8068 2.1415 0.0 0
M  V30 47 H 9.3741 2.1471 0.0 0
M  V30 48 H 6.0257 2.1471 0.0 0
M  V30 49 H 3.0800 6.3486 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 19 1 CFG=3
M  V30 3 1 1 40
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 24 3 CFG=1
M  V30 7 1 27 6 CFG=1
M  V30 8 1 29 7 CFG=3
M  V30 9 1 8 9
M  V30 10 1 8 45
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 33 15 CFG=3
M  V30 17 1 16 37
M  V30 18 1 17 37
M  V30 19 1 39 18 CFG=3
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 22
M  V30 23 1 20 23
M  V30 24 1 20 24
M  V30 25 1 20 46 CFG=1
M  V30 26 1 21 25
M  V30 27 1 22 26
M  V30 28 1 23 27
M  V30 29 1 23 28
M  V30 30 1 23 47 CFG=3
M  V30 31 1 24 26
M  V30 32 1 25 27
M  V30 33 1 27 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 1 29 32
M  V30 37 1 30 31
M  V30 38 1 31 33
M  V30 39 1 31 48 CFG=1
M  V30 40 1 32 34
M  V30 41 1 33 35
M  V30 42 1 33 36
M  V30 43 1 34 35
M  V30 44 1 35 37
M  V30 45 1 35 49 CFG=1
M  V30 46 1 36 38
M  V30 47 1 37 39
M  V30 48 1 38 39
M  V30 49 1 40 41
M  V30 50 1 40 42
M  V30 51 1 41 43
M  V30 52 1 42 44
M  V30 53 1 43 45
M  V30 54 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 19 20 23 24 27 29 31 33 35 39)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1155394-73-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1155394-77-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-4464636
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Synthesis of BA-derivatives 21 and 41-44. A
solution of 20 or 38 (1 eq), EDCI (2 eq), N-Hydroxybenzotriazole (HOBt, 1
eq), Et3N (0.05 mL) and the appropriate amine (2 eq) in anhydrous CH2Cl2
(8 mL) was stirred at room temperature overnight until the starting
material was not observed by TLC. The solution was diluted with CH2Cl2
(20 mL) and washed three times with brine and distilled water. The
organic layer was dried over anhydrous Na2SO4 and concentrated to dryness
under reduced pressure. The residue was chromatographed using a silica
gel column. Pure target compounds.
N'-[N-[3β-Hydroxy-lup-20(29)-en-28-oyl]-4-piperidine-butanoyl]-aminomethane
(41): 46 mg (100% yield) starting from 50 mg of 38, off-white amorphous
powder. Mp 202- 204 °C. MS (ESI+) m/z: 623.5 (M+ + H) for C40H66N2O3. 1H
NMR (300 MHz, CDCl3): δ 5.44 (1H, br s, -CONHCH3), 4.69, 4.54 (1H each,
s, H-29), 3.58-3.54 (4H, m, 28- CON(CH 2CH2)2CH-), 3.16 (1H, m, H-3),
2.95 (1H, m, H-19), 2.78 (3H, d, J = 4.8 Hz, -CONHCH 3), 2.16 (2Η, t, J =
7.5 Hz, -CH 2CONHCH3), 1.66 (3H, s, H-30), 0.93 (6H, s, 2 x CH3) ,0.92,
0.90, 0.79 (3H each, s, 3 x CH3). [α]25 D -10.7 ° (c = 0.19, MeOH).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3,28-Disubstituted betulinic acid derivatives as Anti-HIV agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Kuo-Hsiung; Qian, Keduo; Yu, Donglei; Chen, Chin-Ho; Huang, Li;
Bori, Ibrahim Danlami
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010132334 A1 2010-11-18

$RFMT $RIREG SCHEME69 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(3β)-3-Hydroxy-28-oxolup-20(29)-en-28-yl]-4-piperidinebutanoic acid
C39H63NO4
1155394-73-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  48 53 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 12.4551 6.2609 0.0 0
M  V30 2 O 11.8287 7.6677 0.0 0
M  V30 3 C 11.4902 1.0304 0.0 0
M  V30 4 C 12.6346 0.0000 0.0 0
M  V30 5 C 10.0256 0.5546 0.0 0
M  V30 6 C 8.3357 6.5490 0.0 0
M  V30 7 C 7.3286 6.5025 0.0 0
M  V30 8 C 18.5813 5.6168 0.0 0
M  V30 9 C 19.4865 6.8629 0.0 0
M  V30 10 C 21.0181 6.7018 0.0 0
M  V30 11 C 21.9233 7.9478 0.0 0
M  V30 12 O 23.4548 7.7867 0.0 0
M  V30 13 O 21.2970 9.3546 0.0 0
M  V30 14 C 4.7541 2.1471 0.0 0
M  V30 15 C 0.8629 5.5417 0.0 0
M  V30 16 C 2.5773 6.5316 0.0 0
M  V30 17 O 0.0000 3.6812 0.0 0
M  V30 18 C 11.5500 5.0149 0.0 0 CFG=1
M  V30 19 C 10.7800 3.6812 0.0 0 CFG=2
M  V30 20 C 10.7800 6.3486 0.0 0
M  V30 21 C 13.0563 4.6947 0.0 0
M  V30 22 C 9.2400 3.6812 0.0 0 CFG=1
M  V30 23 C 11.8104 2.5368 0.0 0 CFG=2
M  V30 24 C 9.2400 6.3486 0.0 0
M  V30 25 C 13.2172 3.1632 0.0 0
M  V30 26 C 8.4700 5.0149 0.0 0 CFG=1
M  V30 27 C 8.4700 2.3476 0.0 0
M  V30 28 C 6.9300 5.0149 0.0 0 CFG=1
M  V30 29 C 6.9300 2.3476 0.0 0
M  V30 30 C 6.1600 3.6812 0.0 0 CFG=1
M  V30 31 C 6.1600 6.3486 0.0 0
M  V30 32 C 4.6200 3.6812 0.0 0 CFG=2
M  V30 33 C 4.6200 6.3486 0.0 0
M  V30 34 C 3.8500 5.0149 0.0 0 CFG=2
M  V30 35 C 3.8500 2.3476 0.0 0
M  V30 36 C 2.3100 5.0149 0.0 0
M  V30 37 C 2.3100 2.3476 0.0 0
M  V30 38 C 1.5400 3.6812 0.0 0 CFG=1
M  V30 39 N 13.9867 6.0998 0.0 0
M  V30 40 C 14.8918 7.3458 0.0 0
M  V30 41 C 14.6131 4.6930 0.0 0
M  V30 42 C 16.4235 7.1847 0.0 0
M  V30 43 C 16.1446 4.5321 0.0 0
M  V30 44 C 17.0498 5.7779 0.0 0
M  V30 45 H 10.5390 2.1602 0.0 0
M  V30 46 H 9.6386 2.1937 0.0 0
M  V30 47 H 6.0257 2.1471 0.0 0
M  V30 48 H 3.0800 6.3486 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 18 1 CFG=3
M  V30 3 1 1 39
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 23 3 CFG=1
M  V30 7 1 26 6 CFG=1
M  V30 8 1 28 7 CFG=3
M  V30 9 1 8 9
M  V30 10 1 8 44
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 32 14 CFG=3
M  V30 16 1 15 36
M  V30 17 1 16 36
M  V30 18 1 38 17 CFG=3
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 21
M  V30 22 1 19 22
M  V30 23 1 19 23
M  V30 24 1 19 45 CFG=1
M  V30 25 1 20 24
M  V30 26 1 21 25
M  V30 27 1 22 26
M  V30 28 1 22 27
M  V30 29 1 22 46 CFG=3
M  V30 30 1 23 25
M  V30 31 1 24 26
M  V30 32 1 26 28
M  V30 33 1 27 29
M  V30 34 1 28 30
M  V30 35 1 28 31
M  V30 36 1 29 30
M  V30 37 1 30 32
M  V30 38 1 30 47 CFG=1
M  V30 39 1 31 33
M  V30 40 1 32 34
M  V30 41 1 32 35
M  V30 42 1 33 34
M  V30 43 1 34 36
M  V30 44 1 34 48 CFG=1
M  V30 45 1 35 37
M  V30 46 1 36 38
M  V30 47 1 37 38
M  V30 48 1 39 40
M  V30 49 1 39 41
M  V30 50 1 40 42
M  V30 51 1 41 43
M  V30 52 1 42 44
M  V30 53 1 43 44
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 18 19 22 23 26 28 30 32 34 38)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-[(3β)-3-Hydroxy-28-oxolup-20(29)-en-28-yl]-N-methyl-4-piperidinebutanamide
C40H66N2O3
1155394-77-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 54 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 12.4551 6.2609 0.0 0
M  V30 2 O 11.8287 7.6677 0.0 0
M  V30 3 C 11.4902 1.0304 0.0 0
M  V30 4 C 12.6346 0.0000 0.0 0
M  V30 5 C 10.0256 0.5546 0.0 0
M  V30 6 C 8.3357 6.5490 0.0 0
M  V30 7 C 7.0641 6.5490 0.0 0
M  V30 8 C 18.5813 5.6170 0.0 0
M  V30 9 C 19.4865 6.8629 0.0 0
M  V30 10 C 21.0181 6.7018 0.0 0
M  V30 11 C 21.9233 7.9478 0.0 0
M  V30 12 N 23.4550 7.7867 0.0 0
M  V30 13 O 21.2970 9.3546 0.0 0
M  V30 14 C 24.3600 9.0326 0.0 0
M  V30 15 C 4.7541 2.1471 0.0 0
M  V30 16 C 0.8629 5.5417 0.0 0
M  V30 17 C 2.5773 6.5316 0.0 0
M  V30 18 O 0.0000 3.6812 0.0 0
M  V30 19 C 11.5500 5.0149 0.0 0 CFG=1
M  V30 20 C 10.7800 3.6812 0.0 0 CFG=2
M  V30 21 C 10.7800 6.3486 0.0 0
M  V30 22 C 13.0563 4.6947 0.0 0
M  V30 23 C 9.2400 3.6812 0.0 0 CFG=1
M  V30 24 C 11.8104 2.5368 0.0 0 CFG=2
M  V30 25 C 9.2400 6.3486 0.0 0
M  V30 26 C 13.2172 3.1632 0.0 0
M  V30 27 C 8.4700 5.0149 0.0 0 CFG=1
M  V30 28 C 8.4700 2.3476 0.0 0
M  V30 29 C 6.9300 5.0149 0.0 0 CFG=1
M  V30 30 C 6.9300 2.3476 0.0 0
M  V30 31 C 6.1600 3.6812 0.0 0 CFG=1
M  V30 32 C 6.1600 6.3486 0.0 0
M  V30 33 C 4.6200 3.6812 0.0 0 CFG=2
M  V30 34 C 4.6200 6.3486 0.0 0
M  V30 35 C 3.8500 5.0149 0.0 0 CFG=2
M  V30 36 C 3.8500 2.3476 0.0 0
M  V30 37 C 2.3100 5.0149 0.0 0
M  V30 38 C 2.3100 2.3476 0.0 0
M  V30 39 C 1.5400 3.6812 0.0 0 CFG=1
M  V30 40 N 13.9867 6.0998 0.0 0
M  V30 41 C 14.6131 4.6930 0.0 0
M  V30 42 C 14.8920 7.3458 0.0 0
M  V30 43 C 16.1446 4.5321 0.0 0
M  V30 44 C 16.4235 7.1847 0.0 0
M  V30 45 C 17.0498 5.7779 0.0 0
M  V30 46 H 10.8068 2.1415 0.0 0
M  V30 47 H 9.3741 2.1471 0.0 0
M  V30 48 H 6.0257 2.1471 0.0 0
M  V30 49 H 3.0800 6.3486 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 19 1 CFG=3
M  V30 3 1 1 40
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 24 3 CFG=1
M  V30 7 1 27 6 CFG=1
M  V30 8 1 29 7 CFG=3
M  V30 9 1 8 9
M  V30 10 1 8 45
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 33 15 CFG=3
M  V30 17 1 16 37
M  V30 18 1 17 37
M  V30 19 1 39 18 CFG=3
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 22
M  V30 23 1 20 23
M  V30 24 1 20 24
M  V30 25 1 20 46 CFG=1
M  V30 26 1 21 25
M  V30 27 1 22 26
M  V30 28 1 23 27
M  V30 29 1 23 28
M  V30 30 1 23 47 CFG=3
M  V30 31 1 24 26
M  V30 32 1 25 27
M  V30 33 1 27 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 1 29 32
M  V30 37 1 30 31
M  V30 38 1 31 33
M  V30 39 1 31 48 CFG=1
M  V30 40 1 32 34
M  V30 41 1 33 35
M  V30 42 1 33 36
M  V30 43 1 34 35
M  V30 44 1 35 37
M  V30 45 1 35 49 CFG=1
M  V30 46 1 36 38
M  V30 47 1 37 39
M  V30 48 1 38 39
M  V30 49 1 40 41
M  V30 50 1 40 42
M  V30 51 1 41 43
M  V30 52 1 42 44
M  V30 53 1 43 45
M  V30 54 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 19 20 23 24 27 29 31 33 35 39)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1155394-73-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1155394-77-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2167199
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Synthesis of BA Derivatives 21 and 41-44. A
solution of 20 or 38 (1 equiv), EDCI (2 equiv), N-hydroxybenzotriazole
(HOBt, 1 equiv), Et3N (0.05 mL), and the appropriate amine (2 equiv) in
anhydrous CH2Cl2 (8 mL) was stirred at room temperature overnight until
the starting material was not observed by TLC. The solution was diluted
with CH2Cl2 (20 mL) and washed three times with brine and distilled
water. The organic layer was dried over anhydrous Na2SO4 and concentrated
to dryness under reduced pressure. The residue was chromatographed using
a silica gel column to yield pure target compounds.
N'-[N-[3β-Hydroxy-lup-20(29)-en-28-oyl]-4-piperidinebutanoyl]-aminomethane
(41): 46 mg (100% yield) starting from 50 mg of 38, off-white amorphous
powder. Mp 202-204°C. MS (ESI+) m/z: 623.5 (M+ + H) for C40H66N2O3. 1H
NMR (300 MHz, CDCl3): δ 5.44 (1H, br s, -CONHCH3), 4.69, 4.54 (1H each,
s, H-29), 3.58-3.54 (4H, m, 28-CON(CH2CH2)2CH-), 3.16 (1H, m, H-3), 2.95
(1H, m, H-19), 2.78 (3H, d, J = 4.8 Hz, -CONHCH3), 2.16 (2H, t, J = 7.5
Hz, -CH2CONHCH3), 1.66 (3H, s, H-30), 0.93 (6H, s, 2 × CH3), 0.92, 0.90,
0.79 (3H each, s, 3 × CH3). [α]D 25 -10.7° (c 0.19, MeOH).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anti-AIDS Agents. 78. Design, Synthesis, Metabolic Stability Assessment,
and Antiviral Evaluation of Novel Betulinic Acid Derivatives as Potent
Anti-Human Immunodeficiency Virus (HIV) Agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Qian, Keduo; Yu, Donglei; Chen, Chin-Ho; Huang, Li; Morris-Natschke,
Susan L.; Nitz, Theodore J.; Salzwedel, Karl; Reddick, Mary; Allaway,
Graham P.; Lee, Kuo-Hsiung
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2009), 52(10), 3248-3258

$RFMT $RIREG SCHEME70 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-fluoro-2-methyl-5-nitro-, methyl ester
C9H8FNO4
1163287-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 O 6.9300 2.6674 0.0 0
M  V30 3 O 6.9300 5.3347 0.0 0
M  V30 4 C 8.4700 2.6674 0.0 0
M  V30 5 C 4.6200 6.6685 0.0 0
M  V30 6 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 O 0.0000 1.3338 0.0 0
M  V30 9 F 0.0000 4.0011 0.0 0
M  V30 10 C 4.6200 4.0011 0.0 0
M  V30 11 C 3.8500 2.6674 0.0 0
M  V30 12 C 3.8500 5.3347 0.0 0
M  V30 13 C 2.3100 2.6674 0.0 0
M  V30 14 C 2.3100 5.3347 0.0 0
M  V30 15 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-methyl-4-(methylamino)-5-nitrobenzoate
C10H12N2O4
863885-79-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 2.3101 0.0 0
M  V30 2 C 0.0000 3.0801 0.0 0
M  V30 3 N 4.0012 0.7700 0.0 0 VAL=5
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 O 5.3348 0.0000 0.0 0
M  V30 6 C 4.0012 6.9302 0.0 0
M  V30 7 C 6.6685 5.3901 0.0 0
M  V30 8 O 8.0023 4.6201 0.0 0
M  V30 9 O 6.6685 6.9302 0.0 0
M  V30 10 C 9.3360 5.3901 0.0 0
M  V30 11 C 2.6675 3.0801 0.0 0
M  V30 12 C 4.0012 2.3101 0.0 0
M  V30 13 C 2.6675 4.6201 0.0 0
M  V30 14 C 5.3348 3.0801 0.0 0
M  V30 15 C 4.0012 5.3901 0.0 0
M  V30 16 C 5.3348 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 1 6 15
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 16
M  V30 10 1 8 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1163287-01-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 863885-79-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-18750500
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bisheterocyclic inhibitors of PAD4
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Devraj, Rajesh; Kumaravel, Gnanasambandam; Parker, Michael F.; Beaumont,
Edward; Bowles, Lee; Brombridge, Steve; Cooper, Sophie; Gadouleau, Elise;
Gleave, Laura; Kerry, Philip; Kotey, Adrian; Krulle, Thomas; Lecci,
Cristina; Loke, Pui; Meniconi, Mirco; Monck, Nat; North, Carl; Palfrey,
Jordan; Parrott, Shelley; Ridgill, Mark; Tye, Heather
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017100594 A1 2017-06-15

$RFMT $RIREG SCHEME71 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Hydroxybenzophenone
C13H10O2
117-99-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 O 4.0011 0.0000 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 C 2.6674 2.3100 0.0 0
M  V30 5 C 1.3336 1.5400 0.0 0
M  V30 6 C 2.6674 3.8500 0.0 0
M  V30 7 C 0.0000 2.3100 0.0 0
M  V30 8 C 1.3336 4.6200 0.0 0
M  V30 9 C 0.0000 3.8500 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 6.6685 1.5400 0.0 0
M  V30 12 C 5.3347 3.8500 0.0 0
M  V30 13 C 8.0021 2.3100 0.0 0
M  V30 14 C 6.6685 4.6200 0.0 0
M  V30 15 C 8.0021 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 1 10
M  V30 4 1 3 5
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(Methylimino)phenylmethyl]phenol
C14H13NO
855595-85-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 N 4.0011 0.7700 0.0 0
M  V30 3 C 5.3347 0.0000 0.0 0
M  V30 4 O 1.3336 0.7700 0.0 0
M  V30 5 C 2.6674 3.0800 0.0 0
M  V30 6 C 1.3336 2.3100 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 C 0.0000 3.0800 0.0 0
M  V30 9 C 1.3336 5.3900 0.0 0
M  V30 10 C 0.0000 4.6200 0.0 0
M  V30 11 C 5.3347 3.0800 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 6.6685 2.3100 0.0 0
M  V30 14 C 6.6685 5.3900 0.0 0
M  V30 15 C 8.0021 3.0800 0.0 0
M  V30 16 C 8.0021 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 1 11
M  V30 4 1 2 3
M  V30 5 1 4 6
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 117-99-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 855595-85-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-13168748
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Typical Procedure On one side of an H-tube,
the described ketone was added, and to the other side, aqueous amine
solution or neat amine was added. The tube was sealed immediately with a
rubber seal stopper, and the reaction was monitored by 1H NMR
spectrometry. The excess ammonia or amine gas was removed under reduced
pressure to give the corresponding imine.
2-[(Methylimino)(phenyl)methyl]phenol (3e) Employing the general method,
imine (3e) was prepared from ketone (1d) (50 mg, 0.25 mmol) and 40%
methylamine aq. solution (2 mL). After 48 h, the pale yellow solid ketone
was converted to a yellow oil (3e) with 100% conversion. The excess
methylamine was removed under reduced pressure to give the title compound
(3e) as a yellow oil (53 mg, 100%). 1H NMR (400 MHz, CDCl3) δ 3.16 (s,
3H), 7.20 (m, 2H), 7.51 (m, 3H), 6.62 (dt, J = 1.2, 7.6 Hz, 1H), 6.80
(dd, J = 1.7, 7.9 Hz, 1H), 6.98 (dd, J = 0.9, 7.8 Hz, 1H), 7.26 (dt, J =
1.7, 7.6 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 38.19, 117.04, 118.28,
119.74, 127.40, 128.83, 129.08, 131.33, 132.44, 133.64, 164.01, 175.58.
IR (neat) νmax 3054m, 2924m, 1610s, 1586s, 1498m, 1453m, 1310m, 1262m,
1149m, 1041m, 753s cm-1. Ms calc. (found) for C13H13N2O+ (M + H+): m/z
213.2 (213.3, 100%). HRMS calc. (found) for C13H13N2O+ (M + H+): m/z
213.1028 (213.1028).
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed H-tube used, 100% conversion
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Simplified Ketimine Preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Thienthong, Neeranat; Bergman, Ylva E.; Perlmutter, Patrick
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2009), 39(15), 2683-2693

$RFMT $RIREG SCHEME72 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclohexanepropanol, 4-(dimethylamino)-4-phenyl-, 1-methanesulfonate
C18H29NO3S
1187964-10-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0232 1.1798 0.0 0
M  V30 2 C 2.5065 0.9123 0.0 0
M  V30 3 C 5.0131 0.0000 0.0 0
M  V30 4 C 8.5510 4.9370 0.0 0
M  V30 5 C 9.8846 4.1670 0.0 0
M  V30 6 C 11.2183 4.9370 0.0 0
M  V30 7 O 12.5521 4.1670 0.0 0
M  V30 8 S 13.8858 4.9370 0.0 0 VAL=6
M  V30 9 C 14.6558 3.6032 0.0 0
M  V30 10 O 15.2194 5.7070 0.0 0
M  V30 11 O 13.1158 6.2707 0.0 0
M  V30 12 C 4.5498 2.6270 0.0 0
M  V30 13 C 5.8835 1.8570 0.0 0
M  V30 14 C 4.5498 4.1670 0.0 0
M  V30 15 C 7.2173 2.6270 0.0 0
M  V30 16 C 5.8835 4.9370 0.0 0
M  V30 17 C 7.2173 4.1670 0.0 0
M  V30 18 C 3.0332 2.8943 0.0 0
M  V30 19 C 2.5065 4.3415 0.0 0
M  V30 20 C 2.0433 1.7147 0.0 0
M  V30 21 C 0.9899 4.6088 0.0 0
M  V30 22 C 0.5267 1.9820 0.0 0
M  V30 23 C 0.0000 3.4292 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 4 5
M  V30 5 1 4 17
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 2 8 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 18
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Dimethylamino)-N-methyl-4-phenylcyclohexanepropanamine
C18H30N2
1187964-11-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0231 1.1798 0.0 0
M  V30 2 C 2.5065 0.9123 0.0 0
M  V30 3 C 5.0130 0.0000 0.0 0
M  V30 4 C 8.5508 4.9369 0.0 0
M  V30 5 C 9.8845 4.1669 0.0 0
M  V30 6 C 11.2183 4.9369 0.0 0
M  V30 7 N 12.5519 4.1669 0.0 0
M  V30 8 C 13.8856 4.9369 0.0 0
M  V30 9 C 4.5498 2.6269 0.0 0
M  V30 10 C 5.8834 1.8569 0.0 0
M  V30 11 C 4.5498 4.1669 0.0 0
M  V30 12 C 7.2172 2.6269 0.0 0
M  V30 13 C 5.8834 4.9369 0.0 0
M  V30 14 C 7.2172 4.1669 0.0 0
M  V30 15 C 3.0332 2.8943 0.0 0
M  V30 16 C 2.5065 4.3414 0.0 0
M  V30 17 C 2.0433 1.7146 0.0 0
M  V30 18 C 0.9899 4.6089 0.0 0
M  V30 19 C 0.5267 1.9820 0.0 0
M  V30 20 C 0.0000 3.4291 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 15
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1187964-10-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1187964-11-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-10886420
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Stage (ix): 3-(4-Dimethylamino)-4-phenylcyclohexyl)propyl
methanesulfonate (1 eq.) and methylamine solution (3 mol/l, 2 eq. in
tetrahydrofuran) were heated at 70 °C in a closed vessel for 16 h. The
reaction mixture was concentrated in vacuo and the crude product was
employed in the next stage without further purification. Yield:
quantitative.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituted sulfonamide derivatives as bradykinin 1 receptor and μ opioid
receptor inhibitors and their preparation and use in the treatment of
diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Oberboersch, Stefan; Reich, Melanie; Sundermann, Bernd; Englberger,
Werner; Hees, Sabine; Jostock, Ruth; Schunk, Stefan; Bijsterveld, Edward;
Theil, Fritz
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009115257 A1 2009-09-24

$RFMT $RIREG SCHEME73 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-[5-O-[bis(4-methoxyphenyl)phenylmethyl]-β-D-ribofuranosyl]-3,4-dihyd...
C34H36N2O10
1188522-42-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 50 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 6.9300 0.0 0
M  V30 2 O 8.4700 6.9300 0.0 0
M  V30 3 C 9.2400 8.2636 0.0 0
M  V30 4 O 6.9300 0.7700 0.0 0
M  V30 5 C 5.5962 0.0000 0.0 0
M  V30 6 O 0.7700 6.9300 0.0 0
M  V30 7 C 0.0000 8.2636 0.0 0
M  V30 8 O 11.2092 5.5532 0.0 0
M  V30 9 O 14.3956 6.5886 0.0 0
M  V30 10 O 12.8277 12.0969 0.0 0
M  V30 11 C 18.4552 9.5913 0.0 0
M  V30 12 C 19.7011 10.4965 0.0 0
M  V30 13 C 21.1080 9.8702 0.0 0
M  V30 14 O 22.3539 10.7754 0.0 0
M  V30 15 O 21.2689 8.3386 0.0 0
M  V30 16 C 23.7607 10.1489 0.0 0
M  V30 17 O 18.1333 12.6545 0.0 0
M  V30 18 C 6.9300 5.3900 0.0 0
M  V30 19 C 5.5962 4.6200 0.0 0
M  V30 20 C 8.2636 4.6200 0.0 0
M  V30 21 C 5.5962 3.0800 0.0 0
M  V30 22 C 8.2636 3.0800 0.0 0
M  V30 23 C 6.9300 2.3100 0.0 0
M  V30 24 C 5.3900 6.9300 0.0 0
M  V30 25 C 4.6200 5.5964 0.0 0
M  V30 26 C 4.6200 8.2636 0.0 0
M  V30 27 C 3.0800 5.5964 0.0 0
M  V30 28 C 3.0800 8.2636 0.0 0
M  V30 29 C 2.3100 6.9300 0.0 0
M  V30 30 C 6.9300 8.4700 0.0 0
M  V30 31 C 8.2636 9.2400 0.0 0
M  V30 32 C 5.5962 9.2400 0.0 0
M  V30 33 C 8.2636 10.7800 0.0 0
M  V30 34 C 5.5962 10.7800 0.0 0
M  V30 35 C 6.9300 11.5500 0.0 0
M  V30 36 C 10.7800 8.2636 0.0 0 CFG=2
M  V30 37 O 11.6851 9.5097 0.0 0
M  V30 38 C 11.6851 7.0178 0.0 0 CFG=1
M  V30 39 C 13.1498 9.0336 0.0 0 CFG=1
M  V30 40 C 13.1498 7.4936 0.0 0 CFG=1
M  V30 41 C 14.3956 9.9389 0.0 0
M  V30 42 C 15.8026 9.3125 0.0 0
M  V30 43 C 14.2347 11.4704 0.0 0
M  V30 44 N 17.0484 10.2177 0.0 0
M  V30 45 N 15.4805 12.3756 0.0 0
M  V30 46 C 16.8873 11.7493 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 1 24
M  V30 4 1 1 30
M  V30 5 1 2 3
M  V30 6 1 36 3 CFG=1
M  V30 7 1 4 5
M  V30 8 1 4 23
M  V30 9 1 6 7
M  V30 10 1 6 29
M  V30 11 1 38 8 CFG=3
M  V30 12 1 40 9 CFG=3
M  V30 13 2 10 43
M  V30 14 1 11 12
M  V30 15 1 11 44
M  V30 16 1 12 13
M  V30 17 1 13 14
M  V30 18 2 13 15
M  V30 19 1 14 16
M  V30 20 2 17 46
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 39 1 36 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 1 38 40
M  V30 43 1 39 40
M  V30 44 1 39 41 CFG=1
M  V30 45 2 41 42
M  V30 46 1 41 43
M  V30 47 1 42 44
M  V30 48 1 43 45
M  V30 49 1 44 46
M  V30 50 1 45 46
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 36 38 39 40)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
5-[5-O-[Bis(4-methoxyphenyl)phenylmethyl]-β-D-ribofuranosyl]-3,4-dihydro-N-me...
C34H37N3O9
1188522-43-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 50 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 6.9300 0.0 0
M  V30 2 O 8.4700 6.9300 0.0 0
M  V30 3 C 9.2400 8.2636 0.0 0
M  V30 4 O 6.9300 0.7700 0.0 0
M  V30 5 C 5.5962 0.0000 0.0 0
M  V30 6 O 0.7700 6.9300 0.0 0
M  V30 7 C 0.0000 8.2636 0.0 0
M  V30 8 O 11.2092 5.5532 0.0 0
M  V30 9 O 14.3956 6.5886 0.0 0
M  V30 10 O 12.8277 12.0969 0.0 0
M  V30 11 C 18.4552 9.5913 0.0 0
M  V30 12 C 19.7011 10.4965 0.0 0
M  V30 13 C 21.1080 9.8702 0.0 0
M  V30 14 N 22.3539 10.7754 0.0 0
M  V30 15 O 21.2689 8.3386 0.0 0
M  V30 16 C 23.7607 10.1489 0.0 0
M  V30 17 O 18.1333 12.6545 0.0 0
M  V30 18 C 6.9300 5.3900 0.0 0
M  V30 19 C 5.5962 4.6200 0.0 0
M  V30 20 C 8.2636 4.6200 0.0 0
M  V30 21 C 5.5962 3.0800 0.0 0
M  V30 22 C 8.2636 3.0800 0.0 0
M  V30 23 C 6.9300 2.3100 0.0 0
M  V30 24 C 5.3900 6.9300 0.0 0
M  V30 25 C 4.6200 5.5964 0.0 0
M  V30 26 C 4.6200 8.2636 0.0 0
M  V30 27 C 3.0800 5.5964 0.0 0
M  V30 28 C 3.0800 8.2636 0.0 0
M  V30 29 C 2.3100 6.9300 0.0 0
M  V30 30 C 6.9300 8.4700 0.0 0
M  V30 31 C 8.2636 9.2400 0.0 0
M  V30 32 C 5.5962 9.2400 0.0 0
M  V30 33 C 8.2636 10.7800 0.0 0
M  V30 34 C 5.5962 10.7800 0.0 0
M  V30 35 C 6.9300 11.5500 0.0 0
M  V30 36 C 10.7800 8.2636 0.0 0 CFG=2
M  V30 37 O 11.6851 9.5097 0.0 0
M  V30 38 C 11.6851 7.0178 0.0 0 CFG=1
M  V30 39 C 13.1498 9.0336 0.0 0 CFG=1
M  V30 40 C 13.1498 7.4936 0.0 0 CFG=1
M  V30 41 C 14.3956 9.9389 0.0 0
M  V30 42 C 15.8026 9.3125 0.0 0
M  V30 43 C 14.2347 11.4704 0.0 0
M  V30 44 N 17.0484 10.2177 0.0 0
M  V30 45 N 15.4805 12.3756 0.0 0
M  V30 46 C 16.8873 11.7493 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 1 24
M  V30 4 1 1 30
M  V30 5 1 2 3
M  V30 6 1 36 3 CFG=1
M  V30 7 1 4 5
M  V30 8 1 4 23
M  V30 9 1 6 7
M  V30 10 1 6 29
M  V30 11 1 38 8 CFG=3
M  V30 12 1 40 9 CFG=3
M  V30 13 2 10 43
M  V30 14 1 11 12
M  V30 15 1 11 44
M  V30 16 1 12 13
M  V30 17 1 13 14
M  V30 18 2 13 15
M  V30 19 1 14 16
M  V30 20 2 17 46
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 39 1 36 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 1 38 40
M  V30 43 1 39 40
M  V30 44 1 39 41 CFG=1
M  V30 45 2 41 42
M  V30 46 1 41 43
M  V30 47 1 42 44
M  V30 48 1 43 45
M  V30 49 1 44 46
M  V30 50 1 45 46
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 36 38 39 40)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1188522-42-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1188522-43-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8125367
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM A solution of methylamine in EtOH (33%) was added to compound C (9.98 g,
15.77 mmol) and the mixture was stirred at room temperature overnight.
All solvent was removed and dried in vacuo to give compound D
quantitatively (9.96 g, 15.77 mmol, developed with 10% MeOH in CH2Cl2).
Rf = 0.45, 1H NMR (MeOH-d 4, 400 MHz) δ 7.52 (s, 1 H), 7.43-7.45 (m, 2
H), 7.15-7.33 (m, 7 H), 6.82-6.84 (m, 4 H), 4.68 (d, J = 2.8 Hz, 1 H),
4.09-4.15 (m, 2 H), 4.00-4.01 (m, 1 H), 3.75-3.77 (m, 1 H), 3.73 (s, 6
H), 3.55-3.60 (m, 2 H), 3.43-3.50 (m, 1 H), 2.59 (s, 3 H), 2.37 (t, J =
6.4 Hz, 2 H). 13C NMR (MeOH-d 4, 100 MHz) δ 172.8, 165.3, 160.2, 152.5,
146.5, 144.7, 137.4, 137.2, 131.5, 131.4, 129.5, 128.9, 127.9, 114.2,
113.7, 87.5, 83.3, 81.1, 75.9, 72.6, 64.8, 58.4, 55.8, 46.8, 35.4, 26.4,
18.4. Molecular weight for C34H37N3NaO9 (M+Na)+ Calc. 654.24, Found
654.4.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Non-natural ribonucleosides with modified ribose and base moieties for
use use in siRNAs and their synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Manoharan, Muthiah; Rajeev, Kallanthottathil G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009120878 A2 2009-10-01

$RFMT $RIREG SCHEME74 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2′-Hydroxyacetophenone
C8H8O2
118-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 C 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 O 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[1-(Methylimino)ethyl]phenol
C9H11NO
875-54-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 C 5.3901 1.3337 0.0 0
M  V30 4 C 6.9302 4.0010 0.0 0
M  V30 5 O 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 2.3101 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 118-93-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 875-54-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-20694728
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Protective groups and methods for protecting benzoxaboroles or oxaboroles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tomsho, John W.; Gamrat, James M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019173814 A1 2019-09-12

$RFMT $RIREG SCHEME74 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2′-Hydroxyacetophenone
C8H8O2
118-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 C 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 O 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[1-(Methylimino)ethyl]phenol
C9H11NO
875-54-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 C 5.3901 1.3337 0.0 0
M  V30 4 C 6.9302 4.0010 0.0 0
M  V30 5 O 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 2.3101 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 118-93-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 875-54-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-18849732
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Protection of the Benzoxaborole Moiety: Synthesis and Functionalization
of Zwitterionic Benzoxaborole Complexes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gamrat, James M.; Mancini, Giulia; Burke, Sarah J.; Colandrea, Rebecca
C.; Sadowski, Nicholas R.; Figula, Bryan C.; Tomsho, John W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2018), 83(11), 6193-6201

$RFMT $RIREG SCHEME74 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2′-Hydroxyacetophenone
C8H8O2
118-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 C 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 O 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[1-(Methylimino)ethyl]phenol
C9H11NO
875-54-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 C 5.3901 1.3337 0.0 0
M  V30 4 C 6.9302 4.0010 0.0 0
M  V30 5 O 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 2.3101 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 118-93-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 875-54-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-15306099
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Typical Procedure On one side of an H-tube,
the described ketone was added, and to the other side, aqueous amine
solution or neat amine was added. The tube was sealed immediately with a
rubber seal stopper, and the reaction was monitored by 1H NMR
spectrometry. The excess ammonia or amine gas was removed under reduced
pressure to give the corresponding imine. 2-[1-(Methylimino)ethyl)phenol]
(3g) Employing the general method, imine (3g) was prepared from ketone
(1f) (200 mL, 0.17 mmol) and 40% methylamine aq. solution (2 mL). The
colorless liquid ketone was converted to a yellow liquid of imine (3g)
within 35 min with 33% conversion. After 20 h, the yellow liquid
solidified to a yellow solid corresponding to 3g with 100% conversion.
The excess methylamine was removed under reduced pressure to give the
title compound (3g) as a yellow solid (25 mg, 100%). Mp 68-69°C. 1H NMR
(400 MHz, CDCl3) δ 2.33 (s, 3H), 3.33 (s, 3H) 6.73 (dt, J = 1.2, 7.6 Hz,
1H), 6.92 (d, J = 8.3 Hz, 1H), 7.27 (dt, J = 8.3 Hz, 1H), 7.49 (dd, J =
1.5, 8.0 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 14.05, 35.85, 116.84,
119.26, 119.56, 128.21, 132.95, 165.45, 173.48. IR (neat) νmax 3368w,
1617s, 1503m, 1453m, 1317m, 1010m, 767m cm-1. Ms calc. (found) for
C9H12NO+ (M + H+): m/z 150.1 (244, 100%). HRMS calc. (found) for C9H12NO+
(M + H+): m/z 150.0919 (150.1510).
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed H-tube used, 100% conversion
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Simplified Ketimine Preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Thienthong, Neeranat; Bergman, Ylva E.; Perlmutter, Patrick
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2009), 39(15), 2683-2693

$RFMT $RIREG SCHEME75 STEP1
$RXN



  3  1
$MOL
Thiophosgene
CCl2S
463-71-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 Cl 0.0000 2.3101 0.0 0
M  V30 3 Cl 2.6673 2.3101 0.0 0
M  V30 4 S 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,7-Dimethyl-1H-indol-4-amine
C10H12N2
1190320-92-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.7035 6.1600 0.0 0
M  V30 2 C 3.7035 0.0000 0.0 0
M  V30 3 C 6.3710 4.6200 0.0 0
M  V30 4 C 2.3699 3.8500 0.0 0
M  V30 5 C 2.3699 2.3100 0.0 0
M  V30 6 C 3.7035 4.6200 0.0 0
M  V30 7 C 0.9052 4.3259 0.0 0
M  V30 8 C 3.7035 1.5400 0.0 0
M  V30 9 N 0.9052 1.8341 0.0 0
M  V30 10 C 5.0372 3.8500 0.0 0
M  V30 11 C 0.0000 3.0800 0.0 0
M  V30 12 C 5.0372 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 8
M  V30 3 1 3 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(5,7-Dimethyl-1H-indol-4-yl)-N′-methylthiourea
C12H15N3S
2556942-08-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.6672 0.0 0
M  V30 2 C 6.6685 2.4373 0.0 0
M  V30 3 N 8.0023 1.6672 0.0 0
M  V30 4 S 6.6685 3.9773 0.0 0
M  V30 5 C 9.3360 2.4373 0.0 0
M  V30 6 C 5.3348 4.7473 0.0 0
M  V30 7 C 0.0000 4.7473 0.0 0
M  V30 8 C 2.6675 1.6672 0.0 0
M  V30 9 C 4.0012 2.4373 0.0 0
M  V30 10 C 1.3337 2.4373 0.0 0
M  V30 11 C 2.3473 0.1609 0.0 0
M  V30 12 C 4.0012 3.9773 0.0 0
M  V30 13 C 1.3337 3.9773 0.0 0
M  V30 14 N 0.1893 1.4068 0.0 0
M  V30 15 C 0.8156 0.0000 0.0 0
M  V30 16 C 2.6675 4.7473 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 12
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 16
M  V30 17 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 463-71-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1190320-92-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2556942-08-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31072200
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions also shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of
4-((2S,4S)-4-Ethoxy-1-((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl)benzoic
Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be
Applicable to Treating a Diverse Array of Complement Mediated Diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mainolfi, Nello; Ehara, Takeru; Karki, Rajeshri G.; Anderson, Karen;
MacSweeney, Aengus; Liao, Sha-Mei; Argikar, Upendra A.; Jendza, Keith;
Zhang, Chun; Powers, James; Klosowski, Daniel W.; Crowley, Maura;
Kawanami, Toshio; Ding, Jian; April, Myriam; Forster, Cornelia;
Serrano-Wu, Michael; Capparelli, Michael; Ramqaj, Rrezarta; Solovay,
Catherine; Cumin, Frederic; Smith, Thomas M.; Ferrara, Luciana; Lee,
Wendy; Long, Debby; Prentiss, Melissa; De Erkenez, Andrea; Yang, Louis;
Liu, Fang; Sellner, Holger; Sirockin, Finton; Valeur, Eric; Erbel,
Paulus; Ostermeier, Daniela; Ramage, Paul; Gerhartz, Bernd; Schubart,
Anna; Flohr, Stefanie; Gradoux, Nathalie; Feifel, Roland; Vogg, Barbara;
Wiesmann, Christian; Maibaum, Jurgen; Eder, Jorg; Sedrani, Richard;
Harrison, Richard A.; Mogi, Muneto; Jaffee, Bruce D.; Adams, Christopher
M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(11), 5697-5722

$RFMT $RIREG SCHEME76 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl salicylate
C8H8O3
119-36-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 O 5.3901 1.3337 0.0 0
M  V30 4 C 6.9302 4.0010 0.0 0
M  V30 5 O 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 2.3101 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Hydroxy-N-methylbenzamide
C8H9NO2
1862-88-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 O 5.3901 1.3337 0.0 0
M  V30 4 C 6.9302 4.0010 0.0 0
M  V30 5 O 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 2.3101 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 119-36-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1862-88-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-23518953
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asymmetric Hydrogenation of Cationic Intermediates for the Synthesis of
Chiral N,O-Acetals
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sun, Yongjie; Zhao, Qingyang; Wang, Heng; Yang, Tilong; Wen, Jialin;
Zhang, Xumu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2020), 26(50), 11470-11477

$RFMT $RIREG SCHEME77 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-[5-(2-Chloro-4-pyrimidinyl)-2-(1-methylethyl)-4-thiazolyl]phenyl]-3-fluo...
C22H18ClFN4O2S2
1195769-09-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6829 1.2459 0.0 0
M  V30 2 C 3.5881 0.0000 0.0 0
M  V30 3 C 1.1513 1.0850 0.0 0
M  V30 4 N 10.3115 4.5046 0.0 0
M  V30 5 S 11.6453 5.2746 0.0 0 VAL=6
M  V30 6 O 10.8753 6.6083 0.0 0
M  V30 7 O 12.4153 3.9409 0.0 0
M  V30 8 Cl 0.0000 9.0956 0.0 0
M  V30 9 F 16.9801 5.2746 0.0 0
M  V30 10 C 4.9766 4.5046 0.0 0
M  V30 11 C 3.5698 5.1309 0.0 0
M  V30 12 N 4.8157 2.9730 0.0 0
M  V30 13 S 2.5394 3.9865 0.0 0
M  V30 14 C 3.3094 2.6529 0.0 0
M  V30 15 C 6.3104 5.2746 0.0 0
M  V30 16 C 7.6441 4.5046 0.0 0
M  V30 17 C 6.3104 6.8146 0.0 0
M  V30 18 C 8.9778 5.2746 0.0 0
M  V30 19 C 7.6441 7.5847 0.0 0
M  V30 20 C 8.9778 6.8146 0.0 0
M  V30 21 C 3.2496 6.6374 0.0 0
M  V30 22 N 1.7849 7.1133 0.0 0
M  V30 23 C 4.3940 7.6678 0.0 0
M  V30 24 C 1.4647 8.6197 0.0 0
M  V30 25 C 4.0739 9.1743 0.0 0
M  V30 26 N 2.6091 9.6502 0.0 0
M  V30 27 C 12.9789 6.0446 0.0 0
M  V30 28 C 14.3126 5.2746 0.0 0
M  V30 29 C 12.9789 7.5847 0.0 0
M  V30 30 C 15.6463 6.0446 0.0 0
M  V30 31 C 14.3126 8.3547 0.0 0
M  V30 32 C 15.6463 7.5847 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 4 5
M  V30 5 1 4 18
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 27
M  V30 9 1 8 24
M  V30 10 1 9 30
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 10 15
M  V30 14 1 11 13
M  V30 15 1 11 21
M  V30 16 2 12 14
M  V30 17 1 13 14
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-N-[3-[5-[2-(methylamino)-4-pyrimidinyl]-2-(1-methylethyl)-4-thiazoly...
C23H22FN5O2S2
1195765-73-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.3672 0.9052 0.0 0
M  V30 2 C 11.6130 0.0000 0.0 0
M  V30 3 C 8.9602 0.2789 0.0 0
M  V30 4 N 5.3900 7.5416 0.0 0
M  V30 5 S 4.6200 8.8752 0.0 0 VAL=6
M  V30 6 O 5.9537 9.6452 0.0 0
M  V30 7 O 3.2864 8.1052 0.0 0
M  V30 8 N 16.6153 6.3618 0.0 0
M  V30 9 C 17.6457 7.5061 0.0 0
M  V30 10 F 0.0000 11.5425 0.0 0
M  V30 11 C 10.0100 4.8741 0.0 0
M  V30 12 C 11.5416 4.7132 0.0 0
M  V30 13 N 9.3837 3.4673 0.0 0
M  V30 14 S 11.8617 3.2068 0.0 0
M  V30 15 C 10.5281 2.4367 0.0 0
M  V30 16 C 9.2400 6.2078 0.0 0
M  V30 17 C 7.7000 6.2078 0.0 0
M  V30 18 C 10.0100 7.5416 0.0 0
M  V30 19 C 6.9300 7.5416 0.0 0
M  V30 20 C 9.2400 8.8752 0.0 0
M  V30 21 C 7.7000 8.8752 0.0 0
M  V30 22 C 12.5720 5.8576 0.0 0
M  V30 23 N 14.0784 5.5374 0.0 0
M  V30 24 C 12.0961 7.3223 0.0 0
M  V30 25 C 15.1088 6.6819 0.0 0
M  V30 26 C 13.1267 8.4666 0.0 0
M  V30 27 N 14.6330 8.1465 0.0 0
M  V30 28 C 3.8500 10.2088 0.0 0
M  V30 29 C 2.3100 10.2088 0.0 0
M  V30 30 C 4.6200 11.5425 0.0 0
M  V30 31 C 1.5400 11.5425 0.0 0
M  V30 32 C 3.8500 12.8763 0.0 0
M  V30 33 C 2.3100 12.8763 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 15
M  V30 4 1 4 5
M  V30 5 1 4 19
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 28
M  V30 9 1 8 9
M  V30 10 1 8 25
M  V30 11 1 10 31
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 11 16
M  V30 15 1 12 14
M  V30 16 1 12 22
M  V30 17 2 13 15
M  V30 18 1 14 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1195769-09-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1195765-73-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-5665150
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-36-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 1:
2,6-Difluoro-N-{3-[2-(1-methylethyl)-5-(2-{[2-(methylsulfonyl)ethyl]amino}-4-pyrimidinyl)-1,3-thiazol-4-yl]phenyl}benzenesulfonamide.
A neat mixture of
N-{3-[5-(2-chloro-4-pyrimidinyl)-2-(1-methylethyl)-1,3-thiazol-4-yl]phenyl}-2,6-difluorobenzenesulfonamide
(0.15 g, 0.30 mmol) and 2-aminoethyl-methyl-sulfone (0.20 g, 1.62 mmol)
was heated at 60°C overnight. The reaction mixture was diluted with 1M
HCl and extracted with DCM twice. The organic layer was dried over MgSO4
and evaporated onto silica gel. Purification by ISCO chromatography (0 to
40% 1:9 MeOH:EtOAC in DCM).
3-Fluoro-N-{3-[5-[2-(methylamino)-4-pyrimidinyl]-2-(1-methylethyl)-1,3-thiazol-4-yl]phenyl}benzenesulfonamide.
Following a procedure analogous to the procedure described in Example 1
using
N-{3-[5-(2-chloro-4-pyrimidinyl)-2-(1-methylethyl)-1,3-thiazol-4-yl]phenyl}-3-fluorobenzenesulfonamide
(100 mg, 0.20 mmol), methylamine (2.0 M in THF, 2.0 mL, 4.0 mmol) and
K2CO3 (283 mg, 2.0 mmol) in 1-butanol (5 mL) the title compound was
obtained as a white powder (100 mg, 0.21 mmol, 100% yield). 1H NMR (400
MHz, DMSO-d6): δ 10.51 (s, 1H), 8.02 (d, J=5.1 Hz, 1H), 7.57-7.65 (m,
2H), 7.48-7.53 (m, 2H), 7.33 (t, J=7.8 Hz, 1H), 7.19-7.22 (m, 4H), 6.04
(s, 1H), 3.23-3.30 (m, 1H), 2.76 (s, 3H), 1.36 (d, J=6.7 Hz, 6H); m/z
(ESI): 485.3 [M + H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzenesulfonamidethiazole derivatives and analogs for use
as B-Raf protein kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Adams, Jerry Leroy; Dickerson, Scott Howard; Johnson, Neil W.; Kuntz,
Kevin; Petrov, Kimberly; Ralph, Jeffrey M.; Rheault, Tara Renae; Schaaf,
Gregory; Stellwagen, John; Tian, Xinrong; Uehling, David Edward;
Waterson, Alex Gregory; Wilson, Brian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009137391 A2 2009-11-12

$RFMT $RIREG SCHEME78 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-6-carboxaldehyde
C9H7NO
1196-70-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 O 7.7047 2.3100 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 2.3699 0.7700 0.0 0
M  V30 5 C 3.7036 3.0800 0.0 0
M  V30 6 N 0.9052 2.7859 0.0 0
M  V30 7 C 3.7036 0.0000 0.0 0
M  V30 8 C 0.9052 0.2941 0.0 0
M  V30 9 C 5.0372 2.3100 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1H-indole-6-methanamine
C10H12N2
3468-21-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 N 7.7047 2.3100 0.0 0
M  V30 3 C 9.0383 3.0800 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 C 2.3699 0.7700 0.0 0
M  V30 6 C 3.7036 3.0800 0.0 0
M  V30 7 N 0.9052 2.7859 0.0 0
M  V30 8 C 3.7036 0.0000 0.0 0
M  V30 9 C 0.9052 0.2941 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1196-70-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3468-21-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-8668424
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM c) (1H-Indol-6-ylmethyl)methylamine [0872] Indole-6-carboxaldehyde (90
mg, 0.62 mmol) was dissolved in anhydrous methanol (3 mL). Methylamine
(0.95 mL of 2M solution in methanol, 1.86 mmol) was added and the
reaction was stirred for 3 hr. The solution was concentrated to a yellow
oil and then dissolved into anhydrous methanol (3 mL). Sodium borohydride
(24 mg, 0.62 mmol) was added and the mixture was stirred overnight. Water
(1 mL) was added and the solution was concentrated. Sodium hydroxide (2
mL, 1N) was added and the indole was extracted with ethyl acetate (3×10
mL), dried over MgSO4 and concentrated to afford the title compound as a
yellow oil (98 mg, 100%). 1H NMR (300 MHz, CDCl3) δ 9.02 (s, 1H), 7.57(d,
J=8.1 Hz, 1H), 7.29 (s, 1H), 7.12 (d, J=3.1 Hz, 1H), 7.04 (d, J=8.1 Hz,
1H), 6.49 (d, J=2.7 Hz, 1H), 3.81 (s, 2H), 2.50 (s, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME78 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-6-carboxaldehyde
C9H7NO
1196-70-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 O 7.7047 2.3100 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 2.3699 0.7700 0.0 0
M  V30 5 C 3.7036 3.0800 0.0 0
M  V30 6 N 0.9052 2.7859 0.0 0
M  V30 7 C 3.7036 0.0000 0.0 0
M  V30 8 C 0.9052 0.2941 0.0 0
M  V30 9 C 5.0372 2.3100 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1H-indole-6-methanamine
C10H12N2
3468-21-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 N 7.7047 2.3100 0.0 0
M  V30 3 C 9.0383 3.0800 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 C 2.3699 0.7700 0.0 0
M  V30 6 C 3.7036 3.0800 0.0 0
M  V30 7 N 0.9052 2.7859 0.0 0
M  V30 8 C 3.7036 0.0000 0.0 0
M  V30 9 C 0.9052 0.2941 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1196-70-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3468-21-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-7715872
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME78 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-6-carboxaldehyde
C9H7NO
1196-70-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 O 7.7047 2.3100 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 2.3699 0.7700 0.0 0
M  V30 5 C 3.7036 3.0800 0.0 0
M  V30 6 N 0.9052 2.7859 0.0 0
M  V30 7 C 3.7036 0.0000 0.0 0
M  V30 8 C 0.9052 0.2941 0.0 0
M  V30 9 C 5.0372 2.3100 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1H-indole-6-methanamine
C10H12N2
3468-21-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 N 7.7047 2.3100 0.0 0
M  V30 3 C 9.0383 3.0800 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 C 2.3699 0.7700 0.0 0
M  V30 6 C 3.7036 3.0800 0.0 0
M  V30 7 N 0.9052 2.7859 0.0 0
M  V30 8 C 3.7036 0.0000 0.0 0
M  V30 9 C 0.9052 0.2941 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1196-70-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3468-21-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-14371799
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM c) (1H-Indol-6-ylmethyl)methylamine Indole-6-carboxaldehyde (90 mg, 0.62
mmol) was dissolved in anhydrous methanol (3 mL). Methylamine (0.95 mL of
2M solution in methanol, 1.86 mmol) was added and the reaction was
stirred for 3 hr. The solution was concentrated to a yellow oil and then
dissolved into anhydrous methanol (3 mL). Sodium borohydride (24 mg, 0.62
mmol) was added and the mixture was stirred overnight. Water (1 mL) was
added and the solution was concentrated. Sodium hydroxide (2 mL, 1N) was
added and the indole was extracted with ethyl acetate (3 x 10 mL), dried
over MgSO4 and concentrated to afford the title compound as a yellow oil.
(1H-Indol-6-ylmethyl)methylamine, yield 98 mg, 100%. 1H NMR (300 MHz,
CDCl3) δ 9.02 (s, 1H), 7.57(d, J = 8.1 Hz, 1H), 7.29 (s, 1H), 7.12 ( d ,
J = 3.1 Hz, 1H), 7.04 (d, J = 8.1 Hz, 1H), 6.49 (d, J = 2.7 Hz, 1H), 3.81
(s, 2H), 2.50 (s, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds as antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd; Sampson, Peter; Pauls, Heinz W.; Ramnauth, Jailall;
Manning, David Douglas; Surman, Matthew David; Xie, Dejian; Decornez,
Helene Yvonne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004052890 A1 2004-06-24

$RFMT $RIREG SCHEME79 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Carboxybenzaldehyde
C8H6O3
119-67-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 1.3338 0.0 0
M  V30 2 O 6.1600 1.3338 0.0 0
M  V30 3 C 1.5400 1.3338 0.0 0
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(Methylamino)methyl]benzoic acid
C9H11NO2
527705-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 4.0011 0.0 0
M  V30 2 O 2.3100 5.3349 0.0 0
M  V30 3 O 0.0000 4.0011 0.0 0
M  V30 4 C 4.6200 4.0011 0.0 0
M  V30 5 N 6.1600 4.0011 0.0 0
M  V30 6 C 6.9300 5.3349 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 1.5400 1.3338 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 119-67-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 527705-23-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41927668
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalyst components for the polymerization of olefins
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mignogna, Alessandro; Brustolin, Leonardo; Morini, Giampiero
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024194125 A1 2024-09-26

$RFMT $RIREG SCHEME80 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenemethanol, 2-bromo-5-fluoro-, 1-methanesulfonate
C8H8BrFO3S
1198105-02-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6673 0.0 0
M  V30 2 O 5.3900 4.0009 0.0 0
M  V30 3 S 6.9300 4.0009 0.0 0 VAL=6
M  V30 4 C 6.9300 5.5409 0.0 0
M  V30 5 O 8.4700 4.0009 0.0 0
M  V30 6 O 6.9300 2.4609 0.0 0
M  V30 7 Br 3.0800 0.0000 0.0 0
M  V30 8 F 0.0000 5.3347 0.0 0
M  V30 9 C 3.0800 2.6673 0.0 0
M  V30 10 C 2.3100 1.3336 0.0 0
M  V30 11 C 2.3100 4.0009 0.0 0
M  V30 12 C 0.7700 1.3336 0.0 0
M  V30 13 C 0.7700 4.0009 0.0 0
M  V30 14 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 3 6
M  V30 7 1 7 10
M  V30 8 1 8 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-5-fluoro-N-methylbenzenemethanamine
C8H9BrFN
887139-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 N 5.3900 4.0011 0.0 0
M  V30 3 C 6.9300 4.0011 0.0 0
M  V30 4 Br 3.0800 0.0000 0.0 0
M  V30 5 F 0.0000 5.3349 0.0 0
M  V30 6 C 3.0800 2.6674 0.0 0
M  V30 7 C 2.3100 1.3338 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 0.7700 1.3338 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1198105-02-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 887139-05-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-15544093
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Intramolecular Homolytic Substitution of Sulfinates and Sulfinamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Coulomb, Julien; Certal, Victor; Larraufie, Marie-Helene; Ollivier,
Cyril; Corbet, Jean-Pierre; Mignani, Gerard; Fensterbank, Louis; Lacote,
Emmanuel; Malacria, Max
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2009), 15(39), 10225-10232,
S10225/1-S10225/62

$RFMT $RIREG SCHEME81 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-formyl-1-[4-[[4-(1-methylethyl)benzoyl]amino]butyl]-3-phenyl-1H-indo...
C31H32N2O4
1198593-06-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8308 3.5103 0.0 0
M  V30 2 O 6.5106 2.0040 0.0 0
M  V30 3 C 7.1810 6.8425 0.0 0
M  V30 4 C 8.5148 6.0725 0.0 0
M  V30 5 C 9.8484 6.8425 0.0 0
M  V30 6 C 11.1821 6.0725 0.0 0
M  V30 7 N 12.5157 6.8425 0.0 0
M  V30 8 C 13.8496 6.0725 0.0 0
M  V30 9 O 13.8496 4.5324 0.0 0
M  V30 10 C 1.9823 9.9482 0.0 0
M  V30 11 O 0.4759 10.2684 0.0 0
M  V30 12 O 3.0127 11.0928 0.0 0
M  V30 13 C 0.0000 11.7331 0.0 0
M  V30 14 C 19.1843 9.1525 0.0 0
M  V30 15 C 20.5180 8.3825 0.0 0
M  V30 16 C 19.1843 10.6925 0.0 0
M  V30 17 C 4.1799 4.2206 0.0 0
M  V30 18 C 3.4099 5.5544 0.0 0
M  V30 19 C 5.6864 4.5408 0.0 0
M  V30 20 C 4.4405 6.6988 0.0 0
M  V30 21 C 1.9036 5.8746 0.0 0
M  V30 22 N 5.8473 6.0725 0.0 0
M  V30 23 C 3.9645 8.1635 0.0 0
M  V30 24 C 1.4278 7.3391 0.0 0
M  V30 25 C 2.4582 8.4837 0.0 0
M  V30 26 C 3.5536 2.8138 0.0 0
M  V30 27 C 4.4588 1.5679 0.0 0
M  V30 28 C 2.0220 2.6528 0.0 0
M  V30 29 C 3.8323 0.1609 0.0 0
M  V30 30 C 1.3956 1.2459 0.0 0
M  V30 31 C 2.3008 0.0000 0.0 0
M  V30 32 C 15.1832 6.8425 0.0 0
M  V30 33 C 16.5169 6.0725 0.0 0
M  V30 34 C 15.1832 8.3825 0.0 0
M  V30 35 C 17.8505 6.8425 0.0 0
M  V30 36 C 16.5169 9.1525 0.0 0
M  V30 37 C 17.8505 8.3825 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 19
M  V30 3 1 3 4
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 8 9
M  V30 10 1 8 32
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 25
M  V30 14 1 11 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 37
M  V30 18 1 17 18
M  V30 19 2 17 19
M  V30 20 1 17 26
M  V30 21 1 18 20
M  V30 22 2 18 21
M  V30 23 1 19 22
M  V30 24 1 20 22
M  V30 25 2 20 23
M  V30 26 1 21 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-[(methylamino)methyl]-1-[4-[[4-(1-methylethyl)benzoyl]amino]butyl]-3...
C32H37N3O3
1198593-07-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3051 10.0269 0.0 0
M  V30 2 N 6.4496 11.0575 0.0 0
M  V30 3 C 6.1295 12.5638 0.0 0
M  V30 4 C 8.3659 8.6643 0.0 0
M  V30 5 C 9.6995 7.8943 0.0 0
M  V30 6 C 11.0334 8.6643 0.0 0
M  V30 7 C 12.3670 7.8943 0.0 0
M  V30 8 N 13.7007 8.6643 0.0 0
M  V30 9 C 15.0343 7.8943 0.0 0
M  V30 10 O 15.0343 6.3543 0.0 0
M  V30 11 C 8.4563 2.6091 0.0 0
M  V30 12 O 7.9804 1.1444 0.0 0
M  V30 13 O 9.9626 2.9293 0.0 0
M  V30 14 C 9.0108 0.0000 0.0 0
M  V30 15 C 20.3691 10.9744 0.0 0
M  V30 16 C 21.7029 10.2044 0.0 0
M  V30 17 C 20.3691 12.5144 0.0 0
M  V30 18 C 4.5948 7.3761 0.0 0
M  V30 19 C 5.3648 6.0424 0.0 0
M  V30 20 C 5.6252 8.5206 0.0 0
M  V30 21 C 6.8713 6.3626 0.0 0
M  V30 22 C 4.8890 4.5779 0.0 0
M  V30 23 N 7.0322 7.8943 0.0 0
M  V30 24 C 7.9017 5.2182 0.0 0
M  V30 25 C 5.9194 3.4333 0.0 0
M  V30 26 C 7.4258 3.7535 0.0 0
M  V30 27 C 3.0633 7.5372 0.0 0
M  V30 28 C 2.1580 6.2913 0.0 0
M  V30 29 C 2.4368 8.9440 0.0 0
M  V30 30 C 0.6265 6.4522 0.0 0
M  V30 31 C 0.9052 9.1049 0.0 0
M  V30 32 C 0.0000 7.8591 0.0 0
M  V30 33 C 16.3682 8.6643 0.0 0
M  V30 34 C 16.3682 10.2044 0.0 0
M  V30 35 C 17.7018 7.8943 0.0 0
M  V30 36 C 17.7018 10.9744 0.0 0
M  V30 37 C 19.0355 8.6643 0.0 0
M  V30 38 C 19.0355 10.2044 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 23
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 9 10
M  V30 11 1 9 33
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 26
M  V30 15 1 12 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 38
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 1 18 27
M  V30 22 1 19 21
M  V30 23 2 19 22
M  V30 24 1 20 23
M  V30 25 1 21 23
M  V30 26 2 21 24
M  V30 27 1 22 25
M  V30 28 1 24 26
M  V30 29 2 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 36 2 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 35 37
M  V30 40 2 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1198593-06-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1198593-07-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-13357983
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-14-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Methyl
2-[(methylamino)methyl]-1-[4-({[4-(1-methylethy)phenyl]carbonyl)amino)butyl]-3-phenyl-1H-indole-6-carboxylate
To a hot solution of methyl
2-formyl-1-[4-({[4-(1-methylethyl)phenyl]carbonyl}amino)butyl]-3-phenyl-1H-indole-6-carboxylate
(Intermediate 105) (300 mg, 0.605 mmol) in methanol was added via a
syringe, methylamine (3 ml, 6.05 mmol). The mixture was stirred at room
temperature for 24 hours. The reaction was not complete, the precipitate
formed was dissolved by heating and 3 ml of methylamine were added. The
mixture was stirred at room temperature for 6 hours. The reaction mixture
was concentrated and the white solid obtained was dissolved in ethanol
and concentrated. The solid was dissolved with a mix of THF (10 ml) and
methanol (50 ml) and NaBH4 (115 mg, 3 mmol) was added. The mixture was
stirred at room temperature for 2 hours. Brine was added and the mixture
was extracted with ethyl acetate (2 times). The organic phase was washed
with brine, dried over Na2SO4, filtered and evaporated to give the title
compound as orange amorphous solid (300 mg, quantitative yield). Methyl
2-[(methylamino)methyl]-1-[4-({[4-(1-methylethy)phenyl]carbonyl)amino)butyl]-3-phenyl-1H-indole-6-carboxylate,
yield (300 mg) LC/MS : m/z 512.11 (M+H)+, Rt: 3.62 min.
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of methylamine in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Carboxyl-substituted indole derivatives as hPPAR modulators and their
preparation, pharmaceutical compositions and use in the treatment of
diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Faucher, Nicolas Eric; Martres, Paul; Meunier, Stephane
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009147121 A1 2009-12-10

$RFMT $RIREG SCHEME82 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-2-benzofurancarboxaldehyde
C10H8O2
1199-07-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0204 0.0000 0.0 0
M  V30 2 C 6.0810 1.3627 0.0 0
M  V30 3 O 7.4148 2.1327 0.0 0
M  V30 4 C 3.0800 3.9844 0.0 0
M  V30 5 C 2.3100 2.6508 0.0 0
M  V30 6 O 4.5864 3.6643 0.0 0
M  V30 7 C 2.3100 5.3182 0.0 0
M  V30 8 C 3.3406 1.5064 0.0 0
M  V30 9 C 0.7700 2.6508 0.0 0
M  V30 10 C 4.7474 2.1327 0.0 0
M  V30 11 C 0.7700 5.3182 0.0 0
M  V30 12 C 0.0000 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 3
M  V30 3 1 2 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl(3-methylbenzofuran-2-ylmethyl)amine
C11H13NO
92367-50-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6078 0.0000 0.0 0
M  V30 2 C 6.5770 2.7104 0.0 0
M  V30 3 N 7.3470 4.0442 0.0 0
M  V30 4 C 8.8870 4.0442 0.0 0
M  V30 5 C 2.6673 3.4804 0.0 0
M  V30 6 C 2.6673 1.9404 0.0 0
M  V30 7 O 4.1320 3.9564 0.0 0
M  V30 8 C 1.3336 4.2504 0.0 0
M  V30 9 C 4.1320 1.4645 0.0 0
M  V30 10 C 1.3336 1.1704 0.0 0
M  V30 11 C 5.0370 2.7104 0.0 0
M  V30 12 C 0.0000 3.4804 0.0 0
M  V30 13 C 0.0000 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 11
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1199-07-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 92367-50-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-9163357
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation 67 Preparation of
Methyl-(1-propyl-naphthalen-2-ylmethyl)amine Preparation 103 Preparation
of Methyl-(3-methyl-benzofuran-2-ylmethyl)amine [0858] According to the
procedure of Preparation 67, except substituting
3-methyl-benzofuran-2-carbaldehyde for
1-propyl-naphthalene-2-carbaldehyde, the title compound (2.05 g,
quantitative) was prepared as a yellow oil. 1H NMR (300 MHz, DMSO-d6) δ
7.52 (dd, J=6.7, 2.1 Hz, 1H), 7.46 (dd, J=6.5, 2.0 Hz, 1H), 7.25-7.21 (m,
2H), 3.74 (s, 2H), 2.25 (s, 3H), 2.19 (s, 3H), 2.07 (br s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME82 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-2-benzofurancarboxaldehyde
C10H8O2
1199-07-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0204 0.0000 0.0 0
M  V30 2 C 6.0810 1.3627 0.0 0
M  V30 3 O 7.4148 2.1327 0.0 0
M  V30 4 C 3.0800 3.9844 0.0 0
M  V30 5 C 2.3100 2.6508 0.0 0
M  V30 6 O 4.5864 3.6643 0.0 0
M  V30 7 C 2.3100 5.3182 0.0 0
M  V30 8 C 3.3406 1.5064 0.0 0
M  V30 9 C 0.7700 2.6508 0.0 0
M  V30 10 C 4.7474 2.1327 0.0 0
M  V30 11 C 0.7700 5.3182 0.0 0
M  V30 12 C 0.0000 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 3
M  V30 3 1 2 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl(3-methylbenzofuran-2-ylmethyl)amine
C11H13NO
92367-50-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6078 0.0000 0.0 0
M  V30 2 C 6.5770 2.7104 0.0 0
M  V30 3 N 7.3470 4.0442 0.0 0
M  V30 4 C 8.8870 4.0442 0.0 0
M  V30 5 C 2.6673 3.4804 0.0 0
M  V30 6 C 2.6673 1.9404 0.0 0
M  V30 7 O 4.1320 3.9564 0.0 0
M  V30 8 C 1.3336 4.2504 0.0 0
M  V30 9 C 4.1320 1.4645 0.0 0
M  V30 10 C 1.3336 1.1704 0.0 0
M  V30 11 C 5.0370 2.7104 0.0 0
M  V30 12 C 0.0000 3.4804 0.0 0
M  V30 13 C 0.0000 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 11
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1199-07-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 92367-50-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-8039471
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME82 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-2-benzofurancarboxaldehyde
C10H8O2
1199-07-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0204 0.0000 0.0 0
M  V30 2 C 6.0810 1.3627 0.0 0
M  V30 3 O 7.4148 2.1327 0.0 0
M  V30 4 C 3.0800 3.9844 0.0 0
M  V30 5 C 2.3100 2.6508 0.0 0
M  V30 6 O 4.5864 3.6643 0.0 0
M  V30 7 C 2.3100 5.3182 0.0 0
M  V30 8 C 3.3406 1.5064 0.0 0
M  V30 9 C 0.7700 2.6508 0.0 0
M  V30 10 C 4.7474 2.1327 0.0 0
M  V30 11 C 0.7700 5.3182 0.0 0
M  V30 12 C 0.0000 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 3
M  V30 3 1 2 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl(3-methylbenzofuran-2-ylmethyl)amine
C11H13NO
92367-50-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6078 0.0000 0.0 0
M  V30 2 C 6.5770 2.7104 0.0 0
M  V30 3 N 7.3470 4.0442 0.0 0
M  V30 4 C 8.8870 4.0442 0.0 0
M  V30 5 C 2.6673 3.4804 0.0 0
M  V30 6 C 2.6673 1.9404 0.0 0
M  V30 7 O 4.1320 3.9564 0.0 0
M  V30 8 C 1.3336 4.2504 0.0 0
M  V30 9 C 4.1320 1.4645 0.0 0
M  V30 10 C 1.3336 1.1704 0.0 0
M  V30 11 C 5.0370 2.7104 0.0 0
M  V30 12 C 0.0000 3.4804 0.0 0
M  V30 13 C 0.0000 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 11
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1199-07-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 92367-50-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-12658542
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation of
Methyl-(1-propyl-naphthalen-2-ylmethyl)amine A solution of 2.0 M
methylamine in methanol (20 mL) was added to
1-propylnaphthalene-2-carbaldehyde (0.983 g, 4.95 mmol) under N2 and
allowed to stir for 18 h. The solution was concentrated under reduced
pressure. Then the resulting dark yellow oil was solvated in EtOH (20 mL)
under N2. To the solution was added NaBH4 (0.187 g, 4.95 mmol) and the
mixture allowed to stir for 6.5 h. The reaction was concentrated under
reduced pressure, then solvated in 1 N NaOH (20 mL) and extracted with
Et2O (3 x 50 mL). The organics were combined, washed with brine (2 x 100
mL), dried over Na2SO4, filtered and concentrated to yield the title
compound as a yellow oil. Preparation of
Methyl-(3-methyl-benzofuran-2-ylmethyl)amine According to the procedure
of Preparation 1, except substituting 3-methyl-benzofuran-2-carbaldehyde
for 1-propyl-naphthalene-2-carbaldehyde, the title compound (2.05 g,
quantitative) was prepared as a yellow oil. 1H NMR (300 MHz, DMSO-d6) δ
7.52 (dd, J = 6.7, 2.1 Hz, 1H), 7.46 (dd, J = 6.5,2.0 Hz, 1H), 7.25-7.21
(m, 2H), 3.74 (s, 2H), 2.25 (s, 3H), 2.19 (s, 3H), 2.07 (br s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds as antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd; Sampson, Peter; Pauls, Heinz W.; Ramnauth, Jailall;
Manning, David Douglas; Surman, Matthew David; Xie, Dejian; Decornez,
Helene Yvonne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004052890 A1 2004-06-24

$RFMT $RIREG SCHEME83 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethoxybenzaldehyde
C9H10O3
120-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 O 7.7000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 8
M  V30 5 2 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethoxy-N-methylbenzenemethanamine
C10H15NO2
63-64-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 N 7.7000 5.3349 0.0 0
M  V30 7 C 9.2400 5.3349 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 120-14-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 63-64-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-17937335
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of a series of
resorcinol-based N-benzyl benzamide derivatives as potent Hsp90
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Park, Sun You; Oh, Yong Jin; Lho, Yunmee; Jeong, Ju Hui; Liu,
Kwang-Hyeon; Song, Jaeyoung; Kim, Soong-Hyun; Ha, Eunyoung; Seo, Young Ho
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2018), 143390-401

$RFMT $RIREG SCHEME84 STEP1
$RXN



  2  1
$MOL
6-[2-[[(1R)-1-Methylpropyl]amino]-5-thiazolyl]-8-phenylimidazo[1,2-a]pyridine...
C21H20N4O2S
1202278-10-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 7.9566 0.0 0
M  V30 2 O 1.3336 9.4966 0.0 0
M  V30 3 O 0.0000 7.1866 0.0 0
M  V30 4 N 12.5703 7.0099 0.0 0
M  V30 5 C 13.9772 6.3836 0.0 0 CFG=2
M  V30 6 C 15.2231 7.2888 0.0 0
M  V30 7 C 14.1381 4.8521 0.0 0
M  V30 8 C 16.6298 6.6623 0.0 0
M  V30 9 C 4.3346 5.3347 0.0 0
M  V30 10 C 5.1046 4.0011 0.0 0
M  V30 11 N 5.1046 6.6685 0.0 0
M  V30 12 N 2.8282 5.6549 0.0 0
M  V30 13 C 6.6446 4.0011 0.0 0
M  V30 14 C 6.6446 6.6685 0.0 0
M  V30 15 C 4.0741 7.8129 0.0 0
M  V30 16 C 2.6673 7.1866 0.0 0
M  V30 17 C 7.4146 5.3347 0.0 0
M  V30 18 C 4.3346 2.6674 0.0 0
M  V30 19 C 5.1046 1.3338 0.0 0
M  V30 20 C 2.7946 2.6674 0.0 0
M  V30 21 C 4.3346 0.0000 0.0 0
M  V30 22 C 2.0246 1.3338 0.0 0
M  V30 23 C 2.7946 0.0000 0.0 0
M  V30 24 C 8.9546 5.3347 0.0 0
M  V30 25 S 9.8599 6.5807 0.0 0
M  V30 26 C 9.8599 4.0889 0.0 0
M  V30 27 C 11.3244 6.1047 0.0 0
M  V30 28 N 11.3244 4.5647 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 4 5
M  V30 5 1 4 27
M  V30 6 1 5 6
M  V30 7 1 5 7 CFG=1
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 2 10 13
M  V30 13 1 10 18
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 2 14 17
M  V30 19 2 15 16
M  V30 20 1 17 24
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 1 24 25
M  V30 28 2 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-6-[2-[[(1R)-1-methylpropyl]amino]-5-thiazolyl]-8-phenylimidazo[1,2-a...
C22H23N5OS
1202276-43-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 7.9566 0.0 0
M  V30 2 N 1.3336 9.4966 0.0 0
M  V30 3 O 0.0000 7.1866 0.0 0
M  V30 4 C 0.0000 10.2666 0.0 0
M  V30 5 N 12.5703 7.0099 0.0 0
M  V30 6 C 13.9772 6.3836 0.0 0 CFG=2
M  V30 7 C 15.2231 7.2888 0.0 0
M  V30 8 C 14.1382 4.8521 0.0 0
M  V30 9 C 16.6299 6.6624 0.0 0
M  V30 10 C 4.3346 5.3347 0.0 0
M  V30 11 C 5.1047 4.0011 0.0 0
M  V30 12 N 5.1047 6.6685 0.0 0
M  V30 13 N 2.8282 5.6549 0.0 0
M  V30 14 C 6.6447 4.0011 0.0 0
M  V30 15 C 6.6447 6.6685 0.0 0
M  V30 16 C 4.0741 7.8129 0.0 0
M  V30 17 C 2.6673 7.1866 0.0 0
M  V30 18 C 7.4147 5.3347 0.0 0
M  V30 19 C 4.3346 2.6674 0.0 0
M  V30 20 C 5.1047 1.3338 0.0 0
M  V30 21 C 2.7946 2.6674 0.0 0
M  V30 22 C 4.3346 0.0000 0.0 0
M  V30 23 C 2.0246 1.3338 0.0 0
M  V30 24 C 2.7946 0.0000 0.0 0
M  V30 25 C 8.9547 5.3347 0.0 0
M  V30 26 S 9.8599 6.5807 0.0 0
M  V30 27 C 9.8599 4.0889 0.0 0
M  V30 28 C 11.3244 6.1047 0.0 0
M  V30 29 N 11.3244 4.5647 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 28
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=1
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 2 11 14
M  V30 14 1 11 19
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 2 15 18
M  V30 20 2 16 17
M  V30 21 1 18 25
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1202278-10-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1202276-43-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3179349
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 8. Preparation of
(R)-6-(2-(sec-butylamino)thiazol-5-yl)-N-alkyl-8-phenyl-1H-imidazo[1,2-a]pyridine-2-carboxamide
A solution of
(R)-6-(2-(sec-butylamino)thiazol-5-yl)-8-phenyl-1H-imidazo[1,2-a]pyridine-2-carboxylic
acid (42 mg, 0.107 mmol) in DMF (600 uL) was added HOBt (17.3 mg, 0.128
mmol) and EDCI (24.5 mg, 0.128 mmol). The mixture was stirred at rt for
1h and equally divided into three portions. Each portion was added either
methylamine (2M in THF, 45 uL, 0.089 mmol), ethylamine (7.3 mg, 0.089
mmol) or cyclopropylamine (6.2 uL, 0.089 mmol), and stirred at rt for Ih.
The mixture was added water (0.6 mL) and stirred for several hours. The
solids were filtered, rinsed with water and dried. The corresponding
amides (Methyl-: 16.3 mg, 100% yield). LCMS 406.3, HPLC Tr 3.67 min
(Conditions B).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of triazolopyridine compounds as kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hynes, John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009155389 A1 2009-12-23

$RFMT $RIREG SCHEME84 STEP1
$RXN



  2  1
$MOL
6-[2-[[(1R)-1-Methylpropyl]amino]-5-thiazolyl]-8-phenylimidazo[1,2-a]pyridine...
C21H20N4O2S
1202278-10-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 7.9566 0.0 0
M  V30 2 O 1.3336 9.4966 0.0 0
M  V30 3 O 0.0000 7.1866 0.0 0
M  V30 4 N 12.5703 7.0099 0.0 0
M  V30 5 C 13.9772 6.3836 0.0 0 CFG=2
M  V30 6 C 15.2231 7.2888 0.0 0
M  V30 7 C 14.1381 4.8521 0.0 0
M  V30 8 C 16.6298 6.6623 0.0 0
M  V30 9 C 4.3346 5.3347 0.0 0
M  V30 10 C 5.1046 4.0011 0.0 0
M  V30 11 N 5.1046 6.6685 0.0 0
M  V30 12 N 2.8282 5.6549 0.0 0
M  V30 13 C 6.6446 4.0011 0.0 0
M  V30 14 C 6.6446 6.6685 0.0 0
M  V30 15 C 4.0741 7.8129 0.0 0
M  V30 16 C 2.6673 7.1866 0.0 0
M  V30 17 C 7.4146 5.3347 0.0 0
M  V30 18 C 4.3346 2.6674 0.0 0
M  V30 19 C 5.1046 1.3338 0.0 0
M  V30 20 C 2.7946 2.6674 0.0 0
M  V30 21 C 4.3346 0.0000 0.0 0
M  V30 22 C 2.0246 1.3338 0.0 0
M  V30 23 C 2.7946 0.0000 0.0 0
M  V30 24 C 8.9546 5.3347 0.0 0
M  V30 25 S 9.8599 6.5807 0.0 0
M  V30 26 C 9.8599 4.0889 0.0 0
M  V30 27 C 11.3244 6.1047 0.0 0
M  V30 28 N 11.3244 4.5647 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 4 5
M  V30 5 1 4 27
M  V30 6 1 5 6
M  V30 7 1 5 7 CFG=1
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 2 10 13
M  V30 13 1 10 18
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 2 14 17
M  V30 19 2 15 16
M  V30 20 1 17 24
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 1 24 25
M  V30 28 2 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-6-[2-[[(1R)-1-methylpropyl]amino]-5-thiazolyl]-8-phenylimidazo[1,2-a...
C22H23N5OS
1202276-43-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 7.9566 0.0 0
M  V30 2 N 1.3336 9.4966 0.0 0
M  V30 3 O 0.0000 7.1866 0.0 0
M  V30 4 C 0.0000 10.2666 0.0 0
M  V30 5 N 12.5703 7.0099 0.0 0
M  V30 6 C 13.9772 6.3836 0.0 0 CFG=2
M  V30 7 C 15.2231 7.2888 0.0 0
M  V30 8 C 14.1382 4.8521 0.0 0
M  V30 9 C 16.6299 6.6624 0.0 0
M  V30 10 C 4.3346 5.3347 0.0 0
M  V30 11 C 5.1047 4.0011 0.0 0
M  V30 12 N 5.1047 6.6685 0.0 0
M  V30 13 N 2.8282 5.6549 0.0 0
M  V30 14 C 6.6447 4.0011 0.0 0
M  V30 15 C 6.6447 6.6685 0.0 0
M  V30 16 C 4.0741 7.8129 0.0 0
M  V30 17 C 2.6673 7.1866 0.0 0
M  V30 18 C 7.4147 5.3347 0.0 0
M  V30 19 C 4.3346 2.6674 0.0 0
M  V30 20 C 5.1047 1.3338 0.0 0
M  V30 21 C 2.7946 2.6674 0.0 0
M  V30 22 C 4.3346 0.0000 0.0 0
M  V30 23 C 2.0246 1.3338 0.0 0
M  V30 24 C 2.7946 0.0000 0.0 0
M  V30 25 C 8.9547 5.3347 0.0 0
M  V30 26 S 9.8599 6.5807 0.0 0
M  V30 27 C 9.8599 4.0889 0.0 0
M  V30 28 C 11.3244 6.1047 0.0 0
M  V30 29 N 11.3244 4.5647 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 28
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=1
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 2 11 14
M  V30 14 1 11 19
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 2 15 18
M  V30 20 2 16 17
M  V30 21 1 18 25
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1202278-10-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1202276-43-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14972941
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 8. Preparation of
(R)-6-(2-(sec-butylamino)thiazol-5-yl)-N-alkyl-8-phenyl-1H-imidazo[1,2-a]pyridine-2-carboxamide
A solution of
(R)-6-(2-(sec-butylamino)thiazol-5-yl)-8-phenyl-1H-imidazo[1,2-a]pyridine-2-carboxylic
acid (42 mg, 0.107 mmol) in DMF (600 uL) was added HOBt (17.3 mg, 0.128
mmol) and EDCI (24.5 mg, 0.128 mmol). The mixture was stirred at rt for
1h and equally divided into three portions. Each portion was added either
methylamine (2M in THF, 45 uL, 0.089 mmol), ethylamine (7.3 mg, 0.089
mmol) or cyclopropylamine (6.2 uL, 0.089 mmol), and stirred at rt for 1h.
The mixture was added water (0.6 mL) and stirred for several hours. The
solids were filtered, rinsed with water and dried to give the
corresponding amides (ethyl-: 10.3 mg, 69% yield, cyclopropyl-: 7.2 mg,
47% yield). Methyl-: yield 16.3 mg, 100%. LCMS 406.3, HPLC Tr 3.67 min
(Conditions B).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of imidazopyridine and imidazopyrazine compounds as kinase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hynes, John; De Lucca, George V.; Wu, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009155388 A1 2009-12-23

$RFMT $RIREG SCHEME85 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Benzodioxole-5-carboxaldehyde
C8H6O3
120-57-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 O 7.7047 2.3100 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 2.3699 0.7700 0.0 0
M  V30 5 C 3.7036 3.0800 0.0 0
M  V30 6 O 0.9052 2.7859 0.0 0
M  V30 7 C 3.7036 0.0000 0.0 0
M  V30 8 O 0.9052 0.2941 0.0 0
M  V30 9 C 5.0372 2.3100 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methylpiperonylamine
C9H11NO2
15205-27-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 N 7.7047 2.3100 0.0 0
M  V30 3 C 9.0383 3.0800 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 C 2.3699 0.7700 0.0 0
M  V30 6 C 3.7036 3.0800 0.0 0
M  V30 7 O 0.9052 2.7859 0.0 0
M  V30 8 C 3.7036 0.0000 0.0 0
M  V30 9 O 0.9052 0.2941 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 120-57-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 15205-27-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-17935976
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of a series of
resorcinol-based N-benzyl benzamide derivatives as potent Hsp90
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Park, Sun You; Oh, Yong Jin; Lho, Yunmee; Jeong, Ju Hui; Liu,
Kwang-Hyeon; Song, Jaeyoung; Kim, Soong-Hyun; Ha, Eunyoung; Seo, Young Ho
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2018), 143390-401

$RFMT $RIREG SCHEME86 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-amino-3-oxetaneacetate
C7H13NO3
1207175-54-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.4375 2.3101 0.0 0
M  V30 2 C 4.7712 1.5400 0.0 0
M  V30 3 O 6.1048 2.3101 0.0 0
M  V30 4 O 4.7712 0.0000 0.0 0
M  V30 5 C 7.4387 1.5400 0.0 0
M  V30 6 C 8.7723 2.3101 0.0 0
M  V30 7 N 2.8737 0.2064 0.0 0
M  V30 8 C 2.1037 1.5400 0.0 0
M  V30 9 C 1.3337 2.8737 0.0 0
M  V30 10 C 0.7700 0.7700 0.0 0
M  V30 11 O 0.0000 2.1037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-N-methyl-3-oxetaneacetamide
C6H12N2O2
1613239-86-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.4375 2.3101 0.0 0
M  V30 2 C 4.7712 1.5400 0.0 0
M  V30 3 N 6.1048 2.3101 0.0 0
M  V30 4 O 4.7712 0.0000 0.0 0
M  V30 5 C 7.4387 1.5400 0.0 0
M  V30 6 N 2.8739 0.2064 0.0 0
M  V30 7 C 2.1038 1.5400 0.0 0
M  V30 8 C 1.3338 2.8737 0.0 0
M  V30 9 C 0.7700 0.7700 0.0 0
M  V30 10 O 0.0000 2.1037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1207175-54-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1613239-86-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12167403
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyridine-2-carboxamides useful as CB2 agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Grether, Uwe; Kimbara, Atsushi; Nettekoven, Matthias; Ricklin, Fabienne;
Roever, Stephan; Rogers-Evans, Mark; Rombach, Didier; Schulz-Gasch,
Tanja; Westphal, Matthias
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014086805 A1 2014-06-12

$RFMT $RIREG SCHEME87 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[(2S,4S)-4-amino-1-[(1,1-dimethylethoxy)carbonyl]-2-pyrrolidinyl]-4-t...
C15H23N3O4S
1207593-50-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.8738 3.8500 0.0 0
M  V30 2 O 1.5400 3.0800 0.0 0
M  V30 3 O 4.2074 3.0800 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 3.0800 1.5400 0.0 0
M  V30 6 C 1.5400 0.0000 0.0 0
M  V30 7 C 0.0000 1.5400 0.0 0
M  V30 8 N 1.1986 9.0056 0.0 0
M  V30 9 C 9.5406 6.2952 0.0 0
M  V30 10 O 10.6852 5.2647 0.0 0
M  V30 11 O 9.8608 7.8015 0.0 0
M  V30 12 C 12.1497 5.7405 0.0 0
M  V30 13 C 13.2942 4.7101 0.0 0
M  V30 14 C 4.1197 6.2952 0.0 0 CFG=2
M  V30 15 N 2.8738 5.3900 0.0 0
M  V30 16 C 3.6438 7.7598 0.0 0
M  V30 17 C 1.6278 6.2952 0.0 0
M  V30 18 C 2.1038 7.7598 0.0 0 CFG=2
M  V30 19 C 5.5842 5.8192 0.0 0
M  V30 20 N 6.8301 6.7244 0.0 0
M  V30 21 S 6.0601 4.3547 0.0 0
M  V30 22 C 8.0761 5.8192 0.0 0
M  V30 23 C 7.6001 4.3547 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 18 8 CFG=1
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 22
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 19 CFG=1
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 14 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2S,4S)-4-amino-2-[4-[(methylamino)carbonyl]-2-thiazolyl]-1...
C14H22N4O3S
2522922-49-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.6437 5.3028 0.0 0
M  V30 2 O 2.1037 5.3028 0.0 0
M  V30 3 O 4.4137 6.6365 0.0 0
M  V30 4 C 1.3337 6.6365 0.0 0
M  V30 5 C 0.0000 5.8665 0.0 0
M  V30 6 C 0.5637 7.9701 0.0 0
M  V30 7 C 2.6673 7.4065 0.0 0
M  V30 8 N 4.7709 0.0000 0.0 0
M  V30 9 C 10.6402 6.5187 0.0 0
M  V30 10 N 11.1161 7.9832 0.0 0
M  V30 11 O 11.6707 5.3741 0.0 0
M  V30 12 C 12.6224 8.3036 0.0 0
M  V30 13 C 5.9453 3.8080 0.0 0 CFG=2
M  V30 14 N 4.4137 3.9690 0.0 0
M  V30 15 C 6.2655 2.3017 0.0 0
M  V30 16 C 3.7874 2.5622 0.0 0
M  V30 17 C 4.9318 1.5317 0.0 0 CFG=2
M  V30 18 C 6.9759 4.9526 0.0 0
M  V30 19 N 8.5075 4.7915 0.0 0
M  V30 20 S 6.6556 6.4589 0.0 0
M  V30 21 C 9.1338 6.1985 0.0 0
M  V30 22 C 7.9894 7.2289 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 17 8 CFG=3
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 21
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 18 CFG=3
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 13 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1207593-50-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2522922-49-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-23020656
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Characterization of Specific N-α-Acetyltransferase 50 (Naa50) Inhibitors
Identified Using a DNA Encoded Library
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kung, Pei-Pei; Bingham, Patrick; Burke, Benjamin J.; Chen, Qiuxia; Cheng,
Xuemin; Deng, Ya-Li; Dou, Dengfeng; Feng, Junli; Gallego, Gary M.;
Gehring, Michael R.; Grant, Stephan K.; Greasley, Samantha; Harris,
Anthony R.; Maegley, Karen A.; Meier, Jordan; Meng, Xiaoyun; Montano,
Jose L.; Morgan, Barry A.; Naughton, Brigitte S.; Palde, Prakash B.;
Paul, Thomas A.; Richardson, Paul; Sakata, Sylvie; Shaginian, Alex;
Sonnenburg, William K.; Subramanyam, Chakrapani; Timofeevski, Sergei;
Wan, Jinqiao; Yan, Wen; Stewart, Albert E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2020), 11(6), 1175-1184

$RFMT $RIREG SCHEME88 STEP1
$RXN



  2  1
$MOL
Lup-20(29)-en-28-oic acid, 3,23-bis(acetyloxy)-, anhydride with acetic acid, ...
C36H54O7
1215746-39-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  47 51 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 14.7652 2.8408 0.0 0
M  V30 2 O 16.2967 3.0018 0.0 0
M  V30 3 O 14.1387 1.4339 0.0 0
M  V30 4 C 17.2020 1.7559 0.0 0
M  V30 5 C 16.5756 0.3491 0.0 0
M  V30 6 O 18.7335 1.9168 0.0 0
M  V30 7 C 13.8002 8.0711 0.0 0
M  V30 8 C 12.3357 8.5470 0.0 0
M  V30 9 C 14.9448 9.1017 0.0 0
M  V30 10 C 10.6457 2.5526 0.0 0
M  V30 11 C 9.6386 2.5992 0.0 0
M  V30 12 C 7.0641 6.9545 0.0 0
M  V30 13 C 3.1729 3.5600 0.0 0
M  V30 14 O 2.9055 2.0434 0.0 0
M  V30 15 C 1.4584 1.5167 0.0 0
M  V30 16 C 1.1909 0.0000 0.0 0
M  V30 17 O 0.2786 2.5065 0.0 0
M  V30 18 C 4.8873 2.5701 0.0 0
M  V30 19 O 2.3100 5.4203 0.0 0
M  V30 20 C 1.5400 6.7540 0.0 0
M  V30 21 C 0.0000 6.7540 0.0 0
M  V30 22 O 2.3100 8.0878 0.0 0
M  V30 23 C 13.8600 4.0867 0.0 0 CFG=1
M  V30 24 C 13.0900 5.4203 0.0 0 CFG=2
M  V30 25 C 13.0900 2.7531 0.0 0
M  V30 26 C 15.3663 4.4069 0.0 0
M  V30 27 C 11.5500 5.4203 0.0 0 CFG=1
M  V30 28 C 14.1204 6.5649 0.0 0 CFG=2
M  V30 29 C 11.5500 2.7531 0.0 0
M  V30 30 C 15.5274 5.9384 0.0 0
M  V30 31 C 10.7800 4.0867 0.0 0 CFG=1
M  V30 32 C 10.7800 6.7541 0.0 0
M  V30 33 C 9.2400 4.0867 0.0 0 CFG=1
M  V30 34 C 9.2400 6.7541 0.0 0
M  V30 35 C 8.4700 5.4203 0.0 0 CFG=1
M  V30 36 C 8.4700 2.7531 0.0 0
M  V30 37 C 6.9300 5.4203 0.0 0 CFG=2
M  V30 38 C 6.9300 2.7531 0.0 0
M  V30 39 C 6.1600 4.0867 0.0 0 CFG=2
M  V30 40 C 6.1600 6.7541 0.0 0
M  V30 41 C 4.6200 4.0867 0.0 0 CFG=2
M  V30 42 C 4.6200 6.7541 0.0 0
M  V30 43 C 3.8500 5.4203 0.0 0 CFG=1
M  V30 44 H 12.8491 6.9414 0.0 0
M  V30 45 H 11.9486 6.9080 0.0 0
M  V30 46 H 8.3357 6.9545 0.0 0
M  V30 47 H 5.3900 2.7531 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 23 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 28 7 CFG=3
M  V30 10 1 31 10 CFG=3
M  V30 11 1 33 11 CFG=1
M  V30 12 1 37 12 CFG=1
M  V30 13 1 13 14
M  V30 14 1 41 13 CFG=3
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 41 18 CFG=1
M  V30 19 1 19 20
M  V30 20 1 43 19 CFG=1
M  V30 21 1 20 21
M  V30 22 2 20 22
M  V30 23 1 23 24
M  V30 24 1 23 25
M  V30 25 1 23 26
M  V30 26 1 24 27
M  V30 27 1 24 28
M  V30 28 1 24 44 CFG=3
M  V30 29 1 25 29
M  V30 30 1 26 30
M  V30 31 1 27 31
M  V30 32 1 27 32
M  V30 33 1 27 45 CFG=1
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 33 36
M  V30 40 1 34 35
M  V30 41 1 35 37
M  V30 42 1 35 46 CFG=3
M  V30 43 1 36 38
M  V30 44 1 37 39
M  V30 45 1 37 40
M  V30 46 1 38 39
M  V30 47 1 39 41
M  V30 48 1 39 47 CFG=3
M  V30 49 1 40 42
M  V30 50 1 41 43
M  V30 51 1 42 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(11 23 24 27 28 31 33 35 37 39 41 43)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3β,4α)-3,23-Bis(acetyloxy)-N-methyllup-20(29)-en-28-amide
C35H55NO5
1215746-44-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 49 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 14.7439 9.2474 0.0 0
M  V30 2 N 15.9898 10.1526 0.0 0
M  V30 3 O 14.9048 7.7158 0.0 0
M  V30 4 C 17.3967 9.5263 0.0 0
M  V30 5 C 11.2930 13.2947 0.0 0
M  V30 6 C 11.7689 14.7593 0.0 0
M  V30 7 C 9.7867 12.9744 0.0 0
M  V30 8 C 11.3204 6.9381 0.0 0
M  V30 9 C 10.4249 6.4749 0.0 0
M  V30 10 C 6.0176 8.9596 0.0 0
M  V30 11 C 4.3449 4.0740 0.0 0
M  V30 12 O 4.8717 2.6268 0.0 0
M  V30 13 C 3.8818 1.4472 0.0 0
M  V30 14 C 2.3652 1.7145 0.0 0
M  V30 15 O 4.4085 0.0000 0.0 0
M  V30 16 C 6.3247 4.0740 0.0 0
M  V30 17 O 2.6675 5.2538 0.0 0
M  V30 18 C 1.3337 6.0238 0.0 0
M  V30 19 C 0.0000 5.2538 0.0 0
M  V30 20 O 1.3337 7.5638 0.0 0
M  V30 21 C 13.3371 9.8739 0.0 0 CFG=1
M  V30 22 C 12.0033 10.6439 0.0 0 CFG=2
M  V30 23 C 13.3371 8.3338 0.0 0
M  V30 24 C 14.4815 10.9043 0.0 0
M  V30 25 C 10.6696 9.8739 0.0 0 CFG=1
M  V30 26 C 12.3236 12.1502 0.0 0 CFG=2
M  V30 27 C 12.0033 7.5638 0.0 0
M  V30 28 C 13.8551 12.3111 0.0 0
M  V30 29 C 10.6696 8.3338 0.0 0 CFG=1
M  V30 30 C 9.3359 10.6439 0.0 0
M  V30 31 C 9.3359 7.5638 0.0 0 CFG=1
M  V30 32 C 8.0023 9.8739 0.0 0
M  V30 33 C 8.0023 8.3338 0.0 0 CFG=1
M  V30 34 C 9.3359 6.0238 0.0 0
M  V30 35 C 6.6685 7.5638 0.0 0 CFG=2
M  V30 36 C 8.0023 5.2538 0.0 0
M  V30 37 C 6.6685 6.0238 0.0 0 CFG=2
M  V30 38 C 5.3348 8.3338 0.0 0
M  V30 39 C 5.3348 5.2538 0.0 0 CFG=2
M  V30 40 C 4.0011 7.5638 0.0 0
M  V30 41 C 4.0011 6.0238 0.0 0 CFG=1
M  V30 42 H 11.0341 11.8406 0.0 0
M  V30 43 H 10.2710 11.3614 0.0 0
M  V30 44 H 7.1189 9.5953 0.0 0
M  V30 45 H 6.6685 4.4838 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 21 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 26 5 CFG=3
M  V30 8 1 29 8 CFG=3
M  V30 9 1 31 9 CFG=1
M  V30 10 1 35 10 CFG=1
M  V30 11 1 11 12
M  V30 12 1 39 11 CFG=3
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 39 16 CFG=1
M  V30 17 1 17 18
M  V30 18 1 41 17 CFG=1
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 1 21 22
M  V30 22 1 21 23
M  V30 23 1 21 24
M  V30 24 1 22 25
M  V30 25 1 22 26
M  V30 26 1 22 42 CFG=3
M  V30 27 1 23 27
M  V30 28 1 24 28
M  V30 29 1 25 29
M  V30 30 1 25 30
M  V30 31 1 25 43 CFG=1
M  V30 32 1 26 28
M  V30 33 1 27 29
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 31 34
M  V30 38 1 32 33
M  V30 39 1 33 35
M  V30 40 1 33 44 CFG=3
M  V30 41 1 34 36
M  V30 42 1 35 37
M  V30 43 1 35 38
M  V30 44 1 36 37
M  V30 45 1 37 39
M  V30 46 1 37 45 CFG=3
M  V30 47 1 38 40
M  V30 48 1 39 41
M  V30 49 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(11 21 22 25 26 29 31 33 35 37 39 41)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1215746-39-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1215746-44-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-3429518
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 3: Preparation of 3,23-diacetoxy-betulinic methyl amide (DAOSO)
To a solution of 3,23-diacetoxy-betulinic acetic anhydride (54 mg,
0.090mmoL) dissolved in 2 mL dry methylene chloride, was added oxalyl
dichloride (78μL, 0.90 mmoL) under nitrogen. The mixture was stirred at
room temperature for 2 h and then concentrated under reduced pressure. A
solution of methylamine in ethanol (33%wt, 112 μL, 0.90 mmoL) was added
and the mixture was stirred at room temperature overnight. Aqueous workup
followed by purification by column chromatography on silica gel column,
eluting with 25% ethyl acetate in petroleum ether provided the desired
product (51 mg, 100%) as a white solid. 3,23-diacetoxy-betulinic methyl
amide (DAOSO), yield (51 mg, 100%) 1H NMR (400 MHz, CDCl3) δ 5.70 (br s,
1 H), 4.77 (dd, J= 10.6, 4,6 Hz, 1 H), 4.74 (s, 1 H), 4.59 (s, 1 H), 3.85
(d, J= 10.6 Hz, 1 H), 3.68 (d, J= 10.6 Hz, 1 H), 3.14 (dt, J= 10.6 , 4.6
Hz, 1 H), 2.79 (d, J= 4.6 Hz, 3 H), 2.52-2.40 (m, 1 H), 2.07 (s, 3 H),
2.05-1.87 (m, 2 H), 2.02 (s, 3 H), 1.80-0.75 (m, 22 H), 1.68 (s, 3 H),
0.96 (s, 3 H), 0.94 (s, 3 H), 0.88 (s, 3 H), 0.81 (s, 3 H). 13C NMR (400
MHz, CDCl3) δ 176.64, 170.92, 170.56, 150.76, 109.26, 74.53, 74.46,
65.39, 55.56, 50.61, 50.12, 48.00, 46.74, 42.39, 40.68, 40.56, 38.34,
37.99, 36.95, 34.01, 33.77, 30.84, 29.39, 25.52, 23.12, 20.97, 19.45,
17.93, 16.62, 16.58. MS (ESI) m/z 570.47 (M+H+).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of triterpenoid compounds for pharmaceutical use
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ip, Nancy Yuk-Yu; Ip, Fanny Chui-Fun; Hu, Yueqing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010032123 A1 2010-03-25

$RFMT $RIREG SCHEME89 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(6-Bromo-1-oxo-2(1H)-isoquinolinyl)methyl]benzoic acid
C17H12BrNO3
1216787-92-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 0.0000 0.0 0
M  V30 2 C 8.0022 1.5400 0.0 0
M  V30 3 Br 0.0000 4.6201 0.0 0
M  V30 4 C 13.3370 1.5400 0.0 0
M  V30 5 O 14.6707 2.3101 0.0 0
M  V30 6 O 13.3370 0.0000 0.0 0
M  V30 7 C 4.0010 2.3101 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 5.3348 1.5400 0.0 0
M  V30 10 C 2.6673 1.5400 0.0 0
M  V30 11 C 2.6673 4.6201 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 N 6.6685 2.3101 0.0 0
M  V30 14 C 1.3337 2.3101 0.0 0
M  V30 15 C 1.3337 3.8501 0.0 0
M  V30 16 C 6.6685 3.8501 0.0 0
M  V30 17 C 9.3358 2.3101 0.0 0
M  V30 18 C 10.6697 1.5400 0.0 0
M  V30 19 C 9.3358 3.8501 0.0 0
M  V30 20 C 12.0033 2.3101 0.0 0
M  V30 21 C 10.6697 4.6201 0.0 0
M  V30 22 C 12.0033 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 13
M  V30 3 1 2 17
M  V30 4 1 3 15
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 20
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 1 13 16
M  V30 18 2 14 15
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(6-Bromo-1-oxo-2(1H)-isoquinolinyl)methyl]-N-methylbenzamide
C18H15BrN2O2
2800892-91-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 0.0000 0.0 0
M  V30 2 C 8.0021 1.5400 0.0 0
M  V30 3 Br 0.0000 4.6200 0.0 0
M  V30 4 C 13.3369 1.5400 0.0 0
M  V30 5 N 14.6705 2.3100 0.0 0
M  V30 6 O 13.3369 0.0000 0.0 0
M  V30 7 C 16.0043 1.5400 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 5.3347 1.5400 0.0 0
M  V30 11 C 2.6674 1.5400 0.0 0
M  V30 12 C 2.6674 4.6200 0.0 0
M  V30 13 C 5.3347 4.6200 0.0 0
M  V30 14 N 6.6685 2.3100 0.0 0
M  V30 15 C 1.3338 2.3100 0.0 0
M  V30 16 C 1.3338 3.8500 0.0 0
M  V30 17 C 6.6685 3.8500 0.0 0
M  V30 18 C 9.3358 2.3100 0.0 0
M  V30 19 C 10.6696 1.5400 0.0 0
M  V30 20 C 9.3358 3.8500 0.0 0
M  V30 21 C 12.0032 2.3100 0.0 0
M  V30 22 C 10.6696 4.6200 0.0 0
M  V30 23 C 12.0032 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 14
M  V30 3 1 2 18
M  V30 4 1 3 16
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 21
M  V30 8 1 5 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 13 17
M  V30 18 1 14 17
M  V30 19 2 15 16
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1216787-92-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2800892-91-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33622444
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel substituted bicyclic derivatives as selective
inhibitors of ROCK1 and ROCK2 protein kinases and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Wongil; Devine, William G.; Diebold, R. Bruce; Hwang, So Young;
Choi, Yunggeun; Liu, Yan; Seung, Sang-Ae; Yong, Miyong; Kim, Sewon; Lee,
Jaekyoo; Koh, Jong Sung
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022150381 A1 2022-07-14

$RFMT $RIREG SCHEME90 STEP1
$RXN



  3  1
$MOL
Triethyl orthoformate
C7H16O3
122-51-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0
M  V30 2 O 2.3100 5.3347 0.0 0
M  V30 3 O 4.6200 4.0011 0.0 0
M  V30 4 O 2.3100 2.6674 0.0 0
M  V30 5 C 0.7700 5.3347 0.0 0
M  V30 6 C 5.3900 5.3347 0.0 0
M  V30 7 C 3.0800 1.3338 0.0 0
M  V30 8 C 0.0000 6.6685 0.0 0
M  V30 9 C 6.9300 5.3347 0.0 0
M  V30 10 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Amino-4-(3,4-dichlorophenyl)-1,4-dihydro-3-methylpyrano[2,3-c]pyrazole-5-ca...
C14H10Cl2N4O
315244-85-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 N 2.6674 0.7700 0.0 0
M  V30 3 C 6.6519 6.8702 0.0 0
M  V30 4 N 0.0000 3.8500 0.0 0
M  V30 5 Cl 6.6684 0.0000 0.0 0
M  V30 6 Cl 9.3358 1.5400 0.0 0
M  V30 7 C 4.0011 4.6200 0.0 0
M  V30 8 C 4.0011 6.1600 0.0 0
M  V30 9 C 2.6674 3.8500 0.0 0
M  V30 10 C 2.6674 6.9300 0.0 0
M  V30 11 C 5.1454 7.1904 0.0 0
M  V30 12 C 1.3336 4.6200 0.0 0
M  V30 13 O 1.3336 6.1600 0.0 0
M  V30 14 N 2.9876 8.4363 0.0 0
M  V30 15 N 4.5191 8.5972 0.0 0
M  V30 16 C 5.3347 3.8500 0.0 0
M  V30 17 C 5.3347 2.3100 0.0 0
M  V30 18 C 6.6684 4.6200 0.0 0
M  V30 19 C 6.6684 1.5400 0.0 0
M  V30 20 C 8.0021 3.8500 0.0 0
M  V30 21 C 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 9
M  V30 3 1 3 11
M  V30 4 1 4 12
M  V30 5 1 5 19
M  V30 6 1 6 21
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 16
M  V30 10 2 8 10
M  V30 11 1 8 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 1 12 13
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(3,4-Dichlorophenyl)-1,4-dihydro-N,3-dimethylpyrazolo[4′,3′:5,6]pyrano[2,3-...
C16H13Cl2N5O
895137-28-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 7.0574 0.0 0
M  V30 2 C 4.0012 8.5974 0.0 0
M  V30 3 C 6.6520 1.7270 0.0 0
M  V30 4 Cl 9.3360 3.9773 0.0 0
M  V30 5 Cl 9.3360 7.0574 0.0 0
M  V30 6 C 4.0012 3.9773 0.0 0
M  V30 7 C 2.6675 4.7473 0.0 0
M  V30 8 C 4.0012 2.4373 0.0 0
M  V30 9 C 1.3337 3.9773 0.0 0
M  V30 10 C 2.6675 6.2873 0.0 0
M  V30 11 C 2.6675 1.6672 0.0 0
M  V30 12 C 5.1456 1.4068 0.0 0
M  V30 13 O 1.3337 2.4373 0.0 0
M  V30 14 N 0.0000 4.7473 0.0 0
M  V30 15 N 1.3337 7.0574 0.0 0
M  V30 16 N 2.9877 0.1609 0.0 0
M  V30 17 N 4.5192 0.0000 0.0 0
M  V30 18 C 0.0000 6.2873 0.0 0
M  V30 19 C 5.3348 4.7473 0.0 0
M  V30 20 C 6.6685 3.9773 0.0 0
M  V30 21 C 5.3348 6.2873 0.0 0
M  V30 22 C 8.0023 4.7473 0.0 0
M  V30 23 C 6.6685 7.0574 0.0 0
M  V30 24 C 8.0023 6.2873 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 12
M  V30 4 1 4 22
M  V30 5 1 5 24
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 19
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 2 9 14
M  V30 15 1 10 15
M  V30 16 1 11 13
M  V30 17 1 11 16
M  V30 18 2 12 17
M  V30 19 1 14 18
M  V30 20 2 15 18
M  V30 21 1 16 17
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 122-51-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 315244-85-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 895137-28-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25717037
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrazolopyranopyrimidines as a class of anti-inflammatory agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zaki, Magdy E. A.; Soliman, Hanan A.; Hiekal, Ola A.; Rashad, Aymn E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Zeitschrift fuer Naturforschung, C: Journal of Biosciences (2006),
61(1/2), 1-5

$RFMT $RIREG SCHEME91 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3′-Fluoro-3,4′-dinitro[1,1′-biphenyl]-4-amine
C12H8FN3O4
1228653-84-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 3.8501 0.0 0 VAL=5
M  V30 2 O 0.0000 4.6201 0.0 0
M  V30 3 O 1.3337 2.3101 0.0 0
M  V30 4 F 10.6697 4.6201 0.0 0
M  V30 5 N 1.3337 6.9302 0.0 0
M  V30 6 N 10.6697 1.5400 0.0 0 VAL=5
M  V30 7 O 10.6697 0.0000 0.0 0
M  V30 8 O 12.0033 2.3101 0.0 0
M  V30 9 C 5.3348 4.6201 0.0 0
M  V30 10 C 4.0012 3.8501 0.0 0
M  V30 11 C 5.3348 6.1601 0.0 0
M  V30 12 C 2.6673 4.6201 0.0 0
M  V30 13 C 4.0012 6.9302 0.0 0
M  V30 14 C 2.6673 6.1601 0.0 0
M  V30 15 C 6.6685 3.8501 0.0 0
M  V30 16 C 8.0022 4.6201 0.0 0
M  V30 17 C 6.6685 2.3101 0.0 0
M  V30 18 C 9.3360 3.8501 0.0 0
M  V30 19 C 8.0022 1.5400 0.0 0
M  V30 20 C 9.3360 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 4 18
M  V30 5 1 5 14
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 20
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 15
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N3-Methyl-3′,4-dinitro[1,1′-biphenyl]-3,4′-diamine
C13H12N4O4
1228653-87-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 4.6201 0.0 0
M  V30 2 C 1.3337 6.1601 0.0 0
M  V30 3 N 10.6695 3.8500 0.0 0 VAL=5
M  V30 4 O 12.0032 4.6201 0.0 0
M  V30 5 O 10.6695 2.3100 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 N 10.6695 6.9301 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 11 C 4.0011 4.6201 0.0 0
M  V30 12 C 5.3348 2.3100 0.0 0
M  V30 13 C 2.6673 3.8500 0.0 0
M  V30 14 C 4.0011 1.5400 0.0 0
M  V30 15 C 2.6673 2.3100 0.0 0
M  V30 16 C 6.6684 4.6201 0.0 0
M  V30 17 C 8.0021 3.8500 0.0 0
M  V30 18 C 6.6684 6.1601 0.0 0
M  V30 19 C 9.3359 4.6201 0.0 0
M  V30 20 C 8.0021 6.9301 0.0 0
M  V30 21 C 9.3359 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 19
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 15
M  V30 9 1 9 21
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 16
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1228653-84-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1228653-87-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-7028459
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N3-Methyl-3',4-dinitrobiphenyl-3,4'-diamine (Intermediate 2)
3'-Fluoro-3,4'-dinitrobiphenyl-4-amine (285mg, 1.03mmol) was suspended in
DCM (10mL). K2CO3 (284mg, 2.06mmol) was added, followed by MeNH2 (40% in
H2O, 10mL). The mixture was stirred at room temperature for 72h. The
solution was then washed with H2O and brine. The organic layer was dried
(MgSO4), filtered and concentrated in vacuo to afford the product as a
red solid (296mg, 100%). N3-Methyl-3',4-dinitrobiphenyl-3,4'-diamine
(Intermediate 2), Yield (296mg, 100%). 1H NMR (DMSO): 8.34 (1 H, d, J
2.2), 8.33-8.26 (1 H, m), 8.11 (1 H, d, J 9.0), 7.91 (1 H, dd, J 8.8 and
2.1), 7.71 (2 H, br s), 7.15 (1 H, d, J 9.0), 7.11-7.08 (1 H, m), 6.97 (1
H, dd, J 9.0 and 1.8) and 3.05 (3 H, d, J 5.0).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bibenzo[d]imidazoles and other biheteroaryl compounds as
antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wilson, Francis Xavier; Johnson, Peter David; Vickers, Richard; Storer,
Richard; Wynne, Graham Michael; Roach, Alan Geoffrey; De Moor, Olivier;
Dorgan, Colin Richard; Davis, Paul James
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010063996 A2 2010-06-10

$RFMT $RIREG SCHEME92 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Hydroxybenzaldehyde
C7H6O2
123-08-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 O 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(Methylimino)methyl]phenol
C8H9NO
5766-74-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 1.3337 0.0 0
M  V30 2 N 6.9301 2.6673 0.0 0
M  V30 3 C 8.4701 2.6673 0.0 0
M  V30 4 O 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-08-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5766-74-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-13907933
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quantitative Solid-State Reactions of Amines with Carbonyl Compounds and
Isothiocyanates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kaupp, Gerd; Schmeyers, Jens; Boy, Juergen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2000), 56(36), 6899-6911

$RFMT $RIREG SCHEME93 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzaldehyde
C8H8O2
123-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Methoxyphenyl)methylene]methanamine
C9H11NO
13114-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 5.3348 0.7700 0.0 0
M  V30 8 C 4.0012 3.0801 0.0 0
M  V30 9 C 4.0012 0.0000 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-11-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 13114-23-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-20473731
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of haloallylaminopyrazole derivatives for use as lysyl
oxidase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Findlay, Alison Dorothy; Turner, Craig Ivan; Deodhar, Mandar; Foot,
Jonathan Stuart; Zhou, Wenbin; Jarolimek, Wolfgang; Robertson, Alan
Duncan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018157190 A1 2018-09-07

$RFMT $RIREG SCHEME93 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzaldehyde
C8H8O2
123-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Methoxyphenyl)methylene]methanamine
C9H11NO
13114-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 5.3348 0.7700 0.0 0
M  V30 8 C 4.0012 3.0801 0.0 0
M  V30 9 C 4.0012 0.0000 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-11-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 13114-23-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-15847303
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7487-88-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Four-Electron Electrocyclic Ring-Opening/Intermolecular [4+2]
Cycloadditions of α-Hydroxycyclobutenones: Stereoselective Synthesis of
Multiple Substituted δ-Lactams
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Song, Peidong; Li, Qing; Wang, Congcong; Wu, Wenfa; Mao, Xu; Wang,
Jiajia; Hu, Xiangdong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2016), 358(8), 1208-1212

$RFMT $RIREG SCHEME93 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzaldehyde
C8H8O2
123-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Methoxyphenyl)methylene]methanamine
C9H11NO
13114-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 5.3348 0.7700 0.0 0
M  V30 8 C 4.0012 3.0801 0.0 0
M  V30 9 C 4.0012 0.0000 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-11-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 13114-23-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-8660901
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7487-88-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituent-Controlled Annuloselectivity and Stereoselectivity in the
Sulfa-Staudinger Cycloadditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhanhui; Chen, Ning; Xu, Jiaxi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2015), 80(7), 3611-3620

$RFMT $RIREG SCHEME94 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzaldehyde
C8H8O2
123-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-methoxybenzylamine
C9H13NO
702-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-11-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 702-24-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-17938287
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of a series of
resorcinol-based N-benzyl benzamide derivatives as potent Hsp90
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Park, Sun You; Oh, Yong Jin; Lho, Yunmee; Jeong, Ju Hui; Liu,
Kwang-Hyeon; Song, Jaeyoung; Kim, Soong-Hyun; Ha, Eunyoung; Seo, Young Ho
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2018), 143390-401

$RFMT $RIREG SCHEME95 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4′-(α-D-mannopyranosyloxy)[1,1′-biphenyl]-3-carboxylate
C20H22O8
1231607-98-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 1.5400 0.0 0
M  V30 2 O 2.6675 0.0000 0.0 0
M  V30 3 O 0.0000 1.5400 0.0 0
M  V30 4 C 2.6675 6.1601 0.0 0
M  V30 5 O 1.3338 6.9301 0.0 0
M  V30 6 O 0.0000 4.6201 0.0 0
M  V30 7 C 14.6707 3.8500 0.0 0
M  V30 8 O 16.0043 4.6201 0.0 0
M  V30 9 O 14.6707 2.3100 0.0 0
M  V30 10 C 17.3381 3.8500 0.0 0
M  V30 11 C 4.0011 2.3100 0.0 0 CFG=1
M  V30 12 C 2.6675 1.5400 0.0 0 CFG=1
M  V30 13 O 4.0011 3.8500 0.0 0
M  V30 14 C 1.3338 2.3100 0.0 0 CFG=1
M  V30 15 C 2.6675 4.6201 0.0 0 CFG=2
M  V30 16 C 1.3338 3.8500 0.0 0 CFG=2
M  V30 17 C 6.6686 2.3100 0.0 0
M  V30 18 C 8.0022 1.5400 0.0 0
M  V30 19 C 6.6686 3.8500 0.0 0
M  V30 20 C 9.3359 2.3100 0.0 0
M  V30 21 C 8.0022 4.6201 0.0 0
M  V30 22 C 9.3359 3.8500 0.0 0
M  V30 23 C 10.6695 4.6201 0.0 0
M  V30 24 C 12.0034 3.8500 0.0 0
M  V30 25 C 10.6695 6.1601 0.0 0
M  V30 26 C 13.3370 4.6201 0.0 0
M  V30 27 C 12.0034 6.9301 0.0 0
M  V30 28 C 13.3370 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 11 1 CFG=3
M  V30 2 1 1 17
M  V30 3 1 12 2 CFG=1
M  V30 4 1 14 3 CFG=1
M  V30 5 1 4 5
M  V30 6 1 15 4 CFG=1
M  V30 7 1 16 6 CFG=3
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 26
M  V30 11 1 8 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 1 22 23
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 11 12 14 15 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4′-(α-D-Mannopyranosyloxy)-N-methyl[1,1′-biphenyl]-3-carboxamide
C20H23NO7
1231608-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 1.5400 0.0 0
M  V30 2 O 2.6675 0.0000 0.0 0
M  V30 3 O 0.0000 1.5400 0.0 0
M  V30 4 C 2.6675 6.1601 0.0 0
M  V30 5 O 1.3338 6.9301 0.0 0
M  V30 6 O 0.0000 4.6201 0.0 0
M  V30 7 C 14.6707 3.8500 0.0 0
M  V30 8 N 16.0043 4.6201 0.0 0
M  V30 9 O 14.6707 2.3100 0.0 0
M  V30 10 C 17.3381 3.8500 0.0 0
M  V30 11 C 4.0011 2.3100 0.0 0 CFG=1
M  V30 12 C 2.6675 1.5400 0.0 0 CFG=1
M  V30 13 O 4.0011 3.8500 0.0 0
M  V30 14 C 1.3338 2.3100 0.0 0 CFG=1
M  V30 15 C 2.6675 4.6201 0.0 0 CFG=2
M  V30 16 C 1.3338 3.8500 0.0 0 CFG=2
M  V30 17 C 6.6686 2.3100 0.0 0
M  V30 18 C 8.0022 1.5400 0.0 0
M  V30 19 C 6.6686 3.8500 0.0 0
M  V30 20 C 9.3359 2.3100 0.0 0
M  V30 21 C 8.0022 4.6201 0.0 0
M  V30 22 C 9.3359 3.8500 0.0 0
M  V30 23 C 10.6695 4.6201 0.0 0
M  V30 24 C 12.0034 3.8500 0.0 0
M  V30 25 C 10.6695 6.1601 0.0 0
M  V30 26 C 13.3370 4.6201 0.0 0
M  V30 27 C 12.0034 6.9301 0.0 0
M  V30 28 C 13.3370 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 11 1 CFG=3
M  V30 2 1 1 17
M  V30 3 1 12 2 CFG=1
M  V30 4 1 14 3 CFG=1
M  V30 5 1 4 5
M  V30 6 1 15 4 CFG=1
M  V30 7 1 16 6 CFG=3
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 26
M  V30 11 1 8 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 1 22 23
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 11 12 14 15 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1231607-98-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1231608-05-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1565212
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
N1,N3-Dimethyl-5-[4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxyphenyl]benzene-1,3-dicarboxamide
(15b). 15a (0.050 g, 0.11 mmol) was stirred with 15 mL of MeNH2/EtOH (33
wt %) at room temperature for 40 h. The solvent was removed and the
residue was dried in vacuo.
N-Methyl-3-[4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)
tetrahydropyran-2-yl]oxyphenyl]benzamide (14a). 14a was prepared by
direct amination of 8e, using the same method as for 15b, in quantitative
yield and in pure form. 1H NMR (300 MHz, methanol-d 4) δ ppm 2.94 (s, 3
H), 3.63 (ddd, J =7.28, 4.81, 2.47 Hz, 1 H), 3.69-3.85 (m, 3 H),
3.87-3.98 (m, 1 H), 4.04 (dd, J =3.30, 1.65 Hz, 1 H), 5.54 (d, J =1.92
Hz, 1 H), 7.10-7.27 (m, 2 H), 7.42-7.53 (m, 1 H), 7.54-7.65 (m, 2 H),
7.66-7.79 (m, 2 H), 8.01 (t, J =1.79 Hz, 1 H). MS (ESI): found [M + H]+ ,
390.1.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-Based Drug Design and Optimization of Mannoside Bacterial FimH
Antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Han, Zhenfu; Pinkner, Jerome S.; Ford, Bradley; Obermann, Robert; Nolan,
William; Wildman, Scott A.; Hobbs, Doug; Ellenberger, Tom; Cusumano,
Corinne K.; Hultgren, Scott J.; Janetka, James W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2010), 53(12), 4779-4792

$RFMT $RIREG SCHEME96 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Dimethyl 4′-(α-D-mannopyranosyloxy)[1,1′-biphenyl]-3,5-dicarboxylate
C22H24O10
1231608-50-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 12.0032 2.3100 0.0 0
M  V30 2 O 13.3369 1.5400 0.0 0
M  V30 3 O 10.6694 1.5400 0.0 0
M  V30 4 C 13.3369 0.0000 0.0 0
M  V30 5 C 14.6705 6.9300 0.0 0
M  V30 6 O 16.0041 6.1600 0.0 0
M  V30 7 O 14.6705 8.4700 0.0 0
M  V30 8 C 17.3379 6.9300 0.0 0
M  V30 9 O 5.3347 9.2400 0.0 0
M  V30 10 O 2.6674 10.7800 0.0 0
M  V30 11 C 2.6674 4.6200 0.0 0
M  V30 12 O 1.3338 3.8500 0.0 0
M  V30 13 O 0.0000 9.2400 0.0 0
M  V30 14 O 0.0000 6.1600 0.0 0
M  V30 15 C 10.6694 6.1600 0.0 0
M  V30 16 C 10.6694 4.6200 0.0 0
M  V30 17 C 12.0032 6.9300 0.0 0
M  V30 18 C 12.0032 3.8500 0.0 0
M  V30 19 C 13.3369 6.1600 0.0 0
M  V30 20 C 13.3369 4.6200 0.0 0
M  V30 21 C 9.3358 6.9300 0.0 0
M  V30 22 C 9.3358 8.4700 0.0 0
M  V30 23 C 8.0021 6.1600 0.0 0
M  V30 24 C 8.0021 9.2400 0.0 0
M  V30 25 C 6.6685 6.9300 0.0 0
M  V30 26 C 6.6685 8.4700 0.0 0
M  V30 27 C 4.0011 8.4700 0.0 0 CFG=2
M  V30 28 O 4.0011 6.9300 0.0 0
M  V30 29 C 2.6674 9.2400 0.0 0 CFG=1
M  V30 30 C 2.6674 6.1600 0.0 0 CFG=2
M  V30 31 C 1.3338 8.4700 0.0 0 CFG=1
M  V30 32 C 1.3338 6.9300 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 19
M  V30 8 1 6 8
M  V30 9 1 9 26
M  V30 10 1 27 9 CFG=1
M  V30 11 1 29 10 CFG=3
M  V30 12 1 11 12
M  V30 13 1 30 11 CFG=3
M  V30 14 1 31 13 CFG=3
M  V30 15 1 32 14 CFG=1
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 15 21
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 1 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 27 29 30 31 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4′-(α-D-Mannopyranosyloxy)-N3,N5-dimethyl[1,1′-biphenyl]-3,5-dicarboxamide
C22H26N2O8
1231608-54-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 12.0032 2.3100 0.0 0
M  V30 2 N 13.3369 1.5400 0.0 0
M  V30 3 O 10.6694 1.5400 0.0 0
M  V30 4 C 13.3369 0.0000 0.0 0
M  V30 5 C 14.6705 6.9300 0.0 0
M  V30 6 N 16.0041 6.1600 0.0 0
M  V30 7 O 14.6705 8.4700 0.0 0
M  V30 8 C 17.3379 6.9300 0.0 0
M  V30 9 O 5.3347 9.2400 0.0 0
M  V30 10 O 2.6674 10.7800 0.0 0
M  V30 11 C 2.6674 4.6200 0.0 0
M  V30 12 O 1.3338 3.8500 0.0 0
M  V30 13 O 0.0000 9.2400 0.0 0
M  V30 14 O 0.0000 6.1600 0.0 0
M  V30 15 C 10.6694 6.1600 0.0 0
M  V30 16 C 10.6694 4.6200 0.0 0
M  V30 17 C 12.0032 6.9300 0.0 0
M  V30 18 C 12.0032 3.8500 0.0 0
M  V30 19 C 13.3369 6.1600 0.0 0
M  V30 20 C 13.3369 4.6200 0.0 0
M  V30 21 C 9.3358 6.9300 0.0 0
M  V30 22 C 9.3358 8.4700 0.0 0
M  V30 23 C 8.0021 6.1600 0.0 0
M  V30 24 C 8.0021 9.2400 0.0 0
M  V30 25 C 6.6685 6.9300 0.0 0
M  V30 26 C 6.6685 8.4700 0.0 0
M  V30 27 C 4.0011 8.4700 0.0 0 CFG=2
M  V30 28 O 4.0011 6.9300 0.0 0
M  V30 29 C 2.6674 9.2400 0.0 0 CFG=1
M  V30 30 C 2.6674 6.1600 0.0 0 CFG=2
M  V30 31 C 1.3338 8.4700 0.0 0 CFG=1
M  V30 32 C 1.3338 6.9300 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 19
M  V30 8 1 6 8
M  V30 9 1 9 26
M  V30 10 1 27 9 CFG=1
M  V30 11 1 29 10 CFG=3
M  V30 12 1 11 12
M  V30 13 1 30 11 CFG=3
M  V30 14 1 31 13 CFG=3
M  V30 15 1 32 14 CFG=1
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 15 21
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 1 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 27 29 30 31 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1231608-50-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1231608-54-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4347183
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compounds and methods for treating bacterial infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Janetka, James W.; Han, Zhenfu; Hultgren, Scott; Pinkner, Jerome S.;
Cusumano, Corinne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20120309701 A1 2012-12-06

$RFMT $RIREG SCHEME96 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Dimethyl 4′-(α-D-mannopyranosyloxy)[1,1′-biphenyl]-3,5-dicarboxylate
C22H24O10
1231608-50-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 12.0032 2.3100 0.0 0
M  V30 2 O 13.3369 1.5400 0.0 0
M  V30 3 O 10.6694 1.5400 0.0 0
M  V30 4 C 13.3369 0.0000 0.0 0
M  V30 5 C 14.6705 6.9300 0.0 0
M  V30 6 O 16.0041 6.1600 0.0 0
M  V30 7 O 14.6705 8.4700 0.0 0
M  V30 8 C 17.3379 6.9300 0.0 0
M  V30 9 O 5.3347 9.2400 0.0 0
M  V30 10 O 2.6674 10.7800 0.0 0
M  V30 11 C 2.6674 4.6200 0.0 0
M  V30 12 O 1.3338 3.8500 0.0 0
M  V30 13 O 0.0000 9.2400 0.0 0
M  V30 14 O 0.0000 6.1600 0.0 0
M  V30 15 C 10.6694 6.1600 0.0 0
M  V30 16 C 10.6694 4.6200 0.0 0
M  V30 17 C 12.0032 6.9300 0.0 0
M  V30 18 C 12.0032 3.8500 0.0 0
M  V30 19 C 13.3369 6.1600 0.0 0
M  V30 20 C 13.3369 4.6200 0.0 0
M  V30 21 C 9.3358 6.9300 0.0 0
M  V30 22 C 9.3358 8.4700 0.0 0
M  V30 23 C 8.0021 6.1600 0.0 0
M  V30 24 C 8.0021 9.2400 0.0 0
M  V30 25 C 6.6685 6.9300 0.0 0
M  V30 26 C 6.6685 8.4700 0.0 0
M  V30 27 C 4.0011 8.4700 0.0 0 CFG=2
M  V30 28 O 4.0011 6.9300 0.0 0
M  V30 29 C 2.6674 9.2400 0.0 0 CFG=1
M  V30 30 C 2.6674 6.1600 0.0 0 CFG=2
M  V30 31 C 1.3338 8.4700 0.0 0 CFG=1
M  V30 32 C 1.3338 6.9300 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 19
M  V30 8 1 6 8
M  V30 9 1 9 26
M  V30 10 1 27 9 CFG=1
M  V30 11 1 29 10 CFG=3
M  V30 12 1 11 12
M  V30 13 1 30 11 CFG=3
M  V30 14 1 31 13 CFG=3
M  V30 15 1 32 14 CFG=1
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 15 21
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 1 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 27 29 30 31 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4′-(α-D-Mannopyranosyloxy)-N3,N5-dimethyl[1,1′-biphenyl]-3,5-dicarboxamide
C22H26N2O8
1231608-54-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 12.0032 2.3100 0.0 0
M  V30 2 N 13.3369 1.5400 0.0 0
M  V30 3 O 10.6694 1.5400 0.0 0
M  V30 4 C 13.3369 0.0000 0.0 0
M  V30 5 C 14.6705 6.9300 0.0 0
M  V30 6 N 16.0041 6.1600 0.0 0
M  V30 7 O 14.6705 8.4700 0.0 0
M  V30 8 C 17.3379 6.9300 0.0 0
M  V30 9 O 5.3347 9.2400 0.0 0
M  V30 10 O 2.6674 10.7800 0.0 0
M  V30 11 C 2.6674 4.6200 0.0 0
M  V30 12 O 1.3338 3.8500 0.0 0
M  V30 13 O 0.0000 9.2400 0.0 0
M  V30 14 O 0.0000 6.1600 0.0 0
M  V30 15 C 10.6694 6.1600 0.0 0
M  V30 16 C 10.6694 4.6200 0.0 0
M  V30 17 C 12.0032 6.9300 0.0 0
M  V30 18 C 12.0032 3.8500 0.0 0
M  V30 19 C 13.3369 6.1600 0.0 0
M  V30 20 C 13.3369 4.6200 0.0 0
M  V30 21 C 9.3358 6.9300 0.0 0
M  V30 22 C 9.3358 8.4700 0.0 0
M  V30 23 C 8.0021 6.1600 0.0 0
M  V30 24 C 8.0021 9.2400 0.0 0
M  V30 25 C 6.6685 6.9300 0.0 0
M  V30 26 C 6.6685 8.4700 0.0 0
M  V30 27 C 4.0011 8.4700 0.0 0 CFG=2
M  V30 28 O 4.0011 6.9300 0.0 0
M  V30 29 C 2.6674 9.2400 0.0 0 CFG=1
M  V30 30 C 2.6674 6.1600 0.0 0 CFG=2
M  V30 31 C 1.3338 8.4700 0.0 0 CFG=1
M  V30 32 C 1.3338 6.9300 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 19
M  V30 8 1 6 8
M  V30 9 1 9 26
M  V30 10 1 27 9 CFG=1
M  V30 11 1 29 10 CFG=3
M  V30 12 1 11 12
M  V30 13 1 30 11 CFG=3
M  V30 14 1 31 13 CFG=3
M  V30 15 1 32 14 CFG=1
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 15 21
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 1 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 27 29 30 31 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1231608-50-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1231608-54-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8719647
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM [0133] 4. Procedure for the preparation of
N1,N3-dimethyl-5-[4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxhenyl]benzene-1,3-dicarboxamide
(50): [0134] 35 (0.050 g, 0.11 mmol) was stirred with 15 mL of MeNH2/EtOH
(33 wt.%) at rt for 40 hrs. The solvent was removed and the residue was
dried in vacuo to afford pure 50 (0.050 g) in quantitative yield. 1H NMR
(300 MHz, METHANOL-d4) δ ppm 2.96 (s, 6 H) 3.61-3.66 (m, 1 H) 3.67-3.84
(m, 3 H) 3.86-3.97 (m, 1 H) 4.04 (dd, J=3.30, 1.92 Hz, 1 H) 5.56 (d,
J=1.92 Hz, 1 H) 7.21-7.34 (m, 2 H) 7.63-7.74 (m, 2 H) 8.13-8.26 (m, 3 H).
MS (ESI): found: [M+ H]+, 447.4. (see Table 4)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compounds and methods for treating bacterial infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Janetka, James W.; Han, Zhenfu; Hultgren, Scott; Pinkner, Jerry;
Cusumano, Corrine
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011050323 A1 2011-04-28

$RFMT $RIREG SCHEME96 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Dimethyl 4′-(α-D-mannopyranosyloxy)[1,1′-biphenyl]-3,5-dicarboxylate
C22H24O10
1231608-50-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 12.0032 2.3100 0.0 0
M  V30 2 O 13.3369 1.5400 0.0 0
M  V30 3 O 10.6694 1.5400 0.0 0
M  V30 4 C 13.3369 0.0000 0.0 0
M  V30 5 C 14.6705 6.9300 0.0 0
M  V30 6 O 16.0041 6.1600 0.0 0
M  V30 7 O 14.6705 8.4700 0.0 0
M  V30 8 C 17.3379 6.9300 0.0 0
M  V30 9 O 5.3347 9.2400 0.0 0
M  V30 10 O 2.6674 10.7800 0.0 0
M  V30 11 C 2.6674 4.6200 0.0 0
M  V30 12 O 1.3338 3.8500 0.0 0
M  V30 13 O 0.0000 9.2400 0.0 0
M  V30 14 O 0.0000 6.1600 0.0 0
M  V30 15 C 10.6694 6.1600 0.0 0
M  V30 16 C 10.6694 4.6200 0.0 0
M  V30 17 C 12.0032 6.9300 0.0 0
M  V30 18 C 12.0032 3.8500 0.0 0
M  V30 19 C 13.3369 6.1600 0.0 0
M  V30 20 C 13.3369 4.6200 0.0 0
M  V30 21 C 9.3358 6.9300 0.0 0
M  V30 22 C 9.3358 8.4700 0.0 0
M  V30 23 C 8.0021 6.1600 0.0 0
M  V30 24 C 8.0021 9.2400 0.0 0
M  V30 25 C 6.6685 6.9300 0.0 0
M  V30 26 C 6.6685 8.4700 0.0 0
M  V30 27 C 4.0011 8.4700 0.0 0 CFG=2
M  V30 28 O 4.0011 6.9300 0.0 0
M  V30 29 C 2.6674 9.2400 0.0 0 CFG=1
M  V30 30 C 2.6674 6.1600 0.0 0 CFG=2
M  V30 31 C 1.3338 8.4700 0.0 0 CFG=1
M  V30 32 C 1.3338 6.9300 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 19
M  V30 8 1 6 8
M  V30 9 1 9 26
M  V30 10 1 27 9 CFG=1
M  V30 11 1 29 10 CFG=3
M  V30 12 1 11 12
M  V30 13 1 30 11 CFG=3
M  V30 14 1 31 13 CFG=3
M  V30 15 1 32 14 CFG=1
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 15 21
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 1 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 27 29 30 31 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4′-(α-D-Mannopyranosyloxy)-N3,N5-dimethyl[1,1′-biphenyl]-3,5-dicarboxamide
C22H26N2O8
1231608-54-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 12.0032 2.3100 0.0 0
M  V30 2 N 13.3369 1.5400 0.0 0
M  V30 3 O 10.6694 1.5400 0.0 0
M  V30 4 C 13.3369 0.0000 0.0 0
M  V30 5 C 14.6705 6.9300 0.0 0
M  V30 6 N 16.0041 6.1600 0.0 0
M  V30 7 O 14.6705 8.4700 0.0 0
M  V30 8 C 17.3379 6.9300 0.0 0
M  V30 9 O 5.3347 9.2400 0.0 0
M  V30 10 O 2.6674 10.7800 0.0 0
M  V30 11 C 2.6674 4.6200 0.0 0
M  V30 12 O 1.3338 3.8500 0.0 0
M  V30 13 O 0.0000 9.2400 0.0 0
M  V30 14 O 0.0000 6.1600 0.0 0
M  V30 15 C 10.6694 6.1600 0.0 0
M  V30 16 C 10.6694 4.6200 0.0 0
M  V30 17 C 12.0032 6.9300 0.0 0
M  V30 18 C 12.0032 3.8500 0.0 0
M  V30 19 C 13.3369 6.1600 0.0 0
M  V30 20 C 13.3369 4.6200 0.0 0
M  V30 21 C 9.3358 6.9300 0.0 0
M  V30 22 C 9.3358 8.4700 0.0 0
M  V30 23 C 8.0021 6.1600 0.0 0
M  V30 24 C 8.0021 9.2400 0.0 0
M  V30 25 C 6.6685 6.9300 0.0 0
M  V30 26 C 6.6685 8.4700 0.0 0
M  V30 27 C 4.0011 8.4700 0.0 0 CFG=2
M  V30 28 O 4.0011 6.9300 0.0 0
M  V30 29 C 2.6674 9.2400 0.0 0 CFG=1
M  V30 30 C 2.6674 6.1600 0.0 0 CFG=2
M  V30 31 C 1.3338 8.4700 0.0 0 CFG=1
M  V30 32 C 1.3338 6.9300 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 19
M  V30 8 1 6 8
M  V30 9 1 9 26
M  V30 10 1 27 9 CFG=1
M  V30 11 1 29 10 CFG=3
M  V30 12 1 11 12
M  V30 13 1 30 11 CFG=3
M  V30 14 1 31 13 CFG=3
M  V30 15 1 32 14 CFG=1
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 15 21
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 1 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 27 29 30 31 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1231608-50-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1231608-54-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9434734
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N1,N3-Dimethyl-5-[4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxyphenyl]benzene-1,3-dicarboxamide
(15b). 15a (0.050 g, 0.11 mmol) was stirred with 15 mL of MeNH2/EtOH (33
wt %) at room temperature for 40 h. The solvent was removed and the
residue was dried in vacuo. Pure 15b (0.050 g) in quantitative yield. 1H
NMR (300 MHz, methanol-d 4) δ ppm 2.96 (s, 6 H), 3.61-3.66 (m, 1 H),
3.67-3.84 (m, 3 H), 3.86-3.97 (m, 1 H), 4.04 (dd, J = 3.30, 1.92 Hz, 1
H), 5.56 (d, J =1.92 Hz, 1 H), 7.21-7.34 (m, 2 H), 7.63-7.74 (m, 2 H),
8.13-8.26 (m, 3 H). MS (ESI): found [M + H]+ , 447.4.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-Based Drug Design and Optimization of Mannoside Bacterial FimH
Antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Han, Zhenfu; Pinkner, Jerome S.; Ford, Bradley; Obermann, Robert; Nolan,
William; Wildman, Scott A.; Hobbs, Doug; Ellenberger, Tom; Cusumano,
Corinne K.; Hultgren, Scott J.; Janetka, James W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2010), 53(12), 4779-4792

$RFMT $RIREG SCHEME97 STEP1
$RXN



  2  1
$MOL
3-[[(2-Chlorophenyl)amino]carbonyl]-7-[[[(1S)-5-[(1,1-dimethylethoxy)carbonyl...
C30H28ClN5O6
1234490-59-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 46 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.4666 4.6627 0.0 0
M  V30 2 N 4.2207 5.5679 0.0 0
M  V30 3 O 5.3056 3.1311 0.0 0
M  V30 4 C 11.9606 6.1041 0.0 0
M  V30 5 N 13.4253 5.6283 0.0 0
M  V30 6 O 11.6405 7.6106 0.0 0
M  V30 7 C 10.3120 1.0306 0.0 0
M  V30 8 O 11.7767 0.5546 0.0 0
M  V30 9 O 9.1677 0.0000 0.0 0
M  V30 10 Cl 1.7288 7.3783 0.0 0
M  V30 11 C 19.1562 9.0060 0.0 0
M  V30 12 C 20.6962 6.3385 0.0 0
M  V30 13 O 21.4662 5.0049 0.0 0
M  V30 14 O 21.4662 7.6722 0.0 0
M  V30 15 C 23.0062 5.0049 0.0 0
M  V30 16 C 23.0062 6.5449 0.0 0
M  V30 17 C 24.5462 5.0049 0.0 0
M  V30 18 C 23.0062 3.4649 0.0 0
M  V30 19 C 8.2072 4.5192 0.0 0
M  V30 20 N 9.3515 5.5496 0.0 0
M  V30 21 C 6.8734 5.2892 0.0 0
M  V30 22 N 8.5273 3.0127 0.0 0
M  V30 23 C 10.8162 5.0737 0.0 0
M  V30 24 N 8.7252 6.9564 0.0 0
M  V30 25 C 7.1937 6.7954 0.0 0
M  V30 26 C 9.9919 2.5369 0.0 0
M  V30 27 C 11.1364 3.5673 0.0 0
M  V30 28 C 2.8137 4.9416 0.0 0
M  V30 29 C 1.5679 5.8468 0.0 0
M  V30 30 C 2.6528 3.4100 0.0 0
M  V30 31 C 0.1611 5.2203 0.0 0
M  V30 32 C 1.2460 2.7836 0.0 0
M  V30 33 C 0.0000 3.6888 0.0 0
M  V30 34 C 14.5697 6.6587 0.0 0 CFG=1
M  V30 35 C 16.0761 6.3385 0.0 0
M  V30 36 C 14.4088 8.1904 0.0 0
M  V30 37 C 16.8461 7.6722 0.0 0
M  V30 38 C 16.8461 5.0049 0.0 0
M  V30 39 C 15.8156 8.8167 0.0 0
M  V30 40 C 18.3862 7.6722 0.0 0
M  V30 41 C 18.3862 5.0049 0.0 0
M  V30 42 C 19.1562 6.3385 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 2 28
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 23
M  V30 8 1 34 5 CFG=1
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 7 26
M  V30 12 1 10 29
M  V30 13 1 11 40
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 12 42
M  V30 17 1 13 15
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 1 15 18
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 1 19 22
M  V30 24 1 20 23
M  V30 25 1 20 24
M  V30 26 1 21 25
M  V30 27 2 22 26
M  V30 28 2 23 27
M  V30 29 2 24 25
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 37 1 34 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 2 35 38
M  V30 41 1 36 39
M  V30 42 1 37 39
M  V30 43 2 37 40
M  V30 44 1 38 41
M  V30 45 1 40 42
M  V30 46 2 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 34)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (1S)-1-[[[3-[[(2-chlorophenyl)amino]carbonyl]-5-[(methylami...
C31H31ClN6O5
943760-60-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 47 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.5495 6.8704 0.0 0
M  V30 2 N 4.5191 8.0148 0.0 0
M  V30 3 O 5.0736 5.4057 0.0 0
M  V30 4 C 12.2015 6.9302 0.0 0
M  V30 5 N 13.5352 6.1601 0.0 0
M  V30 6 O 12.2015 8.4702 0.0 0
M  V30 7 C 9.5340 2.3101 0.0 0
M  V30 8 N 8.2004 1.5400 0.0 0
M  V30 9 O 10.8679 1.5400 0.0 0
M  V30 10 C 8.2004 0.0000 0.0 0
M  V30 11 Cl 2.4580 10.3038 0.0 0
M  V30 12 C 19.8432 8.2724 0.0 0
M  V30 13 C 20.7949 5.3431 0.0 0
M  V30 14 O 21.2709 3.8784 0.0 0
M  V30 15 O 21.8255 6.4875 0.0 0
M  V30 16 C 22.7773 3.5582 0.0 0
M  V30 17 C 23.0974 5.0647 0.0 0
M  V30 18 C 24.2836 3.2381 0.0 0
M  V30 19 C 22.4571 2.0519 0.0 0
M  V30 20 C 8.2004 6.1601 0.0 0
M  V30 21 N 9.5340 6.9302 0.0 0
M  V30 22 C 7.0560 7.1906 0.0 0
M  V30 23 N 8.2004 4.6201 0.0 0
M  V30 24 C 10.8679 6.1601 0.0 0
M  V30 25 N 9.2139 8.4365 0.0 0
M  V30 26 C 7.6823 8.5974 0.0 0
M  V30 27 C 9.5340 3.8501 0.0 0
M  V30 28 C 10.8679 4.6201 0.0 0
M  V30 29 C 3.0126 7.6946 0.0 0
M  V30 30 C 1.9822 8.8392 0.0 0
M  V30 31 C 2.5367 6.2301 0.0 0
M  V30 32 C 0.4759 8.5190 0.0 0
M  V30 33 C 1.0304 5.9099 0.0 0
M  V30 34 C 0.0000 7.0543 0.0 0
M  V30 35 C 14.8689 6.9302 0.0 0 CFG=1
M  V30 36 C 16.2758 6.3037 0.0 0
M  V30 37 C 15.0300 8.4617 0.0 0
M  V30 38 C 17.3063 7.4482 0.0 0
M  V30 39 C 16.7517 4.8391 0.0 0
M  V30 40 C 16.5363 8.7819 0.0 0
M  V30 41 C 18.8127 7.1280 0.0 0
M  V30 42 C 18.2582 4.5189 0.0 0
M  V30 43 C 19.2886 5.6633 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 22
M  V30 4 1 2 29
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 24
M  V30 8 1 35 5 CFG=1
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 7 27
M  V30 12 1 8 10
M  V30 13 1 11 30
M  V30 14 1 12 41
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 1 13 43
M  V30 18 1 14 16
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 16 19
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 1 20 23
M  V30 25 1 21 24
M  V30 26 1 21 25
M  V30 27 1 22 26
M  V30 28 2 23 27
M  V30 29 2 24 28
M  V30 30 2 25 26
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 38 1 35 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 2 36 39
M  V30 42 1 37 40
M  V30 43 1 38 40
M  V30 44 2 38 41
M  V30 45 1 39 42
M  V30 46 1 41 43
M  V30 47 2 42 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 35)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1234490-59-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 943760-60-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-6086127
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Step D. To a solution of
(S)-7-(5-tert-butoxycarbonyl-4-methyl-indan-1-ylcarbamoyl)-5-(3,4-difluoro-benzylcarbamoyl)-pyrazolo[1,5-a]pyrimidine-3-carboxylic
acid (8 mg), and DMF (1 μL) in CH2Cl2 (0.3 mL) at 0° C. was added oxalyl
chloride (5 μl). The solution was allowed to warm to 22° C. stirred for 3
h and concentrated. The resulting residue was brought up in CH2Cl2 (0.2
mL) and cooled to 0° C. To this cooled solution were added triethyl amine
(4 μl.) and a solution of morpho line (4 μl.) in CH2Cl2 (0.2 mL). The
resulting solution was stirred at 22° C. for 18 h and absorbed onto
silica and purified by silica gel chromatography. Prep.Ex. #: 51. Yield
100%. [M- H]-: 601.5.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of hetero-bicyclic carbamoyl pyrazolopyrimidine derivatives
as metalloprotease inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gallagher, Brian M.; Van Veldhuizen, Joshua; Wu, Xinyuan; Deng, Hongbo;
Sucholeiki, Irving; Hochguertel, Matthias; Bluhm, Harald; Taveras, Arthur
G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20070155737 A1 2007-07-05

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[2-chloro-6-[[(methylsulfonyl)oxy]methyl]thieno[3,2-d]pyr...
C18H19ClN4O5S2
1235451-21-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 5.3348 0.0 0
M  V30 2 C 5.3901 4.0012 0.0 0
M  V30 3 O 4.6201 2.6673 0.0 0
M  V30 4 O 6.9302 4.0012 0.0 0
M  V30 5 C 5.3901 1.3337 0.0 0
M  V30 6 C 4.0564 0.5637 0.0 0
M  V30 7 C 6.1601 0.0000 0.0 0
M  V30 8 C 6.7238 2.1037 0.0 0
M  V30 9 Cl 4.6201 10.6697 0.0 0
M  V30 10 C 10.7012 5.3804 0.0 0
M  V30 11 O 12.0349 6.1504 0.0 0
M  V30 12 S 13.3687 5.3804 0.0 0 VAL=6
M  V30 13 C 14.1387 6.7141 0.0 0
M  V30 14 O 14.7024 4.6104 0.0 0
M  V30 15 O 12.5987 4.0467 0.0 0
M  V30 16 C 5.3901 6.6685 0.0 0
M  V30 17 C 6.9302 6.6685 0.0 0
M  V30 18 N 4.6201 8.0023 0.0 0
M  V30 19 C 7.7002 8.0023 0.0 0
M  V30 20 S 7.9606 5.5241 0.0 0
M  V30 21 C 5.3901 9.3360 0.0 0
M  V30 22 C 9.2066 7.6820 0.0 0
M  V30 23 N 6.9302 9.3360 0.0 0
M  V30 24 C 9.3676 6.1504 0.0 0
M  V30 25 C 3.0801 5.3348 0.0 0
M  V30 26 C 2.3101 6.6685 0.0 0
M  V30 27 N 2.3101 4.0012 0.0 0
M  V30 28 C 0.7700 6.6685 0.0 0
M  V30 29 C 0.7700 4.0012 0.0 0
M  V30 30 C 0.0000 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 1 25
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 1 10 24
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 2 12 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 2 18 21
M  V30 22 1 19 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methyl-4-(2-pyridinylamino)thieno[3,2-d]pyrimidine-6-methanamine
C13H12ClN5S
1235451-22-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 5.3348 0.0 0
M  V30 2 C 10.7011 5.2892 0.0 0
M  V30 3 N 12.0347 4.5192 0.0 0
M  V30 4 C 13.3685 5.2892 0.0 0
M  V30 5 Cl 4.6200 0.0000 0.0 0
M  V30 6 C 6.9301 4.0011 0.0 0
M  V30 7 C 5.3900 4.0011 0.0 0
M  V30 8 C 7.7001 2.6675 0.0 0
M  V30 9 S 7.9606 5.1456 0.0 0
M  V30 10 N 4.6200 2.6675 0.0 0
M  V30 11 C 9.2065 2.9876 0.0 0
M  V30 12 N 6.9301 1.3338 0.0 0
M  V30 13 C 9.3674 4.5192 0.0 0
M  V30 14 C 5.3900 1.3338 0.0 0
M  V30 15 C 3.0800 5.3348 0.0 0
M  V30 16 C 2.3100 6.6686 0.0 0
M  V30 17 N 2.3100 4.0011 0.0 0
M  V30 18 C 0.7700 6.6686 0.0 0
M  V30 19 C 0.7700 4.0011 0.0 0
M  V30 20 C 0.0000 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 2 13
M  V30 5 1 3 4
M  V30 6 1 5 14
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 2 11 13
M  V30 16 1 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1235451-21-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1235451-22-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-13211382
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Deazapurines, thienopyrimidines and furopyrimidines as phosphoinositide
3-kinase inhibitors with a zinc binding moiety and their preparation and
use in the treatment of diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cai, Xiong; Zhai, Haixiao; Lai, Chengjung; Qian, Changgeng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20120088764 A1 2012-04-12

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[2-chloro-6-[[(methylsulfonyl)oxy]methyl]thieno[3,2-d]pyr...
C18H19ClN4O5S2
1235451-21-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 5.3348 0.0 0
M  V30 2 C 5.3901 4.0012 0.0 0
M  V30 3 O 4.6201 2.6673 0.0 0
M  V30 4 O 6.9302 4.0012 0.0 0
M  V30 5 C 5.3901 1.3337 0.0 0
M  V30 6 C 4.0564 0.5637 0.0 0
M  V30 7 C 6.1601 0.0000 0.0 0
M  V30 8 C 6.7238 2.1037 0.0 0
M  V30 9 Cl 4.6201 10.6697 0.0 0
M  V30 10 C 10.7012 5.3804 0.0 0
M  V30 11 O 12.0349 6.1504 0.0 0
M  V30 12 S 13.3687 5.3804 0.0 0 VAL=6
M  V30 13 C 14.1387 6.7141 0.0 0
M  V30 14 O 14.7024 4.6104 0.0 0
M  V30 15 O 12.5987 4.0467 0.0 0
M  V30 16 C 5.3901 6.6685 0.0 0
M  V30 17 C 6.9302 6.6685 0.0 0
M  V30 18 N 4.6201 8.0023 0.0 0
M  V30 19 C 7.7002 8.0023 0.0 0
M  V30 20 S 7.9606 5.5241 0.0 0
M  V30 21 C 5.3901 9.3360 0.0 0
M  V30 22 C 9.2066 7.6820 0.0 0
M  V30 23 N 6.9302 9.3360 0.0 0
M  V30 24 C 9.3676 6.1504 0.0 0
M  V30 25 C 3.0801 5.3348 0.0 0
M  V30 26 C 2.3101 6.6685 0.0 0
M  V30 27 N 2.3101 4.0012 0.0 0
M  V30 28 C 0.7700 6.6685 0.0 0
M  V30 29 C 0.7700 4.0012 0.0 0
M  V30 30 C 0.0000 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 1 25
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 1 10 24
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 2 12 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 2 18 21
M  V30 22 1 19 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methyl-4-(2-pyridinylamino)thieno[3,2-d]pyrimidine-6-methanamine
C13H12ClN5S
1235451-22-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 5.3348 0.0 0
M  V30 2 C 10.7011 5.2892 0.0 0
M  V30 3 N 12.0347 4.5192 0.0 0
M  V30 4 C 13.3685 5.2892 0.0 0
M  V30 5 Cl 4.6200 0.0000 0.0 0
M  V30 6 C 6.9301 4.0011 0.0 0
M  V30 7 C 5.3900 4.0011 0.0 0
M  V30 8 C 7.7001 2.6675 0.0 0
M  V30 9 S 7.9606 5.1456 0.0 0
M  V30 10 N 4.6200 2.6675 0.0 0
M  V30 11 C 9.2065 2.9876 0.0 0
M  V30 12 N 6.9301 1.3338 0.0 0
M  V30 13 C 9.3674 4.5192 0.0 0
M  V30 14 C 5.3900 1.3338 0.0 0
M  V30 15 C 3.0800 5.3348 0.0 0
M  V30 16 C 2.3100 6.6686 0.0 0
M  V30 17 N 2.3100 4.0011 0.0 0
M  V30 18 C 0.7700 6.6686 0.0 0
M  V30 19 C 0.7700 4.0011 0.0 0
M  V30 20 C 0.0000 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 2 13
M  V30 5 1 3 4
M  V30 6 1 5 14
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 2 11 13
M  V30 16 1 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1235451-21-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1235451-22-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-2182343
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Step 58f:
2-Chloro-6-((methylamino)methyl)-N-phenylthieno[3,2-d]pyrimidin-4-amine
(Compound 0706-164) Compound 0705-164 (600 mg, 1.279 mmol) was dissolved
in a solution of 32% MeNH2 in MeOH (5 mL). This solution was stirred at
room temperature for 1 h. The solvent was removed under reduced pressure
and the residue was washed with water, filtered to obtained 0706-164.
Step 59f:
2-Chloro-6-((methylamino)methyl)-N-(pyridin-2-yl)thieno[3,2-d]pyrimidin-4-amine
(Compound 0706-168) The title compound 0706-168 was prepared (1.80 g,
100%) as a white solid from 0705-168 (2.00 g, 4.255 mmol) and 32% MeNH2
in MeOH (5 mL) using a procedure similar to that described for compound
0706-164 (Example 58). LCMS: 306 [M+1]+. 1H NMR (400 MHz, DMSO-d6): δ
2.32 (s, 3H), 3.97 (s, 2H), 7.15 (m, 1H), 7.26 (s, 1H), 7.83 (m, 2H),
8.38 (m, 1H), 9.71 (s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Treatment of cancers having k-ras mutations using PI3 kinase and HDAC
inhibitors and preparation of bifunctional thienopyrimidine compounds
that inhibit both enzymes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bao, Rudi; Lai, Chengjung; Qian, Changgeng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011130628 A1 2011-10-20

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[2-chloro-6-[[(methylsulfonyl)oxy]methyl]thieno[3,2-d]pyr...
C18H19ClN4O5S2
1235451-21-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 5.3348 0.0 0
M  V30 2 C 5.3901 4.0012 0.0 0
M  V30 3 O 4.6201 2.6673 0.0 0
M  V30 4 O 6.9302 4.0012 0.0 0
M  V30 5 C 5.3901 1.3337 0.0 0
M  V30 6 C 4.0564 0.5637 0.0 0
M  V30 7 C 6.1601 0.0000 0.0 0
M  V30 8 C 6.7238 2.1037 0.0 0
M  V30 9 Cl 4.6201 10.6697 0.0 0
M  V30 10 C 10.7012 5.3804 0.0 0
M  V30 11 O 12.0349 6.1504 0.0 0
M  V30 12 S 13.3687 5.3804 0.0 0 VAL=6
M  V30 13 C 14.1387 6.7141 0.0 0
M  V30 14 O 14.7024 4.6104 0.0 0
M  V30 15 O 12.5987 4.0467 0.0 0
M  V30 16 C 5.3901 6.6685 0.0 0
M  V30 17 C 6.9302 6.6685 0.0 0
M  V30 18 N 4.6201 8.0023 0.0 0
M  V30 19 C 7.7002 8.0023 0.0 0
M  V30 20 S 7.9606 5.5241 0.0 0
M  V30 21 C 5.3901 9.3360 0.0 0
M  V30 22 C 9.2066 7.6820 0.0 0
M  V30 23 N 6.9302 9.3360 0.0 0
M  V30 24 C 9.3676 6.1504 0.0 0
M  V30 25 C 3.0801 5.3348 0.0 0
M  V30 26 C 2.3101 6.6685 0.0 0
M  V30 27 N 2.3101 4.0012 0.0 0
M  V30 28 C 0.7700 6.6685 0.0 0
M  V30 29 C 0.7700 4.0012 0.0 0
M  V30 30 C 0.0000 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 1 25
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 1 10 24
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 2 12 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 2 18 21
M  V30 22 1 19 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methyl-4-(2-pyridinylamino)thieno[3,2-d]pyrimidine-6-methanamine
C13H12ClN5S
1235451-22-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 5.3348 0.0 0
M  V30 2 C 10.7011 5.2892 0.0 0
M  V30 3 N 12.0347 4.5192 0.0 0
M  V30 4 C 13.3685 5.2892 0.0 0
M  V30 5 Cl 4.6200 0.0000 0.0 0
M  V30 6 C 6.9301 4.0011 0.0 0
M  V30 7 C 5.3900 4.0011 0.0 0
M  V30 8 C 7.7001 2.6675 0.0 0
M  V30 9 S 7.9606 5.1456 0.0 0
M  V30 10 N 4.6200 2.6675 0.0 0
M  V30 11 C 9.2065 2.9876 0.0 0
M  V30 12 N 6.9301 1.3338 0.0 0
M  V30 13 C 9.3674 4.5192 0.0 0
M  V30 14 C 5.3900 1.3338 0.0 0
M  V30 15 C 3.0800 5.3348 0.0 0
M  V30 16 C 2.3100 6.6686 0.0 0
M  V30 17 N 2.3100 4.0011 0.0 0
M  V30 18 C 0.7700 6.6686 0.0 0
M  V30 19 C 0.7700 4.0011 0.0 0
M  V30 20 C 0.0000 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 2 13
M  V30 5 1 3 4
M  V30 6 1 5 14
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 2 11 13
M  V30 16 1 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1235451-21-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1235451-22-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-9116587
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Step 58f:
2-Chloro-6-((methylamino)methyl)-N-phenylthieno[3,2-d]pyrimidin-4-amine
(Compound 0706-164) Compound 0705-164 (600 mg, 1.279 mmol) was dissolved
in a solution of 32% MeNH2 in MeOH (5 mL). This solution was stirred at
room temperature for 1h. The solvent was removed under reduced pressure
and the residue was washed with water, filtered. Step 59f:
2-Chloro-6-((methylamino)methyl)-N-(pyridin-2-yl)thieno[3,2-d]pyrimidin-4-amine
(Compound 0706-168) The title compound 0706-168 was prepared (1.80 g,
100%) as a white solid from 0705-168 (2.00 g, 4.255 mmol) and 32% MeNH2
in MeOH (5 mL) using a procedure similar to that described for compound
0706-164 (Example 58). LCMS: 306 [M+1]+. 1H NMR (400 MHz, DMSO-d 6): δ
2.32 (s, 3H), 3.97 (s, 2H), 7.15 (m, 1H), 7.26 (s, 1H), 7.83 (m, 2H),
8.38 (m, 1H), 9.71 (s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Deazapurines, thienopyrimidines and furopyrimidines as phosphoinositide
3-kinase inhibitors with a zinc binding moiety and their preparation and
use in the treatment of diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cai, Xiong; Zhai, Haixiao; Lai, Cheng-Jung; Qian, Changgeng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010080996 A1 2010-07-15

$RFMT $RIREG SCHEME99 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Succinimide
C4H5NO2
123-56-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 2.6218 0.0 0
M  V30 2 O 5.3026 1.4946 0.0 0
M  V30 3 N 2.7406 2.4782 0.0 0
M  V30 4 C 1.3337 1.8517 0.0 0
M  V30 5 C 3.7711 1.3337 0.0 0
M  V30 6 C 1.4946 0.3202 0.0 0
M  V30 7 C 3.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 4
M  V30 2 2 2 5
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N1-Methylbutanediamide
C5H10N2O2
3025-97-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 N 6.6686 1.5400 0.0 0
M  V30 4 O 5.3348 3.8500 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 8.0022 2.3100 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 9 O 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-56-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3025-97-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-7902151
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quantitative Solid-State Reactions of Amines with Carbonyl Compounds and
Isothiocyanates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kaupp, Gerd; Schmeyers, Jens; Boy, Juergen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2000), 56(36), 6899-6911

$RFMT $RIREG SCHEME100 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4H-Cyclopenta[b]thiophene-4-ol, 3a,5,6,6a-tetrahydro-6-methyl-4-(1E)-1-propen...
C11H16O3S
1242147-18-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8625 3.6643 0.0 0
M  V30 2 C 7.6325 4.9981 0.0 0
M  V30 3 C 9.1725 4.9981 0.0 0
M  V30 4 O 5.4836 5.1960 0.0 0
M  V30 5 C 3.7565 0.0000 0.0 0
M  V30 6 O 0.0000 2.9710 0.0 0
M  V30 7 O 1.3789 1.4394 0.0 0
M  V30 8 C 3.8163 3.9844 0.0 0 CFG=2
M  V30 9 C 3.0463 2.6508 0.0 0 CFG=1
M  V30 10 C 5.3225 3.6643 0.0 0 CFG=1
M  V30 11 C 2.7859 5.1290 0.0 0
M  V30 12 C 4.0767 1.5064 0.0 0 CFG=2
M  V30 13 S 1.5400 2.9710 0.0 0 VAL=6
M  V30 14 C 5.4836 2.1327 0.0 0
M  V30 15 C 1.3789 4.5027 0.0 0
M  V30 16 H 4.5863 5.3182 0.0 0
M  V30 17 H 2.2763 1.3172 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 10 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 10 4 CFG=3
M  V30 5 1 12 5 CFG=1
M  V30 6 2 6 13
M  V30 7 2 7 13
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 16 CFG=1
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 9 17 CFG=1
M  V30 15 1 10 14
M  V30 16 2 11 15
M  V30 17 1 12 14
M  V30 18 1 13 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 8 9 10 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2H-Cyclopenta[b]thiophene-4-ol, hexahydro-6-methyl-3-(methylamino)-4-(1E)-1-p...
C12H21NO3S
1242147-20-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8625 4.0015 0.0 0
M  V30 2 C 7.6325 5.3352 0.0 0
M  V30 3 C 9.1725 5.3352 0.0 0
M  V30 4 O 5.4836 2.4699 0.0 0
M  V30 5 N 3.1060 1.0306 0.0 0
M  V30 6 C 1.9615 0.0000 0.0 0
M  V30 7 O 0.0000 4.6948 0.0 0
M  V30 8 O 1.3789 6.2264 0.0 0
M  V30 9 C 3.7565 7.6658 0.0 0
M  V30 10 C 3.8163 3.6814 0.0 0 CFG=2
M  V30 11 C 3.0463 5.0150 0.0 0 CFG=2
M  V30 12 C 5.3225 4.0015 0.0 0 CFG=1
M  V30 13 C 2.7859 2.5368 0.0 0 CFG=2
M  V30 14 S 1.5400 4.6948 0.0 0 VAL=6
M  V30 15 C 4.0767 6.1594 0.0 0 CFG=2
M  V30 16 C 5.4836 5.5331 0.0 0
M  V30 17 C 1.3789 3.1632 0.0 0
M  V30 18 H 4.5863 2.3476 0.0 0
M  V30 19 H 2.2763 6.3486 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 12 4 CFG=1
M  V30 5 1 5 6
M  V30 6 1 13 5 CFG=3
M  V30 7 2 7 14
M  V30 8 2 8 14
M  V30 9 1 15 9 CFG=3
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 18 CFG=3
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 11 19 CFG=3
M  V30 17 1 12 16
M  V30 18 1 13 17
M  V30 19 1 14 17
M  V30 20 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(5 10 11 12 13 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1242147-18-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1242147-20-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-1394770
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Compound 14a (31 mg, 0.142 mmol) was dissolved in anhydrous ethanol (5
mL). Methylamine (200 33% in ethanol) was added. The solution was heated
at 65°C for 16 hours. The reaction mixture was concentrated in vacuo
affording of 16a. Colorless oil, yield 36 mg (100%). IR (film) 3485,
3316, 1290, 1115, 972 cm-1; 1H NMR (500 MHz) δ 5.76 (dq, J=15, 6 Hz, 1H),
5.55 (dq, J=15,2 Hz, 1H), 3.45 (dd, J=13, 6 Hz, 1H), 3.42 (dt, J=6, 2 Hz,
1H) 3.16-3.06 (m, 2H), 2.91-2.85 (m, 2H), 2.37 (s, 3H), 1.85 (dd, J=13, 6
Hz), 1.71 (dd, J=7, 2 Hz, 3H), 1.53 (t, J=13 Hz, 1H), 1.20 (d, J=7 Hz,
3H); 13C NMR (125 MHz) δ 134.3 (CH), 125.4 (CH), 81.4 (C), 69.1 (CH),
57.7 (CH), 54.9 (CH2), 54.2 (CH), 50.0 (CH2), 35.6 (CH), 34.0 (CH3), 19.5
(CH3), 17.8 (CH3); MS (ES+) m/z 262 (4), 260 (100); HRMS calcd for
C12H21NO3S (M+H): 260.1320. Found: 260.1315.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of bicyclic compounds and method for their use as therapeutic
agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wulff, Jeremy E.; Brant, Michael G.; Mason, Jeremy W.; Bromba, Caleb M.;
Boulanger, Martin J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20130210904 A1 2013-08-15

$RFMT $RIREG SCHEME100 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4H-Cyclopenta[b]thiophene-4-ol, 3a,5,6,6a-tetrahydro-6-methyl-4-(1E)-1-propen...
C11H16O3S
1242147-18-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8625 3.6643 0.0 0
M  V30 2 C 7.6325 4.9981 0.0 0
M  V30 3 C 9.1725 4.9981 0.0 0
M  V30 4 O 5.4836 5.1960 0.0 0
M  V30 5 C 3.7565 0.0000 0.0 0
M  V30 6 O 0.0000 2.9710 0.0 0
M  V30 7 O 1.3789 1.4394 0.0 0
M  V30 8 C 3.8163 3.9844 0.0 0 CFG=2
M  V30 9 C 3.0463 2.6508 0.0 0 CFG=1
M  V30 10 C 5.3225 3.6643 0.0 0 CFG=1
M  V30 11 C 2.7859 5.1290 0.0 0
M  V30 12 C 4.0767 1.5064 0.0 0 CFG=2
M  V30 13 S 1.5400 2.9710 0.0 0 VAL=6
M  V30 14 C 5.4836 2.1327 0.0 0
M  V30 15 C 1.3789 4.5027 0.0 0
M  V30 16 H 4.5863 5.3182 0.0 0
M  V30 17 H 2.2763 1.3172 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 10 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 10 4 CFG=3
M  V30 5 1 12 5 CFG=1
M  V30 6 2 6 13
M  V30 7 2 7 13
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 16 CFG=1
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 9 17 CFG=1
M  V30 15 1 10 14
M  V30 16 2 11 15
M  V30 17 1 12 14
M  V30 18 1 13 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 8 9 10 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2H-Cyclopenta[b]thiophene-4-ol, hexahydro-6-methyl-3-(methylamino)-4-(1E)-1-p...
C12H21NO3S
1242147-20-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8625 4.0015 0.0 0
M  V30 2 C 7.6325 5.3352 0.0 0
M  V30 3 C 9.1725 5.3352 0.0 0
M  V30 4 O 5.4836 2.4699 0.0 0
M  V30 5 N 3.1060 1.0306 0.0 0
M  V30 6 C 1.9615 0.0000 0.0 0
M  V30 7 O 0.0000 4.6948 0.0 0
M  V30 8 O 1.3789 6.2264 0.0 0
M  V30 9 C 3.7565 7.6658 0.0 0
M  V30 10 C 3.8163 3.6814 0.0 0 CFG=2
M  V30 11 C 3.0463 5.0150 0.0 0 CFG=2
M  V30 12 C 5.3225 4.0015 0.0 0 CFG=1
M  V30 13 C 2.7859 2.5368 0.0 0 CFG=2
M  V30 14 S 1.5400 4.6948 0.0 0 VAL=6
M  V30 15 C 4.0767 6.1594 0.0 0 CFG=2
M  V30 16 C 5.4836 5.5331 0.0 0
M  V30 17 C 1.3789 3.1632 0.0 0
M  V30 18 H 4.5863 2.3476 0.0 0
M  V30 19 H 2.2763 6.3486 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 12 4 CFG=1
M  V30 5 1 5 6
M  V30 6 1 13 5 CFG=3
M  V30 7 2 7 14
M  V30 8 2 8 14
M  V30 9 1 15 9 CFG=3
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 18 CFG=3
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 11 19 CFG=3
M  V30 17 1 12 16
M  V30 18 1 13 17
M  V30 19 1 14 17
M  V30 20 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(5 10 11 12 13 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1242147-18-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1242147-20-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-1466105
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Compound 6 (31 mg, 0.142 mmol) was dissolved in anhydrous ethanol (5 mL).
Methylamine (200 μL, 33% in ethanol) was added. The solution was heated
at 65 °C for 16 h. The reaction mixture was concentrated in vacuo
affording 36 mg (100%) of 8 as a colorless oil. 8, yield 36 mg, 100% IR
(film) 3485, 3316, 1290, 1115, 972 cm-1; 1H NMR (500 MHz) δ 5.76 (dq, J =
15, 6 Hz, 1 H), 5.55 (dq, J = 15, 2 Hz, 1 H), 3.45 (dd, J = 13, 6 Hz, 1
H), 3.42 (dt, J = 6, 2 Hz, 1H) 3.16-3.06 (m, 2 H ), 2.91-2.85 (m, 2 H),
2.37 (s, 3 H), 1.85 (dd, J= 13, 6 Hz), 1.71 (dd, J = 7, 2 Hz, 3 H), 1.53
(t, J = 13 Hz, 1 H), 1.20 (d, J = 7 Hz, 3 H); 13C NMR (125 MHz) δ 134.3
(CH), 125.4 (CH), 81.4 (C), 69.1 (CH), 57.7 (CH), 54.9 (CH2), 54.2 (CH),
50.0 (CH2), 35.6 (CH), 34.0 (CH3), 19.5 (CH3), 17.8 (CH3); MS (ES+) m/z
262 (4), 260 (100); HRMS calcd for C12H21NO3S (M+H): 260.1320. Found:
260.1315.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tandem Vinylogous 1,2-Addition/Anionic Oxy-Cope Reaction Leading from
Butadiene Sulfone to an Orthogonally Functionalized Bicycle
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Brant, Michael G.; Bromba, Caleb M.; Wulff, Jeremy E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2010), 75(18), 6312-6315

$RFMT $RIREG SCHEME101 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl N-[5-bromo-2-[(6-fluoro-3-pyridinyl)carbonyl]-3-benzofuranyl]-N-pentylc...
C22H22BrFN2O4
1251582-41-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.0737 6.6828 0.0 0
M  V30 2 C 3.5672 7.0029 0.0 0
M  V30 3 C 5.5495 5.2181 0.0 0
M  V30 4 O 2.5368 5.8586 0.0 0
M  V30 5 O 3.0914 8.4676 0.0 0
M  V30 6 C 4.5189 4.0737 0.0 0
M  V30 7 C 1.0304 6.1787 0.0 0
M  V30 8 C 4.9950 2.6091 0.0 0
M  V30 9 C 0.0000 5.0342 0.0 0
M  V30 10 C 3.9644 1.4647 0.0 0
M  V30 11 C 4.4403 0.0000 0.0 0
M  V30 12 C 8.4056 6.3326 0.0 0
M  V30 13 O 7.6356 4.9988 0.0 0
M  V30 14 Br 3.1165 12.4135 0.0 0
M  V30 15 F 14.5655 6.3326 0.0 0
M  V30 16 C 6.1041 7.8272 0.0 0
M  V30 17 C 5.7839 9.3336 0.0 0
M  V30 18 C 7.6356 7.6662 0.0 0
M  V30 19 C 7.1175 10.1036 0.0 0
M  V30 20 C 4.4501 10.1036 0.0 0
M  V30 21 O 8.2619 9.0730 0.0 0
M  V30 22 C 7.1175 11.6436 0.0 0
M  V30 23 C 4.4501 11.6436 0.0 0
M  V30 24 C 5.7839 12.4135 0.0 0
M  V30 25 C 9.9456 6.3326 0.0 0
M  V30 26 C 10.7156 7.6662 0.0 0
M  V30 27 C 10.7156 4.9988 0.0 0
M  V30 28 C 12.2555 7.6662 0.0 0
M  V30 29 N 12.2555 4.9988 0.0 0
M  V30 30 C 13.0255 6.3326 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 2 12 13
M  V30 13 1 12 18
M  V30 14 1 12 25
M  V30 15 1 14 23
M  V30 16 1 15 30
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 2 17 20
M  V30 21 1 18 21
M  V30 22 1 19 21
M  V30 23 2 19 22
M  V30 24 1 20 23
M  V30 25 1 22 24
M  V30 26 2 23 24
M  V30 27 1 25 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Bromo-4-[6-(methylamino)-3-pyridinyl]-1-pentylbenzofuro[3,2-d]pyrimidin-2(1...
C21H21BrN4O2
1431434-31-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.8614 0.0 0
M  V30 2 C 3.8500 7.1952 0.0 0
M  V30 3 C 2.3100 7.1952 0.0 0
M  V30 4 C 1.5400 8.5288 0.0 0
M  V30 5 C 0.0000 8.5288 0.0 0
M  V30 6 O 6.1600 8.5288 0.0 0
M  V30 7 Br 3.4795 0.2789 0.0 0
M  V30 8 N 15.4000 5.8614 0.0 0
M  V30 9 C 16.1700 7.1952 0.0 0
M  V30 10 C 6.9300 4.5278 0.0 0
M  V30 11 C 8.4700 4.5278 0.0 0
M  V30 12 C 6.4541 3.0632 0.0 0
M  V30 13 N 6.1600 5.8614 0.0 0
M  V30 14 C 9.2400 5.8614 0.0 0
M  V30 15 O 8.9459 3.0632 0.0 0
M  V30 16 C 7.7000 2.1580 0.0 0
M  V30 17 C 5.0472 2.4367 0.0 0
M  V30 18 C 6.9300 7.1952 0.0 0
M  V30 19 N 8.4700 7.1952 0.0 0
M  V30 20 C 7.5391 0.6263 0.0 0
M  V30 21 C 4.8863 0.9052 0.0 0
M  V30 22 C 6.1321 0.0000 0.0 0
M  V30 23 C 10.7800 5.8614 0.0 0
M  V30 24 C 11.5500 7.1952 0.0 0
M  V30 25 C 11.5500 4.5278 0.0 0
M  V30 26 C 13.0900 7.1952 0.0 0
M  V30 27 N 13.0900 4.5278 0.0 0
M  V30 28 C 13.8600 5.8614 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 6 18
M  V30 7 1 7 21
M  V30 8 1 8 9
M  V30 9 1 8 28
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 12 17
M  V30 17 1 13 18
M  V30 18 2 14 19
M  V30 19 1 14 23
M  V30 20 1 15 16
M  V30 21 2 16 20
M  V30 22 1 17 21
M  V30 23 1 18 19
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 26 1 23 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1251582-41-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1431434-31-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-901108
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 631-61-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nucleotide competing reverse transcriptase inhibitors: Discovery of a
series of non-basic benzofurano[3,2-d]pyrimidin-2-one derived inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM James, Clint A.; DeRoy, Patrick; Duplessis, Martin; Edwards, Paul J.;
Halmos, Teddy; Minville, Joannie; Morency, Louis; Morin, Sebastien;
Simoneau, Bruno; Tremblay, Martin; Bethell, Richard; Cordingley, Michael;
Duan, Jianmin; Lamorte, Louie; Pelletier, Alex; Rajotte, Daniel; Salois,
Patrick; Tremblay, Sonia; Sturino, Claudio F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2013), 23(9), 2781-2786

$RFMT $RIREG SCHEME102 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(Ethoxycarbonyl)-N-[2-[(6-fluoro-3-pyridinyl)carbonyl]-5-(1-methyl-1H-pyraz...
C26H26FN5O6
1251583-27-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.1759 6.5800 0.0 0
M  V30 2 C 9.3204 5.5496 0.0 0
M  V30 3 C 6.7114 6.1041 0.0 0
M  V30 4 C 9.0003 4.0431 0.0 0
M  V30 5 O 6.3912 4.5977 0.0 0
M  V30 6 O 5.5668 7.1345 0.0 0
M  V30 7 O 10.1446 3.0127 0.0 0
M  V30 8 O 7.5356 3.5673 0.0 0
M  V30 9 C 4.9265 4.1218 0.0 0
M  V30 10 C 9.8245 1.5063 0.0 0
M  V30 11 C 4.6063 2.6155 0.0 0
M  V30 12 C 11.3309 1.1861 0.0 0
M  V30 13 C 9.5043 0.0000 0.0 0
M  V30 14 C 8.3182 1.8266 0.0 0
M  V30 15 C 11.2367 7.9427 0.0 0
M  V30 16 O 11.2367 6.4027 0.0 0
M  V30 17 C 0.0000 12.2397 0.0 0
M  V30 18 F 16.5714 11.0228 0.0 0
M  V30 19 C 8.4962 8.0863 0.0 0
M  V30 20 C 7.4656 9.2308 0.0 0
M  V30 21 C 9.9030 8.7127 0.0 0
M  V30 22 C 8.2357 10.5645 0.0 0
M  V30 23 C 5.9256 9.2308 0.0 0
M  V30 24 O 9.7421 10.2443 0.0 0
M  V30 25 N 7.4656 11.8981 0.0 0
M  V30 26 C 5.1556 10.5645 0.0 0
M  V30 27 C 5.9256 11.8981 0.0 0
M  V30 28 C 12.5705 8.7127 0.0 0
M  V30 29 C 12.5705 10.2528 0.0 0
M  V30 30 C 13.9041 7.9427 0.0 0
M  V30 31 C 13.9041 11.0228 0.0 0
M  V30 32 N 15.2378 8.7127 0.0 0
M  V30 33 C 15.2378 10.2528 0.0 0
M  V30 34 C 3.6156 10.5645 0.0 0
M  V30 35 C 2.7104 9.3186 0.0 0
M  V30 36 C 2.7104 11.8103 0.0 0
M  V30 37 N 1.2459 9.7944 0.0 0
M  V30 38 N 1.2459 11.3345 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 5 9
M  V30 10 1 7 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 2 15 16
M  V30 16 1 15 21
M  V30 17 1 15 28
M  V30 18 1 17 38
M  V30 19 1 18 33
M  V30 20 1 19 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 2 20 23
M  V30 24 1 21 24
M  V30 25 1 22 24
M  V30 26 2 22 25
M  V30 27 1 23 26
M  V30 28 1 25 27
M  V30 29 2 26 27
M  V30 30 1 26 34
M  V30 31 1 28 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 33
M  V30 37 1 34 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(Ethoxycarbonyl)-N-[2-[[6-(methylamino)-3-pyridinyl]carbonyl]-5-(1-methyl-1...
C27H30N6O6
1251583-28-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.1759 6.5800 0.0 0
M  V30 2 C 9.3204 5.5496 0.0 0
M  V30 3 C 6.7114 6.1041 0.0 0
M  V30 4 C 9.0003 4.0431 0.0 0
M  V30 5 O 6.3912 4.5977 0.0 0
M  V30 6 O 5.5668 7.1345 0.0 0
M  V30 7 O 10.1446 3.0127 0.0 0
M  V30 8 O 7.5356 3.5673 0.0 0
M  V30 9 C 4.9265 4.1218 0.0 0
M  V30 10 C 9.8245 1.5063 0.0 0
M  V30 11 C 4.6063 2.6155 0.0 0
M  V30 12 C 8.3180 1.8266 0.0 0
M  V30 13 C 9.5043 0.0000 0.0 0
M  V30 14 C 11.3308 1.1861 0.0 0
M  V30 15 C 11.2367 7.9427 0.0 0
M  V30 16 O 11.2367 6.4027 0.0 0
M  V30 17 C 0.0000 12.2397 0.0 0
M  V30 18 N 16.5714 11.0228 0.0 0
M  V30 19 C 17.9051 10.2528 0.0 0
M  V30 20 C 8.4961 8.0863 0.0 0
M  V30 21 C 7.4657 9.2308 0.0 0
M  V30 22 C 9.9030 8.7127 0.0 0
M  V30 23 C 8.2357 10.5645 0.0 0
M  V30 24 C 5.9256 9.2308 0.0 0
M  V30 25 O 9.7421 10.2443 0.0 0
M  V30 26 N 7.4657 11.8981 0.0 0
M  V30 27 C 5.1556 10.5645 0.0 0
M  V30 28 C 5.9256 11.8981 0.0 0
M  V30 29 C 12.5703 8.7127 0.0 0
M  V30 30 C 13.9041 7.9427 0.0 0
M  V30 31 C 12.5703 10.2528 0.0 0
M  V30 32 C 15.2378 8.7127 0.0 0
M  V30 33 N 13.9041 11.0228 0.0 0
M  V30 34 C 15.2378 10.2528 0.0 0
M  V30 35 C 3.6156 10.5645 0.0 0
M  V30 36 C 2.7104 9.3186 0.0 0
M  V30 37 C 2.7104 11.8103 0.0 0
M  V30 38 N 1.2459 9.7945 0.0 0
M  V30 39 N 1.2459 11.3345 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 5 9
M  V30 10 1 7 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 2 15 16
M  V30 16 1 15 22
M  V30 17 1 15 29
M  V30 18 1 17 39
M  V30 19 1 18 19
M  V30 20 1 18 34
M  V30 21 1 20 21
M  V30 22 2 20 22
M  V30 23 1 21 23
M  V30 24 2 21 24
M  V30 25 1 22 25
M  V30 26 1 23 25
M  V30 27 2 23 26
M  V30 28 1 24 27
M  V30 29 1 26 28
M  V30 30 2 27 28
M  V30 31 1 27 35
M  V30 32 1 29 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 34
M  V30 38 1 35 36
M  V30 39 2 35 37
M  V30 40 2 36 38
M  V30 41 1 37 39
M  V30 42 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1251583-27-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1251583-28-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2251665
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a stirred solution of 54c (50 mg, 1 eq) in THF (0.5 mL), is added a
solution of methylamine (0.19 mL, 2 M in THF, 4 eq) and heated at 50°C
during 30 min. The solution is diluted with H2O, extracted with EtOAc,
the combined organic extracts are washed with brine, dried over Na2SO4
and concentrated to give 54d (50 mg, quant.). 54d, yield (50 mg, quant.).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heterocyclic compounds as inhibitors of HIV replication and their
preparation, pharmaceutical compositions and use in the treatment of HIV
infection
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sturino, Claudio; Deroy, Patrick; Duplessis, Martin; Edwards, Paul J.;
Faucher, Anne-Marie; Halmos, Teddy; James, Clint; Lacoste, Jean-Eric;
Malenfant, Eric; Minville, Joannie; Morency, Louis; Morin, Sebastien;
Tremblay, Martin; Yoakim, Christiane
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010115264 A1 2010-10-14

$RFMT $RIREG SCHEME103 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloro-6,7-dihydro-7-[4-(trifluoromethoxy)phenyl]-5H-cyclopentapyrimidine
C14H9Cl2F3N2O
1263869-39-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 3.9645 0.0 0
M  V30 2 Cl 3.5696 0.0000 0.0 0
M  V30 3 O 11.1390 5.2890 0.0 0
M  V30 4 C 11.9090 6.6227 0.0 0
M  V30 5 F 13.4490 6.6227 0.0 0
M  V30 6 F 12.6790 7.9564 0.0 0
M  V30 7 F 11.1390 7.9564 0.0 0
M  V30 8 C 4.9789 5.2890 0.0 0
M  V30 9 C 4.0737 4.0432 0.0 0
M  V30 10 C 4.0737 6.5349 0.0 0
M  V30 11 C 2.6091 4.5190 0.0 0
M  V30 12 N 4.3938 2.5367 0.0 0
M  V30 13 C 2.6091 6.0591 0.0 0
M  V30 14 C 1.4646 3.4886 0.0 0
M  V30 15 C 3.2494 1.5063 0.0 0
M  V30 16 N 1.7847 1.9822 0.0 0
M  V30 17 C 6.5189 5.2890 0.0 0
M  V30 18 C 7.2889 6.6227 0.0 0
M  V30 19 C 7.2889 3.9554 0.0 0
M  V30 20 C 8.8289 6.6227 0.0 0
M  V30 21 C 8.8289 3.9554 0.0 0
M  V30 22 C 9.5989 5.2890 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 15
M  V30 3 1 3 4
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 17
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-6,7-dihydro-N-methyl-7-[4-(trifluoromethoxy)phenyl]-5H-cyclopentapyr...
C15H13ClF3N3O
1263869-44-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.1445 3.9644 0.0 0
M  V30 2 C 0.0000 2.9340 0.0 0
M  V30 3 Cl 4.7141 0.0000 0.0 0
M  V30 4 O 12.2834 5.2890 0.0 0
M  V30 5 C 13.0534 6.6226 0.0 0
M  V30 6 F 14.5934 6.6226 0.0 0
M  V30 7 F 13.8234 7.9563 0.0 0
M  V30 8 F 12.2834 7.9563 0.0 0
M  V30 9 C 6.1234 5.2890 0.0 0
M  V30 10 C 5.2182 4.0431 0.0 0
M  V30 11 C 5.2182 6.5349 0.0 0
M  V30 12 C 3.7536 4.5190 0.0 0
M  V30 13 N 5.5383 2.5367 0.0 0
M  V30 14 C 3.7536 6.0590 0.0 0
M  V30 15 C 2.6091 3.4886 0.0 0
M  V30 16 C 4.3940 1.5063 0.0 0
M  V30 17 N 2.9292 1.9821 0.0 0
M  V30 18 C 7.6634 5.2890 0.0 0
M  V30 19 C 8.4334 3.9554 0.0 0
M  V30 20 C 8.4334 6.6226 0.0 0
M  V30 21 C 9.9734 3.9554 0.0 0
M  V30 22 C 9.9734 6.6226 0.0 0
M  V30 23 C 10.7434 5.2890 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 3 16
M  V30 4 1 4 5
M  V30 5 1 4 23
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 18
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1263869-39-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1263869-44-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-13294633
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-Chloro-N-methyl-7-(4-(trifluoromethoxy)phenyl)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-amine
A solution of
2,4-dichloro-7-(4-(trifluoromethoxy)phenyl)-6,7-dihydro-5H-cyclopenta[d]pyrimidine
(200 mg, 0.573 mmol), and methanamine (0.286 mL, 0.573 mmol) in MeOH (5
mL) was stirred at rt for 1 h. The solvent was removed in vacuum. Crude
2-chloro-N-methyl-7-(4-(trifluoromethoxy)phenyl)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-amine
(220 mg, 0.640 mmol, 112 % yield). LC-MS (M+H)+ = 343.9.
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bicyclic pyrimidine compounds for the reduction of
β-amyloid production
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Boy, Kenneth M.; Guernon, Jason M.; Macor, John E.; Olson, Richard E.;
Shi, Jianliang; Thompson, Lorin A., III; Wu, Yong-Jin; Xu, Li; Zhang,
Yunhui; Zuev, Dmitry S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012103297 A1 2012-08-02

$RFMT $RIREG SCHEME103 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloro-6,7-dihydro-7-[4-(trifluoromethoxy)phenyl]-5H-cyclopentapyrimidine
C14H9Cl2F3N2O
1263869-39-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 3.9645 0.0 0
M  V30 2 Cl 3.5696 0.0000 0.0 0
M  V30 3 O 11.1390 5.2890 0.0 0
M  V30 4 C 11.9090 6.6227 0.0 0
M  V30 5 F 13.4490 6.6227 0.0 0
M  V30 6 F 12.6790 7.9564 0.0 0
M  V30 7 F 11.1390 7.9564 0.0 0
M  V30 8 C 4.9789 5.2890 0.0 0
M  V30 9 C 4.0737 4.0432 0.0 0
M  V30 10 C 4.0737 6.5349 0.0 0
M  V30 11 C 2.6091 4.5190 0.0 0
M  V30 12 N 4.3938 2.5367 0.0 0
M  V30 13 C 2.6091 6.0591 0.0 0
M  V30 14 C 1.4646 3.4886 0.0 0
M  V30 15 C 3.2494 1.5063 0.0 0
M  V30 16 N 1.7847 1.9822 0.0 0
M  V30 17 C 6.5189 5.2890 0.0 0
M  V30 18 C 7.2889 6.6227 0.0 0
M  V30 19 C 7.2889 3.9554 0.0 0
M  V30 20 C 8.8289 6.6227 0.0 0
M  V30 21 C 8.8289 3.9554 0.0 0
M  V30 22 C 9.5989 5.2890 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 15
M  V30 3 1 3 4
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 17
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-6,7-dihydro-N-methyl-7-[4-(trifluoromethoxy)phenyl]-5H-cyclopentapyr...
C15H13ClF3N3O
1263869-44-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.1445 3.9644 0.0 0
M  V30 2 C 0.0000 2.9340 0.0 0
M  V30 3 Cl 4.7141 0.0000 0.0 0
M  V30 4 O 12.2834 5.2890 0.0 0
M  V30 5 C 13.0534 6.6226 0.0 0
M  V30 6 F 14.5934 6.6226 0.0 0
M  V30 7 F 13.8234 7.9563 0.0 0
M  V30 8 F 12.2834 7.9563 0.0 0
M  V30 9 C 6.1234 5.2890 0.0 0
M  V30 10 C 5.2182 4.0431 0.0 0
M  V30 11 C 5.2182 6.5349 0.0 0
M  V30 12 C 3.7536 4.5190 0.0 0
M  V30 13 N 5.5383 2.5367 0.0 0
M  V30 14 C 3.7536 6.0590 0.0 0
M  V30 15 C 2.6091 3.4886 0.0 0
M  V30 16 C 4.3940 1.5063 0.0 0
M  V30 17 N 2.9292 1.9821 0.0 0
M  V30 18 C 7.6634 5.2890 0.0 0
M  V30 19 C 8.4334 3.9554 0.0 0
M  V30 20 C 8.4334 6.6226 0.0 0
M  V30 21 C 9.9734 3.9554 0.0 0
M  V30 22 C 9.9734 6.6226 0.0 0
M  V30 23 C 10.7434 5.2890 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 3 16
M  V30 4 1 4 5
M  V30 5 1 4 23
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 18
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1263869-39-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1263869-44-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8583864
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation Ra
2-Chloro-N-methyl-7-(4-(trifluoromethoxy)phenyl)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-amine
A solution of
2,4-dichloro-7-(4-(trifluoromethoxy)phenyl)-6,7-dihydro-5H-cyclopenta[d]pyrimidine
(200 mg, 0.573 mmol), and methanamine (0.286 mL, 0.573 mmol) in MeOH (5
mL) was stirred at rt for 1 h. The solvent was removed in vacuum. Crude
2-chloro-N-methyl-7-(4-(trifluoromethoxy)phenyl)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-amine
(220 mg, 0.640 mmol, 112% yield). LC-MS (M+H)+=343.9.
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused pyrimidine compounds as modulators of β-amyloid
production
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Boy, Kenneth M.; Guernon, Jason M.; Macor, John E.; Olson, Richard E.;
Shi, Jianliang; Thompson, Lorin A., III; Wu, Yong-Jin; Xu, Li; Zhang,
Yunhui; Zuev, Dmitry S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20120028994 A1 2012-02-02

$RFMT $RIREG SCHEME103 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloro-6,7-dihydro-7-[4-(trifluoromethoxy)phenyl]-5H-cyclopentapyrimidine
C14H9Cl2F3N2O
1263869-39-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 3.9645 0.0 0
M  V30 2 Cl 3.5696 0.0000 0.0 0
M  V30 3 O 11.1390 5.2890 0.0 0
M  V30 4 C 11.9090 6.6227 0.0 0
M  V30 5 F 13.4490 6.6227 0.0 0
M  V30 6 F 12.6790 7.9564 0.0 0
M  V30 7 F 11.1390 7.9564 0.0 0
M  V30 8 C 4.9789 5.2890 0.0 0
M  V30 9 C 4.0737 4.0432 0.0 0
M  V30 10 C 4.0737 6.5349 0.0 0
M  V30 11 C 2.6091 4.5190 0.0 0
M  V30 12 N 4.3938 2.5367 0.0 0
M  V30 13 C 2.6091 6.0591 0.0 0
M  V30 14 C 1.4646 3.4886 0.0 0
M  V30 15 C 3.2494 1.5063 0.0 0
M  V30 16 N 1.7847 1.9822 0.0 0
M  V30 17 C 6.5189 5.2890 0.0 0
M  V30 18 C 7.2889 6.6227 0.0 0
M  V30 19 C 7.2889 3.9554 0.0 0
M  V30 20 C 8.8289 6.6227 0.0 0
M  V30 21 C 8.8289 3.9554 0.0 0
M  V30 22 C 9.5989 5.2890 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 15
M  V30 3 1 3 4
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 17
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-6,7-dihydro-N-methyl-7-[4-(trifluoromethoxy)phenyl]-5H-cyclopentapyr...
C15H13ClF3N3O
1263869-44-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.1445 3.9644 0.0 0
M  V30 2 C 0.0000 2.9340 0.0 0
M  V30 3 Cl 4.7141 0.0000 0.0 0
M  V30 4 O 12.2834 5.2890 0.0 0
M  V30 5 C 13.0534 6.6226 0.0 0
M  V30 6 F 14.5934 6.6226 0.0 0
M  V30 7 F 13.8234 7.9563 0.0 0
M  V30 8 F 12.2834 7.9563 0.0 0
M  V30 9 C 6.1234 5.2890 0.0 0
M  V30 10 C 5.2182 4.0431 0.0 0
M  V30 11 C 5.2182 6.5349 0.0 0
M  V30 12 C 3.7536 4.5190 0.0 0
M  V30 13 N 5.5383 2.5367 0.0 0
M  V30 14 C 3.7536 6.0590 0.0 0
M  V30 15 C 2.6091 3.4886 0.0 0
M  V30 16 C 4.3940 1.5063 0.0 0
M  V30 17 N 2.9292 1.9821 0.0 0
M  V30 18 C 7.6634 5.2890 0.0 0
M  V30 19 C 8.4334 3.9554 0.0 0
M  V30 20 C 8.4334 6.6226 0.0 0
M  V30 21 C 9.9734 3.9554 0.0 0
M  V30 22 C 9.9734 6.6226 0.0 0
M  V30 23 C 10.7434 5.2890 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 3 16
M  V30 4 1 4 5
M  V30 5 1 4 23
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 18
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1263869-39-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1263869-44-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-6950250
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation Ra
2-Chloro-N-methyl-7-(4-(trifluoromethoxy)phenyl)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-amine
A solution of
2,4-dichloro-7-(4-(trifluoromethoxy)phenyl)-6,7-dihydro-5H-cyclopenta[d]pyrimidine
(200 mg, 0.573 mmol), and methanamine (0.286 mL, 0.573 mmol) in MeOH (5
mL) was stirred at rt for 1 h. The solvent was removed in vacuum to
afford crude
2-chloro-N-methyl-7-(4-(trifluoromethoxy)phenyl)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-amine
(220 mg, 0.640 mmol, 112% yield). LC-MS (M+H)+=343.9.
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused pyrimidine compounds as modulators of β-amyloid
production
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Boy, Kenneth M.; Guernon, Jason M.; Macor, John E.; Olson, Richard E.;
Shi, Jianliang; Thompson, Lorin A., III; Wu, Yong-Jin; Xu, Li; Zhang,
Yunhui; Zuev, Dmitry S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011014535 A1 2011-02-03

$RFMT $RIREG SCHEME104 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 9-[(3-bromophenyl)amino]-2-(hydroxyimino)-9-oxononanoate
C17H23BrN2O4
1280574-74-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 13.3370 4.6201 0.0 0
M  V30 2 C 12.0034 3.8500 0.0 0
M  V30 3 C 10.6695 4.6201 0.0 0
M  V30 4 O 12.0034 2.3100 0.0 0
M  V30 5 C 9.3359 3.8500 0.0 0
M  V30 6 C 8.0022 4.6201 0.0 0
M  V30 7 C 6.6684 3.8500 0.0 0
M  V30 8 C 5.3348 4.6201 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 C 1.3337 3.8500 0.0 0
M  V30 12 N 2.6675 6.1601 0.0 0
M  V30 13 O 1.3337 2.3100 0.0 0
M  V30 14 O 0.0000 4.6201 0.0 0
M  V30 15 O 1.3337 6.9301 0.0 0
M  V30 16 C 0.0000 1.5400 0.0 0
M  V30 17 C 0.0000 0.0000 0.0 0
M  V30 18 Br 18.6718 4.6201 0.0 0
M  V30 19 C 14.6707 3.8500 0.0 0
M  V30 20 C 16.0043 4.6201 0.0 0
M  V30 21 C 14.6707 2.3100 0.0 0
M  V30 22 C 17.3381 3.8500 0.0 0
M  V30 23 C 16.0043 1.5400 0.0 0
M  V30 24 C 17.3381 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 2 10 12 CFG=2
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 16 17
M  V30 18 1 18 22
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 23
M  V30 23 2 22 24
M  V30 24 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N9-(3-Bromophenyl)-2-(hydroxyimino)-N1-methylnonanediamide
C16H22BrN3O3
1280574-29-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 2.3101 0.0 0
M  V30 2 C 6.6685 3.0801 0.0 0
M  V30 3 C 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 4.6201 0.0 0
M  V30 5 C 9.3360 3.0801 0.0 0
M  V30 6 C 10.6697 2.3101 0.0 0
M  V30 7 C 12.0033 3.0801 0.0 0
M  V30 8 C 13.3372 2.3101 0.0 0
M  V30 9 C 14.6708 3.0801 0.0 0
M  V30 10 C 16.0045 2.3101 0.0 0
M  V30 11 C 17.3382 3.0801 0.0 0
M  V30 12 N 16.0045 0.7700 0.0 0
M  V30 13 N 18.6720 2.3101 0.0 0
M  V30 14 O 17.3382 4.6201 0.0 0
M  V30 15 O 14.6708 0.0000 0.0 0
M  V30 16 C 20.0057 3.0801 0.0 0
M  V30 17 Br 0.0000 2.3101 0.0 0
M  V30 18 C 4.0012 3.0801 0.0 0
M  V30 19 C 2.6675 2.3101 0.0 0
M  V30 20 C 4.0012 4.6201 0.0 0
M  V30 21 C 1.3337 3.0801 0.0 0
M  V30 22 C 2.6675 5.3901 0.0 0
M  V30 23 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 2 10 12 CFG=2
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 17 21
M  V30 18 2 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 2 20 22
M  V30 22 2 21 23
M  V30 23 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1280574-74-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1280574-29-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3042820
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure To Convert the Oximino Ester
to α-Oxime Amide. 2-(Hydroxyimino)-N1-methyl-N9-phenylnonanediamide(5).
Compound 3 (0.170 g, 0.302 mmol) was dissolved in 7 mL of methylamine
solution (33 wt % in ethanol), and the reaction mixture was stirred at
room temperature overnight. The solvent was evaporated to dryness and the
residue purified by flash chromatography(dichloromethane/methanol 95:5)
to afford the desired compound 5 as awhite solid (0.074 g, 80%).
N9-(3-Bromophenyl)-2-(hydroxyimino)-N1-methylnonanediamide (19). Compound
19 was prepared from the corresponding α-oxime ester using the procedure
described for 5 in quantitative yield as a white solid. Mp 142-145 °C. 1H
NMR (400 MHz, CD3OD): δ 1.35 (m, 4H), 1.47 (m, 2H), 1.66-1.64 (m, 2H),
2.32 (t, J = 7.2 Hz, 2H), 2.53 (t, J = 6.8 Hz, 2H), 2.69 (s, 3H),
7.17-7.13 (m, 2H), 7.43-7.41 (m, 1H), 7.85 (bs, 1H). 13C NMR (100 MHz,
CD3OD): δ 22.4, 24.4, 24.8, 25.1, 28.2, 28.6, 36.2, 117.7, 121.4, 122.0,
129.5, 125.9, 139.7, 153.3, 165.1, 172.9. MS(ESI) m/z: 405.7 [M + Na]+.
Anal. Calcd for C16H22BrN3O3: C, 50.01; H, 5.77; Br, 20.79; N, 10.94.
Found: C, 49.95; H, 5.74; N, 10.90.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Oxime Amides as a Novel Zinc Binding Group in Histone Deacetylase
Inhibitors: Synthesis, Biological Activity, and Computational Evaluation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Botta, Cinzia B.; Cabri, Walter; Cini, Elena; De Cesare, Lucia;
Fattorusso, Caterina; Giannini, Giuseppe; Persico, Marco; Petrella,
Antonello; Rondinelli, Francesca; Rodriquez, Manuela; Russo, Adele;
Taddei, Maurizio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2011), 54(7), 2165-2182

$RFMT $RIREG SCHEME105 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-3-methoxybenzaldehyde
C8H7FO2
128495-46-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 2.6674 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 F 4.6200 0.0000 0.0 0
M  V30 4 C 1.5400 5.3349 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.8500 4.0011 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 2.3100 1.3338 0.0 0
M  V30 11 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 8
M  V30 4 2 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-3-methoxy-N-methylbenzenemethanamine
C9H12FNO
381236-49-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.5400 1.3338 0.0 0
M  V30 2 C 2.3100 0.0000 0.0 0
M  V30 3 F 0.0000 4.0011 0.0 0
M  V30 4 C 6.1600 4.0011 0.0 0
M  V30 5 N 6.9300 5.3349 0.0 0
M  V30 6 C 8.4700 5.3349 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 4.6200 4.0011 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 12 C 3.8500 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 128495-46-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 381236-49-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-14925811
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 109-Preparation of
7-fluoro-8-methoxy-2-methyl-5-phenyl-2,3,4,5-tetrahydro-1H-benzo[c]azepine,
L-tartrate salt [0733] Step A: To a solution of
3-methoxy-4-fluorobenzaldehyde (8.4 g, 54.5 mmol) in methanol (150 mL)
was added methylamine (40% in water, 7.2 mL, 82 mmol) at room
temperature. The reaction mixture was cooled to 0° C., sodium borohydride
(2.07 g, 82 mmol) was added to the solution portionwise. The reaction
mixture was stirred at 0° C. for 2 hours. The solvent was removed. The
residue was dissolved in water, and the product was extracted with
dichloromethane. The organic layer was washed with brine, dried over
sodium sulfate and concentrated to give the benzylamine (9.2 g,
quantitative) as a colorless liquid. 1H NMR (CDCl3, 300 MHz) δ 7.04-6.95
(m, 2H), 6.83-6.78 (m, 1H), 3.90 (s, 3H), 3.70 (s, 2H), 2.45 (s, 3H); ESI
MS m/z 170 [M+H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof
to block reuptake of norepinephrine, dopamine, and serotonin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Molino, Bruce F.; Liu, Shuang; Sambandam, Aruna; Guzzo, Peter R.; Hu,
Min; Zha, Congxiang; Nacro, Kassoum; Manning, David D.; Isherwood,
Matthew L.; Fleming, Kristen N.; Cui, Wenge; Olson, Richard E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007011820 A2 2007-01-25

$RFMT $RIREG SCHEME106 STEP1
$RXN



  2  1
$MOL
4-(1,1-Dimethylethyl) (2R)-2-[[2-(4-carboxy-2,6-difluorophenyl)-5-methyl-1H-b...
C25H27F2N3O5
1308849-96-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.1820 7.2709 0.0 0
M  V30 2 F 1.5400 6.2874 0.0 0
M  V30 3 F 6.1600 8.9547 0.0 0
M  V30 4 C 6.4717 0.0000 0.0 0
M  V30 5 C 12.2557 8.9194 0.0 0
M  V30 6 O 13.7620 8.5991 0.0 0
M  V30 7 O 11.7799 10.3840 0.0 0
M  V30 8 C 14.7926 9.7437 0.0 0
M  V30 9 C 13.6480 10.7741 0.0 0
M  V30 10 C 15.8230 10.8880 0.0 0
M  V30 11 C 15.9370 8.7132 0.0 0
M  V30 12 C 1.5400 11.6222 0.0 0
M  V30 13 O 0.0000 11.6222 0.0 0
M  V30 14 O 2.3100 12.9558 0.0 0
M  V30 15 N 6.1516 6.1263 0.0 0
M  V30 16 C 4.6200 6.2874 0.0 0
M  V30 17 C 6.4717 4.6200 0.0 0
M  V30 18 N 3.9936 4.8804 0.0 0
M  V30 19 C 5.1381 3.8500 0.0 0
M  V30 20 C 7.8054 3.8500 0.0 0
M  V30 21 C 5.1381 2.3100 0.0 0
M  V30 22 C 7.8054 2.3100 0.0 0
M  V30 23 C 6.4717 1.5400 0.0 0
M  V30 24 C 3.8500 7.6211 0.0 0
M  V30 25 C 2.3100 7.6211 0.0 0
M  V30 26 C 4.6200 8.9547 0.0 0
M  V30 27 C 1.5400 8.9547 0.0 0
M  V30 28 C 3.8500 10.2885 0.0 0
M  V30 29 C 2.3100 10.2885 0.0 0
M  V30 30 C 8.6884 6.9507 0.0 0 CFG=1
M  V30 31 C 9.7189 8.0951 0.0 0
M  V30 32 O 9.1643 5.4860 0.0 0
M  V30 33 N 11.2253 7.7749 0.0 0
M  V30 34 C 10.6706 5.1658 0.0 0
M  V30 35 C 11.7012 6.3103 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 30 1 CFG=3
M  V30 3 1 2 25
M  V30 4 1 3 26
M  V30 5 1 4 23
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 33
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 29
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 1 16 24
M  V30 20 1 17 19
M  V30 21 2 17 20
M  V30 22 1 18 19
M  V30 23 2 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 1 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2R)-2-[[2-[2,6-difluoro-4-[(methylamino)carbonyl]phenyl]-5...
C26H30F2N4O4
1308849-97-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.9521 7.2709 0.0 0
M  V30 2 F 2.3100 6.2874 0.0 0
M  V30 3 F 6.9301 8.9548 0.0 0
M  V30 4 C 7.2418 0.0000 0.0 0
M  V30 5 C 13.0258 8.9195 0.0 0
M  V30 6 O 14.5321 8.5992 0.0 0
M  V30 7 O 12.5499 10.3841 0.0 0
M  V30 8 C 15.5627 9.7437 0.0 0
M  V30 9 C 14.4181 10.7741 0.0 0
M  V30 10 C 16.5931 10.8881 0.0 0
M  V30 11 C 16.7071 8.7133 0.0 0
M  V30 12 C 2.3100 11.6222 0.0 0
M  V30 13 N 0.7700 11.6222 0.0 0
M  V30 14 O 3.0800 12.9559 0.0 0
M  V30 15 C 0.0000 12.9559 0.0 0
M  V30 16 N 6.9216 6.1264 0.0 0
M  V30 17 C 5.3901 6.2874 0.0 0
M  V30 18 C 7.2418 4.6201 0.0 0
M  V30 19 N 4.7636 4.8805 0.0 0
M  V30 20 C 5.9081 3.8501 0.0 0
M  V30 21 C 8.5755 3.8501 0.0 0
M  V30 22 C 5.9081 2.3100 0.0 0
M  V30 23 C 8.5755 2.3100 0.0 0
M  V30 24 C 7.2418 1.5400 0.0 0
M  V30 25 C 4.6201 7.6211 0.0 0
M  V30 26 C 3.0800 7.6211 0.0 0
M  V30 27 C 5.3901 8.9548 0.0 0
M  V30 28 C 2.3100 8.9548 0.0 0
M  V30 29 C 4.6201 10.2886 0.0 0
M  V30 30 C 3.0800 10.2886 0.0 0
M  V30 31 C 9.4585 6.9507 0.0 0 CFG=1
M  V30 32 C 10.4889 8.0951 0.0 0
M  V30 33 O 9.9344 5.4860 0.0 0
M  V30 34 N 11.9954 7.7750 0.0 0
M  V30 35 C 11.4407 5.1658 0.0 0
M  V30 36 C 12.4713 6.3104 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 31 1 CFG=3
M  V30 3 1 2 26
M  V30 4 1 3 27
M  V30 5 1 4 24
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 34
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 30
M  V30 16 1 13 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 1 17 25
M  V30 21 1 18 20
M  V30 22 2 18 21
M  V30 23 1 19 20
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 1 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 31)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1308849-96-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1308849-97-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13845105
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 3945-69-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Part C. Preparation of (R)-tert-butyl
2-((2-(2,6-difluoro-4-(methylcarbamoyl)phenyl)-5-methyl-1H-benzo[d]imidazol-1-yl)methyl)morpholine-
4-carboxylate.
(R)-4-(1-((4-(tert-butoxycarbonyl)morpholin-2-yl)methyl)-5-methyl-1H-
benzo[d]imidazol-2-yl)-3,5-difluorobenzoic acid (750 mg, 1.54 mmol) was
added to DMT-MM (408 mg, 1.69 mmol) in DMF (30.00 mL) under N2. The
resulting suspension was stirred for 30 min. Afterward, methylamine 33%
(by weight) solution in absolute ethanol (0.458 mL, 1.69 mmol) was added,
and the mixture was stirred for 3 hr. The mixture was then concentrated
under reduced pressure, and the resulting residue was dissolved in EtOAc
and washed sequentially with water and brine. The organic layer was dried
over MgSC>4, filtered, and concentrated under reduced pressure. The crude
material was purified on preparative HPLC MS using the short high pH
shallow gradient method (mobile phase: 30-50% B; A: H2O with 10 mM H4CO3
and 0.375% H4OH v/v; B: CH3CN; 10 min run; XBridge Prep CI 8 OBD, Waters
reverse phase column; column size: 30x50 mm; and particle size 5 μm).
This produced (S)-tert-butyl
2-((2-(2,6-difluoro-4-(methylcarbamoyl)phenyl)-5-methyl-1H-benzo[d]imidazol-1-yl)methyl)mo
holine-4- carboxylate as an oil, which was used without further
purification (1.4 g, >100% yield) in the next step. The oil was analyzed
on analytical HPLC MS using the high pH gradient method (mobile phase:
5-95% B; A: H2O with 10 mM H4CO3 and 0.375% H4OH v/v; B: CH3CN; 2.25 min
run; X-Bridge C18; column size: 2.1 x 30 mm, particle size: 5 μm). MS m/z
501.4 [M+H]+ (ESI), Rt 1.85 min.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Combination therapies for treating pain
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cantin, Louis-David; Martino, John; Tomaszewski, Miroslaw; Yu, Xiao Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012158117 A1 2012-11-22

$RFMT $RIREG SCHEME106 STEP1
$RXN



  2  1
$MOL
4-(1,1-Dimethylethyl) (2R)-2-[[2-(4-carboxy-2,6-difluorophenyl)-5-methyl-1H-b...
C25H27F2N3O5
1308849-96-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.1820 7.2709 0.0 0
M  V30 2 F 1.5400 6.2874 0.0 0
M  V30 3 F 6.1600 8.9547 0.0 0
M  V30 4 C 6.4717 0.0000 0.0 0
M  V30 5 C 12.2557 8.9194 0.0 0
M  V30 6 O 13.7620 8.5991 0.0 0
M  V30 7 O 11.7799 10.3840 0.0 0
M  V30 8 C 14.7926 9.7437 0.0 0
M  V30 9 C 13.6480 10.7741 0.0 0
M  V30 10 C 15.8230 10.8880 0.0 0
M  V30 11 C 15.9370 8.7132 0.0 0
M  V30 12 C 1.5400 11.6222 0.0 0
M  V30 13 O 0.0000 11.6222 0.0 0
M  V30 14 O 2.3100 12.9558 0.0 0
M  V30 15 N 6.1516 6.1263 0.0 0
M  V30 16 C 4.6200 6.2874 0.0 0
M  V30 17 C 6.4717 4.6200 0.0 0
M  V30 18 N 3.9936 4.8804 0.0 0
M  V30 19 C 5.1381 3.8500 0.0 0
M  V30 20 C 7.8054 3.8500 0.0 0
M  V30 21 C 5.1381 2.3100 0.0 0
M  V30 22 C 7.8054 2.3100 0.0 0
M  V30 23 C 6.4717 1.5400 0.0 0
M  V30 24 C 3.8500 7.6211 0.0 0
M  V30 25 C 2.3100 7.6211 0.0 0
M  V30 26 C 4.6200 8.9547 0.0 0
M  V30 27 C 1.5400 8.9547 0.0 0
M  V30 28 C 3.8500 10.2885 0.0 0
M  V30 29 C 2.3100 10.2885 0.0 0
M  V30 30 C 8.6884 6.9507 0.0 0 CFG=1
M  V30 31 C 9.7189 8.0951 0.0 0
M  V30 32 O 9.1643 5.4860 0.0 0
M  V30 33 N 11.2253 7.7749 0.0 0
M  V30 34 C 10.6706 5.1658 0.0 0
M  V30 35 C 11.7012 6.3103 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 30 1 CFG=3
M  V30 3 1 2 25
M  V30 4 1 3 26
M  V30 5 1 4 23
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 33
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 29
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 1 16 24
M  V30 20 1 17 19
M  V30 21 2 17 20
M  V30 22 1 18 19
M  V30 23 2 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 1 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2R)-2-[[2-[2,6-difluoro-4-[(methylamino)carbonyl]phenyl]-5...
C26H30F2N4O4
1308849-97-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.9521 7.2709 0.0 0
M  V30 2 F 2.3100 6.2874 0.0 0
M  V30 3 F 6.9301 8.9548 0.0 0
M  V30 4 C 7.2418 0.0000 0.0 0
M  V30 5 C 13.0258 8.9195 0.0 0
M  V30 6 O 14.5321 8.5992 0.0 0
M  V30 7 O 12.5499 10.3841 0.0 0
M  V30 8 C 15.5627 9.7437 0.0 0
M  V30 9 C 14.4181 10.7741 0.0 0
M  V30 10 C 16.5931 10.8881 0.0 0
M  V30 11 C 16.7071 8.7133 0.0 0
M  V30 12 C 2.3100 11.6222 0.0 0
M  V30 13 N 0.7700 11.6222 0.0 0
M  V30 14 O 3.0800 12.9559 0.0 0
M  V30 15 C 0.0000 12.9559 0.0 0
M  V30 16 N 6.9216 6.1264 0.0 0
M  V30 17 C 5.3901 6.2874 0.0 0
M  V30 18 C 7.2418 4.6201 0.0 0
M  V30 19 N 4.7636 4.8805 0.0 0
M  V30 20 C 5.9081 3.8501 0.0 0
M  V30 21 C 8.5755 3.8501 0.0 0
M  V30 22 C 5.9081 2.3100 0.0 0
M  V30 23 C 8.5755 2.3100 0.0 0
M  V30 24 C 7.2418 1.5400 0.0 0
M  V30 25 C 4.6201 7.6211 0.0 0
M  V30 26 C 3.0800 7.6211 0.0 0
M  V30 27 C 5.3901 8.9548 0.0 0
M  V30 28 C 2.3100 8.9548 0.0 0
M  V30 29 C 4.6201 10.2886 0.0 0
M  V30 30 C 3.0800 10.2886 0.0 0
M  V30 31 C 9.4585 6.9507 0.0 0 CFG=1
M  V30 32 C 10.4889 8.0951 0.0 0
M  V30 33 O 9.9344 5.4860 0.0 0
M  V30 34 N 11.9954 7.7750 0.0 0
M  V30 35 C 11.4407 5.1658 0.0 0
M  V30 36 C 12.4713 6.3104 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 31 1 CFG=3
M  V30 3 1 2 26
M  V30 4 1 3 27
M  V30 5 1 4 24
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 34
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 30
M  V30 16 1 13 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 1 17 25
M  V30 21 1 18 20
M  V30 22 2 18 21
M  V30 23 1 19 20
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 1 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 31)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1308849-96-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1308849-97-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13887130
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 3945-69-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Part C. Preparation of (R)-tert-butyl
2-((2-(2,6-difluoro-4-(methylcarbamoyl)phenyl)-5-methyl-1H-benzo[d]imidazol-1-yl)methyl)morpholine-4-carboxylate.
(R)-4-(
1-((4-(tert-butoxycarbonyl)morpholin-2-yl)methyl)-5-methyl-1H-benzo[d]imidazol-2-yl)-3,5-difluorobenzoic
acid (750 mg, 1.54 mmol) was added to DMT-MM (408 mg, 1.69 mmol) in DMF
(30.00 mL) under N2. The resulting suspension was stirred for 30 min.
Aftereward, methylamine 33% (by weight) solution in absolute ethanol
(0.458 mL, 1.69 mmol) was added, and the mixture was stirred for 3 hr.
The mixture was then concentrated under reduced pressure, and the
resulting residue was dissolved in EtOAc and washed sequentially with
water and brine. The organic layer was dried over MgSO4, filtered, and
concentrated under reduced pressure. The crude material was purified on
preparative HPLC MS using the short high pH shallow gradient method
(mobile phase: 30-50% B; A: H2O with 10 mM NH4CO3 and 0.375% NH4OH v/v;
B: CH3CN; 10 min run; XBridge Prep C18 OBD, Waters reverse phase column;
column size: 30x50 mm; and particle size 5 μm). This produced
(S)-tert-butyl
2-((2-(2,6-difluoro-4-(methylcarbamoyl)phenyl)-5-methyl-1H-benzo[d]imidazol-1-yl)methyl)morpholine-4-carboxylate
as an oil, which was used without further purification (1.4 g, >100%
yield) in the next step. The oil was analyzed on analytical HPLC MS using
the high pH gradient method (mobile phase: 5-95% B; A: H2O with 10 mM
NH4CO3 and 0.375% NH4OH v/v; B: CH3CN; 2.25 min run; X-Bridge C18; column
size: 2.1 x 30 mm, particle size: 5 μm). MS m/z 501.4 [M+H]+ (ESI),
Rt1.85 min.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzoimidazole compounds for therapy of disorders
associated with P2X3 or P2X2/3 receptors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cantin, Louis-David; Luo, Xuehong; Tomaszewski, Miroslaw Jerzy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011062550 A1 2011-05-26

$RFMT $RIREG SCHEME107 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dichloro-N-(4-fluorophenyl)-1,3,5-triazin-2-amine
C9H5Cl2FN4
131468-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 5.3347 0.0 0
M  V30 2 Cl 0.0000 2.6674 0.0 0
M  V30 3 Cl 4.6200 0.0000 0.0 0
M  V30 4 F 10.7800 5.3347 0.0 0
M  V30 5 C 3.8500 4.0011 0.0 0
M  V30 6 N 2.3100 4.0011 0.0 0
M  V30 7 N 4.6200 2.6674 0.0 0
M  V30 8 C 1.5400 2.6674 0.0 0
M  V30 9 C 3.8500 1.3338 0.0 0
M  V30 10 N 2.3100 1.3338 0.0 0
M  V30 11 C 6.1600 5.3347 0.0 0
M  V30 12 C 6.9300 6.6685 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 8.4700 6.6685 0.0 0
M  V30 15 C 8.4700 4.0011 0.0 0
M  V30 16 C 9.2400 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 11
M  V30 3 1 2 8
M  V30 4 1 3 9
M  V30 5 1 4 16
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N2-(4-fluorophenyl)-N4-methyl-1,3,5-triazine-2,4-diamine
C10H9ClFN5
1520874-58-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 4.6201 0.0 0
M  V30 2 N 10.6695 4.6201 0.0 0
M  V30 3 C 12.0032 3.8500 0.0 0
M  V30 4 Cl 8.0021 0.0000 0.0 0
M  V30 5 F 0.0000 1.5400 0.0 0
M  V30 6 C 6.6684 3.8500 0.0 0
M  V30 7 N 8.0021 4.6201 0.0 0
M  V30 8 N 6.6684 2.3100 0.0 0
M  V30 9 C 9.3359 3.8500 0.0 0
M  V30 10 C 8.0021 1.5400 0.0 0
M  V30 11 N 9.3359 2.3100 0.0 0
M  V30 12 C 4.0011 3.8500 0.0 0
M  V30 13 C 2.6673 4.6201 0.0 0
M  V30 14 C 4.0011 2.3100 0.0 0
M  V30 15 C 1.3337 3.8500 0.0 0
M  V30 16 C 2.6673 1.5400 0.0 0
M  V30 17 C 1.3337 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 2 9
M  V30 5 1 4 10
M  V30 6 1 5 17
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 131468-33-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1520874-58-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-23893124
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Small-Molecule Cyclic GMP-AMP Synthase Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Padilla-Salinas, Rosaura; Sun, Lijun; Anderson, Rachel; Yang, Xikang;
Zhang, Shuting; Chen, Zhijian J.; Yin, Hang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2020), 85(3), 1579-1600

$RFMT $RIREG SCHEME108 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-(1,8-naphthyridin-2-yl)benzeneacetate
C18H16N2O2
1314796-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.5500 2.6674 0.0 0
M  V30 2 C 12.3200 4.0011 0.0 0
M  V30 3 O 13.8600 4.0011 0.0 0
M  V30 4 O 11.5500 5.3349 0.0 0
M  V30 5 C 14.6300 5.3347 0.0 0
M  V30 6 C 16.1700 5.3347 0.0 0
M  V30 7 C 5.3900 2.6674 0.0 0
M  V30 8 N 4.6200 1.3338 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 3.0800 1.3338 0.0 0
M  V30 11 C 3.0800 4.0011 0.0 0
M  V30 12 C 2.3100 2.6674 0.0 0
M  V30 13 N 2.3100 0.0000 0.0 0
M  V30 14 C 0.7700 2.6674 0.0 0
M  V30 15 C 0.7700 0.0000 0.0 0
M  V30 16 C 0.0000 1.3338 0.0 0
M  V30 17 C 6.9300 2.6674 0.0 0
M  V30 18 C 7.7000 1.3338 0.0 0
M  V30 19 C 7.7000 4.0011 0.0 0
M  V30 20 C 9.2400 1.3338 0.0 0
M  V30 21 C 9.2400 4.0011 0.0 0
M  V30 22 C 10.0100 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 17
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 10 13
M  V30 14 1 11 12
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-(1,8-naphthyridin-2-yl)benzeneacetamide
C17H15N3O
2361972-29-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 5.3901 0.0 0
M  V30 2 C 12.0033 4.6201 0.0 0
M  V30 3 N 13.3370 5.3901 0.0 0
M  V30 4 O 12.0033 3.0801 0.0 0
M  V30 5 C 14.6707 4.6201 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 N 4.0010 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 C 4.0010 0.0000 0.0 0
M  V30 11 C 2.6673 0.7700 0.0 0
M  V30 12 N 1.3337 3.0801 0.0 0
M  V30 13 C 1.3337 0.0000 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 0.0000 0.7700 0.0 0
M  V30 16 C 6.6685 3.0801 0.0 0
M  V30 17 C 6.6685 4.6201 0.0 0
M  V30 18 C 8.0022 2.3101 0.0 0
M  V30 19 C 8.0022 5.3901 0.0 0
M  V30 20 C 9.3358 3.0801 0.0 0
M  V30 21 C 9.3358 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 16
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 9 12
M  V30 13 1 10 11
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1314796-12-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2361972-29-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38115056
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 6674-22-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions gave lower yield,product is further
converted to succinic acid salt
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of naphthyridine compounds targeting SUCNR1 to reduce
neuroinflammation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Xin; Saxena, Deepak; Guo, Yuqi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20230293504 A1 2023-09-21

$RFMT $RIREG SCHEME108 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-(1,8-naphthyridin-2-yl)benzeneacetate
C18H16N2O2
1314796-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.5500 2.6674 0.0 0
M  V30 2 C 12.3200 4.0011 0.0 0
M  V30 3 O 13.8600 4.0011 0.0 0
M  V30 4 O 11.5500 5.3349 0.0 0
M  V30 5 C 14.6300 5.3347 0.0 0
M  V30 6 C 16.1700 5.3347 0.0 0
M  V30 7 C 5.3900 2.6674 0.0 0
M  V30 8 N 4.6200 1.3338 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 3.0800 1.3338 0.0 0
M  V30 11 C 3.0800 4.0011 0.0 0
M  V30 12 C 2.3100 2.6674 0.0 0
M  V30 13 N 2.3100 0.0000 0.0 0
M  V30 14 C 0.7700 2.6674 0.0 0
M  V30 15 C 0.7700 0.0000 0.0 0
M  V30 16 C 0.0000 1.3338 0.0 0
M  V30 17 C 6.9300 2.6674 0.0 0
M  V30 18 C 7.7000 1.3338 0.0 0
M  V30 19 C 7.7000 4.0011 0.0 0
M  V30 20 C 9.2400 1.3338 0.0 0
M  V30 21 C 9.2400 4.0011 0.0 0
M  V30 22 C 10.0100 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 17
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 10 13
M  V30 14 1 11 12
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-(1,8-naphthyridin-2-yl)benzeneacetamide
C17H15N3O
2361972-29-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 5.3901 0.0 0
M  V30 2 C 12.0033 4.6201 0.0 0
M  V30 3 N 13.3370 5.3901 0.0 0
M  V30 4 O 12.0033 3.0801 0.0 0
M  V30 5 C 14.6707 4.6201 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 N 4.0010 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 C 4.0010 0.0000 0.0 0
M  V30 11 C 2.6673 0.7700 0.0 0
M  V30 12 N 1.3337 3.0801 0.0 0
M  V30 13 C 1.3337 0.0000 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 0.0000 0.7700 0.0 0
M  V30 16 C 6.6685 3.0801 0.0 0
M  V30 17 C 6.6685 4.6201 0.0 0
M  V30 18 C 8.0022 2.3101 0.0 0
M  V30 19 C 8.0022 5.3901 0.0 0
M  V30 20 C 9.3358 3.0801 0.0 0
M  V30 21 C 9.3358 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 16
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 9 12
M  V30 13 1 10 11
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1314796-12-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2361972-29-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20482508
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 6674-22-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown,alternate reaction conditions gave lower
yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Periodontal disease therapy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Xin; Saxena, Deepak
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019136022 A1 2019-07-11

$RFMT $RIREG SCHEME109 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Hydroxy-4-methoxybenzophenone
C14H12O3
131-57-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 O 4.0012 0.0000 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 O 9.3360 4.6201 0.0 0
M  V30 5 C 10.6697 3.8501 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 6.6685 1.5400 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 8.0022 2.3101 0.0 0
M  V30 10 C 6.6685 4.6201 0.0 0
M  V30 11 C 8.0022 3.8501 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 2.6673 3.8501 0.0 0
M  V30 14 C 1.3337 1.5400 0.0 0
M  V30 15 C 1.3337 4.6201 0.0 0
M  V30 16 C 0.0000 2.3101 0.0 0
M  V30 17 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 1 12
M  V30 4 1 3 7
M  V30 5 1 4 5
M  V30 6 1 4 11
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Methoxy-2-[(methylimino)phenylmethyl]phenol
C15H15NO2
894079-19-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 N 4.0012 0.7700 0.0 0
M  V30 3 C 2.6673 0.0000 0.0 0
M  V30 4 O 6.6685 0.7700 0.0 0
M  V30 5 O 9.3360 5.3901 0.0 0
M  V30 6 C 10.6697 4.6201 0.0 0
M  V30 7 C 5.3348 3.0801 0.0 0
M  V30 8 C 6.6685 2.3101 0.0 0
M  V30 9 C 5.3348 4.6201 0.0 0
M  V30 10 C 8.0022 3.0801 0.0 0
M  V30 11 C 6.6685 5.3901 0.0 0
M  V30 12 C 8.0022 4.6201 0.0 0
M  V30 13 C 2.6673 3.0801 0.0 0
M  V30 14 C 2.6673 4.6201 0.0 0
M  V30 15 C 1.3337 2.3101 0.0 0
M  V30 16 C 1.3337 5.3901 0.0 0
M  V30 17 C 0.0000 3.0801 0.0 0
M  V30 18 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 7
M  V30 3 1 1 13
M  V30 4 1 2 3
M  V30 5 1 4 8
M  V30 6 1 5 6
M  V30 7 1 5 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 131-57-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 894079-19-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-9744695
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Typical Procedure On one side of an H-tube,
the described ketone was added, and to the other side, aqueous amine
solution or neat amine was added. The tube was sealed immediately with a
rubber seal stopper, and the reaction was monitored by 1H NMR
spectrometry. The excess ammonia or amine gas was removed under reduced
pressure to give the corresponding imine.
5-Methoxy-2-[(methylimino)(phenyl)methyl]phenol (3j) Employing the
general method, imine (3j) was prepared from ketone (1h) (50 mg, 0.22
mmol) and 40% methylamine aq. solution (2 mL). After 8 h, the pale yellow
solid ketone was converted to a yellow solid corresponding to 3j with 80%
conversion. After 23 h, 3j was obtained with 100% conversion. The excess
methylamine was removed under reduced pressure to give the title compound
(3j) as a yellow solid (52 mg, 100%). Mp 95-96°C. 1H NMR (400 MHz, CDCl3)
δ 3.05 (s, 3H), 3.79 (s, 3H), 6.06 (dd, J = 2.5, 9.0 Hz, 1H), 6.36 (d, J
= 2.5 Hz, 1H), 6.60 (dt, J = 9.0 Hz, 1H), 7.20 (m, 2H), 7.48 (m, 3H). 13C
NMR (100 MHz, CDCl3) δ 35.44, 55.27, 102.24, 105.62, 112.27, 127.58,
128.83, 129.41, 132.82, 164.61, 172.05, 174.56. IR (neat) νmax 2853m,
1597s, 1547s, 1444w, 1347w, 1285m, 1212m, 1165m, 1109m, 1031m, 708m cm-1.
Ms calc. (found) for C15H16NO2+ (M + H+): m/z 242.3 (242.3, 100%). HRMS
calc. (found) for C15H16NO2+ (M + H+): m/z 242.1181 (242.1170).
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed H-tube used, 100% conversion
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Simplified Ketimine Preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Thienthong, Neeranat; Bergman, Ylva E.; Perlmutter, Patrick
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2009), 39(15), 2683-2693

$RFMT $RIREG SCHEME110 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[2-[[(1,1-Dimethylethoxy)carbonyl]amino]-5-thiazolyl]-1H-1,2,3-triazole-1-a...
C12H15N5O4S
1326236-67-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 0.5637 0.0 0
M  V30 2 C 4.0010 1.3337 0.0 0
M  V30 3 O 2.6673 0.5637 0.0 0
M  V30 4 O 4.0010 2.8737 0.0 0
M  V30 5 C 1.3337 1.3337 0.0 0
M  V30 6 C 0.5637 0.0000 0.0 0
M  V30 7 C 0.0000 2.1037 0.0 0
M  V30 8 C 2.1037 2.6673 0.0 0
M  V30 9 C 14.4086 2.9789 0.0 0
M  V30 10 C 15.7422 2.2089 0.0 0
M  V30 11 O 15.7422 0.6688 0.0 0
M  V30 12 O 17.0759 2.9789 0.0 0
M  V30 13 C 9.1059 1.8517 0.0 0
M  V30 14 S 8.0753 0.7073 0.0 0
M  V30 15 C 8.3359 3.1854 0.0 0
M  V30 16 C 6.6685 1.3337 0.0 0
M  V30 17 N 6.8294 2.8652 0.0 0
M  V30 18 C 10.6375 1.6908 0.0 0
M  V30 19 C 11.6679 2.8352 0.0 0
M  V30 20 N 11.4075 0.3571 0.0 0
M  V30 21 N 13.0749 2.2089 0.0 0
M  V30 22 N 12.9138 0.6773 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 13 18
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[5-[1-[2-(methylamino)-2-oxoethyl]-1H-1,2,3-triazol-4-yl]...
C13H18N6O3S
1326236-68-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3350 0.5637 0.0 0
M  V30 2 C 4.0012 1.3337 0.0 0
M  V30 3 O 2.6675 0.5637 0.0 0
M  V30 4 O 4.0012 2.8737 0.0 0
M  V30 5 C 1.3338 1.3337 0.0 0
M  V30 6 C 2.1038 2.6673 0.0 0
M  V30 7 C 0.0000 2.1037 0.0 0
M  V30 8 C 0.5638 0.0000 0.0 0
M  V30 9 C 14.4087 2.9789 0.0 0
M  V30 10 C 15.7424 2.2089 0.0 0
M  V30 11 N 17.0760 2.9789 0.0 0
M  V30 12 O 15.7424 0.6688 0.0 0
M  V30 13 C 18.4099 2.2089 0.0 0
M  V30 14 C 9.1061 1.8517 0.0 0
M  V30 15 S 8.0755 0.7073 0.0 0
M  V30 16 C 8.3360 3.1854 0.0 0
M  V30 17 C 6.6687 1.3337 0.0 0
M  V30 18 N 6.8296 2.8652 0.0 0
M  V30 19 C 10.6376 1.6908 0.0 0
M  V30 20 C 11.6681 2.8352 0.0 0
M  V30 21 N 11.4076 0.3571 0.0 0
M  V30 22 N 13.0750 2.2089 0.0 0
M  V30 23 N 12.9140 0.6773 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 9 22
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 19
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1326236-67-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1326236-68-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5150932
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 125700-67-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM N-(5-substituted thiazol-2-yl)-2-aryl-3-(tetrahydro-2H-pyran-4-yl)
propanamides as glucokinase activators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Zhiqing; Zhu, Qingzhang; Li, Fuying; Zhang, Lina; Leng, Ying; Zhang,
Ao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM MedChemComm (2011), 2(6), 531-535

$RFMT $RIREG SCHEME111 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxy-4-(trifluoromethyl)benzaldehyde
C9H7F3O2
132927-09-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3336 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 C 0.7700 4.0009 0.0 0
M  V30 4 O 0.0000 5.3347 0.0 0
M  V30 5 C 6.9300 4.0009 0.0 0
M  V30 6 F 6.9300 2.4609 0.0 0
M  V30 7 F 8.4700 4.0009 0.0 0
M  V30 8 F 6.9300 5.5409 0.0 0
M  V30 9 C 3.0800 2.6673 0.0 0
M  V30 10 C 2.3100 4.0009 0.0 0
M  V30 11 C 4.6200 2.6673 0.0 0
M  V30 12 C 3.0800 5.3347 0.0 0
M  V30 13 C 5.3900 4.0009 0.0 0
M  V30 14 C 4.6200 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 2 3 4
M  V30 4 1 3 10
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxy-N-methyl-4-(trifluoromethyl)benzenemethanamine
C10H12F3NO
1199782-16-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 4.0009 0.0 0
M  V30 2 N 8.4700 5.3347 0.0 0
M  V30 3 C 10.0100 5.3347 0.0 0
M  V30 4 O 6.1600 1.3336 0.0 0
M  V30 5 C 5.3900 0.0000 0.0 0
M  V30 6 C 1.5400 4.0009 0.0 0
M  V30 7 F 1.5400 2.4609 0.0 0
M  V30 8 F 0.0000 4.0009 0.0 0
M  V30 9 F 1.5400 5.5409 0.0 0
M  V30 10 C 6.1600 4.0009 0.0 0
M  V30 11 C 5.3900 2.6673 0.0 0
M  V30 12 C 5.3900 5.3347 0.0 0
M  V30 13 C 3.8500 2.6673 0.0 0
M  V30 14 C 3.8500 5.3347 0.0 0
M  V30 15 C 3.0800 4.0009 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 132927-09-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1199782-16-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40490482
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective Defluorination of Trifluoromethyl Substituents by
Conformationally Induced Remote Substitution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jesani, Mehul H.; Schwarz, Maria; Kim, Shiwhu; Evans, Finlay L.; White,
Alexander; Browning, Alex; Abrams, Roman; Clayden, Jonathan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2024), 63(24), e202403477

$RFMT $RIREG SCHEME112 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-5-phenylthiazole
C9H6BrNS
133311-51-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 8.2357 0.0000 0.0 0
M  V30 2 C 4.6200 1.6752 0.0 0
M  V30 3 S 5.5252 0.4294 0.0 0
M  V30 4 C 5.5252 2.9211 0.0 0
M  V30 5 C 6.9898 0.9052 0.0 0
M  V30 6 N 6.9898 2.4452 0.0 0
M  V30 7 C 3.0800 1.6752 0.0 0
M  V30 8 C 2.3100 3.0089 0.0 0
M  V30 9 C 2.3100 0.3416 0.0 0
M  V30 10 C 0.7700 3.0089 0.0 0
M  V30 11 C 0.7700 0.3416 0.0 0
M  V30 12 C 0.0000 1.6752 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 7
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-5-phenyl-2-thiazolamine
C10H10N2S
1344198-25-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.2359 3.0089 0.0 0
M  V30 2 C 9.6427 2.3826 0.0 0
M  V30 3 C 4.6201 1.3337 0.0 0
M  V30 4 S 5.5253 2.5795 0.0 0
M  V30 5 C 5.5253 0.0878 0.0 0
M  V30 6 C 6.9898 2.1037 0.0 0
M  V30 7 N 6.9898 0.5636 0.0 0
M  V30 8 C 3.0800 1.3337 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 2.3100 2.6673 0.0 0
M  V30 11 C 0.7700 0.0000 0.0 0
M  V30 12 C 0.7700 2.6673 0.0 0
M  V30 13 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 133311-51-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1344198-25-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-18787485
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 1-cyanopyrrolidine-3-carboxamides as USP30 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gibson, Karl Richard; Jones, Alison; Kemp, Mark Ian; Madin, Andrew;
Stockley, Martin Lee; Whitlock, Gavin Alistair; Woodrow, Michael D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017141036 A1 2017-08-24

$RFMT $RIREG SCHEME113 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N2,N6-Bis(6-chloro-4-pyrimidinyl)-N2,N6-dimethyl-2,6-pyridinediamine
C15H13Cl2N7
1333169-63-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.6698 1.5400 0.0 0
M  V30 2 C 10.6698 0.0000 0.0 0
M  V30 3 N 5.3348 1.5400 0.0 0
M  V30 4 C 5.3348 0.0000 0.0 0
M  V30 5 Cl 16.0046 1.5400 0.0 0
M  V30 6 Cl 0.0000 1.5400 0.0 0
M  V30 7 C 9.3360 2.3101 0.0 0
M  V30 8 N 8.0023 1.5400 0.0 0
M  V30 9 C 9.3360 3.8501 0.0 0
M  V30 10 C 6.6687 2.3101 0.0 0
M  V30 11 C 8.0023 4.6201 0.0 0
M  V30 12 C 6.6687 3.8501 0.0 0
M  V30 13 C 12.0035 2.3101 0.0 0
M  V30 14 C 13.3372 1.5400 0.0 0
M  V30 15 N 12.0035 3.8501 0.0 0
M  V30 16 C 14.6708 2.3101 0.0 0
M  V30 17 C 13.3372 4.6201 0.0 0
M  V30 18 N 14.6708 3.8501 0.0 0
M  V30 19 C 4.0012 2.3101 0.0 0
M  V30 20 C 2.6675 1.5400 0.0 0
M  V30 21 N 4.0012 3.8501 0.0 0
M  V30 22 C 1.3338 2.3101 0.0 0
M  V30 23 C 2.6675 4.6201 0.0 0
M  V30 24 N 1.3338 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 1 13
M  V30 4 1 3 4
M  V30 5 1 3 10
M  V30 6 1 3 19
M  V30 7 1 5 16
M  V30 8 1 6 22
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Pyrimidinediamine, N4,N4′-2,6-pyridinediylbis[N4,N6-dimethyl-
C17H21N9
1333169-59-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 1.5400 0.0 0
M  V30 2 C 6.6685 0.0000 0.0 0
M  V30 3 N 12.0035 1.5400 0.0 0
M  V30 4 C 12.0035 0.0000 0.0 0
M  V30 5 N 1.3337 1.5400 0.0 0
M  V30 6 C 0.0000 2.3101 0.0 0
M  V30 7 N 17.3383 1.5400 0.0 0
M  V30 8 C 18.6720 2.3101 0.0 0
M  V30 9 C 8.0023 2.3101 0.0 0
M  V30 10 N 9.3360 1.5400 0.0 0
M  V30 11 C 8.0023 3.8501 0.0 0
M  V30 12 C 10.6697 2.3101 0.0 0
M  V30 13 C 9.3360 4.6201 0.0 0
M  V30 14 C 10.6697 3.8501 0.0 0
M  V30 15 C 5.3348 2.3101 0.0 0
M  V30 16 C 4.0012 1.5400 0.0 0
M  V30 17 N 5.3348 3.8501 0.0 0
M  V30 18 C 2.6675 2.3101 0.0 0
M  V30 19 C 4.0012 4.6201 0.0 0
M  V30 20 N 2.6675 3.8501 0.0 0
M  V30 21 C 13.3372 2.3101 0.0 0
M  V30 22 C 14.6708 1.5400 0.0 0
M  V30 23 N 13.3372 3.8501 0.0 0
M  V30 24 C 16.0045 2.3101 0.0 0
M  V30 25 C 14.6708 4.6201 0.0 0
M  V30 26 N 16.0045 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 1 15
M  V30 4 1 3 4
M  V30 5 1 3 12
M  V30 6 1 3 21
M  V30 7 1 5 6
M  V30 8 1 5 18
M  V30 9 1 7 8
M  V30 10 1 7 24
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1333169-63-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1333169-59-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14392571
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM autoclave used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 1,3,5-alternate azacalix[3]pyridine[3]pyrimidine and its
complexation with fullerenes via multiple π/π and CH/π interactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Li-Xia; Zhao, Liang; Wang, De-Xian; Wang, Mei-Xiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2011), 47(34),
9690-9692

$RFMT $RIREG SCHEME114 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Histidine, N-(carboxymethyl)-N-(2-naphthalenylmethyl)glycyl-, 2-methyl este...
C22H24N4O5.CH2O2
1333226-88-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.2402 7.6448 0.0 0
M  V30 2 N 8.4702 6.3110 0.0 0
M  V30 3 C 6.9302 6.3110 0.0 0
M  V30 4 C 9.2402 4.9774 0.0 0
M  V30 5 C 6.1601 7.6448 0.0 0
M  V30 6 C 8.4702 3.6437 0.0 0
M  V30 7 N 4.6201 7.6448 0.0 0
M  V30 8 O 6.9302 8.9785 0.0 0
M  V30 9 O 9.2402 2.3100 0.0 0
M  V30 10 O 6.9302 3.6437 0.0 0
M  V30 11 C 3.8501 8.9785 0.0 0 CFG=2
M  V30 12 C 4.6201 10.3122 0.0 0
M  V30 13 C 2.3101 8.9785 0.0 0
M  V30 14 O 1.5400 7.6448 0.0 0
M  V30 15 O 1.5400 10.3122 0.0 0
M  V30 16 C 0.0000 7.6448 0.0 0
M  V30 17 C 13.0903 8.9785 0.0 0
M  V30 18 C 13.8603 7.6448 0.0 0
M  V30 19 C 11.5503 8.9785 0.0 0
M  V30 20 C 13.8603 10.3122 0.0 0
M  V30 21 C 13.0903 6.3110 0.0 0
M  V30 22 C 15.4003 7.6448 0.0 0
M  V30 23 C 10.7802 7.6448 0.0 0
M  V30 24 C 15.4003 10.3122 0.0 0
M  V30 25 C 11.5503 6.3110 0.0 0
M  V30 26 C 16.1704 8.9785 0.0 0
M  V30 27 C 3.8501 11.6460 0.0 0
M  V30 28 C 4.4764 13.0528 0.0 0
M  V30 29 N 2.3185 11.8069 0.0 0
M  V30 30 N 3.3320 14.0833 0.0 0
M  V30 31 C 1.9983 13.3133 0.0 0
M  V30 32 C 8.0852 0.0000 0.0 0
M  V30 33 O 6.7515 0.7700 0.0 0
M  V30 34 O 9.4188 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 11 12 CFG=3
M  V30 13 1 11 13
M  V30 14 1 12 27
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 1 18 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 2 20 24
M  V30 25 2 21 25
M  V30 26 2 22 26
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 31
M  V30 34 1 32 33
M  V30 35 2 32 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-(Carboxymethyl)-N-(2-naphthalenylmethyl)glycyl-N-methyl-L-histidinamide
C22H25N5O4
1333227-39-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.2402 5.3348 0.0 0
M  V30 2 N 8.4702 4.0010 0.0 0
M  V30 3 C 6.9302 4.0010 0.0 0
M  V30 4 C 9.2402 2.6673 0.0 0
M  V30 5 C 6.1601 5.3348 0.0 0
M  V30 6 C 8.4702 1.3337 0.0 0
M  V30 7 N 4.6201 5.3348 0.0 0
M  V30 8 O 6.9302 6.6685 0.0 0
M  V30 9 O 9.2402 0.0000 0.0 0
M  V30 10 O 6.9302 1.3337 0.0 0
M  V30 11 C 3.8501 6.6685 0.0 0 CFG=2
M  V30 12 C 4.6201 8.0022 0.0 0
M  V30 13 C 2.3101 6.6685 0.0 0
M  V30 14 N 1.5400 5.3348 0.0 0
M  V30 15 O 1.5400 8.0022 0.0 0
M  V30 16 C 0.0000 5.3348 0.0 0
M  V30 17 C 13.0903 6.6685 0.0 0
M  V30 18 C 13.8603 5.3348 0.0 0
M  V30 19 C 11.5503 6.6685 0.0 0
M  V30 20 C 13.8603 8.0022 0.0 0
M  V30 21 C 13.0903 4.0010 0.0 0
M  V30 22 C 15.4003 5.3348 0.0 0
M  V30 23 C 10.7802 5.3348 0.0 0
M  V30 24 C 15.4003 8.0022 0.0 0
M  V30 25 C 11.5503 4.0010 0.0 0
M  V30 26 C 16.1704 6.6685 0.0 0
M  V30 27 C 3.8501 9.3360 0.0 0
M  V30 28 C 4.4764 10.7428 0.0 0
M  V30 29 N 2.3185 9.4969 0.0 0
M  V30 30 N 3.3320 11.7733 0.0 0
M  V30 31 C 1.9983 11.0032 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 11 12 CFG=3
M  V30 13 1 11 13
M  V30 14 1 12 27
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 1 18 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 2 20 24
M  V30 25 2 21 25
M  V30 26 2 22 26
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1333226-88-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1333227-39-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1123514
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: To a stirred solution of ester (0.5mmol) in
methanol (1 mL) were added 622 μL of a solution of methylamine in ethanol
(33%). The mixture was refluxed overnight. The solvent was evaporated and
the crude product was precipitated in water and filtrated to give the
compound. Reactant: (S)-
2-[2-(Carboxymethyl-naphthalen-2-ylmethyl-amino)-acetylamino]-3-(1H-imidazol-4-yl)-propionic
acid methyl ester (33).
({[(S)-2-(1H-Imidazol-4-yl)-1-methylcarbamoyl-ethylcarbamoyl]-methyl}-naphthalen-2-ylmethyl-amino)-acetic
acid (66) was obtained (100%). Purity: 97%. 1H NMR (DMSO-d6) δ ppm: 8.90
(d, J= 8.3Hz, 1H), 8.05 (q, J= 4.9Hz, 1H), 7.89-7.8 (m, 4H), 7.53-7.44
(m, 3H+1H), 6.76 (s, 1H), 4.41 (m, 1H), 3.84 (s, 2H), 3.16 (s, 2H), 3.05
(s, 2H), 2.91 (m, 2H), 2.59 (d, J= 4.9Hz, 3H); LC : tr = 3.12min; MS
(ESI+) : m/z = 424 (M+H)+. pIC50: 5.9.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzylcarboxymethylaminoacetylaminoimidazolylpropionic
acid derivatives and analogs for use as insulin degrading enzyme
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deprez-Poulain, Rebecca Franziska; Charton, Julie Jeanne Marine; Deprez,
Benoit Gaston Pierre; Leroux, Florence Catherine Gilberte; Gauriot,
Marion; Tang, Wei-Jen; Totobenazara, Jane
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP2371421 A1 2011-10-05

$RFMT $RIREG SCHEME114 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Histidine, N-(carboxymethyl)-N-(2-naphthalenylmethyl)glycyl-, 2-methyl este...
C22H24N4O5.CH2O2
1333226-88-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.2402 7.6448 0.0 0
M  V30 2 N 8.4702 6.3110 0.0 0
M  V30 3 C 6.9302 6.3110 0.0 0
M  V30 4 C 9.2402 4.9774 0.0 0
M  V30 5 C 6.1601 7.6448 0.0 0
M  V30 6 C 8.4702 3.6437 0.0 0
M  V30 7 N 4.6201 7.6448 0.0 0
M  V30 8 O 6.9302 8.9785 0.0 0
M  V30 9 O 9.2402 2.3100 0.0 0
M  V30 10 O 6.9302 3.6437 0.0 0
M  V30 11 C 3.8501 8.9785 0.0 0 CFG=2
M  V30 12 C 4.6201 10.3122 0.0 0
M  V30 13 C 2.3101 8.9785 0.0 0
M  V30 14 O 1.5400 7.6448 0.0 0
M  V30 15 O 1.5400 10.3122 0.0 0
M  V30 16 C 0.0000 7.6448 0.0 0
M  V30 17 C 13.0903 8.9785 0.0 0
M  V30 18 C 13.8603 7.6448 0.0 0
M  V30 19 C 11.5503 8.9785 0.0 0
M  V30 20 C 13.8603 10.3122 0.0 0
M  V30 21 C 13.0903 6.3110 0.0 0
M  V30 22 C 15.4003 7.6448 0.0 0
M  V30 23 C 10.7802 7.6448 0.0 0
M  V30 24 C 15.4003 10.3122 0.0 0
M  V30 25 C 11.5503 6.3110 0.0 0
M  V30 26 C 16.1704 8.9785 0.0 0
M  V30 27 C 3.8501 11.6460 0.0 0
M  V30 28 C 4.4764 13.0528 0.0 0
M  V30 29 N 2.3185 11.8069 0.0 0
M  V30 30 N 3.3320 14.0833 0.0 0
M  V30 31 C 1.9983 13.3133 0.0 0
M  V30 32 C 8.0852 0.0000 0.0 0
M  V30 33 O 6.7515 0.7700 0.0 0
M  V30 34 O 9.4188 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 11 12 CFG=3
M  V30 13 1 11 13
M  V30 14 1 12 27
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 1 18 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 2 20 24
M  V30 25 2 21 25
M  V30 26 2 22 26
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 31
M  V30 34 1 32 33
M  V30 35 2 32 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-(Carboxymethyl)-N-(2-naphthalenylmethyl)glycyl-N-methyl-L-histidinamide
C22H25N5O4
1333227-39-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.2402 5.3348 0.0 0
M  V30 2 N 8.4702 4.0010 0.0 0
M  V30 3 C 6.9302 4.0010 0.0 0
M  V30 4 C 9.2402 2.6673 0.0 0
M  V30 5 C 6.1601 5.3348 0.0 0
M  V30 6 C 8.4702 1.3337 0.0 0
M  V30 7 N 4.6201 5.3348 0.0 0
M  V30 8 O 6.9302 6.6685 0.0 0
M  V30 9 O 9.2402 0.0000 0.0 0
M  V30 10 O 6.9302 1.3337 0.0 0
M  V30 11 C 3.8501 6.6685 0.0 0 CFG=2
M  V30 12 C 4.6201 8.0022 0.0 0
M  V30 13 C 2.3101 6.6685 0.0 0
M  V30 14 N 1.5400 5.3348 0.0 0
M  V30 15 O 1.5400 8.0022 0.0 0
M  V30 16 C 0.0000 5.3348 0.0 0
M  V30 17 C 13.0903 6.6685 0.0 0
M  V30 18 C 13.8603 5.3348 0.0 0
M  V30 19 C 11.5503 6.6685 0.0 0
M  V30 20 C 13.8603 8.0022 0.0 0
M  V30 21 C 13.0903 4.0010 0.0 0
M  V30 22 C 15.4003 5.3348 0.0 0
M  V30 23 C 10.7802 5.3348 0.0 0
M  V30 24 C 15.4003 8.0022 0.0 0
M  V30 25 C 11.5503 4.0010 0.0 0
M  V30 26 C 16.1704 6.6685 0.0 0
M  V30 27 C 3.8501 9.3360 0.0 0
M  V30 28 C 4.4764 10.7428 0.0 0
M  V30 29 N 2.3185 9.4969 0.0 0
M  V30 30 N 3.3320 11.7733 0.0 0
M  V30 31 C 1.9983 11.0032 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 11 12 CFG=3
M  V30 13 1 11 13
M  V30 14 1 12 27
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 1 18 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 2 20 24
M  V30 25 2 21 25
M  V30 26 2 22 26
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1333226-88-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1333227-39-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-6661039
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a stirred solution of ester (0.5mmol) in methanol (1 mL) were added
622 μL of a solution of methylamine in ethanol (33%). The mixture was
refluxed overnight. The solvent was evaporated and the crude product was
precipitated in water and filtrated to give the compound.
({[(S)-2-(1H-Imidazol-4-yl)-1-methylcarbamoyl-ethylcarbamoyl]-methyl}-naphthalen-2-ylmethyl-amino)-acetic
acid (66) was obtained from (33) (100%). Purity : 97% ; 1H NMR (DMSO-d6)
δ ppm: 8.90 (d, J = 8.3Hz, 1H), 8.05 (q, J = 4.9Hz, 1H), 7.89-7.8 (m,
4H), 7.53-7.44 (m, 3H+1H), 6.76 (s, 1H), 4.41 (m, 1H), 3.84 (s, 2H), 3.16
(s, 2H), 3.05 (s, 2H), 2.91 (m, 2H), 2.59 (d, J = 4.9Hz, 3H); LC : tr =
3.12min; MS (ESI+) : m/z = 424 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzylcarboxymethylaminoacetylaminoimidazolylpropionic
acid derivatives and analogs for use as insulin degrading enzyme
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deprez-Poulain, Rebecca Franziska; Charton, Julie Jeanne Marine; Deprez,
Benoit Gaston Pierre; Leroux, Florence Catherine Gilberte; Gauriot,
Marion; Tang, Wei-Jen; Totobenazara, Jane
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011107948 A2 2011-09-09

$RFMT $RIREG SCHEME115 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Histidine, N-(carboxymethyl)-N-(phenylmethyl)glycyl-1-(triphenylmethyl)-, 2...
C37H36N4O5.CH2O2
1333226-98-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 52 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8987 9.3200 0.0 0
M  V30 2 C 9.0543 7.6448 0.0 0
M  V30 3 C 9.8243 6.3111 0.0 0 CFG=1
M  V30 4 N 11.3643 6.3111 0.0 0
M  V30 5 C 9.0543 4.9773 0.0 0
M  V30 6 C 12.1343 7.6448 0.0 0
M  V30 7 O 9.8243 3.6437 0.0 0
M  V30 8 O 7.5143 4.9773 0.0 0
M  V30 9 C 13.6743 7.6448 0.0 0
M  V30 10 O 11.3643 8.9784 0.0 0
M  V30 11 C 9.0543 2.3100 0.0 0
M  V30 12 N 14.4444 8.9784 0.0 0
M  V30 13 C 13.6743 10.3121 0.0 0
M  V30 14 C 15.9844 8.9784 0.0 0
M  V30 15 C 16.7544 7.6448 0.0 0
M  V30 16 O 15.9844 6.3111 0.0 0
M  V30 17 O 18.2944 7.6448 0.0 0
M  V30 18 N 5.1446 8.4148 0.0 0
M  V30 19 C 6.6091 8.8906 0.0 0
M  V30 20 C 5.1446 6.8748 0.0 0
M  V30 21 C 7.5143 7.6448 0.0 0
M  V30 22 N 6.6091 6.3989 0.0 0
M  V30 23 C 4.8037 10.5658 0.0 0
M  V30 24 C 6.3354 10.4049 0.0 0
M  V30 25 C 4.1774 11.9726 0.0 0
M  V30 26 C 7.2407 11.6508 0.0 0
M  V30 27 C 5.0826 13.2187 0.0 0
M  V30 28 C 6.6142 13.0576 0.0 0
M  V30 29 C 2.6527 10.2252 0.0 0
M  V30 30 C 1.2459 9.5987 0.0 0
M  V30 31 C 2.8137 11.7567 0.0 0
M  V30 32 C 0.0000 10.5039 0.0 0
M  V30 33 C 1.5679 12.6620 0.0 0
M  V30 34 C 0.1609 12.0355 0.0 0
M  V30 35 C 2.9935 8.0741 0.0 0
M  V30 36 C 1.4619 8.2350 0.0 0
M  V30 37 C 3.6198 6.6672 0.0 0
M  V30 38 C 0.5567 6.9892 0.0 0
M  V30 39 C 2.7146 5.4213 0.0 0
M  V30 40 C 1.1830 5.5822 0.0 0
M  V30 41 C 14.4444 11.6459 0.0 0
M  V30 42 C 13.6743 12.9795 0.0 0
M  V30 43 C 15.9844 11.6459 0.0 0
M  V30 44 C 14.4444 14.3131 0.0 0
M  V30 45 C 16.7544 12.9795 0.0 0
M  V30 46 C 15.9844 14.3131 0.0 0
M  V30 47 C 9.1472 0.0000 0.0 0
M  V30 48 O 7.8135 0.7700 0.0 0
M  V30 49 O 10.4809 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 1 23
M  V30 3 1 1 29
M  V30 4 1 1 35
M  V30 5 1 2 3
M  V30 6 1 2 21
M  V30 7 1 3 4 CFG=3
M  V30 8 1 3 5
M  V30 9 1 4 6
M  V30 10 1 5 7
M  V30 11 2 5 8
M  V30 12 1 6 9
M  V30 13 2 6 10
M  V30 14 1 7 11
M  V30 15 1 9 12
M  V30 16 1 12 13
M  V30 17 1 12 14
M  V30 18 1 13 41
M  V30 19 1 14 15
M  V30 20 1 15 16
M  V30 21 2 15 17
M  V30 22 1 18 19
M  V30 23 1 18 20
M  V30 24 2 19 21
M  V30 25 2 20 22
M  V30 26 1 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 45 2 41 42
M  V30 46 1 41 43
M  V30 47 1 42 44
M  V30 48 2 43 45
M  V30 49 2 44 46
M  V30 50 1 45 46
M  V30 51 1 47 48
M  V30 52 2 47 49
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-(Carboxymethyl)-N-(phenylmethyl)glycyl-N-methyl-1-(triphenylmethyl)-L-histi...
C37H37N5O4
1333228-06-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 50 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8987 7.0100 0.0 0
M  V30 2 C 9.0543 5.3347 0.0 0
M  V30 3 C 9.8243 4.0011 0.0 0 CFG=1
M  V30 4 N 11.3643 4.0011 0.0 0
M  V30 5 C 9.0543 2.6673 0.0 0
M  V30 6 C 12.1343 5.3347 0.0 0
M  V30 7 N 9.8243 1.3336 0.0 0
M  V30 8 O 7.5143 2.6673 0.0 0
M  V30 9 C 13.6743 5.3347 0.0 0
M  V30 10 O 11.3643 6.6684 0.0 0
M  V30 11 C 9.0543 0.0000 0.0 0
M  V30 12 N 14.4444 6.6684 0.0 0
M  V30 13 C 13.6743 8.0020 0.0 0
M  V30 14 C 15.9844 6.6684 0.0 0
M  V30 15 C 16.7544 5.3347 0.0 0
M  V30 16 O 15.9844 4.0011 0.0 0
M  V30 17 O 18.2944 5.3347 0.0 0
M  V30 18 N 5.1446 6.1047 0.0 0
M  V30 19 C 6.6091 6.5806 0.0 0
M  V30 20 C 5.1446 4.5647 0.0 0
M  V30 21 C 7.5143 5.3347 0.0 0
M  V30 22 N 6.6091 4.0889 0.0 0
M  V30 23 C 4.8037 8.2558 0.0 0
M  V30 24 C 6.3354 8.0949 0.0 0
M  V30 25 C 4.1774 9.6626 0.0 0
M  V30 26 C 7.2407 9.3408 0.0 0
M  V30 27 C 5.0826 10.9086 0.0 0
M  V30 28 C 6.6142 10.7476 0.0 0
M  V30 29 C 2.6527 7.9152 0.0 0
M  V30 30 C 1.2459 7.2887 0.0 0
M  V30 31 C 2.8137 9.4467 0.0 0
M  V30 32 C 0.0000 8.1939 0.0 0
M  V30 33 C 1.5679 10.3519 0.0 0
M  V30 34 C 0.1609 9.7255 0.0 0
M  V30 35 C 2.9935 5.7641 0.0 0
M  V30 36 C 1.4619 5.9250 0.0 0
M  V30 37 C 3.6198 4.3571 0.0 0
M  V30 38 C 0.5567 4.6792 0.0 0
M  V30 39 C 2.7146 3.1113 0.0 0
M  V30 40 C 1.1830 3.2722 0.0 0
M  V30 41 C 14.4444 9.3358 0.0 0
M  V30 42 C 13.6743 10.6695 0.0 0
M  V30 43 C 15.9844 9.3358 0.0 0
M  V30 44 C 14.4444 12.0031 0.0 0
M  V30 45 C 16.7544 10.6695 0.0 0
M  V30 46 C 15.9844 12.0031 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 1 23
M  V30 3 1 1 29
M  V30 4 1 1 35
M  V30 5 1 2 3
M  V30 6 1 2 21
M  V30 7 1 3 4 CFG=3
M  V30 8 1 3 5
M  V30 9 1 4 6
M  V30 10 1 5 7
M  V30 11 2 5 8
M  V30 12 1 6 9
M  V30 13 2 6 10
M  V30 14 1 7 11
M  V30 15 1 9 12
M  V30 16 1 12 13
M  V30 17 1 12 14
M  V30 18 1 13 41
M  V30 19 1 14 15
M  V30 20 1 15 16
M  V30 21 2 15 17
M  V30 22 1 18 19
M  V30 23 1 18 20
M  V30 24 2 19 21
M  V30 25 2 20 22
M  V30 26 1 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 45 2 41 42
M  V30 46 1 41 43
M  V30 47 1 42 44
M  V30 48 2 43 45
M  V30 49 2 44 46
M  V30 50 1 45 46
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1333226-98-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1333228-06-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7537821
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: To a stirred solution of ester (0.5mmol) in
methanol (1 mL) were added 622 μL of a solution of methylamine in ethanol
(33%). The mixture was refluxed overnight. The solvent was evaporated and
the crude product was precipitated in water and filtrated to give the
compound. Reactant: (S)-
2-[2-(Carboxymethyl-naphthalen-2-ylmethyl-amino)-acetylamino]-3-(1H-imidazol-4-yl)-propionic
acid methyl ester (33). Reactant:
(S)-2-[2-(Benzyl-carboxymethyl-amino)-acetylamino]-3-(1-trityl-1H-imidazol-4-yl)-propionic
acid methyl ester as the formiate salt (38).
(Benzyl-{[(S)-1-methylcarbamoyl-2-(1-trityl-1H-imidazol-4-yl)-ethylcarbamoyl]-methyl}-amino)-acetic
acid (64) as the formiate salt was obtained (100%). Purity: 97%. LC : tr
= 4.5min; MS (ESI+) : m/z = 616 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzylcarboxymethylaminoacetylaminoimidazolylpropionic
acid derivatives and analogs for use as insulin degrading enzyme
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deprez-Poulain, Rebecca Franziska; Charton, Julie Jeanne Marine; Deprez,
Benoit Gaston Pierre; Leroux, Florence Catherine Gilberte; Gauriot,
Marion; Tang, Wei-Jen; Totobenazara, Jane
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP2371421 A1 2011-10-05

$RFMT $RIREG SCHEME115 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Histidine, N-(carboxymethyl)-N-(phenylmethyl)glycyl-1-(triphenylmethyl)-, 2...
C37H36N4O5.CH2O2
1333226-98-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 52 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8987 9.3200 0.0 0
M  V30 2 C 9.0543 7.6448 0.0 0
M  V30 3 C 9.8243 6.3111 0.0 0 CFG=1
M  V30 4 N 11.3643 6.3111 0.0 0
M  V30 5 C 9.0543 4.9773 0.0 0
M  V30 6 C 12.1343 7.6448 0.0 0
M  V30 7 O 9.8243 3.6437 0.0 0
M  V30 8 O 7.5143 4.9773 0.0 0
M  V30 9 C 13.6743 7.6448 0.0 0
M  V30 10 O 11.3643 8.9784 0.0 0
M  V30 11 C 9.0543 2.3100 0.0 0
M  V30 12 N 14.4444 8.9784 0.0 0
M  V30 13 C 13.6743 10.3121 0.0 0
M  V30 14 C 15.9844 8.9784 0.0 0
M  V30 15 C 16.7544 7.6448 0.0 0
M  V30 16 O 15.9844 6.3111 0.0 0
M  V30 17 O 18.2944 7.6448 0.0 0
M  V30 18 N 5.1446 8.4148 0.0 0
M  V30 19 C 6.6091 8.8906 0.0 0
M  V30 20 C 5.1446 6.8748 0.0 0
M  V30 21 C 7.5143 7.6448 0.0 0
M  V30 22 N 6.6091 6.3989 0.0 0
M  V30 23 C 4.8037 10.5658 0.0 0
M  V30 24 C 6.3354 10.4049 0.0 0
M  V30 25 C 4.1774 11.9726 0.0 0
M  V30 26 C 7.2407 11.6508 0.0 0
M  V30 27 C 5.0826 13.2187 0.0 0
M  V30 28 C 6.6142 13.0576 0.0 0
M  V30 29 C 2.6527 10.2252 0.0 0
M  V30 30 C 1.2459 9.5987 0.0 0
M  V30 31 C 2.8137 11.7567 0.0 0
M  V30 32 C 0.0000 10.5039 0.0 0
M  V30 33 C 1.5679 12.6620 0.0 0
M  V30 34 C 0.1609 12.0355 0.0 0
M  V30 35 C 2.9935 8.0741 0.0 0
M  V30 36 C 1.4619 8.2350 0.0 0
M  V30 37 C 3.6198 6.6672 0.0 0
M  V30 38 C 0.5567 6.9892 0.0 0
M  V30 39 C 2.7146 5.4213 0.0 0
M  V30 40 C 1.1830 5.5822 0.0 0
M  V30 41 C 14.4444 11.6459 0.0 0
M  V30 42 C 13.6743 12.9795 0.0 0
M  V30 43 C 15.9844 11.6459 0.0 0
M  V30 44 C 14.4444 14.3131 0.0 0
M  V30 45 C 16.7544 12.9795 0.0 0
M  V30 46 C 15.9844 14.3131 0.0 0
M  V30 47 C 9.1472 0.0000 0.0 0
M  V30 48 O 7.8135 0.7700 0.0 0
M  V30 49 O 10.4809 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 1 23
M  V30 3 1 1 29
M  V30 4 1 1 35
M  V30 5 1 2 3
M  V30 6 1 2 21
M  V30 7 1 3 4 CFG=3
M  V30 8 1 3 5
M  V30 9 1 4 6
M  V30 10 1 5 7
M  V30 11 2 5 8
M  V30 12 1 6 9
M  V30 13 2 6 10
M  V30 14 1 7 11
M  V30 15 1 9 12
M  V30 16 1 12 13
M  V30 17 1 12 14
M  V30 18 1 13 41
M  V30 19 1 14 15
M  V30 20 1 15 16
M  V30 21 2 15 17
M  V30 22 1 18 19
M  V30 23 1 18 20
M  V30 24 2 19 21
M  V30 25 2 20 22
M  V30 26 1 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 45 2 41 42
M  V30 46 1 41 43
M  V30 47 1 42 44
M  V30 48 2 43 45
M  V30 49 2 44 46
M  V30 50 1 45 46
M  V30 51 1 47 48
M  V30 52 2 47 49
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-(Carboxymethyl)-N-(phenylmethyl)glycyl-N-methyl-1-(triphenylmethyl)-L-histi...
C37H37N5O4
1333228-06-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 50 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8987 7.0100 0.0 0
M  V30 2 C 9.0543 5.3347 0.0 0
M  V30 3 C 9.8243 4.0011 0.0 0 CFG=1
M  V30 4 N 11.3643 4.0011 0.0 0
M  V30 5 C 9.0543 2.6673 0.0 0
M  V30 6 C 12.1343 5.3347 0.0 0
M  V30 7 N 9.8243 1.3336 0.0 0
M  V30 8 O 7.5143 2.6673 0.0 0
M  V30 9 C 13.6743 5.3347 0.0 0
M  V30 10 O 11.3643 6.6684 0.0 0
M  V30 11 C 9.0543 0.0000 0.0 0
M  V30 12 N 14.4444 6.6684 0.0 0
M  V30 13 C 13.6743 8.0020 0.0 0
M  V30 14 C 15.9844 6.6684 0.0 0
M  V30 15 C 16.7544 5.3347 0.0 0
M  V30 16 O 15.9844 4.0011 0.0 0
M  V30 17 O 18.2944 5.3347 0.0 0
M  V30 18 N 5.1446 6.1047 0.0 0
M  V30 19 C 6.6091 6.5806 0.0 0
M  V30 20 C 5.1446 4.5647 0.0 0
M  V30 21 C 7.5143 5.3347 0.0 0
M  V30 22 N 6.6091 4.0889 0.0 0
M  V30 23 C 4.8037 8.2558 0.0 0
M  V30 24 C 6.3354 8.0949 0.0 0
M  V30 25 C 4.1774 9.6626 0.0 0
M  V30 26 C 7.2407 9.3408 0.0 0
M  V30 27 C 5.0826 10.9086 0.0 0
M  V30 28 C 6.6142 10.7476 0.0 0
M  V30 29 C 2.6527 7.9152 0.0 0
M  V30 30 C 1.2459 7.2887 0.0 0
M  V30 31 C 2.8137 9.4467 0.0 0
M  V30 32 C 0.0000 8.1939 0.0 0
M  V30 33 C 1.5679 10.3519 0.0 0
M  V30 34 C 0.1609 9.7255 0.0 0
M  V30 35 C 2.9935 5.7641 0.0 0
M  V30 36 C 1.4619 5.9250 0.0 0
M  V30 37 C 3.6198 4.3571 0.0 0
M  V30 38 C 0.5567 4.6792 0.0 0
M  V30 39 C 2.7146 3.1113 0.0 0
M  V30 40 C 1.1830 3.2722 0.0 0
M  V30 41 C 14.4444 9.3358 0.0 0
M  V30 42 C 13.6743 10.6695 0.0 0
M  V30 43 C 15.9844 9.3358 0.0 0
M  V30 44 C 14.4444 12.0031 0.0 0
M  V30 45 C 16.7544 10.6695 0.0 0
M  V30 46 C 15.9844 12.0031 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 1 23
M  V30 3 1 1 29
M  V30 4 1 1 35
M  V30 5 1 2 3
M  V30 6 1 2 21
M  V30 7 1 3 4 CFG=3
M  V30 8 1 3 5
M  V30 9 1 4 6
M  V30 10 1 5 7
M  V30 11 2 5 8
M  V30 12 1 6 9
M  V30 13 2 6 10
M  V30 14 1 7 11
M  V30 15 1 9 12
M  V30 16 1 12 13
M  V30 17 1 12 14
M  V30 18 1 13 41
M  V30 19 1 14 15
M  V30 20 1 15 16
M  V30 21 2 15 17
M  V30 22 1 18 19
M  V30 23 1 18 20
M  V30 24 2 19 21
M  V30 25 2 20 22
M  V30 26 1 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 45 2 41 42
M  V30 46 1 41 43
M  V30 47 1 42 44
M  V30 48 2 43 45
M  V30 49 2 44 46
M  V30 50 1 45 46
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1333226-98-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1333228-06-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3134765
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: To a stirred solution of ester (0.5mmol) in
methanol (1 mL) were added 622 μL of a solution of methylamine in ethanol
(33%). The mixture was refluxed overnight. The solvent was evaporated and
the crude product was precipitated in water and filtrated to give the
compound.
(Benzyl-{[(S)-1-methylcarbamoyl-2-(1-trityl-1H-imidazol-4-yl)-ethylcarbamoyl]-methyl}-amino)-acetic
acid (64) as the formiate salt was obtained from (38) (100%). Purity :
97% ; LC : tr = 4.5min; MS (ESI+) : m/z = 616 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzylcarboxymethylaminoacetylaminoimidazolylpropionic
acid derivatives and analogs for use as insulin degrading enzyme
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deprez-Poulain, Rebecca Franziska; Charton, Julie Jeanne Marine; Deprez,
Benoit Gaston Pierre; Leroux, Florence Catherine Gilberte; Gauriot,
Marion; Tang, Wei-Jen; Totobenazara, Jane
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011107948 A2 2011-09-09

$RFMT $RIREG SCHEME116 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Methyl 2-[3-[(1-carboxy-1-methylethyl)amino]phenyl]-6-chloro-1,2,3,4-tetrah...
C23H27ClN2O4
1343457-04-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 2.3101 0.0 0
M  V30 2 O 1.3337 1.5400 0.0 0
M  V30 3 O 4.0010 1.5400 0.0 0
M  V30 4 C 1.3337 0.0000 0.0 0
M  V30 5 C 8.1851 5.8926 0.0 0
M  V30 6 C 7.1952 7.6072 0.0 0
M  V30 7 Cl 0.0000 6.9302 0.0 0
M  V30 8 N 12.0033 4.6201 0.0 0
M  V30 9 C 13.3370 3.8501 0.0 0
M  V30 10 C 14.1070 5.1838 0.0 0
M  V30 11 C 14.6708 3.0801 0.0 0
M  V30 12 C 12.5670 2.5163 0.0 0
M  V30 13 O 15.6471 5.1838 0.0 0
M  V30 14 O 13.3370 6.5174 0.0 0
M  V30 15 C 4.0010 4.6201 0.0 0
M  V30 16 C 4.0010 6.1601 0.0 0
M  V30 17 C 2.6673 3.8501 0.0 0
M  V30 18 N 5.3348 3.8501 0.0 0
M  V30 19 C 5.3348 6.9302 0.0 0
M  V30 20 C 2.6673 6.9302 0.0 0
M  V30 21 C 1.3337 4.6201 0.0 0
M  V30 22 C 6.6685 4.6201 0.0 0
M  V30 23 C 6.6685 6.1601 0.0 0
M  V30 24 C 1.3337 6.1601 0.0 0
M  V30 25 C 8.0022 3.8501 0.0 0
M  V30 26 C 9.3360 4.6201 0.0 0
M  V30 27 C 8.0022 2.3101 0.0 0
M  V30 28 C 10.6697 3.8501 0.0 0
M  V30 29 C 9.3360 1.5400 0.0 0
M  V30 30 C 10.6697 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 5 23
M  V30 6 1 6 23
M  V30 7 1 7 24
M  V30 8 1 8 9
M  V30 9 1 8 28
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 15 18
M  V30 18 1 16 19
M  V30 19 2 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 2 21 24
M  V30 25 1 22 23
M  V30 26 1 22 25
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 6-chloro-2-[3-[[1,1-dimethyl-2-(methylamino)-2-oxoethyl]amino]phenyl]-...
C24H30ClN3O3
1343457-10-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 5.3348 0.0 0
M  V30 2 O 0.7700 5.3348 0.0 0
M  V30 3 O 3.0801 6.6685 0.0 0
M  V30 4 C 0.0000 6.6685 0.0 0
M  V30 5 C 8.8798 4.9911 0.0 0
M  V30 6 C 8.8798 3.0112 0.0 0
M  V30 7 Cl 2.3101 0.0000 0.0 0
M  V30 8 N 11.5503 8.0022 0.0 0
M  V30 9 C 12.3203 9.3360 0.0 0
M  V30 10 C 13.6539 8.5660 0.0 0
M  V30 11 C 10.9864 10.1060 0.0 0
M  V30 12 C 13.0903 10.6697 0.0 0
M  V30 13 N 14.9876 9.3360 0.0 0
M  V30 14 O 13.6539 7.0259 0.0 0
M  V30 15 C 16.3213 8.5660 0.0 0
M  V30 16 C 4.6201 4.0012 0.0 0
M  V30 17 C 5.3901 2.6673 0.0 0
M  V30 18 C 3.0801 4.0012 0.0 0
M  V30 19 N 5.3901 5.3348 0.0 0
M  V30 20 C 6.9302 2.6673 0.0 0
M  V30 21 C 4.6201 1.3337 0.0 0
M  V30 22 C 2.3101 2.6673 0.0 0
M  V30 23 C 6.9302 5.3348 0.0 0
M  V30 24 C 7.7002 4.0012 0.0 0
M  V30 25 C 3.0801 1.3337 0.0 0
M  V30 26 C 7.7002 6.6685 0.0 0
M  V30 27 C 9.2402 6.6685 0.0 0
M  V30 28 C 6.9302 8.0022 0.0 0
M  V30 29 C 10.0102 8.0022 0.0 0
M  V30 30 C 7.7002 9.3360 0.0 0
M  V30 31 C 9.2402 9.3360 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 5 24
M  V30 6 1 6 24
M  V30 7 1 7 25
M  V30 8 1 8 9
M  V30 9 1 8 29
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 13 15
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 1 16 19
M  V30 19 1 17 20
M  V30 20 2 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 2 22 25
M  V30 26 1 23 24
M  V30 27 1 23 26
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1343457-04-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1343457-10-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-4685133
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM A mixture of
2-[3-(1-carboxy-1-methyl-ethylamino)-phenyl]-6-chloro-3,3-dimethyl-1,2,3,4-tetrahydro-quinoline-8-carboxylic
acid methyl ester (73 mg, 0.17 mmol),
1-3-dimethylaminopropyl-3-ethylcarbodiimide hydrochloride (65 mg, 0.34
mmol), 4-dimethylaminopyridine (41.5 mg, 0.34 mmol), methaneamine (0.26
mL, 0.52 mmol) in tetrahydrofuran and triethylamine (34 mg, 0.34 mmol) in
dichloromethane (10 mL) was strirred for 48 hours. Removal of the solvent
to afford the crude product
6-chloro-3,3-dimethyl-2-[3-(1-methyl-1-methylcarbamoyl-ethylamino)-phenyl]-1,2,3,4-tetrahydroquinoline-8-carboxylic
acid methyl ester, which was used in next step without purification.
Yield 75 mg, 100%. LC/MS m/e calcd for C24H30ClN3O3 (M+H)+: 444.98,
observed: 444.1.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 3,3-dimethyl-1,2,3,4-tetrahydroquinoline derivatives as
activators of AMP-activated protein kinase (AMPK)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Li; Feng, Lichun; Huang, Mengwei; Liu, Yongfu; Wu, Guolong; Wu, Jim
Zhen; Zhou, Mingwei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011128251 A1 2011-10-20

$RFMT $RIREG SCHEME117 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxybenzaldehyde
C8H8O2
135-02-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 4.0010 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 4.6201 4.0010 0.0 0
M  V30 4 C 6.1601 4.0010 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 C 1.5400 1.3337 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 2.3101 0.0000 0.0 0
M  V30 10 C 3.8501 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2-Methoxyphenyl)methylene]methanamine
C9H11NO
1125-90-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 N 6.1600 4.0011 0.0 0
M  V30 3 C 6.9300 5.3349 0.0 0
M  V30 4 O 1.5400 4.0011 0.0 0
M  V30 5 C 0.0000 4.0011 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 1.3338 0.0 0
M  V30 9 C 1.5400 1.3338 0.0 0
M  V30 10 C 3.8500 0.0000 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 135-02-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1125-90-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-1239155
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cholinesterase inhibitors: SAR and enzyme inhibitory activity of
3-[ω-(benzylmethylamino)alkoxy]xanthen-9-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Piazzi, Lorna; Belluti, Federica; Bisi, Alessandra; Gobbi, Silvia; Rizzo,
Stefano; Bartolini, Manuela; Andrisano, Vincenza; Recanatini, Maurizio;
Rampa, Angela
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2007), 15(1), 575-585

$RFMT $RIREG SCHEME118 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl α-[(2-chloroacetyl)amino]-α-methyl-3-nitrobenzeneacetate
C12H13ClN2O5
1350523-71-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 3.8500 0.0 0
M  V30 2 N 7.7000 3.8500 0.0 0
M  V30 3 C 6.1600 2.3100 0.0 0
M  V30 4 C 6.1600 5.3900 0.0 0
M  V30 5 C 8.4700 5.1836 0.0 0
M  V30 6 O 7.4936 1.5400 0.0 0
M  V30 7 O 4.8264 1.5400 0.0 0
M  V30 8 C 10.0100 5.1836 0.0 0
M  V30 9 O 7.7000 6.5173 0.0 0
M  V30 10 C 7.4936 0.0000 0.0 0
M  V30 11 Cl 10.7800 6.5173 0.0 0
M  V30 12 N 1.5400 6.5173 0.0 0 VAL=5
M  V30 13 O 2.3100 7.8509 0.0 0
M  V30 14 O 0.0000 6.5173 0.0 0
M  V30 15 C 4.6200 3.8500 0.0 0
M  V30 16 C 3.8500 5.1836 0.0 0
M  V30 17 C 3.8500 2.5162 0.0 0
M  V30 18 C 2.3100 5.1836 0.0 0
M  V30 19 C 2.3100 2.5162 0.0 0
M  V30 20 C 1.5400 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 15
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 2 3 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 2 12 13
M  V30 13 2 12 14
M  V30 14 1 12 18
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Dimethyl-3-(3-nitrophenyl)-2,5-piperazinedione
C12H13N3O4
1350523-40-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8925 5.5397 0.0 0
M  V30 2 O 7.8745 6.0664 0.0 0
M  V30 3 C 10.2339 4.0865 0.0 0
M  V30 4 O 6.8048 0.0000 0.0 0
M  V30 5 N 1.5400 6.6904 0.0 0 VAL=5
M  V30 6 O 0.0000 6.6904 0.0 0
M  V30 7 O 2.3100 8.0240 0.0 0
M  V30 8 C 6.1600 4.0231 0.0 0
M  V30 9 C 7.6071 4.5498 0.0 0
M  V30 10 N 5.8925 2.5065 0.0 0
M  V30 11 N 8.7868 3.5599 0.0 0
M  V30 12 C 7.0723 1.5166 0.0 0
M  V30 13 C 8.5194 2.0433 0.0 0
M  V30 14 C 4.6200 4.0231 0.0 0
M  V30 15 C 3.8500 5.3567 0.0 0
M  V30 16 C 3.8500 2.6893 0.0 0
M  V30 17 C 2.3100 5.3567 0.0 0
M  V30 18 C 2.3100 2.6893 0.0 0
M  V30 19 C 1.5400 4.0231 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 9
M  V30 3 1 3 11
M  V30 4 2 4 12
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 17
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1350523-71-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1350523-40-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-12318895
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation of intermediate 5:
rac-3-(3-bromo-phenyl)-1,3-dimethyl-piperazine-2,5-dione Methylamine 33%
in EtOH (5.36 mL, 43.04 mmol) was added to a stirred solution of
intermediate 4 (2.4 g, 7.17 mmol) in EtOH (53 mL) in a sealed tube at
room temperature. Then, the mixture was stirred at 70 °C for 3 hours. The
solvent was evaporated in vacuo to yield intermediate 5 that was used in
the next step without further purification. Preparation of intermediate
15: rac-1,3-dimethyl-3-(3-nitro-phenyl)-piperazine-2,5-dione Intermediate
15 was synthesized following the same approach described in the Example
A5. Starting from intermediate 14 (2.2 g, 7.32 mmol) intermediate 15 was
obtained (1.92 g, quant, yield).
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 5-amino-3,6-dihydro-1H-pyrazin-2-one derivatives as
inhibitors of beta-secretase (BACE)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Trabanco-Suarez, Andres Avelino; Tresadern, Gary John; MacDonald, Gregor
James; Vega Ramiro, Juan Antonio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011154374 A1 2011-12-15

$RFMT $RIREG SCHEME119 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[1,1′-Biphenyl]-3-yl-1-chloro-6,7-dimethoxyisoquinoline
C23H18ClNO2
1352036-20-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 5.3348 0.0000 0.0 0
M  V30 2 O 0.0000 1.5400 0.0 0
M  V30 3 C 0.0000 0.0000 0.0 0
M  V30 4 O 0.0000 4.6201 0.0 0
M  V30 5 C 0.0000 6.1601 0.0 0
M  V30 6 C 4.0010 2.3101 0.0 0
M  V30 7 C 4.0010 3.8501 0.0 0
M  V30 8 C 2.6673 1.5400 0.0 0
M  V30 9 C 5.3348 1.5400 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 2.6673 4.6201 0.0 0
M  V30 12 C 1.3337 2.3101 0.0 0
M  V30 13 N 6.6685 2.3101 0.0 0
M  V30 14 C 6.6685 3.8501 0.0 0
M  V30 15 C 1.3337 3.8501 0.0 0
M  V30 16 C 8.0022 4.6201 0.0 0
M  V30 17 C 9.3358 3.8501 0.0 0
M  V30 18 C 8.0022 6.1601 0.0 0
M  V30 19 C 10.6697 4.6201 0.0 0
M  V30 20 C 9.3358 6.9302 0.0 0
M  V30 21 C 10.6697 6.1601 0.0 0
M  V30 22 C 12.0033 3.8501 0.0 0
M  V30 23 C 12.0033 2.3101 0.0 0
M  V30 24 C 13.3370 4.6201 0.0 0
M  V30 25 C 13.3370 1.5400 0.0 0
M  V30 26 C 14.6707 3.8501 0.0 0
M  V30 27 C 14.6707 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 12
M  V30 4 1 4 5
M  V30 5 1 4 15
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 15
M  V30 16 1 13 14
M  V30 17 1 14 16
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 19 22
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[1,1′-Biphenyl]-3-yl-6,7-dimethoxy-N-methyl-1-isoquinolinamine
C24H22N2O2
1352035-45-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 0.0000 0.0 0
M  V30 3 O 0.0000 5.3901 0.0 0
M  V30 4 C 0.0000 6.9302 0.0 0
M  V30 5 O 0.0000 2.3101 0.0 0
M  V30 6 C 0.0000 0.7700 0.0 0
M  V30 7 C 4.0010 4.6201 0.0 0
M  V30 8 C 4.0010 3.0801 0.0 0
M  V30 9 C 5.3348 5.3901 0.0 0
M  V30 10 C 2.6673 5.3901 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 6.6685 4.6201 0.0 0
M  V30 14 C 1.3337 4.6201 0.0 0
M  V30 15 N 6.6685 3.0801 0.0 0
M  V30 16 C 1.3337 3.0801 0.0 0
M  V30 17 C 8.0022 5.3901 0.0 0
M  V30 18 C 9.3358 4.6201 0.0 0
M  V30 19 C 8.0022 6.9302 0.0 0
M  V30 20 C 10.6697 5.3901 0.0 0
M  V30 21 C 9.3358 7.7002 0.0 0
M  V30 22 C 10.6697 6.9302 0.0 0
M  V30 23 C 12.0033 4.6201 0.0 0
M  V30 24 C 12.0033 3.0801 0.0 0
M  V30 25 C 13.3370 5.3901 0.0 0
M  V30 26 C 13.3370 2.3101 0.0 0
M  V30 27 C 14.6707 4.6201 0.0 0
M  V30 28 C 14.6707 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 14
M  V30 5 1 5 6
M  V30 6 1 5 16
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 15
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 20 23
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1352036-20-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1352035-45-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-12436924
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 4039-32-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1142811-12-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-Phenyl substituted 6,7-dimethoxyisoquinoline derivatives as
FtsZ-targeting antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kelley, Cody; Zhang, Yongzheng; Parhi, Ajit; Kaul, Malvika; Pilch, Daniel
S.; LaVoie, Edmond J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2012), 20(24), 7012-7029

$RFMT $RIREG SCHEME119 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[1,1′-Biphenyl]-3-yl-1-chloro-6,7-dimethoxyisoquinoline
C23H18ClNO2
1352036-20-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 5.3348 0.0000 0.0 0
M  V30 2 O 0.0000 1.5400 0.0 0
M  V30 3 C 0.0000 0.0000 0.0 0
M  V30 4 O 0.0000 4.6201 0.0 0
M  V30 5 C 0.0000 6.1601 0.0 0
M  V30 6 C 4.0010 2.3101 0.0 0
M  V30 7 C 4.0010 3.8501 0.0 0
M  V30 8 C 2.6673 1.5400 0.0 0
M  V30 9 C 5.3348 1.5400 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 2.6673 4.6201 0.0 0
M  V30 12 C 1.3337 2.3101 0.0 0
M  V30 13 N 6.6685 2.3101 0.0 0
M  V30 14 C 6.6685 3.8501 0.0 0
M  V30 15 C 1.3337 3.8501 0.0 0
M  V30 16 C 8.0022 4.6201 0.0 0
M  V30 17 C 9.3358 3.8501 0.0 0
M  V30 18 C 8.0022 6.1601 0.0 0
M  V30 19 C 10.6697 4.6201 0.0 0
M  V30 20 C 9.3358 6.9302 0.0 0
M  V30 21 C 10.6697 6.1601 0.0 0
M  V30 22 C 12.0033 3.8501 0.0 0
M  V30 23 C 12.0033 2.3101 0.0 0
M  V30 24 C 13.3370 4.6201 0.0 0
M  V30 25 C 13.3370 1.5400 0.0 0
M  V30 26 C 14.6707 3.8501 0.0 0
M  V30 27 C 14.6707 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 12
M  V30 4 1 4 5
M  V30 5 1 4 15
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 15
M  V30 16 1 13 14
M  V30 17 1 14 16
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 19 22
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[1,1′-Biphenyl]-3-yl-6,7-dimethoxy-N-methyl-1-isoquinolinamine
C24H22N2O2
1352035-45-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 0.0000 0.0 0
M  V30 3 O 0.0000 5.3901 0.0 0
M  V30 4 C 0.0000 6.9302 0.0 0
M  V30 5 O 0.0000 2.3101 0.0 0
M  V30 6 C 0.0000 0.7700 0.0 0
M  V30 7 C 4.0010 4.6201 0.0 0
M  V30 8 C 4.0010 3.0801 0.0 0
M  V30 9 C 5.3348 5.3901 0.0 0
M  V30 10 C 2.6673 5.3901 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 6.6685 4.6201 0.0 0
M  V30 14 C 1.3337 4.6201 0.0 0
M  V30 15 N 6.6685 3.0801 0.0 0
M  V30 16 C 1.3337 3.0801 0.0 0
M  V30 17 C 8.0022 5.3901 0.0 0
M  V30 18 C 9.3358 4.6201 0.0 0
M  V30 19 C 8.0022 6.9302 0.0 0
M  V30 20 C 10.6697 5.3901 0.0 0
M  V30 21 C 9.3358 7.7002 0.0 0
M  V30 22 C 10.6697 6.9302 0.0 0
M  V30 23 C 12.0033 4.6201 0.0 0
M  V30 24 C 12.0033 3.0801 0.0 0
M  V30 25 C 13.3370 5.3901 0.0 0
M  V30 26 C 13.3370 2.3101 0.0 0
M  V30 27 C 14.6707 4.6201 0.0 0
M  V30 28 C 14.6707 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 14
M  V30 5 1 5 6
M  V30 6 1 5 16
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 15
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 20 23
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1352036-20-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1352035-45-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8859990
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 4039-32-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1142811-12-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 6 - Preparation of Compound:
3-([1,1'-Biphenyl]-3-yl)-1-chloro-6,7-dimethoxyisoquinoline (20 mg) and
chloro(2-di-t-butylphosphino-2',4',6'-tri-i-propyl-1,1'-biphenyl)[2-(2-aminoethyl)phenyl]PdII)
(4 mg, 0.1 eq.) were combined in a flask and air was evacuated and
replaced with N2. Methylamine (2 mL) followed by LHMDS 1M in THF (0.02
mL, 1.5 eq.) was then added, and reaction was allowed to stir overnight
at room temperature. Reaction mixture was then diluted with EtOAc and
washed with NH4CI. Organic layer was dried over sodium sulfate and
concentrated. Chromatography achieved using ISCO max gradient 50%
EtOAc/hexane. Product as a clear oil,yield 20 mg, 100%. 1H NMR (400MHz)
(CDCl3) δ 8.31 (t, J = 4 Hz, 1H), 8.06 (dt, J = 8 Hz, J = 4 Hz, 1H),
7.64-7.62 (m, 2H), 7.51-7.49 (m, 1H), 7.46 7.43 (m, 1H), 7.41-7.37 (m,
2H), 7.34 (s, 1H), 7.31-7.27 (m, 1H), 6.99 (s, 1H), 6.91 (s, 1H), 4.92
(bs, 1H), 3.93 (s, 6H), 3.21 (s, 3H). 13C NMR (100MHz) (CDCl3) δ 154.47,
152.18, 149.09, 141.73, 141.37, 140.97, 134.06, 128.85, 128.72, 127.16,
126.67, 125.53, 125.46, 112.13, 106.62, 106.56, 101.17, 56.07, 55.92,
28.97.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of phenylisoquinoline derivatives and analogs for use as
antimicrobial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lavoie, Edmond J.; Parhi, Ajit K.; Pilch, Daniel S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011159926 A1 2011-12-22

$RFMT $RIREG SCHEME119 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[1,1′-Biphenyl]-3-yl-1-chloro-6,7-dimethoxyisoquinoline
C23H18ClNO2
1352036-20-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 5.3348 0.0000 0.0 0
M  V30 2 O 0.0000 1.5400 0.0 0
M  V30 3 C 0.0000 0.0000 0.0 0
M  V30 4 O 0.0000 4.6201 0.0 0
M  V30 5 C 0.0000 6.1601 0.0 0
M  V30 6 C 4.0010 2.3101 0.0 0
M  V30 7 C 4.0010 3.8501 0.0 0
M  V30 8 C 2.6673 1.5400 0.0 0
M  V30 9 C 5.3348 1.5400 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 2.6673 4.6201 0.0 0
M  V30 12 C 1.3337 2.3101 0.0 0
M  V30 13 N 6.6685 2.3101 0.0 0
M  V30 14 C 6.6685 3.8501 0.0 0
M  V30 15 C 1.3337 3.8501 0.0 0
M  V30 16 C 8.0022 4.6201 0.0 0
M  V30 17 C 9.3358 3.8501 0.0 0
M  V30 18 C 8.0022 6.1601 0.0 0
M  V30 19 C 10.6697 4.6201 0.0 0
M  V30 20 C 9.3358 6.9302 0.0 0
M  V30 21 C 10.6697 6.1601 0.0 0
M  V30 22 C 12.0033 3.8501 0.0 0
M  V30 23 C 12.0033 2.3101 0.0 0
M  V30 24 C 13.3370 4.6201 0.0 0
M  V30 25 C 13.3370 1.5400 0.0 0
M  V30 26 C 14.6707 3.8501 0.0 0
M  V30 27 C 14.6707 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 12
M  V30 4 1 4 5
M  V30 5 1 4 15
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 15
M  V30 16 1 13 14
M  V30 17 1 14 16
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 19 22
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[1,1′-Biphenyl]-3-yl-6,7-dimethoxy-N-methyl-1-isoquinolinamine
C24H22N2O2
1352035-45-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 0.0000 0.0 0
M  V30 3 O 0.0000 5.3901 0.0 0
M  V30 4 C 0.0000 6.9302 0.0 0
M  V30 5 O 0.0000 2.3101 0.0 0
M  V30 6 C 0.0000 0.7700 0.0 0
M  V30 7 C 4.0010 4.6201 0.0 0
M  V30 8 C 4.0010 3.0801 0.0 0
M  V30 9 C 5.3348 5.3901 0.0 0
M  V30 10 C 2.6673 5.3901 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 6.6685 4.6201 0.0 0
M  V30 14 C 1.3337 4.6201 0.0 0
M  V30 15 N 6.6685 3.0801 0.0 0
M  V30 16 C 1.3337 3.0801 0.0 0
M  V30 17 C 8.0022 5.3901 0.0 0
M  V30 18 C 9.3358 4.6201 0.0 0
M  V30 19 C 8.0022 6.9302 0.0 0
M  V30 20 C 10.6697 5.3901 0.0 0
M  V30 21 C 9.3358 7.7002 0.0 0
M  V30 22 C 10.6697 6.9302 0.0 0
M  V30 23 C 12.0033 4.6201 0.0 0
M  V30 24 C 12.0033 3.0801 0.0 0
M  V30 25 C 13.3370 5.3901 0.0 0
M  V30 26 C 13.3370 2.3101 0.0 0
M  V30 27 C 14.6707 4.6201 0.0 0
M  V30 28 C 14.6707 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 14
M  V30 5 1 5 6
M  V30 6 1 5 16
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 15
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 20 23
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1352036-20-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1352035-45-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14602454
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 4039-32-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1142811-12-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 6 - Preparation of Compound
3-([1,1'-Biphenyl]-3-yl)-1-chloro-6,7-dimethoxyisoquinoline (20 mg) and
chloro(2-di-t-butylphosphino-2', 4', 6'-tri-i-propyl-1,1'-biphenyl)
[2-(2-aminoethyl)phenyl] PdII) (4 mg, 0.1 eq.) were combined in a flask
and air was evacuated and replaced with N2. Methylamine (2 mL) followed
by LHMDS 1M in THF (0.02 mL, 1.5 eq.) was then added, and reaction was
allowed to stir overnight at room temperature. Reaction mixture was then
diluted with EtOAc and washed with NH4Cl. Organic layer was dried over
sodium sulfate and concentrated. Chromatography achieved using ISCO max
gradient 50% EtOAc/hexane yielding product. Clear oil yield 20 mg,
quantitative. 1H NMR (400MHz) (CDCl3) δ 8.31 (t, J = 4 Hz, 1H), 8.06 (dr,
J = 8 Hz, J = 4 Hz, 1H), 7.64 - 7.62 (m, 2H), 7.51 - 7.49 (m, 1H), 7.46
7.43 (m, 1H), 7.41 - 7.37 (m, 2H), 7.34 (s, 1H), 7.31 - 7.27 (m, 1H),
6.99 (s, 1H), 6.91 (s, 1H), 4.92 (bs, 1H), 3.93 (s, 6H), 3.21 (s, 3H).
13C NMR (100MHz) (CDCl3) δ 154.47, 152.18, 149.09, 141.73, 141.37,
140.97, 134.06, 128.85, 128.72, 127.16, 126.67, 125.53, 125.46, 112.13,
106.62, 106.56, 101.17, 56.07, 55.92, 28.97.
$DTYPE RXN:VAR(1):NOTES
$DATUM Buchwald-Hartwig reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of isoquinoline derivatives as antimicrobial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lavoie, Edmond J.; Parhi, Ajit; Pilch, Daniel S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011156626 A1 2011-12-15

$RFMT $RIREG SCHEME120 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1,1-Dimethylethyl) 3-(2,5-dioxo-1-pyrrolidinyl) (3S)-1,3-pyrrolidinedicarb...
C14H20N2O6
1352661-10-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.8741 3.7358 0.0 0
M  V30 2 O 3.9690 2.4898 0.0 0
M  V30 3 O 4.2477 5.1426 0.0 0
M  V30 4 C 10.1769 4.8628 0.0 0
M  V30 5 O 11.5105 4.0928 0.0 0
M  V30 6 O 10.1769 6.4028 0.0 0
M  V30 7 C 12.8442 4.8628 0.0 0
M  V30 8 C 13.6142 3.5291 0.0 0
M  V30 9 C 14.1779 5.6328 0.0 0
M  V30 10 C 12.0742 6.1966 0.0 0
M  V30 11 O 2.2937 5.3914 0.0 0
M  V30 12 O 1.7270 0.0000 0.0 0
M  V30 13 C 6.4058 3.5747 0.0 0 CFG=1
M  V30 14 C 7.4362 4.7193 0.0 0
M  V30 15 C 7.1758 2.2411 0.0 0
M  V30 16 N 8.8430 4.0928 0.0 0
M  V30 17 C 8.6821 2.5612 0.0 0
M  V30 18 N 2.4373 2.6509 0.0 0
M  V30 19 C 1.6672 3.9845 0.0 0
M  V30 20 C 1.4068 1.5063 0.0 0
M  V30 21 C 0.1609 3.6644 0.0 0
M  V30 22 C 0.0000 2.1328 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 13 1 CFG=3
M  V30 4 1 2 18
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 16
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 2 11 19
M  V30 13 2 12 20
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3S)-3-[(methylamino)carbonyl]-1-pyrrolidinecarboxylate
C11H20N2O3
1352661-11-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 O 2.6673 2.3101 0.0 0
M  V30 3 O 4.0012 0.0000 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 2.1037 0.2064 0.0 0
M  V30 6 C 0.0000 0.7700 0.0 0
M  V30 7 C 0.5637 2.8737 0.0 0
M  V30 8 C 9.3038 2.6672 0.0 0
M  V30 9 N 10.2090 3.9131 0.0 0
M  V30 10 O 9.9301 1.2602 0.0 0
M  V30 11 C 11.7406 3.7521 0.0 0
M  V30 12 N 5.3348 2.3101 0.0 0
M  V30 13 C 6.7417 1.6836 0.0 0
M  V30 14 C 5.4958 3.8416 0.0 0
M  V30 15 C 7.7722 2.8281 0.0 0 CFG=1
M  V30 16 C 7.0022 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 15 8 CFG=3
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1352661-10-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1352661-11-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3225131
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 23: Synthesis of Compound 120 Step 1:
To a stirred solution of ester 14 (0.693 g, 2.0 mmol) in THF (20 mL) at 0
°C was added 2.0 M solution of Me2NH in THF dropwise. The resulting
solution was gradually warmed up to room temperature and stirring was
continued overnight. The reaction mixture was then filtered and the
filtrate was evaporated under reduced pressure. The residue was treated
with DCM and DI water. The aqueous layer was separated and extracted with
DCM. The combined organic layer was washed with brine, dried over Na2SO4
and evaporated under reduced pressure. The crude material was purified by
silica gel column chromatography, using DCM/ MeOH with gradient as an
eluent, to give the desired amide 116. Step 3: Amide 123 was synthesized
according to procedure described in Scheme 23 for preparation of compound
116. Quantitative yield. 1H NMR (CDCl3, 400 MHz): δ 6.51 (br s, 1H), 3.57
-3.36 (m, 3H), 3.27 -3.20 (m. 1H), 2.87 -2.79 (m, 1H), 2.73 (d, J= 4.8
Hz, 3H), 2.12 -1.97 (m. 2H), 1.38 (s, 9H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of carbapenem antibacterials with gram-negative activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Choi, Woo-Baeg; Kim, Deog-Il; Gruszecka-Kowalik, Ewa; Joo, Hyung-Yeul;
Liu, Shuangpei; Mao, Shuli; Li, Yongfeng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011160020 A2 2011-12-22

$RFMT $RIREG SCHEME121 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[6-(methoxycarbonyl)-3-pyridinyl]-1-piperazinecarboxylate
C16H23N3O4
1354355-85-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8737 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 C 14.6302 2.8737 0.0 0
M  V30 9 O 15.4002 4.2073 0.0 0
M  V30 10 O 15.4002 1.5400 0.0 0
M  V30 11 C 16.9402 4.2073 0.0 0
M  V30 12 N 8.4701 2.8737 0.0 0
M  V30 13 C 7.7001 4.2073 0.0 0
M  V30 14 C 7.7001 1.5400 0.0 0
M  V30 15 C 6.1601 4.2073 0.0 0
M  V30 16 C 6.1601 1.5400 0.0 0
M  V30 17 N 5.3901 2.8737 0.0 0
M  V30 18 C 10.0101 2.8737 0.0 0
M  V30 19 C 10.7801 1.5400 0.0 0
M  V30 20 C 10.7801 4.2073 0.0 0
M  V30 21 C 12.3201 1.5400 0.0 0
M  V30 22 N 12.3201 4.2073 0.0 0
M  V30 23 C 13.0901 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 23
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 18
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[6-[(methylamino)carbonyl]-3-pyridinyl]-1-piperazinecarbo...
C16H24N4O3
2589532-06-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8737 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 C 14.6302 2.8737 0.0 0
M  V30 9 N 15.4002 4.2073 0.0 0
M  V30 10 O 15.4002 1.5400 0.0 0
M  V30 11 C 16.9402 4.2073 0.0 0
M  V30 12 N 8.4701 2.8737 0.0 0
M  V30 13 C 7.7001 4.2073 0.0 0
M  V30 14 C 7.7001 1.5400 0.0 0
M  V30 15 C 6.1601 4.2073 0.0 0
M  V30 16 C 6.1601 1.5400 0.0 0
M  V30 17 N 5.3901 2.8737 0.0 0
M  V30 18 C 10.0101 2.8737 0.0 0
M  V30 19 C 10.7801 4.2073 0.0 0
M  V30 20 C 10.7801 1.5400 0.0 0
M  V30 21 C 12.3201 4.2073 0.0 0
M  V30 22 N 12.3201 1.5400 0.0 0
M  V30 23 C 13.0901 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 23
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 18
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1354355-85-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2589532-06-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37237061
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quinoxaline derivatives as PARP inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hamerlik, Petra
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023118085 A1 2023-06-29

$RFMT $RIREG SCHEME121 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[6-(methoxycarbonyl)-3-pyridinyl]-1-piperazinecarboxylate
C16H23N3O4
1354355-85-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8737 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 C 14.6302 2.8737 0.0 0
M  V30 9 O 15.4002 4.2073 0.0 0
M  V30 10 O 15.4002 1.5400 0.0 0
M  V30 11 C 16.9402 4.2073 0.0 0
M  V30 12 N 8.4701 2.8737 0.0 0
M  V30 13 C 7.7001 4.2073 0.0 0
M  V30 14 C 7.7001 1.5400 0.0 0
M  V30 15 C 6.1601 4.2073 0.0 0
M  V30 16 C 6.1601 1.5400 0.0 0
M  V30 17 N 5.3901 2.8737 0.0 0
M  V30 18 C 10.0101 2.8737 0.0 0
M  V30 19 C 10.7801 1.5400 0.0 0
M  V30 20 C 10.7801 4.2073 0.0 0
M  V30 21 C 12.3201 1.5400 0.0 0
M  V30 22 N 12.3201 4.2073 0.0 0
M  V30 23 C 13.0901 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 23
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 18
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[6-[(methylamino)carbonyl]-3-pyridinyl]-1-piperazinecarbo...
C16H24N4O3
2589532-06-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8737 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 C 14.6302 2.8737 0.0 0
M  V30 9 N 15.4002 4.2073 0.0 0
M  V30 10 O 15.4002 1.5400 0.0 0
M  V30 11 C 16.9402 4.2073 0.0 0
M  V30 12 N 8.4701 2.8737 0.0 0
M  V30 13 C 7.7001 4.2073 0.0 0
M  V30 14 C 7.7001 1.5400 0.0 0
M  V30 15 C 6.1601 4.2073 0.0 0
M  V30 16 C 6.1601 1.5400 0.0 0
M  V30 17 N 5.3901 2.8737 0.0 0
M  V30 18 C 10.0101 2.8737 0.0 0
M  V30 19 C 10.7801 4.2073 0.0 0
M  V30 20 C 10.7801 1.5400 0.0 0
M  V30 21 C 12.3201 4.2073 0.0 0
M  V30 22 N 12.3201 1.5400 0.0 0
M  V30 23 C 13.0901 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 23
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 18
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1354355-85-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2589532-06-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32103356
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Combination of antibody-drug conjugate and PARP1 selective inhibitor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mettetal, Jerome Thomas, II; Astaneh, Azadeh Cheraghchi Bashi; Leo,
Elisabetta; Wallez, Yann
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022074617 A1 2022-04-14

$RFMT $RIREG SCHEME121 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[6-(methoxycarbonyl)-3-pyridinyl]-1-piperazinecarboxylate
C16H23N3O4
1354355-85-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8737 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 C 14.6302 2.8737 0.0 0
M  V30 9 O 15.4002 4.2073 0.0 0
M  V30 10 O 15.4002 1.5400 0.0 0
M  V30 11 C 16.9402 4.2073 0.0 0
M  V30 12 N 8.4701 2.8737 0.0 0
M  V30 13 C 7.7001 4.2073 0.0 0
M  V30 14 C 7.7001 1.5400 0.0 0
M  V30 15 C 6.1601 4.2073 0.0 0
M  V30 16 C 6.1601 1.5400 0.0 0
M  V30 17 N 5.3901 2.8737 0.0 0
M  V30 18 C 10.0101 2.8737 0.0 0
M  V30 19 C 10.7801 1.5400 0.0 0
M  V30 20 C 10.7801 4.2073 0.0 0
M  V30 21 C 12.3201 1.5400 0.0 0
M  V30 22 N 12.3201 4.2073 0.0 0
M  V30 23 C 13.0901 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 23
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 18
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[6-[(methylamino)carbonyl]-3-pyridinyl]-1-piperazinecarbo...
C16H24N4O3
2589532-06-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8737 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 C 14.6302 2.8737 0.0 0
M  V30 9 N 15.4002 4.2073 0.0 0
M  V30 10 O 15.4002 1.5400 0.0 0
M  V30 11 C 16.9402 4.2073 0.0 0
M  V30 12 N 8.4701 2.8737 0.0 0
M  V30 13 C 7.7001 4.2073 0.0 0
M  V30 14 C 7.7001 1.5400 0.0 0
M  V30 15 C 6.1601 4.2073 0.0 0
M  V30 16 C 6.1601 1.5400 0.0 0
M  V30 17 N 5.3901 2.8737 0.0 0
M  V30 18 C 10.0101 2.8737 0.0 0
M  V30 19 C 10.7801 4.2073 0.0 0
M  V30 20 C 10.7801 1.5400 0.0 0
M  V30 21 C 12.3201 4.2073 0.0 0
M  V30 22 N 12.3201 1.5400 0.0 0
M  V30 23 C 13.0901 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 23
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 18
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1354355-85-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2589532-06-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31138346
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Quinoxalines as anti-cancer drugs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Packer, Martin John; Degorce, Sebastien Louis; Johannes, Jeffrey Wallace;
Hande, Sudhir Mahadeo; Ghosh, Avipsa; Zheng, Xiaolan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021260092 A1 2021-12-30

$RFMT $RIREG SCHEME121 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[6-(methoxycarbonyl)-3-pyridinyl]-1-piperazinecarboxylate
C16H23N3O4
1354355-85-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8737 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 C 14.6302 2.8737 0.0 0
M  V30 9 O 15.4002 4.2073 0.0 0
M  V30 10 O 15.4002 1.5400 0.0 0
M  V30 11 C 16.9402 4.2073 0.0 0
M  V30 12 N 8.4701 2.8737 0.0 0
M  V30 13 C 7.7001 4.2073 0.0 0
M  V30 14 C 7.7001 1.5400 0.0 0
M  V30 15 C 6.1601 4.2073 0.0 0
M  V30 16 C 6.1601 1.5400 0.0 0
M  V30 17 N 5.3901 2.8737 0.0 0
M  V30 18 C 10.0101 2.8737 0.0 0
M  V30 19 C 10.7801 1.5400 0.0 0
M  V30 20 C 10.7801 4.2073 0.0 0
M  V30 21 C 12.3201 1.5400 0.0 0
M  V30 22 N 12.3201 4.2073 0.0 0
M  V30 23 C 13.0901 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 23
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 18
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[6-[(methylamino)carbonyl]-3-pyridinyl]-1-piperazinecarbo...
C16H24N4O3
2589532-06-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8737 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 C 14.6302 2.8737 0.0 0
M  V30 9 N 15.4002 4.2073 0.0 0
M  V30 10 O 15.4002 1.5400 0.0 0
M  V30 11 C 16.9402 4.2073 0.0 0
M  V30 12 N 8.4701 2.8737 0.0 0
M  V30 13 C 7.7001 4.2073 0.0 0
M  V30 14 C 7.7001 1.5400 0.0 0
M  V30 15 C 6.1601 4.2073 0.0 0
M  V30 16 C 6.1601 1.5400 0.0 0
M  V30 17 N 5.3901 2.8737 0.0 0
M  V30 18 C 10.0101 2.8737 0.0 0
M  V30 19 C 10.7801 4.2073 0.0 0
M  V30 20 C 10.7801 1.5400 0.0 0
M  V30 21 C 12.3201 4.2073 0.0 0
M  V30 22 N 12.3201 1.5400 0.0 0
M  V30 23 C 13.0901 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 23
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 18
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1354355-85-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2589532-06-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34334198
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of
5-{4-[(7-Ethyl-6-oxo-5,6-dihydro-1,5-naphthyridin-3-yl)methyl]piperazin-1-yl}-N-methylpyridine-2-carboxamide
(AZD5305): A PARP1-DNA Trapper with High Selectivity for PARP1 over PARP2
and Other PARPs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Johannes, Jeffrey W.; Balazs, Amber; Barratt, Derek; Bista, Michal;
Chuba, Matthew D.; Cosulich, Sabina; Critchlow, Susan E.; Degorce,
Sebastien L.; Di Fruscia, Paolo; Edmondson, Scott D.; Embrey, Kevin;
Fawell, Stephen; Ghosh, Avipsa; Gill, Sonja J.; Gunnarsson, Anders;
Hande, Sudhir M.; Heightman, Tom D.; Hemsley, Paul; Illuzzi, Giuditta;
Lane, Jordan; Larner, Carrie; Leo, Elisabetta; Liu, Lina; Madin, Andrew;
Martin, Scott; McWilliams, Lisa; O'Connor, Mark J.; Orme, Jonathan P.;
Pachl, Fiona; Packer, Martin J.; Pei, Xiaohui; Pike, Andrew; Schimpl,
Marianne; She, Hongyao; Staniszewska, Anna D.; Talbot, Verity; Underwood,
Elizabeth; Varnes, Jeffrey G.; Xue, Lin; Yao, Tieguang; Zhang, Ke; Zhang,
Andrew X.; Zheng, Xiaolan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(19), 14498-14512

$RFMT $RIREG SCHEME121 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[6-(methoxycarbonyl)-3-pyridinyl]-1-piperazinecarboxylate
C16H23N3O4
1354355-85-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8737 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 C 14.6302 2.8737 0.0 0
M  V30 9 O 15.4002 4.2073 0.0 0
M  V30 10 O 15.4002 1.5400 0.0 0
M  V30 11 C 16.9402 4.2073 0.0 0
M  V30 12 N 8.4701 2.8737 0.0 0
M  V30 13 C 7.7001 4.2073 0.0 0
M  V30 14 C 7.7001 1.5400 0.0 0
M  V30 15 C 6.1601 4.2073 0.0 0
M  V30 16 C 6.1601 1.5400 0.0 0
M  V30 17 N 5.3901 2.8737 0.0 0
M  V30 18 C 10.0101 2.8737 0.0 0
M  V30 19 C 10.7801 1.5400 0.0 0
M  V30 20 C 10.7801 4.2073 0.0 0
M  V30 21 C 12.3201 1.5400 0.0 0
M  V30 22 N 12.3201 4.2073 0.0 0
M  V30 23 C 13.0901 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 23
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 18
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[6-[(methylamino)carbonyl]-3-pyridinyl]-1-piperazinecarbo...
C16H24N4O3
2589532-06-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8737 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 C 14.6302 2.8737 0.0 0
M  V30 9 N 15.4002 4.2073 0.0 0
M  V30 10 O 15.4002 1.5400 0.0 0
M  V30 11 C 16.9402 4.2073 0.0 0
M  V30 12 N 8.4701 2.8737 0.0 0
M  V30 13 C 7.7001 4.2073 0.0 0
M  V30 14 C 7.7001 1.5400 0.0 0
M  V30 15 C 6.1601 4.2073 0.0 0
M  V30 16 C 6.1601 1.5400 0.0 0
M  V30 17 N 5.3901 2.8737 0.0 0
M  V30 18 C 10.0101 2.8737 0.0 0
M  V30 19 C 10.7801 4.2073 0.0 0
M  V30 20 C 10.7801 1.5400 0.0 0
M  V30 21 C 12.3201 4.2073 0.0 0
M  V30 22 N 12.3201 1.5400 0.0 0
M  V30 23 C 13.0901 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 23
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 18
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1354355-85-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2589532-06-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-23611612
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of azaquinolone derivatives as PARP1 inhibitors for treatment
of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Packer, Martin John; Johannes, Jeffrey Wallace; Hande, Sudhir Mahadeo;
Degorce, Sebastien Louis
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021013735 A1 2021-01-28

$RFMT $RIREG SCHEME122 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(2-Chlorophenyl)amino]benzo[c]-2,6-naphthyridine-7-carboxylic acid
C19H12ClN3O2
1357171-59-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9301 4.0011 0.0 0
M  V30 2 C 3.0800 8.0022 0.0 0
M  V30 3 O 4.6201 8.0022 0.0 0
M  V30 4 O 2.3100 9.3359 0.0 0
M  V30 5 Cl 10.0101 4.0011 0.0 0
M  V30 6 C 3.0800 2.6675 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 4.6201 2.6675 0.0 0
M  V30 9 C 2.3100 1.3337 0.0 0
M  V30 10 C 3.0800 5.3348 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 5.3901 4.0011 0.0 0
M  V30 13 C 5.3901 1.3337 0.0 0
M  V30 14 N 3.0800 0.0000 0.0 0
M  V30 15 N 4.6201 5.3348 0.0 0
M  V30 16 C 2.3100 6.6684 0.0 0
M  V30 17 C 0.0000 5.3348 0.0 0
M  V30 18 C 4.6201 0.0000 0.0 0
M  V30 19 C 0.7700 6.6684 0.0 0
M  V30 20 C 7.7001 5.3348 0.0 0
M  V30 21 C 9.2401 5.3348 0.0 0
M  V30 22 C 6.9301 6.6684 0.0 0
M  V30 23 C 10.0101 6.6684 0.0 0
M  V30 24 C 7.7001 8.0022 0.0 0
M  V30 25 C 9.2401 8.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 16
M  V30 6 1 5 21
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 2 8 12
M  V30 13 1 8 13
M  V30 14 2 9 14
M  V30 15 2 10 15
M  V30 16 1 10 16
M  V30 17 2 11 17
M  V30 18 1 12 15
M  V30 19 2 13 18
M  V30 20 1 14 18
M  V30 21 2 16 19
M  V30 22 1 17 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(2-Chlorophenyl)amino]-N-methylbenzo[c]-2,6-naphthyridine-7-carboxamide
C20H15ClN4O
1350625-09-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 6.9302 0.0 0
M  V30 2 N 9.3360 7.7002 0.0 0
M  V30 3 O 8.0023 5.3901 0.0 0
M  V30 4 C 10.6697 6.9302 0.0 0
M  V30 5 N 4.0012 3.0801 0.0 0
M  V30 6 Cl 4.0012 0.0000 0.0 0
M  V30 7 C 5.3348 6.9302 0.0 0
M  V30 8 C 4.0012 7.7002 0.0 0
M  V30 9 C 6.6685 7.7002 0.0 0
M  V30 10 N 5.3348 5.3901 0.0 0
M  V30 11 C 2.6673 6.9302 0.0 0
M  V30 12 C 4.0012 9.2402 0.0 0
M  V30 13 C 6.6685 9.2402 0.0 0
M  V30 14 C 4.0012 4.6201 0.0 0
M  V30 15 C 2.6673 5.3901 0.0 0
M  V30 16 C 1.3337 7.7002 0.0 0
M  V30 17 C 5.3348 10.0102 0.0 0
M  V30 18 C 1.3337 4.6201 0.0 0
M  V30 19 N 0.0000 6.9302 0.0 0
M  V30 20 C 0.0000 5.3901 0.0 0
M  V30 21 C 5.3348 2.3101 0.0 0
M  V30 22 C 5.3348 0.7700 0.0 0
M  V30 23 C 6.6685 3.0801 0.0 0
M  V30 24 C 6.6685 0.0000 0.0 0
M  V30 25 C 8.0023 2.3101 0.0 0
M  V30 26 C 8.0023 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 14
M  V30 6 1 5 21
M  V30 7 1 6 22
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 11 16
M  V30 17 2 12 17
M  V30 18 1 13 17
M  V30 19 2 14 15
M  V30 20 1 15 18
M  V30 21 2 16 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1357171-59-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1350625-09-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1302853
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM 39-100% yield;
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 7-(4H-1,2,4-Triazol-3-yl)benzo[c][2,6]naphthyridines: A novel class of
Pim kinase inhibitors with potent cell antiproliferative activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pierre, Fabrice; Stefan, Eric; Nedellec, Anne-Sophie; Chevrel,
Marie-Claire; Regan, Collin F.; Siddiqui-Jain, Adam; Macalino, Diwata;
Streiner, Nicole; Drygin, Denis; Haddach, Mustapha; O'Brien, Sean E.;
Anderes, Kenna; Ryckman, David M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2011), 21(22), 6687-6692

$RFMT $RIREG SCHEME123 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(2-Chloro-3-methoxyphenyl)amino]benzo[c]-2,6-naphthyridine-7-carboxylic acid
C20H14ClN3O3
1357171-61-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 4.0011 0.0 0
M  V30 2 C 3.0800 8.0021 0.0 0
M  V30 3 O 4.6200 8.0021 0.0 0
M  V30 4 O 2.3100 9.3358 0.0 0
M  V30 5 Cl 10.0100 4.0011 0.0 0
M  V30 6 O 11.5500 6.6684 0.0 0
M  V30 7 C 12.3200 8.0021 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 3.0800 5.3347 0.0 0
M  V30 13 C 0.7700 4.0011 0.0 0
M  V30 14 C 5.3900 4.0011 0.0 0
M  V30 15 C 5.3900 1.3336 0.0 0
M  V30 16 N 3.0800 0.0000 0.0 0
M  V30 17 N 4.6200 5.3347 0.0 0
M  V30 18 C 2.3100 6.6684 0.0 0
M  V30 19 C 0.0000 5.3347 0.0 0
M  V30 20 C 4.6200 0.0000 0.0 0
M  V30 21 C 0.7700 6.6684 0.0 0
M  V30 22 C 7.7000 5.3347 0.0 0
M  V30 23 C 9.2400 5.3347 0.0 0
M  V30 24 C 6.9300 6.6684 0.0 0
M  V30 25 C 10.0100 6.6684 0.0 0
M  V30 26 C 7.7000 8.0021 0.0 0
M  V30 27 C 9.2400 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 18
M  V30 6 1 5 23
M  V30 7 1 6 7
M  V30 8 1 6 25
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 1 10 15
M  V30 16 2 11 16
M  V30 17 2 12 17
M  V30 18 1 12 18
M  V30 19 2 13 19
M  V30 20 1 14 17
M  V30 21 2 15 20
M  V30 22 1 16 20
M  V30 23 2 18 21
M  V30 24 1 19 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(2-Chloro-3-methoxyphenyl)amino]-N-methylbenzo[c]-2,6-naphthyridine-7-carb...
C21H17ClN4O2
1350625-11-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6673 0.0 0
M  V30 2 N 2.3100 1.3336 0.0 0
M  V30 3 O 4.6200 2.6673 0.0 0
M  V30 4 C 3.0800 0.0000 0.0 0
M  V30 5 N 6.9300 6.6684 0.0 0
M  V30 6 Cl 10.0100 6.6684 0.0 0
M  V30 7 O 11.5500 4.0011 0.0 0
M  V30 8 C 12.3200 2.6673 0.0 0
M  V30 9 C 3.0800 5.3347 0.0 0
M  V30 10 C 2.3100 6.6684 0.0 0
M  V30 11 N 4.6200 5.3347 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 3.0800 8.0021 0.0 0
M  V30 14 C 0.7700 6.6684 0.0 0
M  V30 15 C 5.3900 6.6684 0.0 0
M  V30 16 C 0.7700 4.0011 0.0 0
M  V30 17 C 4.6200 8.0021 0.0 0
M  V30 18 C 2.3100 9.3358 0.0 0
M  V30 19 C 0.0000 5.3347 0.0 0
M  V30 20 C 5.3900 9.3358 0.0 0
M  V30 21 N 3.0800 10.6694 0.0 0
M  V30 22 C 4.6200 10.6694 0.0 0
M  V30 23 C 7.7000 5.3347 0.0 0
M  V30 24 C 9.2400 5.3347 0.0 0
M  V30 25 C 6.9300 4.0011 0.0 0
M  V30 26 C 10.0100 4.0011 0.0 0
M  V30 27 C 7.7000 2.6673 0.0 0
M  V30 28 C 9.2400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 15
M  V30 6 1 5 23
M  V30 7 1 6 24
M  V30 8 1 7 8
M  V30 9 1 7 26
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 12
M  V30 13 2 10 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 13 18
M  V30 19 2 14 19
M  V30 20 2 15 17
M  V30 21 1 16 19
M  V30 22 1 17 20
M  V30 23 2 18 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1357171-61-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1350625-11-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3796686
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM 39-100% yield;
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 7-(4H-1,2,4-Triazol-3-yl)benzo[c][2,6]naphthyridines: A novel class of
Pim kinase inhibitors with potent cell antiproliferative activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pierre, Fabrice; Stefan, Eric; Nedellec, Anne-Sophie; Chevrel,
Marie-Claire; Regan, Collin F.; Siddiqui-Jain, Adam; Macalino, Diwata;
Streiner, Nicole; Drygin, Denis; Haddach, Mustapha; O'Brien, Sean E.;
Anderes, Kenna; Ryckman, David M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2011), 21(22), 6687-6692

$RFMT $RIREG SCHEME124 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(2-Fluorophenyl)amino]benzo[c]-2,6-naphthyridine-7-carboxylic acid
C19H12FN3O2
1357171-65-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9301 4.0011 0.0 0
M  V30 2 C 3.0800 8.0022 0.0 0
M  V30 3 O 4.6201 8.0022 0.0 0
M  V30 4 O 2.3100 9.3359 0.0 0
M  V30 5 F 10.0101 4.0011 0.0 0
M  V30 6 C 3.0800 2.6675 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 4.6201 2.6675 0.0 0
M  V30 9 C 2.3100 1.3337 0.0 0
M  V30 10 C 3.0800 5.3348 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 5.3901 4.0011 0.0 0
M  V30 13 C 5.3901 1.3337 0.0 0
M  V30 14 N 3.0800 0.0000 0.0 0
M  V30 15 N 4.6201 5.3348 0.0 0
M  V30 16 C 2.3100 6.6684 0.0 0
M  V30 17 C 0.0000 5.3348 0.0 0
M  V30 18 C 4.6201 0.0000 0.0 0
M  V30 19 C 0.7700 6.6684 0.0 0
M  V30 20 C 7.7001 5.3348 0.0 0
M  V30 21 C 9.2401 5.3348 0.0 0
M  V30 22 C 6.9301 6.6684 0.0 0
M  V30 23 C 10.0101 6.6684 0.0 0
M  V30 24 C 7.7001 8.0022 0.0 0
M  V30 25 C 9.2401 8.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 16
M  V30 6 1 5 21
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 2 8 12
M  V30 13 1 8 13
M  V30 14 2 9 14
M  V30 15 2 10 15
M  V30 16 1 10 16
M  V30 17 2 11 17
M  V30 18 1 12 15
M  V30 19 2 13 18
M  V30 20 1 14 18
M  V30 21 2 16 19
M  V30 22 1 17 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(2-Fluorophenyl)amino]-N-methylbenzo[c]-2,6-naphthyridine-7-carboxamide
C20H15FN4O
1350625-17-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 6.9302 0.0 0
M  V30 2 N 9.3360 7.7002 0.0 0
M  V30 3 O 8.0023 5.3901 0.0 0
M  V30 4 C 10.6697 6.9302 0.0 0
M  V30 5 N 4.0012 3.0801 0.0 0
M  V30 6 F 4.0012 0.0000 0.0 0
M  V30 7 C 5.3348 6.9302 0.0 0
M  V30 8 C 4.0012 7.7002 0.0 0
M  V30 9 C 6.6685 7.7002 0.0 0
M  V30 10 N 5.3348 5.3901 0.0 0
M  V30 11 C 2.6673 6.9302 0.0 0
M  V30 12 C 4.0012 9.2402 0.0 0
M  V30 13 C 6.6685 9.2402 0.0 0
M  V30 14 C 4.0012 4.6201 0.0 0
M  V30 15 C 2.6673 5.3901 0.0 0
M  V30 16 C 1.3337 7.7002 0.0 0
M  V30 17 C 5.3348 10.0102 0.0 0
M  V30 18 C 1.3337 4.6201 0.0 0
M  V30 19 N 0.0000 6.9302 0.0 0
M  V30 20 C 0.0000 5.3901 0.0 0
M  V30 21 C 5.3348 2.3101 0.0 0
M  V30 22 C 5.3348 0.7700 0.0 0
M  V30 23 C 6.6685 3.0801 0.0 0
M  V30 24 C 6.6685 0.0000 0.0 0
M  V30 25 C 8.0023 2.3101 0.0 0
M  V30 26 C 8.0023 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 14
M  V30 6 1 5 21
M  V30 7 1 6 22
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 11 16
M  V30 17 2 12 17
M  V30 18 1 13 17
M  V30 19 2 14 15
M  V30 20 1 15 18
M  V30 21 2 16 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1357171-65-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1350625-17-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14091931
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM 39-100% yield;
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 7-(4H-1,2,4-Triazol-3-yl)benzo[c][2,6]naphthyridines: A novel class of
Pim kinase inhibitors with potent cell antiproliferative activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pierre, Fabrice; Stefan, Eric; Nedellec, Anne-Sophie; Chevrel,
Marie-Claire; Regan, Collin F.; Siddiqui-Jain, Adam; Macalino, Diwata;
Streiner, Nicole; Drygin, Denis; Haddach, Mustapha; O'Brien, Sean E.;
Anderes, Kenna; Ryckman, David M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2011), 21(22), 6687-6692

$RFMT $RIREG SCHEME125 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(2,6-Difluorophenyl)amino]benzo[c]-2,6-naphthyridine-7-carboxylic acid
C19H11F2N3O2
1357171-66-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 4.0011 0.0 0
M  V30 2 C 3.0800 8.0021 0.0 0
M  V30 3 O 4.6200 8.0021 0.0 0
M  V30 4 O 2.3100 9.3358 0.0 0
M  V30 5 F 10.0100 4.0011 0.0 0
M  V30 6 F 5.3900 6.6684 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 2.3100 1.3336 0.0 0
M  V30 11 C 3.0800 5.3347 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 5.3900 4.0011 0.0 0
M  V30 14 C 5.3900 1.3336 0.0 0
M  V30 15 N 3.0800 0.0000 0.0 0
M  V30 16 N 4.6200 5.3347 0.0 0
M  V30 17 C 2.3100 6.6684 0.0 0
M  V30 18 C 0.0000 5.3347 0.0 0
M  V30 19 C 4.6200 0.0000 0.0 0
M  V30 20 C 0.7700 6.6684 0.0 0
M  V30 21 C 7.7000 5.3347 0.0 0
M  V30 22 C 9.2400 5.3347 0.0 0
M  V30 23 C 6.9300 6.6684 0.0 0
M  V30 24 C 10.0100 6.6684 0.0 0
M  V30 25 C 7.7000 8.0021 0.0 0
M  V30 26 C 9.2400 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 17
M  V30 6 1 5 22
M  V30 7 1 6 23
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 1 9 14
M  V30 15 2 10 15
M  V30 16 2 11 16
M  V30 17 1 11 17
M  V30 18 2 12 18
M  V30 19 1 13 16
M  V30 20 2 14 19
M  V30 21 1 15 19
M  V30 22 2 17 20
M  V30 23 1 18 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(2,6-Difluorophenyl)amino]-N-methylbenzo[c]-2,6-naphthyridine-7-carboxamide
C20H14F2N4O
1350625-19-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 6.9301 0.0 0
M  V30 2 N 9.3359 7.7001 0.0 0
M  V30 3 O 8.0022 5.3901 0.0 0
M  V30 4 C 10.6695 6.9301 0.0 0
M  V30 5 N 4.0011 3.0800 0.0 0
M  V30 6 F 4.0011 0.0000 0.0 0
M  V30 7 F 6.6684 4.6201 0.0 0
M  V30 8 C 5.3348 6.9301 0.0 0
M  V30 9 C 4.0011 7.7001 0.0 0
M  V30 10 C 6.6684 7.7001 0.0 0
M  V30 11 N 5.3348 5.3901 0.0 0
M  V30 12 C 2.6673 6.9301 0.0 0
M  V30 13 C 4.0011 9.2401 0.0 0
M  V30 14 C 6.6684 9.2401 0.0 0
M  V30 15 C 4.0011 4.6201 0.0 0
M  V30 16 C 2.6673 5.3901 0.0 0
M  V30 17 C 1.3337 7.7001 0.0 0
M  V30 18 C 5.3348 10.0101 0.0 0
M  V30 19 C 1.3337 4.6201 0.0 0
M  V30 20 N 0.0000 6.9301 0.0 0
M  V30 21 C 0.0000 5.3901 0.0 0
M  V30 22 C 5.3348 2.3100 0.0 0
M  V30 23 C 5.3348 0.7700 0.0 0
M  V30 24 C 6.6684 3.0800 0.0 0
M  V30 25 C 6.6684 0.0000 0.0 0
M  V30 26 C 8.0022 2.3100 0.0 0
M  V30 27 C 8.0022 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 15
M  V30 6 1 5 22
M  V30 7 1 6 23
M  V30 8 1 7 24
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 12 17
M  V30 18 2 13 18
M  V30 19 1 14 18
M  V30 20 2 15 16
M  V30 21 1 16 19
M  V30 22 2 17 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1357171-66-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1350625-19-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2821065
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM 39-100% yield;
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 7-(4H-1,2,4-Triazol-3-yl)benzo[c][2,6]naphthyridines: A novel class of
Pim kinase inhibitors with potent cell antiproliferative activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pierre, Fabrice; Stefan, Eric; Nedellec, Anne-Sophie; Chevrel,
Marie-Claire; Regan, Collin F.; Siddiqui-Jain, Adam; Macalino, Diwata;
Streiner, Nicole; Drygin, Denis; Haddach, Mustapha; O'Brien, Sean E.;
Anderes, Kenna; Ryckman, David M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2011), 21(22), 6687-6692

$RFMT $RIREG SCHEME126 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[6-Bromo-8-(methylsulfonyl)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropyl-2-me...
C18H17BrN4O3S
1365244-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.4647 3.9644 0.0 0 VAL=6
M  V30 2 C 0.0000 4.4403 0.0 0
M  V30 3 O 0.9888 2.4997 0.0 0
M  V30 4 O 1.9406 5.4290 0.0 0
M  V30 5 Br 5.0343 0.0000 0.0 0
M  V30 6 C 11.0635 7.9563 0.0 0
M  V30 7 C 12.6035 5.2890 0.0 0
M  V30 8 N 13.3735 3.9553 0.0 0
M  V30 9 O 13.3735 6.6226 0.0 0
M  V30 10 N 5.5385 4.0431 0.0 0
M  V30 11 C 6.4435 5.2890 0.0 0
M  V30 12 C 4.0738 4.5190 0.0 0
M  V30 13 N 5.8586 2.5367 0.0 0
M  V30 14 C 5.5385 6.5348 0.0 0
M  V30 15 C 2.9294 3.4886 0.0 0
M  V30 16 N 4.0738 6.0590 0.0 0
M  V30 17 C 4.7141 1.5063 0.0 0
M  V30 18 C 3.2496 1.9821 0.0 0
M  V30 19 C 7.9835 5.2890 0.0 0
M  V30 20 C 8.7535 6.6226 0.0 0
M  V30 21 C 8.7535 3.9553 0.0 0
M  V30 22 C 10.2935 6.6226 0.0 0
M  V30 23 C 10.2935 3.9553 0.0 0
M  V30 24 C 11.0635 5.2890 0.0 0
M  V30 25 C 14.9135 3.9553 0.0 0
M  V30 26 C 16.2473 4.7253 0.0 0
M  V30 27 C 16.2473 3.1853 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 15
M  V30 5 1 5 17
M  V30 6 1 6 22
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 24
M  V30 10 1 8 25
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 11 14
M  V30 15 1 11 19
M  V30 16 1 12 15
M  V30 17 2 12 16
M  V30 18 2 13 17
M  V30 19 1 14 16
M  V30 20 2 15 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, 4-[6-bromo-8-(methylamino)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopro...
C18H18BrN5O
1365244-37-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.1444 3.9644 0.0 0
M  V30 2 C 0.0000 2.9340 0.0 0
M  V30 3 Br 4.7141 0.0000 0.0 0
M  V30 4 C 10.7434 7.9563 0.0 0
M  V30 5 C 12.2834 5.2890 0.0 0
M  V30 6 N 13.0534 3.9554 0.0 0
M  V30 7 O 13.0534 6.6227 0.0 0
M  V30 8 N 5.2182 4.0431 0.0 0
M  V30 9 C 6.1234 5.2890 0.0 0
M  V30 10 C 3.7535 4.5190 0.0 0
M  V30 11 N 5.5383 2.5367 0.0 0
M  V30 12 C 5.2182 6.5349 0.0 0
M  V30 13 C 2.6091 3.4886 0.0 0
M  V30 14 N 3.7535 6.0590 0.0 0
M  V30 15 C 4.3940 1.5063 0.0 0
M  V30 16 C 2.9292 1.9821 0.0 0
M  V30 17 C 7.6634 5.2890 0.0 0
M  V30 18 C 8.4334 6.6227 0.0 0
M  V30 19 C 8.4334 3.9554 0.0 0
M  V30 20 C 9.9734 6.6227 0.0 0
M  V30 21 C 9.9734 3.9554 0.0 0
M  V30 22 C 10.7434 5.2890 0.0 0
M  V30 23 C 14.5934 3.9554 0.0 0
M  V30 24 C 15.9271 3.1854 0.0 0
M  V30 25 C 15.9271 4.7254 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 3 15
M  V30 4 1 4 20
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 22
M  V30 8 1 6 23
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 2 9 12
M  V30 13 1 9 17
M  V30 14 1 10 13
M  V30 15 2 10 14
M  V30 16 2 11 15
M  V30 17 1 12 14
M  V30 18 2 13 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1365244-33-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1365244-37-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8919797
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 872-50-4
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
4-(6-bromo-8-{[2-(methylsulfonyl)ethyl]amino}imidazo[1,2-b]pyridazin-3-yl)-N-cyclopropyl-2-methylbenzamide
: To a stirred solutlon of 1.12 g (2.5 mmol)
4-[6-bromo-8-(methylsulfonyl)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropyl-2-methyl
benzamide which was prepared according to intermediate example 516b in 15
ml NMP is added 924 mg (7.5 mmol) 2-(methylsulfonyl)ethanamine and 1.94 g
(15 mmol) DIPEA and the mixture is heated at 160°C for 4 h in a heating
block. After working up and without further purification the title
compound are obtained. Using methanamine.
4-[6-bromo-8-(methylamino)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropyl-2-methylbenzamide,
yield 1000 mg, 100%. UPLC-MS: RT = 1.08, MWfound = 401.3, MWcalc = 400.3.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted imidazopyridazines as monopolar spindle 1
kinase inhibitors for treating hyperproliferative and angiogenesis
disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Klar, Ulrich; Koppitz, Marcus; Jautelat, Rolf; Kosemund, Dirk; Bohlmann,
Rolf; Lienau, Philip; Siemeister, Gerhard; Wengner, Antje Margret
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012032031 A1 2012-03-15

$RFMT $RIREG SCHEME127 STEP1
$RXN



  3  1
$MOL
BOC-L-Phenylalanine
C14H19NO4
13734-34-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6675 0.0 0 CFG=1
M  V30 2 C 4.6201 4.0012 0.0 0
M  V30 3 N 6.9302 2.6675 0.0 0
M  V30 4 C 4.6201 1.3338 0.0 0
M  V30 5 C 7.7002 4.0012 0.0 0
M  V30 6 O 3.0801 1.3338 0.0 0
M  V30 7 O 5.3901 0.0000 0.0 0
M  V30 8 O 9.2402 4.0012 0.0 0
M  V30 9 O 6.9302 5.3348 0.0 0
M  V30 10 C 10.0102 5.3348 0.0 0
M  V30 11 C 11.3439 4.5648 0.0 0
M  V30 12 C 10.7802 6.6687 0.0 0
M  V30 13 C 8.6766 6.1048 0.0 0
M  V30 14 C 3.0801 4.0012 0.0 0
M  V30 15 C 2.3101 5.3348 0.0 0
M  V30 16 C 2.3101 2.6675 0.0 0
M  V30 17 C 0.7700 5.3348 0.0 0
M  V30 18 C 0.7700 2.6675 0.0 0
M  V30 19 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Trifluoroacetic acid
C2HF3O2
76-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.3101 0.0 0
M  V30 2 C 2.6673 1.5400 0.0 0
M  V30 3 F 2.1037 3.6437 0.0 0
M  V30 4 F 0.0000 3.0801 0.0 0
M  V30 5 F 0.5637 0.9764 0.0 0
M  V30 6 O 4.0010 2.3101 0.0 0
M  V30 7 O 2.6673 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenepropanamide, α-amino-N-methyl-, (αS)-, 2,2,2-trifluoroacetate (1:1)
C10H14N2O.C2HF3O2
131451-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 6.7237 0.0 0
M  V30 2 C 5.3347 7.4937 0.0 0 CFG=2
M  V30 3 C 6.6684 6.7237 0.0 0
M  V30 4 N 5.3347 9.0337 0.0 0
M  V30 5 N 8.0021 7.4937 0.0 0
M  V30 6 O 6.6684 5.1837 0.0 0
M  V30 7 C 9.3358 6.7237 0.0 0
M  V30 8 C 2.6674 7.4937 0.0 0
M  V30 9 C 1.3336 6.7237 0.0 0
M  V30 10 C 2.6674 9.0337 0.0 0
M  V30 11 C 0.0000 7.4937 0.0 0
M  V30 12 C 1.3336 9.8037 0.0 0
M  V30 13 C 0.0000 9.0337 0.0 0
M  V30 14 C 4.0011 2.3101 0.0 0
M  V30 15 C 5.3347 1.5400 0.0 0
M  V30 16 F 4.7711 3.6437 0.0 0
M  V30 17 F 2.6674 3.0801 0.0 0
M  V30 18 F 3.2310 0.9764 0.0 0
M  V30 19 O 6.6684 2.3101 0.0 0
M  V30 20 O 5.3347 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 2 15 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 13734-34-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 131451-47-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-5653599
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 543-27-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM EXAMPLE 1 Preparation of 2H-Isoindole-2-hexanamide.
N-[hexahydro-1-[2-methylamino)-2-oxo-1-(phenylmethyl)ethyl]-2-oxo-5-phenyl-1H-azepin-3-yl]-1,3-dihydro-α-mercapto-1,3-dioxo-,[3S-[1(R*),3α,
5α]]-; Compound II-1 (MDL 108,180) Step 1.1: Scheme C, step a; Cool a
solution of Boc-Phe-OH (8.00 g, 30.2 mmol) in tetrahydrofuran to −30° C.
and treat sequentially with N-methylmorpholine (3.5 mL, 32 mmol) and
isobutyl chloroformate (4.5 mL, 35 mmol). After 10 min, treat the
reaction mixture with 40% aqueous methylamine (13 mL, 380 mmol), stir for
2 hours, and concentrate. Dissolve the residue in methylene chloride (125
mL) and wash with 1N hydrochloric acid and saturated NaHCO3 (75 mL each).
Dry the organic layer (NaSO4) and concentrate to give crude title
compound, which is used without further purification. Step 1.1.1: Scheme
C, step b; Stir a solution of the crude product of Example 1.1 in
methylene chloride (100 mL) and trifluoroacetic acid (20 mL) at ambient
temperature for 3 hours and concentrate. Remove residual trifluoroacetic
acid by coevaporation with carbon tetrachloride and toluene using a
rotary evaporator. Triturate the sticky residue with diethyl ether to
yield the title compound as a white solid (9.12 g, 100%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 3-mercaptoacetylamino-1,5-disubstituted-2-oxoazepans as
matrix metalloproteinase inhibitors.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Warshawsky, Alan M.; Tsay, Joseph T.; Janusz, Michael J.; Shen, Jian;
Flynn, Gary A.; Dharanipragada, Ramalinga M.; Burkhart, Joseph P.;
Beight, Douglas W.; Patel, Meena V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US6953788 B1 2005-10-11

$RFMT $RIREG SCHEME127 STEP1
$RXN



  3  1
$MOL
BOC-L-Phenylalanine
C14H19NO4
13734-34-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6675 0.0 0 CFG=1
M  V30 2 C 4.6201 4.0012 0.0 0
M  V30 3 N 6.9302 2.6675 0.0 0
M  V30 4 C 4.6201 1.3338 0.0 0
M  V30 5 C 7.7002 4.0012 0.0 0
M  V30 6 O 3.0801 1.3338 0.0 0
M  V30 7 O 5.3901 0.0000 0.0 0
M  V30 8 O 9.2402 4.0012 0.0 0
M  V30 9 O 6.9302 5.3348 0.0 0
M  V30 10 C 10.0102 5.3348 0.0 0
M  V30 11 C 11.3439 4.5648 0.0 0
M  V30 12 C 10.7802 6.6687 0.0 0
M  V30 13 C 8.6766 6.1048 0.0 0
M  V30 14 C 3.0801 4.0012 0.0 0
M  V30 15 C 2.3101 5.3348 0.0 0
M  V30 16 C 2.3101 2.6675 0.0 0
M  V30 17 C 0.7700 5.3348 0.0 0
M  V30 18 C 0.7700 2.6675 0.0 0
M  V30 19 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Trifluoroacetic acid
C2HF3O2
76-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.3101 0.0 0
M  V30 2 C 2.6673 1.5400 0.0 0
M  V30 3 F 2.1037 3.6437 0.0 0
M  V30 4 F 0.0000 3.0801 0.0 0
M  V30 5 F 0.5637 0.9764 0.0 0
M  V30 6 O 4.0010 2.3101 0.0 0
M  V30 7 O 2.6673 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenepropanamide, α-amino-N-methyl-, (αS)-, 2,2,2-trifluoroacetate (1:1)
C10H14N2O.C2HF3O2
131451-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 6.7237 0.0 0
M  V30 2 C 5.3347 7.4937 0.0 0 CFG=2
M  V30 3 C 6.6684 6.7237 0.0 0
M  V30 4 N 5.3347 9.0337 0.0 0
M  V30 5 N 8.0021 7.4937 0.0 0
M  V30 6 O 6.6684 5.1837 0.0 0
M  V30 7 C 9.3358 6.7237 0.0 0
M  V30 8 C 2.6674 7.4937 0.0 0
M  V30 9 C 1.3336 6.7237 0.0 0
M  V30 10 C 2.6674 9.0337 0.0 0
M  V30 11 C 0.0000 7.4937 0.0 0
M  V30 12 C 1.3336 9.8037 0.0 0
M  V30 13 C 0.0000 9.0337 0.0 0
M  V30 14 C 4.0011 2.3101 0.0 0
M  V30 15 C 5.3347 1.5400 0.0 0
M  V30 16 F 4.7711 3.6437 0.0 0
M  V30 17 F 2.6674 3.0801 0.0 0
M  V30 18 F 3.2310 0.9764 0.0 0
M  V30 19 O 6.6684 2.3101 0.0 0
M  V30 20 O 5.3347 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 2 15 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 13734-34-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 131451-47-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-17629679
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 543-27-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of peptides as selective inhibitors of MMP-12
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Warshawsky, Alan M.; Janusz, Michael J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US6352976 B1 2002-03-05

$RFMT $RIREG SCHEME127 STEP1
$RXN



  3  1
$MOL
BOC-L-Phenylalanine
C14H19NO4
13734-34-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6675 0.0 0 CFG=1
M  V30 2 C 4.6201 4.0012 0.0 0
M  V30 3 N 6.9302 2.6675 0.0 0
M  V30 4 C 4.6201 1.3338 0.0 0
M  V30 5 C 7.7002 4.0012 0.0 0
M  V30 6 O 3.0801 1.3338 0.0 0
M  V30 7 O 5.3901 0.0000 0.0 0
M  V30 8 O 9.2402 4.0012 0.0 0
M  V30 9 O 6.9302 5.3348 0.0 0
M  V30 10 C 10.0102 5.3348 0.0 0
M  V30 11 C 11.3439 4.5648 0.0 0
M  V30 12 C 10.7802 6.6687 0.0 0
M  V30 13 C 8.6766 6.1048 0.0 0
M  V30 14 C 3.0801 4.0012 0.0 0
M  V30 15 C 2.3101 5.3348 0.0 0
M  V30 16 C 2.3101 2.6675 0.0 0
M  V30 17 C 0.7700 5.3348 0.0 0
M  V30 18 C 0.7700 2.6675 0.0 0
M  V30 19 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Trifluoroacetic acid
C2HF3O2
76-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.3101 0.0 0
M  V30 2 C 2.6673 1.5400 0.0 0
M  V30 3 F 2.1037 3.6437 0.0 0
M  V30 4 F 0.0000 3.0801 0.0 0
M  V30 5 F 0.5637 0.9764 0.0 0
M  V30 6 O 4.0010 2.3101 0.0 0
M  V30 7 O 2.6673 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenepropanamide, α-amino-N-methyl-, (αS)-, 2,2,2-trifluoroacetate (1:1)
C10H14N2O.C2HF3O2
131451-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 6.7237 0.0 0
M  V30 2 C 5.3347 7.4937 0.0 0 CFG=2
M  V30 3 C 6.6684 6.7237 0.0 0
M  V30 4 N 5.3347 9.0337 0.0 0
M  V30 5 N 8.0021 7.4937 0.0 0
M  V30 6 O 6.6684 5.1837 0.0 0
M  V30 7 C 9.3358 6.7237 0.0 0
M  V30 8 C 2.6674 7.4937 0.0 0
M  V30 9 C 1.3336 6.7237 0.0 0
M  V30 10 C 2.6674 9.0337 0.0 0
M  V30 11 C 0.0000 7.4937 0.0 0
M  V30 12 C 1.3336 9.8037 0.0 0
M  V30 13 C 0.0000 9.0337 0.0 0
M  V30 14 C 4.0011 2.3101 0.0 0
M  V30 15 C 5.3347 1.5400 0.0 0
M  V30 16 F 4.7711 3.6437 0.0 0
M  V30 17 F 2.6674 3.0801 0.0 0
M  V30 18 F 3.2310 0.9764 0.0 0
M  V30 19 O 6.6684 2.3101 0.0 0
M  V30 20 O 5.3347 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 2 15 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 13734-34-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 131451-47-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-18846798
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 543-27-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of peptides as selective inhibitors of MMP-12
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Warshawsky, Alan M.; Janusz, Michael J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000040600 A1 2000-07-13

$RFMT $RIREG SCHEME128 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Propanol, 3-[4-[[2-amino-4-methyl-6-[[(1S)-1-[2-(phenylmethoxy)ethyl]butyl]...
C30H42N4O6S
1376514-47-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 9.2402 5.3348 0.0 0
M  V30 2 C 7.7002 5.3348 0.0 0 CFG=1
M  V30 3 C 6.9302 6.6685 0.0 0
M  V30 4 C 6.9302 4.0012 0.0 0
M  V30 5 C 5.3901 6.6685 0.0 0
M  V30 6 C 5.3901 4.0012 0.0 0
M  V30 7 O 4.6201 8.0022 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.0801 8.0022 0.0 0
M  V30 10 C 12.3203 5.3348 0.0 0
M  V30 11 C 13.8603 2.6673 0.0 0
M  V30 12 N 9.2402 0.0000 0.0 0
M  V30 13 O 13.8603 8.0022 0.0 0
M  V30 14 C 14.6303 9.3360 0.0 0
M  V30 15 O 18.4804 5.3348 0.0 0
M  V30 16 C 19.2504 6.6685 0.0 0
M  V30 17 C 20.7905 6.6685 0.0 0
M  V30 18 C 21.5605 8.0022 0.0 0
M  V30 19 O 23.1005 8.0022 0.0 0
M  V30 20 S 23.8705 9.3360 0.0 0 VAL=6
M  V30 21 C 22.5369 10.1060 0.0 0
M  V30 22 O 24.6405 10.6697 0.0 0
M  V30 23 O 25.2042 8.5660 0.0 0
M  V30 24 C 10.0102 4.0012 0.0 0
M  V30 25 C 11.5503 4.0012 0.0 0
M  V30 26 N 9.2402 2.6673 0.0 0
M  V30 27 C 12.3203 2.6673 0.0 0
M  V30 28 C 10.0102 1.3337 0.0 0
M  V30 29 N 11.5503 1.3337 0.0 0
M  V30 30 C 13.8603 5.3348 0.0 0
M  V30 31 C 14.6303 6.6685 0.0 0
M  V30 32 C 14.6303 4.0012 0.0 0
M  V30 33 C 16.1704 6.6685 0.0 0
M  V30 34 C 16.1704 4.0012 0.0 0
M  V30 35 C 16.9404 5.3348 0.0 0
M  V30 36 C 2.3100 9.3360 0.0 0
M  V30 37 C 0.7700 9.3360 0.0 0
M  V30 38 C 3.0801 10.6697 0.0 0
M  V30 39 C 0.0000 10.6697 0.0 0
M  V30 40 C 2.3100 12.0033 0.0 0
M  V30 41 C 0.7700 12.0033 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 24
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 9 36
M  V30 11 1 10 25
M  V30 12 1 10 30
M  V30 13 1 11 27
M  V30 14 1 12 28
M  V30 15 1 13 14
M  V30 16 1 13 31
M  V30 17 1 15 16
M  V30 18 1 15 35
M  V30 19 1 16 17
M  V30 20 1 17 18
M  V30 21 1 18 19
M  V30 22 1 19 20
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 2 20 23
M  V30 26 1 24 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 38 2 36 37
M  V30 39 1 36 38
M  V30 40 1 37 39
M  V30 41 2 38 40
M  V30 42 2 39 41
M  V30 43 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
5-[[2-Methoxy-4-[3-(methylamino)propoxy]phenyl]methyl]-6-methyl-N4-[(1S)-1-[2...
C30H43N5O3
1378275-60-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 9.2400 5.3347 0.0 0
M  V30 2 C 7.7000 5.3347 0.0 0 CFG=1
M  V30 3 C 6.9300 6.6684 0.0 0
M  V30 4 C 6.9300 4.0011 0.0 0
M  V30 5 C 5.3900 6.6684 0.0 0
M  V30 6 C 5.3900 4.0011 0.0 0
M  V30 7 O 4.6200 8.0020 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.0800 8.0020 0.0 0
M  V30 10 C 12.3200 5.3347 0.0 0
M  V30 11 C 13.8600 2.6673 0.0 0
M  V30 12 N 9.2400 0.0000 0.0 0
M  V30 13 O 13.8600 8.0020 0.0 0
M  V30 14 C 14.6300 9.3358 0.0 0
M  V30 15 O 18.4800 5.3347 0.0 0
M  V30 16 C 19.2500 6.6684 0.0 0
M  V30 17 C 20.7900 6.6684 0.0 0
M  V30 18 C 21.5600 8.0020 0.0 0
M  V30 19 N 23.1000 8.0020 0.0 0
M  V30 20 C 23.8700 9.3358 0.0 0
M  V30 21 C 10.0100 4.0011 0.0 0
M  V30 22 C 11.5500 4.0011 0.0 0
M  V30 23 N 9.2400 2.6673 0.0 0
M  V30 24 C 12.3200 2.6673 0.0 0
M  V30 25 C 10.0100 1.3336 0.0 0
M  V30 26 N 11.5500 1.3336 0.0 0
M  V30 27 C 13.8600 5.3347 0.0 0
M  V30 28 C 14.6300 6.6684 0.0 0
M  V30 29 C 14.6300 4.0011 0.0 0
M  V30 30 C 16.1700 6.6684 0.0 0
M  V30 31 C 16.1700 4.0011 0.0 0
M  V30 32 C 16.9400 5.3347 0.0 0
M  V30 33 C 2.3100 9.3358 0.0 0
M  V30 34 C 0.7700 9.3358 0.0 0
M  V30 35 C 3.0800 10.6694 0.0 0
M  V30 36 C 0.0000 10.6694 0.0 0
M  V30 37 C 2.3100 12.0031 0.0 0
M  V30 38 C 0.7700 12.0031 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 9 33
M  V30 11 1 10 22
M  V30 12 1 10 27
M  V30 13 1 11 24
M  V30 14 1 12 25
M  V30 15 1 13 14
M  V30 16 1 13 28
M  V30 17 1 15 16
M  V30 18 1 15 32
M  V30 19 1 16 17
M  V30 20 1 17 18
M  V30 21 1 18 19
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 35 2 33 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 2 35 37
M  V30 39 2 36 38
M  V30 40 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1376514-47-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1378275-60-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-3934916
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (S)-2-{
3-[4-({2-Amino-4-[1-(benzyloxy)hexan-3-ylamino]-6-methylpyrimidin-5-yl}methyl)-3-methoxyphenoxy]propylamino}ethanol.
The mixture of the product from Example 1 step (xii) (140 mg, 0.231 mmol)
and methylamine (9.8 M in MeOH, 1 mL) in CH3CN/water (2mL/lmL) was
stirred at 80°C for 1.5h. The resulting mixture was diluted with 40%
K2CO3 aq. and extracted with EtOAc. The combined organic solutions were
dried (Na2SO4) and concentrated. Purification by FCC, eluting with CHCl3
/ MeOH gave 122 mg of the sub-title compound. Yield (0.231 mmol, 100%),
colourless oil. 1H NMR: 7.22-7.32 (5H, m), 6.78 (1H, d), 6.44 (1H, d),
6.34 (1H, dd), 4.75 (1H, d), 4.51 (2H, br s), 4.33 (2H, s), 4.20-4.32
(1H, m), 3.96 (2H, t), 3.83 (3H, s), 3.57 (2H, s), 3.24-3.35 (2H, m),
2.73 (2H, t), 2.43 (3H, s), 2.29 (3H, s), 1.88-1.98 (2H, m), 1.73-1.84
(1H, m), 1.45- 1.57 (1H, m), 1.20-1.43 (2H, m), 1.05-1.17 (2H, m), 0.79
(3H, t).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aminoalkoxyphenyl compounds and their use in the treatment of Cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hori, Seiji; McInally, Thomas; Urabe, Daisuke
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012067269 A1 2012-05-24

$RFMT $RIREG SCHEME129 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Azido-5-bromo-3-pyridinecarboxaldehyde
C6H3BrN4O
1378039-92-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 4.0010 0.0 0
M  V30 2 N 6.1601 4.0010 0.0 0 CHG=1 VAL=4
M  V30 3 N 7.7001 4.0010 0.0 0 CHG=-1
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 4.0010 0.0 0
M  V30 6 Br 6.1601 1.3337 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 N 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 8
M  V30 6 1 6 9
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Azido-5-bromo-3-pyridinyl)methylene]methanamine
C7H6BrN5
2244678-78-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 4.0011 0.0 0
M  V30 2 N 6.9300 4.0011 0.0 0 CHG=1 VAL=4
M  V30 3 N 8.4700 4.0011 0.0 0 CHG=-1
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 N 0.7700 4.0011 0.0 0
M  V30 6 C 0.0000 5.3349 0.0 0
M  V30 7 Br 6.9300 1.3338 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.0800 2.6674 0.0 0
M  V30 10 C 5.3900 1.3338 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 4.6200 0.0000 0.0 0
M  V30 13 N 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 2 2 3
M  V30 4 2 4 5 CFG=2
M  V30 5 1 4 9
M  V30 6 1 5 6
M  V30 7 1 7 10
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1378039-92-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2244678-78-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-20630180
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7757-82-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-(3-Chlorophenyl)pyrazol-4-yl carboxamide compounds as Janus kinase
inhibitors, their preparation, compositions and methods of use thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zak, Mark; Romero, F. Anthony; Yuen, Po-Wai; Hanan, Emily J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018166993 A2 2018-09-20

$RFMT $RIREG SCHEME130 STEP1
$RXN



  2  1
$MOL
Methyl 3-bromo-4-fluoro-2-methylbenzoate
C9H8BrFO2
1380305-66-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 O 6.9302 4.0010 0.0 0
M  V30 3 O 6.9302 1.3337 0.0 0
M  V30 4 C 8.4702 4.0010 0.0 0
M  V30 5 C 4.6201 0.0000 0.0 0
M  V30 6 Br 1.5400 0.0000 0.0 0
M  V30 7 F 0.0000 2.6673 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 1.3337 0.0 0
M  V30 10 C 3.8501 4.0010 0.0 0
M  V30 11 C 2.3101 1.3337 0.0 0
M  V30 12 C 2.3101 4.0010 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 11
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-5-fluoro-2,3-dihydro-2-methyl-1H-isoindol-1-one
C9H7BrFNO
1380305-64-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 2.6674 0.0000 0.0 0
M  V30 2 O 5.9416 5.7904 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 C 7.9110 3.0800 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 C 5.4658 1.8340 0.0 0
M  V30 9 C 5.4658 4.3259 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3338 2.3100 0.0 0
M  V30 12 N 6.3710 3.0800 0.0 0
M  V30 13 C 1.3338 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 2 2 9
M  V30 3 1 3 11
M  V30 4 1 4 12
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1380305-66-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1380305-64-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3431867
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 128-08-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1380305-68-9
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 78-67-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 56-23-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Compound 31F: Methyl 3-bromo-5-formyl-4-(methylamino)benzoate. The
regio-isomeric mixture of Compound 31G and Compound 31H (2.02 g, 8.18
mmol) was taken up in carbon tetrachloride (40 mL) and treated with NBS
(2.91 g, 16.4 mmol) and 2,2'-azo-bis-isobutyronitrile (3.12 mg, 0.019
mmol) and allowed to stir at 80 °C overnight. The reaction mixture was
quenched with water (10 mL) and extracted with DCM (2 x 20 mL). The
organic layer was washed with water (10 mL), brine (10 mL), and then
dried over anhydrous sodium sulfate. The solvents were evaporated under
reduced pressure to give a light-yellow oil. The product mixture was
taken up in THF (15 mL) and then treated with a solution of 2.0 M of
methylamine in THF (8.18 mL, 16.4 mmol) and DIPEA (2.85 mL). After
stirring overnight at rt, the reaction mixture was evaporated under
reduced pressure to afford a crude solid which was purified using a
Teledyne ISCO Combiflash® Rf system [gradient eluent EtOAc/Heptane =
50-100%) to give the desired product.
4-bromo-5-fluoro-2-methyl-2,3-dihydro-1H-isoindol-1-one (Compound 31 F).
white solid, yield 1.40 g. 1H NMR (CDCl3, 400 MHz): δ 7.77 (dd, J = 8.3,
4.5 Hz, 1H), 7.24 (app t, J = 8.6 Hz, 1H), 4.33 (s, 2H), 3.22 (s, 3H). MS
(ESI): m/z = 244.05/246.03 [M+H]+. UPLC: tR = 3.33 min (ZQ3:polar-5 min).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrocyclic phosphonates and phosphinates, fused with five- and
six-membered nitrogen heterocycles as specific focal adhesion kinase
inhibitors in cancer therapy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Crew, Andrew P.; Dong, Hanqing; Ferraro, Caterina; Sherman, Dan; Siu, Kam
W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012074951 A1 2012-06-07

$RFMT $RIREG SCHEME131 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-[4-(phenylmethyl)-1-piperazinyl]-2-benzofurancarboxylate
C22H24N2O3
1383842-59-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.2914 6.0811 0.0 0
M  V30 2 O 14.8314 6.0811 0.0 0
M  V30 3 O 12.5214 7.4149 0.0 0
M  V30 4 C 15.6014 7.4149 0.0 0
M  V30 5 C 17.1414 7.4149 0.0 0
M  V30 6 C 4.0011 5.3901 0.0 0
M  V30 7 C 10.6696 3.0801 0.0 0
M  V30 8 C 9.3360 2.3100 0.0 0
M  V30 9 C 12.0033 2.3100 0.0 0
M  V30 10 C 10.9898 4.5865 0.0 0
M  V30 11 C 9.3360 0.7700 0.0 0
M  V30 12 O 13.1478 3.3406 0.0 0
M  V30 13 C 12.0033 0.7700 0.0 0
M  V30 14 C 12.5214 4.7474 0.0 0
M  V30 15 C 10.6696 0.0000 0.0 0
M  V30 16 N 8.0021 3.0801 0.0 0
M  V30 17 C 8.0021 4.6201 0.0 0
M  V30 18 C 6.6685 2.3100 0.0 0
M  V30 19 C 6.6685 5.3901 0.0 0
M  V30 20 C 5.3348 3.0801 0.0 0
M  V30 21 N 5.3348 4.6201 0.0 0
M  V30 22 C 2.6673 4.6201 0.0 0
M  V30 23 C 2.6673 3.0801 0.0 0
M  V30 24 C 1.3337 5.3901 0.0 0
M  V30 25 C 1.3337 2.3100 0.0 0
M  V30 26 C 0.0000 4.6201 0.0 0
M  V30 27 C 0.0000 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 21
M  V30 7 1 6 22
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 16
M  V30 13 1 9 12
M  V30 14 2 9 13
M  V30 15 2 10 14
M  V30 16 2 11 15
M  V30 17 1 12 14
M  V30 18 1 13 15
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-[4-(phenylmethyl)-1-piperazinyl]-2-benzofurancarboxamide
C21H23N3O2
1383842-60-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.0110 5.3803 0.0 0
M  V30 2 N 14.3448 6.1503 0.0 0
M  V30 3 O 13.0110 3.8403 0.0 0
M  V30 4 C 15.6784 5.3803 0.0 0
M  V30 5 C 4.6200 1.3336 0.0 0
M  V30 6 C 9.2400 6.6684 0.0 0
M  V30 7 C 7.7000 6.6684 0.0 0
M  V30 8 C 10.0100 8.0021 0.0 0
M  V30 9 C 10.2706 5.5240 0.0 0
M  V30 10 C 6.9300 8.0021 0.0 0
M  V30 11 O 11.5164 7.6820 0.0 0
M  V30 12 C 9.2400 9.3358 0.0 0
M  V30 13 C 11.6774 6.1503 0.0 0
M  V30 14 C 7.7000 9.3358 0.0 0
M  V30 15 N 6.9300 5.3347 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 5.3900 5.3347 0.0 0
M  V30 18 C 6.9300 2.6674 0.0 0
M  V30 19 C 4.6200 4.0011 0.0 0
M  V30 20 N 5.3900 2.6674 0.0 0
M  V30 21 C 3.0800 1.3336 0.0 0
M  V30 22 C 2.3100 0.0000 0.0 0
M  V30 23 C 2.3100 2.6674 0.0 0
M  V30 24 C 0.7700 0.0000 0.0 0
M  V30 25 C 0.7700 2.6674 0.0 0
M  V30 26 C 0.0000 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 5 20
M  V30 6 1 5 21
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 7 15
M  V30 12 1 8 11
M  V30 13 2 8 12
M  V30 14 2 9 13
M  V30 15 2 10 14
M  V30 16 1 11 13
M  V30 17 1 12 14
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1383842-59-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1383842-60-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10210947
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 143-33-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Method B: Ethyl 4-(4-benzylpiperazin-1-yl)benzofuran-2-carboxylate
(Example 1c), 2.05 g, 5.63 mmol) and sodium cyanide (0.028 g, 0.56 mmol)
were stirred in methylamine (8 M in ethanol) (20 mL, 160 mmol) at rt for
3 h. The solvent was evaporated, the mixture was dissolved in
dichloromethane and washed with 2 M NaOH. The organic phase was
separated, dried over magnesium sulfate, filtered and the solvent was
removed by rotary evaporation to give the title compound.
4-(4-Benzylpiperazin-1-yl)-N-methyl-benzofuran-2-carboxamide, yield 1.95
g, quantitative. MS m/z 350.5 [M+H]+.
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of dihydroquinolinylethylpiperazinylbenzofurancarboxamide
derivative for use in treatment of cognitive disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gybaeck, Helena; Malmstroem, Jonas; Terp, Elgaard Gitte
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012087229 A1 2012-06-28

$RFMT $RIREG SCHEME132 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-6-iodo-3-[4-(trifluoromethyl)phenyl]-4(3H)-quinazolinone
C15H7ClF3IN2O
1383993-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0022 2.1037 0.0 0
M  V30 2 Cl 5.3348 6.7238 0.0 0
M  V30 3 C 1.3337 1.3337 0.0 0
M  V30 4 F 2.1037 0.0000 0.0 0
M  V30 5 F 0.0000 0.5637 0.0 0
M  V30 6 F 0.5637 2.6673 0.0 0
M  V30 7 I 13.3370 3.6437 0.0 0
M  V30 8 N 6.6685 4.4137 0.0 0
M  V30 9 C 8.0022 3.6437 0.0 0
M  V30 10 C 6.6685 5.9538 0.0 0
M  V30 11 C 9.3360 4.4137 0.0 0
M  V30 12 N 8.0022 6.7238 0.0 0
M  V30 13 C 9.3360 5.9538 0.0 0
M  V30 14 C 10.6697 3.6437 0.0 0
M  V30 15 C 10.6697 6.7238 0.0 0
M  V30 16 C 12.0033 4.4137 0.0 0
M  V30 17 C 12.0033 5.9538 0.0 0
M  V30 18 C 5.3348 3.6437 0.0 0
M  V30 19 C 4.0010 4.4137 0.0 0
M  V30 20 C 5.3348 2.1037 0.0 0
M  V30 21 C 2.6673 3.6437 0.0 0
M  V30 22 C 4.0010 1.3337 0.0 0
M  V30 23 C 2.6673 2.1037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 23
M  V30 7 1 7 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 18
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 13
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Iodo-2-(methylamino)-3-[4-(trifluoromethyl)phenyl]-4(3H)-quinazolinone
C16H11F3IN3O
2437407-47-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 C 5.3348 0.0000 0.0 0
M  V30 3 O 8.0022 6.1601 0.0 0
M  V30 4 C 1.3337 6.9302 0.0 0
M  V30 5 F 0.5637 5.5965 0.0 0
M  V30 6 F 0.0000 7.7002 0.0 0
M  V30 7 F 2.1037 8.2638 0.0 0
M  V30 8 I 13.3370 4.6201 0.0 0
M  V30 9 N 6.6685 3.8501 0.0 0
M  V30 10 C 6.6685 2.3101 0.0 0
M  V30 11 C 8.0022 4.6201 0.0 0
M  V30 12 N 8.0022 1.5400 0.0 0
M  V30 13 C 9.3360 3.8501 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 4.6201 0.0 0
M  V30 16 C 10.6697 1.5400 0.0 0
M  V30 17 C 12.0033 3.8501 0.0 0
M  V30 18 C 12.0033 2.3101 0.0 0
M  V30 19 C 5.3348 4.6201 0.0 0
M  V30 20 C 5.3348 6.1601 0.0 0
M  V30 21 C 4.0010 3.8501 0.0 0
M  V30 22 C 4.0010 6.9302 0.0 0
M  V30 23 C 2.6673 4.6201 0.0 0
M  V30 24 C 2.6673 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 3 11
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 24
M  V30 8 1 8 17
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 19
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1383993-88-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2437407-47-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-22297542
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a pressure tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, Structure-Activity Relationship, and Mechanistic Studies of
Aminoquinazolinones Displaying Antimycobacterial Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Akester, Jessica N.; Njaria, Paul; Nchinda, Aloysius; Le Manach, Claire;
Myrick, Alissa; Singh, Vinayak; Lawrence, Nina; Njoroge, Mathew; Taylor,
Dale; Moosa, Atica; Smith, Anthony J.; Brooks, Elizabeth J.; Lenaerts,
Anne J.; Robertson, Gregory T.; Ioerger, Thomas R.; Mueller, Rudolf;
Chibale, Kelly
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Infectious Diseases (2020), 6(7), 1951-1964

$RFMT $RIREG SCHEME133 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Ethyl 2-(3-carboxyphenyl)-1,2,3,4-tetrahydro-4,4-dimethyl-6-quinolinecarbox...
C21H23NO4
1391609-16-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.0124 6.5698 0.0 0
M  V30 2 C 8.9923 6.5698 0.0 0
M  V30 3 C 13.3372 5.3901 0.0 0
M  V30 4 O 14.6708 4.6201 0.0 0
M  V30 5 O 13.3372 6.9302 0.0 0
M  V30 6 C 16.0045 5.3901 0.0 0
M  V30 7 C 17.3383 4.6201 0.0 0
M  V30 8 C 1.3338 3.0801 0.0 0
M  V30 9 O 1.3338 4.6201 0.0 0
M  V30 10 O 0.0000 2.3101 0.0 0
M  V30 11 C 9.3360 3.0801 0.0 0
M  V30 12 C 9.3360 4.6201 0.0 0
M  V30 13 N 8.0023 2.3101 0.0 0
M  V30 14 C 10.6697 2.3101 0.0 0
M  V30 15 C 10.6697 5.3901 0.0 0
M  V30 16 C 8.0023 5.3901 0.0 0
M  V30 17 C 6.6687 3.0801 0.0 0
M  V30 18 C 12.0035 3.0801 0.0 0
M  V30 19 C 12.0035 4.6201 0.0 0
M  V30 20 C 6.6687 4.6201 0.0 0
M  V30 21 C 5.3348 2.3101 0.0 0
M  V30 22 C 4.0012 3.0801 0.0 0
M  V30 23 C 5.3348 0.7700 0.0 0
M  V30 24 C 2.6675 2.3101 0.0 0
M  V30 25 C 4.0012 0.0000 0.0 0
M  V30 26 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 16
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 19
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 24
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 2 12 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 2 18 19
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1,2,3,4-tetrahydro-4,4-dimethyl-2-[3-[(methylamino)carbonyl]phenyl]-6-q...
C22H26N2O3
1391609-66-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.3461 6.5698 0.0 0
M  V30 2 C 10.3259 6.5698 0.0 0
M  V30 3 C 14.6708 5.3901 0.0 0
M  V30 4 O 16.0045 4.6201 0.0 0
M  V30 5 O 14.6708 6.9302 0.0 0
M  V30 6 C 17.3383 5.3901 0.0 0
M  V30 7 C 18.6720 4.6201 0.0 0
M  V30 8 C 2.6675 3.0801 0.0 0
M  V30 9 N 1.3337 2.3101 0.0 0
M  V30 10 O 2.6675 4.6201 0.0 0
M  V30 11 C 0.0000 3.0801 0.0 0
M  V30 12 C 10.6697 4.6201 0.0 0
M  V30 13 C 10.6697 3.0801 0.0 0
M  V30 14 C 12.0035 5.3901 0.0 0
M  V30 15 C 9.3360 5.3901 0.0 0
M  V30 16 N 9.3360 2.3101 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 13.3372 4.6201 0.0 0
M  V30 19 C 8.0023 4.6201 0.0 0
M  V30 20 C 8.0023 3.0801 0.0 0
M  V30 21 C 13.3372 3.0801 0.0 0
M  V30 22 C 6.6685 2.3101 0.0 0
M  V30 23 C 5.3348 3.0801 0.0 0
M  V30 24 C 6.6685 0.7700 0.0 0
M  V30 25 C 4.0012 2.3101 0.0 0
M  V30 26 C 5.3348 0.0000 0.0 0
M  V30 27 C 4.0012 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 2 15
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 18
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 25
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 2 18 21
M  V30 22 1 19 20
M  V30 23 1 20 22
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1391609-16-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1391609-66-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-4623312
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM The mixture solution of
2-(3-carboxy-phenyl)-4,4-dimethyl-1,2,3,4-tetrahydro-quinoline-6-carboxylic
acid ethyl ester (1.2 g, 3.3 mmol),
o-(7-azabenzotriazol-1-yl)-N,N,N',N'-tetramethyluronium
hexafluorophosphate (HATU) (1.52 g, 4.0 mmol), triethylamine (2.0 mL),
methylamine (228.1 mg, 5.8 mmol) in dry dichloromethane (20.0 mL) was
stirred at room temperature for 1 hour, LC/MS showed that reaction
finished completely. The reaction mixture was extracted with ethyl
acetate, washed with brine, dried over anhydrous sodium sulfate and
concentrated in vacuo.
4,4-dimethyl-2-(3-methylcarbamoyl-phenyl)-1,2,3,4-tetrahydro-quinoline-6-carboxylic
acid ethyl ester (1.23 g, quant.) as a light yellow solid which was used
for next step without further purification. MS (ESI) M+1=367.1.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel tetrahydroquinoline derivatives as AMP-activated
protein kinase activators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Feng, Lichun; Huang, Mengwei; Liu, Yongfu; Wu, Guolong; Yan, Shixiang;
Yun, Hongying; Zhou, Mingwei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20120190677 A1 2012-07-26

$RFMT $RIREG SCHEME134 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-3-(bromomethyl)-5-nitrobenzene
C7H5Br2NO2
139194-80-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 2 O 1.3337 6.1601 0.0 0
M  V30 3 O 0.0000 3.8500 0.0 0
M  V30 4 C 6.6686 4.6201 0.0 0
M  V30 5 Br 8.0022 3.8500 0.0 0
M  V30 6 Br 4.0011 0.0000 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 4.0011 4.6201 0.0 0
M  V30 9 C 2.6675 2.3100 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 11 C 4.0011 1.5400 0.0 0
M  V30 12 C 5.3348 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-N-methyl-5-nitrobenzenemethanamine
C8H9BrN2O2
1251863-72-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 N 8.0023 3.8501 0.0 0
M  V30 3 C 9.3360 4.6201 0.0 0
M  V30 4 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 5 O 1.3337 6.1601 0.0 0
M  V30 6 O 0.0000 3.8501 0.0 0
M  V30 7 Br 4.0012 0.0000 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 11
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 139194-80-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1251863-72-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-6841649
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM A8.a) Preparation of intermediate 1-bromo-3-(bromomethyl)-5-nitrobenzene
(5g, 16.9 mmol) and methylamine 2M in THF (33.9 ml, 67.8 mmol) were
diluted in THF (30 ml) and the solution was stirred overnight at room
temperature. The reaction mixture was partitioned between DCM and water.
The organic layer was separated, dried over MgSO4, filtered and
concenatred to afford 4.6g (quantitative) of intermediate shown.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Imidazo[1,2-a]pyridine derivatives as FGFR kinase inhibitors and their
preparation, pharmaceutical compositions and use in the treatment of
cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saxty, Gordon; Berdini, Valerio; Murray, Christopher William; Freyne,
Eddy Jean Edgard; Ligny, Yannick Aime Eddy; Bonnet, Pascal Ghislain
Andre; Wroblowski, Berthold; Papanikos, Alexandra
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010119285 A1 2010-10-21

$RFMT $RIREG SCHEME135 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromoimidazo[1,2-a]pyridine
C7H5BrN2
6188-23-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 6.3710 3.0800 0.0 0
M  V30 2 C 2.3699 0.7700 0.0 0
M  V30 3 N 2.3699 2.3100 0.0 0
M  V30 4 C 3.7036 0.0000 0.0 0
M  V30 5 N 0.9052 0.2941 0.0 0
M  V30 6 C 3.7036 3.0800 0.0 0
M  V30 7 C 0.9052 2.7859 0.0 0
M  V30 8 C 5.0372 0.7700 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Molybdenum hexacarbonyl
C6MoO6
13939-06-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Mo 3.0800 2.0524 0.0 0
M  V30 2 C 5.1324 2.0524 0.0 0
M  V30 3 C 1.0276 2.0524 0.0 0
M  V30 4 C 3.0800 4.1048 0.0 0
M  V30 5 C 1.3022 3.0800 0.0 0
M  V30 6 C 4.8578 3.0800 0.0 0
M  V30 7 C 3.0800 0.0000 0.0 0
M  V30 8 O 6.1600 2.0524 0.0 0 VAL=3
M  V30 9 O 0.0000 2.0524 0.0 0 VAL=3
M  V30 10 O 4.1076 4.1048 0.0 0 VAL=3
M  V30 11 O 0.2746 3.0800 0.0 0 VAL=3
M  V30 12 O 5.8854 3.0800 0.0 0 VAL=3
M  V30 13 O 4.1076 0.0000 0.0 0 VAL=3
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 1 6
M  V30 6 1 1 7
M  V30 7 3 2 8
M  V30 8 3 3 9
M  V30 9 3 4 10
M  V30 10 3 5 11
M  V30 11 3 6 12
M  V30 12 3 7 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methylimidazo[1,2-a]pyridine-6-carboxamide
C9H9N3O
1789287-69-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 1.5400 0.0 0
M  V30 2 N 7.7047 2.3100 0.0 0
M  V30 3 O 6.3709 0.0000 0.0 0
M  V30 4 C 9.0383 1.5400 0.0 0
M  V30 5 N 2.3699 2.3100 0.0 0
M  V30 6 C 2.3699 3.8500 0.0 0
M  V30 7 C 3.7036 1.5400 0.0 0
M  V30 8 C 0.9052 1.8341 0.0 0
M  V30 9 C 3.7036 4.6200 0.0 0
M  V30 10 N 0.9052 4.3259 0.0 0
M  V30 11 C 5.0372 2.3100 0.0 0
M  V30 12 C 0.0000 3.0800 0.0 0
M  V30 13 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6188-23-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 13939-06-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1789287-69-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-176-CAS-22465068
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 6674-22-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1445085-97-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed chamber used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 5-azaindazole derivatives as adenosine receptor
antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Blayo, Anne-Laure; Manteau, Baptiste; Dorange, Ismet; Mayer, Stanislas;
Schann, Stephan; Catelain, Thomas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020083878 A1 2020-04-30

$RFMT $RIREG SCHEME136 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αR)-α-(Bromomethyl)-3-fluoro-4-(trifluoromethyl)benzenemethanol
C9H7BrF4O
1395079-36-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 2.6673 0.0 0 CFG=1
M  V30 2 C 8.4700 4.0011 0.0 0
M  V30 3 O 8.4700 1.3336 0.0 0
M  V30 4 Br 10.0100 4.0011 0.0 0
M  V30 5 F 3.0800 0.0000 0.0 0
M  V30 6 C 1.5400 2.6673 0.0 0
M  V30 7 F 1.5400 4.2073 0.0 0
M  V30 8 F 0.0000 2.6673 0.0 0
M  V30 9 F 1.5400 1.1273 0.0 0
M  V30 10 C 6.1600 2.6673 0.0 0
M  V30 11 C 5.3900 1.3336 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 3.8500 1.3336 0.0 0
M  V30 14 C 3.8500 4.0011 0.0 0
M  V30 15 C 3.0800 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 13
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αR)-3-Fluoro-α-[(methylamino)methyl]-4-(trifluoromethyl)benzenemethanol
C10H11F4NO
1395079-37-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 2.6674 0.0 0 CFG=1
M  V30 2 C 8.4700 4.0011 0.0 0
M  V30 3 O 8.4700 1.3338 0.0 0
M  V30 4 N 10.0100 4.0011 0.0 0
M  V30 5 C 10.7800 5.3349 0.0 0
M  V30 6 F 3.0800 0.0000 0.0 0
M  V30 7 C 1.5400 2.6674 0.0 0
M  V30 8 F 1.5400 1.1274 0.0 0
M  V30 9 F 0.0000 2.6674 0.0 0
M  V30 10 F 1.5400 4.2074 0.0 0
M  V30 11 C 6.1600 2.6674 0.0 0
M  V30 12 C 5.3900 1.3338 0.0 0
M  V30 13 C 5.3900 4.0011 0.0 0
M  V30 14 C 3.8500 1.3338 0.0 0
M  V30 15 C 3.8500 4.0011 0.0 0
M  V30 16 C 3.0800 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1395079-36-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1395079-37-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-890161
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM [00626]step 2: To a solution of 258 (1.0 g, 3.5 mmol) and THF (20 mL) at
RT was added methylamine (2.7 g, 35 mmol, 40% in water) and the reaction
was sealed and stirred for 24 h at RT. The reaction was then concentrated
to afford 0.83 g (100%) of
(R)-1-(3-fluoro-4-(trifluoromethyl)phenyl)-2-(methylamino)ethanol (260)
which was used without further purification. 0.83 g (100%).
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed vessel
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyridopyrimidine derivatives as ERK inhibitors and their preparation and
use for the treatment of hyperproliferative diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Blake, James F.; Chen, Huifen; Chicarelli, Mark Joseph; Demeese, Jason;
Garrey, Rustam; Gaudino, John J.; Kaus, Robert J.; Kolakowski, Gabrielle
R.; Marlow, Allison L.; Mohr, Peter J.; Ren, Li; Schwarz, Jacob; Siedem,
Christopher S.; Thomas, Allen A.; Wallace, Eli; Wenglowsky, Steven Mark
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012118850 A1 2012-09-07

$RFMT $RIREG SCHEME137 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Butyl acrylate
C7H12O2
141-32-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 4.0012 2.3101 0.0 0
M  V30 3 C 1.3337 2.3101 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 6.6685 2.3101 0.0 0
M  V30 8 C 8.0023 1.5400 0.0 0
M  V30 9 C 9.3360 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Butoxy-3-oxopropyl)-N-methyl-β-alanine butyl ester
C15H29NO4
1123109-52-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.6697 1.5400 0.0 0
M  V30 2 C 12.0033 2.3101 0.0 0
M  V30 3 C 9.3360 2.3101 0.0 0
M  V30 4 C 10.6697 0.0000 0.0 0
M  V30 5 C 13.3370 1.5400 0.0 0
M  V30 6 C 8.0022 1.5400 0.0 0
M  V30 7 C 14.6708 2.3101 0.0 0
M  V30 8 C 6.6685 2.3101 0.0 0
M  V30 9 O 16.0045 1.5400 0.0 0
M  V30 10 O 14.6708 3.8501 0.0 0
M  V30 11 O 5.3348 1.5400 0.0 0
M  V30 12 O 6.6685 3.8501 0.0 0
M  V30 13 C 17.3382 2.3101 0.0 0
M  V30 14 C 4.0012 2.3101 0.0 0
M  V30 15 C 18.6720 1.5400 0.0 0
M  V30 16 C 2.6673 1.5400 0.0 0
M  V30 17 C 20.0057 2.3101 0.0 0
M  V30 18 C 1.3337 2.3101 0.0 0
M  V30 19 C 21.3393 1.5400 0.0 0
M  V30 20 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 11 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 141-32-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1123109-52-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41650214
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Renewable oleyl based surfactants for application in liquid explosive
high internal phase emulsions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Robson, Ryan N.; Moore, Jackson E.; Pearson, Graeme R.; Tabor, Rico F.;
Tuck, Kellie L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Engineering Science (2024), 300120651

$RFMT $RIREG SCHEME138 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Chloromethyl)-2-methyloxazole
C5H6ClNO
141399-53-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 2.6218 0.0 0
M  V30 2 Cl 6.6363 1.8517 0.0 0
M  V30 3 C 0.0000 1.4946 0.0 0
M  V30 4 C 3.9690 1.8517 0.0 0
M  V30 5 N 2.5620 2.4782 0.0 0
M  V30 6 C 3.8079 0.3202 0.0 0
M  V30 7 C 1.5316 1.3337 0.0 0
M  V30 8 O 2.3016 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,2-Dimethyl-4-oxazolemethanamine
C6H10N2O
1065073-46-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 2.6218 0.0 0
M  V30 2 N 6.6363 1.8517 0.0 0
M  V30 3 C 7.9700 2.6218 0.0 0
M  V30 4 C 0.0000 1.4946 0.0 0
M  V30 5 C 3.9690 1.8517 0.0 0
M  V30 6 N 2.5620 2.4782 0.0 0
M  V30 7 C 3.8079 0.3202 0.0 0
M  V30 8 C 1.5316 1.3337 0.0 0
M  V30 9 O 2.3016 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 141399-53-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1065073-46-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-11643168
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM [0276] To an aq. solution of MeNH2 (25 mL, 40% in water) was added neat
1.6.2 and stirred for 2h. Excess MeNH2 was removed on rota-vapour,
extracted with chloroform, dried and concentrated to give
N-methyl-1-(2-methyloxazol-4-yl)methanamine. Quantitative yield.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Oxadiazole compounds which inhibit beta-secretase activity, their
synthesis, and therapeutic use for treating Alzheimer's disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bilcer, Geoffrey M.; Devasamudram, Thippeswamy; Lilly, John C.; Ankala,
Sudha V.; Moskalev, Nikolai V.; Liu, Chunfeng; Inoue, Makoto; Kawakami,
Shinpei; Munakata, Ryosuke; Hamajima, Toshihiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012054510 A1 2012-04-26

$RFMT $RIREG SCHEME139 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-[4-(6-chloro-4-pyrimidinyl)-2-thiazolyl]-N-methylbenzamide
C15H10BrClN4OS
1414953-57-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2154 4.1120 0.0 0
M  V30 2 C 9.9854 5.4456 0.0 0
M  V30 3 C 9.9854 2.7783 0.0 0
M  V30 4 O 9.2154 6.7794 0.0 0
M  V30 5 Cl 0.0000 2.7843 0.0 0
M  V30 6 Br 16.1454 5.4456 0.0 0
M  V30 7 C 5.3055 3.3420 0.0 0
M  V30 8 N 6.7701 2.8661 0.0 0
M  V30 9 C 5.3055 4.8820 0.0 0
M  V30 10 C 7.6754 4.1120 0.0 0
M  V30 11 S 6.7701 5.3578 0.0 0
M  V30 12 C 4.0596 2.4367 0.0 0
M  V30 13 C 2.6528 3.0632 0.0 0
M  V30 14 N 4.2207 0.9052 0.0 0
M  V30 15 C 1.4069 2.1580 0.0 0
M  V30 16 C 2.9747 0.0000 0.0 0
M  V30 17 N 1.5679 0.6265 0.0 0
M  V30 18 C 11.5254 5.4456 0.0 0
M  V30 19 C 12.2954 4.1120 0.0 0
M  V30 20 C 12.2954 6.7794 0.0 0
M  V30 21 C 13.8354 4.1120 0.0 0
M  V30 22 C 13.8354 6.7794 0.0 0
M  V30 23 C 14.6054 5.4456 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 2 2 4
M  V30 5 1 2 18
M  V30 6 1 5 15
M  V30 7 1 6 23
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 12
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 10 11
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methyl-N-[4-[6-(methylamino)-4-pyrimidinyl]-2-thiazolyl]benzamide
C16H14BrN5OS
1482497-86-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 4.1120 0.0 0
M  V30 2 C 6.1600 5.4456 0.0 0
M  V30 3 C 6.1600 2.7783 0.0 0
M  V30 4 O 6.9300 6.7794 0.0 0
M  V30 5 N 16.1454 2.7843 0.0 0
M  V30 6 C 17.3913 1.8791 0.0 0
M  V30 7 Br 0.0000 5.4456 0.0 0
M  V30 8 C 10.8398 3.3420 0.0 0
M  V30 9 N 9.3752 2.8661 0.0 0
M  V30 10 C 10.8399 4.8820 0.0 0
M  V30 11 C 8.4700 4.1120 0.0 0
M  V30 12 S 9.3752 5.3578 0.0 0
M  V30 13 C 12.0858 2.4367 0.0 0
M  V30 14 C 13.4926 3.0632 0.0 0
M  V30 15 N 11.9247 0.9052 0.0 0
M  V30 16 C 14.7385 2.1580 0.0 0
M  V30 17 C 13.1707 0.0000 0.0 0
M  V30 18 N 14.5775 0.6265 0.0 0
M  V30 19 C 4.6200 5.4456 0.0 0
M  V30 20 C 3.8500 6.7794 0.0 0
M  V30 21 C 3.8500 4.1120 0.0 0
M  V30 22 C 2.3100 6.7794 0.0 0
M  V30 23 C 2.3100 4.1120 0.0 0
M  V30 24 C 1.5400 5.4456 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 2 2 4
M  V30 5 1 2 19
M  V30 6 1 5 6
M  V30 7 1 5 16
M  V30 8 1 7 24
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 13
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 1 11 12
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1414953-57-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1482497-86-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3876937
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-Bromo-N-methyl-N-(4-(6-(methylamino)pyrimidin-4-yl)thiazol-2-yl)benzamide
(12). A mixture of 10 29 (40 mg, 98 μmol), K2CO3 (27 mg, 197 μmol), and
MeNH2 solution in ethanol (33%; 0.35 mL) in 1,4-dioxane (3 mL) was
stirred at 80 °C for 5 h. The mixture was then cooled to room
temperature, quenched with water, and extracted three times with EtOAc.
The organic layers were dried over MgSO4, and solvent was removed under
reduced pressure. Silica gel chromatography (CH2Cl2/MeOH, 15:1 v/v) of
the residue gave 12 as a white solid (40 mg, 100%). mp 218-220 °C. 1H NMR
((CD3)2SO): δ 2.85 (3H, d, J = 4.8 Hz), 3.62 (3H, s), 7.12 (1H, bs), 7.54
(1H, bs), 7.64-7.67 (1H, m), 7.75-7.78 (2H, m), 7.99 (1H, s), 8.45 (1H,
s). 13C NMR ((CD3)2SO): δ 38.00, 115.62, 124.38, 129.73, 131.56, 133.53,
147.41, 159.71, 169.10. LC-MS: m/z [M + H]+ 404.2. HRMS calcd for
C16H15N5OSBr (M+ + H), 404.0181; found, 404.0185.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Evaluation in Monkey of
[18F]4-Fluoro-N-methyl-N-(4-(6-(methylamino)pyrimidin-4-yl)thiazol-2-yl)benzamide
([18F]FIMX): A Promising Radioligand for PET Imaging of Brain
Metabotropic Glutamate Receptor 1 (mGluR1)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xu, Rong; Zanotti-Fregonara, Paolo; Zoghbi, Sami S.; Gladding, Robert L.;
Woock, Alicia E.; Innis, Robert B.; Pike, Victor W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2013), 56(22), 9146-9155

$RFMT $RIREG SCHEME140 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4(3H)-Quinazolinone, 8-bromo-5-methoxy-2-(3-pyridinyl)-
C14H10BrN3O2
1417301-15-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.5400 5.3348 0.0 0
M  V30 2 C 0.0000 5.3348 0.0 0
M  V30 3 O 3.8501 6.6687 0.0 0
M  V30 4 Br 4.6201 0.0000 0.0 0
M  V30 5 C 3.8501 4.0012 0.0 0
M  V30 6 C 4.6201 2.6675 0.0 0
M  V30 7 C 2.3101 4.0012 0.0 0
M  V30 8 C 4.6201 5.3348 0.0 0
M  V30 9 N 6.1601 2.6675 0.0 0
M  V30 10 C 3.8501 1.3338 0.0 0
M  V30 11 C 1.5400 2.6675 0.0 0
M  V30 12 N 6.1601 5.3348 0.0 0
M  V30 13 C 6.9302 4.0012 0.0 0
M  V30 14 C 2.3101 1.3338 0.0 0
M  V30 15 C 8.4702 4.0012 0.0 0
M  V30 16 C 9.2402 2.6675 0.0 0
M  V30 17 C 9.2402 5.3348 0.0 0
M  V30 18 C 10.7802 2.6675 0.0 0
M  V30 19 N 10.7802 5.3348 0.0 0
M  V30 20 C 11.5503 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 8
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 14
M  V30 15 2 12 13
M  V30 16 1 13 15
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Quinazolinamine, 8-bromo-5-methoxy-N-methyl-2-(3-pyridinyl)-
C15H13BrN4O
1417301-16-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.8501 1.3337 0.0 0
M  V30 2 C 4.6201 0.0000 0.0 0
M  V30 3 O 1.5400 2.6675 0.0 0
M  V30 4 C 0.0000 2.6675 0.0 0
M  V30 5 Br 4.6201 8.0023 0.0 0
M  V30 6 C 3.8501 4.0012 0.0 0
M  V30 7 C 4.6201 5.3348 0.0 0
M  V30 8 C 4.6201 2.6675 0.0 0
M  V30 9 C 2.3101 4.0012 0.0 0
M  V30 10 N 6.1601 5.3348 0.0 0
M  V30 11 C 3.8501 6.6687 0.0 0
M  V30 12 N 6.1601 2.6675 0.0 0
M  V30 13 C 1.5400 5.3348 0.0 0
M  V30 14 C 6.9302 4.0012 0.0 0
M  V30 15 C 2.3101 6.6687 0.0 0
M  V30 16 C 8.4702 4.0012 0.0 0
M  V30 17 C 9.2402 5.3348 0.0 0
M  V30 18 C 9.2402 2.6675 0.0 0
M  V30 19 C 10.7802 5.3348 0.0 0
M  V30 20 N 10.7802 2.6675 0.0 0
M  V30 21 C 11.5503 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1417301-15-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1417301-16-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-12690017
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 6674-22-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56602-33-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 6-Bromo-5-methoxy-1H-benzo[d][1,3]oxazine-2,4-dione (xxiv-b). In a 100 mL
pear shaped flask was added 5-methoxy-1H-benzo[d][1,3]oxazine-2,4-dione
(1.180 g, 6.11 mmol) in CH2Cl2 (10 ml) and DMF (5.00 ml) to give a yellow
solution. N-Bromosuccinimide (1.522 g, 8.55 mmol) was added slowly at 0
°C. The mixture was stirred overnight at room temperature. The reaction
mixture was diluted with water (30 mL) and CH2Cl2 was evaporated in
vacuo. The resultant precipitate was collected by filtration and dried.
The precipitate was purified via ISCO (silica gel, 1:0 to 9:1
CH2Cl2/MeOH; 40 gm column). 0.72 g of a light yellow solid in a 43%
yield. 1H NMR (300 MHz, DMSO) δ 11.79 (s, 1H), 7.93 (d, J=8.8 Hz, 1H),
6.86 (d, J=8.8 Hz, 1H), 3.80 (s, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quinazolines as STEP inhibitors and their preparation and use in the
treatment of central nervous system agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Suzuki, Masaki; Kondo, Kazumi; Kurimura, Muneaki; Valluru, Krishna Reddy;
Takahashi, Akira; Kuroda, Takeshi; Takahashi, Haruka; Fukushima, Tae;
Miyamura, Shin; Ghosh, Indranath; Dogra, Abhishek; Harriman, Geraldine;
Elder, Amy; Shimizu, Satoshi; Hodgetts, Kevin J.; Newcom, Jason S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013003586 A1 2013-01-03

$RFMT $RIREG SCHEME141 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl acetoacetate
C6H10O3
141-97-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 O 5.3348 2.3100 0.0 0
M  V30 5 O 4.0011 0.0000 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 6.6686 1.5400 0.0 0
M  V30 9 C 8.0022 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (2Z)-3-(methylamino)-2-butenoate
C7H13NO2
21759-70-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8501 1.3337 0.0 0
M  V30 2 C 4.6201 2.6673 0.0 0
M  V30 3 C 2.3101 1.3337 0.0 0
M  V30 4 O 6.1601 2.6673 0.0 0
M  V30 5 O 3.8501 4.0010 0.0 0
M  V30 6 N 1.5400 2.6673 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 C 6.9302 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 10 C 8.4702 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 141-97-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 21759-70-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24812552
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nenitzescu Synthesis of 5-Hydroxyindoles with Zinc, Iron and Magnesium
Salts in Cyclopentyl Methyl Ether
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Satta, Giuseppe; Usala, Elena; Solinas, Angelo; Romer, Melina; Livesi,
Marco; Pira, Giovanni Michele; Beccu, Andrea; Carboni, Silvia; Gaspa,
Silvia; De Luca, Lidia; Pisano, Luisa; Azzena, Ugo; Carraro, Massimo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2021), 2021(42), 5835-5842

$RFMT $RIREG SCHEME142 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl acetoacetate
C6H10O3
141-97-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 O 5.3348 2.3100 0.0 0
M  V30 5 O 4.0011 0.0000 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 6.6686 1.5400 0.0 0
M  V30 9 C 8.0022 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Butenoic acid, 3-(methylamino)-, ethyl ester
C7H13NO2
870-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 2.6675 1.5400 0.0 0
M  V30 4 O 6.6685 2.3101 0.0 0
M  V30 5 O 5.3348 0.0000 0.0 0
M  V30 6 N 1.3337 2.3101 0.0 0
M  V30 7 C 2.6675 0.0000 0.0 0
M  V30 8 C 8.0023 1.5400 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 10 C 9.3360 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 141-97-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 870-85-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-2228569
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM exothermic
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Continuous flow synthesis of β-amino α, β-unsaturated esters in aqueous
medium
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Joshi, Ramesh A.; Joshi, Rohini R.; Tibhe, Jagdish; Nivangune, Nayana T.;
Kulkarni, Amol A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Processing and Synthesis (2012), 1(2), 205-210

$RFMT $RIREG SCHEME143 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6,7-Dihydro-1-methylcyclohept[f]indol-5(1H)-one
C14H13NO
1426565-86-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.3825 2.5108 0.0 0
M  V30 2 O 0.6750 4.9223 0.0 0
M  V30 3 C 4.9617 4.5548 0.0 0
M  V30 4 C 5.7317 3.2210 0.0 0
M  V30 5 C 3.4217 4.5548 0.0 0
M  V30 6 C 5.9921 5.6992 0.0 0
M  V30 7 C 4.9617 1.8874 0.0 0
M  V30 8 N 7.2380 3.5414 0.0 0
M  V30 9 C 2.6517 3.2210 0.0 0
M  V30 10 C 7.3990 5.0729 0.0 0
M  V30 11 C 3.4217 1.8874 0.0 0
M  V30 12 C 1.1290 3.4507 0.0 0
M  V30 13 C 2.8592 0.4538 0.0 0
M  V30 14 C 0.0000 2.4032 0.0 0
M  V30 15 C 1.3875 0.0000 0.0 0
M  V30 16 C 0.1150 0.8675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 12
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 13 1 9 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(6,7-Dihydro-1-methylcyclohept[f]indol-5(1H)-ylidene)methanamine
C15H16N2
1426568-73-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.8805 3.9065 0.0 0
M  V30 2 C 9.3521 3.4527 0.0 0
M  V30 3 C 0.0000 5.6720 0.0 0
M  V30 4 C 5.3181 3.4217 0.0 0
M  V30 5 C 3.9844 2.6517 0.0 0
M  V30 6 C 5.3181 4.9617 0.0 0
M  V30 7 C 6.7517 2.8592 0.0 0
M  V30 8 C 2.6508 3.4217 0.0 0
M  V30 9 C 3.7550 1.1290 0.0 0
M  V30 10 C 3.9844 5.7317 0.0 0
M  V30 11 C 7.2057 1.3875 0.0 0
M  V30 12 C 2.6508 4.9617 0.0 0
M  V30 13 C 4.8023 0.0000 0.0 0
M  V30 14 C 3.6643 7.2382 0.0 0
M  V30 15 C 6.3380 0.1152 0.0 0
M  V30 16 N 1.5063 5.9921 0.0 0
M  V30 17 C 2.1327 7.3991 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 7 CFG=2
M  V30 3 1 3 16
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 15
M  V30 18 2 14 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1426565-86-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1426568-73-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-7943961
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7550-45-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1:
N-(1-methyl-6,7-dihydrocyclohepta[f]indol-5(1H)-ylidene)methanamine To a
solution of 1-methyl-6,7-dihydrocyclohepta[f]indol-5(1H)-one (Example 16,
step 7, 0.218 g, 1.03 mmol) in DCM (3 mL) was added MeNH2 solution (2M
THF, 2.00 mL, 4.00 mmol). The mixture was cooled to 0 °C, then a solution
of TICl4 (1M DCM, 0.70 mL, 0.70 mmol) was added dropwise via syringe pump
over 30 min. The reaction mixture was allowed to warm to room temperature
and stirred overnight. The mixture was diluted with DCM (10 mL) and then
the reaction was quenched with NaHCO3 (aqueous saturated 5 mL). After
vigorous shaking, the organic phase was separated using a PTFE phase
separator, and dried over Na2SO4. The solvent was removed and the
resulting crude product was obtained, which was used directly in the next
step without further purification. Yellow oil, yield (~0.23 g, quant).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of multi-ring heterocyclic compounds as antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Branstrom, Arthur; Josyula, Vara Prasad Venkata Nagendra; Arnold, Michael
Andrew; Gerasyuto, Aleksey I.; Karp, Gary; Wang, Jiashi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013033228 A1 2013-03-07

$RFMT $RIREG SCHEME144 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromobenz[d]indeno[1,2-b]pyran-5,11-dione
C16H7BrO3
1426998-09-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.3798 6.6519 0.0 0
M  V30 2 O 7.4000 0.0000 0.0 0
M  V30 3 Br 11.2501 4.0011 0.0 0
M  V30 4 C 5.0900 4.0011 0.0 0
M  V30 5 C 4.3200 2.6674 0.0 0
M  V30 6 C 6.6300 4.0011 0.0 0
M  V30 7 C 4.0596 5.1455 0.0 0
M  V30 8 C 2.8137 2.9876 0.0 0
M  V30 9 O 5.0900 1.3336 0.0 0
M  V30 10 C 7.4000 2.6674 0.0 0
M  V30 11 C 7.4000 5.3347 0.0 0
M  V30 12 C 2.6527 4.5192 0.0 0
M  V30 13 C 1.5679 2.0824 0.0 0
M  V30 14 C 6.6300 1.3336 0.0 0
M  V30 15 C 8.9401 2.6674 0.0 0
M  V30 16 C 8.9401 5.3347 0.0 0
M  V30 17 C 1.2459 5.1455 0.0 0
M  V30 18 C 0.1609 2.7087 0.0 0
M  V30 19 C 9.7101 4.0011 0.0 0
M  V30 20 C 0.0000 4.2404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 14
M  V30 3 1 3 19
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 1 8 12
M  V30 13 2 8 13
M  V30 14 1 9 14
M  V30 15 1 10 14
M  V30 16 2 10 15
M  V30 17 1 11 16
M  V30 18 2 12 17
M  V30 19 1 13 18
M  V30 20 1 15 19
M  V30 21 2 16 19
M  V30 22 1 17 20
M  V30 23 2 18 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-6-methyl-5H-indeno[1,2-c]isoquinoline-5,11(6H)-dione
C17H10BrNO2
1352058-80-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.3798 6.6519 0.0 0
M  V30 2 C 4.3200 0.0000 0.0 0
M  V30 3 O 7.4001 0.0000 0.0 0
M  V30 4 Br 11.2501 4.0011 0.0 0
M  V30 5 C 5.0901 4.0011 0.0 0
M  V30 6 C 4.3200 2.6675 0.0 0
M  V30 7 C 6.6301 4.0011 0.0 0
M  V30 8 C 4.0596 5.1455 0.0 0
M  V30 9 C 2.8138 2.9876 0.0 0
M  V30 10 N 5.0901 1.3337 0.0 0
M  V30 11 C 7.4001 2.6675 0.0 0
M  V30 12 C 7.4001 5.3348 0.0 0
M  V30 13 C 2.6527 4.5192 0.0 0
M  V30 14 C 1.5679 2.0824 0.0 0
M  V30 15 C 6.6301 1.3337 0.0 0
M  V30 16 C 8.9401 2.6675 0.0 0
M  V30 17 C 8.9401 5.3348 0.0 0
M  V30 18 C 1.2459 5.1455 0.0 0
M  V30 19 C 0.1609 2.7087 0.0 0
M  V30 20 C 9.7101 4.0011 0.0 0
M  V30 21 C 0.0000 4.2404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 10
M  V30 3 2 3 15
M  V30 4 1 4 20
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 1 9 13
M  V30 14 2 9 14
M  V30 15 1 10 15
M  V30 16 1 11 15
M  V30 17 2 11 16
M  V30 18 1 12 17
M  V30 19 2 13 18
M  V30 20 1 14 19
M  V30 21 1 16 20
M  V30 22 2 17 20
M  V30 23 1 18 21
M  V30 24 2 19 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1426998-09-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1352058-80-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10034276
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Method 2. 3-Bromoindeno[1,2-c]isochromene-5,11-dione (84, 653 mg, 2 mmol)
was dissolved in tetrahydrofuran (10 mL). A solution of methylamine (28,
0.5 mL, 33% in ethanol) in chloroform (5 mL) was added, and the reaction
mixture was stirred at room temperature for 6 h and then heated at reflux
for 1 h. The solvent was removed under vacuum. Yield (380 mg, 100%). red
solid. HPLC purity: 95.10% (C18 reversed phase, MeOH-H2O, 90:10); 95.72%
(C18 reversed phase, MeOH, 100). mp 265-267 °C. IR (film) 3066, 2917,
1693, 1657, 1603, 1571, 1539, 1498, 1453, 1432, 1381, 1312, 1196, 1082,
882, 845, 833, 719, 691 cm-1; 1H NMR (500 MHz, CDCl3) δ 8.54 (d, J = 8.6
Hz, 1 H), 8.47 (d, J = 2.0 Hz, 1 H), 7.78 (dd, J = 8.6 Hz, J = 2.1 Hz, 1
H), 7.65 (d, J = 6.7 Hz, 1 H), 7.63 (d, J = 7.0 Hz, 1 H), 7.43 (m, 2 H),
4.05 (s, 3 H); 13C NMR (125 MHz, CDCl3) δ 190.0, 162.2, 156.1, 137.4,
136.9, 134.9, 133.1, 131.2, 131.0, 130.7, 128.5, 125.1, 124.6, 123.4,
122.9, 120.8, 107.8, 33.1; EIMS m/z (rel intensity) 339, (M+, 100);
HREIMS m/z calcd for C17H10NO2Br 338.9895 (M+), found 338.9892 (M+).
$DTYPE RXN:VAR(1):NOTES
$DATUM modified literature procedure, alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Biological Evaluation of Indenoisoquinoline
Rexinoids with Chemopreventive Potential
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Conda-Sheridan, Martin; Park, Eun-Jung; Beck, Daniel E.; Reddy, P. V.
Narasimha; Nguyen, Trung X.; Hu, Bingjie; Chen, Lian; White, Jerry J.;
van Breemen, Richard B.; Pezzuto, John M.; Cushman, Mark
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2013), 56(6), 2581-2605

$RFMT $RIREG SCHEME145 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2S,3S,4S)-4-(hydroxymethyl)-3-(phenylmethoxy)-1-(phenylmethyl)-2-azet...
C20H23NO4
1432612-84-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7089 2.3100 0.0 0
M  V30 2 O 4.3753 1.5400 0.0 0
M  V30 3 O 7.0426 1.5400 0.0 0
M  V30 4 C 4.3753 0.0000 0.0 0
M  V30 5 C 3.0800 4.9389 0.0 0
M  V30 6 O 8.3379 4.9389 0.0 0
M  V30 7 C 9.1079 6.2726 0.0 0
M  V30 8 C 5.7089 7.5679 0.0 0
M  V30 9 O 7.0426 8.3379 0.0 0
M  V30 10 C 5.7089 3.8500 0.0 0 CFG=2
M  V30 11 N 4.6200 4.9389 0.0 0
M  V30 12 C 6.7979 4.9389 0.0 0 CFG=1
M  V30 13 C 5.7089 6.0279 0.0 0 CFG=1
M  V30 14 C 2.3100 6.2726 0.0 0
M  V30 15 C 0.7700 6.2726 0.0 0
M  V30 16 C 3.0800 7.6064 0.0 0
M  V30 17 C 0.0000 7.6064 0.0 0
M  V30 18 C 2.3100 8.9400 0.0 0
M  V30 19 C 0.7700 8.9400 0.0 0
M  V30 20 C 10.6479 6.2726 0.0 0
M  V30 21 C 11.4179 7.6064 0.0 0
M  V30 22 C 11.4179 4.9389 0.0 0
M  V30 23 C 12.9579 7.6064 0.0 0
M  V30 24 C 12.9579 4.9389 0.0 0
M  V30 25 C 13.7279 6.2726 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 10 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 1 12 6 CFG=3
M  V30 9 1 7 20
M  V30 10 1 8 9
M  V30 11 1 13 8 CFG=1
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 10 12 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2S,3S,4S)-4-(Hydroxymethyl)-N-methyl-3-(phenylmethoxy)-1-(phenylmethyl)-2-az...
C20H24N2O3
1432612-86-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7089 2.3100 0.0 0
M  V30 2 N 4.3753 1.5400 0.0 0
M  V30 3 O 7.0426 1.5400 0.0 0
M  V30 4 C 4.3753 0.0000 0.0 0
M  V30 5 C 3.0800 4.9389 0.0 0
M  V30 6 O 8.3379 4.9389 0.0 0
M  V30 7 C 9.1079 6.2726 0.0 0
M  V30 8 C 5.7089 7.5679 0.0 0
M  V30 9 O 7.0426 8.3379 0.0 0
M  V30 10 C 5.7089 3.8500 0.0 0 CFG=2
M  V30 11 N 4.6200 4.9389 0.0 0
M  V30 12 C 6.7979 4.9389 0.0 0 CFG=1
M  V30 13 C 5.7089 6.0279 0.0 0 CFG=1
M  V30 14 C 2.3100 6.2726 0.0 0
M  V30 15 C 3.0800 7.6064 0.0 0
M  V30 16 C 0.7700 6.2726 0.0 0
M  V30 17 C 2.3100 8.9400 0.0 0
M  V30 18 C 0.0000 7.6064 0.0 0
M  V30 19 C 0.7700 8.9400 0.0 0
M  V30 20 C 10.6479 6.2726 0.0 0
M  V30 21 C 11.4179 7.6064 0.0 0
M  V30 22 C 11.4179 4.9389 0.0 0
M  V30 23 C 12.9579 7.6064 0.0 0
M  V30 24 C 12.9579 4.9389 0.0 0
M  V30 25 C 13.7279 6.2726 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 10 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 1 12 6 CFG=3
M  V30 9 1 7 20
M  V30 10 1 8 9
M  V30 11 1 13 8 CFG=1
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 10 12 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1432612-84-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1432612-86-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3231454
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 10043-52-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-Hydroxyazetidine Carboxylic Acids: Non-Proteinogenic Amino Acids for
Medicinal Chemists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Glawar, Andreas F. G.; Jenkinson, Sarah F.; Thompson, Amber L.; Nakagawa,
Shinpei; Kato, Atsushi; Butters, Terry D.; Fleet, George W. J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2013), 8(4), 658-666

$RFMT $RIREG SCHEME146 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Furanacetaldehyde, 4-ethenyltetrahydro-5-oxo-, (3R-trans)-
C8H10O3
144461-11-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 1.8386 0.0 0
M  V30 2 C 6.6363 2.6087 0.0 0
M  V30 3 O 7.9700 1.8386 0.0 0
M  V30 4 C 2.2418 0.4759 0.0 0
M  V30 5 C 0.7771 0.0000 0.0 0
M  V30 6 O 0.0000 2.9658 0.0 0
M  V30 7 C 3.9690 2.6087 0.0 0 CFG=1
M  V30 8 C 2.5620 1.9823 0.0 0 CFG=1
M  V30 9 C 3.8079 4.1404 0.0 0
M  V30 10 C 1.5316 3.1267 0.0 0
M  V30 11 O 2.3016 4.4606 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 7 1 CFG=3
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 8 4 CFG=1
M  V30 6 2 6 10
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3R,4R)-3-Ethenyldihydro-4-[2-(methylimino)ethyl]-2(3H)-furanone
C9H13NO2
1192231-08-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 1.8386 0.0 0
M  V30 2 C 6.6363 2.6087 0.0 0
M  V30 3 N 7.9700 1.8386 0.0 0
M  V30 4 C 9.3037 2.6087 0.0 0
M  V30 5 C 2.2418 0.4759 0.0 0
M  V30 6 C 0.7771 0.0000 0.0 0
M  V30 7 O 0.0000 2.9658 0.0 0
M  V30 8 C 3.9688 2.6087 0.0 0 CFG=1
M  V30 9 C 2.5620 1.9823 0.0 0 CFG=1
M  V30 10 C 3.8079 4.1404 0.0 0
M  V30 11 C 1.5316 3.1267 0.0 0
M  V30 12 O 2.3016 4.4606 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 8 1 CFG=3
M  V30 3 2 2 3 CFG=2
M  V30 4 1 3 4
M  V30 5 2 5 6
M  V30 6 1 9 5 CFG=1
M  V30 7 2 7 11
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 8 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 144461-11-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1192231-08-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-3756896
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-71-4
$DTYPE RXN:VAR(1):NOTES
$DATUM molecular sieves used, products depend on reaction conditions (time)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A practical and scaleable total synthesis of the jaborandi alkaloid
(+)-pilocarpine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Davies, Stephen G.; Roberts, Paul M.; Stephenson, Peter T.; Storr, Helen
R.; Thomson, James E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2009), 65(39), 8283-8296

$RFMT $RIREG SCHEME147 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Furanacetaldehyde, 4-ethenyltetrahydro-5-oxo-, (3R-trans)-
C8H10O3
144461-11-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 1.8386 0.0 0
M  V30 2 C 6.6363 2.6087 0.0 0
M  V30 3 O 7.9700 1.8386 0.0 0
M  V30 4 C 2.2418 0.4759 0.0 0
M  V30 5 C 0.7771 0.0000 0.0 0
M  V30 6 O 0.0000 2.9658 0.0 0
M  V30 7 C 3.9690 2.6087 0.0 0 CFG=1
M  V30 8 C 2.5620 1.9823 0.0 0 CFG=1
M  V30 9 C 3.8079 4.1404 0.0 0
M  V30 10 C 1.5316 3.1267 0.0 0
M  V30 11 O 2.3016 4.4606 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 7 1 CFG=3
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 8 4 CFG=1
M  V30 6 2 6 10
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(4R)-3-Ethylidenedihydro-4-[2-(methylimino)ethyl]-2(3H)-furanone
C9H13NO2
1192231-16-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 1.8386 0.0 0
M  V30 2 C 6.6363 2.6087 0.0 0
M  V30 3 N 7.9700 1.8386 0.0 0
M  V30 4 C 9.3037 2.6087 0.0 0
M  V30 5 C 2.2418 0.4759 0.0 0
M  V30 6 C 0.7771 0.0000 0.0 0
M  V30 7 O 0.0000 2.9658 0.0 0
M  V30 8 C 3.9688 2.6087 0.0 0 CFG=1
M  V30 9 C 2.5620 1.9823 0.0 0
M  V30 10 C 3.8079 4.1404 0.0 0
M  V30 11 C 1.5316 3.1267 0.0 0
M  V30 12 O 2.3016 4.4606 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 8 1 CFG=3
M  V30 3 2 2 3 CFG=2
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 2 5 9 CFG=2
M  V30 7 2 7 11
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 144461-11-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1192231-16-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-117-CAS-5892733
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-71-4
$DTYPE RXN:VAR(1):NOTES
$DATUM molecular sieves used, products depend on reaction conditions (time)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A practical and scaleable total synthesis of the jaborandi alkaloid
(+)-pilocarpine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Davies, Stephen G.; Roberts, Paul M.; Stephenson, Peter T.; Storr, Helen
R.; Thomson, James E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2009), 65(39), 8283-8296

$RFMT $RIREG SCHEME148 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2E,3Z)-5-[[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxy]-2-(methoxyimino)-3...
C17H18ClN3O4
1445331-24-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.4701 4.0011 0.0 0
M  V30 2 C 6.9301 4.0011 0.0 0
M  V30 3 C 6.1601 5.3348 0.0 0
M  V30 4 C 4.6201 5.3348 0.0 0
M  V30 5 C 3.8501 4.0011 0.0 0
M  V30 6 C 3.8501 6.6685 0.0 0
M  V30 7 C 4.6201 2.6675 0.0 0
M  V30 8 N 2.3100 4.0011 0.0 0
M  V30 9 O 3.8501 1.3337 0.0 0
M  V30 10 O 6.1601 2.6675 0.0 0
M  V30 11 O 1.5400 5.3348 0.0 0
M  V30 12 C 4.6201 0.0000 0.0 0
M  V30 13 C 0.0000 5.3348 0.0 0
M  V30 14 Cl 16.7194 9.5076 0.0 0
M  V30 15 N 11.0919 7.0022 0.0 0
M  V30 16 N 10.7717 5.4957 0.0 0
M  V30 17 C 9.7582 7.7722 0.0 0
M  V30 18 C 9.2401 5.3348 0.0 0
M  V30 19 C 8.6138 6.7418 0.0 0
M  V30 20 C 12.4988 7.6285 0.0 0
M  V30 21 C 12.6598 9.1601 0.0 0
M  V30 22 C 13.7447 6.7233 0.0 0
M  V30 23 C 14.0666 9.7865 0.0 0
M  V30 24 C 15.1515 7.3498 0.0 0
M  V30 25 C 15.3126 8.8813 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 1 14 25
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 20
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E,3Z)-5-[[1-(4-Chlorophenyl)-1H-pyrazol-3-yl]oxy]-2-(methoxyimino)-N,3-dime...
C17H19ClN4O3
1445331-27-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.4701 4.0011 0.0 0
M  V30 2 C 6.9301 4.0011 0.0 0
M  V30 3 C 6.1601 5.3348 0.0 0
M  V30 4 C 4.6201 5.3348 0.0 0
M  V30 5 C 3.8501 4.0011 0.0 0
M  V30 6 C 3.8501 6.6685 0.0 0
M  V30 7 C 4.6201 2.6675 0.0 0
M  V30 8 N 2.3100 4.0011 0.0 0
M  V30 9 N 3.8501 1.3337 0.0 0
M  V30 10 O 6.1601 2.6675 0.0 0
M  V30 11 O 1.5400 5.3348 0.0 0
M  V30 12 C 4.6201 0.0000 0.0 0
M  V30 13 C 0.0000 5.3348 0.0 0
M  V30 14 Cl 16.7194 9.5076 0.0 0
M  V30 15 N 11.0919 7.0022 0.0 0
M  V30 16 N 10.7717 5.4957 0.0 0
M  V30 17 C 9.7582 7.7722 0.0 0
M  V30 18 C 9.2401 5.3348 0.0 0
M  V30 19 C 8.6138 6.7418 0.0 0
M  V30 20 C 12.4988 7.6285 0.0 0
M  V30 21 C 13.7447 6.7233 0.0 0
M  V30 22 C 12.6598 9.1601 0.0 0
M  V30 23 C 15.1515 7.3498 0.0 0
M  V30 24 C 14.0666 9.7865 0.0 0
M  V30 25 C 15.3126 8.8813 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 1 14 25
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 20
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1445331-24-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1445331-27-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10902331
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Ex. 1d: (Z)-5-[1-(4-Chloro-phenyl)-1
H-pyrazo3-yloxy]-2-[(E)-methoxyimino]-3-methypent-3-enic acid methyl
amide (I-6). 120 mg (0.33 mmol) (Z)-5-[1-(4-chloro-phenyl)-1
H-pyrazo3-yloxy]-2-[(E)-methoxy- imino]-3-methypent-3-enic acid methyl
ester and 0.99 ml (1.98 mmol) of a 2-molar solution of methyl amine in
THF have been stirred overnight at ambient temperature in 2.0 ml of THF
and 0.5 ml of water. After removal of the solvent in vacuo the product
(120 mg) was collected in quantitative yield and good purity.
Quantitative yield Melting point 129-130°C.
$DTYPE RXN:VAR(1):NOTES
$DATUM analogs prepared similarly
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Use of strobilurin type compounds for combating phytopathogenic fungi
resistant to Qo inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rheinheimer, Joachim; Terteryan, Violeta; Redlich, Stefan; Kremzow,
Doris; Rosenbaum, Claudia; Rohrer, Sebastian Georgios; Grammenos,
Wassilios; Pilger, Christian; Roehl, Franz; Gewehr, Markus; Stammler,
Gerd; Montag, Jurith; Sauter, Hubert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013092224 A1 2013-06-27

$RFMT $RIREG SCHEME149 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Morpholinyl)-4-(trifluoromethyl)benzaldehyde
C12H12F3NO2
1446818-58-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 2.6675 0.0000 0.0 0
M  V30 3 C 8.0023 4.6201 0.0 0
M  V30 4 F 7.2323 5.9538 0.0 0
M  V30 5 F 9.3360 5.3901 0.0 0
M  V30 6 F 8.7723 3.2864 0.0 0
M  V30 7 C 4.0012 3.8501 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 5.3348 4.6201 0.0 0
M  V30 10 C 5.3348 1.5400 0.0 0
M  V30 11 C 6.6685 3.8501 0.0 0
M  V30 12 C 6.6685 2.3101 0.0 0
M  V30 13 N 2.6675 4.6201 0.0 0
M  V30 14 C 2.6675 6.1601 0.0 0
M  V30 15 C 1.3337 3.8501 0.0 0
M  V30 16 C 1.3337 6.9302 0.0 0
M  V30 17 C 0.0000 4.6201 0.0 0
M  V30 18 O 0.0000 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenemethanamine, N-methyl-2-(4-morpholinyl)-4-(trifluoromethyl)-
C13H17F3N2O
3040200-80-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 5.3349 0.0 0
M  V30 2 N 1.5400 6.6685 0.0 0
M  V30 3 C 0.0000 6.6685 0.0 0
M  V30 4 C 8.4700 5.3349 0.0 0
M  V30 5 F 8.4700 6.8749 0.0 0
M  V30 6 F 10.0100 5.3349 0.0 0
M  V30 7 F 8.4700 3.7949 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 3.8500 5.3349 0.0 0
M  V30 10 C 6.1600 4.0011 0.0 0
M  V30 11 C 4.6200 6.6685 0.0 0
M  V30 12 C 6.9300 5.3349 0.0 0
M  V30 13 C 6.1600 6.6685 0.0 0
M  V30 14 N 3.8500 2.6674 0.0 0
M  V30 15 C 2.3100 2.6674 0.0 0
M  V30 16 C 4.6200 1.3338 0.0 0
M  V30 17 C 1.5400 1.3338 0.0 0
M  V30 18 C 3.8500 0.0000 0.0 0
M  V30 19 O 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1446818-58-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3040200-80-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40490477
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective Defluorination of Trifluoromethyl Substituents by
Conformationally Induced Remote Substitution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jesani, Mehul H.; Schwarz, Maria; Kim, Shiwhu; Evans, Finlay L.; White,
Alexander; Browning, Alex; Abrams, Roman; Clayden, Jonathan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2024), 63(24), e202403477

$RFMT $RIREG SCHEME150 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chloropyrazine
C4H3ClN2
14508-49-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 N 0.7700 0.0000 0.0 0
M  V30 5 N 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 2 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-pyrazinamine
C5H7N3
32111-28-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 N 2.3101 0.0000 0.0 0
M  V30 6 N 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 14508-49-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 32111-28-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4272861
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 25 General Procedure 2: Preparation of Aminopyrazine 4 from
Chloropyrazine 3 [0056] A mixture of chloropyrazine 3 (5.0 mmol) and
HNR1R2 (10.0 mmol) was heated at 100°C. in a sealed tube for 15 h. The
reaction mixture was cooled to room temperature, diluted with methylene
chloride (50 mL), washed with saturated sodium bicarbonate solution (10
mL), dried over sodium sulfate and concentrated to provide the product 4,
which could be purified by column chromatography, but was usually used in
the next step without purification.
N-Methyl-3-(4-methyl-1,4-diazepan-1-yl)-5-(pyridin-4-yl)pyrazin-2-amine
hydrochloride [0156] Step A: N-Methylpyrazin-2-amine Prepared from
2-chloropyrazine and diethanolamine according to general procedure 2
providing the aminopyrazine (700 mg, quant.) as an oil;. 1H NMR (300 MHz,
CDCl3) δ 7.80-7.99 (dd, J=2.7, 1.5 Hz, 1H), 7.90-7.89 (d, J=1.5 Hz, 1H),
7.79-7.80 (d, J=2.8 Hz, 1H), 4.78 (br s, 1H), 2.80-2.79 (d, J=4.9 Hz,
3H).
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of aminopyrazines for treating glaucoma and other rho
kinase-mediated diseases and conditions.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hellberg, Mark R.; Rusinko, Andrew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142307 A1 2006-06-29

$RFMT $RIREG SCHEME151 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-chloronicotinate
C8H8ClNO2
1452-94-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 O 5.3347 2.3100 0.0 0
M  V30 3 O 4.0011 4.6200 0.0 0
M  V30 4 C 6.6685 3.0800 0.0 0
M  V30 5 C 8.0021 2.3100 0.0 0
M  V30 6 Cl 1.3336 4.6200 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 1.3336 3.0800 0.0 0
M  V30 9 C 2.6674 0.7700 0.0 0
M  V30 10 N 0.0000 2.3100 0.0 0
M  V30 11 C 1.3336 0.0000 0.0 0
M  V30 12 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 8
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Pyridinecarboxylic acid, 2-(methylamino)-, ethyl ester
C9H12N2O2
103976-61-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 O 6.1600 4.0011 0.0 0
M  V30 3 O 3.8500 5.3349 0.0 0
M  V30 4 C 6.9300 5.3349 0.0 0
M  V30 5 C 8.4700 5.3349 0.0 0
M  V30 6 N 1.5400 4.0011 0.0 0
M  V30 7 C 0.0000 4.0011 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 N 1.5400 1.3338 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 13 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 9
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1452-94-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 103976-61-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-22259768
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of 1,8-naphthyridin-2-one derivative as a potent and selective
sphingomyelin synthase 2 inhibitor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yukawa, Takafumi; Nakahata, Takashi; Okamoto, Rei; Ishichi, Yuji;
Miyamoto, Yasufumi; Nishimura, Satoshi; Oikawa, Tatsuo; Kubo, Kazuki;
Adachi, Ryutaro; Satomi, Yoshinori; Nakakariya, Masanori; Amano,
Nobuyuki; Kamaura, Masahiro; Matsunaga, Nobuyuki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2020), 28(7), 115376

$RFMT $RIREG SCHEME152 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenemethanol, α-2-propen-1-yl-3,5-bis(trifluoromethyl)-, 1-methanesulfonate
C13H12F6O3S
1453069-73-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 6.1601 0.0 0
M  V30 2 O 8.0023 5.3901 0.0 0
M  V30 3 C 6.6685 7.7002 0.0 0
M  V30 4 S 9.3360 6.1601 0.0 0 VAL=6
M  V30 5 C 5.3348 8.4702 0.0 0
M  V30 6 C 10.1060 4.8265 0.0 0
M  V30 7 O 10.6697 6.9302 0.0 0
M  V30 8 O 8.5660 7.4938 0.0 0
M  V30 9 C 5.3348 10.0102 0.0 0
M  V30 10 C 4.0012 1.5400 0.0 0
M  V30 11 F 5.5412 1.5400 0.0 0
M  V30 12 F 4.0012 0.0000 0.0 0
M  V30 13 F 2.4611 1.5400 0.0 0
M  V30 14 C 1.3337 6.1601 0.0 0
M  V30 15 F 2.1037 7.4938 0.0 0
M  V30 16 F 0.0000 6.9302 0.0 0
M  V30 17 F 0.5637 4.8265 0.0 0
M  V30 18 C 5.3348 5.3901 0.0 0
M  V30 19 C 5.3348 3.8501 0.0 0
M  V30 20 C 4.0012 6.1601 0.0 0
M  V30 21 C 4.0012 3.0801 0.0 0
M  V30 22 C 2.6673 5.3901 0.0 0
M  V30 23 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 2 4 8
M  V30 9 2 5 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 21
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 14 22
M  V30 18 2 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 2 20 22
M  V30 22 2 21 23
M  V30 23 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-α-2-propen-1-yl-3,5-bis(trifluoromethyl)benzenemethanamine
C13H13F6N
1453069-74-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 6.1600 0.0 0
M  V30 2 C 8.0021 5.3900 0.0 0
M  V30 3 N 6.6684 7.7000 0.0 0
M  V30 4 C 9.3358 6.1600 0.0 0
M  V30 5 C 8.0021 8.4700 0.0 0
M  V30 6 C 10.6694 5.3900 0.0 0
M  V30 7 C 4.0011 1.5400 0.0 0
M  V30 8 F 2.4611 1.5400 0.0 0
M  V30 9 F 4.0011 0.0000 0.0 0
M  V30 10 F 5.5411 1.5400 0.0 0
M  V30 11 C 1.3336 6.1600 0.0 0
M  V30 12 F 0.5636 4.8264 0.0 0
M  V30 13 F 0.0000 6.9300 0.0 0
M  V30 14 F 2.1036 7.4936 0.0 0
M  V30 15 C 5.3347 5.3900 0.0 0
M  V30 16 C 5.3347 3.8500 0.0 0
M  V30 17 C 4.0011 6.1600 0.0 0
M  V30 18 C 4.0011 3.0800 0.0 0
M  V30 19 C 2.6673 5.3900 0.0 0
M  V30 20 C 2.6673 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 18
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 19
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1453069-73-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1453069-74-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-451928
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 1-(3,5-bis(trifluoromethyl)phenyN-methylbut-3-en-1-amine. To a solution
of Intermediate 62 (691 mg, 1.9 mmol) in THF (10 mL) was added MeNH2 (3
mL, 1 M in THF, 3 mmol) at 0 °C. The reaction mixture was stirred at room
temperature for 16 h and poured into water, and then extracted with
EtOAc. The organic layer was dried over anhydrous Na2SO4 and then
concentrated in high vacuum. The residue was purified by silica gel
chromatography (DCM/MeOH=10/1) to give the title compound. Yield 575 mg,
100 %. m/z (ES+): 298 [M + H]+ .
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of phenylmethylphenyloxooctahydropyrrolopiperazinecarboxamide
derivatives for use as neurokinin 1 receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Soerensen, Morten Dahl; Di Fabio, Romani; Pozzan, Alfonso; Catalani,
Maria Pia; Bladh, Haakon; Felding, Jakob
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013124286 A1 2013-08-29

$RFMT $RIREG SCHEME153 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-1-(bromomethyl)-4-(methylsulfonyl)benzene
C8H8Br2O2S
1454848-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 2.6673 0.0 0 VAL=6
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 O 1.5400 4.2073 0.0 0
M  V30 4 O 1.5400 1.1273 0.0 0
M  V30 5 Br 6.1600 0.0000 0.0 0
M  V30 6 C 7.7000 2.6673 0.0 0
M  V30 7 Br 8.4700 4.0011 0.0 0
M  V30 8 C 3.0800 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 5.3900 1.3336 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-4-(methylsulfonyl)benzenemethanamine
C9H12BrNO2S
1454848-17-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 2.6673 0.0 0 VAL=6
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 O 1.5400 4.2073 0.0 0
M  V30 4 O 1.5400 1.1273 0.0 0
M  V30 5 Br 6.1600 0.0000 0.0 0
M  V30 6 C 7.7000 2.6673 0.0 0
M  V30 7 N 8.4700 4.0011 0.0 0
M  V30 8 C 10.0100 4.0011 0.0 0
M  V30 9 C 3.0800 2.6673 0.0 0
M  V30 10 C 3.8500 1.3336 0.0 0
M  V30 11 C 3.8500 4.0011 0.0 0
M  V30 12 C 5.3900 1.3336 0.0 0
M  V30 13 C 5.3900 4.0011 0.0 0
M  V30 14 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 1 5 12
M  V30 6 1 6 7
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1454848-16-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1454848-17-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-10864879
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-Bromo-4-(bromomethyl)-1-(methylsulfonyl)benzene (4.3 g, 13 mmol) was
dissolved in methylamine solution (33% solution in EtOH, 100 mL), and
stirred at room temperature for 16 h. TLC (EtOAc) and LC-MS indicated
consumption of starting material, and the major peak for the product. The
mixture was evaporated.
1-[2-bromo-4-(methylsulfonyl)phenyl]-N-methylmethanamine (57). Yield:
(3.7 g, 100%), white solid. LC-MS (ESI), m/z 278/280 [M+H]+; 1H NMR (400
MHz, CD3OD) δ 8.16 (d, 1 H), 7.94 (dd, 1 H), 7.71 (d, 1 H), 3.97 (s, 2
H), 3.15 (s, 3 H), 2.49 (s, 3 H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of
(10R)-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile
(PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase
(ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and
Broad-Spectrum Potency against ALK-Resistant Mutations
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Johnson, Ted W.; Richardson, Paul F.; Bailey, Simon; Brooun, Alexei;
Burke, Benjamin J.; Collins, Michael R.; Cui, J. Jean; Deal, Judith G.;
Deng, Ya-Li; Dinh, Dac; Engstrom, Lars D.; He, Mingying; Hoffman, Jacqui;
Hoffman, Robert L.; Huang, Qinhua; Kania, Robert S.; Kath, John C.; Lam,
Hieu; Lam, Justine L.; Le, Phuong T.; Lingardo, Laura; Liu, Wei; McTigue,
Michele; Palmer, Cynthia L.; Sach, Neal W.; Smeal, Tod; Smith, Graham L.;
Stewart, Albert E.; Timofeevski, Sergei; Zhu, Huichun; Zhu, Jinjiang;
Zou, Helen Y.; Edwards, Martin P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2014), 57(11), 4720-4744

$RFMT $RIREG SCHEME153 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-1-(bromomethyl)-4-(methylsulfonyl)benzene
C8H8Br2O2S
1454848-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 2.6673 0.0 0 VAL=6
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 O 1.5400 4.2073 0.0 0
M  V30 4 O 1.5400 1.1273 0.0 0
M  V30 5 Br 6.1600 0.0000 0.0 0
M  V30 6 C 7.7000 2.6673 0.0 0
M  V30 7 Br 8.4700 4.0011 0.0 0
M  V30 8 C 3.0800 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 5.3900 1.3336 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-4-(methylsulfonyl)benzenemethanamine
C9H12BrNO2S
1454848-17-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 2.6673 0.0 0 VAL=6
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 O 1.5400 4.2073 0.0 0
M  V30 4 O 1.5400 1.1273 0.0 0
M  V30 5 Br 6.1600 0.0000 0.0 0
M  V30 6 C 7.7000 2.6673 0.0 0
M  V30 7 N 8.4700 4.0011 0.0 0
M  V30 8 C 10.0100 4.0011 0.0 0
M  V30 9 C 3.0800 2.6673 0.0 0
M  V30 10 C 3.8500 1.3336 0.0 0
M  V30 11 C 3.8500 4.0011 0.0 0
M  V30 12 C 5.3900 1.3336 0.0 0
M  V30 13 C 5.3900 4.0011 0.0 0
M  V30 14 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 1 5 12
M  V30 6 1 6 7
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1454848-16-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1454848-17-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-4684718
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 3: Compound 38 (4.3 g, 13 mmol) was dissolved in methylamine
solution (33% solution in ethanol, 100 mL), and stirred at RT for 16
hours. TLC (ethyl acetate) and LCMS indicated consumption of starting
material, and the major peak for the product. The mixture was evaporated.
Compound 39 as a white solid (3.7 g, quantitative yield). 1H NMR (400
MHz, methanol-d4) δ 2.49 (s, 3 H), 3.15 (s, 3 H), 3.97 (s, 2 H), 7.71 (d,
1 H), 7.94 (dd, 1 H), 8.16 (d, 1 H). LCMS m/z 278/280 [M+H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrocyclic derivatives for the treatment of proliferative diseases and
their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bailey, Simon; Burke, Benjamin Joseph; Collins, Michael Raymond; Cui,
Jingrong Jean; Deal, Judith Gail; Hoffman, Robert Louis; Huang, Qinhua;
Johnson, Ted William; Kania, Robert Steven; Kath, John Charles; Le,
Phuong Thi Quy; McTigue, Michele Ann; Palmer, Cynthia Louise; Richardson,
Paul Francis; Sach, Neal William
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013132376 A1 2013-09-12

$RFMT $RIREG SCHEME154 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanol, 2-[2-[2-(triphenylmethoxy)ethoxy]ethoxy]-, 1-methanesulfonate
C26H30O6S
146462-59-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.0012 0.0 0
M  V30 2 O 5.3348 3.2311 0.0 0
M  V30 3 C 6.6685 4.0012 0.0 0
M  V30 4 C 8.0023 3.2311 0.0 0
M  V30 5 O 9.3360 4.0012 0.0 0
M  V30 6 C 10.6697 3.2311 0.0 0
M  V30 7 C 12.0033 4.0012 0.0 0
M  V30 8 O 13.3372 3.2311 0.0 0
M  V30 9 C 14.6708 4.0012 0.0 0
M  V30 10 C 16.0045 3.2311 0.0 0
M  V30 11 O 17.3382 4.0012 0.0 0
M  V30 12 S 18.6720 3.2311 0.0 0 VAL=6
M  V30 13 C 19.4420 4.5648 0.0 0
M  V30 14 O 20.0057 2.4611 0.0 0
M  V30 15 O 17.9020 1.8975 0.0 0
M  V30 16 C 3.2311 2.6675 0.0 0
M  V30 17 C 1.6911 2.6675 0.0 0
M  V30 18 C 4.0012 1.3337 0.0 0
M  V30 19 C 0.9211 1.3337 0.0 0
M  V30 20 C 3.2311 0.0000 0.0 0
M  V30 21 C 1.6911 0.0000 0.0 0
M  V30 22 C 2.6675 4.7712 0.0 0
M  V30 23 C 1.3337 4.0012 0.0 0
M  V30 24 C 2.6675 6.3112 0.0 0
M  V30 25 C 0.0000 4.7712 0.0 0
M  V30 26 C 1.3337 7.0812 0.0 0
M  V30 27 C 0.0000 6.3112 0.0 0
M  V30 28 C 4.7712 5.3348 0.0 0
M  V30 29 C 6.3112 5.3348 0.0 0
M  V30 30 C 4.0012 6.6685 0.0 0
M  V30 31 C 7.0812 6.6685 0.0 0
M  V30 32 C 4.7712 8.0023 0.0 0
M  V30 33 C 6.3112 8.0023 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 1 22
M  V30 4 1 1 28
M  V30 5 1 2 3
M  V30 6 1 3 4
M  V30 7 1 4 5
M  V30 8 1 5 6
M  V30 9 1 6 7
M  V30 10 1 7 8
M  V30 11 1 8 9
M  V30 12 1 9 10
M  V30 13 1 10 11
M  V30 14 1 11 12
M  V30 15 1 12 13
M  V30 16 2 12 14
M  V30 17 2 12 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-[2-[2-(triphenylmethoxy)ethoxy]ethoxy]ethanamine
C26H31NO3
1449213-65-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.0012 0.0 0
M  V30 2 O 5.3348 3.2311 0.0 0
M  V30 3 C 6.6685 4.0012 0.0 0
M  V30 4 C 8.0023 3.2311 0.0 0
M  V30 5 O 9.3360 4.0012 0.0 0
M  V30 6 C 10.6697 3.2311 0.0 0
M  V30 7 C 12.0035 4.0012 0.0 0
M  V30 8 O 13.3372 3.2311 0.0 0
M  V30 9 C 14.6708 4.0012 0.0 0
M  V30 10 C 16.0045 3.2311 0.0 0
M  V30 11 N 17.3383 4.0012 0.0 0
M  V30 12 C 18.6720 3.2311 0.0 0
M  V30 13 C 3.2311 2.6675 0.0 0
M  V30 14 C 4.0012 1.3337 0.0 0
M  V30 15 C 1.6911 2.6675 0.0 0
M  V30 16 C 3.2311 0.0000 0.0 0
M  V30 17 C 0.9211 1.3337 0.0 0
M  V30 18 C 1.6911 0.0000 0.0 0
M  V30 19 C 2.6675 4.7712 0.0 0
M  V30 20 C 2.6675 6.3112 0.0 0
M  V30 21 C 1.3337 4.0012 0.0 0
M  V30 22 C 1.3337 7.0812 0.0 0
M  V30 23 C 0.0000 4.7712 0.0 0
M  V30 24 C 0.0000 6.3112 0.0 0
M  V30 25 C 4.7712 5.3348 0.0 0
M  V30 26 C 6.3112 5.3348 0.0 0
M  V30 27 C 4.0012 6.6687 0.0 0
M  V30 28 C 7.0812 6.6687 0.0 0
M  V30 29 C 4.7712 8.0023 0.0 0
M  V30 30 C 6.3112 8.0023 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 1 19
M  V30 4 1 1 25
M  V30 5 1 2 3
M  V30 6 1 3 4
M  V30 7 1 4 5
M  V30 8 1 5 6
M  V30 9 1 6 7
M  V30 10 1 7 8
M  V30 11 1 8 9
M  V30 12 1 9 10
M  V30 13 1 10 11
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 146462-59-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1449213-65-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-706986
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a solution of 54 (17 g, 36 mmol) in THF (20 mL) was added CH3NH2
aqueous solution slowly (30 %, 80 ml) at 60 °C. The mixture was stirred
at 60 °C for 4h. The mixture was concentrated to provide 55. Yield 14.5
g,99.8%. 1H NMR (300 MHz, CDCl3) δ: 7.7-7.4 (m, 7H), 7.4-7.2 (m, 8 H),
3.9-3.7 (m, 8 H), 3.3-3.2 (m, 2H), 2.8-2.8 (m, 2H), 2.5-2.4 (s, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of macrocyclic compounds as IL-17 modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Taylor, Michael; Terrett, Nicholas K.; Connors, William H.; Shortsleeves,
Kelley C.; Seigal, Benjamin A.; Snedeker, Cheri; Hale, Stephen P.;
Briggs, Timothy F.; Favaloro, Frank G.; Cipriani, Tyler J.; Yan, Dingxue;
Alexander, Sethu L.; Thorarensen, Atli; Xing, Li
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013116682 A1 2013-08-08

$RFMT $RIREG SCHEME155 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon monoxide
CO
630-08-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0 CHG=-1
M  V30 2 O 1.5400 0.0000 0.0 0 CHG=1 VAL=3
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2H-Indazole, 3-bromo-5-cyclopropyl-2-(5-methyl-2-pyridinyl)-6-nitro-
C16H13BrN4O2
1467674-26-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 1.5400 0.0 0 VAL=5
M  V30 2 O 0.2064 2.3100 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 Br 7.4816 5.7906 0.0 0
M  V30 5 C 14.0710 3.0800 0.0 0
M  V30 6 C 2.8738 3.8500 0.0 0
M  V30 7 C 2.8738 2.3100 0.0 0
M  V30 8 C 4.2074 4.6200 0.0 0
M  V30 9 C 4.2074 1.5400 0.0 0
M  V30 10 C 5.5411 3.8500 0.0 0
M  V30 11 C 5.5411 2.3100 0.0 0
M  V30 12 C 7.0058 4.3259 0.0 0
M  V30 13 N 7.0058 1.8341 0.0 0
M  V30 14 N 7.9110 3.0800 0.0 0
M  V30 15 C 1.5400 4.6200 0.0 0
M  V30 16 C 0.7700 5.9537 0.0 0
M  V30 17 C 0.0000 4.6200 0.0 0
M  V30 18 C 9.4510 3.0800 0.0 0
M  V30 19 C 10.2210 4.4137 0.0 0
M  V30 20 N 10.2210 1.7464 0.0 0
M  V30 21 C 11.7610 4.4137 0.0 0
M  V30 22 C 11.7610 1.7464 0.0 0
M  V30 23 C 12.5310 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 12
M  V30 5 1 5 23
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 15
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 17 1 14 18
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2H-Indazole-3-carboxamide, 5-cyclopropyl-N-methyl-2-(5-methyl-2-pyridinyl)-6-...
C18H17N5O3
1467674-29-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.4816 2.6091 0.0 0
M  V30 2 N 6.4512 1.4645 0.0 0
M  V30 3 O 8.9879 2.2889 0.0 0
M  V30 4 C 6.9271 0.0000 0.0 0
M  V30 5 N 1.5400 6.8595 0.0 0 VAL=5
M  V30 6 O 0.2064 6.0895 0.0 0
M  V30 7 O 1.5400 8.3995 0.0 0
M  V30 8 C 14.0710 5.3195 0.0 0
M  V30 9 C 5.5411 4.5495 0.0 0
M  V30 10 C 5.5411 6.0895 0.0 0
M  V30 11 C 7.0058 4.0736 0.0 0
M  V30 12 C 4.2074 3.7795 0.0 0
M  V30 13 N 7.0058 6.5655 0.0 0
M  V30 14 C 4.2074 6.8595 0.0 0
M  V30 15 N 7.9110 5.3195 0.0 0
M  V30 16 C 2.8738 4.5495 0.0 0
M  V30 17 C 2.8738 6.0895 0.0 0
M  V30 18 C 9.4510 5.3195 0.0 0
M  V30 19 C 10.2210 6.6533 0.0 0
M  V30 20 N 10.2210 3.9858 0.0 0
M  V30 21 C 11.7610 6.6533 0.0 0
M  V30 22 C 11.7610 3.9858 0.0 0
M  V30 23 C 12.5310 5.3195 0.0 0
M  V30 24 C 1.5400 3.7795 0.0 0
M  V30 25 C 0.0000 3.7795 0.0 0
M  V30 26 C 0.7700 2.4458 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 17
M  V30 8 1 8 23
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 1 13 15
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 1 16 17
M  V30 20 1 16 24
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 1 24 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 630-08-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1467674-26-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1467674-29-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-182-CAS-9005963
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 14221-01-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 5-Cyclopropyl-N-methyl-2-(5-methylpyridin-2-yl)-6-nitro-2H-indazole-3-carboxamide
(vii): Compound (vi) (5.80 g, 16.0 mmol), methylamine (2M solution in
THF, 120 mL, 230 mmol) and tetrakis(triphenylphosphine)palladium(0) (2.00
g, 1.73 mmol) were placed in a medium pressure reaction vessel. The
mixture was degassed and purged with carbon monoxide gas several times
and then stirred at 70° C. under 40 psi of CO(g) for 1.5 hr. After
cooling to RT, the resulting suspension was filtered and washed with
EtOAc. The solid was set aside and the filtrate was concentrated under
reduced pressure. The residue was triturated with EtOAc and the solids
separated by filtration. The combined solids were dried in vacuo. (vii)
(6.00 g, >100%), which was used in subsequent steps without purification.
ESI-MS: calculated [M+H]+ 352.1, observed [M+1-1]+352.1.
$DTYPE RXN:VAR(1):NOTES
$DATUM medium pressure reaction vessel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 2H-indazole-3-carboxamides as viral polymerase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bond, Silas; Halim, Rosliana; Jeynes, Tyrone Pieter; Draffan, Alistair
George; Harding, Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013152392 A1 2013-10-17

$RFMT $RIREG SCHEME155 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon monoxide
CO
630-08-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0 CHG=-1
M  V30 2 O 1.5400 0.0000 0.0 0 CHG=1 VAL=3
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2H-Indazole, 3-bromo-5-cyclopropyl-2-(5-methyl-2-pyridinyl)-6-nitro-
C16H13BrN4O2
1467674-26-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 1.5400 0.0 0 VAL=5
M  V30 2 O 0.2064 2.3100 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 Br 7.4816 5.7906 0.0 0
M  V30 5 C 14.0710 3.0800 0.0 0
M  V30 6 C 2.8738 3.8500 0.0 0
M  V30 7 C 2.8738 2.3100 0.0 0
M  V30 8 C 4.2074 4.6200 0.0 0
M  V30 9 C 4.2074 1.5400 0.0 0
M  V30 10 C 5.5411 3.8500 0.0 0
M  V30 11 C 5.5411 2.3100 0.0 0
M  V30 12 C 7.0058 4.3259 0.0 0
M  V30 13 N 7.0058 1.8341 0.0 0
M  V30 14 N 7.9110 3.0800 0.0 0
M  V30 15 C 1.5400 4.6200 0.0 0
M  V30 16 C 0.7700 5.9537 0.0 0
M  V30 17 C 0.0000 4.6200 0.0 0
M  V30 18 C 9.4510 3.0800 0.0 0
M  V30 19 C 10.2210 4.4137 0.0 0
M  V30 20 N 10.2210 1.7464 0.0 0
M  V30 21 C 11.7610 4.4137 0.0 0
M  V30 22 C 11.7610 1.7464 0.0 0
M  V30 23 C 12.5310 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 12
M  V30 5 1 5 23
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 15
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 17 1 14 18
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2H-Indazole-3-carboxamide, 5-cyclopropyl-N-methyl-2-(5-methyl-2-pyridinyl)-6-...
C18H17N5O3
1467674-29-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.4816 2.6091 0.0 0
M  V30 2 N 6.4512 1.4645 0.0 0
M  V30 3 O 8.9879 2.2889 0.0 0
M  V30 4 C 6.9271 0.0000 0.0 0
M  V30 5 N 1.5400 6.8595 0.0 0 VAL=5
M  V30 6 O 0.2064 6.0895 0.0 0
M  V30 7 O 1.5400 8.3995 0.0 0
M  V30 8 C 14.0710 5.3195 0.0 0
M  V30 9 C 5.5411 4.5495 0.0 0
M  V30 10 C 5.5411 6.0895 0.0 0
M  V30 11 C 7.0058 4.0736 0.0 0
M  V30 12 C 4.2074 3.7795 0.0 0
M  V30 13 N 7.0058 6.5655 0.0 0
M  V30 14 C 4.2074 6.8595 0.0 0
M  V30 15 N 7.9110 5.3195 0.0 0
M  V30 16 C 2.8738 4.5495 0.0 0
M  V30 17 C 2.8738 6.0895 0.0 0
M  V30 18 C 9.4510 5.3195 0.0 0
M  V30 19 C 10.2210 6.6533 0.0 0
M  V30 20 N 10.2210 3.9858 0.0 0
M  V30 21 C 11.7610 6.6533 0.0 0
M  V30 22 C 11.7610 3.9858 0.0 0
M  V30 23 C 12.5310 5.3195 0.0 0
M  V30 24 C 1.5400 3.7795 0.0 0
M  V30 25 C 0.0000 3.7795 0.0 0
M  V30 26 C 0.7700 2.4458 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 17
M  V30 8 1 8 23
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 1 13 15
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 1 16 17
M  V30 20 1 16 24
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 1 24 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 630-08-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1467674-26-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1467674-29-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-182-CAS-11454135
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 14221-01-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 5-Cyclopropyl-N-methyl-2-(5-methylpyridin-2-yl)-6-nitro-2H-indazole-3-carboxamide
(iv) Compound (iii) (5.80 g, 16.0 mmol), methylamine (2M solution in THF,
120 mL, 230 mmol) and tetrakis(triphenylphosphine)palladium(0) (2.00 g,
1.73 mmol) were placed in a medium pressure reaction vessel. The mixture
was degassed and purged with carbon monoxide gas several times and then
stirred at 70°C under 40 psi of CO(g) for 1.5 hr. After cooling to RT,
the resulting suspension was filtered and washed with EtOAc. The solid
was set aside and the filtrate was concentrated under reduced pressure.
The residue was triturated with EtOAc and the solids separated by
filtration. The combined solids were dried in vacuo. (iv) (6.00 g,
>100%), which was used in subsequent steps without purification. ESI-MS:
calculated [M+H]+352.1. observed [M+H]+ 352.1.
$DTYPE RXN:VAR(1):NOTES
$DATUM pressure vessel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 2H-indazole-3-carboxamides as viral polymerase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jeynes, Tyrone Pieter; Draffan, Alistair George; Harding, Michael; Bond,
Silas; Halim, Rosliana
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013152391 A1 2013-10-17

$RFMT $RIREG SCHEME156 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-6-methoxy-2-naphthalenecarboxaldehyde
C12H9BrO2
148248-97-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 4.0011 0.0000 0.0 0
M  V30 2 C 9.3359 4.6201 0.0 0
M  V30 3 O 10.6695 3.8500 0.0 0
M  V30 4 O 1.3337 1.5400 0.0 0
M  V30 5 C 0.0000 2.3100 0.0 0
M  V30 6 C 5.3348 3.8500 0.0 0
M  V30 7 C 5.3348 2.3100 0.0 0
M  V30 8 C 6.6684 4.6201 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 6.6684 1.5400 0.0 0
M  V30 12 C 8.0022 3.8500 0.0 0
M  V30 13 C 2.6673 3.8500 0.0 0
M  V30 14 C 2.6673 2.3100 0.0 0
M  V30 15 C 8.0022 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 2 2 3
M  V30 3 1 2 12
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 15
M  V30 16 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(5-Bromo-6-methoxy-2-naphthalenyl)methylene]methanamine
C13H12BrNO
479631-60-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 4.0012 0.0000 0.0 0
M  V30 2 O 1.3337 1.5400 0.0 0
M  V30 3 C 0.0000 2.3101 0.0 0
M  V30 4 C 9.3360 4.6201 0.0 0
M  V30 5 N 10.6697 3.8501 0.0 0
M  V30 6 C 12.0033 4.6201 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 4.0012 1.5400 0.0 0
M  V30 10 C 6.6685 1.5400 0.0 0
M  V30 11 C 6.6685 4.6201 0.0 0
M  V30 12 C 4.0012 4.6201 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 8.0022 2.3101 0.0 0
M  V30 15 C 8.0022 3.8501 0.0 0
M  V30 16 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 13
M  V30 4 2 4 5 CFG=2
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 16
M  V30 17 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 148248-97-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 479631-60-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-4845310
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7487-88-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 6-arylamido(methyl)-naphthalen-2-yloxy-acetic acid
derivatives as inhibitors of plasminogen activator inhibitor type-1
(PAI-1)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Commons, Thomas Joseph; Croce, Susan Christman; Woodworth, Richard Page;
Trybulski, Eugene John; Elokdah, Hassan Mahmoud; Crandall, David Leroy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003000649 A1 2003-01-03

$RFMT $RIREG SCHEME157 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Oxohexahydrocyclopenta[c]pyrrole-2(1H)-carboxylic acid tert-butyl ester
C12H19NO3
148404-28-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 O 11.6695 2.8736 0.0 0
M  V30 9 C 7.7598 3.6436 0.0 0
M  V30 10 C 7.7598 2.1036 0.0 0
M  V30 11 C 6.2951 4.1195 0.0 0
M  V30 12 C 9.2244 4.1195 0.0 0
M  V30 13 C 6.2951 1.6278 0.0 0
M  V30 14 C 9.2244 1.6278 0.0 0
M  V30 15 N 5.3900 2.8736 0.0 0
M  V30 16 C 10.1295 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 16
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl hexahydro-5-(methylamino)cyclopenta[c]pyrrole-2(1H)-carboxy...
C13H24N2O2
1793108-50-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 N 11.6695 2.8736 0.0 0
M  V30 9 C 12.4395 4.2073 0.0 0
M  V30 10 C 7.7598 3.6436 0.0 0
M  V30 11 C 7.7598 2.1036 0.0 0
M  V30 12 C 6.2951 4.1195 0.0 0
M  V30 13 C 9.2244 4.1195 0.0 0
M  V30 14 C 6.2951 1.6278 0.0 0
M  V30 15 C 9.2244 1.6278 0.0 0
M  V30 16 N 5.3900 2.8736 0.0 0
M  V30 17 C 10.1295 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 17
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 148404-28-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1793108-50-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-12084310
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituted heteroaryl compounds and methods of use
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xi, Ning; Li, Minxiong; Hu, Haiyang; Wang, Tingjin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015094803 A1 2015-06-25

$RFMT $RIREG SCHEME158 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-hydroxy-4-[(4-methoxyphenyl)methoxy]benzoate
C16H16O5
148965-89-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6674 0.0 0
M  V30 2 O 1.5400 4.0011 0.0 0
M  V30 3 O 1.5400 1.3338 0.0 0
M  V30 4 C 0.0000 4.0011 0.0 0
M  V30 5 O 3.8500 0.0000 0.0 0
M  V30 6 O 8.4700 2.6674 0.0 0
M  V30 7 C 9.2400 4.0011 0.0 0
M  V30 8 O 15.4000 4.0011 0.0 0
M  V30 9 C 16.1700 5.3349 0.0 0
M  V30 10 C 3.8500 2.6674 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 4.6200 4.0011 0.0 0
M  V30 13 C 6.1600 1.3338 0.0 0
M  V30 14 C 6.1600 4.0011 0.0 0
M  V30 15 C 6.9300 2.6674 0.0 0
M  V30 16 C 10.7800 4.0011 0.0 0
M  V30 17 C 11.5500 2.6674 0.0 0
M  V30 18 C 11.5500 5.3349 0.0 0
M  V30 19 C 13.0900 2.6674 0.0 0
M  V30 20 C 13.0900 5.3349 0.0 0
M  V30 21 C 13.8600 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 15
M  V30 8 1 7 16
M  V30 9 1 8 9
M  V30 10 1 8 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Hydroxy-4-[(4-methoxyphenyl)methoxy]-N-methylbenzamide
C16H17NO4
644969-21-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6674 0.0 0
M  V30 2 N 1.5400 4.0011 0.0 0
M  V30 3 O 1.5400 1.3338 0.0 0
M  V30 4 C 0.0000 4.0011 0.0 0
M  V30 5 O 3.8500 0.0000 0.0 0
M  V30 6 O 8.4700 2.6674 0.0 0
M  V30 7 C 9.2400 4.0011 0.0 0
M  V30 8 O 15.4000 4.0011 0.0 0
M  V30 9 C 16.1700 5.3349 0.0 0
M  V30 10 C 3.8500 2.6674 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 4.6200 4.0011 0.0 0
M  V30 13 C 6.1600 1.3338 0.0 0
M  V30 14 C 6.1600 4.0011 0.0 0
M  V30 15 C 6.9300 2.6674 0.0 0
M  V30 16 C 10.7800 4.0011 0.0 0
M  V30 17 C 11.5500 2.6674 0.0 0
M  V30 18 C 11.5500 5.3349 0.0 0
M  V30 19 C 13.0900 2.6674 0.0 0
M  V30 20 C 13.0900 5.3349 0.0 0
M  V30 21 C 13.8600 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 15
M  V30 8 1 7 16
M  V30 9 1 8 9
M  V30 10 1 8 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 148965-89-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 644969-21-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4268708
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and structure activity relationships of spirocyclic
compounds as potent CCR1 antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hossain, Nafizal; Ivanova, Svetlana; Bergare, Jonas; Mensonides-Harsema,
Marguerite; Cooper, Martin E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2013), 23(12), 3500-3504

$RFMT $RIREG SCHEME159 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Fluoro-2-nitrobenzene
C6H4FNO2
1493-27-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-nitrobenzenamine
C7H8N2O2
612-28-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 1.3338 0.0 0
M  V30 2 C 6.1600 1.3338 0.0 0
M  V30 3 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1493-27-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 612-28-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3175416
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Systematic evaluation of structure-activity relationships of the
riminophenazine class and discovery of a C2 pyridylamino series for the
treatment of multidrug-resistant tuberculosis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Binna; Liu, Kai; Lu, Yu; Zhang, Dongfeng; Yang, Tianming; Li, Xuan;
Ma, Chen; Zheng, Meiqin; Bin, Wang; Zhang, Gang; Fei, Wang; Ma, Zhenkun;
Li, Chun; Huang, Haihong; Yin, Dali
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2012), 174545-4559

$RFMT $RIREG SCHEME160 STEP1
$RXN



  1  1
$MOL
Hydrazinecarboximidamide, N-[(1,4-dihydro-4-thioxo-3-pyridinyl)sulfonyl]-, co...
C6H9N5O2S2.H4N2
1500083-07-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 4.6201 0.0 0 VAL=6
M  V30 2 N 5.3348 5.3901 0.0 0
M  V30 3 O 4.7712 3.2864 0.0 0
M  V30 4 O 3.2311 5.9537 0.0 0
M  V30 5 C 6.6685 4.6201 0.0 0
M  V30 6 N 8.0023 5.3901 0.0 0
M  V30 7 N 6.6685 3.0800 0.0 0
M  V30 8 N 9.3360 4.6201 0.0 0
M  V30 9 S 1.3337 6.1601 0.0 0
M  V30 10 C 2.6675 3.8501 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 2.6675 2.3100 0.0 0
M  V30 13 C 0.0000 3.8501 0.0 0
M  V30 14 N 1.3337 1.5400 0.0 0
M  V30 15 C 0.0000 2.3100 0.0 0
M  V30 16 N 3.8980 0.0000 0.0 0
M  V30 17 N 5.4380 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 2 9 11
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 16 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1,4-Dihydro-4-thioxo-3-pyridinyl)sulfonyl]hydrazinecarboximidamide
C6H9N5O2S2
1454274-57-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 N 8.0023 3.8501 0.0 0
M  V30 7 N 6.6685 1.5400 0.0 0
M  V30 8 N 9.3360 3.0801 0.0 0
M  V30 9 S 1.3337 4.6201 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 1.3337 3.0801 0.0 0
M  V30 12 C 2.6675 0.7700 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 N 1.3337 0.0000 0.0 0
M  V30 15 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 2 9 11
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1500083-07-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1454274-57-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-575-CAS-7233590
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and structure determination of
2,3-diaryl-9,9-dioxo-1H-9-thia-1,4,4a,7,10-pentaazaphenanthren-2-ols
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Slawinski, Jaroslaw; Pogorzelska, Aneta; Zolnowska, Beata; Laskowski,
Tomasz; Sowinski, Pawel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2013), 69(41), 8675-8679

$RFMT $RIREG SCHEME161 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Aminobenzoic acid
C7H7NO2
150-13-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 N 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-aminobenzoate
C8H9NO2
619-45-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 O 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 N 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 6.1601 0.0000 0.0 0
M  V30 10 C 6.1601 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(1):AMD
$DATUM reaction products with divinylbenzene-styrene copolymer diazonium salt
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 150-13-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 619-45-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-017-CAS-44813
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 110-71-4
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polymer-supported triazenes as smart reagents for the alkylation of
carboxylic acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Erb, Bernhard; Kucma, Jean-Philippe; Mourey, Sandrine; Struber, Fritz
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2003), 9(11), 2582-2588

$RFMT $RIREG SCHEME162 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Dioctylamino)benzaldehyde
C23H39NO
1512863-10-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2400 6.6684 0.0 0
M  V30 2 C 10.7800 6.6684 0.0 0
M  V30 3 C 8.4700 8.0020 0.0 0
M  V30 4 C 11.5500 8.0020 0.0 0
M  V30 5 C 6.9300 8.0020 0.0 0
M  V30 6 C 13.0900 8.0020 0.0 0
M  V30 7 C 6.1600 9.3358 0.0 0
M  V30 8 C 13.8600 9.3358 0.0 0
M  V30 9 C 4.6200 9.3358 0.0 0
M  V30 10 C 15.4000 9.3358 0.0 0
M  V30 11 C 3.8500 10.6694 0.0 0
M  V30 12 C 16.1700 10.6694 0.0 0
M  V30 13 C 2.3100 10.6694 0.0 0
M  V30 14 C 17.7100 10.6694 0.0 0
M  V30 15 C 1.5400 12.0031 0.0 0
M  V30 16 C 18.4800 12.0031 0.0 0
M  V30 17 C 0.0000 12.0031 0.0 0
M  V30 18 C 9.2400 1.3336 0.0 0
M  V30 19 O 8.4700 0.0000 0.0 0
M  V30 20 C 8.4700 5.3347 0.0 0
M  V30 21 C 9.2400 4.0011 0.0 0
M  V30 22 C 6.9300 5.3347 0.0 0
M  V30 23 C 8.4700 2.6673 0.0 0
M  V30 24 C 6.1600 4.0011 0.0 0
M  V30 25 C 6.9300 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 18 19
M  V30 19 1 18 23
M  V30 20 2 20 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 2 22 24
M  V30 24 2 23 25
M  V30 25 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(Methylimino)methyl]-N,N-dioctylbenzenamine
C24H42N2
1512863-11-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2400 8.0020 0.0 0
M  V30 2 C 10.7800 8.0020 0.0 0
M  V30 3 C 8.4700 9.3358 0.0 0
M  V30 4 C 11.5500 9.3358 0.0 0
M  V30 5 C 6.9300 9.3358 0.0 0
M  V30 6 C 13.0900 9.3358 0.0 0
M  V30 7 C 6.1600 10.6694 0.0 0
M  V30 8 C 13.8600 10.6694 0.0 0
M  V30 9 C 4.6200 10.6694 0.0 0
M  V30 10 C 15.4000 10.6694 0.0 0
M  V30 11 C 3.8500 12.0031 0.0 0
M  V30 12 C 16.1700 12.0031 0.0 0
M  V30 13 C 2.3100 12.0031 0.0 0
M  V30 14 C 17.7100 12.0031 0.0 0
M  V30 15 C 1.5400 13.3367 0.0 0
M  V30 16 C 18.4800 13.3367 0.0 0
M  V30 17 C 0.0000 13.3367 0.0 0
M  V30 18 C 9.2400 2.6673 0.0 0
M  V30 19 N 8.4700 1.3336 0.0 0
M  V30 20 C 9.2400 0.0000 0.0 0
M  V30 21 C 8.4700 6.6684 0.0 0
M  V30 22 C 9.2400 5.3347 0.0 0
M  V30 23 C 6.9300 6.6684 0.0 0
M  V30 24 C 8.4700 4.0009 0.0 0
M  V30 25 C 6.1600 5.3347 0.0 0
M  V30 26 C 6.9300 4.0009 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 18 19 CFG=2
M  V30 19 1 18 24
M  V30 20 1 19 20
M  V30 21 2 21 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 2 23 25
M  V30 25 2 24 26
M  V30 26 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1512863-10-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1512863-11-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-3558449
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aggregation-induced emission of GFP-like chromophores via exclusion of
solvent-solute hydrogen bonding
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tou, Sio-Lon; Huang, Guan-Jhih; Chen, Po-Cheng; Chang, Huan-Tsung; Tsai,
Jun-Yun; Yang, Jye-Shane
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2014), 50(5),
620-622

$RFMT $RIREG SCHEME163 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3-(2-oxoethyl)-1-azetidinecarboxylate
C10H17NO3
152537-04-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8737 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 C 9.1079 2.8737 0.0 0
M  V30 9 C 9.8779 4.2073 0.0 0
M  V30 10 O 11.4179 4.2073 0.0 0
M  V30 11 N 5.3900 2.8737 0.0 0
M  V30 12 C 6.4790 1.7847 0.0 0
M  V30 13 C 6.4790 3.9626 0.0 0
M  V30 14 C 7.5679 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 14
M  V30 10 2 9 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3-[2-(methylamino)ethyl]-1-azetidinecarboxylate
C11H22N2O2
1420813-55-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 O 2.6674 2.3100 0.0 0
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 C 1.3338 1.5400 0.0 0
M  V30 5 C 0.5638 2.8738 0.0 0
M  V30 6 C 0.0000 0.7700 0.0 0
M  V30 7 C 2.1038 0.2064 0.0 0
M  V30 8 C 8.5545 4.1691 0.0 0
M  V30 9 C 9.8882 3.3991 0.0 0
M  V30 10 N 11.2218 4.1691 0.0 0
M  V30 11 C 12.5556 3.3991 0.0 0
M  V30 12 N 5.3347 2.3100 0.0 0
M  V30 13 C 5.7333 3.7976 0.0 0
M  V30 14 C 6.8224 1.9114 0.0 0
M  V30 15 C 7.2209 3.3991 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 152537-04-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1420813-55-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32434026
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted quinazoline and pyrrolotriazine compounds as
ectonucleotide pyrophosphatase-phosphodiesterase-1 (ENPP1) inhibitors and
uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pujala, Brahmam; Ansari, Amantullah; Sapra, Shreya; Jadhavar, Pradeep S.;
Pendharkar, Dhananjay; Ramachandran, Sreekanth A.; Saeed, Uzma; Danodia,
Abhinandan; Khan, Farha; Patni, Sagar; Soni, Sanjeev; Gupta, Ashu;
Chakravarty, Sarvajit; Sathe, Balaji Dashrath
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022091048 A1 2022-05-05

$RFMT $RIREG SCHEME164 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl N-[6-chloro-2-(methylthio)-5-nitro-4-pyrimidinyl]-N-[(3-methoxyphenyl)m...
C16H17ClN4O5S
1539303-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.6201 0.0 0
M  V30 2 C 8.0022 5.3901 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 O 5.3348 2.3101 0.0 0
M  V30 5 O 8.0022 2.3101 0.0 0
M  V30 6 C 5.3348 0.7700 0.0 0
M  V30 7 C 4.0010 0.0000 0.0 0
M  V30 8 N 6.6685 7.7002 0.0 0 VAL=5
M  V30 9 O 6.6685 9.2402 0.0 0
M  V30 10 O 8.0022 6.9302 0.0 0
M  V30 11 Cl 4.0010 9.2402 0.0 0
M  V30 12 S 1.3337 4.6201 0.0 0
M  V30 13 C 0.0000 5.3901 0.0 0
M  V30 14 O 13.3370 5.3901 0.0 0
M  V30 15 C 14.6707 4.6201 0.0 0
M  V30 16 C 5.3348 5.3901 0.0 0
M  V30 17 C 5.3348 6.9302 0.0 0
M  V30 18 N 4.0010 4.6201 0.0 0
M  V30 19 C 4.0010 7.7002 0.0 0
M  V30 20 C 2.6673 5.3901 0.0 0
M  V30 21 N 2.6673 6.9302 0.0 0
M  V30 22 C 9.3358 4.6201 0.0 0
M  V30 23 C 10.6697 5.3901 0.0 0
M  V30 24 C 9.3358 3.0801 0.0 0
M  V30 25 C 12.0033 4.6201 0.0 0
M  V30 26 C 10.6697 2.3101 0.0 0
M  V30 27 C 12.0033 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 16
M  V30 4 1 2 22
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 2 8 9
M  V30 10 2 8 10
M  V30 11 1 8 17
M  V30 12 1 11 19
M  V30 13 1 12 13
M  V30 14 1 12 20
M  V30 15 1 14 15
M  V30 16 1 14 25
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl N-[(3-methoxyphenyl)methyl]-N-[6-(methylamino)-2-(methylthio)-5-nitro-4...
C17H21N5O5S
1870032-04-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.6201 0.0 0
M  V30 2 C 8.0022 5.3901 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 O 5.3348 2.3101 0.0 0
M  V30 5 O 8.0022 2.3101 0.0 0
M  V30 6 C 5.3348 0.7700 0.0 0
M  V30 7 C 4.0010 0.0000 0.0 0
M  V30 8 N 6.6685 7.7002 0.0 0 VAL=5
M  V30 9 O 6.6685 9.2402 0.0 0
M  V30 10 O 8.0022 6.9302 0.0 0
M  V30 11 N 4.0010 9.2402 0.0 0
M  V30 12 C 2.6673 10.0102 0.0 0
M  V30 13 S 1.3337 4.6201 0.0 0
M  V30 14 C 0.0000 5.3901 0.0 0
M  V30 15 O 13.3370 5.3901 0.0 0
M  V30 16 C 14.6707 4.6201 0.0 0
M  V30 17 C 5.3348 5.3901 0.0 0
M  V30 18 C 5.3348 6.9302 0.0 0
M  V30 19 N 4.0010 4.6201 0.0 0
M  V30 20 C 4.0010 7.7002 0.0 0
M  V30 21 C 2.6673 5.3901 0.0 0
M  V30 22 N 2.6673 6.9302 0.0 0
M  V30 23 C 9.3358 4.6201 0.0 0
M  V30 24 C 10.6697 5.3901 0.0 0
M  V30 25 C 9.3358 3.0801 0.0 0
M  V30 26 C 12.0033 4.6201 0.0 0
M  V30 27 C 10.6697 2.3101 0.0 0
M  V30 28 C 12.0033 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 17
M  V30 4 1 2 23
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 2 8 9
M  V30 10 2 8 10
M  V30 11 1 8 18
M  V30 12 1 11 12
M  V30 13 1 11 20
M  V30 14 1 13 14
M  V30 15 1 13 21
M  V30 16 1 15 16
M  V30 17 1 15 26
M  V30 18 1 17 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1539303-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1870032-04-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-12716375
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Potent and Selective Inhibitors of MTH1 Probe Its Role in Cancer Cell
Survival
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kettle, Jason G.; Alwan, Husam; Bista, Michal; Breed, Jason; Davies,
Nichola L.; Eckersley, Kay; Fillery, Shaun; Foote, Kevin M.; Goodwin,
Louise; Jones, David R.; Kack, Helena; Lau, Alan; Nissink, J. Willem M.;
Read, Jon; Scott, James S.; Taylor, Ben; Walker, Graeme; Wissler, Lisa;
Wylot, Marta
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2016), 59(6), 2346-2361

$RFMT $RIREG SCHEME165 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2Z)-4-amino-4-oxo-2-butenoate
C5H7NO3
155063-57-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 C 3.0801 2.6673 0.0 0
M  V30 3 O 0.7700 1.3337 0.0 0
M  V30 4 O 3.0801 0.0000 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 C 5.3901 1.3337 0.0 0
M  V30 8 N 4.6201 0.0000 0.0 0
M  V30 9 O 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-amino-3-(methylamino)-4-oxobutanoate
C6H12N2O3
1021333-68-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3336 1.5400 0.0 0
M  V30 4 N 2.6674 3.8500 0.0 0
M  V30 5 C 5.3347 2.3100 0.0 0
M  V30 6 N 0.0000 2.3100 0.0 0
M  V30 7 O 1.3336 0.0000 0.0 0
M  V30 8 C 1.3336 4.6200 0.0 0
M  V30 9 O 6.6685 1.5400 0.0 0
M  V30 10 O 5.3347 3.8500 0.0 0
M  V30 11 C 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 155063-57-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1021333-68-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-607916
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-methyl-DL-isoasparagine-methyl ester 12 1.3ml of 8M ethanol solution of
methylamine (0.01mol) was added to an ethanol solution (8ml) of methyl
maleamate 11a or methyl fumaramate 11b (1.29 g, 0.01mol) [prepared by
acid catalyzed esterification of maleamic 10a/fumaramic acid 10b] at 0°C.
The reaction mixture was stirred for 12 h at 0 °C. The solvent was
evaporated in vacuo to dryness. oil of 12 was obtained. Transparent oil,
yield (1.60 g), quantitative. Rf (B, a) = 0.84, Rf (B, b) = 0.85 1H-NMR
(DMSO-d6, 500MHz): δ = 7.48 (1H, s, NH), 7.11 (1H, s, NH), 3.59 (3H, s,
OCH3), 3.27 (1H, d-d, 3J1(H,H) = 5.58 Hz, 3J2(H,H) = 8.27 Hz, C-H), 2.57
(1H, d-d, 3J1(H,H) = 5.58 Hz, 2J3(H,H) =15.38Hz, H-CH), 2.39 (1H, d-d,
3J2(H,H) = 8.27 Hz, 2J3(H,H) =15.38Hz, HC-H), 2.21 (3H, s, NCH3) MW =
160.17 ESI-MS m/z: 160.4 [M+H]+ Anal. Calc. for C6H12N2O3 C = 44.99% H =
7.55% N = 17.49% Found C = 45.13% H = 7.62% N = 17.41%.
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Methods for syntheses of N-methyl-DL-aspartic acid derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Boros, M.; Koekoesi, J.; Vamos, J.; Koevesdi, I.; Noszal, B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Amino Acids (2007), 33(4), 709-717

$RFMT $RIREG SCHEME166 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,6,9,12-Tetraoxatetradecane-1,14-diol, 1-4-methylbenzenesulfonate
C17H28O8S
155130-15-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.0801 5.3348 0.0 0 VAL=6
M  V30 2 O 4.4137 4.5648 0.0 0
M  V30 3 O 1.7464 6.1048 0.0 0
M  V30 4 O 3.8501 6.6687 0.0 0
M  V30 5 C 5.7474 5.3348 0.0 0
M  V30 6 C 7.0812 4.5648 0.0 0
M  V30 7 O 8.4149 5.3348 0.0 0
M  V30 8 C 9.7486 4.5648 0.0 0
M  V30 9 C 11.0824 5.3348 0.0 0
M  V30 10 O 12.4161 4.5648 0.0 0
M  V30 11 C 13.7497 5.3348 0.0 0
M  V30 12 C 15.0834 4.5648 0.0 0
M  V30 13 O 16.4172 5.3348 0.0 0
M  V30 14 C 17.7509 4.5648 0.0 0
M  V30 15 C 19.0846 5.3348 0.0 0
M  V30 16 O 20.4182 4.5648 0.0 0
M  V30 17 C 21.7521 5.3348 0.0 0
M  V30 18 C 23.0857 4.5648 0.0 0
M  V30 19 O 24.4194 5.3348 0.0 0
M  V30 20 C 0.0000 0.0000 0.0 0
M  V30 21 C 2.3101 4.0012 0.0 0
M  V30 22 C 3.0801 2.6675 0.0 0
M  V30 23 C 0.7700 4.0012 0.0 0
M  V30 24 C 2.3101 1.3338 0.0 0
M  V30 25 C 0.0000 2.6675 0.0 0
M  V30 26 C 0.7700 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 21
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 1 20 26
M  V30 21 2 21 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 2 23 25
M  V30 25 2 24 26
M  V30 26 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,6,9,12-Tetraoxa-15-azahexadecan-1-ol
C11H25NO5
2248764-45-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 0.7700 0.0 0
M  V30 2 C 12.0033 0.0000 0.0 0
M  V30 3 O 9.3360 0.0000 0.0 0
M  V30 4 O 13.3370 0.7700 0.0 0
M  V30 5 C 8.0022 0.7700 0.0 0
M  V30 6 C 14.6708 0.0000 0.0 0
M  V30 7 C 6.6685 0.0000 0.0 0
M  V30 8 C 16.0045 0.7700 0.0 0
M  V30 9 O 5.3348 0.7700 0.0 0
M  V30 10 O 17.3382 0.0000 0.0 0
M  V30 11 C 4.0012 0.0000 0.0 0
M  V30 12 C 18.6720 0.7700 0.0 0
M  V30 13 C 2.6673 0.7700 0.0 0
M  V30 14 C 20.0057 0.0000 0.0 0
M  V30 15 N 1.3337 0.0000 0.0 0
M  V30 16 O 21.3393 0.7700 0.0 0
M  V30 17 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 155130-15-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2248764-45-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24506972
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterobifunctional molecules useful as TEAD modulators for
treating cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zbieg, Jason Robert; Villemure, Elisia; Rudolph, Joachim; Beroza, Paul
Powell; Crawford, James John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021178339 A1 2021-09-10

$RFMT $RIREG SCHEME167 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (5S)-2,5-anhydro-5-C-[4-[[(3-iodophenyl)methyl]amino]pyrrolo[2,1-f][1,...
C22H23IN4O5
1579953-57-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.5063 2.6091 0.0 0
M  V30 2 O 1.9822 1.1446 0.0 0
M  V30 3 O 0.0000 2.9295 0.0 0
M  V30 4 C 0.9517 0.0000 0.0 0
M  V30 5 C 0.2339 8.1733 0.0 0
M  V30 6 C 2.0188 9.2039 0.0 0
M  V30 7 N 11.3468 5.0593 0.0 0
M  V30 8 C 12.6805 4.2893 0.0 0
M  V30 9 I 18.0153 4.2893 0.0 0
M  V30 10 C 4.6948 4.9996 0.0 0 CFG=2
M  V30 11 C 3.5504 6.0300 0.0 0 CFG=2
M  V30 12 O 4.0685 3.5927 0.0 0
M  V30 13 C 2.2167 5.2600 0.0 0 CFG=2
M  V30 14 O 3.2302 7.5365 0.0 0
M  V30 15 C 2.5369 3.7537 0.0 0 CFG=2
M  V30 16 O 1.0722 6.2906 0.0 0
M  V30 17 C 1.6985 7.6974 0.0 0
M  V30 18 C 6.2013 5.3197 0.0 0
M  V30 19 N 7.3457 4.2893 0.0 0
M  V30 20 C 6.8276 6.7267 0.0 0
M  V30 21 C 8.6793 5.0593 0.0 0
M  V30 22 N 7.3457 2.7493 0.0 0
M  V30 23 C 8.3591 6.5656 0.0 0
M  V30 24 C 10.0131 4.2893 0.0 0
M  V30 25 C 8.6793 1.9793 0.0 0
M  V30 26 N 10.0131 2.7493 0.0 0
M  V30 27 C 14.0142 5.0593 0.0 0
M  V30 28 C 15.3480 4.2893 0.0 0
M  V30 29 C 14.0142 6.5994 0.0 0
M  V30 30 C 16.6816 5.0593 0.0 0
M  V30 31 C 15.3480 7.3694 0.0 0
M  V30 32 C 16.6816 6.5994 0.0 0
M  V30 33 H 4.8841 6.8000 0.0 0
M  V30 34 H 0.8829 4.4900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 15 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 17
M  V30 6 1 6 17
M  V30 7 1 7 8
M  V30 8 1 7 24
M  V30 9 1 8 27
M  V30 10 1 9 30
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 18 CFG=3
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 11 33 CFG=3
M  V30 17 1 12 15
M  V30 18 1 13 15
M  V30 19 1 13 16
M  V30 20 1 13 34 CFG=3
M  V30 21 1 14 17
M  V30 22 1 16 17
M  V30 23 1 18 19
M  V30 24 2 18 20
M  V30 25 1 19 21
M  V30 26 1 19 22
M  V30 27 1 20 23
M  V30 28 2 21 23
M  V30 29 1 21 24
M  V30 30 2 22 25
M  V30 31 2 24 26
M  V30 32 1 25 26
M  V30 33 2 27 28
M  V30 34 1 27 29
M  V30 35 1 28 30
M  V30 36 2 29 31
M  V30 37 2 30 32
M  V30 38 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 10 11 13 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(5S)-2,5-Anhydro-5-C-[4-[[(3-iodophenyl)methyl]amino]pyrrolo[2,1-f][1,2,4]tri...
C22H24IN5O4
1579953-59-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.5063 2.6091 0.0 0
M  V30 2 N 1.9822 1.1446 0.0 0
M  V30 3 O 0.0000 2.9295 0.0 0
M  V30 4 C 0.9517 0.0000 0.0 0
M  V30 5 C 0.2339 8.1733 0.0 0
M  V30 6 C 2.0188 9.2039 0.0 0
M  V30 7 N 11.3468 5.0593 0.0 0
M  V30 8 C 12.6805 4.2893 0.0 0
M  V30 9 I 18.0153 4.2893 0.0 0
M  V30 10 C 4.6948 4.9996 0.0 0 CFG=2
M  V30 11 C 3.5504 6.0300 0.0 0 CFG=2
M  V30 12 O 4.0685 3.5927 0.0 0
M  V30 13 C 2.2166 5.2600 0.0 0 CFG=2
M  V30 14 O 3.2302 7.5365 0.0 0
M  V30 15 C 2.5369 3.7537 0.0 0 CFG=2
M  V30 16 O 1.0722 6.2906 0.0 0
M  V30 17 C 1.6985 7.6974 0.0 0
M  V30 18 C 6.2013 5.3197 0.0 0
M  V30 19 N 7.3457 4.2893 0.0 0
M  V30 20 C 6.8276 6.7267 0.0 0
M  V30 21 C 8.6793 5.0593 0.0 0
M  V30 22 N 7.3457 2.7493 0.0 0
M  V30 23 C 8.3591 6.5656 0.0 0
M  V30 24 C 10.0131 4.2893 0.0 0
M  V30 25 C 8.6793 1.9793 0.0 0
M  V30 26 N 10.0131 2.7493 0.0 0
M  V30 27 C 14.0142 5.0593 0.0 0
M  V30 28 C 15.3480 4.2893 0.0 0
M  V30 29 C 14.0142 6.5994 0.0 0
M  V30 30 C 16.6816 5.0593 0.0 0
M  V30 31 C 15.3480 7.3694 0.0 0
M  V30 32 C 16.6816 6.5994 0.0 0
M  V30 33 H 4.8841 6.8000 0.0 0
M  V30 34 H 0.8829 4.4900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 15 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 17
M  V30 6 1 6 17
M  V30 7 1 7 8
M  V30 8 1 7 24
M  V30 9 1 8 27
M  V30 10 1 9 30
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 18 CFG=3
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 11 33 CFG=3
M  V30 17 1 12 15
M  V30 18 1 13 15
M  V30 19 1 13 16
M  V30 20 1 13 34 CFG=3
M  V30 21 1 14 17
M  V30 22 1 16 17
M  V30 23 1 18 19
M  V30 24 2 18 20
M  V30 25 1 19 21
M  V30 26 1 19 22
M  V30 27 1 20 23
M  V30 28 2 21 23
M  V30 29 1 21 24
M  V30 30 2 22 25
M  V30 31 2 24 26
M  V30 32 1 25 26
M  V30 33 2 27 28
M  V30 34 1 27 29
M  V30 35 1 28 30
M  V30 36 2 29 31
M  V30 37 2 30 32
M  V30 38 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 10 11 13 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1579953-57-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1579953-59-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8340850
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compounds and compositions for modulating adenosine A3 receptor activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Choi, Minjeong; Oh, Su-Sung
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014042433 A2 2014-03-20

$RFMT $RIREG SCHEME168 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-1-(2-methoxy-2-phenylethyl)-6-(methylthio)-3-phenyl-1H-pyrazolo[3,4-...
C21H19ClN4OS
1583284-76-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 1.2896 4.9949 0.0 0
M  V30 2 C 7.8085 6.3194 0.0 0
M  V30 3 C 8.5785 7.6532 0.0 0
M  V30 4 O 7.8085 8.9869 0.0 0
M  V30 5 C 8.5785 10.3205 0.0 0
M  V30 6 S 4.8592 1.0304 0.0 0
M  V30 7 C 3.7148 0.0000 0.0 0
M  V30 8 C 3.8987 5.5494 0.0 0
M  V30 9 C 5.3632 5.0736 0.0 0
M  V30 10 C 3.8987 7.0894 0.0 0
M  V30 11 C 2.7542 4.5190 0.0 0
M  V30 12 N 6.2684 6.3194 0.0 0
M  V30 13 N 5.6834 3.5673 0.0 0
M  V30 14 N 5.3632 7.5654 0.0 0
M  V30 15 N 3.0743 3.0127 0.0 0
M  V30 16 C 4.5390 2.5367 0.0 0
M  V30 17 C 2.6528 7.9946 0.0 0
M  V30 18 C 2.8137 9.5262 0.0 0
M  V30 19 C 1.2459 7.3683 0.0 0
M  V30 20 C 1.5679 10.4314 0.0 0
M  V30 21 C 0.0000 8.2735 0.0 0
M  V30 22 C 0.1609 9.8051 0.0 0
M  V30 23 C 10.1185 7.6532 0.0 0
M  V30 24 C 10.8885 8.9869 0.0 0
M  V30 25 C 10.8885 6.3194 0.0 0
M  V30 26 C 12.4285 8.9869 0.0 0
M  V30 27 C 12.4285 6.3194 0.0 0
M  V30 28 C 13.1985 7.6532 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 1 2 12
M  V30 4 1 3 4
M  V30 5 1 3 23
M  V30 6 1 4 5
M  V30 7 1 6 7
M  V30 8 1 6 16
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 10 17
M  V30 16 1 11 15
M  V30 17 1 12 14
M  V30 18 1 13 16
M  V30 19 2 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Methoxy-2-phenylethyl)-N-methyl-6-(methylthio)-3-phenyl-1H-pyrazolo[3,4-...
C22H23N5OS
1583284-93-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5063 4.7301 0.0 0
M  V30 2 C 0.0000 5.0503 0.0 0
M  V30 3 C 7.8142 6.8424 0.0 0
M  V30 4 C 9.1478 6.0724 0.0 0
M  V30 5 O 9.1478 4.5324 0.0 0
M  V30 6 C 10.4816 3.7624 0.0 0
M  V30 7 S 2.6155 9.9483 0.0 0
M  V30 8 C 1.1091 10.2685 0.0 0
M  V30 9 C 4.0431 5.5543 0.0 0
M  V30 10 C 5.0736 6.6987 0.0 0
M  V30 11 C 4.8131 4.2207 0.0 0
M  V30 12 C 2.5369 5.8745 0.0 0
M  V30 13 N 6.4805 6.0724 0.0 0
M  V30 14 N 4.5977 8.1634 0.0 0
M  V30 15 N 6.3196 4.5409 0.0 0
M  V30 16 N 2.0608 7.3392 0.0 0
M  V30 17 C 3.0914 8.4836 0.0 0
M  V30 18 C 4.1868 2.8137 0.0 0
M  V30 19 C 5.0920 1.5679 0.0 0
M  V30 20 C 2.6553 2.6528 0.0 0
M  V30 21 C 4.4656 0.1611 0.0 0
M  V30 22 C 2.0288 1.2459 0.0 0
M  V30 23 C 2.9340 0.0000 0.0 0
M  V30 24 C 10.4816 6.8424 0.0 0
M  V30 25 C 11.8152 6.0724 0.0 0
M  V30 26 C 10.4816 8.3824 0.0 0
M  V30 27 C 13.1489 6.8424 0.0 0
M  V30 28 C 11.8152 9.1524 0.0 0
M  V30 29 C 13.1489 8.3824 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 4 5
M  V30 6 1 4 24
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 1 7 17
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 1 11 18
M  V30 17 1 12 16
M  V30 18 1 13 15
M  V30 19 1 14 17
M  V30 20 2 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1583284-76-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1583284-93-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-6676787
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure 3 (GP3): 9a-p and 13a-c. The
desired amine (0.45 mmol, 5.00 equiv) was added to a solution of the
appropriate 1-N-substitued
4-chloro-6-(methylthio)-1H-pyrazolo[3,4-d]pyrimidine (8a-f and 12) (0.15
mmol, 1.00 equiv) in EtOH (2 mL). The reaction solution was stirred under
reflux, until the starting material spot disappeared from TLC. The
solvent was removed under reduced pressure to obtain the reaction crude,
that was purified as described in each section.
N-(3-chlorophenyl)-6-(methylthio)-1-phenethyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine
(9a)
1-(2-Methoxy-2-phenylethyl)-N-methyl-6-(methylthio)-3-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine
(9o) Synthesized according to GP3 from 8f; the oily residue was dissolved
in EtOAc and the organic phase was extracted twice with 0.5 N HCl. The
organic layer was dried over Na2SO4, filtered then the solvent evaporated
under reduced pressure. The product as a white solid. Yield: quant. White
solid. 1H NMR (CDCl3): 7.62 (d, J = 7.2 Hz, 2H); 7.48 (m, 3H); 7.32 (m,
5H); 5.26 (bs, 1H); 4.91 (dd, J = 5.2, 8 Hz, 1H); 4.70 (dd, J = 8.0, 9.6
Hz, 1H); 4.44 (dd, J = 5.2, 14 Hz, 1H); 3.21 (s, 3H); 3.04 (d, J = 4.8
Hz, 3H); 2.58 (s, 3H). 13C NMR (CDCl3): 169.5, 156.6, 155.3, 144.0,
139.0, 133.8, 129.3, 128.9, 128.5, 128.4, 128.2, 127.0, 96.3, 81.7, 57.1,
52.7, 27.8, 14.2. MS (ES) m/z: 406 [M+H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Exploring the Chemical Space around the Privileged
Pyrazolo[3,4-d]pyrimidine Scaffold: Toward Novel Allosteric Inhibitors of
T315I-Mutated Abl
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vignaroli, Giulia; Mencarelli, Martina; Sementa, Deborah; Crespan,
Emmanuele; Kissova, Miroslava; Maga, Giovanni; Schenone, Silvia; Radi,
Marco; Botta, Maurizio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Combinatorial Science (2014), 16(4), 168-175

$RFMT $RIREG SCHEME169 STEP1
$RXN



  2  1
$MOL
4-Cyclopropyl-γ-[2-[(2,4-dimethylphenyl)amino]-2-oxoethyl]-5-(4-methylpentyl)...
C25H36N4O3
1608134-81-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.2400 5.3347 0.0 0
M  V30 2 C 8.4700 6.6684 0.0 0
M  V30 3 C 8.4700 4.0011 0.0 0
M  V30 4 C 6.9300 6.6684 0.0 0
M  V30 5 C 9.2400 2.6673 0.0 0
M  V30 6 N 6.1600 8.0021 0.0 0
M  V30 7 O 6.1600 5.3347 0.0 0
M  V30 8 C 8.4700 1.3336 0.0 0
M  V30 9 O 6.9300 1.3336 0.0 0
M  V30 10 O 9.2400 0.0000 0.0 0
M  V30 11 C 14.3958 7.0099 0.0 0
M  V30 12 C 15.8026 6.3835 0.0 0
M  V30 13 C 17.0484 7.2887 0.0 0
M  V30 14 C 18.4554 6.6623 0.0 0
M  V30 15 C 19.7012 7.5676 0.0 0
M  V30 16 C 18.6163 5.1308 0.0 0
M  V30 17 C 4.6200 10.6694 0.0 0
M  V30 18 C 0.0000 8.0021 0.0 0
M  V30 19 N 11.6852 6.5806 0.0 0
M  V30 20 C 10.7800 5.3347 0.0 0
M  V30 21 C 13.1499 6.1047 0.0 0
M  V30 22 N 11.6852 4.0889 0.0 0
M  V30 23 N 13.1499 4.5647 0.0 0
M  V30 24 C 11.2094 8.0453 0.0 0
M  V30 25 C 11.5295 9.5515 0.0 0
M  V30 26 C 10.0648 9.0757 0.0 0
M  V30 27 C 4.6200 8.0021 0.0 0
M  V30 28 C 3.8500 9.3358 0.0 0
M  V30 29 C 3.8500 6.6684 0.0 0
M  V30 30 C 2.3100 9.3358 0.0 0
M  V30 31 C 2.3100 6.6684 0.0 0
M  V30 32 C 1.5400 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 27
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 11 12
M  V30 13 1 11 21
M  V30 14 1 12 13
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 17 28
M  V30 19 1 18 32
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[4-Cyclopropyl-5-(4-methylpentyl)-4H-1,2,4-triazol-3-yl]-N1-(2,4-dimethylph...
C26H39N5O2
1608134-83-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.2400 6.6684 0.0 0
M  V30 2 C 8.4700 8.0020 0.0 0
M  V30 3 C 8.4700 5.3347 0.0 0
M  V30 4 C 6.9300 8.0020 0.0 0
M  V30 5 C 9.2400 4.0011 0.0 0
M  V30 6 N 6.1600 9.3358 0.0 0
M  V30 7 O 6.1600 6.6684 0.0 0
M  V30 8 C 8.4700 2.6673 0.0 0
M  V30 9 N 9.2400 1.3336 0.0 0
M  V30 10 O 6.9300 2.6673 0.0 0
M  V30 11 C 8.4700 0.0000 0.0 0
M  V30 12 C 14.3958 8.3436 0.0 0
M  V30 13 C 15.8026 7.7172 0.0 0
M  V30 14 C 17.0484 8.6223 0.0 0
M  V30 15 C 18.4554 7.9960 0.0 0
M  V30 16 C 19.7012 8.9012 0.0 0
M  V30 17 C 18.6163 6.4645 0.0 0
M  V30 18 C 4.6200 12.0031 0.0 0
M  V30 19 C 0.0000 9.3358 0.0 0
M  V30 20 N 11.6852 7.9142 0.0 0
M  V30 21 C 10.7800 6.6684 0.0 0
M  V30 22 C 13.1499 7.4384 0.0 0
M  V30 23 N 11.6852 5.4225 0.0 0
M  V30 24 N 13.1499 5.8984 0.0 0
M  V30 25 C 11.2094 9.3789 0.0 0
M  V30 26 C 11.5295 10.8852 0.0 0
M  V30 27 C 10.0648 10.4093 0.0 0
M  V30 28 C 4.6200 9.3358 0.0 0
M  V30 29 C 3.8500 10.6694 0.0 0
M  V30 30 C 3.8500 8.0020 0.0 0
M  V30 31 C 2.3100 10.6694 0.0 0
M  V30 32 C 2.3100 8.0020 0.0 0
M  V30 33 C 1.5400 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 28
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 12 13
M  V30 14 1 12 22
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 18 29
M  V30 20 1 19 33
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 20 25
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 1 25 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1608134-81-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1608134-83-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19864341
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Second Generation RORγ Inhibitors Composed of an Azole
Scaffold
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kotoku, Masayuki; Maeba, Takaki; Fujioka, Shingo; Yokota, Masahiro; Seki,
Noriyoshi; Ito, Keisuke; Suwa, Yoshihiro; Ikenogami, Taku; Hirata,
Kazuyuki; Hase, Yasunori; Katsuda, Yoshiaki; Miyagawa, Naoki; Arita,
Kojo; Asahina, Kota; Noguchi, Masato; Nomura, Akihiro; Doi, Satoki;
Adachi, Tsuyoshi; Crowe, Paul; Tao, Haiyan; Thacher, Scott; Hashimoto,
Hiromasa; Suzuki, Takayoshi; Shiozaki, Makoto
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2019), 62(5), 2837-2842

$RFMT $RIREG SCHEME170 STEP1
$RXN



  2  1
$MOL
5-Butyl-6,7,8,9,10,11-hexahydro-6-oxo-5H-cyclohepta[c]quinoline-2-carboxylic ...
C19H23NO3
1616681-46-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 3.8501 0.0 0
M  V30 2 C 9.3360 4.6201 0.0 0
M  V30 3 C 10.6697 3.8501 0.0 0
M  V30 4 C 12.0033 4.6201 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 8.0022 6.9302 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 4.0012 6.1601 0.0 0
M  V30 12 C 2.6673 3.8501 0.0 0
M  V30 13 N 6.6685 4.6201 0.0 0
M  V30 14 C 5.3348 2.3101 0.0 0
M  V30 15 C 5.3348 6.9302 0.0 0
M  V30 16 C 2.5675 6.7227 0.0 0
M  V30 17 C 2.6673 2.3101 0.0 0
M  V30 18 C 6.6685 6.1601 0.0 0
M  V30 19 C 4.0012 1.5400 0.0 0
M  V30 20 C 5.5643 8.4529 0.0 0
M  V30 21 C 2.1135 8.1944 0.0 0
M  V30 22 C 4.5169 9.5818 0.0 0
M  V30 23 C 2.9812 9.4667 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 17
M  V30 8 2 8 18
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 11 16
M  V30 16 1 12 17
M  V30 17 1 13 18
M  V30 18 1 14 19
M  V30 19 1 15 18
M  V30 20 1 15 20
M  V30 21 1 16 21
M  V30 22 2 17 19
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Butyl-6,7,8,9,10,11-hexahydro-N-methyl-6-oxo-5H-cyclohepta[c]quinoline-2-ca...
C20H26N2O2
1616680-15-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 7.3746 0.0 0
M  V30 2 C 2.3100 7.3746 0.0 0
M  V30 3 C 1.5400 8.7084 0.0 0
M  V30 4 C 0.0000 8.7084 0.0 0
M  V30 5 C 10.7800 6.0410 0.0 0
M  V30 6 N 11.5500 7.3746 0.0 0
M  V30 7 O 11.5500 4.7073 0.0 0
M  V30 8 C 13.0900 7.3746 0.0 0
M  V30 9 O 2.3100 4.7073 0.0 0
M  V30 10 C 6.9300 4.7073 0.0 0
M  V30 11 C 6.1600 6.0410 0.0 0
M  V30 12 C 6.1600 3.3737 0.0 0
M  V30 13 C 8.4700 4.7073 0.0 0
M  V30 14 N 4.6200 6.0410 0.0 0
M  V30 15 C 6.9300 7.3746 0.0 0
M  V30 16 C 4.6200 3.3737 0.0 0
M  V30 17 C 7.1202 2.1696 0.0 0
M  V30 18 C 9.2400 6.0410 0.0 0
M  V30 19 C 3.8500 4.7073 0.0 0
M  V30 20 C 8.4700 7.3746 0.0 0
M  V30 21 C 3.6598 2.1696 0.0 0
M  V30 22 C 6.7775 0.6682 0.0 0
M  V30 23 C 4.0025 0.6682 0.0 0
M  V30 24 C 5.3900 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 18
M  V30 8 1 6 8
M  V30 9 2 9 19
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 12 17
M  V30 17 1 13 18
M  V30 18 1 14 19
M  V30 19 1 15 20
M  V30 20 1 16 19
M  V30 21 1 16 21
M  V30 22 1 17 22
M  V30 23 2 18 20
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1616681-46-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1616680-15-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5992356
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-activity relationship study of non-steroidal NPC1L1 ligands
identified through cell-based assay using pharmacological chaperone
effect as a readout
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Karaki, Fumika; Ohgane, Kenji; Fukuda, Hiromitsu; Nakamura, Masahiko;
Dodo, Kosuke; Hashimoto, Yuichi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2014), 22(14), 3587-3609

$RFMT $RIREG SCHEME171 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1-[1-[(1,1-dimethylethoxy)carbonyl]-4-piperidinyl]-2,3-dihydro-3-methy...
C22H30N2O5
1616854-60-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.8140 6.4933 0.0 0
M  V30 2 C 3.3420 4.3918 0.0 0
M  V30 3 C 2.4367 5.6376 0.0 0
M  V30 4 O 0.9052 5.4767 0.0 0
M  V30 5 O 3.0631 7.0446 0.0 0
M  V30 6 C 0.0000 6.7226 0.0 0
M  V30 7 C 4.5533 6.0591 0.0 0
M  V30 8 C 13.4032 3.7827 0.0 0
M  V30 9 O 14.1732 5.1165 0.0 0
M  V30 10 O 14.1732 2.4491 0.0 0
M  V30 11 C 15.7132 5.1165 0.0 0
M  V30 12 C 15.7132 6.6565 0.0 0
M  V30 13 C 17.2532 5.1165 0.0 0
M  V30 14 C 15.7132 3.5765 0.0 0
M  V30 15 C 6.3380 2.5368 0.0 0
M  V30 16 N 7.2432 3.7827 0.0 0
M  V30 17 C 4.8735 3.0127 0.0 0
M  V30 18 C 6.6583 1.0306 0.0 0
M  V30 19 C 6.3380 5.0286 0.0 0
M  V30 20 C 4.8735 4.5527 0.0 0
M  V30 21 C 3.7290 1.9823 0.0 0
M  V30 22 C 5.5138 0.0000 0.0 0
M  V30 23 C 4.0493 0.4760 0.0 0
M  V30 24 C 8.7832 3.7827 0.0 0
M  V30 25 C 9.5532 2.4491 0.0 0
M  V30 26 C 9.5532 5.1165 0.0 0
M  V30 27 C 11.0932 2.4491 0.0 0
M  V30 28 C 11.0932 5.1165 0.0 0
M  V30 29 N 11.8632 3.7827 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 19
M  V30 2 1 2 3
M  V30 3 1 2 20
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 20
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 29
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 2 15 18
M  V30 18 1 16 19
M  V30 19 1 16 24
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 1 19 20
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[2,3-dihydro-3-methyl-3-[2-(methylamino)-2-oxoethyl]-2-ox...
C22H31N3O4
1616855-11-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.8140 6.4933 0.0 0
M  V30 2 C 3.3420 4.3918 0.0 0
M  V30 3 C 2.4367 5.6376 0.0 0
M  V30 4 N 0.9052 5.4767 0.0 0
M  V30 5 O 3.0631 7.0446 0.0 0
M  V30 6 C 0.0000 6.7226 0.0 0
M  V30 7 C 4.5533 6.0591 0.0 0
M  V30 8 C 13.4032 3.7827 0.0 0
M  V30 9 O 14.1732 5.1165 0.0 0
M  V30 10 O 14.1732 2.4491 0.0 0
M  V30 11 C 15.7132 5.1165 0.0 0
M  V30 12 C 15.7132 6.6565 0.0 0
M  V30 13 C 17.2532 5.1165 0.0 0
M  V30 14 C 15.7132 3.5765 0.0 0
M  V30 15 C 6.3380 2.5368 0.0 0
M  V30 16 N 7.2432 3.7827 0.0 0
M  V30 17 C 4.8735 3.0127 0.0 0
M  V30 18 C 6.6583 1.0306 0.0 0
M  V30 19 C 6.3380 5.0286 0.0 0
M  V30 20 C 4.8735 4.5527 0.0 0
M  V30 21 C 3.7290 1.9823 0.0 0
M  V30 22 C 5.5138 0.0000 0.0 0
M  V30 23 C 4.0493 0.4760 0.0 0
M  V30 24 C 8.7832 3.7827 0.0 0
M  V30 25 C 9.5532 2.4491 0.0 0
M  V30 26 C 9.5532 5.1165 0.0 0
M  V30 27 C 11.0932 2.4491 0.0 0
M  V30 28 C 11.0932 5.1165 0.0 0
M  V30 29 N 11.8632 3.7827 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 19
M  V30 2 1 2 3
M  V30 3 1 2 20
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 20
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 29
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 2 15 18
M  V30 18 1 16 19
M  V30 19 1 16 24
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 1 19 20
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1616854-60-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1616855-11-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1336203
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used, alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of piperidinylindoline derivatives for use as nervous system
agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Spear, Kerry L.; Campbell, Una
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014106238 A1 2014-07-03

$RFMT $RIREG SCHEME172 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(T-4)-1,5-Cyclooctanediyl[2-(ethoxycarbonyl-κO)-1,4-diphenyl-1-buten-1-yl-κC]...
C27H33BO2
1620092-39-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.5178 5.3195 0.0 0
M  V30 2 C 8.2878 3.9859 0.0 0
M  V30 3 O 5.5484 2.6091 0.0 0
M  V30 4 C 4.5180 1.4646 0.0 0
M  V30 5 C 4.9938 0.0000 0.0 0
M  V30 6 B 3.6080 6.0895 0.0 0 CHG=3 VAL=4
M  V30 7 C 5.0725 6.5656 0.0 0 CHG=-1 VAL=4
M  V30 8 C 2.3579 6.4208 0.0 0 CHG=-1 VAL=4
M  V30 9 C 2.7942 7.3501 0.0 0 CHG=-1 VAL=4
M  V30 10 O 3.6080 4.5495 0.0 0 VAL=3
M  V30 11 C 5.9777 5.3195 0.0 0
M  V30 12 C 0.8053 5.7449 0.0 0
M  V30 13 C 1.7595 8.0759 0.0 0
M  V30 14 C 2.1463 9.0516 0.0 0
M  V30 15 C 1.1649 6.6609 0.0 0
M  V30 16 C 5.0725 4.0737 0.0 0
M  V30 17 C 0.0000 7.0059 0.0 0
M  V30 18 C 0.6354 8.7533 0.0 0
M  V30 19 C 5.5484 8.0301 0.0 0
M  V30 20 C 7.0548 8.3503 0.0 0
M  V30 21 C 4.5180 9.1747 0.0 0
M  V30 22 C 7.5307 9.8150 0.0 0
M  V30 23 C 4.9938 10.6392 0.0 0
M  V30 24 C 6.5003 10.9594 0.0 0
M  V30 25 C 9.8278 3.9859 0.0 0
M  V30 26 C 10.5978 2.6522 0.0 0
M  V30 27 C 10.5978 5.3195 0.0 0
M  V30 28 C 12.1378 2.6522 0.0 0
M  V30 29 C 12.1378 5.3195 0.0 0
M  V30 30 C 12.9078 3.9859 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 25
M  V30 4 1 3 4
M  V30 5 1 3 16
M  V30 6 1 4 5
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 2 7 11
M  V30 12 1 7 19
M  V30 13 1 8 12
M  V30 14 1 8 13
M  V30 15 1 9 14
M  V30 16 1 9 15
M  V30 17 2 10 16
M  V30 18 1 11 16
M  V30 19 1 12 17
M  V30 20 1 13 18
M  V30 21 1 14 18
M  V30 22 1 15 17
M  V30 23 2 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 23 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-α-(9-Borabicyclo[3.3.1]non-9-ylphenylmethylene)-N-methylbenzenebutanamide
C26H32BNO
1620092-65-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5104 5.3347 0.0 0
M  V30 2 C 6.2804 4.0011 0.0 0
M  V30 3 C 7.8204 4.0011 0.0 0
M  V30 4 C 5.5104 2.6674 0.0 0
M  V30 5 C 8.5904 2.6674 0.0 0
M  V30 6 N 6.2804 1.3336 0.0 0
M  V30 7 O 3.9704 2.6674 0.0 0
M  V30 8 C 5.5104 0.0000 0.0 0
M  V30 9 B 3.9704 5.3347 0.0 0
M  V30 10 C 2.7646 5.8015 0.0 0
M  V30 11 C 2.5712 4.7933 0.0 0
M  V30 12 C 1.9058 7.2609 0.0 0
M  V30 13 C 1.3076 4.8143 0.0 0
M  V30 14 C 1.0470 3.7975 0.0 0
M  V30 15 C 1.6583 6.3086 0.0 0
M  V30 16 C 0.5131 6.7141 0.0 0
M  V30 17 C 0.0000 4.9269 0.0 0
M  V30 18 C 6.2804 6.6684 0.0 0
M  V30 19 C 5.5104 8.0021 0.0 0
M  V30 20 C 7.8204 6.6684 0.0 0
M  V30 21 C 6.2804 9.3358 0.0 0
M  V30 22 C 8.5904 8.0021 0.0 0
M  V30 23 C 7.8204 9.3358 0.0 0
M  V30 24 C 10.1304 2.6674 0.0 0
M  V30 25 C 10.9004 4.0011 0.0 0
M  V30 26 C 10.9004 1.3336 0.0 0
M  V30 27 C 12.4404 4.0011 0.0 0
M  V30 28 C 12.4404 1.3336 0.0 0
M  V30 29 C 13.2104 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 1 18
M  V30 4 1 2 3
M  V30 5 1 2 4
M  V30 6 1 3 5
M  V30 7 1 4 6
M  V30 8 2 4 7
M  V30 9 1 5 24
M  V30 10 1 6 8
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 1 11 15
M  V30 17 1 12 16
M  V30 18 1 13 17
M  V30 19 1 14 17
M  V30 20 1 15 16
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1620092-39-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1620092-65-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11573355
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a solution of 4aa (40 mg, 0.1 mmol) in THF (0.5 mL) was added MeNH2 (2
M in MeOH, 100 μL, 0.2 mmol) at room temperature. After being stirred at
60 °C for 24 h, the mixture was evaporated under reduced pressure. The
residue was purified by flash column chromatography on silica gel (0-20%
EtOAc/hexane). The corresponding secondary amide (38.1 mg, 0.099 mmol)
quantitavely. White solid. M.p. 159-162 °C. IR (neat) 701, 758, 1201,
1354, 1414, 1599, 1737, 2841, 2932, 3456 cm-1. 1H NMR (400 MHz, CDCl3) δ
0.76 (s, 2H), 1.12 (m, 1H), 1.50-1.80 (m, 8H), 1.85-2.05 (m, 3H), 2.21
(t, J = 7.2 Hz, 2H), 2.55 (t, J = 7.2 Hz, 2H), 2.82 (d, J = 4.0 Hz, 3H),
5.12 (d, J = 4.0 Hz, 1H), 6.88-6.90 (m, 2H), 7.04-7.06 (m, 2H), 7.13-7.23
(m, 2H), 7.25-7.30 (m, 4H). 13C NMR (100.5 MHz, CDCl3) δ 24.93, 26.41,
26.90, 28.24, 32.20, 32.93, 36.30, 124.58, 124.88, 125.16, 126.43,
127.68, 128.56, 128.70, 141.45, 144.18, 175.45. A signal for the
sp2-carbon directly attached to the boron atom was not observed. 11B NMR
(128 MHz, CDCl3) δ 10.7. HRMS-EI (m/z): [M]+ calcd for C26H32BNO2,
385.25756; found, 385.25769.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Phosphine-catalyzed anti-carboboration of alkynoates with alkyl-,
alkenyl-, and arylboranes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nagao, Kazunori; Ohmiya, Hirohisa; Sawamura, Masaya
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2014), 136(30), 10605-10608

$RFMT $RIREG SCHEME173 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-[(1R,3R)-4-methyl-3-[methyl[(2S,3S)-3-methyl-2-[[[(2R)-1-methyl-2-pi...
C32H45N5O9S
1621879-54-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  47 49 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 11.5500 7.7393 0.0 0 CFG=2
M  V30 2 C 10.0100 7.7393 0.0 0
M  V30 3 O 12.3200 9.0729 0.0 0
M  V30 4 C 9.2400 9.0729 0.0 0 CFG=2
M  V30 5 C 13.8600 9.0729 0.0 0
M  V30 6 N 7.7000 9.0729 0.0 0
M  V30 7 C 10.0100 10.4067 0.0 0
M  V30 8 O 14.6300 10.4067 0.0 0
M  V30 9 O 14.6300 7.7393 0.0 0
M  V30 10 C 6.9300 7.7393 0.0 0
M  V30 11 C 6.9300 10.4067 0.0 0
M  V30 12 C 9.2400 11.7403 0.0 0
M  V30 13 C 11.5500 10.4067 0.0 0
M  V30 14 C 5.3900 7.7393 0.0 0 CFG=2
M  V30 15 O 7.7000 6.4056 0.0 0
M  V30 16 N 4.6200 9.0729 0.0 0
M  V30 17 C 4.6200 6.4056 0.0 0 CFG=1
M  V30 18 C 3.0800 9.0729 0.0 0
M  V30 19 C 5.3900 5.0720 0.0 0
M  V30 20 C 3.0800 6.4056 0.0 0
M  V30 21 O 2.3100 7.7393 0.0 0
M  V30 22 C 4.6200 3.7382 0.0 0
M  V30 23 C 12.6771 2.4367 0.0 0
M  V30 24 O 13.9230 1.5315 0.0 0
M  V30 25 O 11.2702 1.8104 0.0 0
M  V30 26 C 13.7621 0.0000 0.0 0
M  V30 27 N 20.7900 10.4067 0.0 0 VAL=5
M  V30 28 O 21.5600 11.7403 0.0 0
M  V30 29 O 21.5600 9.0729 0.0 0
M  V30 30 C 0.0000 9.0729 0.0 0
M  V30 31 C 12.3200 6.4056 0.0 0
M  V30 32 N 11.6937 4.9987 0.0 0
M  V30 33 S 13.8515 6.2447 0.0 0
M  V30 34 C 12.8381 3.9683 0.0 0
M  V30 35 C 14.1717 4.7383 0.0 0
M  V30 36 C 16.1700 10.4067 0.0 0
M  V30 37 C 16.9400 11.7403 0.0 0
M  V30 38 C 16.9400 9.0729 0.0 0
M  V30 39 C 18.4800 11.7403 0.0 0
M  V30 40 C 18.4800 9.0729 0.0 0
M  V30 41 C 19.2500 10.4067 0.0 0
M  V30 42 C 2.3100 10.4067 0.0 0 CFG=1
M  V30 43 N 0.7700 10.4067 0.0 0
M  V30 44 C 3.0800 11.7403 0.0 0
M  V30 45 C 0.0000 11.7403 0.0 0
M  V30 46 C 2.3100 13.0740 0.0 0
M  V30 47 C 0.7700 13.0740 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 31
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7 CFG=1
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 6 11
M  V30 12 1 7 12
M  V30 13 1 7 13
M  V30 14 1 8 36
M  V30 15 1 10 14
M  V30 16 2 10 15
M  V30 17 1 14 16 CFG=3
M  V30 18 1 14 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 17 20 CFG=3
M  V30 22 2 18 21
M  V30 23 1 42 18 CFG=3
M  V30 24 1 19 22
M  V30 25 1 23 24
M  V30 26 2 23 25
M  V30 27 1 23 34
M  V30 28 1 24 26
M  V30 29 2 27 28
M  V30 30 2 27 29
M  V30 31 1 27 41
M  V30 32 1 30 43
M  V30 33 2 31 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 2 34 35
M  V30 38 2 36 37
M  V30 39 1 36 38
M  V30 40 1 37 39
M  V30 41 2 38 40
M  V30 42 2 39 41
M  V30 43 1 40 41
M  V30 44 1 42 43
M  V30 45 1 42 44
M  V30 46 1 43 45
M  V30 47 1 44 46
M  V30 48 1 45 47
M  V30 49 1 46 47
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 1 4 14 17 42)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methyl 2-[(1R,3R)-4-methyl-1-[[(methylamino)carbonyl]oxy]-3-[methyl[(2S,3S)-3...
C27H45N5O6S
1621879-55-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.0101 5.3348 0.0 0 CFG=2
M  V30 2 C 9.2401 6.6684 0.0 0
M  V30 3 O 9.2401 4.0010 0.0 0
M  V30 4 C 7.7001 6.6684 0.0 0 CFG=2
M  V30 5 C 10.0101 2.6673 0.0 0
M  V30 6 N 6.9301 8.0021 0.0 0
M  V30 7 C 6.9301 5.3348 0.0 0
M  V30 8 N 9.2401 1.3337 0.0 0
M  V30 9 O 11.5502 2.6673 0.0 0
M  V30 10 C 7.7001 9.3358 0.0 0
M  V30 11 C 5.3901 8.0021 0.0 0
M  V30 12 C 7.7001 4.0010 0.0 0
M  V30 13 C 5.3901 5.3348 0.0 0
M  V30 14 C 10.0101 0.0000 0.0 0
M  V30 15 C 6.9301 10.6696 0.0 0 CFG=2
M  V30 16 O 9.2401 9.3358 0.0 0
M  V30 17 N 5.3901 10.6696 0.0 0
M  V30 18 C 7.7001 12.0032 0.0 0 CFG=1
M  V30 19 C 4.6201 12.0032 0.0 0
M  V30 20 C 9.2401 12.0032 0.0 0
M  V30 21 C 6.9301 13.3369 0.0 0
M  V30 22 O 5.3901 13.3369 0.0 0
M  V30 23 C 10.0101 13.3369 0.0 0
M  V30 24 C 15.1658 7.0099 0.0 0
M  V30 25 O 16.5728 6.3835 0.0 0
M  V30 26 O 15.0049 8.5416 0.0 0
M  V30 27 C 17.8187 7.2888 0.0 0
M  V30 28 C 3.0800 14.6705 0.0 0
M  V30 29 C 11.5502 5.3348 0.0 0
M  V30 30 N 12.4554 6.5807 0.0 0
M  V30 31 S 12.4554 4.0888 0.0 0
M  V30 32 C 13.9199 6.1048 0.0 0
M  V30 33 C 13.9199 4.5648 0.0 0
M  V30 34 C 3.0800 12.0032 0.0 0 CFG=1
M  V30 35 N 2.3100 13.3369 0.0 0
M  V30 36 C 2.3100 10.6696 0.0 0
M  V30 37 C 0.7700 13.3369 0.0 0
M  V30 38 C 0.7700 10.6696 0.0 0
M  V30 39 C 0.0000 12.0032 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 29
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7 CFG=3
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 6 11
M  V30 12 1 7 12
M  V30 13 1 7 13
M  V30 14 1 8 14
M  V30 15 1 10 15
M  V30 16 2 10 16
M  V30 17 1 15 17 CFG=1
M  V30 18 1 15 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 21 CFG=1
M  V30 22 2 19 22
M  V30 23 1 34 19 CFG=1
M  V30 24 1 20 23
M  V30 25 1 24 25
M  V30 26 2 24 26
M  V30 27 1 24 32
M  V30 28 1 25 27
M  V30 29 1 28 35
M  V30 30 2 29 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 1 31 33
M  V30 34 2 32 33
M  V30 35 1 34 35
M  V30 36 1 34 36
M  V30 37 1 35 37
M  V30 38 1 36 38
M  V30 39 1 37 39
M  V30 40 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 1 4 15 18 34)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1621879-54-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1621879-55-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-23625714
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Biological Evaluation of a Carbamate-Containing Tubulysin
Antibody-Drug Conjugate
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cheng, Heng; Cong, Qiang; Dervin, Dan; Stevens, Alice; Vemuri, Kavitha;
Huber, Mary; Juliano, Jennifer; Cuison, Severino; Sung, Janette;
Passmore, David; Chong, Colin; Greenbaum, Meghan; Kwok, Eilene; Jiang,
Jerry; Pan, Chin; Rao-Naik, Chetana; Rangan, Vangipuram; Kempe, Tom;
Tatum, Andrea; Deshpande, Shrikant; Cardarelli, Pina; Vite, Gregory;
Gangwar, Sanjeev
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioconjugate Chemistry (2020), 31(10), 2350-2361

$RFMT $RIREG SCHEME174 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(7-Chloro-2,1,3-benzoxadiazol-4-yl)sulfonyl]-N-methylglycine 1,1-dimethyle...
C13H16ClN3O5S
1622078-09-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 4.2074 0.0 0 VAL=6
M  V30 2 N 7.7000 4.2074 0.0 0
M  V30 3 O 6.1600 5.7474 0.0 0
M  V30 4 O 6.1600 2.6674 0.0 0
M  V30 5 C 8.4700 2.8738 0.0 0
M  V30 6 C 8.4700 5.5411 0.0 0
M  V30 7 C 10.0100 2.8738 0.0 0
M  V30 8 O 10.7800 1.5400 0.0 0
M  V30 9 O 10.7800 4.2074 0.0 0
M  V30 10 C 12.3200 1.5400 0.0 0
M  V30 11 C 12.3200 3.0800 0.0 0
M  V30 12 C 13.8600 1.5400 0.0 0
M  V30 13 C 12.3200 0.0000 0.0 0
M  V30 14 Cl 0.0000 4.2074 0.0 0
M  V30 15 C 3.8500 5.5411 0.0 0
M  V30 16 C 4.6200 4.2074 0.0 0
M  V30 17 C 2.3100 5.5411 0.0 0
M  V30 18 N 4.3259 7.0058 0.0 0
M  V30 19 C 3.8500 2.8738 0.0 0
M  V30 20 C 1.5400 4.2074 0.0 0
M  V30 21 N 1.8341 7.0058 0.0 0
M  V30 22 O 3.0800 7.9110 0.0 0
M  V30 23 C 2.3100 2.8738 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 16
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 20
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 2 15 18
M  V30 18 2 16 19
M  V30 19 1 17 20
M  V30 20 2 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 2 20 23
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-N-[[7-(methylamino)-2,1,3-benzoxadiazol-4-yl]sulfonyl]glycine 1,1-di...
C14H20N4O5S
1622078-10-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 3.7035 0.0 0 VAL=6
M  V30 2 N 8.4700 3.7035 0.0 0
M  V30 3 O 6.9300 5.2435 0.0 0
M  V30 4 O 6.9300 2.1635 0.0 0
M  V30 5 C 9.2400 5.0372 0.0 0
M  V30 6 C 9.2400 2.3699 0.0 0
M  V30 7 C 10.7800 5.0372 0.0 0
M  V30 8 O 11.5500 6.3710 0.0 0
M  V30 9 O 11.5500 3.7035 0.0 0
M  V30 10 C 13.0900 6.3710 0.0 0
M  V30 11 C 13.0900 7.9110 0.0 0
M  V30 12 C 14.6300 6.3710 0.0 0
M  V30 13 C 13.0900 4.8310 0.0 0
M  V30 14 N 0.7700 3.7035 0.0 0
M  V30 15 C 0.0000 5.0372 0.0 0
M  V30 16 C 4.6200 2.3699 0.0 0
M  V30 17 C 5.3900 3.7035 0.0 0
M  V30 18 C 3.0800 2.3699 0.0 0
M  V30 19 N 5.0959 0.9052 0.0 0
M  V30 20 C 4.6200 5.0372 0.0 0
M  V30 21 C 2.3100 3.7035 0.0 0
M  V30 22 N 2.6041 0.9052 0.0 0
M  V30 23 O 3.8500 0.0000 0.0 0
M  V30 24 C 3.0800 5.0372 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 17
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 15
M  V30 15 1 14 21
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 2 16 19
M  V30 19 2 17 20
M  V30 20 1 18 21
M  V30 21 2 18 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 2 21 24
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1622078-09-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1622078-10-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-15801987
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fluorescent Probe Encapsulated in SNAP-Tag Protein Cavity To Eliminate
Nonspecific Fluorescence and Increase Detection Sensitivity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zeng, Yan-Syun; Gao, Ruo-Cing; Wu, Ting-Wei; Cho, Chien; Tan, Kui-Thong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioconjugate Chemistry (2016), 27(8), 1872-1879

$RFMT $RIREG SCHEME174 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(7-Chloro-2,1,3-benzoxadiazol-4-yl)sulfonyl]-N-methylglycine 1,1-dimethyle...
C13H16ClN3O5S
1622078-09-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 4.2074 0.0 0 VAL=6
M  V30 2 N 7.7000 4.2074 0.0 0
M  V30 3 O 6.1600 5.7474 0.0 0
M  V30 4 O 6.1600 2.6674 0.0 0
M  V30 5 C 8.4700 2.8738 0.0 0
M  V30 6 C 8.4700 5.5411 0.0 0
M  V30 7 C 10.0100 2.8738 0.0 0
M  V30 8 O 10.7800 1.5400 0.0 0
M  V30 9 O 10.7800 4.2074 0.0 0
M  V30 10 C 12.3200 1.5400 0.0 0
M  V30 11 C 12.3200 3.0800 0.0 0
M  V30 12 C 13.8600 1.5400 0.0 0
M  V30 13 C 12.3200 0.0000 0.0 0
M  V30 14 Cl 0.0000 4.2074 0.0 0
M  V30 15 C 3.8500 5.5411 0.0 0
M  V30 16 C 4.6200 4.2074 0.0 0
M  V30 17 C 2.3100 5.5411 0.0 0
M  V30 18 N 4.3259 7.0058 0.0 0
M  V30 19 C 3.8500 2.8738 0.0 0
M  V30 20 C 1.5400 4.2074 0.0 0
M  V30 21 N 1.8341 7.0058 0.0 0
M  V30 22 O 3.0800 7.9110 0.0 0
M  V30 23 C 2.3100 2.8738 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 16
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 20
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 2 15 18
M  V30 18 2 16 19
M  V30 19 1 17 20
M  V30 20 2 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 2 20 23
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-N-[[7-(methylamino)-2,1,3-benzoxadiazol-4-yl]sulfonyl]glycine 1,1-di...
C14H20N4O5S
1622078-10-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 3.7035 0.0 0 VAL=6
M  V30 2 N 8.4700 3.7035 0.0 0
M  V30 3 O 6.9300 5.2435 0.0 0
M  V30 4 O 6.9300 2.1635 0.0 0
M  V30 5 C 9.2400 5.0372 0.0 0
M  V30 6 C 9.2400 2.3699 0.0 0
M  V30 7 C 10.7800 5.0372 0.0 0
M  V30 8 O 11.5500 6.3710 0.0 0
M  V30 9 O 11.5500 3.7035 0.0 0
M  V30 10 C 13.0900 6.3710 0.0 0
M  V30 11 C 13.0900 7.9110 0.0 0
M  V30 12 C 14.6300 6.3710 0.0 0
M  V30 13 C 13.0900 4.8310 0.0 0
M  V30 14 N 0.7700 3.7035 0.0 0
M  V30 15 C 0.0000 5.0372 0.0 0
M  V30 16 C 4.6200 2.3699 0.0 0
M  V30 17 C 5.3900 3.7035 0.0 0
M  V30 18 C 3.0800 2.3699 0.0 0
M  V30 19 N 5.0959 0.9052 0.0 0
M  V30 20 C 4.6200 5.0372 0.0 0
M  V30 21 C 2.3100 3.7035 0.0 0
M  V30 22 N 2.6041 0.9052 0.0 0
M  V30 23 O 3.8500 0.0000 0.0 0
M  V30 24 C 3.0800 5.0372 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 17
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 15
M  V30 15 1 14 21
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 2 16 19
M  V30 19 2 17 20
M  V30 20 1 18 21
M  V30 21 2 18 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 2 21 24
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1622078-09-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1622078-10-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-1336220
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of compound 4 Methylamine (40% in methanol, 147 μL, 1.5 mmol)
was added to compound 3 (50 mg, 138 μmol) in a round botoom flask at room
temperature. The resulting mixture was stirred for 1 hour at room
temperature. Excess methylamine was removed under reduced pressure and
the crude was redissolved in 50 mL ethyl acetate. The organic layer was
extracted with 50 mL 1 M HCl (2x) and 30 mL brine (1x). The combined
organic layer was dried over MgSO4, filtered and concentrated. The
desired product 4 as a yellow powder. Product 4 was used in the next step
without further purification. Yield = quantitative (48 mg); Rf = 0.26 (EA
: Hex = 1 : 4); 1H NMR (600 MHz, CDCl3) δ 7.88 (d, J = 7.9 Hz, 1H), 6.06
(d, J = 8.0 Hz, 1H), 5.68 (d, J = 4.6 Hz, 1H), 4.09 (s, 2H), 3.09 (d, J =
5.2 Hz, 3H), 2.96 (s, 3H), 1.32 (s, 9H) ppm; 13C NMR (150 MHz, CDCl3) δ
167.84, 145.99, 144.38, 141.38, 138.40, 112.14, 98.43, 81.95, 51.86,
35.45, 30.03, 27.88 ppm; HRMS (ESI): m/z calc. for C16H19N6O3S 375.1239
[M+H]+, found 375.1225 [M+H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Rapid SNAP-Tag Fluorogenic Probe Based on an Environment-Sensitive
Fluorophore for No-Wash Live Cell Imaging
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Tao-Kai; Hsieh, Pei-Ying; Zhuang, Yu-De; Hsia, Chi-Yang; Huang,
Chi-Ling; Lai, Hsiu-Ping; Lin, Hung-Sheung; Chen, I-Chia; Hsu, Hsin-Yun;
Tan, Kui-Thong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Chemical Biology (2014), 9(10), 2359-2365

$RFMT $RIREG SCHEME175 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(5-Bromo-2-hydroxyphenyl)-2-pyridinylmethanone
C12H8BrNO2
162271-31-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6200 0.0 0
M  V30 2 O 4.0011 6.1600 0.0 0
M  V30 3 O 1.3336 6.1600 0.0 0
M  V30 4 Br 1.3336 0.0000 0.0 0
M  V30 5 C 2.6674 3.8500 0.0 0
M  V30 6 C 1.3336 4.6200 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 0.0000 3.8500 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 5.3347 3.8500 0.0 0
M  V30 12 C 5.3347 2.3100 0.0 0
M  V30 13 N 6.6685 4.6200 0.0 0
M  V30 14 C 6.6685 1.5400 0.0 0
M  V30 15 C 8.0021 3.8500 0.0 0
M  V30 16 C 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 1 11
M  V30 4 1 3 6
M  V30 5 1 4 9
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-[(methylimino)-2-pyridinylmethyl]phenol
C13H11BrN2O
1182372-36-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6200 0.0 0
M  V30 2 N 4.0011 6.1600 0.0 0
M  V30 3 C 5.3347 6.9300 0.0 0
M  V30 4 O 1.3336 6.1600 0.0 0
M  V30 5 Br 1.3336 0.0000 0.0 0
M  V30 6 C 2.6674 3.8500 0.0 0
M  V30 7 C 1.3336 4.6200 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 0.0000 3.8500 0.0 0
M  V30 10 C 1.3336 1.5400 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 5.3347 3.8500 0.0 0
M  V30 13 C 6.6685 4.6200 0.0 0
M  V30 14 N 5.3347 2.3100 0.0 0
M  V30 15 C 8.0021 3.8500 0.0 0
M  V30 16 C 6.6685 1.5400 0.0 0
M  V30 17 C 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 1 12
M  V30 4 1 2 3
M  V30 5 1 4 7
M  V30 6 1 5 10
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 162271-31-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1182372-36-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-1918339
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Typical Procedure On one side of an H-tube,
the described ketone was added, and to the other side, aqueous amine
solution or neat amine was added. The tube was sealed immediately with a
rubber seal stopper, and the reaction was monitored by 1H NMR
spectrometry. The excess ammonia or amine gas was removed under reduced
pressure to give the corresponding imine.
4-Bromo-2-[(methylimino)(pyridin-2-yl)methyl]phenol (3i) Employing the
general method, imine (3i) was prepared from ketone (1b) (55 mg, 0.19
mmol) and 40% methylamine aq. solution (2 mL). After 24 h, the yellow
solid was converted to an orange liquid corresponding to 3i with 100%
conversion. The excess methylamine was removed under reduced pressure to
give the title compound (3i) as a yellow oil (57 mg, 100%). 1H NMR (400
MHz, CDCl3) δ 3.13 (s, 3H), 6.72 (d, J = 2.4 Hz, 1H), 6.84 (d, J = 8.8
Hz, 1H), 7.24 (dt, J = 1.0, 7.7 Hz, 1H), 7.29 (dd, J = 2.4, 8.8 Hz, 1H),
7.40 (dd, J = 4.8, 7.7 Hz, 1H), 7.85 (dt, J = 1.7, 7.7 Hz, 1H), 8.76 (d,
J = 4.8 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 38.33, 108.88, 120.20,
120.28, 123.18, 124.17, 132.68, 135.15, 136.92, 150.52, 151.79, 162.69,
172.02. IR (neat) νmax 1616s, 1585s, 1567m, 1475s, 1430w, 1402w, 1386w,
1332m, 1291s, 1256m, 1012w, 824s, cm-1. Ms calc. (found) for C13H12BrN2O+
(M + H+): m/z 291.1 (291.2. 293.2, 100%). HRMS calc. (found) for
C13H12BrN2O+ (M + H+): m/z 291.0133 (291.0124, 293.0145).
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed H-tube used, 100% conversion
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Simplified Ketimine Preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Thienthong, Neeranat; Bergman, Ylva E.; Perlmutter, Patrick
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2009), 39(15), 2683-2693

$RFMT $RIREG SCHEME176 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2Z)-3-Chloro-N-(4-methylphenyl)-2-(phenylthio)-2-propenamide
C16H14ClNOS
162375-28-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 2.6674 0.0 0
M  V30 2 S 4.6200 1.3338 0.0 0
M  V30 3 C 6.9300 2.6674 0.0 0
M  V30 4 C 4.6200 4.0011 0.0 0
M  V30 5 N 7.7000 4.0011 0.0 0
M  V30 6 O 7.7000 1.3338 0.0 0
M  V30 7 Cl 3.0800 4.0011 0.0 0
M  V30 8 C 13.8600 4.0011 0.0 0
M  V30 9 C 3.0800 1.3338 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 12 C 0.7700 2.6674 0.0 0
M  V30 13 C 0.7700 0.0000 0.0 0
M  V30 14 C 0.0000 1.3338 0.0 0
M  V30 15 C 9.2400 4.0011 0.0 0
M  V30 16 C 10.0100 2.6674 0.0 0
M  V30 17 C 10.0100 5.3349 0.0 0
M  V30 18 C 11.5500 2.6674 0.0 0
M  V30 19 C 11.5500 5.3349 0.0 0
M  V30 20 C 12.3200 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 9
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 15
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Methylamino)-N-(4-methylphenyl)-2-(phenylthio)-2-propenamide
C17H18N2OS
1294897-26-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 2.6674 0.0 0
M  V30 2 S 4.6200 1.3338 0.0 0
M  V30 3 C 6.9300 2.6674 0.0 0
M  V30 4 C 4.6200 4.0011 0.0 0
M  V30 5 N 7.7000 4.0011 0.0 0
M  V30 6 O 7.7000 1.3338 0.0 0
M  V30 7 N 3.0800 4.0011 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 C 13.8600 4.0011 0.0 0
M  V30 10 C 3.0800 1.3338 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 12 C 2.3100 2.6674 0.0 0
M  V30 13 C 0.7700 0.0000 0.0 0
M  V30 14 C 0.7700 2.6674 0.0 0
M  V30 15 C 0.0000 1.3338 0.0 0
M  V30 16 C 9.2400 4.0011 0.0 0
M  V30 17 C 10.0100 2.6674 0.0 0
M  V30 18 C 10.0100 5.3349 0.0 0
M  V30 19 C 11.5500 2.6674 0.0 0
M  V30 20 C 11.5500 5.3349 0.0 0
M  V30 21 C 12.3200 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4 CFG=2
M  V30 4 1 2 10
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 16
M  V30 9 1 7 8
M  V30 10 1 9 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 162375-28-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1294897-26-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-1642299
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, 3:1 E:Z initially but isomers interconvert on silica gel
or in storage
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Addition-substitution reactions of 2-thio-3-chloroacrylamides with
carbon, nitrogen, oxygen, sulfur and selenium nucleophiles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kissane, Marie; Murphy, Maureen; O'Brien, Elisabeth; Chopra, Jay; Murphy,
Linda; Collins, Stuart G.; Lawrence, Simon E.; Maguire, Anita R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2011), 9(7), 2452-2472

$RFMT $RIREG SCHEME177 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-1-(1-methylethyl)-6-[3-(2-oxiranylmethoxy)phenyl]-1H-pyrazolo[3,4-b]...
C18H18ClN3O2
1628459-85-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5063 5.7907 0.0 0
M  V30 2 C 2.5369 6.9351 0.0 0
M  V30 3 C 0.0000 6.1109 0.0 0
M  V30 4 Cl 4.7806 0.0000 0.0 0
M  V30 5 O 11.4492 3.8501 0.0 0
M  V30 6 C 12.7829 4.6201 0.0 0
M  V30 7 C 3.4469 3.8501 0.0 0
M  V30 8 C 3.4469 2.3101 0.0 0
M  V30 9 N 1.9823 4.3260 0.0 0
M  V30 10 N 4.7806 4.6201 0.0 0
M  V30 11 C 4.7806 1.5400 0.0 0
M  V30 12 C 1.9823 1.8342 0.0 0
M  V30 13 N 1.0771 3.0801 0.0 0
M  V30 14 C 6.1144 3.8501 0.0 0
M  V30 15 C 6.1144 2.3101 0.0 0
M  V30 16 C 7.4481 4.6201 0.0 0
M  V30 17 C 8.7817 3.8501 0.0 0
M  V30 18 C 7.4481 6.1601 0.0 0
M  V30 19 C 10.1154 4.6201 0.0 0
M  V30 20 C 8.7817 6.9302 0.0 0
M  V30 21 C 10.1154 6.1601 0.0 0
M  V30 22 C 14.1166 3.8501 0.0 0
M  V30 23 C 14.8866 2.5164 0.0 0
M  V30 24 O 15.6566 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 1 5 19
M  V30 7 1 6 22
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[3-[4-Chloro-1-(1-methylethyl)-1H-pyrazolo[3,4-b]pyridin-6-yl]phenoxy]-3-(m...
C19H23ClN4O2
1628459-86-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5063 5.7906 0.0 0
M  V30 2 C 2.5367 6.9350 0.0 0
M  V30 3 C 0.0000 6.1108 0.0 0
M  V30 4 Cl 4.7805 0.0000 0.0 0
M  V30 5 O 11.4490 3.8501 0.0 0
M  V30 6 C 12.7826 4.6201 0.0 0
M  V30 7 C 14.1164 3.8501 0.0 0
M  V30 8 C 15.4501 4.6201 0.0 0
M  V30 9 O 14.1164 2.3100 0.0 0
M  V30 10 N 16.7838 3.8501 0.0 0
M  V30 11 C 18.1174 4.6201 0.0 0
M  V30 12 C 3.4469 3.8501 0.0 0
M  V30 13 C 3.4469 2.3100 0.0 0
M  V30 14 N 1.9822 4.3259 0.0 0
M  V30 15 N 4.7805 4.6201 0.0 0
M  V30 16 C 4.7805 1.5400 0.0 0
M  V30 17 C 1.9822 1.8342 0.0 0
M  V30 18 N 1.0769 3.0800 0.0 0
M  V30 19 C 6.1142 3.8501 0.0 0
M  V30 20 C 6.1142 2.3100 0.0 0
M  V30 21 C 7.4478 4.6201 0.0 0
M  V30 22 C 8.7817 3.8501 0.0 0
M  V30 23 C 7.4478 6.1601 0.0 0
M  V30 24 C 10.1153 4.6201 0.0 0
M  V30 25 C 8.7817 6.9301 0.0 0
M  V30 26 C 10.1153 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 4 16
M  V30 5 1 5 6
M  V30 6 1 5 24
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 2 12 15
M  V30 15 2 13 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1628459-85-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1628459-86-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-19775574
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM CARM1 inhibitors for treating Cancer and Metabolic disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chesworth, Richard; Moradei, Oscar Miguel; Shapiro, Gideon; Duncan,
Kenneth W.; Mitchell, Lorna Helen; Jin, Lei; Babine, Robert E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016044650 A1 2016-03-24

$RFMT $RIREG SCHEME177 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-1-(1-methylethyl)-6-[3-(2-oxiranylmethoxy)phenyl]-1H-pyrazolo[3,4-b]...
C18H18ClN3O2
1628459-85-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5063 5.7907 0.0 0
M  V30 2 C 2.5369 6.9351 0.0 0
M  V30 3 C 0.0000 6.1109 0.0 0
M  V30 4 Cl 4.7806 0.0000 0.0 0
M  V30 5 O 11.4492 3.8501 0.0 0
M  V30 6 C 12.7829 4.6201 0.0 0
M  V30 7 C 3.4469 3.8501 0.0 0
M  V30 8 C 3.4469 2.3101 0.0 0
M  V30 9 N 1.9823 4.3260 0.0 0
M  V30 10 N 4.7806 4.6201 0.0 0
M  V30 11 C 4.7806 1.5400 0.0 0
M  V30 12 C 1.9823 1.8342 0.0 0
M  V30 13 N 1.0771 3.0801 0.0 0
M  V30 14 C 6.1144 3.8501 0.0 0
M  V30 15 C 6.1144 2.3101 0.0 0
M  V30 16 C 7.4481 4.6201 0.0 0
M  V30 17 C 8.7817 3.8501 0.0 0
M  V30 18 C 7.4481 6.1601 0.0 0
M  V30 19 C 10.1154 4.6201 0.0 0
M  V30 20 C 8.7817 6.9302 0.0 0
M  V30 21 C 10.1154 6.1601 0.0 0
M  V30 22 C 14.1166 3.8501 0.0 0
M  V30 23 C 14.8866 2.5164 0.0 0
M  V30 24 O 15.6566 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 1 5 19
M  V30 7 1 6 22
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[3-[4-Chloro-1-(1-methylethyl)-1H-pyrazolo[3,4-b]pyridin-6-yl]phenoxy]-3-(m...
C19H23ClN4O2
1628459-86-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5063 5.7906 0.0 0
M  V30 2 C 2.5367 6.9350 0.0 0
M  V30 3 C 0.0000 6.1108 0.0 0
M  V30 4 Cl 4.7805 0.0000 0.0 0
M  V30 5 O 11.4490 3.8501 0.0 0
M  V30 6 C 12.7826 4.6201 0.0 0
M  V30 7 C 14.1164 3.8501 0.0 0
M  V30 8 C 15.4501 4.6201 0.0 0
M  V30 9 O 14.1164 2.3100 0.0 0
M  V30 10 N 16.7838 3.8501 0.0 0
M  V30 11 C 18.1174 4.6201 0.0 0
M  V30 12 C 3.4469 3.8501 0.0 0
M  V30 13 C 3.4469 2.3100 0.0 0
M  V30 14 N 1.9822 4.3259 0.0 0
M  V30 15 N 4.7805 4.6201 0.0 0
M  V30 16 C 4.7805 1.5400 0.0 0
M  V30 17 C 1.9822 1.8342 0.0 0
M  V30 18 N 1.0769 3.0800 0.0 0
M  V30 19 C 6.1142 3.8501 0.0 0
M  V30 20 C 6.1142 2.3100 0.0 0
M  V30 21 C 7.4478 4.6201 0.0 0
M  V30 22 C 8.7817 3.8501 0.0 0
M  V30 23 C 7.4478 6.1601 0.0 0
M  V30 24 C 10.1153 4.6201 0.0 0
M  V30 25 C 8.7817 6.9301 0.0 0
M  V30 26 C 10.1153 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 4 16
M  V30 5 1 5 6
M  V30 6 1 5 24
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 2 12 15
M  V30 15 2 13 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1628459-85-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1628459-86-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-13501396
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-Alkylamino-1-phenoxypropan-2-ol derivatives as CARM1 inhibitors and
their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chesworth, Richard; Moradel, Oscar Miguel; Shapiro, Gideon; Duncan,
Kenneth W.; Mitchell, Lorna Helen; Jin, Lei; Babine, Robert E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014144455 A1 2014-09-18

$RFMT $RIREG SCHEME178 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2R)-2-[(3-Bromo-4-fluorophenoxy)methyl]oxirane
C9H8BrFO2
1628833-54-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 4.0010 0.0 0
M  V30 3 Br 1.5400 0.0000 0.0 0
M  V30 4 F 0.0000 2.6673 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 3.8501 4.0010 0.0 0
M  V30 8 C 2.3101 1.3337 0.0 0
M  V30 9 C 2.3101 4.0010 0.0 0
M  V30 10 C 1.5400 2.6673 0.0 0
M  V30 11 C 8.4702 4.0010 0.0 0 CFG=2
M  V30 12 C 9.8039 3.2310 0.0 0
M  V30 13 O 9.8039 4.7710 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 11 2 CFG=3
M  V30 4 1 3 8
M  V30 5 1 4 10
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2R)-1-(3-Bromo-4-fluorophenoxy)-3-(methylamino)-2-propanol
C10H13BrFNO2
1628833-55-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0 CFG=2
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 O 8.0022 0.0000 0.0 0
M  V30 6 N 10.6697 1.5400 0.0 0
M  V30 7 C 12.0033 2.3101 0.0 0
M  V30 8 Br 0.0000 1.5400 0.0 0
M  V30 9 F 0.0000 4.6201 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 2.6673 1.5400 0.0 0
M  V30 12 C 4.0012 3.8501 0.0 0
M  V30 13 C 1.3337 2.3101 0.0 0
M  V30 14 C 2.6673 4.6201 0.0 0
M  V30 15 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5 CFG=1
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 13
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1628833-54-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1628833-55-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-19775343
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM CARM1 inhibitors for treating Cancer and Metabolic disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chesworth, Richard; Moradei, Oscar Miguel; Shapiro, Gideon; Jin, Lei;
Babine, Robert E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016044641 A2 2016-03-24

$RFMT $RIREG SCHEME178 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2R)-2-[(3-Bromo-4-fluorophenoxy)methyl]oxirane
C9H8BrFO2
1628833-54-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 4.0010 0.0 0
M  V30 3 Br 1.5400 0.0000 0.0 0
M  V30 4 F 0.0000 2.6673 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 3.8501 4.0010 0.0 0
M  V30 8 C 2.3101 1.3337 0.0 0
M  V30 9 C 2.3101 4.0010 0.0 0
M  V30 10 C 1.5400 2.6673 0.0 0
M  V30 11 C 8.4702 4.0010 0.0 0 CFG=2
M  V30 12 C 9.8039 3.2310 0.0 0
M  V30 13 O 9.8039 4.7710 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 11 2 CFG=3
M  V30 4 1 3 8
M  V30 5 1 4 10
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2R)-1-(3-Bromo-4-fluorophenoxy)-3-(methylamino)-2-propanol
C10H13BrFNO2
1628833-55-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0 CFG=2
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 O 8.0022 0.0000 0.0 0
M  V30 6 N 10.6697 1.5400 0.0 0
M  V30 7 C 12.0033 2.3101 0.0 0
M  V30 8 Br 0.0000 1.5400 0.0 0
M  V30 9 F 0.0000 4.6201 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 2.6673 1.5400 0.0 0
M  V30 12 C 4.0012 3.8501 0.0 0
M  V30 13 C 1.3337 2.3101 0.0 0
M  V30 14 C 2.6673 4.6201 0.0 0
M  V30 15 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5 CFG=1
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 13
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1628833-54-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1628833-55-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-2584225
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1-Amino-3-(aryloxy)propanol derivatives as CARM1 inhibitors and uses
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chesworth, Richard; Moradei, Oscar Miguel; Shapiro, Gideon; Jin, Lei;
Babine, Robert E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014144169 A1 2014-09-18

$RFMT $RIREG SCHEME179 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(βR)-β-[[(2S)-2-(Acetyloxy)-1-oxopropyl][[(3R,4R)-1-[(1,1-dimethylethoxy)carb...
C36H43F3N4O7
1629738-40-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  50 53 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.9273 7.4547 0.0 0 CFG=1
M  V30 2 N 7.1573 8.7884 0.0 0
M  V30 3 C 9.4674 7.4547 0.0 0
M  V30 4 C 7.9273 10.1220 0.0 0
M  V30 5 C 5.6173 8.7884 0.0 0
M  V30 6 C 9.4674 5.9147 0.0 0
M  V30 7 C 11.0074 7.4547 0.0 0
M  V30 8 C 9.4674 8.9947 0.0 0
M  V30 9 C 4.8473 10.1220 0.0 0 CFG=2
M  V30 10 O 4.8473 7.4547 0.0 0
M  V30 11 O 8.1336 5.1447 0.0 0
M  V30 12 O 10.8010 5.1447 0.0 0
M  V30 13 O 3.3073 10.1220 0.0 0
M  V30 14 C 5.6173 11.4557 0.0 0
M  V30 15 C 2.5373 11.4557 0.0 0
M  V30 16 C 0.9973 11.4557 0.0 0
M  V30 17 O 3.3073 12.7895 0.0 0
M  V30 18 C 9.2899 4.3940 0.0 0
M  V30 19 F 4.9836 1.3905 0.0 0
M  V30 20 F 9.8966 12.8326 0.0 0
M  V30 21 F 0.0000 5.0113 0.0 0
M  V30 22 C 13.0830 8.4468 0.0 0
M  V30 23 O 14.4899 9.0733 0.0 0
M  V30 24 O 12.9221 6.9153 0.0 0
M  V30 25 C 15.7358 8.1680 0.0 0
M  V30 26 C 14.8306 6.9222 0.0 0
M  V30 27 C 16.9817 7.2628 0.0 0
M  V30 28 C 16.6410 9.4139 0.0 0
M  V30 29 C 7.1573 6.1209 0.0 0
M  V30 30 N 7.7837 4.7141 0.0 0
M  V30 31 N 5.6256 5.9600 0.0 0
M  V30 32 C 6.6393 3.6837 0.0 0
M  V30 33 C 5.3055 4.4537 0.0 0
M  V30 34 C 9.7660 2.9292 0.0 0
M  V30 35 C 8.7354 1.7849 0.0 0
M  V30 36 C 11.2722 2.6091 0.0 0
M  V30 37 C 9.2112 0.3202 0.0 0
M  V30 38 C 11.7481 1.1445 0.0 0
M  V30 39 C 10.7177 0.0000 0.0 0
M  V30 40 C 3.8987 3.8272 0.0 0
M  V30 41 C 3.7378 2.2957 0.0 0
M  V30 42 C 2.6528 4.7324 0.0 0
M  V30 43 C 2.3308 1.6694 0.0 0
M  V30 44 C 1.2459 4.1061 0.0 0
M  V30 45 C 1.0849 2.5746 0.0 0
M  V30 46 C 9.4674 10.1220 0.0 0 CFG=1
M  V30 47 C 10.3724 8.8761 0.0 0
M  V30 48 C 10.3724 11.3679 0.0 0 CFG=1
M  V30 49 N 11.8371 9.3520 0.0 0
M  V30 50 C 11.8371 10.8920 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 29
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 3 8
M  V30 9 1 46 4 CFG=1
M  V30 10 1 5 9
M  V30 11 2 5 10
M  V30 12 1 6 11
M  V30 13 2 6 12
M  V30 14 1 9 13
M  V30 15 1 9 14 CFG=1
M  V30 16 1 13 15
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 18 30
M  V30 20 1 18 34
M  V30 21 1 19 41
M  V30 22 1 48 20 CFG=1
M  V30 23 1 21 44
M  V30 24 1 22 23
M  V30 25 2 22 24
M  V30 26 1 22 49
M  V30 27 1 23 25
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 1 25 28
M  V30 31 1 29 30
M  V30 32 2 29 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 33
M  V30 36 1 33 40
M  V30 37 2 34 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 2 36 38
M  V30 41 2 37 39
M  V30 42 1 38 39
M  V30 43 2 40 41
M  V30 44 1 40 42
M  V30 45 1 41 43
M  V30 46 2 42 44
M  V30 47 2 43 45
M  V30 48 1 44 45
M  V30 49 1 46 47
M  V30 50 1 46 48
M  V30 51 1 47 49
M  V30 52 1 48 50
M  V30 53 1 49 50
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 9 46 48)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3R,4R)-3-[[[(2S)-2-(acetyloxy)-1-oxopropyl][(1R)-1-[4-(2,5...
C37H46F3N5O6
1629738-41-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  51 54 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.9273 7.4547 0.0 0 CFG=1
M  V30 2 N 7.1573 8.7884 0.0 0
M  V30 3 C 9.4674 7.4547 0.0 0
M  V30 4 C 7.9273 10.1220 0.0 0
M  V30 5 C 5.6173 8.7884 0.0 0
M  V30 6 C 9.4674 5.9147 0.0 0
M  V30 7 C 11.0074 7.4547 0.0 0
M  V30 8 C 9.4674 8.9947 0.0 0
M  V30 9 C 4.8473 10.1220 0.0 0 CFG=2
M  V30 10 O 4.8473 7.4547 0.0 0
M  V30 11 N 10.8010 5.1447 0.0 0
M  V30 12 O 8.1336 5.1447 0.0 0
M  V30 13 O 3.3073 10.1220 0.0 0
M  V30 14 C 5.6173 11.4557 0.0 0
M  V30 15 C 12.1346 5.9147 0.0 0
M  V30 16 C 2.5373 11.4557 0.0 0
M  V30 17 C 0.9973 11.4557 0.0 0
M  V30 18 O 3.3073 12.7895 0.0 0
M  V30 19 C 9.2899 4.3940 0.0 0
M  V30 20 F 4.9836 1.3905 0.0 0
M  V30 21 F 9.8966 12.8326 0.0 0
M  V30 22 F 0.0000 5.0113 0.0 0
M  V30 23 C 13.0830 8.4468 0.0 0
M  V30 24 O 14.4899 9.0733 0.0 0
M  V30 25 O 12.9221 6.9153 0.0 0
M  V30 26 C 15.7358 8.1680 0.0 0
M  V30 27 C 16.6410 9.4139 0.0 0
M  V30 28 C 16.9817 7.2628 0.0 0
M  V30 29 C 14.8306 6.9222 0.0 0
M  V30 30 C 7.1573 6.1209 0.0 0
M  V30 31 N 7.7837 4.7141 0.0 0
M  V30 32 N 5.6256 5.9600 0.0 0
M  V30 33 C 6.6393 3.6837 0.0 0
M  V30 34 C 5.3055 4.4537 0.0 0
M  V30 35 C 9.7660 2.9292 0.0 0
M  V30 36 C 8.7354 1.7849 0.0 0
M  V30 37 C 11.2722 2.6091 0.0 0
M  V30 38 C 9.2112 0.3202 0.0 0
M  V30 39 C 11.7481 1.1445 0.0 0
M  V30 40 C 10.7177 0.0000 0.0 0
M  V30 41 C 3.8987 3.8272 0.0 0
M  V30 42 C 3.7378 2.2957 0.0 0
M  V30 43 C 2.6528 4.7324 0.0 0
M  V30 44 C 2.3308 1.6694 0.0 0
M  V30 45 C 1.2459 4.1061 0.0 0
M  V30 46 C 1.0849 2.5746 0.0 0
M  V30 47 C 9.4674 10.1220 0.0 0 CFG=1
M  V30 48 C 10.3724 8.8761 0.0 0
M  V30 49 C 10.3724 11.3679 0.0 0 CFG=1
M  V30 50 N 11.8371 9.3520 0.0 0
M  V30 51 C 11.8371 10.8920 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 30
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 3 8
M  V30 9 1 47 4 CFG=1
M  V30 10 1 5 9
M  V30 11 2 5 10
M  V30 12 1 6 11
M  V30 13 2 6 12
M  V30 14 1 9 13
M  V30 15 1 9 14 CFG=1
M  V30 16 1 11 15
M  V30 17 1 13 16
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 1 19 31
M  V30 21 1 19 35
M  V30 22 1 20 42
M  V30 23 1 49 21 CFG=1
M  V30 24 1 22 45
M  V30 25 1 23 24
M  V30 26 2 23 25
M  V30 27 1 23 50
M  V30 28 1 24 26
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 26 29
M  V30 32 1 30 31
M  V30 33 2 30 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 34
M  V30 37 1 34 41
M  V30 38 2 35 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 2 37 39
M  V30 42 2 38 40
M  V30 43 1 39 40
M  V30 44 2 41 42
M  V30 45 1 41 43
M  V30 46 1 42 44
M  V30 47 2 43 45
M  V30 48 2 44 46
M  V30 49 1 45 46
M  V30 50 1 47 48
M  V30 51 1 47 49
M  V30 52 1 48 50
M  V30 53 1 49 51
M  V30 54 1 50 51
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 9 47 49)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1629738-40-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1629738-41-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9685309
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of immunoconjugates as cell proliferation inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barsanti, Paul A.; Chamoin, Sylvie; Doumampouom-Metoul, Lionel;
Geierstanger, Bernhard Hubert; Grotzfeld, Robert Martin; Guerro-Lagasse,
Stephanie; Jones, Darryl Brynley; Karpov, Alexei; Lafrance, Marc;
Nieto-Oberhuber, Cristina; Ou, Weijia; Piizzi, Grazia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014151030 A1 2014-09-25

$RFMT $RIREG SCHEME180 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-(6-bromohexyl)-N-[[4-(1,1-dimethylethyl)phenyl]methyl]car...
C22H36BrNO2
1644296-30-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 6.6684 0.0 0
M  V30 2 N 8.4700 5.3347 0.0 0
M  V30 3 C 7.7000 4.0011 0.0 0
M  V30 4 C 10.0100 5.3347 0.0 0
M  V30 5 O 8.4700 2.6674 0.0 0
M  V30 6 O 6.1600 4.0011 0.0 0
M  V30 7 C 10.7800 6.6684 0.0 0
M  V30 8 C 7.7000 1.3336 0.0 0
M  V30 9 C 12.3200 6.6684 0.0 0
M  V30 10 C 9.0336 0.5636 0.0 0
M  V30 11 C 6.9300 0.0000 0.0 0
M  V30 12 C 6.3664 2.1036 0.0 0
M  V30 13 C 13.0900 8.0021 0.0 0
M  V30 14 C 14.6300 8.0021 0.0 0
M  V30 15 C 15.4000 9.3358 0.0 0
M  V30 16 Br 16.9400 9.3358 0.0 0
M  V30 17 C 1.5400 6.6684 0.0 0
M  V30 18 C 0.7700 5.3347 0.0 0
M  V30 19 C 0.0000 6.6684 0.0 0
M  V30 20 C 0.7700 8.0021 0.0 0
M  V30 21 C 6.1600 6.6684 0.0 0
M  V30 22 C 5.3900 5.3347 0.0 0
M  V30 23 C 5.3900 8.0021 0.0 0
M  V30 24 C 3.8500 5.3347 0.0 0
M  V30 25 C 3.8500 8.0021 0.0 0
M  V30 26 C 3.0800 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 17 20
M  V30 20 1 17 26
M  V30 21 2 21 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 2 23 25
M  V30 25 2 24 26
M  V30 26 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[[4-(1,1-dimethylethyl)phenyl]methyl]-N-[6-(methylamino)h...
C23H40N2O2
2202723-81-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 5.3348 0.0 0
M  V30 2 N 6.1601 5.3348 0.0 0
M  V30 3 C 6.9302 4.0012 0.0 0
M  V30 4 C 6.9302 6.6685 0.0 0
M  V30 5 O 6.1601 2.6673 0.0 0
M  V30 6 O 8.4702 4.0012 0.0 0
M  V30 7 C 8.4702 6.6685 0.0 0
M  V30 8 C 6.9302 1.3337 0.0 0
M  V30 9 C 9.2402 8.0022 0.0 0
M  V30 10 C 5.5965 0.5637 0.0 0
M  V30 11 C 7.7002 0.0000 0.0 0
M  V30 12 C 8.2638 2.1037 0.0 0
M  V30 13 C 10.7802 8.0022 0.0 0
M  V30 14 C 11.5503 9.3360 0.0 0
M  V30 15 C 13.0903 9.3360 0.0 0
M  V30 16 N 13.8603 10.6697 0.0 0
M  V30 17 C 15.4003 10.6697 0.0 0
M  V30 18 C 1.5400 10.6697 0.0 0
M  V30 19 C 0.0000 10.6697 0.0 0
M  V30 20 C 0.7700 12.0033 0.0 0
M  V30 21 C 2.3101 12.0033 0.0 0
M  V30 22 C 3.8501 6.6685 0.0 0
M  V30 23 C 4.6201 8.0022 0.0 0
M  V30 24 C 2.3101 6.6685 0.0 0
M  V30 25 C 3.8501 9.3360 0.0 0
M  V30 26 C 1.5400 8.0022 0.0 0
M  V30 27 C 2.3101 9.3360 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 18 21
M  V30 21 1 18 27
M  V30 22 2 22 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 2 24 26
M  V30 26 2 25 27
M  V30 27 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1644296-30-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2202723-81-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-18545523
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The relationship between the conformational degree of freedom of
template-containing threads and slippage in the formation of [2]rotaxane
building blocks
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Riss-Yaw, B.; Clavel, C.; Laurent, Ph.; Coutrot, F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2017), 53(79),
10874-10877

$RFMT $RIREG SCHEME181 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-3,4,5-trimethoxybenzaldehyde
C10H11ClO4
164660-56-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 6.9302 0.0 0
M  V30 2 C 2.6675 7.7002 0.0 0
M  V30 3 O 6.6687 5.3901 0.0 0
M  V30 4 C 8.0023 4.6201 0.0 0
M  V30 5 O 1.3337 5.3901 0.0 0
M  V30 6 C 0.0000 4.6201 0.0 0
M  V30 7 Cl 6.6687 2.3101 0.0 0
M  V30 8 C 4.0012 0.7700 0.0 0
M  V30 9 O 2.6675 0.0000 0.0 0
M  V30 10 C 4.0012 5.3901 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 5.3348 3.0801 0.0 0
M  V30 14 C 2.6675 3.0801 0.0 0
M  V30 15 C 4.0012 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 1 3 11
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-3,4,5-trimethoxy-N-methylbenzenemethanamine
C11H16ClNO3
2117645-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 4.0011 0.0 0
M  V30 2 C 0.0000 5.3348 0.0 0
M  V30 3 O 2.3100 1.3337 0.0 0
M  V30 4 C 3.0800 0.0000 0.0 0
M  V30 5 O 2.3100 6.6686 0.0 0
M  V30 6 C 3.0800 8.0022 0.0 0
M  V30 7 Cl 5.3901 1.3337 0.0 0
M  V30 8 C 6.9301 4.0011 0.0 0
M  V30 9 N 7.7001 5.3348 0.0 0
M  V30 10 C 9.2401 5.3348 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 3.0800 2.6675 0.0 0
M  V30 13 C 3.0800 5.3348 0.0 0
M  V30 14 C 4.6201 2.6675 0.0 0
M  V30 15 C 4.6201 5.3348 0.0 0
M  V30 16 C 5.3901 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 7 14
M  V30 8 1 8 9
M  V30 9 1 8 16
M  V30 10 1 9 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 164660-56-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2117645-18-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-17935978
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of a series of
resorcinol-based N-benzyl benzamide derivatives as potent Hsp90
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Park, Sun You; Oh, Yong Jin; Lho, Yunmee; Jeong, Ju Hui; Liu,
Kwang-Hyeon; Song, Jaeyoung; Kim, Soong-Hyun; Ha, Eunyoung; Seo, Young Ho
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2018), 143390-401

$RFMT $RIREG SCHEME182 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[2-Chloro-4-(6-methyl-2-pyrazinyl)phenyl]-2-(methylsulfinyl)-8-[2-(2-oxo-3-...
C24H21ClN6O4S
1648865-21-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7710 6.9300 0.0 0
M  V30 2 C 3.7710 8.4700 0.0 0
M  V30 3 O 6.4384 8.4700 0.0 0
M  V30 4 S 2.4374 1.5400 0.0 0 VAL=4
M  V30 5 C 1.1037 2.3100 0.0 0
M  V30 6 O 2.4374 0.0000 0.0 0
M  V30 7 Cl 10.4395 4.6200 0.0 0
M  V30 8 O 3.4208 11.8019 0.0 0
M  V30 9 C 17.1079 8.4700 0.0 0
M  V30 10 C 5.1046 4.6200 0.0 0
M  V30 11 N 5.1046 6.1600 0.0 0
M  V30 12 C 6.4384 3.8500 0.0 0
M  V30 13 N 3.7710 3.8500 0.0 0
M  V30 14 C 6.4384 6.9300 0.0 0
M  V30 15 C 7.7721 4.6200 0.0 0
M  V30 16 C 6.4384 2.3100 0.0 0
M  V30 17 C 3.7710 2.3100 0.0 0
M  V30 18 C 7.7721 6.1600 0.0 0
M  V30 19 N 5.1046 1.5400 0.0 0
M  V30 20 C 9.1057 6.9300 0.0 0
M  V30 21 C 10.4395 6.1600 0.0 0
M  V30 22 C 9.1057 8.4700 0.0 0
M  V30 23 C 11.7731 6.9300 0.0 0
M  V30 24 C 10.4395 9.2400 0.0 0
M  V30 25 C 11.7731 8.4700 0.0 0
M  V30 26 N 2.4374 9.2400 0.0 0
M  V30 27 C 2.2764 10.7715 0.0 0
M  V30 28 C 1.0306 8.6135 0.0 0
M  V30 29 O 0.7700 11.0917 0.0 0
M  V30 30 C 0.0000 9.7581 0.0 0
M  V30 31 C 13.1068 9.2400 0.0 0
M  V30 32 N 14.4404 8.4700 0.0 0
M  V30 33 C 13.1068 10.7800 0.0 0
M  V30 34 C 15.7742 9.2400 0.0 0
M  V30 35 N 14.4404 11.5500 0.0 0
M  V30 36 C 15.7742 10.7800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 26
M  V30 4 2 3 14
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 17
M  V30 8 1 7 21
M  V30 9 2 8 27
M  V30 10 1 9 34
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 2 15 18
M  V30 20 1 16 19
M  V30 21 2 17 19
M  V30 22 1 18 20
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 1 25 31
M  V30 30 1 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[2-Chloro-4-(6-methyl-2-pyrazinyl)phenyl]-2-(methylsulfonyl)-8-[2-(2-oxo-3-...
C24H21ClN6O5S
1648865-22-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.1046 0.0 0
M  V30 2 C 6.1600 3.7710 0.0 0
M  V30 3 O 8.4700 5.1046 0.0 0
M  V30 4 S 1.5400 9.1057 0.0 0 VAL=6
M  V30 5 C 0.0000 9.1057 0.0 0
M  V30 6 O 1.5400 7.5657 0.0 0
M  V30 7 O 1.5400 10.6457 0.0 0
M  V30 8 Cl 10.0100 10.4394 0.0 0
M  V30 9 O 7.5227 0.7102 0.0 0
M  V30 10 C 17.7100 10.4394 0.0 0
M  V30 11 C 5.3900 7.7721 0.0 0
M  V30 12 N 6.1600 6.4383 0.0 0
M  V30 13 C 6.1600 9.1057 0.0 0
M  V30 14 N 3.8500 7.7721 0.0 0
M  V30 15 C 7.7000 6.4383 0.0 0
M  V30 16 C 7.7000 9.1057 0.0 0
M  V30 17 C 5.3900 10.4394 0.0 0
M  V30 18 C 3.0800 9.1057 0.0 0
M  V30 19 C 8.4700 7.7721 0.0 0
M  V30 20 N 3.8500 10.4394 0.0 0
M  V30 21 C 10.0100 7.7721 0.0 0
M  V30 22 C 10.7800 9.1057 0.0 0
M  V30 23 C 10.7800 6.4383 0.0 0
M  V30 24 C 12.3200 9.1057 0.0 0
M  V30 25 C 12.3200 6.4383 0.0 0
M  V30 26 C 13.0900 7.7721 0.0 0
M  V30 27 N 5.3900 2.4374 0.0 0
M  V30 28 C 6.0163 1.0304 0.0 0
M  V30 29 C 3.8585 2.2763 0.0 0
M  V30 30 O 4.8719 0.0000 0.0 0
M  V30 31 C 3.5383 0.7700 0.0 0
M  V30 32 C 14.6300 7.7721 0.0 0
M  V30 33 N 15.4000 9.1057 0.0 0
M  V30 34 C 15.4000 6.4383 0.0 0
M  V30 35 C 16.9400 9.1057 0.0 0
M  V30 36 N 16.9400 6.4383 0.0 0
M  V30 37 C 17.7100 7.7721 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 27
M  V30 4 2 3 15
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 4 7
M  V30 8 1 4 18
M  V30 9 1 8 22
M  V30 10 2 9 28
M  V30 11 1 10 35
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 2 16 19
M  V30 21 1 17 20
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 1 26 32
M  V30 31 1 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 31
M  V30 36 2 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 36
M  V30 40 2 35 37
M  V30 41 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[2-Chloro-4-(6-methyl-2-pyrazinyl)phenyl]-2-(methylamino)-8-[2-(2-oxo-3-oxa...
C24H22ClN7O3
1648865-23-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7710 6.9300 0.0 0
M  V30 2 C 3.7710 8.4700 0.0 0
M  V30 3 O 6.4384 8.4700 0.0 0
M  V30 4 N 2.4374 1.5400 0.0 0
M  V30 5 C 2.4374 0.0000 0.0 0
M  V30 6 Cl 10.4395 4.6200 0.0 0
M  V30 7 O 3.4208 11.8019 0.0 0
M  V30 8 C 17.1079 8.4700 0.0 0
M  V30 9 C 5.1046 4.6200 0.0 0
M  V30 10 N 5.1046 6.1600 0.0 0
M  V30 11 C 6.4384 3.8500 0.0 0
M  V30 12 N 3.7710 3.8500 0.0 0
M  V30 13 C 6.4384 6.9300 0.0 0
M  V30 14 C 7.7721 4.6200 0.0 0
M  V30 15 C 6.4384 2.3100 0.0 0
M  V30 16 C 3.7710 2.3100 0.0 0
M  V30 17 C 7.7721 6.1600 0.0 0
M  V30 18 N 5.1046 1.5400 0.0 0
M  V30 19 C 9.1057 6.9300 0.0 0
M  V30 20 C 10.4395 6.1600 0.0 0
M  V30 21 C 9.1057 8.4700 0.0 0
M  V30 22 C 11.7731 6.9300 0.0 0
M  V30 23 C 10.4395 9.2400 0.0 0
M  V30 24 C 11.7731 8.4700 0.0 0
M  V30 25 N 2.4374 9.2400 0.0 0
M  V30 26 C 2.2764 10.7715 0.0 0
M  V30 27 C 1.0306 8.6135 0.0 0
M  V30 28 O 0.7700 11.0917 0.0 0
M  V30 29 C 0.0000 9.7581 0.0 0
M  V30 30 C 13.1068 9.2400 0.0 0
M  V30 31 N 14.4404 8.4700 0.0 0
M  V30 32 C 13.1068 10.7800 0.0 0
M  V30 33 C 15.7742 9.2400 0.0 0
M  V30 34 N 14.4404 11.5500 0.0 0
M  V30 35 C 15.7742 10.7800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 25
M  V30 4 2 3 13
M  V30 5 1 4 5
M  V30 6 1 4 16
M  V30 7 1 6 20
M  V30 8 2 7 26
M  V30 9 1 8 33
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 2 14 17
M  V30 19 1 15 18
M  V30 20 2 16 18
M  V30 21 1 17 19
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 24 30
M  V30 29 1 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1648865-21-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1648865-22-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1648865-23-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-18059600
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidine-pyridinone serine/threonine kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Crawford, James John; Drobnick, Joy; Gazzard, Lewis J.; Lee, Wendy;
Ndubaku, Chudi; Rudolph, Joachim
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015011252 A1 2015-01-29

$RFMT $RIREG SCHEME183 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-[[1,6-dihydro-6-oxo-4-(phenylmethyl)-5-(2-propen-1-yl)-2-pyrimidinyl...
C17H18N2O3S
1654000-17-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 4.0011 0.0 0
M  V30 2 C 2.3100 6.6684 0.0 0
M  V30 3 C 1.5400 8.0021 0.0 0
M  V30 4 C 0.0000 8.0021 0.0 0
M  V30 5 O 3.8500 9.3358 0.0 0
M  V30 6 S 8.4700 6.6684 0.0 0
M  V30 7 C 9.2400 8.0021 0.0 0
M  V30 8 C 10.7800 8.0021 0.0 0
M  V30 9 O 11.5500 9.3358 0.0 0
M  V30 10 O 11.5500 6.6684 0.0 0
M  V30 11 C 13.0900 9.3358 0.0 0
M  V30 12 C 4.6200 5.3347 0.0 0
M  V30 13 C 3.8500 6.6684 0.0 0
M  V30 14 N 6.1600 5.3347 0.0 0
M  V30 15 C 4.6200 8.0021 0.0 0
M  V30 16 C 6.9300 6.6684 0.0 0
M  V30 17 N 6.1600 8.0021 0.0 0
M  V30 18 C 4.6200 2.6674 0.0 0
M  V30 19 C 6.1600 2.6674 0.0 0
M  V30 20 C 3.8500 1.3336 0.0 0
M  V30 21 C 6.9300 1.3336 0.0 0
M  V30 22 C 4.6200 0.0000 0.0 0
M  V30 23 C 6.1600 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 2 13
M  V30 5 2 3 4
M  V30 6 2 5 15
M  V30 7 1 6 7
M  V30 8 1 6 16
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[1,6-Dihydro-6-oxo-4-(phenylmethyl)-5-(2-propen-1-yl)-2-pyrimidinyl]thio]-...
C17H19N3O2S
1654000-21-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 4.0011 0.0 0
M  V30 2 C 2.3100 6.6684 0.0 0
M  V30 3 C 1.5400 8.0021 0.0 0
M  V30 4 C 0.0000 8.0021 0.0 0
M  V30 5 O 3.8500 9.3358 0.0 0
M  V30 6 S 8.4700 6.6684 0.0 0
M  V30 7 C 9.2400 8.0021 0.0 0
M  V30 8 C 10.7800 8.0021 0.0 0
M  V30 9 N 11.5500 9.3358 0.0 0
M  V30 10 O 11.5500 6.6684 0.0 0
M  V30 11 C 13.0900 9.3358 0.0 0
M  V30 12 C 4.6200 5.3347 0.0 0
M  V30 13 C 3.8500 6.6684 0.0 0
M  V30 14 N 6.1600 5.3347 0.0 0
M  V30 15 C 4.6200 8.0021 0.0 0
M  V30 16 C 6.9300 6.6684 0.0 0
M  V30 17 N 6.1600 8.0021 0.0 0
M  V30 18 C 4.6200 2.6674 0.0 0
M  V30 19 C 6.1600 2.6674 0.0 0
M  V30 20 C 3.8500 1.3336 0.0 0
M  V30 21 C 6.9300 1.3336 0.0 0
M  V30 22 C 4.6200 0.0000 0.0 0
M  V30 23 C 6.1600 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 2 13
M  V30 5 2 3 4
M  V30 6 2 5 15
M  V30 7 1 6 7
M  V30 8 1 6 16
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1654000-17-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1654000-21-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14183458
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Biological Evaluation of 2-Thioxopyrimidin-4(1H)-one
Derivatives as Potential Non-Nucleoside HIV-1 Reverse Transcriptase
Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Khalifa, Nagy M.; Al-Omar, Mohamed A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM International Journal of Molecular Sciences (2014), 15(11), 20723-20735,
13 pp.

$RFMT $RIREG SCHEME184 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Thiophenesulfonyl chloride
C4H3ClO2S2
16629-19-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.9098 1.5400 0.0 0 VAL=6
M  V30 2 Cl 5.4498 1.5400 0.0 0
M  V30 3 O 3.9098 3.0800 0.0 0
M  V30 4 O 3.9098 0.0000 0.0 0
M  V30 5 C 2.3698 1.5400 0.0 0
M  V30 6 C 1.4645 0.2941 0.0 0
M  V30 7 S 1.4645 2.7859 0.0 0
M  V30 8 C 0.0000 0.7700 0.0 0
M  V30 9 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 5
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-thiophenesulfonamide
C5H7NO2S2
53442-30-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.7711 2.6218 0.0 0 VAL=6
M  V30 2 N 5.1049 3.3918 0.0 0
M  V30 3 O 3.0011 3.9554 0.0 0
M  V30 4 O 4.5411 1.2881 0.0 0
M  V30 5 C 6.4386 2.6218 0.0 0
M  V30 6 C 2.4374 1.8517 0.0 0
M  V30 7 C 2.2765 0.3202 0.0 0
M  V30 8 S 1.0306 2.4781 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 2 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16629-19-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 53442-30-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-3475175
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 26:
5-{5-[(Methylamino)sulfonyl]thien-2-yl}-2-(2-phenylethyl)pentanoic acid.
a) N-methylthiophene-2-sulfonamide MeNH2 (10.3 mL, 8 M solution in EtOH,
82.12 mmol) was added to a solution of 2-thiophenesulfonyl chloride (5.0
g, 27.37 mmol) in THF (70 mL). The reaction mixture was stirred at r.t.
for 2 h, poured into H2O (100 mL) and extracted with CH2Cl2 (2×100 mL).
The organic layer was dried over Na2SO4 (anhydrous), filtered and
concentrated, to give 5.05 g of N-methylthiophene-2-sulfonamide, that
were submitted to next step without purification (brown-coloured solid,
yield: quantitative). 1H NMR (CDCl3, 250 MHz) δ ppm: 7.60 (m, 2H), 7.09
(dd, J= 3.7 Hz, 4.0 Hz, 1H), 4.88 (bs, 1H), 2.71 (s, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of phenyl(alkyl)carboxylic acid derivatives for use in the
treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aymami Bofarull, Juan; Nicolas Chevalier, Franck Camille; Soler Lopez,
Montserrat; Luque Garrofe, Maria Teresa; Martinell Pedemonte, Marc
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009080722 A2 2009-07-02

$RFMT $RIREG SCHEME185 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-5-nitro-1-[[2-(trimethylsilyl)ethoxy]methyl]-1H-pyrrolo[2,3-b]pyridine
C13H18ClN3O3Si
1669427-10-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9855 4.5603 0.0 0
M  V30 2 O 9.0161 5.7047 0.0 0
M  V30 3 C 10.5224 5.3846 0.0 0
M  V30 4 C 11.5530 6.5291 0.0 0
M  V30 5 Si 13.0593 6.2090 0.0 0
M  V30 6 C 14.5656 5.8888 0.0 0
M  V30 7 C 12.7392 4.7025 0.0 0
M  V30 8 C 13.3795 7.7153 0.0 0
M  V30 9 Cl 1.3337 4.6201 0.0 0
M  V30 10 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 11 O 0.0000 2.3101 0.0 0
M  V30 12 O 1.3337 0.0000 0.0 0
M  V30 13 C 5.3348 3.8501 0.0 0
M  V30 14 C 4.0010 4.6201 0.0 0
M  V30 15 N 6.4792 4.8805 0.0 0
M  V30 16 N 5.3348 2.3101 0.0 0
M  V30 17 C 2.6673 3.8501 0.0 0
M  V30 18 C 4.3212 6.1264 0.0 0
M  V30 19 C 5.8529 6.2875 0.0 0
M  V30 20 C 4.0010 1.5400 0.0 0
M  V30 21 C 2.6673 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 17
M  V30 10 2 10 11
M  V30 11 2 10 12
M  V30 12 1 10 21
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 2 14 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-5-nitro-1-[[2-(trimethylsilyl)ethoxy]methyl]-1H-pyrrolo[2,3-b]pyridi...
C14H22N4O3Si
1669427-09-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 4.6201 0.0 0
M  V30 2 C 1.3337 6.1601 0.0 0
M  V30 3 C 7.9855 4.5603 0.0 0
M  V30 4 O 9.0161 5.7047 0.0 0
M  V30 5 C 10.5224 5.3846 0.0 0
M  V30 6 C 11.5530 6.5291 0.0 0
M  V30 7 Si 13.0593 6.2090 0.0 0
M  V30 8 C 14.5656 5.8888 0.0 0
M  V30 9 C 13.3795 7.7153 0.0 0
M  V30 10 C 12.7392 4.7025 0.0 0
M  V30 11 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 12 O 1.3337 0.0000 0.0 0
M  V30 13 O 0.0000 2.3101 0.0 0
M  V30 14 C 4.0010 4.6201 0.0 0
M  V30 15 C 5.3348 3.8501 0.0 0
M  V30 16 C 2.6673 3.8501 0.0 0
M  V30 17 C 4.3212 6.1264 0.0 0
M  V30 18 N 6.4792 4.8805 0.0 0
M  V30 19 N 5.3348 2.3101 0.0 0
M  V30 20 C 2.6673 2.3101 0.0 0
M  V30 21 C 5.8529 6.2875 0.0 0
M  V30 22 C 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 3 4
M  V30 4 1 3 18
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 2 11 12
M  V30 12 2 11 13
M  V30 13 1 11 20
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 2 15 19
M  V30 19 1 16 20
M  V30 20 2 17 21
M  V30 21 1 18 21
M  V30 22 1 19 22
M  V30 23 2 20 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1669427-10-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1669427-09-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-5009603
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM aerobic, sealed vessel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tricyclic Covalent Inhibitors Selectively Target Jak3 through an Active
Site Thiol
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Goedken, Eric R.; Argiriadi, Maria A.; Banach, David L.; Fiamengo, Bryan
A.; Foley, Sage E.; Frank, Kristine E.; George, Jonathan S.; Harris,
Christopher M.; Hobson, Adrian D.; Ihle, David C.; Marcotte, Douglas;
Merta, Philip J.; Michalak, Mark E.; Murdock, Sara E.; Tomlinson, Medha
J.; Voss, Jeffrey W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Biological Chemistry (2015), 290(8), 4573-4589

$RFMT $RIREG SCHEME186 STEP1
$RXN



  2  1
$MOL
1-(2-Bromoethyl)-3-methylbenzene
C9H11Br
16799-08-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0800 0.0 0
M  V30 2 C 6.6686 2.3100 0.0 0
M  V30 3 Br 8.0022 3.0800 0.0 0
M  V30 4 C 0.0000 3.0800 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 3.0800 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 1.3337 2.3100 0.0 0
M  V30 9 C 2.6675 0.0000 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2-Bromoethyl)-N,2-dimethylbenzenesulfonamide
C10H14BrNO2S
811807-39-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.3100 2.6673 0.0 0 VAL=6
M  V30 2 N 0.7700 2.6673 0.0 0
M  V30 3 O 2.3100 4.2073 0.0 0
M  V30 4 O 2.3100 1.1273 0.0 0
M  V30 5 C 0.0000 4.0011 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 8.4700 2.6673 0.0 0
M  V30 8 C 9.2400 4.0011 0.0 0
M  V30 9 Br 10.7800 4.0011 0.0 0
M  V30 10 C 3.8500 2.6673 0.0 0
M  V30 11 C 4.6200 1.3336 0.0 0
M  V30 12 C 4.6200 4.0011 0.0 0
M  V30 13 C 6.1600 1.3336 0.0 0
M  V30 14 C 6.1600 4.0011 0.0 0
M  V30 15 C 6.9300 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 5
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 1 7 15
M  V30 9 1 8 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 16799-08-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 811807-39-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-081-CAS-6478925
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7790-94-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 1) Methyl
1-(4-chlorosulfonylphenyl)cyclopropane-1-carboxylate; To a solution of
methyl 1-phenylcyclopropane-1-carboxylate (2.67 g, 15.15 mmol) in
dichloromethane (27 ml) was added dropwise chlorosulfonic acid (5.15 ml,
77.5 mmol) under stirring and ice-cooling, and the resulting mixture was
stirred at room temperature for 5 hours and then concentrated in vacuo.
To the residue was added ethyl acetate, and then water was added
carefully to the resulting mixture under stirring. The resulting mixture
was partitioned, and the organic layer separated was washed with water,
dried over anhydrous magnesium sulfate and evaporated in vacuo. The
residue was purified by chromatography on a silica gel column using a
mixed solvent of hexane and ethyl acetate (10:1) as the eluent to afford
the title compound. Reference Example 8; 4-(N-methylsulfamoyl)phenethyl
bromide; To a solution of 4-(chlorosulfonyl)phenethyl bromide (10.00 g,
35.2 mmol) in tetrahydrofuran (200 ml) was added 40% aqueous methylamine
solution (9.14 ml, 105.6 mmol) under stirring, and the resulting mixture
was stirred at room temperature for one hour. After evaporating the
reaction mixture in vacuo, water was added to the residue, and the
resulting mixture was extracted with dichloromethane. The extract was
washed with water, dried over anhydrous magnesium sulfate and evaporated
in vacuo to afford the title compound.
3-Fluoro-4-(N-methylsulfamoyl)phenethyl bromide
3-Methyl-4-(N-methylsulfamoyl)phenethyl bromide The title compound was
synthesized in a yield of 119% as a white powder by conducting reactions
similar to those mentioned in Reference Example 36, using
3-methylphenethyl bromide.
$DTYPE RXN:VAR(1):NOTES
$DATUM stage 1 regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of cyclic tertiary amine compounds that inhibit inflammatory
cytokine production
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kimura, Tomio; Ohkawa, Nobuyuki; Nakao, Akira; Nagasaki, Takayoshi;
Shimozato, Takaichi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20070049620 A1 2007-03-01

$RFMT $RIREG SCHEME187 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3′-Azido-3′-deoxy-5′-thymidylyl)-L-tryptophan 3-methyl ester
C22H26N7O8P
168478-36-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 15.1936 4.5167 0.0 0
M  V30 2 C 8.4700 4.9995 0.0 0
M  V30 3 O 7.7000 6.3331 0.0 0
M  V30 4 P 6.1600 6.3331 0.0 0 VAL=5
M  V30 5 N 4.6200 6.3331 0.0 0
M  V30 6 O 6.1600 7.8731 0.0 0
M  V30 7 O 6.1600 4.7931 0.0 0
M  V30 8 C 3.8500 7.6669 0.0 0 CFG=2
M  V30 9 C 4.6200 9.0005 0.0 0
M  V30 10 C 2.3100 7.6669 0.0 0
M  V30 11 O 1.5400 6.3331 0.0 0
M  V30 12 O 1.5400 9.0005 0.0 0
M  V30 13 C 0.0000 6.3331 0.0 0
M  V30 14 N 10.4394 2.2889 0.0 0
M  V30 15 N 11.4698 1.1445 0.0 0 CHG=1 VAL=4
M  V30 16 N 12.5003 0.0000 0.0 0 CHG=-1
M  V30 17 C 14.5498 10.6429 0.0 0
M  V30 18 O 17.3635 9.3903 0.0 0
M  V30 19 C 12.3799 5.7695 0.0 0 CFG=1
M  V30 20 O 10.9152 6.2453 0.0 0
M  V30 21 C 12.3799 4.2295 0.0 0
M  V30 22 C 10.0100 4.9995 0.0 0 CFG=2
M  V30 23 C 10.9152 3.7536 0.0 0 CFG=2
M  V30 24 N 13.6258 6.6747 0.0 0
M  V30 25 C 15.0326 6.0484 0.0 0
M  V30 26 C 13.4648 8.2062 0.0 0
M  V30 27 N 16.2786 6.9534 0.0 0
M  V30 28 C 14.7107 9.1114 0.0 0
M  V30 29 C 16.1175 8.4851 0.0 0
M  V30 30 C 3.8500 10.3342 0.0 0
M  V30 31 C 4.4765 11.7411 0.0 0
M  V30 32 C 2.3185 10.4951 0.0 0
M  V30 33 C 3.3319 12.7715 0.0 0
M  V30 34 C 5.9410 12.2170 0.0 0
M  V30 35 N 1.9983 12.0015 0.0 0
M  V30 36 C 3.6521 14.2778 0.0 0
M  V30 37 C 6.2612 13.7232 0.0 0
M  V30 38 C 5.1168 14.7538 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 25
M  V30 2 1 2 3
M  V30 3 1 22 2 CFG=1
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 8 9 CFG=3
M  V30 10 1 8 10
M  V30 11 1 9 30
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 2 14 15
M  V30 16 1 23 14 CFG=3
M  V30 17 2 15 16
M  V30 18 1 17 28
M  V30 19 2 18 29
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=1
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 1 27 29
M  V30 31 1 28 29
M  V30 32 1 30 31
M  V30 33 2 30 32
M  V30 34 1 31 33
M  V30 35 2 31 34
M  V30 36 1 32 35
M  V30 37 1 33 35
M  V30 38 2 33 36
M  V30 39 1 34 37
M  V30 40 1 36 38
M  V30 41 2 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 8 19 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Thymidine, 3′-azido-3′-deoxy-, 5′-[hydrogen [(1S)-1-(1H-indol-3-ylmethyl)-2-(...
C22H27N8O7P
244127-79-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 15.1936 4.5167 0.0 0
M  V30 2 C 8.4700 4.9995 0.0 0
M  V30 3 O 7.7000 6.3331 0.0 0
M  V30 4 P 6.1600 6.3331 0.0 0 VAL=5
M  V30 5 N 4.6200 6.3331 0.0 0
M  V30 6 O 6.1600 7.8731 0.0 0
M  V30 7 O 6.1600 4.7931 0.0 0
M  V30 8 C 3.8500 7.6669 0.0 0 CFG=2
M  V30 9 C 4.6200 9.0005 0.0 0
M  V30 10 C 2.3100 7.6669 0.0 0
M  V30 11 N 1.5400 6.3331 0.0 0
M  V30 12 O 1.5400 9.0005 0.0 0
M  V30 13 C 0.0000 6.3331 0.0 0
M  V30 14 N 10.4394 2.2889 0.0 0
M  V30 15 N 11.4698 1.1445 0.0 0 CHG=1 VAL=4
M  V30 16 N 12.5003 0.0000 0.0 0 CHG=-1
M  V30 17 C 14.5498 10.6429 0.0 0
M  V30 18 O 17.3635 9.3903 0.0 0
M  V30 19 C 12.3799 5.7695 0.0 0 CFG=1
M  V30 20 O 10.9152 6.2453 0.0 0
M  V30 21 C 12.3799 4.2295 0.0 0
M  V30 22 C 10.0100 4.9995 0.0 0 CFG=2
M  V30 23 C 10.9152 3.7536 0.0 0 CFG=2
M  V30 24 N 13.6258 6.6747 0.0 0
M  V30 25 C 15.0326 6.0484 0.0 0
M  V30 26 C 13.4648 8.2062 0.0 0
M  V30 27 N 16.2786 6.9534 0.0 0
M  V30 28 C 14.7107 9.1114 0.0 0
M  V30 29 C 16.1175 8.4851 0.0 0
M  V30 30 C 3.8500 10.3342 0.0 0
M  V30 31 C 4.4765 11.7411 0.0 0
M  V30 32 C 2.3185 10.4951 0.0 0
M  V30 33 C 3.3319 12.7715 0.0 0
M  V30 34 C 5.9410 12.2170 0.0 0
M  V30 35 N 1.9983 12.0015 0.0 0
M  V30 36 C 3.6521 14.2778 0.0 0
M  V30 37 C 6.2612 13.7232 0.0 0
M  V30 38 C 5.1168 14.7538 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 25
M  V30 2 1 2 3
M  V30 3 1 22 2 CFG=1
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 8 9 CFG=3
M  V30 10 1 8 10
M  V30 11 1 9 30
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 2 14 15
M  V30 16 1 23 14 CFG=3
M  V30 17 2 15 16
M  V30 18 1 17 28
M  V30 19 2 18 29
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=1
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 1 27 29
M  V30 31 1 28 29
M  V30 32 1 30 31
M  V30 33 2 30 32
M  V30 34 1 31 33
M  V30 35 2 31 34
M  V30 36 1 32 35
M  V30 37 1 33 35
M  V30 38 2 33 36
M  V30 39 1 34 37
M  V30 40 1 36 38
M  V30 41 2 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 8 19 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 168478-36-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 244127-79-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-16778772
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, in Vitro Anti-Breast Cancer Activity, and Intracellular
Decomposition of Amino Acid Methyl Ester and Alkyl Amide Phosphoramidate
Monoesters of 3'-Azido-3'-deoxythymidine (AZT)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Iyer, Vidhya V.; Griesgraber, George W.; Radmer, Matthew R.; McIntee,
Edward J.; Wagner, Carston R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2000), 43(11), 2266-2274

$RFMT $RIREG SCHEME188 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl acetoacetate
C8H14O3
1694-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 C 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6687 1.3337 0.0 0
M  V30 10 C 8.0023 0.5637 0.0 0
M  V30 11 O 6.6687 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2Z)-3-(methylamino)-2-butenoate
C9H17NO2
1240195-02-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.1037 2.6675 0.0 0
M  V30 2 C 1.3337 4.0012 0.0 0
M  V30 3 C 3.6437 2.6675 0.0 0
M  V30 4 C 2.6673 4.7712 0.0 0
M  V30 5 C 0.5637 5.3350 0.0 0
M  V30 6 C 0.0000 3.2311 0.0 0
M  V30 7 C 4.4137 1.3338 0.0 0
M  V30 8 O 4.4137 4.0012 0.0 0
M  V30 9 C 5.9538 1.3338 0.0 0
M  V30 10 N 6.7238 2.6675 0.0 0
M  V30 11 C 6.7238 0.0000 0.0 0
M  V30 12 C 8.2638 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 2 7 9
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1694-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1240195-02-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31665378
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of triazole-pyridinyl-substituted azacyclohexyl acetic acid
compounds as LPA receptor antagonists for the treatment and prevention of
diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Hongjian; Chen, Ping; Cai, Zhenwei; Jiang, Fei; Sun, Peihua
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022034568 A1 2022-02-17

$RFMT $RIREG SCHEME188 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl acetoacetate
C8H14O3
1694-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 C 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6687 1.3337 0.0 0
M  V30 10 C 8.0023 0.5637 0.0 0
M  V30 11 O 6.6687 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2Z)-3-(methylamino)-2-butenoate
C9H17NO2
1240195-02-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.1037 2.6675 0.0 0
M  V30 2 C 1.3337 4.0012 0.0 0
M  V30 3 C 3.6437 2.6675 0.0 0
M  V30 4 C 2.6673 4.7712 0.0 0
M  V30 5 C 0.5637 5.3350 0.0 0
M  V30 6 C 0.0000 3.2311 0.0 0
M  V30 7 C 4.4137 1.3338 0.0 0
M  V30 8 O 4.4137 4.0012 0.0 0
M  V30 9 C 5.9538 1.3338 0.0 0
M  V30 10 N 6.7238 2.6675 0.0 0
M  V30 11 C 6.7238 0.0000 0.0 0
M  V30 12 C 8.2638 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 2 7 9
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1694-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1240195-02-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21525611
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Carbamoyl-linked isoxazolylaryloxycyclohexanecarboxylic acid as LPA
antagonists and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cheng, Peter Tai Wah; Shi, Yan; Kaltenbach, Robert F., III; Wang, Ying;
Zhang, Hao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019126099 A1 2019-06-27

$RFMT $RIREG SCHEME188 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl acetoacetate
C8H14O3
1694-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 C 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6687 1.3337 0.0 0
M  V30 10 C 8.0023 0.5637 0.0 0
M  V30 11 O 6.6687 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2Z)-3-(methylamino)-2-butenoate
C9H17NO2
1240195-02-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.1037 2.6675 0.0 0
M  V30 2 C 1.3337 4.0012 0.0 0
M  V30 3 C 3.6437 2.6675 0.0 0
M  V30 4 C 2.6673 4.7712 0.0 0
M  V30 5 C 0.5637 5.3350 0.0 0
M  V30 6 C 0.0000 3.2311 0.0 0
M  V30 7 C 4.4137 1.3338 0.0 0
M  V30 8 O 4.4137 4.0012 0.0 0
M  V30 9 C 5.9538 1.3338 0.0 0
M  V30 10 N 6.7238 2.6675 0.0 0
M  V30 11 C 6.7238 0.0000 0.0 0
M  V30 12 C 8.2638 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 2 7 9
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1694-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1240195-02-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21561081
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM ((Carbamoyloxyisoxazolyl)aryloxy)cyclohexanecarboxylic acid as LPA
antagonists and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cheng, Peter Tai Wah; Kaltenbach, Robert F., III; Zhang, Hao; Shi, Yan;
Li, Jun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019126084 A1 2019-06-27

$RFMT $RIREG SCHEME190 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5′-Deoxy-N-[(1,1-dimethylethoxy)carbonyl]-2′,3′-O-(1-methylethylidene)-5′-oxo...
C18H23N5O6
1709790-72-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8839 1.0304 0.0 0
M  V30 2 O 5.0284 0.0000 0.0 0
M  V30 3 C 0.0000 5.2127 0.0 0
M  V30 4 C 1.0304 6.9976 0.0 0
M  V30 5 N 11.1807 8.0724 0.0 0
M  V30 6 C 12.7207 8.0724 0.0 0
M  V30 7 O 13.4907 9.4060 0.0 0
M  V30 8 O 13.4907 6.7387 0.0 0
M  V30 9 C 15.0307 9.4060 0.0 0
M  V30 10 C 15.0307 7.8660 0.0 0
M  V30 11 C 16.5707 9.4060 0.0 0
M  V30 12 C 15.0307 10.9460 0.0 0
M  V30 13 C 5.4499 4.6947 0.0 0 CFG=2
M  V30 14 C 3.9436 5.0149 0.0 0 CFG=2
M  V30 15 O 5.6110 3.1632 0.0 0
M  V30 16 C 3.1736 3.6812 0.0 0 CFG=2
M  V30 17 O 2.9132 6.1594 0.0 0
M  V30 18 C 4.2040 2.5368 0.0 0 CFG=2
M  V30 19 O 1.6672 4.0014 0.0 0
M  V30 20 C 1.5063 5.5329 0.0 0
M  V30 21 N 6.5944 5.7253 0.0 0
M  V30 22 C 8.1007 5.4049 0.0 0
M  V30 23 C 6.4335 7.2568 0.0 0
M  V30 24 C 8.8707 6.7387 0.0 0
M  V30 25 N 8.8707 4.0713 0.0 0
M  V30 26 N 7.8403 7.8831 0.0 0
M  V30 27 C 10.4107 6.7387 0.0 0
M  V30 28 C 10.4107 4.0713 0.0 0
M  V30 29 N 11.1807 5.4049 0.0 0
M  V30 30 H 4.7136 6.3487 0.0 0
M  V30 31 H 2.4036 2.3476 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 18 1 CFG=3
M  V30 3 1 3 20
M  V30 4 1 4 20
M  V30 5 1 5 6
M  V30 6 1 5 27
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 21 CFG=3
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 14 30 CFG=3
M  V30 19 1 15 18
M  V30 20 1 16 18
M  V30 21 1 16 19
M  V30 22 1 16 31 CFG=3
M  V30 23 1 17 20
M  V30 24 1 19 20
M  V30 25 1 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 22 25
M  V30 29 2 23 26
M  V30 30 1 24 26
M  V30 31 2 24 27
M  V30 32 1 25 28
M  V30 33 1 27 29
M  V30 34 2 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 13 14 16 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Adenosine, 5′-deoxy-N-[(1,1-dimethylethoxy)carbonyl]-5′-(methylamino)-2′,3′-O...
C19H28N6O5
2322299-50-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8839 2.5368 0.0 0
M  V30 2 N 5.0284 1.5064 0.0 0
M  V30 3 C 4.7081 0.0000 0.0 0
M  V30 4 C 0.0000 6.7192 0.0 0
M  V30 5 C 1.0304 8.5040 0.0 0
M  V30 6 N 11.1807 9.5788 0.0 0
M  V30 7 C 12.7207 9.5788 0.0 0
M  V30 8 O 13.4907 10.9124 0.0 0
M  V30 9 O 13.4907 8.2450 0.0 0
M  V30 10 C 15.0307 10.9124 0.0 0
M  V30 11 C 15.0307 12.4524 0.0 0
M  V30 12 C 16.5707 10.9124 0.0 0
M  V30 13 C 15.0307 9.3724 0.0 0
M  V30 14 C 5.4499 6.2011 0.0 0 CFG=2
M  V30 15 C 3.9436 6.5213 0.0 0 CFG=2
M  V30 16 O 5.6110 4.6696 0.0 0
M  V30 17 C 3.1736 5.1876 0.0 0 CFG=2
M  V30 18 O 2.9132 7.6657 0.0 0
M  V30 19 C 4.2040 4.0431 0.0 0 CFG=2
M  V30 20 O 1.6672 5.5078 0.0 0
M  V30 21 C 1.5063 7.0393 0.0 0
M  V30 22 N 6.5944 7.2315 0.0 0
M  V30 23 C 8.1007 6.9114 0.0 0
M  V30 24 C 6.4335 8.7631 0.0 0
M  V30 25 C 8.8707 8.2450 0.0 0
M  V30 26 N 8.8707 5.5777 0.0 0
M  V30 27 N 7.8403 9.3895 0.0 0
M  V30 28 C 10.4107 8.2450 0.0 0
M  V30 29 C 10.4107 5.5777 0.0 0
M  V30 30 N 11.1807 6.9114 0.0 0
M  V30 31 H 4.7136 7.8549 0.0 0
M  V30 32 H 2.4036 3.8540 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 19 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 4 21
M  V30 5 1 5 21
M  V30 6 1 6 7
M  V30 7 1 6 28
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 22 CFG=3
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 15 31 CFG=3
M  V30 20 1 16 19
M  V30 21 1 17 19
M  V30 22 1 17 20
M  V30 23 1 17 32 CFG=3
M  V30 24 1 18 21
M  V30 25 1 20 21
M  V30 26 1 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 23 26
M  V30 30 2 24 27
M  V30 31 1 25 27
M  V30 32 2 25 28
M  V30 33 1 26 29
M  V30 34 1 28 30
M  V30 35 2 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 14 15 17 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1709790-72-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2322299-50-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-22638279
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of salicyl-adenosine-monosulfamate analogs and uses thereof
as antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tan, Derek Shieh; Standke, Lisa Charlotte; Quadri, Luis Edmundo Nereo;
Bythrow, Glennon Valere; Bishai, William Ramses; Lun, Shichun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020132603 A2 2020-06-25

$RFMT $RIREG SCHEME190 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5′-Deoxy-N-[(1,1-dimethylethoxy)carbonyl]-2′,3′-O-(1-methylethylidene)-5′-oxo...
C18H23N5O6
1709790-72-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8839 1.0304 0.0 0
M  V30 2 O 5.0284 0.0000 0.0 0
M  V30 3 C 0.0000 5.2127 0.0 0
M  V30 4 C 1.0304 6.9976 0.0 0
M  V30 5 N 11.1807 8.0724 0.0 0
M  V30 6 C 12.7207 8.0724 0.0 0
M  V30 7 O 13.4907 9.4060 0.0 0
M  V30 8 O 13.4907 6.7387 0.0 0
M  V30 9 C 15.0307 9.4060 0.0 0
M  V30 10 C 15.0307 7.8660 0.0 0
M  V30 11 C 16.5707 9.4060 0.0 0
M  V30 12 C 15.0307 10.9460 0.0 0
M  V30 13 C 5.4499 4.6947 0.0 0 CFG=2
M  V30 14 C 3.9436 5.0149 0.0 0 CFG=2
M  V30 15 O 5.6110 3.1632 0.0 0
M  V30 16 C 3.1736 3.6812 0.0 0 CFG=2
M  V30 17 O 2.9132 6.1594 0.0 0
M  V30 18 C 4.2040 2.5368 0.0 0 CFG=2
M  V30 19 O 1.6672 4.0014 0.0 0
M  V30 20 C 1.5063 5.5329 0.0 0
M  V30 21 N 6.5944 5.7253 0.0 0
M  V30 22 C 8.1007 5.4049 0.0 0
M  V30 23 C 6.4335 7.2568 0.0 0
M  V30 24 C 8.8707 6.7387 0.0 0
M  V30 25 N 8.8707 4.0713 0.0 0
M  V30 26 N 7.8403 7.8831 0.0 0
M  V30 27 C 10.4107 6.7387 0.0 0
M  V30 28 C 10.4107 4.0713 0.0 0
M  V30 29 N 11.1807 5.4049 0.0 0
M  V30 30 H 4.7136 6.3487 0.0 0
M  V30 31 H 2.4036 2.3476 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 18 1 CFG=3
M  V30 3 1 3 20
M  V30 4 1 4 20
M  V30 5 1 5 6
M  V30 6 1 5 27
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 21 CFG=3
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 14 30 CFG=3
M  V30 19 1 15 18
M  V30 20 1 16 18
M  V30 21 1 16 19
M  V30 22 1 16 31 CFG=3
M  V30 23 1 17 20
M  V30 24 1 19 20
M  V30 25 1 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 22 25
M  V30 29 2 23 26
M  V30 30 1 24 26
M  V30 31 2 24 27
M  V30 32 1 25 28
M  V30 33 1 27 29
M  V30 34 2 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 13 14 16 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Adenosine, 5′-deoxy-N-[(1,1-dimethylethoxy)carbonyl]-5′-(methylamino)-2′,3′-O...
C19H28N6O5
2322299-50-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8839 2.5368 0.0 0
M  V30 2 N 5.0284 1.5064 0.0 0
M  V30 3 C 4.7081 0.0000 0.0 0
M  V30 4 C 0.0000 6.7192 0.0 0
M  V30 5 C 1.0304 8.5040 0.0 0
M  V30 6 N 11.1807 9.5788 0.0 0
M  V30 7 C 12.7207 9.5788 0.0 0
M  V30 8 O 13.4907 10.9124 0.0 0
M  V30 9 O 13.4907 8.2450 0.0 0
M  V30 10 C 15.0307 10.9124 0.0 0
M  V30 11 C 15.0307 12.4524 0.0 0
M  V30 12 C 16.5707 10.9124 0.0 0
M  V30 13 C 15.0307 9.3724 0.0 0
M  V30 14 C 5.4499 6.2011 0.0 0 CFG=2
M  V30 15 C 3.9436 6.5213 0.0 0 CFG=2
M  V30 16 O 5.6110 4.6696 0.0 0
M  V30 17 C 3.1736 5.1876 0.0 0 CFG=2
M  V30 18 O 2.9132 7.6657 0.0 0
M  V30 19 C 4.2040 4.0431 0.0 0 CFG=2
M  V30 20 O 1.6672 5.5078 0.0 0
M  V30 21 C 1.5063 7.0393 0.0 0
M  V30 22 N 6.5944 7.2315 0.0 0
M  V30 23 C 8.1007 6.9114 0.0 0
M  V30 24 C 6.4335 8.7631 0.0 0
M  V30 25 C 8.8707 8.2450 0.0 0
M  V30 26 N 8.8707 5.5777 0.0 0
M  V30 27 N 7.8403 9.3895 0.0 0
M  V30 28 C 10.4107 8.2450 0.0 0
M  V30 29 C 10.4107 5.5777 0.0 0
M  V30 30 N 11.1807 6.9114 0.0 0
M  V30 31 H 4.7136 7.8549 0.0 0
M  V30 32 H 2.4036 3.8540 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 19 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 4 21
M  V30 5 1 5 21
M  V30 6 1 6 7
M  V30 7 1 6 28
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 22 CFG=3
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 15 31 CFG=3
M  V30 20 1 16 19
M  V30 21 1 17 19
M  V30 22 1 17 20
M  V30 23 1 17 32 CFG=3
M  V30 24 1 18 21
M  V30 25 1 20 21
M  V30 26 1 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 23 26
M  V30 30 2 24 27
M  V30 31 1 25 27
M  V30 32 2 25 28
M  V30 33 1 26 29
M  V30 34 1 28 30
M  V30 35 2 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 14 15 17 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1709790-72-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2322299-50-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-20224440
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Kinetic analyses of the siderophore biosynthesis inhibitor salicyl-AMS
and analogues as MbtA inhibitors and antimycobacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bythrow, Glennon V.; Mohandas, Poornima; Guney, Tezcan; Standke, Lisa C.;
Germain, Gabrielle A.; Lu, Xuequan; Ji, Cheng; Levendosky, Keith;
Chavadi, Sivagami Sundaram; Tan, Derek S.; Quadri, Luis E. N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Biochemistry (2019), 58(6), 833-847

$RFMT $RIREG SCHEME191 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxybenzoyl chloride
C8H7ClO2
1711-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 Cl 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 O 6.6687 1.5400 0.0 0
M  V30 5 C 8.0023 2.3101 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-N-methylbenzamide
C9H11NO2
35129-32-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 3.0801 0.0 0
M  V30 2 N 1.3337 2.3101 0.0 0
M  V30 3 O 2.6675 4.6201 0.0 0
M  V30 4 C 0.0000 3.0801 0.0 0
M  V30 5 O 8.0023 3.0801 0.0 0
M  V30 6 C 9.3360 2.3101 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 5.3348 3.0801 0.0 0
M  V30 9 C 4.0012 0.7700 0.0 0
M  V30 10 C 6.6685 2.3101 0.0 0
M  V30 11 C 5.3348 0.0000 0.0 0
M  V30 12 C 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1711-05-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35129-32-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-901084
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Potent P2Y1 urea antagonists bearing various cyclic amine scaffolds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ruel, Rejean; L'Heureux, Alexandre; Thibeault, Carl; Lapointe, Philippe;
Martel, Alain; Qiao, Jennifer X.; Hua, Ji; Price, Laura A.; Wu, Qimin;
Chang, Ming; Zheng, Joanna; Huang, Christine S.; Wexler, Ruth R.;
Rehfuss, Robert; Lam, Patrick Y. S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2013), 23(24), 6825-6828

$RFMT $RIREG SCHEME192 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Glycine, N-(2-ethoxy-2-oxoethyl)-N-(phenylmethyl)-, ethyl ester
C15H21NO4
17136-37-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 6.6684 0.0 0
M  V30 2 C 4.6200 8.0021 0.0 0
M  V30 3 C 6.9300 6.6684 0.0 0
M  V30 4 C 4.6200 5.3347 0.0 0
M  V30 5 C 7.7000 8.0021 0.0 0
M  V30 6 C 5.3900 4.0011 0.0 0
M  V30 7 O 9.2400 8.0021 0.0 0
M  V30 8 O 6.9300 9.3358 0.0 0
M  V30 9 O 4.6200 2.6674 0.0 0
M  V30 10 O 6.9300 4.0011 0.0 0
M  V30 11 C 10.0100 9.3358 0.0 0
M  V30 12 C 5.3900 1.3336 0.0 0
M  V30 13 C 11.5500 9.3358 0.0 0
M  V30 14 C 4.6200 0.0000 0.0 0
M  V30 15 C 3.0800 8.0021 0.0 0
M  V30 16 C 2.3100 6.6684 0.0 0
M  V30 17 C 2.3100 9.3358 0.0 0
M  V30 18 C 0.7700 6.6684 0.0 0
M  V30 19 C 0.7700 9.3358 0.0 0
M  V30 20 C 0.0000 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 15
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2′-[(Phenylmethyl)imino]bis[N-methylacetamide]
C13H19N3O2
725686-06-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 5.3347 0.0 0
M  V30 2 C 4.6200 6.6685 0.0 0
M  V30 3 C 4.6200 4.0011 0.0 0
M  V30 4 C 6.9300 5.3347 0.0 0
M  V30 5 C 5.3900 2.6674 0.0 0
M  V30 6 C 7.7000 6.6685 0.0 0
M  V30 7 N 4.6200 1.3336 0.0 0
M  V30 8 O 6.9300 2.6674 0.0 0
M  V30 9 N 9.2400 6.6685 0.0 0
M  V30 10 O 6.9300 8.0021 0.0 0
M  V30 11 C 5.3900 0.0000 0.0 0
M  V30 12 C 10.0100 8.0021 0.0 0
M  V30 13 C 3.0800 6.6685 0.0 0
M  V30 14 C 2.3100 8.0021 0.0 0
M  V30 15 C 2.3100 5.3347 0.0 0
M  V30 16 C 0.7700 8.0021 0.0 0
M  V30 17 C 0.7700 5.3347 0.0 0
M  V30 18 C 0.0000 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 13
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 17136-37-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 725686-06-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9474443
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM A solution of N-(2-ethoxy-2-oxoethyl)-N-(phenylmethyl)-glycine ethyl
ester (7.70 g, 27.6 mmol) in methylamine alcohol solution (25-30%, 50 mL)
was heated to 50° C. in a sealed tube for 3 h, cooled to RT and
concentrated in vacuo to yield
N-(2-methylamino-2-oxoethyl)-N-(phenylmethyl)-glycine methylamide in
quantitative yield (7.63 g). 1H NMR (CDCl3): δ 7.35-7.28 (m, 5H), 6.75
(br s, 2H), 3.71 (s, 2H), 3.20 (s, 4H), 2.81 (d, J=5.6 Hz, 6H); MS (ESI)
m/e 250 (M+H+).
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and selection of protein ligands inducing conformational changes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Flynn, Daniel L.; Petillo, Peter A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20080248548 A1 2008-10-09

$RFMT $RIREG SCHEME192 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Glycine, N-(2-ethoxy-2-oxoethyl)-N-(phenylmethyl)-, ethyl ester
C15H21NO4
17136-37-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 6.6684 0.0 0
M  V30 2 C 4.6200 8.0021 0.0 0
M  V30 3 C 6.9300 6.6684 0.0 0
M  V30 4 C 4.6200 5.3347 0.0 0
M  V30 5 C 7.7000 8.0021 0.0 0
M  V30 6 C 5.3900 4.0011 0.0 0
M  V30 7 O 9.2400 8.0021 0.0 0
M  V30 8 O 6.9300 9.3358 0.0 0
M  V30 9 O 4.6200 2.6674 0.0 0
M  V30 10 O 6.9300 4.0011 0.0 0
M  V30 11 C 10.0100 9.3358 0.0 0
M  V30 12 C 5.3900 1.3336 0.0 0
M  V30 13 C 11.5500 9.3358 0.0 0
M  V30 14 C 4.6200 0.0000 0.0 0
M  V30 15 C 3.0800 8.0021 0.0 0
M  V30 16 C 2.3100 6.6684 0.0 0
M  V30 17 C 2.3100 9.3358 0.0 0
M  V30 18 C 0.7700 6.6684 0.0 0
M  V30 19 C 0.7700 9.3358 0.0 0
M  V30 20 C 0.0000 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 15
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2′-[(Phenylmethyl)imino]bis[N-methylacetamide]
C13H19N3O2
725686-06-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 5.3347 0.0 0
M  V30 2 C 4.6200 6.6685 0.0 0
M  V30 3 C 4.6200 4.0011 0.0 0
M  V30 4 C 6.9300 5.3347 0.0 0
M  V30 5 C 5.3900 2.6674 0.0 0
M  V30 6 C 7.7000 6.6685 0.0 0
M  V30 7 N 4.6200 1.3336 0.0 0
M  V30 8 O 6.9300 2.6674 0.0 0
M  V30 9 N 9.2400 6.6685 0.0 0
M  V30 10 O 6.9300 8.0021 0.0 0
M  V30 11 C 5.3900 0.0000 0.0 0
M  V30 12 C 10.0100 8.0021 0.0 0
M  V30 13 C 3.0800 6.6685 0.0 0
M  V30 14 C 2.3100 8.0021 0.0 0
M  V30 15 C 2.3100 5.3347 0.0 0
M  V30 16 C 0.7700 8.0021 0.0 0
M  V30 17 C 0.7700 5.3347 0.0 0
M  V30 18 C 0.0000 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 13
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 17136-37-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 725686-06-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10117716
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM A solution of N-(2-ethoxy-2-oxoethyl)-N-(phenyl-methyl)-glycine ethyl
ester (7.70 g, 27.6 mmol) in methylamine alcohol solution (25-30%, 50 mL)
was heated to 50° C. in a sealed tube for 3 h, cooled to RT and
concentrated in vacuo to yield N-(2-methylamino-2-oxoethyl)-N-(phenylm-
ethyl)-glycine methylamide in quantitative yield (7.63 g). 1H NMR
(CDCl3): δ 7.35-7.28 (m, 5H), 6.75 (br s, 2H), 3.71(s, 2H), 3.20 (s, 4H),
2.81 (d, J=5.6 Hz, 6H); MS (ESI) m/e 250(M+H+).
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 1-pyrazolyl-3-phenylurea p38 MAP kinase inhibitors as
antiinflammatory medicaments
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Flynn, Daniel L.; Petillo, Peter A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20070191336 A1 2007-08-16

$RFMT $RIREG SCHEME192 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Glycine, N-(2-ethoxy-2-oxoethyl)-N-(phenylmethyl)-, ethyl ester
C15H21NO4
17136-37-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 6.6684 0.0 0
M  V30 2 C 4.6200 8.0021 0.0 0
M  V30 3 C 6.9300 6.6684 0.0 0
M  V30 4 C 4.6200 5.3347 0.0 0
M  V30 5 C 7.7000 8.0021 0.0 0
M  V30 6 C 5.3900 4.0011 0.0 0
M  V30 7 O 9.2400 8.0021 0.0 0
M  V30 8 O 6.9300 9.3358 0.0 0
M  V30 9 O 4.6200 2.6674 0.0 0
M  V30 10 O 6.9300 4.0011 0.0 0
M  V30 11 C 10.0100 9.3358 0.0 0
M  V30 12 C 5.3900 1.3336 0.0 0
M  V30 13 C 11.5500 9.3358 0.0 0
M  V30 14 C 4.6200 0.0000 0.0 0
M  V30 15 C 3.0800 8.0021 0.0 0
M  V30 16 C 2.3100 6.6684 0.0 0
M  V30 17 C 2.3100 9.3358 0.0 0
M  V30 18 C 0.7700 6.6684 0.0 0
M  V30 19 C 0.7700 9.3358 0.0 0
M  V30 20 C 0.0000 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 15
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2′-[(Phenylmethyl)imino]bis[N-methylacetamide]
C13H19N3O2
725686-06-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 5.3347 0.0 0
M  V30 2 C 4.6200 6.6685 0.0 0
M  V30 3 C 4.6200 4.0011 0.0 0
M  V30 4 C 6.9300 5.3347 0.0 0
M  V30 5 C 5.3900 2.6674 0.0 0
M  V30 6 C 7.7000 6.6685 0.0 0
M  V30 7 N 4.6200 1.3336 0.0 0
M  V30 8 O 6.9300 2.6674 0.0 0
M  V30 9 N 9.2400 6.6685 0.0 0
M  V30 10 O 6.9300 8.0021 0.0 0
M  V30 11 C 5.3900 0.0000 0.0 0
M  V30 12 C 10.0100 8.0021 0.0 0
M  V30 13 C 3.0800 6.6685 0.0 0
M  V30 14 C 2.3100 8.0021 0.0 0
M  V30 15 C 2.3100 5.3347 0.0 0
M  V30 16 C 0.7700 8.0021 0.0 0
M  V30 17 C 0.7700 5.3347 0.0 0
M  V30 18 C 0.0000 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 13
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 17136-37-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 725686-06-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14366148
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 1-pyrazolyl-3-phenylurea p38 MAP kinase inhibitors as
antiinflammatory medicaments
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Flynn, Daniel L.; Petrillo, Peter A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004060306 A2 2004-07-22

$RFMT $RIREG SCHEME192 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Glycine, N-(2-ethoxy-2-oxoethyl)-N-(phenylmethyl)-, ethyl ester
C15H21NO4
17136-37-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 6.6684 0.0 0
M  V30 2 C 4.6200 8.0021 0.0 0
M  V30 3 C 6.9300 6.6684 0.0 0
M  V30 4 C 4.6200 5.3347 0.0 0
M  V30 5 C 7.7000 8.0021 0.0 0
M  V30 6 C 5.3900 4.0011 0.0 0
M  V30 7 O 9.2400 8.0021 0.0 0
M  V30 8 O 6.9300 9.3358 0.0 0
M  V30 9 O 4.6200 2.6674 0.0 0
M  V30 10 O 6.9300 4.0011 0.0 0
M  V30 11 C 10.0100 9.3358 0.0 0
M  V30 12 C 5.3900 1.3336 0.0 0
M  V30 13 C 11.5500 9.3358 0.0 0
M  V30 14 C 4.6200 0.0000 0.0 0
M  V30 15 C 3.0800 8.0021 0.0 0
M  V30 16 C 2.3100 6.6684 0.0 0
M  V30 17 C 2.3100 9.3358 0.0 0
M  V30 18 C 0.7700 6.6684 0.0 0
M  V30 19 C 0.7700 9.3358 0.0 0
M  V30 20 C 0.0000 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 15
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2′-[(Phenylmethyl)imino]bis[N-methylacetamide]
C13H19N3O2
725686-06-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 5.3347 0.0 0
M  V30 2 C 4.6200 6.6685 0.0 0
M  V30 3 C 4.6200 4.0011 0.0 0
M  V30 4 C 6.9300 5.3347 0.0 0
M  V30 5 C 5.3900 2.6674 0.0 0
M  V30 6 C 7.7000 6.6685 0.0 0
M  V30 7 N 4.6200 1.3336 0.0 0
M  V30 8 O 6.9300 2.6674 0.0 0
M  V30 9 N 9.2400 6.6685 0.0 0
M  V30 10 O 6.9300 8.0021 0.0 0
M  V30 11 C 5.3900 0.0000 0.0 0
M  V30 12 C 10.0100 8.0021 0.0 0
M  V30 13 C 3.0800 6.6685 0.0 0
M  V30 14 C 2.3100 8.0021 0.0 0
M  V30 15 C 2.3100 5.3347 0.0 0
M  V30 16 C 0.7700 8.0021 0.0 0
M  V30 17 C 0.7700 5.3347 0.0 0
M  V30 18 C 0.0000 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 13
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 17136-37-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 725686-06-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14390177
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of sulfamides as anti-cancer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Flynn, Daniel L.; Petrillo, Peter A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004060305 A2 2004-07-22

$RFMT $RIREG SCHEME193 STEP1
$RXN



  2  1
$MOL
3-Methyl-5-phenylisoxazole-4-carboxylic acid
C11H9NO3
17153-21-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.1864 1.1444 0.0 0
M  V30 2 O 2.1559 0.0000 0.0 0
M  V30 3 O 4.6927 0.8242 0.0 0
M  V30 4 C 0.0000 2.1797 0.0 0
M  V30 5 C 3.6156 3.8549 0.0 0
M  V30 6 C 2.7104 2.6091 0.0 0
M  V30 7 O 2.7104 5.1008 0.0 0
M  V30 8 C 1.2459 3.0849 0.0 0
M  V30 9 N 1.2459 4.6250 0.0 0
M  V30 10 C 5.1556 3.8549 0.0 0
M  V30 11 C 5.9256 5.1886 0.0 0
M  V30 12 C 5.9256 2.5213 0.0 0
M  V30 13 C 7.4656 5.1886 0.0 0
M  V30 14 C 7.4656 2.5213 0.0 0
M  V30 15 C 8.2357 3.8549 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 10
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,3-Dimethyl-5-phenyl-4-isoxazolecarboxamide
C12H12N2O2
500165-04-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.1864 2.6092 0.0 0
M  V30 2 N 2.1559 1.4647 0.0 0
M  V30 3 O 4.6927 2.2889 0.0 0
M  V30 4 C 2.6317 0.0000 0.0 0
M  V30 5 C 0.0000 3.6444 0.0 0
M  V30 6 C 3.6156 5.3196 0.0 0
M  V30 7 C 2.7104 4.0738 0.0 0
M  V30 8 O 2.7104 6.5655 0.0 0
M  V30 9 C 1.2459 4.5496 0.0 0
M  V30 10 N 1.2459 6.0897 0.0 0
M  V30 11 C 5.1556 5.3196 0.0 0
M  V30 12 C 5.9256 6.6534 0.0 0
M  V30 13 C 5.9256 3.9860 0.0 0
M  V30 14 C 7.4656 6.6533 0.0 0
M  V30 15 C 7.4656 3.9860 0.0 0
M  V30 16 C 8.2357 5.3196 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 17153-21-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 500165-04-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13427457
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of isoxazolopyridinones as Nurr1 activators for treating
Parkinson's disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hintermann, Samuel; Hengerer, Bastian; Von Krosigk, Ulrike
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003015780 A2 2003-02-27

$RFMT $RIREG SCHEME194 STEP1
$RXN



  2  1
$MOL
trans-3-[4-[6-Fluoro-1-(phenylsulfonyl)-1H-indol-3-yl]-1H-pyrazol-1-yl]cyclob...
C22H18FN3O4S
1771758-90-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0011 6.0551 0.0 0 VAL=6
M  V30 2 O 3.2311 4.7213 0.0 0
M  V30 3 O 4.7711 7.3888 0.0 0
M  V30 4 F 3.9107 0.0000 0.0 0
M  V30 5 C 15.4873 9.4598 0.0 0
M  V30 6 O 15.1672 10.9660 0.0 0
M  V30 7 O 16.9520 8.9837 0.0 0
M  V30 8 C 5.4958 3.7534 0.0 0
M  V30 9 C 7.0021 3.4333 0.0 0
M  V30 10 N 5.3347 5.2851 0.0 0
M  V30 11 C 4.4652 2.6091 0.0 0
M  V30 12 C 7.7721 4.7671 0.0 0
M  V30 13 C 7.4779 1.9687 0.0 0
M  V30 14 C 6.7417 5.9114 0.0 0
M  V30 15 C 4.9411 1.1444 0.0 0
M  V30 16 C 6.4475 0.8242 0.0 0
M  V30 17 C 9.3036 4.9280 0.0 0
M  V30 18 C 10.0736 6.2616 0.0 0
M  V30 19 C 10.3342 3.7835 0.0 0
M  V30 20 N 11.5800 5.9415 0.0 0
M  V30 21 N 11.7410 4.4099 0.0 0
M  V30 22 C 2.6674 6.8251 0.0 0
M  V30 23 C 2.6674 8.3651 0.0 0
M  V30 24 C 1.3336 6.0551 0.0 0
M  V30 25 C 1.3336 9.1351 0.0 0
M  V30 26 C 0.0000 6.8251 0.0 0
M  V30 27 C 0.0000 8.3651 0.0 0
M  V30 28 C 12.7244 6.9719 0.0 0 CFG=1
M  V30 29 C 14.2622 6.8913 0.0 0
M  V30 30 C 12.8049 8.5099 0.0 0
M  V30 31 C 14.3429 8.4292 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 1 22
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 31 5 CFG=3
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 14
M  V30 17 1 12 17
M  V30 18 1 13 16
M  V30 19 2 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 1 28 20 CFG=1
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 1 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 28 31)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
trans-3-[4-[6-Fluoro-1-(phenylsulfonyl)-1H-indol-3-yl]-1H-pyrazol-1-yl]-N-met...
C23H21FN4O3S
1771759-61-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0011 6.0552 0.0 0 VAL=6
M  V30 2 O 4.7711 7.3888 0.0 0
M  V30 3 O 3.2311 4.7214 0.0 0
M  V30 4 F 3.9107 0.0000 0.0 0
M  V30 5 C 15.4876 9.4598 0.0 0
M  V30 6 N 16.9521 8.9838 0.0 0
M  V30 7 O 15.1673 10.9661 0.0 0
M  V30 8 C 18.0967 10.0144 0.0 0
M  V30 9 C 5.4958 3.7535 0.0 0
M  V30 10 C 7.0021 3.4333 0.0 0
M  V30 11 N 5.3349 5.2852 0.0 0
M  V30 12 C 4.4653 2.6091 0.0 0
M  V30 13 C 7.7721 4.7671 0.0 0
M  V30 14 C 7.4780 1.9688 0.0 0
M  V30 15 C 6.7417 5.9115 0.0 0
M  V30 16 C 4.9413 1.1444 0.0 0
M  V30 17 C 6.4476 0.8242 0.0 0
M  V30 18 C 9.3037 4.9280 0.0 0
M  V30 19 C 10.0737 6.2617 0.0 0
M  V30 20 C 10.3343 3.7835 0.0 0
M  V30 21 N 11.5801 5.9415 0.0 0
M  V30 22 N 11.7411 4.4100 0.0 0
M  V30 23 C 2.6675 6.8252 0.0 0
M  V30 24 C 2.6675 8.3652 0.0 0
M  V30 25 C 1.3338 6.0552 0.0 0
M  V30 26 C 1.3338 9.1352 0.0 0
M  V30 27 C 0.0000 6.8252 0.0 0
M  V30 28 C 0.0000 8.3652 0.0 0
M  V30 29 C 12.7245 6.9719 0.0 0 CFG=1
M  V30 30 C 12.8052 8.5100 0.0 0
M  V30 31 C 14.2625 6.8914 0.0 0
M  V30 32 C 14.3431 8.4293 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 1 23
M  V30 5 1 4 16
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 32 5 CFG=1
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 13 15
M  V30 18 1 13 18
M  V30 19 1 14 17
M  V30 20 2 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 29 21 CFG=3
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 1 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 29 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1771758-90-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1771759-61-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-6500136
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of indolylpyrazole derivatives for use as tryptophan
2,3-dioxygenase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Crosignani, Stefano; Cauwenberghs, Sandra; Deroose, Frederik; Driessens,
Gregory
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015067782 A1 2015-05-14

$RFMT $RIREG SCHEME194 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
trans-3-[4-[6-Fluoro-1-(phenylsulfonyl)-1H-indol-3-yl]-1H-pyrazol-1-yl]cyclob...
C22H18FN3O4S
1771758-90-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0011 6.0551 0.0 0 VAL=6
M  V30 2 O 3.2311 4.7213 0.0 0
M  V30 3 O 4.7711 7.3888 0.0 0
M  V30 4 F 3.9107 0.0000 0.0 0
M  V30 5 C 15.4873 9.4598 0.0 0
M  V30 6 O 15.1672 10.9660 0.0 0
M  V30 7 O 16.9520 8.9837 0.0 0
M  V30 8 C 5.4958 3.7534 0.0 0
M  V30 9 C 7.0021 3.4333 0.0 0
M  V30 10 N 5.3347 5.2851 0.0 0
M  V30 11 C 4.4652 2.6091 0.0 0
M  V30 12 C 7.7721 4.7671 0.0 0
M  V30 13 C 7.4779 1.9687 0.0 0
M  V30 14 C 6.7417 5.9114 0.0 0
M  V30 15 C 4.9411 1.1444 0.0 0
M  V30 16 C 6.4475 0.8242 0.0 0
M  V30 17 C 9.3036 4.9280 0.0 0
M  V30 18 C 10.0736 6.2616 0.0 0
M  V30 19 C 10.3342 3.7835 0.0 0
M  V30 20 N 11.5800 5.9415 0.0 0
M  V30 21 N 11.7410 4.4099 0.0 0
M  V30 22 C 2.6674 6.8251 0.0 0
M  V30 23 C 2.6674 8.3651 0.0 0
M  V30 24 C 1.3336 6.0551 0.0 0
M  V30 25 C 1.3336 9.1351 0.0 0
M  V30 26 C 0.0000 6.8251 0.0 0
M  V30 27 C 0.0000 8.3651 0.0 0
M  V30 28 C 12.7244 6.9719 0.0 0 CFG=1
M  V30 29 C 14.2622 6.8913 0.0 0
M  V30 30 C 12.8049 8.5099 0.0 0
M  V30 31 C 14.3429 8.4292 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 1 22
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 31 5 CFG=3
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 14
M  V30 17 1 12 17
M  V30 18 1 13 16
M  V30 19 2 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 1 28 20 CFG=1
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 1 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 28 31)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
trans-3-[4-[6-Fluoro-1-(phenylsulfonyl)-1H-indol-3-yl]-1H-pyrazol-1-yl]-N-met...
C23H21FN4O3S
1771759-61-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0011 6.0552 0.0 0 VAL=6
M  V30 2 O 4.7711 7.3888 0.0 0
M  V30 3 O 3.2311 4.7214 0.0 0
M  V30 4 F 3.9107 0.0000 0.0 0
M  V30 5 C 15.4876 9.4598 0.0 0
M  V30 6 N 16.9521 8.9838 0.0 0
M  V30 7 O 15.1673 10.9661 0.0 0
M  V30 8 C 18.0967 10.0144 0.0 0
M  V30 9 C 5.4958 3.7535 0.0 0
M  V30 10 C 7.0021 3.4333 0.0 0
M  V30 11 N 5.3349 5.2852 0.0 0
M  V30 12 C 4.4653 2.6091 0.0 0
M  V30 13 C 7.7721 4.7671 0.0 0
M  V30 14 C 7.4780 1.9688 0.0 0
M  V30 15 C 6.7417 5.9115 0.0 0
M  V30 16 C 4.9413 1.1444 0.0 0
M  V30 17 C 6.4476 0.8242 0.0 0
M  V30 18 C 9.3037 4.9280 0.0 0
M  V30 19 C 10.0737 6.2617 0.0 0
M  V30 20 C 10.3343 3.7835 0.0 0
M  V30 21 N 11.5801 5.9415 0.0 0
M  V30 22 N 11.7411 4.4100 0.0 0
M  V30 23 C 2.6675 6.8252 0.0 0
M  V30 24 C 2.6675 8.3652 0.0 0
M  V30 25 C 1.3338 6.0552 0.0 0
M  V30 26 C 1.3338 9.1352 0.0 0
M  V30 27 C 0.0000 6.8252 0.0 0
M  V30 28 C 0.0000 8.3652 0.0 0
M  V30 29 C 12.7245 6.9719 0.0 0 CFG=1
M  V30 30 C 12.8052 8.5100 0.0 0
M  V30 31 C 14.2625 6.8914 0.0 0
M  V30 32 C 14.3431 8.4293 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 1 23
M  V30 5 1 4 16
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 32 5 CFG=1
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 13 15
M  V30 18 1 13 18
M  V30 19 1 14 17
M  V30 20 2 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 29 21 CFG=3
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 1 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 29 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1771758-90-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1771759-61-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-18626262
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):NOTES
$DATUM no experimental detail
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of indolylpyrazole derivatives for use as tryptophan
2,3-dioxygenase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Crosignani, Stefano; Cauwenberghs, Sandra; Deroose, Frederik
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20150133422 A1 2015-05-14

$RFMT $RIREG SCHEME195 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-N-(1-methylcyclopropyl)-4-nitrobenzenesulfonamide
C10H11FN2O4S
1776598-35-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 4.6201 0.0 0 VAL=6
M  V30 2 N 8.0023 5.3901 0.0 0
M  V30 3 O 5.8985 5.9538 0.0 0
M  V30 4 O 7.4385 3.2864 0.0 0
M  V30 5 F 1.3337 4.6201 0.0 0
M  V30 6 C 8.8093 3.1729 0.0 0
M  V30 7 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6675 3.8501 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 15 C 2.6675 2.3101 0.0 0
M  V30 16 C 9.3360 4.6201 0.0 0
M  V30 17 C 10.3259 5.7998 0.0 0
M  V30 18 C 10.8526 4.3526 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 16
M  V30 6 1 5 13
M  V30 7 1 6 16
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 15
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Methylamino)-N-(1-methylcyclopropyl)-4-nitrobenzenesulfonamide
C11H15N3O4S
1709761-98-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 4.6201 0.0 0 VAL=6
M  V30 2 N 8.0023 5.3901 0.0 0
M  V30 3 O 5.8985 5.9538 0.0 0
M  V30 4 O 7.4385 3.2864 0.0 0
M  V30 5 N 1.3337 4.6201 0.0 0
M  V30 6 C 1.3337 6.1601 0.0 0
M  V30 7 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 C 8.8093 3.1729 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 12 C 4.0012 4.6201 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 2.6675 3.8501 0.0 0
M  V30 15 C 4.0012 1.5400 0.0 0
M  V30 16 C 2.6675 2.3101 0.0 0
M  V30 17 C 9.3360 4.6201 0.0 0
M  V30 18 C 10.3259 5.7998 0.0 0
M  V30 19 C 10.8526 4.3528 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 11
M  V30 5 1 2 17
M  V30 6 1 5 6
M  V30 7 1 5 14
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 16
M  V30 11 1 10 17
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1776598-35-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1709761-98-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-16323845
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM exothermic
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of oxobenzimidazolesulfonamide derivatives as PARG inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM McGonagle, Alison E.; Jordan, Allan M.; Waszkowycz, Bohdan; Hutton, Colin
P.; Waddell, Ian D.; Hitchin, James R.; Smith, Kate M.; Hamilton, Niall
M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016097749 A1 2016-06-23

$RFMT $RIREG SCHEME196 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3-Bromo-4-methoxyphenyl)cyclopropanecarboxaldehyde
C11H11BrO2
1785405-68-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.4471 4.1839 0.0 0
M  V30 2 O 0.0000 4.7106 0.0 0
M  V30 3 Br 6.3346 0.0000 0.0 0
M  V30 4 O 7.8746 2.6673 0.0 0
M  V30 5 C 8.6446 4.0009 0.0 0
M  V30 6 C 1.7146 2.6673 0.0 0
M  V30 7 C 0.2675 2.1406 0.0 0
M  V30 8 C 1.4471 1.1507 0.0 0
M  V30 9 C 3.2546 2.6673 0.0 0
M  V30 10 C 4.0246 1.3336 0.0 0
M  V30 11 C 4.0246 4.0009 0.0 0
M  V30 12 C 5.5646 1.3336 0.0 0
M  V30 13 C 5.5646 4.0009 0.0 0
M  V30 14 C 6.3346 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanamine, N-[[1-(3-bromo-4-methoxyphenyl)cyclopropyl]methylene]-
C12H14BrNO
2893951-61-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.7145 2.0433 0.0 0
M  V30 2 N 0.2675 1.5166 0.0 0
M  V30 3 C 0.0000 0.0000 0.0 0
M  V30 4 Br 6.6021 6.2272 0.0 0
M  V30 5 O 8.1421 3.5599 0.0 0
M  V30 6 C 8.9121 2.2262 0.0 0
M  V30 7 C 1.9820 3.5599 0.0 0
M  V30 8 C 0.5348 4.0866 0.0 0
M  V30 9 C 1.7145 5.0765 0.0 0
M  V30 10 C 3.5220 3.5599 0.0 0
M  V30 11 C 4.2920 4.8936 0.0 0
M  V30 12 C 4.2920 2.2262 0.0 0
M  V30 13 C 5.8320 4.8936 0.0 0
M  V30 14 C 5.8320 2.2262 0.0 0
M  V30 15 C 6.6021 3.5599 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1785405-68-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2893951-61-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35795540
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7487-88-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of mesembrine alkaloids treating depression, anxiety,
inflammation, and autoimmunity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Protzko, Ryan Joseph; Pfeiffer, Thomas; Gray, Royston Anthony
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023004428 A1 2023-01-26

$RFMT $RIREG SCHEME197 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 2-oxo-7-azaspiro[4.5]decane-7-carboxylate
C14H23NO3
1793108-63-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 O 2.6675 2.3101 0.0 0
M  V30 3 O 4.0012 4.6201 0.0 0
M  V30 4 C 1.3338 3.0801 0.0 0
M  V30 5 C 2.1038 4.4137 0.0 0
M  V30 6 C 0.0000 3.8501 0.0 0
M  V30 7 C 0.5638 1.7464 0.0 0
M  V30 8 O 11.9713 2.6672 0.0 0
M  V30 9 C 8.0023 2.3101 0.0 0
M  V30 10 C 6.6687 3.0801 0.0 0
M  V30 11 C 8.1633 3.8416 0.0 0
M  V30 12 C 9.4091 1.6837 0.0 0
M  V30 13 C 8.0023 0.7700 0.0 0
M  V30 14 N 5.3348 2.3101 0.0 0
M  V30 15 C 9.6697 4.1618 0.0 0
M  V30 16 C 10.4397 2.8281 0.0 0
M  V30 17 C 6.6687 0.0000 0.0 0
M  V30 18 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 16
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 16
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 2-(methylamino)-7-azaspiro[4.5]decane-7-carboxylate
C15H28N2O2
1793108-64-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 O 2.6675 2.3101 0.0 0
M  V30 3 O 4.0012 4.6201 0.0 0
M  V30 4 C 1.3338 3.0801 0.0 0
M  V30 5 C 0.5638 1.7464 0.0 0
M  V30 6 C 0.0000 3.8501 0.0 0
M  V30 7 C 2.1038 4.4137 0.0 0
M  V30 8 N 11.9713 2.6672 0.0 0
M  V30 9 C 12.8765 3.9131 0.0 0
M  V30 10 C 8.0023 2.3101 0.0 0
M  V30 11 C 6.6687 3.0801 0.0 0
M  V30 12 C 9.4091 1.6837 0.0 0
M  V30 13 C 8.1633 3.8416 0.0 0
M  V30 14 C 8.0023 0.7700 0.0 0
M  V30 15 N 5.3348 2.3101 0.0 0
M  V30 16 C 10.4397 2.8281 0.0 0
M  V30 17 C 9.6697 4.1618 0.0 0
M  V30 18 C 6.6687 0.0000 0.0 0
M  V30 19 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 16
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1793108-63-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1793108-64-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-17119340
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heteroaryl derivatives for use in the treatment of
JAK-mediated disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xi, Ning; Li, Minxiong; Hu, Haiyang; Dai, Weilong; Li, Xiaobo; Wang,
Tingjin; Wu, Yanjun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016190847 A1 2016-12-01

$RFMT $RIREG SCHEME197 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 2-oxo-7-azaspiro[4.5]decane-7-carboxylate
C14H23NO3
1793108-63-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 O 2.6675 2.3101 0.0 0
M  V30 3 O 4.0012 4.6201 0.0 0
M  V30 4 C 1.3338 3.0801 0.0 0
M  V30 5 C 2.1038 4.4137 0.0 0
M  V30 6 C 0.0000 3.8501 0.0 0
M  V30 7 C 0.5638 1.7464 0.0 0
M  V30 8 O 11.9713 2.6672 0.0 0
M  V30 9 C 8.0023 2.3101 0.0 0
M  V30 10 C 6.6687 3.0801 0.0 0
M  V30 11 C 8.1633 3.8416 0.0 0
M  V30 12 C 9.4091 1.6837 0.0 0
M  V30 13 C 8.0023 0.7700 0.0 0
M  V30 14 N 5.3348 2.3101 0.0 0
M  V30 15 C 9.6697 4.1618 0.0 0
M  V30 16 C 10.4397 2.8281 0.0 0
M  V30 17 C 6.6687 0.0000 0.0 0
M  V30 18 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 16
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 16
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 2-(methylamino)-7-azaspiro[4.5]decane-7-carboxylate
C15H28N2O2
1793108-64-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 O 2.6675 2.3101 0.0 0
M  V30 3 O 4.0012 4.6201 0.0 0
M  V30 4 C 1.3338 3.0801 0.0 0
M  V30 5 C 0.5638 1.7464 0.0 0
M  V30 6 C 0.0000 3.8501 0.0 0
M  V30 7 C 2.1038 4.4137 0.0 0
M  V30 8 N 11.9713 2.6672 0.0 0
M  V30 9 C 12.8765 3.9131 0.0 0
M  V30 10 C 8.0023 2.3101 0.0 0
M  V30 11 C 6.6687 3.0801 0.0 0
M  V30 12 C 9.4091 1.6837 0.0 0
M  V30 13 C 8.1633 3.8416 0.0 0
M  V30 14 C 8.0023 0.7700 0.0 0
M  V30 15 N 5.3348 2.3101 0.0 0
M  V30 16 C 10.4397 2.8281 0.0 0
M  V30 17 C 9.6697 4.1618 0.0 0
M  V30 18 C 6.6687 0.0000 0.0 0
M  V30 19 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 16
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1793108-63-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1793108-64-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-16494125
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidinediamine derivatives for use as protein kinase
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xi, Ning; Li, Minxiong; Hu, Haiyang; Dai, Weilong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015148867 A1 2015-10-01

$RFMT $RIREG SCHEME197 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 2-oxo-7-azaspiro[4.5]decane-7-carboxylate
C14H23NO3
1793108-63-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 O 2.6675 2.3101 0.0 0
M  V30 3 O 4.0012 4.6201 0.0 0
M  V30 4 C 1.3338 3.0801 0.0 0
M  V30 5 C 2.1038 4.4137 0.0 0
M  V30 6 C 0.0000 3.8501 0.0 0
M  V30 7 C 0.5638 1.7464 0.0 0
M  V30 8 O 11.9713 2.6672 0.0 0
M  V30 9 C 8.0023 2.3101 0.0 0
M  V30 10 C 6.6687 3.0801 0.0 0
M  V30 11 C 8.1633 3.8416 0.0 0
M  V30 12 C 9.4091 1.6837 0.0 0
M  V30 13 C 8.0023 0.7700 0.0 0
M  V30 14 N 5.3348 2.3101 0.0 0
M  V30 15 C 9.6697 4.1618 0.0 0
M  V30 16 C 10.4397 2.8281 0.0 0
M  V30 17 C 6.6687 0.0000 0.0 0
M  V30 18 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 16
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 16
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 2-(methylamino)-7-azaspiro[4.5]decane-7-carboxylate
C15H28N2O2
1793108-64-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 O 2.6675 2.3101 0.0 0
M  V30 3 O 4.0012 4.6201 0.0 0
M  V30 4 C 1.3338 3.0801 0.0 0
M  V30 5 C 0.5638 1.7464 0.0 0
M  V30 6 C 0.0000 3.8501 0.0 0
M  V30 7 C 2.1038 4.4137 0.0 0
M  V30 8 N 11.9713 2.6672 0.0 0
M  V30 9 C 12.8765 3.9131 0.0 0
M  V30 10 C 8.0023 2.3101 0.0 0
M  V30 11 C 6.6687 3.0801 0.0 0
M  V30 12 C 9.4091 1.6837 0.0 0
M  V30 13 C 8.1633 3.8416 0.0 0
M  V30 14 C 8.0023 0.7700 0.0 0
M  V30 15 N 5.3348 2.3101 0.0 0
M  V30 16 C 10.4397 2.8281 0.0 0
M  V30 17 C 9.6697 4.1618 0.0 0
M  V30 18 C 6.6687 0.0000 0.0 0
M  V30 19 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 16
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1793108-63-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1793108-64-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-6020884
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituted heteroaryl compounds and methods of use
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xi, Ning; Li, Minxiong; Hu, Haiyang; Wang, Tingjin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015094803 A1 2015-06-25

$RFMT $RIREG SCHEME198 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-carboxylic acid, 4-formyl-, ethyl ester
C7H8N2O3
179692-09-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.8384 3.7710 0.0 0
M  V30 2 O 6.3784 3.7710 0.0 0
M  V30 3 O 4.0684 5.1048 0.0 0
M  V30 4 C 7.1484 5.1048 0.0 0
M  V30 5 C 8.6884 5.1048 0.0 0
M  V30 6 C 1.5063 3.4208 0.0 0
M  V30 7 O 0.0000 3.1006 0.0 0
M  V30 8 C 4.0684 2.4374 0.0 0
M  V30 9 C 2.5368 2.2764 0.0 0
M  V30 10 N 4.6947 1.0306 0.0 0
M  V30 11 C 2.2167 0.7700 0.0 0
M  V30 12 N 3.5503 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 6 7
M  V30 7 1 6 9
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-[(methylimino)methyl]-1H-pyrazole-3-carboxamide
C7H10N4O
1447948-16-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.6419 3.4207 0.0 0
M  V30 2 N 7.1482 3.1005 0.0 0
M  V30 3 C 8.1787 4.2450 0.0 0
M  V30 4 C 2.3099 3.7709 0.0 0
M  V30 5 N 0.7700 3.7709 0.0 0
M  V30 6 O 3.0799 5.1046 0.0 0
M  V30 7 C 0.0000 5.1046 0.0 0
M  V30 8 C 4.6115 2.2764 0.0 0
M  V30 9 C 3.0799 2.4373 0.0 0
M  V30 10 C 4.9317 0.7700 0.0 0
M  V30 11 N 2.4536 1.0305 0.0 0
M  V30 12 N 3.5979 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 9
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 179692-09-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1447948-16-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-438116
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of N-methy4-((methylimino)methyl)-1H-pyrazole-3-carboxamide
(3-B) The solution of product (2-B) (16.8 g, 0.1 mol) and MeNH2 (0.1 L,
0.2 mol, 2 N in THF) in MeOH (0.2 L) was stirred overnight at 100°C in a
sealed tube. The reaction was monitored by LCMS until completion. The
solvent was removed in vacuo to give crude product (3-B). Brown solid,
yield (17.1 g, 100 %). LC-MS (M+H)+ = 167.
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzhydrol-pyrazole derivatives having kinase inhibitory activity and
uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Keefe, Anthony D.; Wagner, Richard W.; Clark, Matthew; Zhang, Ying;
Gikunju, Diana; Cuozzo, John; Thomson, Heather
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013106432 A1 2013-07-18

$RFMT $RIREG SCHEME199 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl N-[3-cyano-1-[5-O-[(1,1-dimethylethyl)dimethylsilyl]-2,3-O-(1-methylet...
C21H33N3O5Si
1799439-57-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 9.4474 7.7269 0.0 0
M  V30 2 C 10.3527 8.9728 0.0 0
M  V30 3 O 9.7262 10.3798 0.0 0
M  V30 4 C 10.6314 11.6256 0.0 0
M  V30 5 C 4.0011 6.1134 0.0 0
M  V30 6 O 4.0011 7.6535 0.0 0
M  V30 7 Si 2.6675 8.4235 0.0 0
M  V30 8 C 1.3338 9.1935 0.0 0
M  V30 9 C 1.8975 7.0898 0.0 0
M  V30 10 C 3.4375 9.7571 0.0 0
M  V30 11 C 0.5638 7.8598 0.0 0
M  V30 12 C 0.0000 9.9635 0.0 0
M  V30 13 C 2.1038 10.5271 0.0 0
M  V30 14 C 6.5263 0.0000 0.0 0
M  V30 15 C 4.5104 0.4284 0.0 0
M  V30 16 C 12.7246 7.0304 0.0 0
M  V30 17 N 13.8691 8.0608 0.0 0
M  V30 18 C 7.7722 4.8254 0.0 0 CFG=2
M  V30 19 C 7.0022 3.4917 0.0 0 CFG=2
M  V30 20 O 6.7418 5.9699 0.0 0
M  V30 21 C 5.4959 3.8119 0.0 0 CFG=2
M  V30 22 O 7.1631 1.9601 0.0 0
M  V30 23 C 5.3348 5.3434 0.0 0 CFG=2
M  V30 24 O 4.7259 2.4782 0.0 0
M  V30 25 C 5.7563 1.3337 0.0 0
M  V30 26 N 9.3037 4.9863 0.0 0
M  V30 27 C 10.0738 6.3201 0.0 0
M  V30 28 C 10.3343 3.8419 0.0 0
M  V30 29 C 11.5802 5.9999 0.0 0
M  V30 30 C 11.7411 4.4682 0.0 0
M  V30 31 H 8.5086 3.1715 0.0 0
M  V30 32 H 3.9894 4.1320 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 27
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 23 5 CFG=1
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 8 13
M  V30 14 1 14 25
M  V30 15 1 15 25
M  V30 16 3 16 17
M  V30 17 1 16 29
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 18 26 CFG=1
M  V30 21 1 19 21
M  V30 22 1 19 22
M  V30 23 1 19 31 CFG=1
M  V30 24 1 20 23
M  V30 25 1 21 23
M  V30 26 1 21 24
M  V30 27 1 21 32 CFG=1
M  V30 28 1 22 25
M  V30 29 1 24 25
M  V30 30 1 26 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 18 19 21 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
7-[5-O-[(1,1-Dimethylethyl)dimethylsilyl]-2,3-O-(1-methylethylidene)-β-D-ribo...
C21H34N4O4Si
1799439-61-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 6.1134 0.0 0
M  V30 2 O 4.0011 7.6534 0.0 0
M  V30 3 Si 2.6675 8.4235 0.0 0
M  V30 4 C 1.3338 9.1935 0.0 0
M  V30 5 C 3.4375 9.7573 0.0 0
M  V30 6 C 1.8975 7.0898 0.0 0
M  V30 7 C 2.1038 10.5273 0.0 0
M  V30 8 C 0.0000 9.9635 0.0 0
M  V30 9 C 0.5638 7.8598 0.0 0
M  V30 10 C 4.5104 0.4286 0.0 0
M  V30 11 C 6.5263 0.0000 0.0 0
M  V30 12 N 14.1171 6.8241 0.0 0
M  V30 13 C 13.1652 9.7534 0.0 0
M  V30 14 C 7.7722 4.8254 0.0 0 CFG=2
M  V30 15 C 7.0022 3.4917 0.0 0 CFG=2
M  V30 16 O 6.7418 5.9699 0.0 0
M  V30 17 C 5.4959 3.8119 0.0 0 CFG=2
M  V30 18 O 7.1631 1.9601 0.0 0
M  V30 19 C 5.3348 5.3434 0.0 0 CFG=2
M  V30 20 O 4.7259 2.4782 0.0 0
M  V30 21 C 5.7563 1.3338 0.0 0
M  V30 22 N 9.3037 4.9864 0.0 0
M  V30 23 C 10.0737 6.3201 0.0 0
M  V30 24 C 10.3343 3.8419 0.0 0
M  V30 25 C 11.5802 5.9999 0.0 0
M  V30 26 N 9.5979 7.7847 0.0 0
M  V30 27 C 11.7411 4.4684 0.0 0
M  V30 28 C 12.6106 7.1443 0.0 0
M  V30 29 C 10.6283 8.9292 0.0 0
M  V30 30 N 12.1348 8.6090 0.0 0
M  V30 31 H 8.5086 3.1715 0.0 0
M  V30 32 H 3.9894 4.1320 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 19 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 4 9
M  V30 10 1 10 21
M  V30 11 1 11 21
M  V30 12 2 12 28
M  V30 13 1 13 30
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 22 CFG=1
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 15 31 CFG=1
M  V30 20 1 16 19
M  V30 21 1 17 19
M  V30 22 1 17 20
M  V30 23 1 17 32 CFG=1
M  V30 24 1 18 21
M  V30 25 1 20 21
M  V30 26 1 22 23
M  V30 27 1 22 24
M  V30 28 2 23 25
M  V30 29 1 23 26
M  V30 30 2 24 27
M  V30 31 1 25 27
M  V30 32 1 25 28
M  V30 33 2 26 29
M  V30 34 1 28 30
M  V30 35 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 14 15 17 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1799439-57-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1799439-61-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-18223720
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 7-Deaza-cyclic Adenosine-5'-diphosphate-carbocyclic-ribose
and Its 7-Bromo Derivative as Intracellular Ca2+-Mobilizing Agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Takano, Satoshi; Tsuzuki, Takayoshi; Murayama, Takashi; Sakurai, Takashi;
Fukuda, Hayato; Arisawa, Mitsuhiro; Shuto, Satoshi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2015), 80(13), 6619-6627

$RFMT $RIREG SCHEME200 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1R,2R,3S)-2-[(6-Deoxy-α-L-galactopyranosyl)oxy]-3-methylcyclohexyl 2,3-O-[(5...
C26H44O13
1801785-34-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.0021 5.3900 0.0 0
M  V30 2 O 13.3368 2.3100 0.0 0
M  V30 3 C 10.6695 0.7700 0.0 0
M  V30 4 O 9.3359 0.0000 0.0 0
M  V30 5 C 15.9568 5.5405 0.0 0
M  V30 6 O 17.1365 6.5304 0.0 0
M  V30 7 O 16.2242 4.0239 0.0 0
M  V30 8 C 18.5836 6.0036 0.0 0
M  V30 9 O 5.3348 6.9301 0.0 0
M  V30 10 C 2.6673 5.3900 0.0 0
M  V30 11 O 5.3348 10.0101 0.0 0
M  V30 12 O 2.6673 11.5501 0.0 0
M  V30 13 C 0.0000 6.9301 0.0 0
M  V30 14 O 0.0000 10.0101 0.0 0
M  V30 15 C 10.6695 5.3900 0.0 0 CFG=2
M  V30 16 C 9.3359 4.6200 0.0 0 CFG=2
M  V30 17 C 12.0032 4.6200 0.0 0 CFG=1
M  V30 18 O 10.1428 6.8372 0.0 0
M  V30 19 O 9.3359 3.0800 0.0 0
M  V30 20 C 12.0032 3.0800 0.0 0 CFG=1
M  V30 21 O 13.5198 4.8874 0.0 0
M  V30 22 C 10.6695 8.2843 0.0 0
M  V30 23 C 10.6695 2.3100 0.0 0 CFG=2
M  V30 24 C 14.5097 6.0672 0.0 0 CFG=1
M  V30 25 C 12.0032 9.0543 0.0 0
M  V30 26 C 14.5097 7.6072 0.0 0
M  V30 27 C 13.5198 8.7868 0.0 0
M  V30 28 C 6.6684 4.6200 0.0 0 CFG=2
M  V30 29 C 5.3348 5.3900 0.0 0 CFG=2
M  V30 30 C 6.6684 3.0800 0.0 0
M  V30 31 C 4.0010 4.6200 0.0 0 CFG=1
M  V30 32 C 5.3348 2.3100 0.0 0
M  V30 33 C 4.0010 3.0800 0.0 0
M  V30 34 C 4.0010 7.7001 0.0 0 CFG=2
M  V30 35 C 4.0010 9.2401 0.0 0 CFG=1
M  V30 36 O 2.6673 6.9301 0.0 0
M  V30 37 C 2.6673 10.0101 0.0 0 CFG=2
M  V30 38 C 1.3337 7.7001 0.0 0 CFG=1
M  V30 39 C 1.3337 9.2401 0.0 0 CFG=2
M  V30 40 H 9.2224 5.9167 0.0 0
M  V30 41 H 13.1828 3.6301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 16 1 CFG=1
M  V30 2 1 28 1 CFG=3
M  V30 3 1 20 2 CFG=1
M  V30 4 1 3 4
M  V30 5 1 23 3 CFG=1
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 24 5 CFG=3
M  V30 9 1 6 8
M  V30 10 1 29 9 CFG=1
M  V30 11 1 34 9 CFG=3
M  V30 12 1 31 10 CFG=3
M  V30 13 1 35 11 CFG=3
M  V30 14 1 37 12 CFG=1
M  V30 15 1 38 13 CFG=1
M  V30 16 1 39 14 CFG=1
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 15 40 CFG=1
M  V30 21 1 16 19
M  V30 22 1 17 20
M  V30 23 1 17 21
M  V30 24 1 17 41 CFG=3
M  V30 25 1 18 22
M  V30 26 1 19 23
M  V30 27 1 20 23
M  V30 28 1 21 24
M  V30 29 1 22 25
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 1 26 27
M  V30 33 1 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 1 32 33
M  V30 39 1 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(14 15 16 17 20 23 24 28 29 31 34 35 37 38 39)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,2R,3S)-2-[(6-Deoxy-α-L-galactopyranosyl)oxy]-3-methylcyclohexyl 2,3-O-[(5...
C26H45NO12
1801785-33-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.0021 5.3900 0.0 0
M  V30 2 O 13.3368 2.3100 0.0 0
M  V30 3 C 10.6695 0.7700 0.0 0
M  V30 4 O 9.3359 0.0000 0.0 0
M  V30 5 C 15.9568 5.5405 0.0 0
M  V30 6 N 17.1365 6.5304 0.0 0
M  V30 7 O 16.2242 4.0239 0.0 0
M  V30 8 C 18.5836 6.0036 0.0 0
M  V30 9 O 5.3348 6.9301 0.0 0
M  V30 10 C 2.6673 5.3900 0.0 0
M  V30 11 O 5.3348 10.0101 0.0 0
M  V30 12 O 2.6673 11.5501 0.0 0
M  V30 13 C 0.0000 6.9301 0.0 0
M  V30 14 O 0.0000 10.0101 0.0 0
M  V30 15 C 10.6695 5.3900 0.0 0 CFG=2
M  V30 16 C 9.3359 4.6200 0.0 0 CFG=2
M  V30 17 C 12.0032 4.6200 0.0 0 CFG=1
M  V30 18 O 10.1428 6.8372 0.0 0
M  V30 19 O 9.3359 3.0800 0.0 0
M  V30 20 C 12.0032 3.0800 0.0 0 CFG=1
M  V30 21 O 13.5198 4.8874 0.0 0
M  V30 22 C 10.6695 8.2843 0.0 0
M  V30 23 C 10.6695 2.3100 0.0 0 CFG=2
M  V30 24 C 14.5097 6.0672 0.0 0 CFG=1
M  V30 25 C 12.0032 9.0543 0.0 0
M  V30 26 C 14.5097 7.6072 0.0 0
M  V30 27 C 13.5198 8.7868 0.0 0
M  V30 28 C 6.6684 4.6200 0.0 0 CFG=2
M  V30 29 C 5.3348 5.3900 0.0 0 CFG=2
M  V30 30 C 6.6684 3.0800 0.0 0
M  V30 31 C 4.0010 4.6200 0.0 0 CFG=1
M  V30 32 C 5.3348 2.3100 0.0 0
M  V30 33 C 4.0010 3.0800 0.0 0
M  V30 34 C 4.0010 7.7001 0.0 0 CFG=2
M  V30 35 C 4.0010 9.2401 0.0 0 CFG=1
M  V30 36 O 2.6673 6.9301 0.0 0
M  V30 37 C 2.6673 10.0101 0.0 0 CFG=2
M  V30 38 C 1.3337 7.7001 0.0 0 CFG=1
M  V30 39 C 1.3337 9.2401 0.0 0 CFG=2
M  V30 40 H 9.2224 5.9167 0.0 0
M  V30 41 H 13.1828 3.6301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 16 1 CFG=1
M  V30 2 1 28 1 CFG=3
M  V30 3 1 20 2 CFG=1
M  V30 4 1 3 4
M  V30 5 1 23 3 CFG=1
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 24 5 CFG=3
M  V30 9 1 6 8
M  V30 10 1 29 9 CFG=1
M  V30 11 1 34 9 CFG=3
M  V30 12 1 31 10 CFG=3
M  V30 13 1 35 11 CFG=3
M  V30 14 1 37 12 CFG=1
M  V30 15 1 38 13 CFG=1
M  V30 16 1 39 14 CFG=1
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 15 40 CFG=1
M  V30 21 1 16 19
M  V30 22 1 17 20
M  V30 23 1 17 21
M  V30 24 1 17 41 CFG=3
M  V30 25 1 18 22
M  V30 26 1 19 23
M  V30 27 1 20 23
M  V30 28 1 21 24
M  V30 29 1 22 25
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 1 26 27
M  V30 33 1 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 1 32 33
M  V30 39 1 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(14 15 16 17 20 23 24 28 29 31 34 35 37 38 39)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1801785-34-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1801785-33-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3167005
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM overall yield= 70% from benzyl protected macrocycle
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM E-selectin antagonists modified by macrocycle formation to the galactose
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Magnani, John L.; Peterson, John M.; Zierke, Mirko; Smiesko, Martin;
Ernst, Beat
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015109049 A1 2015-07-23

$RFMT $RIREG SCHEME201 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-[(2R,3S)-2-[(4-formyl-2H-1,2,3-triazol-2-yl)methyl]-4-oxo-3-...
C15H15N5O4
1810055-66-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 11.5933 4.5535 0.0 0
M  V30 2 N 8.0022 3.5913 0.0 0
M  V30 3 C 6.6685 2.8213 0.0 0
M  V30 4 O 5.3347 3.5913 0.0 0
M  V30 5 O 6.6685 1.2813 0.0 0
M  V30 6 C 4.0011 2.8213 0.0 0
M  V30 7 O 8.9644 0.0000 0.0 0
M  V30 8 C 16.7491 6.2287 0.0 0
M  V30 9 O 18.1560 5.6024 0.0 0
M  V30 10 C 10.8233 3.2198 0.0 0 CFG=1
M  V30 11 C 9.3358 2.8213 0.0 0 CFG=2
M  V30 12 N 11.2220 1.7323 0.0 0
M  V30 13 C 9.7344 1.3336 0.0 0
M  V30 14 N 13.1333 4.5535 0.0 0
M  V30 15 N 14.0385 5.7993 0.0 0
M  V30 16 N 14.0385 3.3076 0.0 0
M  V30 17 C 15.5032 5.3235 0.0 0
M  V30 18 C 15.5032 3.7835 0.0 0
M  V30 19 C 2.6674 3.5913 0.0 0
M  V30 20 C 1.3338 2.8213 0.0 0
M  V30 21 C 2.6674 5.1313 0.0 0
M  V30 22 C 0.0000 3.5913 0.0 0
M  V30 23 C 1.3338 5.9013 0.0 0
M  V30 24 C 0.0000 5.1313 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 10 1 CFG=1
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 11 2 CFG=1
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 6 19
M  V30 9 2 7 13
M  V30 10 2 8 9
M  V30 11 1 8 17
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 13
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 10 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Phenylmethyl N-[(2R,3S)-2-[[4-[(methylamino)methyl]-2H-1,2,3-triazol-2-yl]met...
C16H20N6O3
1810056-06-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 11.5933 4.5535 0.0 0
M  V30 2 N 8.0022 3.5911 0.0 0
M  V30 3 C 6.6685 2.8211 0.0 0
M  V30 4 O 5.3347 3.5911 0.0 0
M  V30 5 O 6.6685 1.2811 0.0 0
M  V30 6 C 4.0011 2.8211 0.0 0
M  V30 7 O 8.9644 0.0000 0.0 0
M  V30 8 C 16.7491 6.2287 0.0 0
M  V30 9 N 18.1559 5.6022 0.0 0
M  V30 10 C 19.4019 6.5074 0.0 0
M  V30 11 C 10.8233 3.2198 0.0 0 CFG=1
M  V30 12 C 9.3358 2.8211 0.0 0 CFG=2
M  V30 13 N 11.2220 1.7322 0.0 0
M  V30 14 C 9.7344 1.3336 0.0 0
M  V30 15 N 13.1333 4.5535 0.0 0
M  V30 16 N 14.0385 5.7994 0.0 0
M  V30 17 N 14.0385 3.3076 0.0 0
M  V30 18 C 15.5032 5.3235 0.0 0
M  V30 19 C 15.5032 3.7835 0.0 0
M  V30 20 C 2.6674 3.5911 0.0 0
M  V30 21 C 1.3338 2.8211 0.0 0
M  V30 22 C 2.6674 5.1311 0.0 0
M  V30 23 C 0.0000 3.5911 0.0 0
M  V30 24 C 1.3338 5.9011 0.0 0
M  V30 25 C 0.0000 5.1311 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 11 1 CFG=1
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 12 2 CFG=1
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 6 20
M  V30 9 2 7 14
M  V30 10 1 8 9
M  V30 11 1 8 18
M  V30 12 1 9 10
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 11 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1810055-66-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1810056-06-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-11193482
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of monobactam organic compounds for the treatment of
bacterial infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aulakh, Virender Singh; Casarez, Anthony; Lin, Xiaodong; Lindvall, Mika;
McEnroe, Glenn; Moser, Heinz Ernst; Reck, Folkert; Tjandra, Meiliana;
Simmons, Robert Lowell; Yifru, Aregahegn; Zhu, Qingming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20150266867 A1 2015-09-24

$RFMT $RIREG SCHEME202 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-oxo-2-azaspiro[4.4]nonane-2-carboxylate
C13H21NO3
1810076-94-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.5809 0.0000 0.0 0
M  V30 2 C 6.2085 4.0287 0.0 0
M  V30 3 O 7.5422 3.2587 0.0 0
M  V30 4 O 6.2085 5.5688 0.0 0
M  V30 5 C 8.8758 4.0287 0.0 0
M  V30 6 C 8.1058 5.3624 0.0 0
M  V30 7 C 10.2095 4.7987 0.0 0
M  V30 8 C 9.6458 2.6951 0.0 0
M  V30 9 C 2.4373 2.7406 0.0 0
M  V30 10 C 3.4678 3.8850 0.0 0
M  V30 11 C 3.2073 1.4070 0.0 0
M  V30 12 C 1.6672 4.0743 0.0 0
M  V30 13 C 1.4068 1.5961 0.0 0
M  V30 14 N 4.8747 3.2587 0.0 0
M  V30 15 C 4.7137 1.7271 0.0 0
M  V30 16 C 0.1609 3.7541 0.0 0
M  V30 17 C 0.0000 2.2226 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 15
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-(methylamino)-2-azaspiro[4.4]nonane-2-carboxylate
C14H26N2O2
1810076-95-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.5809 1.2459 0.0 0
M  V30 2 C 3.4862 0.0000 0.0 0
M  V30 3 C 6.2085 5.2746 0.0 0
M  V30 4 O 7.5422 4.5046 0.0 0
M  V30 5 O 6.2085 6.8147 0.0 0
M  V30 6 C 8.8758 5.2746 0.0 0
M  V30 7 C 9.6458 3.9409 0.0 0
M  V30 8 C 10.2095 6.0446 0.0 0
M  V30 9 C 8.1058 6.6083 0.0 0
M  V30 10 C 2.4373 3.9865 0.0 0
M  V30 11 C 3.2073 2.6529 0.0 0
M  V30 12 C 3.4678 5.1309 0.0 0
M  V30 13 C 1.4068 2.8420 0.0 0
M  V30 14 C 1.6672 5.3202 0.0 0
M  V30 15 C 4.7137 2.9730 0.0 0
M  V30 16 N 4.8747 4.5046 0.0 0
M  V30 17 C 0.0000 3.4685 0.0 0
M  V30 18 C 0.1609 5.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 16
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 16
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1810076-94-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1810076-95-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-17119319
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heteroaryl derivatives for use in the treatment of
JAK-mediated disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xi, Ning; Li, Minxiong; Hu, Haiyang; Dai, Weilong; Li, Xiaobo; Wang,
Tingjin; Wu, Yanjun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016190847 A1 2016-12-01

$RFMT $RIREG SCHEME202 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-oxo-2-azaspiro[4.4]nonane-2-carboxylate
C13H21NO3
1810076-94-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.5809 0.0000 0.0 0
M  V30 2 C 6.2085 4.0287 0.0 0
M  V30 3 O 7.5422 3.2587 0.0 0
M  V30 4 O 6.2085 5.5688 0.0 0
M  V30 5 C 8.8758 4.0287 0.0 0
M  V30 6 C 8.1058 5.3624 0.0 0
M  V30 7 C 10.2095 4.7987 0.0 0
M  V30 8 C 9.6458 2.6951 0.0 0
M  V30 9 C 2.4373 2.7406 0.0 0
M  V30 10 C 3.4678 3.8850 0.0 0
M  V30 11 C 3.2073 1.4070 0.0 0
M  V30 12 C 1.6672 4.0743 0.0 0
M  V30 13 C 1.4068 1.5961 0.0 0
M  V30 14 N 4.8747 3.2587 0.0 0
M  V30 15 C 4.7137 1.7271 0.0 0
M  V30 16 C 0.1609 3.7541 0.0 0
M  V30 17 C 0.0000 2.2226 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 15
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-(methylamino)-2-azaspiro[4.4]nonane-2-carboxylate
C14H26N2O2
1810076-95-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.5809 1.2459 0.0 0
M  V30 2 C 3.4862 0.0000 0.0 0
M  V30 3 C 6.2085 5.2746 0.0 0
M  V30 4 O 7.5422 4.5046 0.0 0
M  V30 5 O 6.2085 6.8147 0.0 0
M  V30 6 C 8.8758 5.2746 0.0 0
M  V30 7 C 9.6458 3.9409 0.0 0
M  V30 8 C 10.2095 6.0446 0.0 0
M  V30 9 C 8.1058 6.6083 0.0 0
M  V30 10 C 2.4373 3.9865 0.0 0
M  V30 11 C 3.2073 2.6529 0.0 0
M  V30 12 C 3.4678 5.1309 0.0 0
M  V30 13 C 1.4068 2.8420 0.0 0
M  V30 14 C 1.6672 5.3202 0.0 0
M  V30 15 C 4.7137 2.9730 0.0 0
M  V30 16 N 4.8747 4.5046 0.0 0
M  V30 17 C 0.0000 3.4685 0.0 0
M  V30 18 C 0.1609 5.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 16
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 16
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1810076-94-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1810076-95-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-16494060
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidinediamine derivatives for use as protein kinase
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xi, Ning; Li, Minxiong; Hu, Haiyang; Dai, Weilong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015148867 A1 2015-10-01

$RFMT $RIREG SCHEME203 STEP1
$RXN



  3  1
$MOL
Acetone
C3H6O
67-64-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5,5-Trimethylpyrazoline
C6H12N2
3975-85-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.6368 0.0000 0.0 0
M  V30 2 C 0.0000 1.9600 0.0 0
M  V30 3 C 5.3633 0.8578 0.0 0
M  V30 4 C 2.6527 0.4284 0.0 0
M  V30 5 C 1.4068 1.3337 0.0 0
M  V30 6 C 3.8988 1.3337 0.0 0
M  V30 7 N 1.8827 2.7983 0.0 0
M  V30 8 N 3.4227 2.7983 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 5
M  V30 3 1 3 6
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-hydroxy-5-sulfo-, 1-hydrazide, compd. with hydrazine (1:1)
C7H8N2O5S.H4N2
1810747-92-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9538 4.2075 0.0 0
M  V30 2 N 6.7238 5.5412 0.0 0
M  V30 3 O 6.7238 2.8738 0.0 0
M  V30 4 N 8.2638 5.5412 0.0 0
M  V30 5 O 4.4137 1.5400 0.0 0
M  V30 6 S 1.3337 6.8748 0.0 0 VAL=6
M  V30 7 O 0.0000 6.1048 0.0 0
M  V30 8 O 2.6673 7.6448 0.0 0
M  V30 9 O 0.5637 8.2087 0.0 0
M  V30 10 C 4.4137 4.2075 0.0 0
M  V30 11 C 3.6437 5.5412 0.0 0
M  V30 12 C 3.6437 2.8738 0.0 0
M  V30 13 C 2.1037 5.5412 0.0 0
M  V30 14 C 2.1037 2.8738 0.0 0
M  V30 15 C 1.3337 4.2075 0.0 0
M  V30 16 N 3.3619 0.0000 0.0 0
M  V30 17 N 4.9019 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 6 13
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 16 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-hydroxy-5-sulfo-, 1-[2-(1-methylethylidene)hydrazide], compd....
C10H12N2O5S.C6H12N2
1810747-96-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9538 7.0057 0.0 0
M  V30 2 N 6.7238 8.3394 0.0 0
M  V30 3 O 6.7238 5.6721 0.0 0
M  V30 4 N 8.2638 8.3394 0.0 0
M  V30 5 C 9.0338 9.6731 0.0 0
M  V30 6 C 10.5739 9.6731 0.0 0
M  V30 7 C 8.2638 11.0069 0.0 0
M  V30 8 O 4.4137 4.3383 0.0 0
M  V30 9 S 1.3337 9.6731 0.0 0 VAL=6
M  V30 10 O 2.6673 10.4431 0.0 0
M  V30 11 O 0.0000 8.9031 0.0 0
M  V30 12 O 0.5637 11.0069 0.0 0
M  V30 13 C 4.4137 7.0057 0.0 0
M  V30 14 C 3.6437 8.3394 0.0 0
M  V30 15 C 3.6437 5.6721 0.0 0
M  V30 16 C 2.1037 8.3394 0.0 0
M  V30 17 C 2.1037 5.6721 0.0 0
M  V30 18 C 1.3337 7.0057 0.0 0
M  V30 19 C 3.2421 0.0000 0.0 0
M  V30 20 C 2.6053 1.9600 0.0 0
M  V30 21 C 7.9686 0.8578 0.0 0
M  V30 22 C 5.2580 0.4284 0.0 0
M  V30 23 C 4.0121 1.3337 0.0 0
M  V30 24 C 6.5040 1.3337 0.0 0
M  V30 25 N 4.4880 2.7983 0.0 0
M  V30 26 N 6.0280 2.7983 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 2 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 8 15
M  V30 9 2 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 1 9 16
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 19 1 19 23
M  V30 20 1 20 23
M  V30 21 1 21 24
M  V30 22 1 22 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 2 24 26
M  V30 26 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 67-64-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3975-85-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1810747-92-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1810747-96-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-310-CAS-3149367
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-64-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM product further converted into free base
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A synthetic and crystal structure study of a collection of coordination
polymers based on alkaline aroylhydrazonates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Specklin, David; Mameri, Samir; Loukopoulos, Edward; Kostakis, George E.;
Welter, Richard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polyhedron (2015), 100359-372

$RFMT $RIREG SCHEME204 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Bromo-2,3-dihydro-6-methoxy-2-(1-methylethyl)-3-oxo-4H-1,4-benzoxazine-4-ac...
C14H16BrNO5
1820889-51-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 C 2.6673 1.5400 0.0 0
M  V30 3 O 2.6673 0.0000 0.0 0
M  V30 4 O 1.3336 2.3100 0.0 0
M  V30 5 O 1.3336 3.8500 0.0 0
M  V30 6 Br 6.6684 8.4700 0.0 0
M  V30 7 O 9.3358 3.8500 0.0 0
M  V30 8 C 10.6694 4.6200 0.0 0
M  V30 9 C 1.3336 6.9300 0.0 0
M  V30 10 C 1.3336 8.4700 0.0 0
M  V30 11 C 0.0000 6.1600 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 N 4.0011 3.8500 0.0 0
M  V30 14 C 5.3347 6.1600 0.0 0
M  V30 15 C 6.6684 3.8500 0.0 0
M  V30 16 C 2.6673 4.6200 0.0 0
M  V30 17 O 4.0011 6.9300 0.0 0
M  V30 18 C 6.6684 6.9300 0.0 0
M  V30 19 C 8.0021 4.6200 0.0 0
M  V30 20 C 2.6673 6.1600 0.0 0
M  V30 21 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 16
M  V30 6 1 6 18
M  V30 7 1 7 8
M  V30 8 1 7 19
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 20
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 2 12 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 2 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 20
M  V30 21 1 18 21
M  V30 22 2 19 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Bromo-2,3-dihydro-6-methoxy-N-methyl-2-(1-methylethyl)-3-oxo-4H-1,4-benzoxa...
C15H19BrN2O4
1820889-52-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 2.6673 2.3100 0.0 0
M  V30 3 N 2.6673 0.7700 0.0 0
M  V30 4 O 1.3336 3.0800 0.0 0
M  V30 5 C 1.3336 0.0000 0.0 0
M  V30 6 O 1.3336 4.6200 0.0 0
M  V30 7 Br 6.6684 9.2400 0.0 0
M  V30 8 O 9.3358 4.6200 0.0 0
M  V30 9 C 10.6694 5.3900 0.0 0
M  V30 10 C 1.3336 7.7000 0.0 0
M  V30 11 C 0.0000 6.9300 0.0 0
M  V30 12 C 1.3336 9.2400 0.0 0
M  V30 13 C 5.3347 5.3900 0.0 0
M  V30 14 N 4.0011 4.6200 0.0 0
M  V30 15 C 5.3347 6.9300 0.0 0
M  V30 16 C 6.6684 4.6200 0.0 0
M  V30 17 C 2.6673 5.3900 0.0 0
M  V30 18 O 4.0011 7.7000 0.0 0
M  V30 19 C 6.6684 7.7000 0.0 0
M  V30 20 C 8.0021 5.3900 0.0 0
M  V30 21 C 2.6673 6.9300 0.0 0
M  V30 22 C 8.0021 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 6 17
M  V30 7 1 7 19
M  V30 8 1 8 9
M  V30 9 1 8 20
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 21
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 2 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 21
M  V30 22 1 19 22
M  V30 23 2 20 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1820889-51-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1820889-52-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2960789
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and
pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Combs, Andrew P.; Maduskuie, Thomas P., Jr.; Falahatpisheh, Nikoo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015164480 A1 2015-10-29

$RFMT $RIREG SCHEME205 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-[(3,4-dihydro-3-oxo-2H-1,4-benzoxazin-6-yl)carbonyl]-3,4-dihydro-2H-1...
C21H20N2O6
1850385-77-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 5.3347 0.0 0
M  V30 2 O 7.7000 6.6684 0.0 0
M  V30 3 C 10.0100 5.3347 0.0 0
M  V30 4 C 11.5500 5.3347 0.0 0
M  V30 5 O 12.3200 6.6684 0.0 0
M  V30 6 O 12.3200 4.0011 0.0 0
M  V30 7 C 13.8600 6.6684 0.0 0
M  V30 8 C 14.6300 8.0021 0.0 0
M  V30 9 O 0.0000 9.3358 0.0 0
M  V30 10 N 7.7000 4.0011 0.0 0
M  V30 11 C 6.9300 2.6674 0.0 0
M  V30 12 C 9.2400 4.0011 0.0 0
M  V30 13 C 7.7000 1.3336 0.0 0
M  V30 14 C 5.3900 2.6674 0.0 0
M  V30 15 C 10.0100 2.6674 0.0 0
M  V30 16 O 9.2400 1.3336 0.0 0
M  V30 17 C 6.9300 0.0000 0.0 0
M  V30 18 C 4.6200 1.3336 0.0 0
M  V30 19 C 5.3900 0.0000 0.0 0
M  V30 20 C 5.3900 5.3347 0.0 0
M  V30 21 C 4.6200 6.6684 0.0 0
M  V30 22 C 4.6200 4.0011 0.0 0
M  V30 23 C 3.0800 6.6684 0.0 0
M  V30 24 C 3.0800 4.0011 0.0 0
M  V30 25 C 2.3100 5.3347 0.0 0
M  V30 26 N 2.3100 8.0021 0.0 0
M  V30 27 O 0.7700 5.3347 0.0 0
M  V30 28 C 0.7700 8.0021 0.0 0
M  V30 29 C 0.0000 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 10
M  V30 3 1 1 20
M  V30 4 1 3 4
M  V30 5 1 3 12
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 2 9 28
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 16
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 23 26
M  V30 28 2 24 25
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(3,4-Dihydro-3-oxo-2H-1,4-benzoxazin-6-yl)carbonyl]-3,4-dihydro-N-methyl-2...
C20H19N3O5
1850385-53-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 4.0011 0.0 0
M  V30 2 O 7.7000 2.6674 0.0 0
M  V30 3 C 10.0100 4.0011 0.0 0
M  V30 4 C 11.5500 4.0011 0.0 0
M  V30 5 N 12.3200 2.6674 0.0 0
M  V30 6 O 12.3200 5.3347 0.0 0
M  V30 7 C 13.8600 2.6674 0.0 0
M  V30 8 O 0.0000 0.0000 0.0 0
M  V30 9 N 7.7000 5.3347 0.0 0
M  V30 10 C 6.9300 6.6684 0.0 0
M  V30 11 C 9.2400 5.3347 0.0 0
M  V30 12 C 7.7000 8.0021 0.0 0
M  V30 13 C 5.3900 6.6684 0.0 0
M  V30 14 C 10.0100 6.6684 0.0 0
M  V30 15 O 9.2400 8.0021 0.0 0
M  V30 16 C 6.9300 9.3358 0.0 0
M  V30 17 C 4.6200 8.0021 0.0 0
M  V30 18 C 5.3900 9.3358 0.0 0
M  V30 19 C 5.3900 4.0011 0.0 0
M  V30 20 C 4.6200 2.6674 0.0 0
M  V30 21 C 4.6200 5.3347 0.0 0
M  V30 22 C 3.0800 2.6674 0.0 0
M  V30 23 C 3.0800 5.3347 0.0 0
M  V30 24 C 2.3100 4.0011 0.0 0
M  V30 25 N 2.3100 1.3336 0.0 0
M  V30 26 O 0.7700 4.0011 0.0 0
M  V30 27 C 0.7700 1.3336 0.0 0
M  V30 28 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 1 19
M  V30 4 1 3 4
M  V30 5 1 3 11
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 2 8 27
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 15
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 22 25
M  V30 27 2 23 24
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1850385-77-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1850385-53-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13773612
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzoxazinone amides as mineralocorticoid receptor
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM O'Mahony, Gavin; Kossenjans, Michael; Edman, Karl; Kajanus, Johan;
Hogner, Karl Anders; Cornwall, Philip; Turner, Andrew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20150376170 A1 2015-12-31

$RFMT $RIREG SCHEME206 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-fluoro-4-nitro-, methyl ester
C8H6FNO4
185629-31-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6201 0.0 0
M  V30 2 O 8.0022 3.8500 0.0 0
M  V30 3 O 6.6684 6.1601 0.0 0
M  V30 4 C 9.3359 4.6201 0.0 0
M  V30 5 F 1.3337 4.6201 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 C 5.3348 3.8500 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 2.6675 3.8500 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 2.6675 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-(methylamino)-4-nitro-, methyl ester
C9H10N2O4
251643-13-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0
M  V30 2 C 1.3336 6.1600 0.0 0
M  V30 3 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 4 O 1.3336 0.0000 0.0 0
M  V30 5 O 0.0000 2.3100 0.0 0
M  V30 6 C 6.6684 4.6200 0.0 0
M  V30 7 O 8.0021 3.8500 0.0 0
M  V30 8 O 6.6684 6.1600 0.0 0
M  V30 9 C 9.3358 4.6200 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 2.6674 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 5.3347 3.8500 0.0 0
M  V30 15 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 185629-31-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 251643-13-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-20679907
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of dioxobenzothiazolyl hydrazides as inhibitors of
YAP/TAZ-TEAD interaction and their use in the treatment of malignant
mesothelioma
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barth, Martine; Contal, Sylvie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018185266 A1 2018-10-11

$RFMT $RIREG SCHEME207 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-2-fluoro-6-(trifluoromethyl)benzaldehyde
C8H3ClF4O
186517-29-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 1.3336 0.0 0
M  V30 2 O 3.8500 0.0000 0.0 0
M  V30 3 C 1.5400 4.0009 0.0 0
M  V30 4 F 1.5400 2.4609 0.0 0
M  V30 5 F 0.0000 4.0009 0.0 0
M  V30 6 F 1.5400 5.5409 0.0 0
M  V30 7 F 6.1600 1.3336 0.0 0
M  V30 8 Cl 7.7000 4.0009 0.0 0
M  V30 9 C 3.8500 2.6673 0.0 0
M  V30 10 C 3.0800 4.0009 0.0 0
M  V30 11 C 5.3900 2.6673 0.0 0
M  V30 12 C 3.8500 5.3347 0.0 0
M  V30 13 C 6.1600 4.0009 0.0 0
M  V30 14 C 5.3900 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 10
M  V30 7 1 7 11
M  V30 8 1 8 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenemethanamine, 3-chloro-2-fluoro-N-methyl-6-(trifluoromethyl)-
C9H8ClF4N
3040200-81-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6674 0.0 0
M  V30 2 N 3.8500 1.3338 0.0 0
M  V30 3 C 3.0800 0.0000 0.0 0
M  V30 4 C 1.5400 5.3349 0.0 0
M  V30 5 F 1.5400 3.7949 0.0 0
M  V30 6 F 0.0000 5.3349 0.0 0
M  V30 7 F 1.5400 6.8749 0.0 0
M  V30 8 F 6.1600 2.6674 0.0 0
M  V30 9 Cl 7.7000 5.3349 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 3.8500 6.6685 0.0 0
M  V30 14 C 6.1600 5.3349 0.0 0
M  V30 15 C 5.3900 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 11
M  V30 8 1 8 12
M  V30 9 1 9 14
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 186517-29-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3040200-81-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40490487
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective Defluorination of Trifluoromethyl Substituents by
Conformationally Induced Remote Substitution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jesani, Mehul H.; Schwarz, Maria; Kim, Shiwhu; Evans, Finlay L.; White,
Alexander; Browning, Alex; Abrams, Roman; Clayden, Jonathan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2024), 63(24), e202403477

$RFMT $RIREG SCHEME208 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-9-[(3-methoxyphenyl)methyl]-2-(methylthio)-9H-purine
C14H13ClN4OS
1870032-21-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.9833 0.0 0
M  V30 2 Cl 10.5666 0.0000 0.0 0
M  V30 3 S 12.2151 5.0737 0.0 0
M  V30 4 C 13.6798 4.5978 0.0 0
M  V30 5 O 1.5400 7.6507 0.0 0
M  V30 6 C 0.0000 7.6507 0.0 0
M  V30 7 C 8.4617 3.4887 0.0 0
M  V30 8 C 8.7819 1.9823 0.0 0
M  V30 9 N 6.9300 3.6496 0.0 0
M  V30 10 N 9.6061 4.5191 0.0 0
M  V30 11 C 10.2464 1.5064 0.0 0
M  V30 12 N 7.4481 1.2123 0.0 0
M  V30 13 C 6.3037 2.2427 0.0 0
M  V30 14 C 11.0708 4.0433 0.0 0
M  V30 15 N 11.3909 2.5368 0.0 0
M  V30 16 C 4.6200 4.9833 0.0 0
M  V30 17 C 3.8500 6.3169 0.0 0
M  V30 18 C 3.8500 3.6496 0.0 0
M  V30 19 C 2.3100 6.3169 0.0 0
M  V30 20 C 2.3100 3.6496 0.0 0
M  V30 21 C 1.5400 4.9833 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 16
M  V30 3 1 2 11
M  V30 4 1 3 4
M  V30 5 1 3 14
M  V30 6 1 5 6
M  V30 7 1 5 19
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 13
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9-[(3-Methoxyphenyl)methyl]-N-methyl-2-(methylthio)-9H-purin-6-amine
C15H17N5OS
1870032-22-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.8143 3.4260 0.0 0
M  V30 2 N 1.5063 5.5384 0.0 0
M  V30 3 C 0.0000 5.2183 0.0 0
M  V30 4 S 2.6154 0.3202 0.0 0
M  V30 5 C 1.1091 0.0000 0.0 0
M  V30 6 O 13.1491 3.4260 0.0 0
M  V30 7 C 14.4828 4.1960 0.0 0
M  V30 8 C 5.0736 3.5696 0.0 0
M  V30 9 C 4.0432 4.7140 0.0 0
M  V30 10 N 6.4806 4.1960 0.0 0
M  V30 11 N 4.5978 2.1049 0.0 0
M  V30 12 C 2.5369 4.3939 0.0 0
M  V30 13 N 4.8132 6.0479 0.0 0
M  V30 14 C 6.3195 5.7277 0.0 0
M  V30 15 C 3.0915 1.7847 0.0 0
M  V30 16 N 2.0609 2.9293 0.0 0
M  V30 17 C 9.1480 4.1960 0.0 0
M  V30 18 C 10.4818 3.4260 0.0 0
M  V30 19 C 9.1480 5.7360 0.0 0
M  V30 20 C 11.8154 4.1960 0.0 0
M  V30 21 C 10.4818 6.5060 0.0 0
M  V30 22 C 11.8154 5.7360 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 2 12
M  V30 5 1 4 5
M  V30 6 1 4 15
M  V30 7 1 6 7
M  V30 8 1 6 20
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 13 14
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1870032-21-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1870032-22-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8125926
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Potent and Selective Inhibitors of MTH1 Probe Its Role in Cancer Cell
Survival
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kettle, Jason G.; Alwan, Husam; Bista, Michal; Breed, Jason; Davies,
Nichola L.; Eckersley, Kay; Fillery, Shaun; Foote, Kevin M.; Goodwin,
Louise; Jones, David R.; Kack, Helena; Lau, Alan; Nissink, J. Willem M.;
Read, Jon; Scott, James S.; Taylor, Ben; Walker, Graeme; Wissler, Lisa;
Wylot, Marta
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2016), 59(6), 2346-2361

$RFMT $RIREG SCHEME209 STEP1
$RXN



  2  1
$MOL
(4-Bromophenyl)acetic acid
C8H7BrO2
1878-68-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 1.3337 0.0 0
M  V30 3 O 6.1601 0.0000 0.0 0
M  V30 4 O 8.4702 1.3337 0.0 0
M  V30 5 Br 0.0000 2.6673 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 3.8501 4.0010 0.0 0
M  V30 8 C 3.8501 1.3337 0.0 0
M  V30 9 C 2.3101 4.0010 0.0 0
M  V30 10 C 2.3101 1.3337 0.0 0
M  V30 11 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methylbenzeneacetamide
C9H10BrNO
7713-76-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0800 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 N 8.0022 3.0800 0.0 0
M  V30 4 O 6.6684 0.7700 0.0 0
M  V30 5 C 9.3359 2.3100 0.0 0
M  V30 6 Br 0.0000 0.0000 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1878-68-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 7713-76-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2290612
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of
(+/-)-4-benzo[b]thiophen-5-yl-2-methyl-7-morpholin-4-yl-1,2,3,4-tetrahydroisoquinoline.
To a solution of 4-bromophenyl acetic acid (50 g, 233 mmol) in SOCl2 (170
mL, 2.32 mol) was added DMF (2 mL, 26 mmol). After stirred at this
temperature for 1 h, the excess SOCl2 was removed under reduced pressure.
The residue was dissolved in CH2Cl2 (300 mL), and the resulting solution
was added to a cooled (0°C) solution of CH3NH2 (90 mL, 40 wt% in H2O,
1.03 mol) in THF (200 mL) dropwise. After the addition was complete, the
solution was further stirred at 0°C for 15 min. Water (400 mL) was added
to the reaction solution, and organic layer separated. The aqueous layer
was extracted with CH2Cl2 (200 mL). The organic layers were combined,
washed with brine (500 mL), dried and concentrated to give
4-bromophenyl-N-methyl acetamide (54 g, quant.) as a white solid: 1H NMR
(500 MHz, CDCl3) δ 7.48 (d, J= 8.9 Hz, 2H), 7.15 (d, J= 8.9 Hz, 2H), 3.51
(s, 2H), 2.77 (s, 3H); ESI-MS m/z 228 [M+H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aryl- and heteroaryl-substituted tetrahydroisoquinolines and their
preparation, pharmaceutical compositions and use thereof to block
reuptake of norepinephrine, dopamine, and serotonin for the treatment of
neurological and psychological disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Molino, Bruce F.; Liu, Shuang; Berkowitz, Barry A.; Guzzo, Peter R.;
Beck, James P.; Cohen, Marlene
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006020049 A2 2006-02-23

$RFMT $RIREG SCHEME210 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Difluorobenzonitrile
C7H3F2N
1897-52-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 F 3.0800 0.0000 0.0 0
M  V30 4 F 3.0800 5.3349 0.0 0
M  V30 5 C 3.0800 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 0.7700 1.3338 0.0 0
M  V30 9 C 0.7700 4.0011 0.0 0
M  V30 10 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 7
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-6-(methylamino)benzonitrile
C8H7FN2
96783-85-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 3.0800 0.0 0
M  V30 2 C 6.6685 3.8500 0.0 0
M  V30 3 C 2.6674 1.5400 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 F 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 5.3900 0.0 0
M  V30 9 C 1.3338 3.8500 0.0 0
M  V30 10 C 2.6674 6.1600 0.0 0
M  V30 11 C 1.3338 5.3900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 3 3 4
M  V30 4 1 3 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1897-52-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 96783-85-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2817799
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-Fluoro-6-methylamino-benzonitrile. To a stirred solution of
2,6-difluorobenzonitrile (3.5 g, 25.2 mmol) in ethanol (40 mL) was added
2 mL of methylamine (40 wt%, in H2O) and heated at 80 °C for 2 h. The
mixture was then diluted with water and the resulting slurry extracted
with dichloromethane (3 X 50 mL). The combined organic extracts were
dried (Na2SO4), filtered and concentrated to give the title product.
White solid, yield 3.77 g, 99.6%. 1H NMR (500 MHz, CDCl3) δ: 7.35-7.31
(1H, m), 6.41-6.38 (2H, m), 4.74 (1H, br s), 2.93 (3H, d, J = 5.19 Hz).
LCMS calcd for C8H8FN2 (M + H): 151.07; found: 151.07.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzyl pyrimidinecarboxamide derivative as HIV integrase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Naidu, B. Narasimhulu; Walker, Michael A.; Sorenson, Margaret E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004096128 A2 2004-11-11

$RFMT $RIREG SCHEME211 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzyl 4-oxo-1-piperidinecarboxylate
C13H15NO3
19099-93-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 C 4.0012 1.5400 0.0 0
M  V30 5 O 12.0033 4.6201 0.0 0
M  V30 6 N 8.0022 2.3101 0.0 0
M  V30 7 C 8.0022 3.8501 0.0 0
M  V30 8 C 9.3360 1.5400 0.0 0
M  V30 9 C 9.3360 4.6201 0.0 0
M  V30 10 C 10.6697 2.3101 0.0 0
M  V30 11 C 10.6697 3.8501 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 2.6673 3.8501 0.0 0
M  V30 14 C 1.3337 1.5400 0.0 0
M  V30 15 C 1.3337 4.6201 0.0 0
M  V30 16 C 0.0000 2.3101 0.0 0
M  V30 17 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 4 12
M  V30 6 2 5 11
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 4-(methylamino)-1-piperidinecarboxylate
C14H20N2O2
405057-75-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 C 4.0010 1.5400 0.0 0
M  V30 5 N 12.0033 4.6201 0.0 0
M  V30 6 C 13.3370 3.8501 0.0 0
M  V30 7 N 8.0022 2.3101 0.0 0
M  V30 8 C 9.3360 1.5400 0.0 0
M  V30 9 C 8.0022 3.8501 0.0 0
M  V30 10 C 10.6697 2.3101 0.0 0
M  V30 11 C 9.3360 4.6201 0.0 0
M  V30 12 C 10.6697 3.8501 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 1.3337 1.5400 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 16 C 0.0000 2.3101 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 1 5 12
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19099-93-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 405057-75-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-2439402
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a mixture of N-benzyloxycarbonyl-4-piperidone (10.70 g, 43.1 mmol) and
aq. 40% MeNH2 (6.67 g, 85.8 mmol) in CH2Cl2 (200 ml) at R.T. was added
NaBH(OAc)3 (27.25 g, 128.6 mmol). The reaction mixture was stirred at
R.T. for 3 h then poured into sat'd NaHCO3 and extracted with CH2Cl2 (3 x
200 ml). The combined organic layers were dried (Na2SO4), filtered and
concentrated to give the product, yield 10.63 g, 100%. 1H NMR (CDCl3, 400
MHz) δ 7.34 (5H, m), 5.12 (2H, s), 4.19 (2H, b), 2.87 (2H, b), 2.72 (1H,
m), 2.49 (3H, s), 1.92 (2H, b), 1.42 (2H, m). MS m/e 249 (M+H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted ureas as neuropeptide Y5 receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Greenlee, William J.; Huang, Ying; Kelly, Joseph M.; McCombie, Stuart W.;
Stamford, Andrew W.; Wu, Yusheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20030114517 A1 2003-06-19

$RFMT $RIREG SCHEME211 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzyl 4-oxo-1-piperidinecarboxylate
C13H15NO3
19099-93-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 C 4.0012 1.5400 0.0 0
M  V30 5 O 12.0033 4.6201 0.0 0
M  V30 6 N 8.0022 2.3101 0.0 0
M  V30 7 C 8.0022 3.8501 0.0 0
M  V30 8 C 9.3360 1.5400 0.0 0
M  V30 9 C 9.3360 4.6201 0.0 0
M  V30 10 C 10.6697 2.3101 0.0 0
M  V30 11 C 10.6697 3.8501 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 2.6673 3.8501 0.0 0
M  V30 14 C 1.3337 1.5400 0.0 0
M  V30 15 C 1.3337 4.6201 0.0 0
M  V30 16 C 0.0000 2.3101 0.0 0
M  V30 17 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 4 12
M  V30 6 2 5 11
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 4-(methylamino)-1-piperidinecarboxylate
C14H20N2O2
405057-75-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 C 4.0010 1.5400 0.0 0
M  V30 5 N 12.0033 4.6201 0.0 0
M  V30 6 C 13.3370 3.8501 0.0 0
M  V30 7 N 8.0022 2.3101 0.0 0
M  V30 8 C 9.3360 1.5400 0.0 0
M  V30 9 C 8.0022 3.8501 0.0 0
M  V30 10 C 10.6697 2.3101 0.0 0
M  V30 11 C 9.3360 4.6201 0.0 0
M  V30 12 C 10.6697 3.8501 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 1.3337 1.5400 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 16 C 0.0000 2.3101 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 1 5 12
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19099-93-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 405057-75-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-17628549
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of Substituted ureas as neuropeptide Y5 receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Greenlee, William J.; Huang, Ying; Kelly, Joseph M.; McCombie, Stuart W.;
Stamford, Andrew W.; Wu, Yusheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002022592 A2 2002-03-21

$RFMT $RIREG SCHEME212 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1S,3S)-1-(5-chloro-2-thienyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indo...
C17H15ClN2O2S
1918182-64-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.9150 2.3100 0.0 0
M  V30 2 O 3.5813 1.5400 0.0 0
M  V30 3 O 6.2487 1.5400 0.0 0
M  V30 4 C 3.5813 0.0000 0.0 0
M  V30 5 Cl 11.5514 7.2871 0.0 0
M  V30 6 C 4.9150 6.9301 0.0 0
M  V30 7 C 3.5813 6.1601 0.0 0
M  V30 8 C 6.2487 6.1601 0.0 0 CFG=1
M  V30 9 N 4.5948 8.4364 0.0 0
M  V30 10 C 2.4368 7.1905 0.0 0
M  V30 11 C 3.5813 4.6201 0.0 0
M  V30 12 N 6.2487 4.6201 0.0 0
M  V30 13 C 3.0633 8.5974 0.0 0
M  V30 14 C 0.9052 7.0296 0.0 0
M  V30 15 C 4.9150 3.8501 0.0 0 CFG=1
M  V30 16 C 2.1580 9.8432 0.0 0
M  V30 17 C 0.0000 8.2755 0.0 0
M  V30 18 C 0.6265 9.6823 0.0 0
M  V30 19 C 7.5825 6.9301 0.0 0
M  V30 20 S 8.9893 6.3036 0.0 0
M  V30 21 C 7.7434 8.4617 0.0 0
M  V30 22 C 10.0197 7.4482 0.0 0
M  V30 23 C 9.2497 8.7819 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 15 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 22
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 8 19 CFG=1
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 2 10 14
M  V30 16 1 11 15
M  V30 17 1 12 15
M  V30 18 2 13 16
M  V30 19 1 14 17
M  V30 20 1 16 18
M  V30 21 2 17 18
M  V30 22 1 19 20
M  V30 23 2 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 8 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1S,3S)-1-(5-Chloro-2-thienyl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4-b]in...
C17H16ClN3OS
1918182-67-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.9150 2.3100 0.0 0
M  V30 2 N 3.5813 1.5400 0.0 0
M  V30 3 O 6.2487 1.5400 0.0 0
M  V30 4 C 3.5813 0.0000 0.0 0
M  V30 5 Cl 11.5514 7.2871 0.0 0
M  V30 6 C 4.9150 6.9301 0.0 0
M  V30 7 C 3.5813 6.1601 0.0 0
M  V30 8 C 6.2487 6.1601 0.0 0 CFG=1
M  V30 9 N 4.5948 8.4364 0.0 0
M  V30 10 C 2.4368 7.1905 0.0 0
M  V30 11 C 3.5813 4.6201 0.0 0
M  V30 12 N 6.2487 4.6201 0.0 0
M  V30 13 C 3.0633 8.5974 0.0 0
M  V30 14 C 0.9052 7.0296 0.0 0
M  V30 15 C 4.9150 3.8501 0.0 0 CFG=1
M  V30 16 C 2.1580 9.8432 0.0 0
M  V30 17 C 0.0000 8.2755 0.0 0
M  V30 18 C 0.6265 9.6823 0.0 0
M  V30 19 C 7.5825 6.9301 0.0 0
M  V30 20 S 8.9893 6.3036 0.0 0
M  V30 21 C 7.7434 8.4617 0.0 0
M  V30 22 C 10.0197 7.4482 0.0 0
M  V30 23 C 9.2497 8.7819 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 15 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 22
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 8 19 CFG=1
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 2 10 14
M  V30 16 1 11 15
M  V30 17 1 12 15
M  V30 18 2 13 16
M  V30 19 1 14 17
M  V30 20 1 16 18
M  V30 21 2 17 18
M  V30 22 1 19 20
M  V30 23 2 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 8 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1918182-64-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1918182-67-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15877825
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM closed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions and formulations of methylerthritol phosphate pathway
inhibitors and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carlier, Paul R.; Cassera, Maria Belen; Merino, Emilio Fernando; Yao,
Zhong-Ke; Ghavami, Maryam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016069949 A1 2016-05-06

$RFMT $RIREG SCHEME213 STEP1
$RXN



  1  1
$MOL
1H-1,2,3-Triazole-4-carboxylic acid, 5-hydroxy-1-methyl-, ethyl ester, compd....
C6H9N3O3.CH5N
1919035-19-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 3.0800 0.0 0
M  V30 2 O 6.6363 3.8501 0.0 0
M  V30 3 O 5.3026 1.5400 0.0 0
M  V30 4 C 7.9700 3.0800 0.0 0
M  V30 5 C 9.3037 3.8501 0.0 0
M  V30 6 O 2.2418 1.7173 0.0 0
M  V30 7 C 0.0000 4.2072 0.0 0
M  V30 8 C 3.9688 3.8501 0.0 0
M  V30 9 C 2.5620 3.2236 0.0 0
M  V30 10 N 3.8079 5.3816 0.0 0
M  V30 11 N 1.5316 4.3681 0.0 0
M  V30 12 N 2.3016 5.7018 0.0 0
M  V30 13 C 3.8818 0.0000 0.0 0
M  V30 14 N 5.4218 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 9
M  V30 7 1 7 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-hydroxy-1-methyl-1H-1,2,3-triazole-4-carboxylate
C6H9N3O3
1896670-59-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 1.5400 0.0 0
M  V30 2 O 6.6363 2.3101 0.0 0
M  V30 3 O 5.3026 0.0000 0.0 0
M  V30 4 C 7.9700 1.5400 0.0 0
M  V30 5 C 9.3037 2.3101 0.0 0
M  V30 6 O 2.2418 0.1773 0.0 0
M  V30 7 C 0.0000 2.6672 0.0 0
M  V30 8 C 3.9688 2.3101 0.0 0
M  V30 9 C 2.5620 1.6836 0.0 0
M  V30 10 N 3.8079 3.8416 0.0 0
M  V30 11 N 1.5316 2.8281 0.0 0
M  V30 12 N 2.3016 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 9
M  V30 7 1 7 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1919035-19-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1896670-59-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-575-CAS-19933302
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Regioselective N-Alkylation of Ethyl
4-Benzyloxy-1,2,3-triazolecarboxylate: A Useful Tool for the Synthesis of
Carboxylic Acid Bioisosteres
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sainas, Stefano; Pippione, Agnese C.; Giraudo, Alessandro; Martina,
Katia; Bosca, Federica; Rolando, Barbara; Barge, Alessandro; Ducime,
Alex; Federico, Antonella; Grossert, Stuart J.; White, Robert L.; Boschi,
Donatella; Lolli, Marco L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2019), 56(2), 501-519

$RFMT $RIREG SCHEME213 STEP1
$RXN



  1  1
$MOL
1H-1,2,3-Triazole-4-carboxylic acid, 5-hydroxy-1-methyl-, ethyl ester, compd....
C6H9N3O3.CH5N
1919035-19-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 3.0800 0.0 0
M  V30 2 O 6.6363 3.8501 0.0 0
M  V30 3 O 5.3026 1.5400 0.0 0
M  V30 4 C 7.9700 3.0800 0.0 0
M  V30 5 C 9.3037 3.8501 0.0 0
M  V30 6 O 2.2418 1.7173 0.0 0
M  V30 7 C 0.0000 4.2072 0.0 0
M  V30 8 C 3.9688 3.8501 0.0 0
M  V30 9 C 2.5620 3.2236 0.0 0
M  V30 10 N 3.8079 5.3816 0.0 0
M  V30 11 N 1.5316 4.3681 0.0 0
M  V30 12 N 2.3016 5.7018 0.0 0
M  V30 13 C 3.8818 0.0000 0.0 0
M  V30 14 N 5.4218 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 9
M  V30 7 1 7 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-hydroxy-1-methyl-1H-1,2,3-triazole-4-carboxylate
C6H9N3O3
1896670-59-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 1.5400 0.0 0
M  V30 2 O 6.6363 2.3101 0.0 0
M  V30 3 O 5.3026 0.0000 0.0 0
M  V30 4 C 7.9700 1.5400 0.0 0
M  V30 5 C 9.3037 2.3101 0.0 0
M  V30 6 O 2.2418 0.1773 0.0 0
M  V30 7 C 0.0000 2.6672 0.0 0
M  V30 8 C 3.9688 2.3101 0.0 0
M  V30 9 C 2.5620 1.6836 0.0 0
M  V30 10 N 3.8079 3.8416 0.0 0
M  V30 11 N 1.5316 2.8281 0.0 0
M  V30 12 N 2.3016 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 9
M  V30 7 1 7 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1919035-19-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1896670-59-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-575-CAS-16767147
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituted 4-hydroxy-1,2,3-triazoles: synthesis, characterization and
first drug design applications through bioisosteric modulation and
scaffold hopping approaches
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pippione, Agnese C.; Dosio, Franco; Ducime, Alex; Federico, Antonella;
Martina, Katia; Sainas, Stefano; Froelund, Bente; Gooyit, Major; Janda,
Kim D.; Boschi, Donatella; Lolli, Marco L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM MedChemComm (2015), 6(7), 1285-1292

$RFMT $RIREG SCHEME214 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[4-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-1-methylbutyl]-4-hydroxy-3-(1-ox...
C19H32O5Si
196193-60-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 14.6708 1.5400 0.0 0
M  V30 2 C 16.0045 2.3101 0.0 0
M  V30 3 O 14.6708 0.0000 0.0 0
M  V30 4 C 17.3383 1.5400 0.0 0
M  V30 5 O 12.0035 0.0000 0.0 0
M  V30 6 O 14.6708 4.6201 0.0 0
M  V30 7 C 9.3360 4.6201 0.0 0
M  V30 8 C 8.0023 3.8501 0.0 0
M  V30 9 C 9.3360 6.1601 0.0 0
M  V30 10 C 6.6687 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 12 O 4.0012 4.6201 0.0 0
M  V30 13 Si 2.6675 3.8501 0.0 0
M  V30 14 C 1.3338 3.0801 0.0 0
M  V30 15 C 3.4375 2.5164 0.0 0
M  V30 16 C 1.8975 5.1838 0.0 0
M  V30 17 C 2.1038 1.7464 0.0 0
M  V30 18 C 0.0000 2.3101 0.0 0
M  V30 19 C 0.5638 4.4137 0.0 0
M  V30 20 C 13.3372 2.3101 0.0 0
M  V30 21 C 12.0035 1.5400 0.0 0
M  V30 22 C 13.3372 3.8501 0.0 0
M  V30 23 C 10.6697 2.3101 0.0 0
M  V30 24 O 12.0035 4.6201 0.0 0
M  V30 25 C 10.6697 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 2 6 22
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 25
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 14 19
M  V30 20 2 20 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 2 23 25
M  V30 25 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[4-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-1-methylbutyl]-4-hydroxy-1-methy...
C20H35NO4Si
906109-38-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 C 1.3338 2.3101 0.0 0
M  V30 3 O 2.6675 0.0000 0.0 0
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 O 2.6675 4.6201 0.0 0
M  V30 6 O 5.3348 0.0000 0.0 0
M  V30 7 C 5.3348 6.1601 0.0 0
M  V30 8 C 8.0023 4.6201 0.0 0
M  V30 9 C 9.3360 3.8501 0.0 0
M  V30 10 C 8.0023 6.1601 0.0 0
M  V30 11 C 10.6697 4.6201 0.0 0
M  V30 12 C 12.0035 3.8501 0.0 0
M  V30 13 O 13.3372 4.6201 0.0 0
M  V30 14 Si 14.6708 3.8501 0.0 0
M  V30 15 C 16.0045 3.0801 0.0 0
M  V30 16 C 13.9008 2.5164 0.0 0
M  V30 17 C 15.4408 5.1838 0.0 0
M  V30 18 C 15.2345 1.7464 0.0 0
M  V30 19 C 17.3383 2.3101 0.0 0
M  V30 20 C 16.7745 4.4137 0.0 0
M  V30 21 C 4.0012 2.3101 0.0 0
M  V30 22 C 4.0012 3.8501 0.0 0
M  V30 23 C 5.3348 1.5400 0.0 0
M  V30 24 N 5.3348 4.6201 0.0 0
M  V30 25 C 6.6687 2.3101 0.0 0
M  V30 26 C 6.6687 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 2 5 22
M  V30 6 1 6 23
M  V30 7 1 7 24
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 26
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 1 15 19
M  V30 20 1 15 20
M  V30 21 1 21 22
M  V30 22 2 21 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 2 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 196193-60-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 906109-38-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13723590
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient synthesis of (±)-myxopyronin B via versatile pyridone
intermediates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lira, Ricardo; Agrios, Konstantinos A.; Doundoulakis, Thomas; Simonsen,
Klaus B.; Webber, Stephen E.; Xiang, Alan X.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2006), 68(6), 1099-1103

$RFMT $RIREG SCHEME215 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
O,S-Dimethyl carbonodithioate
C3H6OS2
19708-81-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0
M  V30 2 O 1.3338 2.3100 0.0 0
M  V30 3 S 4.0011 2.3100 0.0 0
M  V30 4 S 2.6674 0.0000 0.0 0
M  V30 5 C 0.0000 1.5400 0.0 0
M  V30 6 C 5.3349 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
O-Methyl N-methylcarbamothioate
C3H7NOS
14128-35-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0
M  V30 2 N 1.3338 2.3100 0.0 0
M  V30 3 O 4.0011 2.3100 0.0 0
M  V30 4 S 2.6674 0.0000 0.0 0
M  V30 5 C 0.0000 1.5400 0.0 0
M  V30 6 C 5.3349 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19708-81-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14128-35-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-4906274
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM O-Methyl Alkylcarbamothioates 4a-d; Typical Procedures O-Methyl
Methylcarbamothioate (4a); Procedure A (Table 1, Entry 1) A 40% aq soln
of MeNH2 (1.71 g, 22 mmol) was added dropwise over 5-10 min to MeSC(S)OMe
(1; 2.44 g, 20 mmol) with stirring. The reaction was mildly exothermic,
and during the addition the mixture was maintained at 20-25 °C by means
of a water bath. The progress of the reaction was monitored by GC, GC-MS,
and 1H NMR. The mixture was stirred at r.t. (20-25 °C) for 2 h until the
yellow color faded and the starting compound 1 disappeared. When the
reaction was complete, the mixture was treated with CH2Cl2-H2O (100 mL,
2:1). The aq soln was separated and extracted with CH2Cl2 (2 × 50 mL).
The combined organic extracts were washed with a small amount of H2O
(10-15 mL), dried (Na2SO4), and concentrated under reduced pressure (~200
Torr) at a bath temperature of 25 °C to give a residue consisting of pure
4a. (MeSH formed during the reaction was collected in 10-15% aq NaOH;
when the preparation was performed on a large scale,10 this byproduct
could be recovered as sodium methanethiolate in yields of >95%.)
Colorless oil, yield 2.10 g, quantitative. purity: 100% (GC); bp 122-123
°C/45 Torr (Lit.11b 70-72 °C/4 Torr). 1H NMR: δ = 2.81, 3.03 (2 d, J = 5.
1 Hz, 3 H, NHCH3); 3.92, 4.01 (2 s, 3 H, OCH3); 6.45, 7.12 (2 br s, 1 H,
NH); cis and trans rotamers. Identical to the reported spectrum.11.b 13C
NMR: δ = 29.60, 32.06 (NCH3); 56.95, 57.75 (OCH3); 189.90, 191.57 (C=S);
cis and trans rotamers. MS (EI, 70 eV): m/z (%) = 105 (100) [M+ , 90 (7)
[M+ - CH3], 75 (13) [M+ - NHCH3], 74 (25) [M+ - OCH3], 73 (12), 72 (14),
60 (11), 58 (13), 47 (7).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM O,S-Dimethyl carbonodithioate as a phosgene substitute for the
preparation of S-methyl alkylcarbamothioates and dialkylcarbamothioates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Degani, Iacopo; Fochi, Rita; Magistris, Claudio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2009), (22), 3807-3818

$RFMT $RIREG SCHEME216 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloro-6-methyl-1,3,5-triazine
C4H3Cl2N3
1973-04-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 4.6200 0.0 0
M  V30 2 Cl 5.3349 4.6200 0.0 0
M  V30 3 Cl 2.6674 0.0000 0.0 0
M  V30 4 N 2.6674 4.6200 0.0 0
M  V30 5 C 1.3338 3.8500 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 N 1.3338 2.3100 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 2.6674 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 9
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Piperidinecarboxylic acid
C6H11NO2
498-94-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 N 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[4-Methyl-6-(methylamino)-1,3,5-triazin-2-yl]-4-piperidinecarboxylic acid
C11H17N5O2
1141894-74-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.6694 4.6200 0.0 0
M  V30 2 C 12.0031 3.8500 0.0 0
M  V30 3 C 8.0020 0.0000 0.0 0
M  V30 4 C 1.3336 6.9300 0.0 0
M  V30 5 O 1.3336 8.4700 0.0 0
M  V30 6 O 0.0000 6.1600 0.0 0
M  V30 7 N 5.3347 4.6200 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 5.3347 6.1600 0.0 0
M  V30 10 C 2.6673 4.6200 0.0 0
M  V30 11 C 4.0011 6.9300 0.0 0
M  V30 12 C 2.6673 6.1600 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 N 8.0020 4.6200 0.0 0
M  V30 15 N 6.6684 2.3100 0.0 0
M  V30 16 C 9.3358 3.8500 0.0 0
M  V30 17 C 8.0020 1.5400 0.0 0
M  V30 18 N 9.3358 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 3 17
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 12
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1973-04-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 498-94-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1141894-74-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14774171
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of 1-(1,3,5-triazin-2-yl)piperidine-4-carboxamides as
inhibitors of soluble epoxide hydrolase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Thalji, Reema K.; McAtee, Jeff J.; Belyanskaya, Svetlana; Brandt, Martin;
Brown, Gregory D.; Costell, Melissa H.; Ding, Yun; Dodson, Jason W.;
Eisennagel, Steve H.; Fries, Rusty E.; Gross, Jeffrey W.; Harpel, Mark
R.; Holt, Dennis A.; Israel, David I.; Jolivette, Larry J.; Krosky,
Daniel; Li, Hu; Lu, Quinn; Mandichak, Tracy; Roethke, Theresa;
Schnackenberg, Christine G.; Schwartz, Benjamin; Shewchuk, Lisa M.; Xie,
Wensheng; Behm, David J.; Douglas, Stephen A.; Shaw, Ami L.; Marino,
Joseph P. Jr.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2013), 23(12), 3584-3588

$RFMT $RIREG SCHEME216 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloro-6-methyl-1,3,5-triazine
C4H3Cl2N3
1973-04-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 4.6200 0.0 0
M  V30 2 Cl 5.3349 4.6200 0.0 0
M  V30 3 Cl 2.6674 0.0000 0.0 0
M  V30 4 N 2.6674 4.6200 0.0 0
M  V30 5 C 1.3338 3.8500 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 N 1.3338 2.3100 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 2.6674 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 9
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Piperidinecarboxylic acid
C6H11NO2
498-94-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 N 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[4-Methyl-6-(methylamino)-1,3,5-triazin-2-yl]-4-piperidinecarboxylic acid
C11H17N5O2
1141894-74-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.6694 4.6200 0.0 0
M  V30 2 C 12.0031 3.8500 0.0 0
M  V30 3 C 8.0020 0.0000 0.0 0
M  V30 4 C 1.3336 6.9300 0.0 0
M  V30 5 O 1.3336 8.4700 0.0 0
M  V30 6 O 0.0000 6.1600 0.0 0
M  V30 7 N 5.3347 4.6200 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 5.3347 6.1600 0.0 0
M  V30 10 C 2.6673 4.6200 0.0 0
M  V30 11 C 4.0011 6.9300 0.0 0
M  V30 12 C 2.6673 6.1600 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 N 8.0020 4.6200 0.0 0
M  V30 15 N 6.6684 2.3100 0.0 0
M  V30 16 C 9.3358 3.8500 0.0 0
M  V30 17 C 8.0020 1.5400 0.0 0
M  V30 18 N 9.3358 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 3 17
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 12
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1973-04-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 498-94-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1141894-74-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-10911612
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Intermediate 2:
1-[4-methyl-6-(methylamino)-1,3,5-triazin-2-yl]-4-piperidinecarboxylic
acid 2,4-dichloro-6-methyl-1,3,5-triazine (5 g, 31 mmol) was dissolved in
a 1:1 mixture of acetonitrile and water and treated with an aqueous
solution of methyl amine (0.88 mL, 31 mmol) at a low temperature
maintained by immersing the reaction flask in an ice bath. The pH of the
reaction mixture was adjusted to 9-10 with 1M NaOH and the reaction was
stirred for 30 minutes. Then, 4-piperidinecarboxylic acid (5 g, 39 mmol)
was added and the pH was maintained between 9 and 10 with additions of 1M
NaOH as needed. The reaction was allowed to warm to room temperature and
stirred for one hour. The reaction mixture was then concentrated and
purified by preparative HPLC to provide
1-[4-methyl-6-(methylamino)-1,3,5-triazin-2-yl]-4-piperidinecarboxylic
acid (31 mmol, 100%) as a white solid. MS (ES) m/e 252 [M+ H]+. 1H NMR
(400 MHz, methanol-D4) 4.7 (m, 2H), 3.3 (s, 2H), 3.0 (s, 3H), 2.7 (m,
1H), 2.4 (s, 3H), 2.0 (m, 2H), 1.7 (m, 2H)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 2-amino-1,3,5-triazine derivatives as soluble epoxide
hydrolase (sEH) inhibitors and their use
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ding, Yun; Thalji, Reema K.; Marino, Joseph Paul, Jr.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009049165 A1 2009-04-16

$RFMT $RIREG SCHEME217 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-3-nitro-8-(trifluoromethoxy)quinoline
C10H4ClF3N2O3
1981588-19-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.7000 1.3338 0.0 0
M  V30 2 C 9.2400 1.3338 0.0 0
M  V30 3 F 10.0100 2.6674 0.0 0
M  V30 4 F 10.7800 1.3338 0.0 0
M  V30 5 F 10.0100 0.0000 0.0 0
M  V30 6 Cl 2.3100 5.3349 0.0 0
M  V30 7 N 0.7700 2.6674 0.0 0 VAL=5
M  V30 8 O 0.0000 1.3338 0.0 0
M  V30 9 O 0.0000 4.0011 0.0 0
M  V30 10 C 5.3900 2.6674 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 C 6.9300 2.6674 0.0 0
M  V30 13 N 4.6200 1.3338 0.0 0
M  V30 14 C 3.0800 4.0011 0.0 0
M  V30 15 C 5.3900 5.3349 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 3.0800 1.3338 0.0 0
M  V30 18 C 2.3100 2.6674 0.0 0
M  V30 19 C 6.9300 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 14
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 18
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 1 16 19
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-nitro-8-(trifluoromethoxy)-4-quinolinamine
C11H8F3N3O3
2417038-22-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3101 1.3338 0.0 0
M  V30 2 C 3.0801 0.0000 0.0 0
M  V30 3 O 7.7002 5.3348 0.0 0
M  V30 4 C 9.2402 5.3348 0.0 0
M  V30 5 F 10.0102 6.6687 0.0 0
M  V30 6 F 10.7802 5.3348 0.0 0
M  V30 7 F 10.0102 4.0012 0.0 0
M  V30 8 N 0.7700 4.0012 0.0 0 VAL=5
M  V30 9 O 0.0000 2.6675 0.0 0
M  V30 10 O 0.0000 5.3348 0.0 0
M  V30 11 C 4.6201 2.6675 0.0 0
M  V30 12 C 5.3901 4.0012 0.0 0
M  V30 13 C 3.0801 2.6675 0.0 0
M  V30 14 C 5.3901 1.3338 0.0 0
M  V30 15 C 6.9302 4.0012 0.0 0
M  V30 16 N 4.6201 5.3348 0.0 0
M  V30 17 C 2.3101 4.0012 0.0 0
M  V30 18 C 6.9302 1.3338 0.0 0
M  V30 19 C 7.7002 2.6675 0.0 0
M  V30 20 C 3.0801 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 3 4
M  V30 4 1 3 15
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 17
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 2 16 20
M  V30 20 1 17 20
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1981588-19-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2417038-22-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24530712
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tricyclic pesticidal compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shaikh, Rizwan Shabbir; Von Deyn, Wolfgang; Maity, Pulakesh; Schroeder,
Birte; Chaudhuri, Rupsha; Sambasivan, Sunderraman; Adisechan, Ashokkumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021209265 A1 2021-10-21

$RFMT $RIREG SCHEME217 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-3-nitro-8-(trifluoromethoxy)quinoline
C10H4ClF3N2O3
1981588-19-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.7000 1.3338 0.0 0
M  V30 2 C 9.2400 1.3338 0.0 0
M  V30 3 F 10.0100 2.6674 0.0 0
M  V30 4 F 10.7800 1.3338 0.0 0
M  V30 5 F 10.0100 0.0000 0.0 0
M  V30 6 Cl 2.3100 5.3349 0.0 0
M  V30 7 N 0.7700 2.6674 0.0 0 VAL=5
M  V30 8 O 0.0000 1.3338 0.0 0
M  V30 9 O 0.0000 4.0011 0.0 0
M  V30 10 C 5.3900 2.6674 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 C 6.9300 2.6674 0.0 0
M  V30 13 N 4.6200 1.3338 0.0 0
M  V30 14 C 3.0800 4.0011 0.0 0
M  V30 15 C 5.3900 5.3349 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 3.0800 1.3338 0.0 0
M  V30 18 C 2.3100 2.6674 0.0 0
M  V30 19 C 6.9300 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 14
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 18
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 1 16 19
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-nitro-8-(trifluoromethoxy)-4-quinolinamine
C11H8F3N3O3
2417038-22-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3101 1.3338 0.0 0
M  V30 2 C 3.0801 0.0000 0.0 0
M  V30 3 O 7.7002 5.3348 0.0 0
M  V30 4 C 9.2402 5.3348 0.0 0
M  V30 5 F 10.0102 6.6687 0.0 0
M  V30 6 F 10.7802 5.3348 0.0 0
M  V30 7 F 10.0102 4.0012 0.0 0
M  V30 8 N 0.7700 4.0012 0.0 0 VAL=5
M  V30 9 O 0.0000 2.6675 0.0 0
M  V30 10 O 0.0000 5.3348 0.0 0
M  V30 11 C 4.6201 2.6675 0.0 0
M  V30 12 C 5.3901 4.0012 0.0 0
M  V30 13 C 3.0801 2.6675 0.0 0
M  V30 14 C 5.3901 1.3338 0.0 0
M  V30 15 C 6.9302 4.0012 0.0 0
M  V30 16 N 4.6201 5.3348 0.0 0
M  V30 17 C 2.3101 4.0012 0.0 0
M  V30 18 C 6.9302 1.3338 0.0 0
M  V30 19 C 7.7002 2.6675 0.0 0
M  V30 20 C 3.0801 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 3 4
M  V30 4 1 3 15
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 17
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 2 16 20
M  V30 20 1 17 20
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1981588-19-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2417038-22-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-22481423
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tricycles as pesticidal compounds for controlling
invertebrate pests
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Von Deyn, Wolfgang; Shaikh, Rizwan Shabbir; Vyas, Devendra; Narine, Arun;
Kuzmina, Olesya
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020083662 A1 2020-04-30

$RFMT $RIREG SCHEME218 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromophenyl isothiocyanate
C7H4BrNS
1985-12-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0800 0.0 0
M  V30 2 C 6.6686 2.3100 0.0 0
M  V30 3 S 8.0022 1.5400 0.0 0
M  V30 4 Br 0.0000 0.0000 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 3.0800 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 1.3337 2.3100 0.0 0
M  V30 9 C 2.6675 0.0000 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Bromophenyl)-N′-methylthiourea
C8H9BrN2S
61449-55-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0800 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 N 8.0022 3.0800 0.0 0
M  V30 4 S 6.6684 0.7700 0.0 0
M  V30 5 C 9.3359 2.3100 0.0 0
M  V30 6 Br 0.0000 0.0000 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1985-12-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 61449-55-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-13580609
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):NOTES
$DATUM ANALOGUES HAVE SIMILAR REACTION
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quantitative Solid-State Reactions of Amines with Carbonyl Compounds and
Isothiocyanates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kaupp, Gerd; Schmeyers, Jens; Boy, Juergen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2000), 56(36), 6899-6911

$RFMT $RIREG SCHEME219 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Oxoindoline-5-sulfonyl chloride
C8H6ClNO3S
199328-31-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3338 1.3336 0.0 0 VAL=6
M  V30 2 Cl 0.0000 0.5636 0.0 0
M  V30 3 O 0.5638 2.6673 0.0 0
M  V30 4 O 2.1038 0.0000 0.0 0
M  V30 5 O 9.2447 2.8737 0.0 0
M  V30 6 C 5.3347 2.1037 0.0 0
M  V30 7 C 5.3347 3.6437 0.0 0
M  V30 8 C 4.0011 1.3336 0.0 0
M  V30 9 C 6.7994 1.6278 0.0 0
M  V30 10 C 4.0011 4.4137 0.0 0
M  V30 11 N 6.7994 4.1195 0.0 0
M  V30 12 C 2.6674 2.1037 0.0 0
M  V30 13 C 7.7047 2.8737 0.0 0
M  V30 14 C 2.6674 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 12
M  V30 5 2 5 13
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-N-methyl-2-oxo-1H-indole-5-sulfonamide
C9H10N2O3S
199328-55-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.6675 1.3337 0.0 0 VAL=6
M  V30 2 N 1.3337 0.5636 0.0 0
M  V30 3 O 3.4375 0.0000 0.0 0
M  V30 4 O 1.8975 2.6673 0.0 0
M  V30 5 C 0.0000 1.3337 0.0 0
M  V30 6 O 10.5784 2.8737 0.0 0
M  V30 7 C 6.6684 2.1037 0.0 0
M  V30 8 C 6.6684 3.6437 0.0 0
M  V30 9 C 5.3348 1.3337 0.0 0
M  V30 10 C 8.1332 1.6278 0.0 0
M  V30 11 C 5.3348 4.4137 0.0 0
M  V30 12 N 8.1332 4.1196 0.0 0
M  V30 13 C 4.0011 2.1037 0.0 0
M  V30 14 C 9.0384 2.8737 0.0 0
M  V30 15 C 4.0011 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 13
M  V30 5 1 2 5
M  V30 6 2 6 14
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 199328-31-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 199328-55-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-14921133
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of aminopropyl tetrahydroindole-based indolin-2-ones
as selective and potent inhibitors of Src and Yes tyrosine kinase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guan, Huiping; Laird, A. Douglas; Blake, Robert A.; Tang, Cho; Liang,
Chris
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2004), 14(1), 187-190

$RFMT $RIREG SCHEME220 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
P-[2-Oxo-1-(phenylmethoxy)-3-piperidinyl]phosphonic acid
C12H16NO5P
2004714-48-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 1.3337 3.0801 0.0 0 VAL=5
M  V30 2 O 0.0000 3.8501 0.0 0
M  V30 3 O 0.5637 1.7464 0.0 0
M  V30 4 O 2.1037 4.4137 0.0 0
M  V30 5 O 4.0012 4.6201 0.0 0
M  V30 6 O 6.6685 3.0801 0.0 0
M  V30 7 C 8.0022 2.3101 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 N 5.3348 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 14 C 9.3360 3.0801 0.0 0
M  V30 15 C 9.3360 4.6201 0.0 0
M  V30 16 C 10.6697 2.3101 0.0 0
M  V30 17 C 10.6697 5.3901 0.0 0
M  V30 18 C 12.0033 3.0801 0.0 0
M  V30 19 C 12.0033 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 2 5 9
M  V30 6 1 6 7
M  V30 7 1 6 11
M  V30 8 1 7 14
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-P-[2-oxo-1-(phenylmethoxy)-3-piperidinyl]phosphonamidic acid
C13H19N2O4P
2414317-25-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 10.6697 3.0801 0.0 0 VAL=5
M  V30 2 N 12.0033 3.8501 0.0 0
M  V30 3 O 11.4397 1.7464 0.0 0
M  V30 4 O 9.8996 4.4137 0.0 0
M  V30 5 C 13.3370 3.0801 0.0 0
M  V30 6 O 8.0022 4.6201 0.0 0
M  V30 7 O 5.3348 3.0801 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 9.3360 2.3101 0.0 0
M  V30 10 C 8.0022 3.0801 0.0 0
M  V30 11 C 9.3360 0.7700 0.0 0
M  V30 12 N 6.6685 2.3101 0.0 0
M  V30 13 C 8.0022 0.0000 0.0 0
M  V30 14 C 6.6685 0.7700 0.0 0
M  V30 15 C 2.6673 3.0801 0.0 0
M  V30 16 C 1.3337 2.3101 0.0 0
M  V30 17 C 2.6673 4.6201 0.0 0
M  V30 18 C 0.0000 3.0801 0.0 0
M  V30 19 C 1.3337 5.3901 0.0 0
M  V30 20 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 2 6 10
M  V30 7 1 7 8
M  V30 8 1 7 12
M  V30 9 1 8 15
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2004714-48-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2414317-25-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27418491
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2446-83-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 6674-22-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM Mitsunobu reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Expedient method for direct mono-amidation of phosphonic and phosphoric
acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yan, Victoria C.; Pham, Cong-Dat; Muller, Florian L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemRxiv (2020), 1-14

$RFMT $RIREG SCHEME221 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2-Benzisothiazole-2(3H)-propanoic acid, 5-bromo-α-hydroxy-3-methyl-, methyl...
C12H14BrNO5S
2010978-59-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9416 5.3632 0.0 0
M  V30 2 O 4.8393 0.0000 0.0 0
M  V30 3 O 6.7994 0.6368 0.0 0
M  V30 4 C 7.9110 2.6526 0.0 0
M  V30 5 C 8.6810 3.9864 0.0 0
M  V30 6 C 10.2210 3.9864 0.0 0
M  V30 7 O 7.9110 5.3201 0.0 0
M  V30 8 O 10.9910 5.3201 0.0 0
M  V30 9 O 10.9910 2.6526 0.0 0
M  V30 10 C 12.5310 5.3201 0.0 0
M  V30 11 Br 0.0000 4.1926 0.0 0
M  V30 12 C 4.0011 3.4226 0.0 0
M  V30 13 C 4.0011 1.8826 0.0 0
M  V30 14 C 5.4658 3.8987 0.0 0
M  V30 15 C 2.6674 4.1926 0.0 0
M  V30 16 S 5.4658 1.4068 0.0 0 VAL=6
M  V30 17 C 2.6674 1.1126 0.0 0
M  V30 18 N 6.3710 2.6526 0.0 0
M  V30 19 C 1.3338 3.4226 0.0 0
M  V30 20 C 1.3338 1.8826 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 2 2 16
M  V30 3 2 3 16
M  V30 4 1 4 5
M  V30 5 1 4 18
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 8 10
M  V30 11 1 11 19
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 2 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 18
M  V30 20 1 17 20
M  V30 21 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2-Benzisothiazole-2(3H)-propanamide, 5-bromo-α-hydroxy-N,3-dimethyl-, 1,1-d...
C12H15BrN2O4S
2010978-60-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9416 5.3632 0.0 0
M  V30 2 O 4.8393 0.0000 0.0 0
M  V30 3 O 6.7994 0.6368 0.0 0
M  V30 4 C 7.9110 2.6526 0.0 0
M  V30 5 C 8.6810 3.9864 0.0 0
M  V30 6 C 10.2210 3.9864 0.0 0
M  V30 7 O 7.9110 5.3201 0.0 0
M  V30 8 N 10.9910 5.3201 0.0 0
M  V30 9 O 10.9910 2.6526 0.0 0
M  V30 10 C 12.5310 5.3201 0.0 0
M  V30 11 Br 0.0000 4.1926 0.0 0
M  V30 12 C 4.0011 3.4226 0.0 0
M  V30 13 C 4.0011 1.8826 0.0 0
M  V30 14 C 5.4658 3.8987 0.0 0
M  V30 15 C 2.6674 4.1926 0.0 0
M  V30 16 S 5.4658 1.4068 0.0 0 VAL=6
M  V30 17 C 2.6674 1.1126 0.0 0
M  V30 18 N 6.3710 2.6526 0.0 0
M  V30 19 C 1.3338 3.4226 0.0 0
M  V30 20 C 1.3338 1.8826 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 2 2 16
M  V30 3 2 3 16
M  V30 4 1 4 5
M  V30 5 1 4 18
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 8 10
M  V30 11 1 11 19
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 2 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 18
M  V30 20 1 17 20
M  V30 21 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2010978-59-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2010978-60-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-16991976
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel 5-(indol-3-yl)-2,3-dihydrobenzo[d]isothiazole
1,1-dioxide derivatives as TDO2 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ninkovic, Sacha; Crosignani, Stefano; Scales, Stephanie Anne; McAlpine,
Indrawan James; Collins, Michael Raymond; Maderna, Andreas; Wythes,
Martin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016147144 A1 2016-09-22

$RFMT $RIREG SCHEME221 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2-Benzisothiazole-2(3H)-propanoic acid, 5-bromo-α-hydroxy-3-methyl-, methyl...
C12H14BrNO5S
2010978-59-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9416 5.3632 0.0 0
M  V30 2 O 4.8393 0.0000 0.0 0
M  V30 3 O 6.7994 0.6368 0.0 0
M  V30 4 C 7.9110 2.6526 0.0 0
M  V30 5 C 8.6810 3.9864 0.0 0
M  V30 6 C 10.2210 3.9864 0.0 0
M  V30 7 O 7.9110 5.3201 0.0 0
M  V30 8 O 10.9910 5.3201 0.0 0
M  V30 9 O 10.9910 2.6526 0.0 0
M  V30 10 C 12.5310 5.3201 0.0 0
M  V30 11 Br 0.0000 4.1926 0.0 0
M  V30 12 C 4.0011 3.4226 0.0 0
M  V30 13 C 4.0011 1.8826 0.0 0
M  V30 14 C 5.4658 3.8987 0.0 0
M  V30 15 C 2.6674 4.1926 0.0 0
M  V30 16 S 5.4658 1.4068 0.0 0 VAL=6
M  V30 17 C 2.6674 1.1126 0.0 0
M  V30 18 N 6.3710 2.6526 0.0 0
M  V30 19 C 1.3338 3.4226 0.0 0
M  V30 20 C 1.3338 1.8826 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 2 2 16
M  V30 3 2 3 16
M  V30 4 1 4 5
M  V30 5 1 4 18
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 8 10
M  V30 11 1 11 19
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 2 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 18
M  V30 20 1 17 20
M  V30 21 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2-Benzisothiazole-2(3H)-propanamide, 5-bromo-α-hydroxy-N,3-dimethyl-, 1,1-d...
C12H15BrN2O4S
2010978-60-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9416 5.3632 0.0 0
M  V30 2 O 4.8393 0.0000 0.0 0
M  V30 3 O 6.7994 0.6368 0.0 0
M  V30 4 C 7.9110 2.6526 0.0 0
M  V30 5 C 8.6810 3.9864 0.0 0
M  V30 6 C 10.2210 3.9864 0.0 0
M  V30 7 O 7.9110 5.3201 0.0 0
M  V30 8 N 10.9910 5.3201 0.0 0
M  V30 9 O 10.9910 2.6526 0.0 0
M  V30 10 C 12.5310 5.3201 0.0 0
M  V30 11 Br 0.0000 4.1926 0.0 0
M  V30 12 C 4.0011 3.4226 0.0 0
M  V30 13 C 4.0011 1.8826 0.0 0
M  V30 14 C 5.4658 3.8987 0.0 0
M  V30 15 C 2.6674 4.1926 0.0 0
M  V30 16 S 5.4658 1.4068 0.0 0 VAL=6
M  V30 17 C 2.6674 1.1126 0.0 0
M  V30 18 N 6.3710 2.6526 0.0 0
M  V30 19 C 1.3338 3.4226 0.0 0
M  V30 20 C 1.3338 1.8826 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 2 2 16
M  V30 3 2 3 16
M  V30 4 1 4 5
M  V30 5 1 4 18
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 8 10
M  V30 11 1 11 19
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 2 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 18
M  V30 20 1 17 20
M  V30 21 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2010978-59-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2010978-60-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-16834969
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel indolylbenzoisothiazole derivatives as TDO2 inhibitors,
pharmaceutical compositions, methods for use and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ninkovic, Sacha; Crosignani, Stefano; McAlpine, Indrawan James; Collins,
Michael Raymond; Scales, Stephanie Anne; Maderna, Andreas; Wythes, Martin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20160272628 A1 2016-09-22

$RFMT $RIREG SCHEME222 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acoramone
C12H16O4
2020-90-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 5.3901 0.0 0
M  V30 2 C 8.0023 4.6201 0.0 0
M  V30 3 C 8.0023 3.0801 0.0 0
M  V30 4 O 9.3360 5.3901 0.0 0
M  V30 5 O 4.0012 6.9302 0.0 0
M  V30 6 C 2.6675 7.7002 0.0 0
M  V30 7 O 4.0012 0.7700 0.0 0
M  V30 8 C 5.3348 0.0000 0.0 0
M  V30 9 O 1.3337 2.3101 0.0 0
M  V30 10 C 0.0000 3.0801 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 4.0012 5.3901 0.0 0
M  V30 13 C 5.3348 3.0801 0.0 0
M  V30 14 C 2.6675 4.6201 0.0 0
M  V30 15 C 4.0012 2.3101 0.0 0
M  V30 16 C 2.6675 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 7 8
M  V30 8 1 7 15
M  V30 9 1 9 10
M  V30 10 1 9 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4,5-Trimethoxy-N,α-dimethylbenzeneethanamine
C13H21NO3
93675-32-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 5.3900 0.0 0
M  V30 2 C 8.0021 4.6200 0.0 0
M  V30 3 N 9.3358 5.3900 0.0 0
M  V30 4 C 8.0021 3.0800 0.0 0
M  V30 5 C 10.6694 4.6200 0.0 0
M  V30 6 O 4.0011 6.9300 0.0 0
M  V30 7 C 2.6673 7.7000 0.0 0
M  V30 8 O 4.0011 0.7700 0.0 0
M  V30 9 C 5.3347 0.0000 0.0 0
M  V30 10 O 1.3336 2.3100 0.0 0
M  V30 11 C 0.0000 3.0800 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 4.0011 5.3900 0.0 0
M  V30 14 C 5.3347 3.0800 0.0 0
M  V30 15 C 2.6673 4.6200 0.0 0
M  V30 16 C 4.0011 2.3100 0.0 0
M  V30 17 C 2.6673 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 1 8 9
M  V30 9 1 8 16
M  V30 10 1 10 11
M  V30 11 1 10 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2020-90-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 93675-32-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-15359622
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2,4,5-Trimethoxymethamphetamine (3). To a stirred solution of compound 2
(1.0 g, 4.5 mmol) in dry dichloromethane (10 mL) cooled at -5 °C was
added a 2 M solution of methylamine in THF (10.1 mL, 20.25 mmol, 4.5
equiv). After the reaction mixture was stirred at room temperature for 1
h, 1.15 mL of glacial acetic acid (4.5 equiv) was added, followed by
sodium tri-acetoxyborohydride (Na(AcO)3BH) (1.43 g, 6.75 mmol, 1.5 equiv)
in small portions. Then, the reaction mixture was stirred at room
temperature for 3 h and quenched with 2.5 M sodium hydroxide aqueous
solution (5 mL). The aqueous layer was extracted with diethyl ether (3 ×
100 mL), and the combined ether extracts were washed with 2.5 M sodium
hydroxide aqueous solution (5 mL) dried over anhydrous MgSO4 and
evaporated to dryness to give compound 3 as a white solid (1.07 g, 4.5
mmol) in quantitative yield. mp 74 - 76 °C. 1H NMR (CDCl3) δ 1.01 (d, J =
6.0 Hz, 3H), 1.55 (broad s, 1H), 2.36 (s, 3H), 2.52 (m, J = 13.0 Hz, 1H),
2.64 (m, J = 13.0 Hz, 1H), 2.73 (m, 1H), 3.76 (s, 3H), 3.80 (s, 3H), 3.85
(s, 3H), 6.49 (s, 1H), 6.66 (s, 1H). 13C NMR (CDCl3) δ 19.8, 34.0, 37.5,
55.3, 56.1, 56.3, 56.6, 97.7, 115.1, 119.4, 142.7, 147.9, 151.9. HRMS
(ESI) m/z calcd for[M + H]+ 240.1600; found, 240.1594.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Neurotoxicity Profile of 2,4,5-Trihydroxymethamphetamine
and Its 6-(N-Acetylcystein-S-yl) Conjugate
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Neudorffer, Anne; Mueller, Melanie; Martinez, Claire-Marie; Mechan,
Annis; McCann, Una; Ricaurte, George A.; Largeron, Martine
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Research in Toxicology (2011), 24(6), 968-978

$RFMT $RIREG SCHEME223 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1S,2S)-2-(4-Bromo-3-fluorophenyl)cyclopropanecarboxylic acid
C10H8BrFO2
2035422-06-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.2636 1.3338 0.0 0
M  V30 2 O 9.8036 1.3338 0.0 0
M  V30 3 O 7.4936 0.0000 0.0 0
M  V30 4 F 1.5400 6.1049 0.0 0
M  V30 5 Br 0.0000 3.4374 0.0 0
M  V30 6 C 6.1600 3.4374 0.0 0 CFG=1
M  V30 7 C 7.4936 2.6674 0.0 0 CFG=1
M  V30 8 C 7.4936 4.2074 0.0 0
M  V30 9 C 4.6200 3.4374 0.0 0
M  V30 10 C 3.8500 4.7711 0.0 0
M  V30 11 C 3.8500 2.1038 0.0 0
M  V30 12 C 2.3100 4.7711 0.0 0
M  V30 13 C 2.3100 2.1038 0.0 0
M  V30 14 C 1.5400 3.4374 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 7 1 CFG=3
M  V30 4 1 4 12
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9 CFG=1
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 6 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1S,2S)-2-(4-Bromo-3-fluorophenyl)-N-methylcyclopropanecarboxamide
C11H11BrFNO
2369645-56-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.2085 2.1037 0.0 0
M  V30 2 N 9.5424 1.3337 0.0 0
M  V30 3 O 8.2085 3.6437 0.0 0
M  V30 4 C 10.8760 2.1037 0.0 0
M  V30 5 F 0.0000 1.3337 0.0 0
M  V30 6 Br 0.0000 4.4137 0.0 0
M  V30 7 C 5.3348 1.3337 0.0 0 CFG=1
M  V30 8 C 6.8749 1.3337 0.0 0 CFG=1
M  V30 9 C 6.1048 0.0000 0.0 0
M  V30 10 C 4.0012 2.1037 0.0 0
M  V30 11 C 2.6675 1.3337 0.0 0
M  V30 12 C 4.0012 3.6437 0.0 0
M  V30 13 C 1.3337 2.1037 0.0 0
M  V30 14 C 2.6675 4.4137 0.0 0
M  V30 15 C 1.3337 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 8 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 5 13
M  V30 6 1 6 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10 CFG=3
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2035422-06-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2369645-56-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-21591954
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of cycloalkyl substituted pyrazolopyrimidines having activity
against RSV
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lancois, David Francis Alain; Guillemont, Jerome Emile Georges;
Raboisson, Pierre Jean-Marie Bernard; Roymans, Dirk Andre Emmy; Rigaux,
Peter; Michaut, Antoine Benjamin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019149734 A1 2019-08-08

$RFMT $RIREG SCHEME224 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4Z)-4-[1-[4-(Dimethylamino)phenyl]ethylidene]-2-phenyl-5(4H)-oxazolone
C19H18N2O2
2036341-07-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7854 6.8423 0.0 0
M  V30 2 C 5.7854 8.3824 0.0 0
M  V30 3 O 2.7246 8.2051 0.0 0
M  V30 4 N 11.1202 3.7623 0.0 0
M  V30 5 C 11.1202 2.2223 0.0 0
M  V30 6 C 12.4539 4.5323 0.0 0
M  V30 7 C 2.7844 4.2206 0.0 0
M  V30 8 N 4.2907 4.5408 0.0 0
M  V30 9 O 2.0144 5.5543 0.0 0
M  V30 10 C 4.4517 6.0723 0.0 0
M  V30 11 C 3.0448 6.6988 0.0 0
M  V30 12 C 2.1579 2.8138 0.0 0
M  V30 13 C 3.0631 1.5677 0.0 0
M  V30 14 C 0.6263 2.6527 0.0 0
M  V30 15 C 2.4368 0.1609 0.0 0
M  V30 16 C 0.0000 1.2459 0.0 0
M  V30 17 C 0.9052 0.0000 0.0 0
M  V30 18 C 7.1191 6.0723 0.0 0
M  V30 19 C 7.1191 4.5323 0.0 0
M  V30 20 C 8.4527 6.8423 0.0 0
M  V30 21 C 8.4527 3.7623 0.0 0
M  V30 22 C 9.7865 6.0723 0.0 0
M  V30 23 C 9.7865 4.5323 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 10
M  V30 3 1 1 18
M  V30 4 2 3 11
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 23
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 7 12
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1Z)-2-[4-(Dimethylamino)phenyl]-1-[(methylamino)carbonyl]-1-propen-1-yl]b...
C20H23N3O2
2036341-14-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 6.6684 0.0 0
M  V30 2 C 4.6200 8.0021 0.0 0
M  V30 3 N 4.6200 5.3347 0.0 0
M  V30 4 C 2.3100 6.6684 0.0 0
M  V30 5 C 3.8500 9.3358 0.0 0
M  V30 6 C 3.8500 4.0011 0.0 0
M  V30 7 N 1.5400 8.0021 0.0 0
M  V30 8 O 1.5400 5.3347 0.0 0
M  V30 9 O 2.3100 4.0011 0.0 0
M  V30 10 C 0.0000 8.0021 0.0 0
M  V30 11 N 10.7800 8.0021 0.0 0
M  V30 12 C 11.5500 6.6684 0.0 0
M  V30 13 C 11.5500 9.3358 0.0 0
M  V30 14 C 6.1600 8.0021 0.0 0
M  V30 15 C 6.9300 6.6684 0.0 0
M  V30 16 C 6.9300 9.3358 0.0 0
M  V30 17 C 8.4700 6.6684 0.0 0
M  V30 18 C 8.4700 9.3358 0.0 0
M  V30 19 C 9.2400 8.0021 0.0 0
M  V30 20 C 4.6200 2.6674 0.0 0
M  V30 21 C 6.1600 2.6674 0.0 0
M  V30 22 C 3.8500 1.3336 0.0 0
M  V30 23 C 6.9300 1.3336 0.0 0
M  V30 24 C 4.6200 0.0000 0.0 0
M  V30 25 C 6.1600 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 14
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 2 6 9
M  V30 10 1 6 20
M  V30 11 1 7 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 19
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2036341-07-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2036341-14-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-18006746
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Imidazole derivatives as dual emission fluorescent compounds and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Karuso, Peter; Chatterjee, Soumit
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017147646 A1 2017-09-08

$RFMT $RIREG SCHEME224 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4Z)-4-[1-[4-(Dimethylamino)phenyl]ethylidene]-2-phenyl-5(4H)-oxazolone
C19H18N2O2
2036341-07-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7854 6.8423 0.0 0
M  V30 2 C 5.7854 8.3824 0.0 0
M  V30 3 O 2.7246 8.2051 0.0 0
M  V30 4 N 11.1202 3.7623 0.0 0
M  V30 5 C 11.1202 2.2223 0.0 0
M  V30 6 C 12.4539 4.5323 0.0 0
M  V30 7 C 2.7844 4.2206 0.0 0
M  V30 8 N 4.2907 4.5408 0.0 0
M  V30 9 O 2.0144 5.5543 0.0 0
M  V30 10 C 4.4517 6.0723 0.0 0
M  V30 11 C 3.0448 6.6988 0.0 0
M  V30 12 C 2.1579 2.8138 0.0 0
M  V30 13 C 3.0631 1.5677 0.0 0
M  V30 14 C 0.6263 2.6527 0.0 0
M  V30 15 C 2.4368 0.1609 0.0 0
M  V30 16 C 0.0000 1.2459 0.0 0
M  V30 17 C 0.9052 0.0000 0.0 0
M  V30 18 C 7.1191 6.0723 0.0 0
M  V30 19 C 7.1191 4.5323 0.0 0
M  V30 20 C 8.4527 6.8423 0.0 0
M  V30 21 C 8.4527 3.7623 0.0 0
M  V30 22 C 9.7865 6.0723 0.0 0
M  V30 23 C 9.7865 4.5323 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 10
M  V30 3 1 1 18
M  V30 4 2 3 11
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 23
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 7 12
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1Z)-2-[4-(Dimethylamino)phenyl]-1-[(methylamino)carbonyl]-1-propen-1-yl]b...
C20H23N3O2
2036341-14-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 6.6684 0.0 0
M  V30 2 C 4.6200 8.0021 0.0 0
M  V30 3 N 4.6200 5.3347 0.0 0
M  V30 4 C 2.3100 6.6684 0.0 0
M  V30 5 C 3.8500 9.3358 0.0 0
M  V30 6 C 3.8500 4.0011 0.0 0
M  V30 7 N 1.5400 8.0021 0.0 0
M  V30 8 O 1.5400 5.3347 0.0 0
M  V30 9 O 2.3100 4.0011 0.0 0
M  V30 10 C 0.0000 8.0021 0.0 0
M  V30 11 N 10.7800 8.0021 0.0 0
M  V30 12 C 11.5500 6.6684 0.0 0
M  V30 13 C 11.5500 9.3358 0.0 0
M  V30 14 C 6.1600 8.0021 0.0 0
M  V30 15 C 6.9300 6.6684 0.0 0
M  V30 16 C 6.9300 9.3358 0.0 0
M  V30 17 C 8.4700 6.6684 0.0 0
M  V30 18 C 8.4700 9.3358 0.0 0
M  V30 19 C 9.2400 8.0021 0.0 0
M  V30 20 C 4.6200 2.6674 0.0 0
M  V30 21 C 6.1600 2.6674 0.0 0
M  V30 22 C 3.8500 1.3336 0.0 0
M  V30 23 C 6.9300 1.3336 0.0 0
M  V30 24 C 4.6200 0.0000 0.0 0
M  V30 25 C 6.1600 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 14
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 2 6 9
M  V30 10 1 6 20
M  V30 11 1 7 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 19
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2036341-07-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2036341-14-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-16404843
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient and concise method to synthesize locked GFP chromophore
analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chatterjee, Soumit; Karuso, Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2016), 57(47), 5197-5200

$RFMT $RIREG SCHEME225 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4Z)-4-(3,4-Dihydro-1(2H)-naphthalenylidene)-2-phenyl-5(4H)-oxazolone
C19H15NO2
2036341-08-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0177 7.9521 0.0 0
M  V30 2 C 2.6675 4.6201 0.0 0
M  V30 3 C 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 5.3901 0.0 0
M  V30 5 C 1.3338 2.3100 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 0.0000 4.6201 0.0 0
M  V30 8 C 0.0000 3.0800 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 C 4.0011 5.3901 0.0 0
M  V30 13 N 5.4081 4.7636 0.0 0
M  V30 14 C 4.1621 6.9216 0.0 0
M  V30 15 C 6.4385 5.9081 0.0 0
M  V30 16 O 5.6685 7.2418 0.0 0
M  V30 17 C 7.9701 5.7472 0.0 0
M  V30 18 C 8.8753 6.9931 0.0 0
M  V30 19 C 8.5966 4.3402 0.0 0
M  V30 20 C 10.4069 6.8320 0.0 0
M  V30 21 C 10.1281 4.1793 0.0 0
M  V30 22 C 11.0333 5.4252 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 2 12
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 7 8
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1Z)-1-(3,4-Dihydro-1(2H)-naphthalenylidene)-2-(methylamino)-2-oxoethyl]be...
C20H20N2O2
2036341-15-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.8500 0.0 0
M  V30 2 N 5.3347 4.6200 0.0 0
M  V30 3 C 4.0011 2.3100 0.0 0
M  V30 4 C 6.6684 3.8500 0.0 0
M  V30 5 N 2.6673 1.5400 0.0 0
M  V30 6 O 5.3347 1.5400 0.0 0
M  V30 7 O 6.6684 2.3100 0.0 0
M  V30 8 C 2.6673 0.0000 0.0 0
M  V30 9 C 2.6673 4.6200 0.0 0
M  V30 10 C 2.6673 6.1600 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 12 C 1.3336 6.9300 0.0 0
M  V30 13 C 4.0011 6.9300 0.0 0
M  V30 14 C 0.0000 4.6200 0.0 0
M  V30 15 C 0.0000 6.1600 0.0 0
M  V30 16 C 1.3336 8.4700 0.0 0
M  V30 17 C 4.0011 8.4700 0.0 0
M  V30 18 C 2.6673 9.2400 0.0 0
M  V30 19 C 8.0021 4.6200 0.0 0
M  V30 20 C 9.3358 3.8500 0.0 0
M  V30 21 C 8.0021 6.1600 0.0 0
M  V30 22 C 10.6694 4.6200 0.0 0
M  V30 23 C 9.3358 6.9300 0.0 0
M  V30 24 C 10.6694 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 9
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 4 7
M  V30 8 1 4 19
M  V30 9 1 5 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 15
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2036341-08-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2036341-15-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-18006747
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Imidazole derivatives as dual emission fluorescent compounds and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Karuso, Peter; Chatterjee, Soumit
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017147646 A1 2017-09-08

$RFMT $RIREG SCHEME225 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4Z)-4-(3,4-Dihydro-1(2H)-naphthalenylidene)-2-phenyl-5(4H)-oxazolone
C19H15NO2
2036341-08-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0177 7.9521 0.0 0
M  V30 2 C 2.6675 4.6201 0.0 0
M  V30 3 C 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 5.3901 0.0 0
M  V30 5 C 1.3338 2.3100 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 0.0000 4.6201 0.0 0
M  V30 8 C 0.0000 3.0800 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 C 4.0011 5.3901 0.0 0
M  V30 13 N 5.4081 4.7636 0.0 0
M  V30 14 C 4.1621 6.9216 0.0 0
M  V30 15 C 6.4385 5.9081 0.0 0
M  V30 16 O 5.6685 7.2418 0.0 0
M  V30 17 C 7.9701 5.7472 0.0 0
M  V30 18 C 8.8753 6.9931 0.0 0
M  V30 19 C 8.5966 4.3402 0.0 0
M  V30 20 C 10.4069 6.8320 0.0 0
M  V30 21 C 10.1281 4.1793 0.0 0
M  V30 22 C 11.0333 5.4252 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 2 12
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 7 8
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1Z)-1-(3,4-Dihydro-1(2H)-naphthalenylidene)-2-(methylamino)-2-oxoethyl]be...
C20H20N2O2
2036341-15-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.8500 0.0 0
M  V30 2 N 5.3347 4.6200 0.0 0
M  V30 3 C 4.0011 2.3100 0.0 0
M  V30 4 C 6.6684 3.8500 0.0 0
M  V30 5 N 2.6673 1.5400 0.0 0
M  V30 6 O 5.3347 1.5400 0.0 0
M  V30 7 O 6.6684 2.3100 0.0 0
M  V30 8 C 2.6673 0.0000 0.0 0
M  V30 9 C 2.6673 4.6200 0.0 0
M  V30 10 C 2.6673 6.1600 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 12 C 1.3336 6.9300 0.0 0
M  V30 13 C 4.0011 6.9300 0.0 0
M  V30 14 C 0.0000 4.6200 0.0 0
M  V30 15 C 0.0000 6.1600 0.0 0
M  V30 16 C 1.3336 8.4700 0.0 0
M  V30 17 C 4.0011 8.4700 0.0 0
M  V30 18 C 2.6673 9.2400 0.0 0
M  V30 19 C 8.0021 4.6200 0.0 0
M  V30 20 C 9.3358 3.8500 0.0 0
M  V30 21 C 8.0021 6.1600 0.0 0
M  V30 22 C 10.6694 4.6200 0.0 0
M  V30 23 C 9.3358 6.9300 0.0 0
M  V30 24 C 10.6694 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 9
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 4 7
M  V30 8 1 4 19
M  V30 9 1 5 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 15
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2036341-08-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2036341-15-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-16404846
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient and concise method to synthesize locked GFP chromophore
analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chatterjee, Soumit; Karuso, Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2016), 57(47), 5197-5200

$RFMT $RIREG SCHEME226 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4Z)-4-(2,3-Dihydro-1H-inden-1-ylidene)-2-phenyl-5(4H)-oxazolone
C18H13NO2
2036341-10-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.9820 0.0000 0.0 0
M  V30 2 C 3.3068 2.9015 0.0 0
M  V30 3 C 2.5368 4.2353 0.0 0
M  V30 4 C 2.2764 1.7571 0.0 0
M  V30 5 C 1.0306 3.9151 0.0 0
M  V30 6 C 3.0127 5.6998 0.0 0
M  V30 7 C 0.8695 2.3834 0.0 0
M  V30 8 C 0.0000 5.0595 0.0 0
M  V30 9 C 1.9823 6.8443 0.0 0
M  V30 10 C 0.4759 6.5242 0.0 0
M  V30 11 C 4.8383 2.7406 0.0 0
M  V30 12 N 5.8689 3.8851 0.0 0
M  V30 13 C 5.6083 1.4069 0.0 0
M  V30 14 C 7.2757 3.2586 0.0 0
M  V30 15 O 7.1148 1.7271 0.0 0
M  V30 16 C 8.6093 4.0286 0.0 0
M  V30 17 C 9.9431 3.2586 0.0 0
M  V30 18 C 8.6093 5.5686 0.0 0
M  V30 19 C 11.2767 4.0286 0.0 0
M  V30 20 C 9.9431 6.3386 0.0 0
M  V30 21 C 11.2767 5.5686 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 2 11
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 6 9
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1Z)-1-(2,3-Dihydro-1H-inden-1-ylidene)-2-(methylamino)-2-oxoethyl]benzamide
C19H18N2O2
2036341-17-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0543 4.0011 0.0 0
M  V30 2 N 5.8243 5.3347 0.0 0
M  V30 3 C 5.8243 2.6674 0.0 0
M  V30 4 C 7.3643 5.3347 0.0 0
M  V30 5 N 5.0543 1.3336 0.0 0
M  V30 6 O 7.3643 2.6674 0.0 0
M  V30 7 O 8.1343 4.0011 0.0 0
M  V30 8 C 5.8243 0.0000 0.0 0
M  V30 9 C 3.5143 4.0011 0.0 0
M  V30 10 C 2.6091 5.2469 0.0 0
M  V30 11 C 2.6091 2.7552 0.0 0
M  V30 12 C 1.1445 4.7711 0.0 0
M  V30 13 C 2.9292 6.7534 0.0 0
M  V30 14 C 1.1445 3.2311 0.0 0
M  V30 15 C 0.0000 5.8015 0.0 0
M  V30 16 C 1.7849 7.7838 0.0 0
M  V30 17 C 0.3202 7.3079 0.0 0
M  V30 18 C 8.1343 6.6684 0.0 0
M  V30 19 C 7.3643 8.0021 0.0 0
M  V30 20 C 9.6743 6.6684 0.0 0
M  V30 21 C 8.1343 9.3358 0.0 0
M  V30 22 C 10.4443 8.0021 0.0 0
M  V30 23 C 9.6743 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 9
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 4 7
M  V30 8 1 4 18
M  V30 9 1 5 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2036341-10-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2036341-17-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-18011771
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Imidazole derivatives as dual emission fluorescent compounds and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Karuso, Peter; Chatterjee, Soumit
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017147646 A1 2017-09-08

$RFMT $RIREG SCHEME226 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4Z)-4-(2,3-Dihydro-1H-inden-1-ylidene)-2-phenyl-5(4H)-oxazolone
C18H13NO2
2036341-10-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.9820 0.0000 0.0 0
M  V30 2 C 3.3068 2.9015 0.0 0
M  V30 3 C 2.5368 4.2353 0.0 0
M  V30 4 C 2.2764 1.7571 0.0 0
M  V30 5 C 1.0306 3.9151 0.0 0
M  V30 6 C 3.0127 5.6998 0.0 0
M  V30 7 C 0.8695 2.3834 0.0 0
M  V30 8 C 0.0000 5.0595 0.0 0
M  V30 9 C 1.9823 6.8443 0.0 0
M  V30 10 C 0.4759 6.5242 0.0 0
M  V30 11 C 4.8383 2.7406 0.0 0
M  V30 12 N 5.8689 3.8851 0.0 0
M  V30 13 C 5.6083 1.4069 0.0 0
M  V30 14 C 7.2757 3.2586 0.0 0
M  V30 15 O 7.1148 1.7271 0.0 0
M  V30 16 C 8.6093 4.0286 0.0 0
M  V30 17 C 9.9431 3.2586 0.0 0
M  V30 18 C 8.6093 5.5686 0.0 0
M  V30 19 C 11.2767 4.0286 0.0 0
M  V30 20 C 9.9431 6.3386 0.0 0
M  V30 21 C 11.2767 5.5686 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 2 11
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 6 9
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1Z)-1-(2,3-Dihydro-1H-inden-1-ylidene)-2-(methylamino)-2-oxoethyl]benzamide
C19H18N2O2
2036341-17-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0543 4.0011 0.0 0
M  V30 2 N 5.8243 5.3347 0.0 0
M  V30 3 C 5.8243 2.6674 0.0 0
M  V30 4 C 7.3643 5.3347 0.0 0
M  V30 5 N 5.0543 1.3336 0.0 0
M  V30 6 O 7.3643 2.6674 0.0 0
M  V30 7 O 8.1343 4.0011 0.0 0
M  V30 8 C 5.8243 0.0000 0.0 0
M  V30 9 C 3.5143 4.0011 0.0 0
M  V30 10 C 2.6091 5.2469 0.0 0
M  V30 11 C 2.6091 2.7552 0.0 0
M  V30 12 C 1.1445 4.7711 0.0 0
M  V30 13 C 2.9292 6.7534 0.0 0
M  V30 14 C 1.1445 3.2311 0.0 0
M  V30 15 C 0.0000 5.8015 0.0 0
M  V30 16 C 1.7849 7.7838 0.0 0
M  V30 17 C 0.3202 7.3079 0.0 0
M  V30 18 C 8.1343 6.6684 0.0 0
M  V30 19 C 7.3643 8.0021 0.0 0
M  V30 20 C 9.6743 6.6684 0.0 0
M  V30 21 C 8.1343 9.3358 0.0 0
M  V30 22 C 10.4443 8.0021 0.0 0
M  V30 23 C 9.6743 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 9
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 4 7
M  V30 8 1 4 18
M  V30 9 1 5 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2036341-10-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2036341-17-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-16404848
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient and concise method to synthesize locked GFP chromophore
analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chatterjee, Soumit; Karuso, Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2016), 57(47), 5197-5200

$RFMT $RIREG SCHEME227 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl octahydro-5-oxo-2H-isoindole-2-carboxylate
C13H21NO3
203661-68-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 O 11.7610 4.4136 0.0 0
M  V30 9 C 7.7599 2.1036 0.0 0
M  V30 10 C 7.7599 3.6436 0.0 0
M  V30 11 C 6.2952 1.6278 0.0 0
M  V30 12 C 9.0935 1.3336 0.0 0
M  V30 13 C 6.2952 4.1195 0.0 0
M  V30 14 C 9.0935 4.4136 0.0 0
M  V30 15 N 5.3900 2.8736 0.0 0
M  V30 16 C 10.4272 2.1036 0.0 0
M  V30 17 C 10.4272 3.6436 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 17
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 1 14 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl octahydro-5-(methylamino)-2H-isoindole-2-carboxylate
C14H26N2O2
1793108-46-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 N 11.7608 4.4136 0.0 0
M  V30 9 C 13.0946 3.6436 0.0 0
M  V30 10 C 7.7599 3.6436 0.0 0
M  V30 11 C 7.7599 2.1036 0.0 0
M  V30 12 C 6.2952 4.1195 0.0 0
M  V30 13 C 9.0935 4.4136 0.0 0
M  V30 14 C 6.2952 1.6278 0.0 0
M  V30 15 C 9.0935 1.3336 0.0 0
M  V30 16 N 5.3900 2.8736 0.0 0
M  V30 17 C 10.4272 3.6436 0.0 0
M  V30 18 C 10.4272 2.1036 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 17
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 16
M  V30 18 1 15 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 203661-68-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1793108-46-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-7126398
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituted heteroaryl compounds and methods of use
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xi, Ning; Li, Minxiong; Hu, Haiyang; Wang, Tingjin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015094803 A1 2015-06-25

$RFMT $RIREG SCHEME228 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(5E)-1-(2-Bromophenyl)-4-(methoxymethoxy)-6,10-dimethyl-5,9-undecadien-2-yn-1...
C21H25BrO3
2044764-83-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 6.9302 0.0 0
M  V30 2 C 4.0012 6.1601 0.0 0
M  V30 3 O 1.3338 6.1601 0.0 0
M  V30 4 C 5.3348 5.3901 0.0 0
M  V30 5 C 6.6687 4.6201 0.0 0 CFG=3
M  V30 6 C 8.0023 5.3901 0.0 0
M  V30 7 O 6.6687 3.0801 0.0 0
M  V30 8 C 9.3360 4.6201 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 10.6698 5.3901 0.0 0
M  V30 11 C 9.3360 3.0801 0.0 0
M  V30 12 O 5.3348 0.7700 0.0 0
M  V30 13 C 12.0035 4.6201 0.0 0
M  V30 14 C 4.0012 0.0000 0.0 0
M  V30 15 C 13.3372 5.3901 0.0 0
M  V30 16 C 14.6708 4.6201 0.0 0
M  V30 17 C 16.0046 5.3901 0.0 0
M  V30 18 C 14.6708 3.0801 0.0 0
M  V30 19 Br 0.0000 8.4702 0.0 0
M  V30 20 C 2.6675 8.4702 0.0 0
M  V30 21 C 1.3338 9.2402 0.0 0
M  V30 22 C 4.0012 9.2402 0.0 0
M  V30 23 C 1.3338 10.7802 0.0 0
M  V30 24 C 4.0012 10.7802 0.0 0
M  V30 25 C 2.6675 11.5503 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 3 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 15 16
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 19 21
M  V30 20 2 20 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 2 22 24
M  V30 24 2 23 25
M  V30 25 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2Z,5E)-1-(2-Bromophenyl)-4-(methoxymethoxy)-6,10-dimethyl-3-(methylamino)-2,...
C22H30BrNO3
2044764-87-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 7.7002 0.0 0 CFG=3
M  V30 2 C 4.0010 6.9302 0.0 0
M  V30 3 C 6.6685 6.9302 0.0 0
M  V30 4 O 5.3348 9.2402 0.0 0
M  V30 5 C 4.0010 5.3901 0.0 0
M  V30 6 N 2.6673 7.7002 0.0 0
M  V30 7 C 8.0022 7.7002 0.0 0
M  V30 8 C 4.0010 10.0102 0.0 0
M  V30 9 C 2.6673 4.6201 0.0 0
M  V30 10 C 1.3337 6.9302 0.0 0
M  V30 11 C 9.3358 6.9302 0.0 0
M  V30 12 C 8.0022 9.2402 0.0 0
M  V30 13 O 4.0010 11.5503 0.0 0
M  V30 14 O 1.3337 5.3901 0.0 0
M  V30 15 C 10.6697 7.7002 0.0 0
M  V30 16 C 2.6673 12.3203 0.0 0
M  V30 17 C 12.0033 6.9302 0.0 0
M  V30 18 C 13.3370 7.7002 0.0 0
M  V30 19 C 14.6707 6.9302 0.0 0
M  V30 20 C 13.3370 9.2402 0.0 0
M  V30 21 Br 0.0000 3.0801 0.0 0
M  V30 22 C 2.6673 3.0801 0.0 0
M  V30 23 C 1.3337 2.3101 0.0 0
M  V30 24 C 4.0010 2.3101 0.0 0
M  V30 25 C 1.3337 0.7700 0.0 0
M  V30 26 C 4.0010 0.7700 0.0 0
M  V30 27 C 2.6673 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 1 2 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 2 9 14
M  V30 14 1 9 22
M  V30 15 1 11 15
M  V30 16 1 13 16
M  V30 17 1 15 17
M  V30 18 2 17 18
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 21 23
M  V30 22 2 22 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 2 24 26
M  V30 26 2 25 27
M  V30 27 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2044764-83-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2044764-87-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-16435844
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Divergent Synthesis of Quinolone Natural Products from Pseudonocardia sp.
CL38489
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Geddis, Stephen M.; Carro, Laura; Hodgkinson, James T.; Spring, David R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2016), 2016(35), 5799-5802

$RFMT $RIREG SCHEME229 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,5-Dioxo-1-pyrrolidinyl 4-[2-[ethyl(3-methylphenyl)amino]-2-oxoethyl]-4H-thi...
C22H21N3O5S
2056145-04-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.5862 5.8233 0.0 0
M  V30 2 C 8.9200 6.5933 0.0 0
M  V30 3 N 10.2536 5.8233 0.0 0
M  V30 4 O 8.9200 8.1333 0.0 0
M  V30 5 C 10.2536 4.2833 0.0 0
M  V30 6 C 11.5873 3.5133 0.0 0
M  V30 7 C 4.5255 4.4605 0.0 0
M  V30 8 O 3.0608 3.9847 0.0 0
M  V30 9 O 5.6699 3.4299 0.0 0
M  V30 10 O 0.0000 2.6219 0.0 0
M  V30 11 O 5.3026 1.4947 0.0 0
M  V30 12 C 15.5884 5.8233 0.0 0
M  V30 13 N 6.2525 6.5933 0.0 0
M  V30 14 C 6.0916 8.1249 0.0 0
M  V30 15 C 4.8457 5.9668 0.0 0
M  V30 16 C 4.5851 8.4450 0.0 0
M  V30 17 C 6.8616 9.4585 0.0 0
M  V30 18 C 3.8151 7.1114 0.0 0
M  V30 19 S 4.4242 9.9766 0.0 0
M  V30 20 C 5.8311 10.6031 0.0 0
M  V30 21 N 2.7406 2.4782 0.0 0
M  V30 22 C 1.3337 1.8519 0.0 0
M  V30 23 C 3.7711 1.3338 0.0 0
M  V30 24 C 1.4947 0.3203 0.0 0
M  V30 25 C 3.0010 0.0000 0.0 0
M  V30 26 C 11.5873 6.5933 0.0 0
M  V30 27 C 12.9209 5.8233 0.0 0
M  V30 28 C 11.5873 8.1333 0.0 0
M  V30 29 C 14.2548 6.5933 0.0 0
M  V30 30 C 12.9209 8.9033 0.0 0
M  V30 31 C 14.2548 8.1333 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 26
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 15
M  V30 11 1 8 21
M  V30 12 2 10 22
M  V30 13 2 11 23
M  V30 14 1 12 29
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 1 14 17
M  V30 19 2 15 18
M  V30 20 1 16 18
M  V30 21 1 16 19
M  V30 22 2 17 20
M  V30 23 1 19 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Ethyl-5-[(methylamino)carbonyl]-N-(3-methylphenyl)-4H-thieno[3,2-b]pyrrole-...
C19H21N3O2S
2056144-50-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.8455 3.3451 0.0 0
M  V30 2 C 6.1793 4.1151 0.0 0
M  V30 3 N 7.5130 3.3451 0.0 0
M  V30 4 O 6.1793 5.6551 0.0 0
M  V30 5 C 7.5130 1.8051 0.0 0
M  V30 6 C 8.8467 1.0351 0.0 0
M  V30 7 C 1.7849 1.9823 0.0 0
M  V30 8 N 0.3202 1.5065 0.0 0
M  V30 9 O 2.9293 0.9519 0.0 0
M  V30 10 C 0.0000 0.0000 0.0 0
M  V30 11 C 12.8478 3.3451 0.0 0
M  V30 12 N 3.5119 4.1151 0.0 0
M  V30 13 C 3.3509 5.6467 0.0 0
M  V30 14 C 2.1051 3.4886 0.0 0
M  V30 15 C 1.8445 5.9668 0.0 0
M  V30 16 C 4.1210 6.9803 0.0 0
M  V30 17 C 1.0745 4.6332 0.0 0
M  V30 18 S 1.6836 7.4984 0.0 0
M  V30 19 C 3.0905 8.1249 0.0 0
M  V30 20 C 8.8467 4.1151 0.0 0
M  V30 21 C 10.1805 3.3451 0.0 0
M  V30 22 C 8.8467 5.6551 0.0 0
M  V30 23 C 11.5141 4.1151 0.0 0
M  V30 24 C 10.1805 6.4251 0.0 0
M  V30 25 C 11.5141 5.6551 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 20
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 14
M  V30 11 1 8 10
M  V30 12 1 11 23
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 1 13 16
M  V30 17 2 14 17
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 2 16 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2056145-04-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2056144-50-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-16785564
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thienopyrrole compounds and uses thereof as inhibitors of
oplophorus-derived luciferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Duellman, Sarah; Robers, Matthew B.; Walker, Joel R.; Zhou, Wenhui;
Zimprich, Chad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016210294 A1 2016-12-29

$RFMT $RIREG SCHEME230 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[6-Chloro-3-(ethylsulfonyl)-2-pyridinyl]-5-cyclopropyl-3,5-dihydro-3-methyl...
C18H16ClF3N4O3S
2059118-34-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1601 9.9092 0.0 0
M  V30 2 C 8.8110 7.9521 0.0 0
M  V30 3 C 1.5400 7.2419 0.0 0
M  V30 4 F 1.5400 5.7018 0.0 0
M  V30 5 F 0.0000 7.2419 0.0 0
M  V30 6 F 1.5400 8.7819 0.0 0
M  V30 7 S 7.8275 2.3101 0.0 0 VAL=6
M  V30 8 C 6.4939 1.5400 0.0 0
M  V30 9 O 7.0575 3.6437 0.0 0
M  V30 10 O 8.5975 0.9762 0.0 0
M  V30 11 C 6.4939 0.0000 0.0 0
M  V30 12 Cl 13.1624 5.3901 0.0 0
M  V30 13 C 6.1601 7.2419 0.0 0
M  V30 14 C 5.3901 5.9082 0.0 0
M  V30 15 C 5.3901 8.5755 0.0 0
M  V30 16 N 7.6666 6.9217 0.0 0
M  V30 17 N 6.4206 4.7636 0.0 0
M  V30 18 C 3.8501 5.9082 0.0 0
M  V30 19 N 3.8501 8.5755 0.0 0
M  V30 20 C 7.8275 5.3901 0.0 0
M  V30 21 C 3.0801 7.2419 0.0 0
M  V30 22 C 3.0801 9.9092 0.0 0
M  V30 23 C 3.0801 11.4492 0.0 0
M  V30 24 C 1.7464 10.6792 0.0 0
M  V30 25 C 9.1612 4.6201 0.0 0
M  V30 26 C 9.1612 3.0801 0.0 0
M  V30 27 N 10.4949 5.3901 0.0 0
M  V30 28 C 10.4949 2.3101 0.0 0
M  V30 29 C 11.8287 4.6201 0.0 0
M  V30 30 C 11.8287 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 15
M  V30 2 1 2 16
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 21
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 7 10
M  V30 10 1 7 26
M  V30 11 1 8 11
M  V30 12 1 12 29
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 2 17 20
M  V30 21 2 18 21
M  V30 22 1 19 21
M  V30 23 1 19 22
M  V30 24 1 20 25
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Cyclopropyl-2-[3-(ethylsulfonyl)-6-(methylamino)-2-pyridinyl]-3,5-dihydro-3...
C19H20F3N5O3S
2098440-04-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 9.9090 0.0 0
M  V30 2 C 8.8109 7.9520 0.0 0
M  V30 3 C 1.5400 7.2417 0.0 0
M  V30 4 F 1.5400 5.7017 0.0 0
M  V30 5 F 0.0000 7.2417 0.0 0
M  V30 6 F 1.5400 8.7818 0.0 0
M  V30 7 S 7.8274 2.3100 0.0 0 VAL=6
M  V30 8 C 6.4936 1.5400 0.0 0
M  V30 9 O 7.0574 3.6437 0.0 0
M  V30 10 O 8.5974 0.9762 0.0 0
M  V30 11 C 6.4936 0.0000 0.0 0
M  V30 12 N 13.1622 5.3900 0.0 0
M  V30 13 C 14.4958 4.6200 0.0 0
M  V30 14 C 6.1600 7.2417 0.0 0
M  V30 15 C 5.3900 5.9081 0.0 0
M  V30 16 C 5.3900 8.5754 0.0 0
M  V30 17 N 7.6663 6.9216 0.0 0
M  V30 18 N 6.4205 4.7636 0.0 0
M  V30 19 C 3.8500 5.9081 0.0 0
M  V30 20 N 3.8500 8.5754 0.0 0
M  V30 21 C 7.8274 5.3900 0.0 0
M  V30 22 C 3.0800 7.2417 0.0 0
M  V30 23 C 3.0800 9.9090 0.0 0
M  V30 24 C 1.7464 10.6791 0.0 0
M  V30 25 C 3.0800 11.4491 0.0 0
M  V30 26 C 9.1611 4.6200 0.0 0
M  V30 27 C 9.1611 3.0800 0.0 0
M  V30 28 N 10.4947 5.3900 0.0 0
M  V30 29 C 10.4947 2.3100 0.0 0
M  V30 30 C 11.8285 4.6200 0.0 0
M  V30 31 C 11.8285 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 16
M  V30 2 1 2 17
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 22
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 7 10
M  V30 10 1 7 27
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 1 12 30
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 2 18 21
M  V30 22 2 19 22
M  V30 23 1 20 22
M  V30 24 1 20 23
M  V30 25 1 21 26
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2059118-34-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2098440-04-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-18696638
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pesticidally active heterocyclic derivatives with sulphur
containing substituents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jung, Pierre Joseph Marcel; Edmunds, Andrew; Muehlebach, Michel;
Jeanguenat, Andre; Emery, Daniel; Hall, Roger Graham; Sikervar, Vikas;
Pabba, Jagadish
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017084879 A1 2017-05-26

$RFMT $RIREG SCHEME231 STEP1
$RXN



  3  1
$MOL
Triphosgene
C3Cl6O3
32315-10-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 0.5637 0.0 0
M  V30 2 C 6.6687 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 Cl 8.0023 2.1037 0.0 0
M  V30 5 Cl 5.8986 2.6673 0.0 0
M  V30 6 Cl 7.4387 0.0000 0.0 0
M  V30 7 O 2.6675 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 1.3337 1.3337 0.0 0
M  V30 10 Cl 0.0000 2.1037 0.0 0
M  V30 11 Cl 2.1037 2.6673 0.0 0
M  V30 12 Cl 0.5637 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 6-amino-3-iodo-2-methylbenzoate
C9H10INO2
2092532-60-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 C 8.0021 3.0800 0.0 0
M  V30 5 C 2.6674 4.6200 0.0 0
M  V30 6 N 5.3347 0.0000 0.0 0
M  V30 7 I 0.0000 3.0800 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 2.6674 3.0800 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 1.3336 2.3100 0.0 0
M  V30 12 C 2.6674 0.0000 0.0 0
M  V30 13 C 1.3336 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 10
M  V30 7 1 7 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Iodo-3,5-dimethyl-2,4(1H,3H)-quinazolinedione
C10H9IN2O2
2413894-90-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.8500 0.0000 0.0 0
M  V30 2 C 1.5400 1.3338 0.0 0
M  V30 3 O 8.4700 2.6674 0.0 0
M  V30 4 C 6.9300 0.0000 0.0 0
M  V30 5 I 0.0000 4.0011 0.0 0
M  V30 6 C 4.6200 4.0011 0.0 0
M  V30 7 C 3.8500 2.6674 0.0 0
M  V30 8 N 6.1600 4.0011 0.0 0
M  V30 9 C 3.8500 5.3349 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 6.9300 2.6674 0.0 0
M  V30 13 C 2.3100 5.3349 0.0 0
M  V30 14 N 6.1600 1.3338 0.0 0
M  V30 15 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 11
M  V30 3 2 3 12
M  V30 4 1 4 14
M  V30 5 1 5 15
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 32315-10-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2092532-60-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2413894-90-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31461455
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-Guided Discovery of Silicon-Containing Subnanomolar Inhibitor
of Hydroxyphenylpyruvate Dioxygenase as a Potential Herbicide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Qu, Ren-Yu; Nan, Jia-Xu; Yan, Yao-Chao; Chen, Qiong; Ndikuryayo,
Ferdinand; Wei, Xue-Fang; Yang, Wen-Chao; Lin, Hong-Yan; Yang, Guang-Fu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Agricultural and Food Chemistry (2021), 69(1), 459-473

$RFMT $RIREG SCHEME232 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1-Isocyanato-1-methylethyl)-3-(1-methylethenyl)benzene
C13H15NO
2094-99-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 3.0801 0.0 0
M  V30 2 N 7.4387 1.7464 0.0 0
M  V30 3 C 8.0023 3.8501 0.0 0
M  V30 4 C 5.8986 4.4137 0.0 0
M  V30 5 C 8.9787 1.7464 0.0 0
M  V30 6 O 10.5187 1.7464 0.0 0
M  V30 7 C 1.3338 3.0801 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 9 C 1.3338 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0012 3.0801 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 4.0012 0.0000 0.0 0
M  V30 15 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 10
M  V30 5 2 2 5
M  V30 6 2 5 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 13
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-N′-[1-methyl-1-[3-(1-methylethenyl)phenyl]ethyl]urea
C14H20N2O
393057-65-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 1.5400 0.0 0
M  V30 2 N 7.4387 2.8737 0.0 0
M  V30 3 C 8.0023 0.7700 0.0 0
M  V30 4 C 5.8986 0.2064 0.0 0
M  V30 5 C 8.9787 2.8737 0.0 0
M  V30 6 N 9.7487 4.2075 0.0 0
M  V30 7 O 9.7487 1.5400 0.0 0
M  V30 8 C 11.2888 4.2075 0.0 0
M  V30 9 C 1.3338 1.5400 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 1.3338 0.0000 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 4.0012 1.5400 0.0 0
M  V30 14 C 5.3348 3.8501 0.0 0
M  V30 15 C 2.6675 2.3101 0.0 0
M  V30 16 C 4.0012 4.6201 0.0 0
M  V30 17 C 2.6675 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 12
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 15
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2094-99-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 393057-65-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-2801240
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Key parameters for carbamate stability in dilute aqueous-organic solution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vandenabeele-Trambouze, O.; Garrelly, L.; Mion, L.; Boiteau, L.;
Commeyras, A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advances in Environmental Research (2001), 6(1), 67-80

$RFMT $RIREG SCHEME233 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3S)-3-[[(1,1-Dimethylethoxy)carbonyl]amino]-2,3,4,5-tetrahydro-5-methyl-4-ox...
C16H20N2O6
2095517-13-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.4662 0.0000 0.0 0
M  V30 2 C 13.3286 4.7716 0.0 0
M  V30 3 O 13.3286 6.3117 0.0 0
M  V30 4 O 14.6623 4.0016 0.0 0
M  V30 5 O 5.6618 0.6400 0.0 0
M  V30 6 N 4.4137 3.2316 0.0 0
M  V30 7 C 3.6437 4.5653 0.0 0
M  V30 8 O 2.1037 4.5653 0.0 0
M  V30 9 O 4.4137 5.8989 0.0 0
M  V30 10 C 1.3337 5.8989 0.0 0
M  V30 11 C 2.6675 6.6689 0.0 0
M  V30 12 C 0.5636 7.2326 0.0 0
M  V30 13 C 0.0000 5.1289 0.0 0
M  V30 14 C 9.3275 4.0016 0.0 0
M  V30 15 C 9.3275 2.4616 0.0 0
M  V30 16 C 10.6612 4.7716 0.0 0
M  V30 17 O 8.1235 4.9618 0.0 0
M  V30 18 N 8.1235 1.5014 0.0 0
M  V30 19 C 10.6612 1.6916 0.0 0
M  V30 20 C 11.9948 4.0016 0.0 0
M  V30 21 C 6.6220 4.6190 0.0 0
M  V30 22 C 6.6220 1.8440 0.0 0
M  V30 23 C 11.9948 2.4616 0.0 0
M  V30 24 C 5.9537 3.2316 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 20
M  V30 5 2 5 22
M  V30 6 1 6 7
M  V30 7 1 24 6 CFG=1
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 2 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 2 20 23
M  V30 24 1 21 24
M  V30 25 1 22 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(3S)-2,3,4,5-tetrahydro-5-methyl-8-[(methylamino)carbony...
C17H23N3O5
2095517-14-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.4662 0.0000 0.0 0
M  V30 2 O 5.6618 0.6400 0.0 0
M  V30 3 C 13.3285 4.7716 0.0 0
M  V30 4 N 14.6623 4.0016 0.0 0
M  V30 5 O 13.3285 6.3117 0.0 0
M  V30 6 C 15.9960 4.7716 0.0 0
M  V30 7 N 4.4137 3.2316 0.0 0
M  V30 8 C 3.6437 4.5653 0.0 0
M  V30 9 O 2.1037 4.5653 0.0 0
M  V30 10 O 4.4137 5.8989 0.0 0
M  V30 11 C 1.3337 5.8989 0.0 0
M  V30 12 C 2.6675 6.6689 0.0 0
M  V30 13 C 0.5637 7.2326 0.0 0
M  V30 14 C 0.0000 5.1289 0.0 0
M  V30 15 C 9.3275 2.4616 0.0 0
M  V30 16 C 9.3275 4.0016 0.0 0
M  V30 17 N 8.1234 1.5014 0.0 0
M  V30 18 C 10.6612 1.6916 0.0 0
M  V30 19 C 10.6612 4.7716 0.0 0
M  V30 20 O 8.1234 4.9618 0.0 0
M  V30 21 C 6.6220 1.8440 0.0 0
M  V30 22 C 11.9948 2.4616 0.0 0
M  V30 23 C 11.9948 4.0016 0.0 0
M  V30 24 C 6.6220 4.6190 0.0 0
M  V30 25 C 5.9538 3.2316 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 2 2 21
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 23
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 25 7 CFG=1
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 2 15 18
M  V30 18 2 16 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 2 22 23
M  V30 26 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2095517-13-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2095517-14-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-18867433
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of 7-Oxo-2,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridine
Derivatives as Potent, Orally Available, and Brain-Penetrating Receptor
Interacting Protein 1 (RIP1) Kinase Inhibitors: Analysis of
Structure-Kinetic Relationships
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yoshikawa, Masato; Saitoh, Morihisa; Katoh, Taisuke; Seki, Tomohiro;
Bigi, Simone V.; Shimizu, Yuji; Ishii, Tsuyoshi; Okai, Takuro; Kuno,
Masako; Hattori, Harumi; Watanabe, Etsuro; Saikatendu, Kumar S.; Zou,
Hua; Nakakariya, Masanori; Tatamiya, Takayuki; Nakada, Yoshihisa; Yogo,
Takatoshi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2018), 61(6), 2384-2409

$RFMT $RIREG SCHEME234 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6-[2-(3-fluorophenyl)-1-pyrrolidinyl]imidazo[1,2-b]pyridazine-3-carboxy...
C19H19FN4O2
2098813-41-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.1640 2.9992 0.0 0
M  V30 2 O 13.6957 3.1602 0.0 0
M  V30 3 O 11.5377 1.5924 0.0 0
M  V30 4 C 14.6009 1.9142 0.0 0
M  V30 5 C 16.1324 2.0753 0.0 0
M  V30 6 F 0.0000 5.1046 0.0 0
M  V30 7 N 9.7189 4.2450 0.0 0
M  V30 8 C 9.2429 5.7097 0.0 0
M  V30 9 C 11.2589 4.2450 0.0 0
M  V30 10 N 8.6884 3.1006 0.0 0
M  V30 11 C 7.7367 6.0299 0.0 0
M  V30 12 N 10.4889 6.6149 0.0 0
M  V30 13 C 11.7348 5.7097 0.0 0
M  V30 14 C 7.1821 3.4208 0.0 0
M  V30 15 C 6.7062 4.8855 0.0 0
M  V30 16 N 6.1515 2.2764 0.0 0
M  V30 17 C 4.6200 2.4374 0.0 0
M  V30 18 C 6.4719 0.7700 0.0 0
M  V30 19 C 3.9937 1.0304 0.0 0
M  V30 20 C 5.1381 0.0000 0.0 0
M  V30 21 C 3.8500 3.7710 0.0 0
M  V30 22 C 2.3100 3.7710 0.0 0
M  V30 23 C 4.6200 5.1046 0.0 0
M  V30 24 C 1.5400 5.1046 0.0 0
M  V30 25 C 3.8500 6.4384 0.0 0
M  V30 26 C 2.3100 6.4384 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 24
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 13
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 17 21
M  V30 22 1 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[2-(3-Fluorophenyl)-1-pyrrolidinyl]-N-methylimidazo[1,2-b]pyridazine-3-carb...
C18H18FN5O
2408759-20-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.1640 2.9992 0.0 0
M  V30 2 N 13.6956 3.1602 0.0 0
M  V30 3 O 11.5377 1.5924 0.0 0
M  V30 4 C 14.6008 1.9142 0.0 0
M  V30 5 F 0.0000 5.1047 0.0 0
M  V30 6 N 9.7188 4.2450 0.0 0
M  V30 7 C 9.2429 5.7097 0.0 0
M  V30 8 C 11.2588 4.2450 0.0 0
M  V30 9 N 8.6884 3.1006 0.0 0
M  V30 10 C 7.7367 6.0299 0.0 0
M  V30 11 N 10.4888 6.6149 0.0 0
M  V30 12 C 11.7347 5.7097 0.0 0
M  V30 13 C 7.1820 3.4208 0.0 0
M  V30 14 C 6.7061 4.8855 0.0 0
M  V30 15 N 6.1515 2.2764 0.0 0
M  V30 16 C 4.6200 2.4374 0.0 0
M  V30 17 C 6.4717 0.7700 0.0 0
M  V30 18 C 3.9937 1.0304 0.0 0
M  V30 19 C 5.1381 0.0000 0.0 0
M  V30 20 C 3.8500 3.7710 0.0 0
M  V30 21 C 2.3100 3.7710 0.0 0
M  V30 22 C 4.6200 5.1047 0.0 0
M  V30 23 C 1.5400 5.1047 0.0 0
M  V30 24 C 3.8500 6.4384 0.0 0
M  V30 25 C 2.3100 6.4384 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 23
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 12
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 16 20
M  V30 21 1 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2098813-41-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2408759-20-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-21699133
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of subnanomolar radiofluorinated
(2-pyrrolidin-1-yl)imidazo[1,2-b]pyridazine pan-Trk inhibitors as
candidate PET imaging probes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bernard-Gauthier, Vadim; Bailey, Justin J.; Aliaga, Arturo; Kostikov,
Alexey; Rosa-Neto, Pedro; Wuest, Melinda; Brodeur, Garrett M.; Bedell,
Barry J.; Wuest, Frank; Schirrmacher, Ralf
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM MedChemComm (2015), 6(12), 2184-2193

$RFMT $RIREG SCHEME235 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(4aR,5R)-9-Bromo-1,2,4,4a,5,6-hexahydro[1,4]oxazino[4,3-a]quinoline-5-car...
C13H14BrNO3
2101717-41-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 Br 9.3358 4.6200 0.0 0
M  V30 5 N 4.0011 4.6200 0.0 0
M  V30 6 C 5.3347 3.8500 0.0 0
M  V30 7 C 2.6674 3.8500 0.0 0 CFG=1
M  V30 8 C 4.0011 6.1600 0.0 0
M  V30 9 C 5.3347 2.3100 0.0 0
M  V30 10 C 6.6684 4.6200 0.0 0
M  V30 11 C 2.6674 2.3100 0.0 0 CFG=2
M  V30 12 C 1.3336 4.6200 0.0 0
M  V30 13 C 2.6674 6.9300 0.0 0
M  V30 14 C 4.0011 1.5400 0.0 0
M  V30 15 C 6.6684 1.5400 0.0 0
M  V30 16 C 8.0021 3.8500 0.0 0
M  V30 17 O 1.3336 6.1600 0.0 0
M  V30 18 C 8.0021 2.3100 0.0 0
M  V30 19 H 1.3336 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 11 1 CFG=1
M  V30 4 1 4 16
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 1 7 19 CFG=1
M  V30 13 1 8 13
M  V30 14 1 9 14
M  V30 15 2 9 15
M  V30 16 1 10 16
M  V30 17 1 11 14
M  V30 18 1 12 17
M  V30 19 1 13 17
M  V30 20 1 15 18
M  V30 21 2 16 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 7 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(4aR,5S)-9-Bromo-1,2,4,4a,5,6-hexahydro[1,4]oxazino[4,3-a]quinoline-5-car...
C13H14BrNO3
2101717-42-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 Br 9.3358 4.6200 0.0 0
M  V30 5 N 4.0011 4.6200 0.0 0
M  V30 6 C 5.3347 3.8500 0.0 0
M  V30 7 C 2.6674 3.8500 0.0 0 CFG=1
M  V30 8 C 4.0011 6.1600 0.0 0
M  V30 9 C 5.3347 2.3100 0.0 0
M  V30 10 C 6.6684 4.6200 0.0 0
M  V30 11 C 2.6674 2.3100 0.0 0 CFG=1
M  V30 12 C 1.3336 4.6200 0.0 0
M  V30 13 C 2.6674 6.9300 0.0 0
M  V30 14 C 4.0011 1.5400 0.0 0
M  V30 15 C 6.6684 1.5400 0.0 0
M  V30 16 C 8.0021 3.8500 0.0 0
M  V30 17 O 1.3336 6.1600 0.0 0
M  V30 18 C 8.0021 2.3100 0.0 0
M  V30 19 H 1.3336 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 11 1 CFG=3
M  V30 4 1 4 16
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 1 7 19 CFG=1
M  V30 13 1 8 13
M  V30 14 1 9 14
M  V30 15 2 9 15
M  V30 16 1 10 16
M  V30 17 1 11 14
M  V30 18 1 12 17
M  V30 19 1 13 17
M  V30 20 1 15 18
M  V30 21 2 16 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 7 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
9-Bromo-1,2,4,4a,5,6-hexahydro-N-methyl[1,4]oxazino[4,3-a]quinoline-5-carboxa...
C14H17BrN2O2
2101717-43-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.4700 4.0011 0.0 0
M  V30 2 N 9.2400 5.3347 0.0 0
M  V30 3 O 9.2400 2.6674 0.0 0
M  V30 4 C 10.7800 5.3347 0.0 0
M  V30 5 Br 0.0000 5.3347 0.0 0
M  V30 6 N 4.6200 2.6674 0.0 0
M  V30 7 C 3.8500 4.0011 0.0 0
M  V30 8 C 6.1600 2.6674 0.0 0
M  V30 9 C 3.8500 1.3338 0.0 0
M  V30 10 C 4.6200 5.3347 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 6.9300 4.0011 0.0 0
M  V30 13 C 6.9300 1.3338 0.0 0
M  V30 14 C 4.6200 0.0000 0.0 0
M  V30 15 C 6.1600 5.3347 0.0 0
M  V30 16 C 3.8500 6.6685 0.0 0
M  V30 17 C 1.5400 5.3347 0.0 0
M  V30 18 O 6.1600 0.0000 0.0 0
M  V30 19 C 2.3100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 17
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 1 10 15
M  V30 15 2 10 16
M  V30 16 1 11 17
M  V30 17 1 12 15
M  V30 18 1 13 18
M  V30 19 1 14 18
M  V30 20 1 16 19
M  V30 21 2 17 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2101717-41-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2101717-42-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2101717-43-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-21391216
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 39968-33-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tricyclic compounds as kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aversa, Robert John; Burger, Matthew T.; Dillon, Michael Patrick; Dineen,
Thomas A., Jr.; Karki, Rajesh; Ramurthy, Savithri; Rauniyar, Vivek;
Robinson, Richard; Sarver, Patrick James
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017103824 A1 2017-06-22

$RFMT $RIREG SCHEME236 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-(3-amino-6-bromo-5-methyl-2-pyrazinyl)-1-methyl-1H-1,2,4-triazole-3-c...
C11H13BrN6O2
2101740-38-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5894 0.0000 0.0 0
M  V30 2 N 4.6200 5.3779 0.0 0
M  V30 3 C 9.7758 4.3858 0.0 0
M  V30 4 O 11.1826 3.7593 0.0 0
M  V30 5 O 9.6147 5.9173 0.0 0
M  V30 6 C 12.4285 4.6645 0.0 0
M  V30 7 C 13.8354 4.0382 0.0 0
M  V30 8 Br 1.5400 0.0431 0.0 0
M  V30 9 C 0.0000 2.7106 0.0 0
M  V30 10 C 6.1600 2.7106 0.0 0
M  V30 11 N 7.0652 3.9564 0.0 0
M  V30 12 N 7.0652 1.4647 0.0 0
M  V30 13 C 8.5299 3.4806 0.0 0
M  V30 14 N 8.5299 1.9406 0.0 0
M  V30 15 C 4.6200 2.7106 0.0 0
M  V30 16 C 3.8500 4.0442 0.0 0
M  V30 17 N 3.8500 1.3769 0.0 0
M  V30 18 N 2.3100 4.0442 0.0 0
M  V30 19 C 2.3100 1.3769 0.0 0
M  V30 20 C 1.5400 2.7106 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 16
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 19
M  V30 9 1 9 20
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 15
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(3-Amino-6-bromo-5-methyl-2-pyrazinyl)-N,1-dimethyl-1H-1,2,4-triazole-3-car...
C10H12BrN7O
2101744-23-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5894 0.0000 0.0 0
M  V30 2 N 4.6200 5.3779 0.0 0
M  V30 3 C 9.7757 4.3858 0.0 0
M  V30 4 N 11.1826 3.7593 0.0 0
M  V30 5 O 9.6147 5.9173 0.0 0
M  V30 6 C 12.4285 4.6645 0.0 0
M  V30 7 Br 1.5400 0.0431 0.0 0
M  V30 8 C 0.0000 2.7106 0.0 0
M  V30 9 C 6.1600 2.7106 0.0 0
M  V30 10 N 7.0652 3.9564 0.0 0
M  V30 11 N 7.0652 1.4647 0.0 0
M  V30 12 C 8.5298 3.4806 0.0 0
M  V30 13 N 8.5298 1.9406 0.0 0
M  V30 14 C 4.6200 2.7106 0.0 0
M  V30 15 C 3.8500 4.0442 0.0 0
M  V30 16 N 3.8500 1.3769 0.0 0
M  V30 17 N 2.3100 4.0442 0.0 0
M  V30 18 C 2.3100 1.3769 0.0 0
M  V30 19 C 1.5400 2.7106 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 15
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 1 4 6
M  V30 7 1 7 18
M  V30 8 1 8 19
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 14
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2101740-38-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2101744-23-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-17623955
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a novel aminopyrazine series as selective PI3Kα inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barlaam, Bernard; Cosulich, Sabina; Fitzek, Martina; Germain, Herve;
Green, Stephen; Hanson, Lyndsey L.; Harris, Craig S.; Hancox, Urs;
Hudson, Kevin; Lambert-van der Brempt, Christine; Lamorlette, Maryannick;
Magnien, Francoise; Ouvry, Gilles; Page, Ken; Ruston, Linette; Ward,
Lara; Delouvrie, Benedicte
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2017), 27(13), 3030-3035

$RFMT $RIREG SCHEME237 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3,4-Trimethoxybenzaldehyde
C10H12O4
2103-57-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 4.6201 0.0 0
M  V30 2 C 0.0000 3.8500 0.0 0
M  V30 3 O 4.0011 6.1601 0.0 0
M  V30 4 C 5.3348 6.9301 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 7 O 6.6686 4.6201 0.0 0
M  V30 8 C 8.0022 3.8500 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 2.6675 2.3100 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 5.3348 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 11
M  V30 7 1 7 8
M  V30 8 1 7 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3,4-Trimethoxy-N-methylbenzenemethanamine
C11H17NO3
709649-63-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 6.1601 0.0 0
M  V30 2 C 2.6675 6.9302 0.0 0
M  V30 3 O 1.3337 4.6201 0.0 0
M  V30 4 C 0.0000 3.8501 0.0 0
M  V30 5 C 6.6685 4.6201 0.0 0
M  V30 6 N 8.0023 3.8501 0.0 0
M  V30 7 C 9.3360 4.6201 0.0 0
M  V30 8 O 1.3337 1.5400 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 5.3348 2.3101 0.0 0
M  V30 15 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 1 3 11
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 13
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2103-57-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-63-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-11899245
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation 67 Preparation of
Methyl-(1-propyl-naphthalen-2-ylmethyl)amine Preparation 97 Preparation
of (2,3,4-Trimethoxy-benzyl)methylamine [0852] According to the procedure
of Preparation 67, except substituting 2,3,4-trimethoxy-benzaldehyde for
1-propyl-naphthalene-2-carbaldehyde, the title compound (2.17 g,
quantitative) was prepared as light yellow oil. 1H NMR (300 MHz, DMSO-d6)
δ 7.99 (d, J=8.5 Hz 1H), 6.74 (d, J=8.5 Hz, 1H), 3.76 (s, 6H), 3.72 (s,
3H), 2.53 (s, 2H), 2.25 (s, 3H), 1.92 (br s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME237 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3,4-Trimethoxybenzaldehyde
C10H12O4
2103-57-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 4.6201 0.0 0
M  V30 2 C 0.0000 3.8500 0.0 0
M  V30 3 O 4.0011 6.1601 0.0 0
M  V30 4 C 5.3348 6.9301 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 7 O 6.6686 4.6201 0.0 0
M  V30 8 C 8.0022 3.8500 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 2.6675 2.3100 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 5.3348 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 11
M  V30 7 1 7 8
M  V30 8 1 7 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3,4-Trimethoxy-N-methylbenzenemethanamine
C11H17NO3
709649-63-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 6.1601 0.0 0
M  V30 2 C 2.6675 6.9302 0.0 0
M  V30 3 O 1.3337 4.6201 0.0 0
M  V30 4 C 0.0000 3.8501 0.0 0
M  V30 5 C 6.6685 4.6201 0.0 0
M  V30 6 N 8.0023 3.8501 0.0 0
M  V30 7 C 9.3360 4.6201 0.0 0
M  V30 8 O 1.3337 1.5400 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 5.3348 2.3101 0.0 0
M  V30 15 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 1 3 11
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 13
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2103-57-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-63-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-3493407
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME237 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3,4-Trimethoxybenzaldehyde
C10H12O4
2103-57-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 4.6201 0.0 0
M  V30 2 C 0.0000 3.8500 0.0 0
M  V30 3 O 4.0011 6.1601 0.0 0
M  V30 4 C 5.3348 6.9301 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 7 O 6.6686 4.6201 0.0 0
M  V30 8 C 8.0022 3.8500 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 2.6675 2.3100 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 5.3348 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 11
M  V30 7 1 7 8
M  V30 8 1 7 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3,4-Trimethoxy-N-methylbenzenemethanamine
C11H17NO3
709649-63-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 6.1601 0.0 0
M  V30 2 C 2.6675 6.9302 0.0 0
M  V30 3 O 1.3337 4.6201 0.0 0
M  V30 4 C 0.0000 3.8501 0.0 0
M  V30 5 C 6.6685 4.6201 0.0 0
M  V30 6 N 8.0023 3.8501 0.0 0
M  V30 7 C 9.3360 4.6201 0.0 0
M  V30 8 O 1.3337 1.5400 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 5.3348 2.3101 0.0 0
M  V30 15 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 1 3 11
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 13
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2103-57-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-63-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-8029751
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation of
Methyl-(1-propyl-naphthalen-2-ylmethyl)amine A solution of 2.0 M
methylamine in methanol (20 mL) was added to
1-propylnaphthalene-2-carbaldehyde (0.983 g, 4.95 mmol) under N2 and
allowed to stir for 18 h. The solution was concentrated under reduced
pressure. Then the resulting dark yellow oil was solvated in EtOH (20 mL)
under N2. To the solution was added NaBH4 (0.187 g, 4.95 mmol) and the
mixture allowed to stir for 6.5 h. The reaction was concentrated under
reduced pressure, then solvated in 1 N NaOH (20 mL) and extracted with
Et2O (3 x 50 mL). The organics were combined, washed with brine (2 x 100
mL), dried over Na2SO4, filtered and concentrated to yield the title
compound as a yellow oil. Preparation of
(2,3,4-Trimethoxy-benzyl)methylamine According to the procedure of
Preparation 1, except substituting 2,3,4-trimethoxybenzaldehyde for
1-propyl-naphthalene-2-carbaldehyde, the title compound (2.17 g,
quantitative) was prepared as light yellow oil. 1H NMR (300 MHz, DMSO-d6)
δ 7.99 (d, J = 8.5 Hz 1H), 6.74 (d, J = 8.5 Hz, 1H), 3.76 (s, 6H), 3.72
(s, 3H), 2.53 (s, 2H), 2.25 (s, 3H), 1.92 (brs, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds as antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd; Sampson, Peter; Pauls, Heinz W.; Ramnauth, Jailall;
Manning, David Douglas; Surman, Matthew David; Xie, Dejian; Decornez,
Helene Yvonne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004052890 A1 2004-06-24

$RFMT $RIREG SCHEME238 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(3,4-Dimethoxyphenyl)propionic acid
C11H14O4
2107-70-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3101 1.3338 0.0 0
M  V30 2 C 3.0801 0.0000 0.0 0
M  V30 3 O 0.7700 4.0012 0.0 0
M  V30 4 C 0.0000 5.3348 0.0 0
M  V30 5 C 6.9302 4.0012 0.0 0
M  V30 6 C 7.7002 5.3348 0.0 0
M  V30 7 C 9.2402 5.3348 0.0 0
M  V30 8 O 10.0102 4.0012 0.0 0
M  V30 9 O 10.0102 6.6687 0.0 0
M  V30 10 C 3.0801 2.6675 0.0 0
M  V30 11 C 2.3101 4.0012 0.0 0
M  V30 12 C 4.6201 2.6675 0.0 0
M  V30 13 C 3.0801 5.3348 0.0 0
M  V30 14 C 5.3901 4.0012 0.0 0
M  V30 15 C 4.6201 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 1 3 11
M  V30 5 1 5 6
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3,4-dimethoxydihydrocinnamate
C12H16O4
27798-73-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3348 0.0 0
M  V30 5 C 6.9301 4.0011 0.0 0
M  V30 6 C 7.7001 5.3348 0.0 0
M  V30 7 C 9.2401 5.3348 0.0 0
M  V30 8 O 10.0101 6.6686 0.0 0
M  V30 9 O 10.0101 4.0011 0.0 0
M  V30 10 C 11.5501 6.6686 0.0 0
M  V30 11 C 3.0800 2.6675 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 4.6201 2.6675 0.0 0
M  V30 14 C 3.0800 5.3348 0.0 0
M  V30 15 C 5.3901 4.0011 0.0 0
M  V30 16 C 4.6201 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2107-70-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 27798-73-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29897123
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 32589-78-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mild Esterification of Carboxylic Acids via Continuous Flow Diazotization
of Amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Audubert, Clement; Lebel, Helene
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2017), 19(16), 4407-4410

$RFMT $RIREG SCHEME239 STEP1
$RXN



  2  1
$MOL
Methan-d3-amine
CH2D3N
5581-55-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.3337 0.0 0
M  V30 2 N 0.7700 0.0000 0.0 0
M  V30 3 H 0.0000 1.3337 0.0 0 MASS=2
M  V30 4 H 0.7700 2.6673 0.0 0 MASS=2
M  V30 5 H 3.0800 1.3337 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(S)-Methyl mandelate
C9H10O3
21210-43-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0 CFG=2
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 O 6.6685 1.5400 0.0 0
M  V30 5 O 5.3347 3.8500 0.0 0
M  V30 6 C 8.0021 2.3100 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αS)-α-Hydroxy-N-(methyl-d3)benzeneacetamide
C9H8D3NO2
1162658-04-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0 CFG=2
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 N 6.6684 1.5400 0.0 0
M  V30 5 O 5.3347 3.8500 0.0 0
M  V30 6 C 8.0021 2.3100 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 13 H 9.3358 1.5400 0.0 0 MASS=2
M  V30 14 H 9.3358 3.0800 0.0 0 MASS=2
M  V30 15 H 8.0021 3.8500 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 6 13
M  V30 8 1 6 14
M  V30 9 1 6 15
M  V30 10 2 7 8
M  V30 11 1 7 9
M  V30 12 1 8 10
M  V30 13 2 9 11
M  V30 14 2 10 12
M  V30 15 1 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5581-55-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 21210-43-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1162658-04-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13197116
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of (S)-2-Hydroxy-N-(methyl-d3)-2-phenylacetamide (34). A
solution of methyl (5)-(+)-mandelate 33 (5.00 g, 30.12 mmol, 1.0 eq) in
methanol (100 mL) was cooled to approximately -9 °C in an ice/salt bath
and methylamine-d3 (5.0 g, 147 mmol, 4.9 eq) (CDN Isotopes, 99.6 atom% D)
was condensed into the solution using a dry-ice condenser. The reaction
mixture was allowed to warm to room temperature (rt) and stirred over a
weekend. The solution was concentrated under reduced pressure to a volume
of approximately 25 mL. The mixture was diluted with toluene (75 mL) and
concentrated under reduced pressure to give a white crystalline solid.
The solid was dried under vacuum at rt to give 5.13 g (101%) of 34 as a
white solid.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tetrahydroisoquinoline derivatives as orexin receptor
antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Julie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009079637 A1 2009-06-25

$RFMT $RIREG SCHEME240 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1S,2S,3S,5S)-2-[[5-fluoro-2-[5-fluoro-1-(tetrahydro-2H-pyran-2-yl)-1H...
C23H24F2N6O3
2125499-09-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 9.8046 7.7862 0.0 0
M  V30 2 C 12.8654 6.4234 0.0 0
M  V30 3 O 14.1990 5.6534 0.0 0
M  V30 4 O 12.8654 7.9635 0.0 0
M  V30 5 C 15.5327 6.4234 0.0 0
M  V30 6 F 9.1642 10.7990 0.0 0
M  V30 7 F 0.0000 9.6647 0.0 0
M  V30 8 C 9.0943 5.1354 0.0 0 CFG=1
M  V30 9 C 10.1247 6.2799 0.0 0 CFG=2
M  V30 10 C 9.8643 3.8017 0.0 0 CFG=2
M  V30 11 C 8.3243 3.8017 0.0 0
M  V30 12 C 11.5317 5.6534 0.0 0 CFG=1
M  V30 13 C 11.3706 4.1219 0.0 0
M  V30 14 C 8.3400 8.2621 0.0 0
M  V30 15 N 7.1955 7.2316 0.0 0
M  V30 16 C 8.0197 9.7685 0.0 0
M  V30 17 C 5.7309 7.7075 0.0 0
M  V30 18 C 6.5551 10.2444 0.0 0
M  V30 19 N 5.4106 9.2140 0.0 0
M  V30 20 C 4.5863 6.6771 0.0 0
M  V30 21 C 3.0800 6.9973 0.0 0
M  V30 22 N 4.7473 5.1455 0.0 0
M  V30 23 C 2.3100 5.6636 0.0 0
M  V30 24 C 2.3100 8.3309 0.0 0
M  V30 25 N 3.3405 4.5190 0.0 0
M  V30 26 N 0.7700 5.6636 0.0 0
M  V30 27 C 0.7700 8.3309 0.0 0
M  V30 28 C 0.0000 6.9973 0.0 0
M  V30 29 C 3.0203 3.0127 0.0 0 CFG=3
M  V30 30 C 1.5556 2.5369 0.0 0
M  V30 31 O 4.1647 1.9823 0.0 0
M  V30 32 C 1.2354 1.0304 0.0 0
M  V30 33 C 3.8445 0.4759 0.0 0
M  V30 34 C 2.3800 0.0000 0.0 0
M  V30 35 H 7.8484 6.0406 0.0 0
M  V30 36 H 10.0253 2.2701 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 9 1 CFG=3
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 12 2 CFG=1
M  V30 6 1 3 5
M  V30 7 1 6 16
M  V30 8 1 7 27
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 35 CFG=1
M  V30 13 1 9 12
M  V30 14 1 10 11
M  V30 15 1 10 13
M  V30 16 1 10 36 CFG=1
M  V30 17 1 12 13
M  V30 18 2 14 15
M  V30 19 1 14 16
M  V30 20 1 15 17
M  V30 21 2 16 18
M  V30 22 2 17 19
M  V30 23 1 17 20
M  V30 24 1 18 19
M  V30 25 1 20 21
M  V30 26 2 20 22
M  V30 27 1 21 23
M  V30 28 2 21 24
M  V30 29 1 22 25
M  V30 30 1 23 25
M  V30 31 2 23 26
M  V30 32 1 24 27
M  V30 33 1 25 29
M  V30 34 1 26 28
M  V30 35 2 27 28
M  V30 36 1 29 30
M  V30 37 1 29 31
M  V30 38 1 30 32
M  V30 39 1 31 33
M  V30 40 1 32 34
M  V30 41 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 8 9 10 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1S,2S,3S,5S)-2-[[5-Fluoro-2-[5-fluoro-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazo...
C23H25F2N7O2
2125499-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 9.8046 7.7862 0.0 0
M  V30 2 C 12.8654 6.4234 0.0 0
M  V30 3 N 14.1990 5.6534 0.0 0
M  V30 4 O 12.8654 7.9635 0.0 0
M  V30 5 C 15.5327 6.4234 0.0 0
M  V30 6 F 9.1642 10.7990 0.0 0
M  V30 7 F 0.0000 9.6647 0.0 0
M  V30 8 C 9.0943 5.1354 0.0 0 CFG=1
M  V30 9 C 10.1247 6.2799 0.0 0 CFG=2
M  V30 10 C 9.8643 3.8017 0.0 0 CFG=2
M  V30 11 C 8.3243 3.8017 0.0 0
M  V30 12 C 11.5317 5.6534 0.0 0 CFG=1
M  V30 13 C 11.3706 4.1219 0.0 0
M  V30 14 C 8.3400 8.2621 0.0 0
M  V30 15 N 7.1955 7.2316 0.0 0
M  V30 16 C 8.0197 9.7685 0.0 0
M  V30 17 C 5.7309 7.7075 0.0 0
M  V30 18 C 6.5551 10.2444 0.0 0
M  V30 19 N 5.4106 9.2140 0.0 0
M  V30 20 C 4.5863 6.6771 0.0 0
M  V30 21 C 3.0800 6.9973 0.0 0
M  V30 22 N 4.7473 5.1455 0.0 0
M  V30 23 C 2.3100 5.6636 0.0 0
M  V30 24 C 2.3100 8.3309 0.0 0
M  V30 25 N 3.3405 4.5190 0.0 0
M  V30 26 N 0.7700 5.6636 0.0 0
M  V30 27 C 0.7700 8.3309 0.0 0
M  V30 28 C 0.0000 6.9973 0.0 0
M  V30 29 C 3.0203 3.0127 0.0 0 CFG=3
M  V30 30 C 1.5556 2.5369 0.0 0
M  V30 31 O 4.1647 1.9823 0.0 0
M  V30 32 C 1.2354 1.0304 0.0 0
M  V30 33 C 3.8445 0.4759 0.0 0
M  V30 34 C 2.3800 0.0000 0.0 0
M  V30 35 H 7.8484 6.0406 0.0 0
M  V30 36 H 10.0253 2.2701 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 9 1 CFG=3
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 12 2 CFG=1
M  V30 6 1 3 5
M  V30 7 1 6 16
M  V30 8 1 7 27
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 35 CFG=1
M  V30 13 1 9 12
M  V30 14 1 10 11
M  V30 15 1 10 13
M  V30 16 1 10 36 CFG=1
M  V30 17 1 12 13
M  V30 18 2 14 15
M  V30 19 1 14 16
M  V30 20 1 15 17
M  V30 21 2 16 18
M  V30 22 2 17 19
M  V30 23 1 17 20
M  V30 24 1 18 19
M  V30 25 1 20 21
M  V30 26 2 20 22
M  V30 27 1 21 23
M  V30 28 2 21 24
M  V30 29 1 22 25
M  V30 30 1 23 25
M  V30 31 2 23 26
M  V30 32 1 24 27
M  V30 33 1 25 29
M  V30 34 1 26 28
M  V30 35 2 27 28
M  V30 36 1 29 30
M  V30 37 1 29 31
M  V30 38 1 30 32
M  V30 39 1 31 33
M  V30 40 1 32 34
M  V30 41 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 8 9 10 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2125499-09-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2125499-15-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-18745442
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidine and pyridine derivatives useful in treatment,
amelioration or prevention of influenza
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tan, Xuefei; Shen, Hong; Wu, Jun; Liu, Yongfu; Li, Dongbo; Wang, Lisha;
Neidhart, Werner; Shi, Tianlai; Wu, Guolong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017133667 A1 2017-08-10

$RFMT $RIREG SCHEME241 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3,4,11a-Tetrahydro-2H-benzo[b]quinolizin-11(6H)-one
C13H15NO
21319-54-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 0.0000 0.0 0
M  V30 2 C 2.6674 3.8500 0.0 0
M  V30 3 C 2.6674 2.3100 0.0 0
M  V30 4 C 4.0011 4.6200 0.0 0
M  V30 5 C 1.3336 4.6200 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 1.3336 1.5400 0.0 0
M  V30 8 N 5.3347 3.8500 0.0 0
M  V30 9 C 0.0000 3.8500 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 6.6685 4.6200 0.0 0
M  V30 13 C 6.6685 1.5400 0.0 0
M  V30 14 C 8.0021 3.8500 0.0 0
M  V30 15 C 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 8 12
M  V30 13 2 9 11
M  V30 14 1 10 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(1,3,4,11a-Tetrahydro-2H-benzo[b]quinolizin-11(6H)-ylidene)methanamine
C14H18N2
247105-00-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 0.7700 0.0 0
M  V30 2 C 2.6675 0.0000 0.0 0
M  V30 3 C 2.6675 3.0800 0.0 0
M  V30 4 C 4.0011 2.3100 0.0 0
M  V30 5 C 2.6675 4.6201 0.0 0
M  V30 6 C 1.3337 2.3100 0.0 0
M  V30 7 C 5.3348 3.0800 0.0 0
M  V30 8 C 4.0011 5.3901 0.0 0
M  V30 9 C 1.3337 5.3901 0.0 0
M  V30 10 C 0.0000 3.0800 0.0 0
M  V30 11 N 5.3348 4.6201 0.0 0
M  V30 12 C 6.6686 2.3100 0.0 0
M  V30 13 C 0.0000 4.6201 0.0 0
M  V30 14 C 6.6686 5.3901 0.0 0
M  V30 15 C 8.0022 3.0800 0.0 0
M  V30 16 C 8.0022 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 4 CFG=2
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 1 8 11
M  V30 13 1 9 13
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 21319-54-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 247105-00-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-17658905
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7550-45-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzoquinolizidines and benzoindolizidines for treatment
of neurodegenerative states and diseases associated with memory
impairment
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Szmuszkovicz, Jacob; Regan, Ciaran M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000004905 A1 2000-02-03

$RFMT $RIREG SCHEME242 STEP1
$RXN



  2  1
$MOL

C26H37N5O8
2135821-70-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.0451 12.3769 0.0 0
M  V30 2 O 6.1895 13.4075 0.0 0
M  V30 3 N 12.3421 5.3348 0.0 0
M  V30 4 C 11.5720 4.0011 0.0 0
M  V30 5 C 13.8821 5.3348 0.0 0
M  V30 6 O 12.3421 2.6675 0.0 0
M  V30 7 O 10.0320 4.0011 0.0 0
M  V30 8 O 14.6521 6.6686 0.0 0
M  V30 9 O 14.6521 4.0011 0.0 0
M  V30 10 C 11.5720 1.3338 0.0 0
M  V30 11 C 16.1921 6.6686 0.0 0
M  V30 12 C 12.9057 0.5638 0.0 0
M  V30 13 C 10.8020 0.0000 0.0 0
M  V30 14 C 10.2384 2.1038 0.0 0
M  V30 15 C 16.1921 8.2086 0.0 0
M  V30 16 C 17.7321 6.6686 0.0 0
M  V30 17 C 16.1921 5.1286 0.0 0
M  V30 18 C 5.1047 8.3924 0.0 0 CFG=2
M  V30 19 C 6.6112 8.7125 0.0 0 CFG=2
M  V30 20 C 4.3347 9.7260 0.0 0 CFG=1
M  V30 21 O 4.0743 7.2480 0.0 0
M  V30 22 O 6.7721 10.2441 0.0 0
M  V30 23 O 2.8284 9.4059 0.0 0
M  V30 24 C 5.3653 10.8706 0.0 0 CFG=1
M  V30 25 C 2.6675 7.8743 0.0 0
M  V30 26 C 2.6675 6.3343 0.0 0
M  V30 27 C 1.3337 8.6443 0.0 0
M  V30 28 C 1.3337 5.5643 0.0 0
M  V30 29 C 0.0000 7.8743 0.0 0
M  V30 30 C 0.0000 6.3343 0.0 0
M  V30 31 N 7.7556 7.6821 0.0 0
M  V30 32 C 9.2620 8.0023 0.0 0
M  V30 33 C 7.5946 6.1505 0.0 0
M  V30 34 C 10.0320 6.6686 0.0 0
M  V30 35 N 10.0320 9.3359 0.0 0
M  V30 36 N 9.0016 5.5241 0.0 0
M  V30 37 C 11.5720 6.6686 0.0 0
M  V30 38 C 11.5720 9.3359 0.0 0
M  V30 39 N 12.3421 8.0023 0.0 0
M  V30 40 H 5.8747 7.0587 0.0 0
M  V30 41 H 3.5647 11.0598 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 24 1 CFG=1
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 37
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 11 16
M  V30 17 1 11 17
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 18 21
M  V30 21 1 18 40 CFG=1
M  V30 22 1 19 22
M  V30 23 1 19 31 CFG=1
M  V30 24 1 20 23
M  V30 25 1 20 24
M  V30 26 1 20 41 CFG=1
M  V30 27 1 21 25
M  V30 28 1 22 24
M  V30 29 1 23 25
M  V30 30 1 25 26
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 1 27 29
M  V30 34 1 28 30
M  V30 35 1 29 30
M  V30 36 1 31 32
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 2 32 35
M  V30 40 2 33 36
M  V30 41 1 34 36
M  V30 42 2 34 37
M  V30 43 1 35 38
M  V30 44 1 37 39
M  V30 45 2 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 18 19 20 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C17H24N6O3
2135821-74-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.0451 2.5369 0.0 0
M  V30 2 N 6.1895 1.5065 0.0 0
M  V30 3 C 5.8693 0.0000 0.0 0
M  V30 4 N 12.3421 9.5790 0.0 0
M  V30 5 C 5.1047 6.5214 0.0 0 CFG=2
M  V30 6 C 6.6112 6.2012 0.0 0 CFG=2
M  V30 7 C 4.3347 5.1877 0.0 0 CFG=1
M  V30 8 O 4.0743 7.6659 0.0 0
M  V30 9 O 6.7721 4.6697 0.0 0
M  V30 10 O 2.8284 5.5079 0.0 0
M  V30 11 C 5.3653 4.0432 0.0 0 CFG=1
M  V30 12 C 2.6675 7.0395 0.0 0
M  V30 13 C 2.6675 8.5795 0.0 0
M  V30 14 C 1.3337 6.2694 0.0 0
M  V30 15 C 1.3337 9.3495 0.0 0
M  V30 16 C 0.0000 7.0395 0.0 0
M  V30 17 C 0.0000 8.5795 0.0 0
M  V30 18 N 7.7556 7.2316 0.0 0
M  V30 19 C 9.2620 6.9115 0.0 0
M  V30 20 C 7.5946 8.7634 0.0 0
M  V30 21 C 10.0320 8.2453 0.0 0
M  V30 22 N 10.0320 5.5778 0.0 0
M  V30 23 N 9.0016 9.3897 0.0 0
M  V30 24 C 11.5721 8.2453 0.0 0
M  V30 25 C 11.5721 5.5778 0.0 0
M  V30 26 N 12.3421 6.9115 0.0 0
M  V30 27 H 5.8747 7.8550 0.0 0
M  V30 28 H 3.5647 3.8541 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 11 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 4 24
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 27 CFG=3
M  V30 9 1 6 9
M  V30 10 1 6 18 CFG=3
M  V30 11 1 7 10
M  V30 12 1 7 11
M  V30 13 1 7 28 CFG=3
M  V30 14 1 8 12
M  V30 15 1 9 11
M  V30 16 1 10 12
M  V30 17 1 12 13
M  V30 18 1 12 14
M  V30 19 1 13 15
M  V30 20 1 14 16
M  V30 21 1 15 17
M  V30 22 1 16 17
M  V30 23 1 18 19
M  V30 24 1 18 20
M  V30 25 1 19 21
M  V30 26 2 19 22
M  V30 27 2 20 23
M  V30 28 1 21 23
M  V30 29 2 21 24
M  V30 30 1 22 25
M  V30 31 1 24 26
M  V30 32 2 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 5 6 7 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2135821-70-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2135821-74-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-18008649
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 124-63-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used (stage 3)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and evaluation of analogs of
5'-(((Z)-4-amino-2-butenyl)methylamino)-5'-deoxyadenosine (MDL 73811, or
AbeAdo) - An inhibitor of S-adenosylmethionine decarboxylase with
antitrypanosomal activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Brockway, Anthony J.; Volkov, Oleg A.; Cosner, Casey C.; MacMillan, Karen
S.; Wring, Stephen A.; Richardson, Thomas E.; Peel, Michael; Phillips,
Margaret A.; De Brabander, Jef K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(20), 5433-5440

$RFMT $RIREG SCHEME243 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-bromo-2-hydroxy-3-[1-(3-methoxyphenyl)-2-propen-1-yl]benzoate
C18H17BrO4
2138475-06-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 4.6201 0.0 0
M  V30 2 C 8.0021 6.1601 0.0 0
M  V30 3 C 9.3357 6.9301 0.0 0
M  V30 4 O 5.3348 6.1601 0.0 0
M  V30 5 C 2.6673 4.6201 0.0 0
M  V30 6 O 1.3337 3.8500 0.0 0
M  V30 7 O 2.6673 6.1601 0.0 0
M  V30 8 C 0.0000 4.6201 0.0 0
M  V30 9 Br 5.3348 0.0000 0.0 0
M  V30 10 O 13.3369 4.6201 0.0 0
M  V30 11 C 14.6705 3.8500 0.0 0
M  V30 12 C 6.6684 3.8500 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 6.6684 2.3100 0.0 0
M  V30 15 C 4.0010 3.8500 0.0 0
M  V30 16 C 5.3348 1.5400 0.0 0
M  V30 17 C 4.0010 2.3100 0.0 0
M  V30 18 C 9.3357 3.8500 0.0 0
M  V30 19 C 10.6695 4.6201 0.0 0
M  V30 20 C 9.3357 2.3100 0.0 0
M  V30 21 C 12.0032 3.8500 0.0 0
M  V30 22 C 10.6695 1.5400 0.0 0
M  V30 23 C 12.0032 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 1 18
M  V30 4 2 2 3
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 15
M  V30 9 1 6 8
M  V30 10 1 9 16
M  V30 11 1 10 11
M  V30 12 1 10 21
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-hydroxy-3-[1-(3-methoxyphenyl)-2-propen-1-yl]-N-methylbenzamide
C18H18BrNO3
2138475-07-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 4.6201 0.0 0
M  V30 2 C 8.0021 6.1601 0.0 0
M  V30 3 C 9.3357 6.9301 0.0 0
M  V30 4 O 5.3348 6.1601 0.0 0
M  V30 5 C 2.6673 4.6201 0.0 0
M  V30 6 N 1.3337 3.8500 0.0 0
M  V30 7 O 2.6673 6.1601 0.0 0
M  V30 8 C 0.0000 4.6201 0.0 0
M  V30 9 Br 5.3348 0.0000 0.0 0
M  V30 10 O 13.3369 4.6201 0.0 0
M  V30 11 C 14.6705 3.8500 0.0 0
M  V30 12 C 6.6684 3.8500 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 6.6684 2.3100 0.0 0
M  V30 15 C 4.0010 3.8500 0.0 0
M  V30 16 C 5.3348 1.5400 0.0 0
M  V30 17 C 4.0010 2.3100 0.0 0
M  V30 18 C 9.3357 3.8500 0.0 0
M  V30 19 C 10.6695 4.6201 0.0 0
M  V30 20 C 9.3357 2.3100 0.0 0
M  V30 21 C 12.0032 3.8500 0.0 0
M  V30 22 C 10.6695 1.5400 0.0 0
M  V30 23 C 12.0032 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 1 18
M  V30 4 2 2 3
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 15
M  V30 9 1 6 8
M  V30 10 1 9 16
M  V30 11 1 10 11
M  V30 12 1 10 21
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2138475-06-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2138475-07-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20766074
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted benzo[b]furans as bromodomain inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Atkinson, Stephen John; Demont, Emmanuel Hubert; Harrison, Lee Andrew;
Preston, Alexander G.; Seal, Jonathan Thomas; Wall, Ian David; Watson,
Robert J.; Woolven, James Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017174620 A1 2017-10-12

$RFMT $RIREG SCHEME244 STEP1
$RXN



  2  1
$MOL
7-Benzofurancarboxylic acid, 5-bromo-2-methyl-
C10H7BrO3
2138475-12-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.7700 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 C 7.9110 3.8500 0.0 0
M  V30 5 Br 0.0000 5.3900 0.0 0
M  V30 6 C 4.0011 3.0800 0.0 0
M  V30 7 C 4.0011 4.6200 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 O 5.4658 2.6042 0.0 0
M  V30 10 C 5.4658 5.0959 0.0 0
M  V30 11 C 2.6674 5.3900 0.0 0
M  V30 12 C 1.3338 3.0800 0.0 0
M  V30 13 C 6.3710 3.8500 0.0 0
M  V30 14 C 1.3338 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 13
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N,2-dimethyl-7-benzofurancarboxamide
C11H10BrNO2
2138475-13-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 5.3347 0.0 0
M  V30 2 N 0.7700 5.3347 0.0 0
M  V30 3 O 3.0800 6.6685 0.0 0
M  V30 4 C 0.0000 6.6685 0.0 0
M  V30 5 Br 2.3100 0.0000 0.0 0
M  V30 6 C 8.3912 5.2891 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 5.3900 2.6674 0.0 0
M  V30 11 O 5.6506 5.1456 0.0 0
M  V30 12 C 3.0800 1.3338 0.0 0
M  V30 13 C 6.8964 2.9876 0.0 0
M  V30 14 C 4.6200 1.3338 0.0 0
M  V30 15 C 7.0574 4.5191 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 1 6 15
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2138475-12-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2138475-13-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31168962
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of agent and catalyst in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Multigram Synthesis of Tetrasubstituted Dihydrobenzofuran GSK973 Enabled
by High-Throughput Experimentation and a Claisen Rearrangement in Flow
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Alder, Catherine M.; Gray, Matthew; Huff, Chelsea A.; Manning, Calvin O.;
Preston, Alex; Rushworth, Philip; Shuster, Leanna E.; Watson, Robert J.;
Wheelhouse, Katherine M. P.; Williams, Glynn D.; Demont, Emmanuel H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2022), 26(2), 365-379

$RFMT $RIREG SCHEME244 STEP1
$RXN



  2  1
$MOL
7-Benzofurancarboxylic acid, 5-bromo-2-methyl-
C10H7BrO3
2138475-12-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.7700 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 C 7.9110 3.8500 0.0 0
M  V30 5 Br 0.0000 5.3900 0.0 0
M  V30 6 C 4.0011 3.0800 0.0 0
M  V30 7 C 4.0011 4.6200 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 O 5.4658 2.6042 0.0 0
M  V30 10 C 5.4658 5.0959 0.0 0
M  V30 11 C 2.6674 5.3900 0.0 0
M  V30 12 C 1.3338 3.0800 0.0 0
M  V30 13 C 6.3710 3.8500 0.0 0
M  V30 14 C 1.3338 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 13
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N,2-dimethyl-7-benzofurancarboxamide
C11H10BrNO2
2138475-13-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 5.3347 0.0 0
M  V30 2 N 0.7700 5.3347 0.0 0
M  V30 3 O 3.0800 6.6685 0.0 0
M  V30 4 C 0.0000 6.6685 0.0 0
M  V30 5 Br 2.3100 0.0000 0.0 0
M  V30 6 C 8.3912 5.2891 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 5.3900 2.6674 0.0 0
M  V30 11 O 5.6506 5.1456 0.0 0
M  V30 12 C 3.0800 1.3338 0.0 0
M  V30 13 C 6.8964 2.9876 0.0 0
M  V30 14 C 4.6200 1.3338 0.0 0
M  V30 15 C 7.0574 4.5191 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 1 6 15
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2138475-12-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2138475-13-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20766082
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of oxalyl chloride (stage 1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted benzo[b]furans as bromodomain inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Atkinson, Stephen John; Demont, Emmanuel Hubert; Harrison, Lee Andrew;
Preston, Alexander G.; Seal, Jonathan Thomas; Wall, Ian David; Watson,
Robert J.; Woolven, James Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017174620 A1 2017-10-12

$RFMT $RIREG SCHEME245 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[3-Chloro-1-(3-iodophenoxy)propyl]thiophene
C13H12ClIOS
2143587-57-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 3.8501 0.0 0
M  V30 2 O 5.1047 4.6201 0.0 0
M  V30 3 C 3.7711 2.3100 0.0 0
M  V30 4 C 2.4374 1.5400 0.0 0
M  V30 5 Cl 2.4374 0.0000 0.0 0
M  V30 6 I 10.4395 4.6201 0.0 0
M  V30 7 C 2.4374 4.6201 0.0 0
M  V30 8 C 1.0304 3.9936 0.0 0
M  V30 9 S 2.2763 6.1516 0.0 0
M  V30 10 C 0.0000 5.1381 0.0 0
M  V30 11 C 0.7700 6.4718 0.0 0
M  V30 12 C 6.4384 3.8501 0.0 0
M  V30 13 C 7.7722 4.6201 0.0 0
M  V30 14 C 6.4384 2.3100 0.0 0
M  V30 15 C 9.1059 3.8501 0.0 0
M  V30 16 C 7.7722 1.5400 0.0 0
M  V30 17 C 9.1059 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 2 12
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 6 15
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
γ-(3-Iodophenoxy)-N-methyl-2-thiophenepropanamine
C14H16INOS
2143587-58-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 3.7710 0.0 0
M  V30 2 O 6.1600 3.7710 0.0 0
M  V30 3 C 3.8500 5.1046 0.0 0
M  V30 4 C 2.3100 5.1046 0.0 0
M  V30 5 N 1.5400 6.4384 0.0 0
M  V30 6 C 0.0000 6.4384 0.0 0
M  V30 7 I 10.7800 6.4384 0.0 0
M  V30 8 C 3.8500 2.4374 0.0 0
M  V30 9 C 2.3185 2.2764 0.0 0
M  V30 10 S 4.4763 1.0304 0.0 0
M  V30 11 C 1.9983 0.7700 0.0 0
M  V30 12 C 3.3319 0.0000 0.0 0
M  V30 13 C 6.9300 5.1046 0.0 0
M  V30 14 C 8.4700 5.1046 0.0 0
M  V30 15 C 6.1600 6.4384 0.0 0
M  V30 16 C 9.2400 6.4384 0.0 0
M  V30 17 C 6.9300 7.7721 0.0 0
M  V30 18 C 8.4700 7.7721 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 2 13
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 7 16
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2143587-57-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2143587-58-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-21483418
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Arylpyrimidines and related compounds having multimodal activity against
pain and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yenes-Minguez, Susana; Almansa-Rosales, Carmen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019002173 A1 2019-01-03

$RFMT $RIREG SCHEME246 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Piperidinecarboxylic acid, 1-(4,6-dichloro-1,3,5-triazin-2-yl)-, ethyl ester
C11H14Cl2N4O2
216502-45-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 4.6201 0.0 0
M  V30 2 Cl 2.6673 0.0000 0.0 0
M  V30 3 C 9.3360 6.9302 0.0 0
M  V30 4 O 10.6697 6.1601 0.0 0
M  V30 5 O 9.3360 8.4702 0.0 0
M  V30 6 C 12.0033 6.9302 0.0 0
M  V30 7 C 13.3370 6.1601 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 N 2.6673 4.6201 0.0 0
M  V30 10 N 4.0010 2.3101 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 1.5400 0.0 0
M  V30 13 N 1.3337 2.3101 0.0 0
M  V30 14 N 5.3348 4.6201 0.0 0
M  V30 15 C 5.3348 6.1601 0.0 0
M  V30 16 C 6.6685 3.8501 0.0 0
M  V30 17 C 6.6685 6.9302 0.0 0
M  V30 18 C 8.0022 4.6201 0.0 0
M  V30 19 C 8.0022 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 12
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 19
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 14
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Piperidinecarboxylic acid, 1-[4-chloro-6-(methylamino)-1,3,5-triazin-2-yl]-...
C12H18ClN5O2
1141895-93-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 4.6201 0.0 0
M  V30 2 C 0.0000 3.8501 0.0 0
M  V30 3 Cl 4.0010 0.0000 0.0 0
M  V30 4 C 10.6697 6.9302 0.0 0
M  V30 5 O 12.0033 6.1601 0.0 0
M  V30 6 O 10.6697 8.4702 0.0 0
M  V30 7 C 13.3370 6.9302 0.0 0
M  V30 8 C 14.6707 6.1601 0.0 0
M  V30 9 N 6.6685 4.6201 0.0 0
M  V30 10 C 8.0022 3.8501 0.0 0
M  V30 11 C 6.6685 6.1601 0.0 0
M  V30 12 C 9.3358 4.6201 0.0 0
M  V30 13 C 8.0022 6.9302 0.0 0
M  V30 14 C 9.3358 6.1601 0.0 0
M  V30 15 C 5.3348 3.8501 0.0 0
M  V30 16 N 4.0010 4.6201 0.0 0
M  V30 17 N 5.3348 2.3101 0.0 0
M  V30 18 C 2.6673 3.8501 0.0 0
M  V30 19 C 4.0010 1.5400 0.0 0
M  V30 20 N 2.6673 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 14
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 15
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 216502-45-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1141895-93-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-155398
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM b) Preparation of ethyl
1-[4-chloro-6-(methylamino)-1,3,5-triazin-2-yl]-4-piperidinecarboxylate
To a solution of ethyl
1-(4,6-dichloro-1,3,5-triazin-2-yl)-4-piperidinecarboxylate (1.0 g, 3.3
mmol, 1.0 equiv) in dichloromethane (20 ml) at room temperature, a
premixed solution of methylamine (1.6 ml, 3.3 mmol, 1.0 equiv) and
diisopropylethylamine (DIEA, 1.7 ml, 9.8 mmol, 3.0 equiv) in
dichloromethane (10 ml) was added dropwise. The reaction was stirred for
3 h at room temperature. The solvent was removed under reduced pressure
to afford 983 mg (100%) of the title compound. MS (ES+): m/e 300.1
[M+H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 2-amino-1,3,5-triazine derivatives as soluble epoxide
hydrolase (sEH) inhibitors and their use
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ding, Yun; Thalji, Reema K.; Marino, Joseph Paul, Jr.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009049165 A1 2009-04-16

$RFMT $RIREG SCHEME247 STEP1
$RXN



  2  1
$MOL
5-Bromo-2-chlorobenzoic acid
C7H4BrClO2
21739-92-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 Cl 1.3338 4.6201 0.0 0
M  V30 5 Br 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-chloro-N-methylbenzamide
C8H7BrClNO
435273-54-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6675 0.0 0
M  V30 2 N 5.3901 4.0011 0.0 0
M  V30 3 O 5.3901 1.3338 0.0 0
M  V30 4 C 6.9301 4.0011 0.0 0
M  V30 5 Cl 3.0800 0.0000 0.0 0
M  V30 6 Br 0.0000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6675 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 0.7700 1.3338 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 21739-92-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 435273-54-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-17455810
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fused pyrazole derivatives as kinase inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ford, Daniel James; Horsley, Helen Tracey; Reuberson, James Thomas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017055305 A1 2017-04-06

$RFMT $RIREG SCHEME248 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-(phenylmethoxy)-3-pyridinecarboxylate
C14H13NO3
219817-42-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 4.0010 2.3101 0.0 0
M  V30 3 C 10.6697 3.0801 0.0 0
M  V30 4 O 12.0033 2.3101 0.0 0
M  V30 5 O 10.6697 4.6201 0.0 0
M  V30 6 C 13.3370 3.0801 0.0 0
M  V30 7 C 6.6685 2.3101 0.0 0
M  V30 8 C 8.0022 3.0801 0.0 0
M  V30 9 C 6.6685 0.7700 0.0 0
M  V30 10 C 9.3360 2.3101 0.0 0
M  V30 11 N 8.0022 0.0000 0.0 0
M  V30 12 C 9.3360 0.7700 0.0 0
M  V30 13 C 2.6673 3.0801 0.0 0
M  V30 14 C 1.3337 2.3101 0.0 0
M  V30 15 C 2.6673 4.6201 0.0 0
M  V30 16 C 0.0000 3.0801 0.0 0
M  V30 17 C 1.3337 5.3901 0.0 0
M  V30 18 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 13
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 10
M  V30 7 1 4 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-5-(phenylmethoxy)-3-pyridinecarboxamide
C14H14N2O2
1400807-93-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 4.0010 2.3101 0.0 0
M  V30 3 C 10.6697 3.0801 0.0 0
M  V30 4 N 12.0033 2.3101 0.0 0
M  V30 5 O 10.6697 4.6201 0.0 0
M  V30 6 C 13.3370 3.0801 0.0 0
M  V30 7 C 6.6685 2.3101 0.0 0
M  V30 8 C 8.0022 3.0801 0.0 0
M  V30 9 C 6.6685 0.7700 0.0 0
M  V30 10 C 9.3360 2.3101 0.0 0
M  V30 11 N 8.0022 0.0000 0.0 0
M  V30 12 C 9.3360 0.7700 0.0 0
M  V30 13 C 2.6673 3.0801 0.0 0
M  V30 14 C 1.3337 2.3101 0.0 0
M  V30 15 C 2.6673 4.6201 0.0 0
M  V30 16 C 0.0000 3.0801 0.0 0
M  V30 17 C 1.3337 5.3901 0.0 0
M  V30 18 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 13
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 10
M  V30 7 1 4 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 219817-42-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1400807-93-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2013339
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidinoindole derivatives as gyrase inhibitors for use
as antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bensen, Daniel; Borchardt, Allen; Chen, Zhiyong; Finn, John M.; Lam,
Thanh To; Lee, Suk Joong; Li, Xiaoming; Tari, Leslie William; Teng, Min;
Trzoss, Michael; Zhang, Junhu; Jung, Michael E.; Lightstone, Felice C.;
Wong, Sergio E.; Nguyen, Toan B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014043272 A1 2014-03-20

$RFMT $RIREG SCHEME248 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-(phenylmethoxy)-3-pyridinecarboxylate
C14H13NO3
219817-42-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 4.0010 2.3101 0.0 0
M  V30 3 C 10.6697 3.0801 0.0 0
M  V30 4 O 12.0033 2.3101 0.0 0
M  V30 5 O 10.6697 4.6201 0.0 0
M  V30 6 C 13.3370 3.0801 0.0 0
M  V30 7 C 6.6685 2.3101 0.0 0
M  V30 8 C 8.0022 3.0801 0.0 0
M  V30 9 C 6.6685 0.7700 0.0 0
M  V30 10 C 9.3360 2.3101 0.0 0
M  V30 11 N 8.0022 0.0000 0.0 0
M  V30 12 C 9.3360 0.7700 0.0 0
M  V30 13 C 2.6673 3.0801 0.0 0
M  V30 14 C 1.3337 2.3101 0.0 0
M  V30 15 C 2.6673 4.6201 0.0 0
M  V30 16 C 0.0000 3.0801 0.0 0
M  V30 17 C 1.3337 5.3901 0.0 0
M  V30 18 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 13
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 10
M  V30 7 1 4 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-5-(phenylmethoxy)-3-pyridinecarboxamide
C14H14N2O2
1400807-93-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 4.0010 2.3101 0.0 0
M  V30 3 C 10.6697 3.0801 0.0 0
M  V30 4 N 12.0033 2.3101 0.0 0
M  V30 5 O 10.6697 4.6201 0.0 0
M  V30 6 C 13.3370 3.0801 0.0 0
M  V30 7 C 6.6685 2.3101 0.0 0
M  V30 8 C 8.0022 3.0801 0.0 0
M  V30 9 C 6.6685 0.7700 0.0 0
M  V30 10 C 9.3360 2.3101 0.0 0
M  V30 11 N 8.0022 0.0000 0.0 0
M  V30 12 C 9.3360 0.7700 0.0 0
M  V30 13 C 2.6673 3.0801 0.0 0
M  V30 14 C 1.3337 2.3101 0.0 0
M  V30 15 C 2.6673 4.6201 0.0 0
M  V30 16 C 0.0000 3.0801 0.0 0
M  V30 17 C 1.3337 5.3901 0.0 0
M  V30 18 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 13
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 10
M  V30 7 1 4 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 219817-42-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1400807-93-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8719160
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of compound A31: A solution of compound A30 (12.8 g,
52.9mmol) in methylamine alcohol solution in sealed tube was stirred at
70 °C for overnight. Then the mixture was cooled to room temperature and
the solvent was evaporated. Yield: (12.0 g, 100%). 1H NMR (300 MHz,
CDCl3): δ: 8.50 (d, J = 1.6 Hz, 1H), 8.48(d, J = 2.8 Hz, 1H), 7.73-7.74
(m, 1H), 7.73-7.74 (m, 5H), 6.16(s, 1H), 3.15 (s, 2H), 3.04 (d, J = 4.4
Hz, 3H).
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrimidoindole derivatives as gyrase inhibitors and their preparation and
use as antibacterials
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bensen, Daniel; Finn, John; Lee, Suk Joong; Chen, Zhiyong; Lam, Thanh To;
Li, Xiaoming; Trzoss, Michael; Jung, Michael; Nguyen, Toan B.;
Lightstone, Felice; Tari, Leslie William; Zhang, Junhu; Aristoff, Paul;
Phillipson, Douglas W.; Wong, Sergio E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012125746 A1 2012-09-20

$RFMT $RIREG SCHEME249 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-1-nitro-4-(phenylmethoxy)benzene
C13H10FNO3
221040-07-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6674 0.0 0 VAL=5
M  V30 2 O 0.0000 1.3338 0.0 0
M  V30 3 O 0.0000 4.0011 0.0 0
M  V30 4 F 2.3100 0.0000 0.0 0
M  V30 5 O 6.9300 2.6674 0.0 0
M  V30 6 C 7.7000 4.0011 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 C 5.3900 2.6674 0.0 0
M  V30 13 C 9.2400 4.0011 0.0 0
M  V30 14 C 10.0100 2.6674 0.0 0
M  V30 15 C 10.0100 5.3349 0.0 0
M  V30 16 C 11.5500 2.6674 0.0 0
M  V30 17 C 11.5500 5.3349 0.0 0
M  V30 18 C 12.3200 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 6 13
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-nitro-5-(phenylmethoxy)benzenamine
C14H14N2O3
496837-94-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 5.3348 0.0 0
M  V30 5 O 0.0000 2.6675 0.0 0
M  V30 6 O 6.9301 4.0011 0.0 0
M  V30 7 C 7.7001 5.3348 0.0 0
M  V30 8 C 3.0800 2.6675 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6201 2.6675 0.0 0
M  V30 11 C 3.0800 5.3348 0.0 0
M  V30 12 C 5.3901 4.0011 0.0 0
M  V30 13 C 4.6201 5.3348 0.0 0
M  V30 14 C 9.2401 5.3348 0.0 0
M  V30 15 C 10.0101 4.0011 0.0 0
M  V30 16 C 10.0101 6.6686 0.0 0
M  V30 17 C 11.5501 4.0011 0.0 0
M  V30 18 C 11.5501 6.6686 0.0 0
M  V30 19 C 12.3201 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 1 7 14
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 221040-07-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 496837-94-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14982068
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient solution phase synthesis of 2-(N-acylamino)benzimidazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Seth, Punit P.; Robinson, Dale E.; Jefferson, Elizabeth A.; Swayze, Eric
E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2002), 43(41), 7303-7306

$RFMT $RIREG SCHEME250 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Isoquinolinecarboxylic acid
C10H7NO2
221050-96-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6686 1.5400 0.0 0
M  V30 2 O 8.0022 2.3100 0.0 0
M  V30 3 O 6.6686 0.0000 0.0 0
M  V30 4 C 2.6675 2.3100 0.0 0
M  V30 5 C 2.6675 3.8500 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 4.0011 4.6201 0.0 0
M  V30 9 C 1.3337 4.6201 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 N 0.0000 2.3100 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-7-isoquinolinecarboxamide
C11H10N2O
1158755-24-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 C 9.3360 1.5400 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 3.8501 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 1.3337 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 N 0.0000 2.3101 0.0 0
M  V30 13 C 5.3348 3.8501 0.0 0
M  V30 14 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 221050-96-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1158755-24-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19386776
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 127-19-5
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of MeNH2 and HATU
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Indole-Dihydroisoquinoline Sulfonyl Ureas via
Three-Component Reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pearson, Stuart E.; Fillery, Shaun M.; Goldberg, Kristin; Demeritt, Julie
E.; Eden, Jonathan; Finlayson, Jonathan; Patel, Anil
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2018), 50(24), 4963-4981

$RFMT $RIREG SCHEME251 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-2,4-difluoro-5-nitrobenzoic acid
C7H2ClF2NO4
221221-03-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 4.6200 0.0 0
M  V30 2 O 1.3336 6.1600 0.0 0
M  V30 3 O 0.0000 3.8500 0.0 0
M  V30 4 F 1.3336 1.5400 0.0 0
M  V30 5 Cl 4.0011 0.0000 0.0 0
M  V30 6 N 6.6685 4.6200 0.0 0 VAL=5
M  V30 7 O 8.0021 3.8500 0.0 0
M  V30 8 O 6.6685 6.1600 0.0 0
M  V30 9 F 6.6685 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 2.6674 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 5.3347 3.8500 0.0 0
M  V30 15 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 11
M  V30 5 1 5 13
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-chloro-2-fluoro-4-(methylamino)-5-nitro-
C8H6ClFN2O4
927430-56-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6686 2.3100 0.0 0
M  V30 2 C 8.0022 3.0800 0.0 0
M  V30 3 N 4.0011 0.7700 0.0 0 VAL=5
M  V30 4 O 5.3348 0.0000 0.0 0
M  V30 5 O 2.6675 0.0000 0.0 0
M  V30 6 Cl 6.6686 5.3901 0.0 0
M  V30 7 F 4.0011 6.9301 0.0 0
M  V30 8 C 1.3337 5.3901 0.0 0
M  V30 9 O 0.0000 4.6201 0.0 0
M  V30 10 O 1.3337 6.9301 0.0 0
M  V30 11 C 5.3348 3.0800 0.0 0
M  V30 12 C 4.0011 2.3100 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 2.6675 3.0800 0.0 0
M  V30 15 C 4.0011 5.3901 0.0 0
M  V30 16 C 2.6675 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 1 6 13
M  V30 7 1 7 15
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 221221-03-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 927430-56-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3193930
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM a) Preparation of 3-chloro-2-fluoro-4-methylamino-5-nitro-benzoic acid: A
suspension of 5 g (21.05 mmol) of 3-chloro-2,4-difluoro-5-nitro-benzoic
acid (known from WO 03/077914) in 50 mL of H2O is cooled to a temperature
of 0°C. Then 5.86 ml (42.10 mmol) of triethylamine were added dropwise
followed by the dropwise addition of 1.82 ml (21.05 mmol) of methylamine
(40 % in H2O). After 30 min of stirring at 0°C, 0.18 ml (2.11 mmol) of
methylamine (40 % in H2O) is added and the mixture is stirred again
during 30 min at a temperature of 0°C. The pH of the mixture is adjusted
to 1-0.5 by the addition of concentrated HCl at a temperature of 0°C. The
product is extracted with tert-butyl methyl ether (2 times) and the
organic phase is washed once with brine, dried on Na2SO4, filtrated and
the solvent is evaporated. 5.35 g (21.52 mmol, 102%) of a crude yellow
solid were obtained and used directly in the next step without
purification. LC/MS: 247/249 (M-1)-.
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, incremental addition of reactant in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bis-amide imidazole derivatives as insecticides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jeanguenat, Andre; Hall, Roger Graham; Loiseleur, Olivier; Trah, Stephan;
Durieux, Patricia; Edmunds, Andrew; Stoller, Andre
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007020050 A2 2007-02-22

$RFMT $RIREG SCHEME252 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′-[8-(Dimethylamino)-5,7-quinolinediyl]bis[2,2,2-trifluoroethanone]
C15H10F6N2O2
221636-53-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 3.6437 0.0 0
M  V30 2 C 1.3337 2.1037 0.0 0
M  V30 3 C 0.0000 4.4137 0.0 0
M  V30 4 C 6.6685 6.7238 0.0 0
M  V30 5 C 8.0023 5.9538 0.0 0
M  V30 6 O 6.6685 8.2638 0.0 0
M  V30 7 F 8.7723 7.2874 0.0 0
M  V30 8 F 9.3360 5.1838 0.0 0
M  V30 9 F 7.2323 4.6201 0.0 0
M  V30 10 C 4.0012 2.1037 0.0 0
M  V30 11 C 5.3348 1.3337 0.0 0
M  V30 12 O 2.6675 1.3337 0.0 0
M  V30 13 F 6.1048 2.6673 0.0 0
M  V30 14 F 6.6685 0.5637 0.0 0
M  V30 15 F 4.5648 0.0000 0.0 0
M  V30 16 C 2.6675 5.9538 0.0 0
M  V30 17 C 4.0012 6.7238 0.0 0
M  V30 18 C 2.6675 4.4137 0.0 0
M  V30 19 N 1.3337 6.7238 0.0 0
M  V30 20 C 5.3348 5.9538 0.0 0
M  V30 21 C 4.0012 8.2638 0.0 0
M  V30 22 C 4.0012 3.6437 0.0 0
M  V30 23 C 1.3337 8.2638 0.0 0
M  V30 24 C 5.3348 4.4137 0.0 0
M  V30 25 C 2.6675 9.0338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 18
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 20
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 22
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 16 19
M  V30 19 1 17 20
M  V30 20 1 17 21
M  V30 21 2 18 22
M  V30 22 2 19 23
M  V30 23 2 20 24
M  V30 24 2 21 25
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanone, 1,1′-[8-(methylamino)-5,7-quinolinediyl]bis[2,2,2-trifluoro-
C14H8F6N2O2
221636-55-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 6.7238 0.0 0
M  V30 2 C 8.0023 5.9538 0.0 0
M  V30 3 O 6.6685 8.2638 0.0 0
M  V30 4 F 8.7723 7.2874 0.0 0
M  V30 5 F 9.3360 5.1838 0.0 0
M  V30 6 F 7.2323 4.6201 0.0 0
M  V30 7 N 1.3337 3.6437 0.0 0
M  V30 8 C 0.0000 4.4137 0.0 0
M  V30 9 C 4.0012 2.1037 0.0 0
M  V30 10 C 5.3348 1.3337 0.0 0
M  V30 11 O 2.6675 1.3337 0.0 0
M  V30 12 F 4.5648 0.0000 0.0 0
M  V30 13 F 6.6685 0.5637 0.0 0
M  V30 14 F 6.1048 2.6673 0.0 0
M  V30 15 C 4.0012 6.7238 0.0 0
M  V30 16 C 2.6675 5.9538 0.0 0
M  V30 17 C 5.3348 5.9538 0.0 0
M  V30 18 C 4.0012 8.2638 0.0 0
M  V30 19 C 2.6675 4.4137 0.0 0
M  V30 20 N 1.3337 6.7238 0.0 0
M  V30 21 C 5.3348 4.4137 0.0 0
M  V30 22 C 2.6675 9.0338 0.0 0
M  V30 23 C 4.0012 3.6437 0.0 0
M  V30 24 C 1.3337 8.2638 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 7 8
M  V30 8 1 7 19
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 23
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 15 18
M  V30 18 1 16 19
M  V30 19 1 16 20
M  V30 20 2 17 21
M  V30 21 2 18 22
M  V30 22 2 19 23
M  V30 23 2 20 24
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 221636-53-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 221636-55-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-550-CAS-11347069
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: N-N Exchange Reaction of 3 with Amines;
General Procedures. To a solution of 3 (1.10 g, 3 mmol) in MeCN (21 mL)
were added the appropriate amines (3-15 mmol) and the mixture was stirred
at 0 °C-reflux temperature for 0.5-96 h. The solvent was evaporated in
vacuo to give the practically pure products 4a-l. In the case of 4m, PrCN
was used as a solvent, and separation and purification were carried out
by recrystallization from n-hexane/EtOAc. Compound 4b, yield 100%. Mp
175-176°C. Molecular Formula: C14H8F6N2O2. IR (KBr) ν (cm-1): 3125, 1675,
1633. 1H NMR (CDCl3/TMS) J (Hz): 3.21-4.23 (br, 3 H, CH3), 7.70 (dd, 1 H,
J = 4, 9, H-3), 8.68 (br s, 1 H, H-6), 8.89 (dd, 1 H, J = 2, 4, H-2),
9.51 (dd, 1 H, J = 2, 9, H-4), 10.07-11.79 (br, 1 H, NH).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aromatic nucleophilic N-N, N-S and N-O exchange reactions: efficient
synthesis of 5,7-Bis(trifluoroacetyl)-8-quinolyl amines, sulfides, and
ethers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Okada, Etsuji; Tsukushi, Norikado; Shimomura, Naofumi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2000), (2), 237-242

$RFMT $RIREG SCHEME253 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dibenzo[a,d]cyclohepten-5-one
C15H10O
2222-33-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.5288 0.0000 0.0 0
M  V30 2 C 2.6673 2.4617 0.0 0
M  V30 3 C 2.6673 4.0017 0.0 0
M  V30 4 C 3.8714 1.5015 0.0 0
M  V30 5 C 1.3337 1.6917 0.0 0
M  V30 6 C 3.8714 4.9619 0.0 0
M  V30 7 C 1.3337 4.7717 0.0 0
M  V30 8 C 5.3728 1.8442 0.0 0
M  V30 9 C 0.0000 2.4617 0.0 0
M  V30 10 C 5.3728 4.6191 0.0 0
M  V30 11 C 0.0000 4.0017 0.0 0
M  V30 12 C 6.0410 3.2317 0.0 0
M  V30 13 C 6.2403 0.5718 0.0 0
M  V30 14 C 7.5767 3.3468 0.0 0
M  V30 15 C 7.7760 0.6868 0.0 0
M  V30 16 C 8.4442 2.0744 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 4
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 8 13
M  V30 13 2 9 11
M  V30 14 1 10 12
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-5H-Dibenzo[a,d]cyclohepten-5-ylidenemethanamine
C16H13N
59864-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.5288 0.4538 0.0 0
M  V30 2 C 2.0571 0.0000 0.0 0
M  V30 3 C 2.6673 2.9154 0.0 0
M  V30 4 C 3.8714 1.9553 0.0 0
M  V30 5 C 2.6673 4.4554 0.0 0
M  V30 6 C 1.3336 2.1454 0.0 0
M  V30 7 C 5.3728 2.2980 0.0 0
M  V30 8 C 3.8714 5.4156 0.0 0
M  V30 9 C 1.3336 5.2254 0.0 0
M  V30 10 C 0.0000 2.9154 0.0 0
M  V30 11 C 6.0410 3.6854 0.0 0
M  V30 12 C 6.2402 1.0255 0.0 0
M  V30 13 C 5.3728 5.0729 0.0 0
M  V30 14 C 0.0000 4.4554 0.0 0
M  V30 15 C 7.5766 3.8006 0.0 0
M  V30 16 C 7.7759 1.1407 0.0 0
M  V30 17 C 8.4441 2.5281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 4
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 2 8 13
M  V30 13 1 9 14
M  V30 14 2 10 14
M  V30 15 1 11 13
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2222-33-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 59864-52-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-10416065
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7550-45-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, Structure, and Reactivity of a Stabilized Phosphiranylium Salt
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jansen, Helen; Laeng, Florian B.; Slootweg, J. Chris; Ehlers, Andreas W.;
Lutz, Martin; Lammertsma, Koop; Gruetzmacher, Hansjoerg
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2010), 49(32), 5485-5488,
S5485/1-S5485/21

$RFMT $RIREG SCHEME254 STEP1
$RXN



  2  1
$MOL
(2R,3R)-2-Ethyl-2-(3-methoxyphenyl)-3-(trimethylsilyl)oxirane
C14H22O2Si
2222385-62-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.4275 0.9899 0.0 0
M  V30 2 C 5.2479 0.0000 0.0 0
M  V30 3 Si 9.1237 2.7657 0.0 0
M  V30 4 C 10.6405 2.4983 0.0 0
M  V30 5 C 8.8564 1.2491 0.0 0
M  V30 6 C 9.3912 4.2824 0.0 0
M  V30 7 O 1.5400 5.1738 0.0 0
M  V30 8 C 0.0000 5.1738 0.0 0
M  V30 9 C 6.1600 2.5065 0.0 0 CFG=2
M  V30 10 C 7.6071 3.0332 0.0 0 CFG=1
M  V30 11 O 6.4275 4.0231 0.0 0
M  V30 12 C 4.6200 2.5065 0.0 0
M  V30 13 C 3.8500 3.8401 0.0 0
M  V30 14 C 3.8500 1.1727 0.0 0
M  V30 15 C 2.3100 3.8401 0.0 0
M  V30 16 C 2.3100 1.1727 0.0 0
M  V30 17 C 1.5400 2.5065 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 9 1 CFG=3
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 10 3 CFG=3
M  V30 7 1 7 8
M  V30 8 1 7 15
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12 CFG=1
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αR)-α-Ethyl-3-methoxy-α-[(methylamino)methyl]benzenemethanol
C12H19NO2
861844-37-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.3100 0.0 0 CFG=1
M  V30 2 C 7.7000 2.3100 0.0 0
M  V30 3 C 6.1600 0.7700 0.0 0
M  V30 4 O 6.1600 3.8500 0.0 0
M  V30 5 N 8.4700 3.6436 0.0 0
M  V30 6 C 7.4936 0.0000 0.0 0
M  V30 7 C 10.0100 3.6436 0.0 0
M  V30 8 O 1.5400 4.9773 0.0 0
M  V30 9 C 0.0000 4.9773 0.0 0
M  V30 10 C 4.6200 2.3100 0.0 0
M  V30 11 C 3.8500 3.6436 0.0 0
M  V30 12 C 3.8500 0.9762 0.0 0
M  V30 13 C 2.3100 3.6436 0.0 0
M  V30 14 C 2.3100 0.9762 0.0 0
M  V30 15 C 1.5400 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 1 10
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 13
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2222385-62-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 861844-37-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-19430085
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 429-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, literature preparation, alternative preparation shown,
intermediate isolated with 76% yield (stage 1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of a scalable synthetic route towards a 2,2,6-trisubstituted
chiral morpholine via stereoselective hydroalkoxylation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huh, Chan Woo; Bechle, Bruce M.; Warmus, Joseph S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2018), 59(19), 1808-1812

$RFMT $RIREG SCHEME255 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl α-[2-[7-(dimethylamino)-3,4-dimethyl-2H-pyrazolo[3,4-d]pyridazin-2-yl]...
C24H25N5O3
2228050-46-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0203 9.0629 0.0 0
M  V30 2 O 7.4147 5.3901 0.0 0
M  V30 3 C 8.7484 4.6201 0.0 0
M  V30 4 C 10.0822 5.3901 0.0 0
M  V30 5 O 11.4159 4.6201 0.0 0
M  V30 6 O 10.0822 6.9301 0.0 0
M  V30 7 C 12.7495 5.3901 0.0 0
M  V30 8 N 3.0800 2.4109 0.0 0
M  V30 9 C 4.6201 2.4109 0.0 0
M  V30 10 C 2.3100 1.0772 0.0 0
M  V30 11 C 0.0000 7.7457 0.0 0
M  V30 12 N 4.7474 6.9301 0.0 0
M  V30 13 N 4.5863 5.3985 0.0 0
M  V30 14 C 3.3405 7.5564 0.0 0
M  V30 15 C 3.0800 5.0784 0.0 0
M  V30 16 C 2.3100 6.4120 0.0 0
M  V30 17 C 2.3100 3.7446 0.0 0
M  V30 18 C 0.7700 6.4120 0.0 0
M  V30 19 N 0.7700 3.7446 0.0 0
M  V30 20 N 0.0000 5.0784 0.0 0
M  V30 21 C 6.0811 7.7001 0.0 0
M  V30 22 C 7.4147 6.9301 0.0 0
M  V30 23 C 6.0811 9.2401 0.0 0
M  V30 24 C 8.7484 7.7001 0.0 0
M  V30 25 C 7.4147 10.0101 0.0 0
M  V30 26 C 8.7484 9.2401 0.0 0
M  V30 27 C 8.7484 3.0800 0.0 0
M  V30 28 C 10.0822 2.3100 0.0 0
M  V30 29 C 7.4147 2.3100 0.0 0
M  V30 30 C 10.0822 0.7700 0.0 0
M  V30 31 C 7.4147 0.7700 0.0 0
M  V30 32 C 8.7484 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 1 2 22
M  V30 4 1 3 4
M  V30 5 1 3 27
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 17
M  V30 12 1 11 18
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 21
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-[2-[7-(Dimethylamino)-3,4-dimethyl-2H-pyrazolo[3,4-d]pyridazin-2-yl]phenoxy...
C24H26N6O2
2228050-47-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0203 9.0629 0.0 0
M  V30 2 O 7.4147 5.3901 0.0 0
M  V30 3 C 8.7484 4.6201 0.0 0
M  V30 4 C 10.0822 5.3901 0.0 0
M  V30 5 N 11.4159 4.6201 0.0 0
M  V30 6 O 10.0822 6.9301 0.0 0
M  V30 7 C 12.7495 5.3901 0.0 0
M  V30 8 N 3.0800 2.4109 0.0 0
M  V30 9 C 4.6201 2.4109 0.0 0
M  V30 10 C 2.3100 1.0772 0.0 0
M  V30 11 C 0.0000 7.7457 0.0 0
M  V30 12 N 4.7474 6.9301 0.0 0
M  V30 13 N 4.5863 5.3985 0.0 0
M  V30 14 C 3.3405 7.5564 0.0 0
M  V30 15 C 3.0800 5.0784 0.0 0
M  V30 16 C 2.3100 6.4120 0.0 0
M  V30 17 C 2.3100 3.7446 0.0 0
M  V30 18 C 0.7700 6.4120 0.0 0
M  V30 19 N 0.7700 3.7446 0.0 0
M  V30 20 N 0.0000 5.0784 0.0 0
M  V30 21 C 6.0811 7.7001 0.0 0
M  V30 22 C 7.4147 6.9301 0.0 0
M  V30 23 C 6.0811 9.2401 0.0 0
M  V30 24 C 8.7484 7.7001 0.0 0
M  V30 25 C 7.4147 10.0101 0.0 0
M  V30 26 C 8.7484 9.2401 0.0 0
M  V30 27 C 8.7484 3.0800 0.0 0
M  V30 28 C 10.0822 2.3100 0.0 0
M  V30 29 C 7.4147 2.3100 0.0 0
M  V30 30 C 10.0822 0.7700 0.0 0
M  V30 31 C 7.4147 0.7700 0.0 0
M  V30 32 C 8.7484 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 1 2 22
M  V30 4 1 3 4
M  V30 5 1 3 27
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 17
M  V30 12 1 11 18
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 21
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2228050-46-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2228050-47-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20344260
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of ortho-substituted phenylpyrazolo- and
phenylpyrrolo-pyridazine derivatives with multimodal activity against
pain
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Virgili-Bernado, Marina; Alonso-Xalma, Monica; Almansa-Rosales, Carmen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018100045 A1 2018-06-07

$RFMT $RIREG SCHEME256 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-[[2-[cyclohexyl(2-methylpropyl)amino]-5-(3-ethoxy-1-methyl-3-oxopropy...
C27H40N4O4S
2230865-72-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 12.0033 0.0 0
M  V30 2 C 5.3900 13.3369 0.0 0
M  V30 3 C 4.6200 14.6706 0.0 0
M  V30 4 C 5.3900 16.0044 0.0 0
M  V30 5 C 3.0800 14.6706 0.0 0
M  V30 6 N 7.7000 12.0033 0.0 0
M  V30 7 C 7.7000 6.6685 0.0 0
M  V30 8 C 6.9300 5.3347 0.0 0
M  V30 9 C 9.2400 6.6685 0.0 0
M  V30 10 C 7.7000 4.0011 0.0 0
M  V30 11 O 6.9300 2.6674 0.0 0
M  V30 12 O 9.2400 4.0011 0.0 0
M  V30 13 C 7.7000 1.3338 0.0 0
M  V30 14 C 6.9300 0.0000 0.0 0
M  V30 15 C 12.8558 13.6785 0.0 0
M  V30 16 O 14.2626 13.0520 0.0 0
M  V30 17 O 12.6947 15.2100 0.0 0
M  V30 18 C 15.5085 13.9572 0.0 0
M  V30 19 C 16.9154 13.3309 0.0 0
M  V30 20 C 5.3900 10.6696 0.0 0
M  V30 21 C 6.9300 10.6696 0.0 0
M  V30 22 C 4.6200 9.3358 0.0 0
M  V30 23 C 7.7000 9.3358 0.0 0
M  V30 24 C 5.3900 8.0022 0.0 0
M  V30 25 C 6.9300 8.0022 0.0 0
M  V30 26 C 3.0800 12.0033 0.0 0
M  V30 27 C 2.3100 10.6696 0.0 0
M  V30 28 C 2.3100 13.3369 0.0 0
M  V30 29 C 0.7700 10.6696 0.0 0
M  V30 30 C 0.7700 13.3369 0.0 0
M  V30 31 C 0.0000 12.0033 0.0 0
M  V30 32 C 9.2400 12.0033 0.0 0
M  V30 33 S 10.1453 13.2491 0.0 0
M  V30 34 N 10.1453 10.7574 0.0 0
M  V30 35 C 11.6100 12.7733 0.0 0
M  V30 36 N 11.6100 11.2333 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 1 26
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 1 3 5
M  V30 7 1 6 21
M  V30 8 1 6 32
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 25
M  V30 12 1 8 10
M  V30 13 1 10 11
M  V30 14 2 10 12
M  V30 15 1 11 13
M  V30 16 1 13 14
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 15 35
M  V30 20 1 16 18
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 1 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 31
M  V30 34 1 32 33
M  V30 35 2 32 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 2 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-[cyclohexyl(2-methylpropyl)amino]-β-methyl-3-[[5-[(methylamino)carbon...
C26H39N5O3S
2230865-74-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.1365 4.0012 0.0 0
M  V30 2 C 5.5965 4.0012 0.0 0
M  V30 3 C 4.8265 2.6673 0.0 0
M  V30 4 C 3.2864 2.6673 0.0 0
M  V30 5 C 5.5965 1.3337 0.0 0
M  V30 6 N 5.5965 6.6685 0.0 0
M  V30 7 C 10.2166 9.3360 0.0 0
M  V30 8 C 11.7566 9.3360 0.0 0
M  V30 9 C 9.4466 10.6697 0.0 0
M  V30 10 C 12.5266 10.6697 0.0 0
M  V30 11 O 14.0667 10.6697 0.0 0
M  V30 12 O 11.7566 12.0033 0.0 0
M  V30 13 C 14.8367 12.0033 0.0 0
M  V30 14 C 16.3767 12.0033 0.0 0
M  V30 15 C 1.5678 10.2960 0.0 0
M  V30 16 N 1.4068 11.8276 0.0 0
M  V30 17 O 0.3219 9.3908 0.0 0
M  V30 18 C 0.0000 12.4539 0.0 0
M  V30 19 C 7.9065 5.3348 0.0 0
M  V30 20 C 7.1365 6.6685 0.0 0
M  V30 21 C 9.4466 5.3348 0.0 0
M  V30 22 C 7.9065 8.0022 0.0 0
M  V30 23 C 10.2166 6.6685 0.0 0
M  V30 24 C 9.4466 8.0022 0.0 0
M  V30 25 C 7.9065 2.6673 0.0 0
M  V30 26 C 9.4466 2.6673 0.0 0
M  V30 27 C 7.1365 1.3337 0.0 0
M  V30 28 C 10.2166 1.3337 0.0 0
M  V30 29 C 7.9065 0.0000 0.0 0
M  V30 30 C 9.4466 0.0000 0.0 0
M  V30 31 C 4.8265 8.0022 0.0 0
M  V30 32 S 3.2949 8.1633 0.0 0
M  V30 33 N 5.4530 9.4091 0.0 0
M  V30 34 C 2.9747 9.6696 0.0 0
M  V30 35 N 4.3084 10.4396 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 1 25
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 1 3 5
M  V30 7 1 6 20
M  V30 8 1 6 31
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 24
M  V30 12 1 8 10
M  V30 13 1 10 11
M  V30 14 2 10 12
M  V30 15 1 11 13
M  V30 16 1 13 14
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 15 34
M  V30 20 1 16 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 1 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 30
M  V30 33 1 31 32
M  V30 34 2 31 33
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 2 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2230865-72-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2230865-74-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20457856
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 4-(isobutylamino)-3-(heteroarylamino)phenylalkanoic acids
and derivatives as modulators of indoleamine 2,3-dioxygenase 1 useful in
the treatment and prevention of diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM De la Rosa, Martha Alicia; Kazmierski, Wieslaw Mieczyslaw; Samano,
Vicente
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018116107 A1 2018-06-28

$RFMT $RIREG SCHEME257 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-2-naphthalenylacetamide
C12H10BrNO
22344-79-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 8.0023 0.7700 0.0 0
M  V30 5 Br 10.6697 2.3101 0.0 0
M  V30 6 C 2.6673 0.7700 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 1.3337 3.0801 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 5.3348 2.3101 0.0 0
M  V30 15 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Methylamino)-N-2-naphthalenylacetamide
C13H14N2O
65593-07-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 8.0022 0.7700 0.0 0
M  V30 5 N 10.6697 2.3101 0.0 0
M  V30 6 C 12.0033 3.0801 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 C 2.6673 0.7700 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 1.3337 3.0801 0.0 0
M  V30 11 C 4.0012 0.0000 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 5.3348 0.7700 0.0 0
M  V30 16 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 22344-79-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 65593-07-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-16349701
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 3-Amino-2-carboxamide Tetrahydropyrrolo[2,3-b]quinolines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pilkington, Lisa I.; Haverkate, Natalie A.; van Rensburg, Michelle;
Reynisson, Johannes; Leung, Euphemia; Barker, David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2016), 27(20), 2811-2814

$RFMT $RIREG SCHEME258 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Formylphenyl)-4-methyl-N-2-propen-1-ylbenzenesulfonamide
C17H17NO3S
223526-79-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 4.0011 0.0 0
M  V30 2 S 6.1600 4.0011 0.0 0 VAL=6
M  V30 3 C 3.8500 2.6674 0.0 0
M  V30 4 O 6.1600 5.5411 0.0 0
M  V30 5 O 6.1600 2.4611 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 1.5400 4.0011 0.0 0
M  V30 9 O 0.0000 4.0011 0.0 0
M  V30 10 C 12.3200 4.0011 0.0 0
M  V30 11 C 3.8500 5.3347 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 13 C 4.6200 6.6685 0.0 0
M  V30 14 C 1.5400 6.6685 0.0 0
M  V30 15 C 3.8500 8.0021 0.0 0
M  V30 16 C 2.3100 8.0021 0.0 0
M  V30 17 C 7.7000 4.0011 0.0 0
M  V30 18 C 8.4700 2.6674 0.0 0
M  V30 19 C 8.4700 5.3347 0.0 0
M  V30 20 C 10.0100 2.6674 0.0 0
M  V30 21 C 10.0100 5.3347 0.0 0
M  V30 22 C 10.7800 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 2 17
M  V30 7 1 3 6
M  V30 8 2 6 7
M  V30 9 2 8 9
M  V30 10 1 8 12
M  V30 11 1 10 22
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methyl-N-[2-[(methylimino)methyl]phenyl]-N-2-propen-1-ylbenzenesulfonamide
C18H20N2O2S
1187201-02-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 4.0011 0.0 0
M  V30 2 S 6.9300 4.0011 0.0 0 VAL=6
M  V30 3 C 4.6200 2.6674 0.0 0
M  V30 4 O 6.9300 5.5411 0.0 0
M  V30 5 O 6.9300 2.4611 0.0 0
M  V30 6 C 5.3900 1.3336 0.0 0
M  V30 7 C 4.6200 0.0000 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 N 0.7700 4.0011 0.0 0
M  V30 10 C 0.0000 2.6674 0.0 0
M  V30 11 C 13.0900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3347 0.0 0
M  V30 13 C 3.0800 5.3347 0.0 0
M  V30 14 C 5.3900 6.6685 0.0 0
M  V30 15 C 2.3100 6.6685 0.0 0
M  V30 16 C 4.6200 8.0021 0.0 0
M  V30 17 C 3.0800 8.0021 0.0 0
M  V30 18 C 8.4700 4.0011 0.0 0
M  V30 19 C 9.2400 2.6674 0.0 0
M  V30 20 C 9.2400 5.3347 0.0 0
M  V30 21 C 10.7800 2.6674 0.0 0
M  V30 22 C 10.7800 5.3347 0.0 0
M  V30 23 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 2 18
M  V30 7 1 3 6
M  V30 8 2 6 7
M  V30 9 2 8 9 CFG=2
M  V30 10 1 8 13
M  V30 11 1 9 10
M  V30 12 1 11 23
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 223526-79-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1187201-02-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-12788895
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM molecular sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of diverse heterocyclic scaffolds via tandem additions to imine
derivatives and ring-forming reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sunderhaus, James D.; Dockendorff, Chris; Martin, Stephen F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2009), 65(33), 6454-6469

$RFMT $RIREG SCHEME259 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C72H76N10O8
2242880-79-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  90 101 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 12.5588 10.4617 0.0 0
M  V30 2 O 13.3547 11.7801 0.0 0
M  V30 3 O 13.3026 9.1133 0.0 0
M  V30 4 C 14.8943 11.7501 0.0 0
M  V30 5 C 13.2507 7.9123 0.0 0
M  V30 6 C 14.5843 7.1423 0.0 0
M  V30 7 C 15.9180 7.9123 0.0 0
M  V30 8 N 17.2517 7.1423 0.0 0
M  V30 9 O 15.9180 9.4523 0.0 0
M  V30 10 C 18.5853 7.9123 0.0 0
M  V30 11 C 19.9189 7.1423 0.0 0
M  V30 12 N 21.2525 7.9123 0.0 0
M  V30 13 C 22.5863 7.1423 0.0 0
M  V30 14 C 23.9199 7.9123 0.0 0
M  V30 15 O 22.5863 5.6024 0.0 0
M  V30 16 C 25.2535 7.1423 0.0 0
M  V30 17 O 10.6109 13.2190 0.0 0
M  V30 18 C 6.5347 13.1063 0.0 0
M  V30 19 C 12.8946 4.5657 0.0 0
M  V30 20 C 1.4522 9.3736 0.0 0
M  V30 21 C 0.0000 8.8609 0.0 0
M  V30 22 C 8.0292 0.9152 0.0 0
M  V30 23 C 1.1933 6.0137 0.0 0
M  V30 24 C 4.7084 1.4948 0.0 0
M  V30 25 C 5.0785 0.0000 0.0 0
M  V30 26 C 25.6097 10.4890 0.0 0
M  V30 27 C 25.9454 4.5929 0.0 0
M  V30 28 O 25.1496 3.2746 0.0 0
M  V30 29 O 25.2016 5.9413 0.0 0
M  V30 30 C 23.6099 3.3046 0.0 0
M  V30 31 O 27.8933 1.8356 0.0 0
M  V30 32 C 31.9696 1.9484 0.0 0
M  V30 33 C 30.4750 14.1395 0.0 0
M  V30 34 C 33.7958 13.5598 0.0 0
M  V30 35 C 33.4258 15.0547 0.0 0
M  V30 36 C 37.0521 5.6811 0.0 0
M  V30 37 C 38.5042 6.1937 0.0 0
M  V30 38 C 37.3109 9.0410 0.0 0
M  V30 39 C 10.0583 9.2448 0.0 0
M  V30 40 C 8.6675 9.7398 0.0 0
M  V30 41 C 10.5004 7.7713 0.0 0
M  V30 42 C 11.0192 10.4918 0.0 0 CFG=2
M  V30 43 C 8.6249 11.2945 0.0 0
M  V30 44 N 7.2985 9.1677 0.0 0
M  V30 45 C 11.9171 7.1423 0.0 0 CFG=1
M  V30 46 N 9.4617 6.6201 0.0 0
M  V30 47 C 10.1183 11.7599 0.0 0
M  V30 48 C 7.1081 11.6771 0.0 0
M  V30 49 C 6.2815 10.3601 0.0 0
M  V30 50 C 11.7533 5.5996 0.0 0 CFG=2
M  V30 51 C 10.2346 5.2850 0.0 0
M  V30 52 C 4.7740 10.1092 0.0 0
M  V30 53 C 9.5582 3.9235 0.0 0
M  V30 54 C 4.1311 8.7294 0.0 0
M  V30 55 C 8.0654 3.6708 0.0 0
M  V30 56 C 2.6222 8.3723 0.0 0
M  V30 57 N 4.9414 7.4112 0.0 0
M  V30 58 N 6.9905 4.7808 0.0 0
M  V30 59 C 7.3476 2.2961 0.0 0
M  V30 60 C 2.5024 6.8246 0.0 0
M  V30 61 C 3.9408 6.2427 0.0 0
M  V30 62 C 5.6102 4.1005 0.0 0
M  V30 63 C 5.8180 2.5628 0.0 0
M  V30 64 C 4.2780 4.7830 0.0 0
M  V30 65 C 26.5871 7.9123 0.0 0 CFG=1
M  V30 66 C 28.0039 7.2834 0.0 0
M  V30 67 C 26.7510 9.4550 0.0 0 CFG=2
M  V30 68 C 28.4460 5.8098 0.0 0
M  V30 69 N 29.0426 8.4345 0.0 0
M  V30 70 C 28.2697 9.7697 0.0 0
M  V30 71 C 29.8367 5.3149 0.0 0
M  V30 72 C 27.4851 4.5629 0.0 0 CFG=2
M  V30 73 C 28.9460 11.1311 0.0 0
M  V30 74 C 29.8794 3.7601 0.0 0
M  V30 75 N 31.2058 5.8870 0.0 0
M  V30 76 C 28.3859 3.2947 0.0 0
M  V30 77 C 30.4389 11.3838 0.0 0
M  V30 78 C 31.3961 3.3776 0.0 0
M  V30 79 C 32.2227 4.6946 0.0 0
M  V30 80 N 31.5138 10.2738 0.0 0
M  V30 81 C 31.1566 12.7586 0.0 0
M  V30 82 C 33.7302 4.9454 0.0 0
M  V30 83 C 32.8940 10.9542 0.0 0
M  V30 84 C 32.6863 12.4919 0.0 0
M  V30 85 C 34.3731 6.3252 0.0 0
M  V30 86 C 34.2262 10.2717 0.0 0
M  V30 87 C 35.8820 6.6824 0.0 0
M  V30 88 N 33.5628 7.6434 0.0 0
M  V30 89 C 34.5635 8.8120 0.0 0
M  V30 90 C 36.0018 8.2300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 42 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 45 5 CFG=1
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 1 65 16 CFG=1
M  V30 18 2 17 47
M  V30 19 1 18 48
M  V30 20 1 50 19 CFG=3
M  V30 21 1 20 21
M  V30 22 1 20 56
M  V30 23 1 22 59
M  V30 24 1 23 60
M  V30 25 2 24 25
M  V30 26 1 24 63
M  V30 27 1 67 26 CFG=3
M  V30 28 1 27 28
M  V30 29 2 27 29
M  V30 30 1 72 27 CFG=1
M  V30 31 1 28 30
M  V30 32 2 31 76
M  V30 33 1 32 78
M  V30 34 1 33 81
M  V30 35 2 34 35
M  V30 36 1 34 84
M  V30 37 1 36 37
M  V30 38 1 36 87
M  V30 39 1 38 90
M  V30 40 1 39 40
M  V30 41 2 39 41
M  V30 42 1 39 42
M  V30 43 2 40 43
M  V30 44 1 40 44
M  V30 45 1 41 45
M  V30 46 1 41 46
M  V30 47 1 42 47
M  V30 48 1 43 47
M  V30 49 1 43 48
M  V30 50 1 44 49
M  V30 51 1 45 50
M  V30 52 2 46 51
M  V30 53 2 48 49
M  V30 54 1 49 52
M  V30 55 1 50 51
M  V30 56 1 51 53
M  V30 57 2 52 54
M  V30 58 2 53 55
M  V30 59 1 54 56
M  V30 60 1 54 57
M  V30 61 1 55 58
M  V30 62 1 55 59
M  V30 63 2 56 60
M  V30 64 2 57 61
M  V30 65 1 58 62
M  V30 66 2 59 63
M  V30 67 1 60 61
M  V30 68 1 61 64
M  V30 69 1 62 63
M  V30 70 2 62 64
M  V30 71 1 65 66
M  V30 72 1 65 67
M  V30 73 2 66 68
M  V30 74 1 66 69
M  V30 75 1 67 70
M  V30 76 1 68 71
M  V30 77 1 68 72
M  V30 78 2 69 70
M  V30 79 1 70 73
M  V30 80 2 71 74
M  V30 81 1 71 75
M  V30 82 1 72 76
M  V30 83 2 73 77
M  V30 84 1 74 76
M  V30 85 1 74 78
M  V30 86 1 75 79
M  V30 87 1 77 80
M  V30 88 1 77 81
M  V30 89 2 78 79
M  V30 90 1 79 82
M  V30 91 1 80 83
M  V30 92 2 81 84
M  V30 93 2 82 85
M  V30 94 1 83 84
M  V30 95 2 83 86
M  V30 96 1 85 87
M  V30 97 1 85 88
M  V30 98 1 86 89
M  V30 99 2 87 90
M  V30 100 2 88 89
M  V30 101 1 89 90
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 42 45 50 65 67 72)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C74H86N12O8
2242880-76-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  94 103 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 27.3287 6.4380 0.0 0
M  V30 2 C 25.7924 6.3305 0.0 0
M  V30 3 O 25.1174 4.9463 0.0 0
M  V30 4 O 24.9313 7.6073 0.0 0
M  V30 5 C 23.5811 4.8390 0.0 0
M  V30 6 C 28.7004 4.5450 0.0 0
M  V30 7 N 29.1763 3.0805 0.0 0
M  V30 8 O 27.1941 4.8652 0.0 0
M  V30 9 C 28.1459 1.9359 0.0 0
M  V30 10 C 32.0325 4.1948 0.0 0
M  V30 11 C 24.9433 9.1849 0.0 0
M  V30 12 C 23.6095 9.9549 0.0 0
M  V30 13 C 22.2758 9.1849 0.0 0
M  V30 14 N 20.9422 9.9549 0.0 0
M  V30 15 O 22.2758 7.6449 0.0 0
M  V30 16 C 19.6085 9.1849 0.0 0
M  V30 17 C 18.2747 9.9549 0.0 0
M  V30 18 N 16.9411 9.1849 0.0 0
M  V30 19 C 15.6075 9.9549 0.0 0
M  V30 20 C 14.2738 9.1849 0.0 0
M  V30 21 O 15.6075 11.4949 0.0 0
M  V30 22 C 12.9400 9.9549 0.0 0
M  V30 23 C 25.2935 12.5168 0.0 0
M  V30 24 C 36.6722 7.9521 0.0 0
M  V30 25 C 38.1369 8.4280 0.0 0
M  V30 26 C 37.0224 11.2841 0.0 0
M  V30 27 C 29.9332 16.2741 0.0 0
M  V30 28 C 33.2653 15.9239 0.0 0
M  V30 29 C 32.7894 17.3885 0.0 0
M  V30 30 C 13.4642 6.6457 0.0 0
M  V30 31 C 9.9249 11.9908 0.0 0
M  V30 32 C 11.3809 12.4920 0.0 0
M  V30 33 O 11.6748 14.0039 0.0 0
M  V30 34 O 12.5432 11.4818 0.0 0
M  V30 35 C 13.1310 14.5051 0.0 0
M  V30 36 C 8.1100 13.4641 0.0 0
M  V30 37 N 7.2713 14.7557 0.0 0
M  V30 38 O 9.6478 13.5446 0.0 0
M  V30 39 C 7.9704 16.1278 0.0 0
M  V30 40 C 4.8008 12.9400 0.0 0
M  V30 41 C 9.9549 1.8157 0.0 0
M  V30 42 C 6.6457 1.2914 0.0 0
M  V30 43 C 7.4846 0.0000 0.0 0
M  V30 44 C 1.2916 8.1100 0.0 0
M  V30 45 C 0.0000 7.2711 0.0 0
M  V30 46 C 1.8157 4.8008 0.0 0
M  V30 47 C 29.4108 7.1957 0.0 0
M  V30 48 C 28.0039 7.8221 0.0 0
M  V30 49 C 29.7310 5.6895 0.0 0
M  V30 50 N 30.7445 7.9658 0.0 0
M  V30 51 C 27.6837 9.3286 0.0 0
M  V30 52 C 31.2625 5.5285 0.0 0
M  V30 53 C 31.8888 6.9352 0.0 0
M  V30 54 C 26.2769 9.9549 0.0 0 CFG=1
M  V30 55 N 28.7141 10.4729 0.0 0
M  V30 56 C 33.3953 7.2554 0.0 0
M  V30 57 C 26.4378 11.4864 0.0 0 CFG=2
M  V30 58 C 27.9441 11.8066 0.0 0
M  V30 59 C 34.0216 8.6624 0.0 0
M  V30 60 C 28.5704 13.2135 0.0 0
M  V30 61 C 35.5279 8.9825 0.0 0
M  V30 62 N 33.2516 9.9960 0.0 0
M  V30 63 C 30.0769 13.5337 0.0 0
M  V30 64 C 35.6888 10.5141 0.0 0
M  V30 65 C 34.2820 11.1404 0.0 0
M  V30 66 N 31.2212 12.5031 0.0 0
M  V30 67 C 30.7032 14.9405 0.0 0
M  V30 68 C 33.9618 12.6468 0.0 0
M  V30 69 C 32.5549 13.2731 0.0 0
M  V30 70 C 32.2347 14.7794 0.0 0
M  V30 71 C 11.8511 8.8659 0.0 0 CFG=1
M  V30 72 C 10.3302 9.1068 0.0 0
M  V30 73 C 12.0921 7.3449 0.0 0 CFG=2
M  V30 74 C 9.6310 10.4789 0.0 0
M  V30 75 N 9.6310 7.7347 0.0 0
M  V30 76 C 10.7200 6.6457 0.0 0
M  V30 77 C 8.1100 10.7200 0.0 0
M  V30 78 C 10.4791 5.1247 0.0 0
M  V30 79 C 7.4108 12.0919 0.0 0
M  V30 80 N 7.0210 9.6309 0.0 0
M  V30 81 C 9.1068 4.4255 0.0 0
M  V30 82 C 5.8897 11.8511 0.0 0
M  V30 83 C 5.6489 10.3300 0.0 0
M  V30 84 N 7.7348 5.1247 0.0 0
M  V30 85 C 8.8659 2.9046 0.0 0
M  V30 86 C 4.2766 9.6310 0.0 0
M  V30 87 C 6.6459 4.0357 0.0 0
M  V30 88 C 7.3449 2.6636 0.0 0
M  V30 89 C 4.0357 8.1098 0.0 0
M  V30 90 C 5.1247 4.2766 0.0 0
M  V30 91 C 2.6637 7.4108 0.0 0
M  V30 92 N 5.1248 7.0209 0.0 0
M  V30 93 C 4.4257 5.6487 0.0 0
M  V30 94 C 2.9046 5.8897 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 48
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 49
M  V30 9 1 7 9
M  V30 10 1 10 52
M  V30 11 1 11 12
M  V30 12 1 54 11 CFG=1
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 1 19 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 71 22 CFG=1
M  V30 24 1 57 23 CFG=3
M  V30 25 1 24 25
M  V30 26 1 24 61
M  V30 27 1 26 64
M  V30 28 1 27 67
M  V30 29 2 28 29
M  V30 30 1 28 70
M  V30 31 1 73 30 CFG=3
M  V30 32 1 31 32
M  V30 33 1 31 74
M  V30 34 1 32 33
M  V30 35 2 32 34
M  V30 36 1 33 35
M  V30 37 1 36 37
M  V30 38 2 36 38
M  V30 39 1 36 79
M  V30 40 1 37 39
M  V30 41 1 40 82
M  V30 42 1 41 85
M  V30 43 2 42 43
M  V30 44 1 42 88
M  V30 45 1 44 45
M  V30 46 1 44 91
M  V30 47 1 46 94
M  V30 48 1 47 48
M  V30 49 2 47 49
M  V30 50 1 47 50
M  V30 51 2 48 51
M  V30 52 1 49 52
M  V30 53 1 50 53
M  V30 54 1 51 54
M  V30 55 1 51 55
M  V30 56 2 52 53
M  V30 57 1 53 56
M  V30 58 1 54 57
M  V30 59 2 55 58
M  V30 60 2 56 59
M  V30 61 1 57 58
M  V30 62 1 58 60
M  V30 63 1 59 61
M  V30 64 1 59 62
M  V30 65 2 60 63
M  V30 66 2 61 64
M  V30 67 2 62 65
M  V30 68 1 63 66
M  V30 69 1 63 67
M  V30 70 1 64 65
M  V30 71 1 65 68
M  V30 72 1 66 69
M  V30 73 2 67 70
M  V30 74 2 68 69
M  V30 75 1 69 70
M  V30 76 1 71 72
M  V30 77 1 71 73
M  V30 78 2 72 74
M  V30 79 1 72 75
M  V30 80 1 73 76
M  V30 81 1 74 77
M  V30 82 2 75 76
M  V30 83 1 76 78
M  V30 84 2 77 79
M  V30 85 1 77 80
M  V30 86 2 78 81
M  V30 87 1 79 82
M  V30 88 1 80 83
M  V30 89 1 81 84
M  V30 90 1 81 85
M  V30 91 2 82 83
M  V30 92 1 83 86
M  V30 93 1 84 87
M  V30 94 2 85 88
M  V30 95 2 86 89
M  V30 96 1 87 88
M  V30 97 2 87 90
M  V30 98 1 89 91
M  V30 99 1 89 92
M  V30 100 1 90 93
M  V30 101 2 91 94
M  V30 102 2 92 93
M  V30 103 1 93 94
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 54 57 71 73)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2242880-79-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2242880-76-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-160-CAS-19601128
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2242880-77-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2242880-78-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions also shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dimerization of Pheophorbide a with Activated Carboxylic Group in the
Reaction with Ethylenediamine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Belykh, D. V.; Malshakova, M. V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Journal of General Chemistry (2018), 88(6), 1133-1137

$RFMT $RIREG SCHEME260 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Methyl 1-[(1S)-1-phenylethyl]-1H-pyrazole-3,5-dicarboxylate
C14H14N2O4
2243801-55-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 6.2079 0.0 0 CFG=1
M  V30 2 C 5.3901 7.5415 0.0 0
M  V30 3 C 7.9523 5.8577 0.0 0
M  V30 4 O 9.4586 5.5375 0.0 0
M  V30 5 O 7.4764 7.3222 0.0 0
M  V30 6 C 10.4892 6.6819 0.0 0
M  V30 7 C 5.7473 0.9052 0.0 0
M  V30 8 O 4.3404 0.2787 0.0 0
M  V30 9 O 6.9931 0.0000 0.0 0
M  V30 10 N 5.3901 4.8742 0.0 0
M  V30 11 C 6.9218 4.7131 0.0 0
M  V30 12 N 4.7638 3.4672 0.0 0
M  V30 13 C 7.2420 3.2068 0.0 0
M  V30 14 C 5.9082 2.4368 0.0 0
M  V30 15 C 3.0801 6.2079 0.0 0
M  V30 16 C 2.3101 7.5415 0.0 0
M  V30 17 C 2.3101 4.8742 0.0 0
M  V30 18 C 0.7700 7.5415 0.0 0
M  V30 19 C 0.7700 4.8742 0.0 0
M  V30 20 C 0.0000 6.2079 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 10
M  V30 3 1 1 15
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 11
M  V30 7 1 4 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 14
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methyl 3-[(methylamino)carbonyl]-1-[(1S)-1-phenylethyl]-1H-pyrazole-5-carboxy...
C15H17N3O3
2243801-56-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 5.3196 0.0 0 CFG=1
M  V30 2 C 2.3100 3.9860 0.0 0
M  V30 3 C 5.0494 2.6091 0.0 0
M  V30 4 O 6.0798 1.4647 0.0 0
M  V30 5 O 3.5429 2.2889 0.0 0
M  V30 6 C 5.6039 0.0000 0.0 0
M  V30 7 C 8.2357 6.9949 0.0 0
M  V30 8 N 9.6426 6.3684 0.0 0
M  V30 9 O 8.0747 8.5264 0.0 0
M  V30 10 C 10.8885 7.2736 0.0 0
M  V30 11 N 4.6200 5.3196 0.0 0
M  V30 12 C 5.5252 4.0738 0.0 0
M  V30 13 N 5.5252 6.5655 0.0 0
M  V30 14 C 6.9898 4.5496 0.0 0
M  V30 15 C 6.9898 6.0897 0.0 0
M  V30 16 C 2.3100 6.6533 0.0 0
M  V30 17 C 3.0800 7.9871 0.0 0
M  V30 18 C 0.7700 6.6533 0.0 0
M  V30 19 C 2.3100 9.3207 0.0 0
M  V30 20 C 0.0000 7.9871 0.0 0
M  V30 21 C 0.7700 9.3207 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 11
M  V30 3 1 1 16
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 12
M  V30 7 1 4 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 15
M  V30 11 1 8 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2243801-55-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2243801-56-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33528304
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fragment-based Scaffold Hopping: Identification of Potent, Selective, and
Highly Soluble Bromo and Extra Terminal Domain (BET) Second Bromodomain
(BD2) Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Seal, Jonathan T.; Atkinson, Stephen J.; Bamborough, Paul; Bassil, Anna;
Chung, Chun-wa; Foley, James; Gordon, Laurie; Grandi, Paola; Gray, James
R. J.; Harrison, Lee A.; Kruger, Ryan G.; Matteo, Jeanne J.; McCabe,
Michael T.; Messenger, Cassie; Mitchell, Darren; Phillipou, Alex;
Preston, Alex; Prinjha, Rab K.; Rianjongdee, Francesco; Rioja,
Inmaculada; Taylor, Simon; Wall, Ian D.; Watson, Robert J.; Woolven,
James M.; Wyce, Anastasia; Zhang, Xi-Ping; Demont, Emmanuel H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(15), 10772-10805

$RFMT $RIREG SCHEME260 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Methyl 1-[(1S)-1-phenylethyl]-1H-pyrazole-3,5-dicarboxylate
C14H14N2O4
2243801-55-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 6.2079 0.0 0 CFG=1
M  V30 2 C 5.3901 7.5415 0.0 0
M  V30 3 C 7.9523 5.8577 0.0 0
M  V30 4 O 9.4586 5.5375 0.0 0
M  V30 5 O 7.4764 7.3222 0.0 0
M  V30 6 C 10.4892 6.6819 0.0 0
M  V30 7 C 5.7473 0.9052 0.0 0
M  V30 8 O 4.3404 0.2787 0.0 0
M  V30 9 O 6.9931 0.0000 0.0 0
M  V30 10 N 5.3901 4.8742 0.0 0
M  V30 11 C 6.9218 4.7131 0.0 0
M  V30 12 N 4.7638 3.4672 0.0 0
M  V30 13 C 7.2420 3.2068 0.0 0
M  V30 14 C 5.9082 2.4368 0.0 0
M  V30 15 C 3.0801 6.2079 0.0 0
M  V30 16 C 2.3101 7.5415 0.0 0
M  V30 17 C 2.3101 4.8742 0.0 0
M  V30 18 C 0.7700 7.5415 0.0 0
M  V30 19 C 0.7700 4.8742 0.0 0
M  V30 20 C 0.0000 6.2079 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 10
M  V30 3 1 1 15
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 11
M  V30 7 1 4 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 14
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methyl 3-[(methylamino)carbonyl]-1-[(1S)-1-phenylethyl]-1H-pyrazole-5-carboxy...
C15H17N3O3
2243801-56-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 5.3196 0.0 0 CFG=1
M  V30 2 C 2.3100 3.9860 0.0 0
M  V30 3 C 5.0494 2.6091 0.0 0
M  V30 4 O 6.0798 1.4647 0.0 0
M  V30 5 O 3.5429 2.2889 0.0 0
M  V30 6 C 5.6039 0.0000 0.0 0
M  V30 7 C 8.2357 6.9949 0.0 0
M  V30 8 N 9.6426 6.3684 0.0 0
M  V30 9 O 8.0747 8.5264 0.0 0
M  V30 10 C 10.8885 7.2736 0.0 0
M  V30 11 N 4.6200 5.3196 0.0 0
M  V30 12 C 5.5252 4.0738 0.0 0
M  V30 13 N 5.5252 6.5655 0.0 0
M  V30 14 C 6.9898 4.5496 0.0 0
M  V30 15 C 6.9898 6.0897 0.0 0
M  V30 16 C 2.3100 6.6533 0.0 0
M  V30 17 C 3.0800 7.9871 0.0 0
M  V30 18 C 0.7700 6.6533 0.0 0
M  V30 19 C 2.3100 9.3207 0.0 0
M  V30 20 C 0.0000 7.9871 0.0 0
M  V30 21 C 0.7700 9.3207 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 11
M  V30 3 1 1 16
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 12
M  V30 7 1 4 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 15
M  V30 11 1 8 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2243801-55-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2243801-56-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20524281
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazole derivatives as bromodomain inhibitors for
treatment of cancer, inflammatory disorders, and autoimmune diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Atkinson, Stephen John; Demont, Emmanuel Hubert; Harrison, Lee Andrew;
Liwicki, Gemma Michele; Lucas, Simon Christopher Cranko; Preston,
Alexander G.; Seal, Jonathan Thomas; Wall, Ian David; Watson, Robert J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018158212 A1 2018-09-07

$RFMT $RIREG SCHEME261 STEP1
$RXN



  2  1
$MOL
2-Chloro-4-fluorobenzoic acid
C7H4ClFO2
2252-51-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 F 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-4-fluoro-N-methylbenzamide
C8H7ClFNO
292151-90-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 2.6673 0.0 0
M  V30 2 N 1.5400 4.0010 0.0 0
M  V30 3 O 1.5400 1.3337 0.0 0
M  V30 4 C 0.0000 4.0010 0.0 0
M  V30 5 Cl 3.8501 0.0000 0.0 0
M  V30 6 F 8.4702 2.6673 0.0 0
M  V30 7 C 3.8501 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 6.1601 1.3337 0.0 0
M  V30 11 C 6.1601 4.0010 0.0 0
M  V30 12 C 6.9302 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2252-51-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 292151-90-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-4621838
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 27. 2'-Methyl-5-(4-methyl-piperazin-1-yl)-biphenyl-2-carboxylic
acid (3,5-bis-trifluoromethyl-benzyl)-methyl-amide. a)
2-Chloro-4-fluoro-N-methyl-benzamid. To 1.00 g (5.73 mmol) of
2-chloro-4-fluorobenzoic acid were added 4.16 ml (57.3 mmol) thionyl
chloride and 3 drops of DMF at 0°. After heating the mixture at reflux
over night excess thionyl chloride was removed by distillation. The oily
brown residue was dissolved in 5 ml CH2Cl2. The solution was treated with
methyl amine gas at 0 °C. until no exothermic reaction was observed any
longer. The resulting suspension was diluted with 20 ml CH2Cl2/H2O. The
layers were separated and the aqueous layer extracted with 3 10-ml
portions of CH2Cl2. Drying of the organic layer (Na2SO4) and evaporation.
Yield: 1.07 g (99.6%), light yellow solid. MS (EI): 187 (M+).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of biphenyl derivatives as antagonists of the neurokinin-1
receptor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Boes, Michael; Galley, Guido; Godel, Thierry; Hoffmann, Torsten;
Hunkeler, Walter; Schnider, Patrick; Stadler, Heinz
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000053572 A1 2000-09-14

$RFMT $RIREG SCHEME262 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-2-benzofurancarbonyl chloride
C10H7ClO2
2256-86-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0205 0.1773 0.0 0
M  V30 2 C 6.0811 1.5400 0.0 0
M  V30 3 Cl 7.4149 2.3100 0.0 0
M  V30 4 O 6.0811 0.0000 0.0 0
M  V30 5 C 2.3100 2.8281 0.0 0
M  V30 6 C 3.0801 4.1618 0.0 0
M  V30 7 C 3.3406 1.6836 0.0 0
M  V30 8 C 0.7700 2.8281 0.0 0
M  V30 9 O 4.5865 3.8416 0.0 0
M  V30 10 C 2.3100 5.4954 0.0 0
M  V30 11 C 4.7474 2.3100 0.0 0
M  V30 12 C 0.0000 4.1618 0.0 0
M  V30 13 C 0.7700 5.4954 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,3-Dimethyl-2-benzofurancarboxamide
C11H11NO2
52819-45-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6078 0.0000 0.0 0
M  V30 2 C 6.5770 2.7104 0.0 0
M  V30 3 N 7.3470 4.0442 0.0 0
M  V30 4 O 7.3470 1.3768 0.0 0
M  V30 5 C 8.8870 4.0442 0.0 0
M  V30 6 C 2.6673 3.4804 0.0 0
M  V30 7 C 2.6673 1.9404 0.0 0
M  V30 8 O 4.1320 3.9564 0.0 0
M  V30 9 C 1.3336 4.2504 0.0 0
M  V30 10 C 4.1320 1.4645 0.0 0
M  V30 11 C 1.3336 1.1704 0.0 0
M  V30 12 C 5.0370 2.7104 0.0 0
M  V30 13 C 0.0000 3.4804 0.0 0
M  V30 14 C 0.0000 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2256-86-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 52819-45-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-10573794
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Prodrug derivatives of
(E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Partridge, John J.; Colucci, John; Gareau, Yves; Therien, Michel;
Zamboni, Robert; Hafkin, Barry; Marfat, Anthony; Zaghdane, Helmi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013190384 A1 2013-12-27

$RFMT $RIREG SCHEME263 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-[6-bromo-2,3,4,9-tetrahydro-3-[[[(4-methylphenyl)sulfonyl]ox...
C25H29BrN2O5S
2259833-98-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 12.2649 5.8615 0.0 0
M  V30 2 C 13.0349 7.1951 0.0 0
M  V30 3 O 14.5749 7.1951 0.0 0
M  V30 4 O 12.2649 8.5289 0.0 0
M  V30 5 C 15.3449 8.5289 0.0 0
M  V30 6 C 16.6787 7.7589 0.0 0
M  V30 7 C 16.1149 9.8626 0.0 0
M  V30 8 C 14.0113 9.2990 0.0 0
M  V30 9 C 7.6448 8.5289 0.0 0
M  V30 10 O 6.1048 8.5289 0.0 0
M  V30 11 S 5.3348 9.8626 0.0 0 VAL=6
M  V30 12 O 4.5648 11.1963 0.0 0
M  V30 13 O 6.6686 10.6326 0.0 0
M  V30 14 Br 4.9643 0.2787 0.0 0
M  V30 15 C 0.0000 6.7826 0.0 0
M  V30 16 C 9.9549 4.5278 0.0 0
M  V30 17 C 8.4148 4.5278 0.0 0
M  V30 18 C 10.7249 5.8615 0.0 0
M  V30 19 N 10.4309 3.0631 0.0 0
M  V30 20 C 7.9390 3.0631 0.0 0
M  V30 21 C 7.6448 5.8615 0.0 0
M  V30 22 C 9.9549 7.1951 0.0 0
M  V30 23 C 9.1848 2.1579 0.0 0
M  V30 24 C 6.5322 2.4368 0.0 0
M  V30 25 C 8.4148 7.1951 0.0 0
M  V30 26 C 9.0239 0.6263 0.0 0
M  V30 27 C 6.3711 0.9052 0.0 0
M  V30 28 C 7.6171 0.0000 0.0 0
M  V30 29 C 4.0011 9.0926 0.0 0
M  V30 30 C 2.6675 9.8626 0.0 0
M  V30 31 C 4.0011 7.5526 0.0 0
M  V30 32 C 1.3338 9.0926 0.0 0
M  V30 33 C 2.6675 6.7826 0.0 0
M  V30 34 C 1.3338 7.5526 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 9 25
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 2 11 13
M  V30 14 1 11 29
M  V30 15 1 14 27
M  V30 16 1 15 34
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 20 23
M  V30 25 2 20 24
M  V30 26 1 21 25
M  V30 27 1 22 25
M  V30 28 2 23 26
M  V30 29 1 24 27
M  V30 30 1 26 28
M  V30 31 2 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C19H26BrN3O2
2259834-09-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.1141 6.9302 0.0 0
M  V30 2 C 10.4477 6.1601 0.0 0
M  V30 3 O 11.7814 6.9302 0.0 0
M  V30 4 O 10.4477 4.6201 0.0 0
M  V30 5 C 13.1152 6.1601 0.0 0
M  V30 6 C 13.8853 7.4938 0.0 0
M  V30 7 C 14.4489 5.3901 0.0 0
M  V30 8 C 12.3452 4.8263 0.0 0
M  V30 9 C 6.4466 2.3101 0.0 0
M  V30 10 N 5.1129 1.5400 0.0 0
M  V30 11 C 5.1129 0.0000 0.0 0
M  V30 12 Br 0.0000 8.1144 0.0 0
M  V30 13 C 5.1129 6.1601 0.0 0
M  V30 14 C 6.4466 6.9302 0.0 0
M  V30 15 C 3.9685 7.1906 0.0 0
M  V30 16 C 5.1129 4.6201 0.0 0
M  V30 17 C 7.7802 6.1601 0.0 0
M  V30 18 N 6.1264 8.4365 0.0 0
M  V30 19 C 4.5948 8.5974 0.0 0
M  V30 20 C 2.4368 7.0296 0.0 0
M  V30 21 C 6.4466 3.8501 0.0 0
M  V30 22 C 7.7802 4.6201 0.0 0
M  V30 23 C 3.6896 9.8433 0.0 0
M  V30 24 C 1.5316 8.2755 0.0 0
M  V30 25 C 2.1580 9.6823 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 1 12 24
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 2 15 20
M  V30 20 1 16 21
M  V30 21 1 17 22
M  V30 22 1 18 19
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 1 21 22
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2259833-98-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2259834-09-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-21932213
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Therapeutic compounds and methods to treat infection
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lavoie, Edmond J.; Parhi, Ajit; Sagong, Hye Yeon
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019005841 A1 2019-01-03

$RFMT $RIREG SCHEME264 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-1-(3-phenylpropyl)[1,2,4]triazolo[4,3-a]quinoxaline
C18H15ClN4
2260626-65-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6517 5.3302 0.0 0
M  V30 2 C 7.6823 6.4748 0.0 0
M  V30 3 C 9.1886 6.1546 0.0 0
M  V30 4 Cl 0.0000 5.3900 0.0 0
M  V30 5 N 4.0009 4.6200 0.0 0
M  V30 6 C 4.0009 3.0800 0.0 0
M  V30 7 C 2.6673 5.3900 0.0 0
M  V30 8 C 5.1454 5.6504 0.0 0
M  V30 9 C 2.6673 2.3100 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 1.3336 4.6200 0.0 0
M  V30 12 N 2.9874 6.8963 0.0 0
M  V30 13 N 4.5191 7.0574 0.0 0
M  V30 14 N 1.3336 3.0800 0.0 0
M  V30 15 C 2.6673 0.7700 0.0 0
M  V30 16 C 5.3347 0.7700 0.0 0
M  V30 17 C 4.0009 0.0000 0.0 0
M  V30 18 C 10.2190 7.2990 0.0 0
M  V30 19 C 11.7254 6.9788 0.0 0
M  V30 20 C 9.7431 8.7637 0.0 0
M  V30 21 C 12.7558 8.1232 0.0 0
M  V30 22 C 10.7737 9.9081 0.0 0
M  V30 23 C 12.2800 9.5879 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 18
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 2 7 12
M  V30 13 2 8 13
M  V30 14 1 9 14
M  V30 15 2 9 15
M  V30 16 1 10 16
M  V30 17 2 11 14
M  V30 18 1 12 13
M  V30 19 1 15 17
M  V30 20 2 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[1,2,4]Triazolo[4,3-a]quinoxalin-4-amine, N-methyl-1-(3-phenylpropyl)-
C19H19N5
2529934-38-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9855 5.3302 0.0 0
M  V30 2 C 9.0159 6.4748 0.0 0
M  V30 3 C 10.5222 6.1546 0.0 0
M  V30 4 N 1.3336 5.3900 0.0 0
M  V30 5 C 0.0000 4.6200 0.0 0
M  V30 6 N 5.3347 4.6200 0.0 0
M  V30 7 C 5.3347 3.0800 0.0 0
M  V30 8 C 4.0009 5.3900 0.0 0
M  V30 9 C 6.4791 5.6504 0.0 0
M  V30 10 C 4.0009 2.3100 0.0 0
M  V30 11 C 6.6684 2.3100 0.0 0
M  V30 12 C 2.6673 4.6200 0.0 0
M  V30 13 N 4.3211 6.8963 0.0 0
M  V30 14 N 5.8528 7.0574 0.0 0
M  V30 15 N 2.6673 3.0800 0.0 0
M  V30 16 C 4.0009 0.7700 0.0 0
M  V30 17 C 6.6684 0.7700 0.0 0
M  V30 18 C 5.3347 0.0000 0.0 0
M  V30 19 C 11.5528 7.2990 0.0 0
M  V30 20 C 13.0590 6.9788 0.0 0
M  V30 21 C 11.0768 8.7637 0.0 0
M  V30 22 C 14.0895 8.1232 0.0 0
M  V30 23 C 12.1073 9.9081 0.0 0
M  V30 24 C 13.6136 9.5879 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 19
M  V30 5 1 4 5
M  V30 6 1 4 12
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 2 8 13
M  V30 14 2 9 14
M  V30 15 1 10 15
M  V30 16 2 10 16
M  V30 17 1 11 17
M  V30 18 2 12 15
M  V30 19 1 13 14
M  V30 20 1 16 18
M  V30 21 2 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2260626-65-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2529934-38-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-22841578
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of [1,2,4]triazolo[4,3-a]quinoxaline-1,3,4-oxadiazole
derivatives as potent antiproliferative agents via a hybrid pharmacophore
approach
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kaneko, Daiki; Ninomiya, Masayuki; Yoshikawa, Rina; Ono, Yukari;
Sonawane, Amol D.; Tanaka, Kaori; Nishina, Atsuyoshi; Koketsu, Mamoru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic Chemistry (2020), 104104293

$RFMT $RIREG SCHEME265 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[3-[(1R)-3-Chloro-1-phenylpropoxy]phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxabo...
C21H26BClO3
2260747-51-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.4918 7.9364 0.0 0
M  V30 2 C 0.6089 7.0982 0.0 0
M  V30 3 C 0.0000 6.0432 0.0 0
M  V30 4 C 0.2153 3.9936 0.0 0
M  V30 5 O 9.0180 4.6201 0.0 0
M  V30 6 C 10.3518 3.8501 0.0 0 CFG=1
M  V30 7 C 10.3518 2.3101 0.0 0
M  V30 8 C 11.6855 1.5400 0.0 0
M  V30 9 Cl 11.6855 0.0000 0.0 0
M  V30 10 B 3.6831 4.6201 0.0 0
M  V30 11 O 3.5222 6.1517 0.0 0
M  V30 12 O 2.2763 3.9936 0.0 0
M  V30 13 C 2.0159 6.4718 0.0 0
M  V30 14 C 1.2459 5.1382 0.0 0
M  V30 15 C 5.0170 3.8501 0.0 0
M  V30 16 C 6.3506 4.6201 0.0 0
M  V30 17 C 5.0170 2.3101 0.0 0
M  V30 18 C 7.6843 3.8501 0.0 0
M  V30 19 C 6.3506 1.5400 0.0 0
M  V30 20 C 7.6843 2.3101 0.0 0
M  V30 21 C 11.6855 4.6201 0.0 0
M  V30 22 C 11.6855 6.1601 0.0 0
M  V30 23 C 13.0191 3.8501 0.0 0
M  V30 24 C 13.0191 6.9302 0.0 0
M  V30 25 C 14.3528 4.6201 0.0 0
M  V30 26 C 14.3528 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 13
M  V30 3 1 3 14
M  V30 4 1 4 14
M  V30 5 1 5 6
M  V30 6 1 5 18
M  V30 7 1 6 7 CFG=1
M  V30 8 1 6 21
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 15
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(γR)-N-Methyl-γ-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]benze...
C22H30BNO3
2260747-52-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.2114 4.3919 0.0 0
M  V30 2 C 0.0000 6.0593 0.0 0
M  V30 3 C 0.0000 7.2775 0.0 0
M  V30 4 C 1.2114 8.9447 0.0 0
M  V30 5 O 8.5215 4.0009 0.0 0
M  V30 6 C 10.0615 4.0009 0.0 0 CFG=1
M  V30 7 C 10.8315 5.3347 0.0 0
M  V30 8 C 12.3715 5.3347 0.0 0
M  V30 9 N 13.1415 6.6684 0.0 0
M  V30 10 C 14.6815 6.6684 0.0 0
M  V30 11 B 3.9015 6.6684 0.0 0
M  V30 12 O 2.9962 5.4225 0.0 0
M  V30 13 O 2.9962 7.9143 0.0 0
M  V30 14 C 1.5315 5.8984 0.0 0
M  V30 15 C 1.5315 7.4384 0.0 0
M  V30 16 C 5.4415 6.6684 0.0 0
M  V30 17 C 6.2115 5.3347 0.0 0
M  V30 18 C 6.2115 8.0020 0.0 0
M  V30 19 C 7.7515 5.3347 0.0 0
M  V30 20 C 7.7515 8.0020 0.0 0
M  V30 21 C 8.5215 6.6684 0.0 0
M  V30 22 C 10.8315 2.6673 0.0 0
M  V30 23 C 10.0615 1.3336 0.0 0
M  V30 24 C 12.3715 2.6673 0.0 0
M  V30 25 C 10.8315 0.0000 0.0 0
M  V30 26 C 13.1415 1.3336 0.0 0
M  V30 27 C 12.3715 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 14
M  V30 3 1 3 15
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 1 5 19
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 22
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 16
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2260747-51-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2260747-52-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-21483405
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Arylpyrimidines and related compounds having multimodal activity against
pain and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yenes-Minguez, Susana; Almansa-Rosales, Carmen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019002173 A1 2019-01-03

$RFMT $RIREG SCHEME266 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3,2-Dioxaborolane, 2-[3-[3-chloro-1-(2-thienyl)propoxy]phenyl]-4,4,5,5-tetr...
C19H24BClO3S
2260747-58-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.4919 7.9364 0.0 0
M  V30 2 C 0.6091 7.0981 0.0 0
M  V30 3 C 0.0000 6.0432 0.0 0
M  V30 4 C 0.2154 3.9936 0.0 0
M  V30 5 O 9.0181 4.6201 0.0 0
M  V30 6 C 10.3519 3.8501 0.0 0
M  V30 7 C 10.3519 2.3100 0.0 0
M  V30 8 C 11.6855 1.5400 0.0 0
M  V30 9 Cl 11.6855 0.0000 0.0 0
M  V30 10 B 3.6833 4.6201 0.0 0
M  V30 11 O 3.5223 6.1516 0.0 0
M  V30 12 O 2.2765 3.9936 0.0 0
M  V30 13 C 2.0160 6.4718 0.0 0
M  V30 14 C 1.2460 5.1381 0.0 0
M  V30 15 C 5.0171 3.8501 0.0 0
M  V30 16 C 6.3508 4.6201 0.0 0
M  V30 17 C 5.0171 2.3100 0.0 0
M  V30 18 C 7.6844 3.8501 0.0 0
M  V30 19 C 6.3508 1.5400 0.0 0
M  V30 20 C 7.6844 2.3100 0.0 0
M  V30 21 C 11.6855 4.6201 0.0 0
M  V30 22 C 11.8465 6.1516 0.0 0
M  V30 23 S 13.0924 3.9936 0.0 0
M  V30 24 C 13.3529 6.4718 0.0 0
M  V30 25 C 14.1229 5.1381 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 13
M  V30 3 1 3 14
M  V30 4 1 4 14
M  V30 5 1 5 6
M  V30 6 1 5 18
M  V30 7 1 6 7
M  V30 8 1 6 21
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 15
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-γ-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]-2-thiophe...
C20H28BNO3S
2260747-59-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.2114 4.1621 0.0 0
M  V30 2 C 0.0000 5.8293 0.0 0
M  V30 3 C 0.0000 7.0475 0.0 0
M  V30 4 C 1.2114 8.7147 0.0 0
M  V30 5 O 8.5216 3.7711 0.0 0
M  V30 6 C 10.0616 3.7711 0.0 0
M  V30 7 C 10.8316 5.1047 0.0 0
M  V30 8 C 12.3717 5.1047 0.0 0
M  V30 9 N 13.1417 6.4384 0.0 0
M  V30 10 C 14.6817 6.4384 0.0 0
M  V30 11 B 3.9015 6.4384 0.0 0
M  V30 12 O 2.9963 5.1925 0.0 0
M  V30 13 O 2.9963 7.6843 0.0 0
M  V30 14 C 1.5316 5.6684 0.0 0
M  V30 15 C 1.5316 7.2084 0.0 0
M  V30 16 C 5.4415 6.4384 0.0 0
M  V30 17 C 6.2116 5.1047 0.0 0
M  V30 18 C 6.2116 7.7721 0.0 0
M  V30 19 C 7.7516 5.1047 0.0 0
M  V30 20 C 7.7516 7.7721 0.0 0
M  V30 21 C 8.5216 6.4384 0.0 0
M  V30 22 C 10.8316 2.4373 0.0 0
M  V30 23 C 10.2052 1.0304 0.0 0
M  V30 24 S 12.3632 2.2763 0.0 0
M  V30 25 C 11.3497 0.0000 0.0 0
M  V30 26 C 12.6834 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 14
M  V30 3 1 3 15
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 1 5 19
M  V30 7 1 6 7
M  V30 8 1 6 22
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 16
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2260747-58-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2260747-59-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-21483415
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Arylpyrimidines and related compounds having multimodal activity against
pain and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yenes-Minguez, Susana; Almansa-Rosales, Carmen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019002173 A1 2019-01-03

$RFMT $RIREG SCHEME267 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1′-[(1,1-Dimethylethoxy)carbonyl]-2-oxo[1,4′-bipiperidine]-3-acetic acid
C17H28N2O5
226916-79-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.6696 4.6200 0.0 0
M  V30 2 C 13.3369 3.0800 0.0 0
M  V30 3 C 14.6705 2.3100 0.0 0
M  V30 4 O 16.0043 3.0800 0.0 0
M  V30 5 O 14.6705 0.7700 0.0 0
M  V30 6 C 4.0011 5.3900 0.0 0
M  V30 7 O 2.6674 4.6200 0.0 0
M  V30 8 O 4.0011 6.9300 0.0 0
M  V30 9 C 1.3338 5.3900 0.0 0
M  V30 10 C 0.5638 4.0564 0.0 0
M  V30 11 C 0.0000 6.1600 0.0 0
M  V30 12 C 2.1038 6.7236 0.0 0
M  V30 13 N 9.3358 2.3100 0.0 0
M  V30 14 C 10.6696 3.0800 0.0 0
M  V30 15 C 9.3358 0.7700 0.0 0
M  V30 16 C 12.0032 2.3100 0.0 0
M  V30 17 C 10.6696 0.0000 0.0 0
M  V30 18 C 12.0032 0.7700 0.0 0
M  V30 19 C 8.0021 3.0800 0.0 0
M  V30 20 C 8.0021 4.6200 0.0 0
M  V30 21 C 6.6685 2.3100 0.0 0
M  V30 22 C 6.6685 5.3900 0.0 0
M  V30 23 C 5.3347 3.0800 0.0 0
M  V30 24 N 5.3347 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 1 2 3
M  V30 3 1 2 16
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 24
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-oxo[1,4′-bipiperidine]-3-acetamide
C13H23N3O2
226916-95-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 0.7700 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 N 10.6697 2.3101 0.0 0
M  V30 5 O 9.3360 4.6201 0.0 0
M  V30 6 C 12.0033 3.0801 0.0 0
M  V30 7 N 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 6.6685 3.0801 0.0 0
M  V30 11 C 5.3348 5.3901 0.0 0
M  V30 12 C 6.6685 4.6201 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 2.6673 0.7700 0.0 0
M  V30 15 C 1.3337 3.0801 0.0 0
M  V30 16 C 1.3337 0.0000 0.0 0
M  V30 17 C 0.0000 2.3101 0.0 0
M  V30 18 N 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 3
M  V30 3 1 2 10
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 226916-79-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 226916-95-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-5002877
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 869-24-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification of a novel
1'-[5-((3,5-dichlorobenzoyl)methylamino)-3-(3,4-dichlorophenyl)-4-(methoxyimino)pentyl]-2-oxo-(1,4'-bipiperidine)
as a dual NK1/NK2 antagonist
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ting, Pauline C.; Lee, Joe F.; Shih, Neng-Yang; Piwinski, John J.;
Anthes, John C.; Chapman, Richard W.; Rizzo, Charles A.; Hey, John A.;
Ng, Kwokei; Nomeir, Amin A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2002), 12(16), 2125-2128

$RFMT $RIREG SCHEME268 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Ethoxybenzaldehyde
C9H10O2
22924-15-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 C 1.3337 3.0801 0.0 0
M  V30 5 O 0.0000 2.3101 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Ethoxy-N-methylbenzenemethanamine
C10H15NO
893581-62-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 3.0801 0.0 0
M  V30 2 N 9.3360 2.3101 0.0 0
M  V30 3 C 10.6697 3.0801 0.0 0
M  V30 4 O 2.6673 3.0801 0.0 0
M  V30 5 C 1.3337 2.3101 0.0 0
M  V30 6 C 0.0000 3.0801 0.0 0
M  V30 7 C 5.3348 3.0801 0.0 0
M  V30 8 C 6.6685 2.3101 0.0 0
M  V30 9 C 4.0012 2.3101 0.0 0
M  V30 10 C 6.6685 0.7700 0.0 0
M  V30 11 C 4.0012 0.7700 0.0 0
M  V30 12 C 5.3348 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 22924-15-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 893581-62-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-11793774
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: To a solution of an aldehyde (1 equiv) in
methanol was added an amine derivative (1 equiv). After stirring at room
temperature for 15 min, the solution was cooled to 0 °C prior to the
addition of sodium borohydride (0.5 equiv) portion wise. The resulting
solution was stirred at room temperature for 1 h. After the addition of
water (3 mL), methanol was removed under reduced pressure and the
resulting aqueous phase was extracted with DCM. The combined extracts
were dried over Na2SO4 and concentrated in vacuo to give 5-1 in
quantitative yield. Yield quantitative.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolylphenyl urea and carbamate compounds and analogs
as kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Feng, Yangbo; Lograsso, Philip; Schroeter, Thomas; Yin, Yan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010036316 A1 2010-04-01

$RFMT $RIREG SCHEME269 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2-Hydroxyphenyl)-2-pyridinylmethanone
C12H9NO2
22945-62-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 O 4.0011 0.0000 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 C 2.6674 2.3100 0.0 0
M  V30 5 C 1.3336 1.5400 0.0 0
M  V30 6 C 2.6674 3.8500 0.0 0
M  V30 7 C 0.0000 2.3100 0.0 0
M  V30 8 C 1.3336 4.6200 0.0 0
M  V30 9 C 0.0000 3.8500 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 6.6685 1.5400 0.0 0
M  V30 12 N 5.3347 3.8500 0.0 0
M  V30 13 C 8.0021 2.3100 0.0 0
M  V30 14 C 6.6685 4.6200 0.0 0
M  V30 15 C 8.0021 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 1 10
M  V30 4 1 3 5
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(Methylimino)-2-pyridinylmethyl]phenol
C13H12N2O
1182372-34-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 N 4.0011 0.7700 0.0 0
M  V30 3 C 5.3347 0.0000 0.0 0
M  V30 4 O 1.3336 0.7700 0.0 0
M  V30 5 C 2.6674 3.0800 0.0 0
M  V30 6 C 1.3336 2.3100 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 C 0.0000 3.0800 0.0 0
M  V30 9 C 1.3336 5.3900 0.0 0
M  V30 10 C 0.0000 4.6200 0.0 0
M  V30 11 C 5.3347 3.0800 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 N 6.6685 2.3100 0.0 0
M  V30 14 C 6.6685 5.3900 0.0 0
M  V30 15 C 8.0021 3.0800 0.0 0
M  V30 16 C 8.0021 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 1 11
M  V30 4 1 2 3
M  V30 5 1 4 6
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 22945-62-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1182372-34-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-8915136
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Typical Procedure On one side of an H-tube,
the described ketone was added, and to the other side, aqueous amine
solution or neat amine was added. The tube was sealed immediately with a
rubber seal stopper, and the reaction was monitored by 1H NMR
spectrometry. The excess ammonia or amine gas was removed under reduced
pressure to give the corresponding imine.
2-[(Methylimino)(pyridin-2-yl)methyl]phenol (3c) Employing the general
method, imine (3c) was prepared from ketone (1a) (50mg, 0.25 mmol) and
40% methylamine aq. solution (2mL). After 3.5 h, the yellow solid of the
ketone was converted to an orange oil of (3c) with 100% conversion. The
excessmethylamine was removed under reduced pressure to give the title
compound (3c) as a yellow solid (53mg, 100%). Mp 77-78°C. 1H NMR (400MHz,
CDCl3) δ 3.17 (s, 3H), 6.63 (t, J = 7.3Hz, 1H), 6.67 (dd, J = 2.1, 7.9Hz,
1H), 6.98 (dd, J = 0.4, 8.3Hz, 1H), 7.24 (dd, J = 2.1, 6.7Hz, 1H), 7.27
(dt, J = 1.1, 7.7Hz, 1H), 7.41 (dd, J = 4.9, 7.7Hz, 1H), 7.86 (dt, J =
1.8, 7.7Hz, 1H), 8.80 (d, J = 4.9Hz, 1H). 13C NMR (100MHz, CDCl3) δ
38.32, 117.38, 118.02, 119.07, 123.12, 123.67, 130.56, 132.29, 136.55,
150.26, 152.78, 163.23, 172.91. IR (neat) νmax 1610s, 1578m, 1496m,
1450m, 1334m, 1306m, 1260m, 1005m, 755s cm-1. Ms calc. (found) for
C14H14NO+ (M + H+): m/z 212.2 (212.0, 100%). HRMS calc. (found) for
C14H14NO+ (M + H+): m/z 212.1075 (212.1071).
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed H-tube used, 100% conversion
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Simplified Ketimine Preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Thienthong, Neeranat; Bergman, Ylva E.; Perlmutter, Patrick
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2009), 39(15), 2683-2693

$RFMT $RIREG SCHEME270 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-2-methoxybenzenesulfonyl chloride
C7H6Cl2O3S
22952-32-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.3100 1.3338 0.0 0 VAL=6
M  V30 2 Cl 1.5400 0.0000 0.0 0
M  V30 3 O 0.9764 2.1038 0.0 0
M  V30 4 O 3.6436 0.5638 0.0 0
M  V30 5 O 0.7700 4.0011 0.0 0
M  V30 6 C 0.0000 5.3349 0.0 0
M  V30 7 Cl 6.9300 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 5 6
M  V30 6 1 5 9
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-2-methoxy-N-methylbenzenesulfonamide
C8H10ClNO3S
364067-04-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.3101 5.3348 0.0 0 VAL=6
M  V30 2 N 1.5400 6.6687 0.0 0
M  V30 3 O 0.9764 4.5648 0.0 0
M  V30 4 O 3.6437 6.1048 0.0 0
M  V30 5 C 0.0000 6.6687 0.0 0
M  V30 6 O 5.3901 5.3348 0.0 0
M  V30 7 C 6.9302 5.3348 0.0 0
M  V30 8 Cl 2.3101 0.0000 0.0 0
M  V30 9 C 3.0801 4.0012 0.0 0
M  V30 10 C 4.6201 4.0012 0.0 0
M  V30 11 C 2.3101 2.6675 0.0 0
M  V30 12 C 5.3901 2.6675 0.0 0
M  V30 13 C 3.0801 1.3338 0.0 0
M  V30 14 C 4.6201 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 1 6 10
M  V30 8 1 8 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 22952-32-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 364067-04-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-6926803
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 5-Chloro-2-methoxy-N-methyl-benzenesulfonamide To a solution of
5-Chloro-2-methoxy-benzenesulfonyl chloride (1.0g, 4.15 mmol) in
tetrahydrofuran(8ml) was bubbled methylamine gas until saturated. The
reaction mixture was sealed with a septa and stirred overnight at ambient
temperature. The reaction mixture was then concentrated, triterated in
dichloromethane and ether, filtered and dried yielding the above titled
compound 1.05 g (>100%) white solid.
5-Chloro-2-methoxy-N-methyl-benzenesulfonamide, Yield 1.05 g (>100%)
$DTYPE RXN:VAR(1):NOTES
$DATUM other analogs similarly prepd.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of piperazines for use as pharmaceuticals for the treatment
of inflammation and other immune disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Blumberg, Laura Cook; Brown, Matthew Frank; McGlynn, Molly Ann; Poss,
Christopher Stanley; Gladue, Ronald Paul
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001072728 A2 2001-10-04

$RFMT $RIREG SCHEME271 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(ζS)-5-[4-[(Dimethylamino)methyl]phenyl]-ζ-[[(phenylmethoxy)carbonyl]amino]-2...
C27H33N3O5
2304830-26-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 9.3358 0.0 0 CFG=2
M  V30 2 N 6.9300 10.6696 0.0 0
M  V30 3 C 6.9300 8.0022 0.0 0
M  V30 4 C 5.3900 10.6696 0.0 0
M  V30 5 C 7.7000 6.6685 0.0 0
M  V30 6 O 4.6200 12.0033 0.0 0
M  V30 7 O 4.6200 9.3358 0.0 0
M  V30 8 C 6.9300 5.3347 0.0 0
M  V30 9 C 3.0800 12.0033 0.0 0
M  V30 10 C 7.7000 4.0011 0.0 0
M  V30 11 C 6.9300 2.6674 0.0 0
M  V30 12 C 7.7000 1.3338 0.0 0
M  V30 13 O 9.2400 1.3338 0.0 0
M  V30 14 O 6.9300 0.0000 0.0 0
M  V30 15 C 16.5934 13.7267 0.0 0
M  V30 16 N 18.0002 13.1002 0.0 0
M  V30 17 C 18.1612 11.5687 0.0 0
M  V30 18 C 19.2461 14.0054 0.0 0
M  V30 19 C 9.2400 9.3358 0.0 0
M  V30 20 O 10.1451 10.5817 0.0 0
M  V30 21 N 10.1451 8.0900 0.0 0
M  V30 22 C 11.6098 10.1058 0.0 0
M  V30 23 C 11.6098 8.5658 0.0 0
M  V30 24 C 12.8557 11.0111 0.0 0
M  V30 25 C 12.6947 12.5426 0.0 0
M  V30 26 C 14.2626 10.3847 0.0 0
M  V30 27 C 13.9406 13.4478 0.0 0
M  V30 28 C 15.5085 11.2900 0.0 0
M  V30 29 C 15.3476 12.8215 0.0 0
M  V30 30 C 2.3100 13.3369 0.0 0
M  V30 31 C 0.7700 13.3369 0.0 0
M  V30 32 C 3.0800 14.6706 0.0 0
M  V30 33 C 0.0000 14.6706 0.0 0
M  V30 34 C 2.3100 16.0044 0.0 0
M  V30 35 C 0.7700 16.0044 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 8 10
M  V30 11 1 9 30
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 15 16
M  V30 17 1 15 29
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 19 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C28H36N4O4
2305694-35-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 10.6695 0.0 0 CFG=2
M  V30 2 N 6.9300 12.0033 0.0 0
M  V30 3 C 6.9300 9.3358 0.0 0
M  V30 4 C 5.3900 12.0033 0.0 0
M  V30 5 C 7.7000 8.0022 0.0 0
M  V30 6 O 4.6200 13.3369 0.0 0
M  V30 7 O 4.6200 10.6695 0.0 0
M  V30 8 C 6.9300 6.6685 0.0 0
M  V30 9 C 3.0800 13.3369 0.0 0
M  V30 10 C 7.7000 5.3347 0.0 0
M  V30 11 C 6.9300 4.0011 0.0 0
M  V30 12 C 7.7000 2.6674 0.0 0
M  V30 13 N 6.9300 1.3338 0.0 0
M  V30 14 O 9.2400 2.6674 0.0 0
M  V30 15 C 7.7000 0.0000 0.0 0
M  V30 16 C 16.5934 15.0604 0.0 0
M  V30 17 N 18.0002 14.4339 0.0 0
M  V30 18 C 18.1612 12.9023 0.0 0
M  V30 19 C 19.2461 15.3391 0.0 0
M  V30 20 C 9.2400 10.6695 0.0 0
M  V30 21 O 10.1451 11.9155 0.0 0
M  V30 22 N 10.1451 9.4236 0.0 0
M  V30 23 C 11.6098 11.4395 0.0 0
M  V30 24 C 11.6098 9.8995 0.0 0
M  V30 25 C 12.8557 12.3447 0.0 0
M  V30 26 C 12.6947 13.8762 0.0 0
M  V30 27 C 14.2626 11.7184 0.0 0
M  V30 28 C 13.9406 14.7815 0.0 0
M  V30 29 C 15.5085 12.6236 0.0 0
M  V30 30 C 15.3476 14.1551 0.0 0
M  V30 31 C 2.3100 14.6706 0.0 0
M  V30 32 C 0.7700 14.6706 0.0 0
M  V30 33 C 3.0800 16.0042 0.0 0
M  V30 34 C 0.0000 16.0042 0.0 0
M  V30 35 C 2.3100 17.3380 0.0 0
M  V30 36 C 0.7700 17.3380 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 8 10
M  V30 11 1 9 31
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 16 17
M  V30 18 1 16 30
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 20 21
M  V30 22 2 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 33 2 31 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 35
M  V30 37 2 34 36
M  V30 38 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2304830-26-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2305694-35-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20084579
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of HBTU and MeNH2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Improved selective class I HDAC and novel selective HDAC3 inhibitors:
Beyond hydroxamic acids and benzamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bresciani, Alberto; Ontoria, Jesus M.; Biancofiore, Ilaria; Cellucci,
Antonella; Ciammaichella, Alina; Di Marco, Annalise; Ferrigno, Federica;
Francone, Alessandra; Malancona, Savina; Monteagudo, Edith; Nizi,
Emanuela; Pace, Paola; Ponzi, Simona; Rossetti, Ilaria; Veneziano, Maria;
Summa, Vincenzo; Harper, Steven
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2019), 10(4), 481-486

$RFMT $RIREG SCHEME272 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2-Dichloro-4-fluoro-5-nitrobenzene
C6H2Cl2FNO2
2339-78-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6675 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0011 0.0 0
M  V30 3 O 0.0000 1.3338 0.0 0
M  V30 4 F 2.3100 0.0000 0.0 0
M  V30 5 Cl 5.3901 5.3349 0.0 0
M  V30 6 Cl 6.9301 2.6675 0.0 0
M  V30 7 C 2.3100 2.6675 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 4.6201 1.3338 0.0 0
M  V30 11 C 4.6201 4.0011 0.0 0
M  V30 12 C 5.3901 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 11
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5-Dichloro-N-methyl-2-nitrobenzenamine
C7H6Cl2N2O2
107342-18-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 4.0012 0.0 0 VAL=5
M  V30 2 O 0.0000 2.6675 0.0 0
M  V30 3 O 0.0000 5.3348 0.0 0
M  V30 4 N 2.3101 1.3338 0.0 0
M  V30 5 C 3.0801 0.0000 0.0 0
M  V30 6 Cl 5.3901 6.6687 0.0 0
M  V30 7 Cl 6.9302 4.0012 0.0 0
M  V30 8 C 2.3101 4.0012 0.0 0
M  V30 9 C 3.0801 2.6675 0.0 0
M  V30 10 C 3.0801 5.3348 0.0 0
M  V30 11 C 4.6201 2.6675 0.0 0
M  V30 12 C 4.6201 5.3348 0.0 0
M  V30 13 C 5.3901 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 1 6 12
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2339-78-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 107342-18-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-10438342
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient solution phase synthesis of 2-(N-acylamino)benzimidazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Seth, Punit P.; Robinson, Dale E.; Jefferson, Elizabeth A.; Swayze, Eric
E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2002), 43(41), 7303-7306

$RFMT $RIREG SCHEME273 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[[cis-4-[6-[[(1,1-Dimethylethoxy)carbonyl]methylamino]-3-(1-methyl-1H-pyraz...
C28H33N7O5
2348513-85-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 12.9854 8.8139 0.0 0
M  V30 2 C 14.4500 8.3381 0.0 0
M  V30 3 C 12.6652 10.3202 0.0 0
M  V30 4 O 15.5945 9.3685 0.0 0
M  V30 5 O 14.7702 6.8316 0.0 0
M  V30 6 C 17.0591 8.8926 0.0 0
M  V30 7 C 16.5832 7.4279 0.0 0
M  V30 8 C 18.5238 8.4166 0.0 0
M  V30 9 C 17.5351 10.3572 0.0 0
M  V30 10 C 6.0132 0.0000 0.0 0
M  V30 11 O 4.6201 12.7247 0.0 0
M  V30 12 C 3.0801 15.3920 0.0 0
M  V30 13 O 4.6201 15.3920 0.0 0
M  V30 14 O 2.3101 16.7257 0.0 0
M  V30 15 C 9.2317 7.2288 0.0 0
M  V30 16 C 9.5519 5.7225 0.0 0
M  V30 17 N 7.7002 7.3899 0.0 0
M  V30 18 C 10.3763 8.2594 0.0 0
M  V30 19 C 8.2182 4.9524 0.0 0
M  V30 20 C 11.0166 5.2466 0.0 0
M  V30 21 N 7.0738 5.9829 0.0 0
M  V30 22 C 11.8409 7.7833 0.0 0
M  V30 23 N 12.1610 6.2770 0.0 0
M  V30 24 C 6.9302 8.7235 0.0 0 CFG=2
M  V30 25 C 7.7002 10.0572 0.0 0
M  V30 26 C 5.3901 8.7235 0.0 0
M  V30 27 C 6.9302 11.3909 0.0 0
M  V30 28 C 4.6201 10.0572 0.0 0
M  V30 29 C 5.3901 11.3909 0.0 0 CFG=1
M  V30 30 C 8.0573 3.4209 0.0 0
M  V30 31 C 9.2017 2.3903 0.0 0
M  V30 32 C 6.7236 2.6509 0.0 0
M  V30 33 N 8.5754 0.9835 0.0 0
M  V30 34 N 7.0438 1.1444 0.0 0
M  V30 35 C 3.0801 12.7247 0.0 0
M  V30 36 C 2.3101 14.0584 0.0 0
M  V30 37 C 2.3101 11.3909 0.0 0
M  V30 38 N 0.7700 14.0584 0.0 0
M  V30 39 C 0.7700 11.3909 0.0 0
M  V30 40 C 0.0000 12.7247 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 22
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 34
M  V30 11 1 29 11 CFG=3
M  V30 12 1 11 35
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 36
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 2 16 20
M  V30 21 1 17 21
M  V30 22 1 24 17 CFG=3
M  V30 23 1 18 22
M  V30 24 2 19 21
M  V30 25 1 19 30
M  V30 26 1 20 23
M  V30 27 2 22 23
M  V30 28 1 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 29
M  V30 34 1 30 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 24 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-methyl-N-[1-[cis-4-[[2-[(methylamino)carbonyl]-3-pyridiny...
C29H36N8O4
2348513-86-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 12.9854 9.2454 0.0 0
M  V30 2 C 14.4500 9.7215 0.0 0
M  V30 3 C 12.6652 7.7391 0.0 0
M  V30 4 O 15.5945 8.6909 0.0 0
M  V30 5 O 14.7702 11.2278 0.0 0
M  V30 6 C 17.0591 9.1667 0.0 0
M  V30 7 C 16.5832 10.6315 0.0 0
M  V30 8 C 18.5238 9.6428 0.0 0
M  V30 9 C 17.5351 7.7022 0.0 0
M  V30 10 C 6.0132 18.0594 0.0 0
M  V30 11 O 4.6201 5.3348 0.0 0
M  V30 12 C 3.0801 2.6673 0.0 0
M  V30 13 N 2.3101 1.3337 0.0 0
M  V30 14 O 4.6201 2.6673 0.0 0
M  V30 15 C 3.0801 0.0000 0.0 0
M  V30 16 C 9.2317 10.8306 0.0 0
M  V30 17 C 9.5519 12.3369 0.0 0
M  V30 18 N 7.7002 10.6697 0.0 0
M  V30 19 C 10.3763 9.8002 0.0 0
M  V30 20 C 8.2182 13.1069 0.0 0
M  V30 21 C 11.0166 12.8129 0.0 0
M  V30 22 N 7.0738 12.0765 0.0 0
M  V30 23 C 11.8409 10.2760 0.0 0
M  V30 24 N 12.1610 11.7823 0.0 0
M  V30 25 C 6.9302 9.3358 0.0 0 CFG=1
M  V30 26 C 5.3901 9.3358 0.0 0
M  V30 27 C 7.7002 8.0022 0.0 0
M  V30 28 C 4.6201 8.0022 0.0 0
M  V30 29 C 6.9302 6.6685 0.0 0
M  V30 30 C 5.3901 6.6685 0.0 0 CFG=2
M  V30 31 C 8.0573 14.6386 0.0 0
M  V30 32 C 9.2017 15.6691 0.0 0
M  V30 33 C 6.7236 15.4087 0.0 0
M  V30 34 N 8.5754 17.0759 0.0 0
M  V30 35 N 7.0438 16.9150 0.0 0
M  V30 36 C 3.0801 5.3348 0.0 0
M  V30 37 C 2.3101 4.0010 0.0 0
M  V30 38 C 2.3101 6.6685 0.0 0
M  V30 39 N 0.7700 4.0010 0.0 0
M  V30 40 C 0.7700 6.6685 0.0 0
M  V30 41 C 0.0000 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 23
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 35
M  V30 11 1 30 11 CFG=1
M  V30 12 1 11 36
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 37
M  V30 16 1 13 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 1 25 18 CFG=1
M  V30 24 1 19 23
M  V30 25 2 20 22
M  V30 26 1 20 31
M  V30 27 1 21 24
M  V30 28 2 23 24
M  V30 29 1 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 30
M  V30 35 1 31 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 35
M  V30 39 1 34 35
M  V30 40 2 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 25 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2348513-85-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2348513-86-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-21103290
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Bicyclic fused pyridine compounds as inhibitors of TAM kinases and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Allen, Shelley; Boys, Mark Laurence; Cook, Adam; Gaudino, John; Hinklin,
Ronald Jay; Laird, Ellen; McNulty, Oren T.; Metcalf, Andrew T.; Newhouse,
Brad; Robinson, John E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019113190 A1 2019-06-13

$RFMT $RIREG SCHEME274 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl (2R)-2-[[(methylsulfonyl)oxy]methyl]-4-morpholinecarboxylate
C14H19NO6S
2360518-60-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 1.5400 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 4.0012 1.5400 0.0 0
M  V30 5 C 12.0035 1.5400 0.0 0
M  V30 6 O 13.3372 2.3101 0.0 0
M  V30 7 S 14.6708 1.5400 0.0 0 VAL=6
M  V30 8 C 15.4408 2.8737 0.0 0
M  V30 9 O 16.0046 0.7700 0.0 0
M  V30 10 O 13.9008 0.2064 0.0 0
M  V30 11 N 8.0023 2.3101 0.0 0
M  V30 12 C 9.3360 1.5400 0.0 0
M  V30 13 C 8.0023 3.8501 0.0 0
M  V30 14 C 10.6698 2.3101 0.0 0 CFG=2
M  V30 15 C 9.3360 4.6201 0.0 0
M  V30 16 O 10.6698 3.8501 0.0 0
M  V30 17 C 2.6675 2.3101 0.0 0
M  V30 18 C 2.6675 3.8501 0.0 0
M  V30 19 C 1.3338 1.5400 0.0 0
M  V30 20 C 1.3338 4.6201 0.0 0
M  V30 21 C 0.0000 2.3101 0.0 0
M  V30 22 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 17
M  V30 6 1 5 6
M  V30 7 1 14 5 CFG=1
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 2 7 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Phenylmethyl (2S)-2-[(methylamino)methyl]-4-morpholinecarboxylate
C14H20N2O3
2360518-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 C 4.0010 1.5400 0.0 0
M  V30 5 C 12.0033 1.5400 0.0 0
M  V30 6 N 13.3370 2.3101 0.0 0
M  V30 7 C 14.6707 1.5400 0.0 0
M  V30 8 N 8.0022 2.3101 0.0 0
M  V30 9 C 9.3358 1.5400 0.0 0
M  V30 10 C 8.0022 3.8501 0.0 0
M  V30 11 C 10.6697 2.3101 0.0 0 CFG=2
M  V30 12 C 9.3358 4.6201 0.0 0
M  V30 13 O 10.6697 3.8501 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 C 1.3337 1.5400 0.0 0
M  V30 16 C 2.6673 3.8501 0.0 0
M  V30 17 C 0.0000 2.3101 0.0 0
M  V30 18 C 1.3337 4.6201 0.0 0
M  V30 19 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 1 11 5 CFG=1
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2360518-60-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2360518-62-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24567707
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM autoclave used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bifunctional compounds as MDM2 degraders and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ji, Nan; Weiss, Matthew M.; Zheng, Xiaozhang; Zhu, Xiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021188948 A1 2021-09-23

$RFMT $RIREG SCHEME274 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl (2R)-2-[[(methylsulfonyl)oxy]methyl]-4-morpholinecarboxylate
C14H19NO6S
2360518-60-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 1.5400 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 4.0012 1.5400 0.0 0
M  V30 5 C 12.0035 1.5400 0.0 0
M  V30 6 O 13.3372 2.3101 0.0 0
M  V30 7 S 14.6708 1.5400 0.0 0 VAL=6
M  V30 8 C 15.4408 2.8737 0.0 0
M  V30 9 O 16.0046 0.7700 0.0 0
M  V30 10 O 13.9008 0.2064 0.0 0
M  V30 11 N 8.0023 2.3101 0.0 0
M  V30 12 C 9.3360 1.5400 0.0 0
M  V30 13 C 8.0023 3.8501 0.0 0
M  V30 14 C 10.6698 2.3101 0.0 0 CFG=2
M  V30 15 C 9.3360 4.6201 0.0 0
M  V30 16 O 10.6698 3.8501 0.0 0
M  V30 17 C 2.6675 2.3101 0.0 0
M  V30 18 C 2.6675 3.8501 0.0 0
M  V30 19 C 1.3338 1.5400 0.0 0
M  V30 20 C 1.3338 4.6201 0.0 0
M  V30 21 C 0.0000 2.3101 0.0 0
M  V30 22 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 17
M  V30 6 1 5 6
M  V30 7 1 14 5 CFG=1
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 2 7 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Phenylmethyl (2S)-2-[(methylamino)methyl]-4-morpholinecarboxylate
C14H20N2O3
2360518-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 C 4.0010 1.5400 0.0 0
M  V30 5 C 12.0033 1.5400 0.0 0
M  V30 6 N 13.3370 2.3101 0.0 0
M  V30 7 C 14.6707 1.5400 0.0 0
M  V30 8 N 8.0022 2.3101 0.0 0
M  V30 9 C 9.3358 1.5400 0.0 0
M  V30 10 C 8.0022 3.8501 0.0 0
M  V30 11 C 10.6697 2.3101 0.0 0 CFG=2
M  V30 12 C 9.3358 4.6201 0.0 0
M  V30 13 O 10.6697 3.8501 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 C 1.3337 1.5400 0.0 0
M  V30 16 C 2.6673 3.8501 0.0 0
M  V30 17 C 0.0000 2.3101 0.0 0
M  V30 18 C 1.3337 4.6201 0.0 0
M  V30 19 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 1 11 5 CFG=1
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2360518-60-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2360518-62-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-22610880
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bifunctional compounds as IRAK degraders and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mainolfi, Nello; Ji, Nan; Kluge, Arthur F.; Weiss, Matthew M.; Zhang, Yi;
Zheng, Xiaozhang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020113233 A1 2020-06-04

$RFMT $RIREG SCHEME274 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl (2R)-2-[[(methylsulfonyl)oxy]methyl]-4-morpholinecarboxylate
C14H19NO6S
2360518-60-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 1.5400 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 4.0012 1.5400 0.0 0
M  V30 5 C 12.0035 1.5400 0.0 0
M  V30 6 O 13.3372 2.3101 0.0 0
M  V30 7 S 14.6708 1.5400 0.0 0 VAL=6
M  V30 8 C 15.4408 2.8737 0.0 0
M  V30 9 O 16.0046 0.7700 0.0 0
M  V30 10 O 13.9008 0.2064 0.0 0
M  V30 11 N 8.0023 2.3101 0.0 0
M  V30 12 C 9.3360 1.5400 0.0 0
M  V30 13 C 8.0023 3.8501 0.0 0
M  V30 14 C 10.6698 2.3101 0.0 0 CFG=2
M  V30 15 C 9.3360 4.6201 0.0 0
M  V30 16 O 10.6698 3.8501 0.0 0
M  V30 17 C 2.6675 2.3101 0.0 0
M  V30 18 C 2.6675 3.8501 0.0 0
M  V30 19 C 1.3338 1.5400 0.0 0
M  V30 20 C 1.3338 4.6201 0.0 0
M  V30 21 C 0.0000 2.3101 0.0 0
M  V30 22 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 17
M  V30 6 1 5 6
M  V30 7 1 14 5 CFG=1
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 2 7 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Phenylmethyl (2S)-2-[(methylamino)methyl]-4-morpholinecarboxylate
C14H20N2O3
2360518-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 C 4.0010 1.5400 0.0 0
M  V30 5 C 12.0033 1.5400 0.0 0
M  V30 6 N 13.3370 2.3101 0.0 0
M  V30 7 C 14.6707 1.5400 0.0 0
M  V30 8 N 8.0022 2.3101 0.0 0
M  V30 9 C 9.3358 1.5400 0.0 0
M  V30 10 C 8.0022 3.8501 0.0 0
M  V30 11 C 10.6697 2.3101 0.0 0 CFG=2
M  V30 12 C 9.3358 4.6201 0.0 0
M  V30 13 O 10.6697 3.8501 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 C 1.3337 1.5400 0.0 0
M  V30 16 C 2.6673 3.8501 0.0 0
M  V30 17 C 0.0000 2.3101 0.0 0
M  V30 18 C 1.3337 4.6201 0.0 0
M  V30 19 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 1 11 5 CFG=1
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2360518-60-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2360518-62-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-20995906
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, autoclave used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of peptide conjugates as IRAK4 protein kinase degraders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mainolfi, Nello; Ji, Nan; Kluge, Arthur F.; Weiss, Matthew M.; Zhang, Yi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20190192668 A1 2019-06-27

$RFMT $RIREG SCHEME275 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl (2S)-2-[[(methylsulfonyl)oxy]methyl]-4-morpholinecarboxylate
C14H19NO6S
2360521-09-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 1.5400 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 4.0012 1.5400 0.0 0
M  V30 5 C 12.0035 1.5400 0.0 0
M  V30 6 O 13.3372 2.3101 0.0 0
M  V30 7 S 14.6708 1.5400 0.0 0 VAL=6
M  V30 8 C 15.4408 2.8737 0.0 0
M  V30 9 O 16.0046 0.7700 0.0 0
M  V30 10 O 13.9008 0.2064 0.0 0
M  V30 11 N 8.0023 2.3101 0.0 0
M  V30 12 C 9.3360 1.5400 0.0 0
M  V30 13 C 8.0023 3.8501 0.0 0
M  V30 14 C 10.6698 2.3101 0.0 0 CFG=1
M  V30 15 C 9.3360 4.6201 0.0 0
M  V30 16 O 10.6698 3.8501 0.0 0
M  V30 17 C 2.6675 2.3101 0.0 0
M  V30 18 C 2.6675 3.8501 0.0 0
M  V30 19 C 1.3338 1.5400 0.0 0
M  V30 20 C 1.3338 4.6201 0.0 0
M  V30 21 C 0.0000 2.3101 0.0 0
M  V30 22 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 17
M  V30 6 1 5 6
M  V30 7 1 14 5 CFG=3
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 2 7 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Phenylmethyl (2R)-2-[(methylamino)methyl]-4-morpholinecarboxylate
C14H20N2O3
2360521-11-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 C 4.0010 1.5400 0.0 0
M  V30 5 C 12.0033 1.5400 0.0 0
M  V30 6 N 13.3370 2.3101 0.0 0
M  V30 7 C 14.6707 1.5400 0.0 0
M  V30 8 N 8.0022 2.3101 0.0 0
M  V30 9 C 9.3358 1.5400 0.0 0
M  V30 10 C 8.0022 3.8501 0.0 0
M  V30 11 C 10.6697 2.3101 0.0 0 CFG=1
M  V30 12 C 9.3358 4.6201 0.0 0
M  V30 13 O 10.6697 3.8501 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 16 C 1.3337 1.5400 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 0.0000 2.3101 0.0 0
M  V30 19 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 1 11 5 CFG=3
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2360521-09-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2360521-11-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-22611043
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM autoclave used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bifunctional compounds as IRAK degraders and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mainolfi, Nello; Ji, Nan; Kluge, Arthur F.; Weiss, Matthew M.; Zhang, Yi;
Zheng, Xiaozhang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020113233 A1 2020-06-04

$RFMT $RIREG SCHEME275 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl (2S)-2-[[(methylsulfonyl)oxy]methyl]-4-morpholinecarboxylate
C14H19NO6S
2360521-09-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 1.5400 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 4.0012 1.5400 0.0 0
M  V30 5 C 12.0035 1.5400 0.0 0
M  V30 6 O 13.3372 2.3101 0.0 0
M  V30 7 S 14.6708 1.5400 0.0 0 VAL=6
M  V30 8 C 15.4408 2.8737 0.0 0
M  V30 9 O 16.0046 0.7700 0.0 0
M  V30 10 O 13.9008 0.2064 0.0 0
M  V30 11 N 8.0023 2.3101 0.0 0
M  V30 12 C 9.3360 1.5400 0.0 0
M  V30 13 C 8.0023 3.8501 0.0 0
M  V30 14 C 10.6698 2.3101 0.0 0 CFG=1
M  V30 15 C 9.3360 4.6201 0.0 0
M  V30 16 O 10.6698 3.8501 0.0 0
M  V30 17 C 2.6675 2.3101 0.0 0
M  V30 18 C 2.6675 3.8501 0.0 0
M  V30 19 C 1.3338 1.5400 0.0 0
M  V30 20 C 1.3338 4.6201 0.0 0
M  V30 21 C 0.0000 2.3101 0.0 0
M  V30 22 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 17
M  V30 6 1 5 6
M  V30 7 1 14 5 CFG=3
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 2 7 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Phenylmethyl (2R)-2-[(methylamino)methyl]-4-morpholinecarboxylate
C14H20N2O3
2360521-11-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 C 4.0010 1.5400 0.0 0
M  V30 5 C 12.0033 1.5400 0.0 0
M  V30 6 N 13.3370 2.3101 0.0 0
M  V30 7 C 14.6707 1.5400 0.0 0
M  V30 8 N 8.0022 2.3101 0.0 0
M  V30 9 C 9.3358 1.5400 0.0 0
M  V30 10 C 8.0022 3.8501 0.0 0
M  V30 11 C 10.6697 2.3101 0.0 0 CFG=1
M  V30 12 C 9.3358 4.6201 0.0 0
M  V30 13 O 10.6697 3.8501 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 16 C 1.3337 1.5400 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 0.0000 2.3101 0.0 0
M  V30 19 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 1 11 5 CFG=3
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2360521-09-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2360521-11-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-20996021
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM autoclave used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of peptide conjugates as IRAK4 protein kinase degraders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mainolfi, Nello; Ji, Nan; Kluge, Arthur F.; Weiss, Matthew M.; Zhang, Yi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20190192668 A1 2019-06-27

$RFMT $RIREG SCHEME276 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C17H25N3O5
2378308-10-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5932 4.0738 0.0 0
M  V30 2 O 3.5628 2.9292 0.0 0
M  V30 3 O 6.0996 3.7536 0.0 0
M  V30 4 C 4.0387 1.4647 0.0 0
M  V30 5 C 2.5741 0.9888 0.0 0
M  V30 6 C 4.5145 0.0000 0.0 0
M  V30 7 C 5.5033 1.9406 0.0 0
M  V30 8 C 1.4068 5.1091 0.0 0
M  V30 9 O 0.0000 5.7354 0.0 0
M  V30 10 C 10.2804 6.7843 0.0 0
M  V30 11 O 11.0504 8.1180 0.0 0
M  V30 12 O 11.0504 5.4505 0.0 0
M  V30 13 C 12.5904 8.1180 0.0 0
M  V30 14 C 12.5904 6.5780 0.0 0
M  V30 15 C 14.1304 8.1180 0.0 0
M  V30 16 C 12.5904 9.6580 0.0 0
M  V30 17 C 5.0226 6.7843 0.0 0
M  V30 18 N 4.1173 5.5383 0.0 0
M  V30 19 N 4.1173 8.0302 0.0 0
M  V30 20 C 2.6528 6.0143 0.0 0
M  V30 21 C 2.6528 7.5543 0.0 0
M  V30 22 C 6.5626 6.7843 0.0 0
M  V30 23 C 7.6515 7.8732 0.0 0
M  V30 24 C 7.6515 5.6952 0.0 0
M  V30 25 N 8.7404 6.7843 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 9
M  V30 9 1 8 20
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 25
M  V30 13 1 11 13
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 17 18
M  V30 18 2 17 19
M  V30 19 1 17 22
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 21
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3-[5-[(methylamino)methyl]-1H-imidazol-2-yl]-1-azetidinecar...
C13H22N4O2
2378308-11-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8737 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 C 12.7237 4.5489 0.0 0
M  V30 9 N 14.1305 3.9224 0.0 0
M  V30 10 C 15.3764 4.8276 0.0 0
M  V30 11 C 7.5679 2.8737 0.0 0
M  V30 12 C 6.4790 1.7847 0.0 0
M  V30 13 C 6.4790 3.9626 0.0 0
M  V30 14 N 5.3900 2.8737 0.0 0
M  V30 15 C 9.1079 2.8737 0.0 0
M  V30 16 N 10.0131 4.1195 0.0 0
M  V30 17 N 10.0131 1.6278 0.0 0
M  V30 18 C 11.4777 3.6437 0.0 0
M  V30 19 C 11.4777 2.1037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 18
M  V30 10 1 9 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 15
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2378308-10-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2378308-11-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-21855450
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Imidazopiperazinones as inhibitors of transcription activating proteins
and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Le, Kang; Soth, Michael J.; Liu, Gang; Jones, Philip; Cross, Jason;
McAfoos, Timothy J.; Carroll, Christopher L.; Lewis, Richard T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019195846 A1 2019-10-10

$RFMT $RIREG SCHEME277 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 5-formyl-2-(tetrahydro-4-methyl-2H-pyran-4-yl)-1H-imidazole...
C15H22N2O4
2378308-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.6436 4.5252 0.0 0
M  V30 2 O 2.1036 4.5252 0.0 0
M  V30 3 O 4.4136 5.8590 0.0 0
M  V30 4 C 1.3336 5.8590 0.0 0
M  V30 5 C 0.0000 5.0890 0.0 0
M  V30 6 C 0.5636 7.1926 0.0 0
M  V30 7 C 2.6672 6.6290 0.0 0
M  V30 8 C 5.6696 4.9912 0.0 0
M  V30 9 C 2.2809 1.4647 0.0 0
M  V30 10 O 1.8050 0.0000 0.0 0
M  V30 11 C 5.9451 3.0307 0.0 0
M  V30 12 N 4.4136 3.1916 0.0 0
M  V30 13 N 6.2654 1.5243 0.0 0
M  V30 14 C 3.7873 1.7848 0.0 0
M  V30 15 C 4.9316 0.7543 0.0 0
M  V30 16 C 6.9756 4.1750 0.0 0
M  V30 17 C 7.9237 2.9615 0.0 0
M  V30 18 C 7.5525 5.6029 0.0 0
M  V30 19 C 9.4487 3.1759 0.0 0
M  V30 20 C 9.0774 5.8173 0.0 0
M  V30 21 O 10.0256 4.6038 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 16
M  V30 9 2 9 10
M  V30 10 1 9 14
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 16
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromopropanoyl chloride
C3H4BrClO
7148-74-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 Br 4.0010 2.3101 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 Cl 1.3337 3.8501 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-N-[[2-(tetrahydro-4-methyl-2H-pyran-4-yl)-1H-imidazol-5-yl]m...
C14H22BrN3O2
2378308-35-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0854 1.1867 0.0 0
M  V30 2 C 7.9636 1.5400 0.0 0
M  V30 3 N 9.2973 2.3100 0.0 0
M  V30 4 C 10.6309 1.5400 0.0 0
M  V30 5 C 9.2973 3.8501 0.0 0
M  V30 6 C 11.9647 2.3100 0.0 0
M  V30 7 O 10.6309 0.0000 0.0 0
M  V30 8 Br 13.2984 1.5400 0.0 0
M  V30 9 C 11.9647 3.8501 0.0 0
M  V30 10 C 2.6610 2.6672 0.0 0
M  V30 11 C 1.2768 1.9920 0.0 0
M  V30 12 C 2.7683 4.2033 0.0 0
M  V30 13 C 0.0000 2.8532 0.0 0
M  V30 14 C 1.4917 5.0645 0.0 0
M  V30 15 O 0.1075 4.3894 0.0 0
M  V30 16 C 4.1926 2.8281 0.0 0
M  V30 17 N 5.2230 1.6836 0.0 0
M  V30 18 N 4.9626 4.1618 0.0 0
M  V30 19 C 6.6299 2.3100 0.0 0
M  V30 20 C 6.4689 3.8416 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 1 2 19
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 16
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2378308-34-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 7148-74-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2378308-35-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-21855496
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Imidazopiperazinones as inhibitors of transcription activating proteins
and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Le, Kang; Soth, Michael J.; Liu, Gang; Jones, Philip; Cross, Jason;
McAfoos, Timothy J.; Carroll, Christopher L.; Lewis, Richard T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019195846 A1 2019-10-10

$RFMT $RIREG SCHEME278 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, N-(3-fluoro-4-nitrophenyl)-4-pentyl-
C18H19FN2O3
2378327-77-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 3.8501 0.0 0
M  V30 2 N 6.6685 4.6201 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 C 13.3372 6.9302 0.0 0
M  V30 5 C 14.6708 6.1601 0.0 0
M  V30 6 C 16.0045 6.9302 0.0 0
M  V30 7 C 17.3383 6.1601 0.0 0
M  V30 8 C 18.6720 6.9302 0.0 0
M  V30 9 F 1.3337 4.6201 0.0 0
M  V30 10 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 11 O 1.3337 0.0000 0.0 0
M  V30 12 O 0.0000 2.3101 0.0 0
M  V30 13 C 9.3360 4.6201 0.0 0
M  V30 14 C 9.3360 6.1601 0.0 0
M  V30 15 C 10.6697 3.8501 0.0 0
M  V30 16 C 10.6697 6.9302 0.0 0
M  V30 17 C 12.0035 4.6201 0.0 0
M  V30 18 C 12.0035 6.1601 0.0 0
M  V30 19 C 5.3348 3.8501 0.0 0
M  V30 20 C 4.0012 4.6201 0.0 0
M  V30 21 C 5.3348 2.3101 0.0 0
M  V30 22 C 2.6675 3.8501 0.0 0
M  V30 23 C 4.0012 1.5400 0.0 0
M  V30 24 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 19
M  V30 5 1 4 5
M  V30 6 1 4 18
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 9 22
M  V30 11 2 10 11
M  V30 12 2 10 12
M  V30 13 1 10 24
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, N-[3-(methylamino)-4-nitrophenyl]-4-pentyl-
C19H23N3O3
2378327-86-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6684 4.6201 0.0 0
M  V30 2 C 8.0022 3.8500 0.0 0
M  V30 3 O 8.0022 2.3100 0.0 0
M  V30 4 N 1.3337 4.6201 0.0 0
M  V30 5 C 1.3337 6.1601 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 C 13.3370 6.9301 0.0 0
M  V30 10 C 14.6707 6.1601 0.0 0
M  V30 11 C 16.0043 6.9301 0.0 0
M  V30 12 C 17.3381 6.1601 0.0 0
M  V30 13 C 18.6718 6.9301 0.0 0
M  V30 14 C 5.3348 3.8500 0.0 0
M  V30 15 C 4.0011 4.6201 0.0 0
M  V30 16 C 5.3348 2.3100 0.0 0
M  V30 17 C 2.6675 3.8500 0.0 0
M  V30 18 C 4.0011 1.5400 0.0 0
M  V30 19 C 2.6675 2.3100 0.0 0
M  V30 20 C 9.3359 4.6201 0.0 0
M  V30 21 C 9.3359 6.1601 0.0 0
M  V30 22 C 10.6695 3.8500 0.0 0
M  V30 23 C 10.6695 6.9301 0.0 0
M  V30 24 C 12.0034 4.6201 0.0 0
M  V30 25 C 12.0034 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 2 2 3
M  V30 4 1 2 20
M  V30 5 1 4 5
M  V30 6 1 4 17
M  V30 7 2 6 7
M  V30 8 2 6 8
M  V30 9 1 6 19
M  V30 10 1 9 10
M  V30 11 1 9 25
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2378327-77-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2378327-86-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-20809329
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 2-aminobenzimidazoles analogs as antibiofilm
agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gunn, John; Kuo, Laura; Melander, Christian; Huggins, William M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019195493 A2 2019-10-10

$RFMT $RIREG SCHEME278 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, N-(3-fluoro-4-nitrophenyl)-4-pentyl-
C18H19FN2O3
2378327-77-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 3.8501 0.0 0
M  V30 2 N 6.6685 4.6201 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 C 13.3372 6.9302 0.0 0
M  V30 5 C 14.6708 6.1601 0.0 0
M  V30 6 C 16.0045 6.9302 0.0 0
M  V30 7 C 17.3383 6.1601 0.0 0
M  V30 8 C 18.6720 6.9302 0.0 0
M  V30 9 F 1.3337 4.6201 0.0 0
M  V30 10 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 11 O 1.3337 0.0000 0.0 0
M  V30 12 O 0.0000 2.3101 0.0 0
M  V30 13 C 9.3360 4.6201 0.0 0
M  V30 14 C 9.3360 6.1601 0.0 0
M  V30 15 C 10.6697 3.8501 0.0 0
M  V30 16 C 10.6697 6.9302 0.0 0
M  V30 17 C 12.0035 4.6201 0.0 0
M  V30 18 C 12.0035 6.1601 0.0 0
M  V30 19 C 5.3348 3.8501 0.0 0
M  V30 20 C 4.0012 4.6201 0.0 0
M  V30 21 C 5.3348 2.3101 0.0 0
M  V30 22 C 2.6675 3.8501 0.0 0
M  V30 23 C 4.0012 1.5400 0.0 0
M  V30 24 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 19
M  V30 5 1 4 5
M  V30 6 1 4 18
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 9 22
M  V30 11 2 10 11
M  V30 12 2 10 12
M  V30 13 1 10 24
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, N-[3-(methylamino)-4-nitrophenyl]-4-pentyl-
C19H23N3O3
2378327-86-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6684 4.6201 0.0 0
M  V30 2 C 8.0022 3.8500 0.0 0
M  V30 3 O 8.0022 2.3100 0.0 0
M  V30 4 N 1.3337 4.6201 0.0 0
M  V30 5 C 1.3337 6.1601 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 C 13.3370 6.9301 0.0 0
M  V30 10 C 14.6707 6.1601 0.0 0
M  V30 11 C 16.0043 6.9301 0.0 0
M  V30 12 C 17.3381 6.1601 0.0 0
M  V30 13 C 18.6718 6.9301 0.0 0
M  V30 14 C 5.3348 3.8500 0.0 0
M  V30 15 C 4.0011 4.6201 0.0 0
M  V30 16 C 5.3348 2.3100 0.0 0
M  V30 17 C 2.6675 3.8500 0.0 0
M  V30 18 C 4.0011 1.5400 0.0 0
M  V30 19 C 2.6675 2.3100 0.0 0
M  V30 20 C 9.3359 4.6201 0.0 0
M  V30 21 C 9.3359 6.1601 0.0 0
M  V30 22 C 10.6695 3.8500 0.0 0
M  V30 23 C 10.6695 6.9301 0.0 0
M  V30 24 C 12.0034 4.6201 0.0 0
M  V30 25 C 12.0034 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 2 2 3
M  V30 4 1 2 20
M  V30 5 1 4 5
M  V30 6 1 4 17
M  V30 7 2 6 7
M  V30 8 2 6 8
M  V30 9 1 6 19
M  V30 10 1 9 10
M  V30 11 1 9 25
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2378327-77-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2378327-86-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37524899
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aminobenzimidazoles as antibiofilm agents against Salmonella enterica
serovar Typhimurium
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huggins, William M.; Vu Nguyen, T.; Hahn, Nicholas A.; Baker, James T.;
Kuo, Laura G.; Kaur, Darpan; Melander, Roberta J.; Gunn, John S.;
Melander, Christian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM MedChemComm (2018), 9(9), 1547-1552

$RFMT $RIREG SCHEME279 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-(2,3-dihydro-7-methyl-2-oxo-1H-benzimidazol-1-yl)-2-pyridinecarboxylate
C15H13N3O3
2378817-86-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.4032 0.0000 0.0 0
M  V30 2 C 3.5673 5.7976 0.0 0
M  V30 3 C 9.7544 5.6420 0.0 0
M  V30 4 O 11.0882 4.8720 0.0 0
M  V30 5 O 9.7544 7.1821 0.0 0
M  V30 6 C 12.4218 5.6420 0.0 0
M  V30 7 N 4.4196 2.5620 0.0 0
M  V30 8 C 3.0127 3.1885 0.0 0
M  V30 9 C 4.2586 1.0304 0.0 0
M  V30 10 C 1.9823 2.0439 0.0 0
M  V30 11 C 2.5369 4.6530 0.0 0
M  V30 12 N 2.7523 0.7103 0.0 0
M  V30 13 C 0.4759 2.3641 0.0 0
M  V30 14 C 1.0304 4.9732 0.0 0
M  V30 15 C 0.0000 3.8288 0.0 0
M  V30 16 C 5.7534 3.3320 0.0 0
M  V30 17 C 5.7534 4.8720 0.0 0
M  V30 18 C 7.0870 2.5620 0.0 0
M  V30 19 C 7.0870 5.6420 0.0 0
M  V30 20 N 8.4207 3.3320 0.0 0
M  V30 21 C 8.4207 4.8720 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 21
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 16
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(2,3-Dihydro-7-methyl-2-oxo-1H-benzimidazol-1-yl)-N-methyl-2-pyridinecarbox...
C15H14N4O2
2378817-83-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.4032 0.0000 0.0 0
M  V30 2 C 3.5673 5.7976 0.0 0
M  V30 3 C 9.7544 5.6420 0.0 0
M  V30 4 N 11.0882 4.8720 0.0 0
M  V30 5 O 9.7544 7.1821 0.0 0
M  V30 6 C 12.4218 5.6420 0.0 0
M  V30 7 N 4.4196 2.5620 0.0 0
M  V30 8 C 3.0127 3.1885 0.0 0
M  V30 9 C 4.2586 1.0304 0.0 0
M  V30 10 C 1.9823 2.0439 0.0 0
M  V30 11 C 2.5369 4.6530 0.0 0
M  V30 12 N 2.7523 0.7103 0.0 0
M  V30 13 C 0.4759 2.3641 0.0 0
M  V30 14 C 1.0304 4.9732 0.0 0
M  V30 15 C 0.0000 3.8288 0.0 0
M  V30 16 C 5.7534 3.3320 0.0 0
M  V30 17 C 7.0870 2.5620 0.0 0
M  V30 18 C 5.7534 4.8720 0.0 0
M  V30 19 C 8.4207 3.3320 0.0 0
M  V30 20 N 7.0870 5.6420 0.0 0
M  V30 21 C 8.4207 4.8720 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 21
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 16
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2378817-86-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2378817-83-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20860283
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused cyclic urea derivatives as CRHR2 antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ohmi, Masashi; Matsushita, Takeshi; Ando, Kazuo; Yamaguchi, Ryuichi;
Fukumoto, Yutaka; Magara, Ryohei; Yamagishi, Tatsuya; Takefuji, Mikito
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019198692 A1 2019-10-17

$RFMT $RIREG SCHEME280 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-(7-fluoro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-2-pyridinecarboxylate
C14H10FN3O3
2378818-26-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.4032 0.0000 0.0 0
M  V30 2 F 3.5673 5.7976 0.0 0
M  V30 3 C 9.7544 5.6420 0.0 0
M  V30 4 O 11.0882 4.8720 0.0 0
M  V30 5 O 9.7544 7.1821 0.0 0
M  V30 6 C 12.4218 5.6420 0.0 0
M  V30 7 N 4.4196 2.5620 0.0 0
M  V30 8 C 3.0127 3.1885 0.0 0
M  V30 9 C 4.2586 1.0304 0.0 0
M  V30 10 C 1.9823 2.0439 0.0 0
M  V30 11 C 2.5369 4.6530 0.0 0
M  V30 12 N 2.7523 0.7103 0.0 0
M  V30 13 C 0.4759 2.3641 0.0 0
M  V30 14 C 1.0304 4.9732 0.0 0
M  V30 15 C 0.0000 3.8288 0.0 0
M  V30 16 C 5.7534 3.3320 0.0 0
M  V30 17 C 5.7534 4.8720 0.0 0
M  V30 18 C 7.0870 2.5620 0.0 0
M  V30 19 C 7.0870 5.6420 0.0 0
M  V30 20 N 8.4207 3.3320 0.0 0
M  V30 21 C 8.4207 4.8720 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 21
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 16
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(7-Fluoro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-N-methyl-2-pyridinecarbox...
C14H11FN4O2
2378818-23-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.4032 0.0000 0.0 0
M  V30 2 F 3.5673 5.7976 0.0 0
M  V30 3 C 9.7544 5.6420 0.0 0
M  V30 4 N 11.0882 4.8720 0.0 0
M  V30 5 O 9.7544 7.1821 0.0 0
M  V30 6 C 12.4218 5.6420 0.0 0
M  V30 7 N 4.4196 2.5620 0.0 0
M  V30 8 C 3.0127 3.1885 0.0 0
M  V30 9 C 4.2586 1.0304 0.0 0
M  V30 10 C 1.9823 2.0439 0.0 0
M  V30 11 C 2.5369 4.6530 0.0 0
M  V30 12 N 2.7523 0.7103 0.0 0
M  V30 13 C 0.4759 2.3641 0.0 0
M  V30 14 C 1.0304 4.9732 0.0 0
M  V30 15 C 0.0000 3.8288 0.0 0
M  V30 16 C 5.7534 3.3320 0.0 0
M  V30 17 C 7.0870 2.5620 0.0 0
M  V30 18 C 5.7534 4.8720 0.0 0
M  V30 19 C 8.4207 3.3320 0.0 0
M  V30 20 N 7.0870 5.6420 0.0 0
M  V30 21 C 8.4207 4.8720 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 21
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 16
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2378818-26-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2378818-23-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20860312
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused cyclic urea derivatives as CRHR2 antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ohmi, Masashi; Matsushita, Takeshi; Ando, Kazuo; Yamaguchi, Ryuichi;
Fukumoto, Yutaka; Magara, Ryohei; Yamagishi, Tatsuya; Takefuji, Mikito
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019198692 A1 2019-10-17

$RFMT $RIREG SCHEME281 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-(2,3-dihydro-7-methyl-2-oxo-1H-benzimidazol-1-yl)-4-methyl-2-pyridin...
C16H15N3O3
2378818-90-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.4031 0.0000 0.0 0
M  V30 2 C 3.5673 5.7975 0.0 0
M  V30 3 C 7.0870 1.0220 0.0 0
M  V30 4 C 9.7543 5.6420 0.0 0
M  V30 5 O 11.0881 4.8720 0.0 0
M  V30 6 O 9.7543 7.1820 0.0 0
M  V30 7 C 12.4217 5.6420 0.0 0
M  V30 8 N 4.4195 2.5620 0.0 0
M  V30 9 C 3.0127 3.1884 0.0 0
M  V30 10 C 4.2586 1.0304 0.0 0
M  V30 11 C 1.9823 2.0439 0.0 0
M  V30 12 C 2.5369 4.6530 0.0 0
M  V30 13 N 2.7523 0.7103 0.0 0
M  V30 14 C 0.4759 2.3641 0.0 0
M  V30 15 C 1.0304 4.9732 0.0 0
M  V30 16 C 0.0000 3.8288 0.0 0
M  V30 17 C 5.7533 3.3320 0.0 0
M  V30 18 C 7.0870 2.5620 0.0 0
M  V30 19 C 5.7533 4.8720 0.0 0
M  V30 20 C 8.4206 3.3320 0.0 0
M  V30 21 N 7.0870 5.6420 0.0 0
M  V30 22 C 8.4206 4.8720 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 12
M  V30 3 1 3 18
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 22
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 17
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(2,3-Dihydro-7-methyl-2-oxo-1H-benzimidazol-1-yl)-N,4-dimethyl-2-pyridineca...
C16H16N4O2
2378818-87-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.4031 0.0000 0.0 0
M  V30 2 C 3.5673 5.7975 0.0 0
M  V30 3 C 7.0870 1.0220 0.0 0
M  V30 4 C 9.7543 5.6420 0.0 0
M  V30 5 N 11.0881 4.8720 0.0 0
M  V30 6 O 9.7543 7.1820 0.0 0
M  V30 7 C 12.4217 5.6420 0.0 0
M  V30 8 N 4.4195 2.5620 0.0 0
M  V30 9 C 3.0127 3.1884 0.0 0
M  V30 10 C 4.2586 1.0304 0.0 0
M  V30 11 C 1.9823 2.0439 0.0 0
M  V30 12 C 2.5369 4.6530 0.0 0
M  V30 13 N 2.7523 0.7103 0.0 0
M  V30 14 C 0.4759 2.3641 0.0 0
M  V30 15 C 1.0304 4.9732 0.0 0
M  V30 16 C 0.0000 3.8288 0.0 0
M  V30 17 C 5.7533 3.3320 0.0 0
M  V30 18 C 7.0870 2.5620 0.0 0
M  V30 19 C 5.7533 4.8720 0.0 0
M  V30 20 C 8.4206 3.3320 0.0 0
M  V30 21 N 7.0870 5.6420 0.0 0
M  V30 22 C 8.4206 4.8720 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 12
M  V30 3 1 3 18
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 22
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 17
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2378818-90-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2378818-87-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20860370
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused cyclic urea derivatives as CRHR2 antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ohmi, Masashi; Matsushita, Takeshi; Ando, Kazuo; Yamaguchi, Ryuichi;
Fukumoto, Yutaka; Magara, Ryohei; Yamagishi, Tatsuya; Takefuji, Mikito
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019198692 A1 2019-10-17

$RFMT $RIREG SCHEME282 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-[[1-[(1,1-dimethylethoxy)carbonyl]-4-piperidinyl]amino]-2-pyridineca...
C17H25N3O4
2415122-31-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.3360 4.6201 0.0 0
M  V30 2 C 4.0012 1.5400 0.0 0
M  V30 3 O 2.6675 2.3101 0.0 0
M  V30 4 O 4.0012 0.0000 0.0 0
M  V30 5 C 1.3338 1.5400 0.0 0
M  V30 6 C 2.1038 0.2064 0.0 0
M  V30 7 C 0.0000 0.7700 0.0 0
M  V30 8 C 0.5638 2.8737 0.0 0
M  V30 9 C 14.6708 1.5400 0.0 0
M  V30 10 O 16.0045 2.3101 0.0 0
M  V30 11 O 14.6708 0.0000 0.0 0
M  V30 12 C 17.3383 1.5400 0.0 0
M  V30 13 C 8.0023 3.8501 0.0 0
M  V30 14 C 8.0023 2.3101 0.0 0
M  V30 15 C 6.6687 4.6201 0.0 0
M  V30 16 C 6.6687 1.5400 0.0 0
M  V30 17 C 5.3348 3.8501 0.0 0
M  V30 18 N 5.3348 2.3101 0.0 0
M  V30 19 C 10.6697 3.8501 0.0 0
M  V30 20 C 12.0035 4.6201 0.0 0
M  V30 21 C 10.6697 2.3101 0.0 0
M  V30 22 C 13.3372 3.8501 0.0 0
M  V30 23 N 12.0035 1.5400 0.0 0
M  V30 24 C 13.3372 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 18
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 24
M  V30 13 1 10 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[[6-[(methylamino)carbonyl]-3-pyridinyl]amino]-1-piperidi...
C17H26N4O3
2868276-79-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.3360 4.6201 0.0 0
M  V30 2 C 4.0012 1.5400 0.0 0
M  V30 3 O 2.6675 2.3101 0.0 0
M  V30 4 O 4.0012 0.0000 0.0 0
M  V30 5 C 1.3338 1.5400 0.0 0
M  V30 6 C 0.5638 2.8737 0.0 0
M  V30 7 C 0.0000 0.7700 0.0 0
M  V30 8 C 2.1038 0.2064 0.0 0
M  V30 9 C 14.6708 1.5400 0.0 0
M  V30 10 N 16.0045 2.3101 0.0 0
M  V30 11 O 14.6708 0.0000 0.0 0
M  V30 12 C 17.3383 1.5400 0.0 0
M  V30 13 C 8.0023 3.8501 0.0 0
M  V30 14 C 6.6687 4.6201 0.0 0
M  V30 15 C 8.0023 2.3101 0.0 0
M  V30 16 C 5.3348 3.8501 0.0 0
M  V30 17 C 6.6687 1.5400 0.0 0
M  V30 18 N 5.3348 2.3101 0.0 0
M  V30 19 C 10.6697 3.8501 0.0 0
M  V30 20 C 12.0035 4.6201 0.0 0
M  V30 21 C 10.6697 2.3101 0.0 0
M  V30 22 C 13.3372 3.8501 0.0 0
M  V30 23 N 12.0035 1.5400 0.0 0
M  V30 24 C 13.3372 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 18
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 24
M  V30 13 1 10 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2415122-31-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2868276-79-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34894136
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and in vitro biological evaluation of
3-ethyl-1,5-naphthyridin-2(1H)-one derivatives as potent PARP-1 selective
inhibitors and PARP-1 DNA trappers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ren, Junkang; Quan, Xu; Liu, Ying; Li, Jiani; Zhang, Xiaoyu; Li, Zhiyu;
Zhang, Xiaomeng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2022), 78129046

$RFMT $RIREG SCHEME283 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C21H44N4O2S3
2421247-09-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 9.2401 0.0 0
M  V30 2 C 12.0034 8.4701 0.0 0
M  V30 3 O 13.3370 9.2401 0.0 0
M  V30 4 O 12.0034 6.9301 0.0 0
M  V30 5 C 14.6707 8.4701 0.0 0
M  V30 6 C 16.0045 9.2401 0.0 0
M  V30 7 C 9.3359 3.8500 0.0 0
M  V30 8 C 9.3359 2.3100 0.0 0
M  V30 9 S 10.6697 1.5400 0.0 0
M  V30 10 C 10.6697 0.0000 0.0 0
M  V30 11 C 5.3348 10.7801 0.0 0
M  V30 12 C 4.0011 11.5501 0.0 0
M  V30 13 S 4.0011 13.0901 0.0 0
M  V30 14 C 2.6675 13.8602 0.0 0
M  V30 15 C 4.0011 5.3901 0.0 0
M  V30 16 C 2.6675 6.1601 0.0 0
M  V30 17 S 1.3338 5.3901 0.0 0
M  V30 18 C 0.0000 6.1601 0.0 0
M  V30 19 N 9.3359 8.4701 0.0 0
M  V30 20 C 9.3359 6.9301 0.0 0
M  V30 21 C 8.0022 9.2401 0.0 0
M  V30 22 C 8.0022 6.1601 0.0 0
M  V30 23 C 6.6686 8.4701 0.0 0
M  V30 24 N 8.0022 4.6201 0.0 0
M  V30 25 N 5.3348 9.2401 0.0 0
M  V30 26 C 6.6686 3.8500 0.0 0
M  V30 27 C 4.0011 8.4701 0.0 0
M  V30 28 C 5.3348 4.6201 0.0 0
M  V30 29 C 4.0011 6.9301 0.0 0
M  V30 30 N 5.3348 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 24
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 11 12
M  V30 12 1 11 25
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 15 16
M  V30 16 1 15 30
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 1 26 28
M  V30 28 1 27 29
M  V30 29 1 28 30
M  V30 30 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4,7,10-tris[2-(methylthio)ethyl]-1,4,7,10-tetraazacyclododecane-1-ac...
C20H43N5OS3
2421247-07-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 3.0800 0.0 0
M  V30 2 C 6.6685 2.3100 0.0 0
M  V30 3 N 6.6685 0.7700 0.0 0
M  V30 4 O 5.3347 3.0800 0.0 0
M  V30 5 C 5.3349 0.0000 0.0 0
M  V30 6 C 12.0032 6.9300 0.0 0
M  V30 7 C 13.3369 7.7000 0.0 0
M  V30 8 S 14.6705 6.9300 0.0 0
M  V30 9 C 16.0043 7.7000 0.0 0
M  V30 10 C 4.0011 6.9300 0.0 0
M  V30 11 C 2.6674 7.7000 0.0 0
M  V30 12 S 1.3338 6.9300 0.0 0
M  V30 13 C 0.0000 7.7000 0.0 0
M  V30 14 C 8.0021 10.7800 0.0 0
M  V30 15 C 9.3358 11.5500 0.0 0
M  V30 16 S 9.3358 13.0900 0.0 0
M  V30 17 C 10.6696 13.8600 0.0 0
M  V30 18 N 8.0021 4.6200 0.0 0
M  V30 19 C 9.3358 5.3900 0.0 0
M  V30 20 C 6.6685 5.3900 0.0 0
M  V30 21 C 9.3358 6.9300 0.0 0
M  V30 22 C 6.6685 6.9300 0.0 0
M  V30 23 N 10.6696 7.7000 0.0 0
M  V30 24 N 5.3347 7.7000 0.0 0
M  V30 25 C 10.6696 9.2400 0.0 0
M  V30 26 C 5.3347 9.2400 0.0 0
M  V30 27 C 9.3358 10.0100 0.0 0
M  V30 28 C 6.6685 10.0100 0.0 0
M  V30 29 N 8.0021 9.2400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 23
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 10 24
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 14 15
M  V30 15 1 14 29
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 1 26 28
M  V30 28 1 27 29
M  V30 29 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2421247-09-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2421247-07-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-22605811
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed vial
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Toward novel sulphur-containing derivatives of tetraazacyclododecane:
synthesis, acid-base properties, spectroscopic characterization, DFT
calculations, and cadmium(II) complex formation in aqueous solution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tosato, Marianna; Verona, Marco; Doro, Riccardo; Dalla Tiezza, Marco;
Orian, Laura; Andrighetto, Alberto; Pastore, Paolo; Marzaro, Giovanni; Di
Marco, Valerio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM New Journal of Chemistry (2020), 44(20), 8337-8350

$RFMT $RIREG SCHEME284 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (3S)-4-[bis(phenylmethyl)amino]-4-oxo-3-[[(phenylmethoxy)carbonyl]amin...
C27H28N2O5
2445875-54-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.3901 6.6685 0.0 0
M  V30 2 C 6.9302 6.6685 0.0 0
M  V30 3 C 4.6201 8.0022 0.0 0
M  V30 4 C 4.6201 5.3348 0.0 0
M  V30 5 C 7.7002 5.3348 0.0 0 CFG=2
M  V30 6 O 7.7002 8.0022 0.0 0
M  V30 7 N 9.2402 5.3348 0.0 0
M  V30 8 C 6.9302 4.0012 0.0 0
M  V30 9 C 10.0102 6.6685 0.0 0
M  V30 10 C 7.7002 2.6673 0.0 0
M  V30 11 O 11.5503 6.6685 0.0 0
M  V30 12 O 9.2402 8.0022 0.0 0
M  V30 13 O 6.9302 1.3337 0.0 0
M  V30 14 O 9.2402 2.6673 0.0 0
M  V30 15 C 12.3203 8.0022 0.0 0
M  V30 16 C 7.7002 0.0000 0.0 0
M  V30 17 C 5.3901 9.3360 0.0 0
M  V30 18 C 6.9302 9.3360 0.0 0
M  V30 19 C 4.6201 10.6697 0.0 0
M  V30 20 C 7.7002 10.6697 0.0 0
M  V30 21 C 5.3901 12.0033 0.0 0
M  V30 22 C 6.9302 12.0033 0.0 0
M  V30 23 C 3.0801 5.3348 0.0 0
M  V30 24 C 2.3101 6.6685 0.0 0
M  V30 25 C 2.3101 4.0012 0.0 0
M  V30 26 C 0.7700 6.6685 0.0 0
M  V30 27 C 0.7700 4.0012 0.0 0
M  V30 28 C 0.0000 5.3348 0.0 0
M  V30 29 C 13.8603 8.0022 0.0 0
M  V30 30 C 14.6303 9.3360 0.0 0
M  V30 31 C 14.6303 6.6685 0.0 0
M  V30 32 C 16.1704 9.3360 0.0 0
M  V30 33 C 16.1704 6.6685 0.0 0
M  V30 34 C 16.9404 8.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 17
M  V30 7 1 4 23
M  V30 8 1 5 7
M  V30 9 1 5 8 CFG=1
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 2 10 14
M  V30 16 1 11 15
M  V30 17 1 13 16
M  V30 18 1 15 29
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C27H29N3O4
2445875-59-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.3901 6.6685 0.0 0
M  V30 2 C 6.9302 6.6685 0.0 0
M  V30 3 C 4.6201 8.0022 0.0 0
M  V30 4 C 4.6201 5.3348 0.0 0
M  V30 5 C 7.7002 5.3348 0.0 0 CFG=2
M  V30 6 O 7.7002 8.0022 0.0 0
M  V30 7 N 9.2402 5.3348 0.0 0
M  V30 8 C 6.9302 4.0012 0.0 0
M  V30 9 C 10.0102 6.6685 0.0 0
M  V30 10 C 7.7002 2.6673 0.0 0
M  V30 11 O 11.5503 6.6685 0.0 0
M  V30 12 O 9.2402 8.0022 0.0 0
M  V30 13 N 6.9302 1.3337 0.0 0
M  V30 14 O 9.2402 2.6673 0.0 0
M  V30 15 C 12.3203 8.0022 0.0 0
M  V30 16 C 7.7002 0.0000 0.0 0
M  V30 17 C 5.3901 9.3360 0.0 0
M  V30 18 C 6.9302 9.3360 0.0 0
M  V30 19 C 4.6201 10.6697 0.0 0
M  V30 20 C 7.7002 10.6697 0.0 0
M  V30 21 C 5.3901 12.0033 0.0 0
M  V30 22 C 6.9302 12.0033 0.0 0
M  V30 23 C 3.0801 5.3348 0.0 0
M  V30 24 C 2.3101 6.6685 0.0 0
M  V30 25 C 2.3101 4.0012 0.0 0
M  V30 26 C 0.7700 6.6685 0.0 0
M  V30 27 C 0.7700 4.0012 0.0 0
M  V30 28 C 0.0000 5.3348 0.0 0
M  V30 29 C 13.8603 8.0022 0.0 0
M  V30 30 C 14.6303 9.3360 0.0 0
M  V30 31 C 14.6303 6.6685 0.0 0
M  V30 32 C 16.1704 9.3360 0.0 0
M  V30 33 C 16.1704 6.6685 0.0 0
M  V30 34 C 16.9404 8.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 17
M  V30 7 1 4 23
M  V30 8 1 5 7
M  V30 9 1 5 8 CFG=1
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 2 10 14
M  V30 16 1 11 15
M  V30 17 1 13 16
M  V30 18 1 15 29
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2445875-54-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2445875-59-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-22836861
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Syntheses of enantiopure 1,2-ethylenediamines with tethered secondary
amines of the formula H2NCH2CH[(CH2)nNHMe]NH2 (n = 1 - 4) from α-amino
acids: New agents for asymmetric catalysis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kabes, Connor Q.; Gunn, Jack H.; Selbst, Maximilian A.; Lucas, Reagan F.;
Gladysz, John A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2020), 52(21), 3277-3285

$RFMT $RIREG SCHEME285 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(3-Hydroxypropoxy)benzaldehyde
C10H12O3
245510-06-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 3.0801 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 C 10.6697 2.3101 0.0 0
M  V30 5 O 12.0033 3.0801 0.0 0
M  V30 6 C 1.3337 3.0801 0.0 0
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 6 7
M  V30 7 1 6 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[3-[(Methylamino)methyl]phenoxy]-1-propanol
C11H17NO2
892403-84-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0022 3.0801 0.0 0
M  V30 2 C 9.3360 2.3101 0.0 0
M  V30 3 C 10.6697 3.0801 0.0 0
M  V30 4 C 12.0033 2.3101 0.0 0
M  V30 5 O 13.3370 3.0801 0.0 0
M  V30 6 C 2.6673 3.0801 0.0 0
M  V30 7 N 1.3337 2.3101 0.0 0
M  V30 8 C 0.0000 3.0801 0.0 0
M  V30 9 C 6.6685 2.3101 0.0 0
M  V30 10 C 5.3348 3.0801 0.0 0
M  V30 11 C 6.6685 0.7700 0.0 0
M  V30 12 C 4.0010 2.3101 0.0 0
M  V30 13 C 5.3348 0.0000 0.0 0
M  V30 14 C 4.0010 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 245510-06-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 892403-84-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-10337442
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin
reuptake inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Letavic, Michael A.; Keith, John M.; Jablonowski, Jill A.; Stocking,
Emily M.; Gomez, Leslie A.; Ly, Kiev S.; Miller, Jennifer M.; Barbier,
Ann J.; Bonaventure, Pascal; Boggs, Jamin D.; Wilson, Sandy J.; Miller,
Kirsten L.; Lord, Brian; McAllister, Heather M.; Tognarelli, D. J.; Wu,
Jiejun; Abad, Marta C.; Schubert, Carsten; Lovenberg, Timothy W.;
Carruthers, Nicholas I.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2007), 17(4), 1047-1051

$RFMT $RIREG SCHEME285 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(3-Hydroxypropoxy)benzaldehyde
C10H12O3
245510-06-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 3.0801 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 C 10.6697 2.3101 0.0 0
M  V30 5 O 12.0033 3.0801 0.0 0
M  V30 6 C 1.3337 3.0801 0.0 0
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 6 7
M  V30 7 1 6 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[3-[(Methylamino)methyl]phenoxy]-1-propanol
C11H17NO2
892403-84-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0022 3.0801 0.0 0
M  V30 2 C 9.3360 2.3101 0.0 0
M  V30 3 C 10.6697 3.0801 0.0 0
M  V30 4 C 12.0033 2.3101 0.0 0
M  V30 5 O 13.3370 3.0801 0.0 0
M  V30 6 C 2.6673 3.0801 0.0 0
M  V30 7 N 1.3337 2.3101 0.0 0
M  V30 8 C 0.0000 3.0801 0.0 0
M  V30 9 C 6.6685 2.3101 0.0 0
M  V30 10 C 5.3348 3.0801 0.0 0
M  V30 11 C 6.6685 0.7700 0.0 0
M  V30 12 C 4.0010 2.3101 0.0 0
M  V30 13 C 5.3348 0.0000 0.0 0
M  V30 14 C 4.0010 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 245510-06-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 892403-84-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-2835992
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dual serotonin transporter/histamine H3 ligands: Optimization of the H3
pharmacophore
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Keith, John M.; Gomez, Leslie A.; Letavic, Michael A.; Ly, Kiev S.;
Jablonowski, Jill A.; Seierstad, Mark; Barbier, Ann J.; Wilson, Sandy J.;
Boggs, Jamin D.; Fraser, Ian C.; Mazur, Curt; Lovenberg, Timothy W.;
Carruthers, Nicholas I.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2007), 17(3), 702-706

$RFMT $RIREG SCHEME285 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(3-Hydroxypropoxy)benzaldehyde
C10H12O3
245510-06-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 3.0801 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 C 10.6697 2.3101 0.0 0
M  V30 5 O 12.0033 3.0801 0.0 0
M  V30 6 C 1.3337 3.0801 0.0 0
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 6 7
M  V30 7 1 6 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[3-[(Methylamino)methyl]phenoxy]-1-propanol
C11H17NO2
892403-84-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0022 3.0801 0.0 0
M  V30 2 C 9.3360 2.3101 0.0 0
M  V30 3 C 10.6697 3.0801 0.0 0
M  V30 4 C 12.0033 2.3101 0.0 0
M  V30 5 O 13.3370 3.0801 0.0 0
M  V30 6 C 2.6673 3.0801 0.0 0
M  V30 7 N 1.3337 2.3101 0.0 0
M  V30 8 C 0.0000 3.0801 0.0 0
M  V30 9 C 6.6685 2.3101 0.0 0
M  V30 10 C 5.3348 3.0801 0.0 0
M  V30 11 C 6.6685 0.7700 0.0 0
M  V30 12 C 4.0010 2.3101 0.0 0
M  V30 13 C 5.3348 0.0000 0.0 0
M  V30 14 C 4.0010 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 245510-06-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 892403-84-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-13997042
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 2; 3-(3-Methylaminomethyl-phenoxy)-propan-1 -ol. To a solution of
3-(3-hydroxy-propoxy benzaldehyde (30.0 g, 167 mmol) and aqueous MeNH2
(40% wt, 27.2 mL, 350 mmol) in MeOH (330 mL) at 0°C was added NaBH4 (12.0
g, ,316 mmol) portion-wise. The reaction mixture was stirred at 0°C for
30 min. The ice-water bath was. then removed and the reaction was stirred
at rt overnight; The mixture was concentrated and the residue was stirred
in 1 N NaOH (300 mL) for 2 h. The product wag extracted with DCM and the
combined organic layers were washed with brine, dried over Na2 SO4 and
concentrated to give the product, as a clear oil, yield 32.5 g, 100%. MS
(ESI): mass calcd for C11H17NO2, 195.2; m/z found, 196.4 [M+H]+. 1H NMR
(CDCl3): 7.24-7.21 (m, 1 H), 6.91 -6.88 (m, 1 H), 6.89 (d, J = 7.5, 1H),
6.80 (dd, J .=.8.1, 2.1, IH), 4.12 (1, J =6.1, 2H), 3.82 (1, J =
5.'9,2H), 3.74 (s, 2H), 2.44 (s, 3H), 2.07-2.00 (m, 2H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tetrahydroisoquinolines as histamine H3 receptor and
serotonin transporter modulators for treatment of central nervous system
disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carruthers, Nicholas I.; Gomez, Leslie A.; Jablonowski, Jill A.; Keith,
John M.; Letavic, Michael A.; Ly, Kiev S.; Miller, Jennifer M. B.;
Stocking, Emily M.; Wolin, Ronald L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006066197 A1 2006-06-22

$RFMT $RIREG SCHEME286 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-(1,1-Dimethylethyl)-8,9-dihydro-3,4-dimethoxypyrido[1,2-a]benzimidazol-6(7H...
C17H22N2O3
2455456-79-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.8791 1.9951 0.0 0
M  V30 2 C 0.3476 2.1562 0.0 0
M  V30 3 O 0.6263 4.8089 0.0 0
M  V30 4 C 0.0000 6.2158 0.0 0
M  V30 5 O 8.0195 0.0000 0.0 0
M  V30 6 C 10.6868 4.6200 0.0 0
M  V30 7 C 12.0204 3.8500 0.0 0
M  V30 8 C 12.0204 5.3901 0.0 0
M  V30 9 C 10.6868 6.1601 0.0 0
M  V30 10 C 4.3159 3.0800 0.0 0
M  V30 11 N 5.2211 4.3259 0.0 0
M  V30 12 C 2.7843 3.2411 0.0 0
M  V30 13 N 5.2211 1.8342 0.0 0
M  V30 14 C 6.6857 3.8500 0.0 0
M  V30 15 C 4.5946 5.7329 0.0 0
M  V30 16 C 2.1579 4.6479 0.0 0
M  V30 17 C 6.6857 2.3100 0.0 0
M  V30 18 C 8.0195 4.6200 0.0 0
M  V30 19 C 3.0631 5.8938 0.0 0
M  V30 20 C 8.0195 1.5400 0.0 0
M  V30 21 C 9.3531 3.8500 0.0 0
M  V30 22 C 9.3531 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 3 4
M  V30 4 1 3 16
M  V30 5 2 5 20
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 21
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 2 14 17
M  V30 18 1 14 18
M  V30 19 2 15 19
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 1 18 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[8-(1,1-Dimethylethyl)-8,9-dihydro-3,4-dimethoxypyrido[1,2-a]benzimidazol-6...
C18H25N3O2
2455456-80-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.5659 9.3927 0.0 0
M  V30 2 C 6.3359 10.7265 0.0 0
M  V30 3 C 10.1859 6.7254 0.0 0
M  V30 4 C 10.1859 8.2654 0.0 0
M  V30 5 C 11.7259 6.7254 0.0 0
M  V30 6 C 10.1859 5.1854 0.0 0
M  V30 7 O 1.2459 4.5948 0.0 0
M  V30 8 C 0.0000 3.6896 0.0 0
M  V30 9 O 1.5677 1.5317 0.0 0
M  V30 10 C 1.7288 0.0000 0.0 0
M  V30 11 C 6.3359 5.3917 0.0 0
M  V30 12 N 5.3055 4.2472 0.0 0
M  V30 13 C 5.5659 6.7254 0.0 0
M  V30 14 C 7.8759 5.3917 0.0 0
M  V30 15 C 3.8987 4.8737 0.0 0
M  V30 16 C 5.4664 2.7156 0.0 0
M  V30 17 C 6.3359 8.0590 0.0 0
M  V30 18 N 4.0596 6.4052 0.0 0
M  V30 19 C 8.6459 6.7254 0.0 0
M  V30 20 C 2.6527 3.9684 0.0 0
M  V30 21 C 4.2205 1.8104 0.0 0
M  V30 22 C 7.8759 8.0590 0.0 0
M  V30 23 C 2.8137 2.4368 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 17 CFG=2
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 19
M  V30 7 1 7 8
M  V30 8 1 7 20
M  V30 9 1 9 10
M  V30 10 1 9 23
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 13 18
M  V30 18 1 14 19
M  V30 19 2 15 18
M  V30 20 1 15 20
M  V30 21 2 16 21
M  V30 22 1 17 22
M  V30 23 1 19 22
M  V30 24 2 20 23
M  V30 25 1 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2455456-79-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2455456-80-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-22586560
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted polycyclic carboxylic acids and analogues
thereof for treating hepatitis B virus and hepatitis D virus
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Shuai; Cole, Andrew G.; Dorsey, Bruce D.; Fan, Yi; Gotchev, Dimitar
B.; Kakarla, Ramesh; Kirk, Sharon Marie; Quintero, Jorge; Sofia, Michael
J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020150366 A1 2020-07-23

$RFMT $RIREG SCHEME287 STEP1
$RXN



  2  1
$MOL
(1aR,1bR,4aR,5aR)-Tetrahydro-3,3-dimethyl-5H-oxireno[3,4]cyclopenta[1,2-d][1,...
C8H10O4
247191-04-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 1.3210 5.1778 0.0 0
M  V30 2 C 7.0059 4.6687 0.0 0
M  V30 3 C 7.4345 2.6527 0.0 0
M  V30 4 C 2.6091 1.4068 0.0 0 CFG=1
M  V30 5 C 3.9429 2.1768 0.0 0 CFG=1
M  V30 6 C 1.4647 2.4374 0.0 0 CFG=2
M  V30 7 O 1.1445 0.9309 0.0 0
M  V30 8 C 3.6227 3.6832 0.0 0 CFG=1
M  V30 9 O 5.4744 2.0159 0.0 0
M  V30 10 C 2.0910 3.8442 0.0 0
M  V30 11 O 4.9563 4.4532 0.0 0
M  V30 12 C 6.1007 3.4227 0.0 0
M  V30 13 H 3.2355 0.0000 0.0 0
M  V30 14 H 4.2630 0.6705 0.0 0
M  V30 15 H 0.0000 2.9132 0.0 0
M  V30 16 H 3.3024 5.1895 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 12
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 13 CFG=3
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 5 14 CFG=1
M  V30 11 1 6 7
M  V30 12 1 6 10
M  V30 13 1 6 15 CFG=3
M  V30 14 1 8 10
M  V30 15 1 8 11
M  V30 16 1 8 16 CFG=1
M  V30 17 1 9 12
M  V30 18 1 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 4 5 6 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Phosphonium, (bromomethyl)triphenyl-, compd. with sodium amide (Na(NH2)) (1:1)
C19H17BrP.H2NNa
732308-71-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 4.6201 6.1601 0.0 0 CHG=1 VAL=4
M  V30 2 C 4.6201 7.7001 0.0 0
M  V30 3 Br 3.2864 8.4702 0.0 0
M  V30 4 C 3.0801 6.1601 0.0 0
M  V30 5 C 2.3101 7.4938 0.0 0
M  V30 6 C 2.3101 4.8264 0.0 0
M  V30 7 C 0.7700 7.4938 0.0 0
M  V30 8 C 0.7700 4.8264 0.0 0
M  V30 9 C 0.0000 6.1601 0.0 0
M  V30 10 C 6.1601 6.1601 0.0 0
M  V30 11 C 6.9302 7.4938 0.0 0
M  V30 12 C 6.9302 4.8264 0.0 0
M  V30 13 C 8.4702 7.4938 0.0 0
M  V30 14 C 8.4702 4.8264 0.0 0
M  V30 15 C 9.2402 6.1601 0.0 0
M  V30 16 C 4.6201 4.6201 0.0 0
M  V30 17 C 5.9538 3.8501 0.0 0
M  V30 18 C 3.2864 3.8501 0.0 0
M  V30 19 C 5.9538 2.3100 0.0 0
M  V30 20 C 3.2864 2.3100 0.0 0
M  V30 21 C 4.6201 1.5400 0.0 0
M  V30 22 N 3.8501 0.0000 0.0 0
M  V30 23 Na 5.3901 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 1 10
M  V30 4 1 1 16
M  V30 5 1 2 3
M  V30 6 2 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 2 6 8
M  V30 10 2 7 9
M  V30 11 1 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1aS,1bS,4aS,5aS)-Tetrahydro-3,3-dimethyl-5-methylene-5H-oxireno[3,4]cyclopen...
C9H12O3
247191-05-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.3210 5.1778 0.0 0
M  V30 2 C 7.0059 4.6687 0.0 0
M  V30 3 C 7.4345 2.6527 0.0 0
M  V30 4 C 2.6091 1.4068 0.0 0 CFG=1
M  V30 5 C 3.9429 2.1768 0.0 0 CFG=1
M  V30 6 C 1.4647 2.4374 0.0 0 CFG=2
M  V30 7 O 1.1445 0.9309 0.0 0
M  V30 8 C 3.6227 3.6832 0.0 0 CFG=1
M  V30 9 O 5.4744 2.0159 0.0 0
M  V30 10 C 2.0910 3.8442 0.0 0
M  V30 11 O 4.9563 4.4532 0.0 0
M  V30 12 C 6.1007 3.4227 0.0 0
M  V30 13 H 3.2355 0.0000 0.0 0
M  V30 14 H 4.2630 0.6705 0.0 0
M  V30 15 H 0.0000 2.9132 0.0 0
M  V30 16 H 3.3024 5.1895 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 12
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 13 CFG=3
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 5 14 CFG=1
M  V30 11 1 6 7
M  V30 12 1 6 10
M  V30 13 1 6 15 CFG=3
M  V30 14 1 8 10
M  V30 15 1 8 11
M  V30 16 1 8 16 CFG=1
M  V30 17 1 9 12
M  V30 18 1 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 4 5 6 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 247191-04-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 732308-71-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 247191-05-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-339-CAS-2693930
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM Wittig reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-activity relationships in aminocyclopentitol glycosidase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gartenmann Dickson, Lucas; Leroy, Emmanuel; Reymond, Jean-Louis
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2004), 2(8), 1217-1226

$RFMT $RIREG SCHEME288 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3a,4,5,9b-Tetrahydro-6-methoxy-3H-cyclopenta[c]quinoline-4-carboxylic acid
C14H15NO3
247225-88-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6686 6.2873 0.0 0
M  V30 2 C 8.0023 7.0573 0.0 0
M  V30 3 C 1.3337 4.7473 0.0 0
M  V30 4 O 0.0000 3.9773 0.0 0
M  V30 5 O 1.3337 6.2873 0.0 0
M  V30 6 C 5.3348 2.4373 0.0 0
M  V30 7 C 4.0011 1.6672 0.0 0
M  V30 8 C 5.3348 3.9773 0.0 0
M  V30 9 C 6.6686 1.6672 0.0 0
M  V30 10 C 2.6675 2.4373 0.0 0
M  V30 11 C 3.6810 0.1609 0.0 0
M  V30 12 N 4.0011 4.7473 0.0 0
M  V30 13 C 6.6686 4.7473 0.0 0
M  V30 14 C 8.0023 2.4373 0.0 0
M  V30 15 C 2.6675 3.9773 0.0 0
M  V30 16 C 1.5229 1.4068 0.0 0
M  V30 17 C 2.1494 0.0000 0.0 0
M  V30 18 C 8.0023 3.9773 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 15
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 8 13
M  V30 13 1 9 14
M  V30 14 1 10 15
M  V30 15 1 10 16
M  V30 16 2 11 17
M  V30 17 1 12 15
M  V30 18 1 13 18
M  V30 19 2 14 18
M  V30 20 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3a,4,5,9b-Tetrahydro-6-methoxy-N-methyl-3H-cyclopenta[c]quinoline-4-carboxamide
C15H18N2O2
2503063-70-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 1.3336 0.0 0
M  V30 2 C 2.3100 0.0000 0.0 0
M  V30 3 C 6.9300 5.3347 0.0 0
M  V30 4 N 7.7000 4.0011 0.0 0
M  V30 5 O 7.7000 6.6684 0.0 0
M  V30 6 C 9.2400 4.0011 0.0 0
M  V30 7 C 2.3100 5.3347 0.0 0
M  V30 8 C 3.0800 6.6684 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 0.7700 5.3347 0.0 0
M  V30 11 C 4.6200 6.6684 0.0 0
M  V30 12 C 2.6042 8.1331 0.0 0
M  V30 13 N 4.6200 4.0011 0.0 0
M  V30 14 C 2.3100 2.6674 0.0 0
M  V30 15 C 0.0000 4.0011 0.0 0
M  V30 16 C 5.3900 5.3347 0.0 0
M  V30 17 C 5.0959 8.1331 0.0 0
M  V30 18 C 3.8500 9.0383 0.0 0
M  V30 19 C 0.7700 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 16
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 9 14
M  V30 14 1 10 15
M  V30 15 1 11 16
M  V30 16 1 11 17
M  V30 17 2 12 18
M  V30 18 1 13 16
M  V30 19 1 14 19
M  V30 20 2 15 19
M  V30 21 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 247225-88-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2503063-70-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22856861
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of phenanthridine analogues as novel chemical probes disrupting
the binding of DNA to ΔFosB homodimers and ΔFosB/JunD heterodimers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Yi; Liu, Zhiqing; Aglyamova, Galina; Chen, Jianping; Chen, Haiying;
Bhandari, Mukund; White, Mark A.; Rudenko, Gabrielle; Zhou, Jia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2020), 30(16), 127300

$RFMT $RIREG SCHEME289 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-bromo-1-[(dimethylamino)sulfonyl]-1H-benzimidazole-5-carboxylate
C11H12BrN3O4S
2488051-01-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.6091 2.5368 0.0 0 VAL=6
M  V30 2 N 1.4645 1.5064 0.0 0
M  V30 3 O 3.6395 1.3925 0.0 0
M  V30 4 O 1.5785 3.6814 0.0 0
M  V30 5 C 0.0000 1.9823 0.0 0
M  V30 6 C 1.7847 0.0000 0.0 0
M  V30 7 Br 2.2587 5.8689 0.0 0
M  V30 8 C 9.8797 3.2471 0.0 0
M  V30 9 O 10.6497 1.9135 0.0 0
M  V30 10 O 10.6497 4.5809 0.0 0
M  V30 11 C 12.1897 1.9135 0.0 0
M  V30 12 C 5.2597 3.2471 0.0 0
M  V30 13 C 6.0297 4.5809 0.0 0
M  V30 14 N 3.7534 3.5673 0.0 0
M  V30 15 C 6.0297 1.9135 0.0 0
M  V30 16 C 7.5697 4.5809 0.0 0
M  V30 17 N 4.9993 5.7253 0.0 0
M  V30 18 C 3.5925 5.0989 0.0 0
M  V30 19 C 7.5697 1.9135 0.0 0
M  V30 20 C 8.3397 3.2471 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 14
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 7 18
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 20
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 2 12 15
M  V30 15 2 13 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1-[(dimethylamino)sulfonyl]-2-(methylamino)-1H-benzimidazole-5-carboxy...
C12H16N4O4S
2488051-02-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.6091 4.8721 0.0 0 VAL=6
M  V30 2 N 1.4645 5.9025 0.0 0
M  V30 3 O 1.5785 3.7276 0.0 0
M  V30 4 O 3.6395 6.0165 0.0 0
M  V30 5 C 0.0000 5.4267 0.0 0
M  V30 6 C 1.7847 7.4089 0.0 0
M  V30 7 N 2.2587 1.5400 0.0 0
M  V30 8 C 2.2587 0.0000 0.0 0
M  V30 9 C 9.8797 4.1618 0.0 0
M  V30 10 O 10.6497 5.4955 0.0 0
M  V30 11 O 10.6497 2.8281 0.0 0
M  V30 12 C 12.1897 5.4955 0.0 0
M  V30 13 N 3.7534 3.8417 0.0 0
M  V30 14 C 5.2597 4.1618 0.0 0
M  V30 15 C 3.5925 2.3100 0.0 0
M  V30 16 C 6.0297 2.8281 0.0 0
M  V30 17 C 6.0297 5.4955 0.0 0
M  V30 18 N 4.9993 1.6837 0.0 0
M  V30 19 C 7.5697 2.8281 0.0 0
M  V30 20 C 7.5697 5.4955 0.0 0
M  V30 21 C 8.3397 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 13
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 7 8
M  V30 8 1 7 15
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 21
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 14 17
M  V30 17 2 15 18
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 1 19 21
M  V30 22 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2488051-01-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2488051-02-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-22676038
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fragment Screening Hit Draws Attention to a Novel Transient Pocket
Adjacent to the Recognition Site of the tRNA-Modifying Enzyme TGT
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hassaan, Engi; Hohn, Christoph; Ehrmann, Frederik R.; Goetzke, F.
Wieland; Movsisyan, Levon; Huefner-Wulsdorf, Tobias; Sebastiani, Maurice;
Haertsch, Adrian; Reuter, Klaus; Diederich, Francois; Klebe, Gerhard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(13), 6802-6820

$RFMT $RIREG SCHEME290 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,7-Dihydro-3,8-dimethyl-7-[8-[(methylsulfonyl)oxy]octyl]-1H-purine-2,6-dione
C16H26N4O5S
2488783-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2597 2.4654 0.0 0
M  V30 2 C 8.5934 3.2355 0.0 0
M  V30 3 C 9.9271 2.4654 0.0 0
M  V30 4 C 11.2609 3.2355 0.0 0
M  V30 5 C 12.5945 2.4654 0.0 0
M  V30 6 C 13.9282 3.2355 0.0 0
M  V30 7 C 15.2619 2.4654 0.0 0
M  V30 8 C 16.5957 3.2355 0.0 0
M  V30 9 O 17.9294 2.4654 0.0 0
M  V30 10 S 19.2630 3.2355 0.0 0 VAL=6
M  V30 11 C 20.0331 1.9018 0.0 0
M  V30 12 O 20.5967 4.0055 0.0 0
M  V30 13 O 18.4930 4.5693 0.0 0
M  V30 14 O 5.0736 0.0000 0.0 0
M  V30 15 C 0.9517 4.5779 0.0 0
M  V30 16 C 6.9095 5.7976 0.0 0
M  V30 17 O 0.0000 1.6486 0.0 0
M  V30 18 C 4.5191 2.6091 0.0 0
M  V30 19 C 3.4886 3.7537 0.0 0
M  V30 20 N 5.9260 3.2355 0.0 0
M  V30 21 C 4.0432 1.1444 0.0 0
M  V30 22 N 4.2587 5.0873 0.0 0
M  V30 23 N 1.9822 3.4334 0.0 0
M  V30 24 C 5.7650 4.7672 0.0 0
M  V30 25 N 2.5367 0.8242 0.0 0
M  V30 26 C 1.5063 1.9688 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 2 10 13
M  V30 14 2 14 21
M  V30 15 1 15 23
M  V30 16 1 16 24
M  V30 17 2 17 26
M  V30 18 2 18 19
M  V30 19 1 18 20
M  V30 20 1 18 21
M  V30 21 1 19 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 2 22 24
M  V30 26 1 23 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Purine-2,6-dione, 3,7-dihydro-3,8-dimethyl-7-[8-(methylamino)octyl]-, comp...
C16H27N5O2.CH4O3S
2488782-61-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2597 7.0854 0.0 0
M  V30 2 C 8.5934 7.8555 0.0 0
M  V30 3 C 9.9271 7.0854 0.0 0
M  V30 4 C 11.2609 7.8555 0.0 0
M  V30 5 C 12.5946 7.0854 0.0 0
M  V30 6 C 13.9282 7.8555 0.0 0
M  V30 7 C 15.2619 7.0854 0.0 0
M  V30 8 C 16.5957 7.8555 0.0 0
M  V30 9 N 17.9294 7.0854 0.0 0
M  V30 10 C 19.2631 7.8555 0.0 0
M  V30 11 O 5.0736 4.6200 0.0 0
M  V30 12 C 0.9517 9.1979 0.0 0
M  V30 13 C 6.9095 10.4176 0.0 0
M  V30 14 O 0.0000 6.2686 0.0 0
M  V30 15 C 4.5191 7.2291 0.0 0
M  V30 16 C 3.4886 8.3737 0.0 0
M  V30 17 N 5.9260 7.8555 0.0 0
M  V30 18 C 4.0432 5.7644 0.0 0
M  V30 19 N 4.2587 9.7073 0.0 0
M  V30 20 N 1.9822 8.0534 0.0 0
M  V30 21 C 5.7650 9.3872 0.0 0
M  V30 22 N 2.5369 5.4442 0.0 0
M  V30 23 C 1.5063 6.5888 0.0 0
M  V30 24 S 9.6315 1.5400 0.0 0 VAL=6
M  V30 25 C 8.0915 1.5400 0.0 0
M  V30 26 O 9.6315 3.0800 0.0 0
M  V30 27 O 9.6315 0.0000 0.0 0
M  V30 28 O 11.1715 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 2 11 18
M  V30 12 1 12 20
M  V30 13 1 13 21
M  V30 14 2 14 23
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 15 18
M  V30 18 1 16 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 2 19 21
M  V30 23 1 20 23
M  V30 24 1 22 23
M  V30 25 1 24 25
M  V30 26 2 24 26
M  V30 27 2 24 27
M  V30 28 1 24 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2488783-00-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2488782-61-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-23241873
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted purines and their analogs for the treatment of
disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Iyer, Radhakrishnan P.; Padmanabhan, Seetharamaiyer; Baskaran,
Subramanian; Sheri, Anjaneyulu; Cleary, Dillon; Mastrolia, Ron; Zhou,
Shenghua; Challa, Sreerupa
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020181050 A1 2020-09-10

$RFMT $RIREG SCHEME291 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-[(4,6-Dichloro-5-pyrimidinyl)methyl]-4-morpholineacetonitrile
C11H12Cl2N4O
2488794-80-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6675 0.0 0
M  V30 2 C 5.3901 4.0012 0.0 0
M  V30 3 C 4.6201 5.3348 0.0 0
M  V30 4 N 3.8501 6.6687 0.0 0
M  V30 5 Cl 3.0801 0.0000 0.0 0
M  V30 6 Cl 3.0801 5.3348 0.0 0
M  V30 7 C 3.0801 2.6675 0.0 0
M  V30 8 C 2.3101 1.3338 0.0 0
M  V30 9 C 2.3101 4.0012 0.0 0
M  V30 10 N 0.7700 1.3338 0.0 0
M  V30 11 N 0.7700 4.0012 0.0 0
M  V30 12 C 0.0000 2.6675 0.0 0
M  V30 13 N 6.9302 4.0012 0.0 0
M  V30 14 C 7.7002 5.3348 0.0 0
M  V30 15 C 7.7002 2.6675 0.0 0
M  V30 16 C 9.2402 5.3348 0.0 0
M  V30 17 C 9.2402 2.6675 0.0 0
M  V30 18 O 10.0102 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 2 13
M  V30 5 3 3 4
M  V30 6 1 5 8
M  V30 7 1 6 9
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-[[4-Chloro-6-(methylamino)-5-pyrimidinyl]methyl]-4-morpholineacetonitrile
C12H16ClN5O
2488794-81-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 C 5.3900 5.3347 0.0 0
M  V30 3 C 4.6200 6.6685 0.0 0
M  V30 4 N 3.8500 8.0021 0.0 0
M  V30 5 N 3.0800 1.3336 0.0 0
M  V30 6 C 2.3100 0.0000 0.0 0
M  V30 7 Cl 3.0800 6.6685 0.0 0
M  V30 8 C 3.0800 4.0011 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 2.3100 5.3347 0.0 0
M  V30 11 N 0.7700 2.6674 0.0 0
M  V30 12 N 0.7700 5.3347 0.0 0
M  V30 13 C 0.0000 4.0011 0.0 0
M  V30 14 N 6.9300 5.3347 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 O 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 14
M  V30 5 3 3 4
M  V30 6 1 5 6
M  V30 7 1 5 9
M  V30 8 1 7 10
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2488794-80-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2488794-81-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-23128082
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bicyclic heterocyclyl compounds as SOS1 modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cregg, James Joseph; Buckl, Andreas; Aay, Naing; Tambo-Ong, Arlyn A.;
Koltun, Elena S.; Gill, Adrian Liam; Thompson, Severin; Gliedt, Micah J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020180770 A1 2020-09-10

$RFMT $RIREG SCHEME292 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1R,5S,7R)-2-oxo-3-(phenylmethyl)-6,8-dioxa-3-azabicyclo[3.2.1]octane-...
C14H15NO5
250137-79-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.9226 2.7600 0.0 0
M  V30 2 O 10.5460 1.3517 0.0 0
M  V30 3 O 10.8306 4.0039 0.0 0
M  V30 4 C 12.0773 1.1874 0.0 0
M  V30 5 O 6.2533 6.2066 0.0 0
M  V30 6 C 4.0012 4.6862 0.0 0
M  V30 7 C 7.9332 4.2064 0.0 0 CFG=1
M  V30 8 C 8.3915 2.9244 0.0 0 CFG=2
M  V30 9 C 6.4683 4.6817 0.0 0
M  V30 10 O 6.6046 3.0724 0.0 0
M  V30 11 O 7.5804 1.6224 0.0 0
M  V30 12 N 5.3348 3.9162 0.0 0
M  V30 13 C 6.2342 1.4655 0.0 0 CFG=2
M  V30 14 C 5.2269 2.3861 0.0 0
M  V30 15 C 2.6675 3.9162 0.0 0
M  V30 16 C 2.6675 2.3761 0.0 0
M  V30 17 C 1.3338 4.6862 0.0 0
M  V30 18 C 1.3338 1.6061 0.0 0
M  V30 19 C 0.0000 3.9162 0.0 0
M  V30 20 C 0.0000 2.3761 0.0 0
M  V30 21 H 9.0060 5.3113 0.0 0
M  V30 22 H 5.7611 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 8 1 CFG=3
M  V30 4 1 2 4
M  V30 5 2 5 9
M  V30 6 1 6 12
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 7 21
M  V30 12 1 8 11
M  V30 13 1 9 12
M  V30 14 1 13 10 CFG=3
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 1 13 14
M  V30 18 1 13 22
M  V30 19 2 15 16
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 2 17 19
M  V30 23 2 18 20
M  V30 24 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 7 8 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,5R,7R)-N-Methyl-2-oxo-3-(phenylmethyl)-6,8-dioxa-3-azabicyclo[3.2.1]octan...
C14H16N2O4
939033-30-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.9226 2.7600 0.0 0
M  V30 2 N 10.5460 1.3517 0.0 0
M  V30 3 O 10.8306 4.0039 0.0 0
M  V30 4 C 12.0773 1.1874 0.0 0
M  V30 5 O 6.2533 6.2066 0.0 0
M  V30 6 C 4.0012 4.6862 0.0 0
M  V30 7 C 7.9332 4.2064 0.0 0 CFG=1
M  V30 8 C 8.3915 2.9244 0.0 0 CFG=2
M  V30 9 C 6.4683 4.6817 0.0 0
M  V30 10 O 6.6046 3.0724 0.0 0
M  V30 11 O 7.5804 1.6224 0.0 0
M  V30 12 N 5.3348 3.9162 0.0 0
M  V30 13 C 6.2342 1.4655 0.0 0 CFG=2
M  V30 14 C 5.2269 2.3861 0.0 0
M  V30 15 C 2.6675 3.9162 0.0 0
M  V30 16 C 1.3338 4.6862 0.0 0
M  V30 17 C 2.6675 2.3761 0.0 0
M  V30 18 C 0.0000 3.9162 0.0 0
M  V30 19 C 1.3338 1.6061 0.0 0
M  V30 20 C 0.0000 2.3761 0.0 0
M  V30 21 H 9.0060 5.3113 0.0 0
M  V30 22 H 5.7611 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 8 1 CFG=3
M  V30 4 1 2 4
M  V30 5 2 5 9
M  V30 6 1 6 12
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 7 21
M  V30 12 1 8 11
M  V30 13 1 9 12
M  V30 14 1 13 10 CFG=3
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 1 13 14
M  V30 18 1 13 22
M  V30 19 2 15 16
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 2 17 19
M  V30 23 2 18 20
M  V30 24 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 7 8 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 250137-79-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 939033-30-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8132177
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for Acylation of Volatile
Amines. GP1. Methyl ester (0.014 mmol) and amine (0.14 mmol) were heated
in a sealed microreaction vessel at 60 °C for 16 h. For the workup, the
reaction mixture was treated under a stream of nitrogen. The final
product mainly as a yellow oil. Representative Analytical Data for
Compounds Obtained with Procedure GP1 BnBTG(O)NHMe (1{2}). Yield: 3.9 mg,
100%. 1H NMR: δ 7.39-7.15 (m, 5 H, Ph-H), 6.47 (bs, 1 H, NH), 5.80 (d, J
= 2.2 Hz, 1 H, 5-H), 5.03 (s, 1 H, 7-H), 4.65 (s, 1 H, 1-H), 4.55 (s, 2
H, PhCH 2), 3.36 (dd, J = 2.2 and 12.1 Hz, 1 H, 4-H), 3.10 (d, J = 12.1
Hz, 1 H, 4-H), 2.85 (d, J = 4.8 Hz, 3 H, CH 3N). 13C NMR: δ 168.9 (s,
C=O), 165.8 (s, C=O), 135.4 (s, Ph-C), 128.9 (d, 2 C, Ph-C), 128.1 (d, 2
C, Ph-C), 127.9 (d, Ph-C), 99.9 (d, C-5), 79.4 (d, C-1), 77.5 (d, C-7),
50.9 (t, C-4), 48.3 (t, PhCH 2), 26.0 (q, NCH 3). MS: m/z (%) 276 (M+,
59), 218 ((M - CONHMe)+, 14), 120 (79), 112 (61), 91 ((PhCH 2)+, 100), 71
(90). Anal. Calcd for C14H16N2O4 (276.29): C, 60.86; H, 5.84; N, 10.14.
Found: C, 60.66; H, 5.58; N, 9.96.
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed microreaction vessel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Parallel Synthesis of an Amide Library Based on the
6,8-Dioxa-3-azabicyclo[3.2.1]octane Scaffold by Direct Aminolysis of
Methyl Esters
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Machetti, Fabrizio; Bucelli, Ilaria; Indiani, Giovanni; Kappe, C. Oliver;
Guarna, Antonio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Combinatorial Chemistry (2007), 9(3), 454-461

$RFMT $RIREG SCHEME293 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-[(1E)-2-(4-amino-3,5-dimethylphenyl)diazenyl]-3-pyridinecarboxylate
C16H18N4O2
2512845-35-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.0032 3.8500 0.0 0
M  V30 2 O 13.3369 4.6200 0.0 0
M  V30 3 O 12.0032 2.3100 0.0 0
M  V30 4 C 14.6705 3.8500 0.0 0
M  V30 5 C 16.0043 4.6200 0.0 0
M  V30 6 N 6.6685 3.8500 0.0 0
M  V30 7 N 5.3347 4.6200 0.0 0
M  V30 8 C 0.0000 4.6200 0.0 0
M  V30 9 C 2.6674 0.0000 0.0 0
M  V30 10 N 0.0000 1.5400 0.0 0
M  V30 11 C 10.6696 4.6200 0.0 0
M  V30 12 C 9.3358 3.8500 0.0 0
M  V30 13 C 10.6696 6.1600 0.0 0
M  V30 14 C 8.0021 4.6200 0.0 0
M  V30 15 N 9.3358 6.9300 0.0 0
M  V30 16 C 8.0021 6.1600 0.0 0
M  V30 17 C 4.0011 3.8500 0.0 0
M  V30 18 C 2.6674 4.6200 0.0 0
M  V30 19 C 4.0011 2.3100 0.0 0
M  V30 20 C 1.3338 3.8500 0.0 0
M  V30 21 C 2.6674 1.5400 0.0 0
M  V30 22 C 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 6 7
M  V30 7 1 6 14
M  V30 8 1 7 17
M  V30 9 1 8 20
M  V30 10 1 9 21
M  V30 11 1 10 22
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(1E)-2-(4-Amino-3,5-dimethylphenyl)diazenyl]-N-methyl-3-pyridinecarboxamide
C15H17N5O
2512845-64-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.0033 3.8501 0.0 0
M  V30 2 N 13.3370 4.6201 0.0 0
M  V30 3 O 12.0033 2.3101 0.0 0
M  V30 4 C 14.6707 3.8501 0.0 0
M  V30 5 N 6.6685 3.8501 0.0 0
M  V30 6 N 5.3348 4.6201 0.0 0
M  V30 7 C 0.0000 4.6201 0.0 0
M  V30 8 C 2.6673 0.0000 0.0 0
M  V30 9 N 0.0000 1.5400 0.0 0
M  V30 10 C 10.6697 4.6201 0.0 0
M  V30 11 C 9.3358 3.8501 0.0 0
M  V30 12 C 10.6697 6.1601 0.0 0
M  V30 13 C 8.0022 4.6201 0.0 0
M  V30 14 N 9.3358 6.9302 0.0 0
M  V30 15 C 8.0022 6.1601 0.0 0
M  V30 16 C 4.0010 3.8501 0.0 0
M  V30 17 C 2.6673 4.6201 0.0 0
M  V30 18 C 4.0010 2.3101 0.0 0
M  V30 19 C 1.3337 3.8501 0.0 0
M  V30 20 C 2.6673 1.5400 0.0 0
M  V30 21 C 1.3337 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 13
M  V30 7 1 6 16
M  V30 8 1 7 19
M  V30 9 1 8 20
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2512845-35-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2512845-64-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-23125285
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Activation of Sirtuin 2 Inhibitors Employing Photoswitchable Geometry and
Aqueous Solubility
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Grathwol, Christoph W.; Woessner, Nathalie; Behnisch-Cornwell, Steven;
Schulig, Lukas; Zhang, Lin; Einsle, Oliver; Jung, Manfred; Link, Andreas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2020), 15(15), 1480-1489

$RFMT $RIREG SCHEME294 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[(2R,4S)-4-amino-1-[(1,1-dimethylethoxy)carbonyl]-2-pyrrolidinyl]-4-t...
C15H23N3O4S
2522926-04-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.8738 3.8500 0.0 0
M  V30 2 O 1.5400 3.0800 0.0 0
M  V30 3 O 4.2074 3.0800 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 3.0800 1.5400 0.0 0
M  V30 6 C 1.5400 0.0000 0.0 0
M  V30 7 C 0.0000 1.5400 0.0 0
M  V30 8 N 1.1986 9.0056 0.0 0
M  V30 9 C 9.5406 6.2952 0.0 0
M  V30 10 O 10.6852 5.2647 0.0 0
M  V30 11 O 9.8608 7.8015 0.0 0
M  V30 12 C 12.1497 5.7405 0.0 0
M  V30 13 C 13.2942 4.7101 0.0 0
M  V30 14 C 4.1197 6.2952 0.0 0 CFG=1
M  V30 15 N 2.8738 5.3900 0.0 0
M  V30 16 C 3.6438 7.7598 0.0 0
M  V30 17 C 1.6278 6.2952 0.0 0
M  V30 18 C 2.1038 7.7598 0.0 0 CFG=2
M  V30 19 C 5.5842 5.8192 0.0 0
M  V30 20 N 6.8301 6.7244 0.0 0
M  V30 21 S 6.0601 4.3547 0.0 0
M  V30 22 C 8.0761 5.8192 0.0 0
M  V30 23 C 7.6001 4.3547 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 18 8 CFG=1
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 22
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 19 CFG=3
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 14 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2R,4S)-4-amino-2-[4-[(methylamino)carbonyl]-2-thiazolyl]-1...
C14H22N4O3S
2522920-68-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.6437 5.3028 0.0 0
M  V30 2 O 2.1037 5.3028 0.0 0
M  V30 3 O 4.4137 6.6365 0.0 0
M  V30 4 C 1.3337 6.6365 0.0 0
M  V30 5 C 0.0000 5.8665 0.0 0
M  V30 6 C 0.5637 7.9701 0.0 0
M  V30 7 C 2.6673 7.4065 0.0 0
M  V30 8 N 4.7709 0.0000 0.0 0
M  V30 9 C 10.6402 6.5187 0.0 0
M  V30 10 N 11.1161 7.9832 0.0 0
M  V30 11 O 11.6707 5.3741 0.0 0
M  V30 12 C 12.6224 8.3036 0.0 0
M  V30 13 C 5.9453 3.8080 0.0 0 CFG=1
M  V30 14 N 4.4137 3.9690 0.0 0
M  V30 15 C 6.2655 2.3017 0.0 0
M  V30 16 C 3.7874 2.5622 0.0 0
M  V30 17 C 4.9318 1.5317 0.0 0 CFG=2
M  V30 18 C 6.9759 4.9526 0.0 0
M  V30 19 N 8.5075 4.7915 0.0 0
M  V30 20 S 6.6556 6.4589 0.0 0
M  V30 21 C 9.1338 6.1985 0.0 0
M  V30 22 C 7.9894 7.2289 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 17 8 CFG=3
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 21
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 18 CFG=1
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 13 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2522926-04-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2522920-68-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-23024956
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Characterization of Specific N-α-Acetyltransferase 50 (Naa50) Inhibitors
Identified Using a DNA Encoded Library
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kung, Pei-Pei; Bingham, Patrick; Burke, Benjamin J.; Chen, Qiuxia; Cheng,
Xuemin; Deng, Ya-Li; Dou, Dengfeng; Feng, Junli; Gallego, Gary M.;
Gehring, Michael R.; Grant, Stephan K.; Greasley, Samantha; Harris,
Anthony R.; Maegley, Karen A.; Meier, Jordan; Meng, Xiaoyun; Montano,
Jose L.; Morgan, Barry A.; Naughton, Brigitte S.; Palde, Prakash B.;
Paul, Thomas A.; Richardson, Paul; Sakata, Sylvie; Shaginian, Alex;
Sonnenburg, William K.; Subramanyam, Chakrapani; Timofeevski, Sergei;
Wan, Jinqiao; Yan, Wen; Stewart, Albert E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2020), 11(6), 1175-1184

$RFMT $RIREG SCHEME295 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2R,3R,3aS,7R,8aS,9S,10aR,11S,12R,13aR,13bS,15S,18S,21S,24S,26R,28R,29aS)-Hex...
C41H60O14S
253128-19-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  70 78 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.2422 0.0000 0.0 0
M  V30 2 O 12.2749 11.0069 0.0 0
M  V30 3 O 13.9999 10.1092 0.0 0
M  V30 4 C 15.5062 10.4294 0.0 0
M  V30 5 C 13.9548 1.7373 0.0 0
M  V30 6 C 15.9692 7.3988 0.0 0
M  V30 7 C 16.7392 6.0649 0.0 0 CFG=2
M  V30 8 C 18.2792 6.0649 0.0 0
M  V30 9 O 15.9692 4.7313 0.0 0
M  V30 10 O 19.0492 4.7313 0.0 0
M  V30 11 S 20.5892 4.7313 0.0 0 VAL=6
M  V30 12 C 20.5892 3.1912 0.0 0
M  V30 13 O 22.1293 4.7313 0.0 0
M  V30 14 O 20.5892 6.2713 0.0 0
M  V30 15 C 13.4760 4.7798 0.0 0
M  V30 16 C 3.6553 7.5426 0.0 0 CFG=1
M  V30 17 O 5.3347 8.1397 0.0 0
M  V30 18 O 3.7560 9.1207 0.0 0
M  V30 19 C 2.0424 7.4905 0.0 0
M  V30 20 C 3.7589 6.0101 0.0 0
M  V30 21 C 4.8195 9.7538 0.0 0 CFG=1
M  V30 22 C 2.7819 9.8622 0.0 0 CFG=2
M  V30 23 C 1.4880 8.9814 0.0 0 CFG=1
M  V30 24 C 5.1522 5.3570 0.0 0
M  V30 25 C 3.2344 10.1657 0.0 0 CFG=2
M  V30 26 C 5.8321 10.8304 0.0 0 CFG=1
M  V30 27 C 2.8429 11.5162 0.0 0 CFG=2
M  V30 28 O 1.2599 10.3464 0.0 0
M  V30 29 C 5.2743 3.8359 0.0 0 CFG=1
M  V30 30 C 5.3963 12.3211 0.0 0 CFG=2
M  V30 31 O 7.3447 10.4942 0.0 0
M  V30 32 O 3.9037 12.6801 0.0 0
M  V30 33 O 6.6501 3.1588 0.0 0
M  V30 34 C 4.2032 2.7406 0.0 0
M  V30 35 C 6.4469 13.4238 0.0 0
M  V30 36 C 8.3719 11.5987 0.0 0 CFG=1
M  V30 37 C 6.4278 1.6531 0.0 0 CFG=1
M  V30 38 C 4.9184 1.3837 0.0 0
M  V30 39 C 7.9355 13.0690 0.0 0
M  V30 40 C 9.8271 11.5080 0.0 0
M  V30 41 C 7.5098 0.6308 0.0 0
M  V30 42 C 10.8289 10.4773 0.0 0
M  V30 43 C 8.9643 0.7839 0.0 0
M  V30 44 C 10.7237 8.9577 0.0 0
M  V30 45 C 9.8954 1.8905 0.0 0 CFG=1
M  V30 46 C 12.0593 8.1688 0.0 0 CFG=2
M  V30 47 O 9.6574 3.3930 0.0 0
M  V30 48 C 11.3249 1.3249 0.0 0
M  V30 49 C 12.0593 6.6287 0.0 0 CFG=2
M  V30 50 C 13.5239 8.6446 0.0 0 CFG=1
M  V30 51 C 10.8423 4.3475 0.0 0 CFG=1
M  V30 52 C 12.5178 2.2909 0.0 0 CFG=1
M  V30 53 O 13.5239 6.1527 0.0 0
M  V30 54 C 10.7231 5.8726 0.0 0
M  V30 55 C 14.4291 7.3988 0.0 0 CFG=1
M  V30 56 C 12.2816 3.8076 0.0 0
M  V30 57 H 4.3926 11.2334 0.0 0
M  V30 58 H 0.4743 9.7553 0.0 0
M  V30 59 H 0.0000 8.5843 0.0 0
M  V30 60 H 2.9696 8.6486 0.0 0
M  V30 61 H 6.2853 9.3584 0.0 0
M  V30 62 H 1.4173 12.0988 0.0 0
M  V30 63 H 3.8262 4.3598 0.0 0
M  V30 64 H 4.9607 13.7983 0.0 0
M  V30 65 H 8.9426 10.1683 0.0 0
M  V30 66 H 5.9872 0.1774 0.0 0
M  V30 67 H 8.4116 2.3031 0.0 0
M  V30 68 H 12.2280 9.6996 0.0 0
M  V30 69 H 12.2137 5.0964 0.0 0
M  V30 70 H 9.4282 4.9577 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 38
M  V30 2 2 2 42
M  V30 3 1 3 4
M  V30 4 1 50 3 CFG=1
M  V30 5 1 52 5 CFG=3
M  V30 6 1 6 7
M  V30 7 1 55 6 CFG=1
M  V30 8 1 7 8
M  V30 9 1 7 9 CFG=1
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 11 14
M  V30 15 2 15 56
M  V30 16 1 16 17
M  V30 17 1 16 18 CFG=3
M  V30 18 1 16 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 1 21 26
M  V30 26 1 21 57 CFG=1
M  V30 27 1 22 23
M  V30 28 1 22 27
M  V30 29 1 22 58 CFG=3
M  V30 30 1 23 28 CFG=1
M  V30 31 1 23 59
M  V30 32 1 24 29
M  V30 33 1 25 27
M  V30 34 1 25 28
M  V30 35 1 25 60 CFG=1
M  V30 36 1 26 30
M  V30 37 1 26 31
M  V30 38 1 26 61 CFG=1
M  V30 39 1 27 32 CFG=3
M  V30 40 1 27 62 CFG=1
M  V30 41 1 29 33
M  V30 42 1 29 34
M  V30 43 1 29 63 CFG=1
M  V30 44 1 30 32
M  V30 45 1 30 35
M  V30 46 1 30 64 CFG=3
M  V30 47 1 31 36
M  V30 48 1 33 37
M  V30 49 1 34 38
M  V30 50 1 35 39
M  V30 51 1 36 39
M  V30 52 1 36 40
M  V30 53 1 36 65 CFG=1
M  V30 54 1 37 38
M  V30 55 1 37 41
M  V30 56 1 37 66 CFG=3
M  V30 57 1 40 42
M  V30 58 1 41 43
M  V30 59 1 42 44
M  V30 60 1 43 45
M  V30 61 1 44 46
M  V30 62 1 45 47
M  V30 63 1 45 48
M  V30 64 1 45 67 CFG=1
M  V30 65 1 46 49
M  V30 66 1 46 50
M  V30 67 1 46 68 CFG=1
M  V30 68 1 47 51
M  V30 69 1 48 52
M  V30 70 1 49 53
M  V30 71 1 49 54
M  V30 72 1 49 69 CFG=3
M  V30 73 1 50 55
M  V30 74 1 51 54
M  V30 75 1 51 56
M  V30 76 1 51 70 CFG=1
M  V30 77 1 52 56
M  V30 78 1 53 55
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(19 7 16 21 22 23 25 26 27 29 30 36 37 45 46 49 50 51 52 55)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
11,15:18,21:24,28-Triepoxy-7,9-ethano-12,15-methano-9H,15H-furo[3,2-i]furo[2′...
C41H61NO11
253128-67-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  67 75 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.2422 0.0000 0.0 0
M  V30 2 O 12.2751 11.0070 0.0 0
M  V30 3 O 14.0001 10.1093 0.0 0
M  V30 4 C 15.5064 10.4295 0.0 0
M  V30 5 C 13.9549 1.7373 0.0 0
M  V30 6 C 15.9693 7.3988 0.0 0
M  V30 7 C 16.7393 6.0650 0.0 0 CFG=2
M  V30 8 C 18.2794 6.0650 0.0 0
M  V30 9 O 15.9693 4.7313 0.0 0
M  V30 10 N 19.0494 4.7313 0.0 0
M  V30 11 C 20.5895 4.7313 0.0 0
M  V30 12 C 13.4761 4.7798 0.0 0
M  V30 13 C 3.6553 7.5427 0.0 0 CFG=1
M  V30 14 O 5.3347 8.1397 0.0 0
M  V30 15 O 3.7560 9.1208 0.0 0
M  V30 16 C 2.0424 7.4906 0.0 0
M  V30 17 C 3.7589 6.0102 0.0 0
M  V30 18 C 4.8196 9.7539 0.0 0 CFG=1
M  V30 19 C 2.7819 9.8623 0.0 0 CFG=2
M  V30 20 C 1.4880 8.9815 0.0 0 CFG=1
M  V30 21 C 5.1522 5.3570 0.0 0
M  V30 22 C 3.2344 10.1658 0.0 0 CFG=2
M  V30 23 C 5.8321 10.8305 0.0 0 CFG=1
M  V30 24 C 2.8429 11.5163 0.0 0 CFG=2
M  V30 25 O 1.2599 10.3465 0.0 0
M  V30 26 C 5.2743 3.8359 0.0 0 CFG=1
M  V30 27 C 5.3963 12.3213 0.0 0 CFG=2
M  V30 28 O 7.3448 10.4943 0.0 0
M  V30 29 O 3.9037 12.6803 0.0 0
M  V30 30 O 6.6502 3.1588 0.0 0
M  V30 31 C 4.2032 2.7407 0.0 0
M  V30 32 C 6.4469 13.4239 0.0 0
M  V30 33 C 8.3720 11.5988 0.0 0 CFG=1
M  V30 34 C 6.4278 1.6531 0.0 0 CFG=1
M  V30 35 C 4.9184 1.3837 0.0 0
M  V30 36 C 7.9355 13.0691 0.0 0
M  V30 37 C 9.8272 11.5081 0.0 0
M  V30 38 C 7.5099 0.6308 0.0 0
M  V30 39 C 10.8290 10.4774 0.0 0
M  V30 40 C 8.9644 0.7839 0.0 0
M  V30 41 C 10.7238 8.9578 0.0 0
M  V30 42 C 9.8955 1.8906 0.0 0 CFG=1
M  V30 43 C 12.0595 8.1689 0.0 0 CFG=2
M  V30 44 O 9.6575 3.3930 0.0 0
M  V30 45 C 11.3250 1.3249 0.0 0
M  V30 46 C 12.0595 6.6288 0.0 0 CFG=2
M  V30 47 C 13.5240 8.6447 0.0 0 CFG=1
M  V30 48 C 10.8424 4.3475 0.0 0 CFG=1
M  V30 49 C 12.5179 2.2910 0.0 0 CFG=1
M  V30 50 O 13.5240 6.1528 0.0 0
M  V30 51 C 10.7232 5.8726 0.0 0
M  V30 52 C 14.4293 7.3988 0.0 0 CFG=1
M  V30 53 C 12.2817 3.8076 0.0 0
M  V30 54 H 6.3216 9.4134 0.0 0
M  V30 55 H 0.4743 9.7554 0.0 0
M  V30 56 H 0.0000 8.5844 0.0 0
M  V30 57 H 2.9697 8.6487 0.0 0
M  V30 58 H 6.8848 11.9546 0.0 0
M  V30 59 H 1.4173 12.0989 0.0 0
M  V30 60 H 3.8262 4.3599 0.0 0
M  V30 61 H 4.9608 13.7985 0.0 0
M  V30 62 H 8.9427 10.1684 0.0 0
M  V30 63 H 5.9872 0.1774 0.0 0
M  V30 64 H 8.4117 2.3031 0.0 0
M  V30 65 H 12.2281 9.6997 0.0 0
M  V30 66 H 12.2138 5.0965 0.0 0
M  V30 67 H 9.4283 4.9577 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 35
M  V30 2 2 2 39
M  V30 3 1 3 4
M  V30 4 1 47 3 CFG=1
M  V30 5 1 49 5 CFG=3
M  V30 6 1 6 7
M  V30 7 1 52 6 CFG=1
M  V30 8 1 7 8
M  V30 9 1 7 9 CFG=1
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 2 12 53
M  V30 13 1 13 14
M  V30 14 1 13 15 CFG=3
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 18 23
M  V30 23 1 18 54 CFG=1
M  V30 24 1 19 20
M  V30 25 1 19 24
M  V30 26 1 19 55 CFG=3
M  V30 27 1 20 25 CFG=1
M  V30 28 1 20 56
M  V30 29 1 21 26
M  V30 30 1 22 24
M  V30 31 1 22 25
M  V30 32 1 22 57 CFG=1
M  V30 33 1 23 27
M  V30 34 1 23 28
M  V30 35 1 23 58 CFG=1
M  V30 36 1 24 29 CFG=3
M  V30 37 1 24 59 CFG=1
M  V30 38 1 26 30
M  V30 39 1 26 31
M  V30 40 1 26 60 CFG=1
M  V30 41 1 27 29
M  V30 42 1 27 32
M  V30 43 1 27 61 CFG=3
M  V30 44 1 28 33
M  V30 45 1 30 34
M  V30 46 1 31 35
M  V30 47 1 32 36
M  V30 48 1 33 36
M  V30 49 1 33 37
M  V30 50 1 33 62 CFG=1
M  V30 51 1 34 35
M  V30 52 1 34 38
M  V30 53 1 34 63 CFG=3
M  V30 54 1 37 39
M  V30 55 1 38 40
M  V30 56 1 39 41
M  V30 57 1 40 42
M  V30 58 1 41 43
M  V30 59 1 42 44
M  V30 60 1 42 45
M  V30 61 1 42 64 CFG=1
M  V30 62 1 43 46
M  V30 63 1 43 47
M  V30 64 1 43 65 CFG=1
M  V30 65 1 44 48
M  V30 66 1 45 49
M  V30 67 1 46 50
M  V30 68 1 46 51
M  V30 69 1 46 66 CFG=3
M  V30 70 1 47 52
M  V30 71 1 48 51
M  V30 72 1 48 53
M  V30 73 1 48 67 CFG=1
M  V30 74 1 49 53
M  V30 75 1 50 52
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(19 7 13 18 19 20 22 23 24 26 27 33 34 42 43 46 47 48 49 52)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 253128-19-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 253128-67-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-4038517
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrocyclic ketone analogues of halichondrin B
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zheng, Wanjun; Seletsky, Boris M.; Palme, Monica H.; Lydon, Paul J.;
Singer, Lori A.; Chase, Charles E.; Lemelin, Charles A.; Shen, Yongchun;
Davis, Heather; Tremblay, Lynda; Towle, Murray J.; Salvato, Kathleen A.;
Wels, Bruce F.; Aalfs, Kimberley K.; Kishi, Yoshito; Littlefield, Bruce
A.; Yu, Melvin J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2004), 14(22), 5551-5554

$RFMT $RIREG SCHEME296 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[2-fluoro-6-(methoxycarbonyl)-3-pyridinyl]-1-piperazineca...
C16H22FN3O4
2589532-03-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 10.0102 0.0000 0.0 0
M  V30 2 C 14.6303 2.6673 0.0 0
M  V30 3 O 15.4003 4.0010 0.0 0
M  V30 4 O 15.4003 1.3337 0.0 0
M  V30 5 C 16.9404 4.0010 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 O 3.0801 4.0010 0.0 0
M  V30 8 O 3.0801 1.3337 0.0 0
M  V30 9 C 1.5400 4.0010 0.0 0
M  V30 10 C 1.5400 2.4610 0.0 0
M  V30 11 C 0.0000 4.0010 0.0 0
M  V30 12 C 1.5400 5.5410 0.0 0
M  V30 13 C 10.0102 2.6673 0.0 0
M  V30 14 C 10.7802 1.3337 0.0 0
M  V30 15 C 10.7802 4.0010 0.0 0
M  V30 16 N 12.3203 1.3337 0.0 0
M  V30 17 C 12.3203 4.0010 0.0 0
M  V30 18 C 13.0903 2.6673 0.0 0
M  V30 19 N 8.4702 2.6673 0.0 0
M  V30 20 C 7.7002 4.0010 0.0 0
M  V30 21 C 7.7002 1.3337 0.0 0
M  V30 22 C 6.1601 4.0010 0.0 0
M  V30 23 C 6.1601 1.3337 0.0 0
M  V30 24 N 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 24
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[2-fluoro-6-[(methylamino)carbonyl]-3-pyridinyl]-1-pipera...
C16H23FN4O3
2589532-04-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 10.0102 0.0000 0.0 0
M  V30 2 C 14.6303 2.6673 0.0 0
M  V30 3 N 15.4003 4.0010 0.0 0
M  V30 4 O 15.4003 1.3337 0.0 0
M  V30 5 C 16.9404 4.0010 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 O 3.0801 4.0010 0.0 0
M  V30 8 O 3.0801 1.3337 0.0 0
M  V30 9 C 1.5400 4.0010 0.0 0
M  V30 10 C 1.5400 2.4610 0.0 0
M  V30 11 C 0.0000 4.0010 0.0 0
M  V30 12 C 1.5400 5.5410 0.0 0
M  V30 13 C 10.0102 2.6673 0.0 0
M  V30 14 C 10.7802 1.3337 0.0 0
M  V30 15 C 10.7802 4.0010 0.0 0
M  V30 16 N 12.3203 1.3337 0.0 0
M  V30 17 C 12.3203 4.0010 0.0 0
M  V30 18 C 13.0903 2.6673 0.0 0
M  V30 19 N 8.4702 2.6673 0.0 0
M  V30 20 C 7.7002 1.3337 0.0 0
M  V30 21 C 7.7002 4.0010 0.0 0
M  V30 22 C 6.1601 1.3337 0.0 0
M  V30 23 C 6.1601 4.0010 0.0 0
M  V30 24 N 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 24
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2589532-03-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2589532-04-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37237051
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quinoxaline derivatives as PARP inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hamerlik, Petra
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023118085 A1 2023-06-29

$RFMT $RIREG SCHEME296 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[2-fluoro-6-(methoxycarbonyl)-3-pyridinyl]-1-piperazineca...
C16H22FN3O4
2589532-03-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 10.0102 0.0000 0.0 0
M  V30 2 C 14.6303 2.6673 0.0 0
M  V30 3 O 15.4003 4.0010 0.0 0
M  V30 4 O 15.4003 1.3337 0.0 0
M  V30 5 C 16.9404 4.0010 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 O 3.0801 4.0010 0.0 0
M  V30 8 O 3.0801 1.3337 0.0 0
M  V30 9 C 1.5400 4.0010 0.0 0
M  V30 10 C 1.5400 2.4610 0.0 0
M  V30 11 C 0.0000 4.0010 0.0 0
M  V30 12 C 1.5400 5.5410 0.0 0
M  V30 13 C 10.0102 2.6673 0.0 0
M  V30 14 C 10.7802 1.3337 0.0 0
M  V30 15 C 10.7802 4.0010 0.0 0
M  V30 16 N 12.3203 1.3337 0.0 0
M  V30 17 C 12.3203 4.0010 0.0 0
M  V30 18 C 13.0903 2.6673 0.0 0
M  V30 19 N 8.4702 2.6673 0.0 0
M  V30 20 C 7.7002 4.0010 0.0 0
M  V30 21 C 7.7002 1.3337 0.0 0
M  V30 22 C 6.1601 4.0010 0.0 0
M  V30 23 C 6.1601 1.3337 0.0 0
M  V30 24 N 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 24
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[2-fluoro-6-[(methylamino)carbonyl]-3-pyridinyl]-1-pipera...
C16H23FN4O3
2589532-04-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 10.0102 0.0000 0.0 0
M  V30 2 C 14.6303 2.6673 0.0 0
M  V30 3 N 15.4003 4.0010 0.0 0
M  V30 4 O 15.4003 1.3337 0.0 0
M  V30 5 C 16.9404 4.0010 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 O 3.0801 4.0010 0.0 0
M  V30 8 O 3.0801 1.3337 0.0 0
M  V30 9 C 1.5400 4.0010 0.0 0
M  V30 10 C 1.5400 2.4610 0.0 0
M  V30 11 C 0.0000 4.0010 0.0 0
M  V30 12 C 1.5400 5.5410 0.0 0
M  V30 13 C 10.0102 2.6673 0.0 0
M  V30 14 C 10.7802 1.3337 0.0 0
M  V30 15 C 10.7802 4.0010 0.0 0
M  V30 16 N 12.3203 1.3337 0.0 0
M  V30 17 C 12.3203 4.0010 0.0 0
M  V30 18 C 13.0903 2.6673 0.0 0
M  V30 19 N 8.4702 2.6673 0.0 0
M  V30 20 C 7.7002 1.3337 0.0 0
M  V30 21 C 7.7002 4.0010 0.0 0
M  V30 22 C 6.1601 1.3337 0.0 0
M  V30 23 C 6.1601 4.0010 0.0 0
M  V30 24 N 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 24
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2589532-03-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2589532-04-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32103352
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7783-95-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Combination of antibody-drug conjugate and PARP1 selective inhibitor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mettetal, Jerome Thomas, II; Astaneh, Azadeh Cheraghchi Bashi; Leo,
Elisabetta; Wallez, Yann
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022074617 A1 2022-04-14

$RFMT $RIREG SCHEME296 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[2-fluoro-6-(methoxycarbonyl)-3-pyridinyl]-1-piperazineca...
C16H22FN3O4
2589532-03-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 10.0102 0.0000 0.0 0
M  V30 2 C 14.6303 2.6673 0.0 0
M  V30 3 O 15.4003 4.0010 0.0 0
M  V30 4 O 15.4003 1.3337 0.0 0
M  V30 5 C 16.9404 4.0010 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 O 3.0801 4.0010 0.0 0
M  V30 8 O 3.0801 1.3337 0.0 0
M  V30 9 C 1.5400 4.0010 0.0 0
M  V30 10 C 1.5400 2.4610 0.0 0
M  V30 11 C 0.0000 4.0010 0.0 0
M  V30 12 C 1.5400 5.5410 0.0 0
M  V30 13 C 10.0102 2.6673 0.0 0
M  V30 14 C 10.7802 1.3337 0.0 0
M  V30 15 C 10.7802 4.0010 0.0 0
M  V30 16 N 12.3203 1.3337 0.0 0
M  V30 17 C 12.3203 4.0010 0.0 0
M  V30 18 C 13.0903 2.6673 0.0 0
M  V30 19 N 8.4702 2.6673 0.0 0
M  V30 20 C 7.7002 4.0010 0.0 0
M  V30 21 C 7.7002 1.3337 0.0 0
M  V30 22 C 6.1601 4.0010 0.0 0
M  V30 23 C 6.1601 1.3337 0.0 0
M  V30 24 N 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 24
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[2-fluoro-6-[(methylamino)carbonyl]-3-pyridinyl]-1-pipera...
C16H23FN4O3
2589532-04-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 10.0102 0.0000 0.0 0
M  V30 2 C 14.6303 2.6673 0.0 0
M  V30 3 N 15.4003 4.0010 0.0 0
M  V30 4 O 15.4003 1.3337 0.0 0
M  V30 5 C 16.9404 4.0010 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 O 3.0801 4.0010 0.0 0
M  V30 8 O 3.0801 1.3337 0.0 0
M  V30 9 C 1.5400 4.0010 0.0 0
M  V30 10 C 1.5400 2.4610 0.0 0
M  V30 11 C 0.0000 4.0010 0.0 0
M  V30 12 C 1.5400 5.5410 0.0 0
M  V30 13 C 10.0102 2.6673 0.0 0
M  V30 14 C 10.7802 1.3337 0.0 0
M  V30 15 C 10.7802 4.0010 0.0 0
M  V30 16 N 12.3203 1.3337 0.0 0
M  V30 17 C 12.3203 4.0010 0.0 0
M  V30 18 C 13.0903 2.6673 0.0 0
M  V30 19 N 8.4702 2.6673 0.0 0
M  V30 20 C 7.7002 1.3337 0.0 0
M  V30 21 C 7.7002 4.0010 0.0 0
M  V30 22 C 6.1601 1.3337 0.0 0
M  V30 23 C 6.1601 4.0010 0.0 0
M  V30 24 N 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 24
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2589532-03-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2589532-04-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31138231
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Quinoxalines as anti-cancer drugs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Packer, Martin John; Degorce, Sebastien Louis; Johannes, Jeffrey Wallace;
Hande, Sudhir Mahadeo; Ghosh, Avipsa; Zheng, Xiaolan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021260092 A1 2021-12-30

$RFMT $RIREG SCHEME296 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[2-fluoro-6-(methoxycarbonyl)-3-pyridinyl]-1-piperazineca...
C16H22FN3O4
2589532-03-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 10.0102 0.0000 0.0 0
M  V30 2 C 14.6303 2.6673 0.0 0
M  V30 3 O 15.4003 4.0010 0.0 0
M  V30 4 O 15.4003 1.3337 0.0 0
M  V30 5 C 16.9404 4.0010 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 O 3.0801 4.0010 0.0 0
M  V30 8 O 3.0801 1.3337 0.0 0
M  V30 9 C 1.5400 4.0010 0.0 0
M  V30 10 C 1.5400 2.4610 0.0 0
M  V30 11 C 0.0000 4.0010 0.0 0
M  V30 12 C 1.5400 5.5410 0.0 0
M  V30 13 C 10.0102 2.6673 0.0 0
M  V30 14 C 10.7802 1.3337 0.0 0
M  V30 15 C 10.7802 4.0010 0.0 0
M  V30 16 N 12.3203 1.3337 0.0 0
M  V30 17 C 12.3203 4.0010 0.0 0
M  V30 18 C 13.0903 2.6673 0.0 0
M  V30 19 N 8.4702 2.6673 0.0 0
M  V30 20 C 7.7002 4.0010 0.0 0
M  V30 21 C 7.7002 1.3337 0.0 0
M  V30 22 C 6.1601 4.0010 0.0 0
M  V30 23 C 6.1601 1.3337 0.0 0
M  V30 24 N 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 24
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[2-fluoro-6-[(methylamino)carbonyl]-3-pyridinyl]-1-pipera...
C16H23FN4O3
2589532-04-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 10.0102 0.0000 0.0 0
M  V30 2 C 14.6303 2.6673 0.0 0
M  V30 3 N 15.4003 4.0010 0.0 0
M  V30 4 O 15.4003 1.3337 0.0 0
M  V30 5 C 16.9404 4.0010 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 O 3.0801 4.0010 0.0 0
M  V30 8 O 3.0801 1.3337 0.0 0
M  V30 9 C 1.5400 4.0010 0.0 0
M  V30 10 C 1.5400 2.4610 0.0 0
M  V30 11 C 0.0000 4.0010 0.0 0
M  V30 12 C 1.5400 5.5410 0.0 0
M  V30 13 C 10.0102 2.6673 0.0 0
M  V30 14 C 10.7802 1.3337 0.0 0
M  V30 15 C 10.7802 4.0010 0.0 0
M  V30 16 N 12.3203 1.3337 0.0 0
M  V30 17 C 12.3203 4.0010 0.0 0
M  V30 18 C 13.0903 2.6673 0.0 0
M  V30 19 N 8.4702 2.6673 0.0 0
M  V30 20 C 7.7002 1.3337 0.0 0
M  V30 21 C 7.7002 4.0010 0.0 0
M  V30 22 C 6.1601 1.3337 0.0 0
M  V30 23 C 6.1601 4.0010 0.0 0
M  V30 24 N 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 24
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2589532-03-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2589532-04-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-23609235
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of azaquinolone derivatives as PARP1 inhibitors for treatment
of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Packer, Martin John; Johannes, Jeffrey Wallace; Hande, Sudhir Mahadeo;
Degorce, Sebastien Louis
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021013735 A1 2021-01-28

$RFMT $RIREG SCHEME297 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[2-bromo-6-(methoxycarbonyl)-3-pyridinyl]-1-piperazinecar...
C16H22BrN3O4
2589532-25-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 10.0102 0.0000 0.0 0
M  V30 2 C 14.6303 2.6673 0.0 0
M  V30 3 O 15.4003 4.0010 0.0 0
M  V30 4 O 15.4003 1.3337 0.0 0
M  V30 5 C 16.9404 4.0010 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 O 3.0801 4.0010 0.0 0
M  V30 8 O 3.0801 1.3337 0.0 0
M  V30 9 C 1.5400 4.0010 0.0 0
M  V30 10 C 1.5400 2.4610 0.0 0
M  V30 11 C 0.0000 4.0010 0.0 0
M  V30 12 C 1.5400 5.5410 0.0 0
M  V30 13 C 10.0102 2.6673 0.0 0
M  V30 14 C 10.7802 1.3337 0.0 0
M  V30 15 C 10.7802 4.0010 0.0 0
M  V30 16 N 12.3203 1.3337 0.0 0
M  V30 17 C 12.3203 4.0010 0.0 0
M  V30 18 C 13.0903 2.6673 0.0 0
M  V30 19 N 8.4702 2.6673 0.0 0
M  V30 20 C 7.7002 4.0010 0.0 0
M  V30 21 C 7.7002 1.3337 0.0 0
M  V30 22 C 6.1601 4.0010 0.0 0
M  V30 23 C 6.1601 1.3337 0.0 0
M  V30 24 N 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 24
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[2-bromo-6-[(methylamino)carbonyl]-3-pyridinyl]-1-piperaz...
C16H23BrN4O3
2589532-28-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 10.0102 0.0000 0.0 0
M  V30 2 C 14.6303 2.6673 0.0 0
M  V30 3 N 15.4003 4.0010 0.0 0
M  V30 4 O 15.4003 1.3337 0.0 0
M  V30 5 C 16.9404 4.0010 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 O 3.0801 4.0010 0.0 0
M  V30 8 O 3.0801 1.3337 0.0 0
M  V30 9 C 1.5400 4.0010 0.0 0
M  V30 10 C 1.5400 2.4610 0.0 0
M  V30 11 C 0.0000 4.0010 0.0 0
M  V30 12 C 1.5400 5.5410 0.0 0
M  V30 13 C 10.0102 2.6673 0.0 0
M  V30 14 C 10.7802 1.3337 0.0 0
M  V30 15 C 10.7802 4.0010 0.0 0
M  V30 16 N 12.3203 1.3337 0.0 0
M  V30 17 C 12.3203 4.0010 0.0 0
M  V30 18 C 13.0903 2.6673 0.0 0
M  V30 19 N 8.4702 2.6673 0.0 0
M  V30 20 C 7.7002 1.3337 0.0 0
M  V30 21 C 7.7002 4.0010 0.0 0
M  V30 22 C 6.1601 1.3337 0.0 0
M  V30 23 C 6.1601 4.0010 0.0 0
M  V30 24 N 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 24
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2589532-25-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2589532-28-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32103360
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed pressure vessel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Combination of antibody-drug conjugate and PARP1 selective inhibitor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mettetal, Jerome Thomas, II; Astaneh, Azadeh Cheraghchi Bashi; Leo,
Elisabetta; Wallez, Yann
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022074617 A1 2022-04-14

$RFMT $RIREG SCHEME297 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[2-bromo-6-(methoxycarbonyl)-3-pyridinyl]-1-piperazinecar...
C16H22BrN3O4
2589532-25-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 10.0102 0.0000 0.0 0
M  V30 2 C 14.6303 2.6673 0.0 0
M  V30 3 O 15.4003 4.0010 0.0 0
M  V30 4 O 15.4003 1.3337 0.0 0
M  V30 5 C 16.9404 4.0010 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 O 3.0801 4.0010 0.0 0
M  V30 8 O 3.0801 1.3337 0.0 0
M  V30 9 C 1.5400 4.0010 0.0 0
M  V30 10 C 1.5400 2.4610 0.0 0
M  V30 11 C 0.0000 4.0010 0.0 0
M  V30 12 C 1.5400 5.5410 0.0 0
M  V30 13 C 10.0102 2.6673 0.0 0
M  V30 14 C 10.7802 1.3337 0.0 0
M  V30 15 C 10.7802 4.0010 0.0 0
M  V30 16 N 12.3203 1.3337 0.0 0
M  V30 17 C 12.3203 4.0010 0.0 0
M  V30 18 C 13.0903 2.6673 0.0 0
M  V30 19 N 8.4702 2.6673 0.0 0
M  V30 20 C 7.7002 4.0010 0.0 0
M  V30 21 C 7.7002 1.3337 0.0 0
M  V30 22 C 6.1601 4.0010 0.0 0
M  V30 23 C 6.1601 1.3337 0.0 0
M  V30 24 N 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 24
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[2-bromo-6-[(methylamino)carbonyl]-3-pyridinyl]-1-piperaz...
C16H23BrN4O3
2589532-28-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 10.0102 0.0000 0.0 0
M  V30 2 C 14.6303 2.6673 0.0 0
M  V30 3 N 15.4003 4.0010 0.0 0
M  V30 4 O 15.4003 1.3337 0.0 0
M  V30 5 C 16.9404 4.0010 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 O 3.0801 4.0010 0.0 0
M  V30 8 O 3.0801 1.3337 0.0 0
M  V30 9 C 1.5400 4.0010 0.0 0
M  V30 10 C 1.5400 2.4610 0.0 0
M  V30 11 C 0.0000 4.0010 0.0 0
M  V30 12 C 1.5400 5.5410 0.0 0
M  V30 13 C 10.0102 2.6673 0.0 0
M  V30 14 C 10.7802 1.3337 0.0 0
M  V30 15 C 10.7802 4.0010 0.0 0
M  V30 16 N 12.3203 1.3337 0.0 0
M  V30 17 C 12.3203 4.0010 0.0 0
M  V30 18 C 13.0903 2.6673 0.0 0
M  V30 19 N 8.4702 2.6673 0.0 0
M  V30 20 C 7.7002 1.3337 0.0 0
M  V30 21 C 7.7002 4.0010 0.0 0
M  V30 22 C 6.1601 1.3337 0.0 0
M  V30 23 C 6.1601 4.0010 0.0 0
M  V30 24 N 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 24
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2589532-25-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2589532-28-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-23609393
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed vessel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of azaquinolone derivatives as PARP1 inhibitors for treatment
of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Packer, Martin John; Johannes, Jeffrey Wallace; Hande, Sudhir Mahadeo;
Degorce, Sebastien Louis
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021013735 A1 2021-01-28

$RFMT $RIREG SCHEME298 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxy-4-nitrobenzoic acid
C8H7NO5
2597-56-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 6.1601 0.0 0
M  V30 2 C 2.6675 6.9301 0.0 0
M  V30 3 C 6.6686 4.6201 0.0 0
M  V30 4 O 8.0022 3.8500 0.0 0
M  V30 5 O 6.6686 6.1601 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 11 C 2.6675 3.8500 0.0 0
M  V30 12 C 5.3348 2.3100 0.0 0
M  V30 13 C 2.6675 2.3100 0.0 0
M  V30 14 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxy-N-methyl-4-nitrobenzamide
C9H10N2O4
104775-61-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 N 8.0023 3.8501 0.0 0
M  V30 3 O 6.6685 6.1601 0.0 0
M  V30 4 C 9.3360 4.6201 0.0 0
M  V30 5 O 4.0012 6.1601 0.0 0
M  V30 6 C 2.6675 6.9302 0.0 0
M  V30 7 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6675 3.8501 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 15 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2597-56-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 104775-61-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15579552
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 3945-69-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of 2-thioxoquinazoline-4-one derivatives as dual and
selective inhibitors of dynamin-related protein 1 (Drp1) and
puromycin-sensitive aminopeptidase (PSA)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Numadate, Akiyoshi; Mita, Yusuke; Matsumoto, Yotaro; Fujii, Shinya;
Hashimoto, Yuichi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical & Pharmaceutical Bulletin (2014), 62(10), 979-988

$RFMT $RIREG SCHEME299 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2E)-3-(4-formyl-1-methyl-1H-pyrazol-5-yl)-2-propenoate
C12H16N2O3
2598005-26-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5254 3.3322 0.0 0
M  V30 2 C 5.8591 2.5622 0.0 0
M  V30 3 C 7.1929 3.3322 0.0 0
M  V30 4 O 8.5266 2.5622 0.0 0
M  V30 5 O 7.1929 4.8722 0.0 0
M  V30 6 C 9.8602 3.3322 0.0 0
M  V30 7 C 10.6302 1.9985 0.0 0
M  V30 8 C 11.1939 4.1022 0.0 0
M  V30 9 C 9.0902 4.6658 0.0 0
M  V30 10 C 1.4646 4.6949 0.0 0
M  V30 11 O 0.0000 5.1708 0.0 0
M  V30 12 C 4.1752 0.0000 0.0 0
M  V30 13 C 3.1917 2.5622 0.0 0
M  V30 14 C 1.7847 3.1885 0.0 0
M  V30 15 N 3.0308 1.0306 0.0 0
M  V30 16 C 0.7543 2.0441 0.0 0
M  V30 17 N 1.5243 0.7103 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 2 10 11
M  V30 11 1 10 14
M  V30 12 1 12 15
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 1-methyl-4-[(methylamino)methyl]-1H-pyrazole-5-propanoate
C13H23N3O2
2598005-27-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9536 4.0011 0.0 0
M  V30 2 C 4.4136 4.0011 0.0 0
M  V30 3 C 3.6436 2.6674 0.0 0
M  V30 4 O 2.1036 2.6674 0.0 0
M  V30 5 O 4.4136 1.3336 0.0 0
M  V30 6 C 1.3336 1.3336 0.0 0
M  V30 7 C 2.6674 0.5636 0.0 0
M  V30 8 C 0.5636 0.0000 0.0 0
M  V30 9 C 0.0000 2.1036 0.0 0
M  V30 10 C 9.2857 4.3513 0.0 0
M  V30 11 N 10.7920 4.6714 0.0 0
M  V30 12 C 11.8226 3.5271 0.0 0
M  V30 13 C 4.5910 7.0618 0.0 0
M  V30 14 C 6.7236 5.3347 0.0 0
M  V30 15 C 8.2553 5.4956 0.0 0
M  V30 16 N 6.0973 6.7417 0.0 0
M  V30 17 C 8.5755 7.0021 0.0 0
M  V30 18 N 7.2418 7.7721 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 1 10 15
M  V30 12 1 11 12
M  V30 13 1 13 16
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2598005-26-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2598005-27-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-23600307
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 12135-22-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown,reaction in a closed vessel in stage
2,autoclave used in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 7,8-dihydro-4H-pyrazolo[4,3-c]azepin-6-one compounds as
dual inhibitors of CREBBP and EP300 histone acetyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lumeras Amador, Wenceslao; Brandhuber, Barbara Jean
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021026059 A1 2021-02-11

$RFMT $RIREG SCHEME300 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(1R,8aS)-Dihydro-1-[(triphenylmethoxy)methyl]-1H,3H-oxazolo[4,3-c][1,4]ox...
C26H23NO5
2621997-25-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.0287 0.0 0
M  V30 2 O 5.3348 3.2587 0.0 0
M  V30 3 C 6.6687 4.0287 0.0 0
M  V30 4 O 10.2961 0.0000 0.0 0
M  V30 5 O 13.9284 4.8456 0.0 0
M  V30 6 C 3.2311 2.6949 0.0 0
M  V30 7 C 1.6911 2.6949 0.0 0
M  V30 8 C 4.0012 1.3612 0.0 0
M  V30 9 C 0.9211 1.3612 0.0 0
M  V30 10 C 3.2311 0.0276 0.0 0
M  V30 11 C 1.6911 0.0276 0.0 0
M  V30 12 C 4.7712 5.3624 0.0 0
M  V30 13 C 6.3112 5.3624 0.0 0
M  V30 14 C 4.0012 6.6961 0.0 0
M  V30 15 C 7.0812 6.6961 0.0 0
M  V30 16 C 4.7712 8.0297 0.0 0
M  V30 17 C 6.3112 8.0297 0.0 0
M  V30 18 C 2.6675 4.7987 0.0 0
M  V30 19 C 2.6675 6.3388 0.0 0
M  V30 20 C 1.3338 4.0287 0.0 0
M  V30 21 C 1.3338 7.1088 0.0 0
M  V30 22 C 0.0000 4.7987 0.0 0
M  V30 23 C 0.0000 6.3388 0.0 0
M  V30 24 C 8.0023 3.2587 0.0 0 CFG=1
M  V30 25 C 9.4091 3.8850 0.0 0 CFG=1
M  V30 26 O 8.1633 1.7270 0.0 0
M  V30 27 N 10.4397 2.7405 0.0 0
M  V30 28 C 9.8850 5.3496 0.0 0
M  V30 29 C 9.6697 1.4068 0.0 0
M  V30 30 C 11.9460 3.0608 0.0 0
M  V30 31 O 11.3915 5.6699 0.0 0
M  V30 32 C 12.4219 4.5254 0.0 0
M  V30 33 H 8.2647 4.9155 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 1 12
M  V30 4 1 1 18
M  V30 5 1 2 3
M  V30 6 1 24 3 CFG=3
M  V30 7 2 4 29
M  V30 8 2 5 32
M  V30 9 2 6 7
M  V30 10 1 6 8
M  V30 11 1 7 9
M  V30 12 2 8 10
M  V30 13 2 9 11
M  V30 14 1 10 11
M  V30 15 2 12 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 1 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 25 28
M  V30 31 1 25 33 CFG=3
M  V30 32 1 26 29
M  V30 33 1 27 29
M  V30 34 1 27 30
M  V30 35 1 28 31
M  V30 36 1 30 32
M  V30 37 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 24 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(4R,5S)-4-(Hydroxymethyl)-N-methyl-2-oxo-5-[(triphenylmethoxy)methyl]-3-o...
C27H28N2O5
2621997-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.6200 0.0 0
M  V30 2 O 6.1600 4.6200 0.0 0
M  V30 3 C 6.9300 5.9537 0.0 0
M  V30 4 C 8.8994 8.6642 0.0 0
M  V30 5 O 9.9298 9.8086 0.0 0
M  V30 6 C 12.0858 7.6289 0.0 0
M  V30 7 C 13.4926 7.0026 0.0 0
M  V30 8 N 14.7385 7.9076 0.0 0
M  V30 9 O 13.6536 5.4709 0.0 0
M  V30 10 C 16.1454 7.2813 0.0 0
M  V30 11 O 12.0858 4.2784 0.0 0
M  V30 12 C 4.6200 6.1600 0.0 0
M  V30 13 C 5.9537 6.9300 0.0 0
M  V30 14 C 3.2864 6.9300 0.0 0
M  V30 15 C 5.9537 8.4700 0.0 0
M  V30 16 C 3.2864 8.4700 0.0 0
M  V30 17 C 4.6200 9.2400 0.0 0
M  V30 18 C 3.0800 4.6200 0.0 0
M  V30 19 C 2.3100 3.2864 0.0 0
M  V30 20 C 2.3100 5.9537 0.0 0
M  V30 21 C 0.7700 3.2864 0.0 0
M  V30 22 C 0.7700 5.9537 0.0 0
M  V30 23 C 0.0000 4.6200 0.0 0
M  V30 24 C 4.6200 3.0800 0.0 0
M  V30 25 C 3.2864 2.3100 0.0 0
M  V30 26 C 5.9537 2.3100 0.0 0
M  V30 27 C 3.2864 0.7700 0.0 0
M  V30 28 C 5.9537 0.7700 0.0 0
M  V30 29 C 4.6200 0.0000 0.0 0
M  V30 30 C 8.4700 5.9537 0.0 0 CFG=1
M  V30 31 C 9.3753 7.1995 0.0 0 CFG=1
M  V30 32 O 9.3753 4.7078 0.0 0
M  V30 33 N 10.8400 6.7237 0.0 0
M  V30 34 C 10.8400 5.1837 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 1 18
M  V30 4 1 1 24
M  V30 5 1 2 3
M  V30 6 1 30 3 CFG=3
M  V30 7 1 4 5
M  V30 8 1 31 4 CFG=1
M  V30 9 1 6 7
M  V30 10 1 6 33
M  V30 11 1 7 8
M  V30 12 2 7 9
M  V30 13 1 8 10
M  V30 14 2 11 34
M  V30 15 2 12 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 1 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 30 31)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2621997-25-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2621997-23-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-23539220
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Routes to N-glycinamide oxazolidinone derivatives: The reaction of
4-trityloxymethyl-3-oxa-1-azabicyclo[3.1.0]hexan-2-one with active
halides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zheng, Zilong; Bergmeier, Stephen C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ARKIVOC (Gainesville, FL, United States) (2019), (3), 1-13

$RFMT $RIREG SCHEME301 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-2-[[3-(1,3-dimethyl-1H-pyrazol-4-yl)phenoxy]methyl]-α-(methoxyimi...
C22H23N3O4
2648657-83-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 4.0011 0.0 0
M  V30 2 C 4.6200 5.3347 0.0 0
M  V30 3 N 2.3100 4.0011 0.0 0
M  V30 4 O 3.8500 6.6684 0.0 0
M  V30 5 O 6.1600 5.3347 0.0 0
M  V30 6 O 1.5400 2.6674 0.0 0
M  V30 7 C 4.6200 8.0021 0.0 0
M  V30 8 C 0.0000 2.6673 0.0 0
M  V30 9 C 6.9300 4.0011 0.0 0
M  V30 10 O 8.4700 4.0011 0.0 0
M  V30 11 C 13.5192 9.3789 0.0 0
M  V30 12 C 16.7056 4.9931 0.0 0
M  V30 13 C 4.6200 2.6674 0.0 0
M  V30 14 C 6.1600 2.6674 0.0 0
M  V30 15 C 3.8500 1.3336 0.0 0
M  V30 16 C 6.9300 1.3336 0.0 0
M  V30 17 C 4.6200 0.0000 0.0 0
M  V30 18 C 6.1600 0.0000 0.0 0
M  V30 19 C 9.2400 5.3347 0.0 0
M  V30 20 C 10.7800 5.3347 0.0 0
M  V30 21 C 8.4700 6.6684 0.0 0
M  V30 22 C 11.5500 6.6684 0.0 0
M  V30 23 C 9.2400 8.0021 0.0 0
M  V30 24 C 10.7800 8.0021 0.0 0
M  V30 25 C 13.0900 6.6684 0.0 0
M  V30 26 C 13.9952 5.4225 0.0 0
M  V30 27 C 13.9952 7.9142 0.0 0
M  V30 28 N 15.4598 5.8984 0.0 0
M  V30 29 N 15.4598 7.4384 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 14
M  V30 11 1 10 19
M  V30 12 1 11 27
M  V30 13 1 12 28
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 22 25
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-2-[[3-(1,3-Dimethyl-1H-pyrazol-4-yl)phenoxy]methyl]-α-(methoxyimino)-N-m...
C22H24N4O3
2648657-90-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 4.0011 0.0 0
M  V30 2 C 4.6200 5.3347 0.0 0
M  V30 3 N 2.3100 4.0011 0.0 0
M  V30 4 N 3.8500 6.6684 0.0 0
M  V30 5 O 6.1600 5.3347 0.0 0
M  V30 6 O 1.5400 2.6674 0.0 0
M  V30 7 C 4.6200 8.0021 0.0 0
M  V30 8 C 0.0000 2.6674 0.0 0
M  V30 9 C 6.9300 4.0011 0.0 0
M  V30 10 O 8.4700 4.0011 0.0 0
M  V30 11 C 13.5192 9.3789 0.0 0
M  V30 12 C 16.7056 4.9931 0.0 0
M  V30 13 C 4.6200 2.6674 0.0 0
M  V30 14 C 6.1600 2.6674 0.0 0
M  V30 15 C 3.8500 1.3336 0.0 0
M  V30 16 C 6.9300 1.3336 0.0 0
M  V30 17 C 4.6200 0.0000 0.0 0
M  V30 18 C 6.1600 0.0000 0.0 0
M  V30 19 C 9.2400 5.3347 0.0 0
M  V30 20 C 10.7800 5.3347 0.0 0
M  V30 21 C 8.4700 6.6684 0.0 0
M  V30 22 C 11.5500 6.6684 0.0 0
M  V30 23 C 9.2400 8.0021 0.0 0
M  V30 24 C 10.7800 8.0021 0.0 0
M  V30 25 C 13.0900 6.6684 0.0 0
M  V30 26 C 13.9952 5.4225 0.0 0
M  V30 27 C 13.9952 7.9142 0.0 0
M  V30 28 N 15.4598 5.8984 0.0 0
M  V30 29 N 15.4598 7.4384 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 14
M  V30 11 1 10 19
M  V30 12 1 11 27
M  V30 13 1 12 28
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 22 25
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2648657-83-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2648657-90-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-23616174
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Evaluation of Fungicidal Activity of Novel
Pyrazole-Containing Strobilurin Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hao, Zesheng; Wang, Weibo; Yu, Bin; Qi, Xin; Lv, You; Liu, Xiaoyu; Chen,
Haoyin; Kalinina, Tatiana A.; Glukhareva, Tatiana V.; Fan, Zhijin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Journal of Chemistry (2021), 39(6), 1531-1537

$RFMT $RIREG SCHEME302 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-(3-chloro-2-methylphenyl)acetamide
C9H9BrClNO
264905-54-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 1.5400 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 C 8.0021 1.5400 0.0 0
M  V30 4 O 6.6684 3.8500 0.0 0
M  V30 5 Br 9.3358 2.3100 0.0 0
M  V30 6 C 2.6674 0.0000 0.0 0
M  V30 7 Cl 0.0000 1.5400 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 2.6674 1.5400 0.0 0
M  V30 10 C 4.0011 3.8500 0.0 0
M  V30 11 C 1.3336 2.3100 0.0 0
M  V30 12 C 2.6674 4.6200 0.0 0
M  V30 13 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 9
M  V30 7 1 7 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Chloro-2-methylphenyl)-2-(methylamino)acetamide
C10H13ClN2O
741608-34-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 O 6.6684 3.8500 0.0 0
M  V30 5 N 9.3359 2.3100 0.0 0
M  V30 6 C 10.6695 1.5400 0.0 0
M  V30 7 C 2.6673 0.0000 0.0 0
M  V30 8 Cl 0.0000 1.5400 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 2.6673 1.5400 0.0 0
M  V30 11 C 4.0011 3.8500 0.0 0
M  V30 12 C 1.3337 2.3100 0.0 0
M  V30 13 C 2.6673 4.6201 0.0 0
M  V30 14 C 1.3337 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 10
M  V30 8 1 8 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 264905-54-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 741608-34-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-16364305
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 3-Amino-2-carboxamide Tetrahydropyrrolo[2,3-b]quinolines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pilkington, Lisa I.; Haverkate, Natalie A.; van Rensburg, Michelle;
Reynisson, Johannes; Leung, Euphemia; Barker, David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2016), 27(20), 2811-2814

$RFMT $RIREG SCHEME303 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-5-(chlorosulfonyl)-4-fluorobenzoic acid
C7H3Cl2FO4S
264927-50-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3337 1.5400 0.0 0 VAL=6
M  V30 2 Cl 0.0000 0.7700 0.0 0
M  V30 3 O 0.5637 2.8737 0.0 0
M  V30 4 O 2.1037 0.2064 0.0 0
M  V30 5 F 1.3337 4.6201 0.0 0
M  V30 6 C 6.6687 1.5400 0.0 0
M  V30 7 O 6.6687 0.0000 0.0 0
M  V30 8 O 8.0023 2.3101 0.0 0
M  V30 9 Cl 6.6687 4.6201 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 4.0012 1.5400 0.0 0
M  V30 12 C 2.6675 3.8501 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 4.0012 4.6201 0.0 0
M  V30 15 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 5 12
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-4-fluoro-5-[(methylamino)sulfonyl]benzoic acid
C8H7ClFNO4S
714968-43-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 4.0011 0.0 0 VAL=6
M  V30 2 N 7.7000 4.0011 0.0 0
M  V30 3 O 6.1600 5.5411 0.0 0
M  V30 4 O 6.1600 2.4611 0.0 0
M  V30 5 C 8.4700 2.6674 0.0 0
M  V30 6 F 4.6200 6.6685 0.0 0
M  V30 7 C 1.5400 1.3338 0.0 0
M  V30 8 O 2.3100 0.0000 0.0 0
M  V30 9 O 0.0000 1.3338 0.0 0
M  V30 10 Cl 0.0000 4.0011 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 C 3.8500 2.6674 0.0 0
M  V30 13 C 3.8500 5.3347 0.0 0
M  V30 14 C 2.3100 2.6674 0.0 0
M  V30 15 C 2.3100 5.3347 0.0 0
M  V30 16 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 11
M  V30 5 1 2 5
M  V30 6 1 6 13
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 14
M  V30 10 1 10 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 264927-50-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 714968-43-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-12146308
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 12408-02-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of 2-Chloro-4-Fluoro-5-[(Methylamino)sulfonyl]benzoic Acid.
At 0 °C, to a stirred ice-water suspension (∼200 mL) of
2-chloro-5-(chlorosulfonyl)-4-fluorobenzoic acid was slowly added a
precooled 40% methylamine (13 mL). The reaction mixture was then stirred
for 2 hours before being acidified to pH∼2. The desired product was
precipitated and filtered out. After being dried overnight, the pure
2-chloro-4-fluoro-5-[(methylamino)sulfonyl]benzoic acid was obtained as
white solid (9.8g, 100%).
$DTYPE RXN:VAR(1):NOTES
$DATUM unspecified reagent used for acidification in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzimidazolylazabicyclooctylethylpiperidines as Ccr5
antagonists for the treatment of HIV infection
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kazmierski, Wieslaw Mieczyslaw; Aquino, Christopher Joseph; Bifulco,
Neil; Boros, Eric Eugene; Chauder, Brian Andrew; Chong, Pek Yoke; Duan,
Maosheng; Deanda, Felix, Jr.; Koble, Cecilia Suarez; Mclean, Ed Williams;
Peckham, Jennifer Poole; Perkins, Angilique C.; Thompson, James Benjamin;
Vanderwall, Dana
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004054974 A2 2004-07-01

$RFMT $RIREG SCHEME304 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N,N′-[[4-[11-[[(1,1-dimethylethoxy)carbonyl]amino]-2,3,4,5,6,7...
C35H57N7O8
2676164-76-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  50 51 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 17.9368 11.1789 0.0 0
M  V30 2 C 19.4431 11.4992 0.0 0
M  V30 3 O 20.4735 10.3547 0.0 0
M  V30 4 O 19.9190 12.9637 0.0 0
M  V30 5 C 21.9800 10.6748 0.0 0
M  V30 6 C 21.6598 12.1812 0.0 0
M  V30 7 C 23.4862 10.9950 0.0 0
M  V30 8 C 22.3001 9.1685 0.0 0
M  V30 9 O 15.4000 9.3358 0.0 0
M  V30 10 C 12.3200 9.3358 0.0 0
M  V30 11 C 10.7800 9.3358 0.0 0
M  V30 12 C 10.0100 8.0021 0.0 0
M  V30 13 C 8.4700 8.0021 0.0 0
M  V30 14 N 7.7000 6.6685 0.0 0
M  V30 15 C 6.1600 6.6685 0.0 0
M  V30 16 N 5.3900 8.0021 0.0 0
M  V30 17 N 5.3900 5.3347 0.0 0
M  V30 18 C 3.8500 8.0021 0.0 0
M  V30 19 C 6.1600 4.0011 0.0 0
M  V30 20 O 3.0800 9.3358 0.0 0
M  V30 21 O 3.0800 6.6685 0.0 0
M  V30 22 O 5.3900 2.6674 0.0 0
M  V30 23 O 7.7000 4.0011 0.0 0
M  V30 24 C 1.5400 9.3358 0.0 0
M  V30 25 C 6.1600 1.3338 0.0 0
M  V30 26 C 1.5400 7.7958 0.0 0
M  V30 27 C 0.0000 9.3358 0.0 0
M  V30 28 C 1.5400 10.8758 0.0 0
M  V30 29 C 4.8262 0.5638 0.0 0
M  V30 30 C 6.9300 0.0000 0.0 0
M  V30 31 C 7.4936 2.1038 0.0 0
M  V30 32 C 16.5127 16.4640 0.0 0
M  V30 33 C 15.2668 17.3692 0.0 0
M  V30 34 C 16.3517 14.9325 0.0 0
M  V30 35 C 17.9196 17.0903 0.0 0
M  V30 36 C 15.4277 18.9007 0.0 0
M  V30 37 O 13.8600 16.7429 0.0 0
M  V30 38 N 17.3821 13.7879 0.0 0
M  V30 39 C 18.0805 18.6220 0.0 0
M  V30 40 C 16.8347 19.5272 0.0 0
M  V30 41 C 12.4531 17.3692 0.0 0
M  V30 42 C 16.9063 12.3234 0.0 0
M  V30 43 C 11.2072 16.4640 0.0 0
M  V30 44 N 15.4000 12.0032 0.0 0
M  V30 45 C 11.3681 14.9325 0.0 0
M  V30 46 C 14.6300 10.6696 0.0 0
M  V30 47 C 10.3377 13.7879 0.0 0
M  V30 48 N 13.0900 10.6696 0.0 0
M  V30 49 C 10.8136 12.3234 0.0 0
M  V30 50 C 12.3200 12.0032 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 42
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 2 9 46
M  V30 10 1 10 11
M  V30 11 1 10 48
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 2 14 15
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 18 21
M  V30 22 1 19 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 1 22 25
M  V30 26 1 24 26
M  V30 27 1 24 27
M  V30 28 1 24 28
M  V30 29 1 25 29
M  V30 30 1 25 30
M  V30 31 1 25 31
M  V30 32 1 32 33
M  V30 33 1 32 34
M  V30 34 2 32 35
M  V30 35 2 33 36
M  V30 36 1 33 37
M  V30 37 1 34 38
M  V30 38 1 35 39
M  V30 39 1 36 40
M  V30 40 1 37 41
M  V30 41 1 38 42
M  V30 42 2 39 40
M  V30 43 1 41 43
M  V30 44 2 42 44
M  V30 45 1 43 45
M  V30 46 1 44 46
M  V30 47 1 45 47
M  V30 48 1 46 48
M  V30 49 1 47 49
M  V30 50 1 48 50
M  V30 51 1 49 50
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-[8-[4-[[[[(1,1-dimethylethoxy)carbonyl]amino][[(methylamino)...
C32H52N8O7
2676164-80-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  47 48 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.5494 9.8451 0.0 0
M  V30 2 C 4.0431 10.1653 0.0 0
M  V30 3 O 3.0127 9.0209 0.0 0
M  V30 4 O 3.5673 11.6300 0.0 0
M  V30 5 C 1.5063 9.3410 0.0 0
M  V30 6 C 1.1861 7.8348 0.0 0
M  V30 7 C 0.0000 9.6612 0.0 0
M  V30 8 C 1.8264 10.8475 0.0 0
M  V30 9 O 8.0863 8.0020 0.0 0
M  V30 10 C 11.1663 8.0020 0.0 0
M  V30 11 C 12.7063 8.0020 0.0 0
M  V30 12 C 13.4763 6.6684 0.0 0
M  V30 13 C 15.0163 6.6684 0.0 0
M  V30 14 N 15.7863 5.3347 0.0 0
M  V30 15 C 17.3263 5.3347 0.0 0
M  V30 16 N 18.0963 6.6684 0.0 0
M  V30 17 N 18.0963 4.0009 0.0 0
M  V30 18 C 19.6363 6.6684 0.0 0
M  V30 19 C 17.3263 2.6673 0.0 0
M  V30 20 O 20.4063 8.0020 0.0 0
M  V30 21 O 20.4063 5.3347 0.0 0
M  V30 22 N 18.0963 1.3336 0.0 0
M  V30 23 O 15.7863 2.6673 0.0 0
M  V30 24 C 21.9463 8.0020 0.0 0
M  V30 25 C 17.3263 0.0000 0.0 0
M  V30 26 C 21.9463 9.5420 0.0 0
M  V30 27 C 23.4863 8.0020 0.0 0
M  V30 28 C 21.9463 6.4620 0.0 0
M  V30 29 C 6.9736 15.1302 0.0 0
M  V30 30 C 8.2195 16.0354 0.0 0
M  V30 31 C 7.1345 13.5987 0.0 0
M  V30 32 C 5.5667 15.7566 0.0 0
M  V30 33 C 8.0585 17.5670 0.0 0
M  V30 34 O 9.6263 15.4090 0.0 0
M  V30 35 N 6.1041 12.4542 0.0 0
M  V30 36 C 5.4057 17.2882 0.0 0
M  V30 37 C 6.6516 18.1933 0.0 0
M  V30 38 C 11.0332 16.0354 0.0 0
M  V30 39 C 6.5800 10.9896 0.0 0
M  V30 40 C 12.2791 15.1302 0.0 0
M  V30 41 N 8.0863 10.6695 0.0 0
M  V30 42 C 12.1181 13.5987 0.0 0
M  V30 43 C 8.8563 9.3357 0.0 0
M  V30 44 C 13.1486 12.4542 0.0 0
M  V30 45 N 10.3963 9.3357 0.0 0
M  V30 46 C 12.6727 10.9896 0.0 0
M  V30 47 C 11.1663 10.6695 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 39
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 2 9 43
M  V30 10 1 10 11
M  V30 11 1 10 45
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 2 14 15 CFG=2
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 18 21
M  V30 22 1 19 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 1 22 25
M  V30 26 1 24 26
M  V30 27 1 24 27
M  V30 28 1 24 28
M  V30 29 1 29 30
M  V30 30 1 29 31
M  V30 31 2 29 32
M  V30 32 2 30 33
M  V30 33 1 30 34
M  V30 34 1 31 35
M  V30 35 1 32 36
M  V30 36 1 33 37
M  V30 37 1 34 38
M  V30 38 1 35 39
M  V30 39 2 36 37
M  V30 40 1 38 40
M  V30 41 2 39 41
M  V30 42 1 40 42
M  V30 43 1 41 43
M  V30 44 1 42 44
M  V30 45 1 43 45
M  V30 46 1 44 46
M  V30 47 1 45 47
M  V30 48 1 46 47
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2676164-76-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2676164-80-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-23946411
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of macrocyclic compounds as chitinase inhibitors useful in
treatment and prevention of asthma
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM 
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP3854789 A1 2021-07-28

$RFMT $RIREG SCHEME305 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Methyl (αE)-α-(methoxyimino)-2-[[[(Z)-[1-[(1R,2R)-2-(2-thienyl)cyclopropy...
C20H22N2O4S
268221-50-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.7801 2.6674 0.0 0
M  V30 2 N 9.2400 2.6674 0.0 0
M  V30 3 C 11.5501 1.3336 0.0 0
M  V30 4 O 8.4700 4.0011 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 3.8500 4.0011 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 N 2.3100 4.0011 0.0 0
M  V30 9 O 3.8500 1.3336 0.0 0
M  V30 10 O 6.1600 2.6674 0.0 0
M  V30 11 O 1.5400 5.3347 0.0 0
M  V30 12 C 4.6200 0.0000 0.0 0
M  V30 13 C 0.0000 5.3347 0.0 0
M  V30 14 C 12.8837 4.7711 0.0 0 CFG=1
M  V30 15 C 11.5501 4.0011 0.0 0 CFG=1
M  V30 16 C 11.5501 5.5411 0.0 0
M  V30 17 C 14.4237 4.7711 0.0 0
M  V30 18 C 15.3289 3.5252 0.0 0
M  V30 19 S 15.3289 6.0170 0.0 0
M  V30 20 C 16.7935 4.0011 0.0 0
M  V30 21 C 16.7935 5.5411 0.0 0
M  V30 22 C 6.1600 5.3347 0.0 0
M  V30 23 C 4.6200 5.3347 0.0 0
M  V30 24 C 6.9300 6.6685 0.0 0
M  V30 25 C 3.8500 6.6685 0.0 0
M  V30 26 C 6.1600 8.0022 0.0 0
M  V30 27 C 4.6200 8.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 15 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 22
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 23
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 8 11
M  V30 13 1 9 12
M  V30 14 1 11 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17 CFG=3
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(αE)-α-(Methoxyimino)-N-methyl-2-[[[(Z)-[1-[(1R,2R)-2-(2-thienyl)cyclopro...
C20H23N3O3S
268221-54-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.7801 2.6674 0.0 0
M  V30 2 N 9.2400 2.6674 0.0 0
M  V30 3 C 11.5501 1.3338 0.0 0
M  V30 4 O 8.4700 4.0011 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 3.8500 4.0011 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 N 2.3100 4.0011 0.0 0
M  V30 9 N 3.8500 1.3336 0.0 0
M  V30 10 O 6.1600 2.6674 0.0 0
M  V30 11 O 1.5400 5.3347 0.0 0
M  V30 12 C 4.6200 0.0000 0.0 0
M  V30 13 C 0.0000 5.3347 0.0 0
M  V30 14 C 12.8837 4.7711 0.0 0 CFG=1
M  V30 15 C 11.5501 4.0011 0.0 0 CFG=1
M  V30 16 C 11.5501 5.5411 0.0 0
M  V30 17 C 14.4237 4.7711 0.0 0
M  V30 18 C 15.3289 6.0170 0.0 0
M  V30 19 S 15.3289 3.5252 0.0 0
M  V30 20 C 16.7935 5.5411 0.0 0
M  V30 21 C 16.7935 4.0011 0.0 0
M  V30 22 C 6.1600 5.3347 0.0 0
M  V30 23 C 4.6200 5.3347 0.0 0
M  V30 24 C 6.9300 6.6685 0.0 0
M  V30 25 C 3.8500 6.6685 0.0 0
M  V30 26 C 6.1600 8.0022 0.0 0
M  V30 27 C 4.6200 8.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 15 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 22
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 23
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 8 11
M  V30 13 1 9 12
M  V30 14 1 11 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17 CFG=3
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 268221-50-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 268221-54-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13718651
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: To a 25 ml glass vial equipped with magnetic
stirrer was charged 200 mg (0. 544 mmoles) of 11.50A (E,E)-methyl
2-[2-((((trans-1-(2-(2-thienyl)cyclopropyl)ethylidene)amino)oxy)methyl)phenyl]-2-methoxyiminoacetate
in 10 mis anhydrous methanol, and 1.0 mis (12.9 mmoles) of 40% aqueous
methyl amine. The vial was capped and stirred overnight at ambient
temperature. The solution was then poured into 100 mis of water, and
extracted with 3x50 mis of ethyl ether. The ether extract was washed with
2x100 mis of water, and 100 mis of saturated aqueous sodium chloride
solution. The ether extract was then dried over anhydrous magnesium
sulfate, filtered and concentrated on a rotary evaporator to afford,
which was consistent with the desired product, (E,E)-N-methyl
2-[2-((((trans-1-(2-(2-thienyl)-cyclopropyl)ethylidene)amino)oxy)methyl)phenyl]-2-methoxyiminoacetamide,
upon analysis by 300 MHz 1H NMR. The procedure was repeated for the Z
imine, (Z,E)-methyl
2-[2-((((trans-1-(2-(2-thienyl)cyclopropyl)ethylidene)
amino)oxy)methyl)phenyl]-2-methoxyiminoacetate, with 150 mg and gave 150
mg of a thick yellow oil in a 100% isolated yield which was consistent
with the desired product, (Z,E)-N-methyl
2-[2-((((trans-1-(2-(2-thienyl)-cyclopropyl)ethylidene)amino)oxy)methyl)phenyl]-2-methoxyiminoacetamide
upon analysis by 300 MHz 1H NMR. Compound 12.50B, Isomer B, Z imine NMR
(300 MHz, 1H, CDCl3, TMS=0 ppm) 1.2 (m, 1H), 1.3 (m, 1H), 1.61 (s, 3H),
2.5 (m, 1H), 2.7 (m, 1H), 2.8 (d, 3H), 3.9 (s, 3H), 4.97 (s, 2H), 6.65
(bs, 1H), 6.7 (m, 1H), 6.9 (m, 1H), 7.1 (d, 1H), 7.2 (d, 1H), 7.3-7.5 (m,
3H)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of aryl and heteroarylcyclopropyl oxime ethers as fungicides
and insecticides.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ross, Ronald; Shaber, Steven Howard; Nguyen, Duyan Vuong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US6063956 A 2000-05-16

$RFMT $RIREG SCHEME306 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Methyl (αE)-α-(methoxyimino)-2-[[[(E)-[1-[(1R,2R)-2-(4-methoxyphenyl)cycl...
C23H26N2O5
268221-56-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 5.3901 0.0 0
M  V30 2 N 9.3360 4.6201 0.0 0
M  V30 3 C 10.6697 6.9302 0.0 0
M  V30 4 O 8.0023 5.3901 0.0 0
M  V30 5 C 6.6685 4.6201 0.0 0
M  V30 6 O 18.8783 7.7002 0.0 0
M  V30 7 C 20.2120 6.9302 0.0 0
M  V30 8 C 4.0012 3.0801 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 N 2.6675 2.3101 0.0 0
M  V30 11 O 5.3348 0.7700 0.0 0
M  V30 12 O 6.6685 3.0801 0.0 0
M  V30 13 O 1.3337 3.0801 0.0 0
M  V30 14 C 6.6685 0.0000 0.0 0
M  V30 15 C 0.0000 2.3101 0.0 0
M  V30 16 C 13.5435 4.6201 0.0 0 CFG=1
M  V30 17 C 12.0035 4.6201 0.0 0 CFG=1
M  V30 18 C 12.7735 3.2864 0.0 0
M  V30 19 C 14.8772 5.3901 0.0 0
M  V30 20 C 16.2109 4.6201 0.0 0
M  V30 21 C 14.8772 6.9302 0.0 0
M  V30 22 C 17.5445 5.3901 0.0 0
M  V30 23 C 16.2109 7.7002 0.0 0
M  V30 24 C 17.5445 6.9302 0.0 0
M  V30 25 C 5.3348 5.3901 0.0 0
M  V30 26 C 4.0012 4.6201 0.0 0
M  V30 27 C 5.3348 6.9302 0.0 0
M  V30 28 C 2.6675 5.3901 0.0 0
M  V30 29 C 4.0012 7.7002 0.0 0
M  V30 30 C 2.6675 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 17 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 25
M  V30 7 1 6 7
M  V30 8 1 6 24
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 26
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19 CFG=1
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(αE)-α-(Methoxyimino)-2-[[[(E)-[1-[(1R,2R)-2-(4-methoxyphenyl)cyclopropyl...
C23H27N3O4
268221-58-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 5.3901 0.0 0
M  V30 2 N 9.3360 4.6201 0.0 0
M  V30 3 C 10.6697 6.9302 0.0 0
M  V30 4 O 8.0023 5.3901 0.0 0
M  V30 5 C 6.6685 4.6201 0.0 0
M  V30 6 O 18.8783 7.7002 0.0 0
M  V30 7 C 20.2120 6.9302 0.0 0
M  V30 8 C 4.0012 3.0801 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 N 2.6675 2.3101 0.0 0
M  V30 11 N 5.3348 0.7700 0.0 0
M  V30 12 O 6.6685 3.0801 0.0 0
M  V30 13 O 1.3337 3.0801 0.0 0
M  V30 14 C 6.6685 0.0000 0.0 0
M  V30 15 C 0.0000 2.3101 0.0 0
M  V30 16 C 13.5435 4.6201 0.0 0 CFG=1
M  V30 17 C 12.0035 4.6201 0.0 0 CFG=1
M  V30 18 C 12.7735 3.2864 0.0 0
M  V30 19 C 14.8772 5.3901 0.0 0
M  V30 20 C 14.8772 6.9302 0.0 0
M  V30 21 C 16.2109 4.6201 0.0 0
M  V30 22 C 16.2109 7.7002 0.0 0
M  V30 23 C 17.5445 5.3901 0.0 0
M  V30 24 C 17.5445 6.9302 0.0 0
M  V30 25 C 5.3348 5.3901 0.0 0
M  V30 26 C 4.0012 4.6201 0.0 0
M  V30 27 C 5.3348 6.9302 0.0 0
M  V30 28 C 2.6675 5.3901 0.0 0
M  V30 29 C 4.0012 7.7002 0.0 0
M  V30 30 C 2.6675 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 17 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 25
M  V30 7 1 6 7
M  V30 8 1 6 24
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 26
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19 CFG=1
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 268221-56-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 268221-58-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4582185
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a dry 100 ml round bottom flasks equipped with magnetic stirrer was
charged 210 mg (0.512 mmoles) of Compound 2.23A, E imine, (E,E)-methyl
2-[2-((((trans-1-(2-(4'-methoxyphenyl)cyclopropyl)ethylidene)amino)oxy)methyl)phenyl]-2-methoxyimino-acetate
10 mis anhydrous methanol, and 1.0 mis (12.9 mmoles) of 40% aqueous
methyl amine. The flask was stoppered and stirred over the weekend at
ambient temperature. The solution was then poured into 100 mis of water,
and extracted with 3x50 mis of ethyl ether. The ether extract was washed
with 2x100 mis of water, and 100 mis of saturated aqueous sodium chloride
solution. The ether extract was then dried over anhydrous magnesium
sulfate, filtered and concentrated on a rotary evaporator to afford,
which was consistent with the desired product, (E,E)-N-methyl
2-[2-((((trans-1-(2-(4'-methoxyphenyl)cyclopropyl)ethylidene)amino)oxy)methyl)
phenyl]-2-methoxyiminoacetamide upon analysis by 300 MHz 1H NMR. Thick
yellow oil, isolated yield 210 mg, 100%. Compound 3.23A, Isomer A, E
imine, NMR (300 MHz, 1H, CDCl3, TMS=0 ppm) 1.1 (m, 1H), 1.3 (m, 1H), 1.7
(m, 1H), 1.75 (s, 3H), 2.1 (m, 1H), 2.9 (d, 3H), 3.8 (s, 3H), 3.95 (s,
3H), 4.95 (s, 2H), 6.7 (bs, 1H), 6.8-6.9 (m, 3H), 7.0 (d, 1H), 7.2 (m,
1H) 7.4-7.7 (m, 3H)
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed flask used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of aryl and heteroarylcyclopropyl oxime ethers as fungicides
and insecticides.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ross, Ronald; Shaber, Steven Howard; Nguyen, Duyan Vuong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US6063956 A 2000-05-16

$RFMT $RIREG SCHEME307 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Phenylmethyl)-2-azaspiro[4.4]nonane-1,4-dione
C15H17NO2
271578-86-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.1477 5.3914 0.0 0
M  V30 2 O 2.5809 0.0000 0.0 0
M  V30 3 C 6.2085 4.0286 0.0 0
M  V30 4 C 2.4373 2.7405 0.0 0
M  V30 5 C 3.4678 3.8850 0.0 0
M  V30 6 C 3.2073 1.4068 0.0 0
M  V30 7 C 1.6672 4.0743 0.0 0
M  V30 8 C 1.4068 1.5961 0.0 0
M  V30 9 N 4.8747 3.2586 0.0 0
M  V30 10 C 4.7137 1.7270 0.0 0
M  V30 11 C 0.1609 3.7541 0.0 0
M  V30 12 C 0.0000 2.2224 0.0 0
M  V30 13 C 7.5422 3.2586 0.0 0
M  V30 14 C 8.8758 4.0286 0.0 0
M  V30 15 C 7.5422 1.7185 0.0 0
M  V30 16 C 10.2095 3.2586 0.0 0
M  V30 17 C 8.8758 0.9485 0.0 0
M  V30 18 C 10.2095 1.7185 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 6
M  V30 3 1 3 9
M  V30 4 1 3 13
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 10
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylamino)-2-(phenylmethyl)-2-azaspiro[4.4]nonan-1-one
C16H22N2O
1793108-38-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.5809 1.2459 0.0 0
M  V30 2 C 3.4862 0.0000 0.0 0
M  V30 3 O 3.1477 6.6372 0.0 0
M  V30 4 C 6.2085 5.2746 0.0 0
M  V30 5 C 2.4373 3.9864 0.0 0
M  V30 6 C 3.2073 2.6527 0.0 0
M  V30 7 C 3.4678 5.1309 0.0 0
M  V30 8 C 1.6672 5.3202 0.0 0
M  V30 9 C 1.4068 2.8420 0.0 0
M  V30 10 C 4.7137 2.9729 0.0 0
M  V30 11 N 4.8747 4.5046 0.0 0
M  V30 12 C 0.1609 5.0000 0.0 0
M  V30 13 C 0.0000 3.4683 0.0 0
M  V30 14 C 7.5422 4.5046 0.0 0
M  V30 15 C 8.8758 5.2746 0.0 0
M  V30 16 C 7.5422 2.9646 0.0 0
M  V30 17 C 10.2095 4.5046 0.0 0
M  V30 18 C 8.8758 2.1945 0.0 0
M  V30 19 C 10.2095 2.9646 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 7
M  V30 4 1 4 11
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 11
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 271578-86-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1793108-38-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-14011252
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituted heteroaryl compounds and methods of use
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xi, Ning; Li, Minxiong; Hu, Haiyang; Wang, Tingjin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015094803 A1 2015-06-25

$RFMT $RIREG SCHEME308 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1S,2R)-2-[[(1S)-1-[(1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)methyl]-3,4-dihyd...
C26H26N2O6
2732244-66-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.2181 5.8816 0.0 0
M  V30 2 C 4.0011 6.9300 0.0 0
M  V30 3 O 5.3347 7.7000 0.0 0
M  V30 4 O 8.0020 3.0800 0.0 0
M  V30 5 O 7.1414 9.1020 0.0 0
M  V30 6 O 8.9956 4.0080 0.0 0
M  V30 7 C 4.0011 10.0100 0.0 0
M  V30 8 O 5.3347 9.2400 0.0 0
M  V30 9 O 4.0011 11.5500 0.0 0
M  V30 10 C 5.3347 4.6200 0.0 0 CFG=1
M  V30 11 C 5.3347 3.0800 0.0 0
M  V30 12 N 4.0011 5.3900 0.0 0
M  V30 13 C 4.0011 2.3100 0.0 0
M  V30 14 C 6.6684 2.3100 0.0 0
M  V30 15 C 2.6673 4.6200 0.0 0
M  V30 16 C 2.6673 3.0800 0.0 0
M  V30 17 C 4.0011 0.7700 0.0 0
M  V30 18 C 6.6684 0.7700 0.0 0
M  V30 19 C 5.3347 0.0000 0.0 0
M  V30 20 N 7.6652 6.4082 0.0 0
M  V30 21 C 8.0896 7.8885 0.0 0
M  V30 22 C 8.9419 5.5471 0.0 0
M  V30 23 C 9.6287 7.9422 0.0 0
M  V30 24 C 10.1554 6.4951 0.0 0
M  V30 25 C 10.6186 9.1220 0.0 0
M  V30 26 C 11.6720 6.2278 0.0 0
M  V30 27 C 12.1352 8.8545 0.0 0
M  V30 28 C 12.6619 7.4074 0.0 0
M  V30 29 C 2.6673 7.7000 0.0 0 CFG=2
M  V30 30 C 2.6673 9.2400 0.0 0 CFG=1
M  V30 31 C 1.3336 6.9300 0.0 0
M  V30 32 C 1.3336 10.0100 0.0 0
M  V30 33 C 0.0000 7.7000 0.0 0
M  V30 34 C 0.0000 9.2400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 10 1 CFG=3
M  V30 2 1 1 20
M  V30 3 2 2 3
M  V30 4 1 2 12
M  V30 5 1 29 2 CFG=3
M  V30 6 1 4 14
M  V30 7 2 5 21
M  V30 8 2 6 22
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 30 7 CFG=3
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 2 13 17
M  V30 19 1 14 18
M  V30 20 1 15 16
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 24
M  V30 28 2 23 25
M  V30 29 2 24 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 28
M  V30 33 1 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 10 29 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1S,2R)-2-[[(1S)-1-[(1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)methyl]-3,4-dihyd...
C27H29N3O5
2732244-67-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.2181 5.8816 0.0 0
M  V30 2 C 4.0011 6.9300 0.0 0
M  V30 3 O 5.3347 7.7000 0.0 0
M  V30 4 O 8.0020 3.0800 0.0 0
M  V30 5 O 7.1414 9.1020 0.0 0
M  V30 6 O 8.9956 4.0080 0.0 0
M  V30 7 C 4.0011 10.0100 0.0 0
M  V30 8 N 4.0011 11.5500 0.0 0
M  V30 9 O 5.3347 9.2400 0.0 0
M  V30 10 C 5.3347 12.3200 0.0 0
M  V30 11 C 5.3347 4.6200 0.0 0 CFG=1
M  V30 12 C 5.3347 3.0800 0.0 0
M  V30 13 N 4.0011 5.3900 0.0 0
M  V30 14 C 4.0011 2.3100 0.0 0
M  V30 15 C 6.6684 2.3100 0.0 0
M  V30 16 C 2.6673 4.6200 0.0 0
M  V30 17 C 2.6673 3.0800 0.0 0
M  V30 18 C 4.0011 0.7700 0.0 0
M  V30 19 C 6.6684 0.7700 0.0 0
M  V30 20 C 5.3347 0.0000 0.0 0
M  V30 21 N 7.6652 6.4082 0.0 0
M  V30 22 C 8.0896 7.8885 0.0 0
M  V30 23 C 8.9419 5.5471 0.0 0
M  V30 24 C 9.6287 7.9422 0.0 0
M  V30 25 C 10.1554 6.4951 0.0 0
M  V30 26 C 10.6186 9.1220 0.0 0
M  V30 27 C 11.6720 6.2278 0.0 0
M  V30 28 C 12.1352 8.8545 0.0 0
M  V30 29 C 12.6619 7.4074 0.0 0
M  V30 30 C 2.6673 7.7000 0.0 0 CFG=2
M  V30 31 C 2.6673 9.2400 0.0 0 CFG=1
M  V30 32 C 1.3336 6.9300 0.0 0
M  V30 33 C 1.3336 10.0100 0.0 0
M  V30 34 C 0.0000 7.7000 0.0 0
M  V30 35 C 0.0000 9.2400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 11 1 CFG=3
M  V30 2 1 1 21
M  V30 3 2 2 3
M  V30 4 1 2 13
M  V30 5 1 30 2 CFG=3
M  V30 6 1 4 15
M  V30 7 2 5 22
M  V30 8 2 6 23
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 31 7 CFG=3
M  V30 12 1 8 10
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 2 14 18
M  V30 20 1 15 19
M  V30 21 1 16 17
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 29
M  V30 34 1 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 11 30 31)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2732244-66-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2732244-67-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24948953
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tetrahydroisoquinoline compounds as Nrf2 activators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lucas, Cathy Louise; Blaney, Emma Louise; Martin, Barrie Phillip; Nowak,
Thorsten; Ray, Nicholas Charles; Crumpler, Simon Ross; Seward, Eileen
Mary; Hynd, George
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021214472 A1 2021-10-28

$RFMT $RIREG SCHEME309 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 7-[6-(methoxycarbonyl)-3-pyridinyl]-2,7-diazaspiro[3.5]nona...
C19H27N3O4
2755173-99-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8737 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 C 16.8080 2.8737 0.0 0
M  V30 9 O 17.5780 4.2073 0.0 0
M  V30 10 O 17.5780 1.5400 0.0 0
M  V30 11 C 19.1181 4.2073 0.0 0
M  V30 12 C 7.5679 2.8737 0.0 0
M  V30 13 C 6.4790 1.7847 0.0 0
M  V30 14 C 6.4790 3.9626 0.0 0
M  V30 15 C 8.3379 4.2073 0.0 0
M  V30 16 C 8.3379 1.5400 0.0 0
M  V30 17 N 5.3901 2.8737 0.0 0
M  V30 18 C 9.8780 4.2073 0.0 0
M  V30 19 C 9.8780 1.5400 0.0 0
M  V30 20 N 10.6480 2.8737 0.0 0
M  V30 21 C 12.1880 2.8737 0.0 0
M  V30 22 C 12.9580 4.2073 0.0 0
M  V30 23 C 12.9580 1.5400 0.0 0
M  V30 24 C 14.4980 4.2073 0.0 0
M  V30 25 N 14.4980 1.5400 0.0 0
M  V30 26 C 15.2680 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 26
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 22 1 20 21
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 7-[6-[(methylamino)carbonyl]-3-pyridinyl]-2,7-diazaspiro[3....
C19H28N4O3
2855938-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8737 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 C 16.8080 2.8737 0.0 0
M  V30 9 N 17.5780 4.2073 0.0 0
M  V30 10 O 17.5780 1.5400 0.0 0
M  V30 11 C 19.1181 4.2073 0.0 0
M  V30 12 C 7.5679 2.8737 0.0 0
M  V30 13 C 6.4790 3.9626 0.0 0
M  V30 14 C 6.4790 1.7847 0.0 0
M  V30 15 C 8.3379 4.2073 0.0 0
M  V30 16 C 8.3379 1.5400 0.0 0
M  V30 17 N 5.3901 2.8737 0.0 0
M  V30 18 C 9.8780 4.2073 0.0 0
M  V30 19 C 9.8780 1.5400 0.0 0
M  V30 20 N 10.6480 2.8737 0.0 0
M  V30 21 C 12.1880 2.8737 0.0 0
M  V30 22 C 12.9580 1.5400 0.0 0
M  V30 23 C 12.9580 4.2073 0.0 0
M  V30 24 C 14.4980 1.5400 0.0 0
M  V30 25 N 14.4980 4.2073 0.0 0
M  V30 26 C 15.2680 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 26
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 22 1 20 21
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2755173-99-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2855938-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34894115
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and in vitro biological evaluation of
3-ethyl-1,5-naphthyridin-2(1H)-one derivatives as potent PARP-1 selective
inhibitors and PARP-1 DNA trappers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ren, Junkang; Quan, Xu; Liu, Ying; Li, Jiani; Zhang, Xiaoyu; Li, Zhiyu;
Zhang, Xiaomeng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2022), 78129046

$RFMT $RIREG SCHEME310 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-α-(methoxyimino)-3-methyl-2-[[[(E)-[1-[1-methyl-3-(trifluoromethy...
C19H21F3N4O4
2761370-71-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.7029 3.1257 0.0 0
M  V30 2 C 10.3692 2.3556 0.0 0
M  V30 3 N 13.0365 2.3556 0.0 0
M  V30 4 O 10.3692 0.8156 0.0 0
M  V30 5 O 9.0355 3.1257 0.0 0
M  V30 6 O 14.3704 3.1257 0.0 0
M  V30 7 C 9.0355 0.0456 0.0 0
M  V30 8 C 15.7040 2.3556 0.0 0
M  V30 9 C 9.0355 4.6657 0.0 0
M  V30 10 O 7.7017 5.4357 0.0 0
M  V30 11 N 6.3680 4.6657 0.0 0
M  V30 12 C 5.0344 5.4357 0.0 0
M  V30 13 C 5.0344 6.9757 0.0 0
M  V30 14 C 9.0355 7.7458 0.0 0
M  V30 15 C 1.9736 6.7983 0.0 0
M  V30 16 C 1.4070 1.4070 0.0 0
M  V30 17 F 0.0000 2.0333 0.0 0
M  V30 18 F 0.7805 0.0000 0.0 0
M  V30 19 F 2.8138 0.7805 0.0 0
M  V30 20 C 11.7029 4.6657 0.0 0
M  V30 21 C 10.3692 5.4357 0.0 0
M  V30 22 C 13.0365 5.4357 0.0 0
M  V30 23 C 10.3692 6.9757 0.0 0
M  V30 24 C 13.0365 6.9757 0.0 0
M  V30 25 C 11.7029 7.7458 0.0 0
M  V30 26 C 3.7007 4.6657 0.0 0
M  V30 27 C 3.5396 3.1340 0.0 0
M  V30 28 N 2.2937 5.2920 0.0 0
M  V30 29 C 2.0333 2.8138 0.0 0
M  V30 30 N 1.2633 4.1476 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 12 13
M  V30 14 1 12 26
M  V30 15 1 14 23
M  V30 16 1 15 28
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 1 16 29
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 27 2 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-α-(Methoxyimino)-N,3-dimethyl-2-[[[(E)-[1-[1-methyl-3-(trifluoromethyl)-...
C19H22F3N5O3
2761370-72-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.7029 3.1257 0.0 0
M  V30 2 C 10.3692 2.3556 0.0 0
M  V30 3 N 13.0365 2.3556 0.0 0
M  V30 4 N 10.3692 0.8156 0.0 0
M  V30 5 O 9.0355 3.1257 0.0 0
M  V30 6 O 14.3704 3.1257 0.0 0
M  V30 7 C 9.0355 0.0456 0.0 0
M  V30 8 C 15.7040 2.3556 0.0 0
M  V30 9 C 9.0355 4.6657 0.0 0
M  V30 10 O 7.7017 5.4357 0.0 0
M  V30 11 N 6.3680 4.6657 0.0 0
M  V30 12 C 5.0344 5.4357 0.0 0
M  V30 13 C 5.0344 6.9757 0.0 0
M  V30 14 C 9.0355 7.7458 0.0 0
M  V30 15 C 1.9736 6.7983 0.0 0
M  V30 16 C 1.4070 1.4070 0.0 0
M  V30 17 F 0.0000 2.0333 0.0 0
M  V30 18 F 0.7805 0.0000 0.0 0
M  V30 19 F 2.8138 0.7805 0.0 0
M  V30 20 C 11.7029 4.6657 0.0 0
M  V30 21 C 10.3692 5.4357 0.0 0
M  V30 22 C 13.0365 5.4357 0.0 0
M  V30 23 C 10.3692 6.9757 0.0 0
M  V30 24 C 13.0365 6.9757 0.0 0
M  V30 25 C 11.7029 7.7458 0.0 0
M  V30 26 C 3.7007 4.6657 0.0 0
M  V30 27 C 3.5396 3.1340 0.0 0
M  V30 28 N 2.2937 5.2920 0.0 0
M  V30 29 C 2.0333 2.8138 0.0 0
M  V30 30 N 1.2633 4.1476 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 12 13
M  V30 14 1 12 26
M  V30 15 1 14 23
M  V30 16 1 15 28
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 1 16 29
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 27 2 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2761370-71-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2761370-72-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31600362
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Use of strobilurin type compounds for combating phytopathogenic fungi
containing an amino acid substitution F129L in the mitochondrial
cytochrome b protein conferring resistance to Qo inhibitors VIII
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Koch, Andreas; Fehr, Marcus; Tegge, Vanessa; Dey, Chandan; Poonoth,
Manojkumar; Kulkarni, Sarang; Le Vezouet, Ronan; Winter, Christian
Harald; Rudolf, Georg Christoph; Rath, Rakesh; Khanna, Smriti; Craig, Ian
Robert; Grammenos, Wassilios; Grote, Thomas; Stammler, Gerd; Mentzel,
Tobias; Haden, Egon; Rheinheimer, Joachim
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022033906 A1 2022-02-17

$RFMT $RIREG SCHEME311 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2-(Benzoyloxy)ethyl]-2-methyl-4-phenyl-3-butyne-1-sulfonyl fluoride
C20H19FO4S
2761702-11-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7002 4.0012 0.0 0
M  V30 2 C 9.0340 4.7712 0.0 0
M  V30 3 C 6.9302 5.3348 0.0 0
M  V30 4 C 8.4702 2.6673 0.0 0
M  V30 5 C 6.3665 3.2311 0.0 0
M  V30 6 C 10.3677 5.5412 0.0 0
M  V30 7 C 5.3901 5.3348 0.0 0
M  V30 8 S 7.7002 1.3337 0.0 0 VAL=6
M  V30 9 O 4.6201 6.6685 0.0 0
M  V30 10 F 6.9302 0.0000 0.0 0
M  V30 11 O 6.3665 2.1037 0.0 0
M  V30 12 O 9.0340 0.5637 0.0 0
M  V30 13 C 3.0801 6.6685 0.0 0
M  V30 14 O 2.3101 5.3348 0.0 0
M  V30 15 C 11.7013 6.3112 0.0 0
M  V30 16 C 13.0350 5.5412 0.0 0
M  V30 17 C 11.7013 7.8512 0.0 0
M  V30 18 C 14.3688 6.3112 0.0 0
M  V30 19 C 13.0350 8.6213 0.0 0
M  V30 20 C 14.3688 7.8512 0.0 0
M  V30 21 C 2.3101 8.0023 0.0 0
M  V30 22 C 3.0801 9.3360 0.0 0
M  V30 23 C 0.7700 8.0023 0.0 0
M  V30 24 C 2.3101 10.6697 0.0 0
M  V30 25 C 0.0000 9.3360 0.0 0
M  V30 26 C 0.7700 10.6697 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 3 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 15
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 2 13 14
M  V30 15 1 13 21
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2-(Benzoyloxy)ethyl]-N,2-dimethyl-4-phenyl-3-butyne-1-sulfonamide
C21H23NO4S
2761702-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7002 5.3348 0.0 0
M  V30 2 C 9.0340 6.1048 0.0 0
M  V30 3 C 8.4702 4.0012 0.0 0
M  V30 4 C 6.9302 6.6685 0.0 0
M  V30 5 C 6.3665 4.5648 0.0 0
M  V30 6 C 10.3677 6.8749 0.0 0
M  V30 7 S 7.7002 2.6673 0.0 0 VAL=6
M  V30 8 C 5.3901 6.6685 0.0 0
M  V30 9 N 6.9302 1.3337 0.0 0
M  V30 10 O 6.3665 3.4374 0.0 0
M  V30 11 O 9.0340 1.8973 0.0 0
M  V30 12 O 4.6201 8.0022 0.0 0
M  V30 13 C 7.7002 0.0000 0.0 0
M  V30 14 C 3.0801 8.0022 0.0 0
M  V30 15 O 2.3101 6.6685 0.0 0
M  V30 16 C 11.7013 7.6449 0.0 0
M  V30 17 C 11.7013 9.1849 0.0 0
M  V30 18 C 13.0350 6.8749 0.0 0
M  V30 19 C 13.0350 9.9549 0.0 0
M  V30 20 C 14.3688 7.6449 0.0 0
M  V30 21 C 14.3688 9.1849 0.0 0
M  V30 22 C 2.3101 9.3360 0.0 0
M  V30 23 C 0.7700 9.3360 0.0 0
M  V30 24 C 3.0801 10.6697 0.0 0
M  V30 25 C 0.0000 10.6697 0.0 0
M  V30 26 C 2.3101 12.0033 0.0 0
M  V30 27 C 0.7700 12.0033 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 3 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 16
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 12 14
M  V30 15 2 14 15
M  V30 16 1 14 22
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2761702-11-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2761702-47-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31383671
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM SuFEx click chemistry reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Radical 1-Fluorosulfonyl-2-alkynylation of Unactivated Alkenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Frye, Nils Lennart; Daniliuc, Constantin G.; Studer, Armido
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2022), 61(12), e202115593

$RFMT $RIREG SCHEME312 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(6-Fluoro-1,4-dihydro-2-oxo-3(2H)-quinazolinyl)benzeneacetyl chloride
C16H12ClFN2O2
2768347-98-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3901 0.0000 0.0 0
M  V30 2 C 10.0102 5.3348 0.0 0
M  V30 3 C 11.5503 5.3348 0.0 0
M  V30 4 Cl 12.3203 4.0012 0.0 0
M  V30 5 O 12.3203 6.6687 0.0 0
M  V30 6 F 0.0000 6.6687 0.0 0
M  V30 7 N 5.3901 2.6675 0.0 0
M  V30 8 C 4.6201 4.0012 0.0 0
M  V30 9 C 4.6201 1.3338 0.0 0
M  V30 10 C 3.0801 4.0012 0.0 0
M  V30 11 N 3.0801 1.3338 0.0 0
M  V30 12 C 2.3101 2.6675 0.0 0
M  V30 13 C 2.3101 5.3348 0.0 0
M  V30 14 C 0.7700 2.6675 0.0 0
M  V30 15 C 0.7700 5.3348 0.0 0
M  V30 16 C 0.0000 4.0012 0.0 0
M  V30 17 C 6.9302 2.6675 0.0 0
M  V30 18 C 7.7002 4.0012 0.0 0
M  V30 19 C 7.7002 1.3338 0.0 0
M  V30 20 C 9.2402 4.0012 0.0 0
M  V30 21 C 9.2402 1.3338 0.0 0
M  V30 22 C 10.0102 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 3
M  V30 3 1 2 20
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 17
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 12
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(6-Fluoro-1,4-dihydro-2-oxo-3(2H)-quinazolinyl)-N-methylbenzeneacetamide
C17H16FN3O2
2768346-87-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3901 0.0000 0.0 0
M  V30 2 C 10.0102 5.3348 0.0 0
M  V30 3 C 11.5503 5.3348 0.0 0
M  V30 4 N 12.3203 6.6687 0.0 0
M  V30 5 O 12.3203 4.0012 0.0 0
M  V30 6 C 13.8603 6.6687 0.0 0
M  V30 7 F 0.0000 6.6687 0.0 0
M  V30 8 N 5.3901 2.6675 0.0 0
M  V30 9 C 4.6201 4.0012 0.0 0
M  V30 10 C 4.6201 1.3338 0.0 0
M  V30 11 C 3.0801 4.0012 0.0 0
M  V30 12 N 3.0801 1.3338 0.0 0
M  V30 13 C 2.3101 2.6675 0.0 0
M  V30 14 C 2.3101 5.3348 0.0 0
M  V30 15 C 0.7700 2.6675 0.0 0
M  V30 16 C 0.7700 5.3348 0.0 0
M  V30 17 C 0.0000 4.0012 0.0 0
M  V30 18 C 6.9302 2.6675 0.0 0
M  V30 19 C 7.7002 4.0012 0.0 0
M  V30 20 C 7.7002 1.3338 0.0 0
M  V30 21 C 9.2402 4.0012 0.0 0
M  V30 22 C 9.2402 1.3338 0.0 0
M  V30 23 C 10.0102 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 3
M  V30 3 1 2 21
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 18
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 13
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2768347-98-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2768346-87-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32390981
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quinazolinones and related compounds as interleukin 4
(IL4)-induced gene 1 inhibitors and methods of use thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM MacKinnon, Andrew L.; Li, Jim; Billedeau, Roland J.; Sjogren, Eric B.;
Yuan, Lin; Deberardinis, Albert; Van Zandt, Michael C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022086892 A1 2022-04-28

$RFMT $RIREG SCHEME313 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2S,6R,9S)-2,6,9,13,13-pentamethyl-4,8,11-trioxo-6-(trifluoromethyl)-1...
C17H28F3N3O6
2781121-86-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 9.0338 0.0 0 CFG=2
M  V30 2 C 7.4387 7.7002 0.0 0
M  V30 3 N 5.3348 8.2638 0.0 0
M  V30 4 C 5.8986 10.3675 0.0 0
M  V30 5 C 8.0023 9.8039 0.0 0
M  V30 6 C 8.9787 7.7002 0.0 0
M  V30 7 C 5.3348 6.7238 0.0 0
M  V30 8 F 7.2323 11.1375 0.0 0
M  V30 9 F 5.1286 11.7012 0.0 0
M  V30 10 F 4.5648 9.5975 0.0 0
M  V30 11 N 9.7487 6.3663 0.0 0
M  V30 12 O 9.7487 9.0338 0.0 0
M  V30 13 C 4.0012 5.9538 0.0 0 CFG=2
M  V30 14 O 6.6687 5.9538 0.0 0
M  V30 15 C 11.2888 6.3663 0.0 0 CFG=1
M  V30 16 N 4.0012 4.4137 0.0 0
M  V30 17 C 2.6675 6.7238 0.0 0
M  V30 18 C 12.0588 5.0327 0.0 0
M  V30 19 C 12.0588 7.7002 0.0 0
M  V30 20 C 2.6675 3.6437 0.0 0
M  V30 21 O 13.5988 5.0327 0.0 0
M  V30 22 O 11.2888 3.6990 0.0 0
M  V30 23 O 2.6675 2.1037 0.0 0
M  V30 24 O 1.3338 4.4137 0.0 0
M  V30 25 C 14.3688 3.6990 0.0 0
M  V30 26 C 1.3338 1.3337 0.0 0
M  V30 27 C 0.5638 2.6673 0.0 0
M  V30 28 C 0.0000 0.5637 0.0 0
M  V30 29 C 2.1038 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5 CFG=3
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 4 10
M  V30 10 1 6 11
M  V30 11 2 6 12
M  V30 12 1 7 13
M  V30 13 2 7 14
M  V30 14 1 11 15
M  V30 15 1 13 16
M  V30 16 1 13 17 CFG=1
M  V30 17 1 15 18
M  V30 18 1 15 19 CFG=1
M  V30 19 1 16 20
M  V30 20 1 18 21
M  V30 21 2 18 22
M  V30 22 1 20 23
M  V30 23 2 20 24
M  V30 24 1 21 25
M  V30 25 1 23 26
M  V30 26 1 26 27
M  V30 27 1 26 28
M  V30 28 1 26 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 13 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3S,6R,10S)-3,6,10-trimethyl-4,8,11-trioxo-6-(trifluorometh...
C17H29F3N4O5
2781121-88-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 9.0338 0.0 0 CFG=2
M  V30 2 C 7.4387 7.7002 0.0 0
M  V30 3 N 5.3348 8.2638 0.0 0
M  V30 4 C 5.8986 10.3675 0.0 0
M  V30 5 C 8.0023 9.8039 0.0 0
M  V30 6 C 8.9787 7.7002 0.0 0
M  V30 7 C 5.3348 6.7238 0.0 0
M  V30 8 F 7.2323 11.1375 0.0 0
M  V30 9 F 5.1286 11.7012 0.0 0
M  V30 10 F 4.5648 9.5975 0.0 0
M  V30 11 N 9.7487 6.3663 0.0 0
M  V30 12 O 9.7487 9.0338 0.0 0
M  V30 13 C 4.0012 5.9538 0.0 0 CFG=2
M  V30 14 O 6.6687 5.9538 0.0 0
M  V30 15 C 11.2888 6.3663 0.0 0 CFG=1
M  V30 16 N 4.0012 4.4137 0.0 0
M  V30 17 C 2.6675 6.7238 0.0 0
M  V30 18 C 12.0588 5.0327 0.0 0
M  V30 19 C 12.0588 7.7002 0.0 0
M  V30 20 C 2.6675 3.6437 0.0 0
M  V30 21 N 13.5988 5.0327 0.0 0
M  V30 22 O 11.2888 3.6990 0.0 0
M  V30 23 O 2.6675 2.1037 0.0 0
M  V30 24 O 1.3338 4.4137 0.0 0
M  V30 25 C 14.3688 3.6990 0.0 0
M  V30 26 C 1.3338 1.3337 0.0 0
M  V30 27 C 2.1038 0.0000 0.0 0
M  V30 28 C 0.0000 0.5637 0.0 0
M  V30 29 C 0.5638 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5 CFG=3
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 4 10
M  V30 10 1 6 11
M  V30 11 2 6 12
M  V30 12 1 7 13
M  V30 13 2 7 14
M  V30 14 1 11 15
M  V30 15 1 13 16
M  V30 16 1 13 17 CFG=1
M  V30 17 1 15 18
M  V30 18 1 15 19 CFG=1
M  V30 19 1 16 20
M  V30 20 1 18 21
M  V30 21 2 18 22
M  V30 22 1 20 23
M  V30 23 2 20 24
M  V30 24 1 21 25
M  V30 25 1 23 26
M  V30 26 1 26 27
M  V30 27 1 26 28
M  V30 28 1 26 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 13 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2781121-86-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2781121-88-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32911883
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantiopure β3-Trifluoromethyl-β3-homoalanine derivatives: Coupling with
Boc-protected amino acids and conformational studies of peptides in solid
state
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saraiva Rosa, Nathalie; Grellepois, Fabienne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2022), 54(13), 3025-3046

$RFMT $RIREG SCHEME314 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-5-nitrobenzaldehyde
C7H4FNO3
27996-87-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 4.0011 0.0 0
M  V30 2 O 6.9301 2.6675 0.0 0
M  V30 3 F 4.6201 6.6686 0.0 0
M  V30 4 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 5 O 2.3100 0.0000 0.0 0
M  V30 6 O 0.0000 1.3338 0.0 0
M  V30 7 C 4.6201 4.0011 0.0 0
M  V30 8 C 3.8500 2.6675 0.0 0
M  V30 9 C 3.8500 5.3348 0.0 0
M  V30 10 C 2.3100 2.6675 0.0 0
M  V30 11 C 2.3100 5.3348 0.0 0
M  V30 12 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Methylamino)-5-nitrobenzaldehyde
C8H8N2O3
50609-41-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 0.7700 0.0 0
M  V30 2 O 2.6675 0.0000 0.0 0
M  V30 3 N 6.6687 2.3101 0.0 0
M  V30 4 C 8.0023 3.0801 0.0 0
M  V30 5 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 6 O 1.3337 6.9302 0.0 0
M  V30 7 O 0.0000 4.6201 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 5.3348 3.0801 0.0 0
M  V30 10 C 2.6675 3.0801 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 4.0012 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 27996-87-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 50609-41-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-5275908
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient synthesis and fluorescence properties of highly functionalized
2-arylquinazolin-4(3H)-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Waibel, Michael; Hasserodt, Jens
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2009), 50(23), 2767-2769

$RFMT $RIREG SCHEME315 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(7-Bromo-4-oxo-3(4H)-quinazolinyl)methyl]benzoic acid
C16H11BrN2O3
2800893-15-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 0.0000 0.0 0
M  V30 2 C 8.0022 1.5400 0.0 0
M  V30 3 Br 0.0000 4.6201 0.0 0
M  V30 4 C 13.3370 1.5400 0.0 0
M  V30 5 O 14.6707 2.3101 0.0 0
M  V30 6 O 13.3370 0.0000 0.0 0
M  V30 7 C 4.0010 2.3101 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 5.3348 1.5400 0.0 0
M  V30 10 C 2.6673 1.5400 0.0 0
M  V30 11 C 2.6673 4.6201 0.0 0
M  V30 12 N 5.3348 4.6201 0.0 0
M  V30 13 N 6.6685 2.3101 0.0 0
M  V30 14 C 1.3337 2.3101 0.0 0
M  V30 15 C 1.3337 3.8501 0.0 0
M  V30 16 C 6.6685 3.8501 0.0 0
M  V30 17 C 9.3358 2.3101 0.0 0
M  V30 18 C 10.6697 1.5400 0.0 0
M  V30 19 C 9.3358 3.8501 0.0 0
M  V30 20 C 12.0033 2.3101 0.0 0
M  V30 21 C 10.6697 4.6201 0.0 0
M  V30 22 C 12.0033 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 13
M  V30 3 1 2 17
M  V30 4 1 3 15
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 20
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 1 13 16
M  V30 18 2 14 15
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(7-Bromo-4-oxo-3(4H)-quinazolinyl)methyl]-N-methylbenzamide
C17H14BrN3O2
2800893-16-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 0.0000 0.0 0
M  V30 2 C 8.0021 1.5400 0.0 0
M  V30 3 Br 0.0000 4.6200 0.0 0
M  V30 4 C 13.3369 1.5400 0.0 0
M  V30 5 N 14.6705 2.3100 0.0 0
M  V30 6 O 13.3369 0.0000 0.0 0
M  V30 7 C 16.0043 1.5400 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 5.3347 1.5400 0.0 0
M  V30 11 C 2.6674 1.5400 0.0 0
M  V30 12 C 2.6674 4.6200 0.0 0
M  V30 13 N 5.3347 4.6200 0.0 0
M  V30 14 N 6.6685 2.3100 0.0 0
M  V30 15 C 1.3338 2.3100 0.0 0
M  V30 16 C 1.3338 3.8500 0.0 0
M  V30 17 C 6.6685 3.8500 0.0 0
M  V30 18 C 9.3358 2.3100 0.0 0
M  V30 19 C 10.6696 1.5400 0.0 0
M  V30 20 C 9.3358 3.8500 0.0 0
M  V30 21 C 12.0032 2.3100 0.0 0
M  V30 22 C 10.6696 4.6200 0.0 0
M  V30 23 C 12.0032 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 14
M  V30 3 1 2 18
M  V30 4 1 3 16
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 21
M  V30 8 1 5 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 13 17
M  V30 18 1 14 17
M  V30 19 2 15 16
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2800893-15-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2800893-16-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33622566
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel substituted bicyclic derivatives as selective
inhibitors of ROCK1 and ROCK2 protein kinases and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Wongil; Devine, William G.; Diebold, R. Bruce; Hwang, So Young;
Choi, Yunggeun; Liu, Yan; Seung, Sang-Ae; Yong, Miyong; Kim, Sewon; Lee,
Jaekyoo; Koh, Jong Sung
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022150381 A1 2022-07-14

$RFMT $RIREG SCHEME316 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Cyanobenzyl bromide
C8H6BrN
28188-41-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 Br 0.0000 2.3101 0.0 0
M  V30 3 C 6.6687 3.0801 0.0 0
M  V30 4 N 8.0023 3.8501 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 3 3 4
M  V30 4 1 3 7
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(Methylamino)methyl]benzonitrile
C9H10N2
90389-96-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 C 1.3337 3.0801 0.0 0
M  V30 5 N 0.0000 3.8501 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 3 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 28188-41-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 90389-96-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-14350786
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1: 3-[(methylamino)methyl]benzonitrile In a 3 necked round bottom
flask (250 ml), put under nitrogen atmosphere, a solution of
3-(bromomethyl)benzonitrile (5 g; 25.5 mmol; 1 eq.) in anhydrous THF (20
ml) was added dropwise into methylamine (63.76 ml; 2 M; 127.52 mmol; 5
eq.) (2M solution in THF) over 1 hour. The reaction mixture was stirred
at RT for 2 hours. Some bis-benzylation was observed (7%). The reaction
mixture was filtered to remove the salt. The filtrate was evaporated
under reduced pressure. The residue was taken up with DCM and evaporated
again. The title compound as a yelllow oil (3.78 g, quantitative yield).
It was used in the next step without any further purification. LC/MS
(Method B) 146.8 (M+H)+.
$DTYPE RXN:VAR(1):NOTES
$DATUM 7% bis-benzylation observed
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 5-(biphenyl-4-yl)-3-phenyl-1,2,4-oxadiazolyl derivatives
as ligands on the sphingosine 1-phosphate (S1P) receptors for treating
multiple sclerosis and other diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bombrun, Agnes; Quattropani, Anna; Gonzalez, Jerome; Dorbais, Jerome;
Knight, Chris; Baker-Glenn, Charles
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012004287 A1 2012-01-12

$RFMT $RIREG SCHEME317 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Methyl 1-[(3R,4R)-1-[(1,1-dimethylethoxy)carbonyl]-4-[[4-(trifluoromethyl...
C21H25F3N4O5
2857939-58-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.0543 9.2759 0.0 0
M  V30 2 C 9.8243 10.6097 0.0 0
M  V30 3 C 3.8987 10.9511 0.0 0
M  V30 4 O 2.4917 10.3248 0.0 0
M  V30 5 O 4.0596 12.4827 0.0 0
M  V30 6 C 1.2459 11.2300 0.0 0
M  V30 7 C 2.1511 12.4759 0.0 0
M  V30 8 C 0.0000 12.1351 0.0 0
M  V30 9 C 0.3406 9.9840 0.0 0
M  V30 10 C 6.6091 2.6091 0.0 0
M  V30 11 O 7.6397 1.4645 0.0 0
M  V30 12 O 5.1028 2.2889 0.0 0
M  V30 13 C 7.1637 0.0000 0.0 0
M  V30 14 C 15.9844 10.6097 0.0 0
M  V30 15 F 15.9844 12.1497 0.0 0
M  V30 16 F 17.5244 10.6097 0.0 0
M  V30 17 F 15.9844 9.0697 0.0 0
M  V30 18 C 6.6091 8.0301 0.0 0 CFG=2
M  V30 19 C 7.5143 9.2759 0.0 0 CFG=2
M  V30 20 C 5.1445 8.5059 0.0 0
M  V30 21 C 6.6091 10.5218 0.0 0
M  V30 22 N 5.1445 10.0459 0.0 0
M  V30 23 N 7.0851 6.5655 0.0 0
M  V30 24 C 6.1799 5.3195 0.0 0
M  V30 25 N 8.5497 6.0895 0.0 0
M  V30 26 C 7.0851 4.0736 0.0 0
M  V30 27 N 8.5497 4.5495 0.0 0
M  V30 28 C 11.3643 10.6097 0.0 0
M  V30 29 C 12.1343 11.9434 0.0 0
M  V30 30 C 12.1343 9.2759 0.0 0
M  V30 31 C 13.6743 11.9434 0.0 0
M  V30 32 C 13.6743 9.2759 0.0 0
M  V30 33 C 14.4443 10.6097 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 19 1 CFG=1
M  V30 3 1 2 28
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 22
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 26
M  V30 14 1 11 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 14 33
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 23 CFG=3
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 1 23 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-1,1-Dimethylethyl (3R,4R)-3-[4-[(methylamino)carbonyl]-1H-1,2,3-triazol-1...
C21H26F3N5O4
2857939-61-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.0543 9.2759 0.0 0
M  V30 2 C 9.8243 10.6097 0.0 0
M  V30 3 C 3.8987 10.9511 0.0 0
M  V30 4 O 2.4917 10.3248 0.0 0
M  V30 5 O 4.0596 12.4827 0.0 0
M  V30 6 C 1.2459 11.2300 0.0 0
M  V30 7 C 0.3406 9.9840 0.0 0
M  V30 8 C 0.0000 12.1351 0.0 0
M  V30 9 C 2.1511 12.4759 0.0 0
M  V30 10 C 6.6091 2.6091 0.0 0
M  V30 11 N 7.6397 1.4645 0.0 0
M  V30 12 O 5.1028 2.2889 0.0 0
M  V30 13 C 7.1637 0.0000 0.0 0
M  V30 14 C 15.9844 10.6097 0.0 0
M  V30 15 F 15.9844 12.1497 0.0 0
M  V30 16 F 17.5244 10.6097 0.0 0
M  V30 17 F 15.9844 9.0697 0.0 0
M  V30 18 C 6.6091 8.0301 0.0 0 CFG=2
M  V30 19 C 7.5143 9.2759 0.0 0 CFG=2
M  V30 20 C 5.1445 8.5059 0.0 0
M  V30 21 C 6.6091 10.5218 0.0 0
M  V30 22 N 5.1445 10.0459 0.0 0
M  V30 23 N 7.0851 6.5655 0.0 0
M  V30 24 C 6.1799 5.3195 0.0 0
M  V30 25 N 8.5497 6.0895 0.0 0
M  V30 26 C 7.0851 4.0736 0.0 0
M  V30 27 N 8.5497 4.5495 0.0 0
M  V30 28 C 11.3643 10.6097 0.0 0
M  V30 29 C 12.1343 9.2759 0.0 0
M  V30 30 C 12.1343 11.9434 0.0 0
M  V30 31 C 13.6743 9.2759 0.0 0
M  V30 32 C 13.6743 11.9434 0.0 0
M  V30 33 C 14.4443 10.6097 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 19 1 CFG=1
M  V30 3 1 2 28
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 22
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 26
M  V30 14 1 11 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 14 33
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 23 CFG=3
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 1 23 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2857939-58-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2857939-61-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35057078
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted pyrrolidines as TEAD transcription factor
inhibitors and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gray, Nathanael S.; Zhang, Tinghu; Fan, Mengyang; Che, Jianwei; Lu,
Wenchao; Dhe-Paganon, Sirano; Kwiatkowski, Nicholas Paul
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022232088 A1 2022-11-03

$RFMT $RIREG SCHEME318 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl hexahydro-5-[6-(methoxycarbonyl)-3-pyridinyl]pyrrolo[3,4-c]...
C18H25N3O4
2868276-68-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 C 16.2895 2.8736 0.0 0
M  V30 9 O 17.0595 4.2073 0.0 0
M  V30 10 O 17.0595 1.5400 0.0 0
M  V30 11 C 18.5995 4.2073 0.0 0
M  V30 12 C 7.7598 3.6436 0.0 0
M  V30 13 C 7.7598 2.1036 0.0 0
M  V30 14 C 9.2244 4.1195 0.0 0
M  V30 15 C 6.2951 4.1195 0.0 0
M  V30 16 C 9.2244 1.6278 0.0 0
M  V30 17 C 6.2951 1.6278 0.0 0
M  V30 18 N 10.1295 2.8736 0.0 0
M  V30 19 N 5.3900 2.8736 0.0 0
M  V30 20 C 11.6695 2.8736 0.0 0
M  V30 21 C 12.4395 4.2073 0.0 0
M  V30 22 C 12.4395 1.5400 0.0 0
M  V30 23 C 13.9795 4.2073 0.0 0
M  V30 24 N 13.9795 1.5400 0.0 0
M  V30 25 C 14.7495 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 25
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl hexahydro-5-[6-[(methylamino)carbonyl]-3-pyridinyl]pyrrolo[...
C18H26N4O3
2868276-67-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 C 16.2895 2.8736 0.0 0
M  V30 9 N 17.0595 4.2073 0.0 0
M  V30 10 O 17.0595 1.5400 0.0 0
M  V30 11 C 18.5995 4.2073 0.0 0
M  V30 12 C 7.7598 3.6436 0.0 0
M  V30 13 C 7.7598 2.1036 0.0 0
M  V30 14 C 9.2244 4.1195 0.0 0
M  V30 15 C 6.2951 4.1195 0.0 0
M  V30 16 C 9.2244 1.6278 0.0 0
M  V30 17 C 6.2951 1.6278 0.0 0
M  V30 18 N 10.1295 2.8736 0.0 0
M  V30 19 N 5.3900 2.8736 0.0 0
M  V30 20 C 11.6695 2.8736 0.0 0
M  V30 21 C 12.4395 1.5400 0.0 0
M  V30 22 C 12.4395 4.2073 0.0 0
M  V30 23 C 13.9795 1.5400 0.0 0
M  V30 24 N 13.9795 4.2073 0.0 0
M  V30 25 C 14.7495 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 25
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2868276-68-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2868276-67-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34894111
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and in vitro biological evaluation of
3-ethyl-1,5-naphthyridin-2(1H)-one derivatives as potent PARP-1 selective
inhibitors and PARP-1 DNA trappers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ren, Junkang; Quan, Xu; Liu, Ying; Li, Jiani; Zhang, Xiaoyu; Li, Zhiyu;
Zhang, Xiaomeng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2022), 78129046

$RFMT $RIREG SCHEME319 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,8-Diazabicyclo[3.2.1]octane-3-carboxylic acid, 8-[6-(methoxycarbonyl)-3-pyr...
C18H25N3O4
2868276-70-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8700 2.8380 0.0 0
M  V30 2 O 3.0796 1.5163 0.0 0
M  V30 3 O 3.1203 4.1833 0.0 0
M  V30 4 C 1.5398 1.5398 0.0 0
M  V30 5 C 1.5634 3.0796 0.0 0
M  V30 6 C 0.0000 1.5632 0.0 0
M  V30 7 C 1.5164 0.0000 0.0 0
M  V30 8 C 15.1660 4.2559 0.0 0
M  V30 9 O 15.9360 5.5897 0.0 0
M  V30 10 O 15.9360 2.9223 0.0 0
M  V30 11 C 17.4760 5.5897 0.0 0
M  V30 12 N 9.0061 4.2560 0.0 0
M  V30 13 C 7.7475 3.7712 0.0 0
M  V30 14 C 7.5491 4.8172 0.0 0
M  V30 15 C 6.8721 2.2467 0.0 0
M  V30 16 C 6.9066 4.9792 0.0 0
M  V30 17 C 6.6071 3.2380 0.0 0
M  V30 18 C 6.8954 6.3527 0.0 0
M  V30 19 N 5.4096 2.8145 0.0 0
M  V30 20 C 10.5461 4.2559 0.0 0
M  V30 21 C 11.3161 2.9223 0.0 0
M  V30 22 C 11.3161 5.5897 0.0 0
M  V30 23 C 12.8560 2.9223 0.0 0
M  V30 24 N 12.8560 5.5897 0.0 0
M  V30 25 C 13.6260 4.2559 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 25
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 20
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,8-Diazabicyclo[3.2.1]octane-3-carboxylic acid, 8-[6-[(methylamino)carbonyl]...
C18H26N4O3
2868276-69-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8700 2.8380 0.0 0
M  V30 2 O 3.0796 1.5163 0.0 0
M  V30 3 O 3.1203 4.1833 0.0 0
M  V30 4 C 1.5398 1.5398 0.0 0
M  V30 5 C 1.5634 3.0796 0.0 0
M  V30 6 C 0.0000 1.5632 0.0 0
M  V30 7 C 1.5164 0.0000 0.0 0
M  V30 8 C 15.1660 4.2560 0.0 0
M  V30 9 N 15.9360 5.5897 0.0 0
M  V30 10 O 15.9360 2.9223 0.0 0
M  V30 11 C 17.4760 5.5897 0.0 0
M  V30 12 N 9.0061 4.2560 0.0 0
M  V30 13 C 7.7475 3.7712 0.0 0
M  V30 14 C 7.5491 4.8172 0.0 0
M  V30 15 C 6.8721 2.2467 0.0 0
M  V30 16 C 6.9066 4.9792 0.0 0
M  V30 17 C 6.6071 3.2380 0.0 0
M  V30 18 C 6.8954 6.3527 0.0 0
M  V30 19 N 5.4098 2.8145 0.0 0
M  V30 20 C 10.5461 4.2560 0.0 0
M  V30 21 C 11.3161 2.9223 0.0 0
M  V30 22 C 11.3161 5.5897 0.0 0
M  V30 23 C 12.8560 2.9223 0.0 0
M  V30 24 N 12.8560 5.5897 0.0 0
M  V30 25 C 13.6260 4.2560 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 25
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 20
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2868276-70-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2868276-69-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34894099
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and in vitro biological evaluation of
3-ethyl-1,5-naphthyridin-2(1H)-one derivatives as potent PARP-1 selective
inhibitors and PARP-1 DNA trappers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ren, Junkang; Quan, Xu; Liu, Ying; Li, Jiani; Zhang, Xiaoyu; Li, Zhiyu;
Zhang, Xiaomeng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2022), 78129046

$RFMT $RIREG SCHEME320 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 6-[6-(methoxycarbonyl)-3-pyridinyl]-2,6-diazaspiro[3.3]hept...
C17H23N3O4
2868276-74-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8737 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 C 15.9059 2.8737 0.0 0
M  V30 9 O 16.6759 4.2073 0.0 0
M  V30 10 O 16.6759 1.5400 0.0 0
M  V30 11 C 18.2159 4.2073 0.0 0
M  V30 12 C 7.5679 2.8737 0.0 0
M  V30 13 C 8.6569 1.7847 0.0 0
M  V30 14 C 8.6569 3.9626 0.0 0
M  V30 15 C 6.4790 3.9626 0.0 0
M  V30 16 C 6.4790 1.7847 0.0 0
M  V30 17 N 9.7458 2.8737 0.0 0
M  V30 18 N 5.3901 2.8737 0.0 0
M  V30 19 C 11.2858 2.8737 0.0 0
M  V30 20 C 12.0559 4.2073 0.0 0
M  V30 21 C 12.0559 1.5400 0.0 0
M  V30 22 C 13.5959 4.2073 0.0 0
M  V30 23 N 13.5959 1.5400 0.0 0
M  V30 24 C 14.3659 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 24
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 6-[6-[(methylamino)carbonyl]-3-pyridinyl]-2,6-diazaspiro[3....
C17H24N4O3
2868276-73-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8737 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 C 15.9059 2.8737 0.0 0
M  V30 9 N 16.6759 4.2073 0.0 0
M  V30 10 O 16.6759 1.5400 0.0 0
M  V30 11 C 18.2159 4.2073 0.0 0
M  V30 12 C 7.5679 2.8737 0.0 0
M  V30 13 C 8.6569 1.7847 0.0 0
M  V30 14 C 8.6569 3.9626 0.0 0
M  V30 15 C 6.4790 3.9626 0.0 0
M  V30 16 C 6.4790 1.7847 0.0 0
M  V30 17 N 9.7458 2.8737 0.0 0
M  V30 18 N 5.3901 2.8737 0.0 0
M  V30 19 C 11.2858 2.8737 0.0 0
M  V30 20 C 12.0559 4.2073 0.0 0
M  V30 21 C 12.0559 1.5400 0.0 0
M  V30 22 C 13.5959 4.2073 0.0 0
M  V30 23 N 13.5959 1.5400 0.0 0
M  V30 24 C 14.3659 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 24
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2868276-74-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2868276-73-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34894116
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and in vitro biological evaluation of
3-ethyl-1,5-naphthyridin-2(1H)-one derivatives as potent PARP-1 selective
inhibitors and PARP-1 DNA trappers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ren, Junkang; Quan, Xu; Liu, Ying; Li, Jiani; Zhang, Xiaoyu; Li, Zhiyu;
Zhang, Xiaomeng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2022), 78129046

$RFMT $RIREG SCHEME321 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-[[1-[(1,1-dimethylethoxy)carbonyl]-3-pyrrolidinyl]amino]-2-pyridinec...
C16H23N3O4
2868276-76-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9684 3.4930 0.0 0
M  V30 2 O 3.0631 2.2471 0.0 0
M  V30 3 O 3.3420 4.8998 0.0 0
M  V30 4 C 1.5316 2.4080 0.0 0
M  V30 5 C 1.6925 3.9396 0.0 0
M  V30 6 C 0.0000 2.5689 0.0 0
M  V30 7 C 1.3706 0.8764 0.0 0
M  V30 8 N 9.2710 4.6201 0.0 0
M  V30 9 C 14.6060 1.5400 0.0 0
M  V30 10 O 15.9397 2.3101 0.0 0
M  V30 11 O 14.6060 0.0000 0.0 0
M  V30 12 C 17.2733 1.5400 0.0 0
M  V30 13 N 5.4999 3.3320 0.0 0
M  V30 14 C 6.5305 4.4764 0.0 0
M  V30 15 C 6.2699 1.9982 0.0 0
M  V30 16 C 7.9373 3.8501 0.0 0
M  V30 17 C 7.7764 2.3184 0.0 0
M  V30 18 C 10.6048 3.8501 0.0 0
M  V30 19 C 11.9385 4.6201 0.0 0
M  V30 20 C 10.6048 2.3101 0.0 0
M  V30 21 C 13.2722 3.8501 0.0 0
M  V30 22 N 11.9385 1.5400 0.0 0
M  V30 23 C 13.2722 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 16
M  V30 9 1 8 18
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 23
M  V30 13 1 10 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3-[[6-[(methylamino)carbonyl]-3-pyridinyl]amino]-1-pyrrolid...
C16H24N4O3
2868276-75-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9684 3.4930 0.0 0
M  V30 2 O 3.0631 2.2471 0.0 0
M  V30 3 O 3.3420 4.8998 0.0 0
M  V30 4 C 1.5316 2.4080 0.0 0
M  V30 5 C 1.3706 0.8764 0.0 0
M  V30 6 C 0.0000 2.5689 0.0 0
M  V30 7 C 1.6925 3.9396 0.0 0
M  V30 8 N 9.2710 4.6201 0.0 0
M  V30 9 C 14.6060 1.5400 0.0 0
M  V30 10 N 15.9397 2.3101 0.0 0
M  V30 11 O 14.6060 0.0000 0.0 0
M  V30 12 C 17.2733 1.5400 0.0 0
M  V30 13 N 5.4999 3.3320 0.0 0
M  V30 14 C 6.5305 4.4764 0.0 0
M  V30 15 C 6.2699 1.9982 0.0 0
M  V30 16 C 7.9373 3.8501 0.0 0
M  V30 17 C 7.7764 2.3184 0.0 0
M  V30 18 C 10.6048 3.8501 0.0 0
M  V30 19 C 10.6048 2.3101 0.0 0
M  V30 20 C 11.9385 4.6201 0.0 0
M  V30 21 C 11.9385 1.5400 0.0 0
M  V30 22 N 13.2722 3.8501 0.0 0
M  V30 23 C 13.2722 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 16
M  V30 9 1 8 18
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 23
M  V30 13 1 10 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2868276-76-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2868276-75-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34894118
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and in vitro biological evaluation of
3-ethyl-1,5-naphthyridin-2(1H)-one derivatives as potent PARP-1 selective
inhibitors and PARP-1 DNA trappers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ren, Junkang; Quan, Xu; Liu, Ying; Li, Jiani; Zhang, Xiaoyu; Li, Zhiyu;
Zhang, Xiaomeng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2022), 78129046

$RFMT $RIREG SCHEME322 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-[[(3S)-1-[(1,1-dimethylethoxy)carbonyl]-3-pyrrolidinyl]amino]-2-pyri...
C16H23N3O4
2868276-81-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.9684 3.4930 0.0 0
M  V30 2 O 3.0631 2.2471 0.0 0
M  V30 3 O 3.3420 4.8998 0.0 0
M  V30 4 C 1.5316 2.4080 0.0 0
M  V30 5 C 1.6925 3.9396 0.0 0
M  V30 6 C 0.0000 2.5689 0.0 0
M  V30 7 C 1.3706 0.8764 0.0 0
M  V30 8 N 9.2710 4.6201 0.0 0
M  V30 9 C 14.6060 1.5400 0.0 0
M  V30 10 O 15.9397 2.3101 0.0 0
M  V30 11 O 14.6060 0.0000 0.0 0
M  V30 12 C 17.2733 1.5400 0.0 0
M  V30 13 N 5.4999 3.3320 0.0 0
M  V30 14 C 6.5305 4.4764 0.0 0
M  V30 15 C 6.2699 1.9982 0.0 0
M  V30 16 C 7.9373 3.8501 0.0 0 CFG=1
M  V30 17 C 7.7764 2.3184 0.0 0
M  V30 18 C 10.6048 3.8501 0.0 0
M  V30 19 C 10.6048 2.3101 0.0 0
M  V30 20 C 11.9385 4.6201 0.0 0
M  V30 21 C 11.9385 1.5400 0.0 0
M  V30 22 N 13.2722 3.8501 0.0 0
M  V30 23 C 13.2722 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 16 8 CFG=1
M  V30 9 1 8 18
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 23
M  V30 13 1 10 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3S)-3-[[6-[(methylamino)carbonyl]-3-pyridinyl]amino]-1-pyr...
C16H24N4O3
2868276-80-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.9684 3.4930 0.0 0
M  V30 2 O 3.0631 2.2471 0.0 0
M  V30 3 O 3.3420 4.8998 0.0 0
M  V30 4 C 1.5316 2.4080 0.0 0
M  V30 5 C 1.3706 0.8764 0.0 0
M  V30 6 C 0.0000 2.5689 0.0 0
M  V30 7 C 1.6925 3.9396 0.0 0
M  V30 8 N 9.2710 4.6201 0.0 0
M  V30 9 C 14.6060 1.5400 0.0 0
M  V30 10 N 15.9397 2.3101 0.0 0
M  V30 11 O 14.6060 0.0000 0.0 0
M  V30 12 C 17.2733 1.5400 0.0 0
M  V30 13 N 5.4999 3.3320 0.0 0
M  V30 14 C 6.5305 4.4764 0.0 0
M  V30 15 C 6.2699 1.9982 0.0 0
M  V30 16 C 7.9373 3.8501 0.0 0 CFG=1
M  V30 17 C 7.7764 2.3184 0.0 0
M  V30 18 C 10.6048 3.8501 0.0 0
M  V30 19 C 10.6048 2.3101 0.0 0
M  V30 20 C 11.9385 4.6201 0.0 0
M  V30 21 C 11.9385 1.5400 0.0 0
M  V30 22 N 13.2722 3.8501 0.0 0
M  V30 23 C 13.2722 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 16 8 CFG=1
M  V30 9 1 8 18
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 23
M  V30 13 1 10 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2868276-81-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2868276-80-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34894143
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and in vitro biological evaluation of
3-ethyl-1,5-naphthyridin-2(1H)-one derivatives as potent PARP-1 selective
inhibitors and PARP-1 DNA trappers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ren, Junkang; Quan, Xu; Liu, Ying; Li, Jiani; Zhang, Xiaoyu; Li, Zhiyu;
Zhang, Xiaomeng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2022), 78129046

$RFMT $RIREG SCHEME323 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-[[(3R)-1-[(1,1-dimethylethoxy)carbonyl]-3-pyrrolidinyl]amino]-2-pyri...
C16H23N3O4
2868276-84-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.9684 3.4930 0.0 0
M  V30 2 O 3.0631 2.2471 0.0 0
M  V30 3 O 3.3420 4.8998 0.0 0
M  V30 4 C 1.5316 2.4080 0.0 0
M  V30 5 C 1.6925 3.9396 0.0 0
M  V30 6 C 0.0000 2.5689 0.0 0
M  V30 7 C 1.3706 0.8764 0.0 0
M  V30 8 N 9.2710 4.6201 0.0 0
M  V30 9 C 14.6060 1.5400 0.0 0
M  V30 10 O 15.9397 2.3101 0.0 0
M  V30 11 O 14.6060 0.0000 0.0 0
M  V30 12 C 17.2733 1.5400 0.0 0
M  V30 13 N 5.4999 3.3320 0.0 0
M  V30 14 C 6.5305 4.4764 0.0 0
M  V30 15 C 6.2699 1.9982 0.0 0
M  V30 16 C 7.9373 3.8501 0.0 0 CFG=2
M  V30 17 C 7.7764 2.3184 0.0 0
M  V30 18 C 10.6048 3.8501 0.0 0
M  V30 19 C 10.6048 2.3101 0.0 0
M  V30 20 C 11.9385 4.6201 0.0 0
M  V30 21 C 11.9385 1.5400 0.0 0
M  V30 22 N 13.2722 3.8501 0.0 0
M  V30 23 C 13.2722 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 16 8 CFG=3
M  V30 9 1 8 18
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 23
M  V30 13 1 10 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3R)-3-[[6-[(methylamino)carbonyl]-3-pyridinyl]amino]-1-pyr...
C16H24N4O3
2868276-82-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.9684 3.4930 0.0 0
M  V30 2 O 3.0631 2.2471 0.0 0
M  V30 3 O 3.3420 4.8998 0.0 0
M  V30 4 C 1.5316 2.4080 0.0 0
M  V30 5 C 1.3706 0.8764 0.0 0
M  V30 6 C 0.0000 2.5689 0.0 0
M  V30 7 C 1.6925 3.9396 0.0 0
M  V30 8 N 9.2710 4.6201 0.0 0
M  V30 9 C 14.6060 1.5400 0.0 0
M  V30 10 N 15.9397 2.3101 0.0 0
M  V30 11 O 14.6060 0.0000 0.0 0
M  V30 12 C 17.2733 1.5400 0.0 0
M  V30 13 N 5.4999 3.3320 0.0 0
M  V30 14 C 6.5305 4.4764 0.0 0
M  V30 15 C 6.2699 1.9982 0.0 0
M  V30 16 C 7.9373 3.8501 0.0 0 CFG=2
M  V30 17 C 7.7764 2.3184 0.0 0
M  V30 18 C 10.6048 3.8501 0.0 0
M  V30 19 C 10.6048 2.3101 0.0 0
M  V30 20 C 11.9385 4.6201 0.0 0
M  V30 21 C 11.9385 1.5400 0.0 0
M  V30 22 N 13.2722 3.8501 0.0 0
M  V30 23 C 13.2722 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 16 8 CFG=3
M  V30 9 1 8 18
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 23
M  V30 13 1 10 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2868276-84-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2868276-82-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34894137
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and in vitro biological evaluation of
3-ethyl-1,5-naphthyridin-2(1H)-one derivatives as potent PARP-1 selective
inhibitors and PARP-1 DNA trappers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ren, Junkang; Quan, Xu; Liu, Ying; Li, Jiani; Zhang, Xiaoyu; Li, Zhiyu;
Zhang, Xiaomeng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2022), 78129046

$RFMT $RIREG SCHEME324 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl 2-methoxy-1,3-benzenedicarboxylate
C10H10O5
288099-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 4.6201 0.0 0
M  V30 2 C 2.6675 5.3901 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 O 8.0023 2.3101 0.0 0
M  V30 5 O 6.6685 4.6201 0.0 0
M  V30 6 C 9.3360 3.0801 0.0 0
M  V30 7 C 1.3337 3.0801 0.0 0
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 15 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 12
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-methoxy-3-[(methylamino)carbonyl]benzoate
C11H13NO4
1876439-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 4.6201 0.0 0
M  V30 2 C 4.0012 5.3901 0.0 0
M  V30 3 C 2.6673 3.0801 0.0 0
M  V30 4 N 1.3337 2.3101 0.0 0
M  V30 5 O 2.6673 4.6201 0.0 0
M  V30 6 C 0.0000 3.0801 0.0 0
M  V30 7 C 8.0023 3.0801 0.0 0
M  V30 8 O 9.3360 2.3101 0.0 0
M  V30 9 O 8.0023 4.6201 0.0 0
M  V30 10 C 10.6697 3.0801 0.0 0
M  V30 11 C 5.3348 3.0801 0.0 0
M  V30 12 C 4.0012 2.3101 0.0 0
M  V30 13 C 6.6685 2.3101 0.0 0
M  V30 14 C 4.0012 0.7700 0.0 0
M  V30 15 C 6.6685 0.7700 0.0 0
M  V30 16 C 5.3348 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 288099-33-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1876439-77-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16475668
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 125700-67-6
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM safety
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Siderophore inspired tetra- and octadentate antenna ligands for
luminescent Eu(III) and Tb(III) complexes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Daumann, Lena J.; Werther, Philipp; Ziegler, Michael J.; Raymond, Kenneth
N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Inorganic Biochemistry (2016), 162263-273

$RFMT $RIREG SCHEME326 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclopropanecarboxaldehyde, 1-[3-(cyclopentyloxy)-4-methoxyphenyl]-
C16H20O3
2893951-67-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.6888 6.1417 0.0 0
M  V30 2 O 9.8686 7.1316 0.0 0
M  V30 3 O 2.6217 4.0011 0.0 0
M  V30 4 O 4.1617 1.3338 0.0 0
M  V30 5 C 4.9317 0.0000 0.0 0
M  V30 6 C 7.2417 6.6685 0.0 0
M  V30 7 C 6.0621 7.6583 0.0 0
M  V30 8 C 7.5092 8.1851 0.0 0
M  V30 9 C 6.4717 5.3347 0.0 0
M  V30 10 C 4.9317 5.3347 0.0 0
M  V30 11 C 7.2417 4.0011 0.0 0
M  V30 12 C 4.1617 4.0011 0.0 0
M  V30 13 C 6.4717 2.6674 0.0 0
M  V30 14 C 4.9317 2.6674 0.0 0
M  V30 15 C 1.8517 5.3347 0.0 0
M  V30 16 C 0.3202 5.4958 0.0 0
M  V30 17 C 2.4782 6.7417 0.0 0
M  V30 18 C 0.0000 7.0021 0.0 0
M  V30 19 C 1.3336 7.7721 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 12
M  V30 4 1 3 15
M  V30 5 1 4 5
M  V30 6 1 4 14
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanamine, N-[[1-[3-(cyclopentyloxy)-4-methoxyphenyl]cyclopropyl]methylene]-
C17H23NO2
2893951-68-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.6890 6.1418 0.0 0
M  V30 2 N 9.8687 7.1317 0.0 0
M  V30 3 C 11.3158 6.6050 0.0 0
M  V30 4 O 2.6217 4.0011 0.0 0
M  V30 5 O 4.1618 1.3338 0.0 0
M  V30 6 C 4.9318 0.0000 0.0 0
M  V30 7 C 7.2418 6.6686 0.0 0
M  V30 8 C 6.0622 7.6584 0.0 0
M  V30 9 C 7.5093 8.1852 0.0 0
M  V30 10 C 6.4718 5.3348 0.0 0
M  V30 11 C 4.9318 5.3348 0.0 0
M  V30 12 C 7.2418 4.0011 0.0 0
M  V30 13 C 4.1618 4.0011 0.0 0
M  V30 14 C 6.4718 2.6675 0.0 0
M  V30 15 C 4.9318 2.6675 0.0 0
M  V30 16 C 1.8517 5.3348 0.0 0
M  V30 17 C 2.4781 6.7418 0.0 0
M  V30 18 C 0.3202 5.4959 0.0 0
M  V30 19 C 1.3337 7.7722 0.0 0
M  V30 20 C 0.0000 7.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 13
M  V30 5 1 4 16
M  V30 6 1 5 6
M  V30 7 1 5 15
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2893951-67-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2893951-68-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35795548
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):NOTES
$DATUM no experimental detail
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of mesembrine alkaloids treating depression, anxiety,
inflammation, and autoimmunity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Protzko, Ryan Joseph; Pfeiffer, Thomas; Gray, Royston Anthony
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023004428 A1 2023-01-26

$RFMT $RIREG SCHEME327 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C12H11D3O3
2893951-71-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.3771 6.1417 0.0 0
M  V30 2 O 9.5569 7.1316 0.0 0
M  V30 3 O 2.3100 4.0011 0.0 0
M  V30 4 C 1.5400 5.3347 0.0 0
M  V30 5 O 3.8500 1.3338 0.0 0
M  V30 6 C 4.6200 0.0000 0.0 0
M  V30 7 C 6.9300 6.6685 0.0 0
M  V30 8 C 5.7504 7.6583 0.0 0
M  V30 9 C 7.1975 8.1851 0.0 0
M  V30 10 C 6.1600 5.3347 0.0 0
M  V30 11 C 4.6200 5.3347 0.0 0
M  V30 12 C 6.9300 4.0011 0.0 0
M  V30 13 C 3.8500 4.0011 0.0 0
M  V30 14 C 6.1600 2.6674 0.0 0
M  V30 15 C 4.6200 2.6674 0.0 0
M  V30 16 H 0.0000 5.3347 0.0 0 MASS=2
M  V30 17 H 0.7700 6.6685 0.0 0 MASS=2
M  V30 18 H 2.3100 6.6685 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 4 16
M  V30 6 1 4 17
M  V30 7 1 4 18
M  V30 8 1 5 6
M  V30 9 1 5 15
M  V30 10 1 7 8
M  V30 11 1 7 9
M  V30 12 1 7 10
M  V30 13 1 8 9
M  V30 14 2 10 11
M  V30 15 1 10 12
M  V30 16 1 11 13
M  V30 17 2 12 14
M  V30 18 2 13 15
M  V30 19 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C13H14D3NO2
2893951-72-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.3771 6.1417 0.0 0
M  V30 2 N 9.5568 7.1316 0.0 0
M  V30 3 C 11.0039 6.6049 0.0 0
M  V30 4 O 2.3100 4.0011 0.0 0
M  V30 5 C 1.5400 5.3347 0.0 0
M  V30 6 O 3.8500 1.3338 0.0 0
M  V30 7 C 4.6200 0.0000 0.0 0
M  V30 8 C 6.9300 6.6685 0.0 0
M  V30 9 C 7.1973 8.1851 0.0 0
M  V30 10 C 5.7502 7.6583 0.0 0
M  V30 11 C 6.1600 5.3347 0.0 0
M  V30 12 C 4.6200 5.3347 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 3.8500 4.0011 0.0 0
M  V30 15 C 6.1600 2.6674 0.0 0
M  V30 16 C 4.6200 2.6674 0.0 0
M  V30 17 H 0.0000 5.3347 0.0 0 MASS=2
M  V30 18 H 0.7700 6.6685 0.0 0 MASS=2
M  V30 19 H 2.3100 6.6685 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 5 17
M  V30 7 1 5 18
M  V30 8 1 5 19
M  V30 9 1 6 7
M  V30 10 1 6 16
M  V30 11 1 8 9
M  V30 12 1 8 10
M  V30 13 1 8 11
M  V30 14 1 9 10
M  V30 15 2 11 12
M  V30 16 1 11 13
M  V30 17 1 12 14
M  V30 18 2 13 15
M  V30 19 2 14 16
M  V30 20 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2893951-71-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2893951-72-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35795551
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7487-88-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of mesembrine alkaloids treating depression, anxiety,
inflammation, and autoimmunity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Protzko, Ryan Joseph; Pfeiffer, Thomas; Gray, Royston Anthony
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023004428 A1 2023-01-26

$RFMT $RIREG SCHEME328 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Acetyl-L-phenylalanyl-L-alanine methyl ester
C15H20N2O4
28945-11-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0 CFG=2
M  V30 2 C 3.0800 4.0011 0.0 0
M  V30 3 C 5.3900 5.3347 0.0 0
M  V30 4 N 5.3900 2.6674 0.0 0
M  V30 5 N 6.9300 5.3347 0.0 0
M  V30 6 O 4.6200 6.6685 0.0 0
M  V30 7 C 4.6200 1.3336 0.0 0
M  V30 8 C 7.7000 6.6685 0.0 0 CFG=1
M  V30 9 C 5.3900 0.0000 0.0 0
M  V30 10 O 3.0800 1.3336 0.0 0
M  V30 11 C 9.2400 6.6685 0.0 0
M  V30 12 C 6.9300 8.0021 0.0 0
M  V30 13 O 10.0100 8.0021 0.0 0
M  V30 14 O 10.0100 5.3347 0.0 0
M  V30 15 C 11.5500 8.0021 0.0 0
M  V30 16 C 2.3100 5.3347 0.0 0
M  V30 17 C 3.0800 6.6685 0.0 0
M  V30 18 C 0.7700 5.3347 0.0 0
M  V30 19 C 2.3100 8.0021 0.0 0
M  V30 20 C 0.0000 6.6685 0.0 0
M  V30 21 C 0.7700 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 16
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12 CFG=1
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 13 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-Acetyl-L-phenylalanyl-N-methyl-L-alaninamide
C15H21N3O3
61059-48-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0 CFG=2
M  V30 2 C 3.0800 4.0011 0.0 0
M  V30 3 C 5.3900 5.3347 0.0 0
M  V30 4 N 5.3900 2.6674 0.0 0
M  V30 5 N 6.9300 5.3347 0.0 0
M  V30 6 O 4.6200 6.6685 0.0 0
M  V30 7 C 4.6200 1.3336 0.0 0
M  V30 8 C 7.7000 6.6685 0.0 0 CFG=1
M  V30 9 C 5.3900 0.0000 0.0 0
M  V30 10 O 3.0800 1.3336 0.0 0
M  V30 11 C 9.2400 6.6685 0.0 0
M  V30 12 C 6.9300 8.0021 0.0 0
M  V30 13 N 10.0100 8.0021 0.0 0
M  V30 14 O 10.0100 5.3347 0.0 0
M  V30 15 C 11.5500 8.0021 0.0 0
M  V30 16 C 2.3100 5.3347 0.0 0
M  V30 17 C 3.0800 6.6685 0.0 0
M  V30 18 C 0.7700 5.3347 0.0 0
M  V30 19 C 2.3100 8.0021 0.0 0
M  V30 20 C 0.0000 6.6685 0.0 0
M  V30 21 C 0.7700 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 16
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12 CFG=1
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 13 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 28945-11-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 61059-48-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20423098
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Supramolecular chirality transfer in a stereodynamic catalysts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Storch, Golo; Trapp, Oliver
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chirality (2018), 30(10), 1150-1160

$RFMT $RIREG SCHEME329 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromobenzenesulfonyl chloride
C6H4BrClO2S
2905-25-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6673 0.0 0 VAL=6
M  V30 2 Cl 6.1600 2.6673 0.0 0
M  V30 3 O 4.6200 4.2073 0.0 0
M  V30 4 O 4.6200 1.1273 0.0 0
M  V30 5 Br 3.0800 0.0000 0.0 0
M  V30 6 C 3.0800 2.6673 0.0 0
M  V30 7 C 2.3100 1.3336 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 0.7700 1.3336 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methylbenzenesulfonamide
C7H8BrNO2S
98192-14-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6673 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6673 0.0 0
M  V30 3 O 4.6200 4.2073 0.0 0
M  V30 4 O 4.6200 1.1273 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 Br 3.0800 0.0000 0.0 0
M  V30 7 C 3.0800 2.6673 0.0 0
M  V30 8 C 2.3100 1.3336 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 0.7700 1.3336 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 2 5
M  V30 6 1 6 8
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2905-25-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 98192-14-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-23376830
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cobalt-Catalyzed 1,4-Aryl Migration/Desulfonylation Cascade: Synthesis of
α-Aryl Amides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gillaizeau-Simonian, Nicolas; Barde, Etienne; Guerinot, Amandine; Cossy,
Janine
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2021), 27(12), 4004-4008

$RFMT $RIREG SCHEME330 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-(3-nitrophenyl)acetamide
C8H7BrN2O3
29182-96-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6684 1.5400 0.0 0
M  V30 2 C 8.0022 2.3100 0.0 0
M  V30 3 C 9.3359 1.5400 0.0 0
M  V30 4 O 8.0022 3.8500 0.0 0
M  V30 5 Br 10.6695 2.3100 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 C 5.3348 2.3100 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 5.3348 3.8500 0.0 0
M  V30 12 C 2.6673 2.3100 0.0 0
M  V30 13 C 4.0011 4.6201 0.0 0
M  V30 14 C 2.6673 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Methylamino)-N-(3-nitrophenyl)acetamide
C9H11N3O3
1092306-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 1.5400 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 1.5400 0.0 0
M  V30 4 O 8.0022 3.8501 0.0 0
M  V30 5 N 10.6697 2.3101 0.0 0
M  V30 6 C 12.0033 1.5400 0.0 0
M  V30 7 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 O 1.3337 0.0000 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0012 1.5400 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 4.0012 4.6201 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 13
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 29182-96-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1092306-77-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-16814353
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 3-Amino-2-carboxamide Tetrahydropyrrolo[2,3-b]quinolines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pilkington, Lisa I.; Haverkate, Natalie A.; van Rensburg, Michelle;
Reynisson, Johannes; Leung, Euphemia; Barker, David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2016), 27(20), 2811-2814

$RFMT $RIREG SCHEME331 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-2-hydroxy-5-nitrobenzaldehyde
C7H4FNO4
2923-99-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 O 6.9300 2.6674 0.0 0
M  V30 3 O 4.6200 6.6685 0.0 0
M  V30 4 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 5 O 2.3100 0.0000 0.0 0
M  V30 6 O 0.0000 1.3338 0.0 0
M  V30 7 F 1.5400 6.6685 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 3.8500 2.6674 0.0 0
M  V30 10 C 3.8500 5.3347 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 13 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 3 10
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 11
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-6-[(methylamino)methyl]-4-nitrophenol
C8H9FN2O3
1508296-29-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 N 6.9300 2.6674 0.0 0
M  V30 3 C 8.4700 2.6674 0.0 0
M  V30 4 O 4.6200 6.6685 0.0 0
M  V30 5 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 O 0.0000 1.3338 0.0 0
M  V30 8 F 1.5400 6.6685 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 3.8500 2.6674 0.0 0
M  V30 11 C 3.8500 5.3347 0.0 0
M  V30 12 C 2.3100 2.6674 0.0 0
M  V30 13 C 2.3100 5.3347 0.0 0
M  V30 14 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 11
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 12
M  V30 8 1 8 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2923-99-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1508296-29-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-2738051
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrocyclic compounds as factor VIIa inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Xiaojun; Glunz, Peter W.; Priestley, Eldon Scott; Johnson, James
A.; Wurtz, Nicholas Ronald; Ladziata, Vladimir
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013184734 A1 2013-12-12

$RFMT $RIREG SCHEME332 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzyl glycidyl ether
C10H12O2
2930-05-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 3.0801 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 C 4.0012 3.0801 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 C 9.5424 2.3101 0.0 0
M  V30 6 O 8.7723 0.9764 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 1.3337 0.0000 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 2 3
M  V30 4 1 3 7
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(Methylamino)-3-(phenylmethoxy)-2-propanol
C11H17NO2
57962-52-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 C 8.0022 2.3101 0.0 0
M  V30 5 C 9.3360 3.0801 0.0 0
M  V30 6 O 8.0022 0.7700 0.0 0
M  V30 7 N 10.6697 2.3101 0.0 0
M  V30 8 C 12.0033 3.0801 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 1.3337 3.0801 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2930-05-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 57962-52-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-5991156
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Towards a biomimetic poly-aminoketone foldamer: synthesis of a triply
protected monomer and its coupling to a dimer, trimer and tetramer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barbe, Romain; Hasserodt, Jens
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2007), 63(10), 2199-2207

$RFMT $RIREG SCHEME333 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Quinoline, 5-bromo-6-(bromomethyl)-8-chloro-
C10H6Br2ClN
2930865-83-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 4.0011 6.1600 0.0 0
M  V30 2 Cl 4.0011 0.0000 0.0 0
M  V30 3 C 6.6685 4.6200 0.0 0
M  V30 4 Br 8.0021 3.8500 0.0 0
M  V30 5 C 2.6674 3.8500 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 4.0011 4.6200 0.0 0
M  V30 8 C 1.3336 4.6200 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 N 1.3336 1.5400 0.0 0
M  V30 11 C 5.3347 3.8500 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 13 C 5.3347 2.3100 0.0 0
M  V30 14 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 9
M  V30 3 1 3 4
M  V30 4 1 3 11
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Quinolinemethanamine, 5-bromo-8-chloro-N-methyl-
C11H10BrClN2
2930865-97-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 4.0011 6.1601 0.0 0
M  V30 2 Cl 4.0011 0.0000 0.0 0
M  V30 3 C 6.6684 4.6201 0.0 0
M  V30 4 N 8.0022 3.8500 0.0 0
M  V30 5 C 9.3359 4.6201 0.0 0
M  V30 6 C 2.6675 3.8500 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 4.0011 4.6201 0.0 0
M  V30 9 C 1.3337 4.6201 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 N 1.3337 1.5400 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 14 C 5.3348 2.3100 0.0 0
M  V30 15 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 1 4 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2930865-83-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2930865-97-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38014840
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Therapeutic heteroaromatic compounds and methods of use in the treatment
of cancer and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zbieg, Jason Robert; Beroza, Paul Powell; Verma, Vishal Anil; Zhu,
Bing-Yan; Beveridge, Ramsay; Zhao, Liang; Leblanc, Melissa; Barton, Lisa
Marie; Chan, Bryan; Bouayad-Gervais, Samir; Dey, Anwesha; Evangelista,
Marie Anne; Smith, Russell Tyler
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023097194 A2 2023-06-01

$RFMT $RIREG SCHEME334 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Pyridinecarboxylic acid, 5-bromo-, methyl ester
C7H6BrNO2
29682-15-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 O 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Br 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 N 4.6201 2.6673 0.0 0
M  V30 9 C 6.1601 0.0000 0.0 0
M  V30 10 C 6.1601 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-2-pyridinecarboxamide
C7H7BrN2O
845305-87-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Br 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 N 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 29682-15-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 845305-87-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20377712
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1,2,4-Triazolo[4,3-b]pyridazine derivatives as highly selective c-Met
kinase inhibitors and their preparation, pharmaceutical compositions and
use in the treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhong, Boyu; Shih, Chuan; Yuan, Hongbin; Zhou, Feng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014032498 A1 2014-03-06

$RFMT $RIREG SCHEME335 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Diazaspiro[3.3]heptane-2-carboxylic acid, 6-[6-(methoxycarbonyl)-2-methyl...
C18H25N3O4
3028065-40-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.6673 0.0 0
M  V30 2 O 3.0800 4.0010 0.0 0
M  V30 3 O 3.0800 1.3337 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 C 1.5400 2.4609 0.0 0
M  V30 6 C 0.0000 4.0010 0.0 0
M  V30 7 C 1.5400 5.5410 0.0 0
M  V30 8 C 11.2858 0.0000 0.0 0
M  V30 9 C 15.9059 2.6673 0.0 0
M  V30 10 O 16.6759 4.0010 0.0 0
M  V30 11 O 16.6759 1.3337 0.0 0
M  V30 12 C 18.2159 4.0010 0.0 0
M  V30 13 C 7.5679 2.6673 0.0 0
M  V30 14 C 8.6569 3.7562 0.0 0
M  V30 15 C 6.4790 3.7562 0.0 0
M  V30 16 C 6.4790 1.5784 0.0 0
M  V30 17 C 8.6569 1.5784 0.0 0
M  V30 18 N 9.7458 2.6673 0.0 0
M  V30 19 N 5.3901 2.6673 0.0 0
M  V30 20 C 11.2858 2.6673 0.0 0
M  V30 21 C 12.0559 1.3337 0.0 0
M  V30 22 C 12.0559 4.0010 0.0 0
M  V30 23 N 13.5959 1.3337 0.0 0
M  V30 24 C 13.5959 4.0010 0.0 0
M  V30 25 C 14.3659 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 21
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 25
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 19
M  V30 20 1 17 18
M  V30 21 1 18 20
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Diazaspiro[3.3]heptane-2-carboxylic acid, 6-[2-methyl-6-[(methylamino)car...
C18H26N4O3
3028065-41-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.6673 0.0 0
M  V30 2 O 3.0800 4.0010 0.0 0
M  V30 3 O 3.0800 1.3337 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 C 1.5400 5.5410 0.0 0
M  V30 6 C 0.0000 4.0010 0.0 0
M  V30 7 C 1.5400 2.4609 0.0 0
M  V30 8 C 11.2858 0.0000 0.0 0
M  V30 9 C 15.9059 2.6673 0.0 0
M  V30 10 N 16.6759 4.0010 0.0 0
M  V30 11 O 16.6759 1.3337 0.0 0
M  V30 12 C 18.2159 4.0010 0.0 0
M  V30 13 C 7.5679 2.6673 0.0 0
M  V30 14 C 8.6569 3.7562 0.0 0
M  V30 15 C 6.4790 3.7562 0.0 0
M  V30 16 C 6.4790 1.5784 0.0 0
M  V30 17 C 8.6569 1.5784 0.0 0
M  V30 18 N 9.7458 2.6673 0.0 0
M  V30 19 N 5.3901 2.6673 0.0 0
M  V30 20 C 11.2858 2.6673 0.0 0
M  V30 21 C 12.0559 1.3337 0.0 0
M  V30 22 C 12.0559 4.0010 0.0 0
M  V30 23 N 13.5959 1.3337 0.0 0
M  V30 24 C 13.5959 4.0010 0.0 0
M  V30 25 C 14.3659 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 21
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 25
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 19
M  V30 20 1 17 18
M  V30 21 1 18 20
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3028065-40-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3028065-41-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41162525
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds and methods of use thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kankanala, Jayakanth; Pettigrew, Jeremy D.; Conte, Aurelia; Chen, Jiyun;
Pham, Son Minh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20240132522 A1 2024-04-25

$RFMT $RIREG SCHEME336 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,5-Naphthyridine-1(2H)-acetic acid, 8-[2-[4-[[(1,1-dimethylethoxy)carbonyl]a...
C24H30FN3O6
3032097-00-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 2.3101 0.0 0
M  V30 2 C 5.3348 3.0801 0.0 0
M  V30 3 N 12.0035 5.3901 0.0 0
M  V30 4 C 13.3372 4.6201 0.0 0
M  V30 5 O 14.6708 5.3901 0.0 0
M  V30 6 O 13.3372 3.0801 0.0 0
M  V30 7 C 16.0045 4.6201 0.0 0
M  V30 8 C 15.2345 3.2864 0.0 0
M  V30 9 C 17.3383 3.8501 0.0 0
M  V30 10 C 16.7745 5.9538 0.0 0
M  V30 11 F 5.3348 0.0000 0.0 0
M  V30 12 C 4.0012 5.3901 0.0 0
M  V30 13 C 4.0012 6.9302 0.0 0
M  V30 14 O 5.3348 7.7002 0.0 0
M  V30 15 O 2.6675 7.7002 0.0 0
M  V30 16 O 1.3338 6.9302 0.0 0
M  V30 17 C 8.0023 3.0801 0.0 0
M  V30 18 C 8.0017 4.6210 0.0 0
M  V30 19 C 9.3365 2.3091 0.0 0
M  V30 20 O 9.1293 3.0787 0.0 0
M  V30 21 C 9.3355 5.3910 0.0 0
M  V30 22 C 10.6703 3.0791 0.0 0
M  V30 23 C 10.1074 3.6434 0.0 0
M  V30 24 C 10.6697 4.6201 0.0 0
M  V30 25 C 4.0012 2.3101 0.0 0
M  V30 26 C 2.6675 3.0801 0.0 0
M  V30 27 C 4.0012 0.7700 0.0 0
M  V30 28 C 1.3338 2.3101 0.0 0
M  V30 29 N 2.6675 4.6201 0.0 0
M  V30 30 C 2.6675 0.0000 0.0 0
M  V30 31 C 0.0000 3.0801 0.0 0
M  V30 32 N 1.3338 0.7700 0.0 0
M  V30 33 C 1.3338 5.3901 0.0 0
M  V30 34 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 25
M  V30 4 1 3 4
M  V30 5 1 3 24
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 11 27
M  V30 13 1 12 13
M  V30 14 1 12 29
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 2 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 1 18 21
M  V30 22 1 19 22
M  V30 23 1 20 23
M  V30 24 1 21 24
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 26 29
M  V30 31 2 27 30
M  V30 32 1 28 31
M  V30 33 2 28 32
M  V30 34 1 29 33
M  V30 35 1 30 32
M  V30 36 2 31 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C25H33FN4O5
3032097-07-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 6.9302 0.0 0
M  V30 2 C 5.3348 6.1601 0.0 0
M  V30 3 N 12.0035 3.8501 0.0 0
M  V30 4 C 13.3372 4.6201 0.0 0
M  V30 5 O 14.6708 3.8501 0.0 0
M  V30 6 O 13.3372 6.1601 0.0 0
M  V30 7 C 16.0045 4.6201 0.0 0
M  V30 8 C 16.7745 3.2864 0.0 0
M  V30 9 C 17.3383 5.3901 0.0 0
M  V30 10 C 15.2345 5.9538 0.0 0
M  V30 11 F 5.3348 9.2402 0.0 0
M  V30 12 C 4.0012 3.8501 0.0 0
M  V30 13 C 4.0012 2.3101 0.0 0
M  V30 14 N 5.3348 1.5400 0.0 0
M  V30 15 O 2.6675 1.5400 0.0 0
M  V30 16 C 5.3348 0.0000 0.0 0
M  V30 17 O 1.3338 2.3101 0.0 0
M  V30 18 C 8.0023 6.1601 0.0 0
M  V30 19 C 8.0017 4.6192 0.0 0
M  V30 20 C 9.3366 6.9311 0.0 0
M  V30 21 O 9.1293 6.1615 0.0 0
M  V30 22 C 9.3355 3.8492 0.0 0
M  V30 23 C 10.6703 6.1611 0.0 0
M  V30 24 C 10.1074 5.5968 0.0 0
M  V30 25 C 10.6697 4.6201 0.0 0
M  V30 26 C 4.0012 6.9302 0.0 0
M  V30 27 C 2.6675 6.1601 0.0 0
M  V30 28 C 4.0012 8.4702 0.0 0
M  V30 29 N 2.6675 4.6201 0.0 0
M  V30 30 C 1.3338 6.9302 0.0 0
M  V30 31 C 2.6675 9.2402 0.0 0
M  V30 32 C 1.3338 3.8501 0.0 0
M  V30 33 C 0.0000 6.1601 0.0 0
M  V30 34 N 1.3338 8.4702 0.0 0
M  V30 35 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 26
M  V30 4 1 3 4
M  V30 5 1 3 25
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 11 28
M  V30 13 1 12 13
M  V30 14 1 12 29
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 2 17 32
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 21
M  V30 22 1 19 22
M  V30 23 1 20 23
M  V30 24 1 21 24
M  V30 25 1 22 25
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 27 30
M  V30 32 2 28 31
M  V30 33 1 29 32
M  V30 34 1 30 33
M  V30 35 2 30 34
M  V30 36 1 31 34
M  V30 37 1 32 35
M  V30 38 2 33 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3032097-00-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3032097-07-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34555438
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure activity relationship of N-1 substituted 1,5-naphthyrid-2-one
analogs of oxabicyclooctane-linked novel bacterial topoisomerase
inhibitors as broad-spectrum antibacterial agents (Part-9)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Singh, Sheo B.; Tan, Christopher M.; Kaelin, David; Meinke, Peter T.;
Miesel, Lynn; Olsen, David B.; Fukuda, Hideyuki; Kishii, Ryuta; Takei,
Masaya; Ohata, Kohei; Takeuchi, Tomoko; Shibue, Taku; Takano, Hisashi;
Nishimura, Akinori; Fukuda, Yasumichi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2022), 75128808

$RFMT $RIREG SCHEME337 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-(4-fluorophenyl)-N-methyl-, 2-[3-(2-oxiranylmethyl)-2-oxo-1-...
C22H18F7N3O4
3035073-21-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.4046 6.6684 0.0 0
M  V30 2 C 8.9446 6.6684 0.0 0
M  V30 3 N 9.7146 8.0020 0.0 0
M  V30 4 O 9.7146 5.3347 0.0 0
M  V30 5 C 8.9446 9.3358 0.0 0
M  V30 6 C 8.9446 4.0011 0.0 0
M  V30 7 F 8.9446 5.5411 0.0 0
M  V30 8 F 10.4846 4.0011 0.0 0
M  V30 9 F 8.9446 2.4611 0.0 0
M  V30 10 O 1.7627 5.6849 0.0 0
M  V30 11 C 4.3246 1.3336 0.0 0
M  V30 12 F 5.6584 0.5636 0.0 0
M  V30 13 F 3.5546 0.0000 0.0 0
M  V30 14 F 2.9910 2.1036 0.0 0
M  V30 15 C 1.0661 8.9620 0.0 0
M  V30 16 F 15.8746 8.0020 0.0 0
M  V30 17 C 6.6346 5.3347 0.0 0
M  V30 18 C 5.0946 5.3347 0.0 0
M  V30 19 C 7.4046 4.0011 0.0 0
M  V30 20 C 4.3246 4.0011 0.0 0
M  V30 21 C 6.6346 2.6673 0.0 0
M  V30 22 C 5.0946 2.6673 0.0 0
M  V30 23 N 4.3246 6.6684 0.0 0
M  V30 24 C 2.7931 6.8294 0.0 0
M  V30 25 C 4.9511 8.0753 0.0 0
M  V30 26 N 2.4729 8.3357 0.0 0
M  V30 27 C 3.8066 9.1057 0.0 0
M  V30 28 C 11.2546 8.0020 0.0 0
M  V30 29 C 12.0246 9.3358 0.0 0
M  V30 30 C 12.0246 6.6684 0.0 0
M  V30 31 C 13.5646 9.3358 0.0 0
M  V30 32 C 13.5646 6.6684 0.0 0
M  V30 33 C 14.3346 8.0020 0.0 0
M  V30 34 C 0.9051 10.4937 0.0 0
M  V30 35 C 1.5315 11.9005 0.0 0
M  V30 36 O 0.0000 11.7396 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 28
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 6 19
M  V30 11 2 10 24
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 22
M  V30 16 1 15 26
M  V30 17 1 15 34
M  V30 18 1 16 33
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 18 23
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 37 1 34 35
M  V30 38 1 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-(4-fluorophenyl)-N-methyl-, 2-[3-[2-hydroxy-3-(methylamino)p...
C23H23F7N4O4
3035072-97-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 7.7001 0.0 0
M  V30 2 C 5.3348 8.4702 0.0 0
M  V30 3 N 5.3348 10.0102 0.0 0
M  V30 4 O 4.0011 7.7001 0.0 0
M  V30 5 C 6.6685 10.7802 0.0 0
M  V30 6 C 4.0011 6.1601 0.0 0
M  V30 7 F 3.2311 4.8265 0.0 0
M  V30 8 F 2.6675 6.9301 0.0 0
M  V30 9 F 4.7712 7.4938 0.0 0
M  V30 10 O 11.0630 4.0273 0.0 0
M  V30 11 C 6.6685 1.5400 0.0 0
M  V30 12 F 5.1285 1.5400 0.0 0
M  V30 13 F 6.6685 0.0000 0.0 0
M  V30 14 F 8.2085 1.5400 0.0 0
M  V30 15 C 13.3049 6.5172 0.0 0
M  V30 16 C 14.2102 7.7631 0.0 0
M  V30 17 C 15.7417 7.6022 0.0 0
M  V30 18 O 13.5837 9.1699 0.0 0
M  V30 19 N 16.6469 8.8481 0.0 0
M  V30 20 C 18.1785 8.6871 0.0 0
M  V30 21 F 0.0000 13.0902 0.0 0
M  V30 22 C 8.0023 5.3901 0.0 0
M  V30 23 C 6.6685 6.1601 0.0 0
M  V30 24 C 8.0023 3.8501 0.0 0
M  V30 25 C 5.3348 5.3901 0.0 0
M  V30 26 C 6.6685 3.0801 0.0 0
M  V30 27 C 5.3348 3.8501 0.0 0
M  V30 28 N 9.3360 6.1601 0.0 0
M  V30 29 C 10.7428 5.5338 0.0 0
M  V30 30 C 9.4969 7.6917 0.0 0
M  V30 31 N 11.7734 6.6782 0.0 0
M  V30 32 C 11.0034 8.0118 0.0 0
M  V30 33 C 4.0011 10.7802 0.0 0
M  V30 34 C 4.0011 12.3202 0.0 0
M  V30 35 C 2.6675 10.0102 0.0 0
M  V30 36 C 2.6675 13.0902 0.0 0
M  V30 37 C 1.3337 10.7802 0.0 0
M  V30 38 C 1.3337 12.3202 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 33
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 6 25
M  V30 11 2 10 29
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 26
M  V30 16 1 15 16
M  V30 17 1 15 31
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 19 20
M  V30 22 1 21 38
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 22 28
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 1 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 32
M  V30 35 2 33 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 2 35 37
M  V30 39 2 36 38
M  V30 40 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3035073-21-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3035072-97-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41082008
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrrolidine and imidazolidine based DNA polymerase theta
inhibitors and use thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pomerantz, Richard T.; Ramanjulu, Mercy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024076964 A1 2024-04-11

$RFMT $RIREG SCHEME338 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzaldehyde, 3-azido-5-iodo-
C7H4IN3O
3039884-08-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.6201 0.0 0
M  V30 2 N 8.0023 3.8501 0.0 0 CHG=1 VAL=4
M  V30 3 N 9.3360 3.0801 0.0 0 CHG=-1
M  V30 4 C 1.3337 4.6201 0.0 0
M  V30 5 O 0.0000 3.8501 0.0 0
M  V30 6 I 4.0012 0.0000 0.0 0
M  V30 7 C 5.3348 3.8501 0.0 0
M  V30 8 C 4.0012 4.6201 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 2.6675 3.8501 0.0 0
M  V30 11 C 4.0012 1.5400 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 10
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C8H9IN4
3039884-01-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 4.6201 0.0 0
M  V30 2 N 1.3337 3.8501 0.0 0
M  V30 3 C 0.0000 4.6201 0.0 0
M  V30 4 N 8.0023 4.6201 0.0 0
M  V30 5 N 9.3360 3.8501 0.0 0 CHG=1 VAL=4
M  V30 6 N 10.6697 3.0801 0.0 0 CHG=-1
M  V30 7 I 5.3348 0.0000 0.0 0
M  V30 8 C 4.0012 3.8501 0.0 0
M  V30 9 C 5.3348 4.6201 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 6.6685 3.8501 0.0 0
M  V30 12 C 5.3348 1.5400 0.0 0
M  V30 13 C 6.6685 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 2 5 6
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3039884-08-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3039884-01-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40396759
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Iterative click reactions using trivalent platforms for sequential
molecular assembly
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Orimoto, Gaku; Yoshida, Suguru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2024), 60(45),
5824-5827

$RFMT $RIREG SCHEME339 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzaldehyde, 2-fluoro-3-(propylthio)-4-(trifluoromethyl)-
C11H10F4OS
3040200-91-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 1.3338 0.0 0
M  V30 2 F 5.9536 2.1038 0.0 0
M  V30 3 F 5.3900 0.0000 0.0 0
M  V30 4 F 3.2864 0.5638 0.0 0
M  V30 5 S 6.1600 4.0011 0.0 0
M  V30 6 C 6.9300 5.3347 0.0 0
M  V30 7 C 8.4700 5.3347 0.0 0
M  V30 8 C 9.2400 6.6685 0.0 0
M  V30 9 F 4.6200 6.6685 0.0 0
M  V30 10 C 1.5400 6.6685 0.0 0
M  V30 11 O 0.0000 6.6685 0.0 0
M  V30 12 C 3.8500 2.6674 0.0 0
M  V30 13 C 4.6200 4.0011 0.0 0
M  V30 14 C 2.3100 2.6674 0.0 0
M  V30 15 C 3.8500 5.3347 0.0 0
M  V30 16 C 1.5400 4.0011 0.0 0
M  V30 17 C 2.3100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 12
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenemethanamine, 2-fluoro-N-methyl-3-(propylthio)-4-(trifluoromethyl)-
C12H15F4NS
3040200-86-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9301 4.0011 0.0 0
M  V30 2 C 7.7001 5.3348 0.0 0
M  V30 3 C 9.2401 5.3348 0.0 0
M  V30 4 C 10.0101 6.6686 0.0 0
M  V30 5 C 5.3901 1.3337 0.0 0
M  V30 6 F 4.0564 0.5636 0.0 0
M  V30 7 F 6.1601 0.0000 0.0 0
M  V30 8 F 6.7237 2.1037 0.0 0
M  V30 9 F 5.3901 6.6686 0.0 0
M  V30 10 C 2.3100 6.6686 0.0 0
M  V30 11 N 0.7700 6.6686 0.0 0
M  V30 12 C 0.0000 8.0022 0.0 0
M  V30 13 C 5.3901 4.0011 0.0 0
M  V30 14 C 4.6201 2.6675 0.0 0
M  V30 15 C 4.6201 5.3348 0.0 0
M  V30 16 C 3.0800 2.6675 0.0 0
M  V30 17 C 3.0800 5.3348 0.0 0
M  V30 18 C 2.3100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 14
M  V30 9 1 9 15
M  V30 10 1 10 11
M  V30 11 1 10 17
M  V30 12 1 11 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3040200-91-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3040200-86-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40490535
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective Defluorination of Trifluoromethyl Substituents by
Conformationally Induced Remote Substitution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jesani, Mehul H.; Schwarz, Maria; Kim, Shiwhu; Evans, Finlay L.; White,
Alexander; Browning, Alex; Abrams, Roman; Clayden, Jonathan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2024), 63(24), e202403477

$RFMT $RIREG SCHEME340 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C39H58IrN5O3P.CF3O3S
3041040-24-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  58 62 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.3373 17.7430 0.0 0 VAL=4
M  V30 2 C 8.1106 18.4501 0.0 0
M  V30 3 C 6.8838 17.7430 0.0 0
M  V30 4 H 12.9550 13.2970 0.0 0 CHG=-1 VAL=1
M  V30 5 C 8.4583 5.8467 0.0 0
M  V30 6 C 7.5480 6.9328 0.0 0
M  V30 7 C 7.7511 4.6200 0.0 0
M  V30 8 C 9.1654 4.6200 0.0 0
M  V30 9 C 6.9033 15.1606 0.0 0
M  V30 10 C 16.1742 13.5275 0.0 0
M  V30 11 C 17.4010 14.2347 0.0 0
M  V30 12 C 16.1742 12.1094 0.0 0
M  V30 13 C 12.7284 9.4801 0.0 0
M  V30 14 C 10.1187 18.4697 0.0 0
M  V30 15 C 11.3454 19.1768 0.0 0
M  V30 16 C 8.8919 19.1768 0.0 0
M  V30 17 C 4.0631 9.7731 0.0 0
M  V30 18 O 2.7348 10.8787 0.0 0
M  V30 19 O 5.2898 15.3130 0.0 0
M  V30 20 C 0.0000 14.3831 0.0 0
M  V30 21 C 0.9376 15.9420 0.0 0
M  V30 22 Ir 10.1187 13.2970 0.0 0 CHG=3 VAL=6
M  V30 23 N 11.7283 14.2347 0.0 0 VAL=4
M  V30 24 C 8.5130 12.3555 0.0 0 CHG=-1 VAL=4
M  V30 25 N 11.7283 12.3555 0.0 0 VAL=4
M  V30 26 P 8.5130 14.2347 0.0 0 CFG=1 VAL=4
M  V30 27 C 11.7283 16.1100 0.0 0
M  V30 28 C 14.9475 14.2347 0.0 0 CFG=1
M  V30 29 C 8.5130 10.4802 0.0 0
M  V30 30 C 6.9033 13.2970 0.0 0
M  V30 31 C 11.7283 10.4802 0.0 0
M  V30 32 N 8.5130 16.1100 0.0 0
M  V30 33 C 10.1187 17.0515 0.0 0 CFG=1
M  V30 34 O 13.3379 17.0515 0.0 0
M  V30 35 C 14.9475 16.1100 0.0 0
M  V30 36 C 6.9033 9.5387 0.0 0
M  V30 37 C 5.2898 12.3555 0.0 0
M  V30 38 C 5.2898 10.4802 0.0 0
M  V30 39 C 12.9550 11.6484 0.0 0
M  V30 40 C 12.9550 10.1091 0.0 0
M  V30 41 C 14.2911 12.4180 0.0 0
M  V30 42 C 14.2911 9.3433 0.0 0
M  V30 43 C 15.6195 11.6484 0.0 0
M  V30 44 C 15.6195 10.1091 0.0 0
M  V30 45 N 4.0631 13.0665 0.0 0
M  V30 46 C 2.7348 12.2969 0.0 0
M  V30 47 C 4.0631 14.6019 0.0 0
M  V30 48 C 1.3986 13.0665 0.0 0
M  V30 49 C 2.7348 15.3716 0.0 0
M  V30 50 C 1.3986 14.6019 0.0 0
M  V30 51 C 7.9305 1.5400 0.0 0
M  V30 52 S 9.4705 1.5400 0.0 0 VAL=6
M  V30 53 F 7.1605 0.2064 0.0 0
M  V30 54 F 6.3905 1.5400 0.0 0
M  V30 55 F 7.1605 2.8736 0.0 0
M  V30 56 O 9.4705 3.0800 0.0 0
M  V30 57 O 9.4705 0.0000 0.0 0
M  V30 58 O 11.0105 1.5400 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 1 4 22
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 26
M  V30 9 1 26 9 CFG=3
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 28 10 CFG=3
M  V30 13 1 13 31
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 33 14 CFG=3
M  V30 17 1 17 38
M  V30 18 2 18 46
M  V30 19 2 19 47
M  V30 20 1 20 50
M  V30 21 1 21 50
M  V30 22 1 22 23
M  V30 23 1 22 24
M  V30 24 1 22 25
M  V30 25 1 22 26
M  V30 26 2 23 27
M  V30 27 1 23 28
M  V30 28 1 24 29
M  V30 29 2 24 30
M  V30 30 2 25 31
M  V30 31 1 25 39
M  V30 32 1 26 32
M  V30 33 1 27 33
M  V30 34 1 27 34
M  V30 35 1 28 35
M  V30 36 1 29 31
M  V30 37 2 29 36
M  V30 38 1 30 37
M  V30 39 1 32 33
M  V30 40 1 34 35
M  V30 41 1 36 38
M  V30 42 2 37 38
M  V30 43 1 37 45
M  V30 44 2 39 40
M  V30 45 1 39 41
M  V30 46 1 40 42
M  V30 47 2 41 43
M  V30 48 2 42 44
M  V30 49 1 43 44
M  V30 50 1 45 46
M  V30 51 1 45 47
M  V30 52 1 46 48
M  V30 53 1 47 49
M  V30 54 1 48 50
M  V30 55 1 49 50
M  V30 56 1 51 52
M  V30 57 1 51 53
M  V30 58 1 51 54
M  V30 59 1 51 55
M  V30 60 2 52 56
M  V30 61 2 52 57
M  V30 62 1 52 58
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 26 28 33)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C38H60IrN5O3P.CF3O3S
3041040-26-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  57 61 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 12.9387 14.4176 0.0 0 VAL=4
M  V30 2 C 14.5423 13.4890 0.0 0
M  V30 3 H 9.8640 17.2348 0.0 0 CHG=-1 VAL=1
M  V30 4 C 8.5373 5.8452 0.0 0
M  V30 5 C 7.6282 6.9299 0.0 0
M  V30 6 C 7.8311 4.6200 0.0 0
M  V30 7 C 9.2436 4.6200 0.0 0
M  V30 8 C 6.8985 16.2788 0.0 0
M  V30 9 C 16.1538 14.6478 0.0 0
M  V30 10 C 17.3790 15.3541 0.0 0
M  V30 11 C 16.1538 13.2315 0.0 0
M  V30 12 C 12.7162 10.6055 0.0 0
M  V30 13 C 10.1098 19.5837 0.0 0
M  V30 14 C 11.3350 20.2900 0.0 0
M  V30 15 C 8.8846 20.2900 0.0 0
M  V30 16 C 4.0619 10.8981 0.0 0
M  V30 17 O 2.7313 12.0024 0.0 0
M  V30 18 O 5.2871 16.4310 0.0 0
M  V30 19 C 0.0000 15.5024 0.0 0
M  V30 20 C 0.9404 17.0592 0.0 0
M  V30 21 Ir 10.1098 14.4176 0.0 0 CHG=3 VAL=6
M  V30 22 N 11.7135 15.3541 0.0 0 VAL=4
M  V30 23 C 8.5022 13.4773 0.0 0 CHG=-1 VAL=4
M  V30 24 N 11.7135 13.4773 0.0 0 VAL=4
M  V30 25 P 8.5022 15.3541 0.0 0 CFG=1 VAL=4
M  V30 26 C 11.7135 17.2270 0.0 0
M  V30 27 C 14.9286 15.3541 0.0 0 CFG=1
M  V30 28 C 8.5022 11.6044 0.0 0
M  V30 29 C 6.8946 14.4176 0.0 0
M  V30 30 C 11.7135 11.6044 0.0 0
M  V30 31 N 8.5022 17.2270 0.0 0
M  V30 32 C 10.1098 18.1673 0.0 0 CFG=1
M  V30 33 O 13.3210 18.1673 0.0 0
M  V30 34 C 14.9286 17.2270 0.0 0
M  V30 35 C 6.8946 10.6640 0.0 0
M  V30 36 C 5.2871 13.4773 0.0 0
M  V30 37 C 5.2871 11.6044 0.0 0
M  V30 38 C 14.8935 11.6434 0.0 0
M  V30 39 C 14.8935 10.1061 0.0 0
M  V30 40 C 16.2279 12.4121 0.0 0
M  V30 41 C 16.2279 9.3374 0.0 0
M  V30 42 C 17.5546 11.6434 0.0 0
M  V30 43 C 17.5546 10.1061 0.0 0
M  V30 44 N 4.0619 14.1874 0.0 0
M  V30 45 C 2.7313 13.4188 0.0 0
M  V30 46 C 4.0619 15.7209 0.0 0
M  V30 47 C 1.4008 14.1874 0.0 0
M  V30 48 C 2.7313 16.4895 0.0 0
M  V30 49 C 1.4008 15.7209 0.0 0
M  V30 50 C 8.0073 1.5400 0.0 0
M  V30 51 S 9.5473 1.5400 0.0 0 VAL=6
M  V30 52 F 7.2373 2.8736 0.0 0
M  V30 53 F 6.4673 1.5400 0.0 0
M  V30 54 F 7.2373 0.2064 0.0 0
M  V30 55 O 9.5473 3.0800 0.0 0
M  V30 56 O 9.5473 0.0000 0.0 0
M  V30 57 O 11.0873 1.5400 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 3 21
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 25
M  V30 8 1 25 8 CFG=3
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 27 9 CFG=3
M  V30 12 1 12 30
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 32 13 CFG=3
M  V30 16 1 16 37
M  V30 17 2 17 45
M  V30 18 2 18 46
M  V30 19 1 19 49
M  V30 20 1 20 49
M  V30 21 1 21 22
M  V30 22 1 21 23
M  V30 23 1 21 24
M  V30 24 1 21 25
M  V30 25 2 22 26
M  V30 26 1 22 27
M  V30 27 1 23 28
M  V30 28 2 23 29
M  V30 29 2 24 30
M  V30 30 1 24 38
M  V30 31 1 25 31
M  V30 32 1 26 32
M  V30 33 1 26 33
M  V30 34 1 27 34
M  V30 35 1 28 30
M  V30 36 2 28 35
M  V30 37 1 29 36
M  V30 38 1 31 32
M  V30 39 1 33 34
M  V30 40 1 35 37
M  V30 41 2 36 37
M  V30 42 1 36 44
M  V30 43 2 38 39
M  V30 44 1 38 40
M  V30 45 1 39 41
M  V30 46 2 40 42
M  V30 47 2 41 43
M  V30 48 1 42 43
M  V30 49 1 44 45
M  V30 50 1 44 46
M  V30 51 1 45 47
M  V30 52 1 46 48
M  V30 53 1 47 49
M  V30 54 1 48 49
M  V30 55 1 50 51
M  V30 56 1 50 52
M  V30 57 1 50 53
M  V30 58 1 50 54
M  V30 59 2 51 55
M  V30 60 2 51 56
M  V30 61 1 51 57
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 25 27 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3041040-24-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3041040-26-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40489688
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 1665-00-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cyclometallated Imides as Templates for the H-Bond Directed
Iridium-Catalyzed Asymmetric Hydrogenation of N-Methyl, N-Alkyl and
N-Aryl Imines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wen, Yisong; Fernandez-Sabate, Marc; Lledos, Agusti; Sciortino, Giuseppe;
Eills, James; Marco-Rius, Irene; Riera, Antoni; Verdaguer, Xavier
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2024), 63(26), e202404955

$RFMT $RIREG SCHEME341 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-oxopentanoate
C6H10O3
30414-53-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 2.6675 1.5400 0.0 0
M  V30 4 C 6.6686 2.3100 0.0 0
M  V30 5 O 5.3348 0.0000 0.0 0
M  V30 6 O 1.3337 2.3100 0.0 0
M  V30 7 O 2.6675 0.0000 0.0 0
M  V30 8 C 8.0022 1.5400 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-(methylamino)-2-pentenoate
C7H13NO2
1280735-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6674 0.0 0
M  V30 2 C 3.0800 4.0011 0.0 0
M  V30 3 C 0.7700 2.6674 0.0 0
M  V30 4 N 3.0800 1.3338 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 0.0000 4.0011 0.0 0
M  V30 7 C 2.3100 0.0000 0.0 0
M  V30 8 O 5.3900 5.3349 0.0 0
M  V30 9 O 5.3900 2.6674 0.0 0
M  V30 10 C 6.9300 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 30414-53-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1280735-14-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32495506
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of aryl-benzofuranyl derivatives as transient receptor
potential cation channel (TRPM3) for treating pain and inflammatory
hypersensitivity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Allasia, Sara; Arzel, Philippe; Chaltin, Patrick; Kilonda, Amuri;
Marchand, Arnaud; Vanherck, Thomas; Voets, Thomas; Vriens, Joris; Reich,
Melanie; Welbers, Andre
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022112345 A1 2022-06-02

$RFMT $RIREG SCHEME342 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-1-acetic acid, 4-(2-formylphenyl)-
C12H10N2O3
3052794-18-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 1.3338 0.0 0
M  V30 2 O 2.3100 0.0000 0.0 0
M  V30 3 C 8.2357 5.6763 0.0 0
M  V30 4 C 9.6426 5.0500 0.0 0
M  V30 5 O 9.8035 3.5183 0.0 0
M  V30 6 O 10.8885 5.9552 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 2.3100 2.6674 0.0 0
M  V30 9 C 2.3100 5.3347 0.0 0
M  V30 10 C 0.7700 2.6674 0.0 0
M  V30 11 C 0.7700 5.3347 0.0 0
M  V30 12 C 0.0000 4.0011 0.0 0
M  V30 13 C 4.6200 4.0011 0.0 0
M  V30 14 C 5.5252 5.2470 0.0 0
M  V30 15 C 5.5252 2.7552 0.0 0
M  V30 16 N 6.9898 4.7711 0.0 0
M  V30 17 N 6.9898 3.2311 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 16
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-1-acetamide, 4-(2-formylphenyl)-N-methyl-
C13H13N3O2
3052793-88-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 1.3338 0.0 0
M  V30 2 O 2.3100 0.0000 0.0 0
M  V30 3 C 8.2358 5.6763 0.0 0
M  V30 4 C 9.6426 5.0500 0.0 0
M  V30 5 N 10.8885 5.9552 0.0 0
M  V30 6 O 9.8035 3.5183 0.0 0
M  V30 7 C 12.2954 5.3287 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 5.5252 5.2470 0.0 0
M  V30 10 C 5.5252 2.7552 0.0 0
M  V30 11 N 6.9899 4.7711 0.0 0
M  V30 12 N 6.9899 3.2311 0.0 0
M  V30 13 C 3.0800 4.0011 0.0 0
M  V30 14 C 2.3100 2.6674 0.0 0
M  V30 15 C 2.3100 5.3347 0.0 0
M  V30 16 C 0.7700 2.6674 0.0 0
M  V30 17 C 0.7700 5.3347 0.0 0
M  V30 18 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 3 4
M  V30 4 1 3 11
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 13
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3052794-18-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3052793-88-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42315011
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of lactones and lactams as telomerase inhibitor compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Khera, Manoj Kumar; Soni, Ajay
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024168165 A2 2024-08-15

$RFMT $RIREG SCHEME343 STEP1
$RXN



  2  1
$MOL
Benzoic acid, 4-[[bis[(4-methoxyphenyl)methyl]amino]sulfonyl]-2,3,5,6-tetrafl...
C23H19F4NO6S
3054259-03-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 8.0021 0.0 0 VAL=6
M  V30 2 N 8.4700 8.0021 0.0 0
M  V30 3 O 6.9300 6.4621 0.0 0
M  V30 4 O 6.9300 9.5421 0.0 0
M  V30 5 C 9.2400 9.3358 0.0 0
M  V30 6 C 9.2400 6.6684 0.0 0
M  V30 7 F 5.3900 10.6694 0.0 0
M  V30 8 F 5.3900 5.3347 0.0 0
M  V30 9 F 2.3100 10.6694 0.0 0
M  V30 10 F 2.3100 5.3347 0.0 0
M  V30 11 C 0.7700 8.0021 0.0 0
M  V30 12 O 0.0000 9.3358 0.0 0
M  V30 13 O 0.0000 6.6684 0.0 0
M  V30 14 O 15.4000 9.3358 0.0 0
M  V30 15 C 16.1700 10.6694 0.0 0
M  V30 16 O 6.1600 1.3336 0.0 0
M  V30 17 C 6.9300 0.0000 0.0 0
M  V30 18 C 5.3900 8.0021 0.0 0
M  V30 19 C 4.6200 9.3358 0.0 0
M  V30 20 C 4.6200 6.6684 0.0 0
M  V30 21 C 3.0800 9.3358 0.0 0
M  V30 22 C 3.0800 6.6684 0.0 0
M  V30 23 C 2.3100 8.0021 0.0 0
M  V30 24 C 10.7800 9.3358 0.0 0
M  V30 25 C 11.5500 8.0021 0.0 0
M  V30 26 C 11.5500 10.6694 0.0 0
M  V30 27 C 13.0900 8.0021 0.0 0
M  V30 28 C 13.0900 10.6694 0.0 0
M  V30 29 C 13.8600 9.3358 0.0 0
M  V30 30 C 8.4700 5.3347 0.0 0
M  V30 31 C 9.2400 4.0011 0.0 0
M  V30 32 C 6.9300 5.3347 0.0 0
M  V30 33 C 8.4700 2.6673 0.0 0
M  V30 34 C 6.1600 4.0011 0.0 0
M  V30 35 C 6.9300 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 18
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 24
M  V30 8 1 6 30
M  V30 9 1 7 19
M  V30 10 1 8 20
M  V30 11 1 9 21
M  V30 12 1 10 22
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 11 23
M  V30 16 1 14 15
M  V30 17 1 14 29
M  V30 18 1 16 17
M  V30 19 1 16 35
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, 4-[[bis[(4-methoxyphenyl)methyl]amino]sulfonyl]-2,3,5,6-tetrafluor...
C24H22F4N2O5S
3054259-04-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.4700 8.0021 0.0 0 VAL=6
M  V30 2 N 10.0100 8.0021 0.0 0
M  V30 3 O 8.4700 9.5421 0.0 0
M  V30 4 O 8.4700 6.4621 0.0 0
M  V30 5 C 10.7800 6.6684 0.0 0
M  V30 6 C 10.7800 9.3358 0.0 0
M  V30 7 F 6.9300 5.3347 0.0 0
M  V30 8 F 6.9300 10.6694 0.0 0
M  V30 9 F 3.8500 5.3347 0.0 0
M  V30 10 F 3.8500 10.6694 0.0 0
M  V30 11 C 2.3100 8.0021 0.0 0
M  V30 12 N 1.5400 9.3358 0.0 0
M  V30 13 O 1.5400 6.6684 0.0 0
M  V30 14 C 0.0000 9.3358 0.0 0
M  V30 15 O 7.7000 1.3336 0.0 0
M  V30 16 C 8.4700 0.0000 0.0 0
M  V30 17 O 16.9400 9.3358 0.0 0
M  V30 18 C 17.7100 10.6694 0.0 0
M  V30 19 C 6.9300 8.0021 0.0 0
M  V30 20 C 6.1600 6.6684 0.0 0
M  V30 21 C 6.1600 9.3358 0.0 0
M  V30 22 C 4.6200 6.6684 0.0 0
M  V30 23 C 4.6200 9.3358 0.0 0
M  V30 24 C 3.8500 8.0021 0.0 0
M  V30 25 C 10.0100 5.3347 0.0 0
M  V30 26 C 8.4700 5.3347 0.0 0
M  V30 27 C 10.7800 4.0011 0.0 0
M  V30 28 C 7.7000 4.0011 0.0 0
M  V30 29 C 10.0100 2.6673 0.0 0
M  V30 30 C 8.4700 2.6673 0.0 0
M  V30 31 C 12.3200 9.3358 0.0 0
M  V30 32 C 13.0900 10.6694 0.0 0
M  V30 33 C 13.0900 8.0021 0.0 0
M  V30 34 C 14.6300 10.6694 0.0 0
M  V30 35 C 14.6300 8.0021 0.0 0
M  V30 36 C 15.4000 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 19
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 25
M  V30 8 1 6 31
M  V30 9 1 7 20
M  V30 10 1 8 21
M  V30 11 1 9 22
M  V30 12 1 10 23
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 11 24
M  V30 16 1 12 14
M  V30 17 1 15 16
M  V30 18 1 15 30
M  V30 19 1 17 18
M  V30 20 1 17 36
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 33 2 31 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 35
M  V30 37 2 34 36
M  V30 38 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3054259-03-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3054259-04-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42798820
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzenesulfonamide derivatives and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gunning, Patrick T.; O'Meara, Jeffrey; Ahmar, Siawash; Simpson, Graham
L.; Rosa, David Alexander; Park, Ji Sung; Brown, Giles Albert; St. Denis,
Jeffrey David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024175999 A2 2024-08-29

$RFMT $RIREG SCHEME344 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclohexanone, 4-[[6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl]oxy]-
C16H17N5O2
3056428-26-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 3.7036 0.0 0
M  V30 2 C 10.9587 8.6646 0.0 0
M  V30 3 O 0.0000 9.0383 0.0 0
M  V30 4 C 5.3901 2.3699 0.0 0
M  V30 5 C 4.6200 3.7036 0.0 0
M  V30 6 N 6.9301 2.3699 0.0 0
M  V30 7 C 4.9142 0.9052 0.0 0
M  V30 8 N 5.3901 5.0372 0.0 0
M  V30 9 C 7.7001 3.7036 0.0 0
M  V30 10 N 7.4059 0.9052 0.0 0
M  V30 11 C 6.1601 0.0000 0.0 0
M  V30 12 C 6.9301 5.0372 0.0 0
M  V30 13 C 2.3100 5.0372 0.0 0
M  V30 14 C 0.7700 5.0372 0.0 0
M  V30 15 C 3.0800 6.3709 0.0 0
M  V30 16 C 0.0000 6.3709 0.0 0
M  V30 17 C 2.3100 7.7047 0.0 0
M  V30 18 C 0.7700 7.7047 0.0 0
M  V30 19 C 7.7001 6.3709 0.0 0
M  V30 20 C 9.2316 6.5320 0.0 0
M  V30 21 C 7.0738 7.7778 0.0 0
M  V30 22 N 9.5518 8.0383 0.0 0
M  V30 23 N 8.2181 8.8083 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 13
M  V30 3 1 2 22
M  V30 4 2 3 18
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 2 9 12
M  V30 14 2 10 11
M  V30 15 1 12 19
M  V30 16 1 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclohexanamine, N-methyl-4-[[6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyra...
C17H22N6O
3056428-28-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.8787 3.7036 0.0 0
M  V30 2 C 0.0000 8.6645 0.0 0
M  V30 3 N 10.9587 9.0383 0.0 0
M  V30 4 C 12.4987 9.0383 0.0 0
M  V30 5 C 5.5687 2.3699 0.0 0
M  V30 6 C 6.3387 3.7036 0.0 0
M  V30 7 N 4.0287 2.3699 0.0 0
M  V30 8 C 6.0445 0.9052 0.0 0
M  V30 9 N 5.5687 5.0372 0.0 0
M  V30 10 C 3.2587 3.7036 0.0 0
M  V30 11 N 3.5528 0.9052 0.0 0
M  V30 12 C 4.7987 0.0000 0.0 0
M  V30 13 C 4.0287 5.0372 0.0 0
M  V30 14 C 8.6487 5.0372 0.0 0
M  V30 15 C 10.1887 5.0372 0.0 0
M  V30 16 C 7.8787 6.3709 0.0 0
M  V30 17 C 10.9587 6.3709 0.0 0
M  V30 18 C 8.6487 7.7047 0.0 0
M  V30 19 C 10.1887 7.7047 0.0 0
M  V30 20 C 3.2587 6.3709 0.0 0
M  V30 21 C 1.7271 6.5319 0.0 0
M  V30 22 C 3.8850 7.7778 0.0 0
M  V30 23 N 1.4070 8.0382 0.0 0
M  V30 24 N 2.7406 8.8082 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 14
M  V30 3 1 2 23
M  V30 4 1 3 4
M  V30 5 1 3 19
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 2 10 13
M  V30 15 2 11 12
M  V30 16 1 13 20
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3056428-26-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3056428-28-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40236718
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery and Preclinical Characterization of BIIB129, a Covalent,
Selective, and Brain-Penetrant BTK Inhibitor for the Treatment of
Multiple Sclerosis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Himmelbauer, Martin K.; Bajrami, Bekim; Basile, Rebecca; Capacci, Andrew;
Chen, TeYu; Choi, Colin K.; Gilfillan, Rab; Gonzalez-Lopez de Turiso,
Felix; Gu, Chungang; Hoemberger, Marc; Johnson, Douglas S.; Jones, J.
Howard; Kadakia, Ekta; Kirkland, Melissa; Lin, Edward Y.; Liu, Ying; Ma,
Bin; Magee, Tom; Mantena, Srinivasa; Marx, Isaac E.; Metrick, Claire M.;
Mingueneau, Michael; Murugan, Paramasivam; Muste, Cathy A.; Nadella,
Prasad; Nevalainen, Marta; Parker Harp, Chelsea R.; Pattaropong, Vatee;
Pietrasiewicz, Alicia; Prince, Robin J.; Purgett, Thomas J.; Santoro,
Joseph C.; Schulz, Jurgen; Sciabola, Simone; Tang, Hao; Vandeveer, H.
George; Wang, Ti; Yousaf, Zain; Helal, Christopher J.; Hopkins, Brian T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(10), 8122-8140

$RFMT $RIREG SCHEME345 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Isocyanatoethyl methacrylate
C7H9NO3
30674-80-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 O 4.0012 2.3101 0.0 0
M  V30 3 C 1.3337 2.3101 0.0 0
M  V30 4 O 2.6673 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.3337 3.8501 0.0 0
M  V30 8 C 6.6685 2.3101 0.0 0
M  V30 9 N 8.0023 1.5400 0.0 0
M  V30 10 C 9.3360 2.3101 0.0 0
M  V30 11 O 10.6697 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 9 2 9 10
M  V30 10 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[(Methylamino)carbonyl]amino]ethyl 2-methyl-2-propenoate
C8H14N2O3
126858-63-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 2.3101 0.0 0
M  V30 2 C 2.6673 1.5400 0.0 0
M  V30 3 C 5.3348 1.5400 0.0 0
M  V30 4 C 1.3337 2.3101 0.0 0
M  V30 5 O 2.6673 0.0000 0.0 0
M  V30 6 C 6.6685 2.3101 0.0 0
M  V30 7 C 0.0000 1.5400 0.0 0
M  V30 8 C 1.3337 3.8501 0.0 0
M  V30 9 N 8.0022 1.5400 0.0 0
M  V30 10 C 9.3360 2.3101 0.0 0
M  V30 11 N 10.6697 1.5400 0.0 0
M  V30 12 O 9.3360 3.8501 0.0 0
M  V30 13 C 12.0033 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 30674-80-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 126858-63-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-9723494
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Upconverting nanocomposites dispersed in urea-containing acrylics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Inglefield, D. L. Jr.; Merritt, T. R.; Magill, B. A.; Long, T. E.;
Khodaparast, G. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Materials Chemistry C: Materials for Optical and Electronic
Devices (2015), 3(21), 5556-5565

$RFMT $RIREG SCHEME346 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2R,7R)-7-(acetylamino)octahydro-8-oxo-2-azocinecarboxylate
C11H18N2O4
308125-25-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 2.5764 2.3967 0.0 0
M  V30 2 C 1.4875 3.4857 0.0 0
M  V30 3 C 0.0000 3.0871 0.0 0
M  V30 4 O 1.8861 4.9733 0.0 0
M  V30 5 O 4.2315 0.2399 0.0 0
M  V30 6 C 9.0838 1.5400 0.0 0
M  V30 7 O 10.4176 2.3100 0.0 0
M  V30 8 O 9.0838 0.0000 0.0 0
M  V30 9 C 11.7512 1.5400 0.0 0
M  V30 10 C 4.0641 2.7954 0.0 0 CFG=2
M  V30 11 C 5.0015 1.5736 0.0 0
M  V30 12 C 4.2651 4.3222 0.0 0
M  V30 13 N 6.5284 1.3726 0.0 0
M  V30 14 C 5.4868 5.2598 0.0 0
M  V30 15 C 7.7501 2.3100 0.0 0 CFG=1
M  V30 16 C 7.0137 5.0586 0.0 0
M  V30 17 C 7.9511 3.8369 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 10 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 15 6 CFG=3
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 10 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2R,7R)-7-(Acetylamino)octahydro-N-methyl-8-oxo-2-azocinecarboxamide
C11H19N3O3
308125-13-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 2.5764 2.3967 0.0 0
M  V30 2 C 1.4875 3.4857 0.0 0
M  V30 3 C 0.0000 3.0871 0.0 0
M  V30 4 O 1.8861 4.9733 0.0 0
M  V30 5 O 4.2315 0.2399 0.0 0
M  V30 6 C 9.0838 1.5400 0.0 0
M  V30 7 N 10.4176 2.3100 0.0 0
M  V30 8 O 9.0838 0.0000 0.0 0
M  V30 9 C 11.7512 1.5400 0.0 0
M  V30 10 C 4.0641 2.7954 0.0 0 CFG=2
M  V30 11 C 5.0015 1.5736 0.0 0
M  V30 12 C 4.2651 4.3222 0.0 0
M  V30 13 N 6.5284 1.3726 0.0 0
M  V30 14 C 5.4868 5.2598 0.0 0
M  V30 15 C 7.7501 2.3100 0.0 0 CFG=1
M  V30 16 C 7.0137 5.0586 0.0 0
M  V30 17 C 7.9511 3.8369 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 10 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 15 6 CFG=3
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 10 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 308125-25-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 308125-13-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4305793
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and conformational analysis of a dimerizing eight-membered
lactam dipeptide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Derrer, Sam; Davies, John E.; Holmes, Andrew B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Perkin 1 (2000), (17), 2943-2956

$RFMT $RIREG SCHEME347 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (4S)-4-[acetyl(phenylmethyl)amino]-2-oxo-1-piperidineacetate
C18H24N2O4
309912-74-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 2.6674 0.0 0
M  V30 2 C 4.6200 1.3338 0.0 0
M  V30 3 C 4.6200 4.0011 0.0 0
M  V30 4 C 5.3900 5.3349 0.0 0
M  V30 5 O 3.0800 4.0011 0.0 0
M  V30 6 O 10.0100 0.0000 0.0 0
M  V30 7 C 11.5500 2.6674 0.0 0
M  V30 8 C 12.3200 4.0011 0.0 0
M  V30 9 O 13.8600 4.0011 0.0 0
M  V30 10 O 11.5500 5.3349 0.0 0
M  V30 11 C 14.6300 5.3349 0.0 0
M  V30 12 C 16.1700 5.3349 0.0 0
M  V30 13 C 6.9300 2.6674 0.0 0 CFG=1
M  V30 14 C 7.7000 1.3338 0.0 0
M  V30 15 C 7.7000 4.0011 0.0 0
M  V30 16 C 9.2400 1.3338 0.0 0
M  V30 17 C 9.2400 4.0011 0.0 0
M  V30 18 N 10.0100 2.6674 0.0 0
M  V30 19 C 3.0800 1.3338 0.0 0
M  V30 20 C 2.3100 2.6674 0.0 0
M  V30 21 C 2.3100 0.0000 0.0 0
M  V30 22 C 0.7700 2.6674 0.0 0
M  V30 23 C 0.7700 0.0000 0.0 0
M  V30 24 C 0.0000 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 13 1 CFG=1
M  V30 4 1 2 19
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 2 6 16
M  V30 8 1 7 8
M  V30 9 1 7 18
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(4S)-4-[Acetyl(phenylmethyl)amino]-N-methyl-2-oxo-1-piperidineacetamide
C17H23N3O3
309912-77-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 4.6201 0.0 0
M  V30 2 C 4.0010 3.8501 0.0 0
M  V30 3 C 5.3348 6.1601 0.0 0
M  V30 4 C 4.0010 6.9302 0.0 0
M  V30 5 O 6.6685 6.9302 0.0 0
M  V30 6 O 8.0022 0.0000 0.0 0
M  V30 7 C 10.6697 1.5400 0.0 0
M  V30 8 C 12.0033 2.3101 0.0 0
M  V30 9 N 13.3370 1.5400 0.0 0
M  V30 10 O 12.0033 3.8501 0.0 0
M  V30 11 C 14.6707 2.3101 0.0 0
M  V30 12 C 6.6685 3.8501 0.0 0 CFG=1
M  V30 13 C 6.6685 2.3101 0.0 0
M  V30 14 C 8.0022 4.6201 0.0 0
M  V30 15 C 8.0022 1.5400 0.0 0
M  V30 16 C 9.3358 3.8501 0.0 0
M  V30 17 N 9.3358 2.3101 0.0 0
M  V30 18 C 2.6673 4.6201 0.0 0
M  V30 19 C 1.3337 3.8501 0.0 0
M  V30 20 C 2.6673 6.1601 0.0 0
M  V30 21 C 0.0000 4.6201 0.0 0
M  V30 22 C 1.3337 6.9302 0.0 0
M  V30 23 C 0.0000 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 12 1 CFG=1
M  V30 4 1 2 18
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 2 6 15
M  V30 8 1 7 8
M  V30 9 1 7 17
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 309912-74-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 309912-77-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13397625
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (4S)-[4-(N,N-Acetylbenzylamino)-2-oxopiperidin-1-yl]-N-methylacetamide
(12). A solution of 11c (12 mg, 0.04 mmol) in ethanolic methylamine
solution (5 mL, 8.03 M in EtOH) was stirred for 15 h at room temperature.
After evaporation, the residue was purified by flash chromatography
(CH2Cl2-MeOH, 95:5) to give pure 12 (11.4 mg, 100%) as a colorless oil:
(4S)-[4-(N,N-Acetylbenzylamino)-2-oxopiperidin-1-yl]-N-methylacetamide
(12), yield (11.4 mg, 100%) TLC Rf 0.11 (CH2Cl2-MeOH, 95:5); [α]20 D
-29.7° (c = 1.0, CHCl3); IR 3310, 2930, 1630 cm-1; 1H NMR (360 MHz) δ
1.88-1.96 (m, 1H), 2.00-2.10 (m, 1H), 2.13 (s, 3H), 2.62 (d, J = 7.9,
2H), 2.77 (d, J = 4.8, 3H), 3.37-4.43 (m, 2H), 3.72 (d, J = 15.2, 1H),
4.12 (d, J = 15.2, 1H), 4.47-4.51 (m, 1H), 4.49 (d, J = 17.8, 1H), 4.56
(d, J = 17.8, 1H), 6.60 (s, 1H), 7.17- 7.41 (m, 5H); 13C NMR (63 MHz) δ
22.6, 26.1, 27.3, 35.8, 47.1, 49.6, 50.2, 51.5, 125.8, 127.8, 129.1,
136.9, 169.0, 169.4, 171.7; EIMS 317 (M+). Anal. Calcd for C17H23N3O3: C,
64.33; H, 7.30; N, 13.24. Found: C, 63.78; H, 7.25; N, 13.20.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantiopure 4- and 5-aminopiperidin-2-ones: regiocontrolled synthesis and
conformational characterization as bioactive β-turn mimetics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Weber, Klaus; Ohnmacht, Ursula; Gmeiner, Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2000), 65(22), 7406-7416

$RFMT $RIREG SCHEME348 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1-(6-amino-9-β-D-ribofuranosyl-9H-purin-2-yl)-1H-pyrazole-4-carboxylate
C16H19N7O6
313348-16-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 5.5302 0.0 0
M  V30 2 N 5.9848 10.8915 0.0 0
M  V30 3 C 3.1864 1.1445 0.0 0
M  V30 4 O 2.1560 0.0000 0.0 0
M  V30 5 O 0.0000 2.1799 0.0 0
M  V30 6 C 12.6211 5.9144 0.0 0
M  V30 7 O 13.5262 4.6685 0.0 0
M  V30 8 O 13.2474 7.3212 0.0 0
M  V30 9 C 15.0578 4.8295 0.0 0
M  V30 10 C 15.9631 3.5836 0.0 0
M  V30 11 N 3.1864 6.5655 0.0 0
M  V30 12 C 4.6511 7.0415 0.0 0
M  V30 13 C 2.2812 7.8115 0.0 0
M  V30 14 C 4.6511 8.5815 0.0 0
M  V30 15 N 5.9848 6.2715 0.0 0
M  V30 16 N 3.1864 9.0574 0.0 0
M  V30 17 C 5.9848 9.3515 0.0 0
M  V30 18 C 7.3184 7.0415 0.0 0
M  V30 19 N 7.3184 8.5815 0.0 0
M  V30 20 C 2.7106 5.1010 0.0 0 CFG=1
M  V30 21 O 3.6158 3.8551 0.0 0
M  V30 22 C 1.2460 4.6251 0.0 0 CFG=2
M  V30 23 C 2.7106 2.6091 0.0 0 CFG=2
M  V30 24 C 1.2460 3.0851 0.0 0 CFG=2
M  V30 25 N 8.6522 6.2715 0.0 0
M  V30 26 C 10.0590 6.8978 0.0 0
M  V30 27 N 8.8131 4.7398 0.0 0
M  V30 28 C 11.0894 5.7533 0.0 0
M  V30 29 C 10.3194 4.4197 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 22 1 CFG=1
M  V30 2 1 2 17
M  V30 3 1 3 4
M  V30 4 1 23 3 CFG=3
M  V30 5 1 24 5 CFG=1
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 28
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 20 11 CFG=3
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 14 16
M  V30 18 2 14 17
M  V30 19 1 15 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 1 18 25
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 20 22 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Regadenoson
C15H18N8O5
313348-27-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.9847 10.8915 0.0 0
M  V30 2 O 0.0000 5.5301 0.0 0
M  V30 3 C 3.1864 1.1445 0.0 0
M  V30 4 O 2.1560 0.0000 0.0 0
M  V30 5 O 0.0000 2.1799 0.0 0
M  V30 6 C 12.6211 5.9144 0.0 0
M  V30 7 N 13.5261 4.6685 0.0 0
M  V30 8 O 13.2474 7.3212 0.0 0
M  V30 9 C 15.0578 4.8294 0.0 0
M  V30 10 C 4.6511 7.0415 0.0 0
M  V30 11 N 3.1864 6.5655 0.0 0
M  V30 12 C 4.6511 8.5815 0.0 0
M  V30 13 N 5.9847 6.2715 0.0 0
M  V30 14 C 2.2812 7.8115 0.0 0
M  V30 15 C 5.9847 9.3515 0.0 0
M  V30 16 N 3.1864 9.0574 0.0 0
M  V30 17 C 7.3184 7.0415 0.0 0
M  V30 18 N 7.3184 8.5815 0.0 0
M  V30 19 C 2.7106 5.1009 0.0 0 CFG=1
M  V30 20 O 3.6158 3.8551 0.0 0
M  V30 21 C 1.2460 4.6251 0.0 0 CFG=2
M  V30 22 C 2.7106 2.6091 0.0 0 CFG=2
M  V30 23 C 1.2460 3.0851 0.0 0 CFG=2
M  V30 24 N 8.6522 6.2715 0.0 0
M  V30 25 C 10.0590 6.8978 0.0 0
M  V30 26 N 8.8131 4.7398 0.0 0
M  V30 27 C 11.0894 5.7533 0.0 0
M  V30 28 C 10.3194 4.4196 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 21 2 CFG=1
M  V30 3 1 3 4
M  V30 4 1 22 3 CFG=3
M  V30 5 1 23 5 CFG=1
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 27
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 1 19 11 CFG=3
M  V30 15 2 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 2 14 16
M  V30 19 1 15 18
M  V30 20 2 17 18
M  V30 21 1 17 24
M  V30 22 1 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 23
M  V30 27 1 24 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 313348-16-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 313348-27-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-18767306
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Stable solid forms of regadenoson
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Grisenti, Paride; Shahrzad Reza, Elahi; Guazzi, Giuseppe; Argese, Maria
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP2789624 A1 2014-10-15

$RFMT $RIREG SCHEME349 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 6-oxa-3-azabicyclo[3.1.0]hexane-3-carboxylate
C12H13NO3
31865-25-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 C 4.0012 1.5400 0.0 0
M  V30 5 C 9.6696 4.1618 0.0 0
M  V30 6 C 10.4396 2.8281 0.0 0
M  V30 7 C 8.1633 3.8416 0.0 0
M  V30 8 O 11.2096 4.1618 0.0 0
M  V30 9 C 9.4091 1.6837 0.0 0
M  V30 10 N 8.0022 2.3101 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 2.6673 3.8501 0.0 0
M  V30 13 C 1.3337 1.5400 0.0 0
M  V30 14 C 1.3337 4.6201 0.0 0
M  V30 15 C 0.0000 2.3101 0.0 0
M  V30 16 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 7 10
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Phenylmethyl (3R,4R)-3-hydroxy-4-(methylamino)-1-pyrrolidinecarboxylate
C13H18N2O3
1224172-60-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.0287 0.0 0
M  V30 2 O 5.3348 3.2587 0.0 0
M  V30 3 O 6.6685 5.5688 0.0 0
M  V30 4 C 4.0010 4.0287 0.0 0
M  V30 5 N 11.9711 2.9016 0.0 0
M  V30 6 C 12.5975 4.3086 0.0 0
M  V30 7 O 10.2959 0.0000 0.0 0
M  V30 8 N 8.0022 3.2587 0.0 0
M  V30 9 C 9.4091 3.8850 0.0 0
M  V30 10 C 8.1631 1.7271 0.0 0
M  V30 11 C 10.4396 2.7406 0.0 0 CFG=1
M  V30 12 C 9.6696 1.4070 0.0 0 CFG=1
M  V30 13 C 2.6673 3.2587 0.0 0
M  V30 14 C 1.3337 4.0287 0.0 0
M  V30 15 C 2.6673 1.7187 0.0 0
M  V30 16 C 0.0000 3.2587 0.0 0
M  V30 17 C 1.3337 0.9487 0.0 0
M  V30 18 C 0.0000 1.7187 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 1 11 5 CFG=1
M  V30 8 1 12 7 CFG=3
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 11 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 31865-25-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1224172-60-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-14089151
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 58B. (3R,4R)-Benzyl
3-hydroxy-4-(methylamino)pyrrolidine-1-carboxylate A mixture of Example
58A (1.5 g, 6.8 mmol) and 40% w/w methylamine (13.5 g, 174 mmol) in water
solution was stirred at room temperature O/N. The solvent was evaporated
to afford Example 58B as an oil (1.7 g, 100 % yield), which was carried
on to the next step without purification. LC-MS, [M+H]+ = 251.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Azolopyrrolone compounds as melanin concentrating hormone receptor-1
antagonists and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Devasthale, Pratik; Washburn, William N.; Wang, Wei; Hernandez, Andres;
Ahmad, Saleem; Zhao, Guohua
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010047956 A1 2010-04-29

$RFMT $RIREG SCHEME350 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1S,2S,5S,8E)-8-[2-(1,1-dimethylethoxy)-2-oxoethylidene]-1′,2′-dihydro...
C25H27NO6
321172-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.6021 5.6012 0.0 0
M  V30 2 C 6.4234 4.0011 0.0 0
M  V30 3 C 4.8834 4.0011 0.0 0
M  V30 4 O 4.1134 2.6675 0.0 0
M  V30 5 O 4.1134 5.3348 0.0 0
M  V30 6 C 4.8834 1.3337 0.0 0
M  V30 7 C 6.2171 2.1037 0.0 0
M  V30 8 C 5.6534 0.0000 0.0 0
M  V30 9 C 3.5496 0.5636 0.0 0
M  V30 10 C 2.6590 7.2021 0.0 0
M  V30 11 O 1.3905 8.0753 0.0 0
M  V30 12 C 0.0000 7.4134 0.0 0
M  V30 13 C 11.5274 5.6325 0.0 0
M  V30 14 O 12.6761 6.6581 0.0 0
M  V30 15 O 11.8414 4.1248 0.0 0
M  V30 16 C 14.1386 6.1763 0.0 0
M  V30 17 C 6.5201 8.1875 0.0 0 CFG=2
M  V30 18 C 7.4029 6.6672 0.0 0 CFG=1
M  V30 19 C 5.8582 9.5780 0.0 0
M  V30 20 C 5.4022 7.1283 0.0 0
M  V30 21 C 7.7432 9.1702 0.0 0
M  V30 22 C 7.1934 5.3348 0.0 0
M  V30 23 C 8.8695 6.7915 0.0 0
M  V30 24 C 4.3312 9.3781 0.0 0
M  V30 25 C 6.4485 11.0004 0.0 0
M  V30 26 N 4.0495 7.8641 0.0 0
M  V30 27 C 7.5112 7.9216 0.0 0
M  V30 28 C 8.4079 6.3159 0.0 0 CFG=1
M  V30 29 C 10.0647 6.1144 0.0 0
M  V30 30 C 3.3945 10.6006 0.0 0
M  V30 31 C 5.5119 12.2229 0.0 0
M  V30 32 C 3.9850 12.0230 0.0 0
M  V30 33 H 5.8890 6.3839 0.0 0
M  V30 34 H 8.8323 4.8357 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 20
M  V30 2 1 2 3
M  V30 3 2 2 22
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 1 10 26
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 13 29
M  V30 16 1 14 16
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 17 20
M  V30 20 1 17 21 CFG=1
M  V30 21 1 18 22
M  V30 22 1 18 23
M  V30 23 1 18 33 CFG=3
M  V30 24 1 19 24
M  V30 25 2 19 25
M  V30 26 1 20 26
M  V30 27 2 21 27
M  V30 28 1 22 28
M  V30 29 2 23 29
M  V30 30 1 24 26
M  V30 31 2 24 30
M  V30 32 1 25 31
M  V30 33 1 27 28
M  V30 34 1 28 29
M  V30 35 1 28 34 CFG=1
M  V30 36 1 30 32
M  V30 37 2 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 17 18 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methyl (1S,2S,5R,6S,7S,8Z)-8-[2-(1,1-dimethylethoxy)-2-oxoethylidene]-1′,2′-d...
C26H32N2O6
321172-50-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.6021 5.6011 0.0 0
M  V30 2 C 6.4233 4.0011 0.0 0
M  V30 3 C 4.8833 4.0011 0.0 0
M  V30 4 O 4.1133 2.6674 0.0 0
M  V30 5 O 4.1133 5.3347 0.0 0
M  V30 6 C 4.8833 1.3336 0.0 0
M  V30 7 C 3.5495 0.5636 0.0 0
M  V30 8 C 5.6533 0.0000 0.0 0
M  V30 9 C 6.2170 2.1036 0.0 0
M  V30 10 N 9.1986 8.2958 0.0 0
M  V30 11 C 10.6660 8.7629 0.0 0
M  V30 12 C 2.6590 7.2020 0.0 0
M  V30 13 O 1.3905 8.0751 0.0 0
M  V30 14 C 0.0000 7.4133 0.0 0
M  V30 15 C 11.5272 5.6324 0.0 0
M  V30 16 O 12.6759 6.6580 0.0 0
M  V30 17 O 11.8412 4.1247 0.0 0
M  V30 18 C 14.1384 6.1762 0.0 0
M  V30 19 C 6.5201 8.1874 0.0 0 CFG=2
M  V30 20 C 7.4028 6.6671 0.0 0 CFG=1
M  V30 21 C 5.8582 9.5779 0.0 0
M  V30 22 C 5.4022 7.1282 0.0 0
M  V30 23 C 7.7431 9.1701 0.0 0
M  V30 24 C 7.1933 5.3347 0.0 0
M  V30 25 C 8.8693 6.7914 0.0 0 CFG=2
M  V30 26 C 4.3311 9.3780 0.0 0
M  V30 27 C 6.4484 11.0002 0.0 0
M  V30 28 N 4.0494 7.8640 0.0 0
M  V30 29 C 7.5110 7.9215 0.0 0
M  V30 30 C 8.4078 6.3158 0.0 0 CFG=1
M  V30 31 C 10.0645 6.1143 0.0 0 CFG=1
M  V30 32 C 3.3945 10.6004 0.0 0
M  V30 33 C 5.5118 12.2227 0.0 0
M  V30 34 C 3.9849 12.0228 0.0 0
M  V30 35 H 5.8890 6.3838 0.0 0
M  V30 36 H 8.8322 4.8356 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 22
M  V30 2 1 2 3
M  V30 3 2 2 24
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 1 25 10 CFG=3
M  V30 12 1 12 13
M  V30 13 1 12 28
M  V30 14 1 13 14
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 31 15 CFG=1
M  V30 18 1 16 18
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 19 22
M  V30 22 1 19 23 CFG=1
M  V30 23 1 20 24
M  V30 24 1 20 25
M  V30 25 1 20 35 CFG=3
M  V30 26 1 21 26
M  V30 27 2 21 27
M  V30 28 1 22 28
M  V30 29 2 23 29
M  V30 30 1 24 30
M  V30 31 1 25 31
M  V30 32 1 26 28
M  V30 33 2 26 32
M  V30 34 1 27 33
M  V30 35 1 29 30
M  V30 36 1 30 31
M  V30 37 1 30 36 CFG=1
M  V30 38 1 32 34
M  V30 39 2 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 19 20 25 30 31)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 321172-47-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 321172-50-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-7710354
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective total synthesis of (+)-gelsemine: determination of its
absolute configuration
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yokoshima, Satoshi; Tokuyama, Hidetoshi; Fukuyama, Tohru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2000), 39(22), 4073-4075

$RFMT $RIREG SCHEME351 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(1-Bromoethyl)-3-(4-fluorophenyl)-4(3H)-quinazolinone
C16H12BrFN2O
329190-49-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 1.3338 0.0 0
M  V30 2 Br 6.9300 1.3338 0.0 0
M  V30 3 C 4.6200 0.0000 0.0 0
M  V30 4 O 5.3900 6.6685 0.0 0
M  V30 5 F 11.5500 4.0011 0.0 0
M  V30 6 N 5.3900 4.0011 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 C 4.6200 5.3347 0.0 0
M  V30 9 N 3.0800 2.6674 0.0 0
M  V30 10 C 3.0800 5.3347 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 2.3100 6.6685 0.0 0
M  V30 13 C 0.7700 4.0011 0.0 0
M  V30 14 C 0.7700 6.6685 0.0 0
M  V30 15 C 0.0000 5.3347 0.0 0
M  V30 16 C 6.9300 4.0011 0.0 0
M  V30 17 C 7.7000 2.6674 0.0 0
M  V30 18 C 7.7000 5.3347 0.0 0
M  V30 19 C 9.2400 2.6674 0.0 0
M  V30 20 C 9.2400 5.3347 0.0 0
M  V30 21 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 2 4 8
M  V30 5 1 5 21
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 16
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Fluorophenyl)-2-[1-(methylamino)ethyl]-4(3H)-quinazolinone
C17H16FN3O
330796-26-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 2.6674 0.0 0
M  V30 2 N 4.6200 1.3336 0.0 0
M  V30 3 C 6.9300 2.6674 0.0 0
M  V30 4 C 5.3900 0.0000 0.0 0
M  V30 5 O 5.3900 8.0021 0.0 0
M  V30 6 F 11.5500 5.3347 0.0 0
M  V30 7 N 5.3900 5.3347 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 4.6200 6.6685 0.0 0
M  V30 10 N 3.0800 4.0011 0.0 0
M  V30 11 C 3.0800 6.6685 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 13 C 2.3100 8.0021 0.0 0
M  V30 14 C 0.7700 5.3347 0.0 0
M  V30 15 C 0.7700 8.0021 0.0 0
M  V30 16 C 0.0000 6.6685 0.0 0
M  V30 17 C 6.9300 5.3347 0.0 0
M  V30 18 C 7.7000 4.0011 0.0 0
M  V30 19 C 7.7000 6.6685 0.0 0
M  V30 20 C 9.2400 4.0011 0.0 0
M  V30 21 C 9.2400 6.6685 0.0 0
M  V30 22 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 2 5 9
M  V30 6 1 6 22
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 17
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 329190-49-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 330796-26-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-7209100
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 3-(4-Fluoro-phenyl)-2-(1-methylamino-ethyl)-3H-quinazolin-4-one (2). To
the bromide (117 g; 0.337 mol) was added 8 M methylamine in ethanol (923
mL; 7.41 mol) and the resulting mixture was heated to 40 °C under
nitrogen for 1 h. The solvent was removed by evaporation and the residue
stirred with dichloromethane (1.2 L) for 30 min. The precipitate was
filtered and washed with further dichloromethane then dried.
3-(4-Fluoro-phenyl)-2-(1-methylamino-ethyl)-3H-quinazolin-4-one, yield
104.4 g, 100%. 1H NMR (CDCl3): δ 8.24 (1H, d, J = 8.1 Hz), 7.70 (1H, t, J
= 7.4 Hz), 7.65 (1H, d, J = 8.1 Hz), 7.41 (1H, t, J = 7.1 Hz), 7.28 (4H,
m), 3.26 (1H, q, J = 6.6 Hz), 2.22 (2H, s), 1.17 (3H, d, J = 6.4 Hz). MS
(ES+) m/z 1.39 min, 298 (M+H) HRMS C17H16FN3O; Requires 298.1356, Found
298.1339.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Potent Inhibitors of the Hedgehog Signaling Pathway
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Brunton, Shirley A.; Stibbard, John H. A.; Rubin, Lee L.; Kruse, Lawrence
I.; Guicherit, Oivin M.; Boyd, Edward A.; Price, Steven
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2008), 51(5), 1108-1110

$RFMT $RIREG SCHEME352 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-fluoro-3-nitrobenzoate
C8H6FNO4
329-59-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 1.5400 0.0 0
M  V30 2 O 8.0022 2.3100 0.0 0
M  V30 3 O 6.6684 0.0000 0.0 0
M  V30 4 C 9.3359 1.5400 0.0 0
M  V30 5 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 8 F 1.3337 4.6201 0.0 0
M  V30 9 C 5.3348 2.3100 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 5.3348 3.8500 0.0 0
M  V30 12 C 2.6675 2.3100 0.0 0
M  V30 13 C 4.0011 4.6201 0.0 0
M  V30 14 C 2.6675 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 12
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-(methylamino)-3-nitro-, methyl ester
C9H10N2O4
36242-50-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0 VAL=5
M  V30 2 O 1.3336 6.1600 0.0 0
M  V30 3 O 0.0000 3.8500 0.0 0
M  V30 4 N 1.3336 1.5400 0.0 0
M  V30 5 C 1.3336 0.0000 0.0 0
M  V30 6 C 6.6684 4.6200 0.0 0
M  V30 7 O 8.0021 3.8500 0.0 0
M  V30 8 O 6.6684 6.1600 0.0 0
M  V30 9 C 9.3358 4.6200 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 2.6674 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 5.3347 3.8500 0.0 0
M  V30 15 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 329-59-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 36242-50-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-15030462
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient solution phase synthesis of 2-(N-acylamino)benzimidazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Seth, Punit P.; Robinson, Dale E.; Jefferson, Elizabeth A.; Swayze, Eric
E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2002), 43(41), 7303-7306

$RFMT $RIREG SCHEME353 STEP1
$RXN



  2  1
$MOL
4-[(2R,3R)-3-Hydroxy-2-[(triphenylmethoxy)methyl]-4-penten-1-yl]benzoic acid
C32H30O4
329796-59-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.6200 0.0 0
M  V30 2 O 6.1600 4.6200 0.0 0
M  V30 3 C 6.9300 5.9538 0.0 0
M  V30 4 C 8.4700 5.9538 0.0 0 CFG=2
M  V30 5 C 9.2400 4.6200 0.0 0
M  V30 6 C 9.2400 7.2874 0.0 0 CFG=2
M  V30 7 C 8.4700 8.6211 0.0 0
M  V30 8 O 10.7800 7.2874 0.0 0
M  V30 9 C 9.2400 9.9549 0.0 0
M  V30 10 C 15.4000 4.6200 0.0 0
M  V30 11 O 16.1700 3.2864 0.0 0
M  V30 12 O 16.1700 5.9538 0.0 0
M  V30 13 C 4.6200 6.1600 0.0 0
M  V30 14 C 3.2864 6.9300 0.0 0
M  V30 15 C 5.9536 6.9300 0.0 0
M  V30 16 C 3.2864 8.4700 0.0 0
M  V30 17 C 5.9536 8.4700 0.0 0
M  V30 18 C 4.6200 9.2400 0.0 0
M  V30 19 C 4.6200 3.0800 0.0 0
M  V30 20 C 5.9536 2.3100 0.0 0
M  V30 21 C 3.2864 2.3100 0.0 0
M  V30 22 C 5.9536 0.7700 0.0 0
M  V30 23 C 3.2864 0.7700 0.0 0
M  V30 24 C 4.6200 0.0000 0.0 0
M  V30 25 C 3.0800 4.6200 0.0 0
M  V30 26 C 2.3100 5.9538 0.0 0
M  V30 27 C 2.3100 3.2864 0.0 0
M  V30 28 C 0.7700 5.9538 0.0 0
M  V30 29 C 0.7700 3.2864 0.0 0
M  V30 30 C 0.0000 4.6200 0.0 0
M  V30 31 C 10.7800 4.6200 0.0 0
M  V30 32 C 11.5500 5.9538 0.0 0
M  V30 33 C 11.5500 3.2864 0.0 0
M  V30 34 C 13.0900 5.9538 0.0 0
M  V30 35 C 13.0900 3.2864 0.0 0
M  V30 36 C 13.8600 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 1 19
M  V30 4 1 1 25
M  V30 5 1 2 3
M  V30 6 1 3 4
M  V30 7 1 4 5 CFG=3
M  V30 8 1 4 6
M  V30 9 1 5 31
M  V30 10 1 6 7
M  V30 11 1 6 8 CFG=1
M  V30 12 2 7 9
M  V30 13 1 10 11
M  V30 14 2 10 12
M  V30 15 1 10 36
M  V30 16 2 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(2R,3R)-3-Hydroxy-2-[(triphenylmethoxy)methyl]-4-penten-1-yl]-N-methylbenz...
C33H33NO3
329796-61-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.6200 0.0 0
M  V30 2 O 6.1600 4.6200 0.0 0
M  V30 3 C 6.9300 5.9538 0.0 0
M  V30 4 C 8.4700 5.9538 0.0 0 CFG=2
M  V30 5 C 9.2400 4.6200 0.0 0
M  V30 6 C 9.2400 7.2874 0.0 0 CFG=2
M  V30 7 C 8.4700 8.6211 0.0 0
M  V30 8 O 10.7800 7.2874 0.0 0
M  V30 9 C 9.2400 9.9549 0.0 0
M  V30 10 C 15.4000 4.6200 0.0 0
M  V30 11 N 16.1700 3.2864 0.0 0
M  V30 12 O 16.1700 5.9538 0.0 0
M  V30 13 C 17.7100 3.2864 0.0 0
M  V30 14 C 4.6200 3.0800 0.0 0
M  V30 15 C 5.9536 2.3100 0.0 0
M  V30 16 C 3.2864 2.3100 0.0 0
M  V30 17 C 5.9536 0.7700 0.0 0
M  V30 18 C 3.2864 0.7700 0.0 0
M  V30 19 C 4.6200 0.0000 0.0 0
M  V30 20 C 3.0800 4.6200 0.0 0
M  V30 21 C 2.3100 5.9538 0.0 0
M  V30 22 C 2.3100 3.2864 0.0 0
M  V30 23 C 0.7700 5.9538 0.0 0
M  V30 24 C 0.7700 3.2864 0.0 0
M  V30 25 C 0.0000 4.6200 0.0 0
M  V30 26 C 4.6200 6.1600 0.0 0
M  V30 27 C 3.2864 6.9300 0.0 0
M  V30 28 C 5.9536 6.9300 0.0 0
M  V30 29 C 3.2864 8.4700 0.0 0
M  V30 30 C 5.9536 8.4700 0.0 0
M  V30 31 C 4.6200 9.2400 0.0 0
M  V30 32 C 10.7800 4.6200 0.0 0
M  V30 33 C 11.5500 3.2864 0.0 0
M  V30 34 C 11.5500 5.9538 0.0 0
M  V30 35 C 13.0900 3.2864 0.0 0
M  V30 36 C 13.0900 5.9538 0.0 0
M  V30 37 C 13.8600 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 1 20
M  V30 4 1 1 26
M  V30 5 1 2 3
M  V30 6 1 3 4
M  V30 7 1 4 5 CFG=3
M  V30 8 1 4 6
M  V30 9 1 5 32
M  V30 10 1 6 7
M  V30 11 1 6 8 CFG=1
M  V30 12 2 7 9
M  V30 13 1 10 11
M  V30 14 2 10 12
M  V30 15 1 10 37
M  V30 16 1 11 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 329796-59-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 329796-61-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11468972
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of Benzamides 23b,c. To the mixture of benzoic acid 22 (4.89
g, 10.2 mmol) and 2-chloro-1-methylpyridinium iodide (3.92 g, 15.3 mmol)
in CH2Cl2 (26 mL) was added diisopropylethylamine (5.34 mL, 30.7 mmol) at
0 °C, and the resulting mixture was stirred at 23 °C for 15 min. The
mixture was then cooled to 0 °C and treated with diethyl iminodiacetate
(5.00 mL, 27.9 mmol) or methylamine (6.13 mL, 8.0 M in EtOH). The
resulting mixture was stirred at 23 °C for 15 min and then poured into
EtOAc (150 mL). The organic layer was washed with water (40 mL × 1),
aqueous NaH2PO4 (40 mL, 1.0 M), and brine (40 mL × 1), dried over Na2SO4,
filtered, and concentrated. Purification of the residue by column
chromatography (30 → 40% EtOAc in hexanes for 23c and 55 → 60% EtOAc in
hexanes for 23b). 23c (quantitative) as an oil or 23b (58%) as a white
powder.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Synthetic Library of Cell-Permeable Molecules
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Koide, Kazunori; Finkelstein, Joshua M.; Ball, Zachary; Verdine, Gregory
L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2001), 123(3), 398-408

$RFMT $RIREG SCHEME354 STEP1
$RXN



  2  1
$MOL
Methyl 6-[1-hydroxy-2-methyl-1-[1-(triphenylmethyl)-1H-imidazol-4-yl]propyl]-...
C38H34N2O3
337521-83-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 48 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.0012 0.0 0
M  V30 2 C 7.6286 8.0297 0.0 0
M  V30 3 C 8.2549 9.4367 0.0 0
M  V30 4 O 6.2217 8.6562 0.0 0
M  V30 5 C 7.3498 10.6826 0.0 0
M  V30 6 C 9.7866 9.5976 0.0 0
M  V30 7 C 15.9089 5.8030 0.0 0
M  V30 8 O 17.1549 6.7082 0.0 0
M  V30 9 O 16.0699 4.2714 0.0 0
M  V30 10 C 18.5617 6.0819 0.0 0
M  V30 11 N 5.3348 4.7712 0.0 0
M  V30 12 C 5.4958 6.3027 0.0 0
M  V30 13 C 6.7417 4.1447 0.0 0
M  V30 14 C 7.0022 6.6229 0.0 0
M  V30 15 N 7.7722 5.2892 0.0 0
M  V30 16 C 4.7712 2.6673 0.0 0
M  V30 17 C 6.3112 2.6673 0.0 0
M  V30 18 C 4.0012 1.3337 0.0 0
M  V30 19 C 7.0812 1.3337 0.0 0
M  V30 20 C 4.7712 0.0000 0.0 0
M  V30 21 C 6.3112 0.0000 0.0 0
M  V30 22 C 2.6673 3.2311 0.0 0
M  V30 23 C 2.6673 1.6911 0.0 0
M  V30 24 C 1.3337 4.0012 0.0 0
M  V30 25 C 1.3337 0.9211 0.0 0
M  V30 26 C 0.0000 3.2311 0.0 0
M  V30 27 C 0.0000 1.6911 0.0 0
M  V30 28 C 3.2311 5.3348 0.0 0
M  V30 29 C 1.6911 5.3348 0.0 0
M  V30 30 C 4.0012 6.6685 0.0 0
M  V30 31 C 0.9211 6.6685 0.0 0
M  V30 32 C 3.2311 8.0022 0.0 0
M  V30 33 C 1.6911 8.0022 0.0 0
M  V30 34 C 9.0354 7.4034 0.0 0
M  V30 35 C 10.2814 8.3086 0.0 0
M  V30 36 C 9.1965 5.8718 0.0 0
M  V30 37 C 11.6882 7.6823 0.0 0
M  V30 38 C 10.6033 5.2455 0.0 0
M  V30 39 C 11.8492 6.1506 0.0 0
M  V30 40 C 12.9341 8.5874 0.0 0
M  V30 41 C 13.2561 5.5243 0.0 0
M  V30 42 C 14.3411 7.9610 0.0 0
M  V30 43 C 14.5020 6.4295 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 16
M  V30 3 1 1 22
M  V30 4 1 1 28
M  V30 5 1 2 3
M  V30 6 1 2 4
M  V30 7 1 2 14
M  V30 8 1 2 34
M  V30 9 1 3 5
M  V30 10 1 3 6
M  V30 11 1 7 8
M  V30 12 2 7 9
M  V30 13 1 7 43
M  V30 14 1 8 10
M  V30 15 1 11 12
M  V30 16 1 11 13
M  V30 17 2 12 14
M  V30 18 2 13 15
M  V30 19 1 14 15
M  V30 20 2 16 17
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 2 18 20
M  V30 24 2 19 21
M  V30 25 1 20 21
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 37 40
M  V30 44 1 38 39
M  V30 45 1 39 41
M  V30 46 2 40 42
M  V30 47 2 41 43
M  V30 48 1 42 43
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[1-Hydroxy-2-methyl-1-[1-(triphenylmethyl)-1H-imidazol-4-yl]propyl]-N-methy...
C38H35N3O2
337521-85-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 48 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.0012 0.0 0
M  V30 2 C 7.6286 8.0297 0.0 0
M  V30 3 C 8.2549 9.4367 0.0 0
M  V30 4 O 6.2217 8.6562 0.0 0
M  V30 5 C 9.7866 9.5976 0.0 0
M  V30 6 C 7.3498 10.6826 0.0 0
M  V30 7 C 15.9089 5.8030 0.0 0
M  V30 8 N 17.1549 6.7082 0.0 0
M  V30 9 O 16.0699 4.2714 0.0 0
M  V30 10 C 18.5617 6.0819 0.0 0
M  V30 11 N 5.3348 4.7712 0.0 0
M  V30 12 C 5.4958 6.3027 0.0 0
M  V30 13 C 6.7417 4.1447 0.0 0
M  V30 14 C 7.0022 6.6229 0.0 0
M  V30 15 N 7.7722 5.2892 0.0 0
M  V30 16 C 4.7712 2.6673 0.0 0
M  V30 17 C 6.3112 2.6673 0.0 0
M  V30 18 C 4.0012 1.3337 0.0 0
M  V30 19 C 7.0812 1.3337 0.0 0
M  V30 20 C 4.7712 0.0000 0.0 0
M  V30 21 C 6.3112 0.0000 0.0 0
M  V30 22 C 2.6673 3.2311 0.0 0
M  V30 23 C 2.6673 1.6911 0.0 0
M  V30 24 C 1.3337 4.0012 0.0 0
M  V30 25 C 1.3337 0.9211 0.0 0
M  V30 26 C 0.0000 3.2311 0.0 0
M  V30 27 C 0.0000 1.6911 0.0 0
M  V30 28 C 3.2311 5.3348 0.0 0
M  V30 29 C 4.0012 6.6685 0.0 0
M  V30 30 C 1.6911 5.3348 0.0 0
M  V30 31 C 3.2311 8.0022 0.0 0
M  V30 32 C 0.9211 6.6685 0.0 0
M  V30 33 C 1.6911 8.0022 0.0 0
M  V30 34 C 9.0354 7.4034 0.0 0
M  V30 35 C 10.2814 8.3086 0.0 0
M  V30 36 C 9.1965 5.8718 0.0 0
M  V30 37 C 11.6882 7.6823 0.0 0
M  V30 38 C 10.6033 5.2455 0.0 0
M  V30 39 C 11.8492 6.1506 0.0 0
M  V30 40 C 12.9341 8.5874 0.0 0
M  V30 41 C 13.2561 5.5243 0.0 0
M  V30 42 C 14.3411 7.9610 0.0 0
M  V30 43 C 14.5020 6.4295 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 16
M  V30 3 1 1 22
M  V30 4 1 1 28
M  V30 5 1 2 3
M  V30 6 1 2 4
M  V30 7 1 2 14
M  V30 8 1 2 34
M  V30 9 1 3 5
M  V30 10 1 3 6
M  V30 11 1 7 8
M  V30 12 2 7 9
M  V30 13 1 7 43
M  V30 14 1 8 10
M  V30 15 1 11 12
M  V30 16 1 11 13
M  V30 17 2 12 14
M  V30 18 2 13 15
M  V30 19 1 14 15
M  V30 20 2 16 17
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 2 18 20
M  V30 24 2 19 21
M  V30 25 1 20 21
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 37 40
M  V30 44 1 38 39
M  V30 45 1 39 41
M  V30 46 2 40 42
M  V30 47 2 41 43
M  V30 48 1 42 43
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 337521-83-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 337521-85-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7584706
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 17,20-Lyase inhibitors. Part 4: Design, synthesis and structure-activity
relationships of naphthylmethylimidazole derivatives as novel 17,20-lyase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kaku, Tomohiro; Matsunaga, Nobuyuki; Ojida, Akio; Tanaka, Toshimasa;
Hara, Takahito; Yamaoka, Masuo; Kusaka, Masami; Tasaka, Akihiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2011), 19(5), 1751-1770

$RFMT $RIREG SCHEME355 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-6-fluorobenzo[b]thiophene-2-carboxylic acid
C9H4ClFO2S
34576-92-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 1.6840 4.8720 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 O 1.3338 0.0000 0.0 0
M  V30 5 F 8.9549 4.1618 0.0 0
M  V30 6 C 5.1049 2.8281 0.0 0
M  V30 7 C 4.3349 4.1618 0.0 0
M  V30 8 S 4.0743 1.6836 0.0 0
M  V30 9 C 6.6449 2.8281 0.0 0
M  V30 10 C 2.8284 3.8416 0.0 0
M  V30 11 C 5.1049 5.4954 0.0 0
M  V30 12 C 2.6675 2.3100 0.0 0
M  V30 13 C 7.4149 4.1618 0.0 0
M  V30 14 C 6.6449 5.4954 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 1 5 13
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-chloro-6-fluorobenzo[b]thiophene-2-carboxylate
C10H6ClFO2S
21211-20-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 5.9416 0.0000 0.0 0
M  V30 2 C 7.9110 2.7104 0.0 0
M  V30 3 O 8.6810 4.0442 0.0 0
M  V30 4 O 8.6810 1.3768 0.0 0
M  V30 5 C 10.2210 4.0442 0.0 0
M  V30 6 F 0.0000 4.2504 0.0 0
M  V30 7 C 4.0011 3.4804 0.0 0
M  V30 8 C 4.0011 1.9404 0.0 0
M  V30 9 S 5.4658 3.9564 0.0 0
M  V30 10 C 2.6674 4.2504 0.0 0
M  V30 11 C 5.4658 1.4645 0.0 0
M  V30 12 C 2.6674 1.1704 0.0 0
M  V30 13 C 6.3710 2.7104 0.0 0
M  V30 14 C 1.3338 3.4804 0.0 0
M  V30 15 C 1.3338 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 13
M  V30 5 1 3 5
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 34576-92-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 21211-20-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26483152
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 32589-78-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mild Esterification of Carboxylic Acids via Continuous Flow Diazotization
of Amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Audubert, Clement; Lebel, Helene
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2017), 19(16), 4407-4410

$RFMT $RIREG SCHEME356 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-(2,3-dimethylphenyl)acetamide
C10H12BrNO
349120-89-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 1.5400 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 C 8.0021 1.5400 0.0 0
M  V30 4 O 6.6684 3.8500 0.0 0
M  V30 5 Br 9.3358 2.3100 0.0 0
M  V30 6 C 2.6674 0.0000 0.0 0
M  V30 7 C 0.0000 1.5400 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 2.6674 1.5400 0.0 0
M  V30 10 C 4.0011 3.8500 0.0 0
M  V30 11 C 1.3336 2.3100 0.0 0
M  V30 12 C 2.6674 4.6200 0.0 0
M  V30 13 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 9
M  V30 7 1 7 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2,3-Dimethylphenyl)-2-(methylamino)acetamide
C11H16N2O
900640-54-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 O 6.6684 3.8500 0.0 0
M  V30 5 N 9.3359 2.3100 0.0 0
M  V30 6 C 10.6695 1.5400 0.0 0
M  V30 7 C 2.6673 0.0000 0.0 0
M  V30 8 C 0.0000 1.5400 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 2.6673 1.5400 0.0 0
M  V30 11 C 4.0011 3.8500 0.0 0
M  V30 12 C 1.3337 2.3100 0.0 0
M  V30 13 C 2.6673 4.6201 0.0 0
M  V30 14 C 1.3337 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 10
M  V30 8 1 8 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 349120-89-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 900640-54-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-16814253
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 3-Amino-2-carboxamide Tetrahydropyrrolo[2,3-b]quinolines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pilkington, Lisa I.; Haverkate, Natalie A.; van Rensburg, Michelle;
Reynisson, Johannes; Leung, Euphemia; Barker, David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2016), 27(20), 2811-2814

$RFMT $RIREG SCHEME357 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoronitrobenzene
C6H4FNO2
350-46-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0 VAL=5
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 F 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-nitrobenzenamine
C7H8N2O2
612-28-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 1.3338 0.0 0
M  V30 2 C 6.1600 1.3338 0.0 0
M  V30 3 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 350-46-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 612-28-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39745618
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Arylazobenzimidazoles: versatile visible-light photoswitches with
tuneable Z-isomer stability
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Steinmueller, Sophie A. M.; Odaybat, Magdalena; Galli, Giulia; Prischich,
Davia; Fuchter, Matthew J.; Decker, Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Science (2024), 15(14), 5360-5367

$RFMT $RIREG SCHEME358 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Ethyl-N′-(4,5,6,7-tetrahydro-7-oxo-2-benzothiazolyl)urea
C10H13N3O2S
352529-86-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0010 0.0 0
M  V30 2 N 6.0811 3.9554 0.0 0
M  V30 3 C 7.4148 3.1854 0.0 0
M  V30 4 N 8.7486 3.9554 0.0 0
M  V30 5 O 7.4148 1.6454 0.0 0
M  V30 6 C 10.0823 3.1854 0.0 0
M  V30 7 C 11.4160 3.9554 0.0 0
M  V30 8 C 3.0801 1.3337 0.0 0
M  V30 9 C 2.3101 2.6673 0.0 0
M  V30 10 N 4.5864 1.6538 0.0 0
M  V30 11 C 2.3101 0.0000 0.0 0
M  V30 12 S 3.3405 3.8119 0.0 0
M  V30 13 C 0.7700 2.6673 0.0 0
M  V30 14 C 4.7475 3.1854 0.0 0
M  V30 15 C 0.7700 0.0000 0.0 0
M  V30 16 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 1 2 3
M  V30 3 1 2 14
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 14
M  V30 16 1 13 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(3-Ethyltetrahydro-5-methyl-2-oxo-1,3,5-triazin-1(2H)-yl)-5,6-dihydro-7(4H)...
C13H18N4O2S
352528-65-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.4148 6.1601 0.0 0
M  V30 2 C 10.0823 4.6201 0.0 0
M  V30 3 C 11.4159 3.8501 0.0 0
M  V30 4 C 7.4148 0.0000 0.0 0
M  V30 5 O 0.0000 3.8045 0.0 0
M  V30 6 C 4.7474 4.6201 0.0 0
M  V30 7 N 4.5864 6.1516 0.0 0
M  V30 8 S 3.3405 3.9936 0.0 0
M  V30 9 C 3.0801 6.4718 0.0 0
M  V30 10 C 2.3100 5.1381 0.0 0
M  V30 11 C 2.3100 7.8055 0.0 0
M  V30 12 C 0.7700 5.1381 0.0 0
M  V30 13 C 0.7700 7.8055 0.0 0
M  V30 14 C 0.0000 6.4718 0.0 0
M  V30 15 N 6.0811 3.8501 0.0 0
M  V30 16 C 7.4148 4.6201 0.0 0
M  V30 17 C 6.0811 2.3100 0.0 0
M  V30 18 N 8.7486 3.8501 0.0 0
M  V30 19 N 7.4148 1.5400 0.0 0
M  V30 20 C 8.7486 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 16
M  V30 2 1 2 3
M  V30 3 1 2 18
M  V30 4 1 4 19
M  V30 5 2 5 12
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 15
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 352529-86-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 352528-65-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-11416170
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-(3-Ethy5-methy2-oxo-1,3,5-triazinan-1-yl)-4,5,6,7-tetrahydro-1,3-benzothiazo7-one
To a suspension of
N-ethyN'-(7-oxo-435,6,7-tetrahydro-1,3-benzothiazo2-yl)urea (10.0 g,
41.79 mmol) in EtOH/H2O (1/1, 300 mL) were added formaldehyde (37 wt % in
H2O, 20.4 g, 417.87 mmol), methylamine (40 wt % in H2O, 10.8 mL, 125.37
mmol) and N-methylmorpholine (11.8 mL, 83.6 mmol). The suspension was
heated to about 60 °C for about 5 hrs, then a solution had been formed.
The reaction mixture was pumped down in vacuo to give pure product. Yield
12.41 g, quantitative.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 2-benzothiazolyl ureas as protein kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cusack, Kevin P.; Scott, Barbara; Arnold, Lee D.; Ericsson, Anna
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001057008 A1 2001-08-09

$RFMT $RIREG SCHEME359 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-3,4,5-trimethoxybenzaldehyde
C10H11BrO4
35274-53-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 6.9302 0.0 0
M  V30 2 C 2.6675 7.7002 0.0 0
M  V30 3 O 6.6687 5.3901 0.0 0
M  V30 4 C 8.0023 4.6201 0.0 0
M  V30 5 O 1.3337 5.3901 0.0 0
M  V30 6 C 0.0000 4.6201 0.0 0
M  V30 7 Br 6.6687 2.3101 0.0 0
M  V30 8 C 4.0012 0.7700 0.0 0
M  V30 9 O 2.6675 0.0000 0.0 0
M  V30 10 C 4.0012 5.3901 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 5.3348 3.0801 0.0 0
M  V30 14 C 2.6675 3.0801 0.0 0
M  V30 15 C 4.0012 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 1 3 11
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-3,4,5-trimethoxy-N-methylbenzenemethanamine
C11H16BrNO3
2117645-19-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 4.0011 0.0 0
M  V30 2 C 0.0000 5.3348 0.0 0
M  V30 3 O 2.3100 1.3337 0.0 0
M  V30 4 C 3.0800 0.0000 0.0 0
M  V30 5 O 2.3100 6.6686 0.0 0
M  V30 6 C 3.0800 8.0022 0.0 0
M  V30 7 Br 5.3901 1.3337 0.0 0
M  V30 8 C 6.9301 4.0011 0.0 0
M  V30 9 N 7.7001 5.3348 0.0 0
M  V30 10 C 9.2401 5.3348 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 3.0800 2.6675 0.0 0
M  V30 13 C 3.0800 5.3348 0.0 0
M  V30 14 C 4.6201 2.6675 0.0 0
M  V30 15 C 4.6201 5.3348 0.0 0
M  V30 16 C 5.3901 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 7 14
M  V30 8 1 8 9
M  V30 9 1 8 16
M  V30 10 1 9 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 35274-53-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2117645-19-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-17935979
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of a series of
resorcinol-based N-benzyl benzamide derivatives as potent Hsp90
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Park, Sun You; Oh, Yong Jin; Lho, Yunmee; Jeong, Ju Hui; Liu,
Kwang-Hyeon; Song, Jaeyoung; Kim, Soong-Hyun; Ha, Eunyoung; Seo, Young Ho
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2018), 143390-401

$RFMT $RIREG SCHEME360 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2,2-Trichloro-1-(1H-pyrrol-2-yl)ethanone
C6H4Cl3NO
35302-72-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 O 2.6675 0.0000 0.0 0
M  V30 4 Cl 0.5637 0.9764 0.0 0
M  V30 5 Cl 0.0000 3.0801 0.0 0
M  V30 6 Cl 2.1037 3.6437 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 4.1621 3.8416 0.0 0
M  V30 9 N 5.4080 1.6836 0.0 0
M  V30 10 C 5.6686 4.1618 0.0 0
M  V30 11 C 6.4386 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1H-pyrrole-2-carboxamide
C6H8N2O
132911-42-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 N 5.1049 2.3100 0.0 0
M  V30 3 O 3.7711 0.0000 0.0 0
M  V30 4 C 6.4385 1.5400 0.0 0
M  V30 5 C 2.4374 2.3100 0.0 0
M  V30 6 C 2.2765 3.8416 0.0 0
M  V30 7 N 1.0306 1.6836 0.0 0
M  V30 8 C 0.7700 4.1618 0.0 0
M  V30 9 C 0.0000 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 35302-72-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 132911-42-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-10373099
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Acid catalyzed halogen dance on deactivated pyrroles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tutino, Federico; Papeo, Gianluca; Quartieri, Francesca
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2010), 47(1), 112-117

$RFMT $RIREG SCHEME361 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-4-fluoropyridine
C5H3BrFN
357927-50-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.0000 3.0800 0.0 0
M  V30 2 Br 5.3349 3.0800 0.0 0
M  V30 3 C 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 1.3338 0.7700 0.0 0
M  V30 7 N 4.0011 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-4-pyridinamine
C6H7BrN2
847799-64-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0801 0.0 0
M  V30 2 C 6.6687 2.3101 0.0 0
M  V30 3 Br 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 N 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 357927-50-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 847799-64-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-19631070
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Kinetic analyses and structure-activity relationship studies of synthetic
lysine acetylation catalysts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yamatsugu, Kenzo; Furuta, Masahiro; Xi, Siqi; Amamoto, Yoshifumi; Liu,
Jiaan; Kawashima, Shigehiro A.; Kanai, Motomu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2018), 26(19), 5359-5367

$RFMT $RIREG SCHEME362 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2,4-dichloropyrimidine
C4HBrCl2N2
36082-50-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 1.5400 0.0000 0.0 0
M  V30 2 Br 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.1601 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 1.5400 2.6673 0.0 0
M  V30 6 N 3.8501 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 N 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 8
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-chloro-N-methyl-4-pyrimidinamine
C5H5BrClN3
205672-24-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 1.3338 0.0 0
M  V30 2 C 2.3100 0.0000 0.0 0
M  V30 3 Br 0.0000 4.0011 0.0 0
M  V30 4 Cl 6.1600 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 1.5400 4.0011 0.0 0
M  V30 7 N 3.8500 2.6674 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 N 3.8500 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 36082-50-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 205672-24-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3163866
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrrolopyrimidine-inhibitors with hydantoin moiety as spacer can explore
P4/S4 interaction on plasmin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Teno, Naoki; Gohda, Keigo; Wanaka, Keiko; Tsuda, Yuko; Sueda, Takuya;
Yamashita, Yukiko; Otsubo, Tadamune
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2014), 22(7), 2339-2352

$RFMT $RIREG SCHEME363 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-1-fluoro-2-nitrobenzene
C6H3BrFNO2
364-73-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 F 1.3338 4.6201 0.0 0
M  V30 5 Br 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methyl-2-nitrobenzenamine
C7H7BrN2O2
53484-26-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0 VAL=5
M  V30 2 O 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 1.3338 0.0 0
M  V30 4 N 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 364-73-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 53484-26-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31687542
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 471-34-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Spiroconjugated Tetraaminospirenes as Donors in Color-Tunable
Charge-Transfer Emitters with Donor-Acceptor Structure
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Grenz, David C.; Rose, Daniel; Wossner, Jan S.; Wilbuer, Jennifer; Adler,
Florin; Hermann, Mathias; Chan, Chin-Yiu; Adachi, Chihaya; Esser, Birgit
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2022), 28(6), e202104150

$RFMT $RIREG SCHEME363 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-1-fluoro-2-nitrobenzene
C6H3BrFNO2
364-73-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 F 1.3338 4.6201 0.0 0
M  V30 5 Br 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methyl-2-nitrobenzenamine
C7H7BrN2O2
53484-26-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0 VAL=5
M  V30 2 O 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 1.3338 0.0 0
M  V30 4 N 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 364-73-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 53484-26-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-19571096
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolo[1,5-a]pyrimidinyl carboxamide compounds and their
use in the treatment of medical disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Skerlj, Renato T.; Bourque, Elyse Marie Josee; Lansbury, Peter T.; Good,
Andrew C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017176960 A1 2017-10-12

$RFMT $RIREG SCHEME363 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-1-fluoro-2-nitrobenzene
C6H3BrFNO2
364-73-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 F 1.3338 4.6201 0.0 0
M  V30 5 Br 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methyl-2-nitrobenzenamine
C7H7BrN2O2
53484-26-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0 VAL=5
M  V30 2 O 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 1.3338 0.0 0
M  V30 4 N 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 364-73-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 53484-26-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4001482
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient solution phase synthesis of 2-(N-acylamino)benzimidazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Seth, Punit P.; Robinson, Dale E.; Jefferson, Elizabeth A.; Swayze, Eric
E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2002), 43(41), 7303-7306

$RFMT $RIREG SCHEME364 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-3-nitrobenzotrifluoride
C7H3F4NO2
367-86-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6687 3.0801 0.0 0 VAL=5
M  V30 2 O 8.0023 2.3101 0.0 0
M  V30 3 O 6.6687 4.6201 0.0 0
M  V30 4 F 6.6687 0.0000 0.0 0
M  V30 5 C 1.3337 3.0801 0.0 0
M  V30 6 F 2.1037 4.4137 0.0 0
M  V30 7 F 0.0000 3.8501 0.0 0
M  V30 8 F 0.5638 1.7464 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 4.0012 0.0000 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-nitro-4-(trifluoromethyl)aniline
C8H7F3N2O2
20200-22-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3336 0.0 0 VAL=5
M  V30 2 O 0.7700 1.3336 0.0 0
M  V30 3 O 3.0800 0.0000 0.0 0
M  V30 4 N 0.7700 4.0009 0.0 0
M  V30 5 C 0.0000 5.3347 0.0 0
M  V30 6 C 6.9300 4.0009 0.0 0
M  V30 7 F 6.9300 2.4609 0.0 0
M  V30 8 F 8.4700 4.0009 0.0 0
M  V30 9 F 6.9300 5.5409 0.0 0
M  V30 10 C 3.0800 2.6673 0.0 0
M  V30 11 C 2.3100 4.0009 0.0 0
M  V30 12 C 4.6200 2.6673 0.0 0
M  V30 13 C 3.0800 5.3347 0.0 0
M  V30 14 C 5.3900 4.0009 0.0 0
M  V30 15 C 4.6200 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 14
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 367-86-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 20200-22-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-13170140
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient solution phase synthesis of 2-(N-acylamino)benzimidazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Seth, Punit P.; Robinson, Dale E.; Jefferson, Elizabeth A.; Swayze, Eric
E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2002), 43(41), 7303-7306

$RFMT $RIREG SCHEME365 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Methyl (αE)-2-[[[(E)-[1-[(1R,2R)-2-(2,6-dichlorophenyl)cyclopropyl]ethyli...
C22H22Cl2N2O4
374925-28-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8748 5.3901 0.0 0
M  V30 2 N 8.2086 4.6201 0.0 0
M  V30 3 C 6.8748 6.9301 0.0 0
M  V30 4 O 9.5423 5.3901 0.0 0
M  V30 5 C 10.8759 4.6201 0.0 0
M  V30 6 Cl 4.0011 7.7001 0.0 0
M  V30 7 Cl 1.3338 3.0800 0.0 0
M  V30 8 C 13.5434 3.0800 0.0 0
M  V30 9 C 12.2097 2.3100 0.0 0
M  V30 10 N 14.8770 2.3100 0.0 0
M  V30 11 O 12.2097 0.7700 0.0 0
M  V30 12 O 10.8759 3.0800 0.0 0
M  V30 13 O 16.2107 3.0800 0.0 0
M  V30 14 C 10.8759 0.0000 0.0 0
M  V30 15 C 17.5445 2.3100 0.0 0
M  V30 16 C 4.0011 4.6201 0.0 0 CFG=1
M  V30 17 C 5.5411 4.6201 0.0 0 CFG=1
M  V30 18 C 4.7711 3.2864 0.0 0
M  V30 19 C 2.6675 5.3901 0.0 0
M  V30 20 C 2.6675 6.9301 0.0 0
M  V30 21 C 1.3338 4.6201 0.0 0
M  V30 22 C 1.3338 7.7001 0.0 0
M  V30 23 C 0.0000 5.3901 0.0 0
M  V30 24 C 0.0000 6.9301 0.0 0
M  V30 25 C 12.2097 5.3901 0.0 0
M  V30 26 C 13.5434 4.6201 0.0 0
M  V30 27 C 12.2097 6.9301 0.0 0
M  V30 28 C 14.8770 5.3901 0.0 0
M  V30 29 C 13.5434 7.7001 0.0 0
M  V30 30 C 14.8770 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 17 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 25
M  V30 7 1 6 20
M  V30 8 1 7 21
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 26
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19 CFG=3
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(αE)-2-[[[(E)-[1-[(1R,2R)-2-(2,6-Dichlorophenyl)cyclopropyl]ethylidene]am...
C22H23Cl2N3O3
374925-54-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8748 5.3901 0.0 0
M  V30 2 N 8.2086 4.6201 0.0 0
M  V30 3 C 6.8748 6.9301 0.0 0
M  V30 4 O 9.5423 5.3901 0.0 0
M  V30 5 C 10.8759 4.6201 0.0 0
M  V30 6 Cl 1.3338 3.0800 0.0 0
M  V30 7 Cl 4.0011 7.7001 0.0 0
M  V30 8 C 13.5434 3.0800 0.0 0
M  V30 9 C 12.2097 2.3100 0.0 0
M  V30 10 N 14.8770 2.3100 0.0 0
M  V30 11 N 12.2097 0.7700 0.0 0
M  V30 12 O 10.8759 3.0800 0.0 0
M  V30 13 O 16.2107 3.0800 0.0 0
M  V30 14 C 10.8759 0.0000 0.0 0
M  V30 15 C 17.5445 2.3100 0.0 0
M  V30 16 C 4.0011 4.6201 0.0 0 CFG=1
M  V30 17 C 5.5411 4.6201 0.0 0 CFG=1
M  V30 18 C 4.7711 3.2864 0.0 0
M  V30 19 C 2.6675 5.3901 0.0 0
M  V30 20 C 1.3338 4.6201 0.0 0
M  V30 21 C 2.6675 6.9301 0.0 0
M  V30 22 C 0.0000 5.3901 0.0 0
M  V30 23 C 1.3338 7.7001 0.0 0
M  V30 24 C 0.0000 6.9301 0.0 0
M  V30 25 C 12.2097 5.3901 0.0 0
M  V30 26 C 13.5434 4.6201 0.0 0
M  V30 27 C 12.2097 6.9301 0.0 0
M  V30 28 C 14.8770 5.3901 0.0 0
M  V30 29 C 13.5434 7.7001 0.0 0
M  V30 30 C 14.8770 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 17 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 25
M  V30 7 1 6 20
M  V30 8 1 7 21
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 26
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19 CFG=3
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 374925-28-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 374925-54-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19962581
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of arylcylopropyl oxime ethers and their use as fungicides and
insecticides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ross, Ronald, Jr.; Nguyen, Duyan Vuong; Szapacs, Edward Michael; Smith,
Frisby Davis; Shaber, Steven Howard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US6348627 B1 2002-02-19

$RFMT $RIREG SCHEME366 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1H-pyrazole-4-carboxylate
C6H8N2O2
37622-90-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7710 1.5400 0.0 0
M  V30 2 O 5.1047 2.3100 0.0 0
M  V30 3 O 3.7710 0.0000 0.0 0
M  V30 4 C 6.4385 1.5400 0.0 0
M  V30 5 C 7.7722 2.3100 0.0 0
M  V30 6 C 2.4374 2.3100 0.0 0
M  V30 7 C 1.0304 1.6835 0.0 0
M  V30 8 C 2.2765 3.8416 0.0 0
M  V30 9 N 0.0000 2.8281 0.0 0
M  V30 10 N 0.7700 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1H-pyrazole-4-carboxamide
C5H7N3O
1154383-52-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 N 5.1049 2.3100 0.0 0
M  V30 3 O 3.7711 0.0000 0.0 0
M  V30 4 C 6.4385 1.5400 0.0 0
M  V30 5 C 2.4374 2.3100 0.0 0
M  V30 6 C 2.2765 3.8416 0.0 0
M  V30 7 C 1.0306 1.6836 0.0 0
M  V30 8 N 0.7700 4.1618 0.0 0
M  V30 9 N 0.0000 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 37622-90-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1154383-52-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20787628
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Amine-substituted heterocyclic compounds as EHMT2 inhibitors, salts
thereof, and methods of synthesis thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Campbell, John Emmerson; Duncan, Kenneth William; Mills, James Edward
John; Munchhof, Michael John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019079540 A1 2019-04-25

$RFMT $RIREG SCHEME367 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-2-methyl-N-[4-[2-[(methylsulfonyl)oxy]ethyl]-2-thiazolyl]benzenesulf...
C13H15ClN2O5S3
376640-94-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.9339 0.0 0 VAL=6
M  V30 2 N 6.6685 4.7039 0.0 0
M  V30 3 O 4.5648 5.2675 0.0 0
M  V30 4 O 6.1048 2.6002 0.0 0
M  V30 5 C 2.6673 5.4739 0.0 0
M  V30 6 Cl 0.0000 3.9339 0.0 0
M  V30 7 C 11.9711 3.5767 0.0 0
M  V30 8 C 12.8764 2.3308 0.0 0
M  V30 9 O 14.4079 2.4918 0.0 0
M  V30 10 S 15.3132 1.2459 0.0 0 VAL=6
M  V30 11 C 16.5591 2.1511 0.0 0
M  V30 12 O 16.2184 0.0000 0.0 0
M  V30 13 O 14.0673 0.3407 0.0 0
M  V30 14 C 4.0010 3.1638 0.0 0
M  V30 15 C 2.6673 3.9339 0.0 0
M  V30 16 C 4.0010 1.6238 0.0 0
M  V30 17 C 1.3337 3.1638 0.0 0
M  V30 18 C 2.6673 0.8538 0.0 0
M  V30 19 C 1.3337 1.6238 0.0 0
M  V30 20 C 8.0022 3.9339 0.0 0
M  V30 21 N 9.4091 4.5602 0.0 0
M  V30 22 S 8.1633 2.4023 0.0 0
M  V30 23 C 10.4396 3.4158 0.0 0
M  V30 24 C 9.6696 2.0821 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 14
M  V30 5 1 2 20
M  V30 6 1 5 15
M  V30 7 1 6 17
M  V30 8 1 7 8
M  V30 9 1 7 23
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 2 10 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-2-methyl-N-[4-[2-(methylamino)ethyl]-2-thiazolyl]benzenesulfonamide
C13H16ClN3O2S2
376641-17-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 0.7700 0.0 0
M  V30 2 S 5.3348 1.5400 0.0 0 VAL=6
M  V30 3 O 6.1048 2.8737 0.0 0
M  V30 4 O 4.5648 0.2064 0.0 0
M  V30 5 C 11.9711 1.8972 0.0 0
M  V30 6 C 12.8764 3.1431 0.0 0
M  V30 7 N 14.4079 2.9821 0.0 0
M  V30 8 C 15.3132 4.2280 0.0 0
M  V30 9 C 2.6673 0.0000 0.0 0
M  V30 10 Cl 0.0000 1.5400 0.0 0
M  V30 11 C 8.0022 1.5400 0.0 0
M  V30 12 N 9.4091 0.9137 0.0 0
M  V30 13 S 8.1633 3.0716 0.0 0
M  V30 14 C 10.4396 2.0581 0.0 0
M  V30 15 C 9.6696 3.3918 0.0 0
M  V30 16 C 4.0012 2.3101 0.0 0
M  V30 17 C 2.6673 1.5400 0.0 0
M  V30 18 C 4.0012 3.8501 0.0 0
M  V30 19 C 1.3337 2.3101 0.0 0
M  V30 20 C 2.6673 4.6201 0.0 0
M  V30 21 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 2 16
M  V30 6 1 5 6
M  V30 7 1 5 14
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 9 17
M  V30 11 1 10 19
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 376640-94-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 376641-17-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8823131
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 3-Chloro-2-methyN-{4-[2-(methylamino)ethyl]-1,3-thiazo2-yl}benzenesulfonamide
EXAMPLE 191A (1.50g, 3.66 mmol) was stirred in 40 % aqueous methylamine
(12 mL) for 30 min at 80 °C. Most of the solvent was evaporated, water
was added and the product was extracted with DCM (150 mL) giving of the
title compound. Yield 1.27 g (quant.). 1H NMR (DMSO) δ 2.57 (s, 3H), 2.63
(s, 3H), 2.68 (t, 2H), 3.09 (t, 2H), 6.24 (s, 1H), 7.25 (t, 1H), 7.50 (d,
1H), 7.85 (d, 1H); MS (lonspray, [M+H]+) m/z 345.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-thiazol-2-ylbenzenesulfonamides as 11-β-hydroxysteroid
dehydrogenase type 1 inhibitors for the treatment of diabetes and related
diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barf, Tjeerd; Emond, Rikard; Kurz, Guido; Vallgarda, Jerk; Nilsson,
Marianne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001090090 A1 2001-11-29

$RFMT $RIREG SCHEME368 STEP1
$RXN



  2  1
$MOL
tert-Butoxycarbonyl-D-proline
C10H17NO4
37784-17-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.5254 2.6218 0.0 0
M  V30 2 O 5.8592 1.8517 0.0 0
M  V30 3 O 4.5254 4.1618 0.0 0
M  V30 4 C 7.1929 2.6218 0.0 0
M  V30 5 C 6.4229 3.9554 0.0 0
M  V30 6 C 8.5266 3.3918 0.0 0
M  V30 7 C 7.9629 1.2881 0.0 0
M  V30 8 C 1.4646 3.9845 0.0 0
M  V30 9 O 2.6091 5.0150 0.0 0
M  V30 10 O 0.0000 4.4604 0.0 0
M  V30 11 N 3.1917 1.8517 0.0 0
M  V30 12 C 1.7849 2.4781 0.0 0 CFG=1
M  V30 13 C 3.0308 0.3202 0.0 0
M  V30 14 C 0.7543 1.3337 0.0 0
M  V30 15 C 1.5243 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 12 8 CFG=3
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2R)-2-[(methylamino)methyl]-1-pyrrolidinecarboxylate
C11H22N2O2
783325-25-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.6436 3.7710 0.0 0
M  V30 2 O 2.1036 3.7710 0.0 0
M  V30 3 O 4.4136 5.1048 0.0 0
M  V30 4 C 1.3336 5.1048 0.0 0
M  V30 5 C 0.0000 4.3348 0.0 0
M  V30 6 C 0.5636 6.4384 0.0 0
M  V30 7 C 2.6674 5.8748 0.0 0
M  V30 8 C 6.9757 3.4208 0.0 0
M  V30 9 N 8.4820 3.1006 0.0 0
M  V30 10 C 9.5126 4.2450 0.0 0
M  V30 11 N 4.4136 2.4374 0.0 0
M  V30 12 C 5.9453 2.2764 0.0 0 CFG=1
M  V30 13 C 3.7873 1.0306 0.0 0
M  V30 14 C 6.2655 0.7700 0.0 0
M  V30 15 C 4.9319 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 12 8 CFG=1
M  V30 10 1 9 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 37784-17-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 783325-25-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-6797500
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 100-74-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 14044-65-6
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Diamino Derivatives of [1,2,4]Triazolo[1,5-a][1,3,5]triazine as
Potent and Selective Adenosine A2a Receptor Antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vu, Chi B.; Pan, Deborah; Peng, Bo; Kumaravel, Gnanasambandam; Smits,
Glenn; Jin, Xiaowei; Phadke, Deepali; Engber, Thomas; Huang, Carol;
Reilly, Jennifer; Tam, Stacy; Grant, Donna; Hetu, Gregg; Petter, Russell
C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2005), 48(6), 2009-2018

$RFMT $RIREG SCHEME369 STEP1
$RXN



  2  1
$MOL
5-(1,1-Dimethylethyl) hydrogen N-[(phenylmethoxy)carbonyl]-L-glutamate
C17H23NO6
3886-08-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 11.3436 5.3347 0.0 0
M  V30 2 O 10.5736 4.0011 0.0 0
M  V30 3 C 9.0336 4.0011 0.0 0
M  V30 4 N 8.2636 2.6674 0.0 0
M  V30 5 O 8.2636 5.3347 0.0 0
M  V30 6 C 6.7236 2.6674 0.0 0 CFG=2
M  V30 7 C 5.9536 4.0011 0.0 0
M  V30 8 C 5.9536 1.3336 0.0 0
M  V30 9 C 4.4136 4.0011 0.0 0
M  V30 10 O 4.4136 1.3336 0.0 0
M  V30 11 O 6.7236 0.0000 0.0 0
M  V30 12 C 3.6436 5.3347 0.0 0
M  V30 13 O 2.1036 5.3347 0.0 0
M  V30 14 O 4.4136 6.6685 0.0 0
M  V30 15 C 1.3336 6.6685 0.0 0
M  V30 16 C 2.6673 7.4385 0.0 0
M  V30 17 C 0.5636 8.0021 0.0 0
M  V30 18 C 0.0000 5.8985 0.0 0
M  V30 19 C 12.8836 5.3347 0.0 0
M  V30 20 C 13.6536 4.0011 0.0 0
M  V30 21 C 13.6536 6.6685 0.0 0
M  V30 22 C 15.1936 4.0011 0.0 0
M  V30 23 C 15.1936 6.6685 0.0 0
M  V30 24 C 15.9636 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 23
M  V30 23 2 22 24
M  V30 24 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (4S)-5-(methylamino)-5-oxo-4-[[(phenylmethoxy)carbonyl]amin...
C18H26N2O5
74360-82-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 4.0011 0.0 0 CFG=1
M  V30 2 C 9.2400 4.0011 0.0 0
M  V30 3 N 6.9300 5.3347 0.0 0
M  V30 4 C 6.9300 2.6673 0.0 0
M  V30 5 C 10.0100 5.3347 0.0 0
M  V30 6 C 5.3900 5.3347 0.0 0
M  V30 7 N 7.7000 1.3336 0.0 0
M  V30 8 O 5.3900 2.6673 0.0 0
M  V30 9 C 11.5500 5.3347 0.0 0
M  V30 10 O 4.6200 6.6684 0.0 0
M  V30 11 O 4.6200 4.0011 0.0 0
M  V30 12 C 6.9300 0.0000 0.0 0
M  V30 13 O 12.3200 6.6684 0.0 0
M  V30 14 O 12.3200 4.0011 0.0 0
M  V30 15 C 3.0800 6.6684 0.0 0
M  V30 16 C 13.8600 6.6684 0.0 0
M  V30 17 C 13.8600 5.1284 0.0 0
M  V30 18 C 15.4000 6.6684 0.0 0
M  V30 19 C 13.8600 8.2084 0.0 0
M  V30 20 C 2.3100 8.0021 0.0 0
M  V30 21 C 3.0800 9.3358 0.0 0
M  V30 22 C 0.7700 8.0021 0.0 0
M  V30 23 C 2.3100 10.6694 0.0 0
M  V30 24 C 0.0000 9.3358 0.0 0
M  V30 25 C 0.7700 10.6694 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 1 9 13
M  V30 13 2 9 14
M  V30 14 1 10 15
M  V30 15 1 13 16
M  V30 16 1 15 20
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 2 20 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 2 22 24
M  V30 24 2 23 25
M  V30 25 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3886-08-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 74360-82-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2731329
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 543-27-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel matrix metalloproteinase inhibitors: Generation of lead compounds
by the in silico fragment-based approach
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Takahashi, Kanji; Ikura, Masahiro; Habashita, Hiromu; Nishizaki, Minoru;
Sugiura, Tsuneyuki; Yamamoto, Shingo; Nakatani, Shingo; Ogawa, Koji;
Ohno, Hiroyuki; Nakai, Hisao; Toda, Masaaki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2005), 13(14), 4527-4543

$RFMT $RIREG SCHEME370 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,8-Dioxa-1-azaspiro[4.5]decane-2,4-dione
C7H9NO4
39974-68-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.5092 0.0000 0.0 0
M  V30 2 O 6.6956 4.3856 0.0 0
M  V30 3 C 3.0800 2.7104 0.0 0
M  V30 4 N 3.9852 3.9564 0.0 0
M  V30 5 C 3.9852 1.4645 0.0 0
M  V30 6 C 2.3100 1.3768 0.0 0
M  V30 7 C 2.3100 4.0442 0.0 0
M  V30 8 C 5.4498 3.4804 0.0 0
M  V30 9 O 5.4498 1.9404 0.0 0
M  V30 10 C 0.7700 1.3768 0.0 0
M  V30 11 C 0.7700 4.0442 0.0 0
M  V30 12 O 0.0000 2.7104 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 8
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 9
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Aminotetrahydro-N-methyl-2H-pyran-4-carboxamide
C7H14N2O2
1268883-06-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.2598 1.5166 0.0 0
M  V30 2 N 5.7068 2.0433 0.0 0
M  V30 3 O 3.9923 0.0000 0.0 0
M  V30 4 C 6.8866 1.0534 0.0 0
M  V30 5 N 4.2598 3.4964 0.0 0
M  V30 6 C 3.0800 2.5065 0.0 0
M  V30 7 C 2.3100 1.1729 0.0 0
M  V30 8 C 2.3100 3.8401 0.0 0
M  V30 9 C 0.7700 1.1729 0.0 0
M  V30 10 C 0.7700 3.8401 0.0 0
M  V30 11 O 0.0000 2.5065 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 39974-68-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1268883-06-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-21612554
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed cap
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted cyclohexyl compounds as NOP inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Basinger, Thompson Jillian; Bookser, Brett; Burley, Scott;
Garcia-Reynaga, Pablo; Hudson, Andrew; Peters, Marco; Pratt, Benjamin;
Thompson, Aaron; Tran, Joe; Valdez, Lino
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019168866 A1 2019-09-06

$RFMT $RIREG SCHEME371 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Fluoroindole-2-carboxylic acid
C9H6FNO2
399-76-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 F 8.9549 4.1617 0.0 0
M  V30 5 C 4.3348 4.1617 0.0 0
M  V30 6 C 5.1048 2.8281 0.0 0
M  V30 7 N 2.8284 3.8416 0.0 0
M  V30 8 C 5.1048 5.4954 0.0 0
M  V30 9 C 4.0743 1.6835 0.0 0
M  V30 10 C 6.6448 2.8281 0.0 0
M  V30 11 C 2.6675 2.3100 0.0 0
M  V30 12 C 6.6448 5.4954 0.0 0
M  V30 13 C 7.4149 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-2-carboxylic acid, 5-fluoro-, methyl ester
C10H8FNO2
167631-84-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6211 1.5400 0.0 0
M  V30 2 O 8.9549 2.3100 0.0 0
M  V30 3 O 7.6211 0.0000 0.0 0
M  V30 4 C 10.2886 1.5400 0.0 0
M  V30 5 F 0.0000 4.1618 0.0 0
M  V30 6 C 4.6201 4.1618 0.0 0
M  V30 7 C 3.8501 2.8281 0.0 0
M  V30 8 N 6.1265 3.8416 0.0 0
M  V30 9 C 3.8501 5.4954 0.0 0
M  V30 10 C 4.8806 1.6836 0.0 0
M  V30 11 C 2.3100 2.8281 0.0 0
M  V30 12 C 6.2875 2.3100 0.0 0
M  V30 13 C 2.3100 5.4954 0.0 0
M  V30 14 C 1.5400 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 399-76-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 167631-84-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25557848
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 32589-78-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mild Esterification of Carboxylic Acids via Continuous Flow Diazotization
of Amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Audubert, Clement; Lebel, Helene
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2017), 19(16), 4407-4410

$RFMT $RIREG SCHEME372 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Methyl (αE)-2-[[[(Z)-[1-[(1R,2R)-2-(2,6-dichlorophenyl)cyclopropyl]ethyli...
C22H22Cl2N2O4
400019-69-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.7236 2.6674 0.0 0
M  V30 2 N 8.2636 2.6674 0.0 0
M  V30 3 C 5.9536 1.3336 0.0 0
M  V30 4 O 9.0336 4.0011 0.0 0
M  V30 5 C 10.5736 4.0011 0.0 0
M  V30 6 Cl 3.0800 2.1036 0.0 0
M  V30 7 Cl 3.0800 7.4385 0.0 0
M  V30 8 C 13.6536 4.0011 0.0 0
M  V30 9 C 12.8836 2.6674 0.0 0
M  V30 10 N 15.1936 4.0011 0.0 0
M  V30 11 O 13.6536 1.3336 0.0 0
M  V30 12 O 11.3436 2.6674 0.0 0
M  V30 13 O 15.9636 5.3347 0.0 0
M  V30 14 C 12.8836 0.0000 0.0 0
M  V30 15 C 17.5036 5.3347 0.0 0
M  V30 16 C 4.6200 4.7711 0.0 0 CFG=1
M  V30 17 C 5.9536 4.0011 0.0 0 CFG=1
M  V30 18 C 5.9536 5.5411 0.0 0
M  V30 19 C 3.0800 4.7711 0.0 0
M  V30 20 C 2.3100 3.4374 0.0 0
M  V30 21 C 2.3100 6.1047 0.0 0
M  V30 22 C 0.7700 3.4374 0.0 0
M  V30 23 C 0.7700 6.1047 0.0 0
M  V30 24 C 0.0000 4.7711 0.0 0
M  V30 25 C 11.3436 5.3347 0.0 0
M  V30 26 C 12.8836 5.3347 0.0 0
M  V30 27 C 10.5736 6.6685 0.0 0
M  V30 28 C 13.6536 6.6685 0.0 0
M  V30 29 C 11.3436 8.0021 0.0 0
M  V30 30 C 12.8836 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 17 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 25
M  V30 7 1 6 20
M  V30 8 1 7 21
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 26
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19 CFG=1
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(αE)-2-[[[(Z)-[1-[(1R,2R)-2-(2,6-Dichlorophenyl)cyclopropyl]ethylidene]am...
C22H23Cl2N3O3
400019-72-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.7238 2.6675 0.0 0
M  V30 2 N 8.2638 2.6675 0.0 0
M  V30 3 C 5.9538 1.3338 0.0 0
M  V30 4 O 9.0338 4.0012 0.0 0
M  V30 5 C 10.5739 4.0012 0.0 0
M  V30 6 Cl 3.0801 7.4387 0.0 0
M  V30 7 Cl 3.0801 2.1038 0.0 0
M  V30 8 C 13.6539 4.0012 0.0 0
M  V30 9 C 12.8839 2.6675 0.0 0
M  V30 10 N 15.1940 4.0012 0.0 0
M  V30 11 N 13.6539 1.3337 0.0 0
M  V30 12 O 11.3439 2.6675 0.0 0
M  V30 13 O 15.9640 5.3348 0.0 0
M  V30 14 C 12.8839 0.0000 0.0 0
M  V30 15 C 17.5040 5.3348 0.0 0
M  V30 16 C 4.6201 4.7712 0.0 0 CFG=1
M  V30 17 C 5.9538 4.0012 0.0 0 CFG=1
M  V30 18 C 5.9538 5.5412 0.0 0
M  V30 19 C 3.0801 4.7712 0.0 0
M  V30 20 C 2.3101 6.1048 0.0 0
M  V30 21 C 2.3101 3.4375 0.0 0
M  V30 22 C 0.7700 6.1048 0.0 0
M  V30 23 C 0.7700 3.4375 0.0 0
M  V30 24 C 0.0000 4.7712 0.0 0
M  V30 25 C 11.3439 5.3348 0.0 0
M  V30 26 C 12.8839 5.3348 0.0 0
M  V30 27 C 10.5739 6.6687 0.0 0
M  V30 28 C 13.6539 6.6687 0.0 0
M  V30 29 C 11.3439 8.0023 0.0 0
M  V30 30 C 12.8839 8.0023 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 17 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 25
M  V30 7 1 6 20
M  V30 8 1 7 21
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 26
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19 CFG=1
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 400019-69-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 400019-72-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19962572
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of arylcylopropyl oxime ethers and their use as fungicides and
insecticides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ross, Ronald, Jr.; Nguyen, Duyan Vuong; Szapacs, Edward Michael; Smith,
Frisby Davis; Shaber, Steven Howard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US6348627 B1 2002-02-19

$RFMT $RIREG SCHEME373 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-6-nitro-4(3H)-quinazolinone
C8H4ClN3O3
400784-49-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.0011 0.0000 0.0 0
M  V30 2 O 1.3336 0.0000 0.0 0
M  V30 3 N 6.6685 1.5400 0.0 0 VAL=5
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 O 6.6685 0.0000 0.0 0
M  V30 6 C 2.6674 3.8500 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 4.0011 4.6200 0.0 0
M  V30 9 N 1.3336 4.6200 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 1.3336 1.5400 0.0 0
M  V30 12 C 5.3347 3.8500 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 14 C 5.3347 2.3100 0.0 0
M  V30 15 N 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 2 2 11
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 14
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(Methylamino)-6-nitro-4(3H)-quinazolinone
C9H8N4O3
400784-54-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 0.7700 0.0 0
M  V30 2 C 5.3347 0.0000 0.0 0
M  V30 3 O 1.3336 0.7700 0.0 0
M  V30 4 N 6.6685 2.3100 0.0 0 VAL=5
M  V30 5 O 8.0021 3.0800 0.0 0
M  V30 6 O 6.6685 0.7700 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 2.6674 4.6200 0.0 0
M  V30 10 C 1.3336 2.3100 0.0 0
M  V30 11 C 5.3347 3.0800 0.0 0
M  V30 12 C 4.0011 5.3900 0.0 0
M  V30 13 N 1.3336 5.3900 0.0 0
M  V30 14 N 0.0000 3.0800 0.0 0
M  V30 15 C 5.3347 4.6200 0.0 0
M  V30 16 C 0.0000 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 10
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 2 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 400784-49-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 400784-54-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4945559
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 5-Chloro-6-nitroquinazolm-4-one, from Example 3 (0.26 g, 1.15 mmol) was
suspended in MeOH (3 mL) at -20 °C. Methylamine gas was passed into the
mixture for a few minutes, resulting in a clear solution. The solution
was stirred at room temperature for 5 h and evaporated to give
5-methylamino-6-nitroquinazolin-4-one. Yield 100%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of imidazoquinazolinones as inhibitors of tyrosine kinases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Snow, Roger John; Gao, Donghong A.; Goldberg, Daniel R.; Hammach,
Abdelhakim; Kuzmich, Daniel; Morwick, Tina Marie; Moss, Neil;
Prokopowicz, Anthony S., III; Selliah, Robert D.; Takahashi, Hidenori
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002014319 A2 2002-02-21

$RFMT $RIREG SCHEME374 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4′-Fluoroacetophenone
C8H7FO
403-42-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 F 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[1-(4-Fluorophenyl)ethylidene]methanamine
C9H10FN
1227083-63-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 C 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 F 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 6.1601 0.0000 0.0 0
M  V30 10 C 6.1601 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 403-42-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1227083-63-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-9398235
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: I. Synthesis of ureas To a stirred solution of
CH3NH2 (8M in EtOH, 4 eq.), the ketone (1 eq.) and M.S. 4Å (250 mg /
mmol) were sequentially added at r.t.. The reaction was stirred for 48h
at r.t. in the case of acetophenone derivatives or at 50°C in the case of
propiophenone derivatives, filtered on celite and washed with CH2Cl2.*
The organic phases were combined and concentrated under reduce pressure
to give the imine (quantitative) as a pale yellow oil.
$DTYPE RXN:VAR(1):NOTES
$DATUM mol. sieves used, alternatively reaction carried out using microwave
reactor at 125 degree Celsius for 30-60 minutes
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tandem β-alkylation-α-arylation of amines by carbolithiation and
rearrangement of N-carbamoyl enamines (vinyl ureas)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Clayden, Jonathan; Donnard, Morgan; Lefranc, Julien; Minassi, Alberto;
Tetlow, Daniel J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2010), 132(19), 6624-6625

$RFMT $RIREG SCHEME374 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4′-Fluoroacetophenone
C8H7FO
403-42-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 F 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[1-(4-Fluorophenyl)ethylidene]methanamine
C9H10FN
1227083-63-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 C 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 F 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 6.1601 0.0000 0.0 0
M  V30 10 C 6.1601 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 403-42-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1227083-63-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-2019882
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: I. Synthesis of ureas To a stirred solution of
CH3NH2 (8M in EtOH, 4 eq.), the ketone (1 eq.) and M.S. 4Å (250 mg /
mmol) were sequentially added at r.t.. The reaction was stirred for 48h
at r.t. in the case of acetophenone derivatives or at 50°C in the case of
propiophenone derivatives, filtered on celite and washed with CH2Cl2.*
The organic phases were combined and concentrated under reduce pressure
to give the imine (quantitative) as a pale yellow oil.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tandem β-alkylation-α-arylation of amines by carbolithiation and
rearrangement of N-carbamoyl enamines (vinyl ureas)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Clayden, Jonathan; Donnard, Morgan; Lefranc, Julien; Minassi, Alberto;
Tetlow, Daniel J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2010), 132(19), 6624-6625

$RFMT $RIREG SCHEME375 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Methoxyspiro[4H-1-benzopyran-4,1′-[2,5]cyclohexadiene]-2,4′(3H)-dione
C15H12O4
404393-57-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 0.0000 0.0 0
M  V30 2 O 9.3358 3.8500 0.0 0
M  V30 3 C 10.6694 4.6200 0.0 0
M  V30 4 O 0.0000 6.1600 0.0 0
M  V30 5 C 4.0011 3.8500 0.0 0
M  V30 6 C 5.3347 4.6200 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6673 3.0800 0.0 0
M  V30 9 C 4.0011 5.3900 0.0 0
M  V30 10 C 6.6684 3.8500 0.0 0
M  V30 11 C 5.3347 6.1600 0.0 0
M  V30 12 C 5.3347 1.5400 0.0 0
M  V30 13 C 1.3336 3.8500 0.0 0
M  V30 14 C 2.6673 6.1600 0.0 0
M  V30 15 C 8.0021 4.6200 0.0 0
M  V30 16 O 6.6684 2.3100 0.0 0
M  V30 17 C 6.6684 6.9300 0.0 0
M  V30 18 C 1.3336 5.3900 0.0 0
M  V30 19 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 3
M  V30 3 1 2 15
M  V30 4 2 4 18
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 2 8 13
M  V30 13 2 9 14
M  V30 14 2 10 15
M  V30 15 1 10 16
M  V30 16 1 11 17
M  V30 17 1 12 16
M  V30 18 1 13 18
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 2 17 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(5aR,9aR)-6,7-Dihydro-4-methoxy-N-methyl-7-oxo-9a(5aH)-dibenzofuranacetamide
C16H17NO4
404393-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.4886 5.2023 0.0 0
M  V30 2 C 1.9823 5.5225 0.0 0
M  V30 3 N 1.5064 6.9872 0.0 0
M  V30 4 O 0.9517 4.3781 0.0 0
M  V30 5 C 0.0000 7.3073 0.0 0
M  V30 6 O 9.1101 3.9982 0.0 0
M  V30 7 C 10.4437 4.7682 0.0 0
M  V30 8 O 1.2489 0.0000 0.0 0
M  V30 9 C 3.9644 3.7378 0.0 0 CFG=1
M  V30 10 C 5.1090 4.7682 0.0 0
M  V30 11 C 4.5909 2.3308 0.0 0 CFG=2
M  V30 12 C 2.4329 3.8987 0.0 0
M  V30 13 C 6.4426 3.9982 0.0 0
M  V30 14 C 5.1090 6.3082 0.0 0
M  V30 15 O 6.1225 2.4917 0.0 0
M  V30 16 C 3.6857 1.0849 0.0 0
M  V30 17 C 1.5277 2.6528 0.0 0
M  V30 18 C 7.7763 4.7682 0.0 0
M  V30 19 C 6.4426 7.0782 0.0 0
M  V30 20 C 2.1542 1.2459 0.0 0
M  V30 21 C 7.7763 6.3082 0.0 0
M  V30 22 H 5.3609 0.9972 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 9 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 18
M  V30 8 2 8 20
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 11 16
M  V30 16 1 11 22 CFG=3
M  V30 17 2 12 17
M  V30 18 1 13 15
M  V30 19 2 13 18
M  V30 20 1 14 19
M  V30 21 1 16 20
M  V30 22 1 17 20
M  V30 23 1 18 21
M  V30 24 2 19 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 9 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 404393-57-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 404393-58-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8408189
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient total synthesis of (±)-galanthamine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guillou, Catherine; Beunard, Jean-Luc; Gras, Emmanuel; Thal, Claude
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2001), 40(24), 4745-4746

$RFMT $RIREG SCHEME376 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
p-Phenylene diisothiocyanate
C8H4N2S2
4044-65-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0023 3.0801 0.0 0
M  V30 2 C 9.3360 2.3101 0.0 0
M  V30 3 S 10.6697 1.5400 0.0 0
M  V30 4 N 2.6673 0.0000 0.0 0
M  V30 5 C 1.3337 0.7700 0.0 0
M  V30 6 S 0.0000 1.5400 0.0 0
M  V30 7 C 6.6685 2.3101 0.0 0
M  V30 8 C 6.6685 0.7700 0.0 0
M  V30 9 C 5.3348 3.0801 0.0 0
M  V30 10 C 5.3348 0.0000 0.0 0
M  V30 11 C 4.0012 2.3101 0.0 0
M  V30 12 C 4.0012 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 12
M  V30 6 2 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Thiourea, N,N′′-1,4-phenylenebis[N′-methyl-
C10H14N4S2
16349-55-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0010 3.0801 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 N 1.3337 3.0801 0.0 0
M  V30 4 S 2.6673 0.7700 0.0 0
M  V30 5 C 0.0000 2.3101 0.0 0
M  V30 6 N 9.3360 0.0000 0.0 0
M  V30 7 C 10.6697 0.7700 0.0 0
M  V30 8 N 12.0033 0.0000 0.0 0
M  V30 9 S 10.6697 2.3101 0.0 0
M  V30 10 C 13.3370 0.7700 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 6.6685 3.0801 0.0 0
M  V30 14 C 6.6685 0.0000 0.0 0
M  V30 15 C 8.0022 2.3101 0.0 0
M  V30 16 C 8.0022 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4044-65-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16349-55-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-7248029
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quantitative Solid-State Reactions of Amines with Carbonyl Compounds and
Isothiocyanates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kaupp, Gerd; Schmeyers, Jens; Boy, Juergen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2000), 56(36), 6899-6911

$RFMT $RIREG SCHEME377 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[[(1,1-Dimethylethoxy)carbonyl]amino]methyl]benzeneacetic acid
C14H19NO4
40851-66-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 2.3101 0.0 0
M  V30 2 C 1.3337 1.5400 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 O 0.0000 2.3101 0.0 0
M  V30 5 C 5.3348 3.8501 0.0 0
M  V30 6 N 6.6685 4.6201 0.0 0
M  V30 7 C 8.0022 3.8501 0.0 0
M  V30 8 O 9.3360 4.6201 0.0 0
M  V30 9 O 8.0022 2.3101 0.0 0
M  V30 10 C 10.6697 3.8501 0.0 0
M  V30 11 C 11.4397 5.1838 0.0 0
M  V30 12 C 12.0033 3.0801 0.0 0
M  V30 13 C 9.8996 2.5164 0.0 0
M  V30 14 C 2.6673 3.8501 0.0 0
M  V30 15 C 4.0012 4.6201 0.0 0
M  V30 16 C 1.3337 4.6201 0.0 0
M  V30 17 C 4.0012 6.1601 0.0 0
M  V30 18 C 1.3337 6.1601 0.0 0
M  V30 19 C 2.6673 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[[2-[2-(methylamino)-2-oxoethyl]phenyl]methyl]carbamate
C15H22N2O3
931424-56-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.0337 4.0011 0.0 0
M  V30 2 C 10.5738 4.0011 0.0 0
M  V30 3 N 11.3438 5.3348 0.0 0
M  V30 4 O 11.3438 2.6675 0.0 0
M  V30 5 C 12.8838 5.3348 0.0 0
M  V30 6 C 5.9537 4.0011 0.0 0
M  V30 7 N 4.4137 4.0011 0.0 0
M  V30 8 C 3.6437 5.3348 0.0 0
M  V30 9 O 2.1037 5.3348 0.0 0
M  V30 10 O 4.4137 6.6686 0.0 0
M  V30 11 C 1.3337 6.6686 0.0 0
M  V30 12 C 0.0000 5.8986 0.0 0
M  V30 13 C 0.5636 8.0022 0.0 0
M  V30 14 C 2.6673 7.4386 0.0 0
M  V30 15 C 8.2637 2.6675 0.0 0
M  V30 16 C 6.7237 2.6675 0.0 0
M  V30 17 C 9.0337 1.3337 0.0 0
M  V30 18 C 5.9537 1.3337 0.0 0
M  V30 19 C 8.2637 0.0000 0.0 0
M  V30 20 C 6.7237 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 40851-66-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 931424-56-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15544710
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56602-33-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Molecular modeling study for a novel structured oligomer subunit
selection: the example of 2-aminomethylphenylacetic acid
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Raynal, Nicolas; Averlant-Petit, Marie-Christine; Berge, Gilbert;
Didierjean, Claude; Marraud, Michel; Duru, Christiane; Martinez, Jean;
Amblard, Muriel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2007), 48(10), 1787-1790

$RFMT $RIREG SCHEME378 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Leucine, N-[[[2-[carboxy[2-[(2-cyanoethyl)amino]ethyl]amino]ethyl]phenylami...
C40H58N8O8
416898-03-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  56 57 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 10.6696 8.4700 0.0 0
M  V30 2 C 9.3358 7.7000 0.0 0
M  V30 3 C 12.0032 7.7000 0.0 0
M  V30 4 N 8.0021 8.4700 0.0 0
M  V30 5 O 9.3358 6.1600 0.0 0
M  V30 6 C 13.3369 8.4700 0.0 0
M  V30 7 C 6.6685 7.7000 0.0 0 CFG=1
M  V30 8 N 14.6705 7.7000 0.0 0
M  V30 9 C 5.3347 8.4700 0.0 0
M  V30 10 C 6.6685 6.1600 0.0 0
M  V30 11 C 16.0043 8.4700 0.0 0
M  V30 12 C 14.6705 6.1600 0.0 0
M  V30 13 N 5.3347 10.0100 0.0 0
M  V30 14 O 4.0011 7.7000 0.0 0
M  V30 15 N 17.3379 7.7000 0.0 0
M  V30 16 O 16.0043 10.0100 0.0 0
M  V30 17 C 16.0043 5.3900 0.0 0
M  V30 18 C 4.0011 10.7800 0.0 0 CFG=1
M  V30 19 C 18.6716 8.4700 0.0 0 CFG=1
M  V30 20 N 16.0043 3.8500 0.0 0
M  V30 21 C 4.0011 12.3200 0.0 0
M  V30 22 C 2.6674 10.0100 0.0 0
M  V30 23 C 20.0052 7.7000 0.0 0
M  V30 24 C 18.6716 10.0100 0.0 0
M  V30 25 C 17.3379 3.0800 0.0 0
M  V30 26 O 2.6674 13.0900 0.0 0
M  V30 27 O 5.3347 13.0900 0.0 0
M  V30 28 C 1.3338 10.7800 0.0 0
M  V30 29 N 21.3390 8.4700 0.0 0
M  V30 30 O 20.0052 6.1600 0.0 0
M  V30 31 C 20.0052 10.7800 0.0 0
M  V30 32 C 17.3379 10.7800 0.0 0
M  V30 33 C 17.3379 1.5400 0.0 0
M  V30 34 C 2.6674 14.6300 0.0 0
M  V30 35 C 1.3338 12.3200 0.0 0
M  V30 36 C 0.0000 10.0100 0.0 0
M  V30 37 C 22.6727 7.7000 0.0 0 CFG=1
M  V30 38 C 18.6716 0.7700 0.0 0
M  V30 39 C 24.0063 8.4700 0.0 0
M  V30 40 C 22.6727 6.1600 0.0 0
M  V30 41 N 20.0052 0.0000 0.0 0
M  V30 42 O 25.3399 7.7000 0.0 0
M  V30 43 O 24.0063 10.0100 0.0 0
M  V30 44 C 26.6737 8.4700 0.0 0
M  V30 45 C 10.6696 10.0100 0.0 0
M  V30 46 C 9.3358 10.7800 0.0 0
M  V30 47 C 12.0032 10.7800 0.0 0
M  V30 48 C 9.3358 12.3200 0.0 0
M  V30 49 C 12.0032 12.3200 0.0 0
M  V30 50 C 10.6696 13.0900 0.0 0
M  V30 51 C 5.3347 5.3900 0.0 0
M  V30 52 C 4.0011 6.1600 0.0 0
M  V30 53 C 5.3349 3.8500 0.0 0
M  V30 54 C 2.6674 5.3900 0.0 0
M  V30 55 C 4.0011 3.0800 0.0 0
M  V30 56 C 2.6674 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 45
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=1
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 2 9 14
M  V30 15 1 10 51
M  V30 16 1 11 15
M  V30 17 2 11 16
M  V30 18 1 12 17
M  V30 19 1 13 18
M  V30 20 1 15 19
M  V30 21 1 17 20
M  V30 22 1 18 21
M  V30 23 1 18 22 CFG=1
M  V30 24 1 19 23
M  V30 25 1 19 24 CFG=1
M  V30 26 1 20 25
M  V30 27 1 21 26
M  V30 28 2 21 27
M  V30 29 1 22 28
M  V30 30 1 23 29
M  V30 31 2 23 30
M  V30 32 1 24 31
M  V30 33 1 24 32
M  V30 34 1 25 33
M  V30 35 1 26 34
M  V30 36 1 28 35
M  V30 37 1 28 36
M  V30 38 1 29 37
M  V30 39 1 33 38
M  V30 40 1 37 39
M  V30 41 1 37 40 CFG=3
M  V30 42 3 38 41
M  V30 43 1 39 42
M  V30 44 2 39 43
M  V30 45 1 42 44
M  V30 46 2 45 46
M  V30 47 1 45 47
M  V30 48 1 46 48
M  V30 49 2 47 49
M  V30 50 2 48 50
M  V30 51 1 49 50
M  V30 52 2 51 52
M  V30 53 1 51 53
M  V30 54 1 52 54
M  V30 55 2 53 55
M  V30 56 2 54 56
M  V30 57 1 55 56
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 7 18 19 37)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Leucinamide, N-[[[2-[carboxy[2-[(2-cyanoethyl)amino]ethyl]amino]ethyl]pheny...
C40H60N10O6
416898-04-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  56 57 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 10.6696 8.4700 0.0 0
M  V30 2 C 9.3358 7.7000 0.0 0
M  V30 3 C 12.0032 7.7000 0.0 0
M  V30 4 N 8.0021 8.4700 0.0 0
M  V30 5 O 9.3358 6.1600 0.0 0
M  V30 6 C 13.3369 8.4700 0.0 0
M  V30 7 C 6.6685 7.7000 0.0 0 CFG=1
M  V30 8 N 14.6705 7.7000 0.0 0
M  V30 9 C 5.3347 8.4700 0.0 0
M  V30 10 C 6.6685 6.1600 0.0 0
M  V30 11 C 16.0043 8.4700 0.0 0
M  V30 12 C 14.6705 6.1600 0.0 0
M  V30 13 N 5.3347 10.0100 0.0 0
M  V30 14 O 4.0011 7.7000 0.0 0
M  V30 15 N 17.3379 7.7000 0.0 0
M  V30 16 O 16.0043 10.0100 0.0 0
M  V30 17 C 16.0043 5.3900 0.0 0
M  V30 18 C 4.0011 10.7800 0.0 0 CFG=1
M  V30 19 C 18.6716 8.4700 0.0 0 CFG=1
M  V30 20 N 16.0043 3.8500 0.0 0
M  V30 21 C 4.0011 12.3200 0.0 0
M  V30 22 C 2.6674 10.0100 0.0 0
M  V30 23 C 20.0052 7.7000 0.0 0
M  V30 24 C 18.6716 10.0100 0.0 0
M  V30 25 C 17.3379 3.0800 0.0 0
M  V30 26 N 2.6674 13.0900 0.0 0
M  V30 27 O 5.3347 13.0900 0.0 0
M  V30 28 C 1.3338 10.7800 0.0 0
M  V30 29 N 21.3390 8.4700 0.0 0
M  V30 30 O 20.0052 6.1600 0.0 0
M  V30 31 C 20.0052 10.7800 0.0 0
M  V30 32 C 17.3379 10.7800 0.0 0
M  V30 33 C 17.3379 1.5400 0.0 0
M  V30 34 C 2.6674 14.6300 0.0 0
M  V30 35 C 1.3338 12.3200 0.0 0
M  V30 36 C 0.0000 10.0100 0.0 0
M  V30 37 C 22.6727 7.7000 0.0 0 CFG=1
M  V30 38 C 18.6716 0.7700 0.0 0
M  V30 39 C 24.0063 8.4700 0.0 0
M  V30 40 C 22.6727 6.1600 0.0 0
M  V30 41 N 20.0052 0.0000 0.0 0
M  V30 42 N 25.3399 7.7000 0.0 0
M  V30 43 O 24.0063 10.0100 0.0 0
M  V30 44 C 26.6737 8.4700 0.0 0
M  V30 45 C 10.6696 10.0100 0.0 0
M  V30 46 C 9.3358 10.7800 0.0 0
M  V30 47 C 12.0032 10.7800 0.0 0
M  V30 48 C 9.3358 12.3200 0.0 0
M  V30 49 C 12.0032 12.3200 0.0 0
M  V30 50 C 10.6696 13.0900 0.0 0
M  V30 51 C 5.3347 5.3900 0.0 0
M  V30 52 C 4.0011 6.1600 0.0 0
M  V30 53 C 5.3349 3.8500 0.0 0
M  V30 54 C 2.6674 5.3900 0.0 0
M  V30 55 C 4.0011 3.0800 0.0 0
M  V30 56 C 2.6674 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 45
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=1
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 2 9 14
M  V30 15 1 10 51
M  V30 16 1 11 15
M  V30 17 2 11 16
M  V30 18 1 12 17
M  V30 19 1 13 18
M  V30 20 1 15 19
M  V30 21 1 17 20
M  V30 22 1 18 21
M  V30 23 1 18 22 CFG=1
M  V30 24 1 19 23
M  V30 25 1 19 24 CFG=1
M  V30 26 1 20 25
M  V30 27 1 21 26
M  V30 28 2 21 27
M  V30 29 1 22 28
M  V30 30 1 23 29
M  V30 31 2 23 30
M  V30 32 1 24 31
M  V30 33 1 24 32
M  V30 34 1 25 33
M  V30 35 1 26 34
M  V30 36 1 28 35
M  V30 37 1 28 36
M  V30 38 1 29 37
M  V30 39 1 33 38
M  V30 40 1 37 39
M  V30 41 1 37 40 CFG=3
M  V30 42 3 38 41
M  V30 43 1 39 42
M  V30 44 2 39 43
M  V30 45 1 42 44
M  V30 46 2 45 46
M  V30 47 1 45 47
M  V30 48 1 46 48
M  V30 49 2 47 49
M  V30 50 2 48 50
M  V30 51 1 49 50
M  V30 52 2 51 52
M  V30 53 1 51 53
M  V30 54 1 52 54
M  V30 55 2 53 55
M  V30 56 2 54 56
M  V30 57 1 55 56
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 7 18 19 37)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 416898-03-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 416898-04-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5024353
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Three-stranded mixed artificial β-sheets
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nowick, James S.; Smith, Eric M.; Ziller, Joseph W.; Shaka, A. J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2002), 58(4), 727-739

$RFMT $RIREG SCHEME379 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Chloro-3-nitrophenoxy)-7-methoxy-6-quinolinecarboxylic acid
C17H11ClN2O6
417724-19-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0021 4.6201 0.0 0
M  V30 2 C 4.0010 0.7700 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 O 2.6673 0.0000 0.0 0
M  V30 5 O 1.3337 2.3100 0.0 0
M  V30 6 C 0.0000 3.0800 0.0 0
M  V30 7 N 13.3369 4.6201 0.0 0 VAL=5
M  V30 8 O 14.6705 5.3901 0.0 0
M  V30 9 O 13.3369 3.0800 0.0 0
M  V30 10 Cl 13.3369 7.7001 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 4.0010 5.3901 0.0 0
M  V30 13 C 6.6684 5.3901 0.0 0
M  V30 14 C 5.3348 3.0800 0.0 0
M  V30 15 C 2.6673 4.6201 0.0 0
M  V30 16 N 4.0010 6.9301 0.0 0
M  V30 17 C 6.6684 6.9301 0.0 0
M  V30 18 C 4.0010 2.3100 0.0 0
M  V30 19 C 2.6673 3.0800 0.0 0
M  V30 20 C 5.3348 7.7001 0.0 0
M  V30 21 C 9.3357 5.3901 0.0 0
M  V30 22 C 10.6695 4.6201 0.0 0
M  V30 23 C 9.3357 6.9301 0.0 0
M  V30 24 C 12.0032 5.3901 0.0 0
M  V30 25 C 10.6695 7.7001 0.0 0
M  V30 26 C 12.0032 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 18
M  V30 6 1 5 6
M  V30 7 1 5 19
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 24
M  V30 11 1 10 26
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 2 13 17
M  V30 18 2 14 18
M  V30 19 2 15 19
M  V30 20 2 16 20
M  V30 21 1 17 20
M  V30 22 1 18 19
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Chloro-3-nitrophenoxy)-7-methoxy-N-methyl-6-quinolinecarboxamide
C18H14ClN3O5
417724-20-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0020 6.1600 0.0 0
M  V30 2 C 4.0009 2.3100 0.0 0
M  V30 3 N 2.6673 1.5400 0.0 0
M  V30 4 O 5.3347 1.5400 0.0 0
M  V30 5 C 2.6673 0.0000 0.0 0
M  V30 6 O 1.3336 3.8500 0.0 0
M  V30 7 C 0.0000 4.6200 0.0 0
M  V30 8 N 13.3367 6.1600 0.0 0 VAL=5
M  V30 9 O 13.3367 4.6200 0.0 0
M  V30 10 O 14.6703 6.9300 0.0 0
M  V30 11 Cl 13.3367 9.2400 0.0 0
M  V30 12 C 5.3347 6.1600 0.0 0
M  V30 13 C 4.0009 6.9300 0.0 0
M  V30 14 C 6.6684 6.9300 0.0 0
M  V30 15 C 5.3347 4.6200 0.0 0
M  V30 16 C 2.6673 6.1600 0.0 0
M  V30 17 N 4.0009 8.4700 0.0 0
M  V30 18 C 6.6684 8.4700 0.0 0
M  V30 19 C 4.0009 3.8500 0.0 0
M  V30 20 C 2.6673 4.6200 0.0 0
M  V30 21 C 5.3347 9.2400 0.0 0
M  V30 22 C 9.3356 6.9300 0.0 0
M  V30 23 C 10.6694 6.1600 0.0 0
M  V30 24 C 9.3356 8.4700 0.0 0
M  V30 25 C 12.0031 6.9300 0.0 0
M  V30 26 C 10.6694 9.2400 0.0 0
M  V30 27 C 12.0031 8.4700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 19
M  V30 6 1 3 5
M  V30 7 1 6 7
M  V30 8 1 6 20
M  V30 9 2 8 9
M  V30 10 2 8 10
M  V30 11 1 8 25
M  V30 12 1 11 27
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 2 14 18
M  V30 19 2 15 19
M  V30 20 2 16 20
M  V30 21 2 17 21
M  V30 22 1 18 21
M  V30 23 1 19 20
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 417724-19-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 417724-20-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-12149300
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56602-33-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Production Example 538-3.
N6-Methyl-4-(4-chloro-3-nitrophenoxy)-7-methoxy-6-quinolinecarboxamide.
After dissolving
4-(4-chloro-3-nitrophenoxy)-7-methoxy-6-quinolinecarboxylic acid (897 mg,
2.39 mmol) in dimethylformamide (10 ml) under a nitrogen atmosphere, a
40% methylamine-methanol solution (2.0 ml), triethylamine (1.0 ml) and
(1H-1,2,3-benzotriazol-1-yloxy)(tri(dimethylamino)) phosphonium
hexafluorophosphate (1.27 g, 2.87 mmol) were added in that order at room
temperature and the mixture was stirred for 4 hours. The reaction
solution was distributed between ethyl acetate and water, and the organic
layer was washed with water and saturated brine and dried over anhydrous
sodium sulfate. The solvent was distilled off, the residue was suspended
in ethyl acetate and diluted with hexane, and the crystals were filtered
out and blow-dried to obtain the title compound (928 mg, quantitative) as
white crystals. 1H-NMR Spectrum (DMSO-d6 δ (ppm): 2.82 (3H, d, J = 4.4
Hz), 4.01 (3H, s), 6.77 (1H, d, J = 5.2 Hz), 7.54 (1H, s), 7.68 (1H, dd,
J = 2.8, 8.8 Hz), 7.90 (1H, d, J = 8.8 Hz), 8.13 (1H, d, J = 2.8 Hz),
8.35 (1H, d, J = 4.4 Hz), 8.53 (1H, s), 8.72 (1H, d, J = 5.2 Hz).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of urea derivatives containing nitrogenous aromatic ring
compounds as inhibitors of angiogenesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Funahashi, Yasuhiro; Tsuruoka, Akihiko; Matsukura, Masayuki; Haneda,
Toru; Fukuda, Yoshio; Kamata, Junichi; Takahashi, Keiko; Matsushima,
Tomohiro; Miyazaki, Kazuki; Nomoto, Ken-Ichi; Watanabe, Tatsuo; Obaishi,
Hiroshi; Yamaguchi, Atsumi; Suzuki, Sachi; Nakamura, Katsuji; Mimura,
Fusayo; Yamamoto, Yuji; Matsui, Junji; Matsui, Kenji; Yoshiba, Takako;
Suzuki, Yasuyuki; Arimoto, Itaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US7253286 B2 2007-08-07

$RFMT $RIREG SCHEME380 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,6,9,12,15-Pentaoxaheptadecane-1,17-diol, 1-4-methylbenzenesulfonate
C19H32O9S
42749-28-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.0801 5.3348 0.0 0 VAL=6
M  V30 2 O 4.4137 4.5648 0.0 0
M  V30 3 O 1.7462 6.1048 0.0 0
M  V30 4 O 3.8501 6.6687 0.0 0
M  V30 5 C 5.7474 5.3348 0.0 0
M  V30 6 C 7.0811 4.5648 0.0 0
M  V30 7 O 8.4149 5.3348 0.0 0
M  V30 8 C 9.7486 4.5648 0.0 0
M  V30 9 C 11.0822 5.3348 0.0 0
M  V30 10 O 12.4159 4.5648 0.0 0
M  V30 11 C 13.7497 5.3348 0.0 0
M  V30 12 C 15.0834 4.5648 0.0 0
M  V30 13 O 16.4171 5.3348 0.0 0
M  V30 14 C 17.7507 4.5648 0.0 0
M  V30 15 C 19.0846 5.3348 0.0 0
M  V30 16 O 20.4182 4.5648 0.0 0
M  V30 17 C 21.7519 5.3348 0.0 0
M  V30 18 C 23.0856 4.5648 0.0 0
M  V30 19 O 24.4194 5.3348 0.0 0
M  V30 20 C 25.7531 4.5648 0.0 0
M  V30 21 C 27.0867 5.3348 0.0 0
M  V30 22 O 28.4204 4.5648 0.0 0
M  V30 23 C 0.0000 0.0000 0.0 0
M  V30 24 C 2.3100 4.0012 0.0 0
M  V30 25 C 3.0801 2.6675 0.0 0
M  V30 26 C 0.7700 4.0012 0.0 0
M  V30 27 C 2.3100 1.3338 0.0 0
M  V30 28 C 0.0000 2.6675 0.0 0
M  V30 29 C 0.7700 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 24
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 1 19 20
M  V30 21 1 20 21
M  V30 22 1 21 22
M  V30 23 1 23 29
M  V30 24 2 24 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 2 26 28
M  V30 28 2 27 29
M  V30 29 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,6,9,12,15-Pentaoxa-18-azanonadecan-1-ol
C13H29NO6
2248764-53-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.3370 0.7700 0.0 0
M  V30 2 O 12.0033 0.0000 0.0 0
M  V30 3 C 14.6707 0.0000 0.0 0
M  V30 4 C 10.6697 0.7700 0.0 0
M  V30 5 O 16.0045 0.7700 0.0 0
M  V30 6 C 9.3358 0.0000 0.0 0
M  V30 7 C 17.3382 0.0000 0.0 0
M  V30 8 O 8.0022 0.7700 0.0 0
M  V30 9 C 18.6718 0.7700 0.0 0
M  V30 10 C 6.6685 0.0000 0.0 0
M  V30 11 O 20.0055 0.0000 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 21.3393 0.7700 0.0 0
M  V30 14 O 4.0010 0.0000 0.0 0
M  V30 15 C 22.6730 0.0000 0.0 0
M  V30 16 C 2.6673 0.7700 0.0 0
M  V30 17 N 24.0067 0.7700 0.0 0
M  V30 18 C 1.3337 0.0000 0.0 0
M  V30 19 C 25.3403 0.0000 0.0 0
M  V30 20 O 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 42749-28-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2248764-53-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24506991
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterobifunctional molecules useful as TEAD modulators for
treating cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zbieg, Jason Robert; Villemure, Elisia; Rudolph, Joachim; Beroza, Paul
Powell; Crawford, James John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021178339 A1 2021-09-10

$RFMT $RIREG SCHEME381 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1-(bromomethyl)-6-[1-hydroxy-2-methyl-1-[1-(triphenylmethyl)-1H-imidaz...
C39H35BrN2O3
430472-54-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 50 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.2206 6.2948 0.0 0
M  V30 2 C 8.2493 2.6675 0.0 0
M  V30 3 C 9.0193 1.3338 0.0 0
M  V30 4 O 6.9156 1.8975 0.0 0
M  V30 5 C 8.2493 0.0000 0.0 0
M  V30 6 C 10.5593 1.3338 0.0 0
M  V30 7 C 13.5841 7.2875 0.0 0
M  V30 8 Br 12.2504 8.0576 0.0 0
M  V30 9 C 16.2516 5.7475 0.0 0
M  V30 10 O 17.5852 4.9775 0.0 0
M  V30 11 O 16.2516 7.2875 0.0 0
M  V30 12 C 18.9189 5.7475 0.0 0
M  V30 13 N 5.6276 5.6685 0.0 0
M  V30 14 C 5.9477 4.1621 0.0 0
M  V30 15 C 6.9612 6.4385 0.0 0
M  V30 16 C 7.4793 4.0011 0.0 0
M  V30 17 N 8.1056 5.4081 0.0 0
M  V30 18 C 4.8471 7.7018 0.0 0
M  V30 19 C 6.3786 7.8627 0.0 0
M  V30 20 C 3.9418 8.9477 0.0 0
M  V30 21 C 7.0049 9.2696 0.0 0
M  V30 22 C 4.5682 10.3545 0.0 0
M  V30 23 C 6.0997 10.5156 0.0 0
M  V30 24 C 2.8138 6.9213 0.0 0
M  V30 25 C 1.5679 6.0161 0.0 0
M  V30 26 C 2.6528 8.4529 0.0 0
M  V30 27 C 0.1609 6.6424 0.0 0
M  V30 28 C 1.2459 9.0792 0.0 0
M  V30 29 C 0.0000 8.1740 0.0 0
M  V30 30 C 3.5943 4.8880 0.0 0
M  V30 31 C 4.4995 3.6422 0.0 0
M  V30 32 C 2.0627 4.7271 0.0 0
M  V30 33 C 3.8730 2.2352 0.0 0
M  V30 34 C 1.4362 3.3201 0.0 0
M  V30 35 C 2.3415 2.0743 0.0 0
M  V30 36 C 9.5829 3.4375 0.0 0
M  V30 37 C 10.9168 2.6675 0.0 0
M  V30 38 C 9.5829 4.9775 0.0 0
M  V30 39 C 12.2504 3.4375 0.0 0
M  V30 40 C 10.9168 5.7475 0.0 0
M  V30 41 C 12.2504 4.9775 0.0 0
M  V30 42 C 13.5841 2.6675 0.0 0
M  V30 43 C 13.5841 5.7475 0.0 0
M  V30 44 C 14.9177 3.4375 0.0 0
M  V30 45 C 14.9177 4.9775 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 18
M  V30 3 1 1 24
M  V30 4 1 1 30
M  V30 5 1 2 3
M  V30 6 1 2 4
M  V30 7 1 2 16
M  V30 8 1 2 36
M  V30 9 1 3 5
M  V30 10 1 3 6
M  V30 11 1 7 8
M  V30 12 1 7 43
M  V30 13 1 9 10
M  V30 14 2 9 11
M  V30 15 1 9 45
M  V30 16 1 10 12
M  V30 17 1 13 14
M  V30 18 1 13 15
M  V30 19 2 14 16
M  V30 20 2 15 17
M  V30 21 1 16 17
M  V30 22 2 18 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 2 20 22
M  V30 26 2 21 23
M  V30 27 1 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 40 2 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 39 42
M  V30 46 1 40 41
M  V30 47 1 41 43
M  V30 48 2 42 44
M  V30 49 2 43 45
M  V30 50 1 44 45
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2-Dihydro-7-[1-hydroxy-2-methyl-1-[1-(triphenylmethyl)-1H-imidazol-4-yl]pro...
C39H35N3O2
430472-50-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 50 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 6.6813 0.0 0
M  V30 2 C 7.6284 2.6528 0.0 0
M  V30 3 C 8.2549 1.2459 0.0 0
M  V30 4 O 6.2216 2.0263 0.0 0
M  V30 5 C 9.7864 1.0849 0.0 0
M  V30 6 C 7.3497 0.0000 0.0 0
M  V30 7 O 17.2124 4.6824 0.0 0
M  V30 8 C 16.1770 7.8688 0.0 0
M  V30 9 N 5.3347 5.9113 0.0 0
M  V30 10 C 5.4957 4.3798 0.0 0
M  V30 11 C 6.7417 6.5378 0.0 0
M  V30 12 C 7.0021 4.0596 0.0 0
M  V30 13 N 7.7721 5.3933 0.0 0
M  V30 14 C 4.7711 8.0151 0.0 0
M  V30 15 C 4.0011 9.3488 0.0 0
M  V30 16 C 6.3111 8.0151 0.0 0
M  V30 17 C 4.7711 10.6824 0.0 0
M  V30 18 C 7.0811 9.3488 0.0 0
M  V30 19 C 6.3111 10.6824 0.0 0
M  V30 20 C 2.6674 7.4513 0.0 0
M  V30 21 C 2.6674 8.9913 0.0 0
M  V30 22 C 1.3336 6.6813 0.0 0
M  V30 23 C 1.3336 9.7613 0.0 0
M  V30 24 C 0.0000 7.4513 0.0 0
M  V30 25 C 0.0000 8.9913 0.0 0
M  V30 26 C 3.2311 5.3477 0.0 0
M  V30 27 C 4.0011 4.0140 0.0 0
M  V30 28 C 1.6911 5.3477 0.0 0
M  V30 29 C 3.2311 2.6804 0.0 0
M  V30 30 C 0.9211 4.0140 0.0 0
M  V30 31 C 1.6911 2.6804 0.0 0
M  V30 32 C 9.0354 3.2791 0.0 0
M  V30 33 C 10.2812 2.3739 0.0 0
M  V30 34 C 9.1963 4.8107 0.0 0
M  V30 35 C 11.6880 3.0002 0.0 0
M  V30 36 C 10.6031 5.4370 0.0 0
M  V30 37 C 11.8491 4.5319 0.0 0
M  V30 38 C 12.9339 2.0952 0.0 0
M  V30 39 C 13.2559 5.1583 0.0 0
M  V30 40 C 14.3409 2.7215 0.0 0
M  V30 41 C 14.5018 4.2530 0.0 0
M  V30 42 C 13.7318 6.6230 0.0 0
M  V30 43 C 15.7477 5.1583 0.0 0
M  V30 44 N 15.2718 6.6230 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 14
M  V30 3 1 1 20
M  V30 4 1 1 26
M  V30 5 1 2 3
M  V30 6 1 2 4
M  V30 7 1 2 12
M  V30 8 1 2 32
M  V30 9 1 3 5
M  V30 10 1 3 6
M  V30 11 2 7 43
M  V30 12 1 8 44
M  V30 13 1 9 10
M  V30 14 1 9 11
M  V30 15 2 10 12
M  V30 16 2 11 13
M  V30 17 1 12 13
M  V30 18 2 14 15
M  V30 19 1 14 16
M  V30 20 1 15 17
M  V30 21 2 16 18
M  V30 22 2 17 19
M  V30 23 1 18 19
M  V30 24 2 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 2 22 24
M  V30 28 2 23 25
M  V30 29 1 24 25
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 36 1 32 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 1 35 38
M  V30 42 2 36 37
M  V30 43 1 37 39
M  V30 44 2 38 40
M  V30 45 2 39 41
M  V30 46 1 39 42
M  V30 47 1 40 41
M  V30 48 1 41 43
M  V30 49 1 42 44
M  V30 50 1 43 44
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 430472-54-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 430472-50-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-11803661
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 17,20-Lyase inhibitors. Part 4: Design, synthesis and structure-activity
relationships of naphthylmethylimidazole derivatives as novel 17,20-lyase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kaku, Tomohiro; Matsunaga, Nobuyuki; Ojida, Akio; Tanaka, Toshimasa;
Hara, Takahito; Yamaoka, Masuo; Kusaka, Masami; Tasaka, Akihiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2011), 19(5), 1751-1770

$RFMT $RIREG SCHEME382 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Picolyl chloride
C6H6ClN
4377-33-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 Cl 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 N 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-pyridinemethanamine
C7H10N2
21035-59-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 C 6.9302 2.6673 0.0 0
M  V30 4 C 3.0801 1.3337 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 N 2.3101 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4377-33-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 21035-59-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-11070107
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of highly potent triazole antifungal derivatives by
heterocycle-benzene bioisosteric replacement
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jiang, Zhigan; Wang, Yan; Wang, Wenya; Wang, Shengzheng; Xu, Bo; Fan,
Guorong; Dong, Guoqiang; Liu, Yang; Yao, Jianzhong; Miao, Zhenyuan;
Zhang, Wannian; Sheng, Chunquan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2013), 6416-22

$RFMT $RIREG SCHEME383 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Chloromethyl)quinoline
C10H8ClN
4377-41-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 3.0801 0.0 0
M  V30 2 Cl 8.0023 2.3101 0.0 0
M  V30 3 C 2.6675 2.3101 0.0 0
M  V30 4 C 2.6675 0.7700 0.0 0
M  V30 5 N 4.0012 3.0801 0.0 0
M  V30 6 C 1.3337 3.0801 0.0 0
M  V30 7 C 4.0012 0.0000 0.0 0
M  V30 8 C 1.3337 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-quinolinemethanamine
C11H12N2
136727-11-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 C 2.6675 2.3101 0.0 0
M  V30 5 C 2.6675 0.7700 0.0 0
M  V30 6 N 4.0012 3.0801 0.0 0
M  V30 7 C 1.3337 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4377-41-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 136727-11-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8940184
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of highly potent triazole antifungal derivatives by
heterocycle-benzene bioisosteric replacement
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jiang, Zhigan; Wang, Yan; Wang, Wenya; Wang, Shengzheng; Xu, Bo; Fan,
Guorong; Dong, Guoqiang; Liu, Yang; Yao, Jianzhong; Miao, Zhenyuan;
Zhang, Wannian; Sheng, Chunquan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2013), 6416-22

$RFMT $RIREG SCHEME384 STEP1
$RXN



  2  1
$MOL
5-Bromo-2-(difluoromethoxy)benzoic acid
C8H5BrF2O3
438221-79-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 4.0011 0.0 0
M  V30 2 C 1.5400 5.3347 0.0 0
M  V30 3 F 2.3100 6.6685 0.0 0
M  V30 4 F 0.0000 5.3347 0.0 0
M  V30 5 C 3.8500 1.3338 0.0 0
M  V30 6 O 2.3100 1.3338 0.0 0
M  V30 7 O 4.6200 0.0000 0.0 0
M  V30 8 Br 8.4700 4.0011 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 4.6200 5.3347 0.0 0
M  V30 12 C 6.1600 2.6674 0.0 0
M  V30 13 C 6.1600 5.3347 0.0 0
M  V30 14 C 6.9300 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-(difluoromethoxy)-N-methylbenzamide
C9H8BrF2NO2
1009303-67-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 5.3347 0.0 0
M  V30 2 C 1.5400 6.6685 0.0 0
M  V30 3 F 0.0000 6.6685 0.0 0
M  V30 4 F 2.3100 8.0021 0.0 0
M  V30 5 C 3.8500 2.6674 0.0 0
M  V30 6 N 4.6200 1.3336 0.0 0
M  V30 7 O 2.3100 2.6674 0.0 0
M  V30 8 C 3.8500 0.0000 0.0 0
M  V30 9 Br 8.4700 5.3347 0.0 0
M  V30 10 C 3.8500 5.3347 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 C 4.6200 6.6685 0.0 0
M  V30 13 C 6.1600 4.0011 0.0 0
M  V30 14 C 6.1600 6.6685 0.0 0
M  V30 15 C 6.9300 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 1 6 8
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 438221-79-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1009303-67-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-756739
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a solution of 5-bromo-2-difluoromethoxy-benzoic acid (1 equiv) in DMF
(0.1 M) was added triethylamine (4 equiv). The reaction mixture was
cooled to 0°C and HBTU (1.2 equiv) was added. The reaction mixture was
allowed to reach room temperature over 1 hour and methylamine
hydrochloride (2 equiv) was added. The reaction mixture was stirred at
room temperature for 2 hours. The reaction mixture was partitioned
between EtOAc and water and the aqueous phase was further extracted with
EtOAc. The combined organic phases were washed with water, dried with
magnesium sulphate, filtered and concentrated under in vacuo to give the
desired product in suitably clean form for use in subsequent reactions.
5-Bromo-2-difluoromethoxy-N-methyl-benzamide: (100 % yield, 75 % purity).
m/z (LC-MS, ESP): 280/282 [M+H]+, R/T = 3.55 min)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2-Methylmorpholine-substituted pyrido-, pyrazo- and pyrimidopyrimidine
derivatives as mTOR inhibitors and their preparation, pharmaceutical
compositions and use in the treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Duggan, Heather Mary Ellen; Leroux, Frederic Georges Marie; Malagu,
Karine; Martin, Niall Morrisson Barr; Menear, Keith Allan; Smith, Graeme
Cameron Murray
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008023161 A1 2008-02-28

$RFMT $RIREG SCHEME385 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3-Bromo-1-propen-1-yl)benzene
C9H9Br
4392-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 C 6.6686 3.0800 0.0 0
M  V30 4 Br 8.0022 2.3100 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 1.3337 3.0800 0.0 0
M  V30 7 C 2.6675 0.7700 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-N-Methyl-3-phenyl-2-propen-1-amine
C10H13N
83554-67-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 N 8.0023 2.3101 0.0 0
M  V30 5 C 9.3360 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 0.7700 0.0 0
M  V30 8 C 1.3337 3.0801 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4392-24-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 83554-67-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24414954
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Photoenzymatic generation of unstabilized alkyl radicals: An asymmetric
reductive cyclization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Clayman, Phillip D.; Hyster, Todd K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2020), 142(37), 15673-15677

$RFMT $RIREG SCHEME386 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-4-(2-furanyl)thieno[3,2-d]pyrimidine
C10H5ClN2OS
443147-54-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 7.7722 4.7474 0.0 0
M  V30 2 C 3.7711 3.9774 0.0 0
M  V30 3 C 3.7711 2.4374 0.0 0
M  V30 4 N 5.1047 4.7474 0.0 0
M  V30 5 C 5.1047 1.6674 0.0 0
M  V30 6 S 2.6267 1.4070 0.0 0
M  V30 7 C 6.4385 3.9774 0.0 0
M  V30 8 N 6.4385 2.4374 0.0 0
M  V30 9 C 4.7845 0.1611 0.0 0
M  V30 10 C 3.2530 0.0000 0.0 0
M  V30 11 C 2.4374 4.7474 0.0 0
M  V30 12 C 1.0304 4.1211 0.0 0
M  V30 13 O 2.2765 6.2790 0.0 0
M  V30 14 C 0.0000 5.2655 0.0 0
M  V30 15 C 0.7700 6.5993 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 2 4 7
M  V30 8 2 5 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 1 7 8
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2-Furanyl)-N-methylthieno[3,2-d]pyrimidin-2-amine
C11H9N3OS
443148-09-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.7722 4.7474 0.0 0
M  V30 2 C 9.1059 3.9774 0.0 0
M  V30 3 C 3.7711 3.9774 0.0 0
M  V30 4 C 3.7711 2.4374 0.0 0
M  V30 5 N 5.1047 4.7474 0.0 0
M  V30 6 C 5.1047 1.6674 0.0 0
M  V30 7 S 2.6267 1.4070 0.0 0
M  V30 8 C 6.4385 3.9774 0.0 0
M  V30 9 N 6.4385 2.4374 0.0 0
M  V30 10 C 4.7846 0.1611 0.0 0
M  V30 11 C 3.2530 0.0000 0.0 0
M  V30 12 C 2.4374 4.7474 0.0 0
M  V30 13 C 1.0304 4.1211 0.0 0
M  V30 14 O 2.2763 6.2790 0.0 0
M  V30 15 C 0.0000 5.2655 0.0 0
M  V30 16 C 0.7700 6.5993 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 12
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 5 8
M  V30 9 2 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 8 9
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 443147-54-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 443148-09-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2833962
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 872-50-4
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Antagonists of the human adenosine A2A receptor. Part 2: Design and
synthesis of 4-arylthieno[3,2-d]pyrimidine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gillespie, Roger J.; Cliffe, Ian A.; Dawson, Claire E.; Dourish, Colin
T.; Gaur, Suneel; Giles, Paul R.; Jordan, Allan M.; Knight, Antony R.;
Lawrence, Anthony; Lerpiniere, Joanne; Misra, Anil; Pratt, Robert M.;
Todd, Richard S.; Upton, Rebecca; Weiss, Scott M.; Williamson, Douglas S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2008), 18(9), 2920-2923

$RFMT $RIREG SCHEME387 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-4-methyl-1-nitrobenzene
C7H6FNO2
446-34-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 C 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,5-Dimethyl-2-nitrobenzenamine
C8H10N2O2
65081-42-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 C 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 446-34-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 65081-42-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-1296514
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient solution phase synthesis of 2-(N-acylamino)benzimidazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Seth, Punit P.; Robinson, Dale E.; Jefferson, Elizabeth A.; Swayze, Eric
E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2002), 43(41), 7303-7306

$RFMT $RIREG SCHEME388 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-4-methoxy-1-nitrobenzene
C7H6FNO3
446-38-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 F 1.3337 4.6201 0.0 0
M  V30 5 O 6.6686 4.6201 0.0 0
M  V30 6 C 8.0022 3.8500 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 2.6675 3.8500 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Methoxy-N-methyl-2-nitrobenzenamine
C8H10N2O3
69397-93-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0
M  V30 2 C 1.3336 6.1600 0.0 0
M  V30 3 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 4 O 0.0000 2.3100 0.0 0
M  V30 5 O 1.3336 0.0000 0.0 0
M  V30 6 O 6.6685 4.6200 0.0 0
M  V30 7 C 8.0021 3.8500 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 4.0011 4.6200 0.0 0
M  V30 11 C 4.0011 1.5400 0.0 0
M  V30 12 C 5.3347 3.8500 0.0 0
M  V30 13 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 446-38-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 69397-93-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-10036727
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzimidazole- and benzothiazole-quinones: excellent substrates for
NAD(P)H:quinone oxidoreductase 1
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Newsome, Jeffery J.; Colucci, Marie A.; Hassani, Mary; Beall, Howard D.;
Moody, Christopher J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2007), 5(22), 3665-3673

$RFMT $RIREG SCHEME389 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diglycolic anhydride
C4H4O4
4480-83-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.0800 0.0 0
M  V30 2 O 5.3349 3.0800 0.0 0
M  V30 3 O 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 1.3338 0.7700 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 O 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 4
M  V30 2 2 2 5
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2-(Methylamino)-2-oxoethoxy]acetic acid
C5H9NO4
63449-71-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 N 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 O 4.0012 1.5400 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4480-83-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 63449-71-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-14103249
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazole derivatives as inhibitors of STAT3
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Daniels, David J.; Parney, Ian F.; Peterson, Timothy E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013187965 A1 2013-12-19

$RFMT $RIREG SCHEME390 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-3-nitrobenzoic acid
C7H4FNO4
453-71-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 F 1.3336 4.6200 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylamino)-3-nitrobenzoic acid
C8H8N2O4
41263-74-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 6.1601 0.0 0 VAL=5
M  V30 2 O 5.3348 6.9302 0.0 0
M  V30 3 O 2.6675 6.9302 0.0 0
M  V30 4 N 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 453-71-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 41263-74-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-6113233
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7646-93-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1: 4-(Methylamino)-3-nitrobenzoic acid (279). A 40% solution of
methylamine in water (11 mL; 128mmol) (or any other primary amine) was
slowly added to a stirring suspension of 4-fluoro-3-nitrobenzoic acid
(278, 6.1g; 32.9mmol) in DMF (20mL) at room temperature. After the
addition was completed the mixture was stirred at the same temperature
for 60min; concentrated in vacuo, and suspended in 5% KHSO4 (final pH=2).
The suspension was stirred overnight; the precipitate was collected by
filtration, washed with water, then with ether and dried to afford the
title compound 279 (6.5g; 100% yield). 4-(Methylamino)-3-nitrobenzoic
acid (279), yield (6.5g; 100%). 1H NMR: (400.2 MHz, DMSO) δ (ppm): 12.8
(bs; 1H). 8.59 (d, J= 2.0 Hz; 1H); 8.55 (q, J= 5.0 Hz; 1H); 7.96 (dd, J=
2.0, 9.1 Hz; 1H); 7.04 (d, J= 9.1 Hz; 1H); 3.00 (d, J= 5.0 Hz; 3H). MS:
calc: 196.2; found: 197.1 (M+H)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of amide derivatives as inhibitors of histone deacetylase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Moradei, Oscar; Paquin, Isabelle; Leit, Silvana; Frechette, Sylvie;
Vaisburg, Arkadii; Besterman, Jeffrey M.; Tessier, Pierre; Mallais, Tammy
C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005030704 A1 2005-04-07

$RFMT $RIREG SCHEME391 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-1,2-dihydro-2-oxo-3-pyr...
C24H24ClN5O3
468741-39-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 6.9302 0.0 0
M  V30 2 C 4.0012 6.1601 0.0 0
M  V30 3 C 4.0012 4.6201 0.0 0
M  V30 4 O 5.3348 3.8501 0.0 0
M  V30 5 O 8.0022 11.5503 0.0 0
M  V30 6 C 12.7496 9.2858 0.0 0
M  V30 7 C 12.7496 3.9510 0.0 0
M  V30 8 O 14.2897 3.9510 0.0 0
M  V30 9 N 11.9796 2.6173 0.0 0
M  V30 10 C 15.0597 2.6173 0.0 0
M  V30 11 C 16.5997 2.6173 0.0 0
M  V30 12 Cl 1.3337 0.0000 0.0 0
M  V30 13 C 8.0022 8.4702 0.0 0
M  V30 14 N 9.4091 9.0965 0.0 0
M  V30 15 N 8.1633 6.9386 0.0 0
M  V30 16 C 10.4396 7.9521 0.0 0
M  V30 17 C 9.6696 6.6184 0.0 0
M  V30 18 C 11.9796 7.9521 0.0 0
M  V30 19 C 10.4396 5.2846 0.0 0
M  V30 20 C 12.7496 6.6184 0.0 0
M  V30 21 C 11.9796 5.2846 0.0 0
M  V30 22 C 6.6685 9.2402 0.0 0
M  V30 23 C 5.3348 8.4702 0.0 0
M  V30 24 C 6.6685 10.7802 0.0 0
M  V30 25 C 4.0012 9.2402 0.0 0
M  V30 26 N 5.3348 11.5503 0.0 0
M  V30 27 C 4.0012 10.7802 0.0 0
M  V30 28 C 2.6673 3.8501 0.0 0
M  V30 29 C 2.6673 2.3101 0.0 0
M  V30 30 C 1.3337 4.6201 0.0 0
M  V30 31 C 1.3337 1.5400 0.0 0
M  V30 32 C 0.0000 3.8501 0.0 0
M  V30 33 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 28
M  V30 6 2 5 24
M  V30 7 1 6 18
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 21
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 1 12 31
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 13 22
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[4-[[2-(3-Chlorophenyl)-2-hydroxyethyl]amino]-1,2-dihydro-2-oxo-3-pyridinyl...
C23H23ClN6O2
468738-68-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 6.9302 0.0 0
M  V30 2 C 4.0012 6.1601 0.0 0
M  V30 3 C 4.0012 4.6201 0.0 0
M  V30 4 O 5.3348 3.8501 0.0 0
M  V30 5 O 8.0022 11.5503 0.0 0
M  V30 6 C 12.7496 9.2858 0.0 0
M  V30 7 C 12.7496 3.9510 0.0 0
M  V30 8 N 14.2897 3.9510 0.0 0
M  V30 9 N 11.9796 2.6173 0.0 0
M  V30 10 C 15.0597 2.6173 0.0 0
M  V30 11 Cl 1.3337 0.0000 0.0 0
M  V30 12 C 8.0022 8.4702 0.0 0
M  V30 13 N 9.4091 9.0965 0.0 0
M  V30 14 N 8.1633 6.9386 0.0 0
M  V30 15 C 10.4396 7.9521 0.0 0
M  V30 16 C 9.6696 6.6184 0.0 0
M  V30 17 C 11.9796 7.9521 0.0 0
M  V30 18 C 10.4396 5.2846 0.0 0
M  V30 19 C 12.7496 6.6184 0.0 0
M  V30 20 C 11.9796 5.2846 0.0 0
M  V30 21 C 6.6685 9.2402 0.0 0
M  V30 22 C 5.3348 8.4702 0.0 0
M  V30 23 C 6.6685 10.7802 0.0 0
M  V30 24 C 4.0012 9.2402 0.0 0
M  V30 25 N 5.3348 11.5503 0.0 0
M  V30 26 C 4.0012 10.7802 0.0 0
M  V30 27 C 2.6673 3.8501 0.0 0
M  V30 28 C 2.6673 2.3101 0.0 0
M  V30 29 C 1.3337 4.6201 0.0 0
M  V30 30 C 1.3337 1.5400 0.0 0
M  V30 31 C 0.0000 3.8501 0.0 0
M  V30 32 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 27
M  V30 6 2 5 23
M  V30 7 1 6 17
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 20
M  V30 11 1 8 10
M  V30 12 1 11 30
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 21
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 468741-39-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 468738-68-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12408928
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Imidazole moiety replacements in the
3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one inhibitors of insulin-like
growth factor receptor-1 (IGF-1R) to improve cytochrome P450 profile
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Velaparthi, Upender; Liu, Peiying; Balasubramanian, Balu; Carboni, Joan;
Attar, Ricardo; Gottardis, Marco; Li, Aixin; Greer, Ann; Zoeckler, Mary;
Wittman, Mark D.; Vyas, Dolatrai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2007), 17(11), 3072-3076

$RFMT $RIREG SCHEME392 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Dioxaspiro[4.5]decan-8-one
C8H12O3
4746-97-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9898 1.3337 0.0 0
M  V30 2 C 2.3698 1.3337 0.0 0
M  V30 3 C 3.1398 2.6673 0.0 0
M  V30 4 C 3.1398 0.0000 0.0 0
M  V30 5 O 1.4646 0.0878 0.0 0
M  V30 6 O 1.4646 2.5795 0.0 0
M  V30 7 C 4.6798 2.6673 0.0 0
M  V30 8 C 4.6798 0.0000 0.0 0
M  V30 9 C 0.0000 0.5636 0.0 0
M  V30 10 C 0.0000 2.1037 0.0 0
M  V30 11 C 5.4498 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 11
M  V30 12 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-1,4-Dioxaspiro[4.5]dec-8-ylidenemethanamine
C9H15NO2
1071066-97-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.4386 4.1618 0.0 0
M  V30 2 C 7.7722 3.3918 0.0 0
M  V30 3 C 2.4374 1.8517 0.0 0
M  V30 4 C 3.7711 1.0817 0.0 0
M  V30 5 C 2.4374 3.3918 0.0 0
M  V30 6 O 1.0304 2.4782 0.0 0
M  V30 7 O 2.2765 0.3202 0.0 0
M  V30 8 C 5.1048 1.8517 0.0 0
M  V30 9 C 3.7711 4.1618 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 11 C 0.7700 0.0000 0.0 0
M  V30 12 C 5.1048 3.3918 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 12
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 12
M  V30 13 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4746-97-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1071066-97-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-1308794
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM a) N-(1,4-dioxaspiro-[4,5]-decan-8-yliden)-methanamine Synthesis of the
imine Cyclohexane dion monoethylene ketal (50 g, 0.32 mol) was mixed with
methylamine solution (8 M in ethanol, 100 ml, 0.80 mol) and then with
ethanol (100 ml). The batch was stirred for 2-24 h at room temperature.
The ethanol was distilled off at 40-45 °C at reduced pressure. Yield:
100%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Method for synthesis of aminocyclohexanone derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pruehs, Stefan; Griebel, Carsten; Mueller, Marita
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012076165 A1 2012-06-14

$RFMT $RIREG SCHEME393 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl oxalyl chloride
C4H5ClO3
4755-77-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 O 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 O 2.6674 3.8500 0.0 0
M  V30 5 C 5.3347 2.3100 0.0 0
M  V30 6 Cl 0.0000 2.3100 0.0 0
M  V30 7 O 1.3338 0.0000 0.0 0
M  V30 8 C 6.6685 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetic acid, 2-(methylamino)-2-oxo-, ethyl ester
C5H9NO3
18522-95-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 O 5.3348 2.3100 0.0 0
M  V30 4 O 4.0011 0.0000 0.0 0
M  V30 5 N 1.3337 1.5400 0.0 0
M  V30 6 O 2.6675 3.8500 0.0 0
M  V30 7 C 6.6686 1.5400 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 8.0022 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 5 8
M  V30 8 1 7 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4755-77-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 18522-95-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-17774985
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Evaluation of the Highly Selective and Potent
G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential
Treatment of Heart Failure
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Okawa, Tomohiro; Aramaki, Yoshio; Yamamoto, Mitsuo; Kobayashi, Toshitake;
Fukumoto, Shoji; Toyoda, Yukio; Henta, Tsutomu; Hata, Akito; Ikeda,
Shota; Kaneko, Manami; Hoffman, Isaac D.; Sang, Bi-Ching; Zou, Hua;
Kawamoto, Tetsuji
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2017), 60(16), 6942-6990

$RFMT $RIREG SCHEME394 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Butenenitrile
C4H5N
4786-20-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 1.3336 0.0 0
M  V30 2 C 1.5400 0.0000 0.0 0
M  V30 3 C 3.8500 1.3336 0.0 0
M  V30 4 C 0.0000 0.0000 0.0 0
M  V30 5 N 5.3900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Methylamino)butanenitrile
C5H10N2
67744-69-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 C 4.0011 2.3100 0.0 0
M  V30 3 N 1.3338 2.3100 0.0 0
M  V30 4 C 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 N 6.6686 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 3 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4786-20-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 67744-69-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-2705118
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Carbazole derivatives as cryptochrome modulators and their preparation
and use for the treatment of Cry-mediated diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bersot, Ross; Humphries, Paul
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20150284362 A1 2015-10-08

$RFMT $RIREG SCHEME395 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Chloromethyl)benzimidazole
C8H7ClN2
4857-04-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0811 3.9554 0.0 0
M  V30 2 Cl 7.4149 3.1854 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3100 2.6673 0.0 0
M  V30 5 N 4.5865 1.6538 0.0 0
M  V30 6 C 2.3100 0.0000 0.0 0
M  V30 7 N 3.3406 3.8119 0.0 0
M  V30 8 C 0.7700 2.6673 0.0 0
M  V30 9 C 4.7474 3.1854 0.0 0
M  V30 10 C 0.7700 0.0000 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1H-benzimidazole-2-methanamine
C9H11N3
98997-01-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5772 1.5400 0.0 0
M  V30 2 N 7.3472 2.8737 0.0 0
M  V30 3 C 8.8872 2.8737 0.0 0
M  V30 4 C 2.6673 2.3101 0.0 0
M  V30 5 C 2.6673 0.7700 0.0 0
M  V30 6 N 4.1321 2.7859 0.0 0
M  V30 7 C 1.3337 3.0801 0.0 0
M  V30 8 N 4.1321 0.2941 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 5.0371 1.5400 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4857-04-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 98997-01-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-13197972
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of highly potent triazole antifungal derivatives by
heterocycle-benzene bioisosteric replacement
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jiang, Zhigan; Wang, Yan; Wang, Wenya; Wang, Shengzheng; Xu, Bo; Fan,
Guorong; Dong, Guoqiang; Liu, Yang; Yao, Jianzhong; Miao, Zhenyuan;
Zhang, Wannian; Sheng, Chunquan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2013), 6416-22

$RFMT $RIREG SCHEME396 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloro-5-nitropyrimidine
C4HCl2N3O2
49845-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 Cl 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 N 4.6201 1.3337 0.0 0
M  V30 10 N 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methyl-5-nitro-4-pyrimidinamine
C5H5ClN4O2
89283-49-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Cl 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 N 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 N 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 49845-33-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 89283-49-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-5595750
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted acrylamides as inhibitors of the fibroblast
growth factor receptor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bifulco, Neil, Jr.; Brooijmans, Natasja; Hodous, Brian L.; Kim, Joseph
L.; Miduturu, Chandrasekhar V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014011900 A2 2014-01-16

$RFMT $RIREG SCHEME397 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-chloro-4,4-difluoro-3-(phenylamino)-2-butenoate
C11H10ClF2NO2
850339-09-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6675 0.0 0
M  V30 2 N 3.0801 2.6675 0.0 0
M  V30 3 C 5.3901 4.0012 0.0 0
M  V30 4 C 5.3901 1.3338 0.0 0
M  V30 5 C 6.9302 4.0012 0.0 0
M  V30 6 Cl 6.7238 2.1038 0.0 0
M  V30 7 F 6.1601 0.0000 0.0 0
M  V30 8 F 4.0564 0.5638 0.0 0
M  V30 9 O 7.7002 5.3348 0.0 0
M  V30 10 O 7.7002 2.6675 0.0 0
M  V30 11 C 9.2402 5.3348 0.0 0
M  V30 12 C 2.3101 4.0012 0.0 0
M  V30 13 C 3.0801 5.3348 0.0 0
M  V30 14 C 0.7700 4.0012 0.0 0
M  V30 15 C 2.3101 6.6687 0.0 0
M  V30 16 C 0.0000 5.3348 0.0 0
M  V30 17 C 0.7700 6.6687 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 1 4
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 5 9
M  V30 10 2 5 10
M  V30 11 1 9 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-(chlorodifluoromethyl)-1,2,3,6-tetrahydro-1-methyl-3-phenyl-5-pyrimi...
C14H15ClF2N2O2
850339-01-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 6.1600 0.0 0
M  V30 2 Cl 6.8747 6.1600 0.0 0
M  V30 3 F 5.3347 7.7000 0.0 0
M  V30 4 F 3.7947 6.1600 0.0 0
M  V30 5 C 8.0021 4.6200 0.0 0
M  V30 6 O 9.3358 3.8500 0.0 0
M  V30 7 O 8.0021 6.1600 0.0 0
M  V30 8 C 10.6694 4.6200 0.0 0
M  V30 9 C 5.3347 0.0000 0.0 0
M  V30 10 N 4.0011 3.8500 0.0 0
M  V30 11 C 5.3347 4.6200 0.0 0
M  V30 12 C 4.0011 2.3100 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 N 5.3347 1.5400 0.0 0
M  V30 15 C 6.6684 2.3100 0.0 0
M  V30 16 C 2.6673 4.6200 0.0 0
M  V30 17 C 2.6673 6.1600 0.0 0
M  V30 18 C 1.3336 3.8500 0.0 0
M  V30 19 C 1.3336 6.9300 0.0 0
M  V30 20 C 0.0000 4.6200 0.0 0
M  V30 21 C 0.0000 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 1 6 8
M  V30 9 1 9 14
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 16
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 850339-09-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 850339-01-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-11271161
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A novel and efficient synthesis of fluoroalkylated multifunctional
1,2,3,4-tetrahydropyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhao, Fu-Lu; Liu, Jin-Tao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Fluorine Chemistry (2004), 125(12), 1841-1845

$RFMT $RIREG SCHEME398 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 6-chloro-4,4,5,5,6,6-hexafluoro-3-(phenylamino)-2-hexenoate
C13H10ClF6NO2
850339-11-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 5.3347 0.0 0
M  V30 2 C 4.6200 5.3347 0.0 0
M  V30 3 N 6.9300 4.0011 0.0 0
M  V30 4 C 6.9300 6.6685 0.0 0
M  V30 5 C 3.0800 5.3347 0.0 0
M  V30 6 F 4.6200 6.8747 0.0 0
M  V30 7 F 4.6200 3.7947 0.0 0
M  V30 8 C 8.4700 6.6685 0.0 0
M  V30 9 C 1.5400 5.3347 0.0 0
M  V30 10 F 3.0800 6.8747 0.0 0
M  V30 11 F 3.0800 3.7947 0.0 0
M  V30 12 O 9.2400 8.0021 0.0 0
M  V30 13 O 9.2400 5.3347 0.0 0
M  V30 14 Cl 0.0000 5.3347 0.0 0
M  V30 15 F 1.5400 6.8747 0.0 0
M  V30 16 F 1.5400 3.7947 0.0 0
M  V30 17 C 10.7800 8.0021 0.0 0
M  V30 18 C 6.1600 2.6674 0.0 0
M  V30 19 C 6.9300 1.3336 0.0 0
M  V30 20 C 4.6200 2.6674 0.0 0
M  V30 21 C 6.1600 0.0000 0.0 0
M  V30 22 C 3.8500 1.3336 0.0 0
M  V30 23 C 4.6200 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4 CFG=2
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 3 18
M  V30 8 1 4 8
M  V30 9 1 5 9
M  V30 10 1 5 10
M  V30 11 1 5 11
M  V30 12 1 8 12
M  V30 13 2 8 13
M  V30 14 1 9 14
M  V30 15 1 9 15
M  V30 16 1 9 16
M  V30 17 1 12 17
M  V30 18 2 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 2 20 22
M  V30 22 2 21 23
M  V30 23 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-(3-chloro-1,1,2,2,3,3-hexafluoropropyl)-1,2,3,6-tetrahydro-1-methyl-...
C16H15ClF6N2O2
850339-06-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 6.1600 0.0 0
M  V30 2 C 6.6684 6.9300 0.0 0
M  V30 3 F 4.5647 7.4936 0.0 0
M  V30 4 F 3.7947 6.1600 0.0 0
M  V30 5 C 6.6684 8.4700 0.0 0
M  V30 6 F 7.4384 5.5964 0.0 0
M  V30 7 F 8.2084 6.9300 0.0 0
M  V30 8 Cl 5.1284 8.4700 0.0 0
M  V30 9 F 6.6684 10.0100 0.0 0
M  V30 10 F 8.2084 8.4700 0.0 0
M  V30 11 C 8.0021 4.6200 0.0 0
M  V30 12 O 9.3358 3.8500 0.0 0
M  V30 13 O 8.0021 6.1600 0.0 0
M  V30 14 C 10.6694 4.6200 0.0 0
M  V30 15 C 5.3347 0.0000 0.0 0
M  V30 16 C 5.3347 4.6200 0.0 0
M  V30 17 N 4.0011 3.8500 0.0 0
M  V30 18 C 6.6684 3.8500 0.0 0
M  V30 19 C 4.0011 2.3100 0.0 0
M  V30 20 C 6.6684 2.3100 0.0 0
M  V30 21 N 5.3347 1.5400 0.0 0
M  V30 22 C 2.6673 4.6200 0.0 0
M  V30 23 C 2.6673 6.1600 0.0 0
M  V30 24 C 1.3336 3.8500 0.0 0
M  V30 25 C 1.3336 6.9300 0.0 0
M  V30 26 C 0.0000 4.6200 0.0 0
M  V30 27 C 0.0000 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 16
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 2 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 5 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 18
M  V30 14 1 12 14
M  V30 15 1 15 21
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 1 17 19
M  V30 19 1 17 22
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 850339-11-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 850339-06-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-4244530
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A novel and efficient synthesis of fluoroalkylated multifunctional
1,2,3,4-tetrahydropyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhao, Fu-Lu; Liu, Jin-Tao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Fluorine Chemistry (2004), 125(12), 1841-1845

$RFMT $RIREG SCHEME399 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(3-Bromophenoxy)methyl]oxirane
C9H9BrO2
5002-98-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 2.3101 0.0 0
M  V30 2 O 5.3348 3.0801 0.0 0
M  V30 3 Br 0.0000 3.0801 0.0 0
M  V30 4 C 8.0023 3.0801 0.0 0
M  V30 5 C 9.5424 3.0801 0.0 0
M  V30 6 O 8.7723 4.4137 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 2.6675 3.0801 0.0 0
M  V30 9 C 4.0012 0.7700 0.0 0
M  V30 10 C 1.3337 2.3101 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 2 7
M  V30 4 1 3 10
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3-Bromophenoxy)-3-(methylamino)-2-propanol
C10H14BrNO2
1019528-50-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 3.0801 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 O 8.0022 4.6201 0.0 0
M  V30 6 N 10.6697 3.0801 0.0 0
M  V30 7 C 12.0033 2.3101 0.0 0
M  V30 8 Br 0.0000 3.0801 0.0 0
M  V30 9 C 4.0012 2.3101 0.0 0
M  V30 10 C 2.6673 3.0801 0.0 0
M  V30 11 C 4.0012 0.7700 0.0 0
M  V30 12 C 1.3337 2.3101 0.0 0
M  V30 13 C 2.6673 0.0000 0.0 0
M  V30 14 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5002-98-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1019528-50-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-19775245
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM CARM1 inhibitors for treating Cancer and Metabolic disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chesworth, Richard; Moradei, Oscar Miguel; Shapiro, Gideon; Jin, Lei;
Babine, Robert E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016044641 A2 2016-03-24

$RFMT $RIREG SCHEME399 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(3-Bromophenoxy)methyl]oxirane
C9H9BrO2
5002-98-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 2.3101 0.0 0
M  V30 2 O 5.3348 3.0801 0.0 0
M  V30 3 Br 0.0000 3.0801 0.0 0
M  V30 4 C 8.0023 3.0801 0.0 0
M  V30 5 C 9.5424 3.0801 0.0 0
M  V30 6 O 8.7723 4.4137 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 2.6675 3.0801 0.0 0
M  V30 9 C 4.0012 0.7700 0.0 0
M  V30 10 C 1.3337 2.3101 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 2 7
M  V30 4 1 3 10
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3-Bromophenoxy)-3-(methylamino)-2-propanol
C10H14BrNO2
1019528-50-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 3.0801 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 O 8.0022 4.6201 0.0 0
M  V30 6 N 10.6697 3.0801 0.0 0
M  V30 7 C 12.0033 2.3101 0.0 0
M  V30 8 Br 0.0000 3.0801 0.0 0
M  V30 9 C 4.0012 2.3101 0.0 0
M  V30 10 C 2.6673 3.0801 0.0 0
M  V30 11 C 4.0012 0.7700 0.0 0
M  V30 12 C 1.3337 2.3101 0.0 0
M  V30 13 C 2.6673 0.0000 0.0 0
M  V30 14 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5002-98-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1019528-50-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-13260249
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1-Amino-3-(aryloxy)propanol derivatives as CARM1 inhibitors and uses
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chesworth, Richard; Moradei, Oscar Miguel; Shapiro, Gideon; Jin, Lei;
Babine, Robert E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014144169 A1 2014-09-18

$RFMT $RIREG SCHEME400 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Cyclohexanedione
C6H8O2
504-02-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.0800 0.0 0
M  V30 2 O 5.3349 3.0800 0.0 0
M  V30 3 C 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 1.3338 0.7700 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 4
M  V30 2 2 2 5
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Methylamino)-2-cyclohexen-1-one
C7H11NO
55998-74-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0801 0.0 0
M  V30 2 C 6.6687 2.3101 0.0 0
M  V30 3 O 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 2 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 504-02-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 55998-74-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-6568980
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM Dean-Stark trap used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper(II)-Mediated Synthesis of Indolequinones from Bromoquinones and
Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Inman, Martyn; Moody, Christopher J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2013), 2013(11), 2179-2187

$RFMT $RIREG SCHEME401 STEP1
$RXN



  2  1
$MOL
Ribose
C5H10O5
50-69-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0 CFG=1
M  V30 2 C 2.6674 2.3100 0.0 0 CFG=2
M  V30 3 C 5.3347 2.3100 0.0 0 CFG=1
M  V30 4 O 4.0011 0.0000 0.0 0
M  V30 5 C 1.3336 1.5400 0.0 0
M  V30 6 O 2.6674 3.8500 0.0 0
M  V30 7 C 6.6685 1.5400 0.0 0
M  V30 8 O 5.3347 3.8500 0.0 0
M  V30 9 O 0.0000 2.3100 0.0 0
M  V30 10 O 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=1
M  V30 6 1 3 7
M  V30 7 1 3 8 CFG=1
M  V30 8 1 5 9
M  V30 9 2 7 10
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 2 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Deoxy-1-(methylamino)-D-ribitol
C6H15NO4
7115-47-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0 CFG=2
M  V30 2 C 5.3348 2.3100 0.0 0 CFG=1
M  V30 3 C 2.6675 2.3100 0.0 0 CFG=2
M  V30 4 O 4.0011 0.0000 0.0 0
M  V30 5 C 6.6684 1.5400 0.0 0
M  V30 6 O 5.3348 3.8500 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 O 2.6675 3.8500 0.0 0
M  V30 9 N 8.0022 2.3100 0.0 0
M  V30 10 O 0.0000 2.3100 0.0 0
M  V30 11 C 9.3359 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=1
M  V30 6 1 3 7
M  V30 7 1 3 8 CFG=1
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 1 9 11
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 2 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-69-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 7115-47-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-940442
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1314-15-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-Methylribitylamine (28).28 Methylamine (10.0 mL, 2.0 M in MeOH, 20
mmol) was added to a solution of D-ribose (27) (3.0 g, 18.3 mmol) in MeOH
(40 mL). After the solution was stirred at room temperature for 4 h, PtO2
(200 mg) was added. The mixture was degassed and hydrogenated at 40 psi
for 12 h. The mixture was filtered and solvent was removed to give 28 as
a yellow glass (3.0 g, 100%). N-Methylribitylamine (28).28, yield (3.0 g,
100%). 1H NMR (300 MHz, CD3OD) δ 3.88-3.51 (m, 5 H), 2.85-2.80 (m, 1 H),
2.70-2.63 (m, 1 H), 2.40 (s, 3 H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Evaluation of Acyclic C-Nucleoside and
N-Methylated Derivatives of the Ribitylaminopyrimidine Substrate of
Lumazine Synthase as Potential Enzyme Inhibitors and Mechanistic Probes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Jinhua; Sambaiah, Thota; Illarionov, Boris; Fischer, Markus;
Bacher, Adelbert; Cushman, Mark
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2004), 69(21), 6996-7003

$RFMT $RIREG SCHEME402 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(Phenylmethoxy)carbonyl]-L-prolyl-L-alanine methyl ester
C17H22N2O5
51782-87-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.2620 3.4208 0.0 0
M  V30 2 N 11.7682 3.1006 0.0 0
M  V30 3 O 9.7861 4.8854 0.0 0
M  V30 4 C 12.7988 4.2450 0.0 0 CFG=1
M  V30 5 C 14.3050 3.9248 0.0 0
M  V30 6 C 12.3228 5.7096 0.0 0
M  V30 7 O 15.3354 5.0693 0.0 0
M  V30 8 O 14.7809 2.4603 0.0 0
M  V30 9 C 16.8418 4.7491 0.0 0
M  V30 10 C 6.9299 3.7709 0.0 0
M  V30 11 O 5.3899 3.7709 0.0 0
M  V30 12 O 7.6999 5.1047 0.0 0
M  V30 13 C 4.6199 5.1047 0.0 0
M  V30 14 C 9.2314 2.2764 0.0 0 CFG=2
M  V30 15 N 7.6999 2.4373 0.0 0
M  V30 16 C 9.5517 0.7700 0.0 0
M  V30 17 C 7.0736 1.0306 0.0 0
M  V30 18 C 8.2179 0.0000 0.0 0
M  V30 19 C 3.0800 5.1047 0.0 0
M  V30 20 C 2.3100 3.7709 0.0 0
M  V30 21 C 2.3100 6.4383 0.0 0
M  V30 22 C 0.7700 3.7709 0.0 0
M  V30 23 C 0.7700 6.4383 0.0 0
M  V30 24 C 0.0000 5.1047 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 14 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=1
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 15
M  V30 13 1 11 13
M  V30 14 1 13 19
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-[(Phenylmethoxy)carbonyl]-L-prolyl-N-methyl-L-alaninamide
C17H23N3O4
63095-75-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.2620 3.4208 0.0 0
M  V30 2 N 11.7682 3.1006 0.0 0
M  V30 3 O 9.7861 4.8854 0.0 0
M  V30 4 C 12.7988 4.2450 0.0 0 CFG=1
M  V30 5 C 14.3050 3.9248 0.0 0
M  V30 6 C 12.3228 5.7096 0.0 0
M  V30 7 N 15.3354 5.0693 0.0 0
M  V30 8 O 14.7809 2.4603 0.0 0
M  V30 9 C 16.8418 4.7491 0.0 0
M  V30 10 C 6.9299 3.7709 0.0 0
M  V30 11 O 5.3899 3.7709 0.0 0
M  V30 12 O 7.6999 5.1047 0.0 0
M  V30 13 C 4.6199 5.1047 0.0 0
M  V30 14 C 9.2314 2.2764 0.0 0 CFG=2
M  V30 15 N 7.6999 2.4373 0.0 0
M  V30 16 C 9.5517 0.7700 0.0 0
M  V30 17 C 7.0736 1.0306 0.0 0
M  V30 18 C 8.2179 0.0000 0.0 0
M  V30 19 C 3.0800 5.1047 0.0 0
M  V30 20 C 2.3100 3.7709 0.0 0
M  V30 21 C 2.3100 6.4383 0.0 0
M  V30 22 C 0.7700 3.7709 0.0 0
M  V30 23 C 0.7700 6.4383 0.0 0
M  V30 24 C 0.0000 5.1047 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 14 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=1
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 15
M  V30 13 1 11 13
M  V30 14 1 13 19
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 51782-87-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 63095-75-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-23052780
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General Procedures for the Preparation of RCO-Xaa-Ala- NHMe Derivatives.
Method A: The corresponding ester (4.22 mmol) was dissolved in MeNH2·EtOH
(10 mL, 8M) and reacted over 2-12 h at room temperature. When necessary,
the reaction was purified by flash chromatography or centrifugal circular
thinlayer chromatography, using the system of eluents indicated in each
case. Z-L-Pro-L-Ala-NHMe (8a): Solid, 100% yield (from 5a, Method A). (mp
129-131 °C). HPLC: tR= 9.55 min (trans isomer) and 8.21 min (cis isomer)
(A:B = 15:85). [α]D -89.12 (c 1, CHCl3). 1H NMR (CDCl3): cis/trans
isomers ratio: 1:2.6. Trans isomer: δ 7.25 (m, 5H, Ph), 6.95 (d, 1H, J =
7.2 Hz, NH-Ala), 6.86 (br s, 1H, NH-CH3), 5.05 (br s, 2H, CH2-Z), 4.38
(q, 1H, J = 7.2 Hz, α-H, Ala), 4.25 (m, 1H, α-H, Pro), 3.45 (m, 2H, δ -H,
Pro), 2.65 (m, 3H, CH3-NH), 2.04 (m, 2H, β-H, Pro), 1.83 (m, 2H, γ-H,
Pro), 1.25 (d, 3H, J = 7.2 Hz, β-H, Ala); cis isomer: δ 7.25 (m, 5H, Ph),
6.95 (m, 1H, NH-Ala), 6.86 (br s, 1H, NH-CH3), 5.05 (br s, 2H, CH2-Z),
4.38 (m, 1H, α-H, Ala), 4.25 (m, 1H, α-H, Pro), 3.45 (m, 2H, δ -H, Pro),
2.58 (br s, 3H, CH3-NH), 2.04 (m, 2H, δ -H, Pro), 1.83 (m, 2H, γ-H, Pro),
1.15 (br s, 3H, β-H, Ala). 1H NMR (DMSO-d6): cis/trans isomers ratio:
1:1.15. Trans isomer: δ 8.02 (m, 1H, NH-Ala), 7.71 (m, 1H, NH-CH3), 7.33
(m, 5H, Ph), 5.06 (d, 1H, J = 12.8 Hz, CH2-Z), 4.94 (d, 1H, J = 12.8 Hz,
CH2-Z), 4.25 (m, 1H, α-H, Pro), 4.19 (q, 1H, J = 7.2 Hz, α-H, Ala), 3.40
(m, 2H, δ -H, Pro), 2.55 (br s, 3H, CH3-NH), 2.10 (m, 1H, β-H, Pro), 1.82
(m, 3H, β-H, Pro, γ-H, Pro), 1.06 (d, 3H, J = 7.2 Hz, β-H, Ala); cis
isomer: δ 8.02 (m, 1H, NH-Ala), 7.62 (m, 1H, NHCH3), 7.33 (m, 5H, Ph),
5.05 (s, 2H, CH2-Z), 4.19 (m, 1H, J = 7.2 Hz, α-H, Ala), 4.17 (m, 1H,
α-H, Pro), 3.40 (m, 2H, δ -H, Pro), 2.55 (br s, 3H, CH3-NH), 2.10 (m, 1H,
β-H, Pro), 1.82 (m, 3H, β-H, Pro, γ-H, Pro), 1.18 (d, 3H, J = 7.2 Hz,
β-H, Ala). 13C NMR (CDCl3): trans isomer: δ 172.5 and 171.6 (CON), 155.8
(OCON), 136.1 (C-Ph), 128.3, 128.0, 127.6 (CH-Ph), 67.2 (CH2-Z), 60.8
(α-C, Pro), 48.7 (α-C, Ala), 47.0 (δ -C, Pro), 29.3 (β-C, Pro), 26.0
(CH3-NH), 24.4 (γ-C, Pro), 17.8 (β-C, Ala); cis isomer: δ 172.1 and 171.6
(CON), 154.6 (OCON), 136.1 (C-Ph), 128.3, 128.2, 127.6 (CH-Ph), 67.2
(CH2-Z), 60.4 (α-C, Pro), 48.7 (α-C, Ala), 47.3 (δ - C, Pro), 31.1 (β-C,
Pro), 26.0 (CH3-NH), 23.5 (γ-C, Pro), 18.2 (β-C, Ala). ES-MS: 334.0 [M +
1]+, 356.0 [M + Na]+. Anal. Calcd for C17H23N3O4: C 61.25, H 6.95, N
12.60. Found: C 61.44, H 6.88, N 12.80
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Azetidine-Derived Amino Acids versus Proline Derivatives. Alternative
Trends in Reverse Turn Induction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baeza, Jose Luis; Gerona-Navarro, Guillermo; Perez de Vega, M. Jesus;
Garcia-Lopez, M. Teresa; Gonzalez-Muniz, Rosario; Martin-Martinez,
Mercedes
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2008), 73(5), 1704-1715

$RFMT $RIREG SCHEME403 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-formylbenzoate
C9H8O3
52178-50-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 3.0801 0.0 0
M  V30 2 O 1.3337 2.3101 0.0 0
M  V30 3 O 2.6675 4.6201 0.0 0
M  V30 4 C 0.0000 3.0801 0.0 0
M  V30 5 C 8.0023 3.0801 0.0 0
M  V30 6 O 9.3360 2.3101 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 5.3348 3.0801 0.0 0
M  V30 9 C 4.0012 0.7700 0.0 0
M  V30 10 C 6.6685 2.3101 0.0 0
M  V30 11 C 5.3348 0.0000 0.0 0
M  V30 12 C 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-[(methylamino)methyl]-, methyl ester
C10H13NO2
922163-35-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 3.0801 0.0 0
M  V30 2 O 1.3337 2.3101 0.0 0
M  V30 3 O 2.6673 4.6201 0.0 0
M  V30 4 C 0.0000 3.0801 0.0 0
M  V30 5 C 8.0023 3.0801 0.0 0
M  V30 6 N 9.3360 2.3101 0.0 0
M  V30 7 C 10.6697 3.0801 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 5.3348 3.0801 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 5.3348 0.0000 0.0 0
M  V30 13 C 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 52178-50-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 922163-35-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-5039095
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: To a solution of an aldehyde (1 equiv) in
methanol was added an amine derivative (1 equiv). After stirring at room
temperature for 15 min, the solution was cooled to 0 °C prior to the
addition of sodium borohydride (0.5 equiv) portion wise. The resulting
solution was stirred at room temperature for 1 h. After the addition of
water (3 mL), methanol was removed under reduced pressure and the
resulting aqueous phase was extracted with DCM. The combined extracts
were dried over Na2SO4 and concentrated in vacuo to give 5-1 in
quantitative yield. Yield quantitative.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolylphenyl urea and carbamate compounds and analogs
as kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Feng, Yangbo; Lograsso, Philip; Schroeter, Thomas; Yin, Yan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010036316 A1 2010-04-01

$RFMT $RIREG SCHEME404 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl squarate
C8H10O4
5231-87-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.9014 2.2960 0.0 0
M  V30 2 C 7.2351 3.0661 0.0 0
M  V30 3 C 8.5687 2.2960 0.0 0
M  V30 4 O 2.3101 1.3337 0.0 0
M  V30 5 C 0.7700 1.3337 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 O 4.9390 5.8872 0.0 0
M  V30 8 O 1.3478 4.9250 0.0 0
M  V30 9 C 4.5676 3.0661 0.0 0
M  V30 10 C 3.0801 2.6673 0.0 0
M  V30 11 C 4.1690 4.5536 0.0 0
M  V30 12 C 2.6815 4.1550 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 5 6
M  V30 7 2 7 11
M  V30 8 2 8 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Bis(methylamino)-3-cyclobutene-1,2-dione
C6H8N2O2
52094-05-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 4.5536 0.0 0
M  V30 2 C 0.0000 4.5536 0.0 0
M  V30 3 N 5.1314 3.5914 0.0 0
M  V30 4 C 6.4651 2.8213 0.0 0
M  V30 5 O 0.5778 0.9622 0.0 0
M  V30 6 O 4.1690 0.0000 0.0 0
M  V30 7 C 2.3101 3.2199 0.0 0
M  V30 8 C 3.7976 2.8213 0.0 0
M  V30 9 C 1.9115 1.7322 0.0 0
M  V30 10 C 3.3990 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 8
M  V30 5 2 5 9
M  V30 6 2 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5231-87-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 52094-05-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8170194
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 3,4-Bis(Methylamino)cyclobut-3-ene-1,2-dione (13, R1 = R2 = MeNH).9h To a
stirred solution of diethyl squarate (115 mg, 0.68 mmol) in 20 mL THF was
added methylamine aqueous solution (40 wt% in water) (293 μL, 3.38 mmol).
The mixture was stirred at room temperature for 30 min and then some
white solid precipitated. After filteration the white solid was washed by
methanol carefully to afford the amide (97 mg) as a white powder
3,4-Bis(Methylamino)cyclobut-3-ene-1,2-dione (13, R1 = R2 = MeNH).9h ,
yield 100% 1H NMR (400 MHz, DMSO-d6, TMS): δ 3.36 (s, 6H). 13C NMR (100
MHz, DMSO-d6, TMS): δ 182.6, 168.4, 30.3. EIMS (m/z ) 140 (M+), 84, 69.
HREIMS, m/z calcd for C6H8N2O2 140.0586, found 140.0586. IR (KBr): 3177,
1650, 1594, 1490, 1402 cm-1. UV/vis (CH3CN) (λmax, ε) 289 nm (2.45 x104).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Amino Substituted Bisketenes: Generation, Structure, and Reactivity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fu, Nanyan; Allen, Annette D.; Kobayashi, Shinjiro; Tidwell, Thomas T.;
Vukovic, Sinisa; Arumugam, Selvananthan; Popik, Vladimir V.; Mishima,
Masaaki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2007), 72(6), 1951-1956

$RFMT $RIREG SCHEME405 STEP1
$RXN



  1  1
$MOL
Molybdate (MoO42-), (T-4)-, dihydrogen, compd. with methanamine (1:2)
CH5N.1/2H.1/4MoO4
52364-58-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Mo 1.5400 4.6200 0.0 0 CHG=-2 VAL=8
M  V30 2 O 0.0000 4.6200 0.0 0
M  V30 3 O 3.0800 4.6200 0.0 0
M  V30 4 O 1.5400 3.0800 0.0 0
M  V30 5 O 1.5400 6.1600 0.0 0
M  V30 6 H 1.5400 1.5400 0.0 0 CHG=1 VAL=-1
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 N 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 2 1 5
M  V30 5 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

CH5N.1/6H.1/36Mo7O24
3038328-00-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.3987 7.2226 0.0 0
M  V30 2 O 2.0973 10.4003 0.0 0
M  V30 3 O 3.1719 10.5197 0.0 0
M  V30 4 O 2.8118 3.0800 0.0 0
M  V30 5 O 1.2557 3.8715 0.0 0
M  V30 6 O 0.0000 5.8668 0.0 0
M  V30 7 O 0.0000 7.6617 0.0 0
M  V30 8 O 5.7681 10.4985 0.0 0
M  V30 9 O 4.5740 10.4908 0.0 0
M  V30 10 O 6.7406 3.8715 0.0 0
M  V30 11 O 5.1845 3.0800 0.0 0
M  V30 12 O 7.9097 5.8764 0.0 0
M  V30 13 O 7.9097 7.6733 0.0 0
M  V30 14 Mo 3.7170 6.7816 0.0 0 CHG=4 VAL=7
M  V30 15 O 2.8503 6.2096 0.0 0 CHG=-2 VAL=4
M  V30 16 O 5.1845 6.1518 0.0 0 CHG=-2 VAL=4
M  V30 17 O 3.7247 5.5163 0.0 0 CHG=-2 VAL=3
M  V30 18 O 3.7247 9.6550 0.0 0 CHG=-2 VAL=3
M  V30 19 O 2.3438 7.2419 0.0 0 CHG=-2 VAL=2
M  V30 20 Mo 2.8503 8.8577 0.0 0 CHG=2 VAL=8
M  V30 21 Mo 2.8118 4.7690 0.0 0 CHG=2 VAL=8
M  V30 22 Mo 1.5542 6.7642 0.0 0 CHG=2 VAL=8
M  V30 23 Mo 5.1845 8.8962 0.0 0 CHG=2 VAL=8
M  V30 24 Mo 5.1845 4.7690 0.0 0 CHG=2 VAL=8
M  V30 25 Mo 6.3535 6.7739 0.0 0 CHG=2 VAL=7
M  V30 26 O 4.2312 8.1759 0.0 0 CHG=-2 VAL=2
M  V30 27 O 1.5446 9.5395 0.0 0 CHG=-2 VAL=2
M  V30 28 O 4.0251 4.0699 0.0 0 CHG=-2 VAL=2
M  V30 29 O 1.5619 5.4989 0.0 0 CHG=-2 VAL=2
M  V30 30 O 6.3343 9.5395 0.0 0 CHG=-2 VAL=2
M  V30 31 O 6.3343 5.4508 0.0 0 CHG=-2 VAL=2
M  V30 32 H 3.9548 1.5400 0.0 0 CHG=1 VAL=-1
M  V30 33 C 3.1848 0.0000 0.0 0
M  V30 34 N 4.7248 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 2 2 20
M  V30 3 2 3 20
M  V30 4 2 4 21
M  V30 5 2 5 21
M  V30 6 2 6 22
M  V30 7 2 7 22
M  V30 8 2 8 23
M  V30 9 2 9 23
M  V30 10 2 10 24
M  V30 11 2 11 24
M  V30 12 2 12 25
M  V30 13 2 13 25
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 1 14 19
M  V30 19 1 15 20
M  V30 20 1 15 21
M  V30 21 1 15 22
M  V30 22 1 16 23
M  V30 23 1 16 24
M  V30 24 1 16 25
M  V30 25 1 17 21
M  V30 26 1 17 24
M  V30 27 1 18 20
M  V30 28 1 18 23
M  V30 29 1 19 22
M  V30 30 1 20 26
M  V30 31 1 20 27
M  V30 32 1 21 28
M  V30 33 1 21 29
M  V30 34 1 22 27
M  V30 35 1 22 29
M  V30 36 1 23 26
M  V30 37 1 23 30
M  V30 38 1 24 28
M  V30 39 1 24 31
M  V30 40 1 25 30
M  V30 41 1 25 31
M  V30 42 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 52364-58-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3038328-00-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41524000
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction carried out under air,product depend on reaction conditions
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure Transformation of Methylammonium Polyoxomolybdates via
In-Solution Acidification and Solid-State Heating from Methylammonium
Monomolybdate and Application as Negative Staining Reagents for
Coronavirus Observation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sukmana, Ndaru Candra; Sugiarto; Shinogi, Jun; Minato, Takuo; Kojima,
Tatsuhiro; Fujibayashi, Masaru; Nishihara, Sadafumi; Inoue, Katsuya; Cao,
Yu; Zhu, Tong; Ubukata, Hiroki; Higashiura, Akifumi; Yamamoto, Akima;
Tassel, Cedric; Kageyama, Hiroshi; Sakaguchi, Takemasa; Sadakane,
Masahiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Inorganic Chemistry (2024), 63(22), 10207-10220

$RFMT $RIREG SCHEME406 STEP1
$RXN



  1  1
$MOL
Molybdate (MoO42-), (T-4)-, dihydrogen, compd. with methanamine (1:2)
CH5N.1/2H.1/4MoO4
52364-58-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Mo 1.5400 4.6200 0.0 0 CHG=-2 VAL=8
M  V30 2 O 0.0000 4.6200 0.0 0
M  V30 3 O 3.0800 4.6200 0.0 0
M  V30 4 O 1.5400 3.0800 0.0 0
M  V30 5 O 1.5400 6.1600 0.0 0
M  V30 6 H 1.5400 1.5400 0.0 0 CHG=1 VAL=-1
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 N 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 2 1 5
M  V30 5 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

CH5N.1/4H.1/16Mo8O26
3038328-03-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 47 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6887 8.5348 0.0 0
M  V30 2 O 2.9054 5.6820 0.0 0
M  V30 3 O 4.8768 3.6258 0.0 0
M  V30 4 O 6.6092 4.2835 0.0 0
M  V30 5 O 7.5669 7.1415 0.0 0
M  V30 6 O 2.6494 10.9114 0.0 0
M  V30 7 O 0.9187 10.2537 0.0 0
M  V30 8 O 0.0000 7.3381 0.0 0
M  V30 9 O 5.4989 11.3267 0.0 0
M  V30 10 O 6.5787 10.1910 0.0 0
M  V30 11 O 3.9648 10.9927 0.0 0
M  V30 12 O 2.1375 3.0800 0.0 0
M  V30 13 O 1.0086 4.2293 0.0 0
M  V30 14 O 3.6970 3.5038 0.0 0
M  V30 15 Mo 4.5107 8.0466 0.0 0 CHG=4 VAL=7
M  V30 16 O 4.5107 6.4516 0.0 0 CHG=-2 VAL=4
M  V30 17 O 3.0546 8.0466 0.0 0 CHG=-2 VAL=4
M  V30 18 O 3.7631 9.4621 0.0 0 CHG=-2 VAL=3
M  V30 19 O 6.0261 8.6755 0.0 0 CHG=-2 VAL=3
M  V30 20 O 5.2396 6.3939 0.0 0 CHG=-2 VAL=2
M  V30 21 Mo 3.0546 6.4516 0.0 0 CHG=4 VAL=7
M  V30 22 Mo 5.2396 5.0751 0.0 0 CHG=2 VAL=8
M  V30 23 Mo 6.0261 7.1415 0.0 0 CHG=4 VAL=6
M  V30 24 Mo 2.2867 9.4621 0.0 0 CHG=2 VAL=8
M  V30 25 Mo 1.5392 7.3381 0.0 0 CHG=4 VAL=6
M  V30 26 Mo 5.0616 9.8960 0.0 0 VAL=9
M  V30 27 O 3.6852 5.0751 0.0 0 CHG=-2 VAL=3
M  V30 28 O 1.5392 5.8430 0.0 0 CHG=-2 VAL=3
M  V30 29 O 2.2867 8.1043 0.0 0 CHG=-2 VAL=2
M  V30 30 O 6.0261 6.0396 0.0 0 CHG=-2 VAL=2
M  V30 31 O 5.0616 8.6365 0.0 0 CHG=-2 VAL=2
M  V30 32 O 1.5392 8.6162 0.0 0 CHG=-2 VAL=2
M  V30 33 O 2.5240 5.8040 0.0 0 CHG=-2 VAL=2
M  V30 34 Mo 2.5240 4.5242 0.0 0 VAL=9
M  V30 35 H 3.7835 1.5400 0.0 0 CHG=1 VAL=-1
M  V30 36 C 3.0135 0.0000 0.0 0
M  V30 37 N 4.5535 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 15
M  V30 2 2 2 21
M  V30 3 2 3 22
M  V30 4 2 4 22
M  V30 5 2 5 23
M  V30 6 2 6 24
M  V30 7 2 7 24
M  V30 8 2 8 25
M  V30 9 2 9 26
M  V30 10 2 10 26
M  V30 11 2 11 26
M  V30 12 2 12 34
M  V30 13 2 13 34
M  V30 14 2 14 34
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 18
M  V30 18 1 15 19
M  V30 19 1 15 20
M  V30 20 1 16 21
M  V30 21 1 16 22
M  V30 22 1 16 23
M  V30 23 1 17 21
M  V30 24 1 17 24
M  V30 25 1 17 25
M  V30 26 1 18 24
M  V30 27 1 18 26
M  V30 28 1 19 23
M  V30 29 1 19 26
M  V30 30 1 20 22
M  V30 31 1 21 27
M  V30 32 1 21 28
M  V30 33 1 21 29
M  V30 34 1 22 27
M  V30 35 1 22 30
M  V30 36 1 23 30
M  V30 37 1 23 31
M  V30 38 1 24 29
M  V30 39 1 24 32
M  V30 40 1 25 28
M  V30 41 1 25 32
M  V30 42 1 25 33
M  V30 43 1 26 31
M  V30 44 1 27 34
M  V30 45 1 28 34
M  V30 46 1 33 34
M  V30 47 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 52364-58-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3038328-03-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41524001
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions also shown,reaction carried out under
air,product depend on reaction conditions
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure Transformation of Methylammonium Polyoxomolybdates via
In-Solution Acidification and Solid-State Heating from Methylammonium
Monomolybdate and Application as Negative Staining Reagents for
Coronavirus Observation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sukmana, Ndaru Candra; Sugiarto; Shinogi, Jun; Minato, Takuo; Kojima,
Tatsuhiro; Fujibayashi, Masaru; Nishihara, Sadafumi; Inoue, Katsuya; Cao,
Yu; Zhu, Tong; Ubukata, Hiroki; Higashiura, Akifumi; Yamamoto, Akima;
Tassel, Cedric; Kageyama, Hiroshi; Sakaguchi, Takemasa; Sadakane,
Masahiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Inorganic Chemistry (2024), 63(22), 10207-10220

$RFMT $RIREG SCHEME407 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-phenylacetamide
C8H8BrNO
5326-87-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 C 6.6685 3.0800 0.0 0
M  V30 4 O 5.3347 0.7700 0.0 0
M  V30 5 Br 8.0021 2.3100 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 1.3336 3.0800 0.0 0
M  V30 8 C 2.6674 0.7700 0.0 0
M  V30 9 C 0.0000 2.3100 0.0 0
M  V30 10 C 1.3336 0.0000 0.0 0
M  V30 11 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Methylamino)-N-phenylacetamide
C9H12N2O
31110-53-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 3.0800 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 C 6.6684 3.0800 0.0 0
M  V30 4 O 5.3348 0.7700 0.0 0
M  V30 5 N 8.0022 2.3100 0.0 0
M  V30 6 C 9.3359 3.0800 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 1.3337 3.0800 0.0 0
M  V30 9 C 2.6675 0.7700 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 1.3337 0.0000 0.0 0
M  V30 12 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5326-87-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 31110-53-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-16813552
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 3-Amino-2-carboxamide Tetrahydropyrrolo[2,3-b]quinolines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pilkington, Lisa I.; Haverkate, Natalie A.; van Rensburg, Michelle;
Reynisson, Johannes; Leung, Euphemia; Barker, David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2016), 27(20), 2811-2814

$RFMT $RIREG SCHEME408 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-chloro-3-nitrobenzoate
C8H6ClNO4
53553-14-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 3.0800 0.0 0
M  V30 2 O 8.0022 2.3100 0.0 0
M  V30 3 O 6.6684 4.6201 0.0 0
M  V30 4 C 9.3359 3.0800 0.0 0
M  V30 5 Cl 4.0011 4.6201 0.0 0
M  V30 6 N 1.3337 3.0800 0.0 0 VAL=5
M  V30 7 O 1.3337 4.6201 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 C 5.3348 2.3100 0.0 0
M  V30 10 C 4.0011 3.0800 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6675 2.3100 0.0 0
M  V30 13 C 4.0011 0.0000 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-(methylamino)-3-nitro-, methyl ester
C9H10N2O4
913297-15-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 4.6201 0.0 0
M  V30 2 C 2.6675 5.3901 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 O 8.0023 2.3101 0.0 0
M  V30 5 O 6.6685 4.6201 0.0 0
M  V30 6 C 9.3360 3.0801 0.0 0
M  V30 7 N 1.3337 3.0801 0.0 0 VAL=5
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 15 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 12
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 53553-14-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 913297-15-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4426421
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM ii) Methyl 2-methylamino-3-nitrobenzoate A solution of methyl
2-chloro-3-nitrobenzoate (21.5 g, 99.5 mmol) in tetrahydrofuran (300 mL)
was treated with dropwise addition of methylamine (2M solution in THF,
300 mL, 597 mmol) and was stirred overnight at room temperature. The
reaction mixture was concentrated in vacuo, dissolved in dichloromethane
and washed with aqueous sodium bicarbonate solution and water. The
organics were dried over anhydrous sodium sulfate, filtered, and
concentrated in vacuo to give the title compound (20.8 g, 100%). 1H NMR
(CDCl3) δ 2.82 (d, J=5.5 Hz, 3H), 3.9 (s, 3H), 6.65 (t, J=7.8 Hz, 1H),
7.97 (d, J=8.2 Hz, 1H), 8.04 (J=7.8 Hz, 1H), 8.57 (s, 1H). MS Calcd.:
210; Found: 211 (M+H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzimidazole derivatives as CRF receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aso, Kazuyoshi; Mochizuki, Michiyo; Kojima, Takuto; Kobayashi, Katsumi;
Pratt, Scott Alan; Gyorkos, Albert Charles; Corrette, Christopher Peter;
Cho, Suk Young
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008051533 A2 2008-05-02

$RFMT $RIREG SCHEME408 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-chloro-3-nitrobenzoate
C8H6ClNO4
53553-14-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 3.0800 0.0 0
M  V30 2 O 8.0022 2.3100 0.0 0
M  V30 3 O 6.6684 4.6201 0.0 0
M  V30 4 C 9.3359 3.0800 0.0 0
M  V30 5 Cl 4.0011 4.6201 0.0 0
M  V30 6 N 1.3337 3.0800 0.0 0 VAL=5
M  V30 7 O 1.3337 4.6201 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 C 5.3348 2.3100 0.0 0
M  V30 10 C 4.0011 3.0800 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6675 2.3100 0.0 0
M  V30 13 C 4.0011 0.0000 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-(methylamino)-3-nitro-, methyl ester
C9H10N2O4
913297-15-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 4.6201 0.0 0
M  V30 2 C 2.6675 5.3901 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 O 8.0023 2.3101 0.0 0
M  V30 5 O 6.6685 4.6201 0.0 0
M  V30 6 C 9.3360 3.0801 0.0 0
M  V30 7 N 1.3337 3.0801 0.0 0 VAL=5
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 15 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 12
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 53553-14-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 913297-15-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-5351645
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Methyl 2-Methylamino-3-nitrobenzoate A solution of 21.5 g (99.5 mmol) of
methyl 2-chloro-3-nitrobenzoate in 300 mL of tetrahydrofuran (THF) was
treated with drop wise addition of 300 mL (597 mmol) of methylamine (2M
solution in THF) and was stirred overnight at room temperature. The
reaction was concentrated to dryness, dissolved in dichloromethane, and
washed with aqueous sodium bicarbonate and water. The organics were dried
over sodium sulfate, filtered, and concentrated in vacuo to give 20.8 g
(100%) of the title compound. 1H NMR (CDCl3) δ 2.82 (d, J = 5.5 Hz, 3H),
3.9 (s, 3H), 6.65 (t, J = 7.8 Hz, 1H), 7.97 (d, J = 8.2 Hz, 1H), 8.04 (J
= 7.8 Hz, 1H), 8.57 (s, 1H). MS Calcd.: 210; Found: 211(M+H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused heterocyclic compounds like benzimidazoles as CRF
receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gyorkos, Albert; Corrette, Christopher; Cho, Suk; Pratt, Scott; Siedem,
Christopher; Aso, Kazuyoshi; Gyoten, Michiyo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006116412 A2 2006-11-02

$RFMT $RIREG SCHEME409 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromoveratraldehyde
C9H9BrO3
5392-10-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 0.7700 0.0 0
M  V30 2 C 2.6675 0.0000 0.0 0
M  V30 3 O 6.6687 2.3101 0.0 0
M  V30 4 C 8.0023 3.0801 0.0 0
M  V30 5 C 1.3337 5.3901 0.0 0
M  V30 6 O 0.0000 4.6201 0.0 0
M  V30 7 Br 4.0012 6.9302 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 5.3348 3.0801 0.0 0
M  V30 10 C 2.6675 3.0801 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 4.0012 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 2 5 6
M  V30 6 1 5 12
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2-Bromo-4,5-dimethoxyphenyl)methylene]methanamine
C10H12BrNO2
89525-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 0.7700 0.0 0
M  V30 2 C 5.3348 0.0000 0.0 0
M  V30 3 O 1.3337 2.3101 0.0 0
M  V30 4 C 0.0000 3.0801 0.0 0
M  V30 5 C 6.6685 5.3901 0.0 0
M  V30 6 N 8.0023 4.6201 0.0 0
M  V30 7 C 9.3360 5.3901 0.0 0
M  V30 8 Br 4.0012 6.9302 0.0 0
M  V30 9 C 4.0012 2.3101 0.0 0
M  V30 10 C 2.6675 3.0801 0.0 0
M  V30 11 C 5.3348 3.0801 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 4.0012 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6 CFG=2
M  V30 6 1 5 13
M  V30 7 1 6 7
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5392-10-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 89525-44-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-15311783
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Protecting-Group-Free Total Synthesis of Isoquinoline Alkaloids by
Nickel-Catalyzed Annulation of o-Halobenzaldimine with an Alkyne as the
Key Step
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Korivi, Rajendra Prasad; Cheng, Chien-Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2010), 16(1), 282-287, S282/1-S282/30

$RFMT $RIREG SCHEME410 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzyl acetoacetate
C11H12O3
5396-89-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 O 6.6685 4.6201 0.0 0
M  V30 6 C 9.3360 3.0801 0.0 0
M  V30 7 C 9.3360 4.6201 0.0 0
M  V30 8 O 10.6697 2.3101 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 C 1.3337 3.0801 0.0 0
M  V30 11 C 2.6673 0.7700 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 1.3337 0.0000 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 3-(methylamino)-2-butenoate
C12H15NO2
61312-70-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 C 8.0022 2.3101 0.0 0
M  V30 5 O 6.6685 4.6201 0.0 0
M  V30 6 C 9.3360 3.0801 0.0 0
M  V30 7 N 10.6697 2.3101 0.0 0
M  V30 8 C 9.3360 4.6201 0.0 0
M  V30 9 C 12.0033 3.0801 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 C 2.6673 0.7700 0.0 0
M  V30 12 C 1.3337 3.0801 0.0 0
M  V30 13 C 1.3337 0.0000 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 4 6 CFG=2
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5396-89-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 61312-70-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-14430304
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a solution of benzyl acetoacetate (57.6 g, 300 mmol) in MeOH (50 mL)
in a 350 mL pressure vessel was added H2NMe (150 mL of a 2M solution in
MeOH, 300 mmol) and acetic acid (2 mL). The capped vessel was placed in
an oil bath at 70 °C and the reaction mixture was stirred for 16 hours.
After the mixture had cooled to room temperature, the solvent was
evaporated in vacuo leaving a yellow emulsion, which was dissolved in
EtOAc (500 mL) and MgSO4 was added to remove water. The drying agent was
filtered off, and the solvent evaporated in vacuo. Which was used without
further purification. benzyl 3-(Methylamino)but-2-enoate, Yield: 60 g,
quantitative, viscous yellow oil.
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a pressure vessel
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrrolo[2,3-d]pyrimidine derivatives as inhibitors of tropomyosin-related
kinases and their preparation and use in the treatment of pain
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Andrews, Mark David; Bagal, Sharanjeet Kaur; Gibson, Karl Richard; Omoto,
Kiyoyuki; Ryckmans, Thomas; Skerratt, Sarah Elizabeth; Stupple, Paul
Anthony
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012137089 A1 2012-10-11

$RFMT $RIREG SCHEME411 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Dichloroisonicotinic acid
C6H3Cl2NO2
5398-44-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.6200 0.0 0
M  V30 2 O 6.6685 3.8500 0.0 0
M  V30 3 O 5.3347 6.1600 0.0 0
M  V30 4 Cl 0.0000 4.6200 0.0 0
M  V30 5 Cl 2.6674 0.0000 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 N 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-6-(methylamino)-4-pyridinecarboxylic acid
C7H7ClN2O2
56835-92-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 4.6201 0.0 0
M  V30 2 O 1.3337 6.1601 0.0 0
M  V30 3 O 0.0000 3.8500 0.0 0
M  V30 4 N 6.6686 4.6201 0.0 0
M  V30 5 C 8.0022 3.8500 0.0 0
M  V30 6 Cl 4.0011 0.0000 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 4.0011 4.6201 0.0 0
M  V30 9 C 2.6675 2.3100 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 11 C 4.0011 1.5400 0.0 0
M  V30 12 N 5.3348 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5398-44-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 56835-92-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-12543526
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step A: methylamine coupling To a solution of 2,6-dichloroisonicotinic
acid (25 g, 130.2 mmol) in 52 mL water was added 60 mL of 40% methylamine
in water. Reaction heated to reflux at 100°C. After 16 h, reaction was
cooled to rt. Reaction was acidified with 1N HCl (200 mL) and extracted
with EtOAc (300 mL x 4). The combined organics were washed with brine
(150 mL), dried over Mg2SO4, filtered, and concentrated in vacuo to give
24.2 g (100%) of 2-chloro-6-(methylamino)isonicotinic acid as a brown
solid. 2-chloro-6-(methylamino)isonicotinic acid, yield 24.2 g (100%)
LC/MS [M+H]+ = 187.0.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 2,3,4,6-substituted pyridinyl derivatives as β-secretase
inhibitors for treating Alzheimer's disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nantermet, Philippe G.; Stanton, Matthew G.; Rajapakse, Hemaka A.;
Selnick, Harold G.; Barrow, James C.; Stauffer, Shaun R.; Vacca, Joseph
P.; Moore, Keith P.; Stachel, Shawn J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006057945 A2 2006-06-01

$RFMT $RIREG SCHEME412 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Amino-4,6-dichloropyrimidine
C4H3Cl2N3
5413-85-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6674 0.0000 0.0 0
M  V30 2 Cl 0.0000 1.5400 0.0 0
M  V30 3 Cl 5.3349 1.5400 0.0 0
M  V30 4 C 2.6674 1.5400 0.0 0
M  V30 5 C 1.3338 2.3100 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 N 1.3338 3.8500 0.0 0
M  V30 8 N 4.0011 3.8500 0.0 0
M  V30 9 C 2.6674 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 6
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N4-methyl-4,5-pyrimidinediamine
C5H7ClN4
52602-68-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 C 6.6686 2.3100 0.0 0
M  V30 3 N 2.6675 0.0000 0.0 0
M  V30 4 Cl 0.0000 1.5400 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 1.5400 0.0 0
M  V30 7 N 4.0011 3.8500 0.0 0
M  V30 8 C 1.3338 2.3100 0.0 0
M  V30 9 C 2.6675 4.6201 0.0 0
M  V30 10 N 1.3338 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5413-85-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 52602-68-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-15582461
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-36-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification of HCV inhibitors from a cell-based sub-genomic replicon
screen
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pryde, David C.; Tran, Thien-Duc; Gardner, Mark; Pickford, Chris; Shaw,
Stephen M.; Westby, Mike; Parkinson, Tanya; Smith-Burchnell, Caroline;
Macartney, Malcolm; Tatlock, John H.; Duggal, Rohit; Patel, Leena B.;
Jewell, Tanya M.; Sutton, Scott C.; Tran, Tin H.; Hao, Weidong; Webster,
Rob; Dayalm, Satish
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Open Journal of Medicinal Chemistry (2013), 3(1), 16-25

$RFMT $RIREG SCHEME413 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,4-Dimethoxy-2-butanone
C6H12O3
5436-21-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6674 0.0 0
M  V30 2 C 3.8500 2.6674 0.0 0
M  V30 3 O 1.5400 1.3338 0.0 0
M  V30 4 O 1.5400 4.0011 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 2.3100 0.0000 0.0 0
M  V30 7 C 0.0000 4.0011 0.0 0
M  V30 8 C 6.1600 4.0011 0.0 0
M  V30 9 O 3.8500 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3E)-4-(Methylamino)-3-buten-2-one
C5H9NO
50874-62-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 O 1.3338 0.0000 0.0 0
M  V30 6 N 5.3348 2.3100 0.0 0
M  V30 7 C 6.6686 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5436-21-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 50874-62-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-6696428
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (E)-4-(Dimethylamino)but-3-en-2-one (18). To acetylacetaldehyde dimethyl
acetal (5.30 mL, 37.8 mmol), freshly distilled prior to use (bp 67 °C, 12
mm Hg), was added a solution of methylamine (2 M solution in methanol,
21.0 mL, 42.7 mmol) in one portion. The reaction mixture was stirred at
room temperature for 12 h, and concentrated under reduced pressure. The
resulting oil was purified by bulb-to-bulb distillation (0.25 mm, oven
temperature 80-95°C) to afford 18 (3.75 g, 100%) as a light-yellow oil:
(E)-4-(Dimethylamino)but-3-en-2-one (18), yield (3.75 g, 100%). 1H NMR
(300 MHz, CDCl3) δ 9.8-9.6 (br, 1 H), 6.60 (dd, 1 H, J = 12.9, 7.2 Hz),
4.97 (d, 1 H, J = 7.2 Hz), 2.95 (d, 3 H, J = 13.0 Hz), 2.02 (s, 3 H).
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total Synthesis of (±)-Cycloclavine and (±)-5-epi-Cycloclavine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Petronijevic, Filip R.; Wipf, Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2011), 133(20), 7704-7707

$RFMT $RIREG SCHEME414 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-(2-chlorophenyl)acetamide
C8H7BrClNO
5439-11-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 O 5.3347 3.8500 0.0 0
M  V30 5 Br 8.0021 2.3100 0.0 0
M  V30 6 Cl 1.3336 0.0000 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 C 2.6674 3.8500 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 1.3336 4.6200 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 8
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Chlorophenyl)-2-(methylamino)acetamide
C9H11ClN2O
731827-18-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 C 6.6684 1.5400 0.0 0
M  V30 4 O 5.3347 3.8500 0.0 0
M  V30 5 N 8.0021 2.3100 0.0 0
M  V30 6 C 9.3358 1.5400 0.0 0
M  V30 7 Cl 1.3336 0.0000 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 1.3336 4.6200 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 9
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5439-11-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 731827-18-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-16814484
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 3-Amino-2-carboxamide Tetrahydropyrrolo[2,3-b]quinolines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pilkington, Lisa I.; Haverkate, Natalie A.; van Rensburg, Michelle;
Reynisson, Johannes; Leung, Euphemia; Barker, David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2016), 27(20), 2811-2814

$RFMT $RIREG SCHEME415 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-3-nitropyridine
C5H3ClN2O2
5470-18-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 N 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-nitro-2-pyridinamine
C6H7N3O2
4093-88-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 1.3338 0.0 0
M  V30 2 C 6.1600 1.3338 0.0 0
M  V30 3 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 N 4.6200 4.0011 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5470-18-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4093-88-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-13047282
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-86-4
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Imidoyl dichlorides as new reagents for the rapid formation of
2-aminobenzimidazoles and related azoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pollock, Julie A.; Kim, Sung Hoon; Katzenellenbogen, John A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2015), 56(44), 6097-6099

$RFMT $RIREG SCHEME416 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tulipalin A
C5H6O2
547-65-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.2459 0.0000 0.0 0
M  V30 2 O 3.9563 1.9692 0.0 0
M  V30 3 C 1.2459 1.5400 0.0 0
M  V30 4 C 2.4917 2.4452 0.0 0
M  V30 5 C 0.0000 2.4452 0.0 0
M  V30 6 O 2.0159 3.9098 0.0 0
M  V30 7 C 0.4759 3.9098 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 3
M  V30 2 2 2 4
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2(3H)-Furanone, dihydro-3-[(methylamino)methyl]-
C6H11NO2
2921613-11-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7709 1.3627 0.0 0
M  V30 2 N 5.1047 2.1327 0.0 0
M  V30 3 C 6.4383 1.3627 0.0 0
M  V30 4 O 0.7102 0.0000 0.0 0
M  V30 5 C 2.4373 2.1327 0.0 0
M  V30 6 C 1.0306 1.5064 0.0 0
M  V30 7 C 2.2764 3.6642 0.0 0
M  V30 8 O 0.0000 2.6508 0.0 0
M  V30 9 C 0.7700 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 2 4 6
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 547-65-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2921613-11-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36435630
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyridazinyl amino derivatives as ALK5 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pizzirani, Daniela; Ronchi, Paolo; Guariento, Sara; Pala, Daniele; Bruno,
Paolo; Semeraro, Teresa; Rescigno, Donatella
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023046698 A1 2023-03-30

$RFMT $RIREG SCHEME417 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-hydroxybenzophenone
C13H9BrO2
55082-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6200 0.0 0
M  V30 2 O 4.0011 6.1600 0.0 0
M  V30 3 O 1.3336 6.1600 0.0 0
M  V30 4 Br 1.3336 0.0000 0.0 0
M  V30 5 C 2.6674 3.8500 0.0 0
M  V30 6 C 1.3336 4.6200 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 0.0000 3.8500 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 5.3347 3.8500 0.0 0
M  V30 12 C 5.3347 2.3100 0.0 0
M  V30 13 C 6.6685 4.6200 0.0 0
M  V30 14 C 6.6685 1.5400 0.0 0
M  V30 15 C 8.0021 3.8500 0.0 0
M  V30 16 C 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 1 11
M  V30 4 1 3 6
M  V30 5 1 4 9
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-[(methylamino)phenylmethyl]phenol
C14H14BrNO
1629197-08-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6200 0.0 0
M  V30 2 N 4.0011 6.1600 0.0 0
M  V30 3 C 5.3347 6.9300 0.0 0
M  V30 4 O 1.3336 6.1600 0.0 0
M  V30 5 Br 1.3336 0.0000 0.0 0
M  V30 6 C 2.6674 3.8500 0.0 0
M  V30 7 C 1.3336 4.6200 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 0.0000 3.8500 0.0 0
M  V30 10 C 1.3336 1.5400 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 5.3347 3.8500 0.0 0
M  V30 13 C 6.6685 4.6200 0.0 0
M  V30 14 C 5.3347 2.3100 0.0 0
M  V30 15 C 8.0021 3.8500 0.0 0
M  V30 16 C 6.6685 1.5400 0.0 0
M  V30 17 C 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 1 12
M  V30 4 1 2 3
M  V30 5 1 4 7
M  V30 6 1 5 10
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 55082-33-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1629197-08-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-11797722
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 104-15-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM molecular sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of dihydroquinazolinone analogues as BRD4 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Smethurst, Christian; Engelhardt, Harald; Gianni, Davide; Reiser, Ulrich
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014154762 A1 2014-10-02

$RFMT $RIREG SCHEME418 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Nitrobenzaldehyde
C7H5NO3
552-89-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 1.3338 0.0 0
M  V30 2 O 6.1600 1.3338 0.0 0
M  V30 3 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2-Nitrophenyl)methylene]methanamine
C8H8N2O2
57707-11-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 4.0011 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0011 0.0 0
M  V30 3 O 2.3100 5.3349 0.0 0
M  V30 4 C 4.6200 4.0011 0.0 0
M  V30 5 N 6.1600 4.0011 0.0 0
M  V30 6 C 6.9300 5.3349 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 1.5400 1.3338 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 2 4 5 CFG=2
M  V30 5 1 4 8
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 552-89-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 57707-11-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-8051848
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7487-88-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituent-Controlled Annuloselectivity and Stereoselectivity in the
Sulfa-Staudinger Cycloadditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhanhui; Chen, Ning; Xu, Jiaxi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2015), 80(7), 3611-3620

$RFMT $RIREG SCHEME419 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrobenzaldehyde
C7H5NO3
555-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 C 6.6687 4.6201 0.0 0
M  V30 5 O 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Nitrophenyl)methylene]methanamine
C8H8N2O2
877-80-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 C 6.6685 4.6201 0.0 0
M  V30 5 N 8.0023 3.8501 0.0 0
M  V30 6 C 9.3360 4.6201 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 2.6675 3.8501 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 2 4 5 CFG=2
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 555-16-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 877-80-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-15885541
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7487-88-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Four-Electron Electrocyclic Ring-Opening/Intermolecular [4+2]
Cycloadditions of α-Hydroxycyclobutenones: Stereoselective Synthesis of
Multiple Substituted δ-Lactams
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Song, Peidong; Li, Qing; Wang, Congcong; Wu, Wenfa; Mao, Xu; Wang,
Jiajia; Hu, Xiangdong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2016), 358(8), 1208-1212

$RFMT $RIREG SCHEME419 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrobenzaldehyde
C7H5NO3
555-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 C 6.6687 4.6201 0.0 0
M  V30 5 O 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Nitrophenyl)methylene]methanamine
C8H8N2O2
877-80-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 C 6.6685 4.6201 0.0 0
M  V30 5 N 8.0023 3.8501 0.0 0
M  V30 6 C 9.3360 4.6201 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 2.6675 3.8501 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 2 4 5 CFG=2
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 555-16-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 877-80-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-076-CAS-3779387
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7487-88-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituent-Controlled Annuloselectivity and Stereoselectivity in the
Sulfa-Staudinger Cycloadditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhanhui; Chen, Ning; Xu, Jiaxi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2015), 80(7), 3611-3620

